Psyllid ID: psy13735

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790--
Protein Sequence
KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSDSTLPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDILSHDNEQLR
Secondary Structure (PSIPRED)
cHHHHHHHHcccccccccEEEccccccccEEEEEEEEccccEEEEEccccccHHHHHHHHHHHcccccccccccccccccccEEEEEccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEccccccccccccccccccccccccccccHHHHHHcccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHHccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHccccHHHcEEEEEEccccccEEEEEEEcccccEEEHHHHcHHHHHHHHHHHHHHccccccEEEEEEEEcccccEEEEEEccccHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccccHHHHcHHHHHHcccccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHccHHHcccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHcccHHHcc
Coil and Loop (DISEMBL)
KDVVKELrqknvsasdfdIKRFIqqgnfgdiyLVEEKQSHNTFVMKKVLREkmpntierDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVtggdfvtllenqphgylseskARFYIYELAQAVQYLHGlgyvhrdikpdnmllsatghlkltdfgsatqvdkngriksivpvgtpeyvapevlewmegnhgsdgytgscdlWSIGVVSYElltgstpfnyetldMTYSsilacdtedtvsfpssiRLSTAMVNFVQSLVQKLDARlnmdqvlghpvfdcldsdppcipppsqenkfhkkdkrkaspslkAFQKegryldsalpligisytgepmgantntssdstlppssedmrHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEkenlektddrkLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSlfkdpqpaqsKLEKAEGELTTVREENKKLKVSFFFTlesnslfwldpntflssLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDILSHDNEQLR
Flexible Loop (DISEMBL)
kdvvkelrqknvsasdfdikrfiQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFgsatqvdkngriksivpvgtpEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPsqenkfhkkdkrkaspslkafqkegryLDSALPLIGISYTGEPMGantntssdstlppsSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVsslqqdltshtsllskkeeeIDRLRQEMvkkesdlvatssdlvatrheleevrselkekenlektddrklevcevskelevlrgeleeqktatkqwkkdWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVRemsgisekyekdRKTLLElksakerlelevrgykldlestrreletnkdqtielraksklekaegelttvreenkklkqgkirlvyslfkdpqpaqsklekaegelttvreenkkLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTEresklrsaneiigeyetKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNeqlrkknndilshdneqlr
Low Complexity Region (SEG)
KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSDSTLPPSSEDMRHWKRDRlqllqqlAEAKASLEDLSCSRTRvlalqaqvsslqqdlTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDILSHDNEQLR
Disordered region (IsUnstruct)
***************DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD***********************************YLDSALPLIGISY*****************************************************RVLA****************************************************************************************************WKKDWY**************************************************************************************************************************************************************IRLVYSLF*************************KLKVSFFFTLESNSLFWLDPNTFLSSLE*****************EIIGEYETKITALE*******SYCKEMVEYLETL******************************
Disordered Region (DISOPRED)
***********VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDK*********************PLIGISYTGE****************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************
Disordered Region (DISEMBL)
KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQ**************SLKAFQKEGRYLDSALPLIGISYTGEPMGAN***************MRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQ***********TSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEE*********KDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESM************EMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDILSHDNEQLR
Disordered Region (DISPRO)
KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGA***********PSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDILS*******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSDSTLPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDxxxxxxxxxxxxxxxxxxxxxxxxxxxxLVATSSDxxxxxxxxxxxxxxxxxxxxxEKTDDRKLEVCEVSKExxxxxxxxxxxxxxxxxxxxxWYQSVKExxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxVREMSGISEKxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxLETNKDQTIxxxxxxxxxxxxxxxxxxxxxxxxxxxxKIRLVYSLFKDPQPAQSKxxxxxxxxxxxxxxxxxxxxxFFFTLESNSLFWLDPNTFLSSxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxMTRSESYCKEMVEYxxxxxxxxxxxxxxxxxxxxxNNDILSHDNEQLR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	792	2.2.26 [Sep-21-2011]
O14578	2027	Citron Rho-interacting ki	yes	N/A	0.632	0.247	0.289	8e-64
O75116	1388	Rho-associated protein ki	no	N/A	0.405	0.231	0.342	3e-60
P70336	1388	Rho-associated protein ki	yes	N/A	0.751	0.428	0.289	1e-59
Q7TT50	1713	Serine/threonine-protein	no	N/A	0.845	0.391	0.288	1e-59
Q9Y5S2	1711	Serine/threonine-protein	no	N/A	0.681	0.315	0.300	2e-59
Q13464	1354	Rho-associated protein ki	no	N/A	0.421	0.246	0.328	2e-59
O77819	1354	Rho-associated protein ki	no	N/A	0.412	0.241	0.335	3e-59
Q7TT49	1713	Serine/threonine-protein	no	N/A	0.851	0.393	0.283	4e-59
Q28021	1388	Rho-associated protein ki	no	N/A	0.405	0.231	0.34	5e-59
Q80UW5	1551	Serine/threonine-protein	no	N/A	0.675	0.344	0.293	6e-59

>sp|O14578|CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens GN=CIT PE=1 SV=2

 Score =  245 bits (626), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 160/553 (28%), Positives = 290/553 (52%), Gaps = 52/553 (9%)

Query: 2   DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE--- 58
           D + EL++   SA DF+++  +  G+F ++ +V EK + + + MK V+++K     E   
Sbjct: 82  DTIAELQELQPSAKDFEVRSLVGCGHFAEVQVVREKATGDIYAMK-VMKKKALLAQEQVS 140

Query: 59  -----RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
                R+I+ +S  P+I  L Y+FQD NH+Y +MEY  GGD ++LL N+    L E+  +
Sbjct: 141 FFEEERNILSRSTSPWIPQLQYAFQDKNHLYLVMEYQPGGDLLSLL-NRYEDQLDENLIQ 199

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY+ EL  AV  +H +GYVHRDIKP+N+L+  TGH+KL DFGSA +++ N  + + +P+G
Sbjct: 200 FYLAELILAVHSVHLMGYVHRDIKPENILVDRTGHIKLVDFGSAAKMNSNKMVNAKLPIG 259

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TP+Y+APEVL  M G+ G   Y   CD WS+GV++YE++ G +PF   T   T+++I+  
Sbjct: 260 TPDYMAPEVLTVMNGD-GKGTYGLDCDWWSVGVIAYEMIYGRSPFAEGTSARTFNNIM-- 316

Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD------SDPPCI 287
           + +  + FP   ++S+  ++ +QSL+     RL  + +  HP F  +D      S PP +
Sbjct: 317 NFQRFLKFPDDPKVSSDFLDLIQSLLCGQKERLKFEGLCCHPFFSKIDWNNIRNSPPPFV 376

Query: 288 PPPSQEN---KFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGE--PMGANTNTSS 342
           P    ++    F + +K     S         +    LP +G SY+     +G + +  S
Sbjct: 377 PTLKSDDDTSNFDEPEKNSWVSSSPCQLSPSGFSGEELPFVGFSYSKALGILGRSESVVS 436

Query: 343 DSTLPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHT 402
               P  +  M           ++L      L+D   S+ +   ++ +++ L + ++   
Sbjct: 437 GLDSPAKTSSME----------KKLLIKSKELQD---SQDKCHKMEQEMTRLHRRVSEVE 483

Query: 403 SLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLE 462
           ++LS+KE E+     +    E DL    ++  + +  LE+ R E+ ++      DD+ L+
Sbjct: 484 AVLSQKEVELKASETQRSLLEQDLATYITECSSLKRSLEQARMEVSQE------DDKALQ 537

Query: 463 VC----EVSKELEVLR-----GELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENE 513
           +     E S++L+ ++      ++EE +    Q ++D   + +  +   +EL++++   E
Sbjct: 538 LLHDIREQSRKLQEIKEQEYQAQVEEMRLMMNQLEEDLVSARRRSDLYESELRESRLAAE 597

Query: 514 ALKEKLTSLEQEL 526
             K K T  + +L
Sbjct: 598 EFKRKATECQHKL 610

Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Dual specificity protein kinase activity catalyzing autophosphorylation and phosphorylation of exogenous substrates on both serine/threonine and tyrosine residues. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2.
Homo sapiens (taxid: 9606)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens GN=ROCK2 PE=1 SV=4

 Score =  233 bits (595), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 120/350 (34%), Positives = 193/350 (55%), Gaps = 29/350 (8%)

Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----- 57
           +VK++R   + A D+D+ + I +G FG++ LV  K S   + MK + + +M         
Sbjct: 78  IVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFF 137

Query: 58  --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
             ERDIM  +  P++V LFY+FQD  ++Y +MEY+ GGD V L+ N     + E  A+FY
Sbjct: 138 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFY 194

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
             E+  A+  +H +G +HRD+KPDNMLL   GHLKL DFG+  ++D+ G +     VGTP
Sbjct: 195 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTP 254

Query: 176 EYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
           +Y++PEVL+    + G DG+ G  CD WS+GV  YE+L G TPF  ++L  TYS I+  D
Sbjct: 255 DYISPEVLK----SQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM--D 308

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLDSD 283
            ++++ FP    +S    N + + +   + RL    ++++  HP F        +  ++ 
Sbjct: 309 HKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETA 368

Query: 284 PPCIPPPSQE-NKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGE 332
            P +P  S + +  +  D       ++ F     ++ + LP IG +Y  E
Sbjct: 369 APVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRE 418

Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P70336|ROCK2_MOUSE Rho-associated protein kinase 2 OS=Mus musculus GN=Rock2 PE=1 SV=1

 Score =  231 bits (590), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 196/678 (28%), Positives = 335/678 (49%), Gaps = 83/678 (12%)

Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----- 57
           +VK++R   + A D+D+ + I +G FG++ LV  K S   + MK + + +M         
Sbjct: 78  IVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFF 137

Query: 58  --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
             ERDIM  +  P++V LF +FQD  ++Y +MEY+ GGD V L+ N     + E  A+FY
Sbjct: 138 WEERDIMAFANSPWVVQLFCAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFY 194

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
             E+  A+  +H +G +HRD+KPDNMLL   GHLKL DFG+  ++D+ G +     VGTP
Sbjct: 195 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTP 254

Query: 176 EYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
           +Y++PEVL+    + G DGY G  CD WS+GV  +E+L G TPF  ++L  TYS I+  D
Sbjct: 255 DYISPEVLK----SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM--D 308

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLDSD 283
            ++++ FP    +S    N + + +   + RL    ++++  HP F        +  ++ 
Sbjct: 309 HKNSLCFPEDTEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETA 368

Query: 284 PPCIPPPSQE-NKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSS 342
            P +P  S + +  +  D       ++ F     ++ + LP IG +Y  E +       S
Sbjct: 369 APVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYFRENL-----LLS 423

Query: 343 DSTLPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSS-------LQ 395
           DS  PP  E+      D +Q        + S E     + ++ AL+  +SS       L+
Sbjct: 424 DS--PPCREN------DAIQ-------TRKSEESQEIQK-KLYALEEHLSSEVQAKEELE 467

Query: 396 QDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEK 455
           Q   S  + L K  +E   L +E+  ++S + +T   L   +  L+   +E + K + E 
Sbjct: 468 QKCKSINTRLEKTAKE---LEEEITLRKS-VESTLRQLEREKALLQHKNAEYQRKADHEA 523

Query: 456 TDDRKLE--VCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNA-------AVAELK 506
              R LE  V  +  +LE L+   +  + +T++  +   + + E NA         A L+
Sbjct: 524 DKKRNLENDVNSLKDQLEDLKKRNQSSQISTEKVNQ-LQKQLDEANALLRTESDTAARLR 582

Query: 507 QAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAV 566
           + Q E+    ++L S  ++L+     L TA+  L+   +E   L + +ES +++    + 
Sbjct: 583 KTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLE---KEFINLQSALESERRDRTHGSE 639

Query: 567 RVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYK---LDLESTRRELETNKDQTIEL 623
            + ++ G     E+D KT    K+   ++ELE R  +    DLE  +  +E   D T +L
Sbjct: 640 IINDLQGRISGLEEDLKT---GKALLAKVELEKRQLQEKLTDLEKEKSNMEI--DMTYQL 694

Query: 624 RA-KSKLEKAEGELTTVR 640
           +  +  LE+ E E  T +
Sbjct: 695 KVIQQSLEQEEAEHKTTK 712

Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays a role in placental homeostasis during the perinatal period.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7TT50|MRCKB_MOUSE Serine/threonine-protein kinase MRCK beta OS=Mus musculus GN=Cdc42bpb PE=1 SV=2

 Score =  231 bits (590), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 237/822 (28%), Positives = 387/822 (47%), Gaps = 152/822 (18%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-------RDIMVKSKCP 68
           DF+I + I +G FG++ +V+ K +   + MK + + +M    E       RD++V   C 
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           +I  L Y+FQD N++Y +M+Y  GGD +TLL ++    L E  ARFYI E+  A+  +H 
Sbjct: 135 WITALHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDKLPEDMARFYIGEMVLAIDSIHQ 193

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           L YVHRDIKPDN+LL   GH++L DFGS  +++ +G ++S V VGTP+Y++PE+L+ ME 
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR-L 247
             G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  + E+   FPS +  +
Sbjct: 254 GMGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHEERFQFPSHVTDV 309

Query: 248 STAMVNFVQSLVQKLDARLNMDQV---LGHPVFDCLDS------DPPCIP---PPSQENK 295
           S    + +Q L+   + RL  + +     H  F+ L+       + P IP    PS  + 
Sbjct: 310 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSN 369

Query: 296 FHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPM----GANTNTSSDSTLPPSSE 351
           F   D    +  +        +    LP IG ++T E      G+  + +  +TL    E
Sbjct: 370 FDVDDDMLRNIEILPPGSHTGFSGLHLPFIGFTFTTESCFSDRGSLKSMTQSNTL-TKDE 428

Query: 352 D-----------------MRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSL 394
           D                 +R  ++++L+L ++L E+  +++ L  S TR L         
Sbjct: 429 DVQRDLENSLQIEAYERRIRRLEQEKLELSRKLQESTQTVQSLHGS-TRALG-------- 479

Query: 395 QQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATS------SDLVATRHELEEVRSELK 448
                      S +++EI RL +E+ + +S +  ++       D V  R E E+    LK
Sbjct: 480 ----------NSNRDKEIKRLNEELERMKSKMADSNRLERQLEDTVTLRQEHEDSTHRLK 529

Query: 449 EKENLEKTDDRKLEVCEVSKEL----EVLRGELEEQKTATKQWKKDW--YQSVKERNAAV 502
             E   +   ++ E  E+ K+L    E L+ + +E K A +Q K+    +  + ER + +
Sbjct: 530 GLEKQYRLARQEKE--ELHKQLVEASERLKSQTKELKDAHQQRKRALQEFSELNERMSEL 587

Query: 503 AELKQ--------AQTENEALKEKLTSLEQELKVSEEAL---------ATAQNSLDSKLR 545
             LKQ         + E E   +K+ S+ Q+L+ SE++          A A+ S + KLR
Sbjct: 588 RSLKQKVSRQLRDKEEEMEVAMQKIDSMRQDLRKSEKSRKELEARLEDAAAEASKERKLR 647

Query: 546 EHQALSNTIESMQKEMEQ--SAVRVR--------------EMSGISEKYEK--------- 580
           EH       ES  K+ME+   A++V+              E+S I  + EK         
Sbjct: 648 EHS------ESFCKQMERELEALKVKQGGRGPGAASEHQQEISKIRSELEKKVLFYEEEL 701

Query: 581 ---DRKTLLELKSAKER----------LELEVRGYKLDLESTRRELETNKDQTIELRAKS 627
              +   +LE+K+ K+           L+ EV   K  LE ++RE  +  ++ I     +
Sbjct: 702 VRREASHVLEVKNVKKEVHDSESHQLALQKEVLMLKDKLEKSKRERHSEMEEAI----GT 757

Query: 628 KLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKV 687
             +K E E   + +ENKKL     +L    F D   AQ++  + E EL  +   +KK  V
Sbjct: 758 VKDKYERERAMLFDENKKLTAENEKLCS--FVDKLTAQNR--QLEDELQDL--ASKKESV 811

Query: 688 SFFFTLESNSLFWL-DPNTFLSSLEDLKSNYTERESKLRSAN 728
           + +    +  + W+ D       L+ L S  TE    LRS++
Sbjct: 812 AHWEAQIAEIIQWVSDEKDARGYLQALASKMTEELETLRSSS 853

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates PPP1R12A.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9Y5S2|MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2

 Score =  231 bits (589), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 190/632 (30%), Positives = 313/632 (49%), Gaps = 92/632 (14%)

Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---- 58
           +VKE++   +   DF+I + I +G FG++ +V+ K +   + MK + + +M    E    
Sbjct: 65  LVKEMQ---LHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACF 121

Query: 59  ---RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
              RD++V   C +I  L Y+FQD NH+Y +M+Y  GGD +TLL ++    L E  ARFY
Sbjct: 122 REERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL-SKFEDKLPEDMARFY 180

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           I E+  A+  +H L YVHRDIKPDN+LL   GH++L DFGS  +++ +G ++S V VGTP
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTP 240

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
           +Y++PE+L+ ME   G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  + 
Sbjct: 241 DYISPEILQAMEDGMGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NH 296

Query: 236 EDTVSFPSSIR-LSTAMVNFVQSLVQKLDARLNMDQV---LGHPVFDCLDS------DPP 285
           E+   FPS +  +S    + +Q L+   + RL  + +     H  F+ L+       + P
Sbjct: 297 EERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAP 356

Query: 286 CIP---PPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEP--------- 333
            IP    PS  + F   D    +  +        +    LP IG ++T E          
Sbjct: 357 YIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHTGFSGLHLPFIGFTFTTESCFSDRGSLK 416

Query: 334 --MGANTNTSSDST---------LPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRT 382
             M +NT T  +           +      +R  ++++L+L ++L E+  +++ L  S +
Sbjct: 417 SIMQSNTLTKDEDVQRDLEHSLQMEAYERRIRRLEQEKLELSRKLQESTQTVQSLHGS-S 475

Query: 383 RVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEE 442
           R L+            ++    + K  EEI+RL+ + +   + L     D VA R E E+
Sbjct: 476 RALS-----------NSNRDKEIKKLNEEIERLKNK-IADSNRLERQLEDTVALRQERED 523

Query: 443 VRSELKEKENLEKTDDRKLEVCEVSKEL----EVLRGELEEQKTATKQWKKDWYQSVKER 498
               L+  E   +   ++ E  E+ K+L    E L+ + +E K A +Q +K   Q   E 
Sbjct: 524 STQRLRGLEKQHRVVRQEKE--ELHKQLVEASERLKSQAKELKDAHQQ-RKLALQEFSEL 580

Query: 499 NAAVAELKQAQT-----------ENEALKEKLTSLEQELKVSEEAL---------ATAQN 538
           N  +AEL+  +            E E   +K+ ++ QE++ +E+           A A+ 
Sbjct: 581 NERMAELRAQKQKVSRQLRDKEEEMEVATQKVDAMRQEMRRAEKLRKELEAQLDDAVAEA 640

Query: 539 SLDSKLREHQALSNTIESMQKEMEQSAVRVRE 570
           S + KLREH    N  + M+ E+E  A++V++
Sbjct: 641 SKERKLREHS--ENFCKQMESELE--ALKVKQ 668

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates PPP1R12A.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q13464|ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1

 Score =  231 bits (589), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 126/383 (32%), Positives = 207/383 (54%), Gaps = 49/383 (12%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           KD + ++R   + A D+++ + I +G FG++ LV  K +   + MK + + +M       
Sbjct: 60  KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 119

Query: 58  ----ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  +  P++V LFY+FQD  ++Y +MEY+ GGD V L+ N     + E  AR
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAR 176

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY  E+  A+  +H +G++HRD+KPDNMLL  +GHLKL DFG+  +++K G ++    VG
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           TP+Y++PEVL+    + G DGY G  CD WS+GV  YE+L G TPF  ++L  TYS I+ 
Sbjct: 237 TPDYISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM- 291

Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVFD--------CLD 281
            + +++++FP    +S    N + + +   + RL    ++++  H  F           D
Sbjct: 292 -NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 350

Query: 282 SDPPCIPPPSQE---NKF----HKKDKRKASPSLKAFQKEGRYLDSALPLIGISY----- 329
           +  P +P  S +   + F      K + +  P  KAF      + + LP +G +Y     
Sbjct: 351 TVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAF------VGNQLPFVGFTYYSNRR 404

Query: 330 ---TGEPMGANTNTSSDSTLPPS 349
              +  P    T++++D +L  S
Sbjct: 405 YLSSANPNDNRTSSNADKSLQES 427

Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Required for centrosome positioning and centrosome-dependent exit from mitosis. Plays a role in terminal erythroid differentiation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Promotes keratinocyte terminal differentiation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O77819|ROCK1_RABIT Rho-associated protein kinase 1 OS=Oryctolagus cuniculus GN=ROCK1 PE=1 SV=1

 Score =  230 bits (586), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 125/373 (33%), Positives = 201/373 (53%), Gaps = 46/373 (12%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           KD + ++R   + A D+++ + I +G FG++ LV  K +   + MK + + +M       
Sbjct: 60  KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 119

Query: 58  ----ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  +  P++V LFY+FQD  ++Y +MEY+ GGD V L+ N     + E  AR
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAR 176

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY  E+  A+  +H +G++HRD+KPDNMLL  +GHLKL DFG+  +++K G ++    VG
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           TP+Y++PEVL+    + G DGY G  CD WS+GV  YE+L G TPF  ++L  TYS I+ 
Sbjct: 237 TPDYISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM- 291

Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVFD--------CLD 281
            + +++++FP    +S    N + + +   + RL    ++++  H  F           D
Sbjct: 292 -NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 350

Query: 282 SDPPCIPPPSQE---NKFHKKDKRKAS----PSLKAFQKEGRYLDSALPLIGISYTGE-- 332
           +  P +P  S +   + F   ++ K      P  KAF      + + LP +G +Y     
Sbjct: 351 TVAPVVPDLSSDIDTSNFDDLEEDKGDEETFPIPKAF------VGNQLPFVGFTYYSNRR 404

Query: 333 ---PMGANTNTSS 342
              P   N N +S
Sbjct: 405 YLSPANPNDNRTS 417

Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Required for centrosome positioning and centrosome-dependent exit from mitosis Plays a role in terminal erythroid differentiation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Promotes keratinocyte terminal differentiation.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7TT49|MRCKB_RAT Serine/threonine-protein kinase MRCK beta OS=Rattus norvegicus GN=Cdc42bpb PE=1 SV=1

 Score =  230 bits (586), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 232/818 (28%), Positives = 383/818 (46%), Gaps = 144/818 (17%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-------RDIMVKSKCP 68
           DF+I + I +G FG++ +V+ K +   + MK + + +M    E       RD++V   C 
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           +I  L Y+FQD N++Y +M+Y  GGD +TLL ++    L E  ARFYI E+  A+  +H 
Sbjct: 135 WITALHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDKLPEDMARFYIGEMVLAIDSIHQ 193

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           L YVHRDIKPDN+LL   GH++L DFGS  +++ +G ++S V VGTP+Y++PE+L+ ME 
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR-L 247
             G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  + E+   FPS +  +
Sbjct: 254 GMGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHEERFQFPSHVTDV 309

Query: 248 STAMVNFVQSLVQKLDARLNMDQV---LGHPVFDCLDS------DPPCIP---PPSQENK 295
           S    + +Q L+   + RL  + +     H  F+ L+       + P IP    PS  + 
Sbjct: 310 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSN 369

Query: 296 FHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEP-----------MGANTNTSSDS 344
           F   D    +  +        +    LP IG ++T E            + +NT T  + 
Sbjct: 370 FDVDDDVLRNIEILPPGSHTGFSGLHLPFIGFTFTTESCFSDRGSLKSMIQSNTLTKDED 429

Query: 345 T---------LPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQ 395
                     +      +R  ++++L+L ++L E+  +++ L  S TR L          
Sbjct: 430 VQRDLENSLQIEAYERRIRRLEQEKLELSRKLQESTQTVQSLHGS-TRALG--------- 479

Query: 396 QDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATS------SDLVATRHELEEVRSELKE 449
                     S +++EI RL +E+ + +S +  ++       D V  R E E+    LK 
Sbjct: 480 ---------NSNRDKEIKRLNEELERMKSKMADSNRLERQLEDTVTLRQEHEDSTQRLKG 530

Query: 450 KENLEKTDDRKLEVCEVSKEL----EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAEL 505
            E   +   ++ E  E+ K+L    E L+ + +E K A +Q +K   Q   E N  +AEL
Sbjct: 531 LEKQYRLARQEKE--ELHKQLVEASERLKSQTKELKDAHQQ-RKRALQEFSELNERMAEL 587

Query: 506 KQAQT-----------ENEALKEKLTSLEQELKVSEEAL---------ATAQNSLDSKLR 545
           +  +            E E   +K+ S+ Q+++ SE++          A A+ S + KLR
Sbjct: 588 RSQKQKVSRQLRDKEEEMEVAMQKIDSMRQDIRKSEKSRKELEARLEDAVAEASKERKLR 647

Query: 546 EHQALSNTIESMQKEMEQSAVR------------VREMSGISEKYEK------------D 581
           EH    +  + M++E+E   V+             +E+S I  + EK            +
Sbjct: 648 EHS--ESFSKQMERELETLKVKQGGRGPGATLEHQQEISKIRSELEKKVLFYEEELVRRE 705

Query: 582 RKTLLELKSAKER----------LELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEK 631
              +LE+K+ K+           L+ EV   K  LE ++RE  +  ++ I     +  +K
Sbjct: 706 ASHVLEVKNVKKEVHESESHQLALQKEVLMLKDKLEKSKRERHSEMEEAI----GAMKDK 761

Query: 632 AEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFF 691
            E E   + +ENKKL     +L    F D   AQ++  + E EL  +   +KK  V+ + 
Sbjct: 762 YERERAMLFDENKKLTAENEKLCS--FVDKLTAQNR--QLEDELQDL--ASKKESVAHWE 815

Query: 692 TLESNSLFWL-DPNTFLSSLEDLKSNYTERESKLRSAN 728
              +  + W+ D       L+ L S  TE    LRS++
Sbjct: 816 AQIAEIIQWVSDEKDARGYLQALASKMTEELETLRSSS 853

Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration. Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2. In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Phosphorylates PPP1R12A.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q28021|ROCK2_BOVIN Rho-associated protein kinase 2 OS=Bos taurus GN=ROCK2 PE=1 SV=1

 Score =  229 bits (585), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 119/350 (34%), Positives = 192/350 (54%), Gaps = 29/350 (8%)

Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----- 57
           +VK++R   + A D+D+ + I +G FG++ LV  K S   + MK + + +M         
Sbjct: 78  IVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFF 137

Query: 58  --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
             ERDIM  +  P++V LF +FQD  ++Y +MEY+ GGD V L+ N     + E  A+FY
Sbjct: 138 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFY 194

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
             E+  A+  +H +G +HRD+KPDNMLL   GHLKL DFG+  ++D+ G +     VGTP
Sbjct: 195 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTP 254

Query: 176 EYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
           +Y++PEVL+    + G DGY G  CD WS+GV  +E+L G TPF  ++L  TYS I+  D
Sbjct: 255 DYISPEVLK----SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM--D 308

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLDSD 283
            ++++ FP    +S    N + + +   + RL    ++++  HP F        +  ++ 
Sbjct: 309 HKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETA 368

Query: 284 PPCIPPPSQE-NKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGE 332
            P +P  S + +  +  D       ++ F     ++ + LP IG +Y  E
Sbjct: 369 APVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRE 418

Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q80UW5|MRCKG_MOUSE Serine/threonine-protein kinase MRCK gamma OS=Mus musculus GN=Cdc42bpg PE=2 SV=2

 Score =  229 bits (584), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 182/620 (29%), Positives = 299/620 (48%), Gaps = 85/620 (13%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ 57
           VKELR   +   DF+I + I +G FG++ +V ++ S   F MK + + +M          
Sbjct: 61  VKELR---LQRDDFEILKVIGRGAFGEVAVVRQRGSGQIFAMKMLHKWEMLKRAETACFR 117

Query: 58  -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
            ERD++VK    ++  L Y+FQD  ++Y +M+Y  GGD +TLL ++    L    A+FY+
Sbjct: 118 EERDVLVKGDSRWVTALHYAFQDEEYLYLVMDYYAGGDLLTLL-SRFEDRLPPELAQFYL 176

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
            E+  A+  LH LGYVHRD+KPDN+LL   GH++L DFGS  +++ NG + S V VGTP+
Sbjct: 177 AEMVLAIHSLHQLGYVHRDVKPDNILLDMNGHIRLADFGSCLRLNNNGMVDSSVAVGTPD 236

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           Y++PE+L+ ME   G   Y   CD WS+GV +YELL G TPF  E+L  TY  I+  + E
Sbjct: 237 YISPEILQAME--EGKGHYGPQCDWWSLGVCAYELLFGETPFYAESLVETYGKIM--NHE 292

Query: 237 DTVSFPSSIR-LSTAMVNFVQSLVQKLDARL---NMDQVLGHPVFDCLD------SDPPC 286
           D + FP+ +  +  +  + ++ L+ + + RL    +D    HP F+ +D      S  P 
Sbjct: 293 DHLQFPADVTDVPASAQDLIRQLLCRQEERLGRGGLDDFRKHPFFEGVDWERLATSTAPY 352

Query: 287 IP---PPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYT-GEP--------M 334
           IP    P   + F   D     P        G +    LP +G +YT G P        M
Sbjct: 353 IPELRGPMDTSNFDVDDDTLNRPETLPPSSHGAFSGHHLPFVGFTYTSGSPFDVQSSELM 412

Query: 335 GANTNTS----------SDSTLPPSSEDMRHWKRDRLQ---------LLQQLAEAKASLE 375
            A   T           S     P    ++  +  RLQ         L + L ++KASL 
Sbjct: 413 AAPEGTPHCVEQVKVELSHKCQEPLHGPLQPQELVRLQKEVQVLQEKLAETLRDSKASLS 472

Query: 376 DLSCSRTRVLA----LQAQVSSLQQDLTSHTSLLSKKEEEI-------DRLRQEMVKKES 424
                  R  A    LQ +   LQQ+LT   + L  ++ E+       +   Q + + + 
Sbjct: 473 QTDGLHARSPAPNIQLQQEKDRLQQELTEAQAALRVQDAELCQAQNRQEEFLQRLWEAQE 532

Query: 425 DLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTAT 484
              A +S + A   +LEE     +E E          +V  +S+E+  L+G+ +++ +  
Sbjct: 533 REAAAASQIQALNSQLEEAWVVRRELEG---------QVTTLSQEVTRLQGQCKQESSQA 583

Query: 485 KQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELK-VSEEALATAQNSLDSK 543
           K        +  E N   +   + Q++   L++++ +L ++L+    + ++  +  +  +
Sbjct: 584 KT-----VHAAPETNGIGS--PEGQSQEAQLRKEVAALREQLEHACSQGISVGKEEVLCR 636

Query: 544 LR-EHQALSNTIESMQKEME 562
           L+ E+Q LS   E +  E+E
Sbjct: 637 LQEENQRLSREQERLAGELE 656

May act as a downstream effector of CDC42 in cytoskeletal reorganization. Contributes to the actomyosin contractility required for cell invasion, through the regulation of MYPT1 and thus MLC2 phosphorylation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	792
328722043	1794	PREDICTED: serine/threonine-protein kina	0.761	0.336	0.304	1e-73
195126407	1839	GI13065 [Drosophila mojavensis] gi|19391	0.655	0.282	0.330	5e-73
194750124	1845	GF24009 [Drosophila ananassae] gi|190624	0.655	0.281	0.336	5e-71
195378803	1839	GJ13813 [Drosophila virilis] gi|19415532	0.772	0.332	0.307	3e-69
391330444	1813	PREDICTED: citron Rho-interacting kinase	0.707	0.308	0.310	5e-69
195019802	1840	GH16845 [Drosophila grimshawi] gi|193898	0.678	0.291	0.321	6e-69
195160653	1835	GL24946 [Drosophila persimilis] gi|19411	0.733	0.316	0.314	1e-68
270008485	506	hypothetical protein TcasGA2_TC014999 [T	0.411	0.644	0.393	3e-68
125978741	1855	GA10369 [Drosophila pseudoobscura pseudo	0.655	0.279	0.327	3e-68
195439886	1881	GK12619 [Drosophila willistoni] gi|19416	0.806	0.339	0.285	4e-68

>gi|328722043|ref|XP_001943480.2| PREDICTED: serine/threonine-protein kinase MRCK alpha-like [Acyrthosiphon pisum]

 Score =  284 bits (727), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 208/683 (30%), Positives = 354/683 (51%), Gaps = 80/683 (11%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----- 55
           K  + EL+   V+  DF+ K+ I +G+FGD+ LV EK + + F MK + ++ + N     
Sbjct: 65  KMAIPELKSLRVNRFDFESKQVIGKGHFGDVELVIEKHTKDIFAMKVLKKDNLLNHRDIA 124

Query: 56  --TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  S  P++  L Y+FQD  ++Y +M+Y  GGDF  L++ + +G L E  A+
Sbjct: 125 FYEYERDIMASSSSPFLTQLHYAFQDFQNLYLVMDYHPGGDFANLID-KFNGTLPEETAK 183

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FYI EL  AV++LH +G+ HRDIKP+NM+L   GHLKL DFGS+ +++++G+I +++PVG
Sbjct: 184 FYIAELLLAVKHLHTMGFAHRDIKPENMMLDRVGHLKLVDFGSSAKLNRDGKICALMPVG 243

Query: 174 TPEYVAPEVLEWMEGNHGS-DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           T EY+APEVL +M+ N  S +GY   CDLWS+G+V+YE+ TG TPFN E   + YS+IL 
Sbjct: 244 TSEYLAPEVLIFMQSNSKSLEGYGPQCDLWSVGIVAYEMATGDTPFNSEQQAVIYSNILN 303

Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCL------DSDPPC 286
            D  + + +PS +++S++    ++SLV  +D R  +D +L   +F  +      D  PP 
Sbjct: 304 FD--NILKYPSYLKVSSSYRQMIESLVCHVDKRFTVDMMLDLDIFSKINFNNLHDQVPPY 361

Query: 287 IPPPSQEN---KFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSD 343
           IP  S +N    F   ++   + ++  F+K+ ++    LP IG +Y+ +   +  N S  
Sbjct: 362 IPSLSSDNDVSNFPIHERVPPALNINDFKKQKQFSGRDLPFIGFTYSMQV--SKRNQSYF 419

Query: 344 STLPPSSEDMRHWKRDRLQ----LLQQLAEAKASLEDLSCSRTRVLA--------LQAQV 391
            T  P  E     KR  L+    L+Q   +  A  + L     R +         L   V
Sbjct: 420 MTNNPELETSIRVKRKELEDAQVLIQAYEDKLAEYDSLFIENDRKIKKMEEENVLLHVDV 479

Query: 392 SSLQQDL--------TSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDL--VATRHELE 441
           +SL  +L        TS+TS      E+I+ +     KK++++V    D   + T +EL 
Sbjct: 480 TSLSSELGRLTKISETSNTS-----HEDINNITH---KKQAEMVKNEIDKWEIKTINELY 531

Query: 442 EVRSELKEKENLE-KTDDRKLEVCEVSKELEVLRGELEE-QKTATKQWKKDWYQSVKERN 499
            +     + E+L+ +  + + ++C+   ++++ +   E+  K  TK         +K + 
Sbjct: 532 NIEELKVQNEDLQAQNSELQSQLCKHQDDIKIYQSNEEQLNKKITK---------LKSKL 582

Query: 500 AAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQK 559
             +    +  TE  ++   +++L  E+KV E+     +N L     ++Q L   I  M+K
Sbjct: 583 KHIVRRSKQLTEENSIDNHVSALISEMKVKEDTFEVEKNQLKI---DNQCLKKKIVVMEK 639

Query: 560 EMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQ 619
           +++         S I++  EK+   L E K+  +++         D ES    +   KD 
Sbjct: 640 DLDSLN------SKIAQYTEKELAILSEHKNMCKKM-------ASDFESKLNCITREKDN 686

Query: 620 TIELRAKSKLEKAEGELTTVREE 642
            IE +  ++L + E +L  +  E
Sbjct: 687 EIE-KLHTQLAQLESKLNCITHE 708

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195126407|ref|XP_002007662.1| GI13065 [Drosophila mojavensis] gi|193919271|gb|EDW18138.1| GI13065 [Drosophila mojavensis]

 Score =  282 bits (721), Expect = 5e-73,   Method: Compositional matrix adjust.
 Identities = 192/581 (33%), Positives = 316/581 (54%), Gaps = 62/581 (10%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-IER 59
           + +++E RQ  V+A DF IK  I +G FG+++LV E+Q+ + + MKK+ +  +  + +ER
Sbjct: 89  RPIIEETRQLRVNADDFVIKALIGKGYFGNVHLVVERQTSDVYAMKKIKKSMVTTSQVER 148

Query: 60  DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
           DIM +    ++ NL Y+FQD +++Y +MEY+ GGD ++L+    HG   E  ARFY+ EL
Sbjct: 149 DIMSQRNSEWLTNLQYAFQDNDNLYLVMEYLPGGDLLSLMSR--HGPFDEDMARFYLAEL 206

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
             A+  LH +GYVHRDIKP+N+L+   GH+KL DFG+A  +D++G + S+ PVGTP+Y+A
Sbjct: 207 TLALHTLHTMGYVHRDIKPENILIDRFGHIKLADFGNAAALDRDGHVLSLSPVGTPDYIA 266

Query: 180 PEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           PE+L+ +     S   +  SCD WS+G++ YEL+   TPF+ + +  TYS IL+   ED+
Sbjct: 267 PELLQTISTYKLSKSMHDVSCDYWSMGIIGYELICEITPFHEDNVHETYSKILS-HCEDS 325

Query: 239 -----VSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSD------PPCI 287
                VSFPS +++S+ + + + SLV     RL+ DQ++ HP F+ +         PP I
Sbjct: 326 RLKKIVSFPSDLKISSNLKHLIGSLVTNPTNRLSYDQIVKHPFFESIQWSTVRSQVPPII 385

Query: 288 PPPSQ-------ENKFHKKDKR--KASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANT 338
           P           E+    K +R  +A  SL +  K   +    LP IG S+       + 
Sbjct: 386 PTIKSDDDISNFEDGIRHKARREPQAKKSLTSNMKSNDFSGKDLPFIGYSFVHLENDYSA 445

Query: 339 NTSSDST--------LPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQ 390
              SD+         L    + ++  + + L+L Q+L +A+ +++    S   VL  + +
Sbjct: 446 ADGSDTARTTKLQEKLRTLQQKLKSREGEILKLRQELVKAQQTVKQSDGSSQVVLEAKME 505

Query: 391 VSSLQQDLTSHTSLLSKKEEEIDRLR------QEMVKKESDLVATSSDLV-ATRHELEEV 443
           ++ LQ  +   T  L+  + +I  L+      +EM  K+    AT +DL+   R + EE 
Sbjct: 506 ITKLQDIIKEKTMELASCKTQIKTLQSSAKIDEEMWSKKE---ATITDLLRLNRQKYEEA 562

Query: 444 R--------SELKEKE-----NLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKD 490
           +         +L EK+      ++K D R+LE    + E + L+ +LE  K   KQ K+ 
Sbjct: 563 KIASEQRYEKQLAEKKQELACTVQKLDARELEFHAKTDECKHLQDKLENYKEMLKQLKE- 621

Query: 491 WYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEE 531
             QSVK   A     KQ Q   ++ ++KL+ L Q+L+ S++
Sbjct: 622 --QSVK---ADTNHEKQRQQLTDSYEQKLSELRQKLRESQD 657

Source: Drosophila mojavensis

Species: Drosophila mojavensis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194750124|ref|XP_001957480.1| GF24009 [Drosophila ananassae] gi|190624762|gb|EDV40286.1| GF24009 [Drosophila ananassae]

 Score =  276 bits (705), Expect = 5e-71,   Method: Compositional matrix adjust.
 Identities = 195/579 (33%), Positives = 318/579 (54%), Gaps = 60/579 (10%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           + +V+E R+  V+A DF IK  I QG FG+++LV E+Q+++ + MKK+ +  +  +    
Sbjct: 90  RPIVEETRKLRVNADDFLIKALIGQGYFGNVHLVVERQTNDIYAMKKIKKSVVTTSQVKE 149

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           ERDIM      +++NL Y+FQD +++Y IMEY+ GGD ++L+    HG   E  ARFY+ 
Sbjct: 150 ERDIMSTRHSEWLINLQYAFQDNDNLYLIMEYMPGGDLLSLMSR--HGPFDEDLARFYLA 207

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           EL  A+  LH +GYVHRDIKP+N+L+   GH+KL DFG+A  +D++G + S+ PVGTP+Y
Sbjct: 208 ELTVALHTLHEMGYVHRDIKPENILIDRFGHIKLADFGNAAALDRDGHVLSLSPVGTPDY 267

Query: 178 VAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CD- 234
           +APE+L+ +     S   +  SCD WS+G++ YEL+  +TPF+ + +  TYS IL+ C+ 
Sbjct: 268 IAPELLQTISTYKLSKSMHDVSCDYWSMGIIGYELICETTPFHEDNVHETYSKILSHCEE 327

Query: 235 --TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCL------DSDPPC 286
              ++ +SFPS +++S    N ++SLV     RL+ +++  HP FD +         PP 
Sbjct: 328 SHLKELISFPSDLKVSLNYRNLIESLVTNPSRRLSYERIKKHPFFDEIQWASIRSQVPPI 387

Query: 287 IPPPS--------QENKFHK--KDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGA 336
           IP           ++   HK  +D+  A  SL    K   +    LP IG S+      A
Sbjct: 388 IPTIKSDDDTSNFEDGTRHKSRRDQGVAKKSLTTNMKSHDFSGKDLPFIGYSFVHMEKSA 447

Query: 337 NTNTSSDSTLPPSSEDMRHWKRDR---LQLLQQ-LAEAKASLEDLSCSRTRVLALQAQVS 392
            T  SSD  L    ++++H  + R   + +L+Q L  A+ SL+        V+  + ++ 
Sbjct: 448 LT-ASSDEKLQEKLKELQHKLKTRENEISMLKQDLMRAQQSLKKTDNKSQVVVDAKMEIK 506

Query: 393 SLQQDLTSHTSLLSKKEEEIDRLR------QEMVKKESDLVATSSDLV-ATRHELEEVR- 444
            LQQ +   T  L+  + +I  L+      +EM  K+    AT +DL+   R + EE + 
Sbjct: 507 KLQQIIKEKTMELANCKTQIKTLQSSAKIDEEMWSKKE---ATITDLLRLNRQKYEEAKI 563

Query: 445 -------SELKEKE-----NLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWY 492
                   +L +K+      L+K D R+LE    S E + L  +L+  K   KQ K+   
Sbjct: 564 ASEQRYEKQLADKKQELASTLQKMDARELEFNAKSDECKHLSDKLQNYKDMMKQLKE--- 620

Query: 493 QSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEE 531
           Q++  RN A  E +Q +   E+ ++KLT L ++++ S++
Sbjct: 621 QNL--RNEANNE-EQKRQMAESYEQKLTDLRKKVRDSQD 656

Source: Drosophila ananassae

Species: Drosophila ananassae

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195378803|ref|XP_002048171.1| GJ13813 [Drosophila virilis] gi|194155329|gb|EDW70513.1| GJ13813 [Drosophila virilis]

 Score =  270 bits (689), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 212/689 (30%), Positives = 358/689 (51%), Gaps = 77/689 (11%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-IER 59
           + +++E RQ  V+A DF IK  I +G FG+++LV E+Q+ + + MKK+ +  +  + +ER
Sbjct: 89  RPIIEETRQLRVNADDFVIKALIGKGFFGNVHLVLERQTSDVYAMKKIKKSMVTTSQVER 148

Query: 60  DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
           DIM +    +I NL Y+FQD +H+Y IMEY+ GGD ++L+    HG   E  ARFY+ EL
Sbjct: 149 DIMSQRNSEWITNLQYAFQDNDHLYLIMEYLPGGDLLSLMSR--HGPFDEDLARFYLAEL 206

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
             A+  LH +GYVHRDIKP+N+L+   GH+KL DFG+A  +D++G + S+ PVGTP+Y+A
Sbjct: 207 TLALHTLHLMGYVHRDIKPENILIDRFGHIKLADFGNAAALDRDGHVLSLSPVGTPDYIA 266

Query: 180 PEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CD--- 234
           PE+L+ +     S   +  SCD WS+G++ YEL+   TPF+ + +  TYS IL+ CD   
Sbjct: 267 PELLQTISTYKLSKSMHDVSCDYWSMGIIGYELICEITPFHEDNVHETYSKILSHCDDSL 326

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSD------PPCIP 288
            +  +SFPS +++S+ M + + SLV     RL+ DQ++ HP F+ +         PP IP
Sbjct: 327 LKKLISFPSDLKISSNMKHLIGSLVTNPTNRLSYDQIIKHPFFESIQWSTVRSQMPPIIP 386

Query: 289 PPSQENKF--------HK-KDKRKASPSLKAFQKEGRYLDSALPLIGISYTG-EPMGANT 338
               ++          HK + +++A  SL +  K   +    LP IG S+   E   +  
Sbjct: 387 TIKSDDDISNFEDGIRHKARREQQAKKSLTSNMKSNDFSGKDLPFIGYSFVHMEDDYSTV 446

Query: 339 NTSSDSTLPPSSEDMRHWKR-------DRLQLLQQLAEAKASLEDLSCSRTRVLALQAQV 391
           + S  +      E +R+ ++       + + L Q L  A+ +L+        VL  + ++
Sbjct: 447 DVSETARTAKLQEKLRNLQQKLKSRETEIVMLKQDLIRAQQTLKQTDGKSQVVLEAKVEI 506

Query: 392 SSLQQDLTSHTSLLSKKEEEIDRLR------QEMVKKESDLVATSSDLV-ATRHELEEVR 444
             LQ  +   T  L+  + +I  L+      +EM  K+    AT +DL+   R + EE +
Sbjct: 507 KKLQDIIKEKTMELASCKTQIKTLQSSAKIDEEMWSKKE---ATITDLLRLNRQKYEEAK 563

Query: 445 --------SELKEKE-----NLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDW 491
                    +L EK+      ++K D R+LE      E + L  +LE  K   KQ K+  
Sbjct: 564 IASEQRYEKQLAEKKQELACTVQKLDARELEFNAKVDECKHLGDKLENYKEMLKQLKE-- 621

Query: 492 YQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALS 551
            QSVK  +    +  Q  TEN   ++KL+ L Q+L+ S++               H+ ++
Sbjct: 622 -QSVKAESNHENQRTQL-TEN--YEQKLSELRQKLRESQDT--------------HRRMT 663

Query: 552 NTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRR 611
             ++S++ E+++S    +         E+  + +L+  + +     E+R  K  LE+   
Sbjct: 664 FELQSIRSELDESISSGKSSQEAKHATERSIEDILQRLNCEISANNELRAAKASLET--- 720

Query: 612 ELETNKDQTIELRAKSKLEKAEGELTTVR 640
           +L   K +++E +A+ +    E +L   R
Sbjct: 721 QLNLAKKESLEAQAECQRLDRELQLAECR 749

Source: Drosophila virilis

Species: Drosophila virilis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|391330444|ref|XP_003739670.1| PREDICTED: citron Rho-interacting kinase-like [Metaseiulus occidentalis]

 Score =  269 bits (687), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 192/618 (31%), Positives = 325/618 (52%), Gaps = 58/618 (9%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTI----- 57
           + +LR   VS SDF++K+ I +G+FG++ +V+EK +   F MK + + E +         
Sbjct: 65  ITDLRTLRVSISDFEVKKVIGRGHFGEVKVVKEKATGEVFAMKTLRKIETLSQQAVAFYE 124

Query: 58  -ERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
            ERDIM +++   +I  L Y++QD +++Y +ME++ GGD ++LL+   +  LSE  ARFY
Sbjct: 125 EERDIMAQAQDTKWITKLHYAYQDADNLYLVMEFLPGGDLLSLLDRNDN-ILSEDHARFY 183

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           + EL QA+  LH +GYVHRDIKPDN+L+   GH+KL DFGSA ++     + S +PVGTP
Sbjct: 184 LAELVQAINTLHSMGYVHRDIKPDNILIDRRGHIKLADFGSAARLSSKKDVTSKMPVGTP 243

Query: 176 EYVAPEVLEWMEGNHGSDG--YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           +Y+APEVL+ M    G+ G  Y   CD WS+G+V+YE+L G TPF+ E +  TYS+I+  
Sbjct: 244 DYIAPEVLQAM-NERGTSGQTYGTCCDWWSLGIVAYEMLYGQTPFSDERVMKTYSNII-- 300

Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCL------DSDPPCI 287
           + + T++FP+   +S   V  + +L++  D RL+   +L H  F+           PP +
Sbjct: 301 NFKKTLAFPTDFVVSPPAVALITALLEHSDKRLDYKGLLEHKFFEGTFWSNLRSMVPPFV 360

Query: 288 PP------PSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEP-------- 333
           P        S  + F ++ +  +   L++ QK+  +  + LP +G ++T E         
Sbjct: 361 PQLTGLDDTSNFDDFEEESRASSRAYLRSLQKK-EFETANLPFVGFTHTLEAEQHTMDPS 419

Query: 334 -MGANTNTSSDSTLPPSSEDMRHWKRDRLQLLQ----QLAEAKASLED-LSCSRTRVLAL 387
             G     +   TL  + +  R   +++L L+Q    QL +A   L+  L  S  R    
Sbjct: 420 VEGQTAAMAFSGTLRKNDDTRRKELQEKLALVQASESQLKDANEGLKSRLKESEARTAKF 479

Query: 388 QAQVSSLQQDLTSHTSLLSKKEEEIDR---LRQ-------EMVKKESDLVATSSDLVATR 437
           Q ++S+L++ +    + L K EE+  +   LR+       E+VK        S +L+  +
Sbjct: 480 QDELSALERCMIERDTELKKLEEKCQQETLLRKRSEQKAIEIVKGYQRQYKRSDELI--K 537

Query: 438 HELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKE 497
             L    S L +K N  +  D   ++ E  K +E L  EL++ +T  + +K+ ++    +
Sbjct: 538 WSLTAPDSPLNDK-NQSRLFDLPHQILEQQKTIEDLTKELQKSRTLARDYKEKFHTIFSD 596

Query: 498 RNAAVAELKQAQTEN----EALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNT 553
               V  L++ Q  N    E LK+ LT      +V E  LA A+   +  +   + L +T
Sbjct: 597 SQKCVERLQEIQVGNLAYVEGLKKDLTEAVNSKRVVENNLANARQLCEEYVNRLKELQDT 656

Query: 554 IESMQKEMEQSAVRVREM 571
              ++ +++   VRV+E+
Sbjct: 657 NRELKIKVKTLEVRVQEL 674

Source: Metaseiulus occidentalis

Species: Metaseiulus occidentalis

Genus: Metaseiulus

Family: Phytoseiidae

Order: Mesostigmata

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195019802|ref|XP_001985058.1| GH16845 [Drosophila grimshawi] gi|193898540|gb|EDV97406.1| GH16845 [Drosophila grimshawi]

 Score =  268 bits (686), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 197/613 (32%), Positives = 321/613 (52%), Gaps = 76/613 (12%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-IER 59
           + +V+E RQ  V+A DF IK  I +G FG+++LV E+ + + + MKK+ +  +  + +ER
Sbjct: 90  RPIVEETRQLRVNADDFVIKALIGKGYFGNVHLVLERHTSDVYAMKKIKKSMVTTSQVER 149

Query: 60  DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
           DIM + K  ++ NL Y+FQD +++Y IMEY+ GGD ++L+    HG   E   RFY+ EL
Sbjct: 150 DIMSQRKSEWLTNLQYAFQDNDNLYLIMEYLPGGDLLSLMSR--HGPFDEDLVRFYLAEL 207

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
             A+  LH +GYVHRDIKP+N+L+   GH+KL DFG+A  +D++G + S+ PVGTP+Y+A
Sbjct: 208 TLALHTLHVMGYVHRDIKPENILIDRFGHIKLADFGNAAALDRDGHVLSLSPVGTPDYIA 267

Query: 180 PEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CD--- 234
           PE+L+ +     S   +  SCD WS+G++ YEL+   TPF+ + +  TYS IL+ C+   
Sbjct: 268 PELLQTISTYKLSKSMHDVSCDYWSMGIIGYELICEITPFHEDNVHETYSKILSHCEDSR 327

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSD------PPCIP 288
            +  +SFPS +++S+ + N + SLV     RL+ DQ++ HP F+ +         PP IP
Sbjct: 328 MKKIISFPSDLKISSNLKNLLVSLVTNPTNRLSYDQIVKHPFFENIQWSTVRSQVPPIIP 387

Query: 289 PPSQ-------ENKFHKKDKR--KASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTN 339
                      E+    K +R  +A  SL +  K   +    LP IG S+        T+
Sbjct: 388 TIKSDDDISNFEDGIRHKARREVQAKKSLTSNMKSNDFSGKDLPFIGYSFV-HLENDYTD 446

Query: 340 TSSDSTLPPSSEDMRHWKR------DRLQLLQQ-LAEAKASLEDLSCSRTRVLALQAQVS 392
            S  +      E MR  ++        + +L+Q LA+A+ +L+        VL  +A++ 
Sbjct: 447 ISDTARTAKLQEKMRSLQQMLKSRETEISMLKQDLAKAQQTLKQTDGKSQVVLEAKAEIK 506

Query: 393 SLQQDLTSHTSLLSKKEEEIDRLR------QEM-VKKESDLVATSSDLV-ATRHELEEVR 444
            LQ  +   T  L+  + +I  L+      +EM  KKES    T +DL+   R + EE +
Sbjct: 507 KLQDIIRDKTMELATCKTQIKTLQSSAKIDEEMWSKKES----TITDLLRLNRQKYEEAK 562

Query: 445 --------SELKEKE-----NLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDW 491
                    +L EK+      + K + R LE    + E + L  +L   K   KQ K   
Sbjct: 563 IASEQKYEKQLAEKKQELACTVRKFEARDLEFQAKNDECKHLSDKLTNYKDMLKQLKD-- 620

Query: 492 YQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALS 551
            QS+K  +    + KQ     E+  ++L+ L Q+L+ S++               H  ++
Sbjct: 621 -QSIKTESNHEKQRKQL---TESYDQQLSELRQKLRESQDT--------------HSHMT 662

Query: 552 NTIESMQKEMEQS 564
             + SM+ E+++S
Sbjct: 663 RELNSMRTELDES 675

Source: Drosophila grimshawi

Species: Drosophila grimshawi

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195160653|ref|XP_002021189.1| GL24946 [Drosophila persimilis] gi|194118302|gb|EDW40345.1| GL24946 [Drosophila persimilis]

 Score =  267 bits (683), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 206/655 (31%), Positives = 338/655 (51%), Gaps = 74/655 (11%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           + +V+E R+  V+A DF IK  I QG FG+++LV E+Q+ + + MKK+ +  +  +    
Sbjct: 91  RPIVEETRKLRVNADDFIIKALIGQGYFGNVHLVVERQTSDIYAMKKIKKSVVTTSQVKE 150

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           ERDIM      +++NL Y+FQD +++Y IMEY+ GGD ++L+    HG   E  ARFY+ 
Sbjct: 151 ERDIMSARNSEWLINLQYAFQDNDNLYLIMEYMPGGDLLSLMSR--HGPFDEHLARFYLA 208

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           EL  A+  LH +GYVHRDIKP+N+L+   GH+KL DFG+A  +D++G + S+ PVGTP+Y
Sbjct: 209 ELTLALHTLHEMGYVHRDIKPENILIDRFGHIKLADFGNAAALDRDGHVLSLSPVGTPDY 268

Query: 178 VAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CD- 234
           +APE+L+ +     S   +  SCD WS+G++ YELL  +TPF+ + +  TYS IL+ C+ 
Sbjct: 269 IAPELLQTISTYKLSKSMHDVSCDYWSMGIIGYELLCETTPFHEDNVHETYSKILSHCEE 328

Query: 235 --TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFD-----CLDSD-PPC 286
              ++ ++FPS +++S    + ++SLV     RL+ D++  H  FD     C+ S  PP 
Sbjct: 329 SHLKELINFPSELKVSKNYRDLIESLVTNPSKRLSYDRIKTHAFFDDIQWNCMRSQVPPI 388

Query: 287 IPP-PSQENKFHKKDKRK--------ASPSLKAFQKEGRYLDSALPLIGISYTGEPMGAN 337
           IP   S ++  + KD  +           SL    K   +    LP +G S+       N
Sbjct: 389 IPNIKSDDDTSNFKDGTRHKSRRDQLGKKSLTTNMKSHDFSGKDLPFLGYSFVHMDKPPN 448

Query: 338 TNTSSDSTLPPSSEDMRHWKRDRLQ--------LLQQLAEAKASLEDLSCSRTRVLALQA 389
            ++  ++      E ++  ++ RL+        L Q L  A+ SL+        VL  + 
Sbjct: 449 CDSVDEARANKLQEKLKDLQQ-RLKSRETEISMLKQDLLRAQQSLKKTDNKSQVVLDAKI 507

Query: 390 QVSSLQQDLTSHTSLLSKKEEEIDRLR------QEM-VKKESDLVATSSDLV-ATRHELE 441
           ++  LQQ +   T  L+  + +I  L+      +EM  KKES    T +DL+   R + E
Sbjct: 508 EIKKLQQIIKDKTMELANCKTQIKTLQSSAKVDEEMWSKKES----TITDLLRLNRQKYE 563

Query: 442 EVR--------SELKEKE-----NLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWK 488
           E +         +L EK       L+K D R+LE    S E + L  +L+  K   KQ K
Sbjct: 564 EAKISSEQRYEKQLAEKNQELASTLQKMDARELEFVAKSDECKHLTAKLQNYKDVLKQLK 623

Query: 489 KDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEA---LATAQNSLDSKLR 545
           +   Q++K   A     +Q     E+ ++KL  L  +++ S+++   L      + ++L 
Sbjct: 624 E---QTIK---ADAGHEQQKSQMAESYEQKLLDLRNKIRESQDSYRRLTLEMQGIRTELD 677

Query: 546 EHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVR 600
           E      +I S +   E      R +  I  +   +  +  EL + K +LEL++R
Sbjct: 678 E------SISSGKSTQEAKHATERNIEDILRRLNHEIASNNELHATKAKLELQLR 726

Source: Drosophila persimilis

Species: Drosophila persimilis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270008485|gb|EFA04933.1| hypothetical protein TcasGA2_TC014999 [Tribolium castaneum]

 Score =  266 bits (681), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 135/343 (39%), Positives = 215/343 (62%), Gaps = 17/343 (4%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR----EKMPNT 56
           K+ + E+++  V+ +DF+IK  I +G+FG++++V+EKQ+ + + MK + +    EK    
Sbjct: 64  KNTLLEVKKLRVNETDFEIKDVIGRGHFGEVHVVKEKQTGDIYAMKTIRKCDSFEKTNFD 123

Query: 57  IERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           +ERDIM  +  P+I +L Y+FQD  ++Y++MEY  GGD + LL  Q  G L ES A FY+
Sbjct: 124 VERDIMAFAASPWITSLQYAFQDSVYLYYVMEYHPGGDLLGLLYRQ-GGTLPESAATFYL 182

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
            E+  A++ LH +G+VHRDIKPDN+LL   GHLKL DFGSA ++++ G +   +PVGTP+
Sbjct: 183 AEIVLALEDLHSMGFVHRDIKPDNILLDRCGHLKLVDFGSAAKLNQQGAVDKGLPVGTPD 242

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           Y+APEVL+ +E N  S  Y  SCD WS+G +++EL+ G  PF+ +   +TYS I+  +  
Sbjct: 243 YIAPEVLQSLERNSKSH-YGVSCDFWSLGALAFELVVGKPPFSGQNTSVTYSRII--NHS 299

Query: 237 DTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSD------PPCIPPP 290
           + + FP  + L+ A V+ V+ L+ +  ARL   Q+  HP+F  +  D      PP +P  
Sbjct: 300 NNLKFPQDVCLTQAYVSLVRGLLTEAKARLRGPQIKKHPLFKHIHFDSLRDQVPPYVPKI 359

Query: 291 SQ---ENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYT 330
           S     + F     +K +PS++ F+K+ ++    LP IG ++T
Sbjct: 360 SSMEDTSNFADVGAKKTTPSMENFKKKTQFSGRNLPFIGFTFT 402

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|125978741|ref|XP_001353403.1| GA10369 [Drosophila pseudoobscura pseudoobscura] gi|54642161|gb|EAL30910.1| GA10369 [Drosophila pseudoobscura pseudoobscura]

 Score =  266 bits (680), Expect = 3e-68,   Method: Compositional matrix adjust.
 Identities = 191/584 (32%), Positives = 310/584 (53%), Gaps = 65/584 (11%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           + +V+E R+  V+A DF IK  I QG FG+++LV E+Q+ + + MKK+ +  +  +    
Sbjct: 91  RPIVEETRKLRVNADDFTIKALIGQGYFGNVHLVVERQTSDIYAMKKIKKSVVTTSQVKE 150

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           ERDIM      +++NL Y+FQD +++Y IMEY+ GGD ++L+    HG   E  ARFY+ 
Sbjct: 151 ERDIMSARNSEWLINLQYAFQDNDNLYLIMEYMPGGDLLSLMSR--HGPFDEHLARFYLA 208

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           EL  A+  LH +GYVHRDIKP+N+L+   GH+KL DFG+A  +D++G + S+ PVGTP+Y
Sbjct: 209 ELTLALHTLHEMGYVHRDIKPENILIDRFGHIKLADFGNAAALDRDGHVLSLSPVGTPDY 268

Query: 178 VAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CD- 234
           +APE+L+ +     S   +  SCD WS+G++ YELL  +TPF+ + +  TYS IL+ C+ 
Sbjct: 269 IAPELLQTISTYKLSKSMHDVSCDYWSMGIIGYELLCETTPFHEDNVHETYSKILSHCEE 328

Query: 235 --TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFD-----CLDSD-PPC 286
              ++ ++FPS +++S    + ++SLV     RL+ D++  H  FD     C+ S  PP 
Sbjct: 329 SHLKELINFPSELKVSKNYRDLIESLVTNPSKRLSYDRIKTHAFFDDIQWNCMRSQVPPI 388

Query: 287 IPP-PSQENKFHKKDKRK--------ASPSLKAFQKEGRYLDSALPLIGISYTGEPMGAN 337
           IP   S ++  + KD  +           SL    K   +    LP +G S+       N
Sbjct: 389 IPNIKSDDDTSNFKDGTRHKSRRDQLGKKSLTTNMKSHDFSGKDLPFLGYSFVHMDKPPN 448

Query: 338 TNTSSDSTLPPSSEDMRHWKRDRLQ--------LLQQLAEAKASLEDLSCSRTRVLALQA 389
            ++  ++      E ++  ++ RL+        L Q L  A+ SL+        VL  + 
Sbjct: 449 CDSVDEARAIKLQEKLKDLQQ-RLKSRETEISMLKQDLLRAQQSLKKTDNKSQVVLDAKM 507

Query: 390 QVSSLQQDLTSHTSLLSKKEEEIDRLR------QEM-VKKESDLVATSSDLV-ATRHELE 441
           ++  LQQ +   T  L+  + +I  L+      +EM  KKES    T +DL+   R + E
Sbjct: 508 EIKKLQQIIKDKTMELANCKTQIKTLQSSAKVDEEMWSKKES----TITDLLRLNRQKYE 563

Query: 442 EVR--------SELKEKE-----NLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWK 488
           E +         +L EK       L+K D R+LE    S E + L  +L+  K   KQ K
Sbjct: 564 EAKISSEQRYEKQLAEKNQELASTLQKMDARELEFVAKSDECKHLTAKLQNYKDVLKQLK 623

Query: 489 KDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEA 532
           +   Q++K   A     +Q     E+ ++KL  L  +++ S+++
Sbjct: 624 E---QTIK---ADAGHEQQKSQMAESYEQKLLDLRNKIRESQDS 661

Source: Drosophila pseudoobscura pseudoobscura

Species: Drosophila pseudoobscura

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195439886|ref|XP_002067790.1| GK12619 [Drosophila willistoni] gi|194163875|gb|EDW78776.1| GK12619 [Drosophila willistoni]

 Score =  266 bits (679), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 204/714 (28%), Positives = 375/714 (52%), Gaps = 75/714 (10%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           + +V+E RQ  V+  DF +K  I +G FG+++LV E+++ + + MKKV +  +  +    
Sbjct: 93  RPIVEETRQLRVNIDDFIVKTLIGKGYFGNVHLVIERETSDVYAMKKVKKSVVTTSQVKE 152

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           ERDIM + +  +++NL Y+FQD +H+Y +MEY+ GGD ++L+    HG   E  ARFY+ 
Sbjct: 153 ERDIMARRQSEWLINLQYAFQDNDHLYLVMEYMPGGDLLSLMSR--HGPFDEDLARFYLA 210

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           EL  A+  LH +GYVHRDIKP+N+L+   GH+KL DFG+A ++D++G + S+ PVGTP+Y
Sbjct: 211 ELTLALHALHSMGYVHRDIKPENILIDRLGHIKLADFGNAAELDRDGHVLSLSPVGTPDY 270

Query: 178 VAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CD- 234
           +APE+L+ +     S   +  SCD WS+G++ YEL+   TPF+ + +  TYS IL+ C+ 
Sbjct: 271 IAPELLQTISTYKLSKSMHDVSCDYWSMGIIGYELMCDITPFHDDNVHDTYSKILSHCEE 330

Query: 235 --TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSD------PPC 286
              ++ ++FPS +++S    N ++SLV     RL  DQ++ HP FD +  +      PP 
Sbjct: 331 SHLKELITFPSDLKVSANYKNLIESLVTNPSKRLTYDQLVKHPFFDHIQWNTLRSQVPPI 390

Query: 287 IPPPSQENKF---------HK--KDKRKASP--SLKAFQKEGRYLDSALPLIGISYTGEP 333
           +P    ++           HK  +D++  +   SL    K   +    LP IG S+    
Sbjct: 391 MPTIKSDDDTSNFEDGGSRHKGRRDQKAVASKKSLTTNMKSHDFSGKDLPFIGYSFVH-- 448

Query: 334 MGANTNTSSDSTLPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSS 393
           M   T+ +S      +S ++    +++L+ LQQ          L    T +  L+  +  
Sbjct: 449 MEKQTSATS------ASPNLDAKFQEKLKDLQQ---------KLKLRETEIAMLKKDLQR 493

Query: 394 LQQDLT---SHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEK 450
            QQ L    + + +L + + EI +L Q+++K+++  +A  +  + T     ++  E+  K
Sbjct: 494 AQQSLKQTDTKSPVLVEAKMEIKKL-QQIIKEKTIELAHCNTQIKTLQSSAKIDEEMWSK 552

Query: 451 ENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQ-WKKDWYQSVKERNAAVAELKQAQ 509
           +    TD  +L            R + EE K A++Q ++K   +  +E    + +++  +
Sbjct: 553 KEATITDLLRLN-----------RQKYEEAKIASEQRYEKQLTEKKQELATCLQKMEGRE 601

Query: 510 TENEALKEKLTSLEQELKVSEEALA-TAQNSLDSKLREHQALSNTIESMQKEMEQSAVRV 568
            E  A  ++   L  +LK   E L    + SL +++++ +  +   E+ +K++++   ++
Sbjct: 602 LEFNAKNDECKHLSDKLKNYMEMLKQMKEQSLQAEIKQDKQRTQLAENYEKKLDELNQKL 661

Query: 569 REMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLE---STRREL-ETNKDQTIELR 624
           R+        +  R+T LEL+  + +L   V   K   E   +T+R L E  +    E+ 
Sbjct: 662 RQSK------DTHRRTTLELQDVRNQLNDTVSSSKSTQEAKQATQRNLEELLRRLDREIA 715

Query: 625 AKSKLEKAEGELTT-VREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTT 677
           A ++L     +L T ++ ++K++++ +      L ++ Q A+ +   AE  L +
Sbjct: 716 ANNELHSVNAQLNTEIKSKDKEMQEQQTE-CQRLERELQLAECRCHIAESSLAS 768

Source: Drosophila willistoni

Species: Drosophila willistoni

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	792
FB|FBgn0002466	1854	sti "sticky" [Drosophila melan	0.361	0.154	0.397	9.1e-71
UNIPROTKB|E1C849	2054	CIT "Uncharacterized protein"	0.928	0.357	0.270	1e-65
UNIPROTKB|E2RPN3	2053	CIT "Uncharacterized protein"	0.928	0.358	0.265	2.2e-65
UNIPROTKB|O14578	2027	CIT "Citron Rho-interacting ki	0.950	0.371	0.261	3.5e-65
ZFIN|ZDB-GENE-060125-2	1401	rock2b "rho-associated, coiled	0.936	0.529	0.285	1.3e-63
UNIPROTKB|F1MAI4	2013	Cit "Protein Cit" [Rattus norv	0.952	0.374	0.259	5.9e-63
MGI|MGI:105313	2055	Cit "citron" [Mus musculus (ta	0.898	0.346	0.268	6.2e-63
ZFIN|ZDB-GENE-030131-3647	1708	cdc42bpb "CDC42 binding protei	0.944	0.437	0.267	9e-63
UNIPROTKB|F1NK88	1289	Gga.17943 "Uncharacterized pro	0.944	0.580	0.249	1.2e-62
UNIPROTKB|F1NUB2	1660	CDC42BPA "Uncharacterized prot	0.931	0.444	0.268	1.4e-62

FB|FBgn0002466 sti "sticky" [Drosophila melanogaster (taxid:7227)]

 Score = 599 (215.9 bits), Expect = 9.1e-71, Sum P(2) = 9.1e-71
 Identities = 120/302 (39%), Positives = 193/302 (63%)

Query:     1 KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
             + +++E R+  V+A DF IK  I QG FG+++LV E+Q+++ + MKK+ +  +  +    
Sbjct:    97 RPIIEETRKLRVNADDFLIKTLIGQGYFGNVHLVVERQTNDIYAMKKIKKSVVTTSQVKE 156

Query:    58 ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
             ERDIM      +++NL Y+FQD +++Y +MEY+ GGD ++L+    HG   E  ARFY+ 
Sbjct:   157 ERDIMSIRNSEWLINLQYAFQDNDNLYLVMEYMPGGDLLSLMSR--HGPFDEDLARFYLA 214

Query:   118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
             EL  A+  LH +GYVHRDIKP+N+L+   GH+KL DFG+A  +D++G + S+ PVGTP+Y
Sbjct:   215 ELTVALHTLHEMGYVHRDIKPENILIDRFGHIKLADFGNAAALDRDGHVLSLSPVGTPDY 274

Query:   178 VAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CDT 235
             +APE+L+ +     S   +  SCD WS+G++ YEL+  +TPF+ + +  TYS IL+ C+ 
Sbjct:   275 IAPELLQTISTYKLSKSMHDVSCDYWSMGIIGYELICETTPFHEDNVHETYSKILSHCEE 334

Query:   236 ---EDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFD-----CLDSD-PPC 286
                ++ +SFP+ +++S    N ++SLV     RL+ +++  HP F       + S  PP 
Sbjct:   335 SHLKELISFPADLKVSVNYRNLIESLVTNPSKRLSYERIKNHPFFSEIPWGSIRSQVPPI 394

Query:   287 IP 288
             IP
Sbjct:   395 IP 396

GO:0019992 "diacylglycerol binding" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0000910 "cytokinesis" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0000915 "cytokinesis, actomyosin contractile ring assembly" evidence=IMP

GO:0000281 "cytokinesis after mitosis" evidence=IMP

GO:0005826 "actomyosin contractile ring" evidence=IDA

GO:0007109 "cytokinesis, completion of separation" evidence=IMP

GO:0032956 "regulation of actin cytoskeleton organization" evidence=IMP

GO:0006325 "chromatin organization" evidence=IMP

GO:2000431 "regulation of cytokinesis, actomyosin contractile ring assembly" evidence=IDA

UNIPROTKB|E1C849 CIT "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 683 (245.5 bits), Expect = 1.0e-65, P = 1.0e-65
 Identities = 219/811 (27%), Positives = 397/811 (48%)

Query:     2 DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTI-- 57
             + + ELR+   S  DFD+K  +  G+F D+ +V EK + + + MK + +E +     +  
Sbjct:    82 ETIAELRELQPSVKDFDVKSVVGCGHFADVKVVREKVTGDVYAMKVMSKESLLAQEHVSF 141

Query:    58 ---ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
                ER I+ +S  P+I  L Y+FQD  ++Y +MEY  GGD ++LL N+    L ES  +F
Sbjct:   142 FEEERSILSQSTSPWIPQLQYAFQDKKNLYLVMEYQPGGDLLSLL-NRYEDQLDESMVQF 200

Query:   115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
             Y+ EL  A+  +H +GYVHRDIKP+N+L+  TGH+KL DFGSA ++  N  + + +PVGT
Sbjct:   201 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLVDFGSAAKMTVNKMVNAKLPVGT 260

Query:   175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
             P+Y+APE+L  + G+ G   Y   CD WS+GV++YE++ G +PF   T   T+++I+  +
Sbjct:   261 PDYMAPEMLTGLNGD-GKASYGPECDWWSLGVIAYEMIYGRSPFTEGTSAKTFNNIM--N 317

Query:   235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD------SDPPCIP 288
              +  + FP  +++S+  ++ +QSL+     RL  + +  HP F  +D      S PP +P
Sbjct:   318 FQRYLKFPEDVKVSSEFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSPPPFVP 377

Query:   289 PPSQEN---KFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSDST 345
                 ++    F + +K     S         +    LP +G S+  + +G      S+S 
Sbjct:   378 TLKSDDDTSNFDEPEKNSGVLSSTRQLNPAGFSGEDLPFVGFSFI-KALGT---LRSESV 433

Query:   346 LPPSSEDMRHWKRDRXXXXXXXAEAKASLE--DLSCSRTRXXXXXXXXXXXXXXXTSHTS 403
             L  SS D                E K  L+  +L  ++ +               +   +
Sbjct:   434 L--SSVD--------SPAKVSSMEKKLLLKSKELQDAQDKCHKMEQEMTRLHRRVSEVEA 483

Query:   404 LLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKEN--LEKTDD--- 458
             +LS+KE E+     +    E DL    ++  + +  LE+ R E+ ++++  L+   D   
Sbjct:   484 VLSQKEVELKASETQRSLLEQDLATYITECSSLKRSLEQARMEVSQEDDKALQLLHDIRE 543

Query:   459 --RKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALK 516
               RKL+  E+ KE E  + ++EE +    Q ++D   + +  +   +EL++++   E  K
Sbjct:   544 QSRKLQ--EI-KEQEY-QAQVEEMRLMMNQLEEDLISARRRSDLYESELRESRMAAEEFK 599

Query:   517 EKLTSLEQEL-KVSEEALATAQNSLDSKLR----EHQA-LSNTIESMQKEMEQSAVRVRE 570
              K T    +L KV ++  + A   L  KL     E QA +    E + K ++ S+     
Sbjct:   600 RKATECHNKLQKVKDQGKSEA-GELYCKLEKINTEQQAKIQELQEKLTKAVKASSEATEL 658

Query:   571 MSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETN--KDQTIELRAKSK 628
             +  I +  E+  K L +L++ ++  E  ++   L+ E  R  LE    + +T+E R +++
Sbjct:   659 LQNIRQAKERAEKELEKLQNREDSNE-SMKKKLLEAEERRHSLENQVKRLETVE-RRENR 716

Query:   629 LEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVS 688
             L++   ++ T  ++ +++ + KI  +    ++ Q +   LE    +     EE  KLKV 
Sbjct:   717 LKE---DIQTKSQQIQQMAE-KILELEEKHREAQISAQHLELQLKQKEQFYEE--KLKV- 769

Query:   689 FFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRS 748
                 LE N +        L+  E L++     E + R   +++ E +  I A++S +   
Sbjct:   770 ----LE-NQM-----KKDLADKEALENMLRRHEEEAREKCKVLAEQKAMINAMDSKIRSL 819

Query:   749 ESYCKEMVEYLETLQKNNDILSHDNEQLRKK 779
             E    E+ E    L  N+ + +  N + +++
Sbjct:   820 EQRIVELSE-ANKLAANSSLFTQRNMKAQEE 849

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0000070 "mitotic sister chromatid segregation" evidence=IEA

GO:0001726 "ruffle" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005773 "vacuole" evidence=IEA

GO:0007091 "metaphase/anaphase transition of mitotic cell cycle" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IEA

GO:0015629 "actin cytoskeleton" evidence=IEA

GO:0016358 "dendrite development" evidence=IEA

GO:0033205 "cell cycle cytokinesis" evidence=IEA

GO:0050774 "negative regulation of dendrite morphogenesis" evidence=IEA

UNIPROTKB|E2RPN3 CIT "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 680 (244.4 bits), Expect = 2.2e-65, P = 2.2e-65
 Identities = 215/811 (26%), Positives = 406/811 (50%)

Query:     2 DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK--VLREKMPNT 56
             D + EL++   SA DF+++  +  G+F ++ +V E+ + + +   VMKK  +L ++  + 
Sbjct:    82 DTIAELQELQPSAKDFEVRSLVGCGHFAEVQVVRERATGDIYAMKVMKKKTLLAQEQVSF 141

Query:    57 IE--RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
              E  R+I+ +S  P+I  L Y+FQD N++Y +MEY  GGD ++LL N+    L E+  +F
Sbjct:   142 FEEERNILSQSMSPWIPQLQYAFQDKNNLYLVMEYQPGGDLLSLL-NRYEDQLDENMIQF 200

Query:   115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
             Y+ EL  AV  +H +GYVHRDIKP+N+L+  TGH+KL DFGSA +++ N  + + +P+GT
Sbjct:   201 YLAELILAVHSIHQMGYVHRDIKPENILIDRTGHIKLVDFGSAAKMNSNKMVSAKLPIGT 260

Query:   175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
             P+Y+APEVL  M G+ G   Y+  CD WS+GV++YE++ G +PF   T   T+S+I+  +
Sbjct:   261 PDYMAPEVLTVMNGD-GKGIYSLDCDWWSVGVIAYEMVYGRSPFTEGTSARTFSNIM--N 317

Query:   235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD------SDPPCIP 288
              +  + FP   ++S  +++ +QSL+     RL  + +  HP F  +D      S PP +P
Sbjct:   318 FQRFLKFPDDPKVSGELLDLIQSLLCGQRERLKFEGLCCHPFFSKIDWNNIRNSPPPFVP 377

Query:   289 PPSQEN---KFHKKDKRK-ASPSLKAFQKEGRYLDSALPLIGISYTGEP--MGANTNTSS 342
                 ++    F + +K    S S +     G +    LP +G SY+     +G + +  S
Sbjct:   378 TLKSDDDTSNFDEPEKNSWVSSSPRQLNLSG-FSGEELPFVGFSYSKALGILGRSESIVS 436

Query:   343 DSTLPPSSEDMRHWKRDRXXXXXXXAEAKASLEDLSCSRTRXXXXXXXXXXXXXXXTSHT 402
                 P  +  M   K+          ++K  L+D   S+ +               +   
Sbjct:   437 SLDSPAKTSSME--KK-------LLIKSK-ELQD---SQDKCHKMEQEMTRLHRRVSEVE 483

Query:   403 SLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKEN--LEKTDD-- 458
             ++LS+KE E+     +    E DL    ++  + +  LE+ R E+ ++++  L+   D  
Sbjct:   484 AVLSQKEVELKASETQRSLLEQDLATYITECSSLKRSLEQARMEVSQEDDKALQLLHDIR 543

Query:   459 ---RKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEAL 515
                RKL+  E+ KE E  + ++EE +    Q ++D   + +  +   +EL++++   E  
Sbjct:   544 EQSRKLQ--EI-KEQEY-QAQVEEMRLMMNQLEEDLVSARRRSDLYESELRESRLAAEEF 599

Query:   516 KEKLTSLEQEL-KVSEEALA-TAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVRE--- 570
             K K T  + +L K  ++      + S   K+   Q L   I+ +Q+++E++     E   
Sbjct:   600 KRKATECQHKLMKAKDQGKPEVGEYSKLEKINAEQQLK--IQELQEKLEKAVKASTEATE 657

Query:   571 -MSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKL 629
              +  I +  E+  + L +L++ ++  E  ++   ++ E  R  LE NK + +E      +
Sbjct:   658 LLQNIRQAKERAERELEKLQNREDSSE-GIKKKLVEAEERRHSLE-NKVKRLET-----M 710

Query:   630 EKAEGELTT-VREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVS 688
             E+ E  L   ++ ++++++Q   +++  L +  + AQ   +  E  L   +E++ + K+ 
Sbjct:   711 ERRENRLKDDIQTKSQQIQQMADKIL-ELEEKHREAQVSAQHLEVHLKQ-KEQHYEEKIK 768

Query:   689 FFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRS 748
                +     L   D  T    LE+L   +   E +     +I+ E +  I A++S +   
Sbjct:   769 VLDSQIKKDL--ADKET----LENLMQRH---EEEAHEKGKILSEQKAMINAMDSKIRSL 819

Query:   749 ESYCKEMVEYLETLQKNNDILSHDNEQLRKK 779
             E    E+ E    L  N+ + +  N + +++
Sbjct:   820 EQRIVELSE-ANKLAANSSLFTQRNMKAQEE 849

GO:0050774 "negative regulation of dendrite morphogenesis" evidence=IEA

GO:0033205 "cell cycle cytokinesis" evidence=IEA

GO:0016358 "dendrite development" evidence=IEA

GO:0015629 "actin cytoskeleton" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IEA

GO:0007091 "metaphase/anaphase transition of mitotic cell cycle" evidence=IEA

GO:0005773 "vacuole" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0001726 "ruffle" evidence=IEA

GO:0000070 "mitotic sister chromatid segregation" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

UNIPROTKB|O14578 CIT "Citron Rho-interacting kinase" [Homo sapiens (taxid:9606)]

 Score = 678 (243.7 bits), Expect = 3.5e-65, P = 3.5e-65
 Identities = 216/826 (26%), Positives = 406/826 (49%)

Query:     2 DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK--VLREKMPNT 56
             D + EL++   SA DF+++  +  G+F ++ +V EK + + +   VMKK  +L ++  + 
Sbjct:    82 DTIAELQELQPSAKDFEVRSLVGCGHFAEVQVVREKATGDIYAMKVMKKKALLAQEQVSF 141

Query:    57 IE--RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
              E  R+I+ +S  P+I  L Y+FQD NH+Y +MEY  GGD ++LL N+    L E+  +F
Sbjct:   142 FEEERNILSRSTSPWIPQLQYAFQDKNHLYLVMEYQPGGDLLSLL-NRYEDQLDENLIQF 200

Query:   115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
             Y+ EL  AV  +H +GYVHRDIKP+N+L+  TGH+KL DFGSA +++ N  + + +P+GT
Sbjct:   201 YLAELILAVHSVHLMGYVHRDIKPENILVDRTGHIKLVDFGSAAKMNSNKMVNAKLPIGT 260

Query:   175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
             P+Y+APEVL  M G+ G   Y   CD WS+GV++YE++ G +PF   T   T+++I+  +
Sbjct:   261 PDYMAPEVLTVMNGD-GKGTYGLDCDWWSVGVIAYEMIYGRSPFAEGTSARTFNNIM--N 317

Query:   235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD------SDPPCIP 288
              +  + FP   ++S+  ++ +QSL+     RL  + +  HP F  +D      S PP +P
Sbjct:   318 FQRFLKFPDDPKVSSDFLDLIQSLLCGQKERLKFEGLCCHPFFSKIDWNNIRNSPPPFVP 377

Query:   289 PPSQEN---KFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEP--MGANTNTSSD 343
                 ++    F + +K     S         +    LP +G SY+     +G + +  S 
Sbjct:   378 TLKSDDDTSNFDEPEKNSWVSSSPCQLSPSGFSGEELPFVGFSYSKALGILGRSESVVSG 437

Query:   344 STLPPSSEDMRHWKRDRXXXXXXXAEAKASLEDLSCSRTRXXXXXXXXXXXXXXXTSHTS 403
                P  +  M   K+          ++K  L+D   S+ +               +   +
Sbjct:   438 LDSPAKTSSME--KK-------LLIKSK-ELQD---SQDKCHKMEQEMTRLHRRVSEVEA 484

Query:   404 LLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKEN--LEKTDD--- 458
             +LS+KE E+     +    E DL    ++  + +  LE+ R E+ ++++  L+   D   
Sbjct:   485 VLSQKEVELKASETQRSLLEQDLATYITECSSLKRSLEQARMEVSQEDDKALQLLHDIRE 544

Query:   459 --RKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALK 516
               RKL+  E+ KE E  + ++EE +    Q ++D   + +  +   +EL++++   E  K
Sbjct:   545 QSRKLQ--EI-KEQEY-QAQVEEMRLMMNQLEEDLVSARRRSDLYESELRESRLAAEEFK 600

Query:   517 EKLTSLEQEL-KVSEEALA-TAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVRE---- 570
              K T  + +L K  ++      + +   K+   Q L   I+ +Q+++E++     E    
Sbjct:   601 RKATECQHKLLKAKDQGKPEVGEYAKLEKINAEQQLK--IQELQEKLEKAVKASTEATEL 658

Query:   571 MSGISEKYEKDRKTLLELKSAKERLELEVRGYKL----DLESTRRELETNKDQTIELRAK 626
             +  I +  E+  + L +L++ ++  E  +R  KL    +LE   RE + +  Q +E+  K
Sbjct:   659 LQNIRQAKERAERELEKLQNREDSSE-GIRK-KLVEAEELEEKHREAQVSA-QHLEVHLK 715

Query:   627 SKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLK 686
              K +  E ++  +  + KK    K  L   + +  + A  K +    +   +   + K++
Sbjct:   716 QKEQHYEEKIKVLDNQIKKDLADKETLENMMQRHEEEAHEKGKILSEQKAMINAMDSKIR 775

Query:   687 VSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMT 746
                  +LE   +   + N   ++     S +T+R  K +   E+I E   +   LE+   
Sbjct:   776 -----SLEQRIVELSEANKLAAN----SSLFTQRNMKAQE--EMISELRQQKFYLETQAG 824

Query:   747 RSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDI-LSHDNEQL 791
             + E+  +++ E LE +   +    +   +L  +  ++ L H+ ++L
Sbjct:   825 KLEAQNRKLEEQLEKISHQDHSDKNRLLELETRLREVSLEHEEQKL 870

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0017124 "SH3 domain binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0000070 "mitotic sister chromatid segregation" evidence=IEA

GO:0001726 "ruffle" evidence=IEA

GO:0005773 "vacuole" evidence=IEA

GO:0007091 "metaphase/anaphase transition of mitotic cell cycle" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IEA

GO:0015629 "actin cytoskeleton" evidence=IEA

GO:0016358 "dendrite development" evidence=IEA

GO:0050774 "negative regulation of dendrite morphogenesis" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0007067 "mitosis" evidence=ISS

GO:0048699 "generation of neurons" evidence=ISS

GO:0033205 "cell cycle cytokinesis" evidence=IMP

ZFIN|ZDB-GENE-060125-2 rock2b "rho-associated, coiled-coil containing protein kinase 2b" [Danio rerio (taxid:7955)]

 Score = 660 (237.4 bits), Expect = 1.3e-63, P = 1.3e-63
 Identities = 233/816 (28%), Positives = 376/816 (46%)

Query:     4 VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ 57
             V  L++  V   DFD  + I +G FG + LV  K S   + MK++ + +M          
Sbjct:    65 VCNLKELQVKLDDFDRVKLIGRGAFGAVQLVRHKVSQQVYAMKQLSKFEMVKRSDSAFFW 124

Query:    58 -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
              ERDIM  S+ P+IV L  +FQD  ++Y +ME++ GGD VTL  N     + E  A+FY 
Sbjct:   125 EERDIMAFSQSPWIVQLCCAFQDEKYLYLVMEFMPGGDLVTLTSNYD---IPEEWAQFYT 181

Query:   117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
              E+  A+  +H LG++HRDIKPDNMLL   GHLKL DFG+  ++D  G ++    VGTP+
Sbjct:   182 AEVVLALDAIHSLGFIHRDIKPDNMLLDRNGHLKLADFGTCMKMDSTGMVRCDTAVGTPD 241

Query:   177 YVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
             Y++PEVL     + G  GY G  CD WS+GV  YELL G TPF  E+L  TY  I+  D 
Sbjct:   242 YISPEVLM----SQGGTGYYGRECDWWSVGVFIYELLVGDTPFYSESLVGTYGKIM--DH 295

Query:   236 EDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN---MDQVLGHP-------VFDCL-DSDP 284
             +++++FP  I +S    + + + +   + RL    +D++  HP        FD + D+  
Sbjct:   296 KNSLTFPDDIEMSKNAKDLICAFLSSREVRLGRTGVDEIKCHPFFKNDQWTFDTIRDTMA 355

Query:   285 PCIPPPSQE-NKFHKKDKRKASP-SLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSS 342
             P +P  S + +  +  D  K  P   + F     +  + LP +G +Y  E       T  
Sbjct:   356 PVVPELSSDIDTSNFDDDIKDDPIGTETFPPPRAFAGNQLPFVGFTYFREDQ---LLTQQ 412

Query:   343 DSTLPPSSEDMRHWKRDRXXXXXXXAEAKASLEDLSCSRTRXXXXXXXXXXXXXXXTSHT 402
             +     S ED+     D         + +  L+ L                         
Sbjct:   413 NKC---SEEDIIE---DHGLNHTESNDLEKRLKKLEEKFKHEMQAKEELENKCRIANQRL 466

Query:   403 SLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLE 462
               LSK  EE    RQE    E +L +   + V  +H+    R++   K  LE TD ++L 
Sbjct:   467 EKLSKDLEEEVNARQEA---EDNLRSLEKEKVLLKHQ----RTQSVRKAGLE-TDRKRLL 518

Query:   463 VCEVSKELEVLRGELEEQKTATK-QWKKDWY--QSVKERNAAV-AELKQAQTENEALKEK 518
               EVS   E L  EL+++   +    +K+ +  + ++E +A + AEL++++   +A  E 
Sbjct:   519 ENEVSSLKEQL-AELKKKNQISHLSAEKNIHLERQLEEVSAKLQAELEESERLKKAQIEA 577

Query:   519 LTSLEQ-ELKVSE--EALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGIS 575
                 +Q EL + E  E LA  +NS     ++  +L  ++E  ++E    +  + ++ G  
Sbjct:   578 FRQSQQLELSLRELQERLAQLENSRLVLEQDKLSLQTSLELEKRERNAGSETITDLQGRI 637

Query:   576 EKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNK---DQTIELRA-KSKLEK 631
                E + K    +KS+  + E+E R  + DL  T  E E NK   D + +L+A +  LE+
Sbjct:   638 YGLEGELK---HIKSSLSKAEVEKRQLQEDL--TTLEKEKNKQEIDLSFKLKAVQQSLEQ 692

Query:   632 AEGELTTVRE---ENKKLKQGKIRLVYSLFKDPQ----PAQSKLEKAEGELTTVREENKK 684
              E E  T +    +N K+ Q  I       KD +      +S  ++ E  L  + +EN  
Sbjct:   693 EEAEHKTTKARLADNNKINQS-IEAKSETLKDMEHKLLEERSAKQQLENRLMQLEKENSV 751

Query:   685 LKVSFFFTL-ESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALES 743
             L   +     E   L  L  N     +E L     +   +       +     +I +L S
Sbjct:   752 LDCDYKQAKHELQELRSLKEN-LTEQVEVLNVRVQQETQRKTLCQGDLKVQRQEINSLRS 810

Query:   744 TMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKK 779
             +  + +     ++E   TL+K N  LS + E+  K+
Sbjct:   811 SEQQLKQELNHLLELKLTLEKQNQELSKEREESEKQ 846

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0017048 "Rho GTPase binding" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0060287 "epithelial cilium movement involved in determination of left/right asymmetry" evidence=IMP

GO:0070121 "Kupffer's vesicle development" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

UNIPROTKB|F1MAI4 Cit "Protein Cit" [Rattus norvegicus (taxid:10116)]

 Score = 657 (236.3 bits), Expect = 5.9e-63, P = 5.9e-63
 Identities = 214/824 (25%), Positives = 403/824 (48%)

Query:     2 DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKKV-LREKMPNTI 57
             D + ELR+   S  DF+++  +  G+F ++ +V EK + + +   +MKK  LR +   + 
Sbjct:    82 DTIAELRELQPSVRDFEVRSLVGCGHFAEVQVVREKATGDVYAMKIMKKAALRAQEQVSF 141

Query:    58 ---ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
                ER+I+ +S  P+I  L Y+FQD N++Y +MEY  GGD ++LL N+    L E+  +F
Sbjct:   142 FEEERNILSQSTSPWIPQLQYAFQDKNNLYLVMEYQPGGDLLSLL-NRYEDQLDENMIQF 200

Query:   115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
             Y+ EL  AV  +H +GYVHRDIKP+N+L+  TGH+KL DFGSA +++ N ++ + +P+GT
Sbjct:   201 YLAELILAVHSVHQMGYVHRDIKPENILIDRTGHIKLVDFGSAAKMNSN-KVDAKLPIGT 259

Query:   175 PEYVAPEVLEWM-EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
             P+Y+APEVL  M E   G+ G    CD WS+GVV+YE+L G TPF   T   T+++I+  
Sbjct:   260 PDYMAPEVLTVMNEDRRGTYGL--DCDWWSVGVVAYEMLYGKTPFTEGTSARTFNNIM-- 315

Query:   234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD------SDPPCI 287
             + +  + FP   ++S+ +++ +QSL+     RL  + +  HP F   D      S PP +
Sbjct:   316 NFQRFLKFPDDPKVSSELLDLIQSLLCVQKERLKFEGLCCHPFFARTDWNNIRNSPPPFV 375

Query:   288 PPPSQEN---KFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEP--MGANTNTSS 342
             P    ++    F + +K     S         +    LP +G SY+     +G + +  S
Sbjct:   376 PTLKSDDDTSNFDEPEKNSWVSSSPCQLSPSGFSGEELPFVGFSYSKALGYLGRSESVVS 435

Query:   343 DSTLPPSSEDMRHWKRDRXXXXXXXAEAKASLEDLSCSRTRXXXXXXXXXXXXXXXTSHT 402
                 P     M   K+          ++K  L+D   S+ +               +   
Sbjct:   436 GLDSPAKISSME--KK-------LLIKSK-ELQD---SQDKCHKMEQEMARLHRRVSEVE 482

Query:   403 SLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKEN--LEKTDD-- 458
             ++LS+KE E+     +    E DL    ++  + +  LE+ R E+ ++++  L+   D  
Sbjct:   483 AVLSQKEVELKASETQRSLLEQDLATYITECSSLKRSLEQARMEVSQEDDKALQLLHDIR 542

Query:   459 ---RKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEAL 515
                RKL+  E+ KE E  + ++EE +    Q ++D   + +  +   +EL++++   E  
Sbjct:   543 EQSRKLQ--EI-KEQEY-QAQVEEMRLMMNQLEEDLVSARRRSDLYESELRESRLAAEEF 598

Query:   516 KEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNT-IESMQKEMEQSAVRVRE---- 570
             K K    + +L  +++ L   +    S+L +  A     I+ +Q+++E++     E    
Sbjct:   599 KRKANECQHKLMKAKD-LGKPEVGECSRLEKINAEQQLKIQELQEKLEKAVKASTEATEL 657

Query:   571 MSGISEKYEKDRKTLLELKSAKERLE-LEVRGYKLD-LESTRRELETNKDQTIELRAKSK 628
             +  I +  E+  + L +L + ++  E ++ +  + + LE   RE + +  Q +E+  K K
Sbjct:   658 LQNIRQAKERAERELEKLHNREDSSEGIKKKLVEAEELEEKHREAQVSA-QHLEVHLKQK 716

Query:   629 LEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVS 688
              +  E ++  +  + KK    K  L   + +  + A  K +    +   +   + K++  
Sbjct:   717 EQHYEEKIKVLDNQIKKDLADKESLETMMQRHEEEAHEKGKILSEQKAMINAMDSKIR-- 774

Query:   689 FFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRS 748
                +LE   +   + N   ++     S +T+R  K +   E+I E   +   LE+   + 
Sbjct:   775 ---SLEQRIVELSEANKLAAN----SSLFTQRNMKAQE--EMISELRQQKFYLETQAGKL 825

Query:   749 ESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDI-LSHDNEQL 791
             E+  +++ E LE +   +    +   +L  +  ++ L H+ ++L
Sbjct:   826 EAQNRKLEEQLEKISHQDHSDKNRLLELETRLREVSLEHEEQKL 869

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

MGI|MGI:105313 Cit "citron" [Mus musculus (taxid:10090)]

 Score = 657 (236.3 bits), Expect = 6.2e-63, P = 6.2e-63
 Identities = 212/790 (26%), Positives = 392/790 (49%)

Query:     2 DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK--VLREKMPNT 56
             D + ELR+   SA DF+++  +  G+F ++ +V EK + + +   +MKK  +L ++  + 
Sbjct:    82 DTIAELRELQPSARDFEVRSLVGCGHFAEVQVVREKATGDVYAMKIMKKKALLAQEQVSF 141

Query:    57 IE--RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
              E  R+I+ +S  P+I  L Y+FQD N++Y +MEY  GGDF++LL N+    L ES  +F
Sbjct:   142 FEEERNILSRSTSPWIPQLQYAFQDKNNLYLVMEYQPGGDFLSLL-NRYEDQLDESMIQF 200

Query:   115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
             Y+ EL  AV  +H +GYVHRDIKP+N+L+  TG +KL DFGSA +++ N ++ + +P+GT
Sbjct:   201 YLAELILAVHSVHQMGYVHRDIKPENILIDRTGEIKLVDFGSAAKMNSN-KVDAKLPIGT 259

Query:   175 PEYVAPEVLEWM-EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
             P+Y+APEVL  M E   G+ G    CD WS+GVV+YE++ G TPF   T   T+++I+  
Sbjct:   260 PDYMAPEVLTVMNEDRRGTYGL--DCDWWSVGVVAYEMVYGKTPFTEGTSARTFNNIM-- 315

Query:   234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD------SDPPCI 287
             + +  + FP   ++S+ +++ +QSL+     RL  + +  HP F   D      S PP +
Sbjct:   316 NFQRFLKFPDDPKVSSELLDLLQSLLCVQKERLKFEGLCCHPFFARTDWNNIRNSPPPFV 375

Query:   288 PPPSQEN---KFHKKDKRK-ASPSLKAFQKEGRYLDSALPLIGISYTGEP--MGANTNTS 341
             P    ++    F + +K    S S+      G +    LP +G SY+     +G + +  
Sbjct:   376 PTLKSDDDTSNFDEPEKNSWVSSSVCQLSPSG-FSGEELPFVGFSYSKALGYLGRSESVV 434

Query:   342 SDSTLPPSSEDMRHWKRDRXXXXXXXAEAKASLEDLSCSRTRXXXXXXXXXXXXXXXTSH 401
             S    P     M   K+          ++K  L+D   S+ +               +  
Sbjct:   435 SSLDSPAKVSSME--KK-------LLIKSK-ELQD---SQDKCHKMEQEMTRLHRRVSEV 481

Query:   402 TSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKEN--LEKTDD- 458
              ++LS+KE E+     +    E DL    ++  + +  LE+ R E+ ++++  L+   D 
Sbjct:   482 EAVLSQKEVELKASETQRSLLEQDLATYITECSSLKRSLEQARMEVSQEDDKALQLLHDI 541

Query:   459 ----RKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEA 514
                 RKL+  E+ KE E  + ++EE +    Q ++D   + +  +   +EL++++   E 
Sbjct:   542 REQSRKLQ--EI-KEQEY-QAQVEEMRLMMNQLEEDLVSARRRSDLYESELRESRLAAEE 597

Query:   515 LKEKLTSLEQEL-KVSEEALA-TAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVRE-- 570
              K K    + +L K  ++      + S   K+   Q L   I+ +Q+++E++     E  
Sbjct:   598 FKRKANECQHKLMKAKDQGKPEVGEYSKLEKINAEQQLK--IQELQEKLEKAVKASTEAT 655

Query:   571 --MSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSK 628
               +  I +  E+  + L +L + ++  E  ++   ++ E  R  LE NK + +E      
Sbjct:   656 ELLQNIRQAKERAERELEKLHNREDSSE-GIKKKLVEAEERRHSLE-NKVKRLET----- 708

Query:   629 LEKAEGELTT-VREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKV 687
             +E+ E  L   ++ ++++++Q   +++  L +  + AQ   +  E  L   +E++ + K+
Sbjct:   709 MERRENRLKDDIQTKSEQIQQMADKIL-ELEEKHREAQVSAQHLEVHLKQ-KEQHYEEKI 766

Query:   688 SFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTR 747
                     N +        L+  E L++     E +     +I+ E +  I A++S +  
Sbjct:   767 KVL----DNQI-----KKDLADKESLENMMQRHEEEAHEKGKILSEQKAMINAMDSKIRS 817

Query:   748 SESYCKEMVE 757
              E    E+ E
Sbjct:   818 LEQRIVELSE 827

GO:0000070 "mitotic sister chromatid segregation" evidence=IMP

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000910 "cytokinesis" evidence=IMP

GO:0001726 "ruffle" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0007030 "Golgi organization" evidence=ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0007067 "mitosis" evidence=IDA

GO:0007091 "metaphase/anaphase transition of mitotic cell cycle" evidence=IMP

GO:0007275 "multicellular organismal development" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IMP

GO:0007399 "nervous system development" evidence=IEA

GO:0008064 "regulation of actin polymerization or depolymerization" evidence=ISO

GO:0015629 "actin cytoskeleton" evidence=IDA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016358 "dendrite development" evidence=IMP

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017048 "Rho GTPase binding" evidence=ISO

GO:0017124 "SH3 domain binding" evidence=IEA

GO:0030154 "cell differentiation" evidence=IEA

GO:0031985 "Golgi cisterna" evidence=ISO

GO:0033205 "cell cycle cytokinesis" evidence=ISO

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0043025 "neuronal cell body" evidence=ISO

GO:0045665 "negative regulation of neuron differentiation" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

GO:0048699 "generation of neurons" evidence=IDA

GO:0050774 "negative regulation of dendrite morphogenesis" evidence=IDA

GO:0051301 "cell division" evidence=IEA

ZFIN|ZDB-GENE-030131-3647 cdc42bpb "CDC42 binding protein kinase beta (DMPK-like)" [Danio rerio (taxid:7955)]

 Score = 654 (235.3 bits), Expect = 9.0e-63, P = 9.0e-63
 Identities = 218/814 (26%), Positives = 370/814 (45%)

Query:     4 VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE----KMPNTI-- 57
             VKE+R   +   DF++ + I +G FG++ +V+ K +   + MK +L +    K   T   
Sbjct:    66 VKEMR---LHRDDFEMLKVIGRGAFGEVAVVKMKHTERVYAMK-ILNKWEMLKRAETACF 121

Query:    58 --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
               ER+++V   C +I  L Y+FQD N++Y +M+Y  GGD +TLL ++    L E  A+FY
Sbjct:   122 REERNVLVNGDCQWITTLHYAFQDDNYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMAKFY 180

Query:   116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
             + E+  A+  +H   YVHRDIKPDN+LL   GH++L DFGS  ++ ++G ++S V VGTP
Sbjct:   181 VAEMVLAIHSIHQQRYVHRDIKPDNVLLDMNGHIRLADFGSCLKMMQDGTVQSSVAVGTP 240

Query:   176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
             +Y++PE+L+ ME   G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  + 
Sbjct:   241 DYISPEILQAMEDGMGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NH 296

Query:   236 EDTVSFPSSIR-LSTAMVNFVQSLVQKLDARLN---MDQVLGHPVFDCLD------SDPP 285
             E+   FPS I  +S    + +Q L+   + RL    +++   H  F  +D       + P
Sbjct:   297 EERFQFPSHITDVSEDAKDLIQRLICSRERRLGQHGIEEFRKHAFFSGIDWENIRNMEAP 356

Query:   286 CIPP---PSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSS 342
              IP    PS  + F   D    +P +        +    LP +G +YT E   ++  +  
Sbjct:   357 YIPDVSSPSDTSNFDVDDDVLKNPDIAPPVSHTGFTGQHLPFVGFTYTTESCFSDGGSMR 416

Query:   343 DSTLPP--SSEDMRHWKRD-RXXXXXXXAEAKASLE-DLSCSRTRXXXXXXXXXXXXXXX 398
                L    + ED++                 +  LE +     +                
Sbjct:   417 GVALSDGGTGEDLQDGGMQVEAFEKRIRCLEQEKLELNRKLQESTQAVQSLHGSGRGAGT 476

Query:   399 TSHTSLLSKKEEEIDRLRQEMVKKESD-LVATSSDLVATRHELEEVRSELKEKENLEKTD 457
                   + K  EEIDRL++++   +SD L     + V  R + E   ++LK  +   K  
Sbjct:   477 LGRDKEIKKLNEEIDRLKKKLA--DSDRLEHQLEEAVTLRQDFESSSTKLKALDKQVKA- 533

Query:   458 DRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKE 517
               KLE  ++ K+L      L+  K+ TK+ K D +Q   +R  A+ E  +       L+ 
Sbjct:   534 -LKLEKEDIHKQLVE---SLDRLKSQTKELK-DAHQ---QRKLAMQEFSEVNERMAELRS 585

Query:   518 KLTSLEQELKVSEEALATAQNSLDSK---LREHQALSNTIESMQKEMEQSAVRVREMSGI 574
             +   L ++L+  EE +      +D+    +R+ +     +ES  ++    A + R++   
Sbjct:   586 QKQRLSRQLRDKEEEMEVVMQKIDAMRQDIRKTEKARKELESQLEDARAEASKERKLREH 645

Query:   575 SEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEG 634
             SE Y K  ++ LE    K+       G   + +    +L++  D+   L  + +L + E 
Sbjct:   646 SEVYSKQLESELETLKVKQGAG-RASGLGAETQQELTKLKSELDKK-GLYYEEELVRREA 703

Query:   635 ELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREEN-KKLKVSFF--- 690
               TT  +  +K  Q       SL K+    + KLEKA+ E     EE    LK  +    
Sbjct:   704 SHTTEMKNLRKELQDSEGQQLSLHKELLALKEKLEKAKRERQIEMEEAINALKEQYERER 763

Query:   691 -FTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLR---SANEIIGEYETKITALESTMT 746
                 E N     + +   S ++ L +   + E +L+   S  E +  +E +I  +   ++
Sbjct:   764 NLMSEDNRKLTAETDRLCSFVDKLTAQNRQLEDELQELASKKESVAHWEAQIAEIIQWVS 823

Query:   747 RSESYCKEMVEYLETLQKNNDILSHDNEQLRKKN 780
                   K+   YL+ L      ++ + E LR  +
Sbjct:   824 DE----KDARGYLQALASK---MTEELESLRSSS 850

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

UNIPROTKB|F1NK88 Gga.17943 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 650 (233.9 bits), Expect = 1.2e-62, P = 1.2e-62
 Identities = 202/810 (24%), Positives = 386/810 (47%)

Query:     3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----- 57
             +V+++R   + A D+D+ + I +G FG++ LV  K +   + MK + + +M         
Sbjct:    34 IVEKIRALQMKAEDYDVVKVIGRGAFGEVQLVRHKMTQKVYAMKLLSKFEMIKRSDSAFF 93

Query:    58 --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
               ERDIM  +  P++V LF +FQD  ++Y +MEY+ GGD V L+ N     + E  A+FY
Sbjct:    94 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFY 150

Query:   116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
               E+  A+  +H +G +HRD+KPDNMLL   GHLKL DFG+  ++D+ G ++    VGTP
Sbjct:   151 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP 210

Query:   176 EYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
             +Y++PEVL+    + G DGY G  CD WS+GV  +E+L G TPF  ++L  TYS I+  D
Sbjct:   211 DYISPEVLK----SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM--D 264

Query:   235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN---MDQVLGHPVF-------DCL-DSD 283
              ++++ FP  + +S    N + + +   D RL    ++++  HP F       D + ++ 
Sbjct:   265 HKNSLHFPDDVEISKHAKNLICAFLTDRDVRLGRNGVEEIKHHPFFKSDQWNWDNIRETA 324

Query:   284 PPCIPPPSQE-NKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSS 342
              P +P  S + +  +  D       ++ F     ++ + LP IG +Y  + +  + ++ S
Sbjct:   325 APVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRDNLLLSDSSQS 384

Query:   343 ----DSTLPPSSEDMRHWKRDRXXXXXXXAEAKASLEDLSCS-RTRXXXXXXXXXXXXXX 397
                 +S     +ED + +++         +    + ++L    R+               
Sbjct:   385 CRENESVQSSKNEDSKEFQKKVSKLEEQLSNELQAKDELEQKYRSANTRLEKIVKELDEE 444

Query:   398 XTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEK-ENLEKT 456
              TS  ++ S   + ++R +  +  K ++    +      +  LE   + LK++ E+L+K 
Sbjct:   445 ITSRKNVESAVRQ-LEREKALLQHKNTEYQRKAEHEADKKRNLENEVNSLKDQLEDLKKR 503

Query:   457 DDRKLEVCEVSKE-LEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEAL 515
             +       ++S E +  L+ +L+E  +  +   +   +  K +  +  +++Q +  N  L
Sbjct:   504 NQNS----QISNEKINQLQRQLDEANSLLRSESETAARLRKNQTESTKQIQQLEANNREL 559

Query:   516 KEKLTSLEQ-ELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGI 574
             ++K   LE  +LK+ ++ L   Q++L+S+ R+    S  I  +Q  +      V+     
Sbjct:   560 QDKNCLLENAKLKLEKDFL-NLQSALESERRDRSHGSEIISDLQGRISSLEEEVKNGKSA 618

Query:   575 SEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEG 634
               K E +++ L E  +    LE E    ++D+    + ++ N +Q     A+ K  KA  
Sbjct:   619 LAKLEMEKRQLQEKLTD---LEKEKSNMEIDMTYKFKVMQQNLEQE---EAEHKATKAR- 671

Query:   635 ELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLE 694
              L    +  + +++ K   +  + K     ++  +K E  L    ++   L      + +
Sbjct:   672 -LADKNKIYESIEEAKSEAMKEMEKKLLEERALKQKVENRLLEAEKQRSMLDCDLKQSQQ 730

Query:   695 S-NSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKI-TALESTMTRSESYC 752
               N L  L     L+  ED+K N T +  +  +    + + + K+ T   +T+  SE   
Sbjct:   731 KINEL--LRQKDKLN--EDVK-NLTLKIEQ-ETQKRCLTQNDLKMQTQQVNTLKMSEKQL 784

Query:   753 KEMVEYLETLQKNNDILSHDNEQLRKKNND 782
             K+   +L+ ++ +   L   N +LRK+  D
Sbjct:   785 KQENNHLQEIKLS---LEKQNNELRKERQD 811

GO:0017048 "Rho GTPase binding" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0001843 "neural tube closure" evidence=IEA

GO:0010825 "positive regulation of centrosome duplication" evidence=IEA

GO:0016525 "negative regulation of angiogenesis" evidence=IEA

GO:0030036 "actin cytoskeleton organization" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=IEA

GO:0045616 "regulation of keratinocyte differentiation" evidence=IEA

GO:0051298 "centrosome duplication" evidence=IEA

UNIPROTKB|F1NUB2 CDC42BPA "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 652 (234.6 bits), Expect = 1.4e-62, P = 1.4e-62
 Identities = 212/789 (26%), Positives = 360/789 (45%)

Query:     1 KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE----KMPNT 56
             K    +++Q  +   DF+I + I +G FG++ +V+ K +   F MK +L +    K   T
Sbjct:     2 KPFTSKVKQMRLHKEDFEILKVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAET 60

Query:    57 I----ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKA 112
                  ERD++V     +I  L Y+FQD N++Y +M+Y  GGD +TLL ++    L E  A
Sbjct:    61 ACFREERDVLVNGDNQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMA 119

Query:   113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV 172
             RFY+ E+  A+  +H L YVHRDIKPDN+L+   GH++L DFGS  ++ ++G ++S V V
Sbjct:   120 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 179

Query:   173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
             GTP+Y++PE+L+ ME   G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+ 
Sbjct:   180 GTPDYISPEILQAMEDGKGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM- 236

Query:   233 CDTEDTVSFPSSIR-LSTAMVNFVQSLVQKLDARLNMDQV---LGHPVFDCLD------S 282
              + ++   FP+ +  +S +  + ++ L+   + RL  + +     HP F  +D       
Sbjct:   237 -NHKERFQFPAQVTDVSESAKDLIRRLICSREHRLGQNGIEDFKNHPFFAGIDWDNIRNC 295

Query:   283 DPPCIPP---PSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTN 339
             D P IP    P+  + F   D    +           +    LP +G +YT   + ++ +
Sbjct:   296 DAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPSHTAFSGHHLPFVGFTYTSSCVLSDRS 355

Query:   340 TSSDSTLPPSSEDMRHWKRDRXXXXXXXAEAKA--SLEDLSCSRTRXXXXXXXXXXXXXX 397
                 +  PPS +   + +R         A  +    LE      +R              
Sbjct:   356 CLRLTAGPPSMDLDANIQRTLEDSLATEAYERRIRRLEQEKLELSRKLQESTQTVQALQY 415

Query:   398 XTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTD 457
              T    + + K+ EI  L++E+ K +   V  S  L     E    R EL +     K  
Sbjct:   416 STVDGPIAASKDLEIKSLKEEIEKLKKQ-VTDSGHLEQQLEEASTARRELDDASRQIKAF 474

Query:   458 DRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKE 517
             ++++    + +E E L  EL E     K   K+   +  +R  A+ E  +       L  
Sbjct:   475 EKQVRT--LKQEREDLNKELAESSDRLKSQAKELKDAHSQRKLAMQEFSEMNERLTDLHS 532

Query:   518 KLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEME-QSAVRVREMSGISE 576
             +   L ++L+  EE +      ++S LR  Q L  T E ++KE+E Q+     E S   +
Sbjct:   533 QKQKLARQLRDKEEEMEVVMQKVES-LR--QELRRT-ERLKKELEVQAEAAAAEASKDRK 588

Query:   577 KYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKS-----KLEK 631
               E+  +   +L+S  E L+ +  G    + S   + E  K +  +L  KS     +L K
Sbjct:   589 LRERSEQYSKQLESEVEGLKQKQIGRSPGVSSIEHQQEITKLKA-DLEKKSVFYEEELSK 647

Query:   632 AE-GELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFF 690
              E      ++   K+L+  + + + +L K+    + KLEK   E  + REE    +  F 
Sbjct:   648 REIMHANEIKSLKKELRDAESQQL-ALKKEIMILKDKLEKTRRENQSEREE---FETEFK 703

Query:   691 FTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSES 750
                E   +   + N  LS+  D  +   ER   L   N  + E    +   + ++   E+
Sbjct:   704 QKYEREKILLTEENKKLSNELDKLTTMFER---LSMNNRQLEEEMRDLADKKESVAHWEA 760

Query:   751 YCKEMVEYL 759
                E+++++
Sbjct:   761 QITEIIQWV 769

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0005083 "small GTPase regulator activity" evidence=IEA

GO:0005543 "phospholipid binding" evidence=IEA

GO:0031532 "actin cytoskeleton reorganization" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	792
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-81
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-77
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-77
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-77
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-74
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-72
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-71
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-64
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-64
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-64
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-63
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-63
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-60
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-60
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-59
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-59
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-56
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-56
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-56
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-53
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-53
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-49
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-49
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-48
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-47
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-47
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-45
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-44
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-43
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-42
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-42
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-41
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-41
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-41
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-40
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-40
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-39
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-39
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-38
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-38
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-38
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-38
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-38
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-37
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-37
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-37
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-36
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-36
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-35
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-35
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-35
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-34
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-34
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-34
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-34
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-33
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-33
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-33
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-32
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-32
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-32
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-32
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-31
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-31
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-31
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-30
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-30
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-29
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-29
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-29
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-28
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-28
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-27
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-26
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-26
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-26
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-25
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-25
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-25
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-25
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-25
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-25
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-24
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-24
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-24
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-24
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-24
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-23
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-23
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-23
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-22
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-22
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-22
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-22
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-22
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-21
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-21
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-20
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-19
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-19
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-19
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-17
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-15
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-14
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	3e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-14
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	6e-14
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	8e-14
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	8e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-13
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	4e-13
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	8e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-13
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-12
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	4e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-12
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	5e-12
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	5e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-12
PRK03918	880	PRK03918, PRK03918, chromosome segregation protein	8e-12
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	1e-11
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	1e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-11
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	5e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-11
PRK03918	880	PRK03918, PRK03918, chromosome segregation protein	1e-10
COG0419	908	COG0419, SbcC, ATPase involved in DNA repair [DNA	1e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-10
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-10
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	6e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-09
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-09
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	2e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-09
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	3e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-09
PRK03918	880	PRK03918, PRK03918, chromosome segregation protein	4e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-09
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	5e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-09
COG0419	908	COG0419, SbcC, ATPase involved in DNA repair [DNA	9e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-09
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	1e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-08
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	6e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-08
pfam12128	1198	pfam12128, DUF3584, Protein of unknown function (D	7e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-08
PRK03918	880	PRK03918, PRK03918, chromosome segregation protein	1e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-07
PRK02224	880	PRK02224, PRK02224, chromosome segregation protein	2e-07
PRK03918	880	PRK03918, PRK03918, chromosome segregation protein	3e-07
PRK02224	880	PRK02224, PRK02224, chromosome segregation protein	3e-07
COG4942	420	COG4942, COG4942, Membrane-bound metallopeptidase	3e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-07
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	1e-06
PRK02224	880	PRK02224, PRK02224, chromosome segregation protein	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-06
pfam01576	859	pfam01576, Myosin_tail_1, Myosin tail	3e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-06
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-06
pfam02463	1162	pfam02463, SMC_N, RecF/RecN/SMC N terminal domain	3e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-06
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	4e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-06
PRK02224	880	PRK02224, PRK02224, chromosome segregation protein	7e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-06
COG0419	908	COG0419, SbcC, ATPase involved in DNA repair [DNA	8e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-06
COG4248	637	COG4248, COG4248, Uncharacterized protein with pro	8e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-06
TIGR01843	423	TIGR01843, type_I_hlyD, type I secretion membrane	9e-06
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	1e-05
pfam01576	859	pfam01576, Myosin_tail_1, Myosin tail	1e-05
pfam10174	774	pfam10174, Cast, RIM-binding protein of the cytoma	1e-05
COG1579	239	COG1579, COG1579, Zn-ribbon protein, possibly nucl	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-05
TIGR00618	1042	TIGR00618, sbcc, exonuclease SbcC	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
COG4942	420	COG4942, COG4942, Membrane-bound metallopeptidase	3e-05
pfam02463	1162	pfam02463, SMC_N, RecF/RecN/SMC N terminal domain	3e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
COG5185	622	COG5185, HEC1, Protein involved in chromosome segr	3e-05
PRK02224	880	PRK02224, PRK02224, chromosome segregation protein	4e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-05
TIGR01843	423	TIGR01843, type_I_hlyD, type I secretion membrane	5e-05
COG4372	499	COG4372, COG4372, Uncharacterized protein conserve	5e-05
pfam13166	713	pfam13166, AAA_13, AAA domain	8e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	9e-05
COG1579	239	COG1579, COG1579, Zn-ribbon protein, possibly nucl	1e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
PTZ00121	2084	PTZ00121, PTZ00121, MAEBL; Provisional	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-04
COG2433	652	COG2433, COG2433, Uncharacterized conserved protei	1e-04
TIGR02169	1164	TIGR02169, SMC_prok_A, chromosome segregation prot	2e-04
PRK03918	880	PRK03918, PRK03918, chromosome segregation protein	2e-04
TIGR01843	423	TIGR01843, type_I_hlyD, type I secretion membrane	2e-04
COG1340	294	COG1340, COG1340, Uncharacterized archaeal coiled-	2e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-04
COG0419	908	COG0419, SbcC, ATPase involved in DNA repair [DNA	3e-04
pfam09730	711	pfam09730, BicD, Microtubule-associated protein Bi	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
PRK04863	1486	PRK04863, mukB, cell division protein MukB; Provis	3e-04
pfam10174	774	pfam10174, Cast, RIM-binding protein of the cytoma	4e-04
COG4372	499	COG4372, COG4372, Uncharacterized protein conserve	5e-04
TIGR03185	650	TIGR03185, DNA_S_dndD, DNA sulfur modification pro	5e-04
pfam05701	484	pfam05701, DUF827, Plant protein of unknown functi	5e-04
pfam13514	1118	pfam13514, AAA_27, AAA domain	6e-04
pfam06818	200	pfam06818, Fez1, Fez1	6e-04
PRK04863	1486	PRK04863, mukB, cell division protein MukB; Provis	8e-04
TIGR02168	1179	TIGR02168, SMC_prok_B, chromosome segregation prot	9e-04
COG1196	1163	COG1196, Smc, Chromosome segregation ATPases [Cell	0.001
pfam12128	1198	pfam12128, DUF3584, Protein of unknown function (D	0.001
pfam10174	774	pfam10174, Cast, RIM-binding protein of the cytoma	0.001
PTZ00121	2084	PTZ00121, PTZ00121, MAEBL; Provisional	0.001
PTZ00121	2084	PTZ00121, PTZ00121, MAEBL; Provisional	0.001
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.001
PRK01156	895	PRK01156, PRK01156, chromosome segregation protein	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
pfam02463	1162	pfam02463, SMC_N, RecF/RecN/SMC N terminal domain	0.002
pfam10174	774	pfam10174, Cast, RIM-binding protein of the cytoma	0.002
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.002
TIGR03007	498	TIGR03007, pepcterm_ChnLen, polysaccharide chain l	0.002
PRK12704	520	PRK12704, PRK12704, phosphodiesterase; Provisional	0.002
pfam12718	143	pfam12718, Tropomyosin_1, Tropomyosin like	0.002
PRK03918	880	PRK03918, PRK03918, chromosome segregation protein	0.003
pfam10174	774	pfam10174, Cast, RIM-binding protein of the cytoma	0.003
PTZ00121	2084	PTZ00121, PTZ00121, MAEBL; Provisional	0.003
pfam13514	1118	pfam13514, AAA_27, AAA domain	0.003
PRK01156	895	PRK01156, PRK01156, chromosome segregation protein	0.003
PLN03229	762	PLN03229, PLN03229, acetyl-coenzyme A carboxylase	0.003
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.003
pfam07926	132	pfam07926, TPR_MLP1_2, TPR/MLP1/MLP2-like protein	0.003
PRK02224	880	PRK02224, PRK02224, chromosome segregation protein	0.004
PRK04863	1486	PRK04863, mukB, cell division protein MukB; Provis	0.004
pfam07888	546	pfam07888, CALCOCO1, Calcium binding and coiled-co	0.004
pfam00038	312	pfam00038, Filament, Intermediate filament protein	0.004
PRK11281	1113	PRK11281, PRK11281, hypothetical protein; Provisio	0.004

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  263 bits (674), Expect = 3e-81
 Identities = 105/316 (33%), Positives = 161/316 (50%), Gaps = 53/316 (16%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKSKC 67
            DF++ + I +G FG+++LV +K +   + MK + +  M           ERDI+  +  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+IV L+YSFQD  H+Y +MEY+ GGD + LL         E  ARFYI EL  A+  +H
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV----------------- 170
            LG++HRDIKPDN+L+ A GH+KL DFG   +++K    +  +                 
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178

Query: 171 -----------PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                       VGTP+Y+APEVL           Y   CD WS+GV+ YE+L G  PF 
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLR-------GTPYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 220 YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL-NMDQVLGHPVF- 277
            +TL  TY+ I+      ++ FP    +S   ++ +  L+   + RL + +++  HP F 
Sbjct: 232 SDTLQETYNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFK 289

Query: 278 -----DCLDSDPPCIP 288
                +  ++ PP +P
Sbjct: 290 GIDWENLRETKPPFVP 305

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  252 bits (646), Expect = 2e-77
 Identities = 118/332 (35%), Positives = 189/332 (56%), Gaps = 22/332 (6%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCP 68
           DFD+K  + +G+FG++ +V EK + + + MK + +  +           ERDI+  S  P
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           +I  L Y+FQD +++Y +MEY  GGD ++LL N+      E  A+FY+ EL  A+  +H 
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +GYVHRDIKP+N+L+  TGH+KL DFGSA ++  N  + S +PVGTP+Y+APEVL  M G
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
           +     Y   CD WS+GV++YE++ G +PF+  T   TY++I+  + +  + FP   ++S
Sbjct: 181 DGKG-TYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM--NFQRFLKFPEDPKVS 237

Query: 249 TAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD------SDPPCIPPPSQEN---KFHKK 299
           +  ++ +QSL+     RL  + +  HP F  +D      S PP +P    ++    F + 
Sbjct: 238 SDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEP 297

Query: 300 DKRKASPSLKAFQ--KEGRYLDSALPLIGISY 329
           +K     S  +    K   +    LP +G S+
Sbjct: 298 EKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSF 329

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  249 bits (639), Expect = 2e-77
 Identities = 99/267 (37%), Positives = 145/267 (54%), Gaps = 29/267 (10%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERDIMVKSKCPYIVNLFY 75
           + +G+FG + LV +K +   + MK     K+++ K       ER+I+ +   P+IV L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +FQ    +Y ++EY  GG+  + L     G  SE +ARFY  E+  A++YLH LG ++RD
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGIIYRD 118

Query: 136 IKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           +KP+N+LL A GH+KLTDFG A +   +  R  +    GTPEY+APEVL          G
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL-------GKG 169

Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNF 254
           Y  + D WS+GV+ YE+LTG  PF  E     Y  IL    +D + FP    LS    + 
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL----KDPLRFPEF--LSPEARDL 223

Query: 255 VQSLVQK-LDARL---NMDQVLGHPVF 277
           +  L+QK    RL     +++  HP F
Sbjct: 224 ISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  248 bits (637), Expect = 5e-77
 Identities = 98/268 (36%), Positives = 148/268 (55%), Gaps = 21/268 (7%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPYIV 71
           ++I   + +G+FG +YL  +K++     +K + ++K+         E  I+ K K P IV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L+  F+D + +Y +MEY  GGD   LL+    G LSE +ARFY+ ++  A++YLH  G 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           VHRD+KP+N+LL   GH+KL DFG A Q+D   ++ +   VGTPEY+APEVL        
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF--VGTPEYMAPEVLL------- 169

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTEDTVSFPSSIRLSTA 250
             GY  + D+WS+GV+ YELLTG  PF   + L   +  I           P    +S  
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---PPPEWDISPE 226

Query: 251 MVNFVQSLVQKL-DARLNMDQVLGHPVF 277
             + ++ L+ K  + RL  ++ L HP F
Sbjct: 227 AKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  246 bits (631), Expect = 1e-74
 Identities = 121/351 (34%), Positives = 196/351 (55%), Gaps = 29/351 (8%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM---PNTI 57
           +   +++ +  + A DFD+ + I +G FG++ LV  K S   + MK + + +M    ++ 
Sbjct: 29  EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSA 88

Query: 58  ----ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  +   +IV L Y+FQD  ++Y +MEY+ GGD V L+ N     + E  AR
Sbjct: 89  FFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWAR 145

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY  E+  A+  +H +G++HRD+KPDNMLL  +GHLKL DFG+  ++D NG ++    VG
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           TP+Y++PEVL+    + G DGY G  CD WS+GV  YE+L G TPF  ++L  TYS I+ 
Sbjct: 206 TPDYISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM- 260

Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF-------DCL-D 281
            D +++++FP  I +S    + + + +   + RL    +D++  HP F       D + +
Sbjct: 261 -DHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRE 319

Query: 282 SDPPCIPP-PSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTG 331
           +  P +P   S  +  +  D      + + F     +  + LP IG +Y+ 
Sbjct: 320 TVAPVVPELSSDIDTSNFDDIEDDDKNEETFPLPKAFAGNQLPFIGFTYSK 370

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  237 bits (606), Expect = 2e-72
 Identities = 97/280 (34%), Positives = 155/280 (55%), Gaps = 37/280 (13%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKSKCPYIVNLFY 75
           I +G +G ++L ++K + + + +K + +  M           ERDI+ +++ PY+V L+Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           SFQ   ++Y +MEY+ GGD  +LLEN   G L E  AR YI E+  A++YLH  G +HRD
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 136 IKPDNMLLSATGHLKLTDFG---------SATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           +KPDN+L+ + GHLKLTDFG              D     K I  VGTP+Y+APEV+   
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI--VGTPDYIAPEVIL-- 174

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
                  G++ + D WS+G + YE L G  PF+ ET +  + +IL    E    +P  + 
Sbjct: 175 -----GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE----WPEDVE 225

Query: 247 LSTAMVNFVQSL-----VQKLDARLNMDQVLGHPVFDCLD 281
           +S   ++ +  L      ++L A+ +++++  HP F  +D
Sbjct: 226 VSDEAIDLISKLLVPDPEKRLGAK-SIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  236 bits (605), Expect = 2e-71
 Identities = 120/336 (35%), Positives = 185/336 (55%), Gaps = 27/336 (8%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-------RDIMVKSKCP 68
           DF+I + I +G FG++ +V+ K +   + MK + + +M    E       RD++V     
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           +I NL Y+FQD N++Y +M+Y  GGD +TLL ++    L E  ARFY+ E+  A+  +H 
Sbjct: 62  WITNLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           LGYVHRDIKPDN+LL   GH++L DFGS  ++  +G ++S V VGTP+Y++PE+L+ ME 
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS-SIRL 247
             G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  + ++   FP     +
Sbjct: 181 GKGR--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHKEHFQFPPDVTDV 236

Query: 248 STAMVNFVQSLVQKLDARL---NMDQVLGHPVFDCLD------SDPPCIP---PPSQENK 295
           S    + ++ L+   + RL    +     HP F+ +D      S  P +P    P+  + 
Sbjct: 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSN 296

Query: 296 FH-KKDKRKASPSLKAFQKEGRYLDSALPLIGISYT 330
           F    D  + + SL      G +  + LP +G +YT
Sbjct: 297 FDVDDDDLRNTESLPP-SSHGAFSGNHLPFVGFTYT 331

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  219 bits (558), Expect = 3e-64
 Identities = 117/347 (33%), Positives = 195/347 (56%), Gaps = 29/347 (8%)

Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----- 57
           +V+++R+  + A D+D+ + I +G FG++ LV  K S   + MK + + +M         
Sbjct: 31  IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90

Query: 58  --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
             ERDIM  +  P++V LF +FQD  ++Y +MEY+ GGD V L+ N     + E  A+FY
Sbjct: 91  WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFY 147

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
             E+  A+  +H +G +HRD+KPDNMLL   GHLKL DFG+  ++D+ G ++    VGTP
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP 207

Query: 176 EYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
           +Y++PEVL+    + G DGY G  CD WS+GV  +E+L G TPF  ++L  TYS I+  D
Sbjct: 208 DYISPEVLK----SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM--D 261

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLDSD 283
            +++++FP  + +S    N + + +   + RL    ++++  HP F        +  ++ 
Sbjct: 262 HKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETA 321

Query: 284 PPCIPPPSQE-NKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISY 329
            P +P  S + +  +  D       ++ F     ++ + LP IG +Y
Sbjct: 322 APVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  217 bits (553), Expect = 5e-64
 Identities = 121/335 (36%), Positives = 185/335 (55%), Gaps = 25/335 (7%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-------RDIMVKSKCP 68
           DF+I + I +G FG++ +V+ K +   + MK + + +M    E       R+++V   C 
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           +I  L Y+FQD N++Y +M+Y  GGD +TLL ++    L E  ARFYI E+  A+  +H 
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           L YVHRDIKPDN+LL   GH++L DFGS  +++++G ++S V VGTP+Y++PE+L+ ME 
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR-L 247
             G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  + E+   FPS I  +
Sbjct: 181 GMGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHEERFQFPSHITDV 236

Query: 248 STAMVNFVQSLVQKLDARL---NMDQVLGHPVFDCLDSD------PPCIP---PPSQENK 295
           S    + +Q L+   + RL    ++    H  F+ +D +       P IP    PS  + 
Sbjct: 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSN 296

Query: 296 FHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYT 330
           F   D    +P +        +    LP +G +YT
Sbjct: 297 FDVDDDVLRNPEIAPPSSHTGFSGLHLPFVGFTYT 331

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  217 bits (554), Expect = 9e-64
 Identities = 117/374 (31%), Positives = 179/374 (47%), Gaps = 67/374 (17%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKSKC 67
            DF+  + I +G FG++ LV++K + + + MKK+ + +M           ERDI+ ++  
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P++V L+YSFQD N++Y IMEY+ GGD +TLL  +     +E + RFYI E   A+  +H
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK------------------------- 162
            LGY+HRDIKPDN+LL A GH+KL+DFG  T + K                         
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 163 ------------NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYE 210
                       N R  +   VGTP+Y+APEV           GY   CD WS+GV+ YE
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-------LQTGYNKECDWWSLGVIMYE 231

Query: 211 LLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---N 267
           +L G  PF  +    TY  I+    ++T+ FP  + LS    + ++ L  + + RL    
Sbjct: 232 MLVGYPPFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNG 289

Query: 268 MDQVLGHPVFDCLDSD-----PPCIPP----PSQENKFHKKDKRKASPSLKAFQKEGRYL 318
           ++++  HP F  +D +     P  I P     +  + F   ++             G+  
Sbjct: 290 VNEIKSHPFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIK 349

Query: 319 DSALPLIGISYTGE 332
              L  IG +Y   
Sbjct: 350 SKDLAFIGYTYKRF 363

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  216 bits (551), Expect = 3e-63
 Identities = 117/349 (33%), Positives = 194/349 (55%), Gaps = 29/349 (8%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           KD + ++R   + A D+++ + I +G FG++ LV  K +   + MK + + +M       
Sbjct: 29  KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88

Query: 58  ----ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  +  P++V LFY+FQD  ++Y +MEY+ GGD V L+ N     + E  AR
Sbjct: 89  FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAR 145

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY  E+  A+  +H +G++HRD+KPDNMLL  +GHLKL DFG+  +++K G ++    VG
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           TP+Y++PEVL+    + G DGY G  CD WS+GV  YE+L G TPF  ++L  TYS I+ 
Sbjct: 206 TPDYISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM- 260

Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLD 281
            + +++++FP    +S    N + + +   + RL    ++++  H  F           D
Sbjct: 261 -NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 319

Query: 282 SDPPCIPPPSQE-NKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISY 329
           +  P +P  S + +  +  D  +     + F     ++ + LP +G +Y
Sbjct: 320 TVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPIPKAFVGNQLPFVGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  211 bits (539), Expect = 6e-63
 Identities = 86/271 (31%), Positives = 133/271 (49%), Gaps = 21/271 (7%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNTIERDIMVKSKCPYI 70
           +++ R +  G+FG +Y  + K +     +K + +             E  I+ +   P I
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V L  +F+D +H+Y +MEY  GGD    L     G LSE +A+    ++ + ++YLH  G
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
            +HRD+KP+N+LL   G +K+ DFG A ++ K+    +   VGTP Y+APEVL       
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFVGTPWYMAPEVLL------ 171

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPF---NYETLDMTYSSILACDTEDTVSFPSSIRL 247
           G +GY    D+WS+GV+ YELLTG  PF   N          IL    E     P     
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE--FDEPKWSSG 229

Query: 248 STAMVNFVQS-LVQKLDARLNMDQVLGHPVF 277
           S    + ++  L +    R   +++L HP F
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  208 bits (530), Expect = 1e-60
 Identities = 106/292 (36%), Positives = 156/292 (53%), Gaps = 33/292 (11%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKKVLREKMPNT----IERDIMVKSKC 67
            DF I   + QG +G ++L ++K +        MKK L  K+        ERDI+  +K 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
            ++V L Y+FQD  ++Y  MEYV GGDF TLL N   G LSE  ARFY+ E+ +AV  LH
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            LGY+HRD+KP+N L+ A+GH+KLTDFG +  +       S+  VG+P+Y+APEVL    
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV--VGSPDYMAPEVLR--- 171

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS---- 243
                 GY  + D WS+G + YE L G  PF+  T + T+ ++     ++T+  P     
Sbjct: 172 ----GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK--YWKETLQRPVYDDP 225

Query: 244 SIRLSTAMVNFVQSLVQKLDARL-NMDQVLGHPVFDCLD------SDPPCIP 288
              LS    + +  L+     R  +++ +  HP F  +D        PP +P
Sbjct: 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVP 277

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  205 bits (524), Expect = 1e-60
 Identities = 89/271 (32%), Positives = 143/271 (52%), Gaps = 30/271 (11%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKK-----VLREKMPNTI--ERDIMVKSKCPYIVNLFYSFQ 78
           G FG + LV+ K  + TF +K      ++       I  E++I+ +   P+IV L+ +F+
Sbjct: 4   GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D  ++Y +MEY  GG+  T+L  +  G   E  ARFYI  +  A +YLH  G ++RD+KP
Sbjct: 64  DKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKP 121

Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+LL + G++KL DFG A ++    +  +    GTPEYVAPE++        + GY  S
Sbjct: 122 ENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF--CGTPEYVAPEIIL-------NKGYDFS 172

Query: 199 CDLWSIGVVSYELLTGSTPFNYETLD--MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQ 256
            D WS+G++ YELLTG  PF  +  D    Y+ IL       + FP+   +  A  + ++
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL--KGNGKLEFPN--YIDKAAKDLIK 228

Query: 257 SLVQKLDA-RLNMDQ-----VLGHPVFDCLD 281
            L+++    RL   +     +  H  F+  D
Sbjct: 229 QLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  203 bits (519), Expect = 1e-59
 Identities = 89/295 (30%), Positives = 150/295 (50%), Gaps = 47/295 (15%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPN--TIERDIMVKSKC 67
            DF   + I +G+F  + L +EK+++  + +K     ++++EK      IE++++ +   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 68  -PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            P I+ L+Y+FQD  ++YF++EY   G+ +  +  + +G L E   RFY  E+  A++YL
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYL 118

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--------------- 171
           H  G +HRD+KP+N+LL    H+K+TDFG+A  +D N   +S                  
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 172 ----VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTY 227
               VGT EYV+PE+L     N    G   S DLW++G + Y++LTG  PF      +T+
Sbjct: 179 FASFVGTAEYVSPELL-----NEKPAGK--SSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231

Query: 228 SSILACDTEDTVSFPSSIRLSTAMVNFVQSLV-----QKLDARLNMDQVLGHPVF 277
             IL  +     SFP +        + ++ L+      +L      D++  HP F
Sbjct: 232 QKILKLE----YSFPPNF--PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  202 bits (516), Expect = 4e-59
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 40/298 (13%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERDIMVKSKC 67
            DF+  + +  G+FG + LV  K S   + +K     K+++ K    +  E+ I+   + 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P++VNL+ SFQD +++Y +MEYV GG+  + L     G   E  ARFY  ++  A++YLH
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            L  V+RD+KP+N+LL + G++K+TDFG A +V   GR  ++   GTPEY+APE++    
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK--GRTYTL--CGTPEYLAPEIIL--- 171

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
               S GY  + D W++G++ YE+L G  PF  +     Y  IL       V FPS    
Sbjct: 172 ----SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK----VRFPSFF-- 221

Query: 248 STAMVNFVQSLVQK-LDARL-NMDQ----VLGHPVFDCLDSD--------PPCIPPPS 291
           S    + +++L+Q  L  RL N+      +  HP F  +D           P IP   
Sbjct: 222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVK 279

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  195 bits (498), Expect = 2e-56
 Identities = 96/323 (29%), Positives = 159/323 (49%), Gaps = 57/323 (17%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKC 67
             F   + + +G+ G ++LV  K +   F +K + +++M           E++I+     
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P++  L+ SFQ   ++  +M+Y  GG+   LL+ QP   LSE  ARFY  E+  A++YLH
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---------------- 171
            LG V+RD+KP+N+LL  +GH+ L+DF  + Q D      S                   
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 172 ------------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                       VGT EY+APEV+         DG+  + D W++G++ YE+L G+TPF 
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVIS-------GDGHGSAVDWWTLGILLYEMLYGTTPFK 233

Query: 220 YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-----LDARLNMDQVLGH 274
               D T+S+IL  +    V+FP S  +S++  + ++ L+ K     L ++    ++  H
Sbjct: 234 GSNRDETFSNILKKE----VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289

Query: 275 PVFDCLD------SDPPCIPPPS 291
           P F  ++      + PP IP P 
Sbjct: 290 PFFRGVNWALIRHTTPPIIPRPD 312

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  196 bits (498), Expect = 2e-56
 Identities = 120/341 (35%), Positives = 184/341 (53%), Gaps = 37/341 (10%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-------RDIMVKSKCP 68
           DF+I + I +G FG++ +V+ K +   F MK + + +M    E       RD++V     
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           +I  L Y+FQD N++Y +M+Y  GGD +TLL ++    L E  ARFY+ E+  A+  +H 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           L YVHRDIKPDN+L+   GH++L DFGS  ++ ++G ++S V VGTP+Y++PE+L+ ME 
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR-L 247
             G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  + ++   FP+ +  +
Sbjct: 181 GKGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHKERFQFPAQVTDV 236

Query: 248 STAMVNFVQSLVQKLDARLNMDQV---LGHPVFDCLDSD------PPCIP---PPSQENK 295
           S    + ++ L+   + RL  + +     HP F  +D D       P IP    P+  + 
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSN 296

Query: 296 FH------KKDKRKASPSLKAFQKEGRYLDSALPLIGISYT 330
           F       K  +    PS  AF          LP +G +YT
Sbjct: 297 FDVDDDCLKNSETMPPPSHTAFSGH------HLPFVGFTYT 331

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  196 bits (500), Expect = 5e-56
 Identities = 109/320 (34%), Positives = 158/320 (49%), Gaps = 65/320 (20%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTI-----ERDIMVKSK 66
           S F   + I  G FG++ LV +  ++  + MK  LR+    M N       ERDI+ ++ 
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEAD 59

Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
             ++V L+YSFQD +++YF+M+Y+ GGD ++LL     G   E  ARFYI EL  A++ +
Sbjct: 60  NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESV 117

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT-----------QVDKNGRIKSIVP---- 171
           H +G++HRDIKPDN+L+   GH+KLTDFG  T           Q   + R  S+ P    
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 172 ---------------------------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
                                      VGTP Y+APEVL          GYT  CD WS+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-------RTGYTQLCDWWSV 230

Query: 205 GVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDA 264
           GV+ YE+L G  PF  +T   T   ++  + E T+  PS  +LS    + +  L    + 
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVI--NWETTLHIPSQAKLSREASDLILRLCCGAED 288

Query: 265 RL---NMDQVLGHPVFDCLD 281
           RL     D++  HP F  +D
Sbjct: 289 RLGKNGADEIKAHPFFKGID 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  190 bits (483), Expect = 1e-53
 Identities = 104/324 (32%), Positives = 159/324 (49%), Gaps = 67/324 (20%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKSKCP 68
           DF   + I +G FG++ LV++K +   + MK +L+ +M           ERD++ +S  P
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           ++V+L+YSFQD  ++Y IME++ GGD +T+L    +   SE   RFY+ E   A++ +H 
Sbjct: 62  WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSAT------------------------------ 158
           LG++HRDIKPDN+L+   GH+KL+DFG +T                              
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179

Query: 159 QVD----------------KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLW 202
            VD                KN R+ +   VGTP+Y+APE+           GY   CD W
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-------QQGYGQECDWW 232

Query: 203 SIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL 262
           S+G + +E L G  PF  E    TY  I+     +T+ FP  I LS    + ++ L+   
Sbjct: 233 SLGAIMFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLITNA 290

Query: 263 DARL---NMDQVLGHPVFDCLDSD 283
           + RL      ++  HP F  +D D
Sbjct: 291 ENRLGRGGAHEIKSHPFFRGVDWD 314

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  185 bits (472), Expect = 2e-53
 Identities = 91/271 (33%), Positives = 145/271 (53%), Gaps = 24/271 (8%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERDIMVKSKCPY 69
           F++ R I +G FG + +V+++ +   F MK     K + +     +  ER I+ +   P+
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +VNL+YSFQD  ++Y +++ + GGD    L  +     SE + +F+I E+  A++YLH  
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK--FSEEQVKFWICEIVLALEYLHSK 119

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           G +HRDIKPDN+LL   GH+ +TDF  AT+V  +    S    GTP Y+APEVL      
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLC----- 172

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
               GY+ + D WS+GV +YE L G  P+   +  +    I A      V +P++   ST
Sbjct: 173 --RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETADVLYPAT--WST 227

Query: 250 AMVNFVQSLVQ-KLDARL--NMDQVLGHPVF 277
             ++ +  L++     RL  N+  +  HP F
Sbjct: 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  181 bits (461), Expect = 6e-52
 Identities = 87/233 (37%), Positives = 131/233 (56%), Gaps = 25/233 (10%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTI-----ERDI-MVKSKCPYIVNLF 74
           I +G FG +YL +++ + + F +K + +  M   N +     ER I M++ + PY+  L+
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
           YSFQ  +++Y +MEY+ GGD  +L+  +  G L E  A+ YI E+   V+ LH  G +HR
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           DIKP+N+L+  TGHLKLTDFG +    +N +      VGTP+Y+APE +    G     G
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENKKF-----VGTPDYLAPETI---LGV----G 169

Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD---TEDTVSFPSS 244
                D WS+G V +E L G  PF+ ET D  + +IL+      E+   F S 
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSP 222

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (439), Expect = 2e-49
 Identities = 70/195 (35%), Positives = 110/195 (56%), Gaps = 14/195 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKCPYIVNLFYSF 77
           + +G FG +YL  +K++     +K + +E   + +E      +I+ K   P IV L+  F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           +D NH+Y +MEY  GG    LL+    G LSE +    + ++ + ++YLH  G +HRD+K
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 138 PDNMLL-SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           P+N+LL S  G +KL DFG +  +  +  +   + VGTP Y+APEVL       G   Y+
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLL------GKGYYS 172

Query: 197 GSCDLWSIGVVSYEL 211
              D+WS+GV+ YEL
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  174 bits (442), Expect = 6e-49
 Identities = 97/299 (32%), Positives = 151/299 (50%), Gaps = 48/299 (16%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK-----VLREKMPNTI--ERDIMVKSKC 67
            D +  + +  G FG ++LV ++ S + + +K      V+R K    +  E+ ++ +   
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+I+ LF++  D   +Y +MEYV GG+  + L N   G  S S   FY  E+  A++YLH
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               V+RD+KP+N+LL   GH+KLTDFG A ++    R ++    GTPEY+APEV+    
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPEVI---- 170

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
               S G+  + D W++G++ YE+L G  PF  +     Y  ILA      + FP  + L
Sbjct: 171 ---QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA----GKLEFPRHLDL 223

Query: 248 STAMVNFVQSLVQKL-----DARL-NM----DQVLGHPVFDCLDSD--------PPCIP 288
                 + + L++KL       RL NM    D V  H  F  +D D        PP +P
Sbjct: 224 ------YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVP 276

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  173 bits (441), Expect = 1e-48
 Identities = 92/243 (37%), Positives = 136/243 (55%), Gaps = 30/243 (12%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTI-----ERDIMVKSKC 67
            DF+  + I  G +G +YLV  K++   F MKK+ ++ +   N I     ERDI+  ++ 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P++V++F SF+   H+  +MEYV GGD  TLL+N   G L    AR Y  E   A++YLH
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFG-------SAT------QVDKNGRIKSIVPV-G 173
             G VHRD+KPDN+L+++ GH+KLTDFG       S T       ++K+ R      V G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TPEY+APEV+          GY    D W++G++ YE L G  PF  +T +  +  +++ 
Sbjct: 179 TPEYIAPEVIL-------RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231

Query: 234 DTE 236
           D E
Sbjct: 232 DIE 234

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  172 bits (438), Expect = 1e-47
 Identities = 103/310 (33%), Positives = 160/310 (51%), Gaps = 55/310 (17%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKSKCP 68
           DF+  + I +G FG++ LV++K + + + MK + +  M           ERDI+V++   
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           ++V +FYSFQD  ++Y IME++ GGD +TLL  +    LSE   +FYI E   A+  +H 
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ 119

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---------------------------- 160
           LG++HRDIKPDN+LL A GH+KL+DFG  T +                            
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179

Query: 161 ------DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                  KN R  +   VGTP+Y+APEV           GY   CD WS+GV+ YE+L G
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFM-------QTGYNKLCDWWSLGVIMYEMLIG 232

Query: 215 STPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQV 271
             PF  ET   TY  ++  + ++T+ FP  + +S    + +       + R+    ++++
Sbjct: 233 YPPFCSETPQETYRKVM--NWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEI 290

Query: 272 LGHPVFDCLD 281
             HP F+ +D
Sbjct: 291 KSHPFFEGVD 300

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  167 bits (425), Expect = 7e-47
 Identities = 81/266 (30%), Positives = 128/266 (48%), Gaps = 22/266 (8%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTIER-----DIMVKSKCPY 69
            ++I + I +G+FG +YLV  K     +V+K++ L        E       I+ K   P 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLH 127
           I+  + SF++   +  +MEY  GGD    ++ Q        E +   +  +L  A++YLH
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               +HRDIKP N+ L++ G +KL DFG +  +     +   V VGTP Y++PE+ +   
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQ--- 176

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
               +  Y    D+WS+G V YEL T   PF  E L      IL          P   + 
Sbjct: 177 ----NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-----PIPSQY 227

Query: 248 STAMVNFVQSLVQKL-DARLNMDQVL 272
           S+ + N V SL+QK  + R ++ Q+L
Sbjct: 228 SSELRNLVSSLLQKDPEERPSIAQIL 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  167 bits (425), Expect = 1e-45
 Identities = 108/339 (31%), Positives = 159/339 (46%), Gaps = 69/339 (20%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQ 78
           G FG++ L  +  +H  + MK + ++ + N         ERDI+ ++   ++V L+YSFQ
Sbjct: 12  GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++YF+M+Y+ GGD ++LL         E  ARFYI EL  A++ +H +G++HRDIKP
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKP 129

Query: 139 DNMLLSATGHLKLTDFGSAT-----------QVDKNGRIKSIVP---------------- 171
           DN+L+   GH+KLTDFG  T           Q   + R  S+ P                
Sbjct: 130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRL 189

Query: 172 -------------------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
                              VGTP Y+APEVL          GYT  CD WS+GV+ +E+L
Sbjct: 190 KTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-------RKGYTQLCDWWSVGVILFEML 242

Query: 213 TGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMD 269
            G  PF   T   T + +   + E+T+  P  ++LS   V+ +  L    + RL     D
Sbjct: 243 VGQPPFLAPT--PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300

Query: 270 QVLGHPVFDCLD--SDPPCIPPPSQENKFHKKDKRKASP 306
            +  HP F  +D  SD    P P      H  D     P
Sbjct: 301 DIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDP 339

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  161 bits (408), Expect = 7e-44
 Identities = 92/291 (31%), Positives = 147/291 (50%), Gaps = 40/291 (13%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM---------PNTIERDIMVKSKCPYIV 71
           + + +G+FG + L E K +   + +K VL++ +           T +R + +  K P++ 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVK-VLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L   FQ  + ++F+MEYV GGD   +   Q  G   E +ARFY  E+   +Q+LH  G 
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI 117

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           ++RD+K DN+LL + GH+K+ DFG   +    G + +    GTP+Y+APE+L +      
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQP---- 172

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM 251
              Y  + D W++GV+ YE+L G +PF  +  D  + SIL    ED V +P    LS   
Sbjct: 173 ---YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL----EDEVRYPRW--LSKEA 223

Query: 252 VNFVQSLVQK-LDARL-----NMDQVLGHPVFDCLDSD--------PPCIP 288
            + ++S + K  + RL         + GHP F  +D D        PP  P
Sbjct: 224 KSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKP 274

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  162 bits (410), Expect = 7e-44
 Identities = 96/274 (35%), Positives = 146/274 (53%), Gaps = 52/274 (18%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKSKCP 68
           DF+  + I +G FG++ LV++K + + + MK + +  M           ERDI+V++   
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           ++V +FYSFQD  ++Y IME++ GGD +TLL  +    L+E + +FYI E   A+  +H 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ 119

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-------------------------- 162
           LG++HRDIKPDN+LL + GH+KL+DFG  T + K                          
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 163 --------NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                   N R  +   VGTP+Y+APEV           GY   CD WS+GV+ YE+L G
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFM-------QTGYNKLCDWWSLGVIMYEMLIG 232

Query: 215 STPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
             PF  ET   TY  ++  + ++T+ FP  + +S
Sbjct: 233 YPPFCSETPQETYKKVM--NWKETLIFPPEVPIS 264

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  157 bits (400), Expect = 1e-43
 Identities = 77/269 (28%), Positives = 130/269 (48%), Gaps = 26/269 (9%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSKC--PYIV 71
            F+I   I +G FG++Y    K++     +K +  E       I  +I +  KC  P IV
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
             + S+   + ++ +ME+ +GG    LL++     L+ES+  +   EL + ++YLH  G 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSNGI 119

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           +HRDIK  N+LL++ G +KL DFG + Q+       ++  VGTP ++APEV   + G   
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEV---INGKP- 173

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYET----LDMTYSSILACDTEDTVSFPSSIRL 247
              Y    D+WS+G+ + EL  G  P++       L           T       +  + 
Sbjct: 174 ---YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------ATNGPPGLRNPEKW 223

Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           S    +F++  +QK  + R   +Q+L HP
Sbjct: 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  156 bits (395), Expect = 2e-42
 Identities = 96/295 (32%), Positives = 158/295 (53%), Gaps = 30/295 (10%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNT---FVMKKVLR-----EKMPNT----IERDIMV 63
           +F++ R +  G +G ++LV +   H+    + MK VL+     +K         ER ++ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLKKATIVQKAKTAEHTRTERQVLE 59

Query: 64  K-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
              +CP++V L Y+FQ    ++ I++YV GG+  T L  +   + +ES+ R YI E+  A
Sbjct: 60  AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLA 117

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           + +LH LG ++RDIK +N+LL + GH+ LTDFG + +       ++    GT EY+APEV
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
           +       GS G+  + D WS+GV+++ELLTG++PF  +    + S I     +    FP
Sbjct: 178 I-----RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP 232

Query: 243 SSIRLSTAMVNFVQSLVQK-LDARL---NMDQVLGHPVFDCLDSDPPC---IPPP 290
            ++  S    +F+Q L++K    RL     D++  HP F  +D D      IP P
Sbjct: 233 KTM--SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  155 bits (392), Expect = 9e-42
 Identities = 98/277 (35%), Positives = 150/277 (54%), Gaps = 31/277 (11%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVKS---KCPYIVN 72
           I +G FG +Y V +K +   + MK       V ++++ +TI ER+I+V++   + P+IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L +SFQ  + +Y + +Y++GG+    L  Q  G  SE +A+FYI EL  A+++LH    V
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           +RD+KP+N+LL ATGH+ L DFG S   +  N    +    GT EY+APEVL        
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTEYLAPEVL------LD 170

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM 251
             GYT   D WS+GV+ +E+  G +PF  E     Y +I        V FP ++ LS   
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI----AFGKVRFPKNV-LSDEG 225

Query: 252 VNFVQSLV-----QKLDARLNMDQVLGHPVFDCLDSD 283
             FV+ L+      +L A  +  ++  HP F  +D D
Sbjct: 226 RQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWD 262

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  154 bits (391), Expect = 1e-41
 Identities = 84/221 (38%), Positives = 128/221 (57%), Gaps = 21/221 (9%)

Query: 21  RFIQQGNFGDIYLVEEK------QSHNTFVMKKV---LREKMPNTIERDIMVKSKCPYIV 71
           + + QG+FG ++LV +       Q +   V+KK    +R+++   +ERDI+ +   P+IV
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L Y+FQ    +Y I++++ GGD  T L  +     +E   +FY+ ELA A+ +LH LG 
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGI 119

Query: 132 VHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           ++RD+KP+N+LL   GH+KLTDFG S   +D   +  S    GT EY+APEV+       
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEYMAPEVVN------ 171

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
              G+T S D WS GV+ +E+LTGS PF  +    T + IL
Sbjct: 172 -RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  152 bits (386), Expect = 6e-41
 Identities = 81/225 (36%), Positives = 127/225 (56%), Gaps = 20/225 (8%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERDIMVKSKC 67
           SDF++   +  G+FG + + + K +   + +K     ++L+ K    +  E+ I+++   
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+IVN+  SFQD N VYF++E+V GG+  T L     G      A+FY  EL  A +YLH
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLH 135

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               ++RD+KP+N+LL   GH+K+TDFG A +V      ++    GTPEY+APEV++   
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQ--- 188

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
               S G+  + D W++GV+ YE + G  PF  +T    Y  ILA
Sbjct: 189 ----SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229

Length = 329

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (381), Expect = 6e-41
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTI-----ERDIMVKSKCPYIVNLF 74
             + +G+FG +YL  +K +     +K V L       +     E  I+   + P IV  +
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 75  YSFQD--MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
            S +D   N +   +EYV+GG   +LL+      L E   R Y  ++ + + YLH  G V
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYLHSNGIV 123

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEYVAPEVLEWMEGNHG 191
           HRDIK  N+L+ + G +KL DFG A ++      +      GTP ++APEV+        
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR------- 176

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFN 219
            + Y  + D+WS+G    E+ TG  P++
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWS 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  154 bits (389), Expect = 8e-41
 Identities = 107/340 (31%), Positives = 156/340 (45%), Gaps = 71/340 (20%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTI-----ERDIMVKSKCPYIVNLFYSF 77
           G FG++ L  +  +   + MK  LR+K   + N +     ERDI+ ++   ++V L+YSF
Sbjct: 12  GAFGEVCLARKVDTKALYAMK-TLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF 70

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           QD +++YF+M+Y+ GGD ++LL     G   E  ARFYI EL  AV+ +H +G++HRDIK
Sbjct: 71  QDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIK 128

Query: 138 PDNMLLSATGHLKLTDF--------------------------------GSATQVDKNGR 165
           PDN+L+   GH+KLTDF                                G         R
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188

Query: 166 IKSI--------------VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYEL 211
           +K +                VGTP Y+APEVL          GYT  CD WS+GV+ YE+
Sbjct: 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-------RTGYTQLCDWWSVGVILYEM 241

Query: 212 LTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NM 268
           L G  PF  +T   T   ++   T  ++  P   +LS    + +  L +  + RL     
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQT--SLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGA 299

Query: 269 DQVLGHPVFDCLD--SDPPCIPPPSQENKFHKKDKRKASP 306
           D++  HP F  +D  SD      P      H  D     P
Sbjct: 300 DEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDP 339

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  150 bits (381), Expect = 3e-40
 Identities = 98/309 (31%), Positives = 155/309 (50%), Gaps = 38/309 (12%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKM-------PNTIERDIM-VKSKCPYIVNLFYS 76
           +G+FG + L E K ++  F +K + ++ +          +ER ++ +  + P++ +LF +
Sbjct: 5   KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT 64

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQ   H++F+MEY+ GGD   +   Q  G   E++ARFY  E+   +Q+LH  G ++RD+
Sbjct: 65  FQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           K DN+LL   GH+K+ DFG   + + NG  K+    GTP+Y+APE+L+  +       Y 
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILKGQK-------YN 174

Query: 197 GSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQ 256
            S D WS GV+ YE+L G +PF+ E  D  + SIL     D   FP  I          +
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL----NDRPHFPRWISKEAKDC-LSK 229

Query: 257 SLVQKLDARLNMD-QVLGHPVFDCLD--------SDPPCIP---PPSQENKFHK---KDK 301
              +    RL +D  +  HP F  +D          PP  P    PS  + F +    +K
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEK 289

Query: 302 RKASPSLKA 310
            + SP  K 
Sbjct: 290 VRLSPVDKK 298

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  150 bits (380), Expect = 4e-40
 Identities = 94/301 (31%), Positives = 152/301 (50%), Gaps = 34/301 (11%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERDIMVKS-KCPYIVNLF 74
           I +G+FG + L + K     + +K      +L++K    I  ER++++K+ K P++V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
           YSFQ  + +YF+++YV GG+    L+ +      E +ARFY  E+A A+ YLH L  ++R
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           D+KP+N+LL + GH+ LTDFG   + ++ +    +    GTPEY+APEVL          
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF--CGTPEYLAPEVLRKQP------ 172

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN 253
            Y  + D W +G V YE+L G  PF        Y +IL       +    +I +S    +
Sbjct: 173 -YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL----NKPLRLKPNISVSAR--H 225

Query: 254 FVQSLVQK-----LDARLNMDQVLGHPVFDCLDSDPPC---IPPPSQENKFHKKDKRKAS 305
            ++ L+QK     L A+ +  ++  H  F  ++ D      I PP   N     D +   
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFD 285

Query: 306 P 306
           P
Sbjct: 286 P 286

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 2e-39
 Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 24/268 (8%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTI--ERDIMVKSKCPY 69
           ++ +   I +G FG +Y     ++ +   +K++  EK+      +I  E D++   K P 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV    S +  + +Y I+EY   G    ++  +  G   ES    Y+Y++ Q + YLH  
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           G +HRDIK  N+L +  G +KL DFG AT+++   +      VGTP ++APEV+E     
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVIE----- 172

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
               G + + D+WS+G    ELLTG+ P+ Y+   M  +++     +D    P  I  S 
Sbjct: 173 --MSGASTASDIWSLGCTVIELLTGNPPY-YDLNPM--AALFRIVQDDHPPLPEGI--SP 225

Query: 250 AMVNFVQSLVQKLDARLNMD--QVLGHP 275
            + +F+    QK D  L     Q+L HP
Sbjct: 226 ELKDFLMQCFQK-DPNLRPTAKQLLKHP 252

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  146 bits (371), Expect = 8e-39
 Identities = 91/291 (31%), Positives = 140/291 (48%), Gaps = 47/291 (16%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC-------------PYIV 71
           +G+FG + L E K++   + +K  L  K  + I RD +    C             P++V
Sbjct: 9   RGHFGKVLLAEYKKTGELYAIK-AL--KKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
           NLF  FQ  +HV F+MEY  GGD +  +        SE +A FY   +   +QYLH    
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKI 122

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           V+RD+K DN+LL   G +K+ DFG   +    G   S    GTPE++APEVL        
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF-CGTPEFLAPEVLT------- 174

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM 251
              YT + D W +GV+ YE+L G +PF  +  +  + SI+     D V +P    LS   
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV----NDEVRYP--RFLSREA 228

Query: 252 VNFVQSLVQKL-DARL-----NMDQVLGHPVFDCLDSD--------PPCIP 288
           ++ ++ L+++  + RL     + + V   P F  ++ D        PP +P
Sbjct: 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVP 279

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  145 bits (368), Expect = 2e-38
 Identities = 97/303 (32%), Positives = 151/303 (49%), Gaps = 34/303 (11%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERDIMVKS-KCPYIVN 72
           + I +G+FG + L + K   + + +K      +L++K  N I  ER++++K+ K P++V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L YSFQ    +YF+++YV GG+    L  Q      E +ARFY  E+A A+ YLH L  +
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNII 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           +RD+KP+N+LL + GH+ LTDFG   + V+      +    GTPEY+APEVL        
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF--CGTPEYLAPEVLR------- 169

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM 251
            + Y  + D W +G V YE+L G  PF    +   Y +IL       +  P     + A 
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL----HKPLQLPGG--KTVAA 223

Query: 252 VNFVQSLVQK-----LDARLNMDQVLGHPVFDCLDSDP---PCIPPPSQENKFHKKDKRK 303
            + +  L+ K     L A+ +  ++  H  F  ++ D      I PP   N     D R 
Sbjct: 224 CDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRH 283

Query: 304 ASP 306
             P
Sbjct: 284 FDP 286

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  144 bits (364), Expect = 3e-38
 Identities = 89/288 (30%), Positives = 143/288 (49%), Gaps = 31/288 (10%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVKSKCPYIVNLFY 75
           I +G+FG +  V ++ +   + +K       V R ++ +T+ ER ++ +  CP+IV L +
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           SFQ    +Y ++ ++ GG+    L  Q  G    S+ARFY  EL  A++ LH    ++RD
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP+N+LL   GH+ L DFG   +++     K+    GTPEY+APE+L          GY
Sbjct: 119 LKPENILLDYQGHIALCDFG-LCKLNMKDDDKTNTFCGTPEYLAPELLL-------GHGY 170

Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV 255
           T + D W++GV+ YE+LTG  PF  E ++  Y  IL    ++ + FP       A    +
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL----QEPLRFPDGFD-RDAKDLLI 225

Query: 256 QSLVQKLDARLNM---DQVLGHPVFDCLDSDPPC----IPP--PSQEN 294
             L +    RL      ++  HP F  L           PP  P+  +
Sbjct: 226 GLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSS 273

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  144 bits (364), Expect = 5e-38
 Identities = 92/278 (33%), Positives = 146/278 (52%), Gaps = 31/278 (11%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTF---VMKK--VLRE---KMPNTIERDIMVKSKCPYIVN 72
           R + +G+FG + L   K+S   +   V+KK  +L++   +   T +R + +    P++  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L+  FQ  + ++F+ME+V GGD   +   Q      E++ARFY  E+  A+ +LH  G +
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGII 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           +RD+K DN+LL   GH KL DFG   +   NG+  S    GTP+Y+APE+L+ M      
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-CGTPDYIAPEILQEML----- 172

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV 252
             Y  S D W++GV+ YE+L G  PF  E  D  + +IL     D V +P+   LS   V
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDEVVYPT--WLSQDAV 224

Query: 253 NFVQSLVQKLDA-RLNM------DQVLGHPVFDCLDSD 283
           + +++ + K    RL        + +L HP F  LD +
Sbjct: 225 DILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  143 bits (363), Expect = 8e-38
 Identities = 88/266 (33%), Positives = 135/266 (50%), Gaps = 34/266 (12%)

Query: 20  KRFIQQGNFGDIYLVEEKQSHNT---FVMKKVLREKM---------PNTIERDIMVKSKC 67
            + + +G +G ++ V +    +T   F MK VL++               ER+I+   K 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+IV+L Y+FQ    +Y I+EY++GG+    LE +  G   E  A FY+ E++ A+++LH
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLH 117

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
             G ++RD+KP+N+LL A GH+KLTDFG   +    G +      GT EY+APE+L  M 
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-CGTIEYMAPEIL--MR 174

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
             HG        D WS+G + Y++LTG+ PF  E    T   IL             + L
Sbjct: 175 SGHGKA-----VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG----------KLNL 219

Query: 248 STAMVNFVQSLVQKLDARLNMDQVLG 273
              +    + L++KL  R N    LG
Sbjct: 220 PPYLTPEARDLLKKLLKR-NPSSRLG 244

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  145 bits (365), Expect = 9e-38
 Identities = 94/367 (25%), Positives = 150/367 (40%), Gaps = 34/367 (9%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-----PNTIERDIMVKSKC--- 67
            + I R + +G+FG++YL  +++      +K + ++            R+I + +     
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQP-HGYLSESKARFYIYELAQAVQYL 126
           P IV L+  FQD   +Y +MEYV GG    LL+     G LSES+A F + ++  A++YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 127 HGLGYVHRDIKPDNMLLSATGH-LKLTDFGSATQVDKNG-----RIKSIVPVGTPEYVAP 180
           H  G +HRDIKP+N+LL   G  +KL DFG A  +   G            VGTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYS---SILACDTED 237
           EVL  +   +     + S D+WS+G+  YELLTG  PF  E      S    I+      
Sbjct: 178 EVLLGLSLAY----ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQKL-----DARLNMDQVLGHPVFDCLDSDPPCIPPPSQ 292
           +++ P S      +      L++KL       RL+    L H +   L            
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL----KESDLS 289

Query: 293 ENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSDSTLPPSSED 352
           +                + +     L+S           +   +     +  +  P +  
Sbjct: 290 DLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSS 349

Query: 353 MRHWKRD 359
                  
Sbjct: 350 SLLLSTA 356

Length = 384

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  143 bits (361), Expect = 1e-37
 Identities = 89/276 (32%), Positives = 142/276 (51%), Gaps = 34/276 (12%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKM---------PNTIERDIMVKSKCPYIVNLFY 75
           +G+FG + L E K +   + +K VL++ +           T +R + + +K P++  L  
Sbjct: 5   KGSFGKVMLAELKGTDEVYAIK-VLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHC 63

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
            FQ  + ++F+MEYV GGD   + + Q      E ++RFY  E+  A+ +LH  G ++RD
Sbjct: 64  CFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +K DN+LL A GH KL DFG   +   NG   +    GTP+Y+APE+L+ +E       Y
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF-CGTPDYIAPEILQELE-------Y 173

Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV 255
             S D W++GV+ YE++ G  PF  +  D  + SIL     D V +P  + LS   V+ +
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL----HDDVLYP--VWLSKEAVSIL 227

Query: 256 QSLVQKLDA-RLNM-------DQVLGHPVFDCLDSD 283
           ++ + K    RL         D +  HP F  +D  
Sbjct: 228 KAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  142 bits (360), Expect = 2e-37
 Identities = 96/306 (31%), Positives = 150/306 (49%), Gaps = 40/306 (13%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMK----KVL---REKMPNTIERDIMVKS-KCPYIVN 72
           + I +G+FG + L + K     + +K    K++   +E+     ER++++K+ K P++V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L YSFQ    +YF++++V GG+    L  Q      E +ARFY  E+A A+ YLH +  V
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSINIV 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFG----SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +RD+KP+N+LL + GH+ LTDFG       Q D           GTPEY+APEV+     
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF-----CGTPEYLAPEVIR---- 169

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                 Y  + D W +G V YE+L G  PF    +   Y +IL    +  V  P +   S
Sbjct: 170 ---KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH---KPLVLRPGA---S 220

Query: 249 TAMVNFVQSLVQK-----LDARLNMDQVLGHPVFDCL---DSDPPCIPPPSQENKFHKKD 300
               + ++ L++K     L A+ +  ++  HP F+ L   D +   IPPP   N     D
Sbjct: 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDD 280

Query: 301 KRKASP 306
                 
Sbjct: 281 ISNFDA 286

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  142 bits (359), Expect = 3e-37
 Identities = 87/264 (32%), Positives = 133/264 (50%), Gaps = 36/264 (13%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK-----------VLREKMPNTIERDI 61
           DF+    + +G+FG + L E K +   +   ++KK            + EK      R +
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEK------RVL 54

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
            +  K P++  L   FQ M+ +YF+MEYV GGD   +   Q  G   E  A FY  E+A 
Sbjct: 55  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAI 112

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
            + +LH  G ++RD+K DN++L A GH+K+ DFG   + +  G   +    GTP+Y+APE
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFCGTPDYIAPE 171

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++ +         Y  S D W+ GV+ YE+L G  PF+ E  D  + SI     E  VS+
Sbjct: 172 IIAYQP-------YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI----MEHNVSY 220

Query: 242 PSSIRLSTAMVNFVQSLVQKLDAR 265
           P S  LS   V+  + L+ K  A+
Sbjct: 221 PKS--LSKEAVSICKGLLTKHPAK 242

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  146 bits (370), Expect = 2e-36
 Identities = 73/175 (41%), Positives = 102/175 (58%), Gaps = 10/175 (5%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKS 65
           S  +F I + I +G FG +YL  +K +   + +K V +  M N         ERD +  S
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
           K P+IV+L+YS Q  N+VY +MEY+ GGD  +LL    +GY  E  A  YI E+A A+ Y
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDY 119

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           LH  G +HRD+KPDNML+S  GH+KLTDFG  ++V  N  +  +  + TP    P
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEGHIKLTDFG-LSKVTLNRELNMMDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  139 bits (351), Expect = 3e-36
 Identities = 88/294 (29%), Positives = 145/294 (49%), Gaps = 32/294 (10%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVKSKCPYIVNLFYSF 77
           +G FG + LV EK +   + MK       + ++++ +T+ E  ++  ++ P++  L YSF
Sbjct: 5   KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF 64

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           Q  + + F+MEY  GG+    L  +     SE +ARFY  E+  A+ YLH    V+RD+K
Sbjct: 65  QTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK 122

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
            +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE        + Y  
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEVLE-------DNDYGR 174

Query: 198 SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQS 257
           + D W +GVV YE++ G  PF  +  +  +  IL  +    + FP    LS    + +  
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----IRFPR--TLSPEAKSLLAG 228

Query: 258 LVQK-LDARL-----NMDQVLGHPVFDCL---DSDPPCIPPPSQENKFHKKDKR 302
           L++K    RL     +  +++ H  F  +   D     + PP +     + D R
Sbjct: 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTR 282

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  137 bits (347), Expect = 1e-35
 Identities = 105/347 (30%), Positives = 167/347 (48%), Gaps = 55/347 (15%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERDIMVKS-KCPYIVN 72
           + I +G+FG + L   K     + +K      +L++K    I  ER++++K+ K P++V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L +SFQ  + +YF+++Y+ GG+    L+ +   +L E +ARFY  E+A A+ YLH L  V
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFL-EPRARFYAAEIASALGYLHSLNIV 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           +RD+KP+N+LL + GH+ LTDFG   + ++ NG   +    GTPEY+APEVL        
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF--CGTPEYLAPEVLH------- 169

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM 251
              Y  + D W +G V YE+L G  PF        Y +IL    +   +  +S R     
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR----- 224

Query: 252 VNFVQSLVQK-----LDARLNMDQVLGHPVFDCLDSDP---PCIPPPSQENKFHKKDKRK 303
            + ++ L+QK     L A+ +  ++  H  F  ++ D      I PP   N     D R 
Sbjct: 225 -HLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRH 283

Query: 304 ASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSDSTLPPSS 350
             P                      +T EP+  +   S DS L  +S
Sbjct: 284 FDP---------------------EFTEEPVPNSIGQSPDSILVTAS 309

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  136 bits (343), Expect = 3e-35
 Identities = 90/302 (29%), Positives = 147/302 (48%), Gaps = 40/302 (13%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--------NTIERDIMVKS-K 66
           DF+    + +G+FG + L E K +   + +K +L++ +           +E+ ++  S K
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            P++  L   FQ M+ +YF+MEYV GGD   + + Q  G   E  A FY  E+A  + +L
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H  G ++RD+K DN++L + GH+K+ DFG   +   +G + +    GTP+Y+APE++ + 
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQ 176

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
                   Y  S D W+ GV+ YE+L G  PF  E  D  + SI+    E  V++P S  
Sbjct: 177 P-------YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHNVAYPKS-- 223

Query: 247 LSTAMVNFVQSLVQKLDA-RLNMD-----QVLGHPVFDCLDSD--------PPCIPPPSQ 292
           +S   V   + L+ K    RL         +  H  F  +D +        PP  P    
Sbjct: 224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG 283

Query: 293 EN 294
            +
Sbjct: 284 RD 285

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  135 bits (340), Expect = 8e-35
 Identities = 91/289 (31%), Positives = 153/289 (52%), Gaps = 38/289 (13%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNT---FVMKKVLRE----KMPNTIERDIMVKS--- 65
           +F++ + +  G +G ++LV +   H+T   + MK VL++    +   T+E     ++   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLE 59

Query: 66  ---KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
              + P++V L Y+FQ    ++ I++YV+GG+  T L  + +   SE + RFY  E+  A
Sbjct: 60  HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILA 117

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           +++LH LG V+RDIK +N+LL + GH+ LTDFG + +     + ++    GT EY+APE+
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSS----ILACDTEDT 238
           +       G  G+  + D WS+G++ +ELLTG++PF  E    T S     IL CD    
Sbjct: 178 IR------GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--- 228

Query: 239 VSFPSSIRLSTAMVNFVQSLVQK-LDARL-----NMDQVLGHPVFDCLD 281
             FPS   +     + +  L++K    RL        ++  HP F  LD
Sbjct: 229 -PFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 1e-34
 Identities = 70/208 (33%), Positives = 111/208 (53%), Gaps = 16/208 (7%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---RDIMVKSKC--PY 69
             F +   I +G+FG++Y   +K+++    +K +  E+  + IE   ++I   S+C  PY
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           I   + SF   + ++ IMEY  GG  + LL+      L E+   F + E+   ++YLH  
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLHEE 117

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           G +HRDIK  N+LLS  G +KL DFG + Q+  +   K    VGTP ++APEV+   +  
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQL-TSTMSKRNTFVGTPFWMAPEVI--KQS- 173

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTP 217
               GY    D+WS+G+ + EL  G  P
Sbjct: 174 ----GYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  133 bits (336), Expect = 3e-34
 Identities = 81/258 (31%), Positives = 140/258 (54%), Gaps = 24/258 (9%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIE------RDIMVKSKC 67
           DF+    + +G+FG + L E K +   + +K + ++ +   + +E      R + ++ K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P++  L   FQ ++ +YF+MEYV GGD +  +  Q  G   E +A FY  E++  + +LH
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
             G ++RD+K DN++L + GH+K+ DFG   +   +G + +    GTP+Y+APE++ +  
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQP 177

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  Y  S D W+ GV+ YE+L G  PF+ E  D  + SI+    E  VS+P S  L
Sbjct: 178 -------YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM----EHNVSYPKS--L 224

Query: 248 STAMVNFVQSLVQKLDAR 265
           S   V+  + L+ K  ++
Sbjct: 225 SKEAVSICKGLMTKHPSK 242

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  131 bits (330), Expect = 4e-34
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 28/271 (10%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-LR-----EKMPNTIERDIMVKSKCPY 69
           DF + + + +G++G +Y V+    +  + +K+V L      E+     E  I+     P 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKA--RFYIYELAQAVQYL 126
           I++   +F D N +  +MEY   GD    +   +    L   +   R +I +L + +Q L
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQAL 119

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H    +HRD+K  N+LL A   +K+ D G +  V K    K+   +GTP Y+APEV  W 
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAKTQ--IGTPHYMAPEV--WK 174

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS-SI 245
                   Y+   D+WS+G + YE+ T + PF   ++      +          +P    
Sbjct: 175 -----GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ------RGKYPPIPP 223

Query: 246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHP 275
             S  + NF++S++Q K   R N D++L  P
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  131 bits (331), Expect = 4e-34
 Identities = 81/269 (30%), Positives = 118/269 (43%), Gaps = 26/269 (9%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKV----LREKMPNTIERDIMVKS--KCPYIVNLF 74
             I  G FG +Y      +     +K++       K    I  ++ V    K P +V  +
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-Y 64

Query: 75  YSFQ-DMNHVYFIMEYVTGGDFVTLLENQPHGY-LSESKARFYIYELAQAVQYLHGLGYV 132
           Y  +     VY  MEY +GG    LLE   HG  L E   R Y  +L + + YLH  G V
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-----VGTPEYVAPEVLEWME 187
           HRDIKP N+ L   G +KL DFG A ++  N    ++        GTP Y+APEV+    
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT--TMGEEVQSLAGTPAYMAPEVIT--- 176

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                 G+  + D+WS+G V  E+ TG  P+    LD  +  +           P S++L
Sbjct: 177 -GGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGAGHKPPIPDSLQL 233

Query: 248 STAMVNFV-QSLVQKLDARLNMDQVLGHP 275
           S    +F+ + L      R    ++L HP
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  131 bits (331), Expect = 5e-34
 Identities = 76/288 (26%), Positives = 140/288 (48%), Gaps = 32/288 (11%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKSKCPYIVNLFY 75
           + +G FG++   + K +   +  KK+ ++++           E+ I+ K    +IV+L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +F+  + +  +M  + GGD    + N       E++A FY  ++   +++LH    V+RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP+N+LL   G+++++D G A ++    +IK     GTP Y+APEVL+          Y
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKG--RAGTPGYMAPEVLQGEV-------Y 171

Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV 255
             S D +++G   YE++ G +PF      +    +     E  V +P   + S    +  
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLC 229

Query: 256 QSLVQK-LDARL-----NMDQVLGHPVFDCLD--------SDPPCIPP 289
           ++L+QK  + RL     + D+V  HP+F  L+         +PP IP 
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  131 bits (331), Expect = 7e-34
 Identities = 65/200 (32%), Positives = 108/200 (54%), Gaps = 14/200 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTI--ERDIMVKSKCPYIVNLFYSFQD 79
           I +G  G++Y   ++ +     +KK+ LR++    I  E  IM   K P IV+ + S+  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86

Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
            + ++ +MEY+ GG    ++       ++E +  +   E+ Q ++YLH    +HRDIK D
Sbjct: 87  GDELWVVMEYMDGGSLTDIITQNFV-RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD 145

Query: 140 NMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           N+LLS  G +KL DFG A Q+ K   +  S+  VGTP ++APEV++        D Y   
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSV--VGTPYWMAPEVIK------RKD-YGPK 196

Query: 199 CDLWSIGVVSYELLTGSTPF 218
            D+WS+G++  E+  G  P+
Sbjct: 197 VDIWSLGIMCIEMAEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  129 bits (327), Expect = 1e-33
 Identities = 66/270 (24%), Positives = 127/270 (47%), Gaps = 22/270 (8%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERD--IMVKSKCPY 69
           SD +  + + QG+ G +Y V  K +   + +KK+     E+    + R+   +   + PY
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG- 128
           +V  + +F     +  ++EY+ GG    LL  +  G + E    +   ++ + + YLH  
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRDIKP N+L+++ G +K+ DFG +  ++ N   +    VGT  Y++PE ++    
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLE-NTLDQCNTFVGTVTYMSPERIQ---- 173

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA--CDTEDTVSFPSSIR 246
               + Y+ + D+WS+G+   E   G  PF       ++  ++   CD         +  
Sbjct: 174 ---GESYSYAADIWSLGLTLLECALGKFPFL-PPGQPSFFELMQAICDGP--PPSLPAEE 227

Query: 247 LSTAMVNFVQSLVQKL-DARLNMDQVLGHP 275
            S    +F+ + +QK    R +  ++L HP
Sbjct: 228 FSPEFRDFISACLQKDPKKRPSAAELLQHP 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  129 bits (327), Expect = 5e-33
 Identities = 86/287 (29%), Positives = 144/287 (50%), Gaps = 40/287 (13%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI----------MVKSKCPYI 70
           R I +G++  + LVE K++   + MK + +E +    + DI             S  P++
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFL 58

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V L   FQ  + ++F++E+V+GGD +  ++ Q    L E  ARFY  E++ A+ +LH  G
Sbjct: 59  VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERG 116

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
            ++RD+K DN+LL A GH+KLTD+G   +  + G   S    GTP Y+APE+L       
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF-CGTPNYIAPEILR------ 169

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSSILACDTEDTVSF 241
             + Y  S D W++GV+ +E++ G +PF+           T D  +  IL    E  +  
Sbjct: 170 -GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL----EKQIRI 224

Query: 242 PS--SIRLSTAMVNFV-QSLVQKLDARLN--MDQVLGHPVFDCLDSD 283
           P   S++ S+ +  F+ +   ++L          +  HP F  +D D
Sbjct: 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  129 bits (325), Expect = 6e-33
 Identities = 91/324 (28%), Positives = 159/324 (49%), Gaps = 46/324 (14%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI---MVKSKC-------PYI 70
           + + +G+FG + L E K     F +K + ++ +   I+ D+   MV+ +        P++
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFL 58

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
            +L+ +FQ   H++F+ME++ GGD   +   Q  G     +A FY  E+   +Q+LH  G
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
            ++RD+K DN++L   GH+K+ DFG   + +  G  ++    GTP+Y+APE+L+ ++   
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKE-NVFGDNRASTFCGTPDYIAPEILQGLK--- 172

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA 250
               YT S D WS GV+ YE+L G +PF+ +  D  + SI      DT  +P  I   + 
Sbjct: 173 ----YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI----RVDTPHYPRWITKES- 223

Query: 251 MVNFVQSLVQKL-----DARLNM-DQVLGHPVFDCLD--------SDPPCIPPPSQENKF 296
                + +++KL       RL +   + GHP F  ++         DPP  P     + +
Sbjct: 224 -----KDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDY 278

Query: 297 HKKDKRKASPSLKAFQKEGRYLDS 320
              D+   S   +    +   +DS
Sbjct: 279 SNFDREFLSEKPRLSYSDKNLIDS 302

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  127 bits (322), Expect = 1e-32
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV----LREKMPNTIERDIMV--KSKCPYIVNLFYS 76
           I +G  G ++  +++++  T  +KKV    L   +PN   R+I      + PY+V L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           F   +    +MEY+   D   +L ++    L E++ + Y+  L + V Y+H  G +HRD+
Sbjct: 68  FPHGSGFVLVMEYM-PSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHANGIMHRDL 125

Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L+SA G LK+ DFG A    +         V T  Y APE+L      +G+  Y 
Sbjct: 126 KPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL------YGARKYD 179

Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET 222
              DLW++G +  ELL GS  F  E 
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGEN 205

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  128 bits (322), Expect = 2e-32
 Identities = 82/250 (32%), Positives = 127/250 (50%), Gaps = 26/250 (10%)

Query: 2   DVVKELRQKN-VSASDFDIKRFIQQGNFGDIYLVEEKQSH------NTFVMKKVLREKMP 54
           D  KE ++KN +   DF+  R +  G+FG + L   K           F   K++++K  
Sbjct: 16  DSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQV 75

Query: 55  NTI--ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKA 112
           + +  ER I+     P+ VNL+ SF+D +++Y ++E+V GG+F T L             
Sbjct: 76  DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVG 133

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            FY  ++    +YL  L  V+RD+KP+N+LL   G +K+TDFG A  VD     ++    
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RTYTLC 189

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPEY+APE+L  +   HG      + D W++G+  YE+L G  PF      + Y  IL 
Sbjct: 190 GTPEYIAPEIL--LNVGHGK-----AADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL- 241

Query: 233 CDTEDTVSFP 242
              E  + FP
Sbjct: 242 ---EGIIYFP 248

Length = 340

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  127 bits (321), Expect = 3e-32
 Identities = 79/248 (31%), Positives = 132/248 (53%), Gaps = 23/248 (9%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE------KMPNTI-ERDIMVKSKCPYIVNL 73
           + + +G FG + LV EK +   + MK + +E      ++ +T+ E  ++  ++ P++  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++YLH    V+
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVY 118

Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE        +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEVLE-------DN 170

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN 253
            Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP +  LS    +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRT--LSPEAKS 224

Query: 254 FVQSLVQK 261
            +  L++K
Sbjct: 225 LLAGLLKK 232

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  127 bits (321), Expect = 3e-32
 Identities = 97/305 (31%), Positives = 150/305 (49%), Gaps = 48/305 (15%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC--------PYIVN 72
           R I +G++  + LV  K++   + MK V +E + +  + D +   K         P++V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L   FQ  + ++F++EYV GGD +  ++ Q    L E  ARFY  E++ A+ YLH  G +
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGII 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           +RD+K DN+LL + GH+KLTD+G   +  + G   S    GTP Y+APE+L       G 
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIAPEILR------GE 171

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSSILACDTEDTVSFPS 243
           D Y  S D W++GV+ +E++ G +PF+           T D  +  IL    E  +  P 
Sbjct: 172 D-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EKQIRIPR 226

Query: 244 SIRLSTAMVNFVQSLVQK-LDARL------NMDQVLGHPVFDCLDSD--------PPCIP 288
           S+ +  A V  ++S + K    RL          + GHP F  +D D        PP  P
Sbjct: 227 SLSVKAASV--LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKP 284

Query: 289 PPSQE 293
             S E
Sbjct: 285 NISGE 289

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  126 bits (318), Expect = 6e-32
 Identities = 86/300 (28%), Positives = 147/300 (49%), Gaps = 36/300 (12%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK--MPNTIE------RDIMVKSKCPYIVN 72
           + + +G+FG ++L E K ++  F +K + ++   M + +E      R + +  + P++ +
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L+ +FQ   +++F+MEY+ GGD   +   Q        +A FY  E+   +Q+LH  G V
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           +RD+K DN+LL   GH+K+ DFG   + +  G  K+    GTP+Y+APE+L   + N   
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKE-NMLGDAKTCTFCGTPDYIAPEILLGQKYNT-- 175

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA-- 250
                S D WS GV+ YE+L G +PF+    +  + SI      D   +P  +       
Sbjct: 176 -----SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI----RMDNPCYPRWLTREAKDI 226

Query: 251 -MVNFVQSLVQKLDARLNMDQVLGHPVFDCLD--------SDPPCIPPPSQENKFHKKDK 301
            +  FV+   ++L  + ++ Q   HP F  +D         +PP  P     N     DK
Sbjct: 227 LVKLFVREPERRLGVKGDIRQ---HPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDK 283

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  123 bits (312), Expect = 1e-31
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 19/209 (9%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER--DIMVKSKCPYIVNL 73
            FDI   + +G++G +Y    K++     +K V  E+    I +   I+ +   PYIV  
Sbjct: 4   VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKY 63

Query: 74  FYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           + S+     ++ +MEY   G   D + +        L+E +    +Y+  + ++YLH   
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKGLEYLHSNK 119

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
            +HRDIK  N+LL+  G  KL DFG + Q  D   +  ++  +GTP ++APEV++     
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV--IGTPFWMAPEVIQ----- 172

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
               GY    D+WS+G+ + E+  G  P+
Sbjct: 173 --EIGYNNKADIWSLGITAIEMAEGKPPY 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  125 bits (315), Expect = 2e-31
 Identities = 78/233 (33%), Positives = 127/233 (54%), Gaps = 23/233 (9%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE------KMPNTI-ERDIMVKSKCPYIVNL 73
           + + +G FG + LV EK S   + MK + +E      ++ +T+ E  ++  ++ P++ +L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            YSFQ  + + F+MEYV GG+    L  +     SE + RFY  E+  A+ YLH    V+
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVY 118

Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           RD+K +N++L   GH+K+TDFG   + +     +K+    GTPEY+APEVLE        
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--CGTPEYLAPEVLE-------D 169

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
           + Y  + D W +GVV YE++ G  PF  +  +  +  IL  D    + FP ++
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED----IKFPRTL 218

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  124 bits (313), Expect = 3e-31
 Identities = 78/233 (33%), Positives = 126/233 (54%), Gaps = 22/233 (9%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVKSKCPYIVNL 73
           + + +G FG + LV+EK +   + MK       V ++++ +T+ E  ++  S+ P++  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYV 132
            YSFQ  + + F+MEY  GG+    L  +     SE +ARFY  E+  A+ YLH     V
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVV 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           +RD+K +N++L   GH+K+TDFG   +  K+G        GTPEY+APEVLE        
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPEVLE-------D 170

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
           + Y  + D W +GVV YE++ G  PF  +  +  +  IL  +    + FP ++
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----IRFPRTL 219

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  120 bits (303), Expect = 3e-30
 Identities = 84/288 (29%), Positives = 149/288 (51%), Gaps = 31/288 (10%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNT--FVMKKVLR-----EKMPNT----IERDIMVK 64
           +F++ + +  G +G ++LV +   H++      KVL+     +K   T     ER ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 65  -SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
             + P++V L Y+FQ    ++ I++Y+ GG+  T L  +      E + + Y  E+  A+
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLAL 118

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ--VDKNGRIKSIVPVGTPEYVAPE 181
           ++LH LG ++RDIK +N+LL + GH+ LTDFG + +   D+  R  S    GT EY+AP+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF--CGTIEYMAPD 176

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++       G  G+  + D WS+GV+ YELLTG++PF  +    + + I     +    +
Sbjct: 177 IVR-----GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231

Query: 242 PSSIRLSTAMVNFVQSLVQK-LDARL-----NMDQVLGHPVFDCLDSD 283
           P    +S    + +Q L+ K    RL     + D++  HP F  ++ D
Sbjct: 232 PQE--MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 4e-30
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 12/208 (5%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKC--PYI 70
            D+++ + I  G +GD+Y   +  +     +K +  E   +   I+++I +  +C  P I
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  F S+   + ++ +MEY  GG  +  +     G LSE +  +   E  + + YLH  G
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGS-LQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGN 189
            +HRDIK  N+LL+  G +KL DFG + Q+     + KS   +GTP ++APEV       
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF--IGTPYWMAPEVAA----V 175

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTP 217
               GY G CD+W++G+ + EL     P
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  120 bits (302), Expect = 1e-29
 Identities = 77/243 (31%), Positives = 125/243 (51%), Gaps = 21/243 (8%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSK--------CPYIVN 72
           R I +G++  + LV  K++   + MK V +E + +  + D +   K         P++V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L   FQ  + ++ ++EYV GGD +  ++ Q    L E  ARFY  E+  A+ +LH  G +
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGII 118

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           +RD+K DN+LL A GH+KLTD+G   +    G   S    GTP Y+APE+L         
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF-CGTPNYIAPEILR-------G 170

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYET--LDM-TYSSILACDTEDTVSFPSSIRLST 249
           + Y  S D W++GV+ +E++ G +PF+  T   DM T   +     E  +  P  + +  
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKA 230

Query: 250 AMV 252
           + V
Sbjct: 231 SHV 233

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  118 bits (296), Expect = 1e-29
 Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 13/208 (6%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-----IMVKSKCPYI 70
            +++ R + +G+FG   LV+   S   + MK++   K  + +E       ++ K K P I
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V    SF+   H+Y +MEY  GGD +  ++ Q      E     +  ++   VQ++H   
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
            +HRDIK  N+ L+  G +KL DFGSA  +   G   +   VGTP YV PE+ E M  N+
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-ACTYVGTPYYVPPEIWENMPYNN 179

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            S       D+WS+G + YEL T   PF
Sbjct: 180 KS-------DIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  117 bits (295), Expect = 3e-29
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 23/219 (10%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPY 69
           D+++   I +G+FG +  V  K      V K++    M          E +I+ + K P 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 70  IVNLFYSFQDM-NH-VYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQY 125
           IV  +    D  N  +Y +MEY  GGD   L++   +   Y+ E      + +L  A+  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 126 LHGLGY-----VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            H         +HRD+KP N+ L A  ++KL DFG A  +  +    +   VGTP Y++P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSP 179

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           E L     NH S  Y    D+WS+G + YEL   S PF 
Sbjct: 180 EQL-----NHMS--YDEKSDIWSLGCLIYELCALSPPFT 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  116 bits (291), Expect = 5e-29
 Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 15/209 (7%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYI 70
           ++I + I +G+FG IYL + K      V+K++   KMP      +  E  ++ K K P I
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  F SFQ+   ++ +MEY  GGD +  +  Q     SE +   +  +++  ++++H   
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 131 YVHRDIKPDNMLLSATGHL-KLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
            +HRDIK  N+ LS  G + KL DFG A Q++ +  +     VGTP Y++PE+ +     
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQ----- 175

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             +  Y    D+WS+G V YEL T   PF
Sbjct: 176 --NRPYNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  115 bits (290), Expect = 1e-28
 Identities = 75/257 (29%), Positives = 130/257 (50%), Gaps = 27/257 (10%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---RDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG + +++ K +   FV +K+++ K  N IE     +M  +  P  + L+YS   +  
Sbjct: 27  GKFGKVSVLKHKPTQKLFV-QKIIKAKNFNAIEPMVHQLMKDN--PNFIKLYYSVTTLKG 83

Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
              IM+Y+  GD   LL+ +  G LSE++ +  I +L +A+  LH    +H DIK +N+L
Sbjct: 84  HVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141

Query: 143 LS-ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL 201
              A   + L D+G    +            GT +Y +PE ++          Y  S D 
Sbjct: 142 YDRAKDRIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIK-------GHNYDVSFDW 189

Query: 202 WSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ 260
           W++GV++YELLTG  PF   E  ++   S+L    +  + F  ++  S    +FVQS+++
Sbjct: 190 WAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-LPFIKNV--SKNANDFVQSMLK 246

Query: 261 -KLDARL-NMDQVLGHP 275
             ++ RL N ++++ HP
Sbjct: 247 YNINYRLTNYNEIIKHP 263

Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  115 bits (290), Expect = 1e-28
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 46/295 (15%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPNTI---ERDIMVK----SKCPYIV 71
           I +G FG++Y   +  +   + MK    K ++ K   T+   ER IM+       CP+IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-IMLSLVSTGDCPFIV 60

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            + Y+F   + + FI++ + GGD    L    HG  SE++ RFY  E+   ++++H    
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFV 118

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           V+RD+KP N+LL   GH++++D G A    K    K    VGT  Y+APEVL+       
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQ------K 169

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDT-EDTVSFPSSIRLST 249
              Y  S D +S+G + ++LL G +PF  ++T D         D    T++       S 
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAVELPDSFSP 224

Query: 250 AMVNFVQSLVQKLDARLNM-------DQVLGHPVFDCLDSD--------PPCIPP 289
            + + ++ L+Q+ D    +        +V  HP F  LD          PP IPP
Sbjct: 225 ELRSLLEGLLQR-DVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 4e-28
 Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 40/288 (13%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLR----EKMPNTIERDI--MVKSKCPYIVNLF 74
             I +G +G +Y   +K +     +KK+      E +P T  R+I  + +   P I+ L 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
             F+    +Y + E++    +  + + Q    L ES  + Y+Y+L Q + + H  G +HR
Sbjct: 65  DVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHGILHR 122

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           D+KP+N+L++  G LKL DFG A       R  +   V T  Y APE+L       G  G
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY-VVTRWYRAPELL------LGDKG 175

Query: 195 YTGSCDLWSIGVVSYELLTGSTPF---NY--------ETLDMTYSSILACDTE----DTV 239
           Y+   D+WS+G +  ELL+    F   +          TL      +    T        
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 240 SFPSSI-----RLSTAMVNFVQSLVQKL-----DARLNMDQVLGHPVF 277
           SFP        +L          L+ ++       R+  +Q L HP F
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  113 bits (284), Expect = 7e-28
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 28/279 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---RDIMVKSKC--PY 69
            D+++   I  G    +Y      ++    +K++  EK   +++   +++   S+C  P 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQAVQYLHG 128
           +V  + SF   + ++ +M Y++GG  + ++++  P G L E+     + E+ + ++YLH 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---VGTPEYVAPEVLEW 185
            G +HRDIK  N+LL   G +K+ DFG +  +   G     V    VGTP ++APEV+E 
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NY---ETLDMTYSSILAC--DTEDTV 239
           +       GY    D+WS G+ + EL TG+ P+  Y   + L +T  +         D  
Sbjct: 181 VH------GYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234

Query: 240 SFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVF 277
            +  S R        +   +QK  + R   +++L H  F
Sbjct: 235 KYSKSFR------KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 1e-27
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 35/218 (16%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-------RDI--MVKSKC 67
           ++    + +G +G +Y   +K++     +KK+   ++ N  E       R+I  + + K 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTALREISLLKELKH 57

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P IV L         +Y + EY    D    L+ +P   LS +  +  +Y+L + + Y H
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCH 115

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG--TPE-----YVAP 180
               +HRD+KP N+L++  G LKL DFG A       R   I P+   T E     Y AP
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLA-------RAFGI-PLRTYTHEVVTLWYRAP 167

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           E+L       GS  Y+ + D+WS+G +  E++TG   F
Sbjct: 168 EIL------LGSKHYSTAVDIWSVGCIFAEMITGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (282), Expect = 1e-27
 Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 29/276 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE---KMPNTI--ERDIMVKSKCPY 69
            D +    +  GN G +  V  + +     +K +  E    +   I  E DI+ K   PY
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH-G 128
           IV  + +F +   +   MEY+ GG    +L+ +  G + E         + + + YLH  
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEWM 186
              +HRD+KP N+L+++ G +KL DFG + Q+     + S+    VGT  Y+APE +   
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-----VNSLAKTFVGTSSYMAPERI--- 171

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL----ACDTEDTVSFP 242
           +GN     Y+   D+WS+G+   EL TG  P+  E  +     I         E     P
Sbjct: 172 QGND----YSVKSDIWSLGLSLIELATGRFPYPPE--NDPPDGIFELLQYIVNEPPPRLP 225

Query: 243 SSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVF 277
           S  + S    +FV   + K    R +  ++L HP  
Sbjct: 226 SG-KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  112 bits (281), Expect = 1e-27
 Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 18/214 (8%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVKSKCP 68
           DF+I   I +G+FG ++ V  K     + MK++   KM N  ER+       ++ K    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSS 59

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKA-RFYIYELAQAVQYLH 127
           YI+  + SF D   +  +MEY   GD   LL+ Q    L E +  RF+I  L   + +LH
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-GLAHLH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               +HRDIK  N+ L A  ++K+ D G A  +  N    + + VGTP Y++PE+ E   
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCE--- 174

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                  Y    D+W++GVV YE  TG  PF+  
Sbjct: 175 ----DKPYNEKSDVWALGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 33/273 (12%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE-------KMPNTIERDIMVKS--KCPYIV 71
           + + QG FG +YL  +  +     +K+V  +       K  N +E +I +    +   IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
             +   +D   +   MEY+ GG     L  + +G L+E+  R Y  ++ + V+YLH    
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMI 125

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVD----KNGRIKSIVPVGTPEYVAPEVLEWME 187
           VHRDIK  N+L  + G++KL DFG++ ++         +KS+   GTP +++PEV+    
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV--TGTPYWMSPEVIS--- 180

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTEDTV-SFPSSI 245
                +GY    D+WS+G    E+LT   P+  +E +    ++I    T+ T    PS +
Sbjct: 181 ----GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQPTNPQLPSHV 232

Query: 246 RLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
             S    NF+ ++ V+    R + +++L H   
Sbjct: 233 --SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  110 bits (278), Expect = 3e-27
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKSKC--PYIV 71
             +  G+FG +Y        + F +K+V       T       +E++I + SK   P IV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
               + ++ +++Y  +E V GG    LL  + +G   E   R Y  ++   ++YLH    
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           VHRDIK  N+L+   G +KL DFG A QV +    KS    G+P ++APEV+        
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF--KGSPYWMAPEVIA------Q 175

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPF 218
             GY  + D+WS+G    E+ TG  P+
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  110 bits (277), Expect = 6e-27
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 21/228 (9%)

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E  +M +   P+I+ +  +  + +H    +E++ GG    LL    +G   E+    Y  
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTE 110

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGH-LKLTDFGSA----TQVDKNGRIKSIVPV 172
           +L + + YLH    +HRD+K  N+L+ +TG  L++ DFG+A     +    G  +  + +
Sbjct: 111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL-L 169

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI-- 230
           GT  ++APEVL         + Y  SCD+WS+G V  E+ T   P+N E      + I  
Sbjct: 170 GTIAFMAPEVLR-------GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222

Query: 231 LACDTEDTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
           +A  T    S P    LS  + +   + L  + + R    ++L HPVF
Sbjct: 223 IASATT-APSIPEH--LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  109 bits (275), Expect = 1e-26
 Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 56/300 (18%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTI--ERDIMVK 64
           ++   D +    +  GN G +  V+   +  T + KKV+    +  +   I  E  IM +
Sbjct: 1   DLRNEDLETISDLGAGNGGSVSKVKHIPT-GTVMAKKVVHIGAKSSVRKQILRELQIMHE 59

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
            + PYIV+ + +F + N++   ME++  G    +   +  G +        + ++A AV 
Sbjct: 60  CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVE----ILGKIAVAV- 112

Query: 125 YLHGLGY-------VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTP 175
            + GL Y       +HRDIKP N+L+++ G +KL DFG + ++     I SI    VGT 
Sbjct: 113 -VEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-----INSIADTFVGTS 166

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
            Y++PE ++          YT   D+WS+G+   EL  G  PF +  +D           
Sbjct: 167 TYMSPERIQ-------GGKYTVKSDVWSLGISIIELALGKFPFAFSNID----------- 208

Query: 236 EDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMD---QVLGHPVFDCLDSDPPCIPPPSQ 292
           +D    P  I      ++ +Q +VQ+   RL      + L   V  CL  DP   P P Q
Sbjct: 209 DDGQDDPMGI------LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 2e-26
 Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 48/298 (16%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYI 70
           ++    I +G +G +Y    K++     +KK+     +E  P T  R+I +  K   P I
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 71  VNL--FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           V L    + +    +Y + EY+   D   LL++ P    +ES+ + Y+ +L + +QYLH 
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
            G +HRDIK  N+L++  G LKL DFG A    K         V T  Y  PE+L     
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL----- 173

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFN----YETLDMTYSSILACDTEDTVSFPS- 243
             G+  Y    D+WS+G +  EL  G   F      E L+  +     C +    ++P  
Sbjct: 174 -LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE---LCGSPTDENWPGV 229

Query: 244 -------SIRLSTAMVN-FVQ-----------SLVQKL-----DARLNMDQVLGHPVF 277
                  +++          +            L+ KL       R++ DQ L H  F
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  109 bits (274), Expect = 2e-26
 Identities = 76/286 (26%), Positives = 144/286 (50%), Gaps = 32/286 (11%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSF 77
           +G FG++   + + +   +  KK+ ++++          +E+ I+ K    +IV+L Y+F
Sbjct: 3   KGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF 62

Query: 78  QDMNHVYFIMEYVTGGDF----VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
           Q    +  +M  + GGD       + E  P     E +A FY  ++   +++LH    ++
Sbjct: 63  QTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+KP+N+LL   G+++++D G A ++ K+G+ K+    GTP ++APE+L+  E      
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSKTKGYAGTPGFMAPELLQGEE------ 173

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN 253
            Y  S D +++GV  YE++    PF      +    +      D+V++P   + S A  +
Sbjct: 174 -YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKS 230

Query: 254 FVQSLVQK-LDARL-----NMDQVLGHPVFDCLD---SDPPCIPPP 290
           F ++L+ K  + RL     N D +  HP+F  L+    +   +PPP
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-26
 Identities = 56/151 (37%), Positives = 88/151 (58%), Gaps = 10/151 (6%)

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P I   + S+     ++ IMEY  GG   TL++  P   ++E      I E+  A++Y+H
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALKYIH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            +G +HRDIK  N+L++ TG++KL DFG A  +++N   K    VGTP ++APEV+   E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVI--TE 175

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           G +    Y    D+WS+G+  YE+ TG+ P+
Sbjct: 176 GKY----YDTKADIWSLGITIYEMATGNPPY 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  109 bits (273), Expect = 3e-26
 Identities = 76/261 (29%), Positives = 124/261 (47%), Gaps = 18/261 (6%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTI--ERDIMVKSKCPYIVNLFYSFQD 79
           +GN+G +Y V  + +  T  MK++   L E   N I  E DI+ K+  PYIV+ + +F  
Sbjct: 11  KGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70

Query: 80  MNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESKARFYIYELAQAVQYL-HGLGYVHRDIK 137
              VY  MEY+  G    L         + E   R   Y + + +++L      +HRD+K
Sbjct: 71  EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK 130

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGY 195
           P N+L++  G +KL DFG +  +     + S+    +G   Y+APE ++   G + +  Y
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSGNL-----VASLAKTNIGCQSYMAPERIK-SGGPNQNPTY 184

Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV 255
           T   D+WS+G+   E+  G  P+  ET    ++ + A    D  + PS    S    +FV
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG--YSDDAQDFV 242

Query: 256 QSLVQKLDA-RLNMDQVLGHP 275
              + K+   R    Q+L HP
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHP 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  107 bits (268), Expect = 1e-25
 Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPNTI---ER---DIMVKSKCPYIVN 72
           I +G FG++Y   +  +   + MK    K ++ K   T+   ER    ++    CP+IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           + Y+F   + + FI++ + GGD    L    HG  SE + RFY  E+   ++++H    V
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           +RD+KP N+LL   GH++++D G A    K    K    VGT  Y+APEVL+        
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQ------KG 170

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF 218
             Y  S D +S+G + ++LL G +PF
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 1e-25
 Identities = 67/189 (35%), Positives = 93/189 (49%), Gaps = 19/189 (10%)

Query: 29  GDIYLVEE-KQSH-NTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYF 85
           G+I  +++ K+S  +  V K  LRE K+   +            IVNL  +F+    +Y 
Sbjct: 26  GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH--------ENIVNLKEAFRRKGRLYL 77

Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + EYV     + LLE  P G L     R YI++L QA+ Y H    +HRDIKP+N+L+S 
Sbjct: 78  VFEYV-ERTLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135

Query: 146 TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIG 205
           +G LKL DFG A  +           V T  Y APE+L       G   Y    D+W+IG
Sbjct: 136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV------GDTNYGKPVDVWAIG 189

Query: 206 VVSYELLTG 214
            +  ELL G
Sbjct: 190 CIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  105 bits (263), Expect = 3e-25
 Identities = 81/283 (28%), Positives = 138/283 (48%), Gaps = 30/283 (10%)

Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMV 63
           +L ++N    DF++ + I  G +GD+Y      +     +K +  E   +   ++++I++
Sbjct: 1   DLSRRN-PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM 59

Query: 64  KSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH--GYLSESKARFYIYEL 119
              C    IV  F S+   + ++  ME+  GG     L++  H  G LSES+  +   E 
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRET 115

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYV 178
            Q + YLH  G +HRDIK  N+LL+  GH+KL DFG + Q+     + KS   +GTP ++
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF--IGTPYWM 173

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLD----MTYSSILAC 233
           APEV           GY   CD+W++G+ + EL     P F+   +     MT S+    
Sbjct: 174 APEV----AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229

Query: 234 DTEDTVSFPSSIRLSTAMVNFVQ-SLVQKLDARLNMDQVLGHP 275
             +D + + +S        +FV+ +L +    R   +++L HP
Sbjct: 230 KLKDKMKWSNSFH------HFVKMALTKNPKKRPTAEKLLQHP 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  106 bits (265), Expect = 3e-25
 Identities = 74/295 (25%), Positives = 139/295 (47%), Gaps = 32/295 (10%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPY 69
           F   R + +G FG++   + + +   +  KK+ ++++           E+ I+ K    +
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +V+L Y+++  + +  ++  + GGD    + N  +    E +A FY  E+   ++ LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             V+RD+KP+N+LL   GH++++D G A ++ +   I+    VGT  Y+APEV++     
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG--RVGTVGYMAPEVVK----- 174

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
             ++ YT S D W +G + YE++ G +PF      +    +     ED   +  S + S 
Sbjct: 175 --NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSE 230

Query: 250 AMVNFVQSLVQKLDA-RL-----NMDQVLGHPVFDCLD--------SDPPCIPPP 290
           A  +  + L+ K    RL       ++V  HP F   +         +PP  P P
Sbjct: 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 5e-25
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 24/203 (11%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSK-----CPYIVNL 73
           I +G +G +Y   +  +     +KKV      E +P +  R+I +  +      P IV L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 74  FYSFQDMN-----HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
                         +  + E+V   D  T L   P   L     +  + +L + V +LH 
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              VHRD+KP N+L+++ G +K+ DFG A        + S+V   T  Y APEVL     
Sbjct: 126 HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPEVLL---- 179

Query: 189 NHGSDGYTGSCDLWSIGVVSYEL 211
                 Y    D+WS+G +  EL
Sbjct: 180 ---QSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  105 bits (262), Expect = 6e-25
 Identities = 68/202 (33%), Positives = 109/202 (53%), Gaps = 16/202 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---RDIMVKSKC--PYIVNLFYSF 77
           I +G+FG++Y   + ++     +K +  E+  + IE   ++I V S+C  PYI   + S+
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                ++ IMEY+ GG  + LL+  P   L E+     + E+ + + YLH    +HRDIK
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIK-------QSAYDF 180

Query: 198 SCDLWSIGVVSYELLTGSTPFN 219
             D+WS+G+ + EL  G  P +
Sbjct: 181 KADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  103 bits (258), Expect = 2e-24
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 20/226 (8%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLR--------EKMPNTIERDIMVKSKCPYIVNLFYS 76
           +G FG++  V+ K +   +  KK+ +        EKM   +E++I+ K   P+IVNL Y+
Sbjct: 3   KGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA-LLEKEILEKVNSPFIVNLAYA 61

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           F+   H+  +M  + GGD    + N     L   +   Y  ++   + +LH +  V+RD+
Sbjct: 62  FESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDM 121

Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP+N+LL   G+ +L+D G A ++ K+G  K+I    GT  Y+APE+L+        + Y
Sbjct: 122 KPENVLLDDQGNCRLSDLGLAVEL-KDG--KTITQRAGTNGYMAPEILK-------EEPY 171

Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           +   D +++G   YE++ G TPF      +    +     ED V F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (258), Expect = 3e-24
 Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 27/266 (10%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--IERDIMV--KSKCPYIVNLFYSFQ 78
           I QG  G +Y   +  +     +K++  ++ P    I  +I+V  ++K P IVN   S+ 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 79  DMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
             + ++ +MEY+ GG   D VT  E      + E +      E  QA+++LH    +HRD
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVT--ETC----MDEGQIAAVCRECLQALEFLHSNQVIHRD 140

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           IK DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           Y
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-------RKAY 192

Query: 196 TGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNF 254
               D+WS+G+++ E++ G  P+ N   L   Y  ++A  T  T    +  +LS    +F
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LIA--TNGTPELQNPEKLSAIFRDF 248

Query: 255 V-QSLVQKLDARLNMDQVLGHPVFDC 279
           + + L   ++ R +  ++L HP    
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKI 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  102 bits (258), Expect = 3e-24
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 45/209 (21%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKV------------LREKMPNTIERDIMVKS-----KCP 68
           G FG +YL   K++     +KK+            LRE           VKS     + P
Sbjct: 10  GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE-----------VKSLRKLNEHP 58

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            IV L   F++ + +YF+ EY+ G +   L++++     SES  R  IY++ Q + ++H 
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP----VGTPEYVAPEVLE 184
            G+ HRD+KP+N+L+S    +K+ DFG A +      I+S  P    V T  Y APE+L 
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLARE------IRSRPPYTDYVSTRWYRAPEIL- 170

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
                  S  Y+   D+W++G +  EL T
Sbjct: 171 -----LRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  102 bits (256), Expect = 4e-24
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 29/225 (12%)

Query: 19  IKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCPY 69
           + + + +G FG++Y   L  + +   T V  K L+E        +      IM K   P 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV L         +Y + EY+ GGD +  L       L+         ++A+ ++YL   
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK 121

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----RIKSIVPVGTPEYVAPEVLEW 185
            +VHRD+   N L++    +K++DFG +  + ++     R    +P+   +++APE L+ 
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMAPESLKD 178

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
            +    S       D+WS GV+ +E+ T G  P+    N E L++
Sbjct: 179 GKFTSKS-------DVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL 216

Length = 258

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  101 bits (253), Expect = 6e-24
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 22/264 (8%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKV----LREKMPNTIERDIMVKSKC--PYIVNLF 74
           R + +G FG+  L    +  +  V K+V    L EK       +I++ S    P I+  +
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
             F D N +   MEY  GG     +  Q      E    +Y++++  AV Y+H  G +HR
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           DIK  N+ L+  G +KL DFG +  +     +   V VGTP Y++PE+ + ++ N  S  
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFKS-- 182

Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNF 254
                D+W++G V YELLT    F+          I+  +    VS       S+ +++ 
Sbjct: 183 -----DIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS-----VYSSELISL 232

Query: 255 VQSLVQKLDA--RLNMDQVLGHPV 276
           V SL+Q+ D   R   D+VL  P+
Sbjct: 233 VHSLLQQ-DPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  102 bits (254), Expect = 7e-24
 Identities = 67/200 (33%), Positives = 109/200 (54%), Gaps = 16/200 (8%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---RDIMVKSKC--PYIVNLFYSF 77
           I +G+FG+++   + ++     +K +  E+  + IE   ++I V S+C  PY+   + S+
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                ++ IMEY+ GG  + LLE  P   L E++    + E+ + + YLH    +HRDIK
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIK-------QSAYDS 180

Query: 198 SCDLWSIGVVSYELLTGSTP 217
             D+WS+G+ + EL  G  P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  100 bits (251), Expect = 1e-23
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 16/198 (8%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVKSKCPYIVNLFY 75
           I +G+FG   LV+ K+    +V+K++   KM    ER+       ++   K P IV    
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQE 66

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           SF++  ++Y +M+Y  GGD    +  Q      E +   +  ++  A++++H    +HRD
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           IK  N+ L+  G +KL DFG A  ++    +     +GTP Y++PE+ E       +  Y
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICE-------NRPY 178

Query: 196 TGSCDLWSIGVVSYELLT 213
               D+W++G V YE+ T
Sbjct: 179 NNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  101 bits (252), Expect = 1e-23
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 27/214 (12%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL-----------REKMPNTIERDIMVKSKC--PY 69
           I  G+FG +YL     S     +K+V            +  M + + R+I +  +     
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV    S  D +H+   +EYV GG    LL N  +G   E+  R ++ ++ + + YLH  
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR 125

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPV--GTPEYVAPEVLE 184
           G +HRDIK  N+L+   G +K++DFG + +++ N    +     P   G+  ++APEV++
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                     YT   D+WS+G +  E+LTG  PF
Sbjct: 186 -------QTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  101 bits (252), Expect = 1e-23
 Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 16/200 (8%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---RDIMVKSKC--PYIVNLFYSF 77
           I +G+FG+++   + ++     +K +  E+  + IE   ++I V S+C  PY+   + S+
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                ++ IMEY+ GG  + LL   P     E +    + E+ + + YLH    +HRDIK
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIQ-------QSAYDS 180

Query: 198 SCDLWSIGVVSYELLTGSTP 217
             D+WS+G+ + EL  G  P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 99.3 bits (247), Expect = 5e-23
 Identities = 77/277 (27%), Positives = 134/277 (48%), Gaps = 20/277 (7%)

Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMV 63
           ++ ++N    D+++ + +  G +GD+Y      +     +K +  E   +   I+++I +
Sbjct: 1   DILRRN-PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM 59

Query: 64  KSKCPY--IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH--GYLSESKARFYIYEL 119
             +C +  IV  F S+     ++  MEY  GG     L++  H  G LSE +  +   E 
Sbjct: 60  VKECKHCNIVAYFGSYLSREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRET 115

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYV 178
            Q + YLH  G +HRDIK  N+LL+  G +KL DFG A ++     + KS   +GTP ++
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF--IGTPYWM 173

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           APEV   +E N    GY   CD+W++G+ + EL     P  ++   M    +++      
Sbjct: 174 APEVAA-VEKN---GGYNQLCDIWAVGITAIELAELQPPM-FDLHPMRALFLMSKSNFQP 228

Query: 239 VSFPSSIRLSTAMVNFVQ-SLVQKLDARLNMDQVLGH 274
                  + S+   NFV+ SL +    R   +++L H
Sbjct: 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 8e-23
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 37/284 (13%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMPNTIERDI-MVK--SKCP 68
              F++   I +G +G +Y    K++    V  K++   E     I+ +  +++  S  P
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKT-GQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 69  YIVNLFYSFQDMNH------VYFIMEYVTGG---DFV--TLLENQPHGYLSESKARFYIY 117
            I   + +F   N       ++ +ME   GG   D V     + +    L E    + + 
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR---LKEEWIAYILR 120

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPE 176
           E  + + YLH    +HRDIK  N+LL+    +KL DFG + Q+D   GR  +   +GTP 
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGTPY 178

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM----TYSSILA 232
           ++APEV+   E    S  Y    D+WS+G+ + EL  G  P      DM        I  
Sbjct: 179 WMAPEVIACDEQPDAS--YDARSDVWSLGITAIELADGKPPL----CDMHPMRALFKIPR 232

Query: 233 CDTEDTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHP 275
            +   T+  P     S    +F+ + L++  + R  M+++L HP
Sbjct: 233 -NPPPTLKSPE--NWSKKFNDFISECLIKNYEQRPFMEELLEHP 273

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 98.9 bits (246), Expect = 1e-22
 Identities = 57/205 (27%), Positives = 108/205 (52%), Gaps = 16/205 (7%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNL 73
           R + +G FG++   + + +   +  K++ ++++           E+ I+ K    ++VNL
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            Y+++  + +  ++  + GGD    + N  +    E +A FY  E+   ++ LH    V+
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+KP+N+LL   GH++++D G A ++ +   I+    VGT  Y+APEVL        + 
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG--RVGTVGYMAPEVLN-------NQ 176

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPF 218
            YT S D W +G + YE++ G +PF
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 98.5 bits (245), Expect = 1e-22
 Identities = 56/205 (27%), Positives = 108/205 (52%), Gaps = 16/205 (7%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNL 73
           R + +G FG++   + + +   +  KK+ ++++           E+ I+ K    ++V+L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            Y+++  + +  ++  + GGD    + N  +    E +A FY  EL   ++ L     V+
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+KP+N+LL   GH++++D G A Q+ +   ++    VGT  Y+APEV+        ++
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG--RVGTVGYMAPEVIN-------NE 176

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPF 218
            YT S D W +G + YE++ G +PF
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)

Query: 19  IKRFIQQGNFGDIYLVE-EKQSHNTFVM---KKVLREKMPNTI-----ERDIMVKSKCPY 69
           + + + +G FG++Y    + +     V    K +  +     I     E  IM K   P 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV L     +   +  +MEY+ GGD +  L       LS S    +  ++A+ ++YL   
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYVAPEVLEWM 186
            ++HRD+   N L+     +K++DFG +  +  +   K     +P+    ++APE L   
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL--- 176

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               G   +T   D+WS GV+ +E+ T G  P+
Sbjct: 177 --KEGK--FTSKSDVWSFGVLLWEIFTLGEEPY 205

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 97.0 bits (241), Expect = 4e-22
 Identities = 78/275 (28%), Positives = 137/275 (49%), Gaps = 26/275 (9%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTI---ERDIMVKSKCPYIVNLFYSFQ 78
           I +G+ G + +  EK +     +KK+ LR++    +   E  IM       +V+++ S+ 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
             + ++ +ME++ GG    ++    H  ++E +       + +A+ YLH  G +HRDIK 
Sbjct: 90  VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146

Query: 139 DNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
           D++LL++ G +KL+DFG   QV K   + KS+  VGTP ++APEV+  +        Y  
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPEVISRLP-------YGT 197

Query: 198 SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV--SFPSSIRLSTAMVNFV 255
             D+WS+G++  E++ G  P+  E        I      D +      S ++S+ +  F+
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-----RDNLPPRVKDSHKVSSVLRGFL 252

Query: 256 Q-SLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPP 289
              LV++   R    ++L HP F  L   P CI P
Sbjct: 253 DLMLVREPSQRATAQELLQHP-FLKLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 69/259 (26%), Positives = 128/259 (49%), Gaps = 16/259 (6%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM 80
           G FG +Y  + K++   F   K+++ +         +E DI+ + K P IV L+ ++   
Sbjct: 16  GAFGKVYKAQHKET-GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           N ++ ++E+  GG   +++     G L+E + R+   ++ +A+ +LH    +HRD+K  N
Sbjct: 75  NKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGN 133

Query: 141 MLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +LL+  G +KL DFG SA       +  +   +GTP ++APEV+         + Y    
Sbjct: 134 ILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAPEVV--ACETFKDNPYDYKA 189

Query: 200 DLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQS-L 258
           D+WS+G+   EL     P ++E   M    +L     +  +     + S++  +F++S L
Sbjct: 190 DIWSLGITLIELAQMEPP-HHELNPMRV--LLKILKSEPPTLDQPSKWSSSFNDFLKSCL 246

Query: 259 VQKLDARLNMDQVLGHPVF 277
           V+  D R    ++L HP  
Sbjct: 247 VKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 96.2 bits (239), Expect = 7e-22
 Identities = 57/205 (27%), Positives = 109/205 (53%), Gaps = 16/205 (7%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNL 73
           R + +G FG++   + + +   +  KK+ ++++           E+ I+ K    ++V+L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            Y+++  + +  ++  + GGD    + +       E +A FY  E+   ++ LH    V+
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+KP+N+LL   GH++++D G A  V +   IK    VGT  Y+APEV++       ++
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAPEVVK-------NE 176

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPF 218
            YT S D W++G + YE++ G +PF
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.7 bits (238), Expect = 8e-22
 Identities = 73/268 (27%), Positives = 112/268 (41%), Gaps = 31/268 (11%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER---------DIMVKSKCPYIVNLFY 75
           +G +G +Y     Q     V +  L        E+         D++   K   IV    
Sbjct: 10  KGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +  D N +   ME+V GG   ++L     G L E     Y  ++   V YLH    VHRD
Sbjct: 70  TCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRD 127

Query: 136 IKPDNMLLSATGHLKLTDFGSATQ-------VDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           IK +N++L   G +KL DFG A +          +  +KS+   GTP ++APEV+     
Sbjct: 128 IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM--HGTPYWMAPEVIN---- 181

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                GY    D+WSIG   +E+ TG  P    ++D   +++        +        S
Sbjct: 182 ---ESGYGRKSDIWSIGCTVFEMATGKPPLA--SMD-RLAAMFYIGAHRGLMPRLPDSFS 235

Query: 249 TAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            A ++FV S L +    R +  Q+L H 
Sbjct: 236 AAAIDFVTSCLTRDQHERPSALQLLRHD 263

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 96.3 bits (239), Expect = 8e-22
 Identities = 74/258 (28%), Positives = 125/258 (48%), Gaps = 19/258 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--IERDIMV--KSKCPYIVNLFYSFQ 78
           I QG  G +Y   +  +     +K++  ++ P    I  +I+V  ++K P IVN   S+ 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
             + ++ +MEY+ GG    ++       + E +      E  QA+ +LH    +HRDIK 
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKS 143

Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           Y   
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-------RKAYGPK 195

Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV-QS 257
            D+WS+G+++ E++ G  P+  E       ++    T  T    +  RLS    +F+ + 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252

Query: 258 LVQKLDARLNMDQVLGHP 275
           L   +D R +  ++L HP
Sbjct: 253 LEMDVDRRGSAKELLQHP 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 34/218 (15%)

Query: 23  IQQGNFGDIYL--VEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCPYIVNLF 74
           + +G FG++Y   ++ K    T V  K L+E       +D      +M K   P +V L 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 75  -YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYL 126
               ++   +Y ++EY+ GGD +  L      + S  K+         +  ++A+ ++YL
Sbjct: 63  GVCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS----IVPVGTPEYVAPEV 182
               +VHRD+   N L+     +K++DFG +  V  +   +      +P+    ++APE 
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI---RWMAPES 178

Query: 183 LEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
           L+        DG +T   D+WS GV+ +E+ T G+TP+
Sbjct: 179 LK--------DGIFTSKSDVWSFGVLLWEIFTLGATPY 208

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 94.6 bits (236), Expect = 3e-21
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 23/218 (10%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV----LREKMPNTIERDIMVKSKC- 67
           S  +++    I++G +G +Y   +K++     +KK+     +E  P T  R+I +  K  
Sbjct: 3   SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62

Query: 68  -PYIVNL----FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
            P IV +      S  +++ +Y +MEYV   D  +L+E     +  +S+ +  + +L   
Sbjct: 63  HPNIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPF-LQSEVKCLMLQLLSG 118

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPE 181
           V +LH    +HRD+K  N+LL+  G LK+ DFG A +      +K     V T  Y APE
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP--LKPYTQLVVTLWYRAPE 176

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           +L       G+  Y+ + D+WS+G +  ELLT    F 
Sbjct: 177 LL------LGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 28/208 (13%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKV----LREKMPNTIERDIMVKSKCPY--IVNLFYSFQ 78
           +G +G +Y   +  +     +K++     R   P  +  +I + S   +  IV    S  
Sbjct: 18  KGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP--LHEEIALHSYLKHRNIVQYLGSDS 75

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLS--ESKARFYIYELAQAVQYLHGLGYVHRDI 136
           +       ME V GG    LL ++  G L   E    FY  ++ + ++YLH    VHRDI
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134

Query: 137 KPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPV-----GTPEYVAPEVLEWMEGNH 190
           K DN+L++  +G +K++DFG++       R+  I P      GT +Y+APEV++      
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSK------RLAGINPCTETFTGTLQYMAPEVID-----K 183

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           G  GY    D+WS+G    E+ TG  PF
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 93.0 bits (232), Expect = 5e-21
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)

Query: 19  IKRFIQQGNFGDIY---LVEEKQSHNTFV-MKKVLREKMPNTI-----ERDIMVKSKCPY 69
           + + + +G FG++Y   L  +       V +K +  +     I     E  IM K   P 
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +V L     +   +Y +MEY+ GGD ++ L       LS S    +  ++A+ ++YL   
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYVAPEVLEWM 186
            ++HRD+   N L+     +K++DFG +  +  +   +     +P+    ++APE L   
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL--- 175

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               G   +T   D+WS GV+ +E+ T G  P+
Sbjct: 176 --KEGK--FTSKSDVWSFGVLLWEIFTLGEQPY 204

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 60/264 (22%), Positives = 114/264 (43%), Gaps = 22/264 (8%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERDIMVKSKC--PYIVNLF 74
           R + +G FG ++L   K      ++K++  E+M        + +  V      P I+  +
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            +F +   +  +MEY  GG     ++ + +  L E     +  ++  A+ ++H    +HR
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125

Query: 135 DIKPDNMLLSATGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           D+K  N+LL      +K+ DFG +  +    +  ++  VGTP Y++PE+ E         
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV--VGTPCYISPELCE-------GK 176

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN 253
            Y    D+W++G V YEL +    F    L      I++         P S R S  +  
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-----GTFAPISDRYSPDLRQ 231

Query: 254 FVQSLVQ-KLDARLNMDQVLGHPV 276
            + S++      R  + Q++  P+
Sbjct: 232 LILSMLNLDPSKRPQLSQIMAQPI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 93.7 bits (233), Expect = 6e-21
 Identities = 82/294 (27%), Positives = 141/294 (47%), Gaps = 38/294 (12%)

Query: 12  VSASD--FDIKRFIQ--QGNFGDIYLVEEKQSHNTFVMKKV------LREKMPNTIERDI 61
           V   D    +  F++  +G+ G + +  +K +     +KK+       RE + N  E  I
Sbjct: 12  VDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN--EVVI 69

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYE 118
           M   + P IV ++ S+   + ++ +ME++ GG   D VT      H  ++E +       
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT------HTRMNEEQIATVCLA 123

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEY 177
           + +A+ +LH  G +HRDIK D++LL++ G +KL+DFG   QV K   R KS+  VGTP +
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYW 181

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSILACDTE 236
           +APEV+  +        Y    D+WS+G++  E++ G  P FN   L     ++      
Sbjct: 182 MAPEVISRLP-------YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ----AMKRIRDN 230

Query: 237 DTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPP 289
                 +  ++S  + +F+ + LV+    R    ++L HP F      P  I P
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP-FLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 93.9 bits (234), Expect = 7e-21
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 20/218 (9%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDI----MVKSK 66
            D++I   + +G FG++Y   + ++     +KK+L    ++  P T  R+I     +K  
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67

Query: 67  CPY-IVNLFYSFQD-----MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
               ++++     D        VY +  Y+   D   LLEN P   L+ES+ + Y+ +L 
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLL 125

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-RIKSIVPVGTPEYVA 179
           + + YLH    +HRDIK  N+L+   G LK+ DFG A   D      K     GT +Y  
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185

Query: 180 PEVLEWM---EGNHGSDGYTGSCDLWSIGVVSYELLTG 214
             V  W    E   G   YT + D+W IG V  E+ T 
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 93.3 bits (231), Expect = 1e-20
 Identities = 73/258 (28%), Positives = 125/258 (48%), Gaps = 19/258 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--IERDIMVKS--KCPYIVNLFYSFQ 78
           I QG  G ++   +  +     +K++  +K P    I  +I+V    K P IVN   SF 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
             + ++ +MEY+ GG    ++       + E++      E  QA+++LH    +HRDIK 
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKS 143

Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           Y   
Sbjct: 144 DNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-------RKAYGPK 195

Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV-QS 257
            D+WS+G+++ E++ G  P+  E       ++    T  T    +  +LS    +F+ + 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252

Query: 258 LVQKLDARLNMDQVLGHP 275
           L   ++ R +  ++L HP
Sbjct: 253 LEMDVEKRGSAKELLQHP 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 21/269 (7%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKCPYIVNLFYSFQDM 80
           G FG +Y  + K++       KV+  K    +E      DI+     P IV L  +F   
Sbjct: 16  GAFGKVYKAQNKET-GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE 74

Query: 81  NHVYFIMEYVTGG--DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           N+++ ++E+  GG  D V L   +P   L+E + R    +  +A+ YLH    +HRD+K 
Sbjct: 75  NNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131

Query: 139 DNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
            N+L +  G +KL DFG SA       R  S   +GTP ++APEV+  M        Y  
Sbjct: 132 GNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAPEVV--MCETSKDRPYDY 187

Query: 198 SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQS 257
             D+WS+G+   E+     P ++E   M     +A     T++ PS  R S+   +F++ 
Sbjct: 188 KADVWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKSEPPTLAQPS--RWSSEFKDFLKK 244

Query: 258 LVQK-LDARLNMDQVLGHPVFDCLDSDPP 285
            ++K +DAR    Q+L HP F  ++S+ P
Sbjct: 245 CLEKNVDARWTTTQLLQHP-FVTVNSNKP 272

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 19/211 (9%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC- 67
           S ++F+    I +G +G +Y   +  S     +KKV     R+ +P +  R+I +     
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR 64

Query: 68  -PYIVNLFYSF--QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
            P IV L      + ++ ++ +MEY    D  +LL+N P  + SES+ +  + +L + +Q
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPF-SESQVKCLMLQLLRGLQ 122

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVL 183
           YLH    +HRD+K  N+LL+  G LK+ DFG A         K + P V T  Y APE+L
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP--AKPMTPKVVTLWYRAPELL 180

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                  G   YT + D+W++G +  ELL  
Sbjct: 181 ------LGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 72/279 (25%), Positives = 136/279 (48%), Gaps = 22/279 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTI---ERDIMVKSKCPYIVNLFYSFQ 78
           I +G+ G + +  EK S     +K + LR++    +   E  IM   +   +V ++ S+ 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
               ++ +ME++ GG    ++       L+E +       + QA+ YLH  G +HRDIK 
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145

Query: 139 DNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
           D++LL+  G +KL+DFG   Q+ K+  + KS+  VGTP ++APEV+           Y  
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVI-------SRTPYGT 196

Query: 198 SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQS 257
             D+WS+G++  E++ G  P+  ++      ++            ++ ++S  + +F++ 
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253

Query: 258 -LVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENK 295
            L ++   R    ++L HP F      P C+ P  Q+ +
Sbjct: 254 MLTREPQERATAQELLDHP-FLLQTGLPECLVPLIQQYR 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 76/313 (24%), Positives = 135/313 (43%), Gaps = 58/313 (18%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERD------IMVKSKC 67
           ++  + + +G +  +Y   +K++     +KK+    R++  + I         ++ + K 
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 68  PYIVNL---FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           P I+ L   F    ++N V+  ME     D   ++++     L+ +  + Y+    + ++
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME----TDLEKVIKD-KSIVLTPADIKSYMLMTLRGLE 116

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVL 183
           YLH    +HRD+KP+N+L+++ G LKL DFG A      N ++     V T  Y APE+L
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVVTRWYRAPELL 174

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-----NYETLDMTYSSILACDTEDT 238
                  G+  Y    D+WS+G +  ELL    PF     + + L   +   L   TE+ 
Sbjct: 175 ------FGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIF-EALGTPTEEN 226

Query: 239 ----VSFPSSIRL---------------STAMVNFVQSLVQKLD--ARLNMDQVLGHPVF 277
                S P  +                 S   ++ +Q L+  L+   R+   Q L HP F
Sbjct: 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLL-TLNPNKRITARQALEHPYF 285

Query: 278 DCLDSDPPCIPPP 290
               +DP   PP 
Sbjct: 286 ---SNDPAPTPPS 295

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 29/266 (10%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVL------REKMPNTI-ERDIMVKSKCPYIVNL 73
           R I  G+FG +Y   + +++    +KK+        EK  + I E   + + + P  +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 74  FYSFQDMNHVYFIMEYVTG--GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
              +   +  + +MEY  G   D + + + +P   L E +     +   Q + YLH    
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHK-KP---LQEVEIAAICHGALQGLAYLHSHER 136

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           +HRDIK  N+LL+  G +KL DFGSA+ V           VGTP ++APEV+  M+    
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAPEVILAMDEGQ- 190

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSILACDTEDTVSFPSSIRLSTA 250
              Y G  D+WS+G+   EL     P FN   +   Y   +A +   T+   SS   S  
Sbjct: 191 ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNDSPTL---SSNDWSDY 242

Query: 251 MVNFVQSLVQKL-DARLNMDQVLGHP 275
             NFV S +QK+   R + +++L H 
Sbjct: 243 FRNFVDSCLQKIPQDRPSSEELLKHR 268

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 92.2 bits (230), Expect = 3e-20
 Identities = 55/184 (29%), Positives = 94/184 (51%), Gaps = 31/184 (16%)

Query: 46  KKVLREKMPNTIERDIMVKSKCPYIVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLE 100
           K++LRE     I+  ++   +   I+ L       S +D N VY + E +   D   +++
Sbjct: 44  KRILRE-----IK--LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIK 95

Query: 101 NQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV 160
           +     L++   ++++Y++ + ++YLH    +HRD+KP N+L+++   LK+ DFG A  V
Sbjct: 96  SPQP--LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153

Query: 161 DKNGRIKSIVPVGTPEYV------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
           D +   K  +   T EYV      APE+L        S  YT + D+WS+G +  ELLT 
Sbjct: 154 DPDEDEKGFL---T-EYVVTRWYRAPELL------LSSSRYTKAIDIWSVGCIFAELLTR 203

Query: 215 STPF 218
              F
Sbjct: 204 KPLF 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 91.0 bits (226), Expect = 6e-20
 Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 39/250 (15%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL-----REKMPNTIERDIMVKSKC-- 67
            DF+    +  GN G +  V  + S    +M + L     +  + N I R++ V  +C  
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSG--LIMARKLIHLEIKPAIRNQIIRELKVLHECNS 58

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           PYIV  + +F     +   ME++ GG    +L+    G + E+     + +++ AV  L 
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEN----ILGKISIAV--LR 110

Query: 128 GLGY-------VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYV 178
           GL Y       +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y+
Sbjct: 111 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYM 165

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           +PE L   +G H    YT   D+WS+G+   E+  G  P           ++      + 
Sbjct: 166 SPERL---QGTH----YTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEG 217

Query: 239 VSFPSSIRLS 248
            +  S   +S
Sbjct: 218 EAKESHRPVS 227

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 17/212 (8%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-------DIMVKSKCP 68
           +F I++ I +G F  +Y            +KKV   +M +   R       D++ +   P
Sbjct: 3   NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP 62

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKARF-YIYELAQAVQYL 126
            ++    SF + N +  ++E    GD   ++++ +    L   +  + Y  +L  A++++
Sbjct: 63  NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H    +HRDIKP N+ ++ATG +KL D G            +   VGTP Y++PE +   
Sbjct: 123 HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPERI--- 178

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
              H + GY    D+WS+G + YE+    +PF
Sbjct: 179 ---HEN-GYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 89.8 bits (222), Expect = 1e-19
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 15/200 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--IERDIMV--KSKCPYIVNLFYSFQ 78
           I QG  G +Y   +  +     ++++  ++ P    I  +I+V  ++K P IVN   S+ 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
             + ++ +MEY+ GG    ++       + E +      E  QA+++LH    +HRDIK 
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 144

Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           Y   
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-------RKAYGPK 196

Query: 199 CDLWSIGVVSYELLTGSTPF 218
            D+WS+G+++ E++ G  P+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 15/211 (7%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKV------LREKMPNTIERDIMVKSKCPYIVNLF 74
           R + +G++G++ LV  +     +V+KK+       RE+     E  ++ + K P IV   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 75  YSFQDMN-HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            S++  +  +Y +M +  GGD    L+ Q    L E++   +  ++A A+QYLH    +H
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH 125

Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+K  N+ L+ T  +K+ D G A  ++    + S + +GTP Y++PE+      N+ S 
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL-IGTPYYMSPELFSNKPYNYKS- 183

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLD 224
                 D+W++G   YE+ T    FN + ++
Sbjct: 184 ------DVWALGCCVYEMATLKHAFNAKDMN 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 2e-19
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 37/227 (16%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV------------LREKMPNTIE 58
           +V    +    +I +G +G +     K +     +KK+            LRE     I+
Sbjct: 2   DVG-PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLRE-----IK 55

Query: 59  RDIMVKSKCPYIVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
             I+ + K   I+ +       SF+  N VY + E +   D   L++ Q    LS    +
Sbjct: 56  --ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH---LSNDHIQ 109

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-- 171
           +++Y++ + ++Y+H    +HRD+KP N+LL+    LK+ DFG A   D        +   
Sbjct: 110 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           V T  Y APE++        S GYT + D+WS+G +  E+L+    F
Sbjct: 170 VATRWYRAPEIM------LNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 27/244 (11%)

Query: 39  SHNTFVMKKVLREKMPNTIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYV-TGGDFV 96
           + N    K++L +        D+++KS  CPYIV  +  F   + V+  ME + T  D +
Sbjct: 51  TGNKEENKRILMD-------LDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKL 103

Query: 97  TLLENQPHGYLSESKARFYIYELAQAVQYL---HGLGYVHRDIKPDNMLLSATGHLKLTD 153
                 P   + E         + +A+ YL   HG+  +HRD+KP N+LL A+G++KL D
Sbjct: 104 LKRIQGP---IPEDILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCD 158

Query: 154 FG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
           FG S   VD   + +S    G   Y+APE +   +    +  Y    D+WS+G+   EL 
Sbjct: 159 FGISGRLVDSKAKTRS---AGCAAYMAPERI---DPPDPNPKYDIRADVWSLGISLVELA 212

Query: 213 TGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQV 271
           TG  P+     +    + +    E+  S P +   S    +FV   + K    R    ++
Sbjct: 213 TGQFPYKNCKTEFEVLTKIL--QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270

Query: 272 LGHP 275
           L HP
Sbjct: 271 LQHP 274

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 15/212 (7%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDI-MVKS-KCPYI 70
           F++   + +G +G +     K++     +KK       E++  T  R++ M+++ K   I
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V L  +F+    +Y + EYV   + + LLE  P+G   E K R YIY+L +A+ + H   
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPE-KVRSYIYQLIKAIHWCHKND 120

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
            VHRDIKP+N+L+S    LKL DFG A  + +         V T  Y +PE+L       
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL------ 174

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPFNYET 222
               Y  + D+WS+G +  EL  G   F  E+
Sbjct: 175 -GAPYGKAVDMWSVGCILGELSDGQPLFPGES 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 14/186 (7%)

Query: 31  IYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV 90
           + LV + ++  TF++K + +    +     I+     P +V L       + V+ ++++ 
Sbjct: 9   VLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHA 67

Query: 91  TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLK 150
            GG   + +    +  + E   + +  E+  A+  LH  G V RD+ P+N+LL   GH++
Sbjct: 68  EGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQ 125

Query: 151 LTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYE 210
           LT F   ++V+ +   +++  +    Y APEV    E        T +CD WS+G + +E
Sbjct: 126 LTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISE-------ETEACDWWSLGAILFE 174

Query: 211 LLTGST 216
           LLTG T
Sbjct: 175 LLTGKT 180

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 28/218 (12%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER------DIMVKSKCPYIVNLFYS 76
           I +GNFGD+Y  +     NT V  K  R  +P  ++R      +I+ +   P IV L   
Sbjct: 3   IGKGNFGDVY--KGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
                 +Y +ME V GG  +T L  +    L+  K      + A  ++YL     +HRD+
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119

Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI----VPVGTPEYVAPEVLEWMEGNHGS 192
              N L+     LK++DFG + + +      S     +P+   ++ APE L     N+G 
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI---KWTAPEAL-----NYGR 171

Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
             YT   D+WS G++ +E  + G TP+    N +T + 
Sbjct: 172 --YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 87.4 bits (216), Expect = 8e-19
 Identities = 75/283 (26%), Positives = 137/283 (48%), Gaps = 30/283 (10%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTI---ERDIMVKSKCPYIVNLFYSFQ 78
           I +G+ G + +   K S     +KK+ LR++    +   E  IM   +   +V ++ S+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
             + ++ +ME++ GG    ++    H  ++E +       + +A+  LH  G +HRDIK 
Sbjct: 88  VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144

Query: 139 DNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
           D++LL+  G +KL+DFG   QV K   R KS+  VGTP ++APE++  +        Y  
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPELISRLP-------YGP 195

Query: 198 SCDLWSIGVVSYELLTGSTPFNYE----TLDMTYSSILACDTEDTVSFPSSIRLSTAMVN 253
             D+WS+G++  E++ G  P+  E     + M   ++            +  ++S ++  
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------PPKLKNLHKVSPSLKG 248

Query: 254 FVQS-LVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENK 295
           F+   LV+    R    ++L HP F      P CI P  ++N+
Sbjct: 249 FLDRLLVRDPAQRATAAELLKHP-FLAKAGPPSCIVPLMRQNR 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 88.0 bits (219), Expect = 1e-18
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 39/223 (17%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-----RDIMVK---SKCP 68
           ++I + + +G +G ++   ++++     +KK+  +   N  +     R+IM        P
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDHP 67

Query: 69  YIVNLFYSFQDMNH--VYFIMEYVTGGDFVTLLENQPH-----GYLSESKARFYIYELAQ 121
            IV L    +  N   +Y + EY         +E   H       L +   R+ +Y+L +
Sbjct: 68  NIVKLLNVIKAENDKDIYLVFEY---------METDLHAVIRANILEDVHKRYIMYQLLK 118

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA-- 179
           A++Y+H    +HRD+KP N+LL++   +KL DFG A  + +        PV T +YVA  
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN-PVLT-DYVATR 176

Query: 180 ----PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
               PE+L       GS  YT   D+WS+G +  E+L G   F
Sbjct: 177 WYRAPEIL------LGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 28/204 (13%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDI-MVKS-KCPYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I ++K    P IV L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++  P   +     + Y+++L Q + + H    +HRD+
Sbjct: 68  IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE-------YVAPEVLEWMEGN 189
           KP N+L++  G +KL DFG A            VPV T         Y APE+L      
Sbjct: 127 KPQNLLINTEGAIKLADFGLARAFG--------VPVRTYTHEVVTLWYRAPEIL------ 172

Query: 190 HGSDGYTGSCDLWSIGVVSYELLT 213
            G   Y+ + D+WS+G +  E++T
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 69/273 (25%), Positives = 129/273 (47%), Gaps = 22/273 (8%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNTIERD---IMVKSKCPYIV 71
           ++I   I +G +G +Y V  K+   +    K+L     +   IE +   +      P +V
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKD-GSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVV 82

Query: 72  NLFYSFQDMNH-----VYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQ 124
             +  F   +      ++ ++E   GG    L++        L E+   + +Y     +Q
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           +LH    +HRD+K +N+LL+  G +KL DFG + Q+  + R++    VGTP ++APEV+ 
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIA 201

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSILACDTEDTVSFPS 243
             +    S  Y   CD+WS+G+ + EL  G  P F+   +   +   +  +   T+  P 
Sbjct: 202 CEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK--IPRNPPPTLLHPE 257

Query: 244 SIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHP 275
             +   +  +F+ Q L++  +AR ++  +L HP
Sbjct: 258 --KWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 19/204 (9%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR---EKMPNTIE-RDI-MVKS-KCPYIVNLFYS 76
           + +G++G +   + K++     +KK L    +KM   I  R+I M+K  +   +VNL   
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 77  FQDMNHVYFIMEYVTGGDFVTL--LENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
           F+    +Y + E+V   D   L  LE  P+G L ES+ R Y++++ + +++ H    +HR
Sbjct: 69  FRRKKRLYLVFEFV---DHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCHSHNIIHR 124

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           DIKP+N+L+S +G +KL DFG A  +   G + +   V T  Y APE+L       G   
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY-VATRWYRAPELLV------GDTK 177

Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+W++G +  E+LTG   F
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 10/197 (5%)

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           + ++ +ME+   G    L++N     L E    +   E+ + + +LH    +HRDIK  N
Sbjct: 82  DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 141

Query: 141 MLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +LL+    +KL DFG + Q+D+  GR  +   +GTP ++APEV+   E    +  Y    
Sbjct: 142 VLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDAT--YDFKS 197

Query: 200 DLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQS-L 258
           DLWS+G+ + E+  G+ P      DM     L     +      S + S    +F++S L
Sbjct: 198 DLWSLGITAIEMAEGAPPL----CDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCL 253

Query: 259 VQKLDARLNMDQVLGHP 275
           V+    R   +Q++ HP
Sbjct: 254 VKNHSQRPTTEQLMKHP 270

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 69/265 (26%), Positives = 113/265 (42%), Gaps = 37/265 (13%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIM----VKSKC--PYIVNLFYSFQD 79
           GN G +Y      +     +K +  +     +++ IM    +  KC  PYI+  + +F  
Sbjct: 12  GNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGFYGAFFV 70

Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
            N +    E++ GG          +  + E         + + + YL  L  +HRD+KP 
Sbjct: 71  ENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPS 124

Query: 140 NMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTG 197
           NML++  G +KL DFG +TQ+     + SI    VGT  Y+APE +         + Y  
Sbjct: 125 NMLVNTRGQVKLCDFGVSTQL-----VNSIAKTYVGTNAYMAPERI-------SGEQYGI 172

Query: 198 SCDLWSIGVVSYELLTGSTPFNYETLDMTYSS-----ILACDT-EDTVSFPSSIRLSTAM 251
             D+WS+G+   EL  G  P  Y  +     S     +L C   ED    P   + S   
Sbjct: 173 HSDVWSLGISFMELALGRFP--YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG-QFSEKF 229

Query: 252 VNFVQSLVQKL-DARLNMDQVLGHP 275
           V+F+   ++K    R   + ++ HP
Sbjct: 230 VHFITQCMRKQPKERPAPENLMDHP 254

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 66/223 (29%), Positives = 96/223 (43%), Gaps = 46/223 (20%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDI----MVKSKCPYIVNLF 74
           I +G +G +Y   +K +     +KK       E +P T  R+I    M+ S+  YIV L 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML-SESIYIVRLL 67

Query: 75  YSFQDMNHV---------YFIMEYVTGG--DFVTLLENQPHGYLSESKARFYIYELAQAV 123
               D+ HV         Y + EY+      F+      P   L     + ++Y+L + V
Sbjct: 68  ----DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 124 QYLHGLGYVHRDIKPDNMLL-SATGHLKLTDFGSATQVDKNGRIKSIVPVG-------TP 175
            + H  G +HRD+KP N+L+    G LK+ D G        GR  SI PV        T 
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL-------GRAFSI-PVKSYTHEIVTL 175

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            Y APEVL       GS  Y+   D+WS+G +  E+      F
Sbjct: 176 WYRAPEVL------LGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 10/197 (5%)

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           + ++ +ME+   G    L++N     L E    +   E+ + + +LH    +HRDIK  N
Sbjct: 92  DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQN 151

Query: 141 MLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +LL+    +KL DFG + Q+D+  GR  +   +GTP ++APEV+   E    +  Y    
Sbjct: 152 VLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDAT--YDYRS 207

Query: 200 DLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQS-L 258
           D+WS+G+ + E+  G+ P      DM     L     +      S + S   ++F++  L
Sbjct: 208 DIWSLGITAIEMAEGAPPL----CDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCL 263

Query: 259 VQKLDARLNMDQVLGHP 275
           V+   +R + +Q+L HP
Sbjct: 264 VKNYLSRPSTEQLLKHP 280

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 85.8 bits (213), Expect = 5e-18
 Identities = 49/143 (34%), Positives = 75/143 (52%), Gaps = 19/143 (13%)

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +   + G D   +++ Q    LS+   +F +Y++ + ++Y+H  G +HRD+
Sbjct: 92  FQD---VYLVTHLM-GADLNNIVKCQK---LSDDHIQFLVYQILRGLKYIHSAGIIHRDL 144

Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDGY 195
           KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        Y
Sbjct: 145 KPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH-------Y 193

Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+G +  ELLTG T F
Sbjct: 194 NQTVDIWSVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 34/272 (12%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKV-------LREKMPNTIERDIMVKSKCPY--IV 71
           + + +G FG++YL  +  +     +K+V          K  N +E +I +     +  IV
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 72  NLFYSFQDMNH--VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
             +   +D     +   +EY+ GG     L  + +G L+E+  R Y  ++ Q V YLH  
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYLHSN 125

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVD----KNGRIKSIVPVGTPEYVAPEVLEW 185
             VHRDIK  N+L  + G++KL DFG++ ++         IKS+   GTP +++PEV+  
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV--TGTPYWMSPEVIS- 182

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTEDT-VSFPS 243
                  +GY    D+WS+     E+LT   P+  YE +    ++I    T+ T    P 
Sbjct: 183 ------GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAIFKIATQPTKPMLPD 232

Query: 244 SIRLSTAMVNFVQSLVQKLDARLNMDQVLGHP 275
            +  S A  +F++ +  +   R   + +L HP
Sbjct: 233 GV--SDACRDFLKQIFVEEKRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 65/265 (24%), Positives = 122/265 (46%), Gaps = 28/265 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------LREKMPNTIERDIMVKSKC 67
           ++F I++ I +G F ++Y            +KKV        + +     E D++ +   
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQY 125
           P ++  + SF + N +  ++E    GD   ++++  +    + E     Y  +L  A+++
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV-DKNGRIKSIVPVGTPEYVAPEVLE 184
           +H    +HRDIKP N+ ++ATG +KL D G       K     S+  VGTP Y++PE + 
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIH 179

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   +GY    D+WS+G + YE+    +PF  + +++ YS     +  D    PS 
Sbjct: 180 -------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCDYPPLPSD 231

Query: 245 IRLSTAMVNFVQSLVQKLDARLNMD 269
                   ++ + L Q ++  +N D
Sbjct: 232 --------HYSEELRQLVNMCINPD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.4 bits (208), Expect = 6e-18
 Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 34/272 (12%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNT--------IERDIMVKSKCPYIV 71
           + + QG FG +YL  +  +      K+V    + P T         E  ++   +   IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 72  NLFYSFQDMNH--VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
             +   +D     +   MEY+ GG     L  + +G L+ES  R Y  ++ + + YLH  
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVD----KNGRIKSIVPVGTPEYVAPEVLEW 185
             VHRDIK  N+L  + G++KL DFG++ ++         I+S+   GTP +++PEV+  
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV--TGTPYWMSPEVIS- 182

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTEDT-VSFPS 243
                  +GY    D+WS+G    E+LT   P+  YE +    ++I    T+ T    PS
Sbjct: 183 ------GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAIFKIATQPTNPQLPS 232

Query: 244 SIRLSTAMVNFVQSLVQKLDARLNMDQVLGHP 275
            I  S    +F+  +  +   R + +++L HP
Sbjct: 233 HI--SEHARDFLGCIFVEARHRPSAEELLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 84.3 bits (208), Expect = 9e-18
 Identities = 77/267 (28%), Positives = 129/267 (48%), Gaps = 16/267 (5%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKCPYIVNLFYSFQDM 80
           G FG +Y  + K++       KV+  K    +E      +I+     PYIV L  +F   
Sbjct: 23  GAFGKVYKAKNKET-GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
             ++ ++E+  GG    ++     G L+E + +    ++ +A+QYLH +  +HRD+K  N
Sbjct: 82  GKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGN 140

Query: 141 MLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +LL+  G +KL DFG SA  V    R  S   +GTP ++APEV+  M        Y    
Sbjct: 141 VLLTLDGDIKLADFGVSAKNVKTLQRRDSF--IGTPYWMAPEVV--MCETMKDTPYDYKA 196

Query: 200 DLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLV 259
           D+WS+G+   E+     P ++E   M     +A     T+S PS  + S    +F+++ +
Sbjct: 197 DIWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKSEPPTLSQPS--KWSMEFRDFLKTAL 253

Query: 260 QK-LDARLNMDQVLGHPVFDCLDSDPP 285
            K  + R +  Q+L HP    + S+ P
Sbjct: 254 DKHPETRPSAAQLLEHPFVSSVTSNRP 280

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 19/221 (8%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-------DIMVKSKC 67
           ++F I++ I +G F ++Y            +KKV   +M +   R       D++ +   
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--NQPHGYLSESKARFYIYELAQAVQY 125
           P ++    SF + N +  ++E    GD   +++   +    + E     Y  +L  AV++
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV-DKNGRIKSIVPVGTPEYVAPEVLE 184
           +H    +HRDIKP N+ ++ATG +KL D G       K     S+  VGTP Y++PE + 
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIH 179

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM 225
                   +GY    D+WS+G + YE+    +PF  + +++
Sbjct: 180 -------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 85.0 bits (210), Expect = 1e-17
 Identities = 66/253 (26%), Positives = 105/253 (41%), Gaps = 46/253 (18%)

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S  +    Y +M Y+      T L+      LSE K ++ +Y++   ++Y+H  G +HRD
Sbjct: 88  SGDEFQDFYLVMPYMQ-----TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRD 142

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APEV L WM        
Sbjct: 143 LKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILNWMH------- 191

Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNF 254
           Y  + D+WS+G +  E+LTG T F  +      + IL         F   +    A  ++
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE-DKAAKSY 250

Query: 255 VQSLVQ---------------------------KLDARLNMDQVLGHPVFDCL-DSDPPC 286
           ++SL +                            +D RL   + L HP FD   D+D   
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310

Query: 287 IPPPSQENKFHKK 299
              P  ++  ++K
Sbjct: 311 EQQPYDDSLENEK 323

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 64/295 (21%), Positives = 121/295 (41%), Gaps = 50/295 (16%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IERDI-MVKSKC-PYIVNLFYSFQD 79
            +   ++L + K ++    +KK+  +         ++++I   +    P I+    SF  
Sbjct: 11  EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70

Query: 80  MNHVYFIMEYVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
            + +Y +   +  G    LL+   P G L E    F + ++  A+ Y+H  G++HR +K 
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKA 129

Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY-------VAPEVLEWMEGNHG 191
            ++LLS  G + L+    +  + K+G+ +  V    P+        ++PEVL+       
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGK-RQRVVHDFPKSSVKNLPWLSPEVLQ-----QN 183

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFN--------YETLDMTYSSILACDT-------- 235
             GY    D++S+G+ + EL  G  PF          E +  T   +L   T        
Sbjct: 184 LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243

Query: 236 ------------EDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF 277
                        D+V  P +   S     FV+  +Q+  ++R +  Q+L H  F
Sbjct: 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 26/219 (11%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL-------REKMPNTIERDI-MVKSK 66
           +++ + + + QG FG +YL  +  +     +K+V          K  N +E +I ++K+ 
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 67  C-PYIVNLFYSFQDMNH--VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
               IV  +   +D     +   ME++ GG     L++  +G L+E+  R Y  ++ + V
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGV 119

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD----KNGRIKSIVPVGTPEYVA 179
            YLH    VHRDIK  N+L  + G++KL DFG++ ++         +KS+   GTP +++
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV--TGTPYWMS 177

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PEV+         +GY    D+WS+G    E+LT   P+
Sbjct: 178 PEVIS-------GEGYGRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDI-MVKS-KCPYIVNLFY 75
           I +G +G +Y   +K +     +KK+ R     E +P+T  R+I ++K    P IV L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
                N +Y + E++   D    +++ P   L     + Y+Y+L Q + Y H    +HRD
Sbjct: 66  VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI-VPVGTPE-----YVAPEVLEWMEGN 189
           +KP N+L+   G LKL DFG A       R   + V   T E     Y APE+L      
Sbjct: 125 LKPQNLLIDREGALKLADFGLA-------RAFGVPVRTYTHEVVTLWYRAPEIL------ 171

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            GS  Y+   D+WSIG +  E++     F
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 79/280 (28%), Positives = 120/280 (42%), Gaps = 25/280 (8%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV------LREKMPNTI 57
           V EL  K+     F   R I  G+FG +Y   + ++     +KK+        EK  + I
Sbjct: 4   VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63

Query: 58  -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTL-LENQPHGYLSESKARFY 115
            E   + K + P  +     +   +  + +MEY  G     L +  +P   L E +    
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAV 120

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
            +   Q + YLH    +HRD+K  N+LLS  G +KL DFGSA+ +           VGTP
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTP 175

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
            ++APEV+  M+       Y G  D+WS+G+   EL     P      +M   S L    
Sbjct: 176 YWMAPEVILAMDEGQ----YDGKVDVWSLGITCIELAERKPPL----FNMNAMSALYHIA 227

Query: 236 EDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGH 274
           ++      S   S    NFV S +QK+   R   + +L H
Sbjct: 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 58/279 (20%)

Query: 47  KVLRE-KMPNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQP 103
           K+LR  K  N I  RDI+ +              D   VY +M+ +   D   ++  +QP
Sbjct: 56  KILRHFKHDNIIAIRDIL-RPPGA----------DFKDVYVVMD-LMESDLHHIIHSDQP 103

Query: 104 HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN 163
              L+E   R+++Y+L + ++Y+H    +HRD+KP N+L++    L++ DFG A  +  +
Sbjct: 104 ---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160

Query: 164 GRIKSIVP---VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL-------- 212
                      V T  Y APE+L  +        YT + D+WS+G +  E+L        
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSL------PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214

Query: 213 -------------TGSTP---FNYETLDMTYSSILACDTEDTVSFPSSIRLSTA-MVNFV 255
                         GS      N    D     I     +  V +      ++   ++ +
Sbjct: 215 KNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLL 274

Query: 256 QSLVQKLDA--RLNMDQVLGHPVFD---CLDSDPPCIPP 289
             ++Q  D   R+ ++Q L HP        D +P C PP
Sbjct: 275 SQMLQ-FDPEERITVEQALQHPFLAQYHDPDDEPTCPPP 312

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 28/217 (12%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI-----MVKS-----------K 66
           I +G +G +YL     +     +K+V  E       R       MVK+            
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQV--ELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 67  CPYIVNLFYSFQDMNHVYFI-MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
              IV  +  F+       I +EYV GG   + L    +G   E   RF+  ++ + + Y
Sbjct: 67  HLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAY 123

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYVAPEVLE 184
           LH  G +HRD+K DN+L+ A G  K++DFG + + D      +++   G+  ++APEV+ 
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                  S GY+   D+WS+G V  E+  G  P++ E
Sbjct: 184 -----SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 19/200 (9%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKK-VLREKMPNTIE---RDI-MVKS-KCPYIVNLFYS 76
           I +G++G ++    +++     +KK V  E  P   +   R+I M+K  K P +VNL   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 77  FQDMNHVYFIMEYVTGGDFVTL--LENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
           F+    ++ + EY    D   L  LE  P G + E   +  I++  QAV + H    +HR
Sbjct: 69  FRRKRKLHLVFEYC---DHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHNCIHR 124

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           D+KP+N+L++  G +KL DFG A  +   G   +   V T  Y APE+L       G   
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY-VATRWYRAPELLV------GDTQ 177

Query: 195 YTGSCDLWSIGVVSYELLTG 214
           Y    D+W+IG V  ELLTG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 60/290 (20%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-----IERDIMVKSKC--PYIVNLFYSF 77
           +G  G +     K +   F +K +     PN      I R++ +   C  PYIV  + +F
Sbjct: 11  EGAGGSVTKCRLKNTGMIFALKTITT--DPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 78  QD--MNHVYFIMEYVTGGDFVTLLEN----------QPHGYLSESKARFYIYELAQAVQY 125
            D   + +   MEY  GG   ++ +           +  G ++ES        + + + Y
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAES--------VLKGLSY 120

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVL 183
           LH    +HRDIKP N+LL+  G +KL DFG + ++     + S+     GT  Y+APE +
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-----VNSLAGTFTGTSFYMAPERI 175

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           +          Y+ + D+WS+G+   E+     PF                  +      
Sbjct: 176 QGKP-------YSITSDVWSLGLTLLEVAQNRFPF----------------PPEGEPPLG 212

Query: 244 SIRLSTAMVN-FVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQ 292
            I L + +VN     L  +    +   +     +  CL+ DP   P P  
Sbjct: 213 PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)

Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           +      + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL------ENQPHGYLSESKARFY 115
           M +  C ++V L            +ME +  GD  + L           G    +  +F 
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 116 IY--ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL    +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG--K 180

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
            ++PV    ++APE L         DG +T   D+WS GVV +E+ T    P+
Sbjct: 181 GLLPV---RWMAPESL--------KDGVFTTKSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 83.1 bits (205), Expect = 5e-17
 Identities = 50/144 (34%), Positives = 77/144 (53%), Gaps = 16/144 (11%)

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S    +  Y +M ++ G D   L++   H  LSE + +F +Y++ + ++Y+H  G +HRD
Sbjct: 88  SLDRFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRD 143

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A Q D     +    V T  Y APEV L WM        
Sbjct: 144 LKPGNLAVNEDCELKILDFGLARQTDS----EMTGYVVTRWYRAPEVILNWMH------- 192

Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           YT + D+WS+G +  E+LTG   F
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.7 bits (201), Expect = 9e-17
 Identities = 80/281 (28%), Positives = 123/281 (43%), Gaps = 27/281 (9%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL------REKMPNTI 57
           + EL  K      F   R I  G+FG +Y   + +++    +KK+        EK  + I
Sbjct: 14  IAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII 73

Query: 58  -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTL-LENQPHGYLSESKARFY 115
            E   + + K P  +     +   +  + +MEY  G     L +  +P   L E +    
Sbjct: 74  KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAI 130

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
            +   Q + YLH    +HRDIK  N+LL+  G +KL DFGSA+             VGTP
Sbjct: 131 THGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTP 185

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSILACD 234
            ++APEV+  M+       Y G  D+WS+G+   EL     P FN   +   Y   +A +
Sbjct: 186 YWMAPEVILAMDEGQ----YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQN 239

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGH 274
              T+    S   S    NFV S +QK+   R   +++L H
Sbjct: 240 ESPTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 32/214 (14%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVK---SKC---------PY 69
           G FG +Y V +K +    +  K +    P       ERD  +    S+          P 
Sbjct: 11  GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70

Query: 70  IVNLFYSFQDMNHVYFIMEYVTG---GD-FVTLLENQPHGYLSESKARFYIYELAQAVQY 125
           IV  + +F + + +Y +M+ + G   G+ F +L E       +E +      ++  A++Y
Sbjct: 71  IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRY 128

Query: 126 LHGLGY-VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           LH     VHRD+ P+N++L     + +TDFG A Q     ++ S+  VGT  Y  PE+++
Sbjct: 129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--VGTILYSCPEIVK 186

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                  ++ Y    D+W+ G + Y++ T   PF
Sbjct: 187 -------NEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 15/198 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDI-MVKS-KCPYIVNLFYS 76
           I +G +G +Y    K++     MKK+      E +P+T  R+I ++K  + P IV L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHG-YLSESKARFYIYELAQAVQYLHGLGYVHRD 135
               + +Y I E+++  D    L++ P G Y+     + Y+Y++ Q + + H    +HRD
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP N+L+   G +KL DFG A       R+ +   V T  Y APEVL       GS  Y
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT-HEVVTLWYRAPEVL------LGSPRY 179

Query: 196 TGSCDLWSIGVVSYELLT 213
           +   D+WSIG +  E+ T
Sbjct: 180 STPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 81.2 bits (200), Expect = 2e-16
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 90  SLEEFNDVYLVT-HLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 145

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 146 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 194

Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 41/121 (33%), Positives = 65/121 (53%), Gaps = 20/121 (16%)

Query: 98  LLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA 157
           L++ +    L E + + Y+Y+L +++ ++H  G  HRDIKP+N+L+     LKL DFGS 
Sbjct: 89  LIKGRKR-PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSC 146

Query: 158 TQVDKNGRIKSIVP----VGTPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELL 212
             +       S  P    + T  Y APE L        +DGY G   D+W++G V +E+L
Sbjct: 147 RGIY------SKPPYTEYISTRWYRAPECLL-------TDGYYGPKMDIWAVGCVFFEIL 193

Query: 213 T 213
           +
Sbjct: 194 S 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 54/166 (32%), Positives = 79/166 (47%), Gaps = 29/166 (17%)

Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            + EY+   D    +++   G LS    R ++++L + + Y H    +HRD+KP N+L+S
Sbjct: 80  LVFEYLDT-DLKQYMDDCGGG-LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS 137

Query: 145 ATGHLKLTDFGSATQVDKNGRIKSIVP-------VGTPEYVAPEVLEWMEGNHGSDGYTG 197
             G LKL DFG A       R KS VP       V T  Y  P+VL       GS  Y+ 
Sbjct: 138 ERGELKLADFGLA-------RAKS-VPSKTYSNEVVTLWYRPPDVL------LGSTEYST 183

Query: 198 SCDLWSIGVVSYELLTGSTPF-----NYETLDMTYSSILACDTEDT 238
           S D+W +G + YE+ TG   F       + L   +  +L   TE+T
Sbjct: 184 SLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF-RVLGTPTEET 228

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 57/214 (26%), Positives = 109/214 (50%), Gaps = 16/214 (7%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNTIERD---IMVKSKCPYIV 71
           ++I   I +G +G ++ V  K++ +   +K +L     +   IE +   +   S  P +V
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVV 78

Query: 72  NLF--YSFQDM---NHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQ 124
             +  Y  +D+   + ++ ++E   GG    L++   +    + E    + ++E    +Q
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           +LH    +HRD+K +N+LL+  G +KL DFG + Q+  + R++    VGTP ++APEV+ 
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIA 197

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             +    +  Y   CD+WS+G+ + EL  G  P 
Sbjct: 198 CEQQLDST--YDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.7 bits (202), Expect = 8e-16
 Identities = 69/242 (28%), Positives = 117/242 (48%), Gaps = 54/242 (22%)

Query: 17  FDIKRFIQQGNFGDIYL--------------VEEKQSHNTFVMKKVLREKMPNTIERDIM 62
           +DI R I +G  G++YL              + E  S N  + K+ LRE     I  D++
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREA---KIAADLI 60

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN--------QPHGYLSESKARF 114
                P IV ++    D + VY+ M Y+ G    +LL++        +     +   A  
Sbjct: 61  ----HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT--------QVDKNGR 165
            I+ ++   ++Y+H  G +HRD+KPDN+LL   G + + D+G+A          +D +  
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 166 IKSI------VP---VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGST 216
            ++I      +P   VGTP+Y+APE L    G   S+    S D++++GV+ Y++LT S 
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERL---LGVPASE----STDIYALGVILYQMLTLSF 229

Query: 217 PF 218
           P+
Sbjct: 230 PY 231

Length = 932

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 34/232 (14%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFY 75
           D +  R I  G FG ++ V + +       K+V  +KMPN  +  +  K     +  L +
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDG-----KRVALKKMPNVFQNLVSCKRVFRELKMLCF 55

Query: 76  SFQD----------------MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
              D                   +Y + E +       ++  QP   LS    + ++Y++
Sbjct: 56  FKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQP---LSSDHVKVFLYQI 112

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
            + ++YLH  G +HRDIKP N+L+++   LK+ DFG A   + +        V T  Y A
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN----YETLDMTY 227
           PE+L       GS  YT + D+WS+G +  ELL     F      + LD+  
Sbjct: 173 PEILM------GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 21/214 (9%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV------LREKMPNTI-ERDIMVKSKCPYIVNLFY 75
           I  G+FG +Y      ++    +KK+        EK  + I E   + + K P  +    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 76  SFQDMNHVYFIMEYVTGGDFVTL-LENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            +   +  + +MEY  G     L +  +P   L E +     +   Q + YLH    +HR
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           DIK  N+LL+  G +KL DFGSA++            VGTP ++APEV+  M+       
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMDEGQ---- 196

Query: 195 YTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTY 227
           Y G  D+WS+G+   EL     P FN   +   Y
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 38/218 (17%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G +  V+ K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL--AQAVQYLHG 128
           V  + +F     +   ME++ GG    +L+          +A+    E+    ++  L G
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLK----------EAKRIPEEILGKVSIAVLRG 115

Query: 129 LGYV-------HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVA 179
           L Y+       HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMS 170

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP 217
           PE L   +G H    Y+   D+WS+G+   EL  G  P
Sbjct: 171 PERL---QGTH----YSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 74/290 (25%), Positives = 115/290 (39%), Gaps = 46/290 (15%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD----------IM 62
           +A D      I +G FG +  +  K S  T +  K +R       E++          +M
Sbjct: 2   TAEDLKDLGEIGRGAFGTVNKMLHKPS-GTIMAVKRIRS---TVDEKEQKRLLMDLDVVM 57

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG--DFVTLLENQPHGYLSESKARFYIYELA 120
             S CPYIV  + +       +  ME +      F   +       + E           
Sbjct: 58  RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117

Query: 121 QAVQYL-HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPE 176
           +A+ YL   L  +HRD+KP N+LL   G++KL DFG + Q+     + SI      G   
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-----VDSIAKTRDAGCRP 172

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN-----YETLDMTYSS-- 229
           Y+APE ++        DGY    D+WS+G+  YE+ TG  P+      ++ L        
Sbjct: 173 YMAPERID----PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP 228

Query: 230 -ILACDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVF 277
            IL+   E   S           VNF+   L++    R    ++L HP  
Sbjct: 229 PILSNSEEREFSPS--------FVNFINLCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 27/209 (12%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPYIVNLFYS 76
           I +GNFG+++     ++ NT V  K  RE +P  +      E  I+ +   P IV L   
Sbjct: 3   IGRGNFGEVF-SGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA-VQYLHGLGYVHRD 135
                 +Y +ME V GGDF+T L  +  G   + K    + E A A ++YL     +HRD
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVD-----KNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           +   N L++    LK++DFG + + +       G +K I PV   ++ APE L     N+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-PV---KWTAPEAL-----NY 170

Query: 191 GSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           G   Y+   D+WS G++ +E  + G+ P+
Sbjct: 171 GR--YSSESDVWSFGILLWEAFSLGAVPY 197

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 30/208 (14%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLR----EKMPNTIERDI--MVKSKCPYIVNLFYSFQ 78
           +G +  +Y    + +    V  K +     E  P+T  R+I  M + K   IV L     
Sbjct: 10  EGTYATVYKGRNRTT-GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH 68

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPH-GYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
             N +  + EY+   D    ++     G L  +  + + Y+L + + + H    +HRD+K
Sbjct: 69  TENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLK 127

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE-------YVAPEVLEWMEGNH 190
           P N+L++  G LKL DFG A            +PV T         Y AP+VL       
Sbjct: 128 PQNLLINKRGELKLADFGLARAFG--------IPVNTFSNEVVTLWYRAPDVL------L 173

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           GS  Y+ S D+WS+G +  E++TG   F
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 78.9 bits (194), Expect = 3e-15
 Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 10/152 (6%)

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLH 127
           IV  F  F+  + +  IMEY +GGD    ++   + H    E +     Y++  A+  +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWM 186
               +HRD+K  N+ L  TG +KL DFG + Q   +  +       GTP Y+APE+ E  
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE-- 244

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                   Y+   D+WS+GV+ YELLT   PF
Sbjct: 245 -----RKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 77.4 bits (190), Expect = 4e-15
 Identities = 48/144 (33%), Positives = 75/144 (52%), Gaps = 16/144 (11%)

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +   + G D   +++ Q    LS+   +F IY+L + ++Y+H  G +HRD
Sbjct: 88  SIENFNEVYLVTN-LMGADLNNIVKCQK---LSDEHVQFLIYQLLRGLKYIHSAGIIHRD 143

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    L++ DFG A Q D     +    V T  Y APE+ L WM        
Sbjct: 144 LKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRAPEIMLNWMH------- 192

Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELL G   F
Sbjct: 193 YNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 27/165 (16%)

Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
           F+ EY+   D    +   P G L     R ++++L + + Y+HG   +HRD+KP N+L+S
Sbjct: 80  FVFEYMHT-DLAQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS 137

Query: 145 ATGHLKLTDFGSATQVDKNGRIKSI------VPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
             G LKL DFG A       R KSI        V T  Y  P+VL       G+  Y+ +
Sbjct: 138 YLGELKLADFGLA-------RAKSIPSQTYSSEVVTLWYRPPDVL------LGATDYSSA 184

Query: 199 CDLWSIGVVSYELLTGSTPFN-----YETLDMTYSSILACDTEDT 238
            D+W  G +  E+L G   F      +E L+  + ++L   TEDT
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW-TVLGVPTEDT 228

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 50/247 (20%)

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
           +F D+  VY +M+     D   ++  +Q    LS+   ++++Y+L + ++Y+H    +HR
Sbjct: 80  AFNDVYIVYELMD----TDLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSANVLHR 132

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           D+KP N+LL+A   LK+ DFG A    + G   +   V T  Y APE+L           
Sbjct: 133 DLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELL------LNCSE 185

Query: 195 YTGSCDLWSIGVVSYELLTGSTPF------NYETLDMTYSSILACDTEDTVSFPSS---- 244
           YT + D+WS+G +  ELL     F      +   L      +L   +E+ + F  +    
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT---ELLGSPSEEDLGFIRNEKAR 242

Query: 245 --IRL--STAMVNFVQ----------SLVQKL-----DARLNMDQVLGHPVFDCL---DS 282
             IR    T   +F +           L++K+       R+ +++ L HP    L     
Sbjct: 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302

Query: 283 DPPCIPP 289
           +P C  P
Sbjct: 303 EPVCQTP 309

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 40/286 (13%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDI-MVKS-KCPYIVNLFYS 76
           I +G +G ++  + +++H    +K+V      E +P++  R+I ++K  K   IV L+  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
                 +  + EY    D     ++  +G +     + ++++L + + + H    +HRD+
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDL 125

Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G LKL DFG A       R  S   V T  Y  P+VL       G+  Y+
Sbjct: 126 KPQNLLINKNGELKLADFGLARAFGIPVRCYS-AEVVTLWYRPPDVL------FGAKLYS 178

Query: 197 GSCDLWSIGVVSYELLTGSTPF--NYETLD--MTYSSILACDTEDT-------------V 239
            S D+WS G +  EL     P     +  D       +L   TE++              
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238

Query: 240 SFPSSIRLSTAMVNFVQS---LVQKL-----DARLNMDQVLGHPVF 277
            +P++  L   +     +   L+Q L       R++ ++ L HP F
Sbjct: 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 17/165 (10%)

Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
           +N VY + EY+   D   +LE    G LSE  AR ++Y+L + ++Y+H    +HRD+KP 
Sbjct: 88  LNSVYIVQEYMET-DLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPA 143

Query: 140 NMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVG--TPEYVAPEVLEWMEGNHGSDGYT 196
           N+ ++     LK+ DFG A  VD +   K  +  G  T  Y +P +L  +  N+    YT
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL--LSPNN----YT 197

Query: 197 GSCDLWSIGVVSYELLTGSTPFN----YETLDMTYSSILACDTED 237
            + D+W+ G +  E+LTG   F      E + +   S+     ED
Sbjct: 198 KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 73/249 (29%), Positives = 110/249 (44%), Gaps = 27/249 (10%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYI 70
           FDI   I +G +G +Y   +K +     +KKV     +E  P T  R+I +  +     I
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 71  VNLF---------YSF-QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           VNL            F +D    Y + EY+   D + LLE+    + SE   + ++ +L 
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHF-SEDHIKSFMKQLL 126

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           + + Y H   ++HRDIK  N+LL+  G +KL DFG A   +          V T  Y  P
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF--NYETLDMTYSSILACDTEDT 238
           E+L       G + Y  + D+WS G +  EL T    F  N E   +   S L C +   
Sbjct: 187 ELL------LGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL-CGSPCP 239

Query: 239 VSFPSSIRL 247
             +P  I+L
Sbjct: 240 AVWPDVIKL 248

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 26/212 (12%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 123

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 124 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 174

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP 217
            +G H    Y+   D+WS+G+   E+  G  P
Sbjct: 175 -QGTH----YSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 76.7 bits (189), Expect = 3e-14
 Identities = 68/286 (23%), Positives = 142/286 (49%), Gaps = 13/286 (4%)

Query: 357 KRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLR 416
           + +  +L ++L EA+  +E+L   ++ +  L+ ++  LQ++L      + + E EI  LR
Sbjct: 252 EEELEELQEELEEAEKEIEEL---KSELEELREELEELQEELLELKEEIEELEGEISLLR 308

Query: 417 QEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEV--LR 474
           + + + E++L      L   + ++E ++ EL+E+E L +  ++ L   E +KE     L 
Sbjct: 309 ERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEAKEELEEKLS 368

Query: 475 GELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALA 534
             LEE +   +  +++  +   E      EL++ + E E+L+E+L  L + L+  +E L 
Sbjct: 369 ALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEERLERLSERLEDLKEELK 428

Query: 535 TAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSG-ISEKYEKDRKTLLELKSAKE 593
             +  L+    E + L+  +E +++++E+   R++E+   ++E  E+ ++   EL S + 
Sbjct: 429 ELEAELEELQTELEELNEELEELEEQLEELRDRLKELERELAELQEELQRLEKELSSLEA 488

Query: 594 RLE------LEVRGYKLDLESTRRELETNKDQTIEL-RAKSKLEKA 632
           RL+         +G +  LE+    L        EL + K K E A
Sbjct: 489 RLDRLEAEQRASQGVRAVLEALESGLPGVYGPVAELIKVKEKYETA 534

Length = 1163

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 68/248 (27%), Positives = 102/248 (41%), Gaps = 47/248 (18%)

Query: 10  KNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNT--FVMKKVLREKMPNTIERD----- 60
             V      + R +  G FG++Y  L   +        V  K L E      E D     
Sbjct: 1   PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60

Query: 61  -IMVKSKCPYIVNLF-YSFQDMNHVYFI-MEYVTGGDFVTLL-ENQPH----GYLSESKA 112
            IM K     IV L   SF+      FI +E + GGD  + L EN+P       L+    
Sbjct: 61  LIMSKFNHQNIVRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQV------DKN 163
            F   ++A+  +YL    ++HRDI   N LL+  G     K+ DFG A  +       K 
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF--- 218
           GR  +++P+           +WM      DG +T   D+WS GV+ +E+ + G  P+   
Sbjct: 179 GR--AMLPI-----------KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225

Query: 219 -NYETLDM 225
            N E ++ 
Sbjct: 226 TNQEVMEF 233

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 75.9 bits (186), Expect = 5e-14
 Identities = 70/242 (28%), Positives = 113/242 (46%), Gaps = 47/242 (19%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL------REKMPNTIERDIMVKSKCP 68
           +++++ + I  G FG+++LV+ K++   F  K +       REK    IE ++M + K  
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 69  YIVNLFYSFQDM--NHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQ 124
            IV     F +     +Y +ME+   GD    ++   +  G + E        +L  A+ 
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 125 YLHGLG-------YVHRDIKPDNMLLSATG--HL----------------KLTDFGSATQ 159
           Y H L         +HRD+KP N+ LS TG  H+                K+ DFG    
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLS-TGIRHIGKITAQANNLNGRPIAKIGDFG---- 187

Query: 160 VDKNGRIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP 217
           + KN  I+S+    VGTP Y +PE+L      H +  Y    D+W++G + YEL +G TP
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLL-----HETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 218 FN 219
           F+
Sbjct: 243 FH 244

Length = 1021

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPYIVNLFYSFQ 78
           +GNFG+++  +      T V  K  +E +P  +      E  I+ +   P IV L     
Sbjct: 5   KGNFGEVF--KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
               +Y +ME V GGDF++ L  +     ++   +F + + A  + YL     +HRD+  
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCIHRDLAA 121

Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
            N L+     LK++DFG + Q D      S +     ++ APE L     N+G   Y+  
Sbjct: 122 RNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL-----NYGR--YSSE 174

Query: 199 CDLWSIGVVSYELLT-GSTPF 218
            D+WS G++ +E  + G  P+
Sbjct: 175 SDVWSYGILLWETFSLGVCPY 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 73.3 bits (180), Expect = 6e-14
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 17/180 (9%)

Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +YF+ E + G D   LL ++P   L +   ++++Y++ + ++Y+H  G VHRD+KP N+L
Sbjct: 85  IYFVTE-LLGTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL 140

Query: 143 LSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDGYTGSCDL 201
           ++    LK+ DFG A   D     +    V T  Y APE+ L W +       Y    D+
Sbjct: 141 INENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIMLTWQK-------YDVEVDI 189

Query: 202 WSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK 261
           WS G +  E+L G   F  +     +S I            ++I  S   + FVQSL ++
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI-CSENTLRFVQSLPKR 248

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 75.5 bits (186), Expect = 6e-14
 Identities = 63/290 (21%), Positives = 127/290 (43%), Gaps = 40/290 (13%)

Query: 366 QLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESD 425
           +LA     LE+L   R  +  LQ ++   +++L   T+ L + EE+++ LR E+ + E +
Sbjct: 226 ELALLVLRLEEL---REELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEE 282

Query: 426 LVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATK 485
           +     +L A  +E+  +  + +         +R+LE  E+  +LE L  +L+E      
Sbjct: 283 IEELQKELYALANEISRLEQQKQILRERLANLERQLE--ELEAQLEELESKLDELAEELA 340

Query: 486 QWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDS--- 542
           + ++              +L++ + E E+L+ +L  LE EL+  E  L   +  L++   
Sbjct: 341 ELEE--------------KLEELKEELESLEAELEELEAELEELESRLEELEEQLETLRS 386

Query: 543 ----KLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELE 598
                  +  +L+N IE ++  +E+   R        E+ +++ + LL+     E  EL+
Sbjct: 387 KVAQLELQIASLNNEIERLEARLERLEDRR-------ERLQQEIEELLKKLEEAELKELQ 439

Query: 599 VRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQ 648
                  LE    ELE  +++   L     LE+   EL    +     ++
Sbjct: 440 AE-----LEELEEELEELQEELERLEE--ALEELREELEEAEQALDAAER 482

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 75.5 bits (186), Expect = 8e-14
 Identities = 69/300 (23%), Positives = 137/300 (45%), Gaps = 14/300 (4%)

Query: 357 KRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLR 416
           +   L+L   LA+ K   ++L      +  L+ ++  LQ++       L + E+EI+ L+
Sbjct: 221 ELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEE-------LEEAEKEIEELK 273

Query: 417 QEMVKKESDLVATSSDLVATRHELEEVRSELKE-KENLEKTDDRKLEVCEVSKELEVLRG 475
            E+ +   +L     +L+  + E+EE+  E+   +E LE+ ++   E+ E  +EL+    
Sbjct: 274 SELEELREELEELQEELLELKEEIEELEGEISLLRERLEELENELEELEERLEELKEKIE 333

Query: 476 ELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQ-TENEALKEKLTSLEQELKVSEEALA 534
            L+E+    +   ++  Q + E   A  EL++      E L+E   +L +EL   E  LA
Sbjct: 334 ALKEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELA 393

Query: 535 TAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKER 594
             +N L+   RE ++L   +E + + +E       E+  +  + E+ +  L EL    E 
Sbjct: 394 EIRNELEELKREIESLEERLERLSERLED---LKEELKELEAELEELQTELEELNEELEE 450

Query: 595 LELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLV 654
           LE ++   +  L+   REL   +++    R + +L   E  L  +  E +  +  +  L 
Sbjct: 451 LEEQLEELRDRLKELERELAELQEE--LQRLEKELSSLEARLDRLEAEQRASQGVRAVLE 508

Length = 1163

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 75.5 bits (186), Expect = 8e-14
 Identities = 73/354 (20%), Positives = 133/354 (37%), Gaps = 24/354 (6%)

Query: 437 RHELEEVRSELKEK-ENLEKTDDRKLEVCEVSKELEVLRGE---------LEEQKTATKQ 486
           +   EE   +L+   ENLE+ +D   E+    K+LE L  +         L+ +    + 
Sbjct: 171 KERKEEAERKLERTEENLERLEDLLEEL---EKQLEKLERQAEKAERYQELKAELRELEL 227

Query: 487 W--KKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKL 544
                   +  KE      EL + + E E L+E+L   E+E++  +  L   +  L+   
Sbjct: 228 ALLLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQ 287

Query: 545 REHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERL--ELEVRGY 602
            E   L   IE ++ E+     R+ E   +  + E+  + L ELK   E L  ELE R  
Sbjct: 288 EELLELKEEIEELEGEISLLRERLEE---LENELEELEERLEELKEKIEALKEELEERET 344

Query: 603 KLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQ 662
            L+             + +E +  + LE+ E     +REE  +L+     +   L    +
Sbjct: 345 LLEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNEL----E 400

Query: 663 PAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERES 722
             + ++E  E  L  + E  + LK               +       LE+L+    E   
Sbjct: 401 ELKREIESLEERLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRD 460

Query: 723 KLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQL 776
           +L+     + E + ++  LE  ++  E+    +       Q    +L      L
Sbjct: 461 RLKELERELAELQEELQRLEKELSSLEARLDRLEAEQRASQGVRAVLEALESGL 514

Length = 1163

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 48/212 (22%), Positives = 95/212 (44%), Gaps = 19/212 (8%)

Query: 12  VSASDFDIKRFIQQGNFGDIYL-VEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYI 70
           +++ +  +   I +G FGD+ L     Q      +K           E  +M   + P +
Sbjct: 3   INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNL 62

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V L       N +Y + EY+  G  V  L ++    ++ ++   +  ++ + ++YL    
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWME 187
           +VHRD+   N+L+S     K++DFG A +  +    G++    PV   ++ APE L    
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL----PV---KWTAPEALR--- 172

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
                  ++   D+WS G++ +E+ + G  P+
Sbjct: 173 --EKK--FSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 37/279 (13%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL---REKMPNTIERDIMV--KSKC 67
           S S+ +    I  G  G +Y V  + +   + +K +     + +   I R+I +      
Sbjct: 72  SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH 131

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ---PHGYLSESKARFYIYELAQAVQ 124
           P +V     F     +  ++E++ GG     LE        +L++  AR    ++   + 
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADV-AR----QILSGIA 182

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI--KSIVP----VGTPEYV 178
           YLH    VHRDIKP N+L+++  ++K+ DFG         RI  +++ P    VGT  Y+
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGV-------SRILAQTMDPCNSSVGTIAYM 235

Query: 179 APEVLEWMEGNHGS-DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED 237
           +PE +   + NHG+ DGY G  D+WS+GV   E   G  PF         S + A     
Sbjct: 236 SPERIN-TDLNHGAYDGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ 292

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHP 275
               P++   S    +F+   +Q+  A R +  Q+L HP
Sbjct: 293 PPEAPATA--SREFRHFISCCLQREPAKRWSAMQLLQHP 329

Length = 353

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 73.4 bits (180), Expect = 1e-13
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 23/185 (12%)

Query: 83  VYFIMEYVTGGDFVTLLENQPHGY--LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           +  +++Y   GD    ++++        E +A     ++  AV ++H    +HRDIK  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 141 MLLSATGHLKLTDFG-----SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +LL + G +KL DFG     +AT  D  GR       GTP YVAPE+  W         Y
Sbjct: 174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGR----TFCGTPYYVAPEI--WRR-----KPY 222

Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV 255
           +   D++S+GV+ YELLT   PF+ E ++      LA   +     P SI  S  M   V
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD---PLPPSI--SPEMQEIV 277

Query: 256 QSLVQ 260
            +L+ 
Sbjct: 278 TALLS 282

Length = 496

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 48/229 (20%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSH--NTFVMKKVLREKMPNTIERDIMVKSKC------- 67
           +++ + + QG +G +      ++    T  +KK+      N   + I+ K          
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKI-----TNVFSKKILAKRALRELKLLR 56

Query: 68  -----PYIVNLFYSFQDM--------NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
                  I  L+    DM        N +Y   E +       +   QP   L+++  + 
Sbjct: 57  HFRGHKNITCLY----DMDIVFPGNFNELYLYEELMEADLHQIIRSGQP---LTDAHFQS 109

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-----SATQVDKNGRIKSI 169
           +IY++   ++Y+H    +HRD+KP N+L++A   LK+ DFG     S    +  G +   
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             V T  Y APE+   M        YT + D+WS+G +  ELL G  P 
Sbjct: 170 --VATRWYRAPEI---MLSFQ---SYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC-----PYIVN 72
           I +G +G ++   + ++   FV  K +R     E MP +  R++ V         P +V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 73  LF----YSFQDM-NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           LF     S  D    +  + E+V   D  T L+  P   +     +  +++L + + +LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP N+L++++G +KL DFG A        + S+V   T  Y APEVL    
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL--- 182

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELL 212
                  Y    DLWS+G +  E+ 
Sbjct: 183 ----QSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 53/236 (22%), Positives = 105/236 (44%), Gaps = 46/236 (19%)

Query: 20  KRFIQ------QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------------- 60
           +R+IQ      +G +G +    +  +     +KKV   ++ N + +D             
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 61  -----IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
                IM + K   I+ L   + + + +  +M+ +   D   +++ +    L+ES+ +  
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKI--RLTESQVKCI 124

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ------VDKNGRIKSI 169
           + ++   +  LH   ++HRD+ P N+ +++ G  K+ DFG A +       D   + +++
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 170 VP-------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                    V T  Y APE+L       G++ Y  + D+WS+G +  ELLTG   F
Sbjct: 185 QRREEMTSKVVTLWYRAPELL------MGAEKYHFAVDMWSVGCIFAELLTGKPLF 234

Length = 335

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 73.2 bits (180), Expect = 4e-13
 Identities = 83/373 (22%), Positives = 152/373 (40%), Gaps = 29/373 (7%)

Query: 420  VKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEE 479
             + +   +A   +L     EL E+ ++L++ E          E+  +  EL  L   LEE
Sbjct: 656  SRNKRSSLAQKRELKELEEELAELEAQLEKLEE---------ELKSLKNELRSLEDLLEE 706

Query: 480  QKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNS 539
             +   ++ ++   +  +E  A   EL+Q Q+  E L+E+L  LE+EL+  +E L   +  
Sbjct: 707  LRRQLEELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEE 766

Query: 540  LDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEV 599
            L+S       L   IE ++++ +           + E+ E+  + L E +   + LE E+
Sbjct: 767  LESLEEALAKLKEEIEELEEKRQA----------LQEELEELEEELEEAERRLDALEREL 816

Query: 600  RGYKLDLESTRRELETNKDQTIELRAK-SKLEKAEGELTTVREENKKLKQGKIRLVYSLF 658
               +   E   +E+E  +++  EL  K  +LE+   EL    EE K+  +        L 
Sbjct: 817  ESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELE 876

Query: 659  KDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYT 718
             + +  + + E+ E EL  +  E  +LK       E             + LE L+    
Sbjct: 877  DELKELEEEKEELEEELRELESELAELK-------EEIEKLRERLEELEAKLERLEVELP 929

Query: 719  ERESKLRSANE--IIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQL 776
            E E +L    E  +  E E +I  LE  +          +E  E +++  + L    E L
Sbjct: 930  ELEEELEEEYEDTLETELEREIERLEEEIEALGPVNLRAIEEYEEVEERYEELKSQREDL 989

Query: 777  RKKNNDILSHDNE 789
             +    +L    E
Sbjct: 990  EEAKEKLLEVIEE 1002

Length = 1163

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 72.0 bits (177), Expect = 8e-13
 Identities = 56/299 (18%), Positives = 129/299 (43%), Gaps = 32/299 (10%)

Query: 357 KRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLR 416
           +   L   ++  E    L++      +  A++ Q++SL+++L   T  +S+ E+ ++ + 
Sbjct: 212 RYQALLKEKREYEGYELLKEKEALERQKEAIERQLASLEEELEKLTEEISELEKRLEEIE 271

Query: 417 QE--------MVKKESDLVATSSDLVATRHELEEVRSELKEKE-NLEKTDDR----KLEV 463
           Q             E + +     +     E+  +   + EKE  LE  ++R    + E+
Sbjct: 272 QLLEELNKKIKDLGEEEQLRVKEKIGELEAEIASLERSIAEKERELEDAEERLAKLEAEI 331

Query: 464 CEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLE 523
            ++  E+E L  E+EE++              K R+    E  + + E E L+ +L  ++
Sbjct: 332 DKLLAEIEELEREIEEER--------------KRRDKLTEEYAELKEELEDLRAELEEVD 377

Query: 524 QELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRK 583
           +E   + + L   +  L+   RE   L   ++ +Q+E+++ +  + +   ++        
Sbjct: 378 KEFAETRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELAD---LNAAIAGIEA 434

Query: 584 TLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREE 642
            + EL+  KE   LE++  +  LE    +L   + +      K + ++ E EL+ ++ E
Sbjct: 435 KINELEEEKEDKALEIKKQEWKLEQLAADLSKYEQEL--YDLKEEYDRVEKELSKLQRE 491

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 68.8 bits (168), Expect = 9e-13
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE-----KMPN-----TIERDIMVKSKCP 68
           +++ + +G+FG +YLV++K++     +K VL+E       PN       E  ++ K   P
Sbjct: 4   LQQRLGKGSFGTVYLVKDKKAVAEERLK-VLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHG--YLSESKARFYIYELAQAVQYL 126
            IV    SF + +    I EY  G D    LE   H    LSE++   +  +L   V Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H    +HRD+K  N+ L     LK+ DFG +  +  +  + +    GTP Y++PE L+  
Sbjct: 123 HQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTF-TGTPYYMSPEALK-- 178

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYEL 211
                  GY    D+WS+G + YE+
Sbjct: 179 -----HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 18/216 (8%)

Query: 12  VSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTI------ERDIMV 63
           +   D  + R I +G FGD+Y  +    ++    V  K  +     ++      E  IM 
Sbjct: 3   IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           +   P+IV L     + N V+ +ME    G+  + L+      L  +    Y Y+L+ A+
Sbjct: 63  QFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTAL 120

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
            YL    +VHRDI   N+L+S+   +KL DFG +  ++     K+       +++APE +
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            +         +T + D+W  GV  +E+L  G  PF
Sbjct: 181 NFRR-------FTSASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 71.7 bits (176), Expect = 1e-12
 Identities = 65/284 (22%), Positives = 132/284 (46%), Gaps = 23/284 (8%)

Query: 357 KRDRLQLLQQLAEAKASLE----DLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEI 412
           K +   L   L E +  LE     L   +  + AL+ ++  LQ  L      L + EEE+
Sbjct: 694 KNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEEL 753

Query: 413 DRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEV 472
           + L++ + + E +L +    L   + E+EE+  + +  +                +ELE 
Sbjct: 754 EELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQ----------------EELEE 797

Query: 473 LRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEA 532
           L  ELEE +      +++     + R     E+++ + E E L+EKL  LE+EL+  E+ 
Sbjct: 798 LEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKE 857

Query: 533 LATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAK 592
           L   +  L+    E + L + ++ +++E E+    +RE   +  +  + ++ + +L+   
Sbjct: 858 LEELKEELEELEAEKEELEDELKELEEEKEELEEELRE---LESELAELKEEIEKLRERL 914

Query: 593 ERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGEL 636
           E LE ++   +++L     ELE   + T+E   + ++E+ E E+
Sbjct: 915 EELEAKLERLEVELPELEEELEEEYEDTLETELEREIERLEEEI 958

Length = 1163

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 27/157 (17%)

Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +        L       L   +  + +Y++   +++L
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIKHL 134

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE-----YVAPE 181
           H  G +HRD+KP N+++ +   LK+ DFG A       R      + TP      Y APE
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTAGTSFMMTPYVVTRYYRAPE 187

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           V+  M       GY  + D+WS+G +  E++ G+  F
Sbjct: 188 VILGM-------GYKENVDIWSVGCIMGEMIRGTVLF 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 26/204 (12%)

Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFYSFQ 78
           G FG++++     S  T V  K L+   P T+       E ++M   +   +V L+    
Sbjct: 17  GQFGEVWMGYYNNS--TKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
               +Y I EY+  G  +  L++   G +   K   +  ++A+ + Y+    Y+HRD++ 
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRA 131

Query: 139 DNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
            N+L+S +   K+ DFG A  ++ N    R  +  P+   ++ APE +     N GS  +
Sbjct: 132 ANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAI-----NFGS--F 181

Query: 196 TGSCDLWSIGVVSYELLT-GSTPF 218
           T   D+WS G++ YE++T G  P+
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 69.7 bits (171), Expect = 4e-12
 Identities = 78/343 (22%), Positives = 154/343 (44%), Gaps = 35/343 (10%)

Query: 344 STLPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTS 403
           S L    E +   +    +L +++AE + +L +L   R  +  L+ ++  L+++L   + 
Sbjct: 671 SILERRRE-IEELEEKIEELEEKIAELEKALAEL---RKELEELEEELEQLRKELEELSR 726

Query: 404 LLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEV 463
            +S   +++ RL  E+ + E  +    + L     ELE    EL+E+  LE+ ++   E 
Sbjct: 727 QISALRKDLARLEAEVEQLEERI----AQLSKELTELEAEIEELEER--LEEAEEELAEA 780

Query: 464 CEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLE 523
               +ELE    ++E+ K   K  ++     + E  A +  L +       L+E+L SLE
Sbjct: 781 EAEIEELE---AQIEQLKEELKALREA----LDELRAELTLLNEEAAN---LRERLESLE 830

Query: 524 QELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRK 583
           + +  +E  L   +  ++    + ++L+  IE +++ +E+      E+  +  +     +
Sbjct: 831 RRIAATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELE---SELEALLNERASLEE 887

Query: 584 TLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREEN 643
            L  L+S  E L  E+R    +LES R EL    ++  E  A+ +L         VR +N
Sbjct: 888 ALALLRSELEELSEELR----ELESKRSELRRELEELREKLAQLELRLEG---LEVRIDN 940

Query: 644 KKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLK 686
               Q ++   YSL    + A++   K E +    R   K+L+
Sbjct: 941 ---LQERLSEEYSL--TLEEAEALENKIEDDEEEARRRLKRLE 978

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 60/275 (21%)

Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +        L    H  L   +  + +Y++   +++L
Sbjct: 85  LLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCGIKHL 139

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H  G +HRD+KP N+++ +   LK+ DFG A     N  +   V   T  Y APEV+  M
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGM 197

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF---------------------------- 218
                  GY  + D+WS+G +  EL+ GS  F                            
Sbjct: 198 -------GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250

Query: 219 ----NYETLDMTYSSILACDTEDTVSFPS-----SIRLSTAMVNFVQSLVQKLDARLNMD 269
               NY      Y  I   +      FPS      ++ S A     + LV   D R+++D
Sbjct: 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310

Query: 270 QVLGHPV----FDCLDSDPPCIPPPSQENKFHKKD 300
           + L HP     +D  +++ P  PP   + +  +++
Sbjct: 311 EALRHPYITVWYDPAEAEAP--PPQIYDAQLEERE 343

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 65/233 (27%), Positives = 101/233 (43%), Gaps = 40/233 (17%)

Query: 21  RFIQQGNFGDIY---LVEE--KQSHNTFVMKKVLR------EKMPNTIERDIMVKSKCPY 69
            F+  G FG++Y     +     S    V  K LR      EK     E  +M     P 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-----ENQPHGYLSESKARFYIYELAQAVQ 124
           IV L          Y IME + GGD ++ L     E      L+  +      ++A+   
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 125 YLHGLGYVHRDIKPDNMLLSATGH-----LKLTDFGSATQVDKNG----RIKSIVPVGTP 175
           YL  + ++HRD+   N L+S  G+     +K+ DFG A  + K+       + ++PV   
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV--- 177

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETL 223
            ++APE L  ++G      +T   D+WS GV+ +E+LT G  P+    N E L
Sbjct: 178 RWMAPESL--LDGK-----FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 69.4 bits (170), Expect = 5e-12
 Identities = 70/296 (23%), Positives = 143/296 (48%), Gaps = 19/296 (6%)

Query: 383 RVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEE 442
            +  L+AQ+  L+++L S  + L   E+ ++ LR+++ + E  L     +L A   ELE+
Sbjct: 675 ELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQ 734

Query: 443 VRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAV 502
           ++S L+E E   +  + +LE  +  + LE L  ELE  + A  + K++  +  ++R A  
Sbjct: 735 LQSRLEELEEELEELEEELEELQ--ERLEELEEELESLEEALAKLKEEIEELEEKRQALQ 792

Query: 503 AELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEME 562
            EL++ + E E  + +L +LE+EL+  E+     +  ++    E + L   ++ +++E+E
Sbjct: 793 EELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELE 852

Query: 563 QSAVRVREMSGISEKYEKDRKTL-LELKSAKERLELEVRGYKLDLESTRRELETNKDQTI 621
           +    + E+    E+ E +++ L  ELK  +E  E        +LE   RELE+   +  
Sbjct: 853 ELEKELEELKEELEELEAEKEELEDELKELEEEKE--------ELEEELRELESELAE-- 902

Query: 622 ELRAKSKLEKAEGELTTVREENKKLK---QGKIRLVYSLFKDPQPAQSKLEKAEGE 674
               K ++EK    L  +  + ++L+         +   ++D    + + E    E
Sbjct: 903 ---LKEEIEKLRERLEELEAKLERLEVELPELEEELEEEYEDTLETELEREIERLE 955

Length = 1163

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 69.7 bits (171), Expect = 5e-12
 Identities = 56/247 (22%), Positives = 111/247 (44%), Gaps = 14/247 (5%)

Query: 368 AEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLV 427
           AE +   E L   R  V  L+ ++  LQ++L +  + +S+ E++   LR+ +   E  L 
Sbjct: 260 AELQELEEKLEELRLEVSELEEEIEELQKELYALANEISRLEQQKQILRERLANLERQLE 319

Query: 428 ATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQW 487
              + L     +L+E+  EL E E  EK ++ K E+  +  ELE L  ELEE ++  ++ 
Sbjct: 320 ELEAQLEELESKLDELAEELAELE--EKLEELKEELESLEAELEELEAELEELESRLEEL 377

Query: 488 KKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQEL-KVSEEALATAQNSLDSKLRE 546
           ++       +      ++     E E L+ +L  LE    ++ +E     +   +++L+E
Sbjct: 378 EEQLETLRSKVAQLELQIASLNNEIERLEARLERLEDRRERLQQEIEELLKKLEEAELKE 437

Query: 547 HQALSNTIESMQKEM-EQSAVRVREMSGISEKYEKDRKTLLELKS----------AKERL 595
            QA    +E   +E+ E+       +  + E+ E+  + L   +           + ERL
Sbjct: 438 LQAELEELEEELEELQEELERLEEALEELREELEEAEQALDAAERELAQLQARLDSLERL 497

Query: 596 ELEVRGY 602
           +  + G+
Sbjct: 498 QENLEGF 504

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLR----EKMPNTIERD--IMVKSKCPYIVNLFYSFQ 78
           +G++  +Y  + K  +   V  KV+R    E  P T  R+  ++   K   IV L     
Sbjct: 15  EGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH 73

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
               +  + EYV   D    ++  P G L     + ++++L + + Y+H    +HRD+KP
Sbjct: 74  TKETLTLVFEYVHT-DLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQRYILHRDLKP 131

Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP------VGTPEYVAPEVLEWMEGNHGS 192
            N+L+S TG LKL DFG A       R KS+        V T  Y  P+VL       GS
Sbjct: 132 QNLLISDTGELKLADFGLA-------RAKSVPSHTYSNEVVTLWYRPPDVL------LGS 178

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF 218
             Y+   D+W +G +  E++ G   F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 32/219 (14%)

Query: 15  SDFDIKRFIQQ---GNFGDIYLVE-EKQSHNTF--VMKKVLREKMPNTIERD------IM 62
            +    +FI+Q   G+FG + L   +    NT   V  K L          D      I+
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60

Query: 63  VKSKCPYIVNLFY--SFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESKARFYIYEL 119
                  IV             +  IMEY+  G     L  ++    ++  +   +  ++
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQI 118

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKN---GRIKSIVPVGT 174
            + + YL    Y+HRD+   N+L+ +   +K++DFG A  +  DK+    +     P+  
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI-- 176

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
             + APE L        +  ++ + D+WS GV  YEL T
Sbjct: 177 -FWYAPECLR-------TSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 51/292 (17%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVL---REKMPNTIERDI-MVKS-KCPYIVNLFYSFQD 79
           +G +  +Y    K + N   +K++     E  P T  R++ ++K  K   IV L      
Sbjct: 16  EGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 75

Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
              +  + EY+   D    L++  +  ++    + ++++L + + Y H    +HRD+KP 
Sbjct: 76  EKSLTLVFEYLDK-DLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQ 133

Query: 140 NMLLSATGHLKLTDFGSATQVDKNGRIKSIVP------VGTPEYVAPEVLEWMEGNHGSD 193
           N+L++  G LKL DFG A       R KSI        V T  Y  P++L       GS 
Sbjct: 134 NLLINERGELKLADFGLA-------RAKSIPTKTYSNEVVTLWYRPPDIL------LGST 180

Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETL---------------DMTYSSILACDTEDT 238
            Y+   D+W +G + YE+ TG   F   T+               + T+  IL+ +   +
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240

Query: 239 VSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL 280
            ++P          + RL +     +  L+Q +   R++ ++ + HP F CL
Sbjct: 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional

 Score = 68.6 bits (168), Expect = 8e-12
 Identities = 96/461 (20%), Positives = 196/461 (42%), Gaps = 60/461 (13%)

Query: 365 QQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKES 424
           ++L E    + ++S     +     ++    ++L      + + E+E++ L     K E 
Sbjct: 200 KELEEVLREINEISSELPELREELEKLEKEVKELEELKEEIEELEKELESLEGSKRKLEE 259

Query: 425 DLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTAT 484
            +      +   + E+EE+  ++KE + L++  +  +++ E  +E      E+E++ +  
Sbjct: 260 KIRELEERIEELKKEIEELEEKVKELKELKEKAEEYIKLSEFYEEYLDELREIEKRLSRL 319

Query: 485 KQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQN--SLDS 542
           ++      + +KE       L++ + + + L+++L  LE+  ++ EEA A  +    L  
Sbjct: 320 EEEINGIEERIKELEEKEERLEELKKKLKELEKRLEELEERHELYEEAKAKKEELERLKK 379

Query: 543 KL--REHQALSNTIESMQK---EMEQSAVRVREMSGISEKYEKDRKT-LLELKSAK---- 592
           +L     + L   +E ++K   E+E+   ++    G  +K  K+ K  + ELK AK    
Sbjct: 380 RLTGLTPEKLEKELEELEKAKEEIEEEISKITARIGELKKEIKELKKAIEELKKAKGKCP 439

Query: 593 ---------ERLELEVRGYKLDLESTRRELETNKDQTIELRA-KSKLEKA---EGELTTV 639
                     R EL +  Y  +L+   +EL+  +++  +LR    +LEK    E EL  +
Sbjct: 440 VCGRELTEEHRKEL-LEEYTAELKRIEKELKEIEEKERKLRKELRELEKVLKKESELIKL 498

Query: 640 REENKKLKQGKIRL-VYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSL 698
           +E  ++LK+ + +L  Y+L         +LEK   E   ++E+  KLK     +L+    
Sbjct: 499 KELAEQLKELEEKLKKYNL--------EELEKKAEEYEKLKEKLIKLK-GEIKSLKKE-- 547

Query: 699 FWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITA--------LESTMTRSES 750
                   L  LE+LK    E E KL    E + E   ++          LE  +   E 
Sbjct: 548 --------LEKLEELKKKLAELEKKLDELEEELAELLKELEELGFESVEELEERLKELEP 599

Query: 751 YCKEMVEY------LETLQKNNDILSHDNEQLRKKNNDILS 785
           +  E +E       LE  +K    L  + ++  ++  +   
Sbjct: 600 FYNEYLELKDAEKELEREEKELKKLEEELDKAFEELAETEK 640

Length = 880

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 68.2 bits (167), Expect = 1e-11
 Identities = 61/259 (23%), Positives = 114/259 (44%), Gaps = 13/259 (5%)

Query: 429 TSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWK 488
           T+S ++  R E+EE+  +++E E             E+ K L  LR ELEE +   +Q +
Sbjct: 668 TNSSILERRREIEELEEKIEELEEKIA---------ELEKALAELRKELEELEEELEQLR 718

Query: 489 KDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQ 548
           K+  +  ++ +A   +L + + E E L+E++  L +EL   E  +   +  L+    E  
Sbjct: 719 KELEELSRQISALRKDLARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELA 778

Query: 549 ALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLES 608
                IE ++ ++EQ      E+  + E  ++ R  L  L      L   +   +  + +
Sbjct: 779 EAEAEIEELEAQIEQLK---EELKALREALDELRAELTLLNEEAANLRERLESLERRIAA 835

Query: 609 TRRELETNKDQTIELRAK-SKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSK 667
           T R LE  ++Q  EL      L     EL  + EE +   +  +    SL +     +S+
Sbjct: 836 TERRLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEALALLRSE 895

Query: 668 LEKAEGELTTVREENKKLK 686
           LE+   EL  +  +  +L+
Sbjct: 896 LEELSEELRELESKRSELR 914

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 68.2 bits (167), Expect = 1e-11
 Identities = 62/283 (21%), Positives = 126/283 (44%), Gaps = 11/283 (3%)

Query: 368 AEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLV 427
               A L+ L   R R+  L+ ++SSLQ +L    + L +  +E+    +++ + E ++ 
Sbjct: 670 RSEPAELQRL---RERLEGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIE 726

Query: 428 ATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQW 487
               +    +  LEE+  +L   E  ++ ++ K E+ E+   +E L  +L + + A    
Sbjct: 727 QLEQEEEKLKERLEELEEDLSSLE--QEIENVKSELKELEARIEELEEDLHKLEEALNDL 784

Query: 488 KKDWYQS-VKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLRE 546
           +     S + E  A +++L++  +  EA   +L  +EQ+L          +  +     +
Sbjct: 785 EARLSHSRIPEIQAELSKLEEEVSRIEA---RLREIEQKLNRLTLEKEYLEKEIQELQEQ 841

Query: 547 HQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKS--AKERLELEVRGYKL 604
              L   I+S++KE+E    +  E+    E+ E   + L        KER ELE +  +L
Sbjct: 842 RIDLKEQIKSIEKEIENLNGKKEELEEELEELEAALRDLESRLGDLKKERDELEAQLREL 901

Query: 605 DLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLK 647
           + +    E +  K +      K+KLE  E EL+ + +   + +
Sbjct: 902 ERKIEELEAQIEKKRKRLSELKAKLEALEEELSEIEDPKGEDE 944

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMV--KSKCPYIVNLF-- 74
           I QG FG+++    K++     +KKVL    +E  P T  R+I +    K   +VNL   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 75  -------YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
                  Y+ +     Y + E+    D   LL N  +   + S+ +  +  L   + Y+H
Sbjct: 80  CRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFG-----SATQVDKNGRIKSIVPVGTPEYVAPEV 182
               +HRD+K  N+L++  G LKL DFG     S ++  K  R  +   V T  Y  PE+
Sbjct: 137 RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN--RVVTLWYRPPEL 194

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS 215
           L       G   Y    D+W  G +  E+ T S
Sbjct: 195 L------LGERDYGPPIDMWGAGCIMAEMWTRS 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 43/116 (37%), Positives = 61/116 (52%), Gaps = 11/116 (9%)

Query: 107 LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNG 164
           L+    +F++Y+L +A++Y+H     HRD+KP N+L +A   LK+ DFG A     D   
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159

Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGS--DGYTGSCDLWSIGVVSYELLTGSTPF 218
            I     V T  Y APE+        GS    YT + D+WSIG +  E+LTG   F
Sbjct: 160 AIFWTDYVATRWYRAPELC-------GSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 30/226 (13%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKC 67
               ++R +  G FG+++      +  T V  K L+   P T+       E  IM K + 
Sbjct: 6   ESLKLERKLGAGQFGEVW--MGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRH 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
             +V L+    +   +Y + EY++ G  +  L++     L   +      ++A+ + YL 
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLE 184
              Y+HRD+   N+L+      K+ DFG A  ++ +    R  +  P+   ++ APE   
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI---KWTAPEAA- 176

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
               N+G   +T   D+WS G++  E++T G  P+    N E L+ 
Sbjct: 177 ----NYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 17/222 (7%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI---ERDIMVKSKCP 68
           ++ S+    + +  G FG ++L + + +     +K +    M       E  +M+K   P
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHP 59

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            +V L+        +Y + E++  G  +  L  Q  G LS+        ++ + ++YL  
Sbjct: 60  KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLER 118

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
             ++HRD+   N L+S+TG +K++DFG    V  +    S       ++  PEV  + + 
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK- 177

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
                 Y+   D+WS GV+ +E+ T G  PF    NYE ++M
Sbjct: 178 ------YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 12/159 (7%)

Query: 122 AVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVA 179
           A++YLH  L  +HRD+KP N+L++  G +KL DFG S   VD    +   +  G   Y+A
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMA 171

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PE +   E N    GY    D+WS+G+   EL TG  P  Y++    +  +     E + 
Sbjct: 172 PERIN-PELN--QKGYDVKSDVWSLGITMIELATGRFP--YDSWKTPFQQLKQVVEEPSP 226

Query: 240 SFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
             P+  + S    +FV + L +    R N  ++L HP F
Sbjct: 227 QLPAE-KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 66.6 bits (162), Expect = 2e-11
 Identities = 84/322 (26%), Positives = 135/322 (41%), Gaps = 52/322 (16%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVN 72
               + +   I  G+FG +Y      +     +KKVL++  P    R++++     +I N
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYKNRELLIMKNLNHI-N 120

Query: 73  LFY--------SFQDMNHVYF---IMEYV--TGGDFVTLLENQPHGYLSESKARFYIYEL 119
           + +         F+      F   +ME++  T   ++       H  L     + Y Y+L
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA-LPLFLVKLYSYQL 179

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
            +A+ Y+H     HRD+KP N+L+    H LKL DFGSA  +    R  S+  + +  Y 
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYR 237

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE-TLDMTYS--SILACDT 235
           APE++       G+  YT   DLWS+G +  E++ G   F+ + ++D       +L   T
Sbjct: 238 APELM------LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291

Query: 236 EDT----------VSFP--SSIRLSTAM--------VNFV-QSLVQKLDARLNMDQVLGH 274
           ED           + FP      L            +NF+ Q L  +   RLN  + L  
Sbjct: 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351

Query: 275 PVFDCLDSDPPCIPPPSQENKF 296
           P FD  D   PCI  P   +K 
Sbjct: 352 PFFD--DLRDPCIKLPKYIDKL 371

Length = 440

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 15/198 (7%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREK----MPNTIERDIMVKSKCPY--IVNLFYS 76
           I +G +G +Y   ++ ++ T  +KK+  E+    +P+T  R+I +  +  +  IV L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
                 +Y + EY+   D    +++ P    +    + Y+Y++ + + Y H    +HRD+
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDL 128

Query: 137 KPDNMLLS-ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+L+   T  LKL DFG A       R  +   V T  Y APE+L       GS  Y
Sbjct: 129 KPQNLLIDRRTNALKLADFGLARAFGIPVRTFT-HEVVTLWYRAPEIL------LGSRHY 181

Query: 196 TGSCDLWSIGVVSYELLT 213
           +   D+WS+G +  E++ 
Sbjct: 182 STPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 31/229 (13%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVL---REKMPNTIERDI-MVKS-KCPYIVNLFYSFQD 79
           +G +  ++    K + N   +K++     E  P T  R++ ++K+ K   IV L      
Sbjct: 15  EGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT 74

Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
              +  + EY+   D    L+N  +  +S    + ++++L + + Y H    +HRD+KP 
Sbjct: 75  ERCLTLVFEYLDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQ 132

Query: 140 NMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-------VGTPEYVAPEVLEWMEGNHGS 192
           N+L++  G LKL DFG A       R KS VP       V T  Y  P+VL       GS
Sbjct: 133 NLLINEKGELKLADFGLA-------RAKS-VPTKTYSNEVVTLWYRPPDVL------LGS 178

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI---LACDTEDT 238
             Y+   D+W +G + YE+ TG   F   T+      I   L   TE+T
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 66.2 bits (162), Expect = 5e-11
 Identities = 73/363 (20%), Positives = 138/363 (38%), Gaps = 69/363 (19%)

Query: 403 SLLSKKEEEIDRLRQEMVKKES-----------DLVATSSDLVATRHELEEVRSELKEKE 451
            ++ +K ++++RLR+E  K E            +      +  A   + E +  +L   E
Sbjct: 191 LIIDEKRQQLERLRREREKAERYQALLKEKREYEGYELLKEKEALERQKEAIERQLASLE 250

Query: 452 NLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTE 511
             E+ +    E+ E+ K LE +   LEE     K   ++    VKE      ++ + + E
Sbjct: 251 --EELEKLTEEISELEKRLEEIEQLLEELNKKIKDLGEEEQLRVKE------KIGELEAE 302

Query: 512 NEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREM 571
             +L+  +   E+EL+ +EE LA  +  +D  L E + L   IE  +K  ++      E+
Sbjct: 303 IASLERSIAEKERELEDAEERLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAEL 362

Query: 572 --------SGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIEL 623
                   + + E  ++  +T  ELK  +E+LE         L+    EL+   D+  E 
Sbjct: 363 KEELEDLRAELEEVDKEFAETRDELKDYREKLE--------KLKREINELKRELDRLQEE 414

Query: 624 --RAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREE 681
             R   +L      +  +  +  +L++ K           +    +++K E +L  +  +
Sbjct: 415 LQRLSEELADLNAAIAGIEAKINELEEEK-----------EDKALEIKKQEWKLEQLAAD 463

Query: 682 NKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITAL 741
             K +                       L DLK  Y   E +L      + E E +  A 
Sbjct: 464 LSKYE---------------------QELYDLKEEYDRVEKELSKLQRELAEAEAQARAS 502

Query: 742 EST 744
           E  
Sbjct: 503 EER 505

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 6e-11
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 12/96 (12%)

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---VGT 174
           +L  A+ Y+HG G +HRDIK +N+L++    + L DFG+A      G   +       GT
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA--RGSWSTPFHYGIAGT 325

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYE 210
            +  APEVL         D YT S D+WS G+V +E
Sbjct: 326 VDTNAPEVL-------AGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 42/139 (30%), Positives = 74/139 (53%), Gaps = 12/139 (8%)

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           N +Y +ME ++ G+ V  L  +    +S  +   +  ++A+ ++YL     VHRD+   N
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARN 130

Query: 141 MLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCD 200
           +L+S  G  K++DFG A +V   G   S +PV   ++ APE L+     H    ++   D
Sbjct: 131 ILVSEDGVAKVSDFGLA-RVGSMGVDNSKLPV---KWTAPEALK-----HKK--FSSKSD 179

Query: 201 LWSIGVVSYELLT-GSTPF 218
           +WS GV+ +E+ + G  P+
Sbjct: 180 VWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional

 Score = 65.1 bits (159), Expect = 1e-10
 Identities = 81/362 (22%), Positives = 153/362 (42%), Gaps = 37/362 (10%)

Query: 407 KKEEEIDRL----RQEMVKKESDLVATSSDLVATRHELEEVRSELKE----KENLEKTDD 458
           K+ E I+ L     +E+ +   ++   SS+L   R ELE++  E+KE    KE +E+ + 
Sbjct: 186 KRTENIEELIKEKEKELEEVLREINEISSELPELREELEKLEKEVKELEELKEEIEELEK 245

Query: 459 RKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEK 518
               +    ++LE    ELEE+    K+  ++  + VKE    + ELK+   E   L E 
Sbjct: 246 ELESLEGSKRKLEEKIRELEERIEELKKEIEELEEKVKE----LKELKEKAEEYIKLSEF 301

Query: 519 LTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKY 578
                 EL+  E+ L+               L   I  +++ +++   +   +  + +K 
Sbjct: 302 YEEYLDELREIEKRLSR--------------LEEEINGIEERIKELEEKEERLEELKKKL 347

Query: 579 EKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTT 638
           ++  K L EL+   E  E E +  K +LE  ++ L      T E + + +LE+ E     
Sbjct: 348 KELEKRLEELEERHELYE-EAKAKKEELERLKKRL---TGLTPE-KLEKELEELEKAKEE 402

Query: 639 VREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVR---EENKKLKVSFFFTLES 695
           + EE  K+   +I  +    K+ + A  +L+KA+G+         E  + ++   +T E 
Sbjct: 403 IEEEISKITA-RIGELKKEIKELKKAIEELKKAKGKCPVCGRELTEEHRKELLEEYTAEL 461

Query: 696 NSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEM 755
             +   +          L+    E E  L+  +E+I   E     L+    + + Y  E 
Sbjct: 462 KRIE-KELKEIEEKERKLRKELRELEKVLKKESELIKLKEL-AEQLKELEEKLKKYNLEE 519

Query: 756 VE 757
           +E
Sbjct: 520 LE 521

Length = 880

>gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair]

 Score = 64.8 bits (158), Expect = 1e-10
 Identities = 90/475 (18%), Positives = 187/475 (39%), Gaps = 35/475 (7%)

Query: 350 SEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKE 409
            E ++  + +  +L + L E +  +E L      +  L+ ++  L+  L     LL K +
Sbjct: 266 LEALKIREEELRELERLLEELEEKIERLEELEREIEELEEELEGLRALLEELEELLEKLK 325

Query: 410 EEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKE--KENLEKTDDRKLEVCEVS 467
              +RL +++ +K   L +   +L   ++EL ++  E  +  +E LE+ +    +  E  
Sbjct: 326 SLEERL-EKLEEKLEKLESELEELAEEKNELAKLLEERLKELEERLEELEKELEKALERL 384

Query: 468 KELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELK 527
           K+LE    EL+E+        ++  + ++E    + EL++   E E   +KL     +L+
Sbjct: 385 KQLEEAIQELKEELAELSAALEEIQEELEELEKELEELERELEELEEEIKKLEEQINQLE 444

Query: 528 VSEEALATAQNSLD------SKLREH--QALSNTIESMQKEMEQSAVRVREMSGISEKYE 579
             E  +A    + +       +L E   + L    E   +E+E+   R +E + + E+ E
Sbjct: 445 SKELMIAELAGAGEKCPVCGQELPEEHEKELLELYELELEELEEELSREKEEAELREEIE 504

Query: 580 KDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTV 639
           +  K L EL+     L       K +LE    +LE   ++  EL+ K +L++ + EL  +
Sbjct: 505 ELEKELRELEEELIELLELEEALKEELEEKLEKLENLLEELEELKEKLQLQQLKEELRQL 564

Query: 640 REENKKLK-----QGKIRLVYSLFKDPQPAQ----SKLEKAEGELTTVREENKKLKV--- 687
            +  ++LK        +R      ++ +        KL++ E  L+ + E  + L++   
Sbjct: 565 EDRLQELKELLEELRLLRTRKEELEELRERLKELKKKLKELEERLSQLEELLQSLELSEA 624

Query: 688 ------------SFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYE 735
                       S    L   +         L  LE+          +     E   + E
Sbjct: 625 ENELEEAEEELESELEKLNLQAELEELLQAALEELEEKVEELEAEIRRELQRIENEEQLE 684

Query: 736 TKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDILSHDNEQ 790
            K+  LE      E   +E+ E L+ L +   ++     +  +        +  +
Sbjct: 685 EKLEELEQLEEELEQLREELEELLKKLGEIEQLIEELESRKAELEELKKELEKLE 739

Length = 908

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IVNL  +      +  I EY   GD +  L  +   +L+      + Y++A+ + +L   
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160

Query: 130 GYVHRDIKPDNMLLSATGHL-KLTDFGSATQV--DKNGRIK--SIVPVGTPEYVAPE-VL 183
             +HRD+   N+LL+  G + K+ DFG A  +  D N  +K  + +PV   +++APE + 
Sbjct: 161 NCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIF 216

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
             +        YT   D+WS G++ +E+ + GS P+
Sbjct: 217 NCV--------YTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 64.4 bits (157), Expect = 2e-10
 Identities = 60/262 (22%), Positives = 120/262 (45%), Gaps = 11/262 (4%)

Query: 357  KRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLR 416
            + +  +L ++L E +  LE L  +  +   L+ ++  L++   +    L + EEE++   
Sbjct: 750  EEELEELQERLEELEEELESLEEALAK---LKEEIEELEEKRQALQEELEELEEELEEAE 806

Query: 417  QEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGE 476
            + +   E +L +          E+EE+  E++E E  EK D+ + E+ E+ KELE L+ E
Sbjct: 807  RRLDALERELESLEQRRERLEQEIEELEEEIEELE--EKLDELEEELEELEKELEELKEE 864

Query: 477  LEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKL----TSLEQELKVSEEA 532
            LEE +   ++ + +  +  +E+     EL++ ++E   LKE++      LE+     E  
Sbjct: 865  LEELEAEKEELEDELKELEEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLERL 924

Query: 533  LATAQNSLDSKLREHQA-LSNTIESMQKEMEQSAVRVREM-SGISEKYEKDRKTLLELKS 590
                    +    E++  L   +E   + +E+    +  +     E+YE+  +   ELKS
Sbjct: 925  EVELPELEEELEEEYEDTLETELEREIERLEEEIEALGPVNLRAIEEYEEVEERYEELKS 984

Query: 591  AKERLELEVRGYKLDLESTRRE 612
             +E LE         +E   +E
Sbjct: 985  QREDLEEAKEKLLEVIEELDKE 1006

Length = 1163

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 2e-10
 Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 32/193 (16%)

Query: 68  PYIVNLFYSFQDMNHVYF-IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           P IV L  S +    + F + EYV G     +L     G L   +    + ++  A+   
Sbjct: 38  PNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAAD--GALPAGETGRLMLQVLDALACA 95

Query: 127 HGLGYVHRDIKPDNMLLSATG---HLKLTDFG-----------SATQVDKNGRIKSIVPV 172
           H  G VHRD+KP N+++S TG   H K+ DFG               + +   +     +
Sbjct: 96  HNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEV-----L 150

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTP Y APE L         +  T + DL++ G++  E LTG       ++       L+
Sbjct: 151 GTPTYCAPEQLR-------GEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLS 203

Query: 233 CDTEDTVSFPSSI 245
                 VS P  I
Sbjct: 204 ---PVDVSLPPWI 213

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTI--ERDIMVKSKCPYIVNLFYSFQDM 80
            G FG++++       +T V  K L++    P     E ++M + + P +V L Y+    
Sbjct: 16  AGQFGEVWMGYYN--GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL-YAVVTQ 72

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
             +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N
Sbjct: 73  EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAAN 132

Query: 141 MLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
           +L+S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T 
Sbjct: 133 ILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI-----NYGT--FTI 182

Query: 198 SCDLWSIGVVSYELLT-GSTPF 218
             D+WS G++  E++T G  P+
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.9 bits (153), Expect = 3e-10
 Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 14/177 (7%)

Query: 44  VMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQP 103
           ++K V   K P   E DI+       I+NL ++++  + V  +M      D  T ++   
Sbjct: 123 IVKAVTGGKTPGR-EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRS- 179

Query: 104 HGYLSESKARFYIYE-LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK 162
            G L   +A   I   L +A+ YLHG G +HRD+K +N+ L    +  L DFG+A ++D 
Sbjct: 180 -GPLPLEQA-ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237

Query: 163 N-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +    +     GT E  +PE+L         D Y    D+WS G+V +E+   +   
Sbjct: 238 HPDTPQCYGWSGTLETNSPELL-------ALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 37/234 (15%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------I 61
           V      +KR + +G FG ++L E    E ++    V  K L+E   N   +D      +
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL------------ENQPHGYLSE 109
           +   +   IV  +    + +    + EY+  GD    L             + P G L+ 
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 110 SKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG--RIK 167
           S+      ++A  + YL    +VHRD+   N L+     +K+ DFG +  V      R+ 
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG 181

Query: 168 --SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
             +++P+    ++ PE + + +       +T   D+WS GVV +E+ T G  P+
Sbjct: 182 GHTMLPI---RWMPPESIMYRK-------FTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.0 bits (150), Expect = 5e-10
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 14/143 (9%)

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD
Sbjct: 97  SLEEFQDVYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRD 151

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP N+++ +   LK+ DFG A     +  +   V   T  Y APEV+  M       GY
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGM-------GY 202

Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+G +  E++ G   F
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 62.8 bits (153), Expect = 6e-10
 Identities = 53/279 (18%), Positives = 117/279 (41%), Gaps = 28/279 (10%)

Query: 357  KRDRLQLLQQ-LAEAKASLEDLSC---SRTRVLA-LQAQVSSLQQDLTSHTSLLSKKEEE 411
              + L  L+Q +   K+ L++L          L  L+  ++ L+  L+   S + + + E
Sbjct: 742  LEEDLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARLSH--SRIPEIQAE 799

Query: 412  IDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKEN-LEKTDDRKLEVCEVSKEL 470
            + +L +E+ + E+ L      L     E E +  E++E +       ++   +    KE+
Sbjct: 800  LSKLEEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQRIDLKEQIKSIE---KEI 856

Query: 471  EVLRGELEEQKTATKQWKKDWYQSV-------KERNAAVAELKQAQTENEALKEKLTSLE 523
            E L G+ EE +   ++ +              KER+   A+L++ + + E L+ ++    
Sbjct: 857  ENLNGKKEELEEELEELEAALRDLESRLGDLKKERDELEAQLRELERKIEELEAQIEKKR 916

Query: 524  QELKVSEEALATAQNSLDSKLREHQALSN------TIESMQKEMEQSAVRVREMSGIS-- 575
            + L   +  L   +  L                  ++E +Q E+++    +R +  ++  
Sbjct: 917  KRLSELKAKLEALEEELSEIEDPKGEDEEIPEEELSLEDVQAELQRVEEEIRALEPVNML 976

Query: 576  --EKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRE 612
              ++YE+  K L ELK  + +LE E +     +E   ++
Sbjct: 977  AIQEYEEVLKRLDELKEKRAKLEEERKAILERIEEYEKK 1015

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 7e-10
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 46/244 (18%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNT--FVMKKVLREK-----MPNTIERDIMVKSKC-- 67
           ++I+  I +G +G +Y  + K   +   + +KK   +K     +  +  R+I +  +   
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 68  PYIVNL---FYSFQDMNHVYFIMEYVTGGDFVTLLENQPH---GYLSESKARFYIYELAQ 121
             +V+L   F    D + VY + +Y    D   +++         +  S  +  ++++  
Sbjct: 62  ENVVSLVEVFLEHADKS-VYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSA----TGHLKLTDFGSATQVDKNGRIKSIV----PVG 173
            V YLH    +HRD+KP N+L+       G +K+ D G A   +    +K +      V 
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP--LKPLADLDPVVV 177

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-------------GSTPFNY 220
           T  Y APE+L       G+  YT + D+W+IG +  ELLT              S PF  
Sbjct: 178 TIWYRAPELL------LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231

Query: 221 ETLD 224
           + L+
Sbjct: 232 DQLE 235

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 36/226 (15%)

Query: 12  VSASDFDIKRFIQQGNFGDIYL----VEEKQSHNTFVMKKVLREKMPNTIERD------I 61
           +  S   I++ I  G FG++      +  K+     V  K L+    +    D      I
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEI--DVAIKTLKAGSSDKQRLDFLTEASI 58

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P I+ L         V  I EY+  G     L     G  +  +    +  +A 
Sbjct: 59  MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIAS 117

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--------SATQVDKNGRIKSIVPVG 173
            ++YL  + YVHRD+   N+L+++    K++DFG         AT   K G+I    P+ 
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI----PI- 172

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              + APE +      +    +T + D+WS G+V +E+++ G  P+
Sbjct: 173 --RWTAPEAI-----AYRK--FTSASDVWSFGIVMWEVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 39/125 (31%), Positives = 62/125 (49%), Gaps = 21/125 (16%)

Query: 107 LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI 166
           +S    + ++Y++ + + Y H    +HRD+KP N+L++  G LKL DFG A       R 
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA-------RA 153

Query: 167 KSIVPVGTPE-------YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           KS VP  T         Y  P+VL       GS  Y+   D+W +G + +E+ +G   F 
Sbjct: 154 KS-VPTKTYSNEVVTLWYRPPDVL------LGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206

Query: 220 YETLD 224
             T++
Sbjct: 207 GSTVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFYSF 77
           QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y+ 
Sbjct: 16  QGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-YAV 69

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD++
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
             N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE   +         
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGR------- 179

Query: 195 YTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
           +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 214

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 44/274 (16%)

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P IV    +F   N ++ +  ++  G    L+       +SE    + +  + +A+ Y+H
Sbjct: 59  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV------PVGTPEYVAPE 181
            +GYVHR +K  ++L+S  G + L+   S   +  +G+   +V       V    +++PE
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPE 178

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN--------YETLDMTYSSILAC 233
           VL+         GY    D++S+G+ + EL  G  PF          E L+ T   +L  
Sbjct: 179 VLQ-----QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL-- 231

Query: 234 DTEDTVSFPSS---IRLSTAMVN--FVQSLVQKLDARLNMDQVLGHP------------V 276
              DT + P+    ++ S +  N    +S         N +    HP            V
Sbjct: 232 ---DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSS-HPYNRTFSPHFHHFV 287

Query: 277 FDCLDSDPPCIPPPSQ--ENKFHKKDKRKASPSL 308
             CL  +P   P  S    + F K+ KR+AS +L
Sbjct: 288 EQCLQRNPDARPSASTLLNHSFFKQIKRRASEAL 321

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 60.9 bits (148), Expect = 2e-09
 Identities = 71/352 (20%), Positives = 152/352 (43%), Gaps = 36/352 (10%)

Query: 351  EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE 410
             ++R  +    +L Q+L++A   + ++      +  L+ +   L++ L      LS  E+
Sbjct: 695  SELRRIENRLDELSQELSDASRKIGEIE---KEIEQLEQEEEKLKERLEELEEDLSSLEQ 751

Query: 411  EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKEL 470
            EI+ ++ E+ + E+ +            ELEE   +L+E  N  +       + E+  EL
Sbjct: 752  EIENVKSELKELEARI-----------EELEEDLHKLEEALNDLEARLSHSRIPEIQAEL 800

Query: 471  EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSE 530
              L  E+   +   ++ ++   +   E+     E+++ Q +   LKE++ S+E+E+    
Sbjct: 801  SKLEEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQRIDLKEQIKSIEKEI---- 856

Query: 531  EALATAQNSLDSKLREHQA-----------LSNTIESMQKEMEQSAVRVREMSGISEKYE 579
            E L   +  L+ +L E +A           L    + ++ ++ +   ++ E   +  + E
Sbjct: 857  ENLNGKKEELEEELEELEAALRDLESRLGDLKKERDELEAQLRELERKIEE---LEAQIE 913

Query: 580  KDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTV 639
            K RK L ELK+  E LE E+       +    + E  +++      +++L++ E E+  +
Sbjct: 914  KKRKRLSELKAKLEALEEELSEI---EDPKGEDEEIPEEELSLEDVQAELQRVEEEIRAL 970

Query: 640  REENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFF 691
               N    Q +   V     + +  ++KLE+    +    EE +K K   F 
Sbjct: 971  EPVNMLAIQ-EYEEVLKRLDELKEKRAKLEEERKAILERIEEYEKKKREVFM 1021

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 31/214 (14%)

Query: 21  RFIQQ---GNFGDIYLVE-EKQSHNT--FVMKKVLREKMPNTI---ERDI-MVKS-KCPY 69
           +FIQQ   GNFG + L   +    NT   V  K L+      +   ER+I ++KS +   
Sbjct: 7   KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66

Query: 70  IVN---LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           IV    + YS    N +  +MEY+  G     L+      L   K   Y  ++ + ++YL
Sbjct: 67  IVKYKGVCYSAGRRN-LRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYL 124

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE-----YVAPE 181
               YVHRD+   N+L+ +   +K+ DFG    + ++   K    V  P      + APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---KEYYKVREPGESPIFWYAPE 181

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS 215
            L   + +  S       D+WS GVV YEL T S
Sbjct: 182 SLTESKFSVAS-------DVWSFGVVLYELFTYS 208

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 46/168 (27%), Positives = 83/168 (49%), Gaps = 11/168 (6%)

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQAVQYL 126
           P I+  +  F   + ++ I  ++  G   +LL+   P G +SE+     ++   + + YL
Sbjct: 59  PNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYL 117

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H  GY+HR+IK  ++L+S  G + L+       + +NG+ K+ V    P++ +  VL W+
Sbjct: 118 HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ-KAKVVYDFPQF-STSVLPWL 175

Query: 187 EGN---HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
                     GY    D++S+G+ + EL TG  PF     DM  + +L
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPF----QDMLRTQML 219

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 16/138 (11%)

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD
Sbjct: 90  SLEEFQDVYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRD 144

Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDG 194
           +KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       G
Sbjct: 145 LKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------G 194

Query: 195 YTGSCDLWSIGVVSYELL 212
           Y  + D+WS+G +  E++
Sbjct: 195 YKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------IMV 63
           + AS   I++ I  G FG++     K        V  K L+        RD      IM 
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL---- 119
           +   P I++L         V  + EY+  G            +L +   +F + +L    
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA--------FLRKHDGQFTVIQLVGML 112

Query: 120 ---AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGRIK 167
              A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+I 
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI- 171

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              P+    + APE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 172 ---PI---RWTAPEAIAYRK-------FTSASDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 60.5 bits (147), Expect = 3e-09
 Identities = 64/304 (21%), Positives = 122/304 (40%), Gaps = 31/304 (10%)

Query: 351 EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE 410
            ++   + +  QL  +L E +  LE+L      +     ++    + L    + L ++ E
Sbjct: 723 RELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAKLKEEIE 782

Query: 411 EIDRLRQEMVKKESDLVATSSDLVATRHELE-EVRSELKEKENLEKTDDRKLEVCEVSKE 469
           E++  RQ + ++  +L     +       LE E+ S  + +E LE+            +E
Sbjct: 783 ELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQE----------IEE 832

Query: 470 LEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVS 529
           LE    ELEE+    +          +E      EL++ + E E L+ +   LE ELK  
Sbjct: 833 LEEEIEELEEKLDELE----------EELEELEKELEELKEELEELEAEKEELEDELKEL 882

Query: 530 EEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELK 589
           EE     +  L     E   L   IE +++ +E+   ++  +     + E++ +   E  
Sbjct: 883 EEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLERLEVELPELEEELEEEYEDT 942

Query: 590 SAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQG 649
              E LE E+      LE     L       + LRA  + E+ E     ++ + + L++ 
Sbjct: 943 LETE-LEREIE----RLEEEIEALG-----PVNLRAIEEYEEVEERYEELKSQREDLEEA 992

Query: 650 KIRL 653
           K +L
Sbjct: 993 KEKL 996

Length = 1163

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 3e-09
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 14/133 (10%)

Query: 111 KARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV 170
           + R  + +L  AV+Y+H    +HRDIK +N+ L+  G + L DFG+A   +K        
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG 327

Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-------GSTPFNYETL 223
            VGT    +PE+L         DGY    D+WS G++  ++L+              + L
Sbjct: 328 WVGTVATNSPEIL-------AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380

Query: 224 DMTYSSILACDTE 236
                S+  CD E
Sbjct: 381 LKIIDSLSVCDEE 393

Length = 501

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 52/223 (23%), Positives = 101/223 (45%), Gaps = 26/223 (11%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPY 69
            +F ++R +  G FG+++  E    +   V  K+L+            E   + + +  +
Sbjct: 6   EEFTLERKLGSGYFGEVW--EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKH 63

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI-YELAQAVQYLHG 128
           +++LF        VY I E +  G  +  L + P G +    +   +  ++A+ + YL  
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS--IVPVGTPEYVAPEVLEWM 186
              +HRD+   N+L+      K+ DFG A  + ++  + S   +P    ++ APE     
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAA--- 176

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +HG+  ++   D+WS G++ YE+ T G  P+    N+E  D
Sbjct: 177 --SHGT--FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional

 Score = 60.1 bits (146), Expect = 4e-09
 Identities = 66/243 (27%), Positives = 117/243 (48%), Gaps = 28/243 (11%)

Query: 405 LSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVC 464
           L KK EE ++L+++++K + ++ +   +L     +LEE++ +L E E          ++ 
Sbjct: 520 LEKKAEEYEKLKEKLIKLKGEIKSLKKEL----EKLEELKKKLAELEK---------KLD 566

Query: 465 EVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQ 524
           E+ +EL  L  ELEE    + +  ++  + ++       ELK A+ E E  +++L  LE+
Sbjct: 567 ELEEELAELLKELEELGFESVEELEERLKELEPFYNEYLELKDAEKELEREEKELKKLEE 626

Query: 525 ELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKT 584
           EL  + E LA  +  L+        L   +E ++K+  +      E   + E+Y +  + 
Sbjct: 627 ELDKAFEELAETEKRLEE-------LRKELEELEKKYSE-----EEYEELREEYLELSRE 674

Query: 585 LLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENK 644
           L  L++  E LE      K  LE  + ELE  +    EL    KLEKA   +  +RE+ K
Sbjct: 675 LAGLRAELEELEKRREEIKKTLEKLKEELEEREKAKKELE---KLEKALERVEELREKVK 731

Query: 645 KLK 647
           K K
Sbjct: 732 KYK 734

Length = 880

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 36/210 (17%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC-----PYIVN 72
           I  G +G +Y   +  S   FV  K +R     + +P +  R++ +  +      P IV 
Sbjct: 8   IGVGAYGTVYKARDPHS-GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 73  LF----YSFQDMN-HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           L      S  D    V  + E+V   D  T L+  P   L     +  + +  + + +LH
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE-----YVAPEV 182
               VHRD+KP+N+L+++ G +KL DFG A       RI S     TP      Y APEV
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLA-------RIYSCQMALTPVVVTLWYRAPEV 178

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
           L           Y    D+WS+G +  E+ 
Sbjct: 179 LL-------QSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 59.7 bits (145), Expect = 5e-09
 Identities = 72/354 (20%), Positives = 144/354 (40%), Gaps = 55/354 (15%)

Query: 439 ELEEVRSELKE-KENLEKTDDRKLEVCEVSKELEVLRGELEE----QKTATKQWKKDWYQ 493
           + E+   EL+E +EN+E+ D   L + E  ++LE LR E E+    Q    ++ + + Y+
Sbjct: 171 KKEKALEELEEVEENIERLD---LIIDEKRQQLERLRREREKAERYQALLKEKREYEGYE 227

Query: 494 SVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNT 553
            +KE+ A   + +  + +  +L+E+L  L +E+                       L   
Sbjct: 228 LLKEKEALERQKEAIERQLASLEEELEKLTEEI---------------------SELEKR 266

Query: 554 IESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKL---DLESTR 610
           +E +++ +E+   +++++    E+  + ++ + EL++    LE  +   +    D E   
Sbjct: 267 LEEIEQLLEELNKKIKDLG--EEEQLRVKEKIGELEAEIASLERSIAEKERELEDAEERL 324

Query: 611 RELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEK 670
            +LE   D+       +++E+ E E+   R+   KL +        L ++ +  +++LE+
Sbjct: 325 AKLEAEIDKL-----LAEIEELEREIEEERKRRDKLTE----EYAELKEELEDLRAELEE 375

Query: 671 AEGELTTVREENKKLKVSF-FFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANE 729
            + E    R+E K  +        E N L        L  L++          +L   N 
Sbjct: 376 VDKEFAETRDELKDYREKLEKLKREINEL-----KRELDRLQEELQ---RLSEELADLNA 427

Query: 730 IIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDI 783
            I   E KI  LE          K+    LE L      LS   ++L     + 
Sbjct: 428 AIAGIEAKINELEEEKEDKALEIKKQEWKLEQLAA---DLSKYEQELYDLKEEY 478

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 38/140 (27%), Positives = 72/140 (51%), Gaps = 14/140 (10%)

Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I E++  G  +  L++         K   +  ++A+ + ++    Y+HRD++  N+L
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134

Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +SA+   K+ DFG A  ++ N    R  +  P+   ++ APE +     N GS  +T   
Sbjct: 135 VSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAI-----NFGS--FTIKS 184

Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 185 DVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 57/259 (22%), Positives = 111/259 (42%), Gaps = 46/259 (17%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIER------- 59
           ++   D  +KR + +G FG ++L E            V  K L++  P    R       
Sbjct: 1   HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREA 58

Query: 60  DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF-----------VTLLENQP---HG 105
           +++   +  +IV  +    D + +  + EY+  GD            + L++ QP    G
Sbjct: 59  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118

Query: 106 YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR 165
            L  S+      ++A  + YL    +VHRD+   N L+ A   +K+ DFG +  V     
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 166 IK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNY 220
            +    +++P+    ++ PE + + +       +T   D+WS GV+ +E+ T G  P+  
Sbjct: 179 YRVGGHTMLPI---RWMPPESIMYRK-------FTTESDVWSFGVILWEIFTYGKQPW-- 226

Query: 221 ETLDMTYSSILACDTEDTV 239
               ++ + ++ C T+  V
Sbjct: 227 --FQLSNTEVIECITQGRV 243

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.8 bits (139), Expect = 6e-09
 Identities = 53/246 (21%), Positives = 107/246 (43%), Gaps = 39/246 (15%)

Query: 19  IKRFIQQGNFGDIYLVEE----KQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPY 69
           +KR + +G FG ++L E      +     V  K L++   N       E +++   +  +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDF-----------VTLLENQPHGYLSESKARFYIYE 118
           IV  +    + + +  + EY+  GD            V + E      L++S+      +
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK----SIVPVGT 174
           +A  + YL    +VHRD+   N L+     +K+ DFG +  V      +    +++P+  
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI-- 186

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC 233
             ++ PE + + +       +T   D+WS+GVV +E+ T G  P+      ++ + ++ C
Sbjct: 187 -RWMPPESIMYRK-------FTTESDVWSLGVVLWEIFTYGKQPW----YQLSNNEVIEC 234

Query: 234 DTEDTV 239
            T+  V
Sbjct: 235 ITQGRV 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.1 bits (143), Expect = 7e-09
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 25/145 (17%)

Query: 157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGST 216
           A  V+   RI     +GTP+Y+APE+L  +   HG      + D W++GV  +E LTG  
Sbjct: 532 AAPVE-GERI-----LGTPDYLAPELL--LGKPHGP-----AVDWWALGVCLFEFLTGIP 578

Query: 217 PFNYETLDMTYSSILACDTEDTVSFPS-SIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGH 274
           PFN ET    + +IL  D      +P    +LS    N ++ L+      R  + ++  H
Sbjct: 579 PFNDETPQQVFQNILNRDIP----WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQH 634

Query: 275 PVFDCLDSD------PPCIPPPSQE 293
           P+F  +D +       P IP P  E
Sbjct: 635 PLFHGVDWENLQNQTMPFIPQPDDE 659

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 41/118 (34%), Positives = 60/118 (50%), Gaps = 16/118 (13%)

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT-QVDKNGRIKSIVPVGTPEYVA 179
           +A+QYLH    +HRDIK +N+ ++  G + L DFG+A   VD N   K     GT    A
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNA 251

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYSSILACDTE 236
           PE+L         D Y  + D+WS G+V +E+ T   + F  + LD        CD++
Sbjct: 252 PELL-------ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD------CDSD 296

Length = 391

>gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair]

 Score = 59.0 bits (143), Expect = 9e-09
 Identities = 88/419 (21%), Positives = 154/419 (36%), Gaps = 56/419 (13%)

Query: 401 HTSLLSKKEEEIDRLRQEMVKKESDLVATSS-DLVATRHELEEVRSELKEKENLEKTDDR 459
                 K  E +  + +E   K  +L    S  L      LE +  ELKE + LE+  + 
Sbjct: 165 GLEKYEKLSELLKEVIKEAKAKIEELEGQLSELLEDIEDLLEALEEELKELKKLEEIQEE 224

Query: 460 K---------LEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQT 510
           +           + E   ELE  +  LEE K    + +    +++K R   + EL++   
Sbjct: 225 QEEEELEQEIEALEERLAELEEEKERLEELKARLLEIESLELEALKIREEELRELERLLE 284

Query: 511 ENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVRE 570
           E E   E+L  LE+E++  EE L   +  L+      + L +  E ++K          +
Sbjct: 285 ELEEKIERLEELEREIEELEEELEGLRALLEELEELLEKLKSLEERLEKL-------EEK 337

Query: 571 MSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLES-TRRELETNKD-QTIELRAKSK 628
           +  +  + E+  +   EL    E    E+     +LE    + LE  K  +      K +
Sbjct: 338 LEKLESELEELAEEKNELAKLLEERLKELEERLEELEKELEKALERLKQLEEAIQELKEE 397

Query: 629 LEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVS 688
           L +    L  ++EE ++L++                  +LE+ E EL  + EE KKL+  
Sbjct: 398 LAELSAALEEIQEELEELEK------------------ELEELERELEELEEEIKKLEEQ 439

Query: 689 FFFTLESNSLFWLD---------------PNTFLSSLEDLKSNYTERESKLRSANEIIGE 733
               LES  L   +               P      L +L     E   +  S  +   E
Sbjct: 440 -INQLESKELMIAELAGAGEKCPVCGQELPEEHEKELLELYELELEELEEELSREKEEAE 498

Query: 734 YETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDILSHDNEQLR 792
              +I  LE  +   E   +E++E LE  +   + L    E+L     ++     +   
Sbjct: 499 LREEIEELEKELRELE---EELIELLELEEALKEELEEKLEKLENLLEELEELKEKLQL 554

Length = 908

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 42/179 (23%), Positives = 81/179 (45%), Gaps = 27/179 (15%)

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E  +M+K   P +V L+        ++ + EY+  G  +  L  +     +E     ++ 
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTE-----WLL 103

Query: 118 ELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           ++      A++YL   G++HRD+   N L+     +K++DFG A  V  +    S    G
Sbjct: 104 DMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS---QG 160

Query: 174 TP---EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
           T    ++  PEV      ++    ++   D+WS GV+ +E+ + G  P+    N E ++
Sbjct: 161 TKFPVKWAPPEVF-----DYSR--FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE 212

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 58.2 bits (141), Expect = 1e-08
 Identities = 54/271 (19%), Positives = 115/271 (42%), Gaps = 28/271 (10%)

Query: 362 QLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVK 421
           ++ Q L E    ++DL       L ++ ++  L+ ++ S    +++KE E++   + + K
Sbjct: 269 EIEQLLEELNKKIKDLG--EEEQLRVKEKIGELEAEIASLERSIAEKERELEDAEERLAK 326

Query: 422 KESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQK 481
            E+++    +++     E+EE R   K ++ L +      E  E+ +ELE LR ELEE  
Sbjct: 327 LEAEIDKLLAEIEELEREIEEER---KRRDKLTE------EYAELKEELEDLRAELEEVD 377

Query: 482 TATKQWKKDWYQSVK-------ERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALA 534
               + + +     +       E N    EL + Q E + L E+L  L   +   E  + 
Sbjct: 378 KEFAETRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELADLNAAIAGIEAKIN 437

Query: 535 TAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKER 594
             +   + K  E +     +E +  ++ +     +E+  + E+Y++  K L +L+     
Sbjct: 438 ELEEEKEDKALEIKKQEWKLEQLAADLSKYE---QELYDLKEEYDRVEKELSKLQRELAE 494

Query: 595 LELEVRGYKLDLESTRRELETNKDQTIELRA 625
            E + R       ++   +   +     L+A
Sbjct: 495 AEAQAR-------ASEERVRGGRAVEEVLKA 518

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFYSF 77
            G FG++++     + NT V  K L+   P T+       E  IM K +   +V L Y+ 
Sbjct: 16  NGQFGEVWM--GTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQL-YAV 69

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                +Y + EY++ G  +  L++     L          ++A  + Y+  + Y+HRD++
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 129

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
             N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE   +         
Sbjct: 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGR------- 179

Query: 195 YTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
           +T   D+WS G++  EL+T G  P+    N E L+
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE 214

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 30/222 (13%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIV 71
           + R +  G FG+++  E   ++ T V  K L+   P T+       E  IM K + P ++
Sbjct: 10  LLRKLGAGQFGEVW--EGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLI 64

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L+        +Y + E +  G  +  L+      L   +      ++A  + YL    Y
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N+L+      K+ DFG A  + ++    R  +  P+   ++ APE       
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI---KWTAPEAAL---- 177

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
               + ++   D+WS G++  E++T G  P+    N E L  
Sbjct: 178 ---YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 39/172 (22%), Positives = 77/172 (44%), Gaps = 13/172 (7%)

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E  +M+K     +V L+        +Y + EY++ G  +  L          S+      
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCK 107

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           ++ + + YL    ++HRD+   N L+   G +K++DFG +  V  +    S+       +
Sbjct: 108 DVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             PEVL + +       ++   D+W+ GV+ +E+ + G  P+    N ET++
Sbjct: 168 SPPEVLLYSK-------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 53/245 (21%), Positives = 104/245 (42%), Gaps = 41/245 (16%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTI-----ERDI 61
           ++   D  +K  + +G FG ++L E      +     V  K L+E   +       E ++
Sbjct: 1   HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 60

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------------ENQPHGYLS 108
           +   +  +IV  +    +   +  + EY+  GD    L             E+   G L+
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120

Query: 109 ESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG--RI 166
             +      ++A  + YL  L +VHRD+   N L+     +K+ DFG +  +      R+
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 167 --KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----N 219
             ++++P+    ++ PE + + +       +T   D+WS GVV +E+ T G  P+    N
Sbjct: 181 GGRTMLPI---RWMPPESILYRK-------FTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230

Query: 220 YETLD 224
            E ++
Sbjct: 231 TEAIE 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 45/241 (18%)

Query: 23  IQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERDIMV--KSKCPYIVNL---FY 75
           + +G +G +Y  + K  +    + +K++    +  +  R+I +  + K P ++ L   F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLE-------NQPHGYLSESKARFYIYELAQAVQYLHG 128
           S  D   V+ + +Y    D   +++       N+    L  S  +  +Y++   + YLH 
Sbjct: 69  SHSD-RKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 129 LGYVHRDIKPDNMLLSAT----GHLKLTDFGSATQVDKNGRIKSIVP----VGTPEYVAP 180
              +HRD+KP N+L+       G +K+ D G A     N  +K +      V T  Y AP
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYRAP 184

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-------------STPFNYETLDMTY 227
           E+L       G+  YT + D+W+IG +  ELLT              S PF+++ LD  +
Sbjct: 185 ELL------LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238

Query: 228 S 228
           S
Sbjct: 239 S 239

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNTI--ERDIMVKSKCPYIVNLFYSFQDM 80
           QG FG++++     +  T V  K L+    MP     E  IM K +   +V L Y+    
Sbjct: 16  QGCFGEVWM--GTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL-YAVVSE 72

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
             +Y + E++  G  +  L+     YL   +      ++A  + Y+  + Y+HRD++  N
Sbjct: 73  EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAAN 132

Query: 141 MLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
           +L+      K+ DFG A  ++ N    R  +  P+   ++ APE   +         +T 
Sbjct: 133 ILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGR-------FTI 182

Query: 198 SCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             D+WS G++  EL+T G  P+    N E L+
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLE 214

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 12  VSASDFDIKRFIQQGNFGDIYL----------VEEKQSHNTFVMKKVLREKMPNTIERDI 61
           VS     + R + QG+FG +Y            E + +  T      LRE++    E  +
Sbjct: 3   VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
            +  E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG--K 180

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    ++APE L+        DG +T S D+WS GVV +E+ +
Sbjct: 181 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 21  RFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDIMVKSKCPYI 70
           R + QG+FG +Y      V + +      +K V     +RE++    E  +M +  C ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARFYIY-ELAQA 122
           V L            IME +T GD  + L       EN P       K    +  E+A  
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI----KSIVPVGTPEYV 178
           + YL+   +VHRD+   N +++    +K+ DFG    + +        K ++PV    ++
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---RWM 188

Query: 179 APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
           +PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 189 SPESLK--------DGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 56/233 (24%)

Query: 25  QGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SKCP 68
           +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K  
Sbjct: 25  EGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGKHK 81

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARFY---- 115
            I+NL  +      +Y I+EY + G+    L   +P G         + + +  F     
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 116 -IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NGRI 166
             Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  V+         NGR+
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 202 ----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 42/215 (19%)

Query: 26  GNFGDIY---LVEEKQSHNTFVMKKVLREKMP----NTIERD--IMVKSKCPYIVNLFYS 76
           G FG +Y    + E +     V  KVLRE+        I  +  +M     P++V L   
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL-LG 76

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-------AQAVQYLHGL 129
               + V  I + +  G    LL+     Y+   K       L       A+ + YL   
Sbjct: 77  ICLSSQVQLITQLMPLG---CLLD-----YVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE---VLEWM 186
             VHRD+   N+L+    H+K+TDFG A           ++ V   EY A      ++WM
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLA----------KLLDVDEKEYHAEGGKVPIKWM 178

Query: 187 --EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
             E       YT   D+WS GV  +EL+T G+ P+
Sbjct: 179 ALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 42/231 (18%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTF-VMKKVLREKMPNTIERD------IMVK-SKC 67
           D   +  I +GNFG +     K+         K+L+E       RD      ++ K    
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGG---DFVT---LLENQP-----HGYLSESKAR--- 113
           P I+NL  + ++  ++Y  +EY   G   DF+    +LE  P     HG  S   ++   
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF----GSATQVDKN-GRIKS 168
            +  ++A  +QYL    ++HRD+   N+L+      K+ DF    G    V K  GR+  
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL-- 180

Query: 169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
             PV    ++A E L +         YT   D+WS GV+ +E+++ G TP+
Sbjct: 181 --PV---RWMAIESLNY-------SVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 56.2 bits (136), Expect = 6e-08
 Identities = 63/280 (22%), Positives = 118/280 (42%), Gaps = 36/280 (12%)

Query: 351  EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE 410
            E     +    Q+ Q   E KA  E L   R  +  L  + ++L++ L S    ++  E 
Sbjct: 779  EAEAEIEELEAQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESLERRIAATER 838

Query: 411  EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKEL 470
             ++ L +++ +   D+ + ++++      +EE+ SEL+   N   + +  L    +  EL
Sbjct: 839  RLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEALA--LLRSEL 896

Query: 471  EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSE 530
            E L  EL E +               +R+    EL++ + +   L+ +L  LE  +   +
Sbjct: 897  EELSEELRELE--------------SKRSELRRELEELREKLAQLELRLEGLEVRIDNLQ 942

Query: 531  EALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVRE---------MSGISE-KYEK 580
            E L+   +     L E +AL N IE  ++E  +   R+           ++ I E +  K
Sbjct: 943  ERLSEEYSLT---LEEAEALENKIEDDEEEARRRLKRLENKIKELGPVNLAAIEEYEELK 999

Query: 581  DRKTLLE-----LKSAKERLELEVRGYKLDLESTRRELET 615
            +R   L      L  AKE LE  +   ++D E+  R  +T
Sbjct: 1000 ERYDFLTAQKEDLTEAKETLEEAIE--EIDREARERFKDT 1037

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 12/133 (9%)

Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +  IMEYV  G   +L +  P   L+ ++   +  ++ + + YLH   Y+HRD+   N+L
Sbjct: 83  LQLIMEYVPLG---SLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVL 139

Query: 143 LSATGHLKLTDFGSATQVDKNGRIKSIVPVG-TPEY-VAPEVLEWMEGNHGSDGYTGSCD 200
           L     +K+ DFG A  V +      +   G +P +  A E L+  + ++ S       D
Sbjct: 140 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYAS-------D 192

Query: 201 LWSIGVVSYELLT 213
           +WS GV  YELLT
Sbjct: 193 VWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 47/224 (20%)

Query: 20  KRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLR----EKMPNTI--ERDIMVKSKCPYIV 71
           ++ I  G FG+++  +++        V  K L+    EK       E  IM +     I+
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-------AQAVQ 124
            L            I EY+  G            YL +    F  Y+L       A  ++
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGAL--------DKYLRDHDGEFSSYQLVGMLRGIAAGMK 121

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGRIKSIVPVGTP 175
           YL  + YVHRD+   N+L+++    K++DFG           T     G+I    P+   
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI----PI--- 174

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            + APE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 175 RWTAPEAIAYRK-------FTSASDVWSFGIVMWEVMSFGERPY 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584)

 Score = 55.9 bits (135), Expect = 7e-08
 Identities = 68/291 (23%), Positives = 123/291 (42%), Gaps = 38/291 (13%)

Query: 343 DSTLPPSS----EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDL 398
           D T+PP S    +D+ HW  D  Q L+ + +    +E L     ++L+L+ ++  L  +L
Sbjct: 214 DGTVPPKSRLNPQDVEHWIADI-QALRAIQKVAPEIEKLQEDFEQLLSLELRLQHLHGEL 272

Query: 399 TSHTSLLSKKEEEID----RLRQEMVKKESDLV----ATSSDLVATRHELEEVRSEL--- 447
            +    L++++EE      RLRQ++   E  L       + +L A   +L   RSEL   
Sbjct: 273 VADEERLAEEQEERQEAKNRLRQQLRTLEDQLKEARDELNQELSAANAKLAADRSELELL 332

Query: 448 -KEKENLEKTDDRKL------------EVCEVSKELEVLRG-------ELEEQKTATKQW 487
             +K   E  D  +L            E+ EV   L+ L G       + E  K   K+ 
Sbjct: 333 EDQKGAFEDADIEQLQADLDQLPSIRSELEEVEARLDALTGKHQDVQRKYERLKQKIKEQ 392

Query: 488 KKDWYQSVKERNAAVAELK--QAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLR 545
            +   +   ER AA+ E K  Q     E L+   + L Q+L+  +      +  L+ +L 
Sbjct: 393 LERDLEKNNERLAAIREEKDRQKAAIEEDLQALESQLRQQLEAGKLEFNEEEYELELRLG 452

Query: 546 EHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLE 596
             +   ++  +  +E+EQ  +    +    E+ E+    + +L+S   +L 
Sbjct: 453 RLKQRLDSATATPEELEQLEINDEALEKAQEEQEQAEANVEQLQSELRQLR 503

This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 54.7 bits (131), Expect = 8e-08
 Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 51/270 (18%)

Query: 23  IQQGNFGDIYLVEEKQSHNT--FVMKKVLREKMPNTIERDIMV--KSKCPYIVNL---FY 75
           + +G +G +Y  + K   +   + +K++    +  +  R+I +  + K P +++L   F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLE-------NQPHGYLSESKARFYIYELAQAVQYLHG 128
           S  D   V+ + +Y    D   +++       N+    L     +  +Y++   + YLH 
Sbjct: 69  SHAD-RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 129 LGYVHRDIKPDNMLLSAT----GHLKLTDFGSATQVDKNGRIKSIVP----VGTPEYVAP 180
              +HRD+KP N+L+       G +K+ D G A     N  +K +      V T  Y AP
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYRAP 184

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-------------STPFNYETLDMTY 227
           E+L       G+  YT + D+W+IG +  ELLT              S P++++ LD  +
Sbjct: 185 ELL------LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238

Query: 228 SSI---LACDTEDTVSFPSSIRLSTAMVNF 254
           + +      D ED    P     ST M +F
Sbjct: 239 NVMGFPADKDWEDIKKMPEH---STLMKDF 265

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 54.0 bits (130), Expect = 9e-08
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 46/247 (18%)

Query: 21  RFIQ---QGNFGDIYLVE----EKQSHNTFVMKKVLRE----KMPNTIERDIMVKSKC-- 67
           RF++   +G FG +Y  E     ++   T V  K L+E    K+     ++  + S    
Sbjct: 8   RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHG-------------YLSESKAR 113
           P IV L            + EY+  GD    L+ N PH               L  S   
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG--RI--KSI 169
               ++A  ++YL    +VHRD+   N L+     +K++DFG +  +      R+  KS+
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
           +PV    ++ PE +  + G      +T   D+WS GVV +E+ + G  P+    N E ++
Sbjct: 188 LPV---RWMPPEAI--LYGK-----FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237

Query: 225 MTYSSIL 231
           M  S  L
Sbjct: 238 MIRSRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 75/336 (22%), Positives = 135/336 (40%), Gaps = 53/336 (15%)

Query: 353 MRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEI 412
           +  +  +  ++ ++L E +     L      +  +  + S L +       L   +E+  
Sbjct: 454 LEEYTAELKRIEKELKEIEEKERKLRKELRELEKVLKKESELIKLKELAEQLKELEEKLK 513

Query: 413 DRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEV 472
               +E+ KK  +       L+  + E++ ++ EL++ E L+K   +  E+ +   ELE 
Sbjct: 514 KYNLEELEKKAEEYEKLKEKLIKLKGEIKSLKKELEKLEELKK---KLAELEKKLDELEE 570

Query: 473 LRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEA 532
              EL       K+ ++  ++SV+E    + EL+    E   LK      E+EL+  E+ 
Sbjct: 571 ELAELL------KELEELGFESVEELEERLKELEPFYNEYLELK----DAEKELEREEKE 620

Query: 533 LATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAK 592
           L   +  LD    E       +E ++KE+E+   +  E     E+YE+ R+  LEL    
Sbjct: 621 LKKLEEELDKAFEELAETEKRLEELRKELEELEKKYSE-----EEYEELREEYLELSREL 675

Query: 593 ERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIR 652
             L  E+      LE  R E++              LEK + EL    +  K+L+     
Sbjct: 676 AGLRAELEE----LEKRREEIKKT------------LEKLKEELEEREKAKKELE----- 714

Query: 653 LVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVS 688
                         KLEKA   +  +RE+ KK K  
Sbjct: 715 --------------KLEKALERVEELREKVKKYKAL 736

Length = 880

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 20/124 (16%)

Query: 94  DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD 153
           D  T L  +    L   +A     ++ + ++YLH    +HRD+K +N+ ++    + + D
Sbjct: 142 DLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGD 200

Query: 154 FGSATQVDKNGRIKSIVP-----VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVS 208
            G+A       +   + P      GT E  APEVL         D Y    D+WS G+V 
Sbjct: 201 LGAA-------QFPVVAPAFLGLAGTVETNAPEVL-------ARDKYNSKADIWSAGIVL 246

Query: 209 YELL 212
           +E+L
Sbjct: 247 FEML 250

Length = 357

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 33/109 (30%), Positives = 61/109 (55%), Gaps = 15/109 (13%)

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----RIKSIV 170
           + +++++ +QYL  +  VHRD+   N+L++    +K++DFG +  V +      R K  +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           PV   +++A E L     +H    YT   D+WS GV+ +E++T G  P+
Sbjct: 192 PV---KWMAIESL----FDH---IYTTQSDVWSFGVLLWEIVTLGGNPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 42/225 (18%)

Query: 22  FIQQGNFGD-IYLVEEKQSHNTFVMKKVLREKMPNTIERDIM--VKSKC-----PYIVNL 73
            I +GNFG  +    +K         K ++E       RD    ++  C     P I+NL
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVT------LLENQP-----HGYLSESKAR---FYIYEL 119
             + +   ++Y  +EY   G+ +       +LE  P     +   S   ++    +  ++
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF----GSATQVDKN-GRIKSIVPVGT 174
           A+ + YL    ++HRD+   N+L+      K+ DF    G    V K  GR+    PV  
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL----PV-- 175

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
             ++A E L +         YT + D+WS GV+ +E+++ G TP+
Sbjct: 176 -RWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 48/219 (21%), Positives = 99/219 (45%), Gaps = 19/219 (8%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT---IERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 66  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +  +  +       +  P+   ++ APE L +   
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 179

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMT 226
               + ++   D+W+ GV+ +E+ T G +P  Y  +D++
Sbjct: 180 ----NKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLS 212

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 46/229 (20%)

Query: 20  KRFIQQGNFGDIYLVEEKQSHN---------------TFVMKKVLREKMPNTIERD---- 60
           K  + +G FG+++L E +                     V  K+LRE        D    
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 61  --IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESKARFYIY 117
             IM + K P I+ L       + +  I EY+  GD    L  ++P     ++      Y
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 118 --------ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG--RI- 166
                   ++A  ++YL  L +VHRD+   N L+     +K+ DFG +  +      RI 
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 167 -KSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++++P+            WM       G +T + D+W+ GV  +E+LT
Sbjct: 190 GRAVLPI-----------RWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 45/205 (21%), Positives = 90/205 (43%), Gaps = 13/205 (6%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLF- 74
           +  + + I +G FGD+ L + + +       K          E  +M + +   +V L  
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
              ++   +Y + EY+  G  V  L ++    L       +  ++ +A++YL    +VHR
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           D+   N+L+S     K++DFG   +     +    +PV   ++ APE L           
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPV---KWTAPEALR-------EKK 175

Query: 195 YTGSCDLWSIGVVSYELLT-GSTPF 218
           ++   D+WS G++ +E+ + G  P+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 50/230 (21%)

Query: 25  QGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDIM-------VKSKCPYIV 71
           +G FG +   E       +      V  K+L++   +    D++       +  K   I+
Sbjct: 22  EGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNII 81

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ--------------PHGYLSESKARFYIY 117
           NL         +Y I+EY   G+    L  +              P   LS        Y
Sbjct: 82  NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NGRIKSI 169
           ++A+ ++YL     +HRD+   N+L++    +K+ DFG A  V          NGR+   
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL--- 198

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            PV   +++APE L           YT   D+WS G++ +E+ T G +P+
Sbjct: 199 -PV---KWMAPEAL-------FDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 50/230 (21%)

Query: 25  QGNFGDIYLVE------EKQSHNTFVMKKVLR-----EKMPNTIERDIMVK--SKCPYIV 71
           +G FG + + E      EK +  T V  K+L+     + + + I    M+K   K   I+
Sbjct: 28  EGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII 87

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ--------------PHGYLSESKARFYIY 117
           NL  +      +Y I+EY + G+    L  +              P   LS        Y
Sbjct: 88  NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY 147

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--------DKNGRIKSI 169
           ++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NGR+   
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--- 204

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 205 -PV---KWMAPEAL-------FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 27/216 (12%)

Query: 19  IKRFIQQGNFGDIYLVEEKQ--SHNTFVMKKVLREKMPNTIERD------IMVKSKCPYI 70
           I+  I  G FG++     K       FV  K L+        RD      IM +   P I
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           ++L         V  I E++  G   + L  Q  G  +  +    +  +A  ++YL  + 
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-------GRIKSIVPVGTPEYVAPEVL 183
           YVHRD+   N+L+++    K++DFG +  ++ +         +   +P+    + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI---RWTAPEAI 183

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 184 AYRK-------FTSASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional

 Score = 54.3 bits (131), Expect = 2e-07
 Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 31/284 (10%)

Query: 403 SLLSKKEEEIDRLRQEMVKKES-DLVATSSDLVATRHELEEVRSELKEKE-NLEKTDDRK 460
            +LS +   +D+L+ ++ +KE  DL    + L     EL E+  E++  E   E+  + +
Sbjct: 180 RVLSDQRGSLDQLKAQIEEKEEKDLHERLNGL---ESELAELDEEIERYEEQREQARETR 236

Query: 461 LEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLT 520
            E  EV +E E  R ELE  +   +  ++   ++ +ER     E++  +   E L+E+  
Sbjct: 237 DEADEVLEEHEERREELETLEAEIEDLRETIAETEREREELAEEVRDLRERLEELEEERD 296

Query: 521 SLEQELKV---SEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEK 577
            L  E  +     EA+   +  L+ +           E ++  +E+  V  +  +  +E 
Sbjct: 297 DLLAEAGLDDADAEAVEARREELEDR----------DEELRDRLEECRVAAQAHNEEAES 346

Query: 578 YEKDRKTL----LELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELR-----AKSK 628
             +D   L     EL+     LE E+   +  +E  R E+E  +++  ELR     A   
Sbjct: 347 LREDADDLEERAEELREEAAELESELEEAREAVEDRREEIEELEEEIEELRERFGDAPVD 406

Query: 629 LEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAE 672
           L  AE  L  +REE  +L++        L    + A+ ++E+AE
Sbjct: 407 LGNAEDFLEELREERDELRER----EAELEATLRTARERVEEAE 446

Length = 880

>gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional

 Score = 53.9 bits (130), Expect = 3e-07
 Identities = 92/407 (22%), Positives = 185/407 (45%), Gaps = 42/407 (10%)

Query: 405 LSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEK--TDDRKLE 462
           L +KEE ++ L++++ + E  L     +L       EE +++ +E E L+K  T     +
Sbjct: 333 LEEKEERLEELKKKLKELEKRL----EELEERHELYEEAKAKKEELERLKKRLTGLTPEK 388

Query: 463 VCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQ----------TEN 512
           + +  +ELE  + E+EE+ +       +  + +KE   A+ ELK+A+          TE 
Sbjct: 389 LEKELEELEKAKEEIEEEISKITARIGELKKEIKELKKAIEELKKAKGKCPVCGRELTEE 448

Query: 513 EAL------KEKLTSLEQELKVSEEALATAQNSL---------DSKLREHQALSNTIESM 557
                      +L  +E+ELK  EE     +  L         +S+L + + L+  ++ +
Sbjct: 449 HRKELLEEYTAELKRIEKELKEIEEKERKLRKELRELEKVLKKESELIKLKELAEQLKEL 508

Query: 558 QKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNK 617
           ++++++    + E+   +E+YEK ++ L++LK   + L+ E+   + +L+    ELE   
Sbjct: 509 EEKLKK--YNLEELEKKAEEYEKLKEKLIKLKGEIKSLKKELEKLE-ELKKKLAELEKKL 565

Query: 618 DQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTT 677
           D+  E  A+   E  E    +V E  ++LK+  +   Y+ + + + A+ +LE+ E EL  
Sbjct: 566 DELEEELAELLKELEELGFESVEELEERLKE--LEPFYNEYLELKDAEKELEREEKELKK 623

Query: 678 VREENKKL-----KVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIG 732
           + EE  K      +           L  L+        E+L+  Y E   +L      + 
Sbjct: 624 LEEELDKAFEELAETEKRLEELRKELEELEKKYSEEEYEELREEYLELSRELAGLRAELE 683

Query: 733 EYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKK 779
           E E +   ++ T+ + +   +E  +  + L+K    L    E+LR+K
Sbjct: 684 ELEKRREEIKKTLEKLKEELEEREKAKKELEKLEKALE-RVEELREK 729

Length = 880

>gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional

 Score = 53.5 bits (129), Expect = 3e-07
 Identities = 59/282 (20%), Positives = 107/282 (37%), Gaps = 48/282 (17%)

Query: 349 SSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKK 408
             E++  ++  R Q  +   EA   LE+    R  +  L+A++  L++ +        ++
Sbjct: 218 LDEEIERYEEQREQARETRDEADEVLEEHEERREELETLEAEIEDLRETIAETE---RER 274

Query: 409 EEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLE--VCEV 466
           EE  + +R               DL     ELEE R +L  +  L+  D   +E    E+
Sbjct: 275 EELAEEVR---------------DLRERLEELEEERDDLLAEAGLDDADAEAVEARREEL 319

Query: 467 SKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQEL 526
               E LR  LEE + A +   ++      E     A     +   E L+E+   LE EL
Sbjct: 320 EDRDEELRDRLEECRVAAQAHNEE-----AESLREDA--DDLEERAEELREEAAELESEL 372

Query: 527 KVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLL 586
           + + EA+   +  ++        L   IE +++    + V +       E          
Sbjct: 373 EEAREAVEDRREEIE-------ELEEEIEELRERFGDAPVDLGNAEDFLE---------- 415

Query: 587 ELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSK 628
           EL+  ++ L    R  + +LE+T R      ++   L    K
Sbjct: 416 ELREERDEL----REREAELEATLRTARERVEEAEALLEAGK 453

Length = 880

>gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning]

 Score = 53.6 bits (129), Expect = 3e-07
 Identities = 55/284 (19%), Positives = 103/284 (36%), Gaps = 32/284 (11%)

Query: 376 DLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVA 435
            LS +   VLA     ++  + L      ++  E++I   + +  K E  L +  +++ +
Sbjct: 21  LLSAA---VLAAAFSAAADDKQLKQIQKEIAALEKKIREQQDQRAKLEKQLKSLETEIAS 77

Query: 436 TRHELEEVRSELKEKE-NLEKTDDR--KLEVCEVSKELEVLRGELEEQKTATKQWKKDWY 492
              +L E   +LK+    +   + R   LEV E  +     R  L EQ  A ++  ++  
Sbjct: 78  LEAQLIETADDLKKLRKQIADLNARLNALEVQEREQ-----RRRLAEQLAALQRSGRNPP 132

Query: 493 ----QSVKERNAAVAELKQAQTENEALKEKLTSLEQ---ELKVSEEALATAQNSLDSKLR 545
                S ++   +V         N A  E++ +L+    +L      +A  Q  L + L 
Sbjct: 133 PALLVSPEDAQRSVRLAIYYGALNPARAERIDALKATLKQLAAVRAEIAAEQAELTTLLS 192

Query: 546 EH----QALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRG 601
           E       L+  +E  +K + Q                 D+K L EL++ + RL+ E+  
Sbjct: 193 EQRAQQAKLAQLLEERKKTLAQLNSE----------LSADQKKLEELRANESRLKNEIAS 242

Query: 602 YKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKK 645
            +      R      +      RA       E    T  E+   
Sbjct: 243 AEAAAAKAREAAAAAEAAAARARAAEAKRTGETYKPTAPEKMLI 286

Length = 420

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 17/110 (15%)

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD----------- 227

Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 38/225 (16%)

Query: 15  SDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIV 71
           ++F   + +  G FG +Y    + E +     V  K LRE       ++I+ ++   Y++
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA---YVM 63

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARF-------YIYELA 120
               +  D  HV  ++          + +  P G    Y+ E K          +  ++A
Sbjct: 64  ----ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI----VPVGTPE 176
           + + YL     VHRD+   N+L+    H+K+TDFG A  +  + +        VP+   +
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI---K 176

Query: 177 YVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
           ++A E +L  +        YT   D+WS GV  +EL+T GS P++
Sbjct: 177 WMALESILHRI--------YTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 61/243 (25%), Positives = 108/243 (44%), Gaps = 50/243 (20%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI---- 61
           +S +   + + + +G FG + + E      +K +    V  K+L++   +    D+    
Sbjct: 9   LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEM 68

Query: 62  -MVK--SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSE 109
            M+K   K   I+NL  +      +Y ++EY + G+    L   +P G         L E
Sbjct: 69  EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128

Query: 110 SKARFY-----IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-- 162
            +  F       Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  V    
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188

Query: 163 ------NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GS 215
                 NGR+    PV   +++APE L           YT   D+WS GV+ +E+ T G 
Sbjct: 189 YYKKTTNGRL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLLWEIFTLGG 234

Query: 216 TPF 218
           +P+
Sbjct: 235 SPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 49/229 (21%), Positives = 93/229 (40%), Gaps = 41/229 (17%)

Query: 23  IQQGNFGDI---YLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLF 74
           +  GNFG +     + +        +K + +E +         E  +M +   P IV L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 75  -YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
                +   +  +ME    G  +  L+ +    +  S  +   +++A  + YL    +VH
Sbjct: 63  GVCKGEP--LMLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLESKHFVH 118

Query: 134 RDIKPDNMLLSATGHLKLTDFG--SATQVDKN-------GRIKSIVPVGTPEYVAPEVLE 184
           RD+   N+LL      K++DFG   A     +       GR     P+   ++ APE + 
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW----PL---KWYAPECIN 171

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILA 232
           + + +  S       D+WS GV  +E  + G+ P+     +M  + ++A
Sbjct: 172 YGKFSSKS-------DVWSYGVTLWEAFSYGAKPYG----EMKGAEVIA 209

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.0 bits (124), Expect = 7e-07
 Identities = 23/58 (39%), Positives = 34/58 (58%)

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           LH +G VHRDIKP+N+L++  G +K+ DFG+A  +        +  +  P Y  PE L
Sbjct: 325 LHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 50.7 bits (121), Expect = 9e-07
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 31/209 (14%)

Query: 26  GNFG----DIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPYIVNLFY 75
           GNFG     +Y + +KQ     V  KVL+ +   ++      E +IM +   PYIV +  
Sbjct: 6   GNFGCVKKGVYKMRKKQID---VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
             +    +  +ME  +GG     L  +       +     +++++  ++YL G  +VHRD
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYLEGKNFVHRD 120

Query: 136 IKPDNMLLSATGHLKLTDFG--SATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           +   N+LL    + K++DFG   A   D +    R     P+   ++ APE + + +   
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPL---KWYAPECINFRK--- 174

Query: 191 GSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               ++   D+WS G+  +E  + G  P+
Sbjct: 175 ----FSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 52.0 bits (125), Expect = 1e-06
 Identities = 63/280 (22%), Positives = 115/280 (41%), Gaps = 34/280 (12%)

Query: 503 AELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEME 562
           AEL++ +   E LK +L+SL+ EL+  E  L      L    R+   +   IE +++E E
Sbjct: 674 AELQRLRERLEGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQLEQEEE 733

Query: 563 QSAVRV----REMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKD 618
           +   R+     ++S + ++ E  +  L EL++  E LE ++   +  L      L     
Sbjct: 734 KLKERLEELEEDLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARL----- 788

Query: 619 QTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTV 678
                 + S++ + + EL+ + EE  ++ + ++R +          +  LEK   EL   
Sbjct: 789 ------SHSRIPEIQAELSKLEEEVSRI-EARLREIEQKLNRLTLEKEYLEKEIQELQEQ 841

Query: 679 REENKKLKVSFFFTLESNSLFWLDPNTFL-----------SSLEDLKSNYTERESKLRSA 727
           R + K+   S    +E+ +    +    L           S L DLK    E E++LR  
Sbjct: 842 RIDLKEQIKSIEKEIENLNGKKEELEEELEELEAALRDLESRLGDLKKERDELEAQLREL 901

Query: 728 NEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNND 767
              I E E +I      +        E+   LE L++   
Sbjct: 902 ERKIEELEAQIEKKRKRL-------SELKAKLEALEEELS 934

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional

 Score = 52.0 bits (125), Expect = 1e-06
 Identities = 92/428 (21%), Positives = 154/428 (35%), Gaps = 80/428 (18%)

Query: 361 LQLLQQLAEAKASLED-LSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEM 419
               ++L +    L D L   R    A   +  SL++D           EE  + LR+E 
Sbjct: 313 EARREELEDRDEELRDRLEECRVAAQAHNEEAESLREDADDL-------EERAEELREEA 365

Query: 420 VKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEE 479
            + ES+L      +   R E+EE+  E++E    E+  D  +++      LE LR E +E
Sbjct: 366 AELESELEEAREAVEDRREEIEELEEEIEELR--ERFGDAPVDLGNAEDFLEELREERDE 423

Query: 480 QKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKE--KLTSLEQELKVS-------- 529
            +           +   E  A +   ++   E EAL E  K     Q ++ S        
Sbjct: 424 LR-----------EREAELEATLRTARERVEEAEALLEAGKCPECGQPVEGSPHVETIEE 472

Query: 530 -EEALATAQNSLDSKLREHQALSNTIESMQ--KEMEQSAVRVREMSGISEKYEKDRKTLL 586
             E +   +  L+    E + +   +E  +   E E    R+ E     E+   +R+  +
Sbjct: 473 DRERVEELEAELEDLEEEVEEVEERLERAEDLVEAEDRIERLEERREDLEELIAERRETI 532

Query: 587 ELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKL 646
           E K   ER E E+R    +LE+   E         E  A+   E+   EL +   E K+ 
Sbjct: 533 EEKR--ERAE-ELRERAAELEAEAEEKR-EAAAEAEEEAEEAREEV-AELNSKLAELKER 587

Query: 647 KQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTF 706
            +   R+   L        + +  AE E+  +RE+                         
Sbjct: 588 IESLERIRTLL--------AAIADAEDEIERLREK------------------------- 614

Query: 707 LSSLEDLKSNYTERESKLRSANEIIGEYETK-----ITALESTMTRSESYCKEMVEYLET 761
               E L     ER  +L    E   E E +     I        R+E Y +++ E L+ 
Sbjct: 615 ---REALAELNDERRERLAEKRERKRELEAEFDEARIEEAREDKERAEEYLEQVEEKLDE 671

Query: 762 LQKNNDIL 769
           L++  D L
Sbjct: 672 LREERDDL 679

Length = 880

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 17/110 (15%)

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD----------- 232

Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 26/133 (19%)

Query: 103 PHG----YLSESKARF-------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL 151
           P+G    Y+ E+K R        +  ++A+ + YL  +  VHRD+   N+L+ +  H+K+
Sbjct: 91  PYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKI 150

Query: 152 TDFGSATQVDKNGRIKSIVPVGTPEYVA---PEVLEWME-GNHGSDGYTGSCDLWSIGVV 207
           TDFG A  +D          +   EY A      ++WM   +     +T   D+WS GV 
Sbjct: 151 TDFGLARLLD----------IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVT 200

Query: 208 SYELLT-GSTPFN 219
            +EL+T G+ P++
Sbjct: 201 VWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 49/217 (22%), Positives = 97/217 (44%), Gaps = 31/217 (14%)

Query: 23  IQQGNFGDIYLVEEK----QSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPYIVN 72
           + +G FG+++L + K    +   T V+ K L++     +      E D+  K     +V 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYLSE-----SKARFYI-YELAQAVQY 125
           L    ++    Y I+EY   GD    L   +      +     +K +  +  ++A  + +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK---SIVPVGTPEYVAPEV 182
           L    +VHRD+   N L+S+   +K++    +  V  +   K   +++P+    ++APE 
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL---RWLAPEA 189

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           ++        D ++   D+WS GV+ +E+ T G  PF
Sbjct: 190 VQ-------EDDFSTKSDVWSFGVLMWEVFTQGELPF 219

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.5 bits (120), Expect = 2e-06
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 30/215 (13%)

Query: 21  RFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSF 77
           + +  G FG +Y    V E ++    V  K+L E        + M ++       L  + 
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA-------LIMAS 65

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARF-------YIYELAQAVQYL 126
            D  H+  ++          + +  PHG    Y+ E K          +  ++A+ + YL
Sbjct: 66  MDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP-EYVAPEVLEW 185
                VHRD+   N+L+ +  H+K+TDFG A  ++ + +  +      P +++A E + +
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
            +  H S       D+WS GV  +EL+T G  P++
Sbjct: 186 RKFTHQS-------DVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 62/255 (24%), Positives = 104/255 (40%), Gaps = 43/255 (16%)

Query: 15  SDFDIKRFIQQGNFGDIYLVE-EKQSHNTFVMKKVLREKMPNTIERDIM--VKSKC---- 67
           +D   +  I +GNFG +     +K         K ++E       RD    ++  C    
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 68  -PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
            P I+NL  + +   ++Y  +EY   G+ +  L               N     LS  + 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVP 171
             +  ++A+ + YL    ++HRD+   N+L+      K+ DFG S  Q     +    +P
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN-------YETL 223
           V    ++A E L +         YT + D+WS GV+ +E+++ G TP+        YE L
Sbjct: 187 V---RWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236

Query: 224 DMTY--SSILACDTE 236
              Y     L CD E
Sbjct: 237 PQGYRLEKPLNCDDE 251

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 39/165 (23%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           N +  + EY++ G   + L     G L   +    +  LA  ++YL  +GYVH+ +    
Sbjct: 79  NTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHK 137

Query: 141 MLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE-YVAPEVLEWMEGNHGSDGYTGSC 199
           +L+++    K++ F    Q DK+  I + +   +P  + APE +++         ++ + 
Sbjct: 138 VLVNSDLVCKISGFRRL-QEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-------FSSAS 189

Query: 200 DLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           D+WS G+V +E+++ G  P+     DM+   ++    ED    P+
Sbjct: 190 DVWSFGIVMWEVMSYGERPY----WDMSGQDVIKA-VEDGFRLPA 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 54/231 (23%)

Query: 25  QGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERDI--------MVKS--KCPYI 70
           +G FG +   E    +  +  + V  K+L++   +  E+D+        M+K   K   I
Sbjct: 22  EGAFGQVVKAEAVGLDNPNETSTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHG-YLSESKARFYI------------ 116
           +NL         +Y ++EY   G+    L   +P G Y S    R               
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NGRIKS 168
           Y++A+ +++L     +HRD+   N+L++    +K+ DFG A  +          NGR+  
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL-- 196

Query: 169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
             PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 197 --PV---KWMAPEALF-------DRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail

 Score = 50.8 bits (122), Expect = 3e-06
 Identities = 102/457 (22%), Positives = 175/457 (38%), Gaps = 67/457 (14%)

Query: 358 RDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQ 417
           + + QL  QL EAK SLE+ S  R R   LQAQ+  L+ DL S    L ++ E    L +
Sbjct: 236 KLKSQLESQLEEAKRSLEEES--RER-ANLQAQLRQLEHDLDSLREQLEEESEAKAELER 292

Query: 418 EMVKKESDLVATSS----DLVATRHELEEVR-------SELKEK--------ENLEKTDD 458
           ++ K  +++    S    +      ELEE++       SEL+E         ++LEKT  
Sbjct: 293 QLSKANAEIQQWRSKFESEGALRAEELEELKKKLNQKISELEEAAEAANAKCDSLEKTKS 352

Query: 459 R-KLEVCEVSKELEVLRGELEE----QKTATKQ---WKKDWYQSVKERNAAVAELKQAQT 510
           R + E+ ++  ELE       E    QK   K    WK+   +   E + A  E +   T
Sbjct: 353 RLQSELEDLQIELERANAAASELEKKQKNFDKILAEWKRKVDELQAELDTAQREARNLST 412

Query: 511 EN-------EALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQ 563
           E        E LK+++ +L +E K  ++ +    + L    R        +  ++K   +
Sbjct: 413 ELFRLKNELEELKDQVEALRRENKNLQDEIHDLTDQLGEGGR-------NVHELEKARRR 465

Query: 564 SAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIEL 623
                 E+    E+ E   +     +S   R ++E+   + ++E  RR  E  K++  E 
Sbjct: 466 LEAEKDELQAALEEAEAALE---LEESKVLRAQVELSQIRSEIE--RRLAE--KEEEFEN 518

Query: 624 RAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENK 683
             K+  ++A   L    E   K K    RL           + KLE    EL    +   
Sbjct: 519 TRKN-HQRAIESLQATLEAEAKGKAEASRL-----------KKKLEGDINELEIALDHAN 566

Query: 684 KLKVSFFFTLESNSLFWLDPNTFLS----SLEDLKSNYTERESKLRSANEIIGEYETKIT 739
           K        ++       +  T +     + ED +      E +  +    + E  + + 
Sbjct: 567 KANAEAQKNVKKYQQQVKELQTQVEEEQRAREDAREQLAVAERRATALEAELEELRSALE 626

Query: 740 ALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQL 776
             E    ++E+   E  E +  L   N  L     +L
Sbjct: 627 QAERARKQAETELAEASERVNELTAQNSSLIAQKRKL 663

The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 38/166 (22%), Positives = 73/166 (43%), Gaps = 9/166 (5%)

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E  +M+K   P +V L+    + + +  + E++  G     L  Q  G  S+        
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCL 107

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           ++ + + YL     +HRD+   N L+     +K++DFG    V  +    S       ++
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKW 167

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYET 222
            +PEV  + +       Y+   D+WS GV+ +E+ + G TP+   +
Sbjct: 168 SSPEVFSFSK-------YSSKSDVWSFGVLMWEVFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 17/110 (15%)

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD----------- 226

Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 25/210 (11%)

Query: 23  IQQGNFGDIYLVEEKQSHNTF--VMKKVLR-EKMPNTI-----ERDIMVKSKCPYIVNLF 74
           +  G+FG +   E   S      V  K L+ +K+ + +     E  IM       ++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL- 61

Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
           Y     + +  + E    G  +  L     G+   S    Y  ++A  ++YL    ++HR
Sbjct: 62  YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR 121

Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI-----VPVGTPEYVAPEVLEWMEGN 189
           D+   N+LL++   +K+ DFG    + +N     +     VP     + APE L     +
Sbjct: 122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA---WCAPESLRTRTFS 178

Query: 190 HGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           H S       D+W  GV  +E+ T G  P+
Sbjct: 179 HAS-------DVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain

 Score = 50.7 bits (121), Expect = 3e-06
 Identities = 59/346 (17%), Positives = 120/346 (34%), Gaps = 38/346 (10%)

Query: 437 RHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVK 496
           R E+EE  +  +EK   ++   + +E  E   EL +   EL+ Q+      K        
Sbjct: 156 RLEIEEEAAGSREKRKKKERLKKLIEETENLAELIIDLEELKLQEL-----KLKEQAKKA 210

Query: 497 ERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIES 556
                + E  + + EN    + L   E+ + + +E L   Q  ++S  +E +     +  
Sbjct: 211 LEYYQLKEKLELEEENLLYLDYLKLNEERIDLLQELLRDEQEEIESSKQELEKEEEILAQ 270

Query: 557 MQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETN 616
           + KE ++     +      +   K+ + L       ER +++      + E   ++LE  
Sbjct: 271 VLKENKEEEKEKKLQEEELKLLAKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKE 330

Query: 617 KDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELT 676
             +  E   + + E  E E+    EE ++                     +LEK + +L 
Sbjct: 331 LKKEKEEIEELEKELKELEIKREAEEEEE--------------------EQLEKLQEKLE 370

Query: 677 TVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYET 736
            + EE    K              L+     S+ +  +     +  + + A  ++   E 
Sbjct: 371 QLEEELLAKKK-------------LESERLSSAAKLKEEELELKNEEEKEAKLLLELSEQ 417

Query: 737 KITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNND 782
           +   L+          +E+ E LET Q        + E+   K   
Sbjct: 418 EEDLLKEEKKEELKIVEELEESLETKQGKLTEEKEELEKQALKLLK 463

This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 30/145 (20%)

Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVH 133
           N +  IME++  G   +L E     YL  +K +        Y  ++ + + YL    YVH
Sbjct: 81  NGIKLIMEFLPSG---SLKE-----YLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVH 132

Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI-----VPVGTPEYVAPEVLEWMEG 188
           RD+   N+L+ +   +K+ DFG    ++ +    ++      PV    + APE L     
Sbjct: 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF---WYAPECL----- 184

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT 213
              S  Y  S D+WS GV  YELLT
Sbjct: 185 -IQSKFYIAS-DVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 50.4 bits (121), Expect = 4e-06
 Identities = 50/276 (18%), Positives = 102/276 (36%), Gaps = 13/276 (4%)

Query: 492 YQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALS 551
                + N+++ E ++   E E   E+L     EL+ +   L      L+ +L + +   
Sbjct: 662 TGGSAKTNSSILERRREIEELEEKIEELEEKIAELEKALAELRKELEELEEELEQLRKEL 721

Query: 552 NTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRR 611
             +      + +   R+        + E+  + + +L      LE E+   +  LE    
Sbjct: 722 EELSRQISALRKDLARLE------AEVEQLEERIAQLSKELTELEAEIEELEERLEEAEE 775

Query: 612 ELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKA 671
           EL   + +  EL A  ++E+ + EL  +RE   +L + ++ L+     + +     LE+ 
Sbjct: 776 ELAEAEAEIEELEA--QIEQLKEELKALREALDEL-RAELTLLNEEAANLRERLESLERR 832

Query: 672 EGELTTVREENKKLKVSFFFTLESNSL----FWLDPNTFLSSLEDLKSNYTERESKLRSA 727
                   E+ ++        +ES +              S LE L +     E  L   
Sbjct: 833 IAATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEALALL 892

Query: 728 NEIIGEYETKITALESTMTRSESYCKEMVEYLETLQ 763
              + E   ++  LES  +      +E+ E L  L+
Sbjct: 893 RSELEELSEELRELESKRSELRRELEELREKLAQLE 928

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 34/204 (16%)

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHG----------- 105
           E  +M +   P IV L         V  + EY+  GD    L+   PH            
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 106 ---YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK 162
               L          ++A  ++YL    +VH+D+   N+L+    H+K++D G + ++  
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 163 NG----RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTP 217
                 + KS++P+    ++ PE +  M G   SD      D+WS GVV +E+ + G  P
Sbjct: 177 ADYYRVQPKSLLPI---RWMPPEAI--MYGKFSSDS-----DIWSFGVVLWEIFSFGLQP 226

Query: 218 F----NYETLDMTYSSILACDTED 237
           +    N E ++M     L   +ED
Sbjct: 227 YYGFSNQEVIEMVRKRQLLPCSED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional

 Score = 49.3 bits (118), Expect = 7e-06
 Identities = 53/262 (20%), Positives = 102/262 (38%), Gaps = 29/262 (11%)

Query: 367 LAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDL 426
           + E     EDL  +  R+  L+ +   L++ +      + +K E  + LR+   + E++ 
Sbjct: 494 VEERLERAEDLVEAEDRIERLEERREDLEELIAERRETIEEKRERAEELRERAAELEAEA 553

Query: 427 VATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQ 486
                       E EE R E+ E  +       ++E  E  + L     + E++    ++
Sbjct: 554 EEKREAAAEAEEEAEEAREEVAELNSKLAELKERIESLERIRTLLAAIADAEDEIERLRE 613

Query: 487 WKKDWYQSVKERNAAVAELKQ--AQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKL 544
            ++   +   ER   +AE ++   + E E  + ++    ++ + +EE L   +  LD   
Sbjct: 614 KREALAELNDERRERLAEKRERKRELEAEFDEARIEEAREDKERAEEYLEQVEEKLDELR 673

Query: 545 REHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLE-LEVRGYK 603
            E   L   I +++ E+E                        EL+  +ER E LE R   
Sbjct: 674 EERDDLQAEIGAVENELE------------------------ELEELRERREALENR--V 707

Query: 604 LDLESTRRELETNKDQTIELRA 625
             LE+   E E  +    +LRA
Sbjct: 708 EALEALYDEAEELESMYGDLRA 729

Length = 880

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.4 bits (115), Expect = 7e-06
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 49/231 (21%)

Query: 19  IKRFIQQGNFGDIYLVE-------------EKQSHNTFVMKKVLREKMPNTIERD----- 60
           +K  + +G FG+++L E             E       V  K+LR  +  T   D     
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 61  -IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF------------VTLLENQPHGYL 107
            IM + K P I+ L       + +  I EY+  GD              T   N P   +
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS--V 126

Query: 108 SESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG--R 165
           S +   +   ++A  ++YL  L +VHRD+   N L+     +K+ DFG +  +      R
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 166 I--KSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
           I  ++++P+            WM       G +T + D+W+ GV  +E+ T
Sbjct: 187 IQGRAVLPI-----------RWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair]

 Score = 49.4 bits (118), Expect = 8e-06
 Identities = 62/303 (20%), Positives = 123/303 (40%), Gaps = 35/303 (11%)

Query: 355 HWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDR 414
           H K        +L E +  L            ++     L++       LL  +E   + 
Sbjct: 471 HEKELLELYELELEELEEELSREKEEAELREEIEELEKELRELEEELIELLELEEALKEE 530

Query: 415 LRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKE----NLEKTDDRKLEVCEVSKEL 470
           L +++ +K  +L+    + +  + +L++++ EL++ E     L++  +    +    +EL
Sbjct: 531 LEEKL-EKLENLLEEL-EELKEKLQLQQLKEELRQLEDRLQELKELLEELRLLRTRKEEL 588

Query: 471 EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSE 530
           E LR   E  K   K+ K+     ++ER + + EL Q+   +EA        E EL+ +E
Sbjct: 589 EELR---ERLKELKKKLKE-----LEERLSQLEELLQSLELSEA--------ENELEEAE 632

Query: 531 EALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKS 590
           E L +       KL     L   +++  +E+E+    +        +  ++ + L E   
Sbjct: 633 EELESELE----KLNLQAELEELLQAALEELEEKVEELEAEIRRELQRIENEEQLEEKLE 688

Query: 591 AKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGK 650
             E+LE E       LE  R ELE    +      +  +E+ E     + E  K+L++ +
Sbjct: 689 ELEQLEEE-------LEQLREELEELLKK--LGEIEQLIEELESRKAELEELKKELEKLE 739

Query: 651 IRL 653
             L
Sbjct: 740 KAL 742

Length = 908

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.9 bits (116), Expect = 8e-06
 Identities = 34/118 (28%), Positives = 64/118 (54%), Gaps = 15/118 (12%)

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKN--GRIKSIV 170
           + Y++A+ +++L     VHRD+   N+LL+    +K+ DFG A  +  D N   +  + +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTY 227
           PV   +++APE +         + YT   D+WS G++ +E+ + G TP+    +D T+
Sbjct: 302 PV---KWMAPESI-------FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

 Score = 48.8 bits (116), Expect = 8e-06
 Identities = 29/102 (28%), Positives = 47/102 (46%), Gaps = 5/102 (4%)

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
            LA A   LH  G+V  D+  ++ L+S    + L D  S  Q++ NG +  + PVG  E+
Sbjct: 125 NLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS-FQINANGTL-HLCPVGVSEF 182

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGST-PF 218
             PE+             T + D + + V+ + LL G   P+
Sbjct: 183 TPPELQTLPSFVGF--ERTANHDNFGLAVLIFHLLFGGRHPY 222

Length = 637

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 34/117 (29%), Positives = 65/117 (55%), Gaps = 18/117 (15%)

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV-DK-----NGRIKSIVP 171
           ++A+ ++YL    +VHRD+   N +L  +  +K+ DFG A  + DK     +    + +P
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           V   +++A E L+       +  +T   D+WS GV+ +EL+T G+ P+ + ++ D+T
Sbjct: 166 V---KWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|130902 TIGR01843, type_I_hlyD, type I secretion membrane fusion protein, HlyD family

 Score = 48.5 bits (116), Expect = 9e-06
 Identities = 45/232 (19%), Positives = 91/232 (39%), Gaps = 52/232 (22%)

Query: 423 ESDLVATSSDLVATRHELEEVRSELKEKENLEKTDD-RKLEVCEVSKELEVLRGELEEQK 481
           E+D     S ++    E+  +R+E   +  +E  DD    E   V + ++  +   E +K
Sbjct: 80  EADAAELESQVLRLEAEVARLRAEADSQAAIEFPDDLLSAEDPAVPELIKGQQSLFESRK 139

Query: 482 TATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLD 541
           +          ++  +    +A++KQ + E   L+ +L +L Q+L+V  E          
Sbjct: 140 ST--------LRA--QLELILAQIKQLEAELAGLQAQLQALRQQLEVISE---------- 179

Query: 542 SKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRG 601
                       +E+ +K  E+  V               R  LLEL+  +   + E+  
Sbjct: 180 -----------ELEARRKLKEKGLVS--------------RLELLELERERAEAQGELGR 214

Query: 602 YKLDLESTRRELE------TNKDQTIELRAKSKLEKAEGELTTVREENKKLK 647
            + +LE  +R+++         +QT       +L +A+  L  +RE   K +
Sbjct: 215 LEAELEVLKRQIDELQLERQQIEQTFREEVLEELTEAQARLAELRERLNKAR 266

Type I secretion is an ABC transport process that exports proteins, without cleavage of any signal sequence, from the cytosol to extracellular medium across both inner and outer membranes. The secretion signal is found in the C-terminus of the transported protein. This model represents the adaptor protein between the ATP-binding cassette (ABC) protein of the inner membrane and the outer membrane protein, and is called the membrane fusion protein. This model selects a subfamily closely related to HlyD; it is defined narrowly and excludes, for example, colicin V secretion protein CvaA and multidrug efflux proteins [Protein fate, Protein and peptide secretion and trafficking]. Length = 423

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 48.9 bits (117), Expect = 1e-05
 Identities = 46/208 (22%), Positives = 88/208 (42%), Gaps = 24/208 (11%)

Query: 350 SEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKE 409
              +   +    +L ++LAE +  LE+L   +  + +L+A++  L+ +L    S L + E
Sbjct: 322 EAQLEELESKLDELAEELAELEEKLEEL---KEELESLEAELEELEAELEELESRLEELE 378

Query: 410 EEIDRLRQ---EMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEV 466
           E+++ LR    ++  + + L      L A    LE+ R  L+++         + E+ E+
Sbjct: 379 EQLETLRSKVAQLELQIASLNNEIERLEARLERLEDRRERLQQEIEELLKKLEEAELKEL 438

Query: 467 SKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQEL 526
             ELE L  ELEE                +E       L++ + E E  ++ L + E+EL
Sbjct: 439 QAELEELEEELEEL--------------QEELERLEEALEELREELEEAEQALDAAEREL 484

Query: 527 KVSEEALATAQNSLDSKLREHQALSNTI 554
                 L    +SL+      +  S  +
Sbjct: 485 ----AQLQARLDSLERLQENLEGFSEGV 508

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail

 Score = 48.5 bits (116), Expect = 1e-05
 Identities = 78/347 (22%), Positives = 140/347 (40%), Gaps = 73/347 (21%)

Query: 354 RHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEID 413
           R  + ++ +L   L EA+A+LE      ++VL  Q ++S ++ ++      L++KEEE +
Sbjct: 464 RRLEAEKDELQAALEEAEAALELEE---SKVLRAQVELSQIRSEIERR---LAEKEEEFE 517

Query: 414 RLRQEMVKKESDLVAT-------SSDLVATRHELEEVRSEL--------KEKENLEKT-- 456
             R+   +    L AT        ++    + +LE   +EL        K     +K   
Sbjct: 518 NTRKNHQRAIESLQATLEAEAKGKAEASRLKKKLEGDINELEIALDHANKANAEAQKNVK 577

Query: 457 --------------------DDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVK 496
                               +D + ++    +    L  ELEE ++A +Q ++   Q+  
Sbjct: 578 KYQQQVKELQTQVEEEQRAREDAREQLAVAERRATALEAELEELRSALEQAERARKQAET 637

Query: 497 ERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLD--------------- 541
           E   A   + +   +N +L  +   LE EL   +  L  A N L                
Sbjct: 638 ELAEASERVNELTAQNSSLIAQKRKLEGELAALQSDLDEAVNELKAAEERAKKAQADAAR 697

Query: 542 --SKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEV 599
              +LR+ Q  S  +E ++K++E     V+E+    ++ E     L   K   ++LE  V
Sbjct: 698 LAEELRQEQEHSQHLERLRKQLESQ---VKELQVRLDEAE--AAALKGGKKMIQKLEARV 752

Query: 600 RGYKLDLES-TRRELETNKDQTIELRAKSKLEKAEGELTTVREENKK 645
           R  + +L+   RR  ET K+         K+E+   EL    EE+KK
Sbjct: 753 RELEAELDGEQRRHAETQKNLR-------KMERRVKELQFQVEEDKK 792

The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859

>gnl|CDD|220614 pfam10174, Cast, RIM-binding protein of the cytomatrix active zone

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 59/313 (18%), Positives = 126/313 (40%), Gaps = 20/313 (6%)

Query: 338 TNTSSDSTLPPSSEDMRHWKRDRLQLLQQLAEA-KASLEDLSCSRTRVLALQAQVSSLQQ 396
           T+T++D+ L    + +   +R   +L +Q     +   E+    +     L+ +V +LQ 
Sbjct: 427 TDTNTDTALEKLEKALAEKERIIERLKEQRDRDERYEQEEFETYKKEFEDLKEEVQNLQL 486

Query: 397 DLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKT 456
            L+     L   +EE+ +L    +K+ SDL     +L   R + E++  ELK      ++
Sbjct: 487 KLSERELQLELLKEEVSKLASNQLKQRSDLERAHIELEKIREKHEKLEKELKRLRANPES 546

Query: 457 DDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALK 516
            DR      V       R +    +    +                  L++A+ E +  +
Sbjct: 547 ADR---GSAVDAGTSRSRADSAGARNEVDRLLD--------------RLEKAEQERDDTE 589

Query: 517 EKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISE 576
            +   L +EL+ ++  L   Q   ++   E +  S  +    + +E+S      +   ++
Sbjct: 590 MEAGRLAKELEKAQRHLTKQQEKTEATRIEFERKSAELLEEAERLEKSEAEEETLRQSTQ 649

Query: 577 KYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGEL 636
                      ++   ++LE +++  + + E    +LE ++   +E +   +L  AE E 
Sbjct: 650 IGHAQAAAHNHIEHHVQKLESDLKQLRAEREQLVAQLEKSQQSLMEFQQ--ELNAAEAER 707

Query: 637 TTVREENKKLKQG 649
               EEN++LKQ 
Sbjct: 708 RKHLEENRELKQE 720

This is a family of proteins that form part of the CAZ (cytomatrix at the active zone) complex which is involved in determining the site of synaptic vesicle fusion. The C-terminus is a PDZ-binding motif that binds directly to RIM (a small G protein Rab-3A effector). The family also contains four coiled-coil domains. Length = 774

>gnl|CDD|224495 COG1579, COG1579, Zn-ribbon protein, possibly nucleic acid-binding [General function prediction only]

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 44/183 (24%), Positives = 83/183 (45%), Gaps = 4/183 (2%)

Query: 468 KELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELK 527
             ++ L  E +  +   K+ +K   ++  E  A    L+  + E E L+ +++ LE E++
Sbjct: 10  LAIQKLDLEKDRLEPRIKEIRKALKKAKAELEALNKALEALEIELEDLENQVSQLESEIQ 69

Query: 528 VSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLE 587
              E +  A+  L +   E +  +  IE +Q   E+      E++ + E+ EK  K + +
Sbjct: 70  EIRERIKRAEEKLSAVKDERELRALNIE-IQIAKERINSLEDELAELMEEIEKLEKEIED 128

Query: 588 LKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKL-EKAEGELTTVREENKKL 646
           LK   ERLE  +   +  LE      E  ++       + +L EK + EL +  E  +K 
Sbjct: 129 LKERLERLEKNLAEAEARLEE--EVAEIREEGQELSSKREELKEKLDPELLSEYERIRKN 186

Query: 647 KQG 649
           K+G
Sbjct: 187 KKG 189

Length = 239

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 35/129 (27%), Positives = 62/129 (48%), Gaps = 11/129 (8%)

Query: 92  GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL 151
                TL+   P   LS      + Y++A  +++L     VHRD+   N+L+     +K+
Sbjct: 223 RTRRDTLINESP--ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKI 280

Query: 152 TDFGSATQVDKNGRIKSIVPVGTP-EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYE 210
            DFG A  + ++    S      P +++APE +        ++ YT   D+WS G++ +E
Sbjct: 281 CDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-------FNNLYTTLSDVWSFGILLWE 333

Query: 211 LLT-GSTPF 218
           + T G TP+
Sbjct: 334 IFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 23/144 (15%)

Query: 86  IMEYVTGGDFVTLL-----ENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           I+ ++  GD  + L      + P  YL       ++ ++A  ++YL    ++HRD+   N
Sbjct: 84  ILPFMKHGDLHSFLLYSRLGDCPQ-YLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARN 142

Query: 141 MLLSATGHLKLTDFGSATQV-----DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
            +L+   ++ + DFG + ++      + GRI + +PV   +++A E L           Y
Sbjct: 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRI-AKMPV---KWIAIESL-------ADRVY 191

Query: 196 TGSCDLWSIGVVSYELLT-GSTPF 218
           T   D+WS GV  +E+ T G TP+
Sbjct: 192 TTKSDVWSFGVTMWEIATRGQTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 29/208 (13%)

Query: 26  GNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVKSKCPYIVNLFYS 76
           GNFG +   + + K+S  T V  K+L+    +   +D       +M +   PYIV +   
Sbjct: 6   GNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI-G 63

Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
             +      +ME    G     L+   H  ++E      +++++  ++YL    +VHRD+
Sbjct: 64  ICEAESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETNFVHRDL 121

Query: 137 KPDNMLLSATGHLKLTDFG--SATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
              N+LL    + K++DFG   A   D+N    +     PV   ++ APE + + +    
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV---KWYAPECMNYYK---- 174

Query: 192 SDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              ++   D+WS GV+ +E  + G  P+
Sbjct: 175 ---FSSKSDVWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|129705 TIGR00618, sbcc, exonuclease SbcC

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 56/395 (14%), Positives = 116/395 (29%), Gaps = 34/395 (8%)

Query: 351 EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE 410
           + +   ++ +  L Q+L      L+ L   +  +    +    LQ  L         ++ 
Sbjct: 379 QHIHTLQQQKTTLTQKLQSLCKELDILQREQATIDTRTSAFRDLQGQLAHAKKQQELQQR 438

Query: 411 EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKEL 470
             +     +             L  +   L+E   +L+ KE +   + RK  V       
Sbjct: 439 YAELCAAAITCTAQCEKLEKIHLQESAQSLKEREQQLQTKEQIHLQETRKKAVVLARLL- 497

Query: 471 EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSE 530
                EL+E+              +          +Q       L  ++   EQ     E
Sbjct: 498 -----ELQEEP-----------CPLCGSCIHPNPARQDIDNPGPLTRRMQRGEQTYAQLE 541

Query: 531 EALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKS 590
            +     + L S+ ++  +L   ++ +Q+                   +     L +L  
Sbjct: 542 TSEEDVYHQLTSERKQRASLKEQMQEIQQSFSILTQCDNRSKEDIPNLQNITVRLQDLTE 601

Query: 591 AKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSK--------LEKAEGELTTVREE 642
                E  +   +  L    +  +  +D  + L+  S+        L   +  LT  R  
Sbjct: 602 KLSEAEDMLACEQHALLRKLQPEQDLQDVRLHLQQCSQELALKLTALHALQLTLTQERVR 661

Query: 643 NKKL--KQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFW 700
              L  +     L+ S     Q  QS+ E+       + +    L+       E +  F 
Sbjct: 662 EHALSIRVLPKELLASRQLALQKMQSEKEQLTYWKEMLAQCQTLLRELETHIEEYDREFN 721

Query: 701 LDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYE 735
              N   S   DL        ++  + N+ + E  
Sbjct: 722 EIENASSSLGSDL-------AAREDALNQSLKELM 749

All proteins in this family for which functions are known are part of an exonuclease complex with sbcD homologs. This complex is involved in the initiation of recombination to regulate the levels of palindromic sequences in DNA. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 1042

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 2/104 (1%)

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP- 175
            E+A  + +LH   ++H D+   N LL+A   +K+ D+G +    K     +   +  P 
Sbjct: 107 CEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            ++APE+++ + GN      T   ++WS+GV  +EL   GS P+
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning]

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 45/254 (17%), Positives = 98/254 (38%), Gaps = 8/254 (3%)

Query: 346 LPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLL 405
           +  ++       +   Q+ +++A  +  + +    + +   L+ Q+ SL+ ++ S  + L
Sbjct: 26  VLAAAFSAAADDKQLKQIQKEIAALEKKIRE---QQDQRAKLEKQLKSLETEIASLEAQL 82

Query: 406 SKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEV-----RSELKEKENLEKTDDRK 460
            +  +++ +LR+++    + L A        R  L E      RS       L  + +  
Sbjct: 83  IETADDLKKLRKQIADLNARLNALEVQEREQRRRLAEQLAALQRSGRNPPPALLVSPEDA 142

Query: 461 LEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLT 520
                ++     L     E+  A K   K       E  A  AEL    +E  A + KL 
Sbjct: 143 QRSVRLAIYYGALNPARAERIDALKATLKQLAAVRAEIAAEQAELTTLLSEQRAQQAKLA 202

Query: 521 SLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEK 580
            L +E K +   L +  ++   KL E +A  + +++     E +A + RE +  +E    
Sbjct: 203 QLLEERKKTLAQLNSELSADQKKLEELRANESRLKNEIASAEAAAAKAREAAAAAEAAAA 262

Query: 581 DRKTLLELKSAKER 594
             +     ++ +  
Sbjct: 263 RARAAEAKRTGETY 276

Length = 420

>gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain

 Score = 47.7 bits (113), Expect = 3e-05
 Identities = 49/265 (18%), Positives = 102/265 (38%), Gaps = 21/265 (7%)

Query: 390 QVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKE 449
           ++   +Q+    +    +KEEEI     +  K+E               E +    ELK 
Sbjct: 245 ELLRDEQEEIESSKQELEKEEEILAQVLKENKEEEK-------------EKKLQEEELKL 291

Query: 450 KENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQ 509
               E+    +L   E  K  +  + +  E++    + +    +   E      +  + +
Sbjct: 292 LAKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKELKKEKEEIEELEKELKELEIK 351

Query: 510 TENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVR 569
            E E  +E     EQ  K+ E+     +  L  K  E + LS+  +  ++E+E      +
Sbjct: 352 REAEEEEE-----EQLEKLQEKLEQLEEELLAKKKLESERLSSAAKLKEEELELKNEEEK 406

Query: 570 EMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKL 629
           E   + E  E++   L E K  + ++  E+   +  LE+ + +L   K++  +   K   
Sbjct: 407 EAKLLLELSEQEEDLLKEEKKEELKIVEEL---EESLETKQGKLTEEKEELEKQALKLLK 463

Query: 630 EKAEGELTTVREENKKLKQGKIRLV 654
           +K E + +    +  KL +   +L 
Sbjct: 464 DKLELKKSEDLLKETKLVKLLEQLE 488

This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 52/231 (22%), Positives = 93/231 (40%), Gaps = 54/231 (23%)

Query: 25  QGNFGDIYLVE---------------EKQSHNTFVMKKVLREKMPNTIERD------IMV 63
           +G FG+++L E                ++     V  K+LR         D      I+ 
Sbjct: 15  EGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILS 74

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD---FVT---LLENQPHGYLSESKAR---- 113
           + K P I+ L     D + +  I EY+  GD   F++   L + + +G  +   A     
Sbjct: 75  RLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPA 134

Query: 114 -------FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-- 164
                      ++A  ++YL  L +VHRD+   N L+     +K+ DFG +  +      
Sbjct: 135 ISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY 194

Query: 165 RI--KSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELL 212
           RI  ++++P+            WM       G +T + D+W+ GV  +E+L
Sbjct: 195 RIQGRAVLPI-----------RWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|227512 COG5185, HEC1, Protein involved in chromosome segregation, interacts with SMC proteins [Cell division and chromosome partitioning]

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 66/371 (17%), Positives = 136/371 (36%), Gaps = 41/371 (11%)

Query: 362 QLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVK 421
            L +++ EA    + +   R +  AL++  +  +  + +      +   ++++L+ E+  
Sbjct: 282 NLYEKIQEAMKISQKIKTLREKWRALKSDSNKYENYVNAMKQKSQEWPGKLEKLKSEIEL 341

Query: 422 KESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQK 481
           KE ++ A           L+    EL ++  L K      +   +++E E L  EL++  
Sbjct: 342 KEEEIKA-----------LQSNIDELHKQ--LRKQGISTEQFELMNQEREKLTRELDKIN 388

Query: 482 TATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLD 541
             + +  K       E       L       E    +  SL Q +  S   +    N   
Sbjct: 389 IQSDKLTKSVKSRKLEAQGIFKSL-------EKTLRQYDSLIQNITRSRSQIGHNVNDSS 441

Query: 542 SKLREHQA------LSNTIESMQKEM-EQSAVRVREMSGISEKYEKDRKTLLELKSAKER 594
            K+   Q       ++ +I+    E+ ++   R++     S   E+D K    LK     
Sbjct: 442 LKINIEQLFPKGSGINESIKKSILELNDEIQERIKTEENKSITLEEDIK---NLKHDINE 498

Query: 595 LELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLV 654
           L   +   +L+L     + E +K++        ++E  + E        K+L    +   
Sbjct: 499 LTQILEKLELELSEANSKFELSKEENERELVAQRIEIEKLE--------KELNDLNLLSK 550

Query: 655 YSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLK 714
            S+    Q  QS   K +     +  +  K+       ++  S F +      SSLEDL+
Sbjct: 551 TSILDAEQLVQSTEIKLDELKVDLNRKRYKIHKQVIHVIDITSKFKI---NIQSSLEDLE 607

Query: 715 SNYTERESKLR 725
           +   +   +LR
Sbjct: 608 NELGKVIEELR 618

Length = 622

>gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional

 Score = 47.0 bits (112), Expect = 4e-05
 Identities = 71/324 (21%), Positives = 129/324 (39%), Gaps = 56/324 (17%)

Query: 366 QLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESD 425
            + + +  +E+L      +  L+ +      DL +    L +  EE D LR+   + E+ 
Sbjct: 378 AVEDRREEIEEL---EEEIEELRERFGDAPVDLGNAEDFLEELREERDELREREAELEAT 434

Query: 426 L------VATSSDLVAT----------------------RHELEEVRSELKEKENLEKTD 457
           L      V  +  L+                        R  +EE+ +EL++ E   +  
Sbjct: 435 LRTARERVEEAEALLEAGKCPECGQPVEGSPHVETIEEDRERVEELEAELEDLEEEVEEV 494

Query: 458 DRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKE 517
           + +LE  E   E E     LEE++   ++   +  ++++E+     EL++   E EA  E
Sbjct: 495 EERLERAEDLVEAEDRIERLEERREDLEELIAERRETIEEKRERAEELRERAAELEAEAE 554

Query: 518 KLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQK---------EMEQSAVRV 568
           +      E +   E        L+SKL     L   IES+++         + E    R+
Sbjct: 555 EKREAAAEAEEEAEEAREEVAELNSKL---AELKERIESLERIRTLLAAIADAEDEIERL 611

Query: 569 RE-MSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKS 627
           RE    ++E  ++ R+ L E +  K  LE E    +++     +E           RA+ 
Sbjct: 612 REKREALAELNDERRERLAEKRERKRELEAEFDEARIEEAREDKE-----------RAEE 660

Query: 628 KLEKAEGELTTVREENKKLKQGKI 651
            LE+ E +L  +REE   L Q +I
Sbjct: 661 YLEQVEEKLDELREERDDL-QAEI 683

Length = 880

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 33/120 (27%)

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD------------KNGR 165
           ++A  + YLH  G +H+DI   N ++     +K+TD  +A   D            +N  
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD--NALSRDLFPMDYHCLGDNENRP 182

Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           +K         ++A E L   E +  S       D+WS GV+ +EL+T G TP  Y  +D
Sbjct: 183 VK---------WMALESLVNKEYSSAS-------DVWSFGVLLWELMTLGQTP--YVEID 224

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|130902 TIGR01843, type_I_hlyD, type I secretion membrane fusion protein, HlyD family

 Score = 46.2 bits (110), Expect = 5e-05
 Identities = 22/95 (23%), Positives = 44/95 (46%), Gaps = 2/95 (2%)

Query: 357 KRDRLQLLQQLAEAKASLEDLS-CSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRL 415
            R +L+++ +  EA+  L++    SR  +L L+ + +  Q +L    + L   + +ID L
Sbjct: 170 LRQQLEVISEELEARRKLKEKGLVSRLELLELERERAEAQGELGRLEAELEVLKRQIDEL 229

Query: 416 RQEMVKKESDLVATSSD-LVATRHELEEVRSELKE 449
           + E  + E        + L   +  L E+R  L +
Sbjct: 230 QLERQQIEQTFREEVLEELTEAQARLAELRERLNK 264

Type I secretion is an ABC transport process that exports proteins, without cleavage of any signal sequence, from the cytosol to extracellular medium across both inner and outer membranes. The secretion signal is found in the C-terminus of the transported protein. This model represents the adaptor protein between the ATP-binding cassette (ABC) protein of the inner membrane and the outer membrane protein, and is called the membrane fusion protein. This model selects a subfamily closely related to HlyD; it is defined narrowly and excludes, for example, colicin V secretion protein CvaA and multidrug efflux proteins [Protein fate, Protein and peptide secretion and trafficking]. Length = 423

>gnl|CDD|226809 COG4372, COG4372, Uncharacterized protein conserved in bacteria with the myosin-like domain [Function unknown]

 Score = 46.6 bits (110), Expect = 5e-05
 Identities = 50/280 (17%), Positives = 106/280 (37%), Gaps = 70/280 (25%)

Query: 426 LVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATK 485
           L   + +L +   +L+++R +L+                    EL   +GE    +T   
Sbjct: 62  LFLLNRNLRSGVFQLDDIRPQLRALRT----------------ELGTAQGEKRAAET--- 102

Query: 486 QWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQ---NSLDS 542
                      ER AA +EL++A+ E EA++++L +  Q L  +++ LA        L +
Sbjct: 103 -----------EREAARSELQKARQEREAVRQELAAARQNLAKAQQELARLTKQAQDLQT 151

Query: 543 KLR-----------EHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSA 591
           +L+           + Q+L  + + +Q    Q   +V ++   S + E++ + L    +A
Sbjct: 152 RLKTLAEQRRQLEAQAQSLQASQKQLQASATQLKSQVLDLKLRSAQIEQEAQNLATRANA 211

Query: 592 KERLELEVRGYKLDLESTRRELET------NKDQTIELRAK------SKLEKAEGELTTV 639
            +    E+       + T + ++        K Q I  RA+       +L++ E     +
Sbjct: 212 AQARTEELARRAAAAQQTAQAIQQRDAQISQKAQQIAARAEQIRERERQLQRLETAQARL 271

Query: 640 REENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVR 679
            +E  +L+                 Q+ +   +    T R
Sbjct: 272 EQEVAQLEAY--------------YQAYVRLRQQAAATQR 297

Length = 499

>gnl|CDD|221952 pfam13166, AAA_13, AAA domain

 Score = 45.8 bits (109), Expect = 8e-05
 Identities = 42/183 (22%), Positives = 84/183 (45%), Gaps = 12/183 (6%)

Query: 354 RHWKRDRLQLLQQLAEAKASLED----LSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKE 409
            H+  +  +L++QL E     E            +L  + + S  + D+    +LL   E
Sbjct: 274 AHFDEEYQELIEQLEELIDKYESHIEKALEELESILDTEKENSEFKLDVEELKALLEALE 333

Query: 410 EEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKE-----KENLEKTDDRKLEVC 464
           E +++  Q++ +K  D  +TS +L +    +E +   +       +E+ EK D+ K E  
Sbjct: 334 EILEKNLQKLEEKLKD-PSTSIELESITDLIESINDIIDAINELIREHNEKIDNLKKEKN 392

Query: 465 EVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQ 524
           +  K+L      + E K     ++K+     K  N+   E+KQ + E +AL++++  LE+
Sbjct: 393 KAKKKLW--LHLVAELKEDIDAYQKEKKGLEKAINSLEKEIKQLEAEIKALEKEIKELEK 450

Query: 525 ELK 527
           +L 
Sbjct: 451 QLT 453

This family of domains contain a P-loop motif that is characteristic of the AAA superfamily. Many of the proteins in this family are conjugative transfer proteins. This family includes the PrrC protein that is thought to be the active component of the anticodon nuclease. Length = 713

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.5 bits (103), Expect = 9e-05
 Identities = 32/103 (31%), Positives = 45/103 (43%), Gaps = 15/103 (14%)

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
            A  +Q L  L  +HR  K  N+LL+  G LKL   GS                  P ++
Sbjct: 20  WAVCLQCLGALRELHRQAKSGNILLTWDGLLKL--DGSVAFKTPEQSR------PDPYFM 71

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
           APEV++          YT   D++S+G+  YE L    P+N E
Sbjct: 72  APEVIQGQS-------YTEKADIYSLGITLYEALDYELPYNEE 107

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|224495 COG1579, COG1579, Zn-ribbon protein, possibly nucleic acid-binding [General function prediction only]

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 38/183 (20%), Positives = 79/183 (43%), Gaps = 11/183 (6%)

Query: 404 LLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEV 463
            + K + E DRL   + +    L    ++L A    LE +  EL++ EN       + E+
Sbjct: 11  AIQKLDLEKDRLEPRIKEIRKALKKAKAELEALNKALEALEIELEDLENQVS--QLESEI 68

Query: 464 CEVSKELEVLRGELEEQKTAT--KQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTS 521
            E+ + ++    +L   K     +    +   + +  N+   EL +   E E L++++  
Sbjct: 69  QEIRERIKRAEEKLSAVKDERELRALNIEIQIAKERINSLEDELAELMEEIEKLEKEIED 128

Query: 522 LEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREM-SGISEKYEK 580
           L++ L+  E+ LA A+  L+ ++ E        E  Q+   +      ++   +  +YE+
Sbjct: 129 LKERLERLEKNLAEAEARLEEEVAE------IREEGQELSSKREELKEKLDPELLSEYER 182

Query: 581 DRK 583
            RK
Sbjct: 183 IRK 185

Length = 239

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 39/141 (27%), Positives = 57/141 (40%), Gaps = 36/141 (25%)

Query: 104 HGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATG--------------- 147
           HG  S       I++   A+ Y H  L  +H D+KP+N+L+  +                
Sbjct: 225 HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284

Query: 148 -HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV---LEWMEGNHGSDGYTGSCDLWS 203
             +++ D G       + R      V T  Y +PEV   L WM           S D+WS
Sbjct: 285 CRVRICDLGGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMY----------STDMWS 330

Query: 204 IGVVSYELLTGSTPFNYETLD 224
           +G + YEL TG     Y+T D
Sbjct: 331 MGCIIYELYTGK--LLYDTHD 349

Length = 467

>gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional

 Score = 45.5 bits (107), Expect = 1e-04
 Identities = 50/281 (17%), Positives = 117/281 (41%), Gaps = 10/281 (3%)

Query: 407  KKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEV 466
            KK +E  + + E  KK++D +  ++       E ++   E K+ +  +K  +   +  E 
Sbjct: 1391 KKADEAKK-KAEEDKKKADELKKAAAAKKKADEAKKKAEEKKKADEAKKKAEEAKKADEA 1449

Query: 467  SKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQEL 526
             K+ E  +   E +K A +  K D  +   E      E K+   E +   ++     +  
Sbjct: 1450 KKKAEEAKKAEEAKKKAEEAKKADEAKKKAEEAKKADEAKKKAEEAKKKADEAKKAAEAK 1509

Query: 527  KVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLL 586
            K ++EA    +     + ++ +      E+ + E ++ A  +++   + +  EK  K   
Sbjct: 1510 KKADEAKKAEEAKKADEAKKAEEAKKADEAKKAEEKKKADELKKAEELKKAEEK--KKAE 1567

Query: 587  ELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKL 646
            E K A+E   + +R      E  ++  E   ++ ++L  + K  KAE      + E  K+
Sbjct: 1568 EAKKAEEDKNMALR----KAEEAKKAEEARIEEVMKLYEEEKKMKAE---EAKKAEEAKI 1620

Query: 647  KQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKV 687
            K  +++      K  +  + K  + + +   +++  ++ K+
Sbjct: 1621 KAEELKKAEEEKKKVEQLKKKEAEEKKKAEELKKAEEENKI 1661

Length = 2084

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 32/108 (29%), Positives = 59/108 (54%), Gaps = 17/108 (15%)

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIK--SIVPV 172
           Y++A+ + +L     +HRD+   N+LL+     K+ DFG A  +  D N  +K  + +PV
Sbjct: 221 YQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 173 GTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              +++APE +   +        YT   D+WS G++ +E+ + GS+P+
Sbjct: 281 ---KWMAPESIFNCV--------YTFESDVWSYGILLWEIFSLGSSPY 317

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 31/130 (23%), Positives = 60/130 (46%), Gaps = 19/130 (14%)

Query: 97  TLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF 154
           +LL++  Q    L   +   +  ++A+ + YL     VHR++   N+LL +   +++ DF
Sbjct: 94  SLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADF 153

Query: 155 GSATQVDKNGRIKSIVPVGTPEYVAPEV---LEWM--EGNHGSDGYTGSCDLWSIGVVSY 209
           G          +  ++     +Y   E    ++WM  E       YT   D+WS GV  +
Sbjct: 154 G----------VADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVW 202

Query: 210 ELLT-GSTPF 218
           E+++ G+ P+
Sbjct: 203 EMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|225288 COG2433, COG2433, Uncharacterized conserved protein [Function unknown]

 Score = 45.1 bits (107), Expect = 1e-04
 Identities = 50/223 (22%), Positives = 81/223 (36%), Gaps = 41/223 (18%)

Query: 440 LEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERN 499
           LE+V  +L E    +  +  K  V       E L    EE++   K+          E  
Sbjct: 361 LEKVERKLPELGIWKDVERIKALVIRGYPLAEALSKVKEEERPREKE--------GTEEE 412

Query: 500 AAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQA----LSNTIE 555
               E+   +   + L+E +  LE+E              L  +L E +     L + +E
Sbjct: 413 ERR-EITVYEKRIKKLEETVERLEEENS-----------ELKRELEELKREIEKLESELE 460

Query: 556 SMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELET 615
             ++E+     + RE+     + E+  K L E K   E LE             R+  E 
Sbjct: 461 RFRREVRDKVRKDREIRARDRRIERLEKELEEKKKRVEELE-------------RKLAEL 507

Query: 616 NKDQTIELRAK----SKLEKAEGELTTVREENKKLKQGKIRLV 654
            K + +EL  K      +EK   E     EE   +K+G + LV
Sbjct: 508 RKMRKLELSGKGTPVKVVEKLTLEAIEEAEEEYGIKEGDVILV 550

Length = 652

>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type

 Score = 45.1 bits (107), Expect = 2e-04
 Identities = 40/200 (20%), Positives = 87/200 (43%), Gaps = 29/200 (14%)

Query: 343 DSTLPPSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHT 402
            + +     ++   ++ R +L ++ AE K  LEDL   R  +  +  + +  + +L  + 
Sbjct: 335 LAEIEELEREIEEERKRRDKLTEEYAELKEELEDL---RAELEEVDKEFAETRDELKDYR 391

Query: 403 SLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLE 462
             L K + EI+ L++E+ + + +L   S +L      +  + +++ E E           
Sbjct: 392 EKLEKLKREINELKRELDRLQEELQRLSEELADLNAAIAGIEAKINELEE---------- 441

Query: 463 VCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSL 522
                 E E    E+++Q+   +Q   D        +    EL   + E + ++++L+ L
Sbjct: 442 ------EKEDKALEIKKQEWKLEQLAAD-------LSKYEQELYDLKEEYDRVEKELSKL 488

Query: 523 EQELKVSEEALATAQNSLDS 542
           ++EL    EA A A+ S + 
Sbjct: 489 QREL---AEAEAQARASEER 505

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164

>gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 41/178 (23%), Positives = 95/178 (53%), Gaps = 6/178 (3%)

Query: 515 LKEKLTSLEQELKVSE---EALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREM 571
           +K ++  LE+ +K +E   E +   +  L+  LRE   +S+ +  +++E+E+    V+E+
Sbjct: 174 IKRRIERLEKFIKRTENIEELIKEKEKELEEVLREINEISSELPELREELEKLEKEVKEL 233

Query: 572 SGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEK 631
             + E+ E+  K L  L+ +K +LE ++R  +  +E  ++E+E  +++  EL+   +  +
Sbjct: 234 EELKEEIEELEKELESLEGSKRKLEEKIRELEERIEELKKEIEELEEKVKELKELKEKAE 293

Query: 632 AEGELTTVREE-NKKLKQGKIRL--VYSLFKDPQPAQSKLEKAEGELTTVREENKKLK 686
              +L+   EE   +L++ + RL  +       +    +LE+ E  L  ++++ K+L+
Sbjct: 294 EYIKLSEFYEEYLDELREIEKRLSRLEEEINGIEERIKELEEKEERLEELKKKLKELE 351

Length = 880

>gnl|CDD|130902 TIGR01843, type_I_hlyD, type I secretion membrane fusion protein, HlyD family

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 38/181 (20%), Positives = 76/181 (41%), Gaps = 20/181 (11%)

Query: 364 LQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKE 423
           L+  A+++A++E      +       ++   QQ L    S  S    +++ +  ++ + E
Sbjct: 100 LRAEADSQAAIEFPDDLLSAEDPAVPELIKGQQSL--FESRKSTLRAQLELILAQIKQLE 157

Query: 424 SDLVATSSDLVATRHELEEVRSELKEKENLEK--------TDDRKLEVCEVSKELEVLRG 475
           ++L    + L A R +LE +  EL+ +  L++          + + E  E   EL  L  
Sbjct: 158 AELAGLQAQLQALRQQLEVISEELEARRKLKEKGLVSRLELLELERERAEAQGELGRLEA 217

Query: 476 ELEEQKTATKQWKKDWYQSVKE--RNAAVAELKQAQTENEALKEKLTSLEQELKVSEEAL 533
           ELE  K    + + +  Q +++  R   + EL +AQ         L  L + L  + + L
Sbjct: 218 ELEVLKRQIDELQLE-RQQIEQTFREEVLEELTEAQAR-------LAELRERLNKARDRL 269

Query: 534 A 534
            
Sbjct: 270 Q 270

Type I secretion is an ABC transport process that exports proteins, without cleavage of any signal sequence, from the cytosol to extracellular medium across both inner and outer membranes. The secretion signal is found in the C-terminus of the transported protein. This model represents the adaptor protein between the ATP-binding cassette (ABC) protein of the inner membrane and the outer membrane protein, and is called the membrane fusion protein. This model selects a subfamily closely related to HlyD; it is defined narrowly and excludes, for example, colicin V secretion protein CvaA and multidrug efflux proteins [Protein fate, Protein and peptide secretion and trafficking]. Length = 423

>gnl|CDD|224259 COG1340, COG1340, Uncharacterized archaeal coiled-coil protein [Function unknown]

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 55/261 (21%), Positives = 114/261 (43%), Gaps = 8/261 (3%)

Query: 430 SSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKK 489
           S  ++    ELE  R +LKE   +E+  +++ E+ + + EL   R EL  +    ++  +
Sbjct: 1   SLAMLDKLDELELKRKQLKE--EIEELKEKRDELRKEASELAEKRDELNAKVRELREKAQ 58

Query: 490 DWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQA 549
           +  +   E N  V ELK+ + E  A  ++L    +ELK           S+ S  RE + 
Sbjct: 59  ELREERDEINEEVQELKEKRDEINAKLQELRKEYRELKEKRNEFNLGGRSIKSLEREIER 118

Query: 550 LSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLEST 609
           L    ++     E+    V+++  + ++ E D K  LE     + L+ E+   K      
Sbjct: 119 LEKKQQTSVLTPEEERELVQKIKELRKELE-DAKKALEENEKLKELKAEIDELKKKAREI 177

Query: 610 RRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQ---GKIRLVYSLFKDPQPAQS 666
             +++   ++  E     ++ K   E   +R+E  +L +      + +  L ++ +  Q+
Sbjct: 178 HEKIQELANEAQEY--HEEMIKLFEEADELRKEADELHEEFVELSKKIDELHEEFRNLQN 235

Query: 667 KLEKAEGELTTVREENKKLKV 687
           +L + E ++  +R + K  K 
Sbjct: 236 ELRELEKKIKALRAKEKAAKR 256

Length = 294

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 27/103 (26%), Positives = 49/103 (47%), Gaps = 7/103 (6%)

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI----KSIVPVG 173
           E+A  + +LH   ++H D+   N  L+A   +K+ D+G A +              VP+ 
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL- 166

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGST 216
              ++APE++E    +      T   ++WS+GV  +EL T + 
Sbjct: 167 --RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD 207

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 48/228 (21%), Positives = 93/228 (40%), Gaps = 38/228 (16%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI---------MVKSKC 67
             + + + +G FG +   +  Q   + +   V   K+      +I         M     
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 68  PYIVNLF------YSFQDMNHVYFIMEYVTGGD-----FVTLLENQPHGYLSESKARFYI 116
           P ++ L        S Q +     I+ ++  GD       + L   P     ++  +F +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV-----DKNGRIKSIVP 171
            ++A  ++YL    ++HRD+   N +L     + + DFG + ++      + GRI + +P
Sbjct: 121 -DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI-AKMP 178

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           V   +++A E L           YT   D+W+ GV  +E+ T G TP+
Sbjct: 179 V---KWIAIESL-------ADRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair]

 Score = 44.0 bits (104), Expect = 3e-04
 Identities = 55/261 (21%), Positives = 109/261 (41%), Gaps = 7/261 (2%)

Query: 358 RDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQ 417
            + L+ L++L E K  L+ L     ++     ++  L ++L        ++ EE+    +
Sbjct: 539 ENLLEELEELKE-KLQLQQLKEELRQLEDRLQELKELLEELR-LLRTRKEELEELRERLK 596

Query: 418 EMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGEL 477
           E+ KK  +L    S L      LE   +E + +E  E+ +  +LE   +  ELE L    
Sbjct: 597 ELKKKLKELEERLSQLEELLQSLELSEAENELEEAEEELES-ELEKLNLQAELEELLQAA 655

Query: 478 EEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQ 537
            E+     +  +   +   +R     +L++   E E L+E+L  L +EL+   + L   +
Sbjct: 656 LEELEEKVEELEAEIRRELQRIENEEQLEEKLEELEQLEEELEQLREELEELLKKLGEIE 715

Query: 538 NSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLEL 597
             +  +L   +A    +E ++KE+E+    +  +  + EK  K       L++   ++E 
Sbjct: 716 QLI-EELESRKAE---LEELKKELEKLEKALELLEELREKLGKAGLRADILRNLLAQIEA 771

Query: 598 EVRGYKLDLESTRRELETNKD 618
           E       L   R +L     
Sbjct: 772 EANEILSKLSLNRYDLRRLTI 792

Length = 908

>gnl|CDD|220368 pfam09730, BicD, Microtubule-associated protein Bicaudal-D

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 96/420 (22%), Positives = 163/420 (38%), Gaps = 53/420 (12%)

Query: 395 QQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVAT----SSDLVATRHELEEVRSELKEK 450
            Q  +SH  + +  EE  + L QE   KE+  +       ++L   R EL  V++E    
Sbjct: 1   GQAYSSHRKVAADGEEREESLLQESASKEAYYLQRILELQAELKQLRAELSNVQAEN--- 57

Query: 451 ENLEKTDDRKLEVCEVSKELEV--LRGELEEQKTATKQWKKDWYQSVKERNAA----VAE 504
           E L        E  E+  EL+   LR E++E K    +  +D Y  ++E N +    V+ 
Sbjct: 58  ERLSSLSQELKEENEML-ELQRGRLRDEIKEYKFREARLLQD-YSELEEENISLQKQVSV 115

Query: 505 LKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQS 564
           L+Q+Q E E LK ++  LE+E ++    L  A      ++ E Q L   +E+++ E EQ 
Sbjct: 116 LRQSQVEFEGLKHEIRRLEEETELLNSQLEEAARL--KEIAEKQ-LEEALETLKTEREQK 172

Query: 565 AVRVREMSG--------------ISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTR 610
               +E+S               IS    K  +            E E  G+        
Sbjct: 173 NALRKELSHHLNLEDFYSLSNLSISLDGLKFSEDPEASTEPNNDGEDE-NGHLNGGPGLA 231

Query: 611 RELETNKDQTIELRAKSKLEK-AEGELTTVREENKKLKQGKI---RLVYSLFKDPQPAQS 666
           + L T +   +   A    +  +E  L+    E +KLKQ      R   SL  + Q  Q+
Sbjct: 232 KSLGTPRKGELFPPAPGVSDLFSELNLS----EIQKLKQQLEQVEREKASLLANLQELQT 287

Query: 667 KLEKAEGELTTVREE----------NKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSN 716
           +LE++EG L+   E+           + L+ S       +S      +      E   + 
Sbjct: 288 QLEQSEGALSEQHEKVNRLTEHLNALRNLQASKEQQDGLDSEKDRGSHEDGDYYEVDING 347

Query: 717 YTERESKLRSANEIIGEYETKITALESTMTRSESYCK-EMVEYLETLQK-NNDILSHDNE 774
               E K R A   +GE + ++ AL++     +   + E       +Q     +LS +  
Sbjct: 348 PEILECKYRVAVSEVGELKAELKALKARYNELQERYEDEKDRLRNEIQNLAEKLLSLEKS 407

BicD proteins consist of three coiled-coiled domains and are involved in dynein-mediated minus end-directed transport from the Golgi apparatus to the endoplasmic reticulum (ER). For full functioning they bind with GSK-3beta pfam05350 to maintain the anchoring of microtubules to the centromere. It appears that amino-acid residues 437-617 of BicD and the kinase activity of GSK-3 are necessary for the formation of a complex between BicD and GSK-3beta in intact cells. Length = 711

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 25/67 (37%), Positives = 36/67 (53%), Gaps = 5/67 (7%)

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLS-ATGHLKLTDFGSAT--QVDKNGRIKSIVPVGT 174
           ++  A+  LH  G VHRD+KP N++ S  +G  K+ D G+A   +V  N   K  +    
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL--D 320

Query: 175 PEYVAPE 181
           P Y APE
Sbjct: 321 PRYAAPE 327

Length = 566

>gnl|CDD|235316 PRK04863, mukB, cell division protein MukB; Provisional

 Score = 44.2 bits (105), Expect = 3e-04
 Identities = 59/305 (19%), Positives = 115/305 (37%), Gaps = 58/305 (19%)

Query: 381  RTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRH-- 438
              R + L+  ++  +       S L + +E +  L +         +    +L+A     
Sbjct: 843  NRRRVELERALADHESQEQQQRSQLEQAKEGLSALNR---------LLPRLNLLADETLA 893

Query: 439  -ELEEVRSELKEKENLEKTDDRKLEVCE-VSKELEVLR---GELEEQKTATKQWKKDWYQ 493
              +EE+R +L E E  ++   +       +   + VL+    + E+ K   +Q ++   +
Sbjct: 894  DRVEEIREQLDEAEEAKRFVQQHGNALAQLEPIVSVLQSDPEQFEQLKQDYQQAQQTQ-R 952

Query: 494  SVKERNAAVAELKQAQTE----------------NEALKEKLTSLEQELKVSEEALATAQ 537
              K++  A+ E+ Q +                  NE L+++L   EQE   + E L  AQ
Sbjct: 953  DAKQQAFALTEVVQRRAHFSYEDAAEMLAKNSDLNEKLRQRLEQAEQERTRAREQLRQAQ 1012

Query: 538  NSLDSKLREHQALSNTIES---MQKEMEQ--SAVRVREMSGISEKYEKDRKTLLE-LKSA 591
              L    +   +L ++ ++   M +E++Q    + V   SG  E+    R  L   L + 
Sbjct: 1013 AQLAQYNQVLASLKSSYDAKRQMLQELKQELQDLGVPADSGAEERARARRDELHARLSAN 1072

Query: 592  KERLELEVRGYKLDLESTRRELETNKDQTIELRAKS---KLEKAEGELTTVREENKKLKQ 648
            + R               R +LE  +    E    +   KL K E +   +RE+    K 
Sbjct: 1073 RSR---------------RNQLEK-QLTFCEAEMDNLTKKLRKLERDYHEMREQVVNAKA 1116

Query: 649  GKIRL 653
            G   +
Sbjct: 1117 GWCAV 1121

Length = 1486

>gnl|CDD|220614 pfam10174, Cast, RIM-binding protein of the cytomatrix active zone

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 64/382 (16%), Positives = 143/382 (37%), Gaps = 54/382 (14%)

Query: 383 RVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEE 442
            + A Q + ++   ++        K E ++  L++++   +         L   +  L  
Sbjct: 365 SLQAAQEEKATYAGEIEDMRDRYEKTERKLRVLQKKIENLQETFRRKERRLKEEKERLRS 424

Query: 443 VRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAV 502
           ++++      LEK +       +   E E +   L+EQ+   ++++++            
Sbjct: 425 LQTDTNTDTALEKLE-------KALAEKERIIERLKEQRDRDERYEQE------------ 465

Query: 503 AELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEME 562
            E +  + E E LKE++ +L+ +L   E  L   +  +           + +E    E+E
Sbjct: 466 -EFETYKKEFEDLKEEVQNLQLKLSERELQLELLKEEVSKLASNQLKQRSDLERAHIELE 524

Query: 563 QSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIE 622
           +               EK  K   ELK  +   E   RG  +D  ++R   ++   +   
Sbjct: 525 K-------------IREKHEKLEKELKRLRANPESADRGSAVDAGTSRSRADSAGARNEV 571

Query: 623 LRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQS---------------- 666
            R   +LEKAE E      E  +L +   +    L K  +  ++                
Sbjct: 572 DRLLDRLEKAEQERDDTEMEAGRLAKELEKAQRHLTKQQEKTEATRIEFERKSAELLEEA 631

Query: 667 -KLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLR 725
            +LEK+E E  T+R+  +           +++          S L+ L++   +  ++L 
Sbjct: 632 ERLEKSEAEEETLRQSTQIGHAQA----AAHNHIEHHVQKLESDLKQLRAEREQLVAQLE 687

Query: 726 SANEIIGEYETKITALESTMTR 747
            + + + E++ ++ A E+   +
Sbjct: 688 KSQQSLMEFQQELNAAEAERRK 709

This is a family of proteins that form part of the CAZ (cytomatrix at the active zone) complex which is involved in determining the site of synaptic vesicle fusion. The C-terminus is a PDZ-binding motif that binds directly to RIM (a small G protein Rab-3A effector). The family also contains four coiled-coil domains. Length = 774

>gnl|CDD|226809 COG4372, COG4372, Uncharacterized protein conserved in bacteria with the myosin-like domain [Function unknown]

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 49/242 (20%), Positives = 95/242 (39%), Gaps = 40/242 (16%)

Query: 363 LLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKK 422
           L   + +       L   RT                            E+   + E    
Sbjct: 69  LRSGVFQLDDIRPQLRALRT----------------------------ELGTAQGEKRAA 100

Query: 423 ESDLVATSSDLVATRHELEEVRSELKE-KENLEKTDDRKLEVCEVSKELEVLRGELEEQK 481
           E++  A  S+L   R E E VR EL   ++NL K       + + +++L+     L EQ+
Sbjct: 101 ETEREAARSELQKARQEREAVRQELAAARQNLAKAQQELARLTKQAQDLQTRLKTLAEQR 160

Query: 482 TATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLD 541
              +   +    S K+  A+  +LK   ++   LK +   +EQE +     LAT  N+  
Sbjct: 161 RQLEAQAQSLQASQKQLQASATQLK---SQVLDLKLRSAQIEQEAQN----LATRANAAQ 213

Query: 542 SKLREHQALSNTIESMQKEMEQSAV----RVREMSGISEKYEKDRKTLLELKSAKERLEL 597
           ++  E    +   +   + ++Q       + ++++  +E+  +  + L  L++A+ RLE 
Sbjct: 214 ARTEELARRAAAAQQTAQAIQQRDAQISQKAQQIAARAEQIRERERQLQRLETAQARLEQ 273

Query: 598 EV 599
           EV
Sbjct: 274 EV 275

Length = 499

>gnl|CDD|234141 TIGR03185, DNA_S_dndD, DNA sulfur modification protein DndD

 Score = 43.1 bits (102), Expect = 5e-04
 Identities = 64/348 (18%), Positives = 129/348 (37%), Gaps = 41/348 (11%)

Query: 383 RVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEE 442
            +     +   L Q++    + L + +  ++ L ++   +  DL      L     E+E 
Sbjct: 217 ELKEQSEKYEDLAQEIAHLRNELEEAQRSLESLEKKFRSEGGDLFEEREQLERQLKEIEA 276

Query: 443 VRSELKEK--------------ENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWK 488
            R   + +               NL  +   +L+  E S++ ++ + ELEE+     +  
Sbjct: 277 ARKANRAQLRELAADPLPLLLIPNLLDSTKAQLQKEEQSQQNQLTQEELEER----DKEL 332

Query: 489 KDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQ 548
            +    +      V E+  A+   E  K   T  E   ++S   L   +  +    RE Q
Sbjct: 333 LESLPKLALPAEHVKEI-AAELA-EIDKPATTDSEIPHRLSGSELTQLEVLIQQVKRELQ 390

Query: 549 ALSNTIESMQKEMEQSAVRV-REMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLE 607
              + +    +E+E+    V +++S I        + + +L       + E+   + ++E
Sbjct: 391 DAKSQLLKELRELEEELAEVDKKISTIP-----SEEQIAQLLEELGEAQNELFRSEAEIE 445

Query: 608 STRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSK 667
              R+LET K+    LR     +  +       E    +   K +     F++    + K
Sbjct: 446 ELLRQLETLKEAIEALRKTLDEKTKQKINAFELERAITIAD-KAKKTLKEFREKL-LERK 503

Query: 668 LEKAEGELTTVREENKKLKVSFFFTLESNSLFW---LDPNTFLSSLED 712
           L++ E E+T           SF   +  ++L     +DP TF  SL D
Sbjct: 504 LQQLEEEITK----------SFKKLMRKHNLISRLKIDPETFAVSLYD 541

This model describes the DndB protein encoded by an operon associated with a sulfur-containing modification to DNA. The operon is sporadically distributed in bacteria, much like some restriction enzyme operons. DndD is described as a putative ATPase. The small number of examples known so far include species from among the Firmicutes, Actinomycetes, Proteobacteria, and Cyanobacteria [DNA metabolism, Restriction/modification]. Length = 650

>gnl|CDD|218704 pfam05701, DUF827, Plant protein of unknown function (DUF827)

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 77/331 (23%), Positives = 144/331 (43%), Gaps = 53/331 (16%)

Query: 405 LSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKE--------KENLEKT 456
           L   +EE ++L++E+   E + +    +L +T+  +E+++ +L++        K++ E  
Sbjct: 38  LMLAQEEANKLKKELEVAEKEKLQVLKELESTKRTVEDLKLKLEKAEKEEQQAKQDSELA 97

Query: 457 DDRKLEVCEVSKELEVLR-----GELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTE 511
             R  E+ +  +ELEV R      EL+  K   ++ ++++   V+ER+AA+   ++A   
Sbjct: 98  KLRAEELEQGIQELEVERYITATAELDSVKEELRKIRQEYDALVEERDAALKRAEEAICA 157

Query: 512 NEALKEKLTSLEQELKVSEEALATAQNSLDSKL-------------------------RE 546
           ++  ++K+  L +E+   +E+L  A  +                              +E
Sbjct: 158 SKVNEKKVEELTKEIIAMKESLERAHAAHLEAEEERIGAALEKDQDRETYEKELKEAEKE 217

Query: 547 HQALSNTIES---MQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLE---LEVR 600
            + L   ++    ++K  E SA        IS         L EL+ AK  LE    E +
Sbjct: 218 LERLKQDLDPEKDLEKLAEASAELESLQKEISIM-ASVASVLKELEEAKANLEKAAEEEK 276

Query: 601 GYKLDLESTRRELETNKDQTIELRAKSKLEKA-----EGELTTVREENKKLKQGKIRLVY 655
             +  +ES ++ELE  K +  ELR K    +      E EL   + E +   + K+    
Sbjct: 277 SLRNLVESLKQELEEEKKELEELREKEGEAEEAASSLEAELNRTKSEKESKAREKMV--- 333

Query: 656 SLFKDPQPAQSKLEKAEGELTTVREENKKLK 686
            +    Q A S+ E+A  E    REE +KLK
Sbjct: 334 EIPLKLQQASSEAEEARKEAEAAREELRKLK 364

This family consists of several plant proteins of unknown function. Several sequences in this family are described as being "myosin heavy chain-like". Length = 484

>gnl|CDD|205692 pfam13514, AAA_27, AAA domain

 Score = 43.2 bits (102), Expect = 6e-04
 Identities = 60/338 (17%), Positives = 111/338 (32%), Gaps = 37/338 (10%)

Query: 298 KKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSDSTLPPSSEDMRHWK 357
           ++ +  A   L+  +KE   L+ AL  +  ++  +   A         LP +  +M  W 
Sbjct: 560 RQQEEAARRRLEQLEKELEVLELALAALREAWQAQWAAAG--------LPLTPAEMEDWL 611

Query: 358 RDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSL------QQDLTSHTSLLSKKEEE 411
            +R    +Q+     +  +L     R   L+A + +                LL    + 
Sbjct: 612 AERATAREQVRAYFKARAELDALLDRRARLRAALRAALKAVAIVLPGEELAELLELARQL 671

Query: 412 IDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELE 471
           ++   ++  +K S L     D       LEE      E               E   +  
Sbjct: 672 LEEAEKQAARKAS-LDERLRD---AERALEEAEERHDE------AQSALEAWQEQWYDAL 721

Query: 472 VLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEE 531
           +  G       A      +  Q++KE+  A  +L+Q      A++  L   E+E++   E
Sbjct: 722 LEAGLGGRASPAGALDALELLQNIKEKLQAADDLRQ---RIAAMERDLARFEEEVEALAE 778

Query: 532 ALATAQN--SLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLE-L 588
           A+A        D   R  +          K    +A    +++   E+ EK+       L
Sbjct: 779 AVAPEMLGTPADETARALKQRL-------KRARDTAAAAEKLAEEIEEAEKEVSEAAAAL 831

Query: 589 KSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAK 626
             A+ RL   +R  +              D   ELR +
Sbjct: 832 DEAEARLTALLRAARCTTIEELLAAVERSDTYRELRKR 869

This domain is found in a number of double-strand DNA break proteins. This domain contains a P-loop motif. Length = 1118

>gnl|CDD|219189 pfam06818, Fez1, Fez1

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 41/219 (18%)

Query: 407 KKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEV 466
           +K  EI  L+Q++ + +++L   + ++V+ R +L E R++L+E E  E+  + +  +   
Sbjct: 7   QKSGEISLLKQQLKESQAELAQKAGEIVSLRAQLREARAQLRESE--EQLQELQDALRTK 64

Query: 467 SKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQEL 526
           + ELEV   EL+ +K                            +E E L+EK   LE EL
Sbjct: 65  TLELEVCENELQRKK----------------------------SEAELLREKAGRLEAEL 96

Query: 527 KVSEEALATAQNSLDSKLRE-------HQALSNTIESMQKEMEQSAVRVREMSGISEK-- 577
               EALA+    L   L E        QA    +  +++++E+    +R      E+  
Sbjct: 97  AELREALASCPAPLPVLLTESDEAKAQRQAGEAGLRELRRQVERLRAELRYERRRREEQA 156

Query: 578 --YEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELE 614
             +E++R+   E K    R + +++   + +    +ELE
Sbjct: 157 SSFEQERRVWQEEKEKVIRYQKQLQQSYVQMYQRNQELE 195

This family represents the eukaryotic Fez1 protein. Fez1 contains a leucine-zipper region with similarity to the DNA-binding domain of the cAMP-responsive activating-transcription factor 5. There is evidence that Fez1 inhibits cancer cell growth through regulation of mitosis, and that its alterations result in abnormal cell growth. Note that some family members contain more than one copy of this region. Length = 200

>gnl|CDD|235316 PRK04863, mukB, cell division protein MukB; Provisional

 Score = 42.6 bits (101), Expect = 8e-04
 Identities = 50/248 (20%), Positives = 106/248 (42%), Gaps = 43/248 (17%)

Query: 367 LAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHT---SLLSKKEEEIDRLR-----QE 418
           L E +A  ++ +     +L+L+ ++S  Q   +       L+ K   E+ R       +E
Sbjct: 444 LEEFQAKEQEAT---EELLSLEQKLSVAQAAHSQFEQAYQLVRKIAGEVSRSEAWDVARE 500

Query: 419 MVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVS----KELEVLR 474
           ++++  +    +  L   R  L E+   L++++  E+      +    +     ELE L+
Sbjct: 501 LLRRLREQRHLAEQLQQLRMRLSELEQRLRQQQRAERLLAEFCKRLGKNLDDEDELEQLQ 560

Query: 475 GELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALA 534
            ELE +              ++  + +V+E ++ +       E+L +  Q L     A  
Sbjct: 561 EELEAR--------------LESLSESVSEARERRMALRQQLEQLQARIQRLAARAPAWL 606

Query: 535 TAQNSLDSKLREH--QALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAK 592
            AQ++L ++LRE   +   ++ +  +  M+Q   R RE++      E+D     EL + K
Sbjct: 607 AAQDAL-ARLREQSGEEFEDSQDVTE-YMQQLLERERELT-----VERD-----ELAARK 654

Query: 593 ERLELEVR 600
           + L+ E+ 
Sbjct: 655 QALDEEIE 662

Length = 1486

>gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type

 Score = 42.7 bits (101), Expect = 9e-04
 Identities = 51/258 (19%), Positives = 103/258 (39%), Gaps = 32/258 (12%)

Query: 543 KLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKT---LLELKSAKERLELEV 599
           K R  +     +E  ++ +++    + E+    +  E+  +      ELK+    LEL +
Sbjct: 171 KERRKETERK-LERTRENLDRLEDILNELERQLKSLERQAEKAERYKELKAELRELELAL 229

Query: 600 RGYKLDLESTRRELETNKDQTIEL-----RAKSKLEKAEGELTTVREENKKLKQGKIRLV 654
               L LE  R ELE  +++  E         ++L++ E +L  +R E  +L++      
Sbjct: 230 --LVLRLEELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEI---- 283

Query: 655 YSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLK 714
                  +  Q +L     E++ + ++ + L+                     S L++L 
Sbjct: 284 -------EELQKELYALANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELA 336

Query: 715 SNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNE 774
               E E       E + E + ++ +LE+ +   E+  +E+   LE L++  + L     
Sbjct: 337 EELAELE-------EKLEELKEELESLEAELEELEAELEELESRLEELEEQLETLRSKVA 389

Query: 775 QLRKKNNDILSHDNEQLR 792
           QL  +   I S +NE  R
Sbjct: 390 QLELQ---IASLNNEIER 404

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179

>gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning]

 Score = 42.4 bits (100), Expect = 0.001
 Identities = 53/237 (22%), Positives = 104/237 (43%), Gaps = 22/237 (9%)

Query: 570 EMSGISEKYEKDRKTLLELKSAKE---RLELEVRGYKLDLESTRRELETN---KDQTIEL 623
           E +G+S+  E+  +   +L+  +E   RLE  +   +  LE   R+ E     ++   EL
Sbjct: 163 EAAGVSKYKERKEEAERKLERTEENLERLEDLLEELEKQLEKLERQAEKAERYQELKAEL 222

Query: 624 RAKS------KLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTT 677
           R         KL++   EL  + EE  +L++    L     ++ + A+ ++E+ + EL  
Sbjct: 223 RELELALLLAKLKELRKELEELEEELSRLEEELEELQ----EELEEAEKEIEELKSELEE 278

Query: 678 VREENKKLKVSFF-FTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYET 736
           +REE ++L+        E   L   + +     LE+L++   E E +L    E I   + 
Sbjct: 279 LREELEELQEELLELKEEIEEL-EGEISLLRERLEELENELEELEERLEELKEKIEALKE 337

Query: 737 KITALESTMTRSESYCKEMVEYLETLQKNNDILSHD----NEQLRKKNNDILSHDNE 789
           ++   E+ +   E    E+ E  E L++    L  +     E LR++  ++ +   E
Sbjct: 338 ELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAE 394

Length = 1163

>gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584)

 Score = 42.4 bits (100), Expect = 0.001
 Identities = 59/317 (18%), Positives = 116/317 (36%), Gaps = 28/317 (8%)

Query: 478 EEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQ 537
            E +   +Q ++    +V ++  A  +L QA  E E  K         LK +   L   Q
Sbjct: 603 TELRERLQQAEEALQSAVAKQKQAEEQLVQANAELEEQKRAEAEARTALKQARLDLQRLQ 662

Query: 538 NSLDSKLREHQALSNTIESMQKEMEQSAVR-VREMSGISEKYEKDRKTLLE-LKSAKERL 595
           N       E Q+L + +E    E +Q A   +R++    ++  + ++  LE LK     L
Sbjct: 663 N-------EQQSLKDKLELAIAERKQQAETQLRQLDAQLKQLLEQQQAFLEALKDDFREL 715

Query: 596 ELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGK----I 651
             E       +E             IE    +   +A+  L  ++++  +          
Sbjct: 716 RTERLAKWQVVEGELDNQLAQLSAAIE----AARTQAKARLKELKKQYDRELASLDVDPN 771

Query: 652 RLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLE 711
            +   L +  +  ++ +E+       VRE    ++ ++   L  +SL    PN     L 
Sbjct: 772 TVK-ELKRQIEELETTIERIAVRRPEVREYRAFMQETW---LHRDSLREERPN-LAIQLR 826

Query: 712 DLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSH 771
           +L+S+  E + +L     +I + + +   LE      E   K++ +  E L+   D +  
Sbjct: 827 ELESSAEELQQELT---RLIKDTKLRRKKLEQERKALE---KQLDQLDELLRGLRDEMRQ 880

Query: 772 DNEQLRKKNNDILSHDN 788
             E     N +      
Sbjct: 881 LAELKEPANANQAEGSI 897

This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198

>gnl|CDD|220614 pfam10174, Cast, RIM-binding protein of the cytomatrix active zone

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 74/349 (21%), Positives = 143/349 (40%), Gaps = 43/349 (12%)

Query: 368 AEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLV 427
           AE +    +L   R  +  LQ ++  LQQ        L  ++EEI +L + +  K     
Sbjct: 121 AERERQAMELFLLRDTLEKLQLRMERLQQT-------LDARDEEIKKLLEMLQSKGLSAK 173

Query: 428 ATSSDLVATR---------HELEEVRSELKEKENLEKTDD--RKLEVCEVSKELEVLRGE 476
           A   D                LE +  + KEKE++   ++  +KL++     + E  +  
Sbjct: 174 AEEEDSERLGRIREAEDQQSHLEVLLEQ-KEKEHMMLREEIHQKLQMERDDAKTEASQKL 232

Query: 477 LEEQKTATKQWKKDWYQ--------------SVKERNAAVAELKQAQTENEALKEKLTSL 522
           ++E+ T  K+++K   +              S  +RN    E++  ++   A+K K    
Sbjct: 233 IDEKDTKIKEFEKMLEKAENEIYRLQSRCDTSEADRNRLDKEVEAERSALAAMKAKCDRA 292

Query: 523 EQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISE--KYEK 580
            QEL   +  L   Q  L++   +   +   ++ +++++ ++      +    +  +YE 
Sbjct: 293 AQELSRKKTELLGLQTELETLANQDSDMRQHLDKLKEDLTRAEQEKAILQTEVDALRYEL 352

Query: 581 DRK-TLLELKSAK-ERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTT 638
           +RK   L  K+A  +  + E   Y  ++E  R   E  + +   L+     +K E    T
Sbjct: 353 ERKHNTLTKKTASLQAAQEEKATYAGEIEDMRDRYEKTERKLRVLQ-----KKIENLQET 407

Query: 639 VREENKKLKQGKIRL-VYSLFKDPQPAQSKLEKAEGELTTVREENKKLK 686
            R + ++LK+ K RL       +   A  KLEKA  E   + E  K+ +
Sbjct: 408 FRRKERRLKEEKERLRSLQTDTNTDTALEKLEKALAEKERIIERLKEQR 456

This is a family of proteins that form part of the CAZ (cytomatrix at the active zone) complex which is involved in determining the site of synaptic vesicle fusion. The C-terminus is a PDZ-binding motif that binds directly to RIM (a small G protein Rab-3A effector). The family also contains four coiled-coil domains. Length = 774

>gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional

 Score = 42.1 bits (98), Expect = 0.001
 Identities = 60/282 (21%), Positives = 113/282 (40%), Gaps = 25/282 (8%)

Query: 407  KKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRK----LE 462
            K  EE  +  +E   +E      +      R +      E ++ + L+K +++K     +
Sbjct: 1237 KDAEEAKKAEEERNNEEIRKFEEARMAHFARRQAAIKAEEARKADELKKAEEKKKADEAK 1296

Query: 463  VCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSL 522
              E  K+ +  + + EE K A  + KK   ++ K+ +AA  + ++A+   EA K +  + 
Sbjct: 1297 KAEEKKKADEAKKKAEEAKKA-DEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAA 1355

Query: 523  EQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDR 582
              E + +EE    A+   +   ++  A     E  +K  E             +K E+D+
Sbjct: 1356 ADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADE-----------AKKKAEEDK 1404

Query: 583  KTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREE 642
            K   ELK A           K   +  +++ E  K +  E + K++  K   E     EE
Sbjct: 1405 KKADELKKAAAA--------KKKADEAKKKAE-EKKKADEAKKKAEEAKKADEAKKKAEE 1455

Query: 643  NKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKK 684
             KK ++ K +   +   D    +++  K   E     EE KK
Sbjct: 1456 AKKAEEAKKKAEEAKKADEAKKKAEEAKKADEAKKKAEEAKK 1497

Length = 2084

>gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional

 Score = 42.1 bits (98), Expect = 0.001
 Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 11/220 (5%)

Query: 437  RHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVK 496
            +   E+    L++ E  +K ++ ++E      E E      E +K    + K +  +  +
Sbjct: 1570 KKAEEDKNMALRKAEEAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAE 1629

Query: 497  ERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIES 556
            E    V +LK+ + E +   E+L   E+E K+     A        K  E        E 
Sbjct: 1630 EEKKKVEQLKKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKKKAEE---AKKAEED 1686

Query: 557  MQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETN 616
             +K  E       E    ++K E+ +K   E K   E L+      K+  E  ++E E +
Sbjct: 1687 EKKAAEALKKEAEE----AKKAEELKKKEAEEKKKAEELKKAEEENKIKAEEAKKEAEED 1742

Query: 617  KDQTIELRA----KSKLEKAEGELTTVREENKKLKQGKIR 652
            K +  E +     K K+   + E     EE +K K+  I 
Sbjct: 1743 KKKAEEAKKDEEEKKKIAHLKKEEEKKAEEIRKEKEAVIE 1782

Length = 2084

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 21/143 (14%)

Query: 86  IMEYVTGGDFVTLL-----ENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           I+ ++  GD  T L       +P     ++  RF I ++A  ++YL    ++HRD+   N
Sbjct: 85  ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI-DIASGMEYLSSKNFIHRDLAARN 143

Query: 141 MLLSATGHLKLTDFGSATQVDKNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
            +L+    + + DFG + ++      +    S +PV   +++A E L         + YT
Sbjct: 144 CMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV---KWLALESL-------ADNVYT 193

Query: 197 GSCDLWSIGVVSYELLT-GSTPF 218
              D+W+ GV  +E++T G TP+
Sbjct: 194 THSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|100796 PRK01156, PRK01156, chromosome segregation protein; Provisional

 Score = 42.2 bits (99), Expect = 0.001
 Identities = 60/309 (19%), Positives = 112/309 (36%), Gaps = 39/309 (12%)

Query: 515 LKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGI 574
           L+EKL S   EL+  ++ +A  + S    L+E + LS    +   +       + E+S +
Sbjct: 188 LEEKLKSSNLELENIKKQIADDEKSHSITLKEIERLSIEYNNAMDDYNNLKSALNELSSL 247

Query: 575 SE---KYEKDRKT-----------LLELKSAKERLEL-----------EVRGY---KLDL 606
            +   +YE + KT               K  +ER               +  Y   K D+
Sbjct: 248 EDMKNRYESEIKTAESDLSMELEKNNYYKELEERHMKIINDPVYKNRNYINDYFKYKNDI 307

Query: 607 ESTRRELETNKDQTIE----LRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQ 662
           E+ ++ L     +  +    ++  S L+K   +      + K         +  L     
Sbjct: 308 ENKKQILSNIDAEINKYHAIIKKLSVLQKDYNDY----IKKKSRYDDLNNQILELEGYEM 363

Query: 663 PAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERES 722
              S L+  E     + E +K ++    F  E   +  +DP+     L ++     +  S
Sbjct: 364 DYNSYLKSIESLKKKIEEYSKNIERMSAFISEILKIQEIDPDAIKKELNEINVKLQDISS 423

Query: 723 KLRSANEIIGEYETKITALESTMT--RSESYCKEMVEYLETLQKNNDILSHDNEQLRKKN 780
           K+ S N+ I      +  L   M     +S C      L   +K+N I++H NE+  +  
Sbjct: 424 KVSSLNQRIRALRENLDELSRNMEMLNGQSVCPVCGTTLGE-EKSNHIINHYNEKKSRLE 482

Query: 781 NDILSHDNE 789
             I   + E
Sbjct: 483 EKIREIEIE 491

Length = 895

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 31/108 (28%), Positives = 58/108 (53%), Gaps = 17/108 (15%)

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIK--SIVPV 172
            ++AQ + +L     +HRD+   N+LL+     K+ DFG A  +  D N  +K  + +PV
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 173 GTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              +++APE + + +        YT   D+WS G++ +E+ + G +P+
Sbjct: 279 ---KWMAPESIFDCV--------YTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain

 Score = 41.9 bits (98), Expect = 0.002
 Identities = 43/257 (16%), Positives = 88/257 (34%), Gaps = 12/257 (4%)

Query: 363 LLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKK 422
           L Q L E K   ++       +  L  +   L+ +L          EE++    +E+ K 
Sbjct: 268 LAQVLKENKEEEKEKKLQEEELKLLAKEEEELKSELLKLERRKVDDEEKLKESEKELKKL 327

Query: 423 ESDLVATSSDLVATRHELEEV--RSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQ 480
           E +L     ++     EL+E+  + E +E+E  +    ++       + L   + E E  
Sbjct: 328 EKELKKEKEEIEELEKELKELEIKREAEEEEEEQLEKLQEKLEQLEEELLAKKKLESERL 387

Query: 481 KTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSL 540
            +A K  +++     +E   A   L+ ++ E + LKE+     + ++  EE+L T Q   
Sbjct: 388 SSAAKLKEEELELKNEEEKEAKLLLELSEQEEDLLKEEKKEELKIVEELEESLETKQ--- 444

Query: 541 DSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVR 600
                            Q           + S   +  ++ +   L  +     L  ++ 
Sbjct: 445 -----GKLTEEKEELEKQALKLLKDKLELKKS--EDLLKETKLVKLLEQLELLLLRQKLE 497

Query: 601 GYKLDLESTRRELETNK 617
                    R  L    
Sbjct: 498 EASQKESKAREGLAVLL 514

This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162

>gnl|CDD|220614 pfam10174, Cast, RIM-binding protein of the cytomatrix active zone

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 66/278 (23%), Positives = 102/278 (36%), Gaps = 45/278 (16%)

Query: 405 LSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVC 464
           L K E EI RL+      E+D             E+E  RS L   +   K D    E+ 
Sbjct: 247 LEKAENEIYRLQSRCDTSEADRNRLDK-------EVEAERSALAAMKA--KCDRAAQELS 297

Query: 465 EVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQ 524
               EL  L+ ELE          +     +KE      +L +A+ E   L+ ++ +L  
Sbjct: 298 RKKTELLGLQTELET-LANQDSDMRQHLDKLKE------DLTRAEQEKAILQTEVDALRY 350

Query: 525 ELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSG-ISEKYEKDRK 583
           EL+     L     SL +   E    +  IE M+   E++  ++R +   I    E  R+
Sbjct: 351 ELERKHNTLTKKTASLQAAQEEKATYAGEIEDMRDRYEKTERKLRVLQKKIENLQETFRR 410

Query: 584 TLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREEN 643
               LK  KERL                   + +  T    A  KLEKA  E   + E  
Sbjct: 411 KERRLKEEKERLR------------------SLQTDTNTDTALEKLEKALAEKERIIERL 452

Query: 644 KKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREE 681
           K+ +           +D +  Q + E  + E   ++EE
Sbjct: 453 KEQRD----------RDERYEQEEFETYKKEFEDLKEE 480

This is a family of proteins that form part of the CAZ (cytomatrix at the active zone) complex which is involved in determining the site of synaptic vesicle fusion. The C-terminus is a PDZ-binding motif that binds directly to RIM (a small G protein Rab-3A effector). The family also contains four coiled-coil domains. Length = 774

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 53/235 (22%), Positives = 87/235 (37%), Gaps = 56/235 (23%)

Query: 19  IKRFIQQGNFGDIYLVE-------EKQSHNTFVMK--------KVLR----EKMPNTIER 59
               + +G FG+++L E        +++               KVLR    +       +
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68

Query: 60  D--IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF-----------VTLLENQPHGY 106
           +  I+ +   P I  L         +  IMEY+  GD              L  N     
Sbjct: 69  EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK--S 126

Query: 107 LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN--- 163
           LS S   +   ++A  ++YL  L +VHRD+   N L+     +K+ DFG +  +  +   
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 164 ---GRIKSIVPVGTPEYVAPEVLEWM--EGNHGSDGYTGSCDLWSIGVVSYELLT 213
              GR             AP  + WM  E       +T   D+W+ GV  +E+LT
Sbjct: 187 RVQGR-------------APLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|234084 TIGR03007, pepcterm_ChnLen, polysaccharide chain length determinant protein, PEP-CTERM locus subfamily

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 34/186 (18%), Positives = 68/186 (36%), Gaps = 30/186 (16%)

Query: 405 LSKKEEEIDRLRQE----MVKKESDLVATSSDLVATRHELEEVRSELKEKEN----LEK- 455
           L   E  +   +QE    +  +E D     S++   + ELE  R EL E       L++ 
Sbjct: 177 LEAAENRLKAFKQENGGILPDQEGDYY---SEISEAQEELEAARLELNEAIAQRDALKRQ 233

Query: 456 -TDDRKLEVCEVSKELEVLRGELEEQKTATKQWK---KDWYQSVKERNAAVAELKQAQTE 511
              +  + +   S     L G +E  +      +    D +  V      +A+L++ + E
Sbjct: 234 LGGEEPVLLAGSSVANSELDGRIEALEKQLDALRLRYTDKHPDVIATKREIAQLEEQKEE 293

Query: 512 NEALK--------------EKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESM 557
             + K              ++L     E +    +L      L +++   ++L  TI  +
Sbjct: 294 EGSAKNGGPERGEIANPVYQQLQIELAEAEAEIASLEARVAELTARIERLESLLRTIPEV 353

Query: 558 QKEMEQ 563
           + E+ Q
Sbjct: 354 EAELTQ 359

Members of this protein family belong to the family of polysaccharide chain length determinant proteins (pfam02706). All are found in species that encode the PEP-CTERM/exosortase system predicted to act in protein sorting in a number of Gram-negative bacteria, and are found near the epsH homolog that is the putative exosortase gene [Cell envelope, Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides]. Length = 498

>gnl|CDD|237177 PRK12704, PRK12704, phosphodiesterase; Provisional

 Score = 40.9 bits (97), Expect = 0.002
 Identities = 45/194 (23%), Positives = 74/194 (38%), Gaps = 46/194 (23%)

Query: 448 KEKENLEKTDDRKLEVCEVSKELEVLRGELE-EQKTATKQWKKDWYQSVKERNAAVAEL- 505
            + +  E+   R LE  E  KE E ++ E   E K    + + ++ + ++ER   + +L 
Sbjct: 31  AKIKEAEEEAKRILE--EAKKEAEAIKKEALLEAKEEIHKLRNEFEKELRERRNELQKLE 88

Query: 506 KQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSA 565
           K+   + E L  KL  LE+     EE L   +  L+ K +E       +E  ++E+E   
Sbjct: 89  KRLLQKEENLDRKLELLEKR----EEELEKKEKELEQKQQE-------LEKKEEELE--- 134

Query: 566 VRVREMSGISEKYEKDRKTLLELKS-----AKERLELEVRGYKLDLESTRRELETNKDQT 620
                     E  E+  + L  +       AKE L          LE    E        
Sbjct: 135 ----------ELIEEQLQELERISGLTAEEAKEIL----------LEKVEEEARHEAAVL 174

Query: 621 I---ELRAKSKLEK 631
           I   E  AK + +K
Sbjct: 175 IKEIEEEAKEEADK 188

Length = 520

>gnl|CDD|205039 pfam12718, Tropomyosin_1, Tropomyosin like

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 35/144 (24%), Positives = 66/144 (45%), Gaps = 18/144 (12%)

Query: 441 EEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNA 500
           EE+  +LKE E  ++  +++ E+  + K+ + L  E+E+ +             +KE   
Sbjct: 17  EELEEKLKELE--QENLEKEQEITSLQKKNQQLEEEVEKLEE-----------QLKEAKE 63

Query: 501 AVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKE 560
            + E ++  T  EAL  ++  LE+EL+ SE+ L         KLRE    +   E   K 
Sbjct: 64  KLEESEKLATNAEALTRRIQLLEEELEESEKRLKET----TEKLREADKKAEESERKVKA 119

Query: 561 MEQSAVRV-REMSGISEKYEKDRK 583
           +E        +   + +KY++ +K
Sbjct: 120 LENERDEWEEKYEELEKKYKEAKK 143

This family is a set of eukaryotic tropomyosins. Within the yeast Tmp1 and Tmp2, biochemical and sequence analyses indicate that Tpm2p spans four actin monomers along a filament, whereas Tpmlp spans five. Despite its shorter length, Tpm2p can compete with Tpm1p for binding to F-actin. Over-expression of Tpm2p in vivo alters the axial budding of haploids to a bipolar pattern, and this can be partially suppressed by co-over-expression of Tpm1p. This suggests distinct functions for the two tropomyosins, and indicates that the ratio between them is important for correct morphogenesis. The family also contains higher eukaryote Tmp3 members. Length = 143

>gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional

 Score = 40.8 bits (96), Expect = 0.003
 Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 28/198 (14%)

Query: 405 LSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKE---NLEKTDDRKL 461
           L   E+E++R  +E+ K E +L     +L  T   LEE+R EL+E E   + E+ ++ + 
Sbjct: 607 LKDAEKELEREEKELKKLEEELDKAFEELAETEKRLEELRKELEELEKKYSEEEYEELRE 666

Query: 462 EVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTS 521
           E  E+S+EL  LR ELEE +   ++ KK               L++ + E E  ++    
Sbjct: 667 EYLELSRELAGLRAELEELEKRREEIKKT--------------LEKLKEELEEREKA--- 709

Query: 522 LEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREM-----SGISE 576
            ++EL+  E+AL   +  L  K+++++AL     ++ K  E ++    E+     SG+  
Sbjct: 710 -KKELEKLEKALERVEE-LREKVKKYKALL-KERALSKVGEIASEIFEELTEGKYSGVRV 766

Query: 577 KYEKDRKTLLELKSAKER 594
           K E+++  L  +   KER
Sbjct: 767 KAEENKVKLFVVYQGKER 784

Length = 880

>gnl|CDD|220614 pfam10174, Cast, RIM-binding protein of the cytomatrix active zone

 Score = 41.2 bits (96), Expect = 0.003
 Identities = 61/270 (22%), Positives = 117/270 (43%), Gaps = 18/270 (6%)

Query: 377 LSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVAT 436
           L+  + +      ++S  + +L    + L     +   +RQ + K + DL     +    
Sbjct: 282 LAAMKAKCDRAAQELSRKKTELLGLQTELETLANQDSDMRQHLDKLKEDLTRAEQEKAIL 341

Query: 437 RHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVK 496
           + E++ +R EL+ K N        L+     +E     GE+E+         +D Y+   
Sbjct: 342 QTEVDALRYELERKHNTLTKKTASLQ--AAQEEKATYAGEIED--------MRDRYE-KT 390

Query: 497 ERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIES 556
           ER     +L+  Q + E L+E     E+ LK  +E L + Q   ++     +      E 
Sbjct: 391 ER-----KLRVLQKKIENLQETFRRKERRLKEEKERLRSLQTDTNTDTALEKLEKALAEK 445

Query: 557 MQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETN 616
            +        R R+     E++E  +K   +LK   + L+L++   +L LE  + E+   
Sbjct: 446 ERIIERLKEQRDRDERYEQEEFETYKKEFEDLKEEVQNLQLKLSERELQLELLKEEVS-- 503

Query: 617 KDQTIELRAKSKLEKAEGELTTVREENKKL 646
           K  + +L+ +S LE+A  EL  +RE+++KL
Sbjct: 504 KLASNQLKQRSDLERAHIELEKIREKHEKL 533

This is a family of proteins that form part of the CAZ (cytomatrix at the active zone) complex which is involved in determining the site of synaptic vesicle fusion. The C-terminus is a PDZ-binding motif that binds directly to RIM (a small G protein Rab-3A effector). The family also contains four coiled-coil domains. Length = 774

>gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional

 Score = 40.9 bits (95), Expect = 0.003
 Identities = 55/250 (22%), Positives = 103/250 (41%), Gaps = 19/250 (7%)

Query: 441  EEVRS--ELKEK-ENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKE 497
            EE +   E K+K E  +K D+ K +  E  K+ +  + + EE K A +  K +   +  E
Sbjct: 1299 EEKKKADEAKKKAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADE 1358

Query: 498  RNAAVAELKQAQTENEALKEKLTSLE---QELKVSEEALATAQNSLDSKLREHQALSNTI 554
              AA  + + A+ + E  K+K  + +   +E K ++EA   A+   D K  +    +   
Sbjct: 1359 AEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEE--DKKKADELKKAAAA 1416

Query: 555  ESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELE 614
            +    E ++ A   ++     +K E+ +K     K A+E  + E    K +     ++ +
Sbjct: 1417 KKKADEAKKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAKKAEEAKKKAE---EAKKAD 1473

Query: 615  TNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGE 674
              K +  E +   + +K   E     +E KK  + K        K    A+   E  + +
Sbjct: 1474 EAKKKAEEAKKADEAKKKAEEAKKKADEAKKAAEAK--------KKADEAKKAEEAKKAD 1525

Query: 675  LTTVREENKK 684
                 EE KK
Sbjct: 1526 EAKKAEEAKK 1535

Length = 2084

>gnl|CDD|205692 pfam13514, AAA_27, AAA domain

 Score = 40.9 bits (96), Expect = 0.003
 Identities = 81/371 (21%), Positives = 129/371 (34%), Gaps = 70/371 (18%)

Query: 440 LEEVRSEL-KEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKER 498
           L  VR EL KE + L K   RK E+    KEL+ L  E+ E +  T+ WK      VK  
Sbjct: 128 LGSVRDELEKEADELWKPRGRKPEINVALKELKELEAEIREVQLKTRTWKD----LVKAL 183

Query: 499 NAAVAELKQAQTE---NEALKEKLTSLEQ------ELKVSEEALA--------------- 534
           + A  EL   + E    E  K++L  L +      E K  E+ LA               
Sbjct: 184 DEAEEELANLRKELRQLEKEKQRLERLRRLLPLLAERKALEQQLAALGEVIDLPPDAVER 243

Query: 535 --TAQNSLDSKLREHQALSNTIESMQKEME---------QSAVRVREMSGISEKYEKDRK 583
              A+  L +  R  + L+  +E++Q E++           A  +  +     +Y    +
Sbjct: 244 YEEARAELRAARRNLELLTERLEALQAELDEISLDEELLAQAAAIEALHQQRGEYRNAEQ 303

Query: 584 TLLEL-------KSAKERLELEVRGYKLDLESTR------------RELETNK---DQTI 621
            L +        + A   L  ++ G   D E+               ELE  K   DQ +
Sbjct: 304 DLPDREGEIANAREAAAALLAQI-GPDADEEAVESLRPSLAAKETVTELEKRKEALDQAL 362

Query: 622 ELRAKSKLEKAEGELTTVREENKKL--KQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVR 679
           +  A+  LE+ E EL  VR +   L        L  +L    +        A  E     
Sbjct: 363 KS-ARDALEERERELKQVRAQLAALPTVTVPEPLRAALADALRAGDIDAALAALEQEVAV 421

Query: 680 EENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKS---NYTERESKLRSANEIIGEYET 736
            + +  +      L    L  L     + S E +++      E     R   + + E E 
Sbjct: 422 AKRELAQALSRLGLWRGDLEELVA-LPVPSAEQVQAFLKEAEEIMQAKRQKRDRLLELEE 480

Query: 737 KITALESTMTR 747
            +  LE  +  
Sbjct: 481 DLETLELQLRH 491

This domain is found in a number of double-strand DNA break proteins. This domain contains a P-loop motif. Length = 1118

>gnl|CDD|100796 PRK01156, PRK01156, chromosome segregation protein; Provisional

 Score = 41.0 bits (96), Expect = 0.003
 Identities = 75/488 (15%), Positives = 169/488 (34%), Gaps = 65/488 (13%)

Query: 351 EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE 410
           E ++    +   + +Q+A+ + S         R+            +L S  + LS  E+
Sbjct: 190 EKLKSSNLELENIKKQIADDEKSHSITLKEIERLSIEYNNAMDDYNNLKSALNELSSLED 249

Query: 411 EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKEL 470
             +R   E+   ESDL              +E+     +  N     +R         + 
Sbjct: 250 MKNRYESEIKTAESDLSMELEKNN----YYKELEERHMKIINDPVYKNR-----NYINDY 300

Query: 471 EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSE 530
              + ++E +K        +           ++ L++   +    K +   L  ++    
Sbjct: 301 FKYKNDIENKKQILSNIDAE-INKYHAIIKKLSVLQKDYNDYIKKKSRYDDLNNQI---- 355

Query: 531 EALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISE--------KYEKDR 582
             L   +   +S L+  ++L   IE   K +E+ +  + E+  I E        +  +  
Sbjct: 356 LELEGYEMDYNSYLKSIESLKKKIEEYSKNIERMSAFISEILKIQEIDPDAIKKELNEIN 415

Query: 583 KTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTI--------------------- 621
             L ++ S    L   +R  + +L+   R +E    Q++                     
Sbjct: 416 VKLQDISSKVSSLNQRIRALRENLDELSRNMEMLNGQSVCPVCGTTLGEEKSNHIINHYN 475

Query: 622 --ELRAKSKLEKAEGELTTVREENKKLKQ-------GKIRLVYSLFKDPQPAQSKLEKAE 672
             + R + K+ + E E+  + E+   LK+        +I    + +   + A++ LE  +
Sbjct: 476 EKKSRLEEKIREIEIEVKDIDEKIVDLKKRKEYLESEEINKSINEYNKIESARADLEDIK 535

Query: 673 GELTTVREENKK-------LKVSFFFTLESNSLFWLDPNTFLSS--LEDLKSNYTERESK 723
            ++  +++++ K        K      L+S    WL+    +S   +E  +S   E + +
Sbjct: 536 IKINELKDKHDKYEEIKNRYKSLKLEDLDSKRTSWLNALAVISLIDIETNRSRSNEIKKQ 595

Query: 724 LRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNNDI 783
           L      + E E      +S     +   +E+      L  N      +N+ L +K    
Sbjct: 596 LNDLESRLQEIEIGFPDDKSY---IDKSIREIENEANNL-NNKYNEIQENKILIEKLRGK 651

Query: 784 LSHDNEQL 791
           + +  +Q+
Sbjct: 652 IDNYKKQI 659

Length = 895

>gnl|CDD|178768 PLN03229, PLN03229, acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha; Provisional

 Score = 41.0 bits (96), Expect = 0.003
 Identities = 45/212 (21%), Positives = 89/212 (41%), Gaps = 20/212 (9%)

Query: 441 EEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGE-LEEQKTATKQWKKDWYQSVKERN 499
           E V  + + K N++K +  K  V E+  E+E L+ + L+ +++++K  +    + +++  
Sbjct: 409 EGVPVDPERKVNMKKREAVKTPVRELEGEVEKLKEQILKAKESSSKPSELALNEMIEKLK 468

Query: 500 AAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQK 559
             +            L+E+L +L +E      + A +Q+ L      H  L   IE ++ 
Sbjct: 469 KEIDLEYTEAVIAMGLQERLENLREEF-----SKANSQDQL-----MHPVLMEKIEKLKD 518

Query: 560 EMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQ 619
           E  +   R      +  K +     L E   AK   E + +  KL  E  ++  E     
Sbjct: 519 EFNKRLSRAPNYLSLKYKLDM----LNEFSRAKALSEKKSKAEKLKAEINKKFKEVMDRP 574

Query: 620 TIELRAKSKLEKAE---GELTTVREENKKLKQ 648
             E++ K +  KAE      ++  E +  LK+
Sbjct: 575 --EIKEKMEALKAEVASSGASSGDELDDDLKE 604

Length = 762

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.0 bits (96), Expect = 0.003
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 35/226 (15%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD 60
            D++  L+++NV          I +G  G  Y  +  ++   FV+K++       + E  
Sbjct: 686 NDILSSLKEENV----------ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA 735

Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
            M K + P IV L    +     Y I EY+ G +   +L N     LS  + R     +A
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIA 790

Query: 121 QAVQYLH---GLGYVHRDIKPDNMLLSATG--HLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           +A+++LH       V  ++ P+ +++      HL+L+  G     D    I S       
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLC-TDTKCFISS------- 842

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
            YVAPE  E  +        T   D++  G++  ELLTG +P + E
Sbjct: 843 AYVAPETRETKD-------ITEKSDIYGFGLILIELLTGKSPADAE 881

Length = 968

>gnl|CDD|149160 pfam07926, TPR_MLP1_2, TPR/MLP1/MLP2-like protein

 Score = 38.0 bits (89), Expect = 0.003
 Identities = 24/125 (19%), Positives = 57/125 (45%), Gaps = 17/125 (13%)

Query: 495 VKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTI 554
            +E+++  AELK+   + E  +EK+  L+++L+   E    AQ   + +L +H      +
Sbjct: 2   EEEKSSLQAELKRLLEKKEDAEEKIQKLQEDLEEQAEIANEAQQKYERELVKHAEDIEEL 61

Query: 555 ESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELE 614
           ++++K++ +                  +K + +LK+  E  + E+   +   E  ++ LE
Sbjct: 62  QALRKQLNEL-----------------KKEIAQLKAEAESAQAELSEAEESWEEQKKMLE 104

Query: 615 TNKDQ 619
               +
Sbjct: 105 DELSE 109

The sequences featured in this family are similar to a region of human TPR protein and to yeast myosin-like proteins 1 (MLP1) and 2 (MLP2). These proteins share a number of features; for example, they all have coiled-coil regions and all three are associated with nuclear pores. TPR is thought to be a component of nuclear pore complex- attached intra-nuclear filaments, and is implicated in nuclear protein import. Moreover, its N-terminal region is involved in the activation of oncogenic kinases, possibly by mediating the dimerisation of kinase domains or by targeting these kinases to the nuclear pore complex. MLP1 and MLP2 are involved in the process of telomere length regulation, where they are thought to interact with proteins such as Tel1p and modulate their activity. Length = 132

>gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional

 Score = 40.4 bits (95), Expect = 0.004
 Identities = 57/273 (20%), Positives = 107/273 (39%), Gaps = 37/273 (13%)

Query: 516 KEKLTSLEQELKVSEEA-LATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGI 574
           +  L  L+ +++  EE  L    N L+S+L E   L   IE  +++ EQ+     E   +
Sbjct: 186 RGSLDQLKAQIEEKEEKDLHERLNGLESELAE---LDEEIERYEEQREQARETRDEADEV 242

Query: 575 SEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIEL-------RAKS 627
            E++E+ R+ L  L++  E L   +   + + E    E+   +++  EL        A++
Sbjct: 243 LEEHEERREELETLEAEIEDLRETIAETEREREELAEEVRDLRERLEELEEERDDLLAEA 302

Query: 628 KLEKAEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEG---ELTTVREENKK 684
            L+ A+ E   V    ++L+     L   L +    AQ+  E+AE    +   + E  ++
Sbjct: 303 GLDDADAE--AVEARREELEDRDEELRDRLEECRVAAQAHNEEAESLREDADDLEERAEE 360

Query: 685 LKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALEST 744
           L+                         +L+S   E    +    E I E E +I  L   
Sbjct: 361 LR---------------------EEAAELESELEEAREAVEDRREEIEELEEEIEELRER 399

Query: 745 MTRSESYCKEMVEYLETLQKNNDILSHDNEQLR 777
              +        ++LE L++  D L     +L 
Sbjct: 400 FGDAPVDLGNAEDFLEELREERDELREREAELE 432

Length = 880

>gnl|CDD|235316 PRK04863, mukB, cell division protein MukB; Provisional

 Score = 40.3 bits (95), Expect = 0.004
 Identities = 38/192 (19%), Positives = 79/192 (41%), Gaps = 35/192 (18%)

Query: 362 QLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVK 421
           +LL++L E +   E       ++  L+ ++S L+Q L              +RL  E  K
Sbjct: 500 ELLRRLREQRHLAE-------QLQQLRMRLSELEQRLRQQQRA--------ERLLAEFCK 544

Query: 422 KESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQK 481
           +    +    +L   + ELE     L E   + +  +R++ + +  ++L+     L  + 
Sbjct: 545 RLGKNLDDEDELEQLQEELEARLESLSES--VSEARERRMALRQQLEQLQARIQRLAARA 602

Query: 482 TATKQWKKDWYQSVKERNAAVAELK----QAQTENEALKEKLTSL---EQELKVSEEALA 534
            A       W  +      A+A L+    +   +++ + E +  L   E+EL V  + LA
Sbjct: 603 PA-------WLAA----QDALARLREQSGEEFEDSQDVTEYMQQLLERERELTVERDELA 651

Query: 535 TAQNSLDSKLRE 546
             + +LD ++  
Sbjct: 652 ARKQALDEEIER 663

Length = 1486

>gnl|CDD|116500 pfam07888, CALCOCO1, Calcium binding and coiled-coil domain (CALCOCO1) like

 Score = 40.4 bits (94), Expect = 0.004
 Identities = 65/284 (22%), Positives = 138/284 (48%), Gaps = 30/284 (10%)

Query: 353 MRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEI 412
           +RH      +L +Q  EA++S E +S  R  +LA +A+      +L      L++K++E 
Sbjct: 180 LRHSTEKTEELEEQHKEAQSSSESMSAERNALLAQRAENQQRILELEQDIQTLTQKKQEN 239

Query: 413 DRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEV 472
           DR+ +     E++L     +L   +  L+++  + +++E   +  D +LE  ++ ++L  
Sbjct: 240 DRVLEGTQDIEAELERMKGEL---KQRLKKMTIQRRDEET--ERIDLQLENEQLHEDLRT 294

Query: 473 LRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEA 532
           L+  LE  +       ++       R+  +AEL Q+         +L S +  L++S+  
Sbjct: 295 LQERLESSQQKAGLLGEELASLGSLRDHTIAELHQS---------RLESAQMSLQLSQLN 345

Query: 533 LATAQNSLDSKLREHQA-LSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSA 591
           L          L+E Q+  +   E++++  E    R++++S  +E  + + + L E +S 
Sbjct: 346 L---------ALKEGQSQWAQERETLRQSAEADKDRIQKLS--AELLKLE-EWLQEERSQ 393

Query: 592 KERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGE 635
           +E+LE+E+   K   +  R +L  N+ +  ELR+  ++ + E E
Sbjct: 394 REKLEVELGIEK---DCNRVQLSENRRELSELRSALRVLQKEKE 434

Proteins found in this family are similar to the coiled-coil transcriptional coactivator protein coexpressed by Mus musculus (CoCoA/CALCOCO1). This protein binds to a highly conserved N-terminal domain of p160 coactivators, such as GRIP1, and thus enhances transcriptional activation by a number of nuclear receptors. CALCOCO1 has a central coiled-coil region with three leucine zipper motifs, which is required for its interaction with GRIP1 and may regulate the autonomous transcriptional activation activity of the C-terminal region. Length = 546

>gnl|CDD|200948 pfam00038, Filament, Intermediate filament protein

 Score = 39.5 bits (93), Expect = 0.004
 Identities = 60/265 (22%), Positives = 113/265 (42%), Gaps = 51/265 (19%)

Query: 365 QQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKES 424
           Q++ E +  L++L+  R R   LQ ++ +L+           K E+E+  LRQ       
Sbjct: 54  QEIRELRKQLDELTNERAR---LQLEIDNLRLA---AEDFREKYEDEL-NLRQSA----- 101

Query: 425 DLVATSSDLVATRHELEEVRSELKEKENLEKTD-DRKLEVCEVSKELEVLRGELEEQ-KT 482
                 +D+V  R +L+E          L + D + K+E   + +EL  L+   EE+ + 
Sbjct: 102 -----ENDIVGLRKDLDE--------ATLARVDLEMKIE--SLQEELAFLKKNHEEEVRE 146

Query: 483 ATKQWKKDWYQSV-----KERNAAVAELKQAQTENEALK----------EKLTSLEQELK 527
              Q +      +      +   A+AE++ AQ E  A K           KL  L+Q   
Sbjct: 147 LQSQIQGQVNVEMDAARKLDLTKALAEIR-AQYEELAEKNRQEAEEWYKSKLEELQQAAA 205

Query: 528 VSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLE 587
            + +AL +A+  +    R+ Q+L   ++S++K+      ++ E+    E+YE +     +
Sbjct: 206 RNGDALRSAKEEITELRRQIQSLEIELQSLKKQKASLERQLAEL---EERYELELADYQD 262

Query: 588 LKSAKERLELEVRGYKLDLESTRRE 612
             S  E    E++  K ++    RE
Sbjct: 263 TISELEE---ELQQLKAEMARQLRE 284

Length = 312

>gnl|CDD|236892 PRK11281, PRK11281, hypothetical protein; Provisional

 Score = 40.3 bits (95), Expect = 0.004
 Identities = 44/217 (20%), Positives = 86/217 (39%), Gaps = 50/217 (23%)

Query: 441 EEVRSELKE-KENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERN 499
            +V+++L    +      + KL   ++ + L +L  +++ QK  T+Q K+   Q      
Sbjct: 39  ADVQAQLDALNKQKLLEAEDKLVQQDLEQTLALL-DKIDRQKEETEQLKQQLAQ------ 91

Query: 500 AAVAELKQAQTENEALKE--------------------KLTSLEQELKVSEEALATAQNS 539
            A A+L+QAQ E EALK+                    +L     +L+ ++  LA   NS
Sbjct: 92  -APAKLRQAQAELEALKDDNDEETRETLSTLSLRQLESRLAQTLDQLQNAQNDLAEY-NS 149

Query: 540 LDSKLREHQALSNTIESMQKEMEQSAVRVREMSGI-------SEKYEKDRKT-------L 585
               L+         E  Q  +  ++ R++++  +        +     ++        L
Sbjct: 150 QLVSLQ------TQPERAQAALYANSQRLQQIRNLLKGGKVGGKALRPSQRVLLQAEQAL 203

Query: 586 LELKSAKERLELEVRGYKLDLESTRRELETNKDQTIE 622
           L  ++  +R  LE      DL   +R+  T + Q +E
Sbjct: 204 LNAQNDLQRKSLEGNTQLQDLLQKQRDYLTARIQRLE 240

Length = 1113

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	792
KOG0612|consensus	1317		100.0
KOG0605|consensus	550		100.0
KOG0598|consensus	357		100.0
KOG0616|consensus	355		100.0
KOG0615|consensus	475		100.0
KOG0694|consensus	694		100.0
KOG0575|consensus	592		100.0
KOG0592|consensus	604		100.0
KOG0610|consensus	459		100.0
KOG0690|consensus	516		100.0
KOG0583|consensus	370		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0581|consensus	364		100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0595|consensus	429		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0588|consensus	786		100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0593|consensus	396		100.0
KOG0033|consensus	355		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0032|consensus	382		100.0
KOG0696|consensus	683		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0986|consensus	591		100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0608|consensus	1034		100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0597|consensus	808		100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0599|consensus	411		100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0585|consensus	576		100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0600|consensus	560		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0591|consensus	375		100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0578|consensus	550		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0198|consensus	313		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0659|consensus	318		100.0
KOG0661|consensus	538		100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0580|consensus	281		100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0663|consensus	419		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0604|consensus	400		100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0614|consensus	732		100.0
KOG0582|consensus	516		100.0
KOG0611|consensus	668		100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658|consensus	364		100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0589|consensus	426		100.0
KOG4717|consensus	864		100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0660|consensus	359		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0695|consensus	593		100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0594|consensus	323		100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0607|consensus	463		100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0192|consensus	362		100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0579|consensus	1187		100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0667|consensus	586		100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0586|consensus	596		100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG4236|consensus	888		100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4279|consensus	1226		100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0574|consensus	502		100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0603|consensus	612		100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0577|consensus	948		100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0197|consensus	468		100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1989|consensus	738		100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0596|consensus	677		100.0
KOG4645|consensus	1509		100.0
KOG0983|consensus	391		100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG4721|consensus	904		100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG2345|consensus	302		100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0662|consensus	292		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0587|consensus	953		100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0584|consensus	632		100.0
KOG1187|consensus	361		100.0
KOG0666|consensus	438		100.0
KOG1151|consensus	775		100.0
KOG4250|consensus	732		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0194|consensus	474		100.0
KOG0193|consensus	678		100.0
KOG0671|consensus	415		100.0
KOG1035|consensus	1351		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0669|consensus	376		100.0
KOG1006|consensus	361		100.0
KOG1095|consensus	1025		100.0
KOG1026|consensus	774		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.98
KOG0668|consensus	338		99.98
KOG0670|consensus	752		99.97
KOG4257|consensus	974		99.97
KOG1027|consensus	903		99.97
KOG1152|consensus	772		99.97
KOG0664|consensus	449		99.97
KOG0665|consensus	369		99.97
KOG0196|consensus	996		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0576|consensus	829		99.97
KOG1290|consensus	590		99.96
KOG1094|consensus	807		99.96
KOG0199|consensus	1039		99.96
KOG0984|consensus	282		99.96
KOG1167|consensus	418		99.96
KOG4278|consensus	1157		99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0603|consensus	612		99.95
KOG0200|consensus	609		99.95
KOG2052|consensus	513		99.95
KOG1345|consensus	378		99.95
KOG3653|consensus	534		99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1025|consensus	1177		99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0606|consensus	1205		99.92
KOG0590|consensus	601		99.92
KOG1164|consensus	322		99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1024|consensus	563		99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1165|consensus	449		99.85
KOG1163|consensus	341		99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG1240|consensus	1431		99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
KOG4158|consensus	598		99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
PRK10345	210	hypothetical protein; Provisional	99.79
KOG1166|consensus	974		99.77
smart00090	237	RIO RIO-like kinase.	99.76
KOG0590|consensus	601		99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG0195|consensus	448		99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG1023|consensus	484		99.68
KOG0606|consensus	1205		99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
KOG1033|consensus	516		99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG0601|consensus	524		99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
KOG1243|consensus	690		99.25
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.23
KOG1266|consensus	458		99.2
KOG0601|consensus	524		99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.04
KOG2137|consensus	700		98.99
KOG3087|consensus	229		98.99
KOG3741|consensus	655		98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.83
COG4248	637	Uncharacterized protein with protein kinase and he	98.82
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.67
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.56
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.37
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.27
PRK09902	216	hypothetical protein; Provisional	98.27
KOG0576|consensus	829		98.25
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.25
PF01636	239	APH: Phosphotransferase enzyme family This family	98.18
KOG1035|consensus	1351		98.16
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.09
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.04
PLN02876	822	acyl-CoA dehydrogenase	97.95
KOG1235|consensus	538		97.86
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.78
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.68
KOG1826|consensus	2724		97.65
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.55
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.53
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.4
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.38
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.37
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.28
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.23
PRK10593	297	hypothetical protein; Provisional	97.23
PRK05231	319	homoserine kinase; Provisional	97.2
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.17
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.92
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.9
KOG2268|consensus	465		96.74
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.69
PLN02236	344	choline kinase	96.51
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.5
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.47
PLN02756	418	S-methyl-5-thioribose kinase	96.22
KOG2270|consensus	520		96.15
PRK12396	409	5-methylribose kinase; Reviewed	95.99
TIGR02169	1164	SMC_prok_A chromosome segregation protein SMC, pri	95.96
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.94
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.67
PTZ00384	383	choline kinase; Provisional	94.96
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.88
TIGR02169	1164	SMC_prok_A chromosome segregation protein SMC, pri	94.77
PF05701	522	WEMBL: Weak chloroplast movement under blue light;	94.4
PF00038	312	Filament: Intermediate filament protein; InterPro:	94.34
PRK02224	880	chromosome segregation protein; Provisional	94.26
TIGR02168	1179	SMC_prok_B chromosome segregation protein SMC, com	94.25
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.06
COG1196	1163	Smc Chromosome segregation ATPases [Cell division	94.0
KOG0994|consensus	1758		93.46

>KOG0612|consensus

Probab=100.00  E-value=9.2e-63  Score=576.57  Aligned_cols=325  Identities=38%  Similarity=0.723  Sum_probs=291.2

Q ss_pred             ChhHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCccee
Q psy13735          1 KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNL   73 (792)
Q Consensus         1 ~~~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL   73 (792)
                      |||+.+++.-++..+||.|+++||+|+||.|.+|+++.|++.||||+++|..+..       ..|+.||.--+.++||.+
T Consensus        61 kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~L  140 (1317)
T KOG0612|consen   61 KPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQL  140 (1317)
T ss_pred             HHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence            6899999999999999999999999999999999999999999999998854432       679999999999999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEec
Q psy13735         74 FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD  153 (792)
Q Consensus        74 ~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiD  153 (792)
                      +++|+|+.++|+|||||+||+|..++.+  .+.+|+..+++|+..|+.||.-||+.|+|||||||+|||||..|||||+|
T Consensus       141 hyAFQD~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  141 HYAFQDERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             HHHhcCccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeecc
Confidence            9999999999999999999999999965  34799999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcc
Q psy13735        154 FGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC  233 (792)
Q Consensus       154 FGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~  233 (792)
                      ||.|..+..++...+.+.+|||.|++||++...  +.+.+.|++.|||||+||++|+||.|..||+.++.-.+|.+|++.
T Consensus       219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~--~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h  296 (1317)
T KOG0612|consen  219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQ--GDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH  296 (1317)
T ss_pred             chhHHhcCCCCcEEeccccCCCCccCHHHHHhh--cCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence            999999998888899999999999999999865  233468999999999999999999999999999999999999883


Q ss_pred             cCCCCcCCCCCccccHHHHHHHHHHhhChhhcCC---hhHHhcCCCccCCC------CCCCCCCC---CcccCcCChhhh
Q psy13735        234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN---MDQVLGHPVFDCLD------SDPPCIPP---PSQENKFHKKDK  301 (792)
Q Consensus       234 ~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kRPT---aeEIL~HPwF~~i~------~~pP~~P~---~s~~~~f~~k~~  301 (792)
                        ...+.||....+|+++++||++++++|..|++   ++++..||||.+++      ..||++|.   +.+..+|+....
T Consensus       297 --k~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~d  374 (1317)
T KOG0612|consen  297 --KESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDED  374 (1317)
T ss_pred             --hhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCcccccccccc
Confidence              46788997788999999999999999999999   99999999999887      58899986   678899955443


Q ss_pred             hccCCChhhhhhcccccccCCCcccccccC
Q psy13735        302 RKASPSLKAFQKEGRYLDSALPLIGISYTG  331 (792)
Q Consensus       302 ~k~~~s~k~f~~~~~~~~~~l~fig~s~~~  331 (792)
                      ........+......|.+.++||+||+|.+
T Consensus       375 d~~~~e~~p~~~~~~f~Gn~LPFIGfTy~~  404 (1317)
T KOG0612|consen  375 DLRDAETFPPRIPKAFSGNHLPFIGFTYTH  404 (1317)
T ss_pred             ccchhhccCCCCCCCCcCCcCCeeeeeecc
Confidence            322221111124567889999999999997

>KOG0605|consensus

Probab=100.00  E-value=3.2e-58  Score=509.64  Aligned_cols=318  Identities=36%  Similarity=0.670  Sum_probs=272.1

Q ss_pred             HHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEE
Q psy13735          6 ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQ   78 (792)
Q Consensus         6 ~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfe   78 (792)
                      +++|.++..++|+++.+||+|+||.||+|+.+.||..||+|++.|+.+..       ..|+.||....+|+||+||+.|+
T Consensus       132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            56777899999999999999999999999999999999999999988765       56999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      +..++||||||++||++..+|  ...+.|++..+++|+.+++.||..||..|++||||||+|+|||..||+||+|||+|.
T Consensus       212 D~~~LYLiMEylPGGD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLL--MRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence            999999999999999999999  456789999999999999999999999999999999999999999999999999996


Q ss_pred             ccccC---------------------CC-------------------------cccccCCCCCCccChhhhhhhccCCCC
Q psy13735        159 QVDKN---------------------GR-------------------------IKSIVPVGTPEYVAPEVLEWMEGNHGS  192 (792)
Q Consensus       159 ~l~~~---------------------~~-------------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~  192 (792)
                      .+...                     ..                         ...+..+|||.|||||++.+.      
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k------  363 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK------  363 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC------
Confidence            54210                     00                         011234899999999999854      


Q ss_pred             CCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhhcCC---hh
Q psy13735        193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN---MD  269 (792)
Q Consensus       193 ~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kRPT---ae  269 (792)
                       +|+..+|||||||||||||.|.+||.++++..++.+|.+  |...+.+|....+|++++|||.+||+||.+|++   ++
T Consensus       364 -gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n--wr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~  440 (550)
T KOG0605|consen  364 -GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN--WRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAE  440 (550)
T ss_pred             -CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--HhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHH
Confidence             799999999999999999999999999999999999987  778899999999999999999999999999986   88


Q ss_pred             HHhcCCCccCCC------CCCCCCCC---CcccCcCChhhhhccCCChhh----hhhccc-----ccccCCCcccccccC
Q psy13735        270 QVLGHPVFDCLD------SDPPCIPP---PSQENKFHKKDKRKASPSLKA----FQKEGR-----YLDSALPLIGISYTG  331 (792)
Q Consensus       270 EIL~HPwF~~i~------~~pP~~P~---~s~~~~f~~k~~~k~~~s~k~----f~~~~~-----~~~~~l~fig~s~~~  331 (792)
                      +|..||||++++      .+||++|.   +.+..+|+.............    +.+...     ......+|+||+|..
T Consensus       441 EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~  520 (550)
T KOG0605|consen  441 EIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKN  520 (550)
T ss_pred             HHhcCCccccCCcchhhcCCCCCCCCCCCcccccccccCcccccCcccccccccchhhhhcccccCCcccccccceeeec
Confidence            999999999887      47888887   567888886655432221110    111111     224456799999976


Q ss_pred             CCC
Q psy13735        332 EPM  334 (792)
Q Consensus       332 ~~~  334 (792)
                      -..
T Consensus       521 ~~~  523 (550)
T KOG0605|consen  521 FDG  523 (550)
T ss_pred             ccc
Confidence            543

>KOG0598|consensus

Probab=100.00  E-value=2e-57  Score=486.63  Aligned_cols=280  Identities=36%  Similarity=0.687  Sum_probs=250.3

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ....++|+++++||+|+||+||+|+.++|++.||+|++.|..+..       ..|+.||..++||+||+++..|++...+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            466889999999999999999999999999999999999887765       5799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |||+||+.||+|+.+|.  ..+.|+|..+++|+..|+.||.|||++||+||||||+|||+|.+|||+|+|||+|+.....
T Consensus       101 ylVld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEEEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999999999994  4677999999999999999999999999999999999999999999999999999976544


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      + ..+.+.|||+.|||||++..       .+|+.++|||||||++|+||+|.+||.+.+...++++|..    +....++
T Consensus       179 ~-~~t~tfcGT~eYmAPEil~~-------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~----~k~~~~p  246 (357)
T KOG0598|consen  179 G-DATRTFCGTPEYMAPEILLG-------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK----GKLPLPP  246 (357)
T ss_pred             C-CccccccCCccccChHHHhc-------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc----CcCCCCC
Confidence            3 35567899999999999984       3899999999999999999999999999999999999988    3433332


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcC----ChhHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhhhccC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARL----NMDQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDKRKAS  305 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRP----TaeEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~~k~~  305 (792)
                       ..+|.++++++++||+ +|.+|+    ++.+|..||||..++        ..||+.|.   ..+.++|+...+....
T Consensus       247 -~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~  323 (357)
T KOG0598|consen  247 -GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTV  323 (357)
T ss_pred             -ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccc
Confidence             2589999999999999 999997    478899999999987        57888887   4577788877665543

>KOG0616|consensus

Probab=100.00  E-value=9.6e-55  Score=454.97  Aligned_cols=270  Identities=37%  Similarity=0.728  Sum_probs=246.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ..+++|++++.||.|+||.|.+|+++.+|..||+|++.+.....       .+|+.||+.+.||+++++++.|.+.+++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            67899999999999999999999999999999999999887655       57999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||||++||.|+.++.  ..++|++..+++|+.||+.||.|||+++|++|||||+|||+|.+|++||+|||+|+....  
T Consensus       121 mvmeyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--  196 (355)
T ss_pred             EEEeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence            9999999999999994  467799999999999999999999999999999999999999999999999999998753  


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                        .+++.||||.|+|||++..       .+|+.++|||||||++|||+.|.+||...++..+|++|..    +.+.||. 
T Consensus       197 --rT~TlCGTPeYLAPEii~s-------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~----~~v~fP~-  262 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQS-------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE----GKVKFPS-  262 (355)
T ss_pred             --cEEEecCCccccChHHhhc-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh----CcccCCc-
Confidence              4678899999999999985       4899999999999999999999999999999999999998    7888998 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC--------CCCCCCCC----CcccCcCChhh
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD--------SDPPCIPP----PSQENKFHKKD  300 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~--------~~pP~~P~----~s~~~~f~~k~  300 (792)
                       .+|+++++|++.||+ |-.+|.     +..+|..||||++++        ..||+.|+    +.+..+|+...
T Consensus       263 -~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~  335 (355)
T KOG0616|consen  263 -YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDYE  335 (355)
T ss_pred             -ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcccccccccc
Confidence             889999999999999 999994     467899999999876        46777763    45566665443

>KOG0615|consensus

Probab=100.00  E-value=1.2e-54  Score=469.16  Aligned_cols=259  Identities=32%  Similarity=0.486  Sum_probs=228.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----------HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----------TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----------~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      ..+.|.+.+.||+|+||.|.+|..+.||+.||||++.+.....           .+|++||++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4567889999999999999999999999999999998765433           48999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC---CceEEeccCccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSAT  158 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d---g~VKLiDFGLA~  158 (792)
                      ..||||||+.||+|++.+.  .++.+.+...+.+++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|+
T Consensus       250 s~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             ceEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            9999999999999999994  46779999999999999999999999999999999999999766   679999999999


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh-hhhhhhcccCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTED  237 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e-l~ekIl~~~~~~  237 (792)
                      ..+..  ..+.+.||||.|.|||++...    +...+..++||||+||++|.+|+|.+||.....+. +.+.|.....  
T Consensus       328 ~~g~~--sfm~TlCGTpsYvAPEVl~~k----g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y--  399 (475)
T KOG0615|consen  328 VSGEG--SFMKTLCGTPSYVAPEVLASK----GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY--  399 (475)
T ss_pred             ccccc--eehhhhcCCccccChhheecC----CeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc--
Confidence            98733  355688999999999999754    34455668999999999999999999998887777 7888877221  


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .+..+.|..+|+++.+||.+||. ||++|||+.++|+||||++.+
T Consensus       400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            22224577899999999999999 999999999999999999754

>KOG0694|consensus

Probab=100.00  E-value=1.8e-53  Score=482.02  Aligned_cols=306  Identities=31%  Similarity=0.594  Sum_probs=266.0

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcC-CCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSK-CPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~-HPNIVkL~~vfede~   81 (792)
                      +.+++++|.++++||+|+||+|+++..+.+++.||||+++|..+..       +.|+.|+.... ||+++.++..|++.+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            4688999999999999999999999999999999999999987654       67888888775 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      ++|+||||+.||+++.+.   ..+.|++..+++|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+|+...
T Consensus       443 ~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             eEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence            999999999999955554   44669999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      -.+ ..+++.||||.|||||++..       ..|+.++|||||||+||+||.|.+||.+++.++.+..|+.    ..+.|
T Consensus       520 ~~g-~~TsTfCGTpey~aPEil~e-------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----d~~~y  587 (694)
T KOG0694|consen  520 GQG-DRTSTFCGTPEFLAPEVLTE-------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----DEVRY  587 (694)
T ss_pred             CCC-CccccccCChhhcChhhhcc-------CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----CCCCC
Confidence            333 36778899999999999974       4899999999999999999999999999999999999998    67778


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCCh-----hHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhhhcc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNM-----DQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDKRKA  304 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTa-----eEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~~k~  304 (792)
                      |.  .+|.++.+++++||+ +|++|+++     .+|..||||+.++        ..||++|.   +.+.++|+..++...
T Consensus       588 P~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~  665 (694)
T KOG0694|consen  588 PR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEK  665 (694)
T ss_pred             CC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCC
Confidence            87  789999999999999 99999986     6789999999987        58999987   778999998887654


Q ss_pred             CCChhhhhhcccccccCCCcccccccCCC
Q psy13735        305 SPSLKAFQKEGRYLDSALPLIGISYTGEP  333 (792)
Q Consensus       305 ~~s~k~f~~~~~~~~~~l~fig~s~~~~~  333 (792)
                      +.-.+. ....-....+..|.||+|.++.
T Consensus       666 p~Lt~~-~~~~l~~~~q~~F~~Fs~~~~~  693 (694)
T KOG0694|consen  666 PALTPS-DPRPLTEEEQEAFRDFSFVAEW  693 (694)
T ss_pred             CccCCC-CccccchhhHHHhcCccccCCC
Confidence            432221 1111112234578899987654

>KOG0575|consensus

Probab=100.00  E-value=6e-53  Score=473.38  Aligned_cols=248  Identities=33%  Similarity=0.633  Sum_probs=231.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..|..++.||+|||+.||.+++..+|..||+|+|.+..+..       ..|++|.+.|+|||||+++++|+|.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            46999999999999999999999999999999999866544       67999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |+|..|+|..++++  .+.++|.+|++|++||+.||.|||+++|+|||||..||+++.+.+|||+|||+|+.+..++. .
T Consensus        98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-r  174 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-R  174 (592)
T ss_pred             EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-c
Confidence            99999999999964  56699999999999999999999999999999999999999999999999999999986543 4


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ..+.||||.|+|||++..       .+++..+||||+|||||.||+|+|||...+..+++..|..    ..+.+|.  .+
T Consensus       175 k~TlCGTPNYIAPEVl~k-------~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~----~~Y~~P~--~l  241 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNK-------SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL----NEYSMPS--HL  241 (592)
T ss_pred             cceecCCCcccChhHhcc-------CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh----cCccccc--cc
Confidence            457899999999999973       4799999999999999999999999999999999999988    7778888  88


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      |.++++||.+||. +|.+|||+.+||.||||.
T Consensus       242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence            9999999999999 999999999999999994

>KOG0592|consensus

Probab=100.00  E-value=7.6e-52  Score=458.87  Aligned_cols=256  Identities=33%  Similarity=0.642  Sum_probs=233.6

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCCE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~~   82 (792)
                      .....||.+++.||.|+|++|++|+.+.+++.||||++.|..+..       .+|+++|.+| .||.|++|+..|+|+..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            347889999999999999999999999999999999998876654       5799999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+|+||+++|+|.++|.+  .|.|++..+++|+.||+.||.|||++|||||||||+|||||.+|+++|+|||.|+.+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999999999954  57899999999999999999999999999999999999999999999999999998753


Q ss_pred             CCC----------ccc--ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhh
Q psy13735        163 NGR----------IKS--IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI  230 (792)
Q Consensus       163 ~~~----------~~s--~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekI  230 (792)
                      ...          ..+  .+++||..|++||++..       ...++.+|||+||||+|.|+.|.+||.+.+.-.++++|
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-------~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-------SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcC-------CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            211          111  45789999999999974       36788999999999999999999999999999999999


Q ss_pred             hcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       231 l~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +.    -.+.||.  .+++.++|||+++|. ||.+|+|+.+|..||||.+++
T Consensus       300 ~~----l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  300 QA----LDYEFPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             HH----hcccCCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence            98    5566776  678999999999999 999999999999999999887

>KOG0610|consensus

Probab=100.00  E-value=1.4e-49  Score=430.49  Aligned_cols=275  Identities=33%  Similarity=0.606  Sum_probs=248.7

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      +...+.+++|++++.||.|.-|+||+|..+.++..||+|++.+..+..       ..|++||..++||++++||..|+.+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            345688899999999999999999999999999999999999877654       5799999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ...|++||||+||+|..++++++.+.|++..+++|+..++.||.|||-.|||+|||||+||||..+|||-|+||.++...
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999886532


Q ss_pred             cc---------------------------------C----------------------CCcccccCCCCCCccChhhhhh
Q psy13735        161 DK---------------------------------N----------------------GRIKSIVPVGTPEYVAPEVLEW  185 (792)
Q Consensus       161 ~~---------------------------------~----------------------~~~~s~t~vGTp~Y~APEiL~~  185 (792)
                      ..                                 .                      ....+...+||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            10                                 0                      0012334589999999999984


Q ss_pred             hccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-Chhh
Q psy13735        186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDA  264 (792)
Q Consensus       186 ~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~k  264 (792)
                             .+.+.++|||+|||++||||.|..||.+.+..+++.+|+.    ..+.||....+|..++|||++||. ||.+
T Consensus       310 -------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  310 -------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----QPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             -------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----CCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence                   3788999999999999999999999999999999999988    788999988999999999999999 9999


Q ss_pred             cCC----hhHHhcCCCccCCC------CCCCCCCCCccc
Q psy13735        265 RLN----MDQVLGHPVFDCLD------SDPPCIPPPSQE  293 (792)
Q Consensus       265 RPT----aeEIL~HPwF~~i~------~~pP~~P~~s~~  293 (792)
                      |++    +.+|.+||||++++      ..||.+|.+.+.
T Consensus       379 Rlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             hhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence            999    99999999999988      578888876543

>KOG0690|consensus

Probab=100.00  E-value=5.1e-50  Score=422.52  Aligned_cols=309  Identities=30%  Similarity=0.557  Sum_probs=266.5

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      ++.+++.++|.++++||+|.||.|.+|+.+.+|+.||+|++.|..+..       ..|..+|...+||++..|.+.|+..
T Consensus       161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            455689999999999999999999999999999999999998877654       5688999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +.+|+||||..||.|+.+|.+  ...|++..+++|-..|++||.|||+++||+||||.+|+|+|.+||+||+|||+|+..
T Consensus       241 drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             ceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence            999999999999999999955  456999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ...+ ..+.+.||||.|+|||++..       ..|+.++|||.+||+||+|++|+.||...+...++..|+.    ..+.
T Consensus       319 I~~g-~t~kTFCGTPEYLAPEVleD-------nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----ed~k  386 (516)
T KOG0690|consen  319 IKYG-DTTKTFCGTPEYLAPEVLED-------NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----EDLK  386 (516)
T ss_pred             cccc-ceeccccCChhhcCchhhcc-------ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh----hhcc
Confidence            5443 35668899999999999973       4799999999999999999999999999999999999988    7788


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhhhc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDKRK  303 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~~k  303 (792)
                      ||.  .+|++++.++..||. ||.+|++     +.+|.+|+||.+++        ..||++|.   ..+...|+..++..
T Consensus       387 FPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q  464 (516)
T KOG0690|consen  387 FPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQ  464 (516)
T ss_pred             CCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcc
Confidence            998  889999999999999 9999987     67899999999987        58999997   45778888877765


Q ss_pred             cCCChhhhhhcc---cccccCCCcccccccCC
Q psy13735        304 ASPSLKAFQKEG---RYLDSALPLIGISYTGE  332 (792)
Q Consensus       304 ~~~s~k~f~~~~---~~~~~~l~fig~s~~~~  332 (792)
                      .....++-....   .-......|..|||.+.
T Consensus       465 ~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~  496 (516)
T KOG0690|consen  465 PVTLTPPDRYGSTVDEDEERRPHFPQFSYSAS  496 (516)
T ss_pred             eeEecCCCCCCcccchhhhhccCCcceeeecc
Confidence            432221111111   11222456888888643

>KOG0583|consensus

Probab=100.00  E-value=5.3e-48  Score=425.17  Aligned_cols=255  Identities=31%  Similarity=0.560  Sum_probs=228.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----h-----HHHHHHHHhcC-CCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----N-----TIERDIMVKSK-CPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----~-----~~E~eIL~kL~-HPNIVkL~~vfede~   81 (792)
                      .....|.+++.||+|+||+|+++.+..+|..||+|++.+....    .     ..|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            5677999999999999999999999999999999988775211    1     46889999999 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC-CceEEeccCccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQV  160 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d-g~VKLiDFGLA~~l  160 (792)
                      .+|+|||||.||+|++++.+  .++++|..++.+++||++|+.|||++||+||||||+|||++.+ +++||+|||++...
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            99999999999999999965  6789999999999999999999999999999999999999999 99999999999987


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCC-CCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD-GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~-~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      . .......+.||||.|+|||++.+.      . ..+.++||||+||++|.|++|..||...+...++..|..    +.+
T Consensus       172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~------~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~----~~~  240 (370)
T KOG0583|consen  172 P-GEDGLLKTFCGSPAYAAPEVLSGK------GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK----GEF  240 (370)
T ss_pred             C-CCCCcccCCCCCcccCCHHHhCCC------CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc----CCc
Confidence            4 222355677999999999999743      2 236889999999999999999999999998999999877    777


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+|.+.. |+++++|+.+||. +|.+|+++.+++.||||+..
T Consensus       241 ~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  241 KIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             cCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            8888433 9999999999999 99999999999999999963

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-47  Score=413.76  Aligned_cols=256  Identities=42%  Similarity=0.804  Sum_probs=222.3

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+.....       ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            58999999999999999999999999999999997653221       46899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC--
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR--  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~--  165 (792)
                      |||+||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+.....  
T Consensus        81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            99999999999954  45699999999999999999999999999999999999999999999999999876432110  


Q ss_pred             -----------------------------------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHH
Q psy13735        166 -----------------------------------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYE  210 (792)
Q Consensus       166 -----------------------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYE  210 (792)
                                                         ......+||+.|+|||++..       ..++.++|||||||++|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-------TGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-------CCCCCeeeeecchhHHHH
Confidence                                               01123469999999999863       368899999999999999


Q ss_pred             hhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhhcCC---hhHHhcCCCccCCC
Q psy13735        211 LLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN---MDQVLGHPVFDCLD  281 (792)
Q Consensus       211 LLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kRPT---aeEIL~HPwF~~i~  281 (792)
                      |++|.+||...+....+..+..  +.....+|....+|+.+.+||.+|+.+|.+|++   +.+++.||||+..+
T Consensus       232 l~~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         232 MLVGYPPFCSDNPQETYRKIIN--WKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHc--CCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCC
Confidence            9999999998888777777765  334455666667899999999999999999998   99999999998765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.7e-47  Score=416.33  Aligned_cols=271  Identities=38%  Similarity=0.724  Sum_probs=232.9

Q ss_pred             hhHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeE
Q psy13735          2 DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLF   74 (792)
Q Consensus         2 ~~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~   74 (792)
                      .++..+++..+..++|++.+.||+|+||.||+|.++.+++.||+|++.+.....       ..|+.++..++||||++++
T Consensus        30 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (370)
T cd05621          30 KIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (370)
T ss_pred             HHHHHHHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence            356778888889999999999999999999999999999999999997543221       4688999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEecc
Q psy13735         75 YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        75 ~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                      ++|.++..+|+|||||+||+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         110 CAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999999954   34899999999999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc
Q psy13735        155 GSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD  234 (792)
Q Consensus       155 GLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~  234 (792)
                      |+|..............+||+.|+|||++...   .....++.++||||+||++|+|++|.+||.+.+....+..+... 
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~-  262 (370)
T cd05621         187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH-  262 (370)
T ss_pred             ccceecccCCceecccCCCCcccCCHHHHhcc---CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Confidence            99987654433334466799999999999632   12234788999999999999999999999988887778877652 


Q ss_pred             CCCCcCCCCCccccHHHHHHHHHHhh-Chh--hcCChhHHhcCCCccCC
Q psy13735        235 TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLD--ARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       235 ~~~~l~fP~~~~lS~elkdLIk~LL~-DP~--kRPTaeEIL~HPwF~~i  280 (792)
                       ...+.+|....++..+++++.+||. ++.  .|+++.+++.||||+..
T Consensus       263 -~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         263 -KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             -CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence             2345567666789999999999998 443  38899999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0581|consensus

Probab=100.00  E-value=2.6e-48  Score=416.76  Aligned_cols=255  Identities=27%  Similarity=0.488  Sum_probs=224.3

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE-EE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH-VY   84 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~-ly   84 (792)
                      .+..++.+.++.||+|..|+||+|+|+.|++.||+|+|.-.....     ..|.+|++..+|||||++|++|.++.. ++
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            345568899999999999999999999999999999994433322     679999999999999999999999995 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||+||+|.+++..  .++++|.....++.+|+.||.|||+ ++|+||||||+|||++..|.|||||||.+..+...
T Consensus       155 I~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             eehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999999999955  3779999999999999999999995 99999999999999999999999999999988644


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC-----ChhhhhhhhhcccCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE-----TLDMTYSSILACDTEDT  238 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~-----d~~el~ekIl~~~~~~~  238 (792)
                         .+.+.+||..|||||.+.+       ..|+.++||||||+.+.||.+|+.||...     +..+++..|..   ...
T Consensus       233 ---~a~tfvGT~~YMsPERi~g-------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~pp  299 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISG-------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPP  299 (364)
T ss_pred             ---hcccccccccccChhhhcC-------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCC
Confidence               5567789999999999974       38999999999999999999999999774     45566666654   244


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +.+|.. .+|+++++||..||+ ||.+||++.|+++|||++...
T Consensus       300 P~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  300 PRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             CCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            455653 589999999999999 999999999999999998643

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.1e-47  Score=415.05  Aligned_cols=271  Identities=39%  Similarity=0.728  Sum_probs=232.7

Q ss_pred             hHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEE
Q psy13735          3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFY   75 (792)
Q Consensus         3 ~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~   75 (792)
                      ++..+....+..++|.+.+.||+|+||.||+|.++.+|..||+|++.+.....       ..|+.++..++||||+++++
T Consensus        31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~  110 (370)
T cd05596          31 AAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY  110 (370)
T ss_pred             HHHhhccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            34555667788899999999999999999999999999999999997643221       46889999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         76 SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        76 vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      +|.+...+|+|||||+||+|.+++.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         111 AFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             EEecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecc
Confidence            99999999999999999999999854   348999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC
Q psy13735        156 SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       156 LA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~  235 (792)
                      ++..............+||+.|+|||++...   .....++.++|||||||++|+|++|.+||.+.+....+..+...  
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--  262 (370)
T cd05596         188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--  262 (370)
T ss_pred             ceeeccCCCcccCCCCCCCcCeECHHHhccC---CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--
Confidence            9987654433334456799999999998632   12235788999999999999999999999988888788887652  


Q ss_pred             CCCcCCCCCccccHHHHHHHHHHhh-Chhh--cCChhHHhcCCCccCCC
Q psy13735        236 EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDA--RLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       236 ~~~l~fP~~~~lS~elkdLIk~LL~-DP~k--RPTaeEIL~HPwF~~i~  281 (792)
                      ...+.+|....+|.++.+||.+||. +|.+  |+++.+++.||||+..+
T Consensus       263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            2345567666789999999999999 7887  99999999999998644

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-47  Score=407.51  Aligned_cols=256  Identities=41%  Similarity=0.813  Sum_probs=224.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.....       ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999997653221       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC---
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG---  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~---  164 (792)
                      |||+||+|.+++.+.  +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            999999999999653  569999999999999999999999999999999999999999999999999998765432   


Q ss_pred             -------------------------CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC
Q psy13735        165 -------------------------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       165 -------------------------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~  219 (792)
                                               .......+||+.|+|||++..       ..++.++|||||||++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-------TPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCceeeEecchhhhhhccCCCCCC
Confidence                                     112234579999999999963       368899999999999999999999999


Q ss_pred             CCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhhcCC-hhHHhcCCCccCCC
Q psy13735        220 YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN-MDQVLGHPVFDCLD  281 (792)
Q Consensus       220 ~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kRPT-aeEIL~HPwF~~i~  281 (792)
                      ..+....+..+..  +.....+|....+++.+.+||.+|+.+|.+||+ +.+++.||||..++
T Consensus       232 ~~~~~~~~~~i~~--~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         232 SDTLQETYNKIIN--WKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             CCCHHHHHHHHhc--cCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCC
Confidence            8887777777765  334455666556899999999999999999999 99999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.4e-47  Score=403.75  Aligned_cols=263  Identities=40%  Similarity=0.784  Sum_probs=226.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||+|+||.||+|.++.+|+.||+|++.+.....       ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998654311       46788999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++.+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.......
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            999999999999654 3569999999999999999999999999999999999999999999999999998775443333


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++...... +...++.++|||||||++|+|++|..||...+....+..+...  .....+|....+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~  236 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKV  236 (330)
T ss_pred             eecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCC
Confidence            3445799999999998643111 2346889999999999999999999999888877777777652  233456665678


Q ss_pred             cHHHHHHHHHHhhChhhcCChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ++.+.+|+..||++|.+||++.+++.||||..++
T Consensus       237 ~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         237 SSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             CHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCC
Confidence            9999999999999999999999999999999765

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.8e-47  Score=410.75  Aligned_cols=256  Identities=38%  Similarity=0.746  Sum_probs=220.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+.....       ..|+.++..++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999997643221       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC--
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR--  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~--  165 (792)
                      |||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.....  
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            99999999999954  45699999999999999999999999999999999999999999999999999875432110  


Q ss_pred             --------------------------------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc
Q psy13735        166 --------------------------------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT  213 (792)
Q Consensus       166 --------------------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT  213 (792)
                                                      ......+||+.|+|||++.+       ..++.++|||||||++|+|++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-------CCCCCchhhhhhHHHHHHHHh
Confidence                                            01124579999999999863       368899999999999999999


Q ss_pred             CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhh---cCChhHHhcCCCccCCC
Q psy13735        214 GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDA---RLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       214 Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~k---RPTaeEIL~HPwF~~i~  281 (792)
                      |..||.+.+....+..+..  +.....+|....++++++++|.+|+.+|.+   ||++.++++||||.+++
T Consensus       232 G~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         232 GYPPFCSETPQETYKKVMN--WKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             CCCCCCCCCHHHHHHHHHc--CcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCC
Confidence            9999998888888888765  334456676667899999999998875544   58999999999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0595|consensus

Probab=100.00  E-value=7.4e-48  Score=416.77  Aligned_cols=254  Identities=33%  Similarity=0.573  Sum_probs=224.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ...+|.+.+.||+|+||+||+++++.+|..+|||.|.+..+..      ..|+.||+.++|||||.+++++.+.+++|||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4679999999999999999999999999999999999887543      5799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC------CceEEeccCccccc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT------GHLKLTDFGSATQV  160 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d------g~VKLiDFGLA~~l  160 (792)
                      ||||.||+|.++|.+  .+.+++..++.+|.||+.||++||+++|+||||||+||||+.+      ..+||+|||+|+.+
T Consensus        88 MEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999999999954  5679999999999999999999999999999999999999765      46899999999998


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .+..  ...+.||+|.|||||+++.       ..|+.++|+||+|+|+|+|++|.+||...+..+.+..+....  ....
T Consensus       166 ~~~~--~a~tlcGSplYMAPEV~~~-------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~--~~~~  234 (429)
T KOG0595|consen  166 QPGS--MAETLCGSPLYMAPEVIMS-------QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN--EIVP  234 (429)
T ss_pred             Cchh--HHHHhhCCccccCHHHHHh-------ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc--cccC
Confidence            7543  4457799999999999974       489999999999999999999999999999999988776521  1111


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+ ...++....+++..+++ +|..|.+..+-+.||+...-
T Consensus       235 ~~-~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  235 VL-PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             ch-hhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            11 23567778899999999 99999999999999998754

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-46  Score=409.33  Aligned_cols=256  Identities=38%  Similarity=0.751  Sum_probs=218.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+++.||+|+||.||+|.+..+|+.||+|++.+.....       ..|+.++..++|||||+++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999987643211       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC--
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR--  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~--  165 (792)
                      |||+||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......  
T Consensus        81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            99999999999954  45689999999999999999999999999999999999999999999999999864321000  


Q ss_pred             --------------------------------------------cccccCCCCCCccChhhhhhhccCCCCCCCCccccc
Q psy13735        166 --------------------------------------------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL  201 (792)
Q Consensus       166 --------------------------------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDI  201 (792)
                                                                  ......+||+.|+|||++..       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di  231 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-------QGYGQECDW  231 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-------CCCCCceee
Confidence                                                        00012469999999999863       368899999


Q ss_pred             ccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhhc---CChhHHhcCCCcc
Q psy13735        202 WSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDAR---LNMDQVLGHPVFD  278 (792)
Q Consensus       202 WSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kR---PTaeEIL~HPwF~  278 (792)
                      |||||++|+|++|.+||...+....+..+..  +.....+|....++.++.+||.+||.+|.+|   +++.+++.||||.
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~  309 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSHETYRKIIN--WRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFR  309 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHHHHHHHHHc--cCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcC
Confidence            9999999999999999988887777777754  3345566766678999999999999977665   5999999999999


Q ss_pred             CCC
Q psy13735        279 CLD  281 (792)
Q Consensus       279 ~i~  281 (792)
                      +++
T Consensus       310 ~~~  312 (377)
T cd05629         310 GVD  312 (377)
T ss_pred             CCC
Confidence            765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.9e-47  Score=401.97  Aligned_cols=245  Identities=33%  Similarity=0.644  Sum_probs=214.1

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      +.||+|+||.||+|.++.+|+.||+|++.+.....       ..|..++..++||||++++++|.+.+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999997653321       45888999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCC
Q psy13735         94 DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG  173 (792)
Q Consensus        94 sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vG  173 (792)
                      +|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~g  157 (323)
T cd05571          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG  157 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccceec
Confidence            99999954  4568999999999999999999999999999999999999999999999999987643222 12234579


Q ss_pred             CCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHH
Q psy13735        174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN  253 (792)
Q Consensus       174 Tp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkd  253 (792)
                      |+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+..    ....+|.  .+++.+.+
T Consensus       158 t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~----~~~~~p~--~~~~~~~~  224 (323)
T cd05571         158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPR--TLSPEAKS  224 (323)
T ss_pred             CccccChhhhcC-------CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc----CCCCCCC--CCCHHHHH
Confidence            999999999863       3688999999999999999999999988887777777665    3445565  67999999


Q ss_pred             HHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        254 FVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       254 LIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      ||.+||. ||.+||     ++.+++.||||..++
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             HHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999 999999     899999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-46  Score=408.18  Aligned_cols=272  Identities=38%  Similarity=0.726  Sum_probs=232.1

Q ss_pred             hhHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeE
Q psy13735          2 DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLF   74 (792)
Q Consensus         2 ~~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~   74 (792)
                      +-+..++...+..++|.+.+.||+|+||.||+|.++.+++.||+|++.+.....       ..|+.++..++||||++++
T Consensus        30 ~~~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (371)
T cd05622          30 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (371)
T ss_pred             hHhhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            345557778889999999999999999999999999999999999987543221       4688899999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEecc
Q psy13735         75 YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        75 ~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                      ++|.+...+|+|||||+||+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+||
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         110 YAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999999999999854   34899999999999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc
Q psy13735        155 GSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD  234 (792)
Q Consensus       155 GLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~  234 (792)
                      |++..............+||+.|+|||++...   ...+.++.++|||||||++|+|++|.+||.+.+....+..|... 
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-  262 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH-  262 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhcc---CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-
Confidence            99987754433334456799999999998632   12234789999999999999999999999988888888887652 


Q ss_pred             CCCCcCCCCCccccHHHHHHHHHHhhChhh---cCChhHHhcCCCccCCC
Q psy13735        235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDA---RLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       235 ~~~~l~fP~~~~lS~elkdLIk~LL~DP~k---RPTaeEIL~HPwF~~i~  281 (792)
                       .....+|....++..++++|..||.+|..   |+++.++++||||.+..
T Consensus       263 -~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         263 -KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             -CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence             23355666667899999999999995443   78999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.1e-46  Score=407.88  Aligned_cols=256  Identities=38%  Similarity=0.707  Sum_probs=219.5

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +.|.+++.||+|+||.||+|++..+++.||+|++.+.....       ..|+.+++.++|||||+++++|.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36999999999999999999999999999999997654321       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC---
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG---  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~---  164 (792)
                      |||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+....   
T Consensus        81 E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          81 DYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            99999999999954  3568999999999999999999999999999999999999999999999999975331000   


Q ss_pred             -------------------------------------------CcccccCCCCCCccChhhhhhhccCCCCCCCCccccc
Q psy13735        165 -------------------------------------------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL  201 (792)
Q Consensus       165 -------------------------------------------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDI  201 (792)
                                                                 .......+||+.|+|||++..       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di  231 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDW  231 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-------CCCCCeeeE
Confidence                                                       001123479999999999863       368899999


Q ss_pred             ccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhhcCC---hhHHhcCCCcc
Q psy13735        202 WSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN---MDQVLGHPVFD  278 (792)
Q Consensus       202 WSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kRPT---aeEIL~HPwF~  278 (792)
                      |||||++|+|++|.+||.+.+.......+..  +.....+|....+++++.++|.+|+.+|.+|++   +.+++.||||+
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~  309 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK  309 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcC
Confidence            9999999999999999998877776666654  334455666667899999999998779999997   99999999998


Q ss_pred             CCC
Q psy13735        279 CLD  281 (792)
Q Consensus       279 ~i~  281 (792)
                      .++
T Consensus       310 ~~~  312 (382)
T cd05625         310 TID  312 (382)
T ss_pred             CcC
Confidence            765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-46  Score=400.94  Aligned_cols=255  Identities=35%  Similarity=0.652  Sum_probs=225.1

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      ...++..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.....       ..|+.++..++||||++++++|.+.
T Consensus        11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            456678899999999999999999999999999999999997653221       4688999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +.+|+|||||.||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            999999999999999999954  456899999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ...    ....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+..    +...
T Consensus       169 ~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----~~~~  233 (329)
T PTZ00263        169 PDR----TFTLCGTPEYLAPEVIQS-------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA----GRLK  233 (329)
T ss_pred             CCC----cceecCChhhcCHHHHcC-------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc----CCcC
Confidence            432    224579999999999863       3578899999999999999999999998888777777765    4445


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD  281 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~  281 (792)
                      +|.  .++..+.+||.+||. ||.+||+     +.+++.||||...+
T Consensus       234 ~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        234 FPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             CCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            555  578999999999999 9999997     79999999998754

>KOG0588|consensus

Probab=100.00  E-value=2e-47  Score=430.54  Aligned_cols=256  Identities=25%  Similarity=0.495  Sum_probs=231.2

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCC-------CChHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK-------MPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~-------~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      ...-|+.++.||.|+-|.|.+++|..||+..|||+|.+..       .....|+-||+.+.|||++.+|++|++..++|+
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            4567999999999999999999999999999999999872       222678888999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |.||++||.|++++.  ..|++++.++..++.||+.|+.|||..+|+||||||+|+|+|..++|||+|||+|..-.++. 
T Consensus        90 vlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             EEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            999999999999995  46789999999999999999999999999999999999999999999999999998654333 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                       .-.+.||+|+|.|||++.+.      ...+.++||||+|||||.||+|++||++++...++.++..    +.+..|.  
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~------pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~----G~f~MPs--  233 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGR------PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR----GVFEMPS--  233 (786)
T ss_pred             -cccccCCCcccCCchhhcCC------CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc----CcccCCC--
Confidence             23456899999999999843      5568899999999999999999999999999999998877    7777776  


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                      .+|+++++|+.+||. ||.+|+|.++|+.|||+.+....|
T Consensus       234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  234 NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence            889999999999999 999999999999999999876433

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.4e-46  Score=406.23  Aligned_cols=256  Identities=39%  Similarity=0.701  Sum_probs=217.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +.|.+++.||+|+||+||+|.+..+|..||+|++.+.....       ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997654322       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC---
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG---  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~---  164 (792)
                      |||+||+|.+++.+  .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||++..+....   
T Consensus        81 E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          81 DYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            99999999999954  4568999999999999999999999999999999999999999999999999976431100   


Q ss_pred             -------------------------------------------CcccccCCCCCCccChhhhhhhccCCCCCCCCccccc
Q psy13735        165 -------------------------------------------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL  201 (792)
Q Consensus       165 -------------------------------------------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDI  201 (792)
                                                                 .......+||+.|+|||++..       ..++.++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di  231 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-------KGYTQLCDW  231 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-------CCCCCccce
Confidence                                                       000123479999999999863       368899999


Q ss_pred             ccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh---ChhhcCChhHHhcCCCcc
Q psy13735        202 WSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ---KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       202 WSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~---DP~kRPTaeEIL~HPwF~  278 (792)
                      |||||++|+|++|.+||...+.......+..  +.....+|....+++++.+||.+|++   +|..|+++.+++.||||.
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~  309 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS  309 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence            9999999999999999988777666666654  33445566666789999999999876   355599999999999998


Q ss_pred             CCC
Q psy13735        279 CLD  281 (792)
Q Consensus       279 ~i~  281 (792)
                      .++
T Consensus       310 ~~~  312 (381)
T cd05626         310 EVD  312 (381)
T ss_pred             CCC
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6e-46  Score=387.37  Aligned_cols=255  Identities=26%  Similarity=0.495  Sum_probs=215.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.+.....       ..|+.++..++||||++++++|.+.+.+|+|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4889999999999999999999999999999987544321       468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||+||+|..++.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......  ..
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--ee
Confidence            9999999988865444568999999999999999999999999999999999999999999999999998764322  22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...+||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+..........++.  .++
T Consensus       159 ~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~s  229 (285)
T cd05631         159 RGRVGTVGYMAPEVINN-------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFS  229 (285)
T ss_pred             cCCCCCCCccCHhhhcC-------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc--cCC
Confidence            34569999999999963       368899999999999999999999998765433332222211112333443  679


Q ss_pred             HHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD  281 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~  281 (792)
                      +.+.+|+++||. ||.+||+     +.++++||||..++
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999999 9999997     89999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0593|consensus

Probab=100.00  E-value=1.4e-47  Score=402.04  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=220.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +.|+.+.++|+|+||+||+|+++.||+.||||++..+....      .+|+.+|++++|||+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            57899999999999999999999999999999997665532      689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||+ .++.+-+.+.++| ++...++.|++|++.|+.|||+++++||||||+||||+.+|.+||||||+|+.+..++. ..
T Consensus        82 ~~d-hTvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-~Y  158 (396)
T KOG0593|consen   82 YCD-HTVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-NY  158 (396)
T ss_pred             ecc-hHHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-hh
Confidence            995 5777778776665 89999999999999999999999999999999999999999999999999999875433 33


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc--------------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD--------------  234 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~--------------  234 (792)
                      ...+.|.||.|||.+.      |...|+.++||||+||++.||++|.+.|++.+.-+.+-.|...-              
T Consensus       159 TDYVATRWYRaPELLv------GDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLV------GDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             hhhhhhhhccChhhhc------ccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence            4557999999999997      45789999999999999999999999999887655544443210              


Q ss_pred             C-CCCcCCCCC----------ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        235 T-EDTVSFPSS----------IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       235 ~-~~~l~fP~~----------~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      . -..+.+|..          ..++..+.||++.||. ||.+|+++++++.||||+++-
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            0 011222321          3578899999999999 999999999999999997653

>KOG0033|consensus

Probab=100.00  E-value=9.3e-49  Score=401.48  Aligned_cols=255  Identities=30%  Similarity=0.507  Sum_probs=226.3

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      -.+.|++.++||+|.|+.|++|.+..||+.||+|+|....+..      ..|+.|.+.|+|||||+|++.+...+..|||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3467999999999999999999999999999999998666543      5789999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCcccccccC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~~~  163 (792)
                      +|++.||+|..-|...  ..+||..+..+++||+.+|.|||.+||+|||+||+|+++..   ..-+||+|||+|..+. +
T Consensus        89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~  165 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D  165 (355)
T ss_pred             EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence            9999999996554322  45899999999999999999999999999999999999943   3459999999999887 3


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC-
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP-  242 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP-  242 (792)
                      + ......+|||.|||||++..       .+|+.++|||+.|||+|.||.|++||.+++...+|+.|+.    +.+.+| 
T Consensus       166 g-~~~~G~~GtP~fmaPEvvrk-------dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~----g~yd~~~  233 (355)
T KOG0033|consen  166 G-EAWHGFAGTPGYLSPEVLKK-------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA----GAYDYPS  233 (355)
T ss_pred             c-cccccccCCCcccCHHHhhc-------CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc----cccCCCC
Confidence            2 34456789999999999973       5899999999999999999999999999999999999998    444443 


Q ss_pred             -CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        243 -SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       243 -~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                       .|.++++++++||++||. ||.+|+|+.++|+|||+..-+.
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~  275 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER  275 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence             477999999999999999 9999999999999999986543

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.4e-46  Score=402.76  Aligned_cols=256  Identities=40%  Similarity=0.718  Sum_probs=218.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+....       ...|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            5799999999999999999999999999999999754321       146899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC----
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN----  163 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~----  163 (792)
                      |||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..+...    
T Consensus        81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            99999999999954  456899999999999999999999999999999999999999999999999998533100    


Q ss_pred             --------------------------------------CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccch
Q psy13735        164 --------------------------------------GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIG  205 (792)
Q Consensus       164 --------------------------------------~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLG  205 (792)
                                                            ........+||+.|+|||++..       ..++.++||||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG  231 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDWWSVG  231 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-------CCCCcceeeeecc
Confidence                                                  0001123479999999999863       3688999999999


Q ss_pred             hhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhhcC---ChhHHhcCCCccCCC
Q psy13735        206 VVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVFDCLD  281 (792)
Q Consensus       206 VILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kRP---TaeEIL~HPwF~~i~  281 (792)
                      |++|+|++|..||.+.+.......+..  +.....+|....+++.+.++|.+|+.+|.+|+   ++.+++.||||..++
T Consensus       232 vilyell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         232 VILYEMLVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             ceeeehhhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            999999999999998887766666644  33344555556789999999999877999999   899999999999765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-46  Score=392.62  Aligned_cols=248  Identities=34%  Similarity=0.638  Sum_probs=219.5

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||+|+||.||+|.++.+|+.||+|++.......       ..|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997543221       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++||+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......    
T Consensus        81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            99999999999954  456899999999999999999999999999999999999999999999999999876432    


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+..    ....+|.  .+
T Consensus       155 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~----~~~~~~~--~~  221 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQS-------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA----GKLEFPR--HL  221 (291)
T ss_pred             cccccCChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCcCCCc--cC
Confidence            234579999999999863       3578899999999999999999999998888888887766    4445555  56


Q ss_pred             cHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~  281 (792)
                      ++.++++|++||. ||.+||+     +.+++.||||..++
T Consensus       222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence            8999999999999 9999995     99999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-45  Score=399.17  Aligned_cols=256  Identities=40%  Similarity=0.772  Sum_probs=220.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.+.....       ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999997543211       45888999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC--
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR--  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~--  165 (792)
                      |||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|+++|+|||++..+.....  
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            99999999999954  45699999999999999999999999999999999999999999999999999875432110  


Q ss_pred             --------------------------------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc
Q psy13735        166 --------------------------------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT  213 (792)
Q Consensus       166 --------------------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT  213 (792)
                                                      ......+||+.|+|||++.+       ..++.++|||||||++|+|++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-------CCCCCcceeccccceeeeccc
Confidence                                            01123579999999999863       368899999999999999999


Q ss_pred             CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhhcCC---hhHHhcCCCccCCC
Q psy13735        214 GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN---MDQVLGHPVFDCLD  281 (792)
Q Consensus       214 Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kRPT---aeEIL~HPwF~~i~  281 (792)
                      |.+||...+....+..+..  +.....+|....+++.++++|.+|+.+|.+|++   +.+++.||||.+++
T Consensus       232 G~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         232 GYPPFCSETPQETYRKVMN--WKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             CCCCCCCCCHHHHHHHHHc--CCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCC
Confidence            9999998888888877765  334455666566899999999998779999985   78999999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0032|consensus

Probab=100.00  E-value=5.2e-46  Score=410.80  Aligned_cols=255  Identities=35%  Similarity=0.564  Sum_probs=230.1

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcC-CCCcceeEEEEEeCCEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSK-CPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~-HPNIVkL~~vfede~~ly   84 (792)
                      ....|.+.+.||.|.||.||+|+++.||+.||+|++.+.....       ..|+.||+++. |||||.++++|++...+|
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457999999999999999999999999999999999887732       68999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC----CCceEEeccCccccc
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA----TGHLKLTDFGSATQV  160 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~----dg~VKLiDFGLA~~l  160 (792)
                      +|||+|.||+|++.+...   .+++..+..+++||+.++.|||+.||+||||||+|+|+..    ++.+|++|||++...
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            999999999999999765   3999999999999999999999999999999999999853    357999999999988


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..  .......||||.|+|||++..       .+|+..+||||+||++|.|++|.+||.+.+....+..|....+  .+.
T Consensus       190 ~~--~~~~~~~~Gtp~y~APEvl~~-------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--~f~  258 (382)
T KOG0032|consen  190 KP--GERLHTIVGTPEYVAPEVLGG-------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--DFT  258 (382)
T ss_pred             cC--CceEeeecCCccccCchhhcC-------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--CCC
Confidence            76  334567799999999999963       4899999999999999999999999999999999999988443  334


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .+.+..+|..+++||+.||. ||.+|+|+.++|+|||+....
T Consensus       259 ~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  259 SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            45567899999999999999 999999999999999998753

>KOG0696|consensus

Probab=100.00  E-value=1.9e-47  Score=411.74  Aligned_cols=307  Identities=30%  Similarity=0.570  Sum_probs=265.0

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcC-CCCcceeEEEEEeCCE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSK-CPYIVNLFYSFQDMNH   82 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~-HPNIVkL~~vfede~~   82 (792)
                      .+...+|.++.+||+|+||.|.++..+.|...||||++.++.+..       +.|..+|.... -|+++.++..|++-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            467789999999999999999999999999999999998876543       68899998774 7899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+||||+.||+|...|  +.-|.|.|+.+.+|+..|+.||-+||++||++||||.+|||+|.+|+|||+|||+|+.-..
T Consensus       425 LyFVMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             eeeEEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999999999999  4567899999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      . ...+.+.||||.|+|||++.+.       +|+.++||||+||++|+||.|++||.+++.+++++.|+.    ....||
T Consensus       503 ~-~~TTkTFCGTPdYiAPEIi~Yq-------PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e----hnvsyP  570 (683)
T KOG0696|consen  503 D-GVTTKTFCGTPDYIAPEIIAYQ-------PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME----HNVSYP  570 (683)
T ss_pred             C-CcceeeecCCCcccccceEEec-------ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH----ccCcCc
Confidence            3 3456788999999999999864       899999999999999999999999999999999999988    677888


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCCh-----hHHhcCCCccCCC--------CCCCCCCCC---cccCcCChhhhhccC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNM-----DQVLGHPVFDCLD--------SDPPCIPPP---SQENKFHKKDKRKAS  305 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTa-----eEIL~HPwF~~i~--------~~pP~~P~~---s~~~~f~~k~~~k~~  305 (792)
                      .  .+|.++.++++.+|+ .|.+|+++     .+|..||||+.++        ..||++|..   .+..+|+...++.+.
T Consensus       571 K--slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~  648 (683)
T KOG0696|consen  571 K--SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPT  648 (683)
T ss_pred             c--cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCC
Confidence            7  789999999999999 89999985     5789999999887        578888874   567788887776543


Q ss_pred             CChhhhhhcccccccCCCcccccccCCCC
Q psy13735        306 PSLKAFQKEGRYLDSALPLIGISYTGEPM  334 (792)
Q Consensus       306 ~s~k~f~~~~~~~~~~l~fig~s~~~~~~  334 (792)
                      .-.+ ....-...-.+..|+||||.++..
T Consensus       649 ~lTP-pD~~v~~nldq~eF~gFsfvNpef  676 (683)
T KOG0696|consen  649 DLTP-PDKLVMMNLDQSEFEGFSFVNPEF  676 (683)
T ss_pred             CCCC-chHHHHhcCchhhcCceeeeChhh
Confidence            2111 111112223467899999987653

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.7e-45  Score=390.07  Aligned_cols=250  Identities=33%  Similarity=0.669  Sum_probs=216.8

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +|.+.+.||+|+||.||+|.+..++..||+|++.+.....       ..|..++..+ .||+|+.++++|.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            6899999999999999999999999999999998654321       3466677666 5899999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT  157 (323)
T ss_pred             cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence            99999999999854  4569999999999999999999999999999999999999999999999999997543222 22


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+..    ....+|.  .+
T Consensus       158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----~~~~~p~--~~  224 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNVAYPK--SM  224 (323)
T ss_pred             cccCCCChhhcCHHHhcC-------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCC--cC
Confidence            334579999999999863       3688999999999999999999999998888888887776    3445555  67


Q ss_pred             cHHHHHHHHHHhh-ChhhcCCh-----hHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNM-----DQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTa-----eEIL~HPwF~~i~  281 (792)
                      ++.+.+++.+||+ +|.+|+++     .+++.||||+.++
T Consensus       225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999 99999985     7899999999776

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0986|consensus

Probab=100.00  E-value=5.5e-47  Score=412.82  Aligned_cols=279  Identities=29%  Similarity=0.531  Sum_probs=245.1

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEE
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSF   77 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vf   77 (792)
                      ++++...++.+.|+.-++||+||||.||-|+.+.||+.||+|.+.|..+..       .+|+.||.+++.|+||.+-++|
T Consensus       175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            678888899999999999999999999999999999999999887665433       6899999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      ++.+.+|+||..|+||+|..+|.+.....|++..+++|+.+|+.||.+||..+||+||+||+|||+|+.|||+|+|+|+|
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence            99999999999999999999998766678999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC
Q psy13735        158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       158 ~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      ..+.......  ..+||.+|||||++...       .|+..+|||||||++|+|+.|+.||.......-.+.+-......
T Consensus       335 vei~~g~~~~--~rvGT~GYMAPEvl~ne-------~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~  405 (591)
T KOG0986|consen  335 VEIPEGKPIR--GRVGTVGYMAPEVLQNE-------VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED  405 (591)
T ss_pred             EecCCCCccc--cccCcccccCHHHHcCC-------cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc
Confidence            9987655443  44799999999999843       59999999999999999999999997554433333333333336


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCCh-----hHHhcCCCccCCC--------CCCCCCCCCcccC
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNM-----DQVLGHPVFDCLD--------SDPPCIPPPSQEN  294 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTa-----eEIL~HPwF~~i~--------~~pP~~P~~s~~~  294 (792)
                      ...+|.  .+|++++++++.||+ ||.+|+++     +++..||||++++        ..||++|.|....
T Consensus       406 ~~ey~~--kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVy  474 (591)
T KOG0986|consen  406 PEEYSD--KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVY  474 (591)
T ss_pred             hhhccc--ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccc
Confidence            667776  889999999999999 99999885     5789999999988        5899999875443

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-45  Score=391.41  Aligned_cols=262  Identities=40%  Similarity=0.747  Sum_probs=218.5

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|++++.||+|+||.||++.+..+|+.||+|++.+.....       ..|+.++..++||||+.++++|.+.+++|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999997532211       46788899999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++||+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.......
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999999652 3568999999999999999999999999999999999999999999999999997765443333


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC-Ccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS-SIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~-~~~  246 (792)
                      ....+||+.|+|||++...  ..+...++.++||||+||++|+|++|..||...+....+..+....  ....+|. ...
T Consensus       160 ~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~  235 (331)
T cd05597         160 SNVAVGTPDYISPEILQAM--EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--EHFQFPPDVTD  235 (331)
T ss_pred             ccceeccccccCHHHHhhc--cccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CcccCCCccCC
Confidence            3345699999999998632  1123457889999999999999999999998887777777775421  2222332 235


Q ss_pred             ccHHHHHHHHHHhh-C--hhhcCChhHHhcCCCccCCC
Q psy13735        247 LSTAMVNFVQSLVQ-K--LDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       247 lS~elkdLIk~LL~-D--P~kRPTaeEIL~HPwF~~i~  281 (792)
                      +++.+++|+++||+ +  +..|+++.+++.||||...+
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            79999999999998 3  33478999999999998765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0608|consensus

Probab=100.00  E-value=1.2e-46  Score=420.18  Aligned_cols=287  Identities=39%  Similarity=0.711  Sum_probs=255.9

Q ss_pred             HHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEE
Q psy13735          6 ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQ   78 (792)
Q Consensus         6 ~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfe   78 (792)
                      +|+|.++.-+-|..++.||-|+||.|++|+..+|...||+|.+.|.....       ..|+.||..-+.++||+||+.|+
T Consensus       620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ  699 (1034)
T KOG0608|consen  620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ  699 (1034)
T ss_pred             HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence            67888899999999999999999999999999999999999998776543       46999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      +.+++|+||+|++||++..+|.+  .|.|.|..+++|+..+.+|+.+.|..|+|||||||+|||||.+|||||+|||+|+
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence            99999999999999999999954  5779999999999999999999999999999999999999999999999999998


Q ss_pred             ccccC-----------------------------------------CCcccccCCCCCCccChhhhhhhccCCCCCCCCc
Q psy13735        159 QVDKN-----------------------------------------GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG  197 (792)
Q Consensus       159 ~l~~~-----------------------------------------~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~  197 (792)
                      .+.-.                                         ........+||+.|+|||++.       ..+|+.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-------r~g~~q  850 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-------RTGYTQ  850 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-------ccCccc
Confidence            65310                                         011122347999999999997       358999


Q ss_pred             ccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhhChhhcCC---hhHHhcC
Q psy13735        198 SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN---MDQVLGH  274 (792)
Q Consensus       198 ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~DP~kRPT---aeEIL~H  274 (792)
                      .|||||.|||||+|+.|++||...++..+..++.+  |...+.+|.-.++|.++.++|.+|++++..|++   ++++..|
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaH  928 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAH  928 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcC
Confidence            99999999999999999999999999998888866  888899998889999999999999999999987   6789999


Q ss_pred             CCccCCC------CCCCCCCC---CcccCcCChhhhhc
Q psy13735        275 PVFDCLD------SDPPCIPP---PSQENKFHKKDKRK  303 (792)
Q Consensus       275 PwF~~i~------~~pP~~P~---~s~~~~f~~k~~~k  303 (792)
                      |||+.++      ..+|++|.   +.+.++|+..+..+
T Consensus       929 pfFkgIDfsslRkq~ApYIP~ItHptDTSNFdpvdpek  966 (1034)
T KOG0608|consen  929 PFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDPVDPEK  966 (1034)
T ss_pred             ccccccchHhhhhccCCcCccccCCCccccCCcCCccc
Confidence            9999998      46778876   78899998776543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-45  Score=396.60  Aligned_cols=254  Identities=33%  Similarity=0.610  Sum_probs=222.4

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCC-cEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSH-NTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tG-k~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      ..++..++|.+.+.||+|+||.||+|.++.++ ..||+|.+.+.....       ..|+.++..++||||++++++|.+.
T Consensus        24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            34567889999999999999999999987665 689999987643221       4688999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +.+|+|||||+||+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999999999954  456999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ...    ....+||+.|+|||++.+       ..++.++||||+||++|+|++|.+||.+.+....+..+..    ....
T Consensus       182 ~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~----~~~~  246 (340)
T PTZ00426        182 DTR----TYTLCGTPEYIAPEILLN-------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE----GIIY  246 (340)
T ss_pred             CCC----cceecCChhhcCHHHHhC-------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc----CCCC
Confidence            432    234579999999999963       3578899999999999999999999998888877888776    3445


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      +|.  .+++.+.++|++||. ||.+|+     ++++++.||||.+++
T Consensus       247 ~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        247 FPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             CCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            555  678999999999999 999995     899999999999875

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-45  Score=391.25  Aligned_cols=252  Identities=38%  Similarity=0.702  Sum_probs=218.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.....       ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997653221       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....    .
T Consensus        81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~  154 (333)
T cd05600          81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y  154 (333)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence            99999999999954  45689999999999999999999999999999999999999999999999999986543    2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC---
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS---  244 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~---  244 (792)
                      ....+||+.|+|||++..       ..++.++|||||||++|+|++|..||...+....+..+....  .....|..   
T Consensus       155 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~  225 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRG-------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDP  225 (333)
T ss_pred             cCCcccCccccChhHhcC-------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCcc
Confidence            334579999999999863       368899999999999999999999999888877777665421  11222221   


Q ss_pred             -ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        245 -IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       245 -~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                       ..+++++.+|+.+||. +|.+||++.+++.||||..++
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence             2569999999999999 899999999999999999764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-45  Score=391.50  Aligned_cols=245  Identities=35%  Similarity=0.667  Sum_probs=211.8

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.++.+|+.||+|++.+.....       ..|..++..+ +||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999997643211       4567777765 699999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....+
T Consensus        81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~~~  157 (320)
T cd05590          81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFC  157 (320)
T ss_pred             chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccccc
Confidence            999999854  45699999999999999999999999999999999999999999999999999876432221 233457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+..    ....+|.  .+++++.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~--~~~~~~~  224 (320)
T cd05590         158 GTPDYIAPEILQE-------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----DEVVYPT--WLSQDAV  224 (320)
T ss_pred             cCccccCHHHHcC-------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc----CCCCCCC--CCCHHHH
Confidence            9999999999863       3688899999999999999999999998888888887765    3444554  6799999


Q ss_pred             HHHHHHhh-ChhhcCCh------hHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNM------DQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTa------eEIL~HPwF~~i~  281 (792)
                      +|+.+||+ ||.+||++      .+++.||||..++
T Consensus       225 ~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         225 DILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             HHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999 99999998      8999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-45  Score=388.66  Aligned_cols=243  Identities=34%  Similarity=0.673  Sum_probs=212.4

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ||+|+||.||+|.+..+|+.||+|++.+.....       ..|..++..++||||++++++|.+.+.+|+|||||+||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999997643211       4688999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP  175 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp  175 (792)
                      .+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++....... ......+||+
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~  157 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP  157 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence            999954  4569999999999999999999999999999999999999999999999999997643222 2233457999


Q ss_pred             CccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHH
Q psy13735        176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV  255 (792)
Q Consensus       176 ~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLI  255 (792)
                      .|+|||++.+       ..++.++||||+||++|+|++|.+||...+....+..+..    ....+|.  .+++.+.+|+
T Consensus       158 ~y~aPE~~~~-------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----~~~~~~~--~~~~~~~~li  224 (312)
T cd05585         158 EYLAPELLLG-------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----EPLRFPD--GFDRDAKDLL  224 (312)
T ss_pred             ccCCHHHHcC-------CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc----CCCCCCC--cCCHHHHHHH
Confidence            9999999863       3688999999999999999999999998888777777765    4455555  6799999999


Q ss_pred             HHHhh-ChhhcCC---hhHHhcCCCccCCC
Q psy13735        256 QSLVQ-KLDARLN---MDQVLGHPVFDCLD  281 (792)
Q Consensus       256 k~LL~-DP~kRPT---aeEIL~HPwF~~i~  281 (792)
                      .+||. ||.+||+   +.+++.||||...+
T Consensus       225 ~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             HHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence            99999 9999974   78999999999764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.2e-45  Score=388.31  Aligned_cols=262  Identities=39%  Similarity=0.744  Sum_probs=219.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||+|+||.||++.++.+++.||+|++.+.....       ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997532211       45778888999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.......
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999999653 3468999999999999999999999999999999999999999999999999997665443333


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC-cc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS-IR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~-~~  246 (792)
                      ....+||+.|+|||++...  ..+...++.++|||||||++|+|++|..||...+....+..+....  ....+|.. ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~  235 (332)
T cd05623         160 SSVAVGTPDYISPEILQAM--EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTD  235 (332)
T ss_pred             ecccccCccccCHHHHhcc--ccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCcccc
Confidence            3445799999999998632  1123468889999999999999999999999888888888776522  22233332 36


Q ss_pred             ccHHHHHHHHHHhh-Chh--hcCChhHHhcCCCccCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLD--ARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~--kRPTaeEIL~HPwF~~i~  281 (792)
                      +++++.+|+.+||+ ++.  .|+++.+++.||||.+++
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            79999999999998 433  368999999999999765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.6e-45  Score=387.24  Aligned_cols=250  Identities=33%  Similarity=0.656  Sum_probs=215.8

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCC-CCcceeEEEEEeCCEEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKC-PYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~H-PNIVkL~~vfede~~lyLVm   87 (792)
                      +|.+++.||+|+||.||+|.+..+++.||+|++.+.....       ..|..++..+.| ++|+.++++|.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            6899999999999999999999999999999997643211       457788888876 56889999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ..
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT  157 (324)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence            99999999999854  4568999999999999999999999999999999999999999999999999987543221 12


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++.+       ..++.++||||+||++|+|++|..||.+.+....+..+..    ....+|.  .+
T Consensus       158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----~~~~~~~--~~  224 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME----HNVSYPK--SL  224 (324)
T ss_pred             eeeecCCccccChhhhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCC--CC
Confidence            234579999999999863       3678899999999999999999999998888888887765    3444555  67


Q ss_pred             cHHHHHHHHHHhh-ChhhcCCh-----hHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNM-----DQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTa-----eEIL~HPwF~~i~  281 (792)
                      ++.+.+++.+||. ||.+|++.     .+++.||||..++
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         225 SKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999 99999986     7999999998765

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.8e-45  Score=388.31  Aligned_cols=248  Identities=33%  Similarity=0.623  Sum_probs=213.1

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHH---HhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIM---VKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL---~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      |++.+.||+|+||.||+|.+..+|+.||+|++.+.....       ..|+.++   ..++||||++++++|.+...+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999997653221       2344444   456799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||||+||+|..++..   +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D  156 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence            999999999988843   459999999999999999999999999999999999999999999999999987543222 1


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+|++.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+.......+..    ....+|.  .
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~----~~~~~p~--~  223 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN----DEVRYPR--F  223 (324)
T ss_pred             cccccccCccccCHhHhcC-------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCC--C
Confidence            2334579999999999863       3678899999999999999999999998888777777765    3344554  6


Q ss_pred             ccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      +++.+.++|.+||. ||.+||     ++.+++.||||.+++
T Consensus       224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            79999999999999 999999     689999999999865

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.5e-45  Score=386.56  Aligned_cols=252  Identities=32%  Similarity=0.612  Sum_probs=210.3

Q ss_pred             CceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCCh--------HHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPN--------TIERDIMVKS-KCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~~--------~~E~eIL~kL-~HPNIVkL~~vfede~~l   83 (792)
                      +|++++.||+|+||.||+|.+.   .+|..||+|++.+.....        ..|..++..+ +||||+.++++|...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999874   578999999997543211        4688899998 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+|||||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            999999999999999954  455999999999999999999999999999999999999999999999999999875443


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh----hhhhhhhcccCCCCc
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD----MTYSSILACDTEDTV  239 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~----el~ekIl~~~~~~~l  239 (792)
                      ........+||+.|+|||++.+      ...++.++|||||||++|+|++|..||......    .....+..    ...
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----~~~  228 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRG------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----CDP  228 (332)
T ss_pred             CCCccccccCCccccCHHHhcC------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----CCC
Confidence            3333345679999999999863      234788999999999999999999999654322    22223322    223


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      .+|.  .+++.+.+++.+||. ||.+||     ++.++++||||...+
T Consensus       229 ~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         229 PFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            3443  679999999999999 999999     788999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-44  Score=387.35  Aligned_cols=262  Identities=39%  Similarity=0.758  Sum_probs=218.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||+|+||.||++.++.+++.||+|++.+.....       ..|..++..++||||+.++++|.+.+.+|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999987632211       45778888999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++.+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999999653 3468999999999999999999999999999999999999999999999999998765443333


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC-cc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS-IR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~-~~  246 (792)
                      ....+||+.|+|||++...  ..+...++.++||||+||++|+|++|..||...+....+..+....  ....+|.. ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~  235 (331)
T cd05624         160 SSVAVGTPDYISPEILQAM--EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE--ERFQFPSHITD  235 (331)
T ss_pred             eccccCCcccCCHHHHhcc--ccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC--CcccCCCcccc
Confidence            3345799999999998632  1112357889999999999999999999999888777777776522  22334432 35


Q ss_pred             ccHHHHHHHHHHhh-Chhh--cCChhHHhcCCCccCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDA--RLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~k--RPTaeEIL~HPwF~~i~  281 (792)
                      +++.+++++.+||+ ++.+  |+++++++.||||+.++
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            78999999999999 4433  56899999999999765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.7e-45  Score=386.96  Aligned_cols=245  Identities=35%  Similarity=0.682  Sum_probs=209.3

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHh-cCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~k-L~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.+..+++.||+|++.+.....       ..|+.++.. .+||||++++++|.....+|+|||||+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999997643211       346666654 4799999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus        81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC  157 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence            999999854  4569999999999999999999999999999999999999999999999999997654322 2333457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+....+..+..    ....+|.  .++.++.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~~~~~~--~~~~~~~  224 (316)
T cd05592         158 GTPDYIAPEILKG-------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN----DRPHFPR--WISKEAK  224 (316)
T ss_pred             CCccccCHHHHcC-------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCC--CCCHHHH
Confidence            9999999999863       3688999999999999999999999998888777777654    3334444  6789999


Q ss_pred             HHHHHHhh-ChhhcCChh-HHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNMD-QVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTae-EIL~HPwF~~i~  281 (792)
                      +|+.+||. +|.+||++. +++.||||..++
T Consensus       225 ~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         225 DCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             HHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence            99999999 999999865 788999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0597|consensus

Probab=100.00  E-value=1.8e-46  Score=416.19  Aligned_cols=250  Identities=36%  Similarity=0.599  Sum_probs=228.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .++|-+.+.||+|+||.||+++.+.|++.||+|.+.|.....      ..|++|++.++|||||.+++.|++..++|+|+
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            368999999999999999999999999999999999887665      67999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||.| +|+.++.  ..+.++|+.++.++.++++||.|||+++|+|||+||.|||++.+|++|+||||+|+....+.. .
T Consensus        81 e~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-v  156 (808)
T KOG0597|consen   81 EYAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-V  156 (808)
T ss_pred             hhhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce-e
Confidence            99976 9999994  467799999999999999999999999999999999999999999999999999998765433 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      .....|||.|||||++.+       .+|+..+|+||||||+|||++|++||.....-.....|..    .+..+|.  ..
T Consensus       157 ltsikGtPlYmAPElv~e-------~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----d~v~~p~--~~  223 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEE-------QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----DPVKPPS--TA  223 (808)
T ss_pred             eeeccCcccccCHHHHcC-------CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc----CCCCCcc--cc
Confidence            334469999999999973       4899999999999999999999999999988888888887    5556666  78


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      |..+.+|++.||. ||.+|++..+++.|||++..
T Consensus       224 S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             cHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence            9999999999999 99999999999999999853

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-44  Score=387.42  Aligned_cols=245  Identities=33%  Similarity=0.634  Sum_probs=212.5

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      +.||+|+||.||+|.+..+|..||+|++.+.....       ..|..+++.++||||++++++|.+.+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997653321       45888999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCC
Q psy13735         94 DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG  173 (792)
Q Consensus        94 sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vG  173 (792)
                      +|..++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~g  157 (328)
T cd05593          81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCG  157 (328)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccC
Confidence            99998854  4569999999999999999999999999999999999999999999999999987643221 12234579


Q ss_pred             CCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHH
Q psy13735        174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN  253 (792)
Q Consensus       174 Tp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkd  253 (792)
                      |+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+..    ....+|.  .+++++.+
T Consensus       158 t~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~----~~~~~p~--~~~~~~~~  224 (328)
T cd05593         158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EDIKFPR--TLSADAKS  224 (328)
T ss_pred             CcCccChhhhcC-------CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc----CCccCCC--CCCHHHHH
Confidence            999999999863       3688999999999999999999999988777776666654    3445555  67999999


Q ss_pred             HHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        254 FVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       254 LIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      ||.+||. ||.+||     ++.+++.||||...+
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999 999997     899999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.5e-45  Score=386.87  Aligned_cols=245  Identities=33%  Similarity=0.693  Sum_probs=211.9

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||.|+||.||+|.++.++..||+|++.+.....       ..|..++..+ +||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999998653221       4577788777 699999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......+
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC  157 (318)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence            999999854  4569999999999999999999999999999999999999999999999999987533221 2233457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      |++.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+....+..+..    ....+|.  .+++.+.
T Consensus       158 g~~~y~aPE~~~~-------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~----~~~~~~~--~~~~~~~  224 (318)
T cd05570         158 GTPDYIAPEILSY-------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE----DEVRYPR--WLSKEAK  224 (318)
T ss_pred             cCccccCHHHhcC-------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc----CCCCCCC--cCCHHHH
Confidence            9999999999863       3688899999999999999999999998887777777765    3344554  6799999


Q ss_pred             HHHHHHhh-ChhhcCCh-----hHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNM-----DQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTa-----eEIL~HPwF~~i~  281 (792)
                      +||.+||. ||.+||++     .+++.||||...+
T Consensus       225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             HHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999 99999999     9999999998765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.6e-45  Score=386.22  Aligned_cols=245  Identities=33%  Similarity=0.643  Sum_probs=209.3

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHH-HHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERD-IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~e-IL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.++.+|+.||+|++.+.....       ..|.. +++.++||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999997653321       23333 45678999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ......+
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  157 (323)
T cd05575          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFC  157 (323)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccccc
Confidence            999999954  4569999999999999999999999999999999999999999999999999987543222 2233457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|..||...+....+..+..    ....++.  .+++.+.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~~~--~~~~~~~  224 (323)
T cd05575         158 GTPEYLAPEVLRK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN----KPLRLKP--NISVSAR  224 (323)
T ss_pred             CChhhcChhhhcC-------CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc----CCCCCCC--CCCHHHH
Confidence            9999999999863       3688999999999999999999999998888887777765    3334444  5699999


Q ss_pred             HHHHHHhh-ChhhcCCh----hHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNM----DQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTa----eEIL~HPwF~~i~  281 (792)
                      ++|.+||. ||.+||++    .+++.||||..++
T Consensus       225 ~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         225 HLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             HHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999 99999997    5999999998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8e-45  Score=386.37  Aligned_cols=245  Identities=31%  Similarity=0.637  Sum_probs=209.7

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHh-cCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~k-L~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.++.+|..||+|++.+....       ...|..++.. ++||||++++++|.+.+.+|+|||||.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999999764321       1456667765 4899999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......+
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFC  157 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccC
Confidence            999999854  4568999999999999999999999999999999999999999999999999987543221 1233457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++.+       ..++.++||||+||++|+|++|..||.+.+.......+..    ....+|.  .++..+.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~--~~~~~~~  224 (316)
T cd05620         158 GTPDYIAPEILQG-------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV----DTPHYPR--WITKESK  224 (316)
T ss_pred             CCcCccCHHHHcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCC--CCCHHHH
Confidence            9999999999863       3688999999999999999999999998887777777654    3344554  5799999


Q ss_pred             HHHHHHhh-ChhhcCCh-hHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNM-DQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTa-eEIL~HPwF~~i~  281 (792)
                      +++.+||. ||.+||++ .+++.||||..++
T Consensus       225 ~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         225 DILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            99999999 99999998 5789999998865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.6e-45  Score=385.90  Aligned_cols=245  Identities=34%  Similarity=0.659  Sum_probs=212.5

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.++.+|+.||+|++.+.....       ..|..++..+ +||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999997653221       4577788765 799999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ .....+
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~  157 (321)
T cd05591          81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFC  157 (321)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccccc
Confidence            999999854  45689999999999999999999999999999999999999999999999999876432222 223457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|..||...+....+..+..    ....+|.  .+++++.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~----~~~~~p~--~~~~~~~  224 (321)
T cd05591         158 GTPDYIAPEILQE-------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH----DDVLYPV--WLSKEAV  224 (321)
T ss_pred             cCccccCHHHHcC-------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCC--CCCHHHH
Confidence            9999999999863       3688899999999999999999999999888888888876    3444554  5789999


Q ss_pred             HHHHHHhh-ChhhcC-------ChhHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARL-------NMDQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRP-------TaeEIL~HPwF~~i~  281 (792)
                      +++..||. ||.+||       ++.+++.||||..++
T Consensus       225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         225 SILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            99999999 999999       899999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.3e-45  Score=387.00  Aligned_cols=245  Identities=33%  Similarity=0.641  Sum_probs=212.7

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      +.||+|+||.||+|.++.+|..||+|++.+.....       ..|..++..++||||++++++|...+.+|+|||||+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999997643221       46888999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCC
Q psy13735         94 DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG  173 (792)
Q Consensus        94 sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vG  173 (792)
                      +|..++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g  157 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG  157 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccC
Confidence            99998854  4568999999999999999999999999999999999999999999999999987543221 12234579


Q ss_pred             CCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHH
Q psy13735        174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN  253 (792)
Q Consensus       174 Tp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkd  253 (792)
                      |+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+..    ....+|.  .+++.+.+
T Consensus       158 t~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~----~~~~~p~--~~~~~~~~  224 (323)
T cd05595         158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPR--TLSPEAKS  224 (323)
T ss_pred             CcCcCCcccccC-------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc----CCCCCCC--CCCHHHHH
Confidence            999999999863       3688999999999999999999999988887777777655    3445555  67999999


Q ss_pred             HHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        254 FVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       254 LIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      +|..||. ||.+||     ++.+++.||||....
T Consensus       225 li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             HHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999 999998     899999999998765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0599|consensus

Probab=100.00  E-value=1.9e-46  Score=388.83  Aligned_cols=260  Identities=26%  Similarity=0.458  Sum_probs=229.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------HHHHHHHHhc-CCCCcceeEEEEEeC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------TIERDIMVKS-KCPYIVNLFYSFQDM   80 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------~~E~eIL~kL-~HPNIVkL~~vfede   80 (792)
                      ...|.-.+.||.|..++|.+|.++.+|+.+|+|+|.......            ..|+.||+++ .||+|++++++|+++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            456788899999999999999999999999999986433221            4688999998 599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+++|+|.|+.|.|+|++..  .-.+||..++.||+|++.|+.|||.++|+||||||+|||+|++.+++|+|||+|+.+
T Consensus        96 sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             chhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence            999999999999999999943  456999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .++..  -...||||+|+|||.+.+. ...+.++|+..+|+|++|||||.||.|.+||.......++..|+...  ..+.
T Consensus       174 ~~Gek--LrelCGTPgYLAPEtikC~-m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk--yqF~  248 (411)
T KOG0599|consen  174 EPGEK--LRELCGTPGYLAPETIKCS-MYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK--YQFR  248 (411)
T ss_pred             CCchh--HHHhcCCCcccChhheeee-cccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc--cccC
Confidence            87653  3457999999999999864 34456789999999999999999999999999888888888887722  2334


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      -|.|.++|...+|+|.+||+ ||.+|+|++++|.||||..+
T Consensus       249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            46688999999999999999 99999999999999999644

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-44  Score=384.14  Aligned_cols=245  Identities=33%  Similarity=0.640  Sum_probs=208.2

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHH-HHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERD-IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~e-IL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.+..+|+.||+|++.+.....       ..|.. +++.++||||++++++|...+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999997653221       23333 46678999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ......+
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~  157 (325)
T cd05604          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFC  157 (325)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccccc
Confidence            999998854  4569999999999999999999999999999999999999999999999999987543222 1223457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|.+||...+....+..+..    ....++.  ..+..+.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~----~~~~~~~--~~~~~~~  224 (325)
T cd05604         158 GTPEYLAPEVIRK-------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH----KPLVLRP--GASLTAW  224 (325)
T ss_pred             CChhhCCHHHHcC-------CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc----CCccCCC--CCCHHHH
Confidence            9999999999863       3678899999999999999999999998888777777765    3333333  5789999


Q ss_pred             HHHHHHhh-ChhhcCCh----hHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNM----DQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTa----eEIL~HPwF~~i~  281 (792)
                      +++..||. +|.+||++    .+++.||||....
T Consensus       225 ~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         225 SILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             HHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            99999999 99999986    5899999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-44  Score=373.16  Aligned_cols=254  Identities=28%  Similarity=0.418  Sum_probs=208.3

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++|.+.+.||+|+||.||+|+++.+++.||+|++.......      ..|+.+++.++||||++++++|...+.+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999999999999999987653321      568899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++++.+..+..  ..+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            999887765542  235689999999999999999999999999999999999999999999999999987654332233


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC-------------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT-------------  235 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~-------------  235 (792)
                      ....|++.|+|||++..       ..++.++||||+||++|+|++|++||.+.+.......+.....             
T Consensus       159 ~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07848         159 TEYVATRWYRSPELLLG-------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN  231 (287)
T ss_pred             cccccccccCCcHHHcC-------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence            34569999999999863       3578899999999999999999999987654333222211000             


Q ss_pred             --CCCcCCCC-----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        236 --EDTVSFPS-----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       236 --~~~l~fP~-----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                        .....+|.           ...+|..+.+|+++||. ||.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              00011111           11368899999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0585|consensus

Probab=100.00  E-value=5.3e-45  Score=399.39  Aligned_cols=261  Identities=26%  Similarity=0.480  Sum_probs=228.8

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------------HHHHHHHHhcCCCCcc
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------------TIERDIMVKSKCPYIV   71 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------------~~E~eIL~kL~HPNIV   71 (792)
                      ++..+++|.+++.||+|.||.|.++++..+|+.||||++.+.....                  ..|+.||+++.|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            4567899999999999999999999999999999999998765432                  4699999999999999


Q ss_pred             eeEEEEEeC--CEEEEEEeccCCCCHHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc
Q psy13735         72 NLFYSFQDM--NHVYFIMEYVTGGDFVTLLENQPHGY-LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH  148 (792)
Q Consensus        72 kL~~vfede--~~lyLVmEy~~GGsL~dlL~r~~~g~-LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~  148 (792)
                      +|+++..+.  +.+|||+|||..|.+...-   ..+. +++.++++|++.++.||.|||.+||+||||||.|+||+.+|+
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence            999999875  5799999999999877653   3444 999999999999999999999999999999999999999999


Q ss_pred             eEEeccCcccccccCC----CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh
Q psy13735        149 LKLTDFGSATQVDKNG----RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD  224 (792)
Q Consensus       149 VKLiDFGLA~~l~~~~----~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~  224 (792)
                      |||+|||.+.......    .......+|||.|+|||.+...   ......+.+.||||+||.+|.|+.|+.||.++...
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~---~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG---NSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC---CCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            9999999998763221    1111224799999999998642   11334578899999999999999999999999999


Q ss_pred             hhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        225 MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       225 el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .++.+|.+    ..+.||....+.+.++|+|.+||+ ||.+|+++.+|..|||...-
T Consensus       326 ~l~~KIvn----~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  326 ELFDKIVN----DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHHhc----CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            99999998    788999887899999999999999 99999999999999999754

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.4e-44  Score=380.55  Aligned_cols=250  Identities=32%  Similarity=0.659  Sum_probs=215.7

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVm   87 (792)
                      +|++.+.||+|+||.||+|.++.+|+.||+|++.+.....       ..|..++..+. ||+|+.++++|.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5889999999999999999999999999999997653211       45777777775 678889999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT  157 (323)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence            99999999999954  4569999999999999999999999999999999999999999999999999987643222 12


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++.+       ..++.++||||+||++|+|++|.+||.+.+....+..+..    ....+|.  .+
T Consensus       158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----~~~~~p~--~~  224 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME----HNVSYPK--SL  224 (323)
T ss_pred             ccCccCCccccCHHHHcC-------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCc--cC
Confidence            334569999999999863       3688999999999999999999999998888888887776    3445555  67


Q ss_pred             cHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~  281 (792)
                      +..+.+++.+||. +|.+|++     ..+++.||||..++
T Consensus       225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            8999999999999 9999998     46899999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-44  Score=381.12  Aligned_cols=246  Identities=34%  Similarity=0.660  Sum_probs=211.6

Q ss_pred             EeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCCh--------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         20 KRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPN--------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~~--------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++.||+|+||.||+|...   .+|+.||+|++.+.....        ..|+.+++.++||||++++++|..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   578999999997643211        468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus        81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  157 (323)
T cd05584          81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT  157 (323)
T ss_pred             CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence            9999999999954  4568999999999999999999999999999999999999999999999999987543222 123


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...+||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+..    ....+|.  .++
T Consensus       158 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~----~~~~~~~--~~~  224 (323)
T cd05584         158 HTFCGTIEYMAPEILMR-------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK----GKLNLPP--YLT  224 (323)
T ss_pred             cccCCCccccChhhccC-------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCC--CCC
Confidence            34579999999999863       3578899999999999999999999998887777777765    3444554  678


Q ss_pred             HHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      +.+.+||.+||. +|.+||     ++.+++.||||....
T Consensus       225 ~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         225 PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999 999999     899999999998654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.4e-44  Score=382.05  Aligned_cols=245  Identities=32%  Similarity=0.655  Sum_probs=205.6

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.++.+|+.||+|++.+.....       ..|..++..+ +||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999998654322       3577888887 699999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFC  157 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccccc
Confidence            999998854  4569999999999999999999999999999999999999999999999999987532221 1233457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh---------hhhhhhhhcccCCCCcCCCC
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL---------DMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~---------~el~ekIl~~~~~~~l~fP~  243 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|..||.....         ...+..+..    ....+|.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~p~  226 (329)
T cd05588         158 GTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE----KQIRIPR  226 (329)
T ss_pred             CCccccCHHHHcC-------CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc----CCCCCCC
Confidence            9999999999863       3688899999999999999999999963211         122333333    3344555


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCC------hhHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLN------MDQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPT------aeEIL~HPwF~~i~  281 (792)
                        .++..+.+++.+||. ||.+||+      +.+++.||||..++
T Consensus       227 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         227 --SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             --CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence              679999999999999 9999997      68999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.3e-44  Score=381.18  Aligned_cols=245  Identities=34%  Similarity=0.645  Sum_probs=211.9

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      +.||+|+||.||+|.+..+|..||+|++.+.....       ..|..++..++||||++++++|.+.+.+|+||||++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999997653321       45778899999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         94 DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        94 sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      +|..++.+  .+.+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++........ .....+
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~  157 (325)
T cd05594          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFC  157 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccccc
Confidence            99998854  4568999999999999999999997 7999999999999999999999999999875432221 223456


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+.......+..    ....+|.  .+++++.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~----~~~~~p~--~~~~~~~  224 (325)
T cd05594         158 GTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPR--TLSPEAK  224 (325)
T ss_pred             CCcccCCHHHHcc-------CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc----CCCCCCC--CCCHHHH
Confidence            9999999999863       3688999999999999999999999988877777766654    4445555  6799999


Q ss_pred             HHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      +|+.+||. ||.+|+     ++.+++.||||.+..
T Consensus       225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             HHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999 999997     899999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0600|consensus

Probab=100.00  E-value=7.6e-45  Score=400.77  Aligned_cols=258  Identities=25%  Similarity=0.403  Sum_probs=224.8

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC--CEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM--NHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede--~~ly   84 (792)
                      ..+.|+.++.||+|.||.||++++..+|+.||+|+|.......      .+|+.||++|+||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            4568999999999999999999999999999999998766433      6899999999999999999988776  7899


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      ||+|||+ .||.-++.. ..-.|++.+++.||+||+.||.|||++||+|||||..|||||.+|.+||+|||+|+++....
T Consensus       195 lVFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  195 LVFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            9999995 588888854 33469999999999999999999999999999999999999999999999999999887766


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcc-------cCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC-------DTED  237 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~-------~~~~  237 (792)
                      .......+-|.||.|||++.+      ...|+.++|+||+||||.||+.|++.|.+.+.-+.+..|...       .|. 
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-  345 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLG------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-  345 (560)
T ss_pred             CcccccceEEeeccChHHhcC------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-
Confidence            555666788999999999974      478999999999999999999999999999988888888751       122 


Q ss_pred             CcCCCC-----------------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        238 TVSFPS-----------------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       238 ~l~fP~-----------------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ...+|.                 ...+++.+.+|+..||+ ||.+|.|+.++|.|+||..
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            111221                 13568899999999999 9999999999999999953

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.4e-44  Score=373.88  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=211.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..++|.+.+.||.|+||.||+|.++.++..||+|.+......     ...|+.+++.++||||+++++++.+.+.+|+||
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            467899999999999999999999999999999998754322     157999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++| +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus        83 e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~  159 (288)
T cd07871          83 EYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T  159 (288)
T ss_pred             eCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence            99975 899888543 34589999999999999999999999999999999999999999999999999976543221 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-----------
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-----------  236 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-----------  236 (792)
                      .....|++.|+|||++.+      ...++.++||||+||++|+|++|.+||.+.+.......+......           
T Consensus       160 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLG------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             ccCceecccccChHHhcC------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            233468999999999852      246888999999999999999999999887765555444321100           


Q ss_pred             ----CCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        237 ----DTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       237 ----~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                          ....+|.         ...+++++.+|+.+||+ ||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                0001111         12568899999999999 99999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-44  Score=380.29  Aligned_cols=245  Identities=36%  Similarity=0.679  Sum_probs=211.7

Q ss_pred             eEeeecCceEEEEEEE---ecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         21 RFIQQGNFGDIYLVEE---KQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        21 k~IGsGsFGtVyla~~---k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      +.||+|+||.||+|.+   +.+|..||+|++.+.....      ..|+.++.+++||||++++++|.+.+.+|+|||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999976   3578999999997654321      468899999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      ||+|.+++.+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  158 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSF  158 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceecc
Confidence            9999999954  4568999999999999999999999999999999999999999999999999988654332 223345


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      +||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+..    ....+|.  .+++.+
T Consensus       159 ~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~----~~~~~p~--~~~~~~  225 (318)
T cd05582         159 CGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK----AKLGMPQ--FLSPEA  225 (318)
T ss_pred             cCChhhcCHHHHcC-------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc----CCCCCCC--CCCHHH
Confidence            79999999999863       3578899999999999999999999998887777777765    3344554  678999


Q ss_pred             HHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC
Q psy13735        252 VNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD  281 (792)
Q Consensus       252 kdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~  281 (792)
                      .+++.+||. ||.+||+     +.+++.||||..++
T Consensus       226 ~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         226 QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            999999999 9999999     67799999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-44  Score=370.98  Aligned_cols=255  Identities=26%  Similarity=0.502  Sum_probs=215.1

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +|++.+.||+|+||.||++.+..+|..||+|.+.+.....       ..|+.+++.++||||++++++|.+.+.+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            5899999999999999999999999999999987543221       458899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--I  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--c
Confidence            99999999988665455699999999999999999999999999999999999999999999999999987643221  2


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...+|++.|+|||++..       ..++.++||||+||++|+|++|..||.+.+.......+..........++.  .++
T Consensus       159 ~~~~~~~~y~aPE~~~~-------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  229 (285)
T cd05605         159 RGRVGTVGYMAPEVVKN-------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFS  229 (285)
T ss_pred             ccccCCCCccCcHHhcC-------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc--ccC
Confidence            23469999999999863       367889999999999999999999998766544333332211122333343  578


Q ss_pred             HHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      +.+.+|+..|+. ||.+||     ++.+++.||||...+
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence            999999999999 999999     899999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0591|consensus

Probab=100.00  E-value=1.5e-46  Score=391.21  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=218.4

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEE-EEEeCCE-
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFY-SFQDMNH-   82 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~-vfede~~-   82 (792)
                      ..++.+|.|.++||.|+||.||+|++..+|..+|.|.|.-..+..      ..|+.+|++|+|||||++++ .|..+.. 
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            346678999999999999999999999999999999998555543      57999999999999999998 5655554 


Q ss_pred             EEEEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccCCCCCCceEeCCCCceEEeccCc
Q psy13735         83 VYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHG--LG--YVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs--~g--IVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                      ++||||||.+|+|..+++.  .....++|..++.++.|++.||.+||+  .+  |+||||||.||+++.+|.|||+|||+
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence            9999999999999999964  345679999999999999999999999  45  99999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC
Q psy13735        157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       157 A~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      ++.+.... ....+.+|||+||+||++..       .+|+.++||||+||++|||+.-++||.+.+...+..+|..++. 
T Consensus       175 ~r~l~s~~-tfA~S~VGTPyYMSPE~i~~-------~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~-  245 (375)
T KOG0591|consen  175 GRFLSSKT-TFAHSLVGTPYYMSPERIHE-------SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY-  245 (375)
T ss_pred             HhHhcchh-HHHHhhcCCCcccCHHHHhc-------CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-
Confidence            99987543 33456789999999999984       4899999999999999999999999999999999999987421 


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                        ...| ...+|.++..+|..|+. ||..||+.     ||++..
T Consensus       246 --~~~p-~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d  281 (375)
T KOG0591|consen  246 --PPLP-DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD  281 (375)
T ss_pred             --CCCc-HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence              1233 24789999999999999 99999986     555543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7e-44  Score=379.55  Aligned_cols=245  Identities=32%  Similarity=0.633  Sum_probs=208.2

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHH-HHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIER-DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~-eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|++..+++.||+|++.+.....       ..|. .+++.++||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999997643221       2232 346778999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ......+
T Consensus        81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~  157 (325)
T cd05602          81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFC  157 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccccc
Confidence            999999954  4568999999999999999999999999999999999999999999999999987543222 1233457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++.+       ..++.++|||||||++|+|++|.+||...+....+..+..    ....++.  .+++.+.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~~~~~~--~~~~~~~  224 (325)
T cd05602         158 GTPEYLAPEVLHK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----KPLQLKP--NITNSAR  224 (325)
T ss_pred             CCccccCHHHHcC-------CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh----CCcCCCC--CCCHHHH
Confidence            9999999999863       3688899999999999999999999998888877777765    3333333  6799999


Q ss_pred             HHHHHHhh-ChhhcCChh----HHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNMD----QVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTae----EIL~HPwF~~i~  281 (792)
                      +++.+||+ +|.+||++.    ++++||||...+
T Consensus       225 ~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         225 HLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             HHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence            99999999 999999876    889999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.6e-44  Score=378.55  Aligned_cols=245  Identities=31%  Similarity=0.627  Sum_probs=209.3

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHh-cCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~k-L~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|++..++..||+|++.+....       ...|..++.. ++||||++++++|.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999765321       1456677765 4899999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC  157 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence            999999954  3458999999999999999999999999999999999999999999999999987543221 1223456


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++..       ..++.++||||+||++|+|++|..||.+.+....+..+..    ....+|.  .++..+.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~----~~~~~~~--~~~~~~~  224 (316)
T cd05619         158 GTPDYIAPEILLG-------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM----DNPCYPR--WLTREAK  224 (316)
T ss_pred             CCccccCHHHHcC-------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCc--cCCHHHH
Confidence            9999999999863       3688999999999999999999999988887777766654    2334444  5789999


Q ss_pred             HHHHHHhh-ChhhcCChh-HHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNMD-QVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTae-EIL~HPwF~~i~  281 (792)
                      +|+.+||. +|.+||++. +++.||||..++
T Consensus       225 ~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         225 DILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             HHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence            99999999 999999996 899999999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-43  Score=379.18  Aligned_cols=245  Identities=33%  Similarity=0.665  Sum_probs=204.2

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.++.+++.||+|++.+.....       ..|..++.++ +||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998754322       3566777666 799999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....+
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~~  157 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFC  157 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccccc
Confidence            999988854  45699999999999999999999999999999999999999999999999999875432221 223457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC---------hhhhhhhhhcccCCCCcCCCC
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET---------LDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d---------~~el~ekIl~~~~~~~l~fP~  243 (792)
                      ||+.|+|||++.+       ..++.++|||||||++|+|++|..||....         .......+..    ....+|.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~----~~~~~p~  226 (329)
T cd05618         158 GTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----KQIRIPR  226 (329)
T ss_pred             CCccccCHHHHcC-------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc----CCCCCCC
Confidence            9999999999863       367889999999999999999999995211         1122233332    3445555


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCC------hhHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLN------MDQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPT------aeEIL~HPwF~~i~  281 (792)
                        .++..+.+++.+||. ||.+||+      +.+++.||||..++
T Consensus       227 --~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         227 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             --CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence              678999999999999 9999998      47999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0578|consensus

Probab=100.00  E-value=9e-45  Score=404.97  Aligned_cols=253  Identities=28%  Similarity=0.504  Sum_probs=227.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ....|.....||+|+.|.||.+....+++.||+|.+.....+.    .+|+.+|+..+|+|||.+++.|--.+.+|+|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            3457888999999999999999999999999999999887765    789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++..   ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|.++..... ..
T Consensus       351 ym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR  426 (550)
T KOG0578|consen  351 YMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR  426 (550)
T ss_pred             ecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence            9999999999943   4499999999999999999999999999999999999999999999999999999875543 44


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      .+.+|||+|||||++..       ..|++++||||||+++.||+-|.+||..+++-.....|..   .+.+.+.....+|
T Consensus       427 ~TmVGTPYWMAPEVvtr-------k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~---ng~P~lk~~~klS  496 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTR-------KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPKLKNPEKLS  496 (550)
T ss_pred             ccccCCCCccchhhhhh-------cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh---cCCCCcCCccccC
Confidence            56789999999999974       4899999999999999999999999988777666666644   2445555556899


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +.+++|+.+||+ ||.+|+++.++|.||||..
T Consensus       497 ~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  497 PELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            999999999999 9999999999999999953

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=9e-44  Score=373.52  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=208.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .++|.+.+.||.|+||.||+|.++.+|+.||+|++......     ...|+.+++.++||||+++++++.+...+|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            57899999999999999999999999999999998754322     2578999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||. ++|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus        84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  160 (303)
T cd07869          84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY  160 (303)
T ss_pred             CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence            995 6788777543 3568999999999999999999999999999999999999999999999999987653222 122


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-hhhhhhhhcc-------cCCCCcC
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-DMTYSSILAC-------DTEDTVS  240 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-~el~ekIl~~-------~~~~~l~  240 (792)
                      ...+||+.|+|||++.+      ...++.++||||+||++|+|++|..||.+... ......+...       .+.....
T Consensus       161 ~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         161 SNEVVTLWYRPPDVLLG------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCcccCCCCChHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            34568999999999853      24578899999999999999999999976432 1222222110       0000000


Q ss_pred             ------------CCC-------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        241 ------------FPS-------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       241 ------------fP~-------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                  .|.       ...+++.+.+|+..||+ ||.+|||+.+++.||||++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence                        000       11346789999999999 999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-43  Score=376.61  Aligned_cols=245  Identities=33%  Similarity=0.635  Sum_probs=208.4

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHH-HHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIER-DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~-eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|++..+|..||+|++.+.....       ..|. .+++.++||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999997643321       2233 356788999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|...+.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ......+
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  157 (321)
T cd05603          81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFC  157 (321)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccccc
Confidence            999988854  4568999999999999999999999999999999999999999999999999987543221 1233457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|.+||...+....+..+..    ....+|.  ..+..+.
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~~~~~~--~~~~~~~  224 (321)
T cd05603         158 GTPEYLAPEVLRK-------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH----KPLQLPG--GKTVAAC  224 (321)
T ss_pred             CCcccCCHHHhcC-------CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc----CCCCCCC--CCCHHHH
Confidence            9999999999863       3688899999999999999999999998887777777765    3444554  5689999


Q ss_pred             HHHHHHhh-ChhhcCCh----hHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNM----DQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTa----eEIL~HPwF~~i~  281 (792)
                      +++.+||+ +|.+||++    .+++.||||..++
T Consensus       225 ~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         225 DLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             HHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            99999999 99999985    4899999998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-43  Score=369.32  Aligned_cols=249  Identities=27%  Similarity=0.533  Sum_probs=206.7

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ||+|+||+||+|.++.+|+.||+|.+.+.....       ..|+.+++.++||||++++++|.....+|+|||||+||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999999999999999997654322       4688899999999999999999999999999999999999


Q ss_pred             HHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCC
Q psy13735         96 VTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG  173 (792)
Q Consensus        96 ~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vG  173 (792)
                      ..++...  ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+..... ......|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g  159 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAG  159 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCC
Confidence            8887432  345689999999999999999999999999999999999999999999999999976653322 2234469


Q ss_pred             CCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHH
Q psy13735        174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN  253 (792)
Q Consensus       174 Tp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkd  253 (792)
                      |+.|+|||++..       ..++.++|+||+||++|+|++|..||...+.......+..........+|.  .+++.+.+
T Consensus       160 ~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  230 (280)
T cd05608         160 TPGFMAPELLQG-------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKS  230 (280)
T ss_pred             CcCccCHHHhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc--cCCHHHHH
Confidence            999999999963       367889999999999999999999997654322222222111113334444  67999999


Q ss_pred             HHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        254 FVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       254 LIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      ++.+||. ||.+||     ++.+++.||||+.++
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             HHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence            9999999 999999     789999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0198|consensus

Probab=100.00  E-value=2.8e-44  Score=386.67  Aligned_cols=257  Identities=29%  Similarity=0.489  Sum_probs=213.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCC--EEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMN--HVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~--~lyLVm   87 (792)
                      ..+|..++.||+|+||.||++.+..+|..+|+|.+.......    ..|+.+|.+++|||||+.++......  .++|+|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            456889999999999999999999999999999998774332    78999999999999999999755444  699999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEeccCccccccc--CC
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDK--NG  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~~l~~--~~  164 (792)
                      ||++||+|.+++.+... .|++..++.|.+||+.||.|||++||+||||||+|||++. +|.+||+|||++.....  ..
T Consensus        96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999976544 7999999999999999999999999999999999999999 79999999999987763  11


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC-ChhhhhhhhhcccCCCCcCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE-TLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~-d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      ........|||.|||||++..      ....++++|||||||++.+|+||.+||... ......-.+....  ..+.+|.
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~  246 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRN------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPD  246 (313)
T ss_pred             ccccccccCCccccCchhhcC------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCc
Confidence            222334679999999999962      112235899999999999999999999762 3333333332211  2235555


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                        .+|+++++|+..|+. +|.+|||+.++|.|||.....
T Consensus       247 --~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  247 --SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             --ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence              689999999999999 999999999999999997643

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.4e-43  Score=376.80  Aligned_cols=245  Identities=32%  Similarity=0.622  Sum_probs=205.5

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.+..+++.||+|++.+.....       ..|..++.++ +||||+.++++|.+.+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998754322       4677788777 699999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFC  157 (327)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceeccc
Confidence            999998854  3569999999999999999999999999999999999999999999999999987533221 2233557


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-------hhhhhhhhcccCCCCcCCCCCc
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-------DMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-------~el~ekIl~~~~~~~l~fP~~~  245 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|..||.....       ...+..+..    ....+|.  
T Consensus       158 gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~p~--  224 (327)
T cd05617         158 GTPNYIAPEILRG-------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE----KPIRIPR--  224 (327)
T ss_pred             CCcccCCHHHHCC-------CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh----CCCCCCC--
Confidence            9999999999863       3688999999999999999999999964221       223333332    3344555  


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCCh------hHHhcCCCccCCC
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNM------DQVLGHPVFDCLD  281 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTa------eEIL~HPwF~~i~  281 (792)
                      .++..+.+++.+||. ||.+|+++      .+++.||||..++
T Consensus       225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            678999999999999 99999984      6999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-43  Score=376.07  Aligned_cols=245  Identities=37%  Similarity=0.658  Sum_probs=208.2

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc---CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS---KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL---~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      ||+|+||.||+|.++.+|..||+|++.+.....       ..|..++..+   .||||+.++++|.+...+|+||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997643322       2355666554   699999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......+
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~  157 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC  157 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence            999999854  4569999999999999999999999999999999999999999999999999987643222 2233457


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||+.|+|||++..      ...++.++|||||||++|+|++|..||.+.+....+..+..    ....+|. ..+++.+.
T Consensus       158 gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~----~~~~~~~-~~~~~~~~  226 (330)
T cd05586         158 GTTEYLAPEVLLD------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF----GKVRFPK-NVLSDEGR  226 (330)
T ss_pred             CCccccCHHHHcC------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc----CCCCCCC-ccCCHHHH
Confidence            9999999999853      23578899999999999999999999998888777777765    3344443 24789999


Q ss_pred             HHHHHHhh-ChhhcC----ChhHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARL----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRP----TaeEIL~HPwF~~i~  281 (792)
                      +|+.+||. ||.+||    ++.+++.||||...+
T Consensus       227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            99999999 999998    689999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0659|consensus

Probab=100.00  E-value=9.8e-44  Score=368.13  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=223.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++|...++||+|.||.||++++..||+.||+|.|.......      .+|+..|+.++||||+.++++|-..+++.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            57889999999999999999999999999999998765442      689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++ .+|...++. ..-.++...++.|+.+++.||+|||++.|+||||||+|+|++.+|.+||+|||+|+.+.+......
T Consensus        82 fm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             ecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            995 589998865 345689999999999999999999999999999999999999999999999999999886654433


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcc-------cCCCCcCC
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC-------DTEDTVSF  241 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~-------~~~~~l~f  241 (792)
                      .. +-|.||.|||++.      |...|+..+||||+|||+.||+-|.+-|.+.+.-+....|...       .|+....+
T Consensus       160 ~~-V~TRWYRAPELLf------Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  160 HQ-VVTRWYRAPELLF------GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             cc-eeeeeccChHHhc------cchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            33 7899999999996      4578999999999999999999999999998887777777652       22222111


Q ss_pred             ---------CC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        242 ---------PS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       242 ---------P~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                               |.      ....++++.||+.+|+. ||.+|+++.|+|.||||...+
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                     21      12457889999999999 999999999999999999743

>KOG0661|consensus

Probab=100.00  E-value=1.1e-44  Score=397.37  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=223.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcC-CCCcceeEEEEEeCC-EEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSK-CPYIVNLFYSFQDMN-HVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~-HPNIVkL~~vfede~-~ly   84 (792)
                      ...++|.+++.||.|.||.||+++.+.+|..||||.+++.-..-     .+|+.-|++++ |||||+|++++.+.+ .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            34578999999999999999999999999999999998765443     67999999998 999999999998887 999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||||| ..+|..+++.+ +..|++..++.||+||+.||+|+|.+|++|||+||+|||+..+..|||+|||+|+.+.+..
T Consensus        87 fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             eeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence            999999 57999999875 6789999999999999999999999999999999999999988899999999999987654


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------CC-
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------TE-  236 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------~~-  236 (792)
                      +.  ...+.|.||.|||++..      .+.|+.++|||++|||++|+.+-++.|.|.+.-+.+.+|...-       |. 
T Consensus       165 PY--TeYVSTRWYRAPEvLLr------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  165 PY--TEYVSTRWYRAPEVLLR------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             Cc--chhhhcccccchHHhhh------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            43  45579999999999974      4689999999999999999999999999888766665554311       00 


Q ss_pred             -------CCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        237 -------DTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       237 -------~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                             -.+.||.         -..+++++.++|.+||. ||.+|||+.++|+||||+.-
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence                   0122222         13578999999999999 99999999999999999853

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-42  Score=363.08  Aligned_cols=255  Identities=25%  Similarity=0.494  Sum_probs=211.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.+.....       ..|+.+++.++|+||+.+++++.+.+.+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4889999999999999999999999999999987643321       358899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........  .
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--I  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--c
Confidence            99999999988654445699999999999999999999999999999999999999999999999999876543321  2


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....|++.|+|||++..       ..++.++||||+||++|+|++|..||......................++.  .++
T Consensus       159 ~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  229 (285)
T cd05630         159 KGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE--KFS  229 (285)
T ss_pred             cCCCCCccccChHHHcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCc--cCC
Confidence            23469999999999863       368889999999999999999999997644321111111100011122333  578


Q ss_pred             HHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD  281 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~  281 (792)
                      +.+.+|+..||+ ||.+|||     +.+++.||||..++
T Consensus       230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             HHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence            999999999999 9999999     89999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0580|consensus

Probab=100.00  E-value=1.5e-44  Score=369.90  Aligned_cols=254  Identities=33%  Similarity=0.579  Sum_probs=233.7

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +.+++++|++++.||.|-||.||+++.+.++-.+|+|++.|+.+..       ..|++|-..|+||||+++|++|.+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            5678999999999999999999999999999999999999887543       568888899999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+++||.++|+|+..|..+..+.+++..+..|++|++.||.|||..+|+||||||+|+|++..|.+|++|||-+.....
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            99999999999999999766788899999999999999999999999999999999999999999999999998876542


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                         ....+.|||..|.+||...+       ..++..+|+|++|++.|+++.|.+||...+..++|+.|..    ..+.+|
T Consensus       177 ---~kR~tlcgt~dyl~pEmv~~-------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----~~~~~p  242 (281)
T KOG0580|consen  177 ---NKRKTLCGTLDYLPPEMVEG-------RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----VDLKFP  242 (281)
T ss_pred             ---CCceeeecccccCCHhhcCC-------CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----ccccCC
Confidence               24457799999999999874       3789999999999999999999999999999999999988    556677


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      .  .+|..+.|+|..|+. +|.+|++..+++.|||+..
T Consensus       243 ~--~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  243 S--TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             c--ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            5  889999999999999 9999999999999999864

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.9e-43  Score=362.48  Aligned_cols=249  Identities=27%  Similarity=0.503  Sum_probs=205.2

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ||+|+||.||++..+.+|+.||+|.+.+.....       ..|+++++.++||||++++++|.+...+|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999999999999997543321       4589999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP  175 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp  175 (792)
                      .+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......  ......|++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCC
Confidence            988865444558999999999999999999999999999999999999999999999999998765332  223346999


Q ss_pred             CccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHH
Q psy13735        176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV  255 (792)
Q Consensus       176 ~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLI  255 (792)
                      .|+|||++..       ..++.++|+||+||++|+|++|..||...........+..........++ ...+++++.+++
T Consensus       159 ~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li  230 (277)
T cd05607         159 GYMAPEILKE-------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDIC  230 (277)
T ss_pred             CccCHHHHcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHH
Confidence            9999999863       35889999999999999999999999754332222222111111222222 235799999999


Q ss_pred             HHHhh-ChhhcCCh----hHHhcCCCccCCC
Q psy13735        256 QSLVQ-KLDARLNM----DQVLGHPVFDCLD  281 (792)
Q Consensus       256 k~LL~-DP~kRPTa----eEIL~HPwF~~i~  281 (792)
                      ..||. ||.+||++    .+++.||||+.++
T Consensus       231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             HHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence            99999 99999999    6678999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-43  Score=371.45  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=205.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeC-----CEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDM-----NHVY   84 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede-----~~ly   84 (792)
                      +|.+.+.||+|+||.||+|.++.+|..||+|.+......      ...|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            589999999999999999999999999999998643221      14689999999999999999988543     3589


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||||| +++|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus        81 lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            999999 5789998854  4469999999999999999999999999999999999999999999999999997653221


Q ss_pred             C--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc--------
Q psy13735        165 R--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD--------  234 (792)
Q Consensus       165 ~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~--------  234 (792)
                      .  ......+||+.|+|||++...     ...++.++|||||||++|+|++|++||.+.+.......+....        
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhcc-----ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            1  112345799999999998531     2368889999999999999999999997765433222111100        


Q ss_pred             ----------------CCCCcCCC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        235 ----------------TEDTVSFP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       235 ----------------~~~~l~fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                      ......+. ....+++.+.+++.+||. ||.+||++.+++.||||..+..
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                            00000000 012467889999999999 9999999999999999987543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-42  Score=360.26  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=205.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEec-CCcEEEEEEeccCCCCh------HHHHHHHHhc---CCCCcceeEEEEE-----e
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQ-SHNTFVMKKVLREKMPN------TIERDIMVKS---KCPYIVNLFYSFQ-----D   79 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~-tGk~vAVKiI~Ks~~~~------~~E~eIL~kL---~HPNIVkL~~vfe-----d   79 (792)
                      .+|.+.+.||+|+||.||+|.+.. +|..+|+|.+.......      ..|..+++.+   .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 56889999886543221      4577777665   6999999999985     3


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ...+++||||+. |+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            456999999995 6899998765556689999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-CC
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-DT  238 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-~~  238 (792)
                      ....  .......||+.|+|||++..       ..++.++||||+||++|+|++|.+||.+.+....+..+...... ..
T Consensus       160 ~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~  230 (290)
T cd07862         160 YSFQ--MALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  230 (290)
T ss_pred             ccCC--cccccccccccccChHHHhC-------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            6433  22334569999999999863       36888999999999999999999999888776666666532110 00


Q ss_pred             cCCCC--------------------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        239 VSFPS--------------------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       239 l~fP~--------------------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ..+|.                    ...+++.+.+++.+||+ ||.+|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            00000                    12467889999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.1e-43  Score=390.63  Aligned_cols=261  Identities=25%  Similarity=0.400  Sum_probs=211.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeC--------CEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDM--------NHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede--------~~ly   84 (792)
                      ...+|.+++.||+|+||.||+|.+..+|+.||+|.+.........|+.+++.++|||||+++++|...        ..++
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            45689999999999999999999999999999999977665557899999999999999999887532        2578


Q ss_pred             EEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccc
Q psy13735         85 FIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVD  161 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~  161 (792)
                      +|||||++ +|.+++..  .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            99999965 67666642  2345699999999999999999999999999999999999998665 69999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-----
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-----  236 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-----  236 (792)
                      ...  .....+||+.|+|||++.+      ...|+.++|||||||++|+|++|.+||.+.+....+..+......     
T Consensus       223 ~~~--~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        223 AGQ--RSVSYICSRFYRAPELMLG------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             CCC--CcccCCCCcCccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            332  2234568999999999853      246889999999999999999999999887665554444321000     


Q ss_pred             --------CCcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        237 --------DTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       237 --------~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                              ....+|.          +...++++.+||.+||. ||.+|||+.+++.||||..+..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                    0111111          11467899999999999 9999999999999999987654

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-43  Score=384.10  Aligned_cols=261  Identities=22%  Similarity=0.285  Sum_probs=209.6

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +.++...+|.+++.||+|+||.||+|.+..+++.||+|......  ...|+.+++.++|||||+++++|......|+|||
T Consensus        86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~--~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGG--TATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             hcccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhh--hHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            34566778999999999999999999999999999999765432  3679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ++ +++|..++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...........
T Consensus       164 ~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~  240 (391)
T PHA03212        164 RY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY  240 (391)
T ss_pred             cC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence            99 5789888854  34589999999999999999999999999999999999999999999999999975433222233


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-------hhhhhhhhcccCC-----
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-------DMTYSSILACDTE-----  236 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-------~el~ekIl~~~~~-----  236 (792)
                      ...+||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.       ......+......     
T Consensus       241 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        241 YGWAGTIATNAPELLAR-------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             ccccCccCCCChhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            34579999999999863       3689999999999999999999988753221       1111111110000     


Q ss_pred             ---------------------CCcCCCCC---ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        237 ---------------------DTVSFPSS---IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       237 ---------------------~~l~fP~~---~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                           .....|.+   ..++.++.+||.+||+ ||.+|||+.++|.||||..+.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                                 00001111   1346789999999999 999999999999999998754

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.7e-42  Score=364.80  Aligned_cols=268  Identities=22%  Similarity=0.399  Sum_probs=216.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..++|.+.+.||+|+||.||++.++.++..+|+|.+......     ...|+.+++.++||||+++++++.+++.+|+||
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            457899999999999999999999999999999998754332     157899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||+++ +|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus        84 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  160 (309)
T cd07872          84 EYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T  160 (309)
T ss_pred             eCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence            99964 888887543 34589999999999999999999999999999999999999999999999999876543221 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-----------
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-----------  236 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-----------  236 (792)
                      .....|++.|+|||++..      ...++.++||||+||++|+|++|.+||.+.+.......+......           
T Consensus       161 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLG------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             cccccccccccCCHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence            223468999999999853      235788999999999999999999999877665444443321000           


Q ss_pred             ----CCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCCCCCCC
Q psy13735        237 ----DTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDPPCIPP  289 (792)
Q Consensus       237 ----~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~pP~~P~  289 (792)
                          ....+|.         ...+++++.+||.+||. ||.+|||+.+++.||||+.+.......|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~  301 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPE  301 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCCc
Confidence                0011111         12578899999999999 99999999999999999976544333333

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0663|consensus

Probab=100.00  E-value=2e-43  Score=374.57  Aligned_cols=260  Identities=26%  Similarity=0.393  Sum_probs=222.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC--CEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM--NHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede--~~ly   84 (792)
                      +.++|+.+..|++|+||.||+++++.|+..||+|+++...-..      .+|+.||.+++|||||.+-.+....  +.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            5678999999999999999999999999999999997655322      7899999999999999999988644  5799


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      ||||||+ .+|..++.+.. .+|+..+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.++..-
T Consensus       154 ~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            9999995 69999997754 569999999999999999999999999999999999999999999999999999987542


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhc-------ccCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-------CDTED  237 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~-------~~~~~  237 (792)
                       .+....+-|.||.|||++.+      ...|+.++||||+|||+.+|+++.+.|.+.+.-....+|+.       ..|++
T Consensus       232 -k~~T~lVVTLWYRaPELLLG------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  232 -KPYTPLVVTLWYRAPELLLG------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             -ccCcceEEEeeecCHHHhcC------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence             23344578999999999974      46899999999999999999999999999888777777765       12322


Q ss_pred             CcCCC--------C-----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        238 TVSFP--------S-----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       238 ~l~fP--------~-----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ...+|        .           ...+|+...+|+..||. ||.+|.|+.++|.|+||...+
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            22222        1           01267999999999999 999999999999999999744

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3e-42  Score=368.43  Aligned_cols=256  Identities=24%  Similarity=0.357  Sum_probs=212.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +..++|++++.||+|+||.||+|++..+|..+|+|++.......     ..|+.++..++||||+++++++.+.+.+|+|
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            45789999999999999999999999999999999987643221     5688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||++||+|.+++..  .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++......  
T Consensus        82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          82 MEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             eecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999999954  34589999999999999999999986 6999999999999999999999999999766432  


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC----------
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT----------  235 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~----------  235 (792)
                       ......|++.|+|||++.+       ..++.++|||||||++|+|++|..||...+.......+.....          
T Consensus       158 -~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSI  229 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcccc
Confidence             2234469999999999863       3688999999999999999999999976554433221110000          


Q ss_pred             ---------------------------------CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        236 ---------------------------------EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       236 ---------------------------------~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                                       ......+ ...+++++.+||.+||. ||.+|||+.+++.||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             CcccccccccccccccccccchhHHHHHHHHHhCCCcCCC-CccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                             0000011 12468899999999999 99999999999999999854

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0604|consensus

Probab=100.00  E-value=9.1e-44  Score=372.82  Aligned_cols=256  Identities=29%  Similarity=0.532  Sum_probs=218.8

Q ss_pred             CCCCceEE-eEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhc-CCCCcceeEEEEEe----CCEEEEE
Q psy13735         13 SASDFDIK-RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-KCPYIVNLFYSFQD----MNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~-k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL-~HPNIVkL~~vfed----e~~lyLV   86 (792)
                      ..++|.+. ++||-|-.|.|..|.++.||+.||+|++..+. ..++|+++.... .|||||.++++|++    ..++.+|
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            56788885 79999999999999999999999999875433 337788776555 69999999999875    4578999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCcccccccC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~~~  163 (792)
                      ||.|+||+|+..+..+....|+|.++..|++||..|+.|||+.+|+||||||+|+|+..   |..+||+|||+|+.-...
T Consensus       138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            99999999999998877788999999999999999999999999999999999999964   446999999999876543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh----hhhhhhhcccCCCCc
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD----MTYSSILACDTEDTV  239 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~----el~ekIl~~~~~~~l  239 (792)
                      .  ...++|.||+|+|||++.       ...|+..+|+||+|||||.||+|.+||+.....    .+..+|..    +.+
T Consensus       218 ~--~L~TPc~TPyYvaPevlg-------~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~----gqy  284 (400)
T KOG0604|consen  218 G--DLMTPCFTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT----GQY  284 (400)
T ss_pred             c--cccCCcccccccCHHHhC-------chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc----cCc
Confidence            2  445778999999999985       457999999999999999999999999755432    33444544    667


Q ss_pred             CCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        240 SFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       240 ~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      .||.  |..+|++++|+|+.||. +|.+|+|+.+++.|||+..-..
T Consensus       285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            7765  68899999999999999 9999999999999999986543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.6e-42  Score=356.96  Aligned_cols=255  Identities=26%  Similarity=0.488  Sum_probs=214.4

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .|++.+.||.|+||.||++.+..+|+.||+|.+.+.....       ..|+.+++.++|+||+.++++|...+.+|+|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4788999999999999999999999999999987543221       468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cc
Confidence            9999999988865545569999999999999999999999999999999999999999999999999987654322  12


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....|++.|+|||++..       ..++.++|+||+||++|+|++|..||...........+..........++.  .++
T Consensus       159 ~~~~g~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  229 (285)
T cd05632         159 RGRVGTVGYMAPEVLNN-------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA--KFS  229 (285)
T ss_pred             cCCCCCcCccChHHhcC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc--cCC
Confidence            23469999999999863       368889999999999999999999998765544333333211112223333  578


Q ss_pred             HHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD  281 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~  281 (792)
                      +.+.+|+..|+. +|.+||+     +.+++.||||+..+
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            999999999999 9999999     78999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.1e-42  Score=354.72  Aligned_cols=252  Identities=24%  Similarity=0.358  Sum_probs=204.7

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhc---CCCCcceeEEEEEe-----CC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKS---KCPYIVNLFYSFQD-----MN   81 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL---~HPNIVkL~~vfed-----e~   81 (792)
                      +|.+.+.||+|+||.||+|.++.+|+.||+|.+......      ...|..++..+   +||||++++++|..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            589999999999999999999999999999998754322      14577777655   79999999999864     34


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+++||||+. ++|.+++.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            6899999997 589888866555569999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------  234 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------  234 (792)
                      ...  ......||+.|+|||++.+       ..++.++||||+||++|+|++|.+||.+.........+....       
T Consensus       160 ~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07863         160 CQM--ALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  230 (288)
T ss_pred             Ccc--cCCCccccccccCchHhhC-------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            322  2223468999999999863       368899999999999999999999998776655554443210       


Q ss_pred             CCCCcCCC--------------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        235 TEDTVSFP--------------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       235 ~~~~l~fP--------------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +......+              ....++..+.+++.+||+ ||.+|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00000000              012467889999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-42  Score=360.00  Aligned_cols=256  Identities=36%  Similarity=0.646  Sum_probs=221.5

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|.+.+.....       ..|++++..++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998765442       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC--
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR--  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~--  165 (792)
                      ||+.|++|.+++.+.....+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999999765556799999999999999999999999999999999999999999999999999876532211  


Q ss_pred             --------------------------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC
Q psy13735        166 --------------------------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       166 --------------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~  219 (792)
                                                .......|++.|+|||++.+       ..++.++|||||||++|+|++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-------DGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-------CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence                                      01113368899999999863       357889999999999999999999998


Q ss_pred             CCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCC----hhHHhcCCCccCCC
Q psy13735        220 YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLN----MDQVLGHPVFDCLD  281 (792)
Q Consensus       220 ~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPT----aeEIL~HPwF~~i~  281 (792)
                      +.+....+..+..    ....++....+++.+.+++.+|+. +|.+||+    +.+++.||||...+
T Consensus       234 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         234 GSNRDETFSNILK----KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             CCchHHHHHHHhc----CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            8887777766654    334455544579999999999999 9999999    99999999999765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0614|consensus

Probab=100.00  E-value=1.6e-44  Score=396.77  Aligned_cols=276  Identities=35%  Similarity=0.635  Sum_probs=249.6

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      ..+.+++++++..||-||||.|-+|..+.....||+|+++|..+..       ..|++||..++.|+||++|-+|.++.+
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            4567889999999999999999999988776679999999887654       579999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|++||-|-||+|+.++  ...|.|.+..+++|+..++.|+.|||++||++|||||+|+|++.+|.+||.|||+|+.+..
T Consensus       495 vYmLmEaClGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhhhHHhhcCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999999999  4567899999999999999999999999999999999999999999999999999999986


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      +.  +++++||||.|+|||++...       +++.++|.||||+++|+||+|.+||.+.++..+|..|+.  ....+.||
T Consensus       573 g~--KTwTFcGTpEYVAPEIILnK-------GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--Gid~i~~P  641 (732)
T KOG0614|consen  573 GR--KTWTFCGTPEYVAPEIILNK-------GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--GIDKIEFP  641 (732)
T ss_pred             CC--ceeeecCCcccccchhhhcc-------CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--hhhhhhcc
Confidence            54  67889999999999999854       788999999999999999999999999999999999988  33556777


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhh
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKD  300 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~  300 (792)
                      .  .++..+.++|++|+. +|.+|++     +.+|..|.||.+++        .+||++|+   |.+..+|+...
T Consensus       642 r--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p  714 (732)
T KOG0614|consen  642 R--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFP  714 (732)
T ss_pred             c--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCC
Confidence            6  889999999999999 8999987     78999999999887        57787776   67778886543

>KOG0582|consensus

Probab=100.00  E-value=2.4e-42  Score=376.71  Aligned_cols=265  Identities=26%  Similarity=0.416  Sum_probs=225.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +...+|++..+||.|..++||+++...++..||||++.-.+...     ..|+..|..++||||++++..|..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            56779999999999999999999999999999999998777655     5788999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-  165 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-  165 (792)
                      |.||.+|++.+++...-...++|..+..|+++++.||.|||.+|-||||||+.||||+.+|.|||+|||.+..+...+. 
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            9999999999999876666799999999999999999999999999999999999999999999999998766544332 


Q ss_pred             --cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC----Cc
Q psy13735        166 --IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED----TV  239 (792)
Q Consensus       166 --~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~----~l  239 (792)
                        ....+.+|||+|||||++...     ..+|+.++||||||+...||.+|+.||....+-..+-.-+....+.    ..
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~-----~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~  257 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQ-----LHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL  257 (516)
T ss_pred             eeEeeccccCcccccChHHhhhc-----ccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence              112456899999999996532     4689999999999999999999999997655544333333211111    11


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .+.....++..++.+|..||. ||.+|||+.++|.||||+...
T Consensus       258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            222235678899999999999 999999999999999998654

>KOG0611|consensus

Probab=100.00  E-value=1.7e-43  Score=380.69  Aligned_cols=251  Identities=24%  Similarity=0.460  Sum_probs=225.1

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ..+|++.+.||+|.||.|-++....+|+.||||.|.++.+..       ..|++||..|+||||+.+|++|++.+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            357999999999999999999999999999999999887754       6799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||..||+|.+++.+  .+.|++.+++.|++||++|+.|||.++++|||||.+|||+|.++++||+|||++..+....  
T Consensus       132 MEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--  207 (668)
T ss_pred             EEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc--
Confidence            999999999999954  5679999999999999999999999999999999999999999999999999998876543  


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      ...++||+|.|.+||++++.      +.-++.+|.|||||++|.|+.|..||++.+...+...|..    +.+.-|.   
T Consensus       208 fLqTFCGSPLYASPEIvNG~------PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~----GaYrEP~---  274 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGT------PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR----GAYREPE---  274 (668)
T ss_pred             HHHHhcCCcccCCccccCCC------CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc----ccccCCC---
Confidence            33467999999999999843      4557899999999999999999999999999999999987    4444343   


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      -+.++..||++||- +|.+|.|+.+|-+|=|.. +..
T Consensus       275 ~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN-wgy  310 (668)
T KOG0611|consen  275 TPSDASGLIRWMLMVNPERRATIEDIASHWWVN-WGY  310 (668)
T ss_pred             CCchHHHHHHHHHhcCcccchhHHHHhhhheee-ccc
Confidence            36688999999999 999999999999996654 443

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.6e-42  Score=370.93  Aligned_cols=258  Identities=23%  Similarity=0.318  Sum_probs=207.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ...++|.+++.||.|+||.||+|.+..+|+.||+|++.......     ..|+.+++.++||||++++++|...+.+|+|
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            45678999999999999999999999999999999986543322     4688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||||.||+|....      ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... .
T Consensus       151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~  223 (353)
T PLN00034        151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D  223 (353)
T ss_pred             EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence            9999999986532      25788889999999999999999999999999999999999999999999998765322 1


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+||+.|+|||++...  .......+.++|||||||++|+|++|..||...........+...........+  ..
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  299 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTD--LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP--AT  299 (353)
T ss_pred             cccccccCccccCccccccc--cccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCC--Cc
Confidence            22345799999999987521  011223467899999999999999999999743322222111111111112222  36


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ++..+.+||.+||. ||.+||++.+++.||||...
T Consensus       300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            78999999999999 99999999999999999864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-41  Score=353.49  Aligned_cols=248  Identities=37%  Similarity=0.703  Sum_probs=217.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||.|+||.||++.+..+++.||+|.+.+.....       ..|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999987644321       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++||+|.+++..  .+.+++..+..++.||+.||.|||++||+|+||+|.||+++.+|.++|+|||++......    
T Consensus        81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            99999999999954  356999999999999999999999999999999999999999999999999999876533    


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+|++.|+|||.+..       ..++.++|+||||+++|+|++|..||...+.......+..    ....+|.  .+
T Consensus       155 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~--~~  221 (290)
T cd05580         155 TYTLCGTPEYLAPEIILS-------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE----GKVRFPS--FF  221 (290)
T ss_pred             CCCCCCCccccChhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----CCccCCc--cC
Confidence            234469999999998853       2577889999999999999999999988776666666654    3344554  56


Q ss_pred             cHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      ++.+.+++.+||. +|.+|+     ++.+++.||||..++
T Consensus       222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            8999999999999 999999     899999999998776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.1e-42  Score=372.22  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=209.7

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCC-----EEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMN-----HVY   84 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~-----~ly   84 (792)
                      +|++++.||+|+||.||++.+..+|+.||+|.+......      ...|+.+++.++||||+++++++....     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            588999999999999999999999999999998654221      156889999999999999999998876     899


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||||+. ++|..++.  ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            9999995 67888874  34569999999999999999999999999999999999999999999999999998654333


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC--------
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE--------  236 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~--------  236 (792)
                      ........|++.|+|||++.+      ...++.++||||+||++|+|++|++||.+.+.......+......        
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMG------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcC------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            222334468999999999863      235788999999999999999999999887765554444321000        


Q ss_pred             -----------CCcC-------CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        237 -----------DTVS-------FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       237 -----------~~l~-------fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                 ....       +......++.+.+||.+||. ||.+|||+.+++.||||...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                       0000       01112458899999999999 99999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-41  Score=366.79  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=203.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC-----
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN-----   81 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~-----   81 (792)
                      ..++|.+.+.||+|+||.||+|.+..+|..||+|.+.+.....      ..|..++..++||||++++++|....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999999999999999997543221      46888999999999999999987543     


Q ss_pred             -EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         82 -HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        82 -~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                       .+|+||||+.+ +|...+.    ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence             57999999965 5666652    23889999999999999999999999999999999999999999999999999765


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC----
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE----  236 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~----  236 (792)
                      ....  ......||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+....+..+......    
T Consensus       174 ~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         174 CTNF--MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             ccCc--cCCCCcccCCCCCchhccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            4322  2233468999999999863       36888999999999999999999999876543332222110000    


Q ss_pred             --------------C--------------CcCCCC----CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        237 --------------D--------------TVSFPS----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       237 --------------~--------------~l~fP~----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                    .              .+.+|.    ....++.+.+||.+||. ||.+|||+.+++.||||..+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence                          0              000111    11246789999999999 999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-41  Score=354.98  Aligned_cols=260  Identities=23%  Similarity=0.418  Sum_probs=213.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..++|.+.+.||.|+||.||+|.++.++..||+|.+......     ...|+.+++.++||||+++++++.+.+.+|+||
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            567899999999999999999999999999999998754322     156899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||+. ++|..++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ .
T Consensus        84 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~  160 (301)
T cd07873          84 EYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  160 (301)
T ss_pred             eccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence            9996 5888888653 34589999999999999999999999999999999999999999999999999876542221 1


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------C-----
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------T-----  235 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------~-----  235 (792)
                      .....+++.|+|||++..      ...++.++|||||||++|+|++|.+||...+.......+....       +     
T Consensus       161 ~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         161 YSNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             ccccceeecccCcHHHhC------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            223457999999999853      2357889999999999999999999998777654443332210       0     


Q ss_pred             ---CCCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        236 ---EDTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       236 ---~~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                         .....+|.         ...+++.+.+||.+||+ ||.+|||+.+++.||||.++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence               00111111         13578899999999999 999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0658|consensus

Probab=100.00  E-value=3.4e-42  Score=369.17  Aligned_cols=266  Identities=31%  Similarity=0.514  Sum_probs=223.2

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeC-----CEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDM-----NHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede-----~~lyLVmEy   89 (792)
                      -.|.-.++||.|+||.||.+....++..+|||.+..+......|..||+.++|||||+|..+|...     -++.+||||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            358889999999999999999999999999999998888889999999999999999999998643     256789999


Q ss_pred             cCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC-CceEEeccCcccccccCCCc
Q psy13735         90 VTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        90 ~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d-g~VKLiDFGLA~~l~~~~~~  166 (792)
                      ++. +|...+...  .+..++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+..+.+.
T Consensus       104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn  182 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN  182 (364)
T ss_pred             chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence            964 888888531  23558999999999999999999999999999999999999976 88999999999999876544


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC----------
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE----------  236 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~----------  236 (792)
                        .+...|..|.|||.+.      |...|+.+.||||.|||+.||+-|++-|.|++.......|.++-..          
T Consensus       183 --iSYicSRyYRaPELif------ga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  183 --ISYICSRYYRAPELIF------GATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             --eeEEEeccccCHHHHc------CccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence              3445899999999997      4578999999999999999999999999999887777666541100          


Q ss_pred             -C--CcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCCCCCCC
Q psy13735        237 -D--TVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDPPCIPP  289 (792)
Q Consensus       237 -~--~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~pP~~P~  289 (792)
                       .  ...+|.          ....++++.+|+.++|. +|.+|.++.+++.||||+.+-.+.-..|+
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~  321 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPN  321 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcC
Confidence             0  111221          23578999999999999 99999999999999999976554434444

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=345.68  Aligned_cols=250  Identities=26%  Similarity=0.449  Sum_probs=211.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---------HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---------TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---------~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      ++|.+.+.||.|+||.||.|.+..+|+.||+|.+.......         ..|+.+++.++||||+++++++.+...+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999999999999999987543221         458889999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||||++|++|.+++..  .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus        82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            9999999999999954  34589999999999999999999999999999999999999999999999999876543221


Q ss_pred             ccc--ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        166 IKS--IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       166 ~~s--~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      ...  ....|++.|+|||.+..       ..++.++||||+||++|+|++|..||...+.......+..  ......+|.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~  230 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISG-------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPQLPS  230 (263)
T ss_pred             ccccccCCCcCccccCcceecc-------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc--cCCCCCCCc
Confidence            111  23468899999999863       2588999999999999999999999976655444444433  112233443


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                        .++..+.+++..|+. +|.+||++.+++.||||
T Consensus       231 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         231 --HVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             --cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence              678999999999999 99999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-42  Score=349.17  Aligned_cols=250  Identities=34%  Similarity=0.584  Sum_probs=208.0

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      |++++.||+|+||+||+|.+..+++.||+|++.......      ..|..++..++||||+++++++.+...+++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            889999999999999999999999999999998776543      23788999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      ++++|.+++.  ..+.+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+...... ......
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~~~~  157 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NENFNP  157 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSEBSS
T ss_pred             cccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc
Confidence            9999999996  2355899999999999999999999999999999999999999999999999999764211 223345


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC---hhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET---LDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d---~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ..|++.|+|||++.      ....++.++||||||+++|+|++|..||....   ............  ...........
T Consensus       158 ~~~~~~y~aPE~~~------~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  229 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQ------QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP--LPSSSQQSREK  229 (260)
T ss_dssp             SSSSGGGSCHHHHT------TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH--HHHHTTSHTTS
T ss_pred             cccccccccccccc------ccccccccccccccccccccccccccccccccchhhhhhhhhccccc--ccccccccchh
Confidence            57999999999986      12468899999999999999999999998763   222222222210  00111111122


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +..+.+++..||+ ||.+||++.++++||||
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            4899999999999 99999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0589|consensus

Probab=100.00  E-value=3.4e-42  Score=380.85  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=230.9

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCE-EEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNH-VYF   85 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~-lyL   85 (792)
                      ..++|..+++||+|+||.+++++++..+..||+|.|.-.....      ..|..++.++.|||||.+.+.|..++. +||
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            4678999999999999999999999999999999998776544      678999999999999999999998888 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||+||+||+|.+.|.+++...|++..+..|+.||+.|+.|||+++|+|||||+.||+++.++.|+|+|||+|+.+.+.. 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-  160 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-  160 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence            9999999999999998877789999999999999999999999999999999999999999999999999999987553 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                      ....+.+|||.||+||++.+       .+|+.++|||||||++|+|++-+++|...+...+..+|....     ..|-+.
T Consensus       161 ~~a~tvvGTp~YmcPEil~d-------~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----~~Plp~  228 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSD-------IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----YSPLPS  228 (426)
T ss_pred             hhhheecCCCcccCHHHhCC-------CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----CCCCCc
Confidence            24456789999999999974       489999999999999999999999999999999999998722     344455


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      .+|.+++.+|..||. +|..||++.++|.+|...
T Consensus       229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  229 MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence            889999999999999 999999999999998876

>KOG4717|consensus

Probab=100.00  E-value=1.6e-42  Score=380.96  Aligned_cols=256  Identities=26%  Similarity=0.450  Sum_probs=231.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..=|...+.||+|.|++|.+++|.=||..||||+|.|.++..      +.|+.+|+.++|||||+||++......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            345888999999999999999999999999999999988765      68999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe-CCCCceEEeccCcccccccCCCc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL-SATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL-d~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |+=.||+|+++|-... ..+.|..+++|++||+.|+.|||..++|||||||+|+.+ -+-|-|||+|||++..+.++.  
T Consensus        97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--  173 (864)
T ss_pred             EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence            9999999999997644 449999999999999999999999999999999999876 578899999999999887665  


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .-.+.||+..|.|||++.+      .....+++||||||||+|.|++|++||...+..+++-.|+.    +.+..|.  .
T Consensus       174 kL~TsCGSLAYSAPEILLG------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD----CKYtvPs--h  241 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLG------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD----CKYTVPS--H  241 (864)
T ss_pred             hhhcccchhhccCchhhhc------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc----ccccCch--h
Confidence            3446789999999999974      33446789999999999999999999999999999999988    5677777  8


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                      +|.++++||..||. ||.+|.+.++|..|+|++.++..+
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence            89999999999999 999999999999999999876543

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.3e-41  Score=339.04  Aligned_cols=257  Identities=26%  Similarity=0.456  Sum_probs=215.2

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|++.+.||.|+||.||++....+|..+|+|++.......     ..|+.+++.++||||+++++.+.....+|+|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47999999999999999999999999999999987655432     4688889999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc--
Q psy13735         90 VTGGDFVTLLENQPH-GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI--  166 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~-g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~--  166 (792)
                      ++|++|.+++..... +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.........  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            999999999965433 56899999999999999999999999999999999999999999999999999876543322  


Q ss_pred             -ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        167 -KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       167 -~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                       .....+|++.|+|||++...      ..++.++|+|||||++|+|++|..||...+....+..+...............
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQV------HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             cccccccCChhhcChHHHccc------cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence             12334689999999998631      35788999999999999999999999877665555555442211111111123


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+++.+.+++..|+. +|.+||++.+++.||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999 99999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5e-41  Score=346.18  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=205.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||.|+||.||++.+..+|..||+|.+......      ...|+.+++.++||||+++++++.++..+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            689999999999999999999999999999998654322      15688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         90 VTGGDFVTLLENQP-HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~-~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ++ |+|.+++.... .+.+++..++.++.||+.||.|||++||+||||+|+||+++.+|.++|+|||++........ ..
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~  158 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VY  158 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-cc
Confidence            97 68888886533 25689999999999999999999999999999999999999999999999999976543221 12


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------C------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------T------  235 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------~------  235 (792)
                      ....|++.|+|||++..      ...++.++|||||||++|+|++|++||.+.+.......+....       +      
T Consensus       159 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         159 THEVVTLWYRAPEVLLG------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             cCCcccccccChHHhcC------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            23357899999999853      2357889999999999999999999998665432222211100       0      


Q ss_pred             ----------CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        236 ----------EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       236 ----------~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                                ...........+++++.++|.+||. ||.+|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      0000000123478999999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.2e-41  Score=349.75  Aligned_cols=272  Identities=23%  Similarity=0.408  Sum_probs=222.1

Q ss_pred             HHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735          6 ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus         6 ~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +|...-...+.|++++.||.|+||.||++.+..+|..+|+|.+.......    ..|+.+++.++||||++++++|..+.
T Consensus         3 ~~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644           3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             hhhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            34444455678999999999999999999999999999999987654322    45888999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+||||++||+|..++.+. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999998887543 3458999999999999999999999999999999999999999999999999987643


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ... .......|++.|+|||++...  ......++.++|||||||++|+|++|.+||...+.......+....   ....
T Consensus       162 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~  235 (292)
T cd06644         162 KTL-QRRDSFIGTPYWMAPEVVMCE--TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTL  235 (292)
T ss_pred             ccc-cccceecCCccccCceeeccc--cccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC---CccC
Confidence            221 122334689999999998521  1123457889999999999999999999998776655555544321   1122


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                      +....++..+.+++.+|+. +|.+||++.+++.||||..+...+
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            2233678999999999999 999999999999999998776554

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.3e-41  Score=362.80  Aligned_cols=254  Identities=22%  Similarity=0.367  Sum_probs=205.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------   80 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------   80 (792)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.+.....      ..|+.+++.++||||++++++|...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999999999999999987643221      4688899999999999999988643      


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+|+||||+.+ +|...+..    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence            357999999964 67777632    3789999999999999999999999999999999999999999999999999866


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC----
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE----  236 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~----  236 (792)
                      ....  ......||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+....+..+......    
T Consensus       177 ~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         177 GTSF--MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             CCCC--cccCCcccCCcCCHHHHhC-------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            4322  2234469999999999863       36888999999999999999999999877765555444321000    


Q ss_pred             ----------------------------CCcCCCC----CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        237 ----------------------------DTVSFPS----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       237 ----------------------------~~l~fP~----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                                  ....++.    ....+..+++||.+||. ||.+|||+.++|.||||..+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                                        0000110    11235689999999999 99999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.1e-41  Score=343.31  Aligned_cols=257  Identities=23%  Similarity=0.392  Sum_probs=210.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhc-CCCCcceeEEEEEeC------CEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKS-KCPYIVNLFYSFQDM------NHV   83 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL-~HPNIVkL~~vfede------~~l   83 (792)
                      .+.|.+.+.||.|+||.||++....++..+|+|.+.......   ..|..++..+ +||||++++++|...      ..+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            356899999999999999999999999999999987654332   5678888888 699999999998753      468


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||+++|+|.+++.......+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence            99999999999999997655566899999999999999999999999999999999999999999999999999865432


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      . .......|++.|+|||++...  ......++.++||||+||++|+|++|..||...........+..    .......
T Consensus       165 ~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~  237 (272)
T cd06637         165 V-GRRNTFIGTPYWMAPEVIACD--ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----NPAPRLK  237 (272)
T ss_pred             c-ccCCcccccccccCHhHhccc--cCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc----CCCCCCC
Confidence            2 122345699999999998632  11234688899999999999999999999976554444433322    1111112


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ...++..+.+|+.+||. +|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            23578899999999999 99999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.9e-41  Score=338.36  Aligned_cols=249  Identities=24%  Similarity=0.469  Sum_probs=211.1

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe-CCEEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD-MNHVYFIME   88 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed-e~~lyLVmE   88 (792)
                      +|++.+.||.|+||.||++.++.+++.||+|.+.......      ..|..+++.++|||++++++.+.. ...+|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5999999999999999999999999999999987654322      468889999999999999998874 446899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++|++|.+++.......+++..+..++.||+.||.+||++||+||||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~  159 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MA  159 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-cc
Confidence            99999999999765555689999999999999999999999999999999999999999999999999987643322 22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....|++.|+|||++..       ..++.++|+||+||++|+|++|..||...+.......+....   ....+  ..++
T Consensus       160 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~  227 (257)
T cd08223         160 STLIGTPYYMSPELFSN-------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK---LPPMP--KDYS  227 (257)
T ss_pred             ccccCCcCccChhHhcC-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---CCCCc--cccC
Confidence            34568999999999863       367889999999999999999999998776655555544311   11222  3678


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +.+.+|+.+|+. +|.+||++.+++.||||
T Consensus       228 ~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         228 PELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0660|consensus

Probab=100.00  E-value=6.6e-42  Score=366.40  Aligned_cols=257  Identities=25%  Similarity=0.423  Sum_probs=212.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe-----CCEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD-----MNHVY   84 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed-----e~~ly   84 (792)
                      .|..++.||.|+||.|+.+.++.+|..||+|++...-...      .+|..+|+.++|+||+.+.+++..     -+.+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            4555799999999999999999999999999987432222      679999999999999999999875     45799


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|+|+| +.+|..+++.  +..+++..+..+++||++||+|+|+.||+||||||.|++++.++.+||||||+|+......
T Consensus       103 iV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             EehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            999999 7789999954  3349999999999999999999999999999999999999999999999999999886431


Q ss_pred             C-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc---------
Q psy13735        165 R-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD---------  234 (792)
Q Consensus       165 ~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~---------  234 (792)
                      . ...+..+-|.||.|||++...      ..|+.++||||+|||+.|||+|++-|.|.+.-..+..|+...         
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~------~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNS------SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             cccchhcceeeeeecCHHHHhcc------ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            1 122455789999999999643      589999999999999999999999998887655555554311         


Q ss_pred             ---------------CCCCcCCCC-CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        235 ---------------TEDTVSFPS-SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       235 ---------------~~~~l~fP~-~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                     ......|.. ..+.++.+.+|+.+||. ||.+|+|++++|.|||+....
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence                           001111100 13679999999999999 999999999999999998654

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.7e-41  Score=360.35  Aligned_cols=255  Identities=21%  Similarity=0.350  Sum_probs=204.2

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------   80 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------   80 (792)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|.+.......      ..|..+++.++||||++++++|...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4678999999999999999999999999999999987643322      4688899999999999999998654      


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+|+||||+.+ ++...+..    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            357999999965 67666632    3889999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC-----
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT-----  235 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~-----  235 (792)
                      ....  ......||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+....+..+.....     
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         170 GTSF--MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             CCcc--ccCCccccCCccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            4322  2234569999999999863       3688899999999999999999999987664333322211000     


Q ss_pred             ------------------CCCcC---------CCC----CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        236 ------------------EDTVS---------FPS----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       236 ------------------~~~l~---------fP~----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                        .....         ++.    ....+..+.+||.+||. ||.+|||+.+++.||||....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                              00000         000    11246788999999999 999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0695|consensus

Probab=100.00  E-value=3.8e-42  Score=363.70  Aligned_cols=306  Identities=29%  Similarity=0.553  Sum_probs=250.4

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~   81 (792)
                      ..+.+++|+.+++||+|+|+.|.+++++.|.+.||+|+++|.-...       ..|..+..+- +||++|.++.+|+++.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            3478899999999999999999999999999999999998875543       5678887665 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+++|.||++||+|.-.+.+  ...+|++.+++|...|+.||.|||+.||++||||.+|+|+|..|++||+|+|+|+..-
T Consensus       325 rlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             eEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999999999999855  4459999999999999999999999999999999999999999999999999998755


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC--------CChhhhhhhhhcc
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY--------ETLDMTYSSILAC  233 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~--------~d~~el~ekIl~~  233 (792)
                      .++ ..+++.||||.|+|||++.+.       .|+..+|||+|||+|++|+.|+.||+-        .+.+-+++-|+. 
T Consensus       403 ~~g-d~tstfcgtpnyiapeilrge-------eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-  473 (593)
T KOG0695|consen  403 GPG-DTTSTFCGTPNYIAPEILRGE-------EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-  473 (593)
T ss_pred             CCC-cccccccCCCcccchhhhccc-------ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-
Confidence            443 355678999999999999853       799999999999999999999999951        223445555555 


Q ss_pred             cCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCC------hhHHhcCCCccCCC--------CCCCCCCCCc---ccCc
Q psy13735        234 DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLN------MDQVLGHPVFDCLD--------SDPPCIPPPS---QENK  295 (792)
Q Consensus       234 ~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPT------aeEIL~HPwF~~i~--------~~pP~~P~~s---~~~~  295 (792)
                         ..+..|.  .+|-.+..+++..|. ||.+|++      ..++..||||+.++        ..||+.|...   ...+
T Consensus       474 ---kqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~  548 (593)
T KOG0695|consen  474 ---KQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDN  548 (593)
T ss_pred             ---hcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccc
Confidence               5666776  678888999999999 9999987      46889999999887        3678888744   3455


Q ss_pred             CChhhhhccC---CChhhhhhcccccccCCCcccccccCCCCC
Q psy13735        296 FHKKDKRKAS---PSLKAFQKEGRYLDSALPLIGISYTGEPMG  335 (792)
Q Consensus       296 f~~k~~~k~~---~s~k~f~~~~~~~~~~l~fig~s~~~~~~g  335 (792)
                      |+..++....   |......    ....+..|.||.|.+|...
T Consensus       549 fd~qft~e~~qltpdd~d~i----~ridqsefegfeyinpl~m  587 (593)
T KOG0695|consen  549 FDTQFTSEPVQLTPDDEDAI----KRIDQSEFEGFEYINPLLM  587 (593)
T ss_pred             cccccccCCcccCCCCHHHH----HhcchhhcCcceecchhhc
Confidence            6555443322   1111111    1224578999999887543

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-41  Score=362.28  Aligned_cols=254  Identities=24%  Similarity=0.422  Sum_probs=207.3

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------C
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------N   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------~   81 (792)
                      .++|.+++.||.|+||.||+|.+..++..||+|.+.+.....      ..|+.+++.++||||++++++|...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            468999999999999999999999999999999987643221      4689999999999999999988643      4


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|++|+++ |++|.+++.   .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        94 ~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            579999998 889988874   3459999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC---
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT---  238 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~---  238 (792)
                      ..    ....+||+.|+|||++.+      ...++.++|||||||++|+|++|..||.+.+....+..+........   
T Consensus       170 ~~----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         170 DE----MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             CC----cCCccccccccCchHhcC------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            32    234469999999999863      23688899999999999999999999987665444443322100000   


Q ss_pred             ----------------cCCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        239 ----------------VSFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       239 ----------------l~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                      ...+.      ....++.+.+|+.+||. ||.+|||+.+++.||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                            00111      12356789999999999 999999999999999998653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-41  Score=360.89  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=210.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +..++|++.+.||.|+||.||++.+..+|..+|+|.+.......     ..|+.++..++||||++++++|.+.+.+|+|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            45689999999999999999999999999999999887653221     4688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||++||+|.+++.+  .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||++......  
T Consensus        82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          82 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999999954  45689999999999999999999985 7999999999999999999999999998765422  


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-----------
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-----------  234 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-----------  234 (792)
                       ......|++.|+|||++.+       ..++.++|||||||++|+|++|..||...........+....           
T Consensus       158 -~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             -ccccCCCCccccCHHHhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence             1233469999999999863       368889999999999999999999997654432221110000           


Q ss_pred             ------------------------------CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        235 ------------------------------TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       235 ------------------------------~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                                    ......++ ...++.++.+|+.+||+ ||.+|||+.+++.||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                          00000011 12357889999999999 99999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-40  Score=335.58  Aligned_cols=249  Identities=29%  Similarity=0.461  Sum_probs=214.4

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||+|+||.||+|.+..+|..|++|.+.......      ..|..+++.++||||+++++++.+.+.+|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            6899999999999999999999999999999987654332      4678889999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++|++|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~  159 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FAN  159 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-hhh
Confidence            9999999999765456789999999999999999999999999999999999999999999999999887654322 223


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|++.|+|||++..       ..++.++|+|||||++|+|++|..||...+.......+....   ...++.  .++.
T Consensus       160 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~--~~~~  227 (256)
T cd08529         160 TIVGTPYYLSPELCED-------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV---FPPVSQ--MYSQ  227 (256)
T ss_pred             ccccCccccCHHHhcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---CCCCcc--ccCH
Confidence            4468999999999863       357889999999999999999999998877666666554411   112222  6789


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+.+++.+|++ +|.+||++.+++.|||+
T Consensus       228 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         228 QLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999 99999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6e-41  Score=353.18  Aligned_cols=251  Identities=24%  Similarity=0.407  Sum_probs=193.5

Q ss_pred             EeEeeecCceEEEEEEEec--CCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEe--CCEEEEEEeccCCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQ--SHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQD--MNHVYFIMEYVTGG   93 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~--tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfed--e~~lyLVmEy~~GG   93 (792)
                      +.+||+|+||.||+|.++.  +++.||+|.+.......  ..|+.+++.++||||++++++|..  ...+|+||||+ ++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CC
Confidence            4689999999999999764  67899999987654432  679999999999999999999854  46789999999 46


Q ss_pred             CHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe----CCCCceEEeccCccccccc
Q psy13735         94 DFVTLLENQ-------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        94 sL~dlL~r~-------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL----d~dg~VKLiDFGLA~~l~~  162 (792)
                      +|.+++...       ....+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|.....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence            888887432       12358999999999999999999999999999999999999    4567899999999987643


Q ss_pred             CCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh---------hhhhhhh
Q psy13735        163 NGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD---------MTYSSIL  231 (792)
Q Consensus       163 ~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~---------el~ekIl  231 (792)
                      ...  ......+||+.|+|||++.+      ...++.++||||+||++|+|++|.+||.+....         .....+.
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         165 PLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             CCccccccCCccccccccCCHHHcC------CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            221  12234578999999999863      245888999999999999999999999654321         1111111


Q ss_pred             ccc-------CCCCcCCC-------------------------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        232 ACD-------TEDTVSFP-------------------------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       232 ~~~-------~~~~l~fP-------------------------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ...       +......+                         .....+..+.+||.+||+ ||.+|||+.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            100       00000000                         011235678999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0594|consensus

Probab=100.00  E-value=3.8e-41  Score=360.25  Aligned_cols=263  Identities=27%  Similarity=0.419  Sum_probs=220.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCC-cceeEEEEEeCC-----
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPY-IVNLFYSFQDMN-----   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPN-IVkL~~vfede~-----   81 (792)
                      ...|..+++||.|+||+||+|+.+.+|+.||+|.+.-....      ...|+.++..++|+| ||.+++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45688889999999999999999999999999999765442      178999999999999 999999999888     


Q ss_pred             -EEEEEEeccCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         82 -HVYFIMEYVTGGDFVTLLENQPH--GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        82 -~lyLVmEy~~GGsL~dlL~r~~~--g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                       .+++|+||+ .-+|..++.....  ..++...++.+|.||+.||.|||+++|+||||||+||||+.+|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             899999999 5699999976543  357889999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcc-----
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC-----  233 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~-----  233 (792)
                      ...-+.. .....++|.+|.|||++.+      ...|+..+||||+|||+++|+++++-|.+.+.......|...     
T Consensus       169 a~~ip~~-~yt~evvTlWYRaPEvLlG------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  169 AFSIPMR-TYTPEVVTLWYRAPEVLLG------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             HhcCCcc-cccccEEEeeccCHHHhcC------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence            7653322 1234479999999999974      457999999999999999999999999998887777766541     


Q ss_pred             --cCCCCc-------CCCCC----------ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        234 --DTEDTV-------SFPSS----------IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       234 --~~~~~l-------~fP~~----------~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                        .|++..       .||.+          ...+++..+++.+||+ +|.+|.|+..++.||||.......
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence              222221       22221          2334689999999999 999999999999999999775443

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-41  Score=345.11  Aligned_cols=260  Identities=25%  Similarity=0.432  Sum_probs=217.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      .++|.+.+.||.|+||.||++.+..++..+|+|.+.......    ..|+.+++.++||||+++++++.+...+|+||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999999999999999986543222    4688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++||+|.+++... ...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........ ...
T Consensus        84 ~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~  161 (280)
T cd06611          84 CDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRD  161 (280)
T ss_pred             cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccc
Confidence            9999999998653 34599999999999999999999999999999999999999999999999999876543222 223


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|++.|+|||.+...  ......++.++|+||+||++|+|++|.+||...+.......+....   ...+.....++.
T Consensus       162 ~~~~~~~y~~PE~~~~~--~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  236 (280)
T cd06611         162 TFIGTPYWMAPEVVACE--TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQPSKWSS  236 (280)
T ss_pred             eeecchhhcCHHHHhhc--ccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC---CCCcCCcccCCH
Confidence            44689999999998632  2233457889999999999999999999998776655555554321   112222336789


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+.+|+..|+. +|.+||++.++++||||...
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            99999999999 99999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-40  Score=339.69  Aligned_cols=256  Identities=26%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ...+|.+.+.||+|+||.||++.+..+|+.||+|++.......    ..|+.++..++||||+++++++.....+|+|||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            4568999999999999999999999999999999987543322    468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+++|+|.+++.+  .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ...
T Consensus        87 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~  163 (267)
T cd06646          87 YCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKR  163 (267)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-ccc
Confidence            9999999999854  4568999999999999999999999999999999999999999999999999998764321 112


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....|++.|+|||.+...    ....++.++|+||+||++|+|++|..||...........+..... .....+....++
T Consensus       164 ~~~~~~~~y~~PE~~~~~----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVE----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-QPPKLKDKTKWS  238 (267)
T ss_pred             CccccCccccCHhHcccc----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC-CCCCCccccccC
Confidence            334689999999987421    233577899999999999999999999965544333322222111 111122223578


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPV  276 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPw  276 (792)
                      ..+.+|+++||. +|.+||++.+++.|+|
T Consensus       239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         239 STFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999 9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-40  Score=343.14  Aligned_cols=248  Identities=28%  Similarity=0.525  Sum_probs=206.1

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ||+|+||+||+|.+..+|+.||+|.+.+.....       ..|..+++.++||||++++++|...+.+|+||||++|++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999987543221       4688999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP  175 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp  175 (792)
                      .+++.+.....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.......  ......|++
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccccCCC
Confidence            999976544469999999999999999999999999999999999999999999999999987664322  222345889


Q ss_pred             CccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHH
Q psy13735        176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV  255 (792)
Q Consensus       176 ~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLI  255 (792)
                      .|+|||++..       ..++.++||||+||++|+|++|..||...........+..........+|.  .+++.+.++|
T Consensus       159 ~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li  229 (277)
T cd05577         159 GYMAPEVLQG-------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLC  229 (277)
T ss_pred             CcCCHHHhcC-------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc--cCCHHHHHHH
Confidence            9999999863       247889999999999999999999997655422222222211112233333  5699999999


Q ss_pred             HHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        256 QSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       256 k~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      .+||. +|.+||     ++.+++.||||..++
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             HHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence            99999 999999     888899999998766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.4e-41  Score=356.23  Aligned_cols=252  Identities=20%  Similarity=0.347  Sum_probs=200.6

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEe
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQD   79 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfed   79 (792)
                      .+..++|++.+.||.|+||.||+|.+.     .++..||+|++.......     ..|..++..+ +||||++++++|..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            456679999999999999999999853     346789999987543222     5688999999 89999999998876


Q ss_pred             C-CEEEEEEeccCCCCHHHHHHhCC-------------------------------------------------------
Q psy13735         80 M-NHVYFIMEYVTGGDFVTLLENQP-------------------------------------------------------  103 (792)
Q Consensus        80 e-~~lyLVmEy~~GGsL~dlL~r~~-------------------------------------------------------  103 (792)
                      . ..+|+|||||+||+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 46899999999999999986421                                                       


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc-ccccCCCCCCc
Q psy13735        104 -----HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEY  177 (792)
Q Consensus       104 -----~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y  177 (792)
                           ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ......+++.|
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence                 124788899999999999999999999999999999999999999999999999865432211 12233467889


Q ss_pred             cChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHH
Q psy13735        178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQ  256 (792)
Q Consensus       178 ~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk  256 (792)
                      +|||++..       ..++.++|||||||++|+|++ |..||.+......+......  ......|  ..+++.+.+++.
T Consensus       243 ~aPE~~~~-------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~l~~li~  311 (338)
T cd05102         243 MAPESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--GTRMRAP--ENATPEIYRIML  311 (338)
T ss_pred             cCcHHhhc-------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc--CCCCCCC--CCCCHHHHHHHH
Confidence            99999863       368899999999999999997 99999876544333333221  1122233  367899999999


Q ss_pred             HHhh-ChhhcCChhHHhc
Q psy13735        257 SLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       257 ~LL~-DP~kRPTaeEIL~  273 (792)
                      .|+. ||.+||++.+++.
T Consensus       312 ~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         312 ACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHccCChhhCcCHHHHHH
Confidence            9999 9999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.5e-41  Score=374.67  Aligned_cols=254  Identities=23%  Similarity=0.371  Sum_probs=199.9

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---hHHHHHHHHhcCC------CCcceeEEEEEeC-CE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC------PYIVNLFYSFQDM-NH   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---~~~E~eIL~kL~H------PNIVkL~~vfede-~~   82 (792)
                      ...+|.+++.||+|+||+||+|.+..+++.||+|++......   ...|+.++..+.|      ++++.++++|... .+
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            357899999999999999999999999999999998643221   1457777776654      5689999998865 57


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCC--------------
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATG--------------  147 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg--------------  147 (792)
                      +|+||+++ |++|.+++.+  .+.+++..+..|+.||+.||.|||+ .||+||||||+|||++.++              
T Consensus       207 ~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             EEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            99999998 8889988854  4569999999999999999999998 5999999999999998765              


Q ss_pred             --ceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh
Q psy13735        148 --HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM  225 (792)
Q Consensus       148 --~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e  225 (792)
                        .+||+|||.+.....    .....+||+.|+|||++.+       ..|+.++|||||||++|+|++|++||.+.+...
T Consensus       284 ~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        284 PCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG-------LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             CceEEECCCCccccCcc----ccccccCCccccCcHHhhc-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence              499999998864321    2234579999999999973       368999999999999999999999998776544


Q ss_pred             hhhhhhcccCC---------------------CCc--CC-C------------CCccccHHHHHHHHHHhh-ChhhcCCh
Q psy13735        226 TYSSILACDTE---------------------DTV--SF-P------------SSIRLSTAMVNFVQSLVQ-KLDARLNM  268 (792)
Q Consensus       226 l~ekIl~~~~~---------------------~~l--~f-P------------~~~~lS~elkdLIk~LL~-DP~kRPTa  268 (792)
                      ....+......                     ..+  .+ +            .....++.+.+||.+||+ ||.+|||+
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            33333211000                     000  00 0            000124668899999999 99999999


Q ss_pred             hHHhcCCCccCC
Q psy13735        269 DQVLGHPVFDCL  280 (792)
Q Consensus       269 eEIL~HPwF~~i  280 (792)
                      .++|.||||...
T Consensus       433 ~e~L~Hp~~~~~  444 (467)
T PTZ00284        433 RQMTTHPYVLKY  444 (467)
T ss_pred             HHHhcCcccccc
Confidence            999999999864

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-40  Score=354.04  Aligned_cols=258  Identities=23%  Similarity=0.362  Sum_probs=204.4

Q ss_pred             EEeEeeec--CceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         19 IKRFIQQG--NFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        19 I~k~IGsG--sFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      ++++||+|  +||+||++.++.+|+.||+|.+.......      ..|+.+++.++||||++++++|.+++.+|+|||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56889999  78999999999999999999997654332      46888999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc----
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI----  166 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~----  166 (792)
                      ++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+......+..    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            9999999996544456899999999999999999999999999999999999999999999999875543221110    


Q ss_pred             --ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC-------
Q psy13735        167 --KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED-------  237 (792)
Q Consensus       167 --~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~-------  237 (792)
                        ......++..|+|||++...     ...++.++||||+||++|+|++|..||...................       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ccccccccceecccChHHhhcc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence              11123577889999998631     2358899999999999999999999997544322221111100000       


Q ss_pred             ---------------------------------CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        238 ---------------------------------TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       238 ---------------------------------~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                                       ....+....+++.+.+|+.+||+ ||.+|||+.+++.||||+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                             00001122467899999999999 999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-40  Score=375.63  Aligned_cols=254  Identities=25%  Similarity=0.402  Sum_probs=215.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecC-CcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQS-HNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~t-Gk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..|.+.+.||+|+||.||+|....+ +..+|+|.+.......    ..|+.++..++|||||+++++|...+.+||||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3499999999999999999998887 7888998775443221    4689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-c
Q psy13735         90 VTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-I  166 (792)
Q Consensus        90 ~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~  166 (792)
                      |+||+|.+++.+.  ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            9999999888532  345689999999999999999999999999999999999999999999999999987653322 1


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+....   ...+|  ..
T Consensus       227 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~---~~~~~--~~  294 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWER-------KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK---YDPFP--CP  294 (478)
T ss_pred             cccccCCCccccCHhHhCC-------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CCCCC--cc
Confidence            2334579999999999863       368899999999999999999999998887777777665521   11233  36


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +++.+.++|..||. +|.+||++.+++.|||++.+
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            78999999999999 99999999999999999754

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-40  Score=341.08  Aligned_cols=258  Identities=28%  Similarity=0.450  Sum_probs=211.0

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +...++|.+.+.||.|+||.||+|.+..+++.||+|.+.......    ..|..+++.++||||+++++++...+.+|+|
T Consensus         5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            345678999999999999999999999999999999987553322    4578899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||++||+|.+++..  .+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06645          85 MEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A  161 (267)
T ss_pred             EeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence            999999999999854  4569999999999999999999999999999999999999999999999999987654321 1


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      ......|++.|+|||++...    ....++.++|+|||||++|+|++|.+||...........+..... ....++....
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  236 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF-QPPKLKDKMK  236 (267)
T ss_pred             ccccccCcccccChhhhccc----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCC-CCCcccccCC
Confidence            22344699999999997421    123578899999999999999999999965544333222222111 1111222235


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPV  276 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPw  276 (792)
                      ++..+.+|+.+||. +|.+||++.+++.|||
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            78899999999999 9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-40  Score=341.02  Aligned_cols=255  Identities=28%  Similarity=0.467  Sum_probs=210.7

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||.|+||.||+|.+..+|..||+|++.......      ..|+.+++.++||||+++++++.+...+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5899999999999999999999999999999997655322      5688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      + |++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++............
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            9 999999986533 56999999999999999999999999999999999999999999999999999877544322233


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-------------
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-------------  236 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-------------  236 (792)
                      ...|++.|+|||.+..      ...++.++||||+||++|+|++|.+||.+.+....+..+......             
T Consensus       159 ~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         159 HQVATRWYRAPELLYG------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             cccCcccccCceeeec------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            4468999999998752      235688999999999999999999999776654444333321000             


Q ss_pred             --CCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        237 --DTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       237 --~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                        ....++.         ....+..+.++|.+||. +|.+||++.+++.||||.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence              0111111         12457899999999999 999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=335.65  Aligned_cols=259  Identities=25%  Similarity=0.430  Sum_probs=212.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhc-CCCCcceeEEEEEeCC------E
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKS-KCPYIVNLFYSFQDMN------H   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL-~HPNIVkL~~vfede~------~   82 (792)
                      ..++|.+.+.||.|+||.||+|.++.+++.+++|++.......   ..|..+++++ .||||++++++|....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            3578999999999999999999999999999999987654432   4688889988 6999999999997644      5


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQP--HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~--~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +|+||||+++++|.+++....  ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            899999999999999986533  467999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..... ......|++.|+|||++...  ......++.++|||||||++|+|++|.+||...........+....   ...
T Consensus       164 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~  237 (275)
T cd06608         164 DSTLG-RRNTFIGTPYWMAPEVIACD--EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PPT  237 (275)
T ss_pred             ccchh-hhcCccccccccCHhHhccc--ccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CCC
Confidence            43221 22345689999999998532  1123457889999999999999999999997665544444444311   112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+....++..+.+|+.+||. ||.+|||+.+++.|||+
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            22223578899999999999 99999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.7e-40  Score=342.80  Aligned_cols=248  Identities=25%  Similarity=0.435  Sum_probs=205.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|+++++||+|+||.||+|.+..+++.||+|.+.......     ..|..++.+++||||++++++|...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            47899999999999999999999999999999987653322     4688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++||+|..+.      .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......   ...
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~  151 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK  151 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence            9999986542      3789999999999999999999999999999999999999999999999999866432   223


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-------hhhhhhhcccCCCCcCCC
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-------MTYSSILACDTEDTVSFP  242 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-------el~ekIl~~~~~~~l~fP  242 (792)
                      ..+|++.|+|||++..       ..++.++|+|||||++|+|++|..||......       .....+..   ...... 
T Consensus       152 ~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  220 (279)
T cd06619         152 TYVGTNAYMAPERISG-------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD---EDPPVL-  220 (279)
T ss_pred             CCCCChhhcCceeecC-------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc---cCCCCC-
Confidence            4579999999999863       35788999999999999999999999643221       11111111   011111 


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      ....+++++.+|+.+|++ +|.+||++.+++.||||...+.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            123468899999999999 9999999999999999987644

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.7e-40  Score=337.37  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=207.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----h--HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----N--TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----~--~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++|++...||+|+||.||++.++.+|+.||+|.+......    .  ..|+.+++.++||||++++++|.....+|+|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            4799999999999999999999999999999988654321    1  468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++++.|..++..  ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~  157 (286)
T cd07847          81 YCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY  157 (286)
T ss_pred             ccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence            9999888877743  34589999999999999999999999999999999999999999999999999987654321 12


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc--------------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD--------------  234 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~--------------  234 (792)
                      ....|++.|+|||.+.+      ...++.++||||+||++|+|++|.+||.+.+.......+....              
T Consensus       158 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         158 TDYVATRWYRAPELLVG------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cCcccccccCCHHHHhC------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            23458899999999852      2357889999999999999999999998766543332221100              


Q ss_pred             -CCCCcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        235 -TEDTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       235 -~~~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                       +......|.          ...++..+.+|+.+|+. +|.+||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence             000001111          12468899999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.3e-40  Score=340.64  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=213.4

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      |++.+.||.|+||.||++.+..++..+++|.+.......    ..|+.+++.++||||++++++|......|+||||++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            688999999999999999999999999999986543222    4688899999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|..++.+ ..+.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++....... .......
T Consensus        87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~  164 (282)
T cd06643          87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFI  164 (282)
T ss_pred             CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccccc
Confidence            999988754 23568999999999999999999999999999999999999999999999999987654321 1223446


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      |++.|+|||++...  ......++.++||||+||++|+|++|.+||...+.......+.....   ...+....++..+.
T Consensus       165 ~~~~y~aPE~~~~~--~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  239 (282)
T cd06643         165 GTPYWMAPEVVMCE--TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP---PTLAQPSRWSSEFK  239 (282)
T ss_pred             ccccccCHhhcccc--CCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC---CCCCCccccCHHHH
Confidence            89999999998522  12234578899999999999999999999987766555555543211   11222236789999


Q ss_pred             HHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        253 NFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +||.+|+. +|.+||++.+++.||||...
T Consensus       240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         240 DFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            99999999 99999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-40  Score=342.38  Aligned_cols=253  Identities=23%  Similarity=0.414  Sum_probs=203.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+......      ...|+.+++.++||||+++++++.+...+|+|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            589999999999999999999999999999998754322      15689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      +. ++|.+++... .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (284)
T cd07839          81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYS  157 (284)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcC
Confidence            96 5788777542 45699999999999999999999999999999999999999999999999999986543221 122


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCC-CCCChhhhhhhhhccc--------------
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACD--------------  234 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF-~~~d~~el~ekIl~~~--------------  234 (792)
                      ...+++.|+|||++.+      ...++.++|||||||++|+|++|..|| .+.+....+..+....              
T Consensus       158 ~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         158 AEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCccccCCcChHHHhC------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence            3458899999999863      235788999999999999999988885 4444333333332110              


Q ss_pred             --CCCCcCCCC-------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        235 --TEDTVSFPS-------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       235 --~~~~l~fP~-------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                        ......++.       ...+++.+.+||.+||. ||.+|||+.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence              000001111       12478999999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.5e-40  Score=332.84  Aligned_cols=249  Identities=26%  Similarity=0.449  Sum_probs=213.5

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|++.+.||+|+||.||++....+|+.||+|.+.......      ..|+.+++.++||||+++++++...+..|+||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5899999999999999999999999999999987543322      5688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++|++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++........ ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~  159 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LAR  159 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhh
Confidence            9999999999654445689999999999999999999999999999999999999999999999999987653321 222


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|++.|+|||++..       ..++.++|+||+||++|+|++|..||...+.......+...   .....|  ..++.
T Consensus       160 ~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~  227 (256)
T cd08218         160 TCIGTPYYLSPEICEN-------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG---SYPPVS--SHYSY  227 (256)
T ss_pred             hccCCccccCHHHhCC-------CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC---CCCCCc--ccCCH
Confidence            3458999999999853       35778999999999999999999999877776666666542   111223  36789


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+.++|.+|+. +|.+||++.+++.||||
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         228 DLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            99999999999 99999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-40  Score=362.61  Aligned_cols=256  Identities=23%  Similarity=0.391  Sum_probs=206.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEec--CCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQ--SHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~--tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      ..+|.+++.||.|+||.||+|....  ++..+|+|.+.... ....|+.+++.++|||||+++++|.....+|+|||++ 
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-  168 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-  168 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-
Confidence            4469999999999999999997653  56789999886543 2367999999999999999999999999999999999 


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-ccccc
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIV  170 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~s~t  170 (792)
                      +++|.+++.  ..+.+++..+..|+.||+.||.|||++||+||||||+|||++.++.++|+|||++........ .....
T Consensus       169 ~~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~  246 (392)
T PHA03207        169 KCDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG  246 (392)
T ss_pred             CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccc
Confidence            468888883  345699999999999999999999999999999999999999999999999999976653322 12234


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh---hhhhhhhcccCCCC---------
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD---MTYSSILACDTEDT---------  238 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~---el~ekIl~~~~~~~---------  238 (792)
                      .+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+....   ..+..+........         
T Consensus       247 ~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        247 WSGTLETNSPELLAL-------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             cccccCccCHhHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            579999999999863       36889999999999999999999999765432   11122211100000         


Q ss_pred             ----------------cCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        239 ----------------VSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       239 ----------------l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                      ...|.   ...++.++.+||.+||. ||.+|||+.++|.||||...
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                            11111   12456789999999999 99999999999999999863

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.2e-40  Score=340.07  Aligned_cols=260  Identities=23%  Similarity=0.395  Sum_probs=211.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhc-CCCCcceeEEEEEe------C
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKS-KCPYIVNLFYSFQD------M   80 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL-~HPNIVkL~~vfed------e   80 (792)
                      ....+.|++.+.||.|+||.||++.+..+++.+|+|.+.......   ..|..++..+ +||||++++++|..      .
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            345678999999999999999999999999999999986653322   4577788887 69999999999853      4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+|+||||+++|+|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            67899999999999999997655566899999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..... ......|++.|+|||.+...  ......++.++|+|||||++|+|++|..||...........+...   ....
T Consensus       172 ~~~~~-~~~~~~~~~~y~aPE~l~~~--~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~  245 (282)
T cd06636         172 DRTVG-RRNTFIGTPYWMAPEVIACD--ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PPPK  245 (282)
T ss_pred             hcccc-CCCcccccccccCHhhcCcc--cCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CCCC
Confidence            42211 22345699999999998521  122346788999999999999999999999765544333333221   1111


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                       .....++..+.+||.+||. ||.+||++.+++.||||
T Consensus       246 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         246 -LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence             1123578999999999999 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-40  Score=359.44  Aligned_cols=256  Identities=20%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      +...+|.+++.||.|+||.||+|.+..++..||+|+..+..  ...|+.++..++||||++++++|......|+|||++.
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            34568999999999999999999999999999999755433  3679999999999999999999999999999999994


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                       |+|.+++.. ..+.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .....
T Consensus       141 -~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~  216 (357)
T PHA03209        141 -SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGL  216 (357)
T ss_pred             -CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccccc
Confidence             688888754 34568999999999999999999999999999999999999999999999999997543221  22345


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC-CCCCChh---------hhhhhhhcccCCCCcCC
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLD---------MTYSSILACDTEDTVSF  241 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P-F~~~d~~---------el~ekIl~~~~~~~l~f  241 (792)
                      .||+.|+|||++..       ..++.++|||||||++|+|+++..| |......         ..+..+..........+
T Consensus       217 ~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        217 AGTVETNAPEVLAR-------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             cccccccCCeecCC-------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence            69999999999863       3688999999999999999985444 4322111         00111111000000011


Q ss_pred             C----------------------------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        242 P----------------------------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       242 P----------------------------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      |                            ....++.++.+||.+||+ ||.+|||+.++|+||||+.+
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            1                            112457788899999999 99999999999999999863

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-40  Score=375.70  Aligned_cols=256  Identities=26%  Similarity=0.407  Sum_probs=216.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC----
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN----   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~----   81 (792)
                      ....+|.+.+.||+|+||+||+|.+..+|+.||+|++.......      ..|+.++..++|+||+++++.|....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            45579999999999999999999999999999999997665432      45778888999999999998875432    


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         82 ----HVYFIMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        82 ----~lyLVmEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                          .+++||||++||+|.+++...  ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                478999999999999998642  23568999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc
Q psy13735        156 SATQVDKNG-RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD  234 (792)
Q Consensus       156 LA~~l~~~~-~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~  234 (792)
                      +++...... .......+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~  261 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR  261 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            998754321 112334579999999999863       368899999999999999999999999888777777665521


Q ss_pred             CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        235 TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       235 ~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                         ...+|.  .+++.+.+++..||. +|.+||++.+++.|||+..
T Consensus       262 ---~~~~~~--~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        262 ---YDPLPP--SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             ---CCCCCC--CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence               112333  679999999999999 9999999999999999874

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-40  Score=342.84  Aligned_cols=261  Identities=27%  Similarity=0.459  Sum_probs=213.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|++++.||.|+||.||+|.+..+|..||+|.+.......     ..|..++.+++||||++++++|...+.+|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47999999999999999999999999999999886542221     4688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         90 VTGGDFVTLLENQP-HGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        90 ~~GGsL~dlL~r~~-~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |+|++|..++.... .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++......   .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---L  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---c
Confidence            99999999885421 2368999999999999999999997 59999999999999999999999999998766422   2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      .....|++.|+|||.+.... ......++.++||||+||++|+|++|..||........+..+..........+|.  .+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~  234 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGG-PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS--GY  234 (286)
T ss_pred             cccCCCccCccCcchhcCCC-CCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc--cc
Confidence            22346899999999985321 1123356889999999999999999999997665544443332211112233443  57


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ++++.+|+.+|+. +|.+||++.+++.||||....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            9999999999999 999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-39  Score=342.39  Aligned_cols=263  Identities=27%  Similarity=0.458  Sum_probs=220.1

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      ..+-..+....+|.+.+.||.|+||.||++.+..+|+.||+|.+.......    ..|..+++.++||||++++++|...
T Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (296)
T cd06655           9 RTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG   88 (296)
T ss_pred             HHHHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence            344556666778999999999999999999999999999999987654433    4688899999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+|+||||++||+|..++..   ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++...
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          89 DELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             ceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            999999999999999999853   34899999999999999999999999999999999999999999999999998876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..... ......|++.|+|||.+..       ..++.++|+|||||++|+|++|..||...+.......+...   ....
T Consensus       166 ~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~---~~~~  234 (296)
T cd06655         166 TPEQS-KRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---GTPE  234 (296)
T ss_pred             ccccc-cCCCcCCCccccCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---CCcc
Confidence            53322 2233468999999999863       35788999999999999999999999877654444333321   1112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +.....+++.+.+||.+||. +|.+||++.+++.||||....
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            22234678999999999999 999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7e-40  Score=345.89  Aligned_cols=254  Identities=25%  Similarity=0.387  Sum_probs=208.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|++.+.||+|+||.||++.+..+|..+|+|.+.......     ..|++++.+++||||++++++|.+.+.+|+||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            47999999999999999999999999999999886543221     4689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ++||+|.+++.+  .+.+++..+..++.||+.||.|||+ .+|+||||+|.|||++.++.++|+|||++......   ..
T Consensus        81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~  155 (308)
T cd06615          81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA  155 (308)
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence            999999999954  3568999999999999999999998 59999999999999999999999999998765422   12


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC-------------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT-------------  235 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~-------------  235 (792)
                      ...+|++.|+|||.+.+       ..++.++|+|||||++|+|++|..||...+.......+.....             
T Consensus       156 ~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         156 NSFVGTRSYMSPERLQG-------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ccCCCCcCccChhHhcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence            34568999999998853       3578899999999999999999999976554332222211000             


Q ss_pred             --------------------CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        236 --------------------EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       236 --------------------~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                          ......|. ..++.++.+|+.+||. +|.+||++.+++.||||....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence                                00011111 1367889999999999 999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-40  Score=337.48  Aligned_cols=251  Identities=29%  Similarity=0.500  Sum_probs=213.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|.+.+.||.|+||.||++.+..+|..||+|.+.......     ..|+.+++.++||||++++++|.+...+|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47899999999999999999999999999999987654222     4688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++|++|.+++...   .+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  156 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRN  156 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccc
Confidence            9999999999542   68999999999999999999999999999999999999999999999999998776432 1223


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|++.|+|||.+..       ..++.++|||||||++|+|++|.+||...+.......+...   .....+. ..+++
T Consensus       157 ~~~~~~~y~~PE~~~~-------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~  225 (274)
T cd06609         157 TFVGTPFWMAPEVIKQ-------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN---NPPSLEG-NKFSK  225 (274)
T ss_pred             cccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---CCCCCcc-cccCH
Confidence            4568999999999863       24889999999999999999999999876655554444331   1122222 12788


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+.+++.+||. +|.+||++.+++.||||...
T Consensus       226 ~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            99999999999 99999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.5e-40  Score=340.27  Aligned_cols=246  Identities=30%  Similarity=0.577  Sum_probs=198.6

Q ss_pred             EeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHH---hcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         22 FIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMV---KSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        22 ~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~---kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      .||+|+||.||++.+..+|..+|+|.+.+.....       ..|..++.   ..+||||+.++++|...+.+|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999987654321       22333333   3479999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      ||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......   ....
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  155 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS  155 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence            9999999854  4569999999999999999999999999999999999999999999999999987654322   2234


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      .|++.|+|||.+..      ...++.++|+||+||++|+|++|..||........ ..+..........+|.  .+++.+
T Consensus       156 ~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~  226 (279)
T cd05633         156 VGTHGYMAPEVLQK------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPD--SFSPEL  226 (279)
T ss_pred             CCCcCccCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCcc--ccCHHH
Confidence            69999999998742      23578899999999999999999999975432211 1111111112223343  578999


Q ss_pred             HHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        252 VNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       252 kdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      .++|..||. ||.+||     ++.++++||||++++
T Consensus       227 ~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            999999999 999999     599999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-39  Score=342.81  Aligned_cols=257  Identities=28%  Similarity=0.471  Sum_probs=213.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +-...+|.+++.||.|+||.||++.+..+|+.||+|.+.......    ..|..+++.++||||++++++|...+.+|+|
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            334578999999999999999999999999999999997654433    4578899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||++||+|.+++..   ..+++..+..++.|++.||.|||+.||+||||+|+|||++.++.++|+|||++........ 
T Consensus        95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            999999999999854   3489999999999999999999999999999999999999999999999999876543321 


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      ......|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...+.......+..   ...........
T Consensus       171 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~  240 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPER  240 (297)
T ss_pred             CcCcccCCccccCHHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc---CCCCCCCCccc
Confidence            2233468999999999863       3578899999999999999999999977654333222221   11111122236


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +++.+.+|+.+|+. +|.+||++.+++.||||....
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            78899999999999 999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-39  Score=329.91  Aligned_cols=249  Identities=28%  Similarity=0.463  Sum_probs=215.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|++.+.||.|+||.||.+....+|..+++|.+.......      ..|+.++++++||||++++++|.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5899999999999999999999999999999987654332      5688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      |+||+|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~  159 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAE  159 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-ccc
Confidence            9999999999765456689999999999999999999999999999999999999999999999999987643332 223


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...+.......+.....   ...+  ..++.
T Consensus       160 ~~~~~~~y~ape~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~~~  227 (256)
T cd08221         160 TVVGTPYYMSPELCQG-------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY---TPVV--SVYSS  227 (256)
T ss_pred             ccCCCccccCHhhcCC-------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---CCCc--cccCH
Confidence            4569999999999853       2577889999999999999999999988777777776654221   1112  36789


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+.+++..|+. +|.+||++.+++.|||+
T Consensus       228 ~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         228 ELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            99999999999 99999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-39  Score=329.19  Aligned_cols=248  Identities=24%  Similarity=0.465  Sum_probs=212.5

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||.|+||.||+|.+..++..+|+|.+.......      ..|..+++.++||||+++++.+...+.+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5899999999999999999999999999999997664432      4688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCCCccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ++|++|.+++.......+++..+..++.|++.||.|||++||+|+||+|+||+++.++ .++|+|||++.......  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~  158 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KA  158 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--cc
Confidence            9999999999765455689999999999999999999999999999999999998654 58999999998765432  22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...+.......+...   ....++.  .++
T Consensus       159 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~  226 (256)
T cd08220         159 YTVVGTPCYISPELCEG-------KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG---TFAPISD--RYS  226 (256)
T ss_pred             cccccCCcccCchhccC-------CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc---CCCCCCC--CcC
Confidence            33468999999999863       35788999999999999999999999887766666555441   1122333  578


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +.+.+++.+|+. +|.+|||+.++++||||
T Consensus       227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         227 PDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            999999999999 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0607|consensus

Probab=100.00  E-value=2.9e-41  Score=356.10  Aligned_cols=254  Identities=25%  Similarity=0.485  Sum_probs=216.2

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEeccCCCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEYVTGGD   94 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmEy~~GGs   94 (792)
                      .+.||+|+||.|--|....||..||||+|.|.....    ..|++++.+.+ |+||+.|+++|+++..+|||||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            478999999999999999999999999998874433    67999998885 9999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEEeccCcccccccCCC------
Q psy13735         95 FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGR------  165 (792)
Q Consensus        95 L~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKLiDFGLA~~l~~~~~------  165 (792)
                      |...|..  ...|+|.++..+++.|+.||.|||.+||.||||||+|||-....   .||||||.+...+.-...      
T Consensus       163 lLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  163 LLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             HHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            9999954  45699999999999999999999999999999999999986554   389999988765432211      


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC---------------hhhhhhhh
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET---------------LDMTYSSI  230 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d---------------~~el~ekI  230 (792)
                      ..-.+++|+..|||||++.-.-  .....|+.++|.||||||+|.||+|++||.+.-               .+.++..|
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv--~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFV--DQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             ccccCcccchhhcchhHHhhhc--cccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence            1223568999999999986441  234579999999999999999999999996543               23455556


Q ss_pred             hcccCCCCcCCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        231 LACDTEDTVSFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       231 l~~~~~~~l~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ..    +.+.||.  |..+|.+++|+|..||. |+.+|+++.++++|||+....
T Consensus       319 QE----GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  319 QE----GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             hc----cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            55    8889987  67899999999999999 999999999999999998654

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.4e-39  Score=336.54  Aligned_cols=261  Identities=24%  Similarity=0.428  Sum_probs=211.7

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhc-CCCCcceeEEEEEeC-----CE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKS-KCPYIVNLFYSFQDM-----NH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL-~HPNIVkL~~vfede-----~~   82 (792)
                      -..++|.+...||+|+||.||+|....+|+.+|+|.+.......   ..|..++..+ +||||++++++|...     ..
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            35688999999999999999999999999999999987543322   4678888888 799999999998754     36


Q ss_pred             EEEEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +|+||||++||+|.+++..  .....+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            8999999999999998853  23456899999999999999999999999999999999999999999999999998876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..... ......|++.|+|||++...  ......++.++||||+||++|+|++|.+||...+.......+...   ....
T Consensus       179 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~  252 (291)
T cd06639         179 TSTRL-RRNTSVGTPFWMAPEVIACE--QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPT  252 (291)
T ss_pred             ccccc-cccCccCCccccChhhhcCC--CCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCC
Confidence            53221 22344689999999998532  111224688999999999999999999999876655444444331   1112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      +.....++..+.++|.+|+. +|.+||++.+++.||||+
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            22223567899999999999 999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-39  Score=341.82  Aligned_cols=261  Identities=26%  Similarity=0.376  Sum_probs=213.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeC--CEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDM--NHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede--~~ly   84 (792)
                      ..++|++.+.||.|+||.||+|.+..+|..||+|.+......      ...|+.++++++||||+++++++.+.  +.+|
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            578999999999999999999999999999999998644321      14699999999999999999999765  5789


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||||+. ++|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus        85 lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          85 LVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            9999996 5888888653 3568999999999999999999999999999999999999999999999999998765332


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC--------
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE--------  236 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~--------  236 (792)
                      . ......+++.|+|||++.+      ...++.++||||+||++|+|++|.+||...+....+..+......        
T Consensus       163 ~-~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         163 K-PMTPKVVTLWYRAPELLLG------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             C-CCCcccccccccChhhhcC------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            1 1222346889999999852      235788999999999999999999999887776666555431100        


Q ss_pred             -------CCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        237 -------DTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       237 -------~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                             ....++.         ....++.+.+||.+||. ||.+|||+.+++.||||+..+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~  298 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL  298 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence                   0001110         02358899999999999 9999999999999999986553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.9e-40  Score=333.51  Aligned_cols=248  Identities=28%  Similarity=0.491  Sum_probs=208.1

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      .|.+...||.|+||.||++.+..++..||+|.+.......             ..|+.++..++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999999999999999887543321             357888999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .++||||++|++|.+++.+  .+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            9999999999999999954  35689999999999999999999999999999999999999999999999999887653


Q ss_pred             CCCc-----ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC
Q psy13735        163 NGRI-----KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       163 ~~~~-----~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      ....     ......|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...+.......+..   ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~  228 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-------TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---NA  228 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhcc-------CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---cC
Confidence            2111     1112358899999999863       3578889999999999999999999987655444433332   11


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ...+|.  .++..+.+++.+||+ +|.+||++.+++.||||
T Consensus       229 ~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 SPEIPS--NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCcCCc--ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            223333  578999999999999 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.5e-40  Score=335.01  Aligned_cols=245  Identities=36%  Similarity=0.676  Sum_probs=210.1

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+.+.....       ..|+.++++++||||++++++|.+...+|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999999999999997654322       468889999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+.|++|.+++...  +.+++..+..++.||+.||.|||++||+|+||+|.||+++.++.++|+|||++.......  ..
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  156 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT  156 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence            99999999999553  568999999999999999999999999999999999999999999999999988765432  22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh---hhhhhhhhcccCCCCcCCCCCc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL---DMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~---~el~ekIl~~~~~~~l~fP~~~  245 (792)
                      ....|+..|+|||++...       .++.++|+||+|+++|+|++|..||...+.   .........    ....+|.  
T Consensus       157 ~~~~~~~~y~~PE~~~~~-------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~--  223 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQ-------GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----ADVLYPA--  223 (258)
T ss_pred             cccCCChhhcCHHHHccc-------CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----ccccCcc--
Confidence            344689999999998632       478899999999999999999999987663   222222221    2233443  


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCCh--hHHhcCCCc
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNM--DQVLGHPVF  277 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTa--eEIL~HPwF  277 (792)
                      .++..+.++|.+|+. ||.+||++  .+++.||||
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            578999999999999 99999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.1e-39  Score=329.55  Aligned_cols=246  Identities=29%  Similarity=0.501  Sum_probs=209.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      +|.+.+.||.|+||.||++.+..+|..||+|.+.......     ..|..+++.++||||++++++|.+.+.+|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5899999999999999999999999999999986543222     46888999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      +||+|.+++.......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  159 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACT  159 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cccc
Confidence            999999998765556689999999999999999999999999999999999999999999999999976653322 2223


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      ..|++.|+|||++.+       ..++.++|+||+|+++|+|++|..||...+.......+...   .....|  ..++..
T Consensus       160 ~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~  227 (255)
T cd08219         160 YVGTPYYVPPEIWEN-------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG---SYKPLP--SHYSYE  227 (255)
T ss_pred             ccCCccccCHHHHcc-------CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC---CCCCCC--cccCHH
Confidence            468999999999863       35888999999999999999999999887766665555431   111223  367899


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +.+|+.+||. ||.+||++.+++.-
T Consensus       228 ~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         228 LRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHhCCcccCCCHHHHhhc
Confidence            9999999999 99999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0201|consensus

Probab=100.00  E-value=9e-42  Score=371.91  Aligned_cols=253  Identities=26%  Similarity=0.457  Sum_probs=220.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .....|...+.||+|+||.||++.+..+++.||+|++.......     ..|+.+|.+++||||.++|+.|-....++++
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            34457888899999999999999999999999999998766544     4688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||||.||++.+.+  ...+.+++..+..++++++.||.|||..+.+|||||+.|||+..+|.|||+|||++.++......
T Consensus        90 Mey~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   90 MEYCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999999999  44455699999999999999999999999999999999999999999999999999988755433


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      . .+++|||.|||||++.+       ..|+.++||||||++.|+|++|.+||....+....-.|..   ..++.+.  ..
T Consensus       168 r-~tfvGTPfwMAPEVI~~-------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---~~PP~L~--~~  234 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQ-------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SAPPRLD--GD  234 (467)
T ss_pred             c-ccccccccccchhhhcc-------ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---CCCCccc--cc
Confidence            3 67899999999999984       4899999999999999999999999987766443333332   1122222  37


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +|+.+++||..||. +|+.||++.++|.|+|++.
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            89999999999999 9999999999999999985

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.7e-40  Score=344.08  Aligned_cols=251  Identities=24%  Similarity=0.426  Sum_probs=191.9

Q ss_pred             EeEeeecCceEEEEEEEec--CCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEE--eCCEEEEEEeccCCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQ--SHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQ--DMNHVYFIMEYVTGG   93 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~--tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfe--de~~lyLVmEy~~GG   93 (792)
                      +.+||+|+||.||+|..+.  ++..||+|.+.......  ..|..+++.++||||++++++|.  ....+|+||||+. +
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            4689999999999999764  56899999987654432  57999999999999999999985  4567899999995 5


Q ss_pred             CHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe----CCCCceEEeccCccccccc
Q psy13735         94 DFVTLLENQ-------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        94 sL~dlL~r~-------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL----d~dg~VKLiDFGLA~~l~~  162 (792)
                      +|.+++...       ....+++..+..++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||++.....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            787776421       22358999999999999999999999999999999999999    4567899999999987653


Q ss_pred             CCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh---------hhhhh
Q psy13735        163 NGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT---------YSSIL  231 (792)
Q Consensus       163 ~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el---------~ekIl  231 (792)
                      ...  ......+||+.|+|||++.+      ...++.++||||+||++|+|++|.+||.....+..         ...+.
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             CcccccccCcceecccccCcHHhcC------CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            321  11223468999999999863      23578899999999999999999999965432110         00000


Q ss_pred             cc-------cCCC---CcCC----------------------CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        232 AC-------DTED---TVSF----------------------PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       232 ~~-------~~~~---~l~f----------------------P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ..       .+..   ...+                      ......+..+.+++.+||. ||.+|||+.++|.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00       0000   0000                      0011345678999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-39  Score=340.97  Aligned_cols=254  Identities=27%  Similarity=0.459  Sum_probs=213.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      -...+|.+.+.||+|+||.||++.+..+|..||+|.+.......    ..|..+++.+.||||+++++.|......|+||
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            35568999999999999999999999999999999987655443    46888999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++||+|.+++..   ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++........ .
T Consensus        97 e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~  172 (296)
T cd06654          97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (296)
T ss_pred             cccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence            99999999999854   3489999999999999999999999999999999999999999999999999886543321 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      .....|++.|+|||.+..       ..++.++|||||||++|+|++|..||...+.......+...   .....+....+
T Consensus       173 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~  242 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKL  242 (296)
T ss_pred             cCcccCCccccCHHHHcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC---CCCCCCCcccc
Confidence            223469999999999863       35788999999999999999999999876654333222221   11122222367


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ++.+.+++.+|+. +|.+||++.+++.||||..
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence            8999999999999 9999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-39  Score=341.96  Aligned_cols=255  Identities=37%  Similarity=0.676  Sum_probs=214.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||+|+||.||++.+..+++.||+|.+.+.....       ..|+.+++.++||||+++++.|...+.+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987654321       36888999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC---
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG---  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~---  164 (792)
                      ||++||+|.+++..  .+.+++..+..++.|++.||.|||++||+||||+|.||+++.+|.++|+|||++.......   
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            99999999999954  3568999999999999999999999999999999999999999999999999986421100   


Q ss_pred             -----------CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcc
Q psy13735        165 -----------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC  233 (792)
Q Consensus       165 -----------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~  233 (792)
                                 ........|++.|+|||.+..       ..++.++|+|||||++|+|++|..||.+.+.......+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~-  230 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-  230 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Confidence                       001112357889999999853       3678999999999999999999999988877776666654 


Q ss_pred             cCCCCcCCCCC-ccccHHHHHHHHHHhh-ChhhcCC---hhHHhcCCCccCCCC
Q psy13735        234 DTEDTVSFPSS-IRLSTAMVNFVQSLVQ-KLDARLN---MDQVLGHPVFDCLDS  282 (792)
Q Consensus       234 ~~~~~l~fP~~-~~lS~elkdLIk~LL~-DP~kRPT---aeEIL~HPwF~~i~~  282 (792)
                         ....+|.. ..+++.+.+++.+|+. +|.+||+   +.+++.||||...+.
T Consensus       231 ---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         231 ---DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             ---cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence               22222221 2578999999999999 9999998   788999999987553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-39  Score=330.20  Aligned_cols=252  Identities=27%  Similarity=0.465  Sum_probs=211.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      .++|.+.+.||.|+||.||++.+..++..||+|.+......  ...|..+++.++||||+++++++.+...+|+++||++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            46899999999999999999999999999999998765422  2578899999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      |++|.+++... ...+++..+..++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++........ .....
T Consensus        82 ~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~  159 (256)
T cd06612          82 AGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTV  159 (256)
T ss_pred             CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccc
Confidence            99999998543 35689999999999999999999999999999999999999999999999999987654321 22334


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      .|++.|+|||++.+       ..++.++||||+||++|+|++|..||...+.......+...   ....+.....++..+
T Consensus       160 ~~~~~y~~PE~~~~-------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  229 (256)
T cd06612         160 IGTPFWMAPEVIQE-------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPTLSDPEKWSPEF  229 (256)
T ss_pred             cCCccccCHHHHhc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CCCCCCchhhcCHHH
Confidence            58999999999863       26788999999999999999999999866554433333221   111222223578899


Q ss_pred             HHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        252 VNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       252 kdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+|+..|+. +|.+|||+.+++.||||
T Consensus       230 ~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         230 NDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999 99999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-39  Score=335.77  Aligned_cols=260  Identities=22%  Similarity=0.405  Sum_probs=209.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhc-CCCCcceeEEEEE-----eCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKS-KCPYIVNLFYSFQ-----DMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL-~HPNIVkL~~vfe-----de~~   82 (792)
                      ...++|++.+.||+|+||.||+|.+..+|..+|+|++.......   ..|..++..+ +||||+++++++.     +...
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            35679999999999999999999999999999999876543221   4588888888 6999999999873     4567


Q ss_pred             EEEEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +|+||||++||+|.+++..  .....+++..+..++.||+.||.|||+++|+||||+|+||+++.++.++|+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            9999999999999998753  23356899999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .... .......|++.|+|||++...  ......++.++||||+||++|+|++|..||...........+...   ....
T Consensus       175 ~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~  248 (286)
T cd06638         175 TSTR-LRRNTSVGTPFWMAPEVIACE--QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---PPPT  248 (286)
T ss_pred             ccCC-CccccccCCCcccChhhhchh--hhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---CCCc
Confidence            4322 222344699999999998532  112345788999999999999999999999766543333332221   1111


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ......++..+.+++.+|+. ||.+||++.+++.||||
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            11222467899999999999 99999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-39  Score=339.16  Aligned_cols=260  Identities=24%  Similarity=0.379  Sum_probs=212.3

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---h------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---N------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +|.+.+.||.|+||.||++.+..+|+.||+|.+......   .      ..|+.++..++||||+++++++.+...+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            488999999999999999999999999999999766543   1      4688899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||+ +|+|.+++.+.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.+|.++|+|||++........ 
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-  157 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence            9999 999999995532 3699999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------CC---
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------TE---  236 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------~~---  236 (792)
                      ......+++.|+|||.+..      ...++.++|+|||||++|+|++|.+||.+.+....+..+....       +.   
T Consensus       158 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFG------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             cccccccceeeeCHHHHhC------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            1223357889999999852      2357889999999999999999998887766544444332210       00   


Q ss_pred             ---CC------cCCC---CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        237 ---DT------VSFP---SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       237 ---~~------l~fP---~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                         ..      ...+   .....+..+.+||.+||. +|.+|||+.+++.||||.+...++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence               00      0000   012457899999999999 999999999999999999765443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2e-39  Score=332.08  Aligned_cols=251  Identities=25%  Similarity=0.442  Sum_probs=206.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----h-----HHHHHHHHhcCCCCcceeEEEEEeC--CEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----N-----TIERDIMVKSKCPYIVNLFYSFQDM--NHV   83 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----~-----~~E~eIL~kL~HPNIVkL~~vfede--~~l   83 (792)
                      .+|.+.+.||+|+||.||.+.+..+|..||+|.+......    .     ..|+.+++.+.||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5899999999999999999999999999999988643211    1     4588999999999999999998764  578


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||++||+|.+++.+.  +.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            9999999999999998653  45899999999999999999999999999999999999999999999999998765421


Q ss_pred             CC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        164 GR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       164 ~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ..  .......|+..|+|||.+..       ..++.++|+|||||++|+|++|..||...+.......+...  ......
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~  230 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVL  230 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--CCCCCC
Confidence            11  11223458999999999853       35788999999999999999999999766544444433321  111223


Q ss_pred             CCCccccHHHHHHHHHHhhChhhcCChhHHhcCCCcc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~DP~kRPTaeEIL~HPwF~  278 (792)
                      |.  .++..+.+++.+|+.+|.+||++.+++.|||+.
T Consensus       231 ~~--~~~~~~~~~i~~~l~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         231 PP--HVSDHCRDFLKRIFVEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ch--hhCHHHHHHHHHHhcChhhCCCHHHHhcCcccC
Confidence            33  578899999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0192|consensus

Probab=100.00  E-value=5.2e-40  Score=360.80  Aligned_cols=250  Identities=23%  Similarity=0.413  Sum_probs=208.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC-EEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN-HVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~-~ly   84 (792)
                      +...+..+.+.||+|+||+||++..+.+ ..+|+|++.......      ..|+.+|.+++|||||.++|++.+.. .++
T Consensus        38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   38 IDPDELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             cChHHhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            3445666777899999999999988744 239999998765432      67999999999999999999999888 799


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCceEeCCCC-ceEEeccCccccccc
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG-YVHRDIKPDNMLLSATG-HLKLTDFGSATQVDK  162 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g-IVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~  162 (792)
                      |||||+++|+|..++.....+.++...+..++.+|+.||.|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            9999999999999997644577999999999999999999999999 99999999999999998 999999999987654


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      .. .......||+.|||||++...     ...|+.++||||||+++|+|+||..||...........+..  ....+.+|
T Consensus       197 ~~-~~~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~--~~~Rp~~p  268 (362)
T KOG0192|consen  197 SK-TSMTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV--GGLRPPIP  268 (362)
T ss_pred             cc-ccccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--cCCCCCCC
Confidence            32 222235699999999999731     34799999999999999999999999988877555555543  11223333


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      .  ..++.+..++..|+. ||..||+..+++
T Consensus       269 ~--~~~~~l~~l~~~CW~~dp~~RP~f~ei~  297 (362)
T KOG0192|consen  269 K--ECPPHLSSLMERCWLVDPSRRPSFLEIV  297 (362)
T ss_pred             c--cCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence            3  478999999999999 999999999884

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.7e-39  Score=333.42  Aligned_cols=251  Identities=26%  Similarity=0.446  Sum_probs=205.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---------hHHHHHHHHhcCCCCcceeEEEEEe--CCEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---------NTIERDIMVKSKCPYIVNLFYSFQD--MNHV   83 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---------~~~E~eIL~kL~HPNIVkL~~vfed--e~~l   83 (792)
                      .+|.+.+.||+|+||.||++.+..+|..||+|.+......         ...|+.+++.++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4799999999999999999999999999999998654321         1458889999999999999999876  3678


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      +++|||++|++|.+++.+  .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus        82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            999999999999999954  345899999999999999999999999999999999999999999999999998765321


Q ss_pred             CC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        164 GR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       164 ~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ..  .......|+..|+|||.+..       ..++.++|+||+||++|+|++|..||...+.......+..  ......+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~  230 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG-------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNPQL  230 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC-------CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc--CCCCCCC
Confidence            11  11122458899999999863       3578899999999999999999999976654443333322  1122333


Q ss_pred             CCCccccHHHHHHHHHHhhChhhcCChhHHhcCCCcc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~DP~kRPTaeEIL~HPwF~  278 (792)
                      |.  .+++.+.+++.+|+.+|.+||++.+++.||||+
T Consensus       231 ~~--~~~~~~~~li~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         231 PS--HISEHARDFLGCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ch--hcCHHHHHHHHHhcCChhhCcCHHHHhcCcccc
Confidence            43  568899999955444999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=335.93  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=204.3

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..++|.+.+.||.|+||.||++.++.+|..||+|.+......     ...|+.+++.++||||+++++++.+....|+||
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            467899999999999999999999999999999998654322     256999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||+. ++|.+++.+.. +.+++..++.++.||+.||.|||++||+||||+|+||+++.+|.++|+|||++........ .
T Consensus        83 e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~  159 (291)
T cd07844          83 EYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T  159 (291)
T ss_pred             ecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence            9997 48999886543 4689999999999999999999999999999999999999999999999999876432211 1


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-hhhhhhhhhccc-------C----
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACD-------T----  235 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-~~el~ekIl~~~-------~----  235 (792)
                      .....+++.|+|||++.+      ...++.++||||+||++|+|++|.+||.... .......+....       +    
T Consensus       160 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLG------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             ccccccccccCCcHHhhc------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            122347889999999852      2357889999999999999999999997554 222221111100       0    


Q ss_pred             ----CCCcCCC----C-----Ccccc--HHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        236 ----EDTVSFP----S-----SIRLS--TAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       236 ----~~~l~fP----~-----~~~lS--~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                          .....++    .     ...++  ..+.+++.+||+ +|.+|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                0000000    0     01234  889999999999 99999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.3e-40  Score=331.23  Aligned_cols=246  Identities=38%  Similarity=0.752  Sum_probs=210.7

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ||.|+||.||+|.+..+|+.+|+|.+.......       ..|..++..++||||+++++.+.....+|+||||++|++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            699999999999999999999999997665421       5678899999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-------ccc
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-------IKS  168 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-------~~s  168 (792)
                      .+++.+.  +.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........       ...
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence            9999653  3689999999999999999999999999999999999999999999999999876543211       122


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....+++.|+|||.+..       ..++.++|+||||+++|+|++|..||...+.......+..    ....+|....++
T Consensus       159 ~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~  227 (265)
T cd05579         159 KRIVGTPDYIAPEVILG-------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN----GKIEWPEDVEVS  227 (265)
T ss_pred             cCcccCccccCHHHhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----CCcCCCccccCC
Confidence            33468899999999863       2478899999999999999999999988877777666654    334455544468


Q ss_pred             HHHHHHHHHHhh-ChhhcCCh---hHHhcCCCccCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNM---DQVLGHPVFDCLD  281 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTa---eEIL~HPwF~~i~  281 (792)
                      +.+.+|+.+|++ +|.+|||+   .+++.||||.+++
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            999999999999 99999999   9999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-39  Score=332.38  Aligned_cols=244  Identities=36%  Similarity=0.688  Sum_probs=208.9

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ||.|+||.||+|.+..+++.||+|.+.+.....       ..|+.+++.++||||+++++++.+...+|+||||++||+|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999999999999999997654331       4688899999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP  175 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp  175 (792)
                      .+++.+  ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......  ......|++
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~  156 (262)
T cd05572          81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP  156 (262)
T ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence            999954  3458999999999999999999999999999999999999999999999999998765432  223446899


Q ss_pred             CccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC--hhhhhhhhhcccCCCCcCCCCCccccHHHHH
Q psy13735        176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET--LDMTYSSILACDTEDTVSFPSSIRLSTAMVN  253 (792)
Q Consensus       176 ~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d--~~el~ekIl~~~~~~~l~fP~~~~lS~elkd  253 (792)
                      .|+|||.+..       ..++.++|+||+||++|+|++|..||....  ....+..+..  ......+|.  ..++.+.+
T Consensus       157 ~~~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~  225 (262)
T cd05572         157 EYVAPEIILN-------KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--GNGKLEFPN--YIDKAAKD  225 (262)
T ss_pred             CccChhHhcC-------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--cCCCCCCCc--ccCHHHHH
Confidence            9999999852       357889999999999999999999998766  4455555543  123344554  45899999


Q ss_pred             HHHHHhh-ChhhcCC-----hhHHhcCCCccCCC
Q psy13735        254 FVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD  281 (792)
Q Consensus       254 LIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~  281 (792)
                      ++.+|+. +|.+||+     +.++++||||.+++
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence            9999999 9999999     99999999998654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-39  Score=336.83  Aligned_cols=243  Identities=32%  Similarity=0.598  Sum_probs=200.0

Q ss_pred             EeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHH---HHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         22 FIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERD---IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        22 ~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~e---IL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      .||+|+||.||++.+..+|+.||+|.+.+.....       ..|..   ++....||||+.++++|.+.+.+|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999999999999999987654321       22333   3344579999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      ||+|..++.+  .+.+++..++.++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++..+....   ....
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~  155 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS  155 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence            9999998854  4569999999999999999999999999999999999999999999999999987654322   2234


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh---hhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL---DMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~---~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      +|++.|+|||.+..      ...++.++||||+||++|+|++|..||.....   ......+..    ....+|.  .+|
T Consensus       156 ~~~~~y~aPE~~~~------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~--~~s  223 (278)
T cd05606         156 VGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MAVELPD--SFS  223 (278)
T ss_pred             CCCcCCcCcHHhcC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----cCCCCCC--cCC
Confidence            69999999999852      23578899999999999999999999976532   222222211    2233443  568


Q ss_pred             HHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      ..+.+++.+||. +|.+||     ++.+++.||||...+
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            999999999999 999999     999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=328.17  Aligned_cols=256  Identities=27%  Similarity=0.470  Sum_probs=211.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      .++|.+.+.||.|+||.||+|.+..++..+|+|.+.......    ..|..+++.++||||+++++++.+...+|++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            468999999999999999999999999999999987654322    5688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++|++|.+++... ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........ ...
T Consensus        82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  159 (262)
T cd06613          82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRK  159 (262)
T ss_pred             CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccc
Confidence            9999999998653 25699999999999999999999999999999999999999999999999999987653221 223


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|++.|+|||.+...    ....++.++|+|||||++|+|++|.+||...+.......+...... .........++.
T Consensus       160 ~~~~~~~y~~Pe~~~~~----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (262)
T cd06613         160 SFIGTPYWMAPEVAAVE----RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-PPKLKDKEKWSP  234 (262)
T ss_pred             cccCCccccCchhhccc----ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CccccchhhhhH
Confidence            34689999999998521    1136788999999999999999999999876654444333321100 111111235678


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCC
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPV  276 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPw  276 (792)
                      .+.+|+.+|+. +|..||++.+++.|||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999 9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.7e-40  Score=335.03  Aligned_cols=248  Identities=34%  Similarity=0.686  Sum_probs=214.1

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~-HPNIVkL~~vfede~~lyLV   86 (792)
                      ++|.+.+.||+|+||.||++....+|..||+|++.+.....       ..|..++.++. ||||++++++|.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            57999999999999999999999999999999987644321       46788899998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-  165 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-  165 (792)
                      |||+.|++|.+++.+  .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.+|+++|+|||++........ 
T Consensus        81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999999999955  34699999999999999999999999999999999999999999999999999887653321 


Q ss_pred             ------------------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhh
Q psy13735        166 ------------------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTY  227 (792)
Q Consensus       166 ------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~  227 (792)
                                        .......|++.|+|||++..       ..++.++|+|||||++++|++|..||...+....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  231 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-------KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF  231 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCC-------CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence                              12223467899999998863       35788999999999999999999999887766666


Q ss_pred             hhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCCh----hHHhcCCCc
Q psy13735        228 SSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNM----DQVLGHPVF  277 (792)
Q Consensus       228 ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTa----eEIL~HPwF  277 (792)
                      ..+..    ....+|.  .+++.+.+|+..||+ +|.+||++    .++++||||
T Consensus       232 ~~~~~----~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         232 QKILK----LEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHh----cCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            66554    3334444  668999999999999 99999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.2e-39  Score=332.51  Aligned_cols=257  Identities=23%  Similarity=0.430  Sum_probs=205.1

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHH-HHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDI-MVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eI-L~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++|.+.+.||+|+||.||++.++.+|..||+|.+.......     ..|..+ ++.++||||+++++++...+.+|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            58999999999999999999999999999999987654332     234443 566789999999999999999999999


Q ss_pred             ccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         89 YVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        89 y~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |++ |+|.+++...  ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            996 6787777532  235689999999999999999999997 99999999999999999999999999988664321 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-hhhhhhhhhcccCCCCcCCCCC
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-~~el~ekIl~~~~~~~l~fP~~  244 (792)
                       ......|++.|+|||.+...   .....++.++|+||+||++|+|++|..||.... .......+..   .....+|. 
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~---~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~-  230 (283)
T cd06617         159 -AKTIDAGCKPYMAPERINPE---LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EPSPQLPA-  230 (283)
T ss_pred             -ccccccCCccccChhhcCCc---ccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh---cCCCCCCc-
Confidence             11234689999999988531   112457889999999999999999999996422 1122222221   12222332 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ..+|.++.+||.+||. +|.+||++.+++.||||....
T Consensus       231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            2578999999999999 999999999999999998643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.6e-40  Score=338.03  Aligned_cols=254  Identities=26%  Similarity=0.443  Sum_probs=207.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+.....      ..|..+++.++||||++++++|.+...+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47999999999999999999999999999999886544322      468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+++++|..+...  .+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~  157 (286)
T cd07846          81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY  157 (286)
T ss_pred             cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence            9999998887743  3458999999999999999999999999999999999999999999999999998765432 222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC------------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE------------  236 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~------------  236 (792)
                      ....|++.|+|||++.+      ...++.++|||||||++|+|++|.+||...+.......+..+...            
T Consensus       158 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         158 TDYVATRWYRAPELLVG------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CcccceeeccCcHHhcc------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            33468899999999852      235778899999999999999999999766543332222210000            


Q ss_pred             ---CCcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        237 ---DTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       237 ---~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                         .....|.          ...++..+.+|+.+|+. +|.+||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence               0000110          12568899999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-39  Score=336.83  Aligned_cols=254  Identities=25%  Similarity=0.428  Sum_probs=207.1

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|++++.||.|+||.||+|.+..+|..||+|.+......      ...|+.++++++||||+++++++.+.+.+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            589999999999999999999999999999988654322      15689999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      +. ++|..++.....+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~  158 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYT  158 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccc
Confidence            95 6899888665566799999999999999999999999999999999999999999999999999876543221 122


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-C-----------
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-D-----------  237 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-~-----------  237 (792)
                      ...+++.|+|||++.+      ...++.++|||||||++|+|++|..||...+.......+...... .           
T Consensus       159 ~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         159 HEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             cccccccccCCeEEec------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence            3357899999998752      234678899999999999999999999776554333322210000 0           


Q ss_pred             --CcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        238 --TVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       238 --~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                        ...++.         ...+++.+.++|.+|+. ||.+|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              001111         12467899999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-39  Score=331.54  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=207.8

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----------~~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      +|++.+.||+|+||.||++.+..+|..||+|.+......          ...|+.+++.++||||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588999999999999999999999999999998754421          1468889999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNG  164 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~  164 (792)
                      ||||++|++|.+++.+  .+.+++..+..++.||+.||.|||++|++|+||+|.||+++.++ .++|+|||++.......
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            9999999999999965  34689999999999999999999999999999999999998776 59999999998765331


Q ss_pred             C---cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-CCCCcC
Q psy13735        165 R---IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-TEDTVS  240 (792)
Q Consensus       165 ~---~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-~~~~l~  240 (792)
                      .   .......|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...........+.... ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRG-------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS  231 (268)
T ss_pred             ccCCccccccccccceeCHhHhcc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC
Confidence            1   11123468899999999853       357889999999999999999999997554433333332210 111223


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      +|.  .+++.+.+++.+|+. +|.+||++.+++.||||+
T Consensus       232 ~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         232 IPE--HLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             Cch--hhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            333  678999999999999 999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-39  Score=330.63  Aligned_cols=249  Identities=29%  Similarity=0.417  Sum_probs=204.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----------~~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      +|.+.+.||.|+||.||++.. .+|..+|+|.+......          ...|+++++.++||||+++++++.+...+|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999976 47889999988654321          1458889999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC-
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-  164 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~-  164 (792)
                      ||||++||+|.+++.+  .+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            9999999999999954  3458999999999999999999999999999999999999999999999999987653211 


Q ss_pred             ----CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        165 ----RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       165 ----~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                          ........|++.|+|||.+..       ..++.++|+|||||++|+|++|..||...+.......+... ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~  229 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINE-------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RGLMPR  229 (265)
T ss_pred             cccccccccccCCCccccChhhhcC-------CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cCCCCC
Confidence                111223468999999999863       35788999999999999999999999765543333333221 011112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+  ..++..+.+||.+|+. +|.+||++.+++.||||
T Consensus       230 ~~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         230 LP--DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CC--CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            33  3678999999999999 99999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-39  Score=335.74  Aligned_cols=247  Identities=28%  Similarity=0.528  Sum_probs=201.7

Q ss_pred             CCceEEeEe--eecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         15 SDFDIKRFI--QQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        15 ~dY~I~k~I--GsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      ++|.+.+.+  |.|+||.||+|.++.+|..||+|.+...... ..|..+...+ +||||+++++.|...+.+|+||||++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~   92 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK   92 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence            467777776  9999999999999999999999998765433 2234333333 69999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCCCccccc
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      ||+|.+++...  +.+++..+..++.||+.||.|||+.||+||||+|+||+++.++ .++|+|||++......     ..
T Consensus        93 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~  165 (267)
T PHA03390         93 DGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SC  165 (267)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----cc
Confidence            99999999653  3699999999999999999999999999999999999999988 9999999998766432     23


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhh-hhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTY-SSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~-ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ..|++.|+|||++..       ..++.++||||+||++|+|++|..||......... ..+... .......+  ..+|+
T Consensus       166 ~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~  235 (267)
T PHA03390        166 YDGTLDYFSPEKIKG-------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-QQKKLPFI--KNVSK  235 (267)
T ss_pred             CCCCCcccChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-hcccCCcc--cccCH
Confidence            358999999999863       36788999999999999999999999755433221 112111 11222233  26899


Q ss_pred             HHHHHHHHHhh-ChhhcCC-hhHHhcCCCccC
Q psy13735        250 AMVNFVQSLVQ-KLDARLN-MDQVLGHPVFDC  279 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPT-aeEIL~HPwF~~  279 (792)
                      .+.+||.+||+ +|.+||+ ++++|.||||.+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999 9999996 699999999973

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.6e-39  Score=335.69  Aligned_cols=261  Identities=24%  Similarity=0.377  Sum_probs=209.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +++|.+.+.||.|+||.||++.++.+|+.||+|.+......      ...|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            36899999999999999999999999999999998654332      156889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEeccCcccccccCCCc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||++ ++|..++.......+++..+..++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++........ 
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-  158 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-  158 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence            9995 57888875544444788999999999999999999999999999999999985 45799999999976543211 


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC---------
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED---------  237 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~---------  237 (792)
                      ......|++.|+|||.+..      ...++.++||||+||++|+|++|.+||...+.......+.......         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT  232 (294)
T ss_pred             ccccCceeecccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence            1223457899999998852      2357889999999999999999999998766544443332210000         


Q ss_pred             --------CcCCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        238 --------TVSFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       238 --------~l~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                              ...++.      ...+++.+.+++.+||+ +|.+||++.+++.||||..++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                    000000      12468899999999999 9999999999999999997654

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.4e-39  Score=334.78  Aligned_cols=256  Identities=24%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcC-CCCcceeEEEEEeCCE-----
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSK-CPYIVNLFYSFQDMNH-----   82 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~-HPNIVkL~~vfede~~-----   82 (792)
                      ++|++.+.||.|+||.||++.+..+|+.||+|.+......      ...|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999999999999999988654322      156889999995 6999999999987665     


Q ss_pred             EEEEEeccCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEeccCccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQP---HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSAT  158 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~---~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~  158 (792)
                      +|+||||+++ +|.+++....   ...+++..+..++.||+.||.|||++||+||||+|+||+++. ++.++|+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8999999975 7888875432   245899999999999999999999999999999999999998 8899999999988


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC-CC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT-ED  237 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~-~~  237 (792)
                      .+..... ......+++.|+|||++..      ...++.++|||||||++|+|++|.+||.+.+.......+..... +.
T Consensus       160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  232 (295)
T cd07837         160 AFSIPVK-SYTHEIVTLWYRAPEVLLG------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT  232 (295)
T ss_pred             ecCCCcc-ccCCcccccCCCChHHhhC------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            6543211 1223357899999999852      23578899999999999999999999987665444433322100 00


Q ss_pred             C------------cCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        238 T------------VSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       238 ~------------l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      .            ..++.         ...+++.+.+||.+||. +|.+||++.+++.||||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            0            00111         12478999999999999 999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-38  Score=380.54  Aligned_cols=263  Identities=26%  Similarity=0.450  Sum_probs=214.0

Q ss_pred             HhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe-
Q psy13735          7 LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD-   79 (792)
Q Consensus         7 L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed-   79 (792)
                      +.......++|.+++.||.|+||.||+|.+..++..||+|++.......      ..|+.++..++|||||+++++|.+ 
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            3445667889999999999999999999999999999999987654432      468999999999999999999865 


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCccCCCCCCceEeCC----
Q psy13735         80 -MNHVYFIMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGL-------GYVHRDIKPDNMLLSA----  145 (792)
Q Consensus        80 -e~~lyLVmEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~-------gIVHRDLKPeNILLd~----  145 (792)
                       ...+|||||||++|+|.++|...  ..+.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.    
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             45799999999999999998642  235699999999999999999999984       4999999999999954    


Q ss_pred             -------------CCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhh
Q psy13735        146 -------------TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL  212 (792)
Q Consensus       146 -------------dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELL  212 (792)
                                   .+.+||+|||++..+....  .....+||+.|+|||++...     ...++.++||||||||+|+|+
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge-----~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHE-----TKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhcc-----CCCCCchhHHHHHHHHHHHHH
Confidence                         2358999999998764332  22345799999999998532     235788999999999999999


Q ss_pred             cCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        213 TGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       213 TGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +|..||...+....+...+.    ....+|. ...+.++.+||..||. +|.+||++.++|.||||..+.
T Consensus       238 TGk~PF~~~~~~~qli~~lk----~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        238 SGKTPFHKANNFSQLISELK----RGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HCCCCCCcCCcHHHHHHHHh----cCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            99999976544333322222    1112221 2468999999999999 999999999999999998664

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=330.96  Aligned_cols=243  Identities=37%  Similarity=0.680  Sum_probs=203.1

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHH-HhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIM-VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL-~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||.|+||.||+|.+..+|+.||+|.+.+.....       ..|..++ ...+||||++++++|...+.+|+||||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999999999999999997654321       2343333 345899999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|.+++..  .+.+++..+..++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++.....     .....
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~  154 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV  154 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence            999999954  35689999999999999999999999999999999999999999999999999876432     22345


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC--CccccHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS--SIRLSTA  250 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~--~~~lS~e  250 (792)
                      |++.|+|||.+.+       ..++.++||||+|+++|+|++|.+||...+....+..+....    ..++.  ...+++.
T Consensus       155 ~~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  223 (260)
T cd05611         155 GTPDYLAPETILG-------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR----INWPEEVKEFCSPE  223 (260)
T ss_pred             CCcCccChhhhcC-------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc----cCCCCcccccCCHH
Confidence            8999999999863       247889999999999999999999998887777666665422    22221  1257899


Q ss_pred             HHHHHHHHhh-ChhhcCCh---hHHhcCCCccCCC
Q psy13735        251 MVNFVQSLVQ-KLDARLNM---DQVLGHPVFDCLD  281 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTa---eEIL~HPwF~~i~  281 (792)
                      +.+++.+||. +|.+||++   .+++.||||.++.
T Consensus       224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         224 AVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            9999999999 99999954   7999999998653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0579|consensus

Probab=100.00  E-value=2.5e-41  Score=377.09  Aligned_cols=260  Identities=23%  Similarity=0.407  Sum_probs=225.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      +.|.|+..||-|+||.||++.++.++-..|.|+|....-..    ..|++||..++||+||+|+++|--++.++|+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45789999999999999999999999899999886554332    67999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      .||-+..++-.- ...|.+..+..+++|++.||.|||+++|+|||||..|||++-+|.|+|+|||.+...... .....+
T Consensus       112 ~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDs  189 (1187)
T KOG0579|consen  112 GGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDS  189 (1187)
T ss_pred             CCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-Hhhhcc
Confidence            999998887553 345999999999999999999999999999999999999999999999999998765422 223345


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      +.|||+|||||++.+  ..+...+|+.++||||||+.+.+|..|.+|...-++...+-+|...   .++.+-.+..||..
T Consensus       190 FIGTPYWMAPEVvmC--ET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTLlqPS~Ws~~  264 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMC--ETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLLQPSHWSRS  264 (1187)
T ss_pred             ccCCcccccchheee--ccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCcccCcchhhhH
Confidence            679999999999974  4677889999999999999999999999999887777777777652   22233334489999


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +.||+..||. ||..||++.++|.||||.+++
T Consensus       265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            9999999999 999999999999999999765

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.5e-39  Score=330.99  Aligned_cols=253  Identities=25%  Similarity=0.436  Sum_probs=206.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--------------hHHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--------------NTIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--------------~~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      .|.+.+.||.|+||.||++....+|+.+|+|.+......              ...|..+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588899999999999999999999999999988542111              135788899999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+++||||++||+|.+++.+  .+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            99999999999999999954  3569999999999999999999999999999999999999999999999999997654


Q ss_pred             cCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        162 KNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       162 ~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .... .......|++.|+|||.+...     ...++.++|+||||+++|+|++|..||...+.......+...  .....
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~  232 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSY-----SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RSAPP  232 (272)
T ss_pred             ccccccccccccCCccccCHHHhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--ccCCc
Confidence            2211 112234689999999998632     124788999999999999999999999755443333332221  11222


Q ss_pred             CCCC--ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        241 FPSS--IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       241 fP~~--~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ++..  ..++..+.+++..|+. +|.+||++.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            2221  2568999999999999 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0667|consensus

Probab=100.00  E-value=2.8e-39  Score=366.15  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=214.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcC-C-----CCcceeEEEEEeCCEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSK-C-----PYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~-H-----PNIVkL~~vfede~~lyL   85 (792)
                      .+|.|.++||+|+||.|.+|.+..|++.||||+++......   .+|+.||..++ |     -|+|+++++|...+++||
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            37899999999999999999999999999999997665433   68999999987 4     489999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC--ceEEeccCcccccccC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG--HLKLTDFGSATQVDKN  163 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg--~VKLiDFGLA~~l~~~  163 (792)
                      |+|++ +-+|.++++.....+|+...++.++.||+.||.+||+.||||+|||||||||...+  .|||+|||+|+.....
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~  344 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR  344 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence            99999 67999999987777899999999999999999999999999999999999996544  5999999999987533


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc---------
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD---------  234 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~---------  234 (792)
                         . .+.+-+..|.|||++.+.       +|+.+.||||||||++||++|.+.|.+++..+.+..|....         
T Consensus       345 ---v-ytYiQSRfYRAPEVILGl-------pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  345 ---V-YTYIQSRFYRAPEVILGL-------PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ---c-eeeeeccccccchhhccC-------CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence               2 256688999999999854       89999999999999999999999999888766655554200         


Q ss_pred             ----------C-----------------------------CCCcCCC-CC--------ccccHHHHHHHHHHhh-Chhhc
Q psy13735        235 ----------T-----------------------------EDTVSFP-SS--------IRLSTAMVNFVQSLVQ-KLDAR  265 (792)
Q Consensus       235 ----------~-----------------------------~~~l~fP-~~--------~~lS~elkdLIk~LL~-DP~kR  265 (792)
                                .                             ......| ..        ..-...+.||+.+||. ||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                      0                             0011122 10        0123468999999999 99999


Q ss_pred             CChhHHhcCCCccCCC
Q psy13735        266 LNMDQVLGHPVFDCLD  281 (792)
Q Consensus       266 PTaeEIL~HPwF~~i~  281 (792)
                      +|+.++|+||||....
T Consensus       494 ~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTS  509 (586)
T ss_pred             CCHHHHhcCccccccc
Confidence            9999999999999654

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.3e-39  Score=325.80  Aligned_cols=254  Identities=29%  Similarity=0.485  Sum_probs=212.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||+|+||.||++....+++.||+|.+.......      ..|..+++.++||||+++++++.+.+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5899999999999999999999999999999987765531      5688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc-
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS-  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s-  168 (792)
                      ++|++|.+++..  .+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........... 
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            999999999954  44589999999999999999999999999999999999999999999999999987654332211 


Q ss_pred             --ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        169 --IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       169 --~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                        ....|++.|+|||.+...    ....++.++||||+||++|+|++|..||...+..........  ......+|....
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~----~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~  232 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGG----KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--AGHKPPIPDSLQ  232 (264)
T ss_pred             cccCCcCCcCccChhhccCC----CCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh--cCCCCCCCcccc
Confidence              134688999999998632    113478899999999999999999999975532222211111  123445566556


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +++.+.+|+..|++ +|.+||++.+++.|||+
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            79999999999999 99999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.6e-40  Score=343.21  Aligned_cols=255  Identities=26%  Similarity=0.437  Sum_probs=212.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      +.|.....||.|+||.||++.+..++..||+|.+.......    ..|..+++.++||||+++++.|...+..|+||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            45666788999999999999999999999999986543322    46888999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      +|++|.+++..   +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........ ....
T Consensus       102 ~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  177 (292)
T cd06658         102 EGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS  177 (292)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence            99999998843   3589999999999999999999999999999999999999999999999999876543221 2233


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      ..|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...+.......+...   ....++....++..
T Consensus       178 ~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  247 (292)
T cd06658         178 LVGTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN---LPPRVKDSHKVSSV  247 (292)
T ss_pred             eecCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---CCCccccccccCHH
Confidence            468999999999853       35788999999999999999999999877665554444321   11122233357889


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCC
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSD  283 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~  283 (792)
                      +.+|+..|+. +|.+|||+.+++.||||.....+
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            9999999999 99999999999999999975443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.7e-39  Score=330.35  Aligned_cols=251  Identities=20%  Similarity=0.340  Sum_probs=211.7

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++...+|.+.+.||.|+||.||+|..+.++..+|+|.+.......   ..|+.+++.++||||+++++++.....+++||
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            356678999999999999999999999999999999987654322   56889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||+++|+|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            99999999999966555568999999999999999999999999999999999999999999999999998765332211


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+++.|+|||.+.+       ..++.++|||||||++|+|++ |..||.+.+.......+...   ....+|  ..
T Consensus       162 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~  229 (263)
T cd05052         162 HAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERP--EG  229 (263)
T ss_pred             cCCCCCccccCCHHHhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CCCCCC--CC
Confidence            122234668999998863       367889999999999999998 99999887777666666441   122233  36


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++..+.+++.+|+. +|.+||++.+++.
T Consensus       230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         230 CPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            78999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=331.57  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=210.2

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcC---CCCcceeEEEEEeCCEEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSK---CPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~---HPNIVkL~~vfede~~lyLVm   87 (792)
                      .|++.+.||.|+||.||+|.+..+|..||+|.+.......     ..|+.+++.+.   |||+++++++|.+...+|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5888999999999999999999999999999987543322     45778888886   999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++|++|.+++..   +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .
T Consensus        82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06917          82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-K  157 (277)
T ss_pred             ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-c
Confidence            99999999999844   3589999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      .....|++.|+|||.+..      ...++.++|+|||||++|+|++|..||...+.......+...   ....++. ..+
T Consensus       158 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~-~~~  227 (277)
T cd06917         158 RSTFVGTPYWMAPEVITE------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---KPPRLED-NGY  227 (277)
T ss_pred             cccccCCcceeCHHHhcc------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---CCCCCCc-ccC
Confidence            233469999999999852      235788999999999999999999999876654443333221   1112222 236


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +..+.+|+..|+. ||.+||++.+++.||||+...
T Consensus       228 ~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         228 SKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            8899999999999 999999999999999998654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=332.72  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=206.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+......      ...|+.+++.+.||||++++++|.+.+.+|+|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            4799999999999999999999999999999988654322      1578899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++++.+..+..+  ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            9988777666533  34589999999999999999999999999999999999999999999999999987765433233


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc--------------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD--------------  234 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~--------------  234 (792)
                      ....|++.|+|||++..      ...++.++|+||+||++|+|++|.+||.+.+.......+....              
T Consensus       159 ~~~~~~~~~~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         159 TDYVATRWYRAPELLVG------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             cCcccccCCcCCchhcC------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            34568999999999863      2367889999999999999999999997655433222211100              


Q ss_pred             C-CCCcCCCC-----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        235 T-EDTVSFPS-----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       235 ~-~~~l~fP~-----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      . .....++.           ...+++.+.+||++||. +|.+||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0 00000100           11348899999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.7e-39  Score=332.06  Aligned_cols=249  Identities=17%  Similarity=0.309  Sum_probs=205.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      +...+|++.+.||+|+||.||++.++   ..+..+|+|.+.......     ..|..++..++||||+++++++...+.+
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            45678999999999999999999875   456789999987653322     4588889999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||++||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||.+......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999999653 356899999999999999999999999999999999999999999999999987654322


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      .........+++.|+|||.+..       ..++.++||||+||++|+|++ |..||...+.......+...     ...|
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~  228 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-----FRLP  228 (266)
T ss_pred             chhcccCCCCceeecCHHHHhh-------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-----CCCC
Confidence            2111222235678999999863       368899999999999999775 99999887776666655431     1223


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ....++..+.+++..|+. +|.+||++.+++.
T Consensus       229 ~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         229 APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            334678999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.6e-39  Score=324.93  Aligned_cols=249  Identities=30%  Similarity=0.491  Sum_probs=211.2

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe--CCEEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD--MNHVYFIM   87 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed--e~~lyLVm   87 (792)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+.......      ..|+.+++.++||||+++++++..  ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999987655433      357889999999999999998754  45789999


Q ss_pred             eccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         88 EYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLH-----GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLH-----s~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ||+++++|.+++.+.  ....+++..+..++.||+.||.|||     +.+|+|+||+|+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998642  2456899999999999999999999     999999999999999999999999999999877


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..... ......|++.|+|||.+..       ..++.++|+||||+++|+|++|..||...+.......+....   ...
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~  229 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNH-------MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK---FRR  229 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcC-------CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC---CCC
Confidence            64332 1233469999999999863       357889999999999999999999998877666665554421   122


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +|.  .++..+.+++..|+. +|.+||++.+++.|||+
T Consensus       230 ~~~--~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         230 IPY--RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             Ccc--ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            333  678999999999999 99999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.7e-39  Score=325.43  Aligned_cols=249  Identities=31%  Similarity=0.525  Sum_probs=211.1

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||.|+||.||++..+.+|..+|+|.+.......      ..|+.+++.++||||+++++.+.+...+|+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5899999999999999999999999999999987643221      4788999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc-eEEeccCcccccccCCCccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH-LKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~-VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ++|++|.+++.+.....+++..+..++.||+.||.|||+++|+|+||+|.||+++.++. ++|+|||.+........ ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-cc
Confidence            99999999997655556899999999999999999999999999999999999988864 69999999987654322 22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....|++.|+|||++..       ..++.++|+||+||++|+|++|..||...+.......+...    .. .+....++
T Consensus       160 ~~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~-~~~~~~~~  227 (257)
T cd08225         160 YTCVGTPYYLSPEICQN-------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG----YF-APISPNFS  227 (257)
T ss_pred             cccCCCccccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc----cC-CCCCCCCC
Confidence            33468999999998852       35788999999999999999999999877665555544431    11 11123568


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ..+.+++.+|+. +|.+|||+.+++.||||
T Consensus       228 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         228 RDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            899999999999 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.5e-39  Score=333.82  Aligned_cols=252  Identities=19%  Similarity=0.323  Sum_probs=210.2

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCC-----cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSH-----NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tG-----k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      ++..++|++.+.||.|+||.||++.....+     ..+|+|.+.......     ..|+.++..++||||+++++++.+.
T Consensus         1 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             CCChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            356789999999999999999999987665     689999886544322     4688899999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPH--------------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT  146 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~--------------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d  146 (792)
                      ...|++|||+++|+|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            999999999999999999965321              458899999999999999999999999999999999999999


Q ss_pred             CceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChh
Q psy13735        147 GHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLD  224 (792)
Q Consensus       147 g~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~  224 (792)
                      +.++|+|||++........ .......+++.|+|||.+..       ..++.++|||||||++|+|++ |..||.+.+..
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-------GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-------CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999976543221 12233457889999998853       368889999999999999998 99999888877


Q ss_pred             hhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        225 MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       225 el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .....+....   ....|  ..+++.+.+++.+|+. +|.+||++.+++.|
T Consensus       234 ~~~~~i~~~~---~~~~~--~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQ---LLPCP--EDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCC---cCCCc--ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7776665421   11222  3678999999999999 99999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-39  Score=324.06  Aligned_cols=248  Identities=28%  Similarity=0.455  Sum_probs=207.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +|++.+.||+|+||.||++....+|..||+|.+......         ...|..+++.++||||+++++++.+...+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            478889999999999999999989999999998765421         14688899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||++|++|.+++.+  .+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......  
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            999999999999954  3458999999999999999999999999999999999999999999999999988765332  


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      ......|++.|+|||.+...      ..++.++|+||+||++|+|++|..||...........+..  ......+|.  .
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~------~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~--~  226 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQ------GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPPIPD--H  226 (258)
T ss_pred             cccccCCCcceeCHHHhcCC------CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCCcCC--C
Confidence            22344689999999998532      1378899999999999999999999976554333333322  111222333  5


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +++.+.+|+.+|+. +|.+||++.+++.|||+
T Consensus       227 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         227 LSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            78999999999999 99999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.9e-39  Score=327.93  Aligned_cols=249  Identities=20%  Similarity=0.381  Sum_probs=208.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|++++.||+|+||.||++... ++..||+|.+.......   ..|..+++.++||||+++++++.+.+..|+|||
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            56789999999999999999999865 55779999876544332   568899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.......++...+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence            99999999999765566789999999999999999999999999999999999999999999999999987653322222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....++..|+|||.+..       ..++.++|||||||++|+|++ |..||...+.......+...     ..+|....+
T Consensus       162 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~  229 (261)
T cd05072         162 EGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-----YRMPRMENC  229 (261)
T ss_pred             CCCccceecCCHHHhcc-------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCC
Confidence            22345678999999863       357889999999999999998 99999877766666665431     223334467


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +..+.+++.+|+. +|.+||++++++.
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            8999999999999 9999999999854

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-39  Score=331.24  Aligned_cols=251  Identities=28%  Similarity=0.462  Sum_probs=210.2

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|++.+.||.|+||.||+|.++.+++.+|+|.+.......     ..|+++++.+.||||+++++++.....+|+||||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47889999999999999999999999999999987764332     4688889999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ++|++|.+++.... ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---  156 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---  156 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence            99999999996543 568999999999999999999999 9999999999999999999999999999876643221   


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-----hhhhhhhhhcccCCCCcCCCC
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-----LDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-----~~el~ekIl~~~~~~~l~fP~  243 (792)
                      ....|++.|+|||.+.+       ..++.++||||+||++|+|++|..||...+     .......+..   ......+.
T Consensus       157 ~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  226 (265)
T cd06605         157 KTFVGTSSYMAPERIQG-------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPRLPS  226 (265)
T ss_pred             hcccCChhccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCCCCh
Confidence            12568999999999863       368889999999999999999999996542     2222222322   11222232


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      . .+++.+.++|..|+. +|.+||++.+++.||||+..
T Consensus       227 ~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         227 G-KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             h-hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            1 278999999999999 99999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0586|consensus

Probab=100.00  E-value=9.4e-40  Score=367.47  Aligned_cols=254  Identities=29%  Similarity=0.445  Sum_probs=230.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      .....|.+.+.||+|.|+.|.++++..||..||||.|.+.....      ..|++||..++|||||+++.+.+....+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            45678999999999999999999999999999999999887654      579999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||||+.||++++++.  .++++.+..++.++.|+++|++|||+++|+|||||++||||+.+.++||+|||++..+.... 
T Consensus       133 V~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-  209 (596)
T KOG0586|consen  133 VMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-  209 (596)
T ss_pred             EEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc-
Confidence            999999999999995  46778889999999999999999999999999999999999999999999999999987443 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                       ...+.||+|.|.|||++.+.      ...++.+|+||+|+++|.|++|.+||++.+........+.    +.+..|.  
T Consensus       210 -~lqt~cgsppyAaPEl~~g~------~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----gk~rIp~--  276 (596)
T KOG0586|consen  210 -MLQTFCGSPPYAAPELFNGK------KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----GKYRIPF--  276 (596)
T ss_pred             -cccccCCCCCccChHhhcCc------ccCCcceehhhhhhhheeeeecccccCCcccccccchhee----eeecccc--
Confidence             44567899999999999754      4568899999999999999999999999988888777766    5555555  


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .+|.++.++|+++|. +|.+|++++++..|+|.....
T Consensus       277 ~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  277 YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             eeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence            679999999999999 999999999999999997544

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.8e-39  Score=325.41  Aligned_cols=251  Identities=25%  Similarity=0.484  Sum_probs=212.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|.+.+.||.|+||.||+|.+..+|+.||+|.+.......     ..|..++..++||||+++++++.....+|+||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            47999999999999999999999999999999988765421     5678889999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ++|++|.+++.+.  +.+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~  157 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QC  157 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-cc
Confidence            9999999999653  568999999999999999999999 9999999999999999999999999999987653322 22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC---hhhhhhhhhcccCCCCcCCCCCc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET---LDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d---~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                      ....|++.|+|||.+..       ..++.++|+||||+++|+|++|..||....   .......+..   ......+.  
T Consensus       158 ~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~--  225 (264)
T cd06623         158 NTFVGTVTYMSPERIQG-------ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPPSLPA--  225 (264)
T ss_pred             cceeecccccCHhhhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCCCCCc--
Confidence            23458899999999853       367889999999999999999999997663   3333333332   11122222  


Q ss_pred             c-ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        246 R-LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       246 ~-lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      . ++..+.+++..|+. +|..||++.+++.||||+..
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         226 EEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            3 78999999999999 99999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.6e-39  Score=332.74  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=201.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ..+|.+.+.||+|+||.||+|.+..+|..||+|.+.......     ..|+.+++.++||||+++++++.+....|+|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            468999999999999999999999999999999986543221     568899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+. +++.+.+... .+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........ ..
T Consensus        84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~  160 (291)
T cd07870          84 YMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TY  160 (291)
T ss_pred             ccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CC
Confidence            995 6777766443 34588899999999999999999999999999999999999999999999999876543221 12


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-hhhhhhhccc-------------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-MTYSSILACD-------------  234 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-el~ekIl~~~-------------  234 (792)
                      ....+++.|+|||.+..      ...++.++|||||||++|+|++|..||...+.. .....+....             
T Consensus       161 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         161 SSEVVTLWYRPPDVLLG------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCccccccccCCceeec------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            33458999999998852      235778899999999999999999999754431 1111111000             


Q ss_pred             ---CCCC---cCCC-------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        235 ---TEDT---VSFP-------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       235 ---~~~~---l~fP-------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                         ....   ...+       .....++.+.+++.+|+. ||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence               0000   0000       011236789999999999 99999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.8e-39  Score=333.13  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=203.1

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC-----
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN-----   81 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~-----   81 (792)
                      ..++|.+.+.||.|+||.||+|.+..+|+.||+|.+.......      ..|+.++++++||||+++++++.+..     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            4568999999999999999999999999999999886543221      46889999999999999999987653     


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         82 ---HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        82 ---~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                         .+|+||||+. ++|.+.+... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence               4699999995 5888887543 3468999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC
Q psy13735        159 QVDKNGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       159 ~l~~~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~  235 (792)
                      ........   ......+++.|+|||.+.+      ...++.++||||+||++|+|++|.+||.+.+.......+.....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcC------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            66432211   1123457889999998853      23467899999999999999999999987765443332222100


Q ss_pred             C---------------CCcCCCC-----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        236 E---------------DTVSFPS-----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       236 ~---------------~~l~fP~-----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .               ....+|.           ....+..+.+||.+||. ||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            0               0001111           01235778899999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.2e-39  Score=332.78  Aligned_cols=257  Identities=29%  Similarity=0.579  Sum_probs=208.7

Q ss_pred             CceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCCh--------HHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPN--------TIERDIMVKS-KCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~~--------~~E~eIL~kL-~HPNIVkL~~vfede~~l   83 (792)
                      +|++.+.||.|+||.||+|...   .+|..||+|++.......        ..|+.++..+ +||||+.++++|..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999875   478999999987543211        4588899999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||++||+|.+++..  ...+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            999999999999999954  345899999999999999999999999999999999999999999999999999876433


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      .........|++.|+|||.+...     ...++.++|||||||++|+|++|..||...........+..........+|.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGG-----DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  233 (290)
T ss_pred             cccccccccCCcccCChhhccCC-----CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc
Confidence            22223345689999999998521     2346788999999999999999999997543322222222211112223333


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                        .+++.+.+++.+|+. +|.+||     ++.+++.||||..++
T Consensus       234 --~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         234 --EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             --cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence              578999999999999 999997     789999999998765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.2e-39  Score=330.13  Aligned_cols=250  Identities=24%  Similarity=0.390  Sum_probs=203.3

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcC-CCCcceeEEEEEeC--CEEEEEEe
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSK-CPYIVNLFYSFQDM--NHVYFIME   88 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~-HPNIVkL~~vfede--~~lyLVmE   88 (792)
                      |++.+.||.|+||.||++.+..++..||+|.+.+.....     ..|..++.++. ||||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            788999999999999999999999999999987643221     35777888885 99999999999988  89999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+. |+|.+.+... .+.+++..+..++.||+.||.|||+.||+||||+|.||+++. +.+||+|||++.........  
T Consensus        81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~--  155 (282)
T cd07831          81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--  155 (282)
T ss_pred             cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc--
Confidence            996 5788777543 356899999999999999999999999999999999999999 99999999999876533222  


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc--------------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD--------------  234 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~--------------  234 (792)
                      ....+++.|+|||.+..      ...++.++||||+||++|+|++|.+||.+.+.......+....              
T Consensus       156 ~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         156 TEYISTRWYRAPECLLT------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             CCCCCCcccCChhHhhc------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence            23458999999998742      2357889999999999999999999998776554443332210              


Q ss_pred             CCCCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        235 TEDTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       235 ~~~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ......+|.         ...++..+.++|.+||. +|.+||++.+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            001112222         12468999999999999 99999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=336.91  Aligned_cols=255  Identities=24%  Similarity=0.434  Sum_probs=202.1

Q ss_pred             CceEEeEeeecCceEEEEEEEec--CCcEEEEEEeccCC-----CCh--HHHHHHHHhcCCCCcceeEEEEEeC--CEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQ--SHNTFVMKKVLREK-----MPN--TIERDIMVKSKCPYIVNLFYSFQDM--NHVY   84 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~--tGk~vAVKiI~Ks~-----~~~--~~E~eIL~kL~HPNIVkL~~vfede--~~ly   84 (792)
                      .|.+.+.||+|+||.||+|....  +|..||+|.+....     ...  ..|+.++..++||||++++++|.+.  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48999999999999999999988  89999999998733     111  5688999999999999999999988  8899


Q ss_pred             EEEeccCCCCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC----CCceEEeccCcc
Q psy13735         85 FIMEYVTGGDFVTLLENQ---PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA----TGHLKLTDFGSA  157 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~---~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~----dg~VKLiDFGLA  157 (792)
                      +||||++ ++|.+++...   ....+++..++.++.||+.||.|||+.||+||||+|+|||++.    ++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999996 4677766422   2236899999999999999999999999999999999999999    899999999999


Q ss_pred             cccccCCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh---------h
Q psy13735        158 TQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM---------T  226 (792)
Q Consensus       158 ~~l~~~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e---------l  226 (792)
                      ........  ......+|++.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.....         .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            87643322  12233468999999998853      2357889999999999999999999997654332         0


Q ss_pred             hhhhhcc----------------c------CCCCcCCC---------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        227 YSSILAC----------------D------TEDTVSFP---------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       227 ~ekIl~~----------------~------~~~~l~fP---------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...+...                .      ......++         .....+..+.+++.+||. ||.+|||+.+++.|
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000000                0      00001111         011567889999999999 99999999999999


Q ss_pred             CCc
Q psy13735        275 PVF  277 (792)
Q Consensus       275 PwF  277 (792)
                      |||
T Consensus       314 ~~f  316 (316)
T cd07842         314 PYF  316 (316)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-38  Score=319.43  Aligned_cols=249  Identities=33%  Similarity=0.543  Sum_probs=214.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||.|+||.||++.+..++..||+|.+.......      ..|.++++.++|||++++++.+.....+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5899999999999999999999999999999997655421      4688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         90 VTGGDFVTLLENQP--HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        90 ~~GGsL~dlL~r~~--~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ++|++|.+++.+..  ...+++..+..++.+|+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~  159 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL  159 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence            99999999997643  4679999999999999999999999999999999999999999999999999998765443 12


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      .....|++.|+|||.+..       ..++.++|+||+|+++|+|++|..||...+.......+....   ...+|.  .+
T Consensus       160 ~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~--~~  227 (258)
T cd08215         160 AKTVVGTPYYLSPELCQN-------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---YPPIPS--QY  227 (258)
T ss_pred             ecceeeeecccChhHhcc-------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC---CCCCCC--CC
Confidence            234468999999998763       357889999999999999999999998777666665554421   222333  67


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +..+.+++..||. +|.+||++.+++.||||
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            8999999999999 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG4236|consensus

Probab=100.00  E-value=7e-40  Score=360.78  Aligned_cols=246  Identities=31%  Similarity=0.558  Sum_probs=216.2

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      .++||+|.||+||-+.++.+|+.||||+|.|-.++.      +.|+.||+++.||.||.+...|++.+.+++|||-+ .|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            479999999999999999999999999999887765      68999999999999999999999999999999999 56


Q ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC---CceEEeccCcccccccCCCccccc
Q psy13735         94 DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        94 sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d---g~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      ++.+.|-....|++++...++++.||+.||.|||-+||+|.||||+|||+...   .++||||||+|+.++....  ..+
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--Rrs  725 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--RRS  725 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--hhh
Confidence            77777766677899999999999999999999999999999999999999543   4799999999999875432  335


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC--CCcccc
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP--SSIRLS  248 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP--~~~~lS  248 (792)
                      .+|||.|+|||++...       +|...-||||+|||+|.-|+|..||+.+  +++-..|.+    ..+-||  +|..+|
T Consensus       726 VVGTPAYLaPEVLrnk-------GyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQN----AaFMyPp~PW~eis  792 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNK-------GYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQN----AAFMYPPNPWSEIS  792 (888)
T ss_pred             hcCCccccCHHHHhhc-------cccccccceeeeEEEEEEecccccCCCc--cchhHHhhc----cccccCCCchhhcC
Confidence            6799999999999854       8999999999999999999999999633  345555655    333444  467899


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +.+.|||..||+ +..+|.++++.|.|||+++..
T Consensus       793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            999999999999 999999999999999998654

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-38  Score=315.57  Aligned_cols=248  Identities=30%  Similarity=0.520  Sum_probs=211.5

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      +|.+.+.||+|+||.||++.+..+|..+++|++......    ...|..+++.++||||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            589999999999999999999999999999999776542    2578899999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      |++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........  ....
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~  157 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM  157 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence            999999986532 5689999999999999999999999999999999999999999999999999987764332  2345


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      .|+..|+|||.+...       .++.++|+||||+++|+|++|..||...+.......+..   .....++....++..+
T Consensus       158 ~~~~~~~~PE~~~~~-------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  227 (253)
T cd05122         158 VGTPYWMAPEVINGK-------PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEF  227 (253)
T ss_pred             ecCCcccCHHHHcCC-------CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHH
Confidence            689999999998632       478899999999999999999999987654444333332   1222334434458999


Q ss_pred             HHHHHHHhh-ChhhcCChhHHhcCCC
Q psy13735        252 VNFVQSLVQ-KLDARLNMDQVLGHPV  276 (792)
Q Consensus       252 kdLIk~LL~-DP~kRPTaeEIL~HPw  276 (792)
                      .+++..|+. ||.+|||+.+++.|||
T Consensus       228 ~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         228 KDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCCC
Confidence            999999999 9999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.5e-39  Score=335.16  Aligned_cols=244  Identities=18%  Similarity=0.251  Sum_probs=203.8

Q ss_pred             CCCCceEE--eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEe----
Q psy13735         13 SASDFDIK--RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQD----   79 (792)
Q Consensus        13 ~l~dY~I~--k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfed----   79 (792)
                      ...+++..  ..||.|++|.||++..  +|+.||+|.+.+.....       ..|+.++.+++|||||+++++|.+    
T Consensus        16 ~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   93 (283)
T PHA02988         16 ESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD   93 (283)
T ss_pred             CHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence            44455555  7899999999999977  68999999997654332       378999999999999999999977    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      ...+++|||||+||+|.+++..  .+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence            4578999999999999999954  4568999999999999999999998 499999999999999999999999999988


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      .....    .....|++.|+|||++...     ...++.++|||||||++|+|++|..||...+....+..+....  ..
T Consensus       172 ~~~~~----~~~~~~~~~y~aPE~~~~~-----~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~--~~  240 (283)
T PHA02988        172 ILSSP----PFKNVNFMVYFSYKMLNDI-----FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN--NS  240 (283)
T ss_pred             hhccc----cccccCcccccCHHHhhhc-----cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC--CC
Confidence            65432    1234689999999998631     2368999999999999999999999999888777777765422  22


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+|  ...++.+.+|+.+||+ ||.+|||+.+++.
T Consensus       241 ~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        241 LKLP--LDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2333  2568999999999999 9999999999864

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-39  Score=334.18  Aligned_cols=252  Identities=25%  Similarity=0.422  Sum_probs=209.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +..++|++++.||+|+||.||++.+..+|..||+|++.......     ..|.+++..++||||+++++++.+...+|+|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            45689999999999999999999999999999999887543322     4688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||++||+|.+++..  .+.+++..+..++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++......  
T Consensus        82 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          82 MEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             EecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999999999854  4568999999999999999999997 69999999999999999999999999998755322  


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-----------hhhhhhhccc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-----------MTYSSILACD  234 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-----------el~ekIl~~~  234 (792)
                       .....+|++.|+|||++..       ..++.++|+||+||++|+|++|..||......           .....+..  
T Consensus       158 -~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  227 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQG-------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ--  227 (284)
T ss_pred             -ccCccccCcccCCHHHHcc-------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh--
Confidence             1223469999999999852       36788999999999999999999999755432           12222222  


Q ss_pred             CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        235 TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       235 ~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                       .....++. ..++..+.+|+..|+. ||.+||++.+++.||||..
T Consensus       228 -~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         228 -EPPPRLPS-SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             -ccCCCCCc-hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence             11112222 2367899999999999 9999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.3e-39  Score=334.23  Aligned_cols=254  Identities=28%  Similarity=0.419  Sum_probs=208.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC--CEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM--NHVYF   85 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede--~~lyL   85 (792)
                      .++|.+.+.||.|+||.||+|.+..+|..+|+|.+.......      ..|+.++.+++||||+++++++.+.  ..+|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            468999999999999999999999999999999987543322      4688999999999999999999887  89999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 v~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  160 (293)
T cd07843          84 VMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-  160 (293)
T ss_pred             EehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence            999996 58998886533 358999999999999999999999999999999999999999999999999998765432 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC---------
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE---------  236 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~---------  236 (792)
                      .......+++.|+|||.+.+.      ..++.++||||+||++|+|++|.+||...+.......+......         
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGA------KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF  234 (293)
T ss_pred             cccccccccccccCchhhcCC------ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence            122334588999999998632      34688999999999999999999999877655544443321000         


Q ss_pred             ------C------------CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        237 ------D------------TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       237 ------~------------~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                            .            ...++. ..+++.+.++|++||. +|.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         235 SELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hccchhcccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                  0            001111 1158899999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-38  Score=328.71  Aligned_cols=254  Identities=25%  Similarity=0.411  Sum_probs=207.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      +|++.+.||.|++|.||++++..+|..||+|.+.......     ..|+.+++.++||||++++++|.+.+.+|+||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5899999999999999999999999999999987654321     56889999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         91 TGGDFVTLLENQP-HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        91 ~GGsL~dlL~r~~-~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      +| +|.+++.... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFS  158 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccc
Confidence            75 8888875432 24589999999999999999999999999999999999999999999999999976543221 122


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC--------------
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT--------------  235 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~--------------  235 (792)
                      ...+++.|++||.+..      ...++.++|||||||++|+|++|.+||.+.+....+..+.....              
T Consensus       159 ~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         159 NEVVTLWYRAPDVLLG------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             cccccccccChHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            3457899999999852      23578899999999999999999999987766554444332100              


Q ss_pred             CCCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        236 EDTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       236 ~~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .....+|.         ...+++.+.+++..|++ ||.+||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00001111         01457889999999999 99999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-38  Score=324.58  Aligned_cols=247  Identities=23%  Similarity=0.388  Sum_probs=206.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..++|++.+.||+|+||.||++..+. +..+|+|.+.......   ..|+.+++.++||||+++++++.....+|+||||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            45789999999999999999998764 5689999887654433   5688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++||+|.+++... .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||.+............
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          81 MENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            9999999998643 346899999999999999999999999999999999999999999999999998865433222222


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...++..|+|||.+..       ..++.++|+||+||++|+|++ |+.||...+.......+....   ....|.  ..+
T Consensus       160 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~--~~~  227 (256)
T cd05114         160 GAKFPVKWSPPEVFNF-------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF---RLYRPK--LAS  227 (256)
T ss_pred             CCCCchhhCChhhccc-------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCC--CCC
Confidence            2235668999999863       367889999999999999999 999998887777777775521   112222  467


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+.+++.+|+. +|.+||++.+++.
T Consensus       228 ~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         228 MTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            899999999999 9999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.5e-39  Score=334.16  Aligned_cols=259  Identities=24%  Similarity=0.417  Sum_probs=205.1

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~-HPNIVkL~~vfede~~lyLV   86 (792)
                      ..++|...+.||+|+||.||++.+..+|..+|+|.+.+.....     ..|..++.++. ||||+++++++..+...+++
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            3567888899999999999999999999999999987654332     45778888886 99999999999999999999


Q ss_pred             EeccCCCCHHHHH---HhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         87 MEYVTGGDFVTLL---ENQPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        87 mEy~~GGsL~dlL---~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      |||+. +++.++.   .....+.+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            99995 4554433   222346699999999999999999999975 999999999999999999999999999976643


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      ..  ......|++.|+|||++...    ....++.++||||+||++|+|++|.+||....  .....+..........++
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~  232 (288)
T cd06616         161 SI--AKTRDAGCRPYMAPERIDPS----ARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILS  232 (288)
T ss_pred             CC--ccccccCccCccCHHHhccc----cccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcCC
Confidence            22  12233589999999998631    11368889999999999999999999997544  122222221111111222


Q ss_pred             C--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        243 S--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       243 ~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .  ...++..+.+|+.+|+. +|.+|||+.+++.||||+..
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            1  23578999999999999 99999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-38  Score=333.90  Aligned_cols=254  Identities=20%  Similarity=0.279  Sum_probs=200.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec----------------CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCc
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ----------------SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYI   70 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~----------------tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNI   70 (792)
                      +..++|.+.+.||+|+||.||+|.+..                ++..||+|.+.......     ..|+.++..++||||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence            456789999999999999999998542                34579999887543221     468899999999999


Q ss_pred             ceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy13735         71 VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQP-----------------HGYLSESKARFYIYELAQAVQYLHGLGYVH  133 (792)
Q Consensus        71 VkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~-----------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVH  133 (792)
                      +++++++.+.+.+|+||||++||+|.+++....                 ...+++..+..++.||+.||.|||+.||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999985421                 123678889999999999999999999999


Q ss_pred             CCCCCCceEeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhh
Q psy13735        134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL  212 (792)
Q Consensus       134 RDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELL  212 (792)
                      |||||+|||++.++.+||+|||++......... ......+++.|+|||++..       ..++.++|||||||++|+|+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-------GKFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-------CCCCchhhhHHHHHHHHHHH
Confidence            999999999999999999999999866433221 1223346789999999863       36889999999999999998


Q ss_pred             c--CCCCCCCCChhhhhhhhhccc--CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        213 T--GSTPFNYETLDMTYSSILACD--TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       213 T--Gk~PF~~~d~~el~ekIl~~~--~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      +  |..||...+.......+....  ............++..+.+++.+|+. +|.+|||+.++.
T Consensus       235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             HccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            6  667887666555444332210  00111111122568899999999999 999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.8e-39  Score=342.58  Aligned_cols=259  Identities=23%  Similarity=0.386  Sum_probs=207.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe----CCEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD----MNHVY   84 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed----e~~ly   84 (792)
                      ++|.+.+.||.|+||.||+|.++.+|..||+|.+.......      ..|+.++..++||||++++++|..    ...+|
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            68999999999999999999999999999999987643211      468899999999999999998863    35789


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||||+. |+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus        85 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          85 VVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            9999995 689988843  4559999999999999999999999999999999999999999999999999997654322


Q ss_pred             Ccc---cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC------
Q psy13735        165 RIK---SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT------  235 (792)
Q Consensus       165 ~~~---s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~------  235 (792)
                      ...   ....+|++.|+|||.+..      ...++.++||||+||++|+|++|++||.+.+.......+.....      
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLS------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             cCCCcccccccccccccChHHhcC------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            211   123468999999999853      23578899999999999999999999977654333322221100      


Q ss_pred             ----------------CCCcCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        236 ----------------EDTVSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       236 ----------------~~~l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                      ......+.   ....++.+.+||+.||+ +|.+||++.+++.||||.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                            00000100   12468999999999999 9999999999999999986653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-38  Score=342.81  Aligned_cols=255  Identities=22%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------C
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------N   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------~   81 (792)
                      ..+|++.+.||+|+||.||+|.+..+|..||+|.+.+.....      ..|+.++..++||||++++++|...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            568999999999999999999999999999999986543221      4688999999999999999998644      3


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||. ++|.+.+..    .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            5799999995 588888743    28999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-----
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-----  236 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-----  236 (792)
                      ...  ......|++.|+|||.+.+       ..++.++|||||||++|+|++|..||...+....+..+......     
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         170 TSF--MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             CCC--CCCCCcccccccCHHHHhC-------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            322  2233468999999999863       36889999999999999999999999876644433333210000     


Q ss_pred             ---------------------------CCcCCCC-----CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        237 ---------------------------DTVSFPS-----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       237 ---------------------------~~l~fP~-----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                                 ....++.     ....++.+.+||.+||. ||.+|||+.++|.||||+.+-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                                       0000111     11346779999999999 9999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.7e-39  Score=330.26  Aligned_cols=252  Identities=27%  Similarity=0.451  Sum_probs=211.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..|+..+.||.|+||.||++.+..++..+|+|.+.......     ..|+.++..+.||||+++++++.+...+|+||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            46888999999999999999999999999999987654322     4688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++||+|.+++..   +.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~  159 (277)
T cd06640          84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN  159 (277)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccc
Confidence            999999999843   458999999999999999999999999999999999999999999999999997765332 2223


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|+..|+|||++..       ..++.++|+|||||++|+|++|.+||...+.......+..   .....++  ..++.
T Consensus       160 ~~~~~~~y~apE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~--~~~~~  227 (277)
T cd06640         160 TFVGTPFWMAPEVIQQ-------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK---NNPPTLT--GEFSK  227 (277)
T ss_pred             cccCcccccCHhHhcc-------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc---CCCCCCc--hhhhH
Confidence            3468899999999863       3578899999999999999999999987665544443322   1112222  25678


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      .+.+++.+|+. +|.+||++.+++.||||.....
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            99999999999 9999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-38  Score=334.40  Aligned_cols=256  Identities=27%  Similarity=0.469  Sum_probs=214.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      -...+|.+.+.||+|+||.||++....++..||+|.+.......    ..|..+++.++||||++++++|...+..|+|+
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            34578999999999999999999998899999999986544332    46788899999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++||+|.+++.+   ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~  171 (293)
T cd06647          96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (293)
T ss_pred             ecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence            99999999999854   3488999999999999999999999999999999999999999999999999876654322 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      .....|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...+.......+..   .....++....+
T Consensus       172 ~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~  241 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKL  241 (293)
T ss_pred             cccccCChhhcCchhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc---CCCCCCCCcccc
Confidence            223468999999999853       3578899999999999999999999987655433332221   122233334467


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +..+.+++..|+. +|.+||++.+++.||||+...
T Consensus       242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            8899999999999 999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-38  Score=329.72  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=209.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|.+.+.||+|+||.||+|..+.     .+..||+|.+.......     ..|..+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            456789999999999999999997653     35589999886544322     45778899999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEec
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP--------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD  153 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~--------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiD  153 (792)
                      ..|+||||++||+|.+++....        ...++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999999999999996422        12346778899999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhh
Q psy13735        154 FGSATQVDKNGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       154 FGLA~~l~~~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl  231 (792)
                      ||+++......... .....+++.|+|||.+..       ..++.++|+|||||++|+|++ |.+||.+.+.......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-------GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhcc-------CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99988654322111 122245778999999863       367889999999999999998 899998877666665554


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc------CCCccCCC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG------HPVFDCLD  281 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~------HPwF~~i~  281 (792)
                      ..   ....++.  ..++.+.+++.+|++ +|.+||++.+++.      ||||.+++
T Consensus       236 ~~---~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         236 DG---GYLDQPD--NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             cC---CCCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            31   1222333  567899999999999 9999999999865      99998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-38  Score=359.79  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=203.0

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      ..+|.+.+.||.|+||.||+|.+..+++.||+|.....  ....|+.++++++|||||++++++...+..|+||+++ +|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~--~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~  244 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA--SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RS  244 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc--CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CC
Confidence            45799999999999999999999999999999964332  2368999999999999999999999999999999999 57


Q ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc-ccccCC
Q psy13735         94 DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-KSIVPV  172 (792)
Q Consensus        94 sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~v  172 (792)
                      +|..++... .+.+++..+..|+.||+.||.|||++||+||||||+||||+.++.++|+|||+++........ .....+
T Consensus       245 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        245 DLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence            888888543 346999999999999999999999999999999999999999999999999999865432211 122456


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC--------hhhhhhhhhcccCC--C-----
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET--------LDMTYSSILACDTE--D-----  237 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d--------~~el~ekIl~~~~~--~-----  237 (792)
                      ||+.|+|||++.+       ..++.++|||||||++|+|++|..|+....        ...+...+......  .     
T Consensus       324 GT~~Y~APE~~~~-------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        324 GTVDTNAPEVLAG-------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             CCcCCcCHHHHcC-------CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            9999999999863       368899999999999999999876653221        11122222111000  0     


Q ss_pred             ------------------CcC---CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        238 ------------------TVS---FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       238 ------------------~l~---fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                                        ...   +.....++..+.+||..||+ ||.+|||+.++|.||||++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                              000   01112456789999999999 9999999999999999974

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=340.33  Aligned_cols=259  Identities=23%  Similarity=0.419  Sum_probs=204.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC-----CEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM-----NHV   83 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede-----~~l   83 (792)
                      .++|.+.+.||+|+||.||++.+..+|..||+|.+.......     ..|+.++..++||||+++++++...     ..+
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999999999999999986432221     4588999999999999999887654     358


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||+. ++|..++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            99999995 588888743   45999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhc---------
Q psy13735        164 GRIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA---------  232 (792)
Q Consensus       164 ~~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~---------  232 (792)
                      ....  ....+|++.|+|||.+..      ...++.++||||+||++|+|++|++||.+.+.......+..         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLN------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            2111  123468999999998752      23578899999999999999999999976554332222111         


Q ss_pred             ------ccCC---------CCcCCC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        233 ------CDTE---------DTVSFP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       233 ------~~~~---------~~l~fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                            ....         ....++ .....++.+.+|+.+||. +|.+|||+.+++.||||.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                  0000         000000 012457889999999999 9999999999999999987653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-38  Score=328.67  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=207.3

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC--CEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM--NHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede--~~lyLVm   87 (792)
                      ++|.+.+.||.|++|.||+|.+..+++.||+|.+.......     ..|+++++.++||||++++++|.+.  ..+|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            47999999999999999999999999999999987654422     5788999999999999999998654  4789999


Q ss_pred             eccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         88 EYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||++||+|.+++..  .....+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            99999999988753  2345689999999999999999999999999999999999999999999999999876542211


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-----hhhhhhhhhcccCCCCc-
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-----LDMTYSSILACDTEDTV-  239 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-----~~el~ekIl~~~~~~~l-  239 (792)
                         ....++..|+|||.+..       ..++.++|||||||++|+|++|..||....     .......+......... 
T Consensus       161 ---~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd06621         161 ---GTFTGTSFYMAPERIQG-------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD  230 (287)
T ss_pred             ---ccccCCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc
Confidence               13358889999999863       367889999999999999999999997652     22223332221111111 


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ..+....+++.+.+|+.+|+. +|.+|||+.+++.||||...
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            111123467899999999999 99999999999999999754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.4e-38  Score=324.64  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=205.0

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +..+.+.....||+|+||.||++.+..++..+|+|.+.......    ..|+.++..++||||+++++++...+.+|+||
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34455666679999999999999999999999999887654322    56889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEeccCcccccccCC
Q psy13735         88 EYVTGGDFVTLLENQPHGYL--SESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~L--SE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~~l~~~~  164 (792)
                      ||++|++|.+++.... +.+  ++..+..++.||+.||.|||++||+||||+|+||+++. ++.++|+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            9999999999996532 335  88899999999999999999999999999999999976 6789999999987654322


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh-hhhhhcccCCCCcCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-YSSILACDTEDTVSFPS  243 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el-~ekIl~~~~~~~l~fP~  243 (792)
                      . ......|++.|+|||++...     ...++.++|+||+||++|+|++|.+||........ ...+..  ......+|.
T Consensus       164 ~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (268)
T cd06624         164 P-CTETFTGTLQYMAPEVIDKG-----PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPE  235 (268)
T ss_pred             C-ccccCCCCccccChhhhccc-----cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCc
Confidence            2 12234589999999998521     23478899999999999999999999965332111 111100  111222333


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                        .+++.+.+|+.+|+. +|.+|||+.+++.||||
T Consensus       236 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         236 --SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             --ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence              578999999999999 99999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-39  Score=335.83  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=211.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..|.+.+.||.|+||.||++.+..+|..+|+|.+.......     ..|+.+++.++||||++++++|.+...+|+||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            35777889999999999999999999999999987554322     5688899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++||+|.+++..   +.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus        84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~  159 (277)
T cd06642          84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN  159 (277)
T ss_pred             cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhh
Confidence            999999999843   458999999999999999999999999999999999999999999999999997765322 1223


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|++.|+|||.+..       ..++.++|+|||||++|+|++|..||...........+...   ....++  ..++.
T Consensus       160 ~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~  227 (277)
T cd06642         160 TFVGTPFWMAPEVIKQ-------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---SPPTLE--GQYSK  227 (277)
T ss_pred             cccCcccccCHHHhCc-------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---CCCCCC--cccCH
Confidence            3468999999999863       35788999999999999999999999765544433333221   111122  25688


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                      .+.+++.+|+. +|.+||++.+++.||||......+
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         228 PFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKT  263 (277)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence            99999999999 999999999999999998655443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-38  Score=328.43  Aligned_cols=249  Identities=28%  Similarity=0.482  Sum_probs=210.2

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      -|++.+.||.|+||.||++.+..++..||+|.+.......     ..|+.++..++||||++++++|.....+|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4788999999999999999999999999999886554322     46888999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      +||+|..++.+   +.+++..+..++.|++.|+.|||+.||+|+||+|.||+++.++.++|+|||++..+.... .....
T Consensus        85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~  160 (277)
T cd06641          85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNT  160 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhcc
Confidence            99999999843   458999999999999999999999999999999999999999999999999987664322 12233


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      ..|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...........+...   ....++.  .++..
T Consensus       161 ~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~  228 (277)
T cd06641         161 FVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN---NPPTLEG--NYSKP  228 (277)
T ss_pred             ccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC---CCCCCCc--ccCHH
Confidence            468999999999853       35678899999999999999999999876655544444321   1122222  56899


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +.+++..|+. +|.+||++.+++.||||...
T Consensus       229 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            9999999999 99999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.5e-39  Score=351.11  Aligned_cols=252  Identities=19%  Similarity=0.275  Sum_probs=203.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCC-----cEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEe
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSH-----NTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQD   79 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tG-----k~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfed   79 (792)
                      ++..++|.+.+.||+|+||.||+|++..+|     ..||+|++.......     ..|+.+++.+ +|||||+++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            466778999999999999999999875544     579999997654332     4688999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCC--------------------------------------------------------
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQP--------------------------------------------------------  103 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~--------------------------------------------------------  103 (792)
                      .+.+|+|||||+||+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999985321                                                        


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc-ccc
Q psy13735        104 ------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK-SIV  170 (792)
Q Consensus       104 ------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~-s~t  170 (792)
                                  ...+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++.......... ...
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                        1247888999999999999999999999999999999999999999999999998664332211 112


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ..+++.|+|||++..       ..++.++|||||||++|+|++ |..||........+..+....  .....|  ..+++
T Consensus       274 ~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~--~~~~~~--~~~~~  342 (374)
T cd05106         274 ARLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG--YQMSRP--DFAPP  342 (374)
T ss_pred             CCCccceeCHHHhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc--cCccCC--CCCCH
Confidence            235668999999852       368999999999999999997 999997665544433333311  112223  35689


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+++..|+. ||.+||++.++++
T Consensus       343 ~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         343 EIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.9e-39  Score=336.30  Aligned_cols=257  Identities=25%  Similarity=0.424  Sum_probs=214.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      -....|.....||.|+||.||++.+..+|..||+|.+.......    ..|+.++..++||||++++++|...+.+|+||
T Consensus        18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            34466777789999999999999999999999999986543322    46788899999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++|++|..++..   ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ..
T Consensus        98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~  173 (297)
T cd06659          98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK  173 (297)
T ss_pred             ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence            99999999998843   458999999999999999999999999999999999999999999999999987654332 12


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+|++.|+|||++..       ..++.++||||+||++|+|++|..||...+.......+....   .........+
T Consensus       174 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  243 (297)
T cd06659         174 RKSLVGTPYWMAPEVISR-------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNAHKI  243 (297)
T ss_pred             ccceecCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---CCCccccCCC
Confidence            234569999999999863       357889999999999999999999998776655554443311   1111222357


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      ++.+.+|+..|++ +|.+||++.+++.||||.....
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            8899999999999 9999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-38  Score=329.32  Aligned_cols=257  Identities=33%  Similarity=0.627  Sum_probs=206.3

Q ss_pred             CceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCCh--------HHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPN--------TIERDIMVKS-KCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~~--------~~E~eIL~kL-~HPNIVkL~~vfede~~l   83 (792)
                      +|.+.+.||.|+||.||++...   .++..||+|.+.+.....        ..|..++..+ +||||+++++.|.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   467899999987543211        4688889999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||++||+|.+++..  ...+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++..+...
T Consensus        81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            999999999999999854  356899999999999999999999999999999999999999999999999998876543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      ........+|++.|+|||.+...     ...++.++|+||+|+++|+|++|..||...........+...........|.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGG-----SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK  233 (288)
T ss_pred             cccccccccCCccccCHHHhcCC-----CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc
Confidence            33233345689999999998532     2246788999999999999999999996443222222221111112222333


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCCh---hHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNM---DQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTa---eEIL~HPwF~~i~  281 (792)
                        .++..+.+++.+|++ +|.+|||+   .+++.||||+++.
T Consensus       234 --~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         234 --TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             --ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence              578899999999999 99999985   5669999999876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-38  Score=315.62  Aligned_cols=247  Identities=31%  Similarity=0.552  Sum_probs=211.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|.+.+.||+|+||.||++.+..+|+.||+|.+.......      ..|.+++..++|||++++++++.+...+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5899999999999999999999999999999998776521      5788899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++|++|.+++.+.  +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......... ..
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~  157 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA  157 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence            9999999999553  56999999999999999999999999999999999999999999999999999877643321 23


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ...|++.|+|||.+..       ..++.++||||+|+++|+|++|..||...+.......+..   .....+|.  .+++
T Consensus       158 ~~~~~~~y~~pe~~~~-------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~--~~~~  225 (254)
T cd06627         158 SVVGTPYWMAPEVIEM-------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DDHPPLPE--GISP  225 (254)
T ss_pred             ccccchhhcCHhhhcC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cCCCCCCC--CCCH
Confidence            4468999999999863       2478899999999999999999999976654433333322   12223333  6789


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+.+++.+||. +|.+||++.+++.||||
T Consensus       226 ~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         226 ELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            99999999999 99999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=328.50  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=205.9

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      |++.+.||.|++|.||++.+..+|..||+|++......      ...|+.+++.++||||+++++++.+....|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67899999999999999999999999999998755422      156899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                       +++|.+++.......+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++........ ....
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~  158 (283)
T cd07835          81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTH  158 (283)
T ss_pred             -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccCc
Confidence             46899998665444689999999999999999999999999999999999999999999999999976543221 1122


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC--------------C
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT--------------E  236 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~--------------~  236 (792)
                      ..+++.|+|||++..      ...++.++||||+||++|+|++|.+||...+.......+.....              .
T Consensus       159 ~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         159 EVVTLWYRAPEILLG------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             cccccCCCCCceeec------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence            357899999998752      23568899999999999999999999987665443333221000              0


Q ss_pred             CCcCCC---------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        237 DTVSFP---------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       237 ~~l~fP---------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ....++         ....++..+.++|.+|++ +|.+||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            000010         023567899999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=322.67  Aligned_cols=249  Identities=18%  Similarity=0.299  Sum_probs=207.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|++.+.||.|+||.||++.... +..||+|.+.......   ..|..+++.++||||+++++++...+.+|+|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            556789999999999999999998754 5789999987655432   468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR  161 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence            99999999999654445689999999999999999999999999999999999999999999999999987653221111


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....++..|+|||.+..       ..++.++|+|||||++|+|++ |+.||.+.+.......+...     ...+.....
T Consensus       162 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~  229 (261)
T cd05068         162 EGAKFPIKWTAPEAALY-------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-----YRMPCPPGC  229 (261)
T ss_pred             CCCcCceeccCcccccc-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcC
Confidence            11123457999998853       367889999999999999999 99999887776666665431     122233367


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +..+.+++.+|+. +|.+||++.+++.
T Consensus       230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         230 PKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            8999999999999 9999999999853

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=323.56  Aligned_cols=249  Identities=21%  Similarity=0.366  Sum_probs=207.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ..++|++.+.||+|+||.||+|..+.+   ...+|+|.+.......     ..|..++..++||||+++++++...+.+|
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            457899999999999999999988754   4578999886554332     35888999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc-C
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-N  163 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~-~  163 (792)
                      +||||++||+|.+++... .+.+++..+..++.|++.||.|||++||+|+||+|.||+++.++.++|+|||++..... .
T Consensus        82 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          82 IITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999999653 34689999999999999999999999999999999999999999999999999987752 2


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      .........+++.|+|||.+..       ..++.++|||||||++|+|++ |..||...........+...     ...|
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~  228 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAY-------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-----YRLP  228 (266)
T ss_pred             cceeccCCCCCccccChhhhcc-------CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCC
Confidence            2222222345678999999863       367889999999999999998 99999776666666655431     1223


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .....++.+.+++.+|+. +|.+||++.+++.+
T Consensus       229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            334678999999999999 99999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.4e-39  Score=349.09  Aligned_cols=253  Identities=20%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEE-----ecCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEe
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEE-----KQSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQD   79 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~-----k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfed   79 (792)
                      .+..++|++.+.||+|+||.||+|+.     ..++..||+|++.......     ..|+.++..+ +|||||+++++|.+
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            45566899999999999999999974     3567789999986543322     4689999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCC--------------------------------------------------------
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQP--------------------------------------------------------  103 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~--------------------------------------------------------  103 (792)
                      .+..|+|||||+||+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999985421                                                        


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735        104 -----------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus       104 -----------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                                       ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                             124788899999999999999999999999999999999999999999999999876533221


Q ss_pred             c-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        167 K-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       167 ~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                      . .....+++.|+|||++..       ..++.++|||||||++|+|++ |..||...........+.....  ....|  
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~--  339 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--RMLSP--  339 (375)
T ss_pred             cccCCCCCCcceeChhHhcC-------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--cCCCC--
Confidence            1 112235667999999863       368899999999999999998 9999976554433333332111  11122  


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...+.++.+++..|+. ||.+||++.+++..
T Consensus       340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            2567899999999999 99999999999754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4279|consensus

Probab=100.00  E-value=1.4e-38  Score=358.25  Aligned_cols=250  Identities=26%  Similarity=0.446  Sum_probs=211.9

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCHH
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFV   96 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL~   96 (792)
                      -+||+|.||+||.+++.+|....|||-|......    ...|+.+.+.|+|.|||++.|.+..++++-|+||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            4899999999999999999999999998755433    267899999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC-CCCceEEeccCcccccccCCCcccccCCC
Q psy13735         97 TLLENQPHGYL--SESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS-ATGHLKLTDFGSATQVDKNGRIKSIVPVG  173 (792)
Q Consensus        97 dlL~r~~~g~L--SE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd-~dg~VKLiDFGLA~~l~~~~~~~s~t~vG  173 (792)
                      +++.. ..|++  .|..+.+|.+||+.||.|||++.|||||||.+|+||+ -.|.+||+|||-++.+..-++ .+.++.|
T Consensus       661 sLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFTG  738 (1226)
T KOG4279|consen  661 SLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFTG  738 (1226)
T ss_pred             HHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccccc
Confidence            99965 57778  8999999999999999999999999999999999995 578999999999998864333 3345669


Q ss_pred             CCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhc-ccCCCCcCCCCCccccHHHH
Q psy13735        174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       174 Tp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~-~~~~~~l~fP~~~~lS~elk  252 (792)
                      |..|||||++.     .|..+|+.++|||||||.+.+|.||++||........  .++. ....-.+..|.  .+|.+++
T Consensus       739 TLQYMAPEvID-----qG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVGmyKvHP~iPe--elsaeak  809 (1226)
T KOG4279|consen  739 TLQYMAPEVID-----QGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVGMYKVHPPIPE--ELSAEAK  809 (1226)
T ss_pred             chhhhChHhhc-----cCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhcceecCCCCcH--HHHHHHH
Confidence            99999999996     4567899999999999999999999999953222111  1111 11123334444  8899999


Q ss_pred             HHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        253 NFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .||.+|.. +|..||++.++|..||+..-+
T Consensus       810 ~FilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  810 NFILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             HHHHHHcCCCcccCccHHHhccCcccccCC
Confidence            99999999 999999999999999998653

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=323.61  Aligned_cols=248  Identities=22%  Similarity=0.379  Sum_probs=205.3

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ...+|.+.+.||+|+||.||++.++ ++..+|+|.+.+.....   ..|..+++.++||||+++++++...+..|+||||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            3567999999999999999999876 46789999987654433   4688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++|++|.+++.... +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++............
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          81 MANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            99999999996533 46899999999999999999999999999999999999999999999999998765432211111


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...++..|+|||.+..       ..++.++|||||||++|+|++ |.+||...+.......+...   .....|  ...+
T Consensus       160 ~~~~~~~y~~Pe~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~  227 (256)
T cd05059         160 GTKFPVKWAPPEVFDY-------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG---YRLYRP--KLAP  227 (256)
T ss_pred             CCCCCccccCHHHhcc-------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC---CcCCCC--CCCC
Confidence            2224457999999863       368889999999999999999 89999877766666655431   112222  3579


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +.+.+++.+|+. +|.+||++.+++..
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999 99999999999764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.5e-38  Score=328.12  Aligned_cols=252  Identities=26%  Similarity=0.436  Sum_probs=211.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      .|.....||.|+||.||++.+..++..+|+|.+.......    ..|+.+++.++||||+++++++...+..|+|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            5667789999999999999999999999999886443322    468889999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      |++|.+++..   +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........ .....
T Consensus       100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~  175 (285)
T cd06648         100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSL  175 (285)
T ss_pred             CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccc
Confidence            9999999854   4589999999999999999999999999999999999999999999999998876543221 22234


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      .|++.|+|||.+..       ..++.++|+||+||++|+|++|..||...+.......+....   .........++..+
T Consensus       176 ~~~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l  245 (285)
T cd06648         176 VGTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL---PPKLKNLHKVSPRL  245 (285)
T ss_pred             cCCccccCHHHhcC-------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC---CCCCcccccCCHHH
Confidence            69999999999853       357889999999999999999999998777666666554421   11112222478999


Q ss_pred             HHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        252 VNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       252 kdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .+|+.+|+. +|.+||++.+++.||||....
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence            999999999 999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=323.17  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=204.4

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhc---CCCCcceeEEEEEeCCE-----
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKS---KCPYIVNLFYSFQDMNH-----   82 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL---~HPNIVkL~~vfede~~-----   82 (792)
                      |++.+.||.|+||.||++.++.+|..||+|.+.......      ..|..++..+   .||||+++++++.+...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            789999999999999999999999999999997543221      3466666655   59999999999998776     


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|++|||+. ++|.+++.+.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            999999996 5899988765445699999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-CCcC-
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-DTVS-  240 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-~~l~-  240 (792)
                      ...  .....+++.|+|||++..       ..++.++||||+||++|+|++|.+||...+....+..+...... .... 
T Consensus       160 ~~~--~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         160 EMA--LTSVVVTLWYRAPEVLLQ-------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             Ccc--cccccccccccChHHhcc-------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence            322  123358889999999863       35788999999999999999999999887766665555431100 0000 


Q ss_pred             ----------CCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        241 ----------FPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       241 ----------fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                                ++.         ...+++.+.++|.+||+ ||.+||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                      000         02456888999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2e-38  Score=330.14  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=207.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC----
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN----   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~----   81 (792)
                      ...++|++.+.||.|+||.||++.++.+|..||+|.+.......      ..|..+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45689999999999999999999999999999999986543211      46888999999999999999987655    


Q ss_pred             ------EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         82 ------HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        82 ------~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                            .+|+||||+++ ++...+... ...+++..+..++.||+.||.|||++||+|+||+|.||+++.++.+||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                  79999999975 677777543 3468999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC
Q psy13735        156 SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       156 LA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~  235 (792)
                      ++...............+++.|+|||.+..      ...++.++||||+||++|+|++|++||...+.......+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            998765433222233357889999998852      23467899999999999999999999987665444443332100


Q ss_pred             CC-CcCC-----------------------CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        236 ED-TVSF-----------------------PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       236 ~~-~l~f-----------------------P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .. ...+                       .....++..+.+++..||. +|.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00 0000                       0112468899999999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-38  Score=321.74  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=206.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----h-----HHHHHHHHhcCCCCcceeEEEEEeC--CEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----N-----TIERDIMVKSKCPYIVNLFYSFQDM--NHV   83 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----~-----~~E~eIL~kL~HPNIVkL~~vfede--~~l   83 (792)
                      .+|.+.+.||+|+||.||++.+..+|..||+|.+......    .     ..|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5899999999999999999999999999999988543211    1     4588899999999999999998764  568


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      ++||||++|++|.+++..  .+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            999999999999999854  345899999999999999999999999999999999999999999999999999865421


Q ss_pred             CC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        164 GR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       164 ~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ..  .......|++.|+|||.+..       ..++.++|+|||||++|+|++|.+||...........+..  ......+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~  230 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-------EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPML  230 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCC
Confidence            11  11123458999999999863       3578899999999999999999999976654444444432  1122334


Q ss_pred             CCCccccHHHHHHHHHHhhChhhcCChhHHhcCCCc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVF  277 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~DP~kRPTaeEIL~HPwF  277 (792)
                      |.  .+++.+.+|+..|+.+|..||++.+++.|||.
T Consensus       231 p~--~~~~~~~~~i~~~l~~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         231 PD--GVSDACRDFLKQIFVEEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             Cc--ccCHHHHHHHHHHhcCcccCccHHHHhcCCCC
Confidence            44  67899999999999988999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=337.61  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=212.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCC-----EEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMN-----HVY   84 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~-----~ly   84 (792)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+......      ...|..+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            589999999999999999999999999999998764321      156889999999999999999998775     799


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||||++ ++|..++.+  .+.+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++.......
T Consensus        81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            9999996 589888854  3479999999999999999999999999999999999999999999999999998765432


Q ss_pred             C--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc---
Q psy13735        165 R--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV---  239 (792)
Q Consensus       165 ~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l---  239 (792)
                      .  .......|++.|+|||++.+.      ..++.++|+||+||++|+|++|.+||...+....+..+.........   
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSS------SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             cccccccccccccCcCCceeeecc------cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            1  112334689999999998632      26788999999999999999999999887766555554431110000   


Q ss_pred             ---------------------CCC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        240 ---------------------SFP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       240 ---------------------~fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                                           .+. ....+++.+.+||.+||. +|.+||++.+++.||||..+..++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence                                 000 012368899999999999 999999999999999999776543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=324.23  Aligned_cols=253  Identities=28%  Similarity=0.446  Sum_probs=206.9

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeC--CEEEEEEe
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDM--NHVYFIME   88 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede--~~lyLVmE   88 (792)
                      |.+.+.||.|+||.||++.+..+|+.+|+|.+......      ...|..+++.++|||++++++++.+.  +..|+|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            78999999999999999999999999999999876311      14688999999999999999999988  89999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++ ++|..++... ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++...........
T Consensus        81 ~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          81 YMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            996 5888888543 24689999999999999999999999999999999999999999999999999987754432222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC-CCCcCCCC----
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT-EDTVSFPS----  243 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~-~~~l~fP~----  243 (792)
                      ....+++.|+|||.+.+      ...++.++|||||||++|+|++|..||...+.......+..... .....++.    
T Consensus       159 ~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         159 TNRVITLWYRPPELLLG------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             cccccccccCCceeeEc------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            33457889999998752      23578899999999999999999999987776555544433100 00000000    


Q ss_pred             -------------------Ccc-ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        244 -------------------SIR-LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       244 -------------------~~~-lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                                         ... .++.+.+++.+|+. +|.+||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                               011 38899999999999 99999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-38  Score=324.77  Aligned_cols=247  Identities=19%  Similarity=0.332  Sum_probs=210.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ...+|.+.+.||.|+||.||++.+.. +..+|+|.+.......    ..|..+++.++||||+++++++.+...+|+|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34579999999999999999999988 8899999987665422    568889999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++......... .
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~  161 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-S  161 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-c
Confidence            999999999997655567899999999999999999999999999999999999999999999999999876433221 1


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+++.|+|||.+..       ..++.++|||||||++|+|++ |..||...+....+..+..     ....+.....
T Consensus       162 ~~~~~~~~~~~PE~~~~-------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~  229 (261)
T cd05148         162 SDKKIPYKWTAPEAASH-------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-----GYRMPCPAKC  229 (261)
T ss_pred             cCCCCceEecCHHHHcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-----CCcCCCCCCC
Confidence            23346778999999853       367889999999999999998 8999988777777766653     1222333477


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+.+++.+|+. +|.+|||+.+++.
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         230 PQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.9e-38  Score=330.71  Aligned_cols=260  Identities=28%  Similarity=0.400  Sum_probs=213.1

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEE
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSF   77 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vf   77 (792)
                      +.+-.+......|.+.+.||+|+||.||++.+..+|+.||+|.+.......       ..|+.+++.++||||++++++|
T Consensus         5 ~~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~   84 (307)
T cd06607           5 AELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY   84 (307)
T ss_pred             HHhhcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            444445556677999999999999999999999999999999986543321       4688899999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      .+.+..|+||||+. |++.+++... .+.+++..+..++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++
T Consensus        85 ~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          85 LREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             EeCCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcc
Confidence            99999999999996 5777776542 345899999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC
Q psy13735        158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       158 ~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      ......     ....|++.|+|||++...    ....++.++|||||||++|+|++|.+||...+.......+...   .
T Consensus       163 ~~~~~~-----~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~---~  230 (307)
T cd06607         163 SLVSPA-----NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---D  230 (307)
T ss_pred             eecCCC-----CCccCCccccCceeeecc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---C
Confidence            765422     234589999999987421    1245788999999999999999999999876655444433321   1


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ...++ ...++..+.+++.+|+. +|.+||++.+++.||||..
T Consensus       231 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         231 SPTLS-SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             CCCCC-chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            11121 12468899999999999 9999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-38  Score=322.41  Aligned_cols=250  Identities=21%  Similarity=0.319  Sum_probs=207.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCC-----cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSH-----NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tG-----k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|.+.+.||.|+||.||++..+..+     ..||+|.+.......     ..|+.++..++||||+++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            55679999999999999999999887544     889999986554322     46888999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEec
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP--------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD  153 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~--------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiD  153 (792)
                      ..|+||||+++|+|.+++....        .+.+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence            9999999999999999996422        23478889999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhh
Q psy13735        154 FGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       154 FGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl  231 (792)
                      ||+++....... .......+++.|+|||.+..       ..++.++|||||||++|+|++ |.+||...+.......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-------GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhc-------CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence            999876543321 12233457889999999853       357889999999999999998 999998877766666554


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .   .....+|.  ..+..+.+++.+|++ +|.+|||+.+++.
T Consensus       236 ~---~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         236 D---GGHLDLPE--NCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             c---CCCCCCCC--CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3   12233444  568999999999999 9999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-38  Score=319.14  Aligned_cols=249  Identities=19%  Similarity=0.346  Sum_probs=208.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|.+.+.||.|+||.||++... ++..+|+|.+.......   ..|+.+++.++||||+++++++.+...+++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            56789999999999999999999876 45789999988655433   578899999999999999999999899999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++|++|.+++.......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence            99999999999665545689999999999999999999999999999999999999999999999999987653221112


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+++.|+|||.+.+       ..++.++||||+||++|+|++ |+.||.+.+.......+...     ...+.....
T Consensus       162 ~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~  229 (261)
T cd05034         162 EGAKFPIKWTAPEAANY-------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-----YRMPRPPNC  229 (261)
T ss_pred             hccCCCccccCHHHhcc-------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCC
Confidence            22235678999999863       367889999999999999998 99999887776666666441     122223355


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +..+.+++.+|+. +|.+||++.+++.
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         230 PEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            8899999999999 9999999998853

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.2e-38  Score=337.74  Aligned_cols=258  Identities=22%  Similarity=0.376  Sum_probs=207.1

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeC-----CE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDM-----NH   82 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede-----~~   82 (792)
                      ...|.+.+.||.|+||.||++.+..+|..||+|.+......      ...|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999999999999999998653221      14688999999999999999988654     35


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+||||+. ++|.+++..  .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            899999995 789888843  45699999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC------
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE------  236 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~------  236 (792)
                      .. .......|++.|+|||.+...      ..++.++|||||||++|+|++|.+||.+.+.......+......      
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         161 KG-DFMTEYVVTRWYRAPELLLNC------SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             Cc-ccccccccccCccChHHHhcC------CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            32 122344689999999998621      24788999999999999999999999776543333222210000      


Q ss_pred             ------------------CCcCCC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        237 ------------------DTVSFP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       237 ------------------~~l~fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                        ....+. ....+++.+.+||++||+ +|.+|||+.+++.||||..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                              000000 013578999999999999 999999999999999998764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-37  Score=311.39  Aligned_cols=249  Identities=29%  Similarity=0.482  Sum_probs=209.3

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeC--CEEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDM--NHVYFIM   87 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede--~~lyLVm   87 (792)
                      +|.+.+.||+|+||.||++.+..+|..+++|++......      ...|..++++++||||+++++.+.+.  ..+++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            588999999999999999999999999999998776531      15688899999999999999999988  8999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc-
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-  166 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-  166 (792)
                      ||++|++|.+++.+..  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            9999999999996543  6999999999999999999999999999999999999999999999999999877644321 


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-hhhhhhhhhcccCCCCcCCCCCc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                      ......+++.|+|||.+..       ..++.++|+||||+++|+|++|..||...+ .......+..  ......+|.  
T Consensus       159 ~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~--  227 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRG-------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPE--  227 (260)
T ss_pred             cccCCCCCccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCc--
Confidence            1234468999999999863       247889999999999999999999997665 1122222211  112223333  


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .++..+.+|+.+|+. +|.+||++.+++.||||
T Consensus       228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            568999999999999 99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.8e-38  Score=319.97  Aligned_cols=248  Identities=21%  Similarity=0.375  Sum_probs=205.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|+++++||+|+||.||+|..+ +++.||+|.+.......   ..|..+++.++||||+++++++. .+.+|+|||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            45678999999999999999999865 56889999988665543   56889999999999999999875 457899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+.||+|.+++.......+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence            99999999999765556789999999999999999999999999999999999999999999999999977653222222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....++..|+|||++..       ..++.++|||||||++|+|++ |.+||.+.+.......+..     ....+.....
T Consensus       161 ~~~~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~  228 (260)
T cd05067         161 EGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-----GYRMPRPDNC  228 (260)
T ss_pred             cCCcccccccCHHHhcc-------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-----CCCCCCCCCC
Confidence            23346778999999863       357889999999999999998 9999987776665555433     1122233367


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +..+.+++.+|+. +|.+||++.+++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            8899999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.5e-38  Score=320.62  Aligned_cols=247  Identities=19%  Similarity=0.340  Sum_probs=204.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|++.+.||+|+||.||+|... ++..+|+|.+.......   ..|+.++++++||||+++++++. ....|+|||
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence            45678999999999999999999766 55679999987654433   57889999999999999999885 456899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.......+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence            99999999999665555689999999999999999999999999999999999999999999999999987653322221


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....++..|+|||.+..       ..++.++|||||||++|+|++ |.+||.+.+.......+...     ...+.....
T Consensus       161 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~  228 (260)
T cd05070         161 QGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-----YRMPCPQDC  228 (260)
T ss_pred             cCCCCCccccChHHHhc-------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----CCCCCCCcC
Confidence            22235668999998853       367889999999999999999 99999887766666665431     122223467


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      +..+.+|+.+|+. +|.+|||+.++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHH
Confidence            8999999999999 999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.1e-38  Score=330.96  Aligned_cols=250  Identities=22%  Similarity=0.378  Sum_probs=202.7

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEE--EEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeCCE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF--VMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~v--AVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede~~   82 (792)
                      .+..++|.+.+.||+|+||.||+|.++.+|..+  |+|.+.......     ..|+.++.++ +||||+++++++...+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            356789999999999999999999998887654  666654322111     3588889999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH  148 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~  148 (792)
                      +|+||||++||+|.+++.+..              ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999996432              235889999999999999999999999999999999999999999


Q ss_pred             eEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhh
Q psy13735        149 LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTY  227 (792)
Q Consensus       149 VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~  227 (792)
                      ++|+|||++.......  ......+++.|+|||.+..       ..++.++|||||||++|+|++ |.+||...+.....
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  233 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY  233 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhc-------cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence            9999999986432111  1112234668999998863       357889999999999999998 99999877766665


Q ss_pred             hhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        228 SSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       228 ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..+..     ....+.....++.+.+++.+|+. +|.+||++.+++.+
T Consensus       234 ~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         234 EKLPQ-----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHHhc-----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            55533     11112223568899999999999 99999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.5e-38  Score=321.61  Aligned_cols=248  Identities=20%  Similarity=0.346  Sum_probs=205.2

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ...+|.+.+.||+|+||.||++.... +..+|+|.+.......   ..|..++..++||||+++++++.....+|+||||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            45689999999999999999997754 4569999887654432   5688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      +.+|+|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|.||+++.++.+||+|||.+............
T Consensus        81 ~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          81 MSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence            99999999996533 36899999999999999999999999999999999999999999999999998766433222222


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...++..|+|||.+.+       ..++.++|||||||++|+|++ |..||...+.......+....   ....+  ...+
T Consensus       160 ~~~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~--~~~~  227 (256)
T cd05113         160 GSKFPVRWSPPEVLLY-------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL---RLYRP--HLAS  227 (256)
T ss_pred             CCccChhhCCHHHHhc-------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC---CCCCC--CCCC
Confidence            2235678999999863       358889999999999999998 999998777666666665421   11122  2468


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..+.+++.+|+. +|.+||++.+++.+
T Consensus       228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         228 EKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            999999999999 99999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.9e-38  Score=324.86  Aligned_cols=250  Identities=20%  Similarity=0.331  Sum_probs=206.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +...+|.+.+.||.|+||.||+|.+..     ++..||+|.+.......     ..|++++..++||||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            345689999999999999999998753     46889999987654431     46889999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCce
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHL  149 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~V  149 (792)
                      ..|+||||++||+|.+++....            ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999999996432            2457899999999999999999999999999999999999999999


Q ss_pred             EEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhh
Q psy13735        150 KLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTY  227 (792)
Q Consensus       150 KLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~  227 (792)
                      +|+|||++......... ......+++.|+|||++..       ..++.++|||||||++|+|++ |..||...+.....
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhcc-------CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999765322211 1123346789999999863       368889999999999999998 99999877776666


Q ss_pred             hhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        228 SSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       228 ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+..    +....+ ...++..+.+++.+|+. +|.+||++.+++.
T Consensus       235 ~~~~~----~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         235 ECITQ----GRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHc----CCcCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66653    222111 23678999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.9e-38  Score=325.41  Aligned_cols=251  Identities=19%  Similarity=0.317  Sum_probs=205.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe----cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK----QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +..++|++.+.||+|+||.||++...    .++..+|+|.+.......     ..|..+++.++||||+++++++.....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            56789999999999999999999853    456789999987543322     468899999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC
Q psy13735         83 VYFIMEYVTGGDFVTLLENQP---------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~---------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg  147 (792)
                      .|+||||+++|+|.+++....               ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            999999999999999985321               12478899999999999999999999999999999999999999


Q ss_pred             ceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhh
Q psy13735        148 HLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDM  225 (792)
Q Consensus       148 ~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~e  225 (792)
                      .+||+|||++........ .......++..|+|||.+..       ..++.++|+|||||++|+|++ |.+||.+.+...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999987643221 11223346778999999853       358889999999999999998 999998776655


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ....+...   .  ..+....+++.+.+++..|+. +|.+||++.+++++
T Consensus       235 ~~~~~~~~---~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         235 VIEMVRKR---Q--LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHcC---C--cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            55555431   1  122233678999999999999 99999999998765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.1e-38  Score=319.84  Aligned_cols=249  Identities=26%  Similarity=0.449  Sum_probs=204.0

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .++|.+.+.||.|+||.||++++..+|..||+|.+.......       ..|+.+++.++||||+++++++.+.+..|+|
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            368999999999999999999999999999999886543322       4588999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         87 MEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||+++|+|.+++...  ....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            9999999999888532  23458999999999999999999999999999999999999999999999999988765332


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh--hhhhhhhhcccCCCCcCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL--DMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~--~el~ekIl~~~~~~~l~fP  242 (792)
                      . ......|++.|+|||.+..       ..++.++|+||+||++|+|++|..||.....  ......+...   .....+
T Consensus       161 ~-~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  229 (267)
T cd08228         161 T-AAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC---DYPPLP  229 (267)
T ss_pred             H-HHhcCCCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC---CCCCCC
Confidence            1 1223468999999999863       3578899999999999999999999965432  2333333221   111111


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                       ...++..+.+++.+|+. +|.+||++.++++.
T Consensus       230 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         230 -TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             -hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence             12567899999999999 99999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.3e-38  Score=327.76  Aligned_cols=257  Identities=29%  Similarity=0.429  Sum_probs=203.9

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeC------
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDM------   80 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede------   80 (792)
                      ..++|.+.+.||.|+||.||+|.++.+|..+|+|.+......      ...|.++++.++||||+++++++...      
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            368999999999999999999999999999999998654322      25689999999999999999887543      


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         81 --NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        81 --~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                        ..+|+||+|+. +++...+.. ....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          86 KRGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             cCceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence              35799999995 467776643 34569999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCc----------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhh
Q psy13735        159 QVDKNGRI----------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYS  228 (792)
Q Consensus       159 ~l~~~~~~----------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~e  228 (792)
                      ........          ......|++.|+|||.+..      ...++.++||||+||++|+|++|.+||.+.+......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~  237 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH  237 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhC------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            65432211          1122357889999998852      2357889999999999999999999998776655444


Q ss_pred             hhhcccC-------------------CCCcCCCC-----CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        229 SILACDT-------------------EDTVSFPS-----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       229 kIl~~~~-------------------~~~l~fP~-----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .+.....                   ......+.     ...+++.+.+||.+||. +|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            4332100                   00000110     12355789999999999 99999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.3e-38  Score=324.70  Aligned_cols=253  Identities=20%  Similarity=0.364  Sum_probs=207.9

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCC-----cEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSH-----NTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQ   78 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tG-----k~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfe   78 (792)
                      -.+..++|++.+.||+|+||.||++.+...+     ..+|+|.+.......     ..|+.++..+ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            4567789999999999999999999887543     789999887643322     4688889999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQ--------------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS  144 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~--------------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd  144 (792)
                      ..+.+|+||||+++|+|..++.+.              ..+.+++..+..++.||+.||.|||++||+||||||.||+++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999999999999642              235689999999999999999999999999999999999999


Q ss_pred             CCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCC
Q psy13735        145 ATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYET  222 (792)
Q Consensus       145 ~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d  222 (792)
                      .++.+||+|||++......... ......+++.|+|||.+..       ..++.++|||||||++|+|++ |..||....
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-------CCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            9999999999999876532211 1122235678999998753       368889999999999999997 999998777


Q ss_pred             hhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        223 LDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       223 ~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ....+..+...   .....|  ...+..+.+|+.+|+. +|.+|||+.+++.+
T Consensus       240 ~~~~~~~~~~~---~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         240 VEELFKLLKEG---YRMEKP--QNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHHHcC---CcCCCC--CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66666655441   111223  3568899999999999 99999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.1e-38  Score=321.40  Aligned_cols=248  Identities=19%  Similarity=0.353  Sum_probs=204.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +...+|.+.+.||+|+||.||++.+..+ ..+|+|++.......   ..|+.++..++||||+++++++.. ...|+|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            3456899999999999999999988766 469999987655432   568899999999999999998754 56899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||.+...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~  160 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  160 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence            99999999999654445689999999999999999999999999999999999999999999999999987654332222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....++..|+|||....       ..++.++|||||||++|+|++ |..||...........+...     ...+....+
T Consensus       161 ~~~~~~~~y~~PE~~~~-------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~  228 (262)
T cd05071         161 QGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPEC  228 (262)
T ss_pred             cCCcccceecCHhHhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-----CCCCCcccc
Confidence            23346778999998753       368899999999999999999 89999877766666655431     112223467


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +..+.+++.+|+. +|.+||++.+++.
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            8999999999999 9999999998853

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-38  Score=316.23  Aligned_cols=239  Identities=41%  Similarity=0.771  Sum_probs=206.9

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ||.|+||.||++.+..+|..||+|.+.+.....       ..|+.+++.++||||+++++.+.+...+|+||||++|++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999999999999999988765432       5688899999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP  175 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp  175 (792)
                      .+++.+.  +.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......|+.
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~  157 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP  157 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence            9999543  458999999999999999999999999999999999999999999999999998765332 1233446899


Q ss_pred             CccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHH
Q psy13735        176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV  255 (792)
Q Consensus       176 ~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLI  255 (792)
                      .|+|||.+..       ..++.++|+||||+++|+|++|..||...+.......+..    ....+|.  ..+..+.+|+
T Consensus       158 ~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~--~~~~~l~~~i  224 (250)
T cd05123         158 EYLAPEVLLG-------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----DPLRFPE--FLSPEARDLI  224 (250)
T ss_pred             cccChHHhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc----CCCCCCC--CCCHHHHHHH
Confidence            9999999863       2477889999999999999999999987776666666554    3344444  5689999999


Q ss_pred             HHHhh-ChhhcCCh---hHHhcCCCc
Q psy13735        256 QSLVQ-KLDARLNM---DQVLGHPVF  277 (792)
Q Consensus       256 k~LL~-DP~kRPTa---eEIL~HPwF  277 (792)
                      ++|+. ||.+||++   .+++.||||
T Consensus       225 ~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         225 SGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            99999 99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=313.74  Aligned_cols=242  Identities=23%  Similarity=0.384  Sum_probs=205.9

Q ss_pred             eEeeecCceEEEEEEEecC---CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||.|+||.||+|.....   +..||+|.+.......     ..|+.++..++||||+++++++.+...+++||||++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999876   8999999997765432     4688899999999999999999999999999999999


Q ss_pred             CCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         93 GDFVTLLENQP-------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        93 GsL~dlL~r~~-------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |+|.+++....       ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  160 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY  160 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence            99999996531       36689999999999999999999999999999999999999999999999999987754321


Q ss_pred             -cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        166 -IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       166 -~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                       .......+++.|+|||.+..       ..++.++|||||||++|+|++ |..||...+.......+..   ......|.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~  230 (262)
T cd00192         161 YRKKTGGKLPIRWMAPESLKD-------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---GYRLPKPE  230 (262)
T ss_pred             cccccCCCcCccccCHHHhcc-------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCc
Confidence             12233457899999998863       268889999999999999999 6999988877777776664   12223333


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        .+++++.+++.+|+. +|.+||++.+++.|
T Consensus       231 --~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         231 --YCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              668999999999999 99999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.8e-38  Score=315.35  Aligned_cols=247  Identities=28%  Similarity=0.478  Sum_probs=211.2

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +|++.+.||.|+||.||++.++.+|..||+|.+.......      ..|..+++.++||||+++++++.+....|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5899999999999999999999999999999987654332      4678899999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         90 VTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        90 ~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ++|++|..++.+.  ....+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++......   .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence            9999999988652  2345899999999999999999999999999999999999999999999999999876543   2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      .....|++.|+|||.+..       ..++.++|+||+|+++|+|++|+.||...+.......+...   .....+  ..+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~  225 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKG-------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---KYPPIP--PIY  225 (256)
T ss_pred             cccccCCccccCHHHHCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCc--hhh
Confidence            223468999999999863       36788999999999999999999999887766555555431   111222  267


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      +.++.+++.+|+. +|.+||++.+++.||+.
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            8999999999999 99999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.2e-38  Score=317.78  Aligned_cols=240  Identities=23%  Similarity=0.391  Sum_probs=196.0

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      +.||+|+||.||+++++.+|+.+|+|.+.......     ..|.++++.++||||+++++++.....+|+||||++|++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999999999999999876543221     5688899999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc-ccCCCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS-IVPVGT  174 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s-~t~vGT  174 (792)
                      .+++.+. ...+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++........... ....++
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            9998543 34589999999999999999999999999999999999999999999999999876542211111 111234


Q ss_pred             CCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHH
Q psy13735        175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN  253 (792)
Q Consensus       175 p~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkd  253 (792)
                      ..|+|||.+..       ..++.++|||||||++|+|++ |.+||...+.......+...   ....+|  ...+..+.+
T Consensus       160 ~~y~aPE~~~~-------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~  227 (252)
T cd05084         160 VKWTAPEALNY-------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPCP--ELCPDAVYR  227 (252)
T ss_pred             eeecCchhhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC---CCCCCc--ccCCHHHHH
Confidence            57999999863       357889999999999999997 99999766655544444331   112233  366899999


Q ss_pred             HHHHHhh-ChhhcCChhHHhc
Q psy13735        254 FVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       254 LIk~LL~-DP~kRPTaeEIL~  273 (792)
                      |+.+|+. +|.+||++.+++.
T Consensus       228 li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         228 LMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            9999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.2e-38  Score=325.64  Aligned_cols=250  Identities=21%  Similarity=0.354  Sum_probs=205.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +...+|.+.+.||.|+||.||++...     .++..+|+|.+.......    ..|+.++.+++||||+++++++...+.
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            45578999999999999999999853     345678999886543221    568899999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEE
Q psy13735         83 VYFIMEYVTGGDFVTLLENQP-----------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL  151 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~-----------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKL  151 (792)
                      +|+||||+++|+|.+++....           ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            999999999999999996432           234899999999999999999999999999999999999999999999


Q ss_pred             eccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhh
Q psy13735        152 TDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSS  229 (792)
Q Consensus       152 iDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ek  229 (792)
                      +|||++......... ......+++.|+|||.+..       ..++.++|||||||++|+|++ |.+||...........
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999865432211 1122346788999999863       368889999999999999998 9999988777766666


Q ss_pred             hhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        230 ILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       230 Il~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +....   ....+  ...++.+.+|+.+|+. ||.+|||+.+++.
T Consensus       235 i~~~~---~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         235 ITQGR---VLQRP--RTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHcCC---cCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            65421   11222  3578899999999999 9999999999843

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-37  Score=323.19  Aligned_cols=257  Identities=27%  Similarity=0.452  Sum_probs=216.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      -..+.|.+...||.|+||.||++.+..++..||+|++......   ...|.++++.++||||+++++++......|+|+|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3666799999999999999999999989999999999765431   1568899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++|++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ..
T Consensus        96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~  173 (286)
T cd06614          96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KR  173 (286)
T ss_pred             ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hh
Confidence            999999999996532 3699999999999999999999999999999999999999999999999999876543221 22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....|++.|+|||++..       ..++.++|+|||||++|+|++|..||...+.......+...   ....++....++
T Consensus       174 ~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  243 (286)
T cd06614         174 NSVVGTPYWMAPEVIKR-------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK---GIPPLKNPEKWS  243 (286)
T ss_pred             ccccCCcccCCHhHhcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---CCCCCcchhhCC
Confidence            33458899999998853       35788999999999999999999999877665544444331   112223333478


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ..+.+||..|++ +|.+||++.+++.||||...
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            999999999999 99999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.4e-38  Score=335.91  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=200.1

Q ss_pred             eEeeec--CceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQG--NFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsG--sFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      ..||.|  +||+||++.+..+|+.||+|++.......      ..|+.++..++||||++++++|...+.+|+||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999999999999999987654332      4577788889999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc-----
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK-----  167 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~-----  167 (792)
                      |+|.+++.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||.+..........     
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            999999976544568999999999999999999999999999999999999999999999998654332111100     


Q ss_pred             -cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC----------
Q psy13735        168 -SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE----------  236 (792)
Q Consensus       168 -s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~----------  236 (792)
                       .....++..|+|||++...     ...++.++||||+||++|+|++|.+||...........+......          
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQD-----LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             ccccccCccCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence             0112356679999998631     235788999999999999999999999766543333222211000          


Q ss_pred             -------------------------------CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        237 -------------------------------DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       237 -------------------------------~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                                     .....+....+++.+.+|+++||+ ||.+|||+.++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                           001111223467889999999999 99999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0574|consensus

Probab=100.00  E-value=3.7e-40  Score=345.24  Aligned_cols=253  Identities=28%  Similarity=0.472  Sum_probs=222.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      -|.++.+||.|+||.||++.|+.+|+.+|+|.+.......  ..|+.|+++++.|++|++|+.|-....+|||||||..|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            4888999999999999999999999999999998765433  56899999999999999999999999999999999999


Q ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCC
Q psy13735         94 DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG  173 (792)
Q Consensus        94 sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vG  173 (792)
                      ++.+++.. ++..+++.++..+++..+.||.|||...=+|||||..|||++.+|+.||+|||.|.++.+.. ...++..|
T Consensus       114 SiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIG  191 (502)
T KOG0574|consen  114 SISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIG  191 (502)
T ss_pred             cHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCcccc
Confidence            99999964 45679999999999999999999999999999999999999999999999999998886432 34456789


Q ss_pred             CCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHH
Q psy13735        174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN  253 (792)
Q Consensus       174 Tp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkd  253 (792)
                      ||.|||||++...       +|+..+||||||+...+|..|++||..-.+   ...|+-.....+..|..+..+|.++.|
T Consensus       192 TPFWMAPEVI~EI-------GY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~KPE~WS~~F~D  261 (502)
T KOG0574|consen  192 TPFWMAPEVIEEI-------GYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFKKPEEWSSEFND  261 (502)
T ss_pred             CcccccHHHHHHh-------ccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCCChHhhhhHHHH
Confidence            9999999999865       799999999999999999999999965443   233443334455556556689999999


Q ss_pred             HHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        254 FVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       254 LIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ||++||. +|++|-|+-++++|||+++.
T Consensus       262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  262 FIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             HHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            9999999 89999999999999999864

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.9e-38  Score=336.82  Aligned_cols=256  Identities=25%  Similarity=0.434  Sum_probs=208.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC-----
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN-----   81 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~-----   81 (792)
                      ..++|.+++.||.|+||.||++.+..+|..||+|.+.+.....      ..|+.+++.++||||++++++|....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3567999999999999999999999999999999986543221      46889999999999999999997654     


Q ss_pred             -EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         82 -HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        82 -~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                       .+|+||+|+ |++|.+++..   ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence             469999999 8899988843   45899999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC--
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT--  238 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~--  238 (792)
                      ...    .....+++.|+|||.+..      ...++.++|+||+||++|+|++|.+||...+....+..+........  
T Consensus       169 ~~~----~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         169 DSE----MTGYVVTRWYRAPEVILN------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccC----ccccccCCcccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            432    123458999999999852      13578899999999999999999999987665444443332110000  


Q ss_pred             -------------------c---CCC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        239 -------------------V---SFP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       239 -------------------l---~fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                         .   .+. ....+++.+.++|.+||. ||.+|||+.+++.||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                               0   000 013568889999999999 9999999999999999997754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.3e-38  Score=335.29  Aligned_cols=258  Identities=26%  Similarity=0.407  Sum_probs=204.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeC---------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDM---------   80 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede---------   80 (792)
                      ..+|.+.+.||.|+||.||+|.+..+|..||+|.+.......    ..|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999999999999999986654432    5688999999999999999876654         


Q ss_pred             -----CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEecc
Q psy13735         81 -----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDF  154 (792)
Q Consensus        81 -----~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDF  154 (792)
                           ..+|+||||++ ++|.+++..   +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                 36899999996 589888843   45899999999999999999999999999999999999974 557899999


Q ss_pred             CcccccccCCCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhc
Q psy13735        155 GSATQVDKNGRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA  232 (792)
Q Consensus       155 GLA~~l~~~~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~  232 (792)
                      |++.........  ......|++.|+|||.+..      ...++.++|||||||++|+|++|..||...+.......+..
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~  233 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE  233 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhC------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999765422111  1122358899999998752      23578899999999999999999999976655444333322


Q ss_pred             ccC---------------------CCCcCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        233 CDT---------------------EDTVSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       233 ~~~---------------------~~~l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ...                     ......|.   ...++.++.+|+.+||+ ||.+|||+.+++.||||+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence            100                     00000000   12468899999999999 999999999999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.1e-38  Score=329.19  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=208.7

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      |.....||.|+||.||++..+.+|..+|+|.+.......    ..|..+++.++||||++++++|...+..|+||||++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            334568999999999999999999999999885433222    4588899999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      ++|.+++..   +.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++........ ......
T Consensus       102 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  177 (292)
T cd06657         102 GALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV  177 (292)
T ss_pred             CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence            999998743   3589999999999999999999999999999999999999999999999999876643221 223346


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      |++.|+|||.+..       ..++.++|+||+||++|+|++|..||.+.+.......+....   ...++....+++.+.
T Consensus       178 ~~~~y~~pE~~~~-------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~  247 (292)
T cd06657         178 GTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---PPKLKNLHKVSPSLK  247 (292)
T ss_pred             cCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC---CcccCCcccCCHHHH
Confidence            8999999998852       357889999999999999999999998766555444443211   112222235788999


Q ss_pred             HHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        253 NFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      +++.+||. +|.+||++.+++.||||.....
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            99999999 9999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-37  Score=321.51  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=203.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|++.+.||+|+||.||++.++.     ++..||+|.+.......     ..|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            345789999999999999999998653     45689999886543221     46888999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEec
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP--------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD  153 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~--------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiD  153 (792)
                      ..++||||+++|+|.+++.+..        ...++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            9999999999999999986432        12357788999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhh
Q psy13735        154 FGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       154 FGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl  231 (792)
                      ||++......... ......+++.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9998765432211 1122346788999999863       368889999999999999999 799998777666665554


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..   ....++  ...++.+.+++.+|+. +|.+||++.+++.+
T Consensus       236 ~~---~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         236 EG---GLLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cC---CcCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            41   112223  3578899999999999 99999999999764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7e-38  Score=319.87  Aligned_cols=247  Identities=25%  Similarity=0.453  Sum_probs=202.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +++|.+.+.||.|+||.||++.+..+|..||+|.+.......       ..|..+++.++||||++++++|...+.++++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            368999999999999999999999999999999887543322       4688899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         87 MEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||++|++|.+++...  ....+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            9999999999988632  23568999999999999999999999999999999999999999999999999987764332


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh--hhhhhhhcccCCCCcCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD--MTYSSILACDTEDTVSFP  242 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~--el~ekIl~~~~~~~l~fP  242 (792)
                      . ......|++.|+|||.+..       ..++.++|+||+|+++|+|++|..||.+....  .....+...   ..... 
T Consensus       161 ~-~~~~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~-  228 (267)
T cd08229         161 T-AAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DYPPL-  228 (267)
T ss_pred             c-ccccccCCcCccCHHHhcC-------CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC---CCCCC-
Confidence            2 1223468999999999863       35788999999999999999999999754432  222222221   11111 


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      .....++.+.+++.+|+. +|.+|||+.+++
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~  259 (267)
T cd08229         229 PSDHYSEELRQLVNMCINPDPEKRPDITYVY  259 (267)
T ss_pred             CcccccHHHHHHHHHhcCCCcccCCCHHHHH
Confidence            123578899999999999 999999999775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-38  Score=359.61  Aligned_cols=262  Identities=20%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcE-EEEEE--------------eccCCCC-------hHHHHHHHHhcCCC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNT-FVMKK--------------VLREKMP-------NTIERDIMVKSKCP   68 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~-vAVKi--------------I~Ks~~~-------~~~E~eIL~kL~HP   68 (792)
                      ....++|++++.||+|+||.||+|..+..... ++.|.              +.+....       ...|+.++..++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            34457899999999999999999987543322 22221              1111000       14688999999999


Q ss_pred             CcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC
Q psy13735         69 YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQP---HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA  145 (792)
Q Consensus        69 NIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~---~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~  145 (792)
                      |||++++++.+.+..|+||+++ +++|..++....   ........++.|+.||+.||.|||++||+||||||+|||++.
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            9999999999999999999999 567777764321   122456778899999999999999999999999999999999


Q ss_pred             CCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC-CCCCC--
Q psy13735        146 TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYET--  222 (792)
Q Consensus       146 dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P-F~~~d--  222 (792)
                      +|.+||+|||++..+...........+||+.|+|||++.+       ..++.++|||||||++|+|++|..| |....  
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~  375 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-------DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK  375 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence            9999999999998776443333345679999999999863       3688999999999999999998754 43221  


Q ss_pred             hhhhhhhhhcccCCCCcCCC--------------------------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCC
Q psy13735        223 LDMTYSSILACDTEDTVSFP--------------------------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHP  275 (792)
Q Consensus       223 ~~el~ekIl~~~~~~~l~fP--------------------------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HP  275 (792)
                      ....+..+..........+|                          ....++.++.++|.+||+ ||.+|||+.++|.||
T Consensus       376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            11111111110000000011                          012456788899999999 999999999999999


Q ss_pred             CccCC
Q psy13735        276 VFDCL  280 (792)
Q Consensus       276 wF~~i  280 (792)
                      ||...
T Consensus       456 ~f~~~  460 (501)
T PHA03210        456 LFSAE  460 (501)
T ss_pred             hhhcC
Confidence            99864

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-38  Score=336.87  Aligned_cols=257  Identities=22%  Similarity=0.397  Sum_probs=210.2

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCE----
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNH----   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~----   82 (792)
                      ..++|.+...||.|+||.||++.+..++..||+|++.......      ..|+.+++.+.||||+++++++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999999999999999886542211      458899999999999999998876654    


Q ss_pred             --EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         83 --VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        83 --lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                        +|+|+||+ |++|.+++..   +.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence              89999999 7799999853   45999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC--
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT--  238 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~--  238 (792)
                      ...    .....+++.|+|||.+...      ..++.++|||||||++|+|++|+.||.+.+....+..+........  
T Consensus       169 ~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         169 DDE----MTGYVATRWYRAPEIMLNW------MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             ccc----ccCCcccccccCHHHHhCC------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            432    2334689999999998521      2578899999999999999999999987766555544433110000  


Q ss_pred             ----------------------cCCCC-CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCC
Q psy13735        239 ----------------------VSFPS-SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSD  283 (792)
Q Consensus       239 ----------------------l~fP~-~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~  283 (792)
                                            ..++. ...+++.+.+||.+||. +|.+|||+.+++.||||.....+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                                  00000 12358999999999999 99999999999999999976543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-37  Score=329.36  Aligned_cols=249  Identities=20%  Similarity=0.289  Sum_probs=202.7

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcE----EEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNT----FVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~----vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +...+|++.+.||+|+||.||++.+..+|..    ||+|.+.......     ..|+.+++.++||||+++++++... .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            5677899999999999999999998766664    8999886543322     4678899999999999999998765 5


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .++|++|+++|+|.+++... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            78999999999999999653 34589999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..... .....+++.|+|||.+..       ..++.++|||||||++|+|++ |..||.+.........+..     ...
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~  229 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-----GER  229 (316)
T ss_pred             CCcceeccCCccceeecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-----CCC
Confidence            32211 122234678999999863       368899999999999999997 9999987665544333222     222


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +|.....+..+.+++..|+. +|.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33334668899999999999 99999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.9e-37  Score=314.14  Aligned_cols=247  Identities=26%  Similarity=0.454  Sum_probs=202.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|.+.+.||.|+||.||+|.+..+|+.||+|.+.......       ..|+.+++.++||||++++++|.+.+.+++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999886433221       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         88 EYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||++||+|..++...  ....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            999999999998642  234589999999999999999999999999999999999999999999999999876643221


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh--hhhhhhhhcccCCCCcCCCC
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL--DMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~--~el~ekIl~~~~~~~l~fP~  243 (792)
                       ......|++.|+|||.+..       ..++.++|+||+||++|+|++|..||.....  ......+...   .....| 
T Consensus       162 -~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~-  229 (267)
T cd08224         162 -AAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---DYPPLP-  229 (267)
T ss_pred             -ccceecCCccccCHHHhcc-------CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC---CCCCCC-
Confidence             1233468999999999863       3578899999999999999999999965432  2222332221   111112 


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ...++..+.+++.+|+. +|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            12568899999999999 9999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-37  Score=322.18  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=205.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|.+.+.||+|+||.||+|.+..     ++..||+|.+.......     ..|..+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            456789999999999999999999987     78899999886543322     45788999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEEec
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPH-----GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTD  153 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~-----g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKLiD  153 (792)
                      ..|+||||++||+|.+++.+...     ..+++..+..++.||+.||.|||+++++||||||+||+++.++   .+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            99999999999999999965432     2589999999999999999999999999999999999998665   599999


Q ss_pred             cCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhh
Q psy13735        154 FGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       154 FGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl  231 (792)
                      ||+++........ ......+++.|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~  235 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT  235 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999876322111 1112234568999999863       368899999999999999997 999998877666655554


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..   ....+|.  .++..+.+++.+|+. +|.+||++.+++.|
T Consensus       236 ~~---~~~~~~~--~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         236 GG---GRLDPPK--GCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cC---CcCCCCC--CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            31   1223333  678999999999999 99999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=331.40  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=207.9

Q ss_pred             CCceE-EeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------------------hHHHHHHHHhcCCCCcceeEE
Q psy13735         15 SDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------------------NTIERDIMVKSKCPYIVNLFY   75 (792)
Q Consensus        15 ~dY~I-~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------------------~~~E~eIL~kL~HPNIVkL~~   75 (792)
                      ++|.. .+.||.|+||.||+|.+..+|+.||+|.+......                  ...|+.++..++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            46654 57899999999999999999999999998654332                  146889999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         76 SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        76 vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      +|...+.+|+||||+. |+|.+++..  ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence            9999999999999996 689998854  4558999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-------------CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC
Q psy13735        156 SATQVDKNG-------------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET  222 (792)
Q Consensus       156 LA~~l~~~~-------------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d  222 (792)
                      ++.......             ........+++.|+|||.+.+      ...++.++|+|||||++|+|++|.+||...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG------AEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhccc------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            987654110             111122357889999999852      2357889999999999999999999998877


Q ss_pred             hhhhhhhhhccc-------CCCCcCC----------CC-----CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        223 LDMTYSSILACD-------TEDTVSF----------PS-----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       223 ~~el~ekIl~~~-------~~~~l~f----------P~-----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ....+..+....       +......          |.     ....+..+.++|..||. +|.+||++.+++.||||+.
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence            665554443211       0000000          00     12457889999999999 9999999999999999986


Q ss_pred             CC
Q psy13735        280 LD  281 (792)
Q Consensus       280 i~  281 (792)
                      ..
T Consensus       319 ~~  320 (335)
T PTZ00024        319 DP  320 (335)
T ss_pred             CC
Confidence            53

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.4e-38  Score=328.74  Aligned_cols=250  Identities=23%  Similarity=0.363  Sum_probs=195.9

Q ss_pred             CceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCHHHHHH
Q psy13735         27 NFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE  100 (792)
Q Consensus        27 sFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL~dlL~  100 (792)
                      ++|.||.+++..+|+.||+|++.......      ..|+.++..++||||++++++|.+.+.+|++||||++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            45667777777799999999997653222      578899999999999999999999999999999999999999997


Q ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC------cccccCCCC
Q psy13735        101 NQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR------IKSIVPVGT  174 (792)
Q Consensus       101 r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~------~~s~t~vGT  174 (792)
                      ......+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||.+........      .......++
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN  171 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence            65555689999999999999999999999999999999999999999999999998876542211      011223577


Q ss_pred             CCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhh-hhhhccc---------------C---
Q psy13735        175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTY-SSILACD---------------T---  235 (792)
Q Consensus       175 p~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~-ekIl~~~---------------~---  235 (792)
                      +.|+|||++...     ...++.++||||+||++|+|++|..||......... ..+....               .   
T Consensus       172 ~~y~aPE~~~~~-----~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         172 LPWLSPEVLQQN-----LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             ccccCHHHhcCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence            899999998631     235788999999999999999999999755432221 1111000               0   


Q ss_pred             ---------CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        236 ---------EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       236 ---------~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                               ......+....++.++.+|+..||. +|.+|||+.+++.||||+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                     0000111112456789999999999 999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.7e-37  Score=322.35  Aligned_cols=255  Identities=20%  Similarity=0.283  Sum_probs=205.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCC----------------cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCc
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSH----------------NTFVMKKVLREKMPN-----TIERDIMVKSKCPYI   70 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tG----------------k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNI   70 (792)
                      +...+|++++.||+|+||.||+|.+..++                ..+|+|.+.......     ..|+.++..++||||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence            45678999999999999999999877644                568999987654332     458899999999999


Q ss_pred             ceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCce
Q psy13735         71 VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQP---------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNM  141 (792)
Q Consensus        71 VkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~---------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNI  141 (792)
                      ++++++|.++..+++||||+++++|.+++.+..         ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999996532         12589999999999999999999999999999999999


Q ss_pred             EeCCCCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc--CCCCC
Q psy13735        142 LLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT--GSTPF  218 (792)
Q Consensus       142 LLd~dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT--Gk~PF  218 (792)
                      +++.++.++|+|||++........ .......+++.|+|||.+..       ..++.++|||||||++|+|++  |..||
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-------GKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-------CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            999999999999999876543221 11223456789999999863       368899999999999999998  78899


Q ss_pred             CCCChhhhhhhhhcccC--CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        219 NYETLDMTYSSILACDT--EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       219 ~~~d~~el~ekIl~~~~--~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ...+....+..+.....  ......+.....+.++.+++.+|+. ||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            76665555555443210  1111222233567899999999999 9999999999854

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-38  Score=320.97  Aligned_cols=252  Identities=27%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      |.+.+.||.|++|.||+|.+..+|..+|+|.+......      ...|..+++.++||||+++++++.+...+|+||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999999999999999998765543      156888999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      ++ +|.+++... .+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH  157 (283)
T ss_pred             CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence            65 888887553 3568999999999999999999999999999999999999999999999999998775433 11223


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC---------------
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT---------------  235 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~---------------  235 (792)
                      ..+++.|+|||.+..      ...++.++|+||+||++|+|++|+.||...+.......+.....               
T Consensus       158 ~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         158 YVVTRWYRAPELLLG------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccCcccccCcHHHhc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence            458889999999852      23678899999999999999999999977665444333322100               


Q ss_pred             CCCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        236 EDTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       236 ~~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      .....++.         ...++..+.+||.+|+. ||.+||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            00001111         12468899999999999 99999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0603|consensus

Probab=100.00  E-value=1.4e-38  Score=359.59  Aligned_cols=250  Identities=32%  Similarity=0.531  Sum_probs=214.8

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      ..+.|.+...||.|+||.|..|.+..+++.+++|++.+.......|..++... +||||++++++|.+..++|+|||++.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            46789999999999999999999999999999999998866667777776655 69999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe-CCCCceEEeccCcccccccCCCccccc
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL-SATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL-d~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      ||.+.+.+...+  .++ .++..|+++|+.|+.|||++||+||||||+|||+ +..|+++|+|||.++...+.    ..+
T Consensus       400 g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t  472 (612)
T KOG0603|consen  400 GGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT  472 (612)
T ss_pred             ccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcc
Confidence            999988885433  233 7888999999999999999999999999999999 69999999999999987644    445


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-hhhhhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-MTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      +|-|..|+|||++.       ...|+.+|||||||+++|+||+|+.||.....+ ++...|..      ..+.  ..+|.
T Consensus       473 p~~t~~y~APEvl~-------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~------~~~s--~~vS~  537 (612)
T KOG0603|consen  473 PALTLQYVAPEVLA-------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM------PKFS--ECVSD  537 (612)
T ss_pred             cchhhcccChhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC------Cccc--cccCH
Confidence            67889999999996       358999999999999999999999999766555 44444432      2222  48899


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                      .+++|+++||+ ||.+||++.+++.||||-..+..|
T Consensus       538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t~p  573 (612)
T KOG0603|consen  538 EAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPTFP  573 (612)
T ss_pred             HHHHHHHHhccCChhhCcChhhhccCcchhcCCCCC
Confidence            99999999999 999999999999999994444333

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-37  Score=316.64  Aligned_cols=247  Identities=19%  Similarity=0.341  Sum_probs=202.9

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..++|.+...||.|+||.||++....+ ..+|+|.+.......   ..|+.+++.++|||++++++++. .+..|+||||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            446799999999999999999987665 468999876554332   56889999999999999999885 4568999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      +.+|+|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++............
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence            99999999997654556899999999999999999999999999999999999999999999999999876433222222


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...++..|+|||....       ..++.++|||||||++|+|++ |.+||.+.........+...     ...+.....+
T Consensus       162 ~~~~~~~y~~Pe~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~  229 (260)
T cd05069         162 GAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-----YRMPCPQGCP  229 (260)
T ss_pred             CCccchhhCCHHHhcc-------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCcccC
Confidence            2346678999998853       357889999999999999999 99999887776666655431     1122223678


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+.+++.+|+. +|.+||++++++.
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999 9999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-37  Score=327.47  Aligned_cols=253  Identities=19%  Similarity=0.315  Sum_probs=206.6

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEE-----ecCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEE-----KQSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQ   78 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~-----k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfe   78 (792)
                      ..+..++|.+.+.||.|+||.||++..     ..++..+|+|.+.......     ..|..+++++ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            456777999999999999999999975     3356689999887654322     4688999999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      ..+.+|+||||++||+|.+++.+.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999999999976444558999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCC
Q psy13735        159 QVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       159 ~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      ........ ......+++.|+|||.+..       ..++.++||||+||++|+|++ |..||........+......   
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~---  259 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE---  259 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhcc-------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc---
Confidence            66433211 1122346788999998863       357889999999999999998 99999876655444444331   


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                       ....+.....++.+.+|+.+|+. +|.+||++.+++.
T Consensus       260 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         260 -GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             11122223568999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0577|consensus

Probab=100.00  E-value=5.9e-39  Score=357.14  Aligned_cols=248  Identities=28%  Similarity=0.407  Sum_probs=214.2

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      -|.-++.||.|+||.||.+++..+...||||.+..+....       ..|+..|+++.|||++.+.++|-.+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3667889999999999999999999999999998665433       568999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      || -|+-.|++.-. ..++.+.++..|..+.+.||.|||+++.||||||..|||++.+|.|||+|||.|....+     .
T Consensus       107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A  179 (948)
T KOG0577|consen  107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A  179 (948)
T ss_pred             HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence            99 56778887653 35599999999999999999999999999999999999999999999999999987653     3


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      .+++|||+|||||++..+    .-+.|+-++||||||+.+.+|.-.++|+...+....+.-|..   ...+.++ ...||
T Consensus       180 nsFvGTPywMAPEVILAM----DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ---NesPtLq-s~eWS  251 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESPTLQ-SNEWS  251 (948)
T ss_pred             hcccCCccccchhHheec----cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh---cCCCCCC-CchhH
Confidence            466899999999999754    346799999999999999999999999877665555554543   1223333 34789


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      ..++.||..||+ -|..|||.+++|.|+|+.
T Consensus       252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             HHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence            999999999999 699999999999999986

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-37  Score=318.02  Aligned_cols=248  Identities=22%  Similarity=0.373  Sum_probs=204.8

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCc---EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk---~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ...+|++.+.||+|+||.||++.++.++.   .+|+|.+.......     ..|..++..++||||+++++++.+.+.+|
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            45689999999999999999999875543   79999886543322     45788999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||||++||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus        82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          82 IVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999999653 3568999999999999999999999999999999999999999999999999998765332


Q ss_pred             Cccc--ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        165 RIKS--IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       165 ~~~s--~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ....  ....+++.|+|||.+..       ..++.++|+|||||++|++++ |..||...+.......+...     ...
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~  228 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-----YRL  228 (267)
T ss_pred             ceeeecCCCccceeecCHhHhcc-------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-----CcC
Confidence            2111  11223568999999863       368889999999999999886 99999877666666655441     223


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      |....+++.+.+++.+|++ +|.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            4344678999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=315.67  Aligned_cols=246  Identities=17%  Similarity=0.291  Sum_probs=200.3

Q ss_pred             ceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCE-----
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNH-----   82 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~-----   82 (792)
                      |.+.+.||+|+||.||.+....+   +..||+|.+.......      ..|..+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67889999999999999987653   4789999987654332      458889999999999999998765443     


Q ss_pred             -EEEEEeccCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         83 -VYFIMEYVTGGDFVTLLENQ----PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        83 -lyLVmEy~~GGsL~dlL~r~----~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                       .++||||+++|+|..++...    ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             79999999999999888542    2235899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccC
Q psy13735        158 TQVDKNGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       158 ~~l~~~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~  235 (792)
                      +......... .....+++.|+|||.+..       ..++.++|||||||++|+|++ |.+||.+.+....+..+...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--  231 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-------RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--  231 (273)
T ss_pred             eeccccccccccccccCCccccCHhhccc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--
Confidence            8764332211 112235678999998852       367889999999999999999 99999887776666666542  


Q ss_pred             CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        236 EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       236 ~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                       .....|.  .++..+.+++.+|+. ||.+||++.+++.+
T Consensus       232 -~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         232 -NRLKQPE--DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -CCCCCCc--CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1222333  678999999999999 99999999998754

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.8e-38  Score=323.77  Aligned_cols=251  Identities=16%  Similarity=0.231  Sum_probs=207.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecC-----CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQS-----HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~t-----Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +...+|.+.+.||.|+||.||++.+..+     +..+|+|++.......     ..|..++..++||||+++++++....
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            5567899999999999999999987653     5789999987554322     45778889999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQ--------------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~--------------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg  147 (792)
                      ..++++||+.+++|.+++...              ....+++..+..++.|++.||.|||++||+||||||.|||++.++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            999999999999999998421              123578899999999999999999999999999999999999999


Q ss_pred             ceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhh
Q psy13735        148 HLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDM  225 (792)
Q Consensus       148 ~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~e  225 (792)
                      .+||+|||+++....... .......+++.|+|||.+..       ..++.++|||||||++|+|++ |..||.+.....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  234 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  234 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhc-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999886543221 11223346789999999863       357889999999999999998 999998887777


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ....+....   ...+|  ...+..+.+++..|++ +|.+||++.+++.+
T Consensus       235 ~~~~i~~~~---~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         235 VIEMIRNRQ---VLPCP--DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHcCC---cCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            777766522   11223  3678999999999999 99999999999754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5e-37  Score=325.32  Aligned_cols=252  Identities=27%  Similarity=0.391  Sum_probs=207.1

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .+-|...+.||+|+||.||+|.+..+|..||+|.+.......       ..|..+++.++|||++++++++.+....|+|
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            344777889999999999999999999999999987543321       4678899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||+. |++.+++... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....    
T Consensus       100 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         100 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            99995 5787777543 34589999999999999999999999999999999999999999999999999865332    


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                       .....|++.|+|||.+...    ....++.++|||||||++|+|++|.+||...+.......+....   .... ....
T Consensus       174 -~~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~-~~~~  244 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTL-QSNE  244 (313)
T ss_pred             -CCCccccccccChhhcccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---CCCC-Cccc
Confidence             2234689999999998421    12357889999999999999999999998766555444443311   1111 1235


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ++..+.+|+.+||+ +|.+||++.+++.||||+..
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            67889999999999 99999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.3e-37  Score=312.20  Aligned_cols=248  Identities=21%  Similarity=0.363  Sum_probs=205.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ...+|.+.+.||.|+||.||++.+. ++..+|+|.+.......   ..|..+++.++||||+++++++.....+|+||||
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            4578999999999999999999875 46789999887655432   5688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      ++||+|.+++... .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          81 MEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9999999998643 355899999999999999999999999999999999999999999999999998765432211112


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...++..|+|||.+..       ..++.++|||||||++|+|++ |..||...........+...   .....|  ...+
T Consensus       160 ~~~~~~~~~aPe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~  227 (256)
T cd05112         160 GTKFPVKWSSPEVFSF-------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG---FRLYKP--RLAS  227 (256)
T ss_pred             CCccchhhcCHhHhcc-------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC---CCCCCC--CCCC
Confidence            2235678999998863       357889999999999999998 99999877766666665431   111112  2468


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..+.+|+.+|+. +|.+||++.+++++
T Consensus       228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         228 QSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            999999999999 99999999999764

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.6e-38  Score=336.17  Aligned_cols=252  Identities=20%  Similarity=0.338  Sum_probs=200.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEe-
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQD-   79 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfed-   79 (792)
                      +..++|++.+.||.|+||.||+|....     +++.||+|++.......     ..|..++.++ +||||+++++++.. 
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            455689999999999999999997543     45789999886543222     4588899998 79999999998864 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCC-------------------------------------------------------
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPH-------------------------------------------------------  104 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~-------------------------------------------------------  104 (792)
                      ...++++|||++||+|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            4578999999999999999854221                                                       


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-cccccCCCCCCccC
Q psy13735        105 ----GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVA  179 (792)
Q Consensus       105 ----g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~A  179 (792)
                          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..... .......+++.|+|
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                2578999999999999999999999999999999999999999999999999987643222 12223346778999


Q ss_pred             hhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHH
Q psy13735        180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL  258 (792)
Q Consensus       180 PEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~L  258 (792)
                      ||++..       ..++.++|||||||++|+|++ |.+||.+......+.......  .....|  ...++.+.+++.+|
T Consensus       244 PE~~~~-------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~l~~~c  312 (337)
T cd05054         244 PESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG--TRMRAP--EYATPEIYSIMLDC  312 (337)
T ss_pred             cHHhcC-------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc--CCCCCC--ccCCHHHHHHHHHH
Confidence            999863       368899999999999999998 999997654443333332211  111222  35688999999999


Q ss_pred             hh-ChhhcCChhHHhcC
Q psy13735        259 VQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       259 L~-DP~kRPTaeEIL~H  274 (792)
                      ++ +|.+||++.+++.|
T Consensus       313 l~~~p~~RPs~~ell~~  329 (337)
T cd05054         313 WHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99 99999999999775

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=320.27  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=205.9

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEecc
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      |.+.+.||.|+||.||+|....+++.+|+|.+.......     ..|...+..+. ||||+++++++.+.+..|+||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            788999999999999999999999999999987654321     45778888998 999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                       +|+|.+++.......+++..+..++.||+.+|.|||++||+|+||+|.||+++.++.++|+|||++........  ...
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cCC
Confidence             88999988665445689999999999999999999999999999999999999999999999999987653322  223


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC--------------
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE--------------  236 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~--------------  236 (792)
                      ..|+..|+|||++..      ...++.++|+||||+++++|++|.+||........+..+......              
T Consensus       158 ~~~~~~~~aPE~~~~------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         158 YVSTRWYRAPEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcccccCceeeec------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            458999999998752      235788999999999999999999999876654444333210000              


Q ss_pred             -CCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        237 -DTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       237 -~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                       ....++.         ....+..+.+|+..|+. +|.+||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence             0000000         01236889999999999 99999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.5e-37  Score=323.82  Aligned_cols=246  Identities=22%  Similarity=0.357  Sum_probs=200.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCc--EEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHN--TFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk--~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede~~lyLV   86 (792)
                      ++|.+.+.||.|+||.||+|..+.+|.  .+++|.+.......     ..|..++.++ +||||+++++++.....+|+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            689999999999999999999887765  46777765322211     4588888888 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEe
Q psy13735         87 MEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLT  152 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLi  152 (792)
                      |||+++|+|.+++....              .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence            99999999999995422              1358899999999999999999999999999999999999999999999


Q ss_pred             ccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhh
Q psy13735        153 DFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       153 DFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl  231 (792)
                      |||++......  .......++..|+|||.+..       ..++.++|||||||++|+|++ |..||...+.......+.
T Consensus       162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~  232 (297)
T cd05089         162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNY-------SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP  232 (297)
T ss_pred             CcCCCccccce--eccCCCCcCccccCchhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence            99998643211  11111223557999998863       368889999999999999997 999998887777666654


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..     ...+....++..+.+|+.+|+. +|.+||++.+++..
T Consensus       233 ~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         233 QG-----YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             cC-----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            31     1122223678999999999999 99999999999654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.7e-37  Score=314.83  Aligned_cols=244  Identities=20%  Similarity=0.371  Sum_probs=202.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEE-EeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSF-QDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vf-ede~~lyLVmE   88 (792)
                      +...+|.+.+.||+|+||.||++...  |..+|+|.+.......  ..|+.+++.++|||++++++++ .....+|+|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            45678999999999999999999664  7789999886554322  5788999999999999999875 45667999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----  156 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  156 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence            9999999999976554568999999999999999999999999999999999999999999999999987654321    


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....++..|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+...   .....+  ..+
T Consensus       157 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~  224 (256)
T cd05082         157 DTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAP--DGC  224 (256)
T ss_pred             CCCccceeecCHHHHcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCCCC--CCC
Confidence            22345678999999863       367889999999999999997 99999877766665555431   112222  367


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+.+++.+|+. +|.+|||+.+++.
T Consensus       225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         225 PPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            8999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.4e-37  Score=318.49  Aligned_cols=248  Identities=18%  Similarity=0.298  Sum_probs=201.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCc----EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHN----TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk----~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +..++|.+.+.||.|+||+||+|.+..+|.    .||+|++.......     ..|..++..++||||+++++++... .
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            456799999999999999999999887776    48999886544332     4577888999999999999998754 5


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .+++|+|+++|+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            78999999999999998542 35689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .... ......+++.|+|||.+..       ..++.++|||||||++|+|++ |..||...........+...     ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-----~~  229 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILH-------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-----ER  229 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----Cc
Confidence            2211 1112235678999999853       368889999999999999998 99999776655554444331     11


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+.....+..+.+++..|+. ||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22233678999999999999 9999999999974

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7e-37  Score=324.30  Aligned_cols=252  Identities=28%  Similarity=0.386  Sum_probs=209.0

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ...|...+.||+|+||.||++.+..+|..+|+|.+.......       ..|+.+++.++|||++++++++.+....|+|
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            345899999999999999999999999999999987543321       4588899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||+.| +|.+++... ...+++..+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||++......   
T Consensus       104 ~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         104 MEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            999964 777777542 455899999999999999999999999999999999999999999999999998754422   


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                        ....|++.|+|||.+...    ....++.++||||+||++|+|++|..||...+.......+...    .........
T Consensus       179 --~~~~~~~~y~aPE~~~~~----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~  248 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQSNE  248 (317)
T ss_pred             --ccccCCccccChhhhhcC----CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc----cCCCCCCcc
Confidence              234689999999997421    1235788999999999999999999999876655555555441    111122235


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +++.+.+++.+|+. +|.+||++.+++.|||+...
T Consensus       249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            78899999999999 99999999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.3e-37  Score=318.01  Aligned_cols=252  Identities=20%  Similarity=0.330  Sum_probs=207.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|.+.+.||.|+||.||+|+.+.     +.+.+++|.+......     ...|+.++++++||||+++++++.+..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            345789999999999999999999764     3467999988765543     156889999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEecc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPH-------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~-------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                      ..|+||||+++|+|.+++.....       ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999999965431       15899999999999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcc
Q psy13735        155 GSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC  233 (792)
Q Consensus       155 GLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~  233 (792)
                      |++...............+++.|+|||.+..       ..++.++|||||||++|+|++ |..||...........+.. 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~-  233 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA-  233 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence            9987553322222223356788999998863       256788999999999999998 8899977666665555544 


Q ss_pred             cCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        234 DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       234 ~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                         ....++....++..+.+++.+||. +|.+||++.+++.+
T Consensus       234 ---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 ---GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ---CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence               222333334678999999999999 99999999998764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.1e-37  Score=310.20  Aligned_cols=245  Identities=22%  Similarity=0.366  Sum_probs=205.9

Q ss_pred             ceEEeEeeecCceEEEEEEEecCC----cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSH----NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tG----k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +.+.+.||.|+||.||++.+..++    ..+|+|.+.......     ..|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999998876    899999997665431     56889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++|++|.+++.......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            99999999999965433338999999999999999999999999999999999999999999999999998765432222


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+++.|+|||.+..       ..++.++|+||+||++|+|++ |.+||...+.......+....   ....+.  .
T Consensus       161 ~~~~~~~~~y~~Pe~~~~-------~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~--~  228 (258)
T smart00219      161 KKGGKLPIRWMAPESLKD-------GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY---RLPKPE--N  228 (258)
T ss_pred             cccCCCcccccChHHhcc-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCCC--c
Confidence            212237789999999852       368889999999999999998 899998877777666665421   222233  4


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+..+.+++.+|+. +|.+|||+.+++.
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      229 CPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            78999999999999 9999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.8e-37  Score=322.87  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=208.7

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede~~l   83 (792)
                      ..+..++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+.....     ..|..++... .||||+++++++.+...+
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            4567889999999999999999999999999999999997654332     2355555555 499999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      |+||||+ ++++.+++... .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++..+..
T Consensus        90 ~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          90 FICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9999998 45777777543 3468999999999999999999997 5999999999999999999999999999876643


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-hhhhhhhhcccCCCCcCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-DMTYSSILACDTEDTVSF  241 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-~el~ekIl~~~~~~~l~f  241 (792)
                      ...  .....|++.|+|||.+...   ...+.++.++|||||||++|+|++|..||..... ...+..+...   .....
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~  239 (296)
T cd06618         168 SKA--KTRSAGCAAYMAPERIDPP---DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EPPSL  239 (296)
T ss_pred             CCc--ccCCCCCccccCHhhcCCC---CCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CCCCC
Confidence            221  1233588899999998532   1124578899999999999999999999965322 2333333331   12223


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +....++..+.+|+.+||. ||.+||++.+++.||||...
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            3333578999999999999 99999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-37  Score=331.36  Aligned_cols=256  Identities=24%  Similarity=0.401  Sum_probs=206.2

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------   80 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------   80 (792)
                      ..++|.+.+.||+|+||.||++.+..+|..||+|++.+.....      ..|+.++.+++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            3478999999999999999999999999999999987643221      4588999999999999999998643      


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+|++++++ |++|.+++..   ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++...
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            3478999987 8899988843   34899999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC----
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE----  236 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~----  236 (792)
                      ...    .....|++.|+|||++.+      ...++.++||||+||++|+|++|.+||...+.......+......    
T Consensus       171 ~~~----~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T cd07877         171 DDE----MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  240 (345)
T ss_pred             ccc----ccccccCCCccCHHHHhC------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            322    223468999999999853      235788999999999999999999999766554433333221000    


Q ss_pred             --------------------CCcCCCC-CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        237 --------------------DTVSFPS-SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       237 --------------------~~l~fP~-~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                          ....+.. ....++.+.+||..||+ ||.+||++.+++.||||.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                                0000000 12357889999999999 9999999999999999997554

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.6e-37  Score=362.00  Aligned_cols=144  Identities=47%  Similarity=0.805  Sum_probs=132.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      .+++|.+++.||+|+||.||+|.+..+|+.||+|++.+.....       ..|+.++..++||||+++++++.....+||
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            4679999999999999999999999999999999997654322       467888999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      ||||+.||+|.+++..  .+.+++..++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999954  4568999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-37  Score=344.04  Aligned_cols=258  Identities=20%  Similarity=0.295  Sum_probs=205.9

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecC-----CcEEEEEEeccCCCCh-----HHHHHHHHhcC-CCCccee
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQS-----HNTFVMKKVLREKMPN-----TIERDIMVKSK-CPYIVNL   73 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~t-----Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~-HPNIVkL   73 (792)
                      +...+-.+..++|.+++.||+|+||.||+|.+...     +..||+|++.......     ..|+.++..+. |||||++
T Consensus        27 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l  106 (400)
T cd05105          27 PYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNL  106 (400)
T ss_pred             CCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            44456677889999999999999999999987543     3479999986543322     46889999996 9999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHhCC--------------------------------------------------
Q psy13735         74 FYSFQDMNHVYFIMEYVTGGDFVTLLENQP--------------------------------------------------  103 (792)
Q Consensus        74 ~~vfede~~lyLVmEy~~GGsL~dlL~r~~--------------------------------------------------  103 (792)
                      +++|.....+|||||||+||+|.+++....                                                  
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence            999999999999999999999999885421                                                  


Q ss_pred             --------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy13735        104 --------------------------------------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD  139 (792)
Q Consensus       104 --------------------------------------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPe  139 (792)
                                                                  ...+++..+..++.||+.||.|||++||+||||||+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~  266 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR  266 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence                                                        124788889999999999999999999999999999


Q ss_pred             ceEeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCC
Q psy13735        140 NMLLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTP  217 (792)
Q Consensus       140 NILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~P  217 (792)
                      |||++.++.+||+|||++......... ......|++.|+|||.+..       ..++.++|||||||++|+|++ |..|
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt~g~~P  339 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-------NLYTTLSDVWSYGILLWEIFSLGGTP  339 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999865432221 2223357788999999863       368889999999999999997 9999


Q ss_pred             CCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        218 FNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       218 F~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      |..............    .....+....++..+.+++.+|+. +|.+||++.++..
T Consensus       340 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         340 YPGMIVDSTFYNKIK----SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CcccchhHHHHHHHh----cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            976544333322222    111222233678999999999999 9999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.8e-37  Score=314.49  Aligned_cols=249  Identities=20%  Similarity=0.340  Sum_probs=206.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCc---EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk---~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      +..++|...+.||+|+||.||+|..+.++.   .+|+|.+.......     ..|+.++..++||||+++++++.+.+.+
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            456789999999999999999999887665   78999886543322     4588899999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||+++|+|.+++... .+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          82 MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999998653 356899999999999999999999999999999999999999999999999998766432


Q ss_pred             CCccc--ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        164 GRIKS--IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       164 ~~~~s--~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .....  ....+++.|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+...     ..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-----~~  228 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAY-------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-----FR  228 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhc-------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-----CC
Confidence            21111  11123457999999863       357889999999999999997 99999877776666666541     23


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .|.....+..+.+++.+|+. +|.+||++.++++
T Consensus       229 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33334678999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.9e-37  Score=313.13  Aligned_cols=247  Identities=19%  Similarity=0.369  Sum_probs=204.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +...+|.+.+.||+|+||.||++... .+..+|+|.+.......   ..|+.+++.++|+||+++++++.. ...|++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            56789999999999999999999765 45679999887654332   468899999999999999999987 78899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+++|+|.+++.......++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..+........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence            99999999999765556688999999999999999999999999999999999999999999999999987653322222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....++..|+|||.+..       ..++.++|+|||||++|+|++ |.+||...+.......+..     ....+.....
T Consensus       161 ~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~  228 (260)
T cd05073         161 EGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-----GYRMPRPENC  228 (260)
T ss_pred             cCCcccccccCHhHhcc-------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----CCCCCCcccC
Confidence            22345678999999863       357889999999999999998 9999987776665555543     1122223467


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      +..+.+++.+|+. +|.+||++.+++
T Consensus       229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~  254 (260)
T cd05073         229 PEELYNIMMRCWKNRPEERPTFEYIQ  254 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHH
Confidence            8999999999999 999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.5e-37  Score=325.41  Aligned_cols=254  Identities=21%  Similarity=0.350  Sum_probs=204.9

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEec-------CCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEE
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQ-------SHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFY   75 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~-------tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~   75 (792)
                      +-.+..++|.+.+.||+|+||.||++.+..       ++..+|+|.+.......     ..|..++..+ +||||+++++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            344556889999999999999999998754       23579999987643221     4578888888 7999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCce
Q psy13735         76 SFQDMNHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNM  141 (792)
Q Consensus        76 vfede~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNI  141 (792)
                      ++...+.+|+||||+++|+|.+++....              ...++...+..++.||+.||.|||++||+||||||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            9999999999999999999999996532              13488899999999999999999999999999999999


Q ss_pred             EeCCCCceEEeccCcccccccCCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCC
Q psy13735        142 LLSATGHLKLTDFGSATQVDKNGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN  219 (792)
Q Consensus       142 LLd~dg~VKLiDFGLA~~l~~~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~  219 (792)
                      +++.++.++|+|||++.......... .....+++.|+|||++.+       ..++.++|||||||++|+|++ |..||.
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-------CCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999987654221111 111234578999999863       357889999999999999998 999998


Q ss_pred             CCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        220 YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       220 ~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..+.......+...   .....|.  .++.++.+++.+|+. +|.+||++.+++.+
T Consensus       245 ~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         245 GVPVEELFKLLKEG---HRMDKPS--NCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             cCCHHHHHHHHHcC---CCCCCCC--cCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            77766655555431   1122333  678999999999999 99999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.5e-37  Score=315.45  Aligned_cols=250  Identities=19%  Similarity=0.288  Sum_probs=193.0

Q ss_pred             eEeeecCceEEEEEEEec--CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQ--SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~--tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      +.||+|+||.||++....  ....+|+|.+.......     ..|+.+++.++||||+++++.+.....+|+||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999996543  34578888765443221     46788889999999999999999999999999999999


Q ss_pred             CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc-ccc
Q psy13735         94 DFVTLLENQP---HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-KSI  169 (792)
Q Consensus        94 sL~dlL~r~~---~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-~s~  169 (792)
                      +|.+++....   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD  160 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence            9999996533   233567888999999999999999999999999999999999999999999998754322211 122


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCC---Cc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPS---SI  245 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~---~~  245 (792)
                      ...+++.|+|||++.....+.....++.++|||||||++|+|++ |.+||...........+....   ...+|.   ..
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  237 (269)
T cd05042         161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ---DIKLPKPQLDL  237 (269)
T ss_pred             CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc---CccCCCCcccc
Confidence            33467789999998643222233467889999999999999999 889997766555444443311   111111   23


Q ss_pred             cccHHHHHHHHHHhhChhhcCChhHHhc
Q psy13735        246 RLSTAMVNFVQSLVQKLDARLNMDQVLG  273 (792)
Q Consensus       246 ~lS~elkdLIk~LL~DP~kRPTaeEIL~  273 (792)
                      .++..+.+++..|+.||.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~dp~~Rpt~~~v~~  265 (269)
T cd05042         238 KYSDRWYEVMQFCWLDPETRPTAEEVHE  265 (269)
T ss_pred             cCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence            5788899999988889999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-37  Score=331.96  Aligned_cols=254  Identities=26%  Similarity=0.460  Sum_probs=204.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeC------C
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDM------N   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede------~   81 (792)
                      .++|.+...||+|+||.||+|.+..+|..||+|.+.+....      ...|+.+++.++||||++++++|...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            36899999999999999999999999999999998754221      14688999999999999999998754      3


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+||||+. ++|..++    ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus        94 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             eEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            5799999995 5777665    2348999999999999999999999999999999999999999999999999987653


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC----
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED----  237 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~----  237 (792)
                      ..    .....|++.|+|||.+..      ...++.++|||||||++|+|++|+.||.+.+....+..+.......    
T Consensus       169 ~~----~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         169 AE----MTGYVVTRWYRAPEVILN------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CC----CCCceeeecccChhhhcC------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            21    223458899999999852      2357889999999999999999999998776544443333210000    


Q ss_pred             ---------------CcCCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        238 ---------------TVSFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       238 ---------------~l~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                     ...++.      ....++.+.+||.+||+ ||.+||++.+++.||||..+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                           000110      12467889999999999 9999999999999999997653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.6e-37  Score=319.60  Aligned_cols=250  Identities=20%  Similarity=0.343  Sum_probs=203.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +...+|.+.++||+|+||.||+|...     .++..+|+|.+.......    ..|++++..++||||+++++++.+.+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            45678999999999999999999753     356789999876543221    568889999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCce
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPH-------------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHL  149 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~-------------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~V  149 (792)
                      .|+||||+++|+|.+++.+...             ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence            9999999999999999965321             348899999999999999999999999999999999999999999


Q ss_pred             EEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhh
Q psy13735        150 KLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTY  227 (792)
Q Consensus       150 KLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~  227 (792)
                      +|+|||++........ .......+++.|+|||.+..       ..++.++|||||||++|+|++ |.+||.........
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-------RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            9999999876542221 11122345788999998863       368899999999999999998 99999776666555


Q ss_pred             hhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        228 SSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       228 ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+...   .....|  ..+++.+.+++.+|++ ||.+||++.+++.
T Consensus       235 ~~~~~~---~~~~~~--~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         235 ECITQG---RELERP--RTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHcC---ccCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            555431   112222  3678999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.3e-37  Score=315.47  Aligned_cols=248  Identities=27%  Similarity=0.453  Sum_probs=204.5

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC---C------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM---P------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~---~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .|.+.+.||+|+||.||++.+..++..+++|++.....   .      ...|..+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58899999999999999999988877777776654222   1      13577899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         87 MEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        87 mEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||++|++|.+++..  .....+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988853  23456899999999999999999999999999999999999964 679999999987764332


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                      . ......|++.|+|||.+..       ..++.++|+||+|+++|+|++|..||...+.......+...   ....++. 
T Consensus       160 ~-~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-  227 (260)
T cd08222         160 D-LATTFTGTPYYMSPEALKH-------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---PTPSLPE-  227 (260)
T ss_pred             c-cccCCCCCcCccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---CCCCCcc-
Confidence            2 2234468999999998853       35778899999999999999999999876655555554431   1222232 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                       .++.++.++|.+|+. +|.+||++.+++.||||
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         228 -TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -hhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence             678899999999999 99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.4e-37  Score=320.62  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=204.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +...+|.+.+.||.|+||.||+|....     ++..+++|.+.......    ..|+.++..++||||+++++++.....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            456789999999999999999998643     45678888876544322    468889999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH  148 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~  148 (792)
                      .++||||++||+|.+++....              .+.+++..+..++.||+.||.|||++||+||||||.|||++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999996432              245899999999999999999999999999999999999999999


Q ss_pred             eEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhh
Q psy13735        149 LKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMT  226 (792)
Q Consensus       149 VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el  226 (792)
                      ++|+|||++........ .......|++.|+|||.+..       ..++.++|||||||++|+|++ |.+||...+....
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999976543221 11223357889999998863       368889999999999999998 9999987776666


Q ss_pred             hhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        227 YSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       227 ~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ...+.....   ...+  ...+..+.+++.+|+. +|.+||++.+++.
T Consensus       235 ~~~~~~~~~---~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         235 IECITQGRV---LERP--RVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHhCCCC---CCCC--ccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            655544211   1122  2568899999999999 9999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4e-37  Score=315.15  Aligned_cols=246  Identities=18%  Similarity=0.301  Sum_probs=197.9

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCc--EEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe------CCE
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHN--TFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD------MNH   82 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk--~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed------e~~   82 (792)
                      |.+.+.||+|+||.||++....++.  .+|+|.+.......      ..|..+++.++||||+++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578999999999999999887775  58999886543222      457889999999999999987642      235


Q ss_pred             EEEEEeccCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQ----PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~----~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      .++||||+++|+|..++...    ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            79999999999999887421    22448999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCC
Q psy13735        159 QVDKNGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       159 ~l~~~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      ......... .....+++.|+|||.+..       ..++.++|||||||++|+|++ |.+||.+......+..+...   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---  230 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG---  230 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccC-------CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence            765332211 122346778999999863       368889999999999999999 89999887766666666542   


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ....++  ..++..+.+++.+|+. +|.+|||+.+++.+
T Consensus       231 ~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         231 NRLKQP--PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            112223  3678899999999999 99999999998754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2e-37  Score=330.65  Aligned_cols=260  Identities=23%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhc-CCCCcceeEEEEEeC--CEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKS-KCPYIVNLFYSFQDM--NHV   83 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL-~HPNIVkL~~vfede--~~l   83 (792)
                      ..++|.+.+.||+|+||.||+|.+..+|..+|+|.+.+....      ...|..++.++ +||||++++++|...  ..+
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            456899999999999999999999999999999988653211      14688999999 999999999998654  468


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||+. ++|..++...   .+++..+..++.||+.||.|||++||+||||+|+||+++.+|.+||+|||++......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            99999996 5999888442   6899999999999999999999999999999999999999999999999999866433


Q ss_pred             CCc----ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC----
Q psy13735        164 GRI----KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT----  235 (792)
Q Consensus       164 ~~~----~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~----  235 (792)
                      ...    ......|++.|+|||.+..      ...++.++|+|||||++|+|++|++||.+.........+.....    
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLG------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             cccccCcchhcccccccccCceeeec------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            211    1223468999999998752      24578899999999999999999999976654433332221100    


Q ss_pred             --------------------CCCcCCCC-CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        236 --------------------EDTVSFPS-SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       236 --------------------~~~l~fP~-~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                          .....+.. ...++..+.++|.+|++ +|.+|||+.+++.||||..+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                                00000000 12368899999999999 9999999999999999998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.9e-37  Score=314.04  Aligned_cols=248  Identities=22%  Similarity=0.353  Sum_probs=204.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCc---EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk---~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ...+|++.+.||+|+||.||+|..+.+|.   .||+|.+.......     ..|+.+++.+.||||+++++++.+...++
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            45689999999999999999999987765   69999886543221     46889999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||||++||+|.+++... .+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          82 IITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999998653 4568999999999999999999999999999999999999999999999999987654322


Q ss_pred             Cccc--ccCC--CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        165 RIKS--IVPV--GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       165 ~~~s--~t~v--GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      ....  ....  ++..|+|||.+..       ..++.++||||+||++|+|++ |..||...+.......+..     ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-----~~  228 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-----DY  228 (269)
T ss_pred             cccccccccCCCcceeecCHhHhcc-------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-----CC
Confidence            1111  1111  2457999999863       367889999999999999886 9999987776666665533     12


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..|....++..+.+++..|+. +|.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            233334678899999999999 9999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.4e-37  Score=314.88  Aligned_cols=250  Identities=20%  Similarity=0.252  Sum_probs=192.8

Q ss_pred             eEeeecCceEEEEEEEe--cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         21 RFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k--~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      +.||+|+||.||++...  .++..+|+|.+.......     ..|+.+++.++||||+++++++.+...+|+||||++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999764  356789999886544322     45889999999999999999999999999999999999


Q ss_pred             CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc-ccc
Q psy13735         94 DFVTLLENQP---HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-KSI  169 (792)
Q Consensus        94 sL~dlL~r~~---~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-~s~  169 (792)
                      +|.+++....   ...+++..+..++.|++.||.|||+.||+||||||+||+++.+++++|+|||++......... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD  160 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence            9999996432   224577788899999999999999999999999999999999999999999998754432211 122


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCC---Cc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPS---SI  245 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~---~~  245 (792)
                      ...|++.|+|||++.....+.....++.++|||||||++|+|++ |..||...............   ....++.   ..
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  237 (269)
T cd05087         161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE---QQLKLPKPRLKL  237 (269)
T ss_pred             CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc---ccCCCCCCccCC
Confidence            34578899999998633111112346889999999999999996 99999766554443322221   1111111   12


Q ss_pred             cccHHHHHHHHHHhhChhhcCChhHHhc
Q psy13735        246 RLSTAMVNFVQSLVQKLDARLNMDQVLG  273 (792)
Q Consensus       246 ~lS~elkdLIk~LL~DP~kRPTaeEIL~  273 (792)
                      ..++.+.+++..|+.+|.+|||+.+++.
T Consensus       238 ~~~~~~~~l~~~c~~~P~~Rpt~~~l~~  265 (269)
T cd05087         238 PLSDRWYEVMQFCWLQPEQRPSAEEVHL  265 (269)
T ss_pred             CCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence            4678899999999889999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.4e-37  Score=322.51  Aligned_cols=255  Identities=21%  Similarity=0.354  Sum_probs=208.2

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEe-------cCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeE
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEK-------QSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLF   74 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k-------~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~   74 (792)
                      .+-.+...+|.+.+.||+|+||.||+|++.       ..+..+|+|.+.......     ..|+.++..+ +||||++++
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence            345677889999999999999999999753       234579999886543221     4688899999 799999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q psy13735         75 YSFQDMNHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN  140 (792)
Q Consensus        75 ~vfede~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeN  140 (792)
                      +++.....+|+||||+++|+|.+++.+..              ...++...+..++.||+.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999996532              1347888899999999999999999999999999999


Q ss_pred             eEeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCC
Q psy13735        141 MLLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF  218 (792)
Q Consensus       141 ILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF  218 (792)
                      |+++.++.+||+|||++......... ......+++.|+|||++..       ..++.++|||||||++|+|++ |..||
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999876432221 1222346778999999863       368889999999999999998 89999


Q ss_pred             CCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        219 NYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       219 ~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+.+.......+...   .....|  ...+..+.+|+.+|+. +|.+||++.+++..
T Consensus       241 ~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         241 PGIPVEELFKLLKEG---HRMDKP--ANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ccCCHHHHHHHHHcC---CcCCCC--CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            888777777766542   111222  3678999999999999 99999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-37  Score=315.21  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=205.9

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      |++.+.||+|+||.||++.+..+|+.||+|.+.......      ..|+.+++.++||||+++++++.+...+|+||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            678899999999999999999999999999998753211      46888999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      + ++|.+++.+.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........ ....
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~  157 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH  157 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence            7 58999996532 4599999999999999999999999999999999999999999999999999987653322 2223


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC--------------C
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT--------------E  236 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~--------------~  236 (792)
                      ..+++.|+|||.+..      ...++.++|+|||||++|+|++|.+||...+....+..+.....              .
T Consensus       158 ~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         158 EVVTLWYRAPEILLG------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             cccCcCcCChHHhcC------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence            346788999999852      23678899999999999999999999987765544433322000              0


Q ss_pred             CCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        237 DTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       237 ~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ....++.         ...++..+.+++.+||. +|.+||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0001111         11347889999999999 99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.6e-37  Score=308.93  Aligned_cols=239  Identities=23%  Similarity=0.405  Sum_probs=196.7

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ++||+|+||.||++... ++..+|+|.+.......     ..|+.++..++||||+++++++...+..++||||++||+|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            47999999999999865 67899999887554322     4688899999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP  175 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp  175 (792)
                      .+++... ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...............+++
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          80 LSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            9998653 345899999999999999999999999999999999999999999999999998765432211112223567


Q ss_pred             CccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHH
Q psy13735        176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNF  254 (792)
Q Consensus       176 ~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdL  254 (792)
                      .|+|||++..       ..++.++|||||||++|+|++ |..||...........+...   ....++.  .++..+.++
T Consensus       159 ~y~aPE~~~~-------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~~l  226 (250)
T cd05085         159 KWTAPEALNY-------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---YRMSCPQ--KCPDDVYKV  226 (250)
T ss_pred             cccCHHHhcc-------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CCCCCCC--CCCHHHHHH
Confidence            8999999863       357889999999999999998 99999877666655555431   1222333  578999999


Q ss_pred             HHHHhh-ChhhcCChhHHhc
Q psy13735        255 VQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       255 Ik~LL~-DP~kRPTaeEIL~  273 (792)
                      +.+|+. +|.+||++.+++.
T Consensus       227 i~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         227 MQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.1e-37  Score=322.57  Aligned_cols=260  Identities=28%  Similarity=0.378  Sum_probs=211.1

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEE
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSF   77 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vf   77 (792)
                      ++.--+.-....|...+.||.|+||.||+++++.+|..+|+|.+.......       ..|..+++.++|||++++++++
T Consensus         5 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   84 (308)
T cd06634           5 AELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY   84 (308)
T ss_pred             hHhhhcCCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            333344445667999999999999999999999999999999986532211       3588899999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      ......|+||||+. |++.+++... ...+++..+..++.|++.||.|||+++++||||+|.||+++.++.++|+|||++
T Consensus        85 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  162 (308)
T cd06634          85 LREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA  162 (308)
T ss_pred             EcCCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccc
Confidence            99999999999996 5787776443 345899999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC
Q psy13735        158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       158 ~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      ......     ....|++.|+|||.+...    ....++.++|||||||++|+|++|..||...+.......+..    .
T Consensus       163 ~~~~~~-----~~~~~~~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~  229 (308)
T cd06634         163 SIMAPA-----NXFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----N  229 (308)
T ss_pred             eeecCc-----ccccCCccccCHHHHhhc----ccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh----c
Confidence            765432     234589999999998532    123477899999999999999999999976654444333332    1


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      .........++..+.++|.+||. +|.+||++.+++.|||+..
T Consensus       230 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            11111123578899999999999 9999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0197|consensus

Probab=100.00  E-value=1.5e-37  Score=345.79  Aligned_cols=244  Identities=22%  Similarity=0.402  Sum_probs=211.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      ..+.+++.||+|.||.|+.+..+.+ ..+|+|.+....+..   ..|+.||++|+|+|||++++++..+..+|||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3456678999999999999998754 478999988765553   569999999999999999999999899999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      .|+|.++|.....+.+.......++.||+.|++||+++++|||||-..||||+.+..+||+|||+|+.+.++........
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence            99999999765567799999999999999999999999999999999999999999999999999996554332222222


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      --...|.|||.+..       ..++.++|||||||+|+||+| |+.||.+.+..+....+..     .+..|.+...|+.
T Consensus       365 kfPIkWtAPEa~~~-------~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~-----GyRlp~P~~CP~~  432 (468)
T KOG0197|consen  365 KFPIKWTAPEALNY-------GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER-----GYRLPRPEGCPDE  432 (468)
T ss_pred             CCCceecCHHHHhh-------CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc-----cCcCCCCCCCCHH
Confidence            23447999999984       379999999999999999999 9999999998888888865     4556666689999


Q ss_pred             HHHHHHHHhh-ChhhcCChhHH
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQV  271 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEI  271 (792)
                      +-+++..|+. +|++|||...+
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L  454 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETL  454 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHH
Confidence            9999999999 99999998865

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1e-36  Score=324.98  Aligned_cols=257  Identities=23%  Similarity=0.357  Sum_probs=202.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecC--CcEEEEEEeccCCCC------hHHHHHHHHhc-CCCCcceeEEEEEe----CCE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQS--HNTFVMKKVLREKMP------NTIERDIMVKS-KCPYIVNLFYSFQD----MNH   82 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~t--Gk~vAVKiI~Ks~~~------~~~E~eIL~kL-~HPNIVkL~~vfed----e~~   82 (792)
                      +|.+.+.||.|+||.||+|.+..+  +..||+|.+......      ...|+.++..+ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999988  999999998643211      15688899988 59999999987542    356


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|++|+|+. ++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            899999994 689988843  45699999999999999999999999999999999999999999999999999986643


Q ss_pred             CCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-----
Q psy13735        163 NGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-----  234 (792)
Q Consensus       163 ~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-----  234 (792)
                      ....   ......|++.|+|||.+..      ...++.++||||+||++|+|++|.+||...+.......+....     
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            2211   1123468999999998752      2357889999999999999999999997665433332222110     


Q ss_pred             -------------------CCCCcCCCC-CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        235 -------------------TEDTVSFPS-SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       235 -------------------~~~~l~fP~-~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                         ......++. ....+..+.+|+.+||+ +|.+|||+.+++.||||+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                               000011111 12457899999999999 999999999999999998664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1989|consensus

Probab=100.00  E-value=1.3e-37  Score=361.29  Aligned_cols=250  Identities=28%  Similarity=0.470  Sum_probs=209.2

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcC-CCCcceeEEE-EEe------C
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSK-CPYIVNLFYS-FQD------M   80 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~-HPNIVkL~~v-fed------e   80 (792)
                      ....++|.+.|.+|||+.||+|+....|..||+|++.......    ..|+++|++|. |+|||.+++. ...      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            4456789999999999999999999988999999987664333    68999999997 9999999993 221      1


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      -.++|.||||.||.|-+++..+...+|++.++..||++++.||.+||...  |||||||-|||||+.+|++||||||.++
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            35789999999999999998666666999999999999999999999998  9999999999999999999999999987


Q ss_pred             ccccCCCc--------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhh
Q psy13735        159 QVDKNGRI--------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI  230 (792)
Q Consensus       159 ~l~~~~~~--------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekI  230 (792)
                      ........        ......-||.|.|||.+.-    +.+-+.+.++|||+|||+||-|+....||.....    -.|
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl----ysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI  266 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL----YSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI  266 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhh----hcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence            54322100        0011246999999999963    3455789999999999999999999999975432    245


Q ss_pred             hcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       231 l~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ++    +.+.||....+|..+++||+.||+ +|.+||++-|++.+
T Consensus       267 ln----g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  267 LN----GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             Ee----ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            55    778889888999999999999999 99999999988643

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=309.94  Aligned_cols=244  Identities=20%  Similarity=0.369  Sum_probs=205.0

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +...+|.+.+.||.|+||.||++...  |+.+|+|.+......   ...|..+++.++||||+++++++.+....|+|||
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            45679999999999999999999765  789999999766541   1568899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |+++|+|.+++.......+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            99999999999765444699999999999999999999999999999999999999999999999999987632211   


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                       ...++..|+|||.+..       ..++.++|+|||||++|+|++ |..||...+.......+...   .....|  ..+
T Consensus       158 -~~~~~~~~~ape~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~  224 (256)
T cd05039         158 -SGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAP--EGC  224 (256)
T ss_pred             -cCCCcccccCchhhcC-------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---CCCCCc--cCC
Confidence             2235667999998852       357889999999999999997 99999877666655544431   112223  356


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+.+++.+||. +|.+||++.+++.
T Consensus       225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         225 PPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            8999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.3e-37  Score=312.00  Aligned_cols=236  Identities=21%  Similarity=0.355  Sum_probs=193.9

Q ss_pred             EeeecCceEEEEEEE--ecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         22 FIQQGNFGDIYLVEE--KQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        22 ~IGsGsFGtVyla~~--k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      .||+|+||.||++..  ..++..+|+|++.......      ..|+.++..+.||||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999865  4578899999886544322      467889999999999999998864 5679999999999


Q ss_pred             CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc--cccC
Q psy13735         94 DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK--SIVP  171 (792)
Q Consensus        94 sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~--s~t~  171 (792)
                      +|.+++..  .+.+++..+..++.||+.||.|||++||+||||||.||+++.++.++|+|||++..........  ....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            99999954  3468999999999999999999999999999999999999999999999999998765332211  1122


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      .+++.|+|||.+..       ..++.++|||||||++|+|++ |.+||...+.......+...   .....|.  .+++.
T Consensus       159 ~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~---~~~~~~~--~~~~~  226 (257)
T cd05116         159 KWPVKWYAPECMNY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG---ERMECPQ--RCPPE  226 (257)
T ss_pred             CCCccccCHhHhcc-------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC---CCCCCCC--CCCHH
Confidence            34678999998852       367889999999999999998 99999877776666665431   1223343  67999


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHh
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      +.++|..|++ ||.+||++..|.
T Consensus       227 l~~li~~~~~~~p~~Rp~~~~i~  249 (257)
T cd05116         227 MYDLMKLCWTYGVDERPGFAVVE  249 (257)
T ss_pred             HHHHHHHHhccCchhCcCHHHHH
Confidence            9999999999 999999999884

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.3e-37  Score=329.97  Aligned_cols=253  Identities=20%  Similarity=0.350  Sum_probs=199.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEE-----ecCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEe
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEE-----KQSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQD   79 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~-----k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfed   79 (792)
                      .+..++|++.+.||.|+||.||+|.+     ..+++.||+|++.......     ..|+.++..+ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            35677999999999999999999984     3467899999997544322     4688999999 68999999998765


Q ss_pred             C-CEEEEEEeccCCCCHHHHHHhCC-------------------------------------------------------
Q psy13735         80 M-NHVYFIMEYVTGGDFVTLLENQP-------------------------------------------------------  103 (792)
Q Consensus        80 e-~~lyLVmEy~~GGsL~dlL~r~~-------------------------------------------------------  103 (792)
                      . ..+++|||||+||+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 56899999999999999985421                                                       


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-cccccCC
Q psy13735        104 ----------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPV  172 (792)
Q Consensus       104 ----------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~s~t~v  172 (792)
                                ...++...+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++........ .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                      12367888899999999999999999999999999999999999999999999986543221 1122234


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      +++.|+|||.+..       ..++.++|||||||++|+|++ |..||...............  ......|.  ..++.+
T Consensus       243 ~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~  311 (343)
T cd05103         243 LPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--GTRMRAPD--YTTPEM  311 (343)
T ss_pred             CCcceECcHHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc--cCCCCCCC--CCCHHH
Confidence            5678999999853       368889999999999999997 99999765433222222221  11122232  468899


Q ss_pred             HHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        252 VNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       252 kdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+++..|+. +|.+||++.+++.|
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999 99999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-36  Score=309.32  Aligned_cols=241  Identities=19%  Similarity=0.272  Sum_probs=199.6

Q ss_pred             eEeeecCceEEEEEEEec-CCc--EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQ-SHN--TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~-tGk--~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||++.+.. ++.  .+|+|.+.......     ..|..++.+++||||+++++++.+ ..+++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 333  68999998766622     468899999999999999999988 899999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc--cccc
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI--KSIV  170 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~--~s~t  170 (792)
                      |+|.+++.+.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..+......  ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  159 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH  159 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence            99999997644356899999999999999999999999999999999999999999999999999877542221  1112


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ..++..|+|||.+..       ..++.++|||||||++|+|++ |..||...+.......+...    ....+.....+.
T Consensus       160 ~~~~~~y~~pE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  228 (257)
T cd05040         160 LKVPFAWCAPESLRT-------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE----GERLERPEACPQ  228 (257)
T ss_pred             CCCCceecCHHHhcc-------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----CCcCCCCccCCH
Confidence            357789999999863       368889999999999999998 99999877776666665541    112222235689


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+.+++..|+. +|.+||++.+++.
T Consensus       229 ~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         229 DIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHHCCCCcccCCCHHHHHH
Confidence            99999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.3e-36  Score=312.24  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      +..++|.+.+.||.|+||.||++.+..+   ...+|+|.+.......     ..|+.+++.+.||||+++++++.+ ...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            4567899999999999999999987654   3578999886554221     468889999999999999999876 457


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          82 WIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            8999999999999999653 235899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      .........+++.|+|||.+..       ..++.++|||||||++|+|++ |..||...+.......+...   .....|
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~  230 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG---ERLPMP  230 (270)
T ss_pred             cceecCCCCccccccChhhhcc-------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CcCCCC
Confidence            2222223335568999998753       367889999999999999986 99999877766655555431   122233


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        ..+++.+.+++.+|+. +|.+||++.+++.+
T Consensus       231 --~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         231 --PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              3678999999999999 99999999998653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-36  Score=313.21  Aligned_cols=246  Identities=21%  Similarity=0.315  Sum_probs=192.6

Q ss_pred             Cc-eEEeEeeecCceEEEEEE----EecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC--CEE
Q psy13735         16 DF-DIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM--NHV   83 (792)
Q Consensus        16 dY-~I~k~IGsGsFGtVyla~----~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede--~~l   83 (792)
                      +| .+.+.||.|+||+||++.    ...++..+|+|.+.......     ..|+.+++.++||||+++++++...  ..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            45 899999999999998865    34578899999987653321     4688999999999999999988653  468


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||+++|+|.+++..   ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        84 ~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            999999999999999954   34999999999999999999999999999999999999999999999999999876532


Q ss_pred             CCcc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC------
Q psy13735        164 GRIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT------  235 (792)
Q Consensus       164 ~~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~------  235 (792)
                      ....  .....++..|+|||.+..       ..++.++|||||||++|+|++|..||.......  ..+.....      
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~  231 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKE-------NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVV  231 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcc-------cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchh
Confidence            2111  112235678999998853       357889999999999999999999986433211  00000000      


Q ss_pred             ------CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        236 ------EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       236 ------~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                            ......+....++..+.+++..|+. +|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  0011122233678999999999999 9999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-36  Score=320.69  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=204.0

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEec-------CCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQ-------SHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSF   77 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~-------tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vf   77 (792)
                      .+..++|.+.+.||+|+||.||+|.+..       .+..+|+|.+.......     ..|+.++..+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3556789999999999999999998642       34578999887543322     4688889888 599999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL  143 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL  143 (792)
                      .+.+.+|+||||+++|+|.+++....              ...++...+..++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            99999999999999999999996532              2458899999999999999999999999999999999999


Q ss_pred             CCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCC
Q psy13735        144 SATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYE  221 (792)
Q Consensus       144 d~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~  221 (792)
                      +.++.+||+|||+++........ ......+++.|+|||.+..       ..++.++|||||||++|+|++ |..||.+.
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-------CCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999865432111 1112234568999999863       368889999999999999999 99999887


Q ss_pred             ChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        222 TLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       222 d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +....+..+...   .....|.  .++..+.+++.+|+. +|.+||++.+++.
T Consensus       241 ~~~~~~~~~~~~---~~~~~~~--~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         241 PVEELFKLLREG---HRMDKPS--NCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CHHHHHHHHHcC---CCCCCCC--CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            777766666542   1122333  568899999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.6e-36  Score=315.14  Aligned_cols=248  Identities=15%  Similarity=0.230  Sum_probs=197.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcE----EEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNT----FVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~----vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +...+|++.+.||.|+||.||++....+|..    +++|.+.......     ..|..++..+.||||+++++++. ...
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~   82 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS   82 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence            4567999999999999999999999877764    6667664332211     23455677889999999999875 456


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .++|+||+++|+|.+++... .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            78999999999999999653 35689999999999999999999999999999999999999999999999999986643


Q ss_pred             CCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .... ......|++.|+|||.+..       ..++.++|||||||++|+|++ |..||.+.........+...   .  .
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~--~  229 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG---E--R  229 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---C--c
Confidence            3221 2223346778999999863       368899999999999999998 99999877665544444321   1  1


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+.....+.++.+++..|+. +|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            12222457789999999999 9999999999865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=308.65  Aligned_cols=238  Identities=19%  Similarity=0.332  Sum_probs=194.9

Q ss_pred             eEeeecCceEEEEEEEecCC---cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSH---NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tG---k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|....++   ..+|+|.+.......     ..|..+++.+.||||+++++++.. ..+++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            47999999999999876654   789999988766532     467889999999999999998864 468999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc--
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV--  170 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t--  170 (792)
                      |+|.+++.+.  +.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.............  
T Consensus        80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            9999999543  368999999999999999999999999999999999999999999999999998765433221111  


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ..++..|+|||.+..       ..++.++|||||||++|+|++ |.+||...+.......+...   ..  .+....++.
T Consensus       158 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~---~~--~~~~~~~~~  225 (257)
T cd05060         158 GRWPLKWYAPECINY-------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---ER--LPRPEECPQ  225 (257)
T ss_pred             ccccccccCHHHhcC-------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---Cc--CCCCCCCCH
Confidence            123467999998853       358889999999999999998 99999877766655555431   11  222336789


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+.+++.+|+. +|.+||++.+++.
T Consensus       226 ~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         226 EIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999 9999999999854

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=311.85  Aligned_cols=248  Identities=20%  Similarity=0.301  Sum_probs=204.7

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCc----EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHN----TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk----~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +...+|++.+.||+|+||.||++..+.+|.    .+|+|.+.......     ..|+.++..++||||+++++++.. ..
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            456789999999999999999999887765    58999887665432     468889999999999999999987 78


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .++||||+++|+|.+++.+. .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999999653 34589999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..... .....+++.|+|||.+..       ..++.++|+|||||++|+|++ |..||...........+...   ....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~  231 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILH-------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG---ERLP  231 (279)
T ss_pred             cccceecCCCcccccccCHHHhhc-------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC---CCCC
Confidence            32211 111224568999998852       367889999999999999998 99999888777766666541   1222


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .|  ...+..+.+++..|+. +|..||++.+++.
T Consensus       232 ~~--~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         232 QP--PICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            23  3568899999999999 9999999998753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-36  Score=315.89  Aligned_cols=246  Identities=20%  Similarity=0.339  Sum_probs=200.7

Q ss_pred             CceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      +|.+.+.||+|+||.||++....     .+..+|+|.+.......     ..|+.++..++||||+++++.|...+..|+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998753     23568888876544321     468899999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe
Q psy13735         86 IMEYVTGGDFVTLLENQP----------------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL  143 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~----------------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL  143 (792)
                      ||||+.||+|.+++....                      ...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            999999999999985321                      1347889999999999999999999999999999999999


Q ss_pred             CCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCC
Q psy13735        144 SATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYE  221 (792)
Q Consensus       144 d~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~  221 (792)
                      +.++.++|+|||++......... ......++..|+|||.+..       ..++.++|||||||++|+|++ |..||.+.
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-------HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-------CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999865432221 1223346778999998752       358889999999999999998 99999887


Q ss_pred             ChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        222 TLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       222 d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+......+..     ....+....++..+.+|+..|+. +|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERLFNLLKT-----GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHHHHHHhC-----CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            77666555433     12222234678999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.1e-37  Score=314.60  Aligned_cols=244  Identities=25%  Similarity=0.430  Sum_probs=196.8

Q ss_pred             eEEeEeeecCceEEEEEEEe----cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         18 DIKRFIQQGNFGDIYLVEEK----QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .+.+.||.|+||.||+|...    ..+..|++|.+.......     ..|.+++++++||||+++++++.....+++|||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46899999999999999998    456789999995432221     568889999999999999999998888999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-cc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IK  167 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~  167 (792)
                      ||++|+|.+++.......+++.....++.||+.||.|||+++|+|+||+|.||+++.++.+||+|||++........ ..
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~  161 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN  161 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999876456799999999999999999999999999999999999999999999999999987632211 12


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+...|+|||.+...       .++.++||||||+++|+|++ |..||...+.......+...     ...+....
T Consensus       162 ~~~~~~~~~~~aPE~~~~~-------~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-----~~~~~~~~  229 (259)
T PF07714_consen  162 DSSQQLPLRYLAPEVLKDG-------EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-----QRLPIPDN  229 (259)
T ss_dssp             STTSESGGGGS-HHHHHHS-------EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-----EETTSBTT
T ss_pred             ccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccc-----ccceeccc
Confidence            2233467789999999753       48999999999999999999 78999888777777776441     12223336


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++..+.+++..|+. +|.+||++.+++.
T Consensus       230 ~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  230 CPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             SBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             hhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            79999999999999 9999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-36  Score=308.59  Aligned_cols=242  Identities=20%  Similarity=0.342  Sum_probs=200.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      ...+|.+.+.||+|+||.||++.  .++..||+|.+.......  ..|+.++..++||||+++++++... ..|+||||+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            45689999999999999999885  468899999986543322  5688999999999999999998764 579999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      +||+|.+++.......+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.......    ..
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~  156 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DN  156 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----CC
Confidence            99999999976555568999999999999999999999999999999999999999999999999987643211    12


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ..+++.|+|||.+..       ..++.++|+|||||++|+|++ |.+||...+.......+...     ...+....+++
T Consensus       157 ~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~  224 (254)
T cd05083         157 SKLPVKWTAPEALKH-------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-----YRMEPPEGCPA  224 (254)
T ss_pred             CCCCceecCHHHhcc-------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-----CCCCCCCcCCH
Confidence            234678999998852       367889999999999999997 99999887776665555431     11222236789


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+.+++.+|+. +|.+||++.+++.
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-36  Score=314.71  Aligned_cols=250  Identities=20%  Similarity=0.319  Sum_probs=204.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|++.+.||.|+||.||+|.+..     ++..||+|.+.......     ..|+.++..++||||+++++++.+..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            456789999999999999999998753     67899999887543321     45888999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCce
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP--------------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNM  141 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~--------------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNI  141 (792)
                      .+|+||||+++|+|.+++....                    ...+++..+..++.||+.||.|||++|++||||+|.||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999996321                    12478889999999999999999999999999999999


Q ss_pred             EeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCC
Q psy13735        142 LLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN  219 (792)
Q Consensus       142 LLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~  219 (792)
                      +++.++.++|+|||++......... ......+++.|+|||.+.+       ..++.++|||||||++|+|++ |..||.
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-------CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999998765432211 1112235677999998863       368899999999999999997 889998


Q ss_pred             CCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        220 YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       220 ~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +.+.......+....   ....|.  ..+..+.+|+.+|++ +|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~---~~~~~~--~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         235 GMAHEEVIYYVRDGN---VLSCPD--NCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCHHHHHHHHhcCC---CCCCCC--CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            777766666554421   112232  568999999999999 9999999999853

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.7e-36  Score=362.12  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=200.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.......       ..|+.++..++||||+++++++.+.+..|+|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            368999999999999999999999999999999997643321       4688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         87 MEYVTGGDFVTLLENQP---------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~---------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      ||||+||+|.+++.+..         ...++...+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            99999999999986421         123566778899999999999999999999999999999999999999999999


Q ss_pred             cccccCC-----------------CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC
Q psy13735        158 TQVDKNG-----------------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY  220 (792)
Q Consensus       158 ~~l~~~~-----------------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~  220 (792)
                      .......                 .......+||+.|+|||++.+       ..++.++||||+||++|+|++|..||..
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-------~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-------VPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-------CCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            8662110                 001122469999999999863       3678999999999999999999999976


Q ss_pred             CChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        221 ETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       221 ~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+.........   .......+....+++.+.+++.+|+. ||.+||+..+.+.
T Consensus       234 ~~~~ki~~~~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        234 KKGRKISYRDV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             cchhhhhhhhh---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            55433222111   11112222334678999999999999 9999988665543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.4e-37  Score=311.29  Aligned_cols=228  Identities=28%  Similarity=0.458  Sum_probs=189.6

Q ss_pred             cCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCC
Q psy13735         26 GNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHG  105 (792)
Q Consensus        26 GsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g  105 (792)
                      |.||.||+|.++.+|+.||+|.+.+.... ..|...+....||||+++++++.+...+|+||||++||+|.+++.+.  .
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~-~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~   80 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY-SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF--L   80 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhh-hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh--c
Confidence            89999999999999999999999776433 33445555567999999999999999999999999999999998543  4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhh
Q psy13735        106 YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW  185 (792)
Q Consensus       106 ~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~  185 (792)
                      .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||.+......    .....+++.|+|||.+..
T Consensus        81 ~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~  156 (237)
T cd05576          81 NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGI  156 (237)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCC
Confidence            5899999999999999999999999999999999999999999999999988765432    123346788999998752


Q ss_pred             hccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-Chhh
Q psy13735        186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDA  264 (792)
Q Consensus       186 ~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~k  264 (792)
                             ..++.++|+||+||++|+|++|..||......     +.   ......+|.  .+++.+.++|.+|++ ||.+
T Consensus       157 -------~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~---~~~~~~~~~--~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         157 -------SEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN---THTTLNIPE--WVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             -------CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc---cccccCCcc--cCCHHHHHHHHHHccCCHHH
Confidence                   35788999999999999999999988543211     00   011223443  578999999999999 9999


Q ss_pred             cCCh-----hHHhcCCCc
Q psy13735        265 RLNM-----DQVLGHPVF  277 (792)
Q Consensus       265 RPTa-----eEIL~HPwF  277 (792)
                      ||++     .+++.||||
T Consensus       220 R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         220 RLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hcCCCccchHHHHcCCCC
Confidence            9986     899999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.3e-36  Score=310.73  Aligned_cols=250  Identities=18%  Similarity=0.252  Sum_probs=203.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEe-CC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQD-MN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfed-e~   81 (792)
                      +..++|.+.+.||+|+||.||++.+..    ++..+++|.+.......     ..|..+++.++||||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            466899999999999999999999886    35788899876432221     468889999999999999998665 56


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPH------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      ..+++++|+++|+|.+++.....      ..+++..+..++.||+.||.|||+++|+||||+|.||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence            78999999999999999865322      458999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcc
Q psy13735        156 SATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC  233 (792)
Q Consensus       156 LA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~  233 (792)
                      +++.+...... ......++..|+|||.+..       ..++.++|||||||++|++++ |.+||...+.......+.. 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-  234 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-  234 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhc-------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence            99865432211 1112245678999999863       357899999999999999999 9999987776665555443 


Q ss_pred             cCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        234 DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       234 ~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                          ...++....+++.+.+++.+|+. +|.+|||+.+++.
T Consensus       235 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 ----GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ----CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                12222334578999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=305.22  Aligned_cols=239  Identities=24%  Similarity=0.395  Sum_probs=198.1

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      +.||.|+||.||++.+.. |+.||+|.+.......     ..|+.+++++.||||+++++++.+....|+||||++|++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999887 9999999887655432     4688999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc-ccCCCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS-IVPVGT  174 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s-~t~vGT  174 (792)
                      .+++... ...+++..+..++.+++.||.|||++||+||||+|+||+++.++.++|+|||++........... ....++
T Consensus        80 ~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          80 LTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            9998653 34589999999999999999999999999999999999999999999999999976542211111 112345


Q ss_pred             CCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHH
Q psy13735        175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVN  253 (792)
Q Consensus       175 p~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkd  253 (792)
                      ..|+|||.+.+       ..++.++|||||||++|+|++ |..||...........+...     ...+.....+..+.+
T Consensus       159 ~~y~~PE~~~~-------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  226 (251)
T cd05041         159 IKWTAPEALNY-------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-----YRMPAPQLCPEEIYR  226 (251)
T ss_pred             eccCChHhhcc-------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-----CCCCCCccCCHHHHH
Confidence            67999999863       367889999999999999999 89999877766555555431     122223367899999


Q ss_pred             HHHHHhh-ChhhcCChhHHhc
Q psy13735        254 FVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       254 LIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+|+. +|.+||++.+++.
T Consensus       227 li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         227 LMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            9999999 9999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.9e-36  Score=322.77  Aligned_cols=256  Identities=23%  Similarity=0.394  Sum_probs=205.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEe-CCEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQD-MNHVYF   85 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfed-e~~lyL   85 (792)
                      ..++|.+.+.||.|+||.||+|.+..+|..||+|.+.+....      ...|..+++.++||||++++++|.. ...+|+
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            467899999999999999999999999999999988653221      1468999999999999999999875 567999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||||+ +++|..++..   +.+++..+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||++......  
T Consensus        88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--  161 (328)
T cd07856          88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--  161 (328)
T ss_pred             Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence            99999 6789888843   45899999999999999999999999999999999999999999999999998765321  


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-----------
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-----------  234 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-----------  234 (792)
                        .....+++.|+|||.+..      ...++.++||||+||++|+|++|.+||...........+....           
T Consensus       162 --~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         162 --MTGYVSTRYYRAPEIMLT------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             --cCCCcccccccCceeeec------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence              123458899999998752      2357889999999999999999999997665432222111100           


Q ss_pred             -----------CCCCcCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        235 -----------TEDTVSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       235 -----------~~~~l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                 .......|.   ...+++.+.++|.+||+ +|.+||++.+++.||||.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence                       000001111   12467899999999999 9999999999999999985543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.3e-36  Score=314.74  Aligned_cols=255  Identities=21%  Similarity=0.340  Sum_probs=200.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec----------------CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCc
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ----------------SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYI   70 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~----------------tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNI   70 (792)
                      +..++|++.+.||+|+||.||+|.+..                ++..+|+|.+.......     ..|+.+++.++||||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence            456789999999999999999986543                34578999887543321     468899999999999


Q ss_pred             ceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCce
Q psy13735         71 VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQP---------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNM  141 (792)
Q Consensus        71 VkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~---------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNI  141 (792)
                      +++++++...+.+|+||||++||+|.+++....         ...+++..+..++.||+.||.|||+.||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999986532         12467889999999999999999999999999999999


Q ss_pred             EeCCCCceEEeccCcccccccCCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc--CCCCC
Q psy13735        142 LLSATGHLKLTDFGSATQVDKNGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT--GSTPF  218 (792)
Q Consensus       142 LLd~dg~VKLiDFGLA~~l~~~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT--Gk~PF  218 (792)
                      |++.++.++|+|||++..+....... .....+++.|++||....       ..++.++|+|||||++|+|++  |..||
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-------CCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            99999999999999998654322111 112235678999998752       368899999999999999998  78899


Q ss_pred             CCCChhhhhhhhhcc--cCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        219 NYETLDMTYSSILAC--DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       219 ~~~d~~el~ekIl~~--~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ...+...........  .......+|....+++.+.+|+..|+. ||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            766554444332110  001112233334678999999999999 9999999999853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-36  Score=322.77  Aligned_cols=255  Identities=21%  Similarity=0.345  Sum_probs=206.1

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecC-------CcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeE
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQS-------HNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLF   74 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~t-------Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~   74 (792)
                      .+-.+...+|.+++.||+|+||.||+|.+...       +..+|+|.+.......     ..|+.++.++ +||||++++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            44456667899999999999999999987532       2368999876543222     4688899999 799999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q psy13735         75 YSFQDMNHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN  140 (792)
Q Consensus        75 ~vfede~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeN  140 (792)
                      ++|...+.+|+||||+++|+|.+++.+..              ...++...+..++.||+.||.|||++||+||||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            99999999999999999999999996532              2247788899999999999999999999999999999


Q ss_pred             eEeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCC
Q psy13735        141 MLLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF  218 (792)
Q Consensus       141 ILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF  218 (792)
                      ||++.++.+||+|||+++........ ......+++.|+|||++..       ..++.++|||||||++|+|++ |..||
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-------CCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999865432211 1122234568999999863       368889999999999999998 89999


Q ss_pred             CCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        219 NYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       219 ~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+.+.......+...   .....|  ...+..+.+++.+|+. +|.+||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~---~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         238 PGIPVEELFKLLKEG---HRMDKP--ANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCCCHHHHHHHHHcC---CCCCCC--CCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            887777766666441   111222  3568899999999999 99999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-36  Score=312.71  Aligned_cols=251  Identities=20%  Similarity=0.286  Sum_probs=195.9

Q ss_pred             CCceEEeEeeecCceEEEEEEE----ecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC--CEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEE----KQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM--NHV   83 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~----k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede--~~l   83 (792)
                      ..|.+++.||+|+||.||+|..    ..++..||+|.+.......     ..|+.+++.+.||||+++++++.+.  ..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4588999999999999999974    4678899999986543222     4688999999999999999998875  578


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      ++||||++|++|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            9999999999999998653 235899999999999999999999999999999999999999999999999999876533


Q ss_pred             CCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-----------hhhhhh
Q psy13735        164 GRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-----------MTYSSI  230 (792)
Q Consensus       164 ~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-----------el~ekI  230 (792)
                      ...  ......|+..|+|||++..       ..++.++|||||||++|+|++|..|+......           ......
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQ-------SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhcc-------CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            221  1123356778999998852       35788999999999999999987765321100           000000


Q ss_pred             hcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       231 l~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..... .....+....++..+.+|+.+|+. +|.+||++.+++.+
T Consensus       236 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         236 VRVLE-EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHH-cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            00000 111223334678999999999999 99999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-36  Score=310.53  Aligned_cols=239  Identities=23%  Similarity=0.394  Sum_probs=193.0

Q ss_pred             eEeeecCceEEEEEEEecCCcE--EEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNT--FVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~--vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||++..+.+|..  +|+|.+.......     ..|+.++.++ +||||++++++|...+.+|+||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            3689999999999999888764  5778776432222     4588889999 799999999999999999999999999


Q ss_pred             CCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         93 GDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        93 GsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      |+|.+++....              ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            99999996432              1347899999999999999999999999999999999999999999999999986


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      .....  .......+++.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+....+..+...   .
T Consensus       161 ~~~~~--~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~  228 (270)
T cd05047         161 GQEVY--VKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---Y  228 (270)
T ss_pred             ccchh--hhccCCCCccccCChHHHcc-------CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC---C
Confidence            43211  11112234567999999853       368889999999999999997 99999877766666655431   1


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ....+  ...+.++.+++.+|+. +|.+||++.+++.
T Consensus       229 ~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 RLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCC--CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            11222  3568899999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.4e-36  Score=309.55  Aligned_cols=253  Identities=17%  Similarity=0.218  Sum_probs=191.7

Q ss_pred             eEeeecCceEEEEEEEecCC--cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQSH--NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tG--k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      +.||+|+||.||++....++  ..+++|.+.......     ..|+.+++.++||||+++++.|.+...+|+|||||+||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999754432  356677665443221     46778889999999999999999999999999999999


Q ss_pred             CHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-ccccc
Q psy13735         94 DFVTLLENQP--HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIV  170 (792)
Q Consensus        94 sL~dlL~r~~--~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~s~t  170 (792)
                      +|.+++.+..  ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++........ .....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            9999996532  23467778889999999999999999999999999999999999999999999864322111 12234


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      .+|++.|+|||++...........++.++|||||||++|+|++ |..||...+....+..+................+++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE  240 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence            5688999999998532111122356789999999999999997 678987666655555544321111111111235788


Q ss_pred             HHHHHHHHHhhChhhcCChhHHhc
Q psy13735        250 AMVNFVQSLVQKLDARLNMDQVLG  273 (792)
Q Consensus       250 elkdLIk~LL~DP~kRPTaeEIL~  273 (792)
                      .+.+++..|+.+|.+||++.+++.
T Consensus       241 ~~~~l~~~c~~~P~~Rp~~~~i~~  264 (268)
T cd05086         241 RWYEVLQFCWLSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHHhhCcccCCCHHHHHH
Confidence            999999999989999999999854

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=315.42  Aligned_cols=255  Identities=18%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCC--------------cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcce
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSH--------------NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVN   72 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tG--------------k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVk   72 (792)
                      +..++|++.+.||+|+||.||+|.+..++              ..||+|.+.......     ..|++++..++||||++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            34568999999999999999999876432              358999887543322     45889999999999999


Q ss_pred             eEEEEEeCCEEEEEEeccCCCCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceE
Q psy13735         73 LFYSFQDMNHVYFIMEYVTGGDFVTLLENQP----------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML  142 (792)
Q Consensus        73 L~~vfede~~lyLVmEy~~GGsL~dlL~r~~----------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNIL  142 (792)
                      +++++.....+|+|||||+|++|.+++....          ...+++..+..++.||+.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999985421          123688899999999999999999999999999999999


Q ss_pred             eCCCCceEEeccCcccccccCCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc--CCCCCC
Q psy13735        143 LSATGHLKLTDFGSATQVDKNGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT--GSTPFN  219 (792)
Q Consensus       143 Ld~dg~VKLiDFGLA~~l~~~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT--Gk~PF~  219 (792)
                      ++.++.+||+|||++.......... .....+++.|+|||++..       ..++.++|||||||++|+|++  |..||.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-------CCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            9999999999999997654322111 122345778999999863       358899999999999999988  778887


Q ss_pred             CCChhhhhhhhhccc-CCCC-cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        220 YETLDMTYSSILACD-TEDT-VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       220 ~~d~~el~ekIl~~~-~~~~-l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+.......+.... .... .........++.+.+|+.+|+. +|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            766555544432210 0011 1111223568999999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0596|consensus

Probab=100.00  E-value=4.7e-37  Score=341.47  Aligned_cols=261  Identities=25%  Similarity=0.434  Sum_probs=205.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcC-CCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSK-CPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~-HPNIVkL~~vfede~~ly   84 (792)
                      +....|++++.||+||.+.||+|...+. +.||+|.+.-.....      ..|+..|.+|+ |.+||.|++|-..++.+|
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            4566899999999999999999987765 456666554332222      68999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||||= ..+|..+|... .+.++.-.+++|.+||+.|+.++|.+||||.||||-|+|+ -.|.+||+|||+|..+..+.
T Consensus       437 mvmE~G-d~DL~kiL~k~-~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKK-KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEeecc-cccHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence            999985 57999999653 3345545899999999999999999999999999999998 67899999999998876442


Q ss_pred             -CcccccCCCCCCccChhhhhhhccCC----CCCCCCcccccccchhhHHHhhcCCCCCCCCC-hhhhhhhhhcccCCCC
Q psy13735        165 -RIKSIVPVGTPEYVAPEVLEWMEGNH----GSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDT  238 (792)
Q Consensus       165 -~~~s~t~vGTp~Y~APEiL~~~~~~~----~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-~~el~ekIl~~~~~~~  238 (792)
                       ......-+||+.||+||.+.......    ..-..++++||||||||+|+|+.|++||..-. ...-+..|..  ....
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~--P~~~  591 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD--PNHE  591 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC--CCcc
Confidence             22334458999999999998652221    12236789999999999999999999996322 2333344433  2234


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +.||.... ..++.++++.||. ||.+||++.++|+|||...
T Consensus       592 Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  592 IEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            56665332 2339999999999 9999999999999999874

>KOG4645|consensus

Probab=100.00  E-value=3.6e-38  Score=374.24  Aligned_cols=254  Identities=29%  Similarity=0.501  Sum_probs=212.7

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++.-+..||.|.||.||-|.+..+|...|+|-+.-.....      ..|..++..++|||+|+.|++=...+.++|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            4555789999999999999999999999999775443322      6789999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC---c
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR---I  166 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~---~  166 (792)
                      |.||+|.+++..  .+-.+|.....|..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+..+..   .
T Consensus      1316 C~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             hccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            999999999943  44578888889999999999999999999999999999999999999999999998864421   1


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .-....|||.|||||++.+.    ...+.+.++|||||||++.||+||+.||...+..  +.-+.....+..+.+|.  .
T Consensus      1394 el~~~~GT~~YMAPEvit~t----~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~Pq~P~--~ 1465 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGT----KGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKPQIPE--R 1465 (1509)
T ss_pred             HHHhhcCCchhcCchhhccc----ccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCCCCch--h
Confidence            11245799999999999854    2345677899999999999999999999643322  22222233445667777  5


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +|++.++||..||. ||.+|.++.|++.|.|-+.
T Consensus      1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            99999999999999 9999999999999998664

>KOG0983|consensus

Probab=100.00  E-value=3.2e-37  Score=320.61  Aligned_cols=261  Identities=25%  Similarity=0.434  Sum_probs=214.9

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHH------hc-CCCCcceeEEEEEeC
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV------KS-KCPYIVNLFYSFQDM   80 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~------kL-~HPNIVkL~~vfede   80 (792)
                      ++.....++..++..||+|+.|.|++++.+.+|...|||.+.+..-.. .-.+||.      +. .+|+||+.+++|..+
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            344566778888999999999999999999999999999998765432 2223443      33 489999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ..++|.||.|. --+..++.+ ..+.++|.-+-++...++.||.||.+ +||+|||+||+|||+|..|+|||||||++..
T Consensus       164 ~dV~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  164 TDVFICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             chHHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence            99999999993 334555554 44669999999999999999999997 4899999999999999999999999999988


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC-ChhhhhhhhhcccCCCC
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE-TLDMTYSSILACDTEDT  238 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~-d~~el~ekIl~~~~~~~  238 (792)
                      +.+.....  ...|.+.|||||.+.-.    ....|+..+||||||+.+++|.||+.||.+. ...+.+.+|++   ...
T Consensus       242 lvdSkAht--rsAGC~~YMaPERidp~----~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~eP  312 (391)
T KOG0983|consen  242 LVDSKAHT--RSAGCAAYMAPERIDPP----DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEP  312 (391)
T ss_pred             eecccccc--cccCCccccCccccCCC----CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCC
Confidence            76443222  23599999999998632    3567999999999999999999999999764 44566666665   233


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ..+|....+|+++.+|+..||+ |+.+||...++|.|||+...
T Consensus       313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            5667767799999999999999 99999999999999999854

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.7e-36  Score=306.44  Aligned_cols=238  Identities=22%  Similarity=0.367  Sum_probs=191.9

Q ss_pred             EeeecCceEEEEEEEe--cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCC
Q psy13735         22 FIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD   94 (792)
Q Consensus        22 ~IGsGsFGtVyla~~k--~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGs   94 (792)
                      .||.|+||.||++...  .++..+|+|++.......     ..|+.+++.++||||+++++++.. ..+++||||++||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999998765  445679999886553322     468899999999999999998864 57899999999999


Q ss_pred             HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc--ccCC
Q psy13735         95 FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS--IVPV  172 (792)
Q Consensus        95 L~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s--~t~v  172 (792)
                      |.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........  ....
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            99998542 35689999999999999999999999999999999999999999999999999986543322111  1112


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      +++.|+|||.+..       ..++.++|||||||++|+|++ |..||...........+...   ....+|.  ..++++
T Consensus       160 ~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~l  227 (257)
T cd05115         160 WPLKWYAPECINF-------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG---KRLDCPA--ECPPEM  227 (257)
T ss_pred             CCcccCCHHHHcc-------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---CCCCCCC--CCCHHH
Confidence            3578999999863       357889999999999999996 99999877666555444331   1223333  568999


Q ss_pred             HHHHHHHhh-ChhhcCChhHHhc
Q psy13735        252 VNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       252 kdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+++..|+. +|.+||++.++.+
T Consensus       228 ~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         228 YALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999 9999999998843

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG4721|consensus

Probab=100.00  E-value=1.9e-37  Score=344.15  Aligned_cols=243  Identities=23%  Similarity=0.356  Sum_probs=209.8

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      .++...-++-||+|+.|.||+++..  +..||||++..-   ...++..|++|+||||+.+.++|.....+|||||||..
T Consensus       122 PFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  122 PFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             CHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            3344455788999999999999876  689999987543   26678889999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |.|..+|+.  ...+.......|.++|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++....-  .....++
T Consensus       197 GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa  272 (904)
T KOG4721|consen  197 GQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA  272 (904)
T ss_pred             ccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence            999999954  456889999999999999999999999999999999999999999999999999887643  2334568


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      ||..|||||++..       .+.+.++|||||||+||+||||..||..-+...+    +-....+.+.+|-+...+.-++
T Consensus       273 GTVaWMAPEvIrn-------ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVGsNsL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  273 GTVAWMAPEVIRN-------EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVGSNSLHLPVPSTCPDGFK  341 (904)
T ss_pred             hhHhhhCHHHhhc-------CCcccccceehhHHHHHHHHhcCCCccccchhee----EEeccCCcccccCcccCchHHH
Confidence            9999999999984       4899999999999999999999999976554433    3333446677777778899999


Q ss_pred             HHHHHHhh-ChhhcCChhHHhcCC
Q psy13735        253 NFVQSLVQ-KLDARLNMDQVLGHP  275 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTaeEIL~HP  275 (792)
                      -|++.|+. +|.+||++.+||.|-
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHH
Confidence            99999999 999999999999994

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.8e-36  Score=308.61  Aligned_cols=251  Identities=20%  Similarity=0.298  Sum_probs=194.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEE----ecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEe--CCEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEE----KQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQD--MNHV   83 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~----k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfed--e~~l   83 (792)
                      -.+|++.+.||+|+||.||++..    ..+|..||+|.+.......    ..|+.++..++||||+++++++..  ...+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            45899999999999999999974    4578899999986554321    468899999999999999998753  3578


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||++||+|.+++.+. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            9999999999999999643 345899999999999999999999999999999999999999999999999999876533


Q ss_pred             CCccc--ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------
Q psy13735        164 GRIKS--IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------  234 (792)
Q Consensus       164 ~~~~s--~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------  234 (792)
                      .....  ....++..|+|||.+..       ..++.++|||||||++|+|++|..|+...... ....+....       
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhcc-------CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence            22111  11123456999999863       35788999999999999999988776433211 111000000       


Q ss_pred             -----CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        235 -----TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       235 -----~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                           ......++....++..+.+|+.+|+. +|.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                 00112233344678999999999999 9999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-36  Score=311.13  Aligned_cols=235  Identities=19%  Similarity=0.276  Sum_probs=188.6

Q ss_pred             eEeeecCceEEEEEEEecCCcE-------EEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNT-------FVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~-------vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +.||.|+||.||+|.++.++..       +|+|.+.......    ..|..++..+.||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            3699999999999998765543       8888775543221    4577888999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc--------eEEeccCcccccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH--------LKLTDFGSATQVD  161 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~--------VKLiDFGLA~~l~  161 (792)
                      |++|+|..++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.        ++++|||++....
T Consensus        81 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          81 VKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             CCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            9999999999653 235899999999999999999999999999999999999987664        6999999987654


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ..     ....|++.|+|||++..      ...++.++|||||||++|+|++| .+||...+...... +..    ....
T Consensus       160 ~~-----~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~----~~~~  223 (258)
T cd05078         160 PK-----EILLERIPWVPPECIEN------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE----DRHQ  223 (258)
T ss_pred             Cc-----hhccccCCccCchhccC------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH----cccc
Confidence            22     23458899999999863      23578899999999999999998 56766554433222 222    2233


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +|.  ..+..+.+++.+||+ +|.+|||+.+++..
T Consensus       224 ~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         224 LPA--PKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            444  456889999999999 99999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.6e-36  Score=332.97  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=203.2

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhcC-CCCcceeEEEEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKSK-CPYIVNLFYSFQ   78 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~-HPNIVkL~~vfe   78 (792)
                      -.+..++|.+++.||+|+||.||+|++.     .++..||+|++.......     ..|+.++..+. |||||++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3456678889999999999999999864     355789999997653322     46889999997 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCC------------------------------------------------------
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPH------------------------------------------------------  104 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~------------------------------------------------------  104 (792)
                      ..+.+|+|||||+||+|.+++.+...                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999964311                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceE
Q psy13735        105 ------------------------------------------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML  142 (792)
Q Consensus       105 ------------------------------------------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNIL  142 (792)
                                                                ..++...+..|+.||+.||.|||+.+|+||||||.|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                      23677788999999999999999999999999999999


Q ss_pred             eCCCCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCC
Q psy13735        143 LSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNY  220 (792)
Q Consensus       143 Ld~dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~  220 (792)
                      ++.++.+||+|||++........ .......|++.|+|||.+..       ..++.++|||||||++|+|++ |..||..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-------NLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-------CCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999986543221 11223357889999999863       357889999999999999998 8999976


Q ss_pred             CChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        221 ETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       221 ~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..............  .....|  ..++..+.+++..|+. +|.+||++.+++..
T Consensus       345 ~~~~~~~~~~~~~~--~~~~~p--~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         345 LPMNEQFYNAIKRG--YRMAKP--AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCchHHHHHHHHcC--CCCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55444333332211  112233  3678999999999999 99999999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.9e-36  Score=306.61  Aligned_cols=241  Identities=24%  Similarity=0.369  Sum_probs=195.5

Q ss_pred             eEeeecCceEEEEEEEecCC------cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         21 RFIQQGNFGDIYLVEEKQSH------NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tG------k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +.||.|+||.||++..+..+      ..+|+|.+.+.....     ..|..+++.++||||+++++++.+....|+||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999987544      689999886543221     5688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-----ceEEeccCcccc
Q psy13735         90 VTGGDFVTLLENQ-----PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-----HLKLTDFGSATQ  159 (792)
Q Consensus        90 ~~GGsL~dlL~r~-----~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-----~VKLiDFGLA~~  159 (792)
                      ++||+|.+++.+.     ....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++     .++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999999643     224478999999999999999999999999999999999998877     899999999876


Q ss_pred             cccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCC
Q psy13735        160 VDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       160 l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      ...... .......+++.|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+..   ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~  230 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLD-------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA---GG  230 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHcc-------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---CC
Confidence            542211 11122346788999999863       367899999999999999998 9999987766555555432   12


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ....+  ..++..+.+++.+||. +|.+||++.+++.
T Consensus       231 ~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 RLQKP--ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccCCc--ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            22223  3678999999999999 9999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.8e-36  Score=313.18  Aligned_cols=249  Identities=18%  Similarity=0.294  Sum_probs=200.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCc----EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHN----TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk----~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +...+|++.+.||+|+||.||++.+..+|.    .+|+|.+.......     ..|..++..++||||+++++++... .
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            456789999999999999999999988776    46888876554322     4678899999999999999998764 4


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .+++++|+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            67999999999999998643 34589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .... ......+++.|+|||.+.+       ..++.++|||||||++|+|++ |..||.+.........+..     ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~  229 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-----GER  229 (303)
T ss_pred             cccccccCCCccccccCCHHHhcc-------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-----CCC
Confidence            3221 1223346778999999863       368889999999999999997 9999977655444333322     112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ++.....+..+.+++..|+. +|.+||++.+++..
T Consensus       230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            23333568899999999999 99999999998664

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-35  Score=301.29  Aligned_cols=241  Identities=20%  Similarity=0.286  Sum_probs=189.3

Q ss_pred             eEeeecCceEEEEEEEec---CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEE-eCCEEEEEEeccC
Q psy13735         21 RFIQQGNFGDIYLVEEKQ---SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQ-DMNHVYFIMEYVT   91 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~---tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfe-de~~lyLVmEy~~   91 (792)
                      +.||+|+||.||+|....   .+..+|+|.+.......     ..|..+++.++||||+++++++. .++..|+||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998754   34579999875433211     45788899999999999999765 4566899999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC---ccc
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR---IKS  168 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~---~~s  168 (792)
                      +|+|.+++.+. ...++...+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++........   ...
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            99999999653 33467888899999999999999999999999999999999999999999999976542211   011


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+++.|+|||.+..       ..++.++|||||||++|+|++ |.+||...+.......+...   .....+  ...
T Consensus       160 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~  227 (262)
T cd05058         160 TGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG---RRLLQP--EYC  227 (262)
T ss_pred             ccCcCCccccChhHhcc-------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC---CCCCCC--CcC
Confidence            12246778999998853       367889999999999999999 57778766655555544331   112222  356


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ++.+.+++..|+. +|.+||++.+++..
T Consensus       228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         228 PDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            8899999999999 99999999998653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG2345|consensus

Probab=100.00  E-value=9.2e-37  Score=314.00  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=209.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEe-----CCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQD-----MNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfed-----e~~   82 (792)
                      ++.++|+|.+.||.|||+.||+|++-.++..||+|+|.......    ..|++..++++|||+++++++...     ...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            46678999999999999999999999999999999998766333    678999999999999999876532     345


Q ss_pred             EEEEEeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      .||+++|...|+|.+.+.+.  .+..++|..+..|+.+|++||.+||+..  .+||||||.|||++.++.++|+|||.++
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999999753  3346899999999999999999999998  9999999999999999999999999987


Q ss_pred             ccccCC--C-------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhh
Q psy13735        159 QVDKNG--R-------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSS  229 (792)
Q Consensus       159 ~l~~~~--~-------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ek  229 (792)
                      ...-.-  .       ... .-..|..|.|||.+...    .....+.++|||||||++|.|+.|..||...-.  .-..
T Consensus       178 ~a~i~i~~~~~a~~lQe~a-~e~Ct~pyRAPELf~vk----~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~GgS  250 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWA-EERCTIPYRAPELFNVK----SHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--QGGS  250 (302)
T ss_pred             ccceEeechHHHHHHHHHH-HHhCCCcccCchheecc----cCcccccccchhhhhHHHHHHHHcCCcchHHhh--cCCe
Confidence            653110  0       000 11368899999999754    233578899999999999999999999963211  0011


Q ss_pred             hhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        230 ILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       230 Il~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +.-....+.+.+|....+|+.+..+|+.||+ ||.+||++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1112233677888888899999999999999 99999999999765

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-35  Score=304.26  Aligned_cols=246  Identities=23%  Similarity=0.429  Sum_probs=200.9

Q ss_pred             CceEEeEeeecCceEEEEEEEec-CCcEEEEEEeccCCCC--------h------HHHHHHHH-hcCCCCcceeEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQ-SHNTFVMKKVLREKMP--------N------TIERDIMV-KSKCPYIVNLFYSFQD   79 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~-tGk~vAVKiI~Ks~~~--------~------~~E~eIL~-kL~HPNIVkL~~vfed   79 (792)
                      +|.+.+.||+|+||.||++.+.. +++.+|+|.+......        .      ..|..++. .++||||++++++|..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58899999999999999999988 7889999988543211        0      34566665 4789999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                      .+.+|+||||++|++|.+++..  .....+++..++.++.|++.||.|||+ .||+|+||+|.||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743  234568999999999999999999996 7899999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC
Q psy13735        157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       157 A~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      +.......  ......|++.|+|||.+..       ..++.++|+||||+++|+|++|.+||...+.......+...   
T Consensus       161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---  228 (269)
T cd08528         161 AKQKQPES--KLTSVVGTILYSCPEIVKN-------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA---  228 (269)
T ss_pred             eeeccccc--ccccccCcccCcChhhhcC-------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhc---
Confidence            98765432  2234568999999999863       35788999999999999999999999877665555555431   


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                       .........+++.+.+++.+|+. ||.+||++.++..+
T Consensus       229 -~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         229 -VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence             11111223568999999999999 99999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-35  Score=305.85  Aligned_cols=235  Identities=19%  Similarity=0.226  Sum_probs=185.6

Q ss_pred             eEeeecCceEEEEEEEecC------------CcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         21 RFIQQGNFGDIYLVEEKQS------------HNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~t------------Gk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      +.||.|+||.||++.....            ...+|+|.+.......    ..|..++..++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999985422            2357888765443221    45678899999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc-------eEEeccCcc
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH-------LKLTDFGSA  157 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~-------VKLiDFGLA  157 (792)
                      +||||+++|+|..++.+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.       ++++|||++
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            999999999998888543 356899999999999999999999999999999999999987664       899999998


Q ss_pred             cccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhh-cCCCCCCCCChhhhhhhhhcccCC
Q psy13735        158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL-TGSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       158 ~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELL-TGk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      ......     ....|++.|+|||++..      ...++.++|||||||++|+|+ .|..||.......... +..    
T Consensus       160 ~~~~~~-----~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~----  223 (262)
T cd05077         160 ITVLSR-----QECVERIPWIAPECVED------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYE----  223 (262)
T ss_pred             ccccCc-----ccccccccccChhhhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHh----
Confidence            765322     23458889999998752      246888999999999999998 5899987654433221 111    


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ......  ...++++.+++.+|++ ||.+||++.+|+.+
T Consensus       224 ~~~~~~--~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         224 GQCMLV--TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             cCccCC--CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            111111  2346789999999999 99999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0662|consensus

Probab=100.00  E-value=1.7e-36  Score=300.27  Aligned_cols=257  Identities=24%  Similarity=0.415  Sum_probs=217.1

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ..|.-.++||+|.||+||+++++.++..||+|.+.-.....      ..|+-+++.++|.|||+++++...+..+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            45777899999999999999999999999999997655433      689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      || ..+|..+... -+|.++.+.++.+|.|++.||.|||+++++|||+||.|+||+.+|.+||+|||+++-++-.... .
T Consensus        82 ~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc-y  158 (292)
T KOG0662|consen   82 FC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-Y  158 (292)
T ss_pred             Hh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-e
Confidence            99 5688888765 3577999999999999999999999999999999999999999999999999999987643221 2


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcc-------cCCCCc-
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC-------DTEDTV-  239 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~-------~~~~~l-  239 (792)
                      +..+-|.+|.+|.++.+      ..-|+...||||.|||+.++.. |++.|.+.+.++....|...       .|+..- 
T Consensus       159 saevvtlwyrppdvlfg------akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             eceeeeeeccCcceeee------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            23467999999999963      4679999999999999999987 88999999998888888651       222211 


Q ss_pred             --------CCCCC-------ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        240 --------SFPSS-------IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       240 --------~fP~~-------~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                              .||..       ..++...+|+++.+|. +|.+|++++.+++||||.+.
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                    22222       2344567999999999 99999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9e-36  Score=344.33  Aligned_cols=272  Identities=19%  Similarity=0.290  Sum_probs=187.3

Q ss_pred             HhcCCCCCCCceEEeEeeecCceEEEEEEEecC----CcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEE-----
Q psy13735          7 LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQS----HNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSF-----   77 (792)
Q Consensus         7 L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~t----Gk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vf-----   77 (792)
                      ..+..+..++|.+.+.||+|+||.||+|.+..+    +..||+|.+...........+.+....+.+++.+...|     
T Consensus       124 ~~~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        124 LFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccc
Confidence            345678899999999999999999999999998    99999998764332211111122222333333333222     


Q ss_pred             -EeCCEEEEEEeccCCCCHHHHHHhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q psy13735         78 -QDMNHVYFIMEYVTGGDFVTLLENQPHG------------------YLSESKARFYIYELAQAVQYLHGLGYVHRDIKP  138 (792)
Q Consensus        78 -ede~~lyLVmEy~~GGsL~dlL~r~~~g------------------~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKP  138 (792)
                       .....+++||||+.+++|.+++......                  ......+..++.||+.||.|||++||+||||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP  283 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP  283 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence             3556799999999999999998543211                  112345678999999999999999999999999


Q ss_pred             CceEeCC-CCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCC---------------CCCCCcccccc
Q psy13735        139 DNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG---------------SDGYTGSCDLW  202 (792)
Q Consensus       139 eNILLd~-dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~---------------~~~ys~ksDIW  202 (792)
                      +|||++. ++.+||+|||+|..+...........+|+|.|+|||.+........               ...++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999985 6799999999998765433333345679999999997643211110               01245567999


Q ss_pred             cchhhHHHhhcCCCCCCCCChhhhhhhhh-cccCC---------CC--c----CCCCCccccHHHHHHHHHHhh-Chhhc
Q psy13735        203 SIGVVSYELLTGSTPFNYETLDMTYSSIL-ACDTE---------DT--V----SFPSSIRLSTAMVNFVQSLVQ-KLDAR  265 (792)
Q Consensus       203 SLGVILYELLTGk~PF~~~d~~el~ekIl-~~~~~---------~~--l----~fP~~~~lS~elkdLIk~LL~-DP~kR  265 (792)
                      |+||++|+|+++..|+...  ...+..++ .....         ..  .    .+......+..+.+||.+||+ ||.+|
T Consensus       364 SlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            9999999999977765422  11111111 10000         00  0    000011123456799999999 99999


Q ss_pred             CChhHHhcCCCccCC
Q psy13735        266 LNMDQVLGHPVFDCL  280 (792)
Q Consensus       266 PTaeEIL~HPwF~~i  280 (792)
                      ||+.++|+||||...
T Consensus       442 ~ta~e~L~Hpff~~~  456 (566)
T PLN03225        442 ISAKAALAHPYFDRE  456 (566)
T ss_pred             CCHHHHhCCcCcCCC
Confidence            999999999999864

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-35  Score=303.40  Aligned_cols=252  Identities=18%  Similarity=0.314  Sum_probs=199.3

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEe----cCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEe--CC
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEK----QSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQD--MN   81 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k----~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfed--e~   81 (792)
                      ...+|.+.+.||+|+||.||++...    .++..+|+|.+......     ...|+.+++.+.||||+++++++..  ..
T Consensus         2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            3467899999999999999999865    35889999999876553     1568889999999999999999887  56


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      ..++||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|.||+++.++.++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            8999999999999999996533 358999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh-----------hh
Q psy13735        162 KNGRIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-----------YS  228 (792)
Q Consensus       162 ~~~~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el-----------~e  228 (792)
                      ......  .....++..|+|||.+..       ..++.++|||||||++|+|++|..||........           ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRT-------SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHcc-------CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            322111  112235567999998853       3678899999999999999999999865432211           11


Q ss_pred             hhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        229 SILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       229 kIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+... ......++.....+..+.+++.+|+. +|.+||++.+++.
T Consensus       234 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         234 RLLEL-LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHH-HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11100 00122233334567899999999999 9999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-35  Score=299.21  Aligned_cols=234  Identities=20%  Similarity=0.259  Sum_probs=187.6

Q ss_pred             eEeeecCceEEEEEEEecCC----------cEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         21 RFIQQGNFGDIYLVEEKQSH----------NTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tG----------k~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +.||+|+||.||++.+..++          ..+++|.+.......   ..|..+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46999999999999998877          347777765443311   467889999999999999999988 7789999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-------ceEEeccCccccc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-------HLKLTDFGSATQV  160 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-------~VKLiDFGLA~~l  160 (792)
                      ||+++|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++.++       .++|+|||++...
T Consensus        80 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~  158 (259)
T cd05037          80 EYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV  158 (259)
T ss_pred             EcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence            9999999999996533 2689999999999999999999999999999999999999887       7999999999876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      ..     .....+++.|+|||++...     ...++.++|||||||++|+|++ |..||...+..........   ....
T Consensus       159 ~~-----~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~---~~~~  225 (259)
T cd05037         159 LS-----REERVERIPWIAPECIRNG-----QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD---QHRL  225 (259)
T ss_pred             cc-----ccccccCCCccChhhhcCC-----CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc---CCCC
Confidence            43     1233577889999998631     1468889999999999999999 6888866543332222211   1111


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+    .+..+.+++.+|+. +|.+||++.+++.
T Consensus       226 ~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         226 PMP----DCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCC----CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            122    24899999999999 9999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-35  Score=308.39  Aligned_cols=234  Identities=18%  Similarity=0.223  Sum_probs=186.0

Q ss_pred             EeeecCceEEEEEEEecCC------------------------cEEEEEEeccCCCCh----HHHHHHHHhcCCCCccee
Q psy13735         22 FIQQGNFGDIYLVEEKQSH------------------------NTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNL   73 (792)
Q Consensus        22 ~IGsGsFGtVyla~~k~tG------------------------k~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL   73 (792)
                      .||+|+||.||++....++                        ..+|+|++.......    ..|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999998754322                        357888875443211    456788899999999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC------
Q psy13735         74 FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG------  147 (792)
Q Consensus        74 ~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg------  147 (792)
                      ++++.+....|+|||||+||+|..++.+ ..+.+++..+..++.||+.||.|||++||+||||||.|||++..+      
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            9999999999999999999999998854 345689999999999999999999999999999999999997644      


Q ss_pred             -ceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhh-cCCCCCCCCChhh
Q psy13735        148 -HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL-TGSTPFNYETLDM  225 (792)
Q Consensus       148 -~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELL-TGk~PF~~~d~~e  225 (792)
                       .++++|||++......     ....+++.|+|||.+..      ...++.++|||||||++|+|+ +|..||.......
T Consensus       161 ~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         161 PFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPG------GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ceeeecCCccccccccc-----cccccCCcccCchhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence             3899999988654322     12357889999998852      245789999999999999984 6999997765544


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ....+ .    ....+|.  ..++.+.+++.+|+. +|.+||++.+++.+
T Consensus       230 ~~~~~-~----~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KERFY-E----KKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHH-H----hccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            32222 1    1222333  346789999999999 99999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0587|consensus

Probab=100.00  E-value=2.9e-35  Score=340.10  Aligned_cols=263  Identities=23%  Similarity=0.411  Sum_probs=226.5

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhc-CCCCcceeEEEEE-----eC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKS-KCPYIVNLFYSFQ-----DM   80 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL-~HPNIVkL~~vfe-----de   80 (792)
                      .....+.|.|..+||.|.+|.||+++++.+|+..|+|+........   ..|.+|++.. .|||++.+|++|.     ..
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            3455678999999999999999999999999999999987665443   4567888877 5999999999986     35


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +.+|||||||.||+..|+++......+.|..+..|++.++.|+.+||.+.++|||||-.|||++.+|.|||+|||++.++
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            68999999999999999998877788999999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ... .....+.+|||+|||||++.+.  ......|+..+|+||||++..+|--|.+|+...-+...+-.|..   ...+.
T Consensus       174 dsT-~grRnT~iGtP~WMAPEViac~--e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPk  247 (953)
T KOG0587|consen  174 DST-VGRRNTFIGTPYWMAPEVIACD--ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPK  247 (953)
T ss_pred             ecc-cccccCcCCCcccccceeeecc--cCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCcc
Confidence            754 3455677899999999999754  44556788999999999999999999999976665554444433   12333


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      +..+..++..+.+||..||. |-.+||+..++|.|||++
T Consensus       248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            44455899999999999999 999999999999999997

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.9e-35  Score=300.57  Aligned_cols=246  Identities=19%  Similarity=0.314  Sum_probs=197.0

Q ss_pred             ceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC------
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN------   81 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~------   81 (792)
                      |.+.++||+|+||.||+|...   .+|..+|+|.+.......      ..|..+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999865   357899999987654332      46889999999999999999886532      


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP----HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~----~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      ..+++++|+.+|+|.+++....    ...++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            3478999999999988874321    224789999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccC
Q psy13735        158 TQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       158 ~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~  235 (792)
                      +........ ......+++.|++||.+..       ..++.++|||||||++|+|++ |.+||...+....+..+...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--  231 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLAD-------NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--  231 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhc-------CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--
Confidence            866432211 1122345678999998863       357889999999999999999 99999877766666655442  


Q ss_pred             CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        236 EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       236 ~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                       .....+  ...+..+.+++.+|+. +|.+||++.+++.+
T Consensus       232 -~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         232 -NRLKQP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -CcCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             112222  2568899999999999 99999999998653

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.4e-35  Score=308.77  Aligned_cols=250  Identities=15%  Similarity=0.220  Sum_probs=186.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCCChHHH---------------HHHHHhcCCCCcce
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPNTIE---------------RDIMVKSKCPYIVN   72 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~~~E---------------~eIL~kL~HPNIVk   72 (792)
                      .+....|.+.+.||+|+||.||+|.+..+   +..+|+|+..........|               ...+..+.|+||+.
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            35567899999999999999999999887   6778888654333222111               12234568999999


Q ss_pred             eEEEEEeCC----EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc
Q psy13735         73 LFYSFQDMN----HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH  148 (792)
Q Consensus        73 L~~vfede~----~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~  148 (792)
                      +++++....    ..+++|+++ ++++.+.+..  ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence            998766543    457888988 4567777643  233688999999999999999999999999999999999999999


Q ss_pred             eEEeccCcccccccCCC------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC
Q psy13735        149 LKLTDFGSATQVDKNGR------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET  222 (792)
Q Consensus       149 VKLiDFGLA~~l~~~~~------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d  222 (792)
                      ++|+|||+|+.+.....      .......||+.|+|||++.+       ..++.++||||+||++|+|++|.+||.+..
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-------~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-------ACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999987643221      11123469999999999863       368999999999999999999999997663


Q ss_pred             hhhhhhh-----hhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        223 LDMTYSS-----ILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       223 ~~el~ek-----Il~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .......     +..........++   ..++.+.+++..|+. +|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        238 HNGNLIHAAKCDFIKRLHEGKIKIK---NANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             cchHHHHHhHHHHHHHhhhhhhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            2211111     1010011112222   347899999999999 9999999999864

>KOG0584|consensus

Probab=100.00  E-value=8.2e-36  Score=336.23  Aligned_cols=248  Identities=23%  Similarity=0.423  Sum_probs=209.3

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEE---EEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE--EEEEE
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVM---KKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH--VYFIM   87 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAV---KiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~--lyLVm   87 (792)
                      ++..+||+|+|-+||++.+..+|..||=   |.-.....+.     ..|+.+|..|+|||||++|++|.+..+  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            5568999999999999999999988872   2211111111     579999999999999999999987765  89999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCC-CCceEEeccCcccccccCC
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~-dg~VKLiDFGLA~~l~~~~  164 (792)
                      |++.+|+|+.|+.+  .+.++...++.|++||+.||.|||++.  |+|||||.+||+|+. .|.|||+|+|+|+..... 
T Consensus       123 EL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             ecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            99999999999965  556889999999999999999999985  999999999999964 578999999999987643 


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC-CCChhhhhhhhhcccCCCCcCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN-YETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~-~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                        .....+|||.|||||...        ..|+..+||||||++|.||+|+..||. +.++..+|.++.....+..+.--.
T Consensus       200 --~aksvIGTPEFMAPEmYE--------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  200 --HAKSVIGTPEFMAPEMYE--------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             --ccceeccCccccChHHHh--------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence              223367999999999986        479999999999999999999999995 778899999998754433332222


Q ss_pred             CccccHHHHHHHHHHhhChhhcCChhHHhcCCCccCCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                          .++++.||.+||.-...|||+.++|.||||+.-..
T Consensus       270 ----dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  270 ----DPEVREFIEKCLATKSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             ----CHHHHHHHHHHhcCchhccCHHHHhhChhhccccc
Confidence                68999999999998899999999999999986543

>KOG1187|consensus

Probab=100.00  E-value=2.7e-34  Score=315.72  Aligned_cols=249  Identities=23%  Similarity=0.317  Sum_probs=192.2

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----hHHHHHHHHhcCCCCcceeEEEEEeCC-EEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERDIMVKSKCPYIVNLFYSFQDMN-HVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----~~~E~eIL~kL~HPNIVkL~~vfede~-~lyLVmEy   89 (792)
                      ++|.-...||+|+||.||++...++ ..+|||++......    -..|+.++.+++|||+|+|+|||.+.+ ..+||+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            6788889999999999999988754 89999988776653    268999999999999999999999998 59999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCceEeCCCCceEEeccCccccccc-CCC
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG---YVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGR  165 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g---IVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~-~~~  165 (792)
                      |++|+|.++|.......++|.....|+.+++.||.|||+..   |+||||||.|||+|.+.+.||+|||+|+.... ...
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~  233 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS  233 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc
Confidence            99999999996533227899999999999999999999854   99999999999999999999999999966543 221


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC---hhhhhh---hhhcccCCCCc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET---LDMTYS---SILACDTEDTV  239 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d---~~el~e---kIl~~~~~~~l  239 (792)
                      .... ..||.+|+|||.+..       +..+.++|||||||++.||++|+.|.+...   ......   .......-..+
T Consensus       234 ~~~~-~~gt~gY~~PEy~~~-------g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei  305 (361)
T KOG1187|consen  234 VSTT-VMGTFGYLAPEYAST-------GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI  305 (361)
T ss_pred             eeee-cCCCCccCChhhhcc-------CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence            1111 169999999999862       478999999999999999999998886432   111111   11110000001


Q ss_pred             CCCCC--cccc-----HHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        240 SFPSS--IRLS-----TAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       240 ~fP~~--~~lS-----~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      ..|.-  ...+     ..+..+...|++ +|..||++.++.
T Consensus       306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence            11110  1122     235566677888 899999999974

>KOG0666|consensus

Probab=100.00  E-value=8.3e-36  Score=314.16  Aligned_cols=262  Identities=25%  Similarity=0.377  Sum_probs=206.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCc----EEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe-CCE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHN----TFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD-MNH   82 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk----~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed-e~~   82 (792)
                      +..|++++.||+|.||.||++..+.++.    .||+|.+.-.+...      -+|+.+++.++||||+.|..+|-. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4579999999999999999997665543    78999987663322      578899999999999999999987 889


Q ss_pred             EEEEEeccCCCCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC----CceEEeccC
Q psy13735         83 VYFIMEYVTGGDFVTLLEN---QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT----GHLKLTDFG  155 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r---~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d----g~VKLiDFG  155 (792)
                      +++++||.+ .+|..+|.-   .....++...++.|+.||+.|+.|||++-|+||||||.||||..+    |.|||+|||
T Consensus       103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            999999995 589998852   123468999999999999999999999999999999999999887    899999999


Q ss_pred             cccccccCCC-c-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh---------
Q psy13735        156 SATQVDKNGR-I-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD---------  224 (792)
Q Consensus       156 LA~~l~~~~~-~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~---------  224 (792)
                      +++.+...-. . .....+-|.+|.|||.+.+      ...|++++|||++|||+.|||+-.+.|.+...+         
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLG------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLG------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcc------cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            9998764321 1 1223457899999999974      478999999999999999999998888654321         


Q ss_pred             hhhhhhhc-------ccCCCCcCCCCC------------------------ccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        225 MTYSSILA-------CDTEDTVSFPSS------------------------IRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       225 el~ekIl~-------~~~~~~l~fP~~------------------------~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      .....|+.       ..|+.-..+|..                        ..-++.+.+|+.+||+ ||.+|+|+.+++
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl  335 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL  335 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence            12223322       112221122221                        1135568999999999 999999999999


Q ss_pred             cCCCccCCCC
Q psy13735        273 GHPVFDCLDS  282 (792)
Q Consensus       273 ~HPwF~~i~~  282 (792)
                      +|+||+..+.
T Consensus       336 eh~yF~~d~l  345 (438)
T KOG0666|consen  336 EHPYFTEDPL  345 (438)
T ss_pred             cccccccCCC
Confidence            9999997544

>KOG1151|consensus

Probab=100.00  E-value=1.4e-35  Score=322.10  Aligned_cols=260  Identities=26%  Similarity=0.434  Sum_probs=214.5

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----------HHHHHHHHhcCCCCcceeEEEEE-
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----------TIERDIMVKSKCPYIVNLFYSFQ-   78 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----------~~E~eIL~kL~HPNIVkL~~vfe-   78 (792)
                      ..-.++|-++.+||+|||+.||++.+....+.+|||+-...+...           ..|..|...|+||.||++|++|. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            345567889999999999999999999889999999764333221           46899999999999999999997 


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCccCCCCCCceEeC---CCCceEEec
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL--GYVHRDIKPDNMLLS---ATGHLKLTD  153 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~--gIVHRDLKPeNILLd---~dg~VKLiD  153 (792)
                      +.+.+|-|+|||+|.+|..+|+.  +..+++.+++.|+.||+.||.||.+.  .|+|.||||.|||+-   .-|.+||+|
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            55679999999999999999954  55689999999999999999999986  599999999999983   345799999


Q ss_pred             cCcccccccCCC------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-hh
Q psy13735        154 FGSATQVDKNGR------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-MT  226 (792)
Q Consensus       154 FGLA~~l~~~~~------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-el  226 (792)
                      ||+++.......      ..+....||.||++||.|.-.   ...+..+.++||||+|||+|.++.|+.||.....+ .+
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg---kePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG---KEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecC---CCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence            999998764332      223445799999999998621   22456788999999999999999999999754332 22


Q ss_pred             hh--hhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        227 YS--SILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       227 ~e--kIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      ++  .|++   ...+.||....+|+++++||++||. ....|....++-.||+|.
T Consensus       694 LqeNTIlk---AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  694 LQENTILK---ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             Hhhhchhc---ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence            22  2222   2456889888999999999999999 899999999999999986

>KOG4250|consensus

Probab=100.00  E-value=7.8e-35  Score=331.60  Aligned_cols=244  Identities=31%  Similarity=0.458  Sum_probs=194.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC------EE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN------HV   83 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~------~l   83 (792)
                      ..+...+.||+|+||.||+++++.+|+.+|+|.+.+.....     ..|++||++++|||||+++++=++..      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            34667789999999999999999999999999998754433     57999999999999999998866543      46


Q ss_pred             EEEEeccCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe--CCCCc--eEEeccCccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL--SATGH--LKLTDFGSAT  158 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~-~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL--d~dg~--VKLiDFGLA~  158 (792)
                      .+|||||+||+|+..+.+- ...+|++.+...++..+..||.|||++||+||||||.||++  ..+|.  .||+|||.|+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            8999999999999999642 23469999999999999999999999999999999999997  33453  7999999999


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-----hhhhhhhc-
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-----MTYSSILA-  232 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-----el~ekIl~-  232 (792)
                      .+.++.  ...+.+||+.|.+||.+..      ...|+..+|.|||||++|++.||..||-.....     .++..+.. 
T Consensus       173 el~d~s--~~~S~vGT~~YLhPel~E~------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk  244 (732)
T KOG4250|consen  173 ELDDNS--LFTSLVGTEEYLHPELYER------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK  244 (732)
T ss_pred             cCCCCC--eeeeecCchhhcChHHHhh------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence            998765  4456679999999999963      247899999999999999999999999544332     23322221 


Q ss_pred             -------------ccCCCCcCCCCCccccHHH----HHHHHHHhh-ChhhcC
Q psy13735        233 -------------CDTEDTVSFPSSIRLSTAM----VNFVQSLVQ-KLDARL  266 (792)
Q Consensus       233 -------------~~~~~~l~fP~~~~lS~el----kdLIk~LL~-DP~kRP  266 (792)
                                   ........+|.+..+++.+    -.++..+|. +|.+|.
T Consensus       245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                         1111223445554666554    445556777 899998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.5e-33  Score=278.08  Aligned_cols=236  Identities=41%  Similarity=0.732  Sum_probs=198.9

Q ss_pred             CceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCHHHHHHh
Q psy13735         27 NFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN  101 (792)
Q Consensus        27 sFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r  101 (792)
                      +||.||++....+|..+|+|++.......     ..|..++++++|+||+++++++......+++|||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            68999999999999999999997655422     5788899999999999999999999999999999999999999955


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCCCccChh
Q psy13735        102 QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE  181 (792)
Q Consensus       102 ~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APE  181 (792)
                      ..  .++...+..++.+++.++.|||+.||+|+||+|.||+++.++.++|+|||.+.......  ......|++.|++||
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE  156 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPE  156 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHH
Confidence            32  38999999999999999999999999999999999999999999999999998775432  223446899999999


Q ss_pred             hhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC-CChhhhhhhhhcccCCCCcCCCCCc-cccHHHHHHHHHHh
Q psy13735        182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY-ETLDMTYSSILACDTEDTVSFPSSI-RLSTAMVNFVQSLV  259 (792)
Q Consensus       182 iL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~-~d~~el~ekIl~~~~~~~l~fP~~~-~lS~elkdLIk~LL  259 (792)
                      .+..       ..++.++|+||+|+++|+|++|..||.. .+.......+..    .....+... .++..+.+++.+|+
T Consensus       157 ~~~~-------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l  225 (244)
T smart00220      157 VLLG-------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK----PKPPFPPPEWKISPEAKDLIRKLL  225 (244)
T ss_pred             HHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc----cCCCCccccccCCHHHHHHHHHHc
Confidence            9862       3678899999999999999999999977 454444444433    222222211 17889999999999


Q ss_pred             h-ChhhcCChhHHhcCCCc
Q psy13735        260 Q-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       260 ~-DP~kRPTaeEIL~HPwF  277 (792)
                      . +|.+||++.+++.||||
T Consensus       226 ~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      226 VKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             cCCchhccCHHHHhhCCCC
Confidence            9 99999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0194|consensus

Probab=100.00  E-value=4.1e-34  Score=321.26  Aligned_cols=247  Identities=21%  Similarity=0.366  Sum_probs=206.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCc---E-EEEEEeccCC-CCh------HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHN---T-FVMKKVLREK-MPN------TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk---~-vAVKiI~Ks~-~~~------~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      +.+++-.+.++||+|+||.||++..+..+.   . ||+|...-+. ...      ..|+++|++++|||||++||+....
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            455667778999999999999999876533   3 7888877522 222      6899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+|||||+|+||+|.++|.... +.++..+...++.+.+.||.|||+++++||||-..|+|++.++.+||+|||+++..
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999999996543 35999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCcccccC-CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        161 DKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       161 ~~~~~~~s~t~-vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ...  ...... .-...|+|||.+..       +.|+.++||||+||++||+++ |..||.+....+....|..    ..
T Consensus       313 ~~~--~~~~~~~klPirWLAPEtl~~-------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~----~~  379 (474)
T KOG0194|consen  313 SQY--VMKKFLKKLPIRWLAPETLNT-------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK----NG  379 (474)
T ss_pred             cce--eeccccccCcceecChhhhcc-------CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh----cC
Confidence            411  111111 13458999999973       379999999999999999999 8999999999999999855    23


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      +..+.+...+..+..++..|+. +|.+||++.++.
T Consensus       380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence            3333333668889999999999 999999999874

>KOG0193|consensus

Probab=100.00  E-value=1.3e-34  Score=325.09  Aligned_cols=249  Identities=22%  Similarity=0.313  Sum_probs=204.7

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      +..++..++..||+|+||+||++.+.+   .||||++.......      .+|+.++++-+|-||+-++|++..... .|
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            445567788999999999999998874   58999998776654      579999999999999999999998877 99


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC-C
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-G  164 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~-~  164 (792)
                      |+-+|.|.+|..+|.... ..|.....+.|++||+.|+.|||.++|||||||..||++..++.|||+|||++..-..- +
T Consensus       465 iTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             eehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            999999999999996533 55899999999999999999999999999999999999999999999999998754311 1


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC---C
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS---F  241 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~---f  241 (792)
                      ........|...|||||+++..    ...+|++.+|||||||++|||++|..||.....+.++-.+-.    +...   .
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmq----d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr----G~l~pd~s  615 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQ----DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR----GYLMPDLS  615 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhc----ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc----cccCccch
Confidence            1222344588899999999843    355899999999999999999999999986655554443322    2111   1


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ......+.++++|+..|+. ++++||...+||.
T Consensus       616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            1123556799999999999 9999999998865

>KOG0671|consensus

Probab=100.00  E-value=4e-35  Score=315.83  Aligned_cols=256  Identities=25%  Similarity=0.436  Sum_probs=206.9

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC---ChHHHHHHHHhcCC--C----CcceeEEEEEeCCEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM---PNTIERDIMVKSKC--P----YIVNLFYSFQDMNHV   83 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~---~~~~E~eIL~kL~H--P----NIVkL~~vfede~~l   83 (792)
                      -...|.++..+|+|.||.|..|.+..++..+|+|++..-..   ....|++++.++.+  |    -+|.+.++|+-.+++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            36789999999999999999999999999999998864322   23789999999842  2    478888999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC------------------
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA------------------  145 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~------------------  145 (792)
                      |||+|.+ |-++++++.....-+|+-..++.+.+||+.+++|||+++++|-||||+|||+..                  
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~  245 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP  245 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence            9999999 779999997766677999999999999999999999999999999999999832                  


Q ss_pred             --CCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh
Q psy13735        146 --TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL  223 (792)
Q Consensus       146 --dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~  223 (792)
                        +..|+|+|||.|+......    ++.+.|..|.|||++.+.       +++.++||||+|||++|+.+|...|++.+.
T Consensus       246 ~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgL-------GwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  246 LKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGL-------GWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             CCCcceEEEecCCcceeccCc----ceeeeccccCCchheecc-------CcCCccCceeeeeEEEEeeccceecccCCc
Confidence              2359999999998764322    456789999999999865       799999999999999999999999987764


Q ss_pred             hh---hhhhhhcccC--------------CCCcCCCC-----------------------CccccHHHHHHHHHHhh-Ch
Q psy13735        224 DM---TYSSILACDT--------------EDTVSFPS-----------------------SIRLSTAMVNFVQSLVQ-KL  262 (792)
Q Consensus       224 ~e---l~ekIl~~~~--------------~~~l~fP~-----------------------~~~lS~elkdLIk~LL~-DP  262 (792)
                      .+   +.+.|+....              .+.+.+|.                       ...--.++.||+++||. ||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            44   3333332000              00111111                       01112458999999999 99


Q ss_pred             hhcCChhHHhcCCCccCC
Q psy13735        263 DARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       263 ~kRPTaeEIL~HPwF~~i  280 (792)
                      .+|+|+.++|.||||+..
T Consensus       395 ~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  395 ARRITLREALSHPFFARL  412 (415)
T ss_pred             cccccHHHHhcCHHhhcC
Confidence            999999999999999853

>KOG1035|consensus

Probab=100.00  E-value=9.6e-35  Score=344.01  Aligned_cols=253  Identities=23%  Similarity=0.416  Sum_probs=197.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEe---------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQD---------   79 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfed---------   79 (792)
                      .++|+.+..||+||||.||+|+++-+|+.||||+|.......     ..|+..|.+|+|||||++|..|..         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            457888999999999999999999999999999997664211     569999999999999999865400         


Q ss_pred             --------------------------------------------------------------------------------
Q psy13735         80 --------------------------------------------------------------------------------   79 (792)
Q Consensus        80 --------------------------------------------------------------------------------   79 (792)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy13735         80 ----------------------M--------NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL  129 (792)
Q Consensus        80 ----------------------e--------~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~  129 (792)
                                            +        ..+||-||||+...+.+++.+..... .-..++.++++|+.||.|+|+.
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC
Confidence                                  0        23688999999988888886543211 4788999999999999999999


Q ss_pred             CCccCCCCCCceEeCCCCceEEeccCcccccc----------------c-CCCcccccCCCCCCccChhhhhhhccCCCC
Q psy13735        130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVD----------------K-NGRIKSIVPVGTPEYVAPEVLEWMEGNHGS  192 (792)
Q Consensus       130 gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~----------------~-~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~  192 (792)
                      |||||||||.||+++.+++|||+|||+|+...                . .+....+..+||..|+|||++...    ..
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~----~~  792 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT----SS  792 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc----cc
Confidence            99999999999999999999999999998721                0 111123455899999999999744    22


Q ss_pred             CCCCcccccccchhhHHHhhcCCCCCCCC-ChhhhhhhhhcccCCCCcCCCCC--ccccHHHHHHHHHHhh-ChhhcCCh
Q psy13735        193 DGYTGSCDLWSIGVVSYELLTGSTPFNYE-TLDMTYSSILACDTEDTVSFPSS--IRLSTAMVNFVQSLVQ-KLDARLNM  268 (792)
Q Consensus       193 ~~ys~ksDIWSLGVILYELLTGk~PF~~~-d~~el~ekIl~~~~~~~l~fP~~--~~lS~elkdLIk~LL~-DP~kRPTa  268 (792)
                      ..|+.++||||||||++||+.   ||... ....++.++..    +.+.+|..  ..--+.-..+|++|+. ||.+|||+
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~----g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA  865 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK----GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA  865 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc----CCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence            479999999999999999994   57532 22223333322    33333311  1224567889999999 99999999


Q ss_pred             hHHhcCCCcc
Q psy13735        269 DQVLGHPVFD  278 (792)
Q Consensus       269 eEIL~HPwF~  278 (792)
                      .++|++-||-
T Consensus       866 ~eLL~s~llp  875 (1351)
T KOG1035|consen  866 TELLNSELLP  875 (1351)
T ss_pred             HHHhhccCCC
Confidence            9999999886

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.3e-33  Score=318.86  Aligned_cols=270  Identities=21%  Similarity=0.306  Sum_probs=194.1

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEe----------------cCCcEEEEEEeccCCCC------------------
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEK----------------QSHNTFVMKKVLREKMP------------------   54 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k----------------~tGk~vAVKiI~Ks~~~------------------   54 (792)
                      +.++..++|.+.++||+|+||+||++...                ..++.||+|.+......                  
T Consensus       139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~  218 (507)
T PLN03224        139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET  218 (507)
T ss_pred             CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence            45678999999999999999999998642                34568999998643211                  


Q ss_pred             hHHHHHHHHhcCCCCc-----ceeEEEEEe--------CCEEEEEEeccCCCCHHHHHHhCC------------------
Q psy13735         55 NTIERDIMVKSKCPYI-----VNLFYSFQD--------MNHVYFIMEYVTGGDFVTLLENQP------------------  103 (792)
Q Consensus        55 ~~~E~eIL~kL~HPNI-----VkL~~vfed--------e~~lyLVmEy~~GGsL~dlL~r~~------------------  103 (792)
                      ...|..++.+++|.++     +.++++|..        .+..|+||||+++|+|.+++....                  
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            1346666777766544     667776643        356899999999999999885321                  


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCCCccC
Q psy13735        104 ----HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA  179 (792)
Q Consensus       104 ----~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~A  179 (792)
                          ...+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++...............+||.|+|
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence                1124567788999999999999999999999999999999999999999999997654332222222345899999


Q ss_pred             hhhhhhhccCCCC---------------CCCCcccccccchhhHHHhhcCCC-CCCCCChhh----hhhhhh---cccCC
Q psy13735        180 PEVLEWMEGNHGS---------------DGYTGSCDLWSIGVVSYELLTGST-PFNYETLDM----TYSSIL---ACDTE  236 (792)
Q Consensus       180 PEiL~~~~~~~~~---------------~~ys~ksDIWSLGVILYELLTGk~-PF~~~d~~e----l~ekIl---~~~~~  236 (792)
                      ||.+.........               ......+||||+||++|+|++|.. ||.......    .+....   .....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            9998532100000               011234799999999999999875 774321110    000000   01112


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-Ch---hhcCChhHHhcCCCcc
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KL---DARLNMDQVLGHPVFD  278 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP---~kRPTaeEIL~HPwF~  278 (792)
                      ..+.++.....++.++||+.+||. +|   .+|+|+.++|.||||.
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            344566566789999999999999 54   6899999999999996

>KOG0669|consensus

Probab=100.00  E-value=2e-35  Score=304.44  Aligned_cols=258  Identities=26%  Similarity=0.361  Sum_probs=209.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEecc----CCCCh--HHHHHHHHhcCCCCcceeEEEEEe--------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR----EKMPN--TIERDIMVKSKCPYIVNLFYSFQD--------   79 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~K----s~~~~--~~E~eIL~kL~HPNIVkL~~vfed--------   79 (792)
                      .+.|.-..+||+|.||.||+++++.+|+.||+|++..    ...+.  ..|+.||..++|+|++.+++.|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            4567888999999999999999999999999987754    33332  689999999999999999887743        


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ...+|+||.+|+ .+|+-++.+. .-+|+..++..+|++++.||.|+|.+.|+|||+||.|+||+.+|.+||+|||+++.
T Consensus        96 r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   96 RATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             cceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            235899999995 5899998653 35699999999999999999999999999999999999999999999999999976


Q ss_pred             cccCCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhc----
Q psy13735        160 VDKNGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA----  232 (792)
Q Consensus       160 l~~~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~----  232 (792)
                      +......   .....+-|.+|.+||.+.+      ...|+++.|||..||||.+|.+|.+.|.+.+....+..|..    
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLG------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhc------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            6432211   1223356999999999974      46899999999999999999999999998887766655532    


Q ss_pred             ---ccCCCCcCCCCCc----------------------cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        233 ---CDTEDTVSFPSSI----------------------RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       233 ---~~~~~~l~fP~~~----------------------~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                         ..|++...+|-..                      .-.+++.+++..||. ||.+|+.+.++++|.||..
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence               2233222111100                      114588999999999 9999999999999999985

>KOG1006|consensus

Probab=100.00  E-value=8.9e-35  Score=301.57  Aligned_cols=261  Identities=25%  Similarity=0.434  Sum_probs=207.7

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHH-HHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDI-MVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eI-L~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      ++.++.+-+..||.|+||+|++..|+.+|+..|||.|.......     ..|.+. ++.-++||||++||+.-.++..||
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            55566677889999999999999999999999999998765532     234433 345579999999999999999999


Q ss_pred             EEeccCCCCHHHHH---HhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         86 IMEYVTGGDFVTLL---ENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        86 VmEy~~GGsL~dlL---~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .||+| ..+|..+.   .......++|.-.-.|....+.||.||.. .+|+|||+||+|||++..|.|||||||.|..+.
T Consensus       141 CMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  141 CMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             eHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            99999 45654433   23345569999999999999999999996 589999999999999999999999999998875


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC-
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS-  240 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~-  240 (792)
                      ..  .....-.|...|||||.+...     ..+|+.++|+||||+.|||+.||..||..-+.  .++.+-....+.... 
T Consensus       220 ~S--iAkT~daGCrpYmAPERi~p~-----~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  220 DS--IAKTVDAGCRPYMAPERIDPS-----DKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL  290 (361)
T ss_pred             HH--HHhhhccCCccccChhccCCc-----cCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee
Confidence            32  222344699999999999633     33799999999999999999999999975443  444443332223222 


Q ss_pred             -CCC-CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        241 -FPS-SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       241 -fP~-~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                       ++. ..++|..+..||.-||. |-+.||...+++.+||++....
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence             222 25689999999999999 8999999999999999986543

>KOG1095|consensus

Probab=100.00  E-value=4.3e-32  Score=323.62  Aligned_cols=250  Identities=22%  Similarity=0.370  Sum_probs=209.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCc-----EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHN-----TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk-----~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +........+.||+|.||.||.+...+...     .||+|.+.+.....     ..|..+|..++|||||+++|++-+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            345567889999999999999998876433     38999887664433     57999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP-----HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~-----~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                      ..+|++|||.||+|..+|...+     ...++......++.+|+.|+.||+++++|||||-..|+||+....|||+|||+
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999999997531     34588999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccC-CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhccc
Q psy13735        157 ATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACD  234 (792)
Q Consensus       157 A~~l~~~~~~~s~t~-vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~  234 (792)
                      |+.+-.......... .-...|||||.+..       +.++.++|||||||++||++| |..||...+..+.....+.  
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-------~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~--  919 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKD-------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE--  919 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhh-------cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh--
Confidence            996543332222222 12348999999973       579999999999999999999 9999998887777765555  


Q ss_pred             CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        235 TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       235 ~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                       ++  .++.+...+..+-+++..|++ +|..||+...|+.
T Consensus       920 -gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  920 -GG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -CC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence             23  444445889999999999999 9999999998875

>KOG1026|consensus

Probab=100.00  E-value=9.9e-33  Score=320.01  Aligned_cols=249  Identities=21%  Similarity=0.370  Sum_probs=212.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      .++..+..+.+.||+|+||.||+++...     .-..||||.++......     .+|++++..++|||||+|+|++..+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            3567788899999999999999997643     33679999987665542     6899999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQP------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH  148 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~  148 (792)
                      +.+|+|+|||..|||-.+|....            .+.++..+...|+.||+.|+.||-++.+|||||-..|+||..+-.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence            99999999999999999995311            234889999999999999999999999999999999999999999


Q ss_pred             eEEeccCcccccccCCCcccc-cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhh
Q psy13735        149 LKLTDFGSATQVDKNGRIKSI-VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMT  226 (792)
Q Consensus       149 VKLiDFGLA~~l~~~~~~~s~-t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el  226 (792)
                      |||+|||+++.+-....++.. ...-...|||||.+.+       +.|+.++||||+||+|+|+++ |..||.+.+.++.
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-------~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-------GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-------CcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence            999999999976544332221 1122458999999985       389999999999999999998 9999999999999


Q ss_pred             hhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHH
Q psy13735        227 YSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQV  271 (792)
Q Consensus       227 ~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEI  271 (792)
                      .+-|..    +.+ ++.+.+.+..+-+++..|++ .|.+||++.+|
T Consensus       715 Ie~i~~----g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  715 IECIRA----GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHHHc----CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            888877    333 44455889999999999999 99999999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.98  E-value=4.6e-32  Score=328.50  Aligned_cols=241  Identities=22%  Similarity=0.304  Sum_probs=188.6

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      .|.....||+|+||.||+|.+..+|..||+|.+.........|+.++++++|||||++++++.+....|+|||||+||+|
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L  770 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL  770 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence            45567799999999999999999999999999876655556788999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLH---GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH---s~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      .+++..     +++..+..++.||+.||.|||   +.+|+||||||+||+++.++..++. ||.+......     ....
T Consensus       771 ~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~  839 (968)
T PLN00113        771 SEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCF  839 (968)
T ss_pred             HHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcc
Confidence            999942     789999999999999999999   6799999999999999988887775 6655433211     1235


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh--hhhh---hhhc-cc---C-CCCc--C
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD--MTYS---SILA-CD---T-EDTV--S  240 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~--el~e---kIl~-~~---~-~~~l--~  240 (792)
                      ||+.|+|||++..       ..++.++||||+||++|+|++|+.||......  ....   .... ..   + ....  .
T Consensus       840 ~t~~y~aPE~~~~-------~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        840 ISSAYVAPETRET-------KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             ccccccCcccccC-------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence            8999999999863       36899999999999999999999999543211  0000   0000 00   0 0000  0


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+.......++.+++.+|+. +|.+||++.++++.
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            01111223467789999999 99999999999765

>KOG0668|consensus

Probab=99.98  E-value=3.8e-33  Score=284.64  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=205.9

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC-CCCcceeEEEEEeCC--EEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK-CPYIVNLFYSFQDMN--HVYFIME   88 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~-HPNIVkL~~vfede~--~lyLVmE   88 (792)
                      ..++|++.+++|+|.|+.||.+.+..++..+++|+++.-+... ..|+.||..|. ||||++++++..+..  ...+|+|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            5679999999999999999999999999999999987554433 68999999996 999999999998764  5789999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCCCcc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |+++.+...+..     .++...++.++.+++.||.|||+.||.|||+||.|+|+|... .++|+|+|+|.+..++..  
T Consensus       116 ~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e--  188 (338)
T KOG0668|consen  116 YVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  188 (338)
T ss_pred             hhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce--
Confidence            999888776662     388999999999999999999999999999999999998655 599999999998876543  


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC-CCChhhhhhhhhc--------------
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN-YETLDMTYSSILA--------------  232 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~-~~d~~el~ekIl~--------------  232 (792)
                      .+..+.+.+|--||.+...      +.|+..-|||||||++..|++.+-||. +.+..+.+.+|..              
T Consensus       189 YnVRVASRyfKGPELLVdy------~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  189 YNVRVASRYFKGPELLVDY------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             eeeeeehhhcCCchheeec------hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            3456788999999998743      468889999999999999999999984 3333222222211              


Q ss_pred             -------------ccCC-CCcCC--CCCc-cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        233 -------------CDTE-DTVSF--PSSI-RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       233 -------------~~~~-~~l~f--P~~~-~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                   .-.. ....|  +... -.++++.||+..+|. |..+|||+.+++.||||..+
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                         0000 00011  1112 246999999999999 99999999999999999753

>KOG0670|consensus

Probab=99.97  E-value=4.2e-32  Score=299.88  Aligned_cols=257  Identities=23%  Similarity=0.375  Sum_probs=209.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCC------CCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKC------PYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~H------PNIVkL~~vfede~~   82 (792)
                      +--+.|.+....|+|-||+|..|.+..-|..||||+|.....-.   ..|.+||.+|+.      -|++.++-.|...++
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            34568999999999999999999999999999999998765432   689999999963      489999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQV  160 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~-~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l  160 (792)
                      +|||+|.+ .-+|.++|+.. .+-.|....++.|+.|++.||..|...||+|.||||.||||+... .+||||||.|...
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~  587 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA  587 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence            99999998 56899999753 234588899999999999999999999999999999999998665 4899999999887


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC--
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT--  238 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~--  238 (792)
                      ..+.-.   .+.-+..|.|||++.+.       +|+...|+||+||+||+|.||+..|++.+...++...+.+....+  
T Consensus       588 ~eneit---PYLVSRFYRaPEIiLG~-------~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  588 SENEIT---PYLVSRFYRAPEIILGL-------PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             cccccc---HHHHHHhccCcceeecC-------cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            644321   22346689999999865       799999999999999999999999998887766655443111100  


Q ss_pred             ---------------c------------------------------------CCCC-CccccHHHHHHHHHHhh-Chhhc
Q psy13735        239 ---------------V------------------------------------SFPS-SIRLSTAMVNFVQSLVQ-KLDAR  265 (792)
Q Consensus       239 ---------------l------------------------------------~fP~-~~~lS~elkdLIk~LL~-DP~kR  265 (792)
                                     +                                    .+|. ...+-..+++|+..||. ||.+|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence                           0                                    0111 01223568999999999 99999


Q ss_pred             CChhHHhcCCCccC
Q psy13735        266 LNMDQVLGHPVFDC  279 (792)
Q Consensus       266 PTaeEIL~HPwF~~  279 (792)
                      +|+.++|.||||..
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999973

>KOG4257|consensus

Probab=99.97  E-value=3.3e-31  Score=296.98  Aligned_cols=245  Identities=23%  Similarity=0.406  Sum_probs=204.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecC----CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQS----HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~t----Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ........+.||.|.||.||.+....-    .--||||..+.+..+.     ..|..||+.++|||||+++|++.. ..+
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            333444567999999999999986432    3458889877654443     568899999999999999999975 578


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |||||+++-|.|..++++.+ ..++......|++||+.||.|||+.++|||||-..|||+..+..|||+|||+++.+...
T Consensus       466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999999997644 55999999999999999999999999999999999999999999999999999999876


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      .....+...-..-|||||.++.       ..++.++|||.|||+|||+|. |.-||.+-...+....|-+     ...+|
T Consensus       545 ~yYkaS~~kLPIKWmaPESINf-------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-----GeRlP  612 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINF-------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-----GERLP  612 (974)
T ss_pred             chhhccccccceeecCccccch-------hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-----CCCCC
Confidence            6555554334557999999974       378999999999999999887 9999988766666555543     23445


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHH
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQV  271 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEI  271 (792)
                      .+.+.++.+-.++.+|+. +|.+||...++
T Consensus       613 ~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  613 CPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence            555889999999999999 99999998765

>KOG1027|consensus

Probab=99.97  E-value=1e-31  Score=309.77  Aligned_cols=247  Identities=25%  Similarity=0.379  Sum_probs=192.0

Q ss_pred             EeEeeecCceE-EEEEEEecCCcEEEEEEeccCCCC-hHHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCCCCHH
Q psy13735         20 KRFIQQGNFGD-IYLVEEKQSHNTFVMKKVLREKMP-NTIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFV   96 (792)
Q Consensus        20 ~k~IGsGsFGt-Vyla~~k~tGk~vAVKiI~Ks~~~-~~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~GGsL~   96 (792)
                      .+.+|.|+-|+ ||++...  |+.||||.+...... ..+|+..|+.. .|||||++|+.=++....||..|+| ..+|.
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~  590 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ  590 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence            46789999986 7887664  789999998776553 37899999887 4999999999999999999999999 57999


Q ss_pred             HHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CC--ceEEeccCcccccccCCCc--c
Q psy13735         97 TLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TG--HLKLTDFGSATQVDKNGRI--K  167 (792)
Q Consensus        97 dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg--~VKLiDFGLA~~l~~~~~~--~  167 (792)
                      +++...  ..........+.++.|++.||++||+.+|+||||||.||||+.   ++  .++|+|||+|+.+..+...  .
T Consensus       591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r  670 (903)
T KOG1027|consen  591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR  670 (903)
T ss_pred             HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc
Confidence            999652  1111122456889999999999999999999999999999976   34  5899999999998754321  2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      ..+..||-+|+|||++...       .-+.++||||+||++|+.++| ..||...  -..-.+|+..+. ....+.+...
T Consensus       671 ~s~~sGt~GW~APE~L~~~-------~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~-~L~~L~~~~d  740 (903)
T KOG1027|consen  671 LSGGSGTSGWQAPEQLRED-------RKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNY-TLVHLEPLPD  740 (903)
T ss_pred             ccCCCCcccccCHHHHhcc-------ccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCcc-ceeeeccCch
Confidence            3455799999999999843       345689999999999999995 9999633  223334544211 1111111111


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                        .++.+||.+|+. +|..||++.++|.||||.+..
T Consensus       741 --~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  741 --CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             --HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence              189999999999 999999999999999998643

>KOG1152|consensus

Probab=99.97  E-value=1.6e-31  Score=298.23  Aligned_cols=196  Identities=28%  Similarity=0.482  Sum_probs=175.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------HHHHHHHHhcC---CCCcceeEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------TIERDIMVKSK---CPYIVNLFYSF   77 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------~~E~eIL~kL~---HPNIVkL~~vf   77 (792)
                      ...+|..++.+|.|+||.|++|.++.+...|++|.|.|.+.-.            ..|+.||..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4568999999999999999999999999999999999876533            46999999997   99999999999


Q ss_pred             EeCCEEEEEEecc-CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCc
Q psy13735         78 QDMNHVYFIMEYV-TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        78 ede~~lyLVmEy~-~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                      ++++++||+||.. +|-+|+++|...  ..++|.+++.|++|++.|+++||+.||+|||||-+|+.++.+|.+||+|||.
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            9999999999986 456899999654  4599999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC
Q psy13735        157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       157 A~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~  219 (792)
                      |.....+   +..+++||..|.|||++.+.      ...+.+-|||+||+++|.++....||+
T Consensus       717 aa~~ksg---pfd~f~gtv~~aapevl~g~------~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSG---PFDVFVGTVDYAAPEVLGGE------KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCC---CcceeeeeccccchhhhCCC------ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9876543   34456799999999999743      456788999999999999999999985

>KOG0664|consensus

Probab=99.97  E-value=1e-32  Score=286.73  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=207.5

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC-----EEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN-----HVY   84 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~-----~ly   84 (792)
                      +.+-.+.||.|+||.||-|++..+|+.+|+|++..-....      ..|..+|...+|.|++...++.+..+     .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4556789999999999999999999999999876432211      57888999999999999998887654     468


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|+|+| ..+|-.+|  -....++.+.++-+++||++||+|||+.||+||||||.|+|++.|..+||||||+++......
T Consensus       134 V~TELm-QSDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  134 VLTELM-QSDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHH-Hhhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            899999 45777777  345569999999999999999999999999999999999999999999999999999887665


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc----------
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD----------  234 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~----------  234 (792)
                      .......+-|.+|.|||++++      ...|+.++||||+|||+.|||..+..|...++-+.++.|...-          
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMG------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMG------ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhc------chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            555555567999999999984      4789999999999999999999999998877766665554310          


Q ss_pred             ---------CCCCc---CCC------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        235 ---------TEDTV---SFP------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       235 ---------~~~~l---~fP------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                               .....   .++      +...-..+..+++..++. ||.+|.+..+++.||+...
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence                     00111   111      112334678889999999 9999999999999999864

>KOG0665|consensus

Probab=99.97  E-value=2.2e-31  Score=282.01  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=203.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------C
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------N   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------~   81 (792)
                      ..+|.-+..+|.|.- .|.-+-+.-+++++|+|.+.......      ..|..++..+.|+||++++.+|-..      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777889999998 78888888899999999886652211      5788899999999999999999643      4


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||+| .++|...+.    ..++-..+.+++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus        95 e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence            689999999 568887774    237788999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------  234 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------  234 (792)
                      ..  ...+..+.|..|.|||++.+.       +|...+||||+|||+.+|++|...|.+.+.-..+.++...-       
T Consensus       170 ~~--~~mtpyVvtRyyrapevil~~-------~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  170 TD--FMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             cc--cccCchhheeeccCchheecc-------CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence            43  455566899999999999854       48899999999999999999999998877555544443200       


Q ss_pred             --------------------CCCCcCCCCC---------ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        235 --------------------TEDTVSFPSS---------IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       235 --------------------~~~~l~fP~~---------~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                                          ......||+.         ..-+..+++++.+||. +|++|.+++++|+||||+-
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v  315 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV  315 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence                                0011112221         1234678999999999 9999999999999999983

>KOG0196|consensus

Probab=99.97  E-value=7.4e-31  Score=300.37  Aligned_cols=252  Identities=22%  Similarity=0.380  Sum_probs=220.7

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCc---EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk---~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +.+..+...|.++||.|.||.||.++.+..|+   .||||.++......     ..|+.||-+.+||||+.|.++.....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            45677788999999999999999999988774   68999886443322     57999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+.||+|||++|+|..+|.. ..|.|+.-+..-+++.|+.|++||-+.|.|||||-..||||+.+-.+|++|||+++.+.
T Consensus       704 PvMIiTEyMENGsLDsFLR~-~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhh-cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999999999976 45779999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCcccccCCCC--CCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        162 KNGRIKSIVPVGT--PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       162 ~~~~~~s~t~vGT--p~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ++......+..|.  ..|.|||.+..       ..++.++|+||+||+|+|.++ |..||...+.++....|..     .
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~-------RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~-----g  850 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ-----G  850 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhh-------cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh-----c
Confidence            6553333333332  48999999974       379999999999999999776 9999999988888888864     6


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +.+|++...+..+-.|+..|++ |-.+||...||+.+
T Consensus       851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            7888888999999999999999 89999999999664

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.2e-29  Score=237.61  Aligned_cols=208  Identities=35%  Similarity=0.655  Sum_probs=183.0

Q ss_pred             eeecCceEEEEEEEecCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCHHH
Q psy13735         23 IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT   97 (792)
Q Consensus        23 IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL~d   97 (792)
                      ||.|++|.||+|....+|+.+++|++......     ...|..+++.+.|++|+++++++......+++||++.|++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            69999999999999988999999999877663     3678899999999999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEeccCcccccccCCCcccccCCCCCC
Q psy13735         98 LLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPE  176 (792)
Q Consensus        98 lL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~  176 (792)
                      ++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+...
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~  158 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPA  158 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCC
Confidence            996532 35899999999999999999999999999999999999998 89999999999987654321 1223458889


Q ss_pred             ccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHH
Q psy13735        177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQ  256 (792)
Q Consensus       177 Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk  256 (792)
                      |++||.+...      ..++.+.|+|++|+++++|                                     ..+.+++.
T Consensus       159 ~~~pe~~~~~------~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~  195 (215)
T cd00180         159 YMAPEVLLGK------GYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIR  195 (215)
T ss_pred             ccChhHhccc------CCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHH
Confidence            9999998621      3678889999999999999                                     57889999


Q ss_pred             HHhh-ChhhcCChhHHhcCC
Q psy13735        257 SLVQ-KLDARLNMDQVLGHP  275 (792)
Q Consensus       257 ~LL~-DP~kRPTaeEIL~HP  275 (792)
                      .|+. +|.+||++.+++.||
T Consensus       196 ~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         196 KMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHhhCCcccCcCHHHHhhCC
Confidence            9999 999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576|consensus

Probab=99.97  E-value=5.6e-31  Score=297.65  Aligned_cols=260  Identities=27%  Similarity=0.449  Sum_probs=219.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      -..++|..+..+|+|.||.||+++++.+|...|+|+|+-.....    ..|+-+++..+|||||.+++.|-....++|.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            35689999999999999999999999999999999997654333    56788889999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||.||+|.++.  +.-|.+++.++.+..+..+.||+|||+.|=+|||||-.||+++..|.+||.|||.+..+...- .+
T Consensus        92 EycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K  168 (829)
T KOG0576|consen   92 EYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK  168 (829)
T ss_pred             EecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence            999999999988  566889999999999999999999999999999999999999999999999999998876432 23


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ...+.|||+|||||+..-.    ..++|...+|||++|+...++---++|-...-+......... .....+...+...+
T Consensus       169 rksfiGtpywmapEvaave----rkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-S~~qpp~lkDk~kw  243 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-SGFQPPTLKDKTKW  243 (829)
T ss_pred             hhcccCCccccchhHHHHH----hcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-cCCCCCcccCCccc
Confidence            4456799999999997533    356899999999999999999888888654443333322222 11233344455789


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ++.+.+|++.+|. +|.+||+++.+|.|||...
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            9999999999999 8999999999999999874

>KOG1290|consensus

Probab=99.96  E-value=1.4e-29  Score=278.99  Aligned_cols=132  Identities=22%  Similarity=0.396  Sum_probs=116.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcC-----C---CCcceeEEEEEe-
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSK-----C---PYIVNLFYSFQD-   79 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~-----H---PNIVkL~~vfed-   79 (792)
                      +...+|-+.++||.|.|++||+|.+..+.+.||+|+++......   ..|+.+|+++.     |   .+||+|++.|.. 
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            45578999999999999999999999999999999987655433   67999998873     3   479999999974 


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeC
Q psy13735         80 ---MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLS  144 (792)
Q Consensus        80 ---e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd  144 (792)
                         ..++|||+|++ |.+|..+|.......++...++.|++||+.||.|||. .||||-||||+|||+.
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence               56899999999 8899999987777789999999999999999999996 5999999999999984

>KOG1094|consensus

Probab=99.96  E-value=8.8e-30  Score=284.57  Aligned_cols=253  Identities=21%  Similarity=0.311  Sum_probs=203.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +..+...+.++||+|-||.|.+|.... +..||+|++.......     ..|+.+|.+|+|||||.++++|..++.+++|
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            445566789999999999999997764 6899999987665544     5799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||++.|+|..++.......+.-.....++.||++|++||.+.++|||||-|.|+|++.++++||+|||+++.+-.....
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999999997653333445566779999999999999999999999999999999999999999999977654433


Q ss_pred             ccc-cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc--CCCCCCCCChhhhhhhhhcc--cCCCCcCC
Q psy13735        167 KSI-VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT--GSTPFNYETLDMTYSSILAC--DTEDTVSF  241 (792)
Q Consensus       167 ~s~-t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT--Gk~PF~~~d~~el~ekIl~~--~~~~~l~f  241 (792)
                      ... ..+-...|||||.+..       +.++.++|+|++|+.+||+++  ...||...+.+...++.-..  ..+.....
T Consensus       694 ~vqgr~vlpiRwmawEsill-------gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             eeecceeeeeeehhHHHHHh-------ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence            322 1234568999999873       479999999999999999765  78899766655554443221  12222223


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      +.+.-.+..+-.++..|+. +..+||+.+++-
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            3344678888899999999 999999999984

>KOG0199|consensus

Probab=99.96  E-value=1.5e-29  Score=286.57  Aligned_cols=244  Identities=21%  Similarity=0.332  Sum_probs=207.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecC-C--cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQS-H--NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~t-G--k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .+....++||+|+||.|+++.+... |  -.||||++.......     ..|+.+|.+|+|||+++||++..+ ..+.+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            3456678999999999999998753 3  368999998766552     679999999999999999999988 788999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||++++|+|.+.|.....+.|.....+.|+.||+.|+.||.++++|||||-..|||+.....|||||||+.+.+..+...
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999999997766778999999999999999999999999999999999999999889999999999988755433


Q ss_pred             ccccC--CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        167 KSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       167 ~s~t~--vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      .....  --...|+|||.++.       ..++.++|+|++||.+|||++ |..||.+-....++++|-.     ...++.
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh-------~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~-----~erLpR  336 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRH-------RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA-----GERLPR  336 (1039)
T ss_pred             eEecCCCcCcccccCHhHhcc-------ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc-----cccCCC
Confidence            22111  12347999999973       478999999999999999999 9999999998888888753     233444


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHH
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQV  271 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEI  271 (792)
                      ....|+++-+++..|+. +|.+|||+..|
T Consensus       337 Pk~csedIY~imk~cWah~paDRptFsai  365 (1039)
T KOG0199|consen  337 PKYCSEDIYQIMKNCWAHNPADRPTFSAI  365 (1039)
T ss_pred             CCCChHHHHHHHHHhccCCccccccHHHH
Confidence            45789999999999999 99999998766

>KOG0984|consensus

Probab=99.96  E-value=1e-29  Score=256.67  Aligned_cols=215  Identities=22%  Similarity=0.416  Sum_probs=172.0

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHH-hcCCCCcceeEEEEEeCCEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMV-KSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~-kL~HPNIVkL~~vfede~~lyL   85 (792)
                      +..++..-+..||+|++|.|-+.+|..+|...|+|.+....-..     ..|.++.. ...+|++|.+|+.+-.+..++|
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            34455566789999999999999999999999999987544332     34444443 3469999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         86 IMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .||.| ..+|..+...  ..++.++|...-+++..++.||.|||++ .|+|||+||+|||++.+|+||+||||.+..+.+
T Consensus       123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99999 4566554432  3467799999999999999999999986 899999999999999999999999999987754


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC-CCChhhhhhhhhc
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN-YETLDMTYSSILA  232 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~-~~d~~el~ekIl~  232 (792)
                      .-  ..+.-.|+..|||||.+...   ....+|+.++||||||+.+.||.+++.||. ..++.+.+..+..
T Consensus       202 Si--Akt~daGCkpYmaPEri~~e---~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  202 SI--AKTMDAGCKPYMAPERINPE---LNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hh--HHHHhcCCCccCChhhcCcc---cCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            32  22224599999999999743   222379999999999999999999999985 3444555555544

>KOG1167|consensus

Probab=99.96  E-value=3.2e-29  Score=272.94  Aligned_cols=261  Identities=27%  Similarity=0.415  Sum_probs=202.4

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEec---CCcEEEEEEeccCCCCh--HHHHHHHHhcC-CCCcceeEEEEEeCCEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQ---SHNTFVMKKVLREKMPN--TIERDIMVKSK-CPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~---tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~-HPNIVkL~~vfede~~l   83 (792)
                      -......|.++.+||.|+|++||++....   .+..||+|.+.....+.  .+|.++|..+. +.||+++.+++..++.+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            44566789999999999999999998877   78899999998776665  67889998884 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEeccCcccccc-
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVD-  161 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~~l~-  161 (792)
                      .+||||++..+..++...     ++...+..|++.++.||.++|.+||+||||||.|+|++. .+.-.|+|||+|.... 
T Consensus       111 ~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             EEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            999999999888888732     788999999999999999999999999999999999974 5678999999987211 


Q ss_pred             ----------------c-----------------CCC---------cccccCCCCCCccChhhhhhhccCCCCCCCCccc
Q psy13735        162 ----------------K-----------------NGR---------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC  199 (792)
Q Consensus       162 ----------------~-----------------~~~---------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ks  199 (792)
                                      +                 .+.         ...-...|||+|.|||++...      +.-+.++
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~------~~Qttai  259 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC------PRQTTAI  259 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc------cCcCCcc
Confidence                            0                 000         000122699999999999743      4567889


Q ss_pred             ccccchhhHHHhhcCCCCCCCCChh-hhhhhhh---------------cc--cCC---------------C---------
Q psy13735        200 DLWSIGVVSYELLTGSTPFNYETLD-MTYSSIL---------------AC--DTE---------------D---------  237 (792)
Q Consensus       200 DIWSLGVILYELLTGk~PF~~~d~~-el~ekIl---------------~~--~~~---------------~---------  237 (792)
                      ||||.|||+..++++..||.....+ .....|.               ..  .|.               .         
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999999432210 0000000               00  000               0         


Q ss_pred             ----CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        238 ----TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       238 ----~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                          ..........+..+.+|+.+||. ||.+|+|++++|.||||....
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence                00001112345689999999999 999999999999999998543

>KOG4278|consensus

Probab=99.96  E-value=3.4e-29  Score=280.17  Aligned_cols=245  Identities=20%  Similarity=0.347  Sum_probs=210.0

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      ..+..+..+||-|.||.||.+.++.-.-.+|||.++.+.+.-   ..|+.+|+.++|||+|+|+++|..+-.+|||+|||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            345566789999999999999999998999999998777654   56899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      ..|+|.++|.+.....++.....+++.||.+|+.||..+++|||||-..|+|+..+..||++|||+++....+.. ....
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAHA  424 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAHA  424 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-eccc
Confidence            999999999877667788888889999999999999999999999999999999999999999999998753321 1111


Q ss_pred             -CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        171 -PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       171 -~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                       .--..-|.|||.+-+.       .++.++|||+|||++|++.| |-.||.+-+....|..+-+   +....-|.  .++
T Consensus       425 GAKFPIKWTAPEsLAyN-------tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk---gyRM~~Pe--GCP  492 (1157)
T KOG4278|consen  425 GAKFPIKWTAPESLAYN-------TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK---GYRMDGPE--GCP  492 (1157)
T ss_pred             CccCcccccCccccccc-------ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc---cccccCCC--CCC
Confidence             1124579999998643       68999999999999999998 9999999998888876654   12223344  789


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHH
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQV  271 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEI  271 (792)
                      +..-.|++.|++ .|..||+..++
T Consensus       493 pkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  493 PKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHHHHHHHhcCCcccCccHHHH
Confidence            999999999999 99999998877

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=4.7e-28  Score=238.42  Aligned_cols=209  Identities=39%  Similarity=0.678  Sum_probs=177.0

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-h----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-N----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...... .    ..|...+..++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            67889999999999999999998999999999876543 1    568889999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      +++|.+++...... +++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+..............
T Consensus        81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            99999999653321 79999999999999999999999999999999999999999999999999987754321122334


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC--CChhhhhhhhhc
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY--ETLDMTYSSILA  232 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~--~d~~el~ekIl~  232 (792)
                      .++..|++||.+.      +...++.++|+|+||+++|+|++|+.||..  .+.....+.+..
T Consensus       160 ~~~~~~~~pe~~~------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~  216 (225)
T smart00221      160 KGTPFYLAPEVLL------GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF  216 (225)
T ss_pred             eccCCcCCHhHhc------CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence            6888999999983      134677799999999999999999999976  333455555554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0603|consensus

Probab=99.95  E-value=3e-29  Score=284.12  Aligned_cols=284  Identities=31%  Similarity=0.547  Sum_probs=228.7

Q ss_pred             EeeecCceEEEEEEE---ecCCcEEEEEEeccCCCCh------HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         22 FIQQGNFGDIYLVEE---KQSHNTFVMKKVLREKMPN------TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        22 ~IGsGsFGtVyla~~---k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      ++|.|+||.|++|+.   .+.|..||+|+..+.....      ..|+.++..++ ||++|+++..|+.+..+|++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999998764   4567889999987765432      57899999997 9999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      ||+|+..+.  ....+.+.....+...++.++.++|+.+|+|||+|++||+++.+|++++.|||+++..-...     ..
T Consensus        81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----~~  153 (612)
T KOG0603|consen   81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----IA  153 (612)
T ss_pred             cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----hc
Confidence            999999984  45568999999999999999999999999999999999999999999999999998765332     22


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      |||..|||||+++         ++...+|+||+|+++++|++|..||.+    ++...|..    ..+..|.  .++..+
T Consensus       154 cgt~eymApEI~~---------gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~----~~~~~p~--~l~~~a  214 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN---------GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK----AELEMPR--ELSAEA  214 (612)
T ss_pred             ccchhhhhhHhhh---------ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh----hccCCch--hhhHHH
Confidence            8999999999996         578899999999999999999999987    55666655    3444555  789999


Q ss_pred             HHHHHHHhh-ChhhcCCh-----hHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhhhccCCChhhhhhc
Q psy13735        252 VNFVQSLVQ-KLDARLNM-----DQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDKRKASPSLKAFQKE  314 (792)
Q Consensus       252 kdLIk~LL~-DP~kRPTa-----eEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~~k~~~s~k~f~~~  314 (792)
                      .+++..++. +|.+|+..     .++++|+||..++        ..||++|.   +.+..+|+...+...+...+.   .
T Consensus       215 ~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~---~  291 (612)
T KOG0603|consen  215 RSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPL---L  291 (612)
T ss_pred             HHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCC---C
Confidence            999999999 99999874     6889999999876        35667775   345666766555443322221   1


Q ss_pred             ccccccCCCcccccccCCCC
Q psy13735        315 GRYLDSALPLIGISYTGEPM  334 (792)
Q Consensus       315 ~~~~~~~l~fig~s~~~~~~  334 (792)
                      .........|.|++|.++.+
T Consensus       292 ~~~~s~~~if~g~sfva~~i  311 (612)
T KOG0603|consen  292 SASGSDHTIFSGPSFVAPGV  311 (612)
T ss_pred             CCCccccchhcCCCccChHH
Confidence            12222335677777766643

>KOG0200|consensus

Probab=99.95  E-value=3.4e-27  Score=275.34  Aligned_cols=246  Identities=22%  Similarity=0.401  Sum_probs=198.1

Q ss_pred             CCceEEeEeeecCceEEEEEEEec-------CCcEEEEEEeccCCCCh-----HHHHHHHHhcC-CCCcceeEEEEEeCC
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQ-------SHNTFVMKKVLREKMPN-----TIERDIMVKSK-CPYIVNLFYSFQDMN   81 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~-------tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~-HPNIVkL~~vfede~   81 (792)
                      ++..+.+.||.|.||.|+++....       ....||+|.+.......     ..|..+|..+. ||||+.+.+++...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            344566799999999999987542       14578999887555442     56888898885 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP------H--------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~------~--------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg  147 (792)
                      .+++|+|||..|+|.+++....      .        ..++......++.||+.|+.||++.+++||||-..|||+..+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence            9999999999999999996543      0        1388899999999999999999999999999999999999999


Q ss_pred             ceEEeccCcccccccCCCcccccCCCCC--CccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCC-h
Q psy13735        148 HLKLTDFGSATQVDKNGRIKSIVPVGTP--EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYET-L  223 (792)
Q Consensus       148 ~VKLiDFGLA~~l~~~~~~~s~t~vGTp--~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d-~  223 (792)
                      .+||+|||+|+..............|+.  .|||||.+..       ..|+.++||||+||++||+++ |..||.+-. .
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-------~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-------RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-------CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            9999999999976554443322222323  4999999973       479999999999999999999 999998744 3


Q ss_pred             hhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        224 DMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       224 ~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      ...++.+..   +.....|.  ..++++-++++.|++ +|.+||+..++.
T Consensus       529 ~~l~~~l~~---G~r~~~P~--~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  529 EELLEFLKE---GNRMEQPE--HCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             HHHHHHHhc---CCCCCCCC--CCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            444443433   23334444  669999999999999 999999998874

>KOG2052|consensus

Probab=99.95  E-value=2.1e-27  Score=259.95  Aligned_cols=253  Identities=19%  Similarity=0.298  Sum_probs=187.1

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHH--hcCCCCcceeEEEEEeC----CEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMV--KSKCPYIVNLFYSFQDM----NHVYF   85 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~--kL~HPNIVkL~~vfede----~~lyL   85 (792)
                      ...+..+.+.||+|-||.||++.++  |..||||++....-.. .+|.+|.+  .|+|+||+.+++.-..+    ..+||
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            4557789999999999999999887  7899999997655443 66777775  67999999999876543    36899


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL--------GYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~--------gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      |++|.+.|+|+|+|.+.   .++-..+..++..+++||+|||..        .|+|||||..||||.++|.+.|+|+|+|
T Consensus       287 vTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             eeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            99999999999999663   489999999999999999999952        4999999999999999999999999999


Q ss_pred             cccccCC---CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC----------CCCCCCCCh-
Q psy13735        158 TQVDKNG---RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG----------STPFNYETL-  223 (792)
Q Consensus       158 ~~l~~~~---~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG----------k~PF~~~d~-  223 (792)
                      .......   ....+..+||..|||||++...-..... .--..+||||||.|++|+.-.          ++||.+-.+ 
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~F-esyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHF-ESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhh-hhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            8765432   2345667999999999999743111011 112358999999999998752          578854322 


Q ss_pred             hhhhhhhhc--ccCCCCcCCCCCcccc---HHHHHHHHHHhh-ChhhcCChhHH
Q psy13735        224 DMTYSSILA--CDTEDTVSFPSSIRLS---TAMVNFVQSLVQ-KLDARLNMDQV  271 (792)
Q Consensus       224 ~el~ekIl~--~~~~~~l~fP~~~~lS---~elkdLIk~LL~-DP~kRPTaeEI  271 (792)
                      +..++.+..  +.....+.+|..=.-.   ..+..+++.|+. +|.-|.|+--|
T Consensus       443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            112222222  2222223333311112   235566778888 99999997655

>KOG1345|consensus

Probab=99.95  E-value=2.4e-28  Score=254.45  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=192.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHH-hcCCCCcceeEE-EEEeCCEEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMV-KSKCPYIVNLFY-SFQDMNHVYFIME   88 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~-kL~HPNIVkL~~-vfede~~lyLVmE   88 (792)
                      .+.|.|.+.+|.|.||.+-+|.|+.++..+|+|.+++.....   ..|..--- ...|.||+.-|+ .|++.+.++++||
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            357999999999999999999999999999999998776543   22322211 225899998876 4899999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC-CC-CceEEeccCcccccccCCCc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS-AT-GHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd-~d-g~VKLiDFGLA~~l~~~~~~  166 (792)
                      |++.|+|..-+.   ..++.|...+.++.|+++||.|||+.++||||||.+||||- .+ -.|||||||..+..+.....
T Consensus       103 ~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~  179 (378)
T KOG1345|consen  103 FAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY  179 (378)
T ss_pred             cCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence            999999999883   24489999999999999999999999999999999999983 33 36999999998766532211


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-hhhhhhhhcccCCCCcCCCCC-
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-DMTYSSILACDTEDTVSFPSS-  244 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-~el~ekIl~~~~~~~l~fP~~-  244 (792)
                          .--+..|.+||.+...  ..+.-...+.+|+|.||+|+|.+|+|.+||..... +..|..............|.. 
T Consensus       180 ----~~~~~~y~~pe~~~~~--~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  180 ----LEYVNNYHAPELCDTV--VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             ----hhhhcccCCcHHHhhc--cccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence                1245678999987633  12233456789999999999999999999974322 233333333222233344432 


Q ss_pred             ccccHHHHHHHHHHhh-Chhhc---CChhHHhcCCCccC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDAR---LNMDQVLGHPVFDC  279 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kR---PTaeEIL~HPwF~~  279 (792)
                      ..+|+.+..+.++-|. +|++|   .++..-....|..+
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            4578999999999999 88888   34444455566654

>KOG3653|consensus

Probab=99.95  E-value=1.1e-27  Score=263.63  Aligned_cols=257  Identities=20%  Similarity=0.266  Sum_probs=193.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHh--cCCCCcceeEEEEEeCC----EEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVK--SKCPYIVNLFYSFQDMN----HVYF   85 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~k--L~HPNIVkL~~vfede~----~lyL   85 (792)
                      ........++||+|.||.||+++..  ++.||||++....... ..|++|...  +.|+||+.++++-....    .++|
T Consensus       208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3456677899999999999999775  5999999998665544 678888875  47999999998876554    7999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCceEeCCCCceEEeccCc
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL---------GYVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~---------gIVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                      |++|.+.|+|.++|....   +++.....++..|++||+|||+-         .|+|||||..||||..+++..|+|||+
T Consensus       286 Vt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999996543   89999999999999999999963         599999999999999999999999999


Q ss_pred             ccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC------------CC----
Q psy13735        157 ATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP------------FN----  219 (792)
Q Consensus       157 A~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P------------F~----  219 (792)
                      |..+.+.... ....-+||..|||||++.+. -+......-.+.||||+|.+++||++...-            |.    
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            9988754322 23335899999999999753 122222223468999999999999985432            21    


Q ss_pred             -CCChhhhhhhhhcccCCCCcCCCCC---ccccHHHHHHHHHHhh-ChhhcCChhHH------hcCCCc
Q psy13735        220 -YETLDMTYSSILACDTEDTVSFPSS---IRLSTAMVNFVQSLVQ-KLDARLNMDQV------LGHPVF  277 (792)
Q Consensus       220 -~~d~~el~ekIl~~~~~~~l~fP~~---~~lS~elkdLIk~LL~-DP~kRPTaeEI------L~HPwF  277 (792)
                       ..+.+++...++.  ....+.+|+.   -.....+++.+..|+. ||..|+|+.=+      +.|+|-
T Consensus       442 ~hPt~e~mq~~VV~--kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  442 NHPTLEEMQELVVR--KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCCHHHHHHHHHh--hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence             1222333333332  1122333331   1224568888999999 99999997533      667663

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=4.1e-28  Score=289.95  Aligned_cols=199  Identities=18%  Similarity=0.254  Sum_probs=146.0

Q ss_pred             hcCC-CCcceeEEEE-------EeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q psy13735         64 KSKC-PYIVNLFYSF-------QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD  135 (792)
Q Consensus        64 kL~H-PNIVkL~~vf-------ede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRD  135 (792)
                      .+.| +||+.++++|       .....++++|||+ +++|.++|.. ....+++..+..|++||+.||.|||++||+|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            4456 6888888887       3335688889988 7799999964 245599999999999999999999999999999


Q ss_pred             CCCCceEeCCCC-------------------ceEEeccCcccccccCC---------------CcccccCCCCCCccChh
Q psy13735        136 IKPDNMLLSATG-------------------HLKLTDFGSATQVDKNG---------------RIKSIVPVGTPEYVAPE  181 (792)
Q Consensus       136 LKPeNILLd~dg-------------------~VKLiDFGLA~~l~~~~---------------~~~s~t~vGTp~Y~APE  181 (792)
                      |||+||||+..|                   .+|++|||+++......               .......+||++|||||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            999999996544                   45556666654321100               00011236899999999


Q ss_pred             hhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC-CccccHHHHHHHHHHhh
Q psy13735        182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS-SIRLSTAMVNFVQSLVQ  260 (792)
Q Consensus       182 iL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~-~~~lS~elkdLIk~LL~  260 (792)
                      ++.+       ..|+.++|||||||++|+|++|.+||....  .....+...      .+|. .....+...+++..||.
T Consensus       186 ~~~~-------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~L~  250 (793)
T PLN00181        186 EDNG-------SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR------VLPPQILLNWPKEASFCLWLLH  250 (793)
T ss_pred             hhcc-------CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh------hcChhhhhcCHHHHHHHHHhCC
Confidence            9863       368999999999999999999999875322  122222110      0111 11224567789999999


Q ss_pred             -ChhhcCChhHHhcCCCccC
Q psy13735        261 -KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       261 -DP~kRPTaeEIL~HPwF~~  279 (792)
                       +|.+||++.+++.||||..
T Consensus       251 ~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        251 PEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             CChhhCcChHHHhhchhhhh
Confidence             9999999999999999974

>KOG1025|consensus

Probab=99.94  E-value=5.8e-27  Score=269.23  Aligned_cols=241  Identities=19%  Similarity=0.289  Sum_probs=201.3

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCc----EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHN----TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk----~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .+..++||+|+||+||++.+...|.    +||+|++.......     ..|+-+|.+++|||+++|++++.... +-||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            4456899999999999998865554    68899887766553     56888999999999999999998776 88999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      +|+++|.|.++++. ..+.+-......|..||+.|+.|||.++++||||-..||||....++|++|||+++.+.+.....
T Consensus       777 q~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             HhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99999999999976 34568889999999999999999999999999999999999999999999999999887554322


Q ss_pred             c-ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        168 S-IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       168 s-~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                      . ....-.+.|||=|.+..       ..|+.++||||+||.+||++| |..|+.+....++-..+..     ...++.+.
T Consensus       856 ~~~~gK~pikwmale~i~~-------~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-----geRLsqPp  923 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRI-------RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-----GERLSQPP  923 (1177)
T ss_pred             cccccccCcHHHHHHHhhc-------cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-----cccCCCCC
Confidence            2 11122457899998863       589999999999999999998 9999998887776665544     12244444


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHH
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQV  271 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEI  271 (792)
                      ..+.++--++.+|+. |+..||++.++
T Consensus       924 iCtiDVy~~mvkCwmid~~~rp~fkel  950 (1177)
T KOG1025|consen  924 ICTIDVYMVMVKCWMIDADSRPTFKEL  950 (1177)
T ss_pred             CccHHHHHHHHHHhccCcccCccHHHH
Confidence            788899999999999 99999998876

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.1e-24  Score=216.06  Aligned_cols=257  Identities=36%  Similarity=0.594  Sum_probs=202.0

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCC-CcceeEEEEEeCCEEEEEEe
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCP-YIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HP-NIVkL~~vfede~~lyLVmE   88 (792)
                      |.+...||.|+||.||.+.+.   ..+++|.+.......       ..|..++..+.|+ +|+++.+++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999887   788999887665432       4677788999988 79999999988888999999


Q ss_pred             ccCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCCCc
Q psy13735         89 YVTGGDFVTLLENQPH-GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~-g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~~~  166 (792)
                      ++.|+++.+++..... ..++...+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++.........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9999999977744221 2689999999999999999999999999999999999999988 6999999999865433221


Q ss_pred             -----ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh----hhhhhhhhcccCCC
Q psy13735        167 -----KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL----DMTYSSILACDTED  237 (792)
Q Consensus       167 -----~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~----~el~ekIl~~~~~~  237 (792)
                           .....+|++.|++||.+....    ...++...|+||+|++++++++|..||.....    ......+...... 
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-  233 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-  233 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence                 234567999999999986310    13678899999999999999999999876653    3444444332211 


Q ss_pred             CcCCCCCcc----ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        238 TVSFPSSIR----LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       238 ~l~fP~~~~----lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ....+....    ....+.+++..++. +|..|.+......++|.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            011111111    12678999999999 999999999998887766443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=1.3e-25  Score=217.27  Aligned_cols=164  Identities=24%  Similarity=0.295  Sum_probs=127.8

Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV  172 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~v  172 (792)
                      |+|.+++... ...+++..++.|+.||+.||.|||+++      ||+|||++.++.+++  ||++.......      ..
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~   65 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SR   65 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------CC
Confidence            7899999642 345999999999999999999999999      999999999999999  99998764321      25


Q ss_pred             CCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-hhhhhhhhcccCCCC-cCCCCCccccH-
Q psy13735        173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-DMTYSSILACDTEDT-VSFPSSIRLST-  249 (792)
Q Consensus       173 GTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-~el~ekIl~~~~~~~-l~fP~~~~lS~-  249 (792)
                      ||+.|+|||++..       ..++.++|||||||++|+|++|..||..... ...+..+........ ...+....++. 
T Consensus        66 g~~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (176)
T smart00750       66 VDPYFMAPEVIQG-------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA  138 (176)
T ss_pred             CcccccChHHhcC-------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence            8999999999963       3688999999999999999999999965433 223333322111110 01111223444 


Q ss_pred             -HHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        250 -AMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       250 -elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                       .+.+|+..|+. +|.+||++.+++.|||+.
T Consensus       139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      139 RSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             hhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence             69999999999 999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0606|consensus

Probab=99.92  E-value=1.3e-25  Score=264.63  Aligned_cols=242  Identities=34%  Similarity=0.642  Sum_probs=192.0

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      ...-++|+.++.|..|+||.||+++|+.+.+.||+ .+++..+..   +.|+.....|++|                   
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lil---Rnilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLIL---RNILTFAGNPFVV-------------------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhh---hccccccCCccee-------------------
Confidence            34667999999999999999999999999999999 566655432   2255555566666                   


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC-------
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-------  163 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~-------  163 (792)
                        |+-...++.  .+.++...        +.+++|||+-||+|||+||+|.+|+.-|++|++|||+++.....       
T Consensus       136 --gDc~tllk~--~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  136 --GDCATLLKN--IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             --chhhhhccc--CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence              666667633  34455443        88999999999999999999999999999999999998764311       


Q ss_pred             -------CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC
Q psy13735        164 -------GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       164 -------~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~  236 (792)
                             ........||||.|+|||++..       .+|+..+|||++|+|+|+++.|+.||.++++++++..++.    
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilr-------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis----  272 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----  272 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhh-------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh----
Confidence                   0112224489999999999974       4899999999999999999999999999999999999987    


Q ss_pred             CCcCCCCC-ccccHHHHHHHHHHhh-ChhhcCC---hhHHhcCCCccCCCCC------CCCCCC---CcccCcCCh
Q psy13735        237 DTVSFPSS-IRLSTAMVNFVQSLVQ-KLDARLN---MDQVLGHPVFDCLDSD------PPCIPP---PSQENKFHK  298 (792)
Q Consensus       237 ~~l~fP~~-~~lS~elkdLIk~LL~-DP~kRPT---aeEIL~HPwF~~i~~~------pP~~P~---~s~~~~f~~  298 (792)
                      ....+|.. ..+.++++++|..||. +|..|..   +-++.+|+||..++..      .+++|.   ..+..+|+.
T Consensus       273 d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdT  348 (1205)
T KOG0606|consen  273 DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDT  348 (1205)
T ss_pred             hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhhcc
Confidence            44555543 4578999999999999 9999975   5677999999998855      677775   334444443

>KOG0590|consensus

Probab=99.92  E-value=4.4e-26  Score=265.22  Aligned_cols=255  Identities=24%  Similarity=0.382  Sum_probs=195.4

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEeccC----CCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE----KMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks----~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .....+|.|++|.|+.+........++.|.+...    ....      ..|.-+-..+.|||++.....+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4678999999999998888777777777755421    1111      12333335678999988877777666666669


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC--
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR--  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~--  165 (792)
                      |||++ +|+.++.+  .++++..++..+++|++.||.|||+.||.|||+||+|++++.+|.+||+|||.+..+.....  
T Consensus       401 E~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            99999 99999944  45799999999999999999999999999999999999999999999999999987654333  


Q ss_pred             -cccccCCCCCCccChhhhhhhccCCCCCCC-CcccccccchhhHHHhhcCCCCCCCCChhhhh-hhhhcccCCCCcC--
Q psy13735        166 -IKSIVPVGTPEYVAPEVLEWMEGNHGSDGY-TGSCDLWSIGVVSYELLTGSTPFNYETLDMTY-SSILACDTEDTVS--  240 (792)
Q Consensus       166 -~~s~t~vGTp~Y~APEiL~~~~~~~~~~~y-s~ksDIWSLGVILYELLTGk~PF~~~d~~el~-ekIl~~~~~~~l~--  240 (792)
                       ......+|+..|+|||++...       .| ...+||||.|++++.|.+|+.||......+.. .......+.....  
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~-------~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGK-------EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP  550 (601)
T ss_pred             hhhhcCcccCCcCcCccccccc-------ccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence             345567899999999999743       44 44699999999999999999999755443221 1111111111111  


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      .+....++...+.+|.+||+ +|.+|.|+++|++.|||+.+..
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            11234578889999999999 9999999999999999998763

>KOG1164|consensus

Probab=99.91  E-value=1.9e-23  Score=225.18  Aligned_cols=248  Identities=21%  Similarity=0.256  Sum_probs=189.2

Q ss_pred             CceEEeEeeecCceEEEEEEEecCC-cEEEEEEeccCCCC----hHHHHHHHHhcC----CCCcceeEEEE-EeCCEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSH-NTFVMKKVLREKMP----NTIERDIMVKSK----CPYIVNLFYSF-QDMNHVYF   85 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tG-k~vAVKiI~Ks~~~----~~~E~eIL~kL~----HPNIVkL~~vf-ede~~lyL   85 (792)
                      .|.+.+.||+|+||.||.|.+..++ ..+|+|........    ...|..++..+.    .+++..+++.+ .....-||
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999998775 68899988764322    367888988886    36999999999 58888999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC-----CceEEeccCccc--
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-----GHLKLTDFGSAT--  158 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d-----g~VKLiDFGLA~--  158 (792)
                      ||+.+ |.+|.++......+.|+..++..++.|++.+|.+||+.|++||||||.|+++...     ..+.|.|||+|+  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99999 9999999876666789999999999999999999999999999999999999765     359999999998  


Q ss_pred             ccccCCC------cc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhh
Q psy13735        159 QVDKNGR------IK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       159 ~l~~~~~------~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl  231 (792)
                      .......      .. .....||..|+++.+..+       ...++..|+||++.++.+|+.|..||...........+.
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-------IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCC-------CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            3221111      01 123459999999998764       478899999999999999999999997655433333332


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      ......... +.....+..+..+...+-. +...+|....+.
T Consensus       251 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~  291 (322)
T KOG1164|consen  251 KDPRKLLTD-RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLA  291 (322)
T ss_pred             HHhhhhccc-cccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence            211111111 0111234566666666665 777777766653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.9e-23  Score=230.33  Aligned_cols=179  Identities=17%  Similarity=0.220  Sum_probs=134.3

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEec-CCcEEEEEEeccCCC----C-----hHHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQ-SHNTFVMKKVLREKM----P-----NTIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~-tGk~vAVKiI~Ks~~----~-----~~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      +.-.++|.+.+.||+|+||+||+|.++. +|..+|+|++.....    .     ...|+.+|..++|+|++..+..   .
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence            3456789999999999999999999886 678889998753311    1     1579999999999999853322   2


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCceEeCCCCceEEeccCcccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI-KPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDL-KPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      +..|+|||||+|++|.. +  ...+      ...++.|++.||.|||++||+|||| ||+|||++.++.++|+|||+|+.
T Consensus        91 ~~~~LVmE~~~G~~L~~-~--~~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-A--RPHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             CCcEEEEEccCCCCHHH-h--Cccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            45899999999999973 2  1111      1468899999999999999999999 99999999999999999999997


Q ss_pred             cccCCCccc-------ccCCCCCCccChhhhhhhccCCCCCCCCcccccc
Q psy13735        160 VDKNGRIKS-------IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLW  202 (792)
Q Consensus       160 l~~~~~~~s-------~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIW  202 (792)
                      +...+....       ...+|++.|+|||.+...... .....+...|-|
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~-~~~~~~~~~dgW  210 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERK-ILARKSLPSRIW  210 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhc-cccccccccCcE
Confidence            654321111       234688999999998643111 122333446655

>KOG1024|consensus

Probab=99.86  E-value=9.8e-22  Score=212.87  Aligned_cols=249  Identities=17%  Similarity=0.235  Sum_probs=194.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCC-----cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEe-C
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSH-----NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQD-M   80 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tG-----k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfed-e   80 (792)
                      +...+++..-++-+|.||.||.+.++...     +.+-+|.+.....+.     ..|.-.+.-+.|||+..+.++... .
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            44456777888999999999999776432     233445443322211     345556666789999999998764 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEecc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQ------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                      ...++++.++.-|+|..++...      ....++..+...++.|+..|+.|||++||+|.||-..|.+||+.-+|||+|=
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence            5678889999889999999621      1234677788889999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcccc-cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhc
Q psy13735        155 GSATQVDKNGRIKSI-VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILA  232 (792)
Q Consensus       155 GLA~~l~~~~~~~s~-t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~  232 (792)
                      .+++.+-+.....-. .......||+||.+...       .|+.++|+|||||+||||+| |+.|+-.-++.++...+..
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-------~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd  513 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-------HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD  513 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhh-------hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence            999877543221110 01134579999999754       79999999999999999998 9999999999988888775


Q ss_pred             ccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       233 ~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                           .+.+..+.+.++++..++..|+. .|++||+..|+.
T Consensus       514 -----GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  514 -----GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             -----cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence                 34444455889999999999999 999999999874

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.2e-21  Score=197.21  Aligned_cols=136  Identities=19%  Similarity=0.194  Sum_probs=109.1

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------------------------HHHHHHHHhcCCCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------------------------TIERDIMVKSKCPY   69 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------------------------~~E~eIL~kL~HPN   69 (792)
                      ...||+|+||.||+|.+. +|+.||+|++.......                              ..|..++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999987 89999999997542110                              23888999998877


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCceEeCCCCc
Q psy13735         70 IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL-HGLGYVHRDIKPDNMLLSATGH  148 (792)
Q Consensus        70 IVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YL-Hs~gIVHRDLKPeNILLd~dg~  148 (792)
                      +.....+...  ..+|||||++|+++...+.  ..+.+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence            7544333222  2389999999887765532  235689999999999999999999 799999999999999998 578


Q ss_pred             eEEeccCcccccc
Q psy13735        149 LKLTDFGSATQVD  161 (792)
Q Consensus       149 VKLiDFGLA~~l~  161 (792)
                      ++|+|||+|....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165|consensus

Probab=99.85  E-value=3e-21  Score=206.07  Aligned_cols=211  Identities=21%  Similarity=0.287  Sum_probs=172.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-Ch-HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-PN-TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-~~-~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..-.|+++++||.|+||..+.+.+--++.+||||.-+.... +. ..|....+.|. .++|+..|.+.+...+-.||||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            44579999999999999999999999999999998765443 22 67888888774 79999999999998899999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-----ceEEeccCcccccccCC
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-----HLKLTDFGSATQVDKNG  164 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-----~VKLiDFGLA~~l~~~~  164 (792)
                      + |.+|.|++.-. ...|+..++..++.|++.-+.|+|++++|+|||||+|+||...+     .|.++|||+|+...+..
T Consensus       106 L-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             h-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            9 88888777532 34599999999999999999999999999999999999997655     48999999999875432


Q ss_pred             C------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC---Chhhhhhhhhc
Q psy13735        165 R------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE---TLDMTYSSILA  232 (792)
Q Consensus       165 ~------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~---d~~el~ekIl~  232 (792)
                      .      ..-....||..||+-....+       ..-+...|+-|||.+++++|-|.+||.+-   +..+-|++|-.
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlG-------rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLG-------REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             ccccCccccccccccceeeeEeecccc-------chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence            1      11123469999999655432       25677899999999999999999999754   45566666643

>KOG1163|consensus

Probab=99.85  E-value=4.1e-21  Score=198.19  Aligned_cols=236  Identities=20%  Similarity=0.242  Sum_probs=181.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--hHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--~~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +....|.++++||+|+||.+|++.+..+|..||+|+-......  ...|..+.+.|+ .+.|+.+..++....+-.+||+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4567899999999999999999999999999999987644322  278999999987 5889999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEEeccCcccccccCCC
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKLiDFGLA~~l~~~~~  165 (792)
                      ++ |.+|.+++.-. ...|+..++..++-|++.-+.|+|.++++||||||+|+|..-+-   .+.|+|||+|+...+...
T Consensus        92 LL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             cc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence            99 89998887432 23489999999999999999999999999999999999985433   489999999987643211


Q ss_pred             ------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC---hhhhhhhhhcccCC
Q psy13735        166 ------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET---LDMTYSSILACDTE  236 (792)
Q Consensus       166 ------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d---~~el~ekIl~~~~~  236 (792)
                            .......||..|.+--...+.       .-+...|+-|+|.++.++.-|..||.+-.   ..+-+++|...   
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g~-------eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek---  239 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLGI-------EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK---  239 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhhh-------hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh---
Confidence                  111233599999886655422       45677899999999999999999998654   45556666542   


Q ss_pred             CCcCCCCC---ccccHHHHHHHHHHhh
Q psy13735        237 DTVSFPSS---IRLSTAMVNFVQSLVQ  260 (792)
Q Consensus       237 ~~l~fP~~---~~lS~elkdLIk~LL~  260 (792)
                       ....|..   ..++.++.-.+.-|-.
T Consensus       240 -K~s~~ie~LC~G~P~EF~myl~Y~R~  265 (341)
T KOG1163|consen  240 -KMSTPIEVLCKGFPAEFAMYLNYCRG  265 (341)
T ss_pred             -hcCCCHHHHhCCCcHHHHHHHHHHhh
Confidence             1111111   2445666666655544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=1.3e-20  Score=188.40  Aligned_cols=137  Identities=16%  Similarity=0.153  Sum_probs=111.1

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------------------------------hHHHHHHHHhcCCC
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------------------------------NTIERDIMVKSKCP   68 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------------------------------~~~E~eIL~kL~HP   68 (792)
                      +.+.||+|+||.||+|.+. +|+.||+|++......                              ...|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999998765211                              03577888899999


Q ss_pred             CcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCC
Q psy13735         69 YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        69 NIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg  147 (792)
                      ++.....+....  .||||||++|+++.....  ....++...+..++.|++.++.+||+ .||+||||||+|||++ ++
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence            886554444332  489999999886544321  23458889999999999999999999 9999999999999998 89


Q ss_pred             ceEEeccCcccccc
Q psy13735        148 HLKLTDFGSATQVD  161 (792)
Q Consensus       148 ~VKLiDFGLA~~l~  161 (792)
                      .++|+|||+|....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240|consensus

Probab=99.83  E-value=1.5e-21  Score=230.67  Aligned_cols=237  Identities=20%  Similarity=0.285  Sum_probs=181.3

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +|...+.||++.|=+|.+|++.. | .+++|++.+.....        ..|+. ....+|||++++.-+.......|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            68889999999999999998864 4 48899887765332        12233 56678999999988888888899999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc--cccCCC
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ--VDKNGR  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~--l~~~~~  165 (792)
                      +|. ..+|.|.+.  ...++..-+.+.|+.||+.||.-||..||+|||||.+||||+.-+.+.|+||..-+.  +..+++
T Consensus       101 qyv-khnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  101 QYV-KHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHH-hhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            999 568999994  455689999999999999999999999999999999999999999999999987643  222222


Q ss_pred             cccccC----CCCCCccChhhhhhhc----cCCCCCCCCcccccccchhhHHHhhc-CCCCCCCC-----------Chhh
Q psy13735        166 IKSIVP----VGTPEYVAPEVLEWME----GNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYE-----------TLDM  225 (792)
Q Consensus       166 ~~s~t~----vGTp~Y~APEiL~~~~----~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~-----------d~~e  225 (792)
                      .....+    ..-.+|+|||.|....    .....+..+++.||||+||+++||++ |++||...           +++.
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence            221111    2334899999997532    11122237889999999999999998 89999522           1111


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+++|                -+..++.+|..|++ ||.+|+++++.|+.
T Consensus       258 ~Le~I----------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEKI----------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhC----------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            22211                13468999999999 99999999998754

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=4.4e-20  Score=192.21  Aligned_cols=167  Identities=13%  Similarity=0.159  Sum_probs=128.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------------HHHHHHHHhcCCCCcceeEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------------TIERDIMVKSKCPYIVNLFYSFQD   79 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------------~~E~eIL~kL~HPNIVkL~~vfed   79 (792)
                      -..+|+++++||.|+||.||++..  ++..+|+|.+.......             ..|+..+.++.||+|+.+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            356899999999999999999654  46789999986443222             356668999999999999988764


Q ss_pred             C--------CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEE
Q psy13735         80 M--------NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL  151 (792)
Q Consensus        80 e--------~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKL  151 (792)
                      .        +..+|||||++|.+|.++..      +++.    .+.+|+.+|..||..||+|||++|+||+++.+| ++|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            3        35799999999999988741      3332    466999999999999999999999999999988 999


Q ss_pred             eccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhh
Q psy13735        152 TDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL  212 (792)
Q Consensus       152 iDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELL  212 (792)
                      +|||...........             .-++..       ..|+.++|+||||+.+..+.
T Consensus       176 iDfg~~~~~~e~~a~-------------d~~vle-------r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAK-------------DRIDLE-------RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhH-------------HHHHHH-------hHhcccccccceeEeehHHH
Confidence            999987654321100             012221       24667899999999876544

>KOG4158|consensus

Probab=99.82  E-value=2.4e-20  Score=202.63  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=175.8

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCc-----------------------------------EEEEEEeccCCC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHN-----------------------------------TFVMKKVLREKM   53 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk-----------------------------------~vAVKiI~Ks~~   53 (792)
                      .+++.+++|.|+..||+|..+.||.++....|.                                   +.|+|.+..-..
T Consensus       151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~  230 (598)
T KOG4158|consen  151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH  230 (598)
T ss_pred             hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence            467899999999999999999999987653221                                   234443321111


Q ss_pred             ChHHHHHHH------------------------H-------h-cCCCCcceeEEEEEe----------------------
Q psy13735         54 PNTIERDIM------------------------V-------K-SKCPYIVNLFYSFQD----------------------   79 (792)
Q Consensus        54 ~~~~E~eIL------------------------~-------k-L~HPNIVkL~~vfed----------------------   79 (792)
                      .. .-..||                        +       . -+|||||.+..+|.+                      
T Consensus       231 ~s-~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p  309 (598)
T KOG4158|consen  231 DS-GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP  309 (598)
T ss_pred             CC-chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence            11 000111                        1       1 259999999988844                      


Q ss_pred             -----CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe--CCCC--ceE
Q psy13735         80 -----MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL--SATG--HLK  150 (792)
Q Consensus        80 -----e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL--d~dg--~VK  150 (792)
                           ...+|+||..+ ..+|..++-.+.   .+....+-++.|++.|+.|||.+||.|||+|.+|||+  |+++  .+.
T Consensus       310 ~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LV  385 (598)
T KOG4158|consen  310 SGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLV  385 (598)
T ss_pred             cccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEE
Confidence                 23579999988 468999985433   6788889999999999999999999999999999997  4444  589


Q ss_pred             EeccCcccccccCC---Cc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh
Q psy13735        151 LTDFGSATQVDKNG---RI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM  225 (792)
Q Consensus       151 LiDFGLA~~l~~~~---~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e  225 (792)
                      |+|||+|---...+   +.  ..-...|.-.-||||+....++....-.|+ ++|.|+.|.+.||++....||+.... .
T Consensus       386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~-kAD~WA~GalaYEIfg~~NPFY~rGe-m  463 (598)
T KOG4158|consen  386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYE-KADTWAAGALAYEIFGRSNPFYKRGE-M  463 (598)
T ss_pred             EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccc-hhhhhhhhhhHHHHhccCCcccccch-h
Confidence            99999874322111   01  111234888999999998665554444444 69999999999999999999976321 1


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChh
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMD  269 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTae  269 (792)
                      .+..-. .....-...|+  .+++.+++++..+|+ ||++|++++
T Consensus       464 ~L~~r~-Yqe~qLPalp~--~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  464 LLDTRT-YQESQLPALPS--RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eechhh-hhhhhCCCCcc--cCChHHHHHHHHHhcCCccccCCcc
Confidence            111111 11112223333  789999999999999 999999954

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2e-19  Score=185.12  Aligned_cols=186  Identities=17%  Similarity=0.171  Sum_probs=142.3

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--------hHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEE
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--------NTIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--------~~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVm   87 (792)
                      +.+...||+|+||+|+++..  .+..++.+.+.-....        ...|+++|.++. |++|++++++    +..|++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45678999999999997755  5778887776655441        157999999995 5889999886    4569999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI-KPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDL-KPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      +|+.|++|...+..        . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus        78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            99999998754411        1 1357889999999999999999999 799999999999999999999865543310


Q ss_pred             ----c--------cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC
Q psy13735        167 ----K--------SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET  222 (792)
Q Consensus       167 ----~--------s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d  222 (792)
                          .        ......+|.|++|+-....     ...--...+|++.|+-+|.++||..|+..+.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-----~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVL-----KRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-----ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                0        1112368899999876522     1122256799999999999999999886543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=2.7e-19  Score=191.57  Aligned_cols=235  Identities=21%  Similarity=0.311  Sum_probs=146.1

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHH-----HHH--HhcC----------CCCcceeEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIM--VKSK----------CPYIVNLFYSFQ   78 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~-----eIL--~kL~----------HPNIVkL~~vfe   78 (792)
                      .+..++.||.|+||.||.|++..||+.+|+|++.........+.     +.+  ..+.          |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45678999999999999999999999999999876554331111     111  1111          212222222221


Q ss_pred             ---------eC---C-----EEEEEEeccCCCCHHHHHHh----CCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q psy13735         79 ---------DM---N-----HVYFIMEYVTGGDFVTLLEN----QPH-GYLSESKARFYIYELAQAVQYLHGLGYVHRDI  136 (792)
Q Consensus        79 ---------de---~-----~lyLVmEy~~GGsL~dlL~r----~~~-g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDL  136 (792)
                               ..   .     +.+++|+-+ .++|.+++.-    ... ..+.......+..|++..+++||+.||+|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     237788888 5688777631    111 11222233445589999999999999999999


Q ss_pred             CCCceEeCCCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhcc-CCCCCCCCcccccccchhhHHHhhcCC
Q psy13735        137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG-NHGSDGYTGSCDLWSIGVVSYELLTGS  215 (792)
Q Consensus       137 KPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~-~~~~~~ys~ksDIWSLGVILYELLTGk  215 (792)
                      +|+|++++.+|.+.|+||+.....+...  ..  ...++.|.+||....... ......++.+.|.|+||+++|.|.||.
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRY--RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEE--EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCcee--ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999999999999999877654321  11  235678999998764310 001234788899999999999999999


Q ss_pred             CCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-Chhhc
Q psy13735        216 TPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDAR  265 (792)
Q Consensus       216 ~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kR  265 (792)
                      .||...........        .+....  ++++..+.+|.+||+ +|.+|
T Consensus       248 lPf~~~~~~~~~~~--------~f~~C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW--------DFSRCR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG--------GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc--------cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence            99976544332221        111111  678999999999999 99987

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=7.5e-19  Score=180.48  Aligned_cols=132  Identities=15%  Similarity=0.135  Sum_probs=105.4

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----hHHHHHHHHhc-----CCCCcceeEEEEEeCC---EEE-
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERDIMVKS-----KCPYIVNLFYSFQDMN---HVY-   84 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----~~~E~eIL~kL-----~HPNIVkL~~vfede~---~ly-   84 (792)
                      .-...||+|+||.||.  ++.++.. +||++......    ...|+.+++.+     .||||++++++++++.   .++ 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3457899999999995  7777666 68988764322    26799999999     5799999999999874   434 


Q ss_pred             EEEec--cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCccCCCCCCceEeCC----CCceEEeccCcc
Q psy13735         85 FIMEY--VTGGDFVTLLENQPHGYLSESKARFYIYELAQAV-QYLHGLGYVHRDIKPDNMLLSA----TGHLKLTDFGSA  157 (792)
Q Consensus        85 LVmEy--~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL-~YLHs~gIVHRDLKPeNILLd~----dg~VKLiDFGLA  157 (792)
                      +||||  +.+|+|.+++.+   +.+++.  ..++.|++.++ .|||+++|+||||||+|||++.    ++.++|+||+.+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  557999999954   236666  36688888888 8999999999999999999974    337999995443

>KOG1166|consensus

Probab=99.77  E-value=9.8e-19  Score=209.82  Aligned_cols=195  Identities=24%  Similarity=0.326  Sum_probs=160.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC---CCCcceeEEEEEeCCEEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK---CPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~---HPNIVkL~~vfede~~lyLVm   87 (792)
                      +....|.|.+.||.|+||+||+|.+.+ |+.||+|+-.....-. .+-.+++.+|+   -+.|..++..+.-.+.-++|+
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            677889999999999999999999987 9999999876554433 34455666666   355666666666677789999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-------CCceEEeccCccccc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-------TGHLKLTDFGSATQV  160 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-------dg~VKLiDFGLA~~l  160 (792)
                      +|.+.|+|.+++  ...+.+++..+.+++.||+..|.+||..+|||+||||+|+||..       +.-++|+|||.+...
T Consensus       774 ey~~~Gtlld~~--N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  774 EYSPYGTLLDLI--NTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eccccccHHHhh--ccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            999999999999  46777999999999999999999999999999999999999842       224999999998654


Q ss_pred             ccCC-CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCC
Q psy13735        161 DKNG-RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGST  216 (792)
Q Consensus       161 ~~~~-~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~  216 (792)
                      .-.. .......++|-.|-++|...+       .+++..+|.|.|..++|.||+|+.
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~g-------rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREG-------RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcC-------CCCchhhhhHHHHHHHHHHHHHHH
Confidence            3221 134556689999999999864       379999999999999999999874

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=2.7e-18  Score=178.88  Aligned_cols=139  Identities=15%  Similarity=0.127  Sum_probs=111.8

Q ss_pred             CceEEeEeeecCceEEEEEE-EecCCcEEEEEEeccCCCC----------------------------hHHHHHHHHhcC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVE-EKQSHNTFVMKKVLREKMP----------------------------NTIERDIMVKSK   66 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~-~k~tGk~vAVKiI~Ks~~~----------------------------~~~E~eIL~kL~   66 (792)
                      .|.+.+.||.|+||.||+|. +..+|..||+|++......                            ...|..++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58899999999999999998 7778999999998754210                            135888888887


Q ss_pred             CC--CcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCceEe
Q psy13735         67 CP--YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG-YVHRDIKPDNMLL  143 (792)
Q Consensus        67 HP--NIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g-IVHRDLKPeNILL  143 (792)
                      +.  .++++++.   . ..||||||++|++|.....  ....+....+..++.||+.+|.+||+.| |+||||||+||++
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            53  34444432   2 3489999999988876552  2344677778899999999999999999 9999999999999


Q ss_pred             CCCCceEEeccCcccccc
Q psy13735        144 SATGHLKLTDFGSATQVD  161 (792)
Q Consensus       144 d~dg~VKLiDFGLA~~l~  161 (792)
                      + ++.++|+|||.|....
T Consensus       183 ~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             E-CCCEEEEEChhhhccC
Confidence            8 8899999999987543

>KOG0590|consensus

Probab=99.75  E-value=2.3e-19  Score=209.31  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=205.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEec-CCcEEEEEEeccCCCCh------HHHHHHHHhcC-CCCcceeEEEEEeCCEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQ-SHNTFVMKKVLREKMPN------TIERDIMVKSK-CPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~-tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~-HPNIVkL~~vfede~~lyL   85 (792)
                      ...|.+.+.||+|+|+.|-.+.... +...+|+|.+.......      ..|..+-..+. |+|++.+++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            6789999999999999999887744 34456677665543111      23555666666 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCceEeCCCC-ceEEeccCccccccc-
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH-GLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDK-  162 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH-s~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~-  162 (792)
                      +++|..||++++.+........+...+..++.|+..++.|+| ..++.||||+|+|.+++..+ .+++.|||+|..+.. 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            999999999999883222225788889999999999999999 99999999999999999999 999999999998775 


Q ss_pred             -CCCcccccCCC-CCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhh-hhhhcccCCCCc
Q psy13735        163 -NGRIKSIVPVG-TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTY-SSILACDTEDTV  239 (792)
Q Consensus       163 -~~~~~s~t~vG-Tp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~-ekIl~~~~~~~l  239 (792)
                       +........+| ++.|+|||...+.      ...++..|+||+|+++..|++|..||......... .....  .....
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~------~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~--~~~~~  250 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGK------AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS--NKGRF  250 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccch------hhcCCCcccccccccccccccCCCCccccccccccceeecc--ccccc
Confidence             22333455689 9999999998642      35577899999999999999999999765543321 11111  11222


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ....+..++....+++.+++. +|..|.+..++..+||+..
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            344556789999999999998 9999999999999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.6e-17  Score=166.22  Aligned_cols=130  Identities=26%  Similarity=0.378  Sum_probs=111.0

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +.||+|++|.||++..  .|..+++|+........            ..|..++..+.|++|+....++.+....++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  67789999765433211            357888999999999888878778888999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      |++|++|.+++...     .. ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998542     12 7889999999999999999999999999999998 78999999999865

>KOG0195|consensus

Probab=99.71  E-value=5e-18  Score=177.62  Aligned_cols=244  Identities=16%  Similarity=0.248  Sum_probs=189.8

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      .++...+..++.+|.....|..|+++...+  .+++|++.......      ..|.-.|+-..||||+.+++.+....++
T Consensus       185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  185 TGIDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             cCcchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            346667777888999999999999988754  56678776655443      2344456667899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCCCCceEE--eccCcccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSATGHLKL--TDFGSATQ  159 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~dg~VKL--iDFGLA~~  159 (792)
                      .+|..||+.|+|+..+..+..-..+..++..++..|++|+.|||+..  |...-|....+++|.+-+.+|  +|--++.+
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq  342 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ  342 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence            99999999999999997766666788999999999999999999975  555678889999998877555  34222211


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                              .....-.|.||+||.+...+    ....-.++|||||.+++++|.|...||..-.+.+.-.+|.-  -+-..
T Consensus       343 --------e~gr~y~pawmspealqrkp----ed~n~raadmwsfaillwel~trevpfadlspmecgmkial--eglrv  408 (448)
T KOG0195|consen  343 --------EVGRAYSPAWMSPEALQRKP----EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL--EGLRV  408 (448)
T ss_pred             --------ccccccCcccCCHHHHhcCc----hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--ccccc
Confidence                    11233578999999997542    12334579999999999999999999987777766666643  11223


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHH
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQV  271 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEI  271 (792)
                      ..|+  .+|..+..++.-|+. ||.+||..+++
T Consensus       409 ~ipp--gis~hm~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  409 HIPP--GISRHMNKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             cCCC--CccHHHHHHHHHHhcCCCCcCCCccee
Confidence            4455  789999999999999 99999998776

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=5.7e-17  Score=162.48  Aligned_cols=134  Identities=16%  Similarity=0.163  Sum_probs=107.3

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--------------------------hHHHHHHHHhcCCCC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--------------------------NTIERDIMVKSKCPY   69 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--------------------------~~~E~eIL~kL~HPN   69 (792)
                      .|.+.+.||.|+||.||++... +|+.+|+|++......                          ...|..++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4888999999999999999875 7999999987653210                          135677788887774


Q ss_pred             --cceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC
Q psy13735         70 --IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        70 --IVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg  147 (792)
                        ++..++    ....++||||++|++|..+...        .....++.+|+.++.++|+.||+||||+|.||+++.++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~  162 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence              444443    2455899999999998766421        34567889999999999999999999999999999999


Q ss_pred             ceEEeccCccccccc
Q psy13735        148 HLKLTDFGSATQVDK  162 (792)
Q Consensus       148 ~VKLiDFGLA~~l~~  162 (792)
                      .++|+|||++.....
T Consensus       163 ~~~liDfg~~~~~~~  177 (198)
T cd05144         163 KIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEEECCccccCCC
Confidence            999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=6.2e-17  Score=160.88  Aligned_cols=127  Identities=22%  Similarity=0.301  Sum_probs=104.1

Q ss_pred             EeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         22 FIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        22 ~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      .||+|+||.||++..  +|..+++|.........            ..|..++..+.|+++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  57889999865432211            3588899999888766555556667778999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ++|++|.+++...  . .      .++.+|+.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus        79 ~~g~~l~~~~~~~--~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEG--N-D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhc--H-H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999988431  1 1      7899999999999999999999999999998 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023|consensus

Probab=99.68  E-value=1.1e-16  Score=181.61  Aligned_cols=210  Identities=21%  Similarity=0.270  Sum_probs=158.0

Q ss_pred             HHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccCCCCCCc
Q psy13735         62 MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY-VHRDIKPDN  140 (792)
Q Consensus        62 L~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gI-VHRDLKPeN  140 (792)
                      |+.+.|.|+.++++.+-+...+++|.+||..|+|.+.+... .-.++.-....+++.|+.||.|||+..| +|+.+++.|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            35678999999999999999999999999999999999763 3447888888999999999999999877 999999999


Q ss_pred             eEeCCCCceEEeccCcccccccCCCcc-cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC
Q psy13735        141 MLLSATGHLKLTDFGSATQVDKNGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       141 ILLd~dg~VKLiDFGLA~~l~~~~~~~-s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~  219 (792)
                      .++|....+||+|||+........... .....-...|.|||.+............+.+.|+||+|+++|++++...||.
T Consensus        80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            999999999999999987764210000 0011134479999999854222222336788999999999999999999996


Q ss_pred             CCCh----hhhhhhhhc-ccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        220 YETL----DMTYSSILA-CDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       220 ~~d~----~el~ekIl~-~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      ....    .++...+.. ......+..+......+++..++..|+. +|..||++.++-
T Consensus       160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            5322    234444433 1111111111112456689999999999 999999999873

>KOG0606|consensus

Probab=99.66  E-value=3.6e-17  Score=194.07  Aligned_cols=259  Identities=31%  Similarity=0.456  Sum_probs=211.0

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      .+.+.+++.+.+-+-+|+||.++.+.-..+|..++.|+..+.....       ..+..++....||.++.....|-....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            4568889999999999999999999988899888887665543322       234444445567888877777777788


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .+|+|+|..||+|...+.  ..+..+++-++.++..++.++.|||+..+.|+|++|.|++...+|+.+++|||.....+-
T Consensus       879 ~~L~~~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             cchhhHHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            999999999999999994  456688889999999999999999999999999999999999999999999984322210


Q ss_pred             ------C------------------------CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhh
Q psy13735        163 ------N------------------------GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL  212 (792)
Q Consensus       163 ------~------------------------~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELL  212 (792)
                            .                        .........||+.|.+||+..+.       ..+..+|||++|+++++.+
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-------~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-------RHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-------cCCCcchhhhhhhhhhhhh
Confidence                  0                        00112234699999999998743       6778899999999999999


Q ss_pred             cCCCCCCCCChhhhhhhhhcccCCCCcCCCC-CccccHHHHHHHHHHhh-ChhhcCChh---HHhcCCCccCCC
Q psy13735        213 TGSTPFNYETLDMTYSSILACDTEDTVSFPS-SIRLSTAMVNFVQSLVQ-KLDARLNMD---QVLGHPVFDCLD  281 (792)
Q Consensus       213 TGk~PF~~~d~~el~ekIl~~~~~~~l~fP~-~~~lS~elkdLIk~LL~-DP~kRPTae---EIL~HPwF~~i~  281 (792)
                      +|.+||....++..+++|..    ....+|. ....++.+.+++..++. +|.+|.++.   ++..||||+..+
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~----~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILN----RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             cCCCCCCCcchhhhhhcccc----CCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            99999999999999999987    3444443 24678999999999999 999999987   789999999877

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=5.8e-16  Score=178.43  Aligned_cols=132  Identities=22%  Similarity=0.264  Sum_probs=108.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------------hHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------------NTIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------------~~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      .|...+.||+|+||.||++.....  .+++|+.......            ...|..++..++|++++..+.++.+....
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            345678999999999999876543  3444433221111            14688999999999999888887777788


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ++||||++|++|.+++.          ....++.+|+.+|.+||+.||+||||||.|||+ .++.++|+|||+++..
T Consensus       412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999999883          356789999999999999999999999999999 6789999999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.1e-15  Score=150.29  Aligned_cols=132  Identities=18%  Similarity=0.229  Sum_probs=97.3

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------------------------HHHHHHHHhcCCC--C
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------------------------TIERDIMVKSKCP--Y   69 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------------------------~~E~eIL~kL~HP--N   69 (792)
                      .+.||+|+||.||+|.+. +|..||+|++.......                            ..|...+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999886 78999999887543211                            1244444444333  2


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCCHHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCC
Q psy13735         70 IVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        70 IVkL~~vfede~~lyLVmEy~~GGsL~d-lL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg  147 (792)
                      +++.+++    ...++||||++|+.+.. .+....   .. ..+..++.+++.++.++|. .||+||||+|+||+++ ++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence            4444443    23589999999965432 221100   11 6788999999999999999 9999999999999999 89


Q ss_pred             ceEEeccCcccccc
Q psy13735        148 HLKLTDFGSATQVD  161 (792)
Q Consensus       148 ~VKLiDFGLA~~l~  161 (792)
                      .++|+|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            99999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033|consensus

Probab=99.62  E-value=1.4e-16  Score=178.96  Aligned_cols=178  Identities=27%  Similarity=0.363  Sum_probs=134.5

Q ss_pred             CEEEEEEeccCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~-~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      .++||.|++|.-.+|.++|.+. .....+...+..++.|+..|+.|   ++.+|+|+||.||.+..+..+||+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            3689999999999999999643 33456788899999999999999   9999999999999999999999999999877


Q ss_pred             cccCC-----CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcc
Q psy13735        160 VDKNG-----RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC  233 (792)
Q Consensus       160 l~~~~-----~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~  233 (792)
                      .....     ......-+||++||+||.+.+       ..|+.++||||||+|+++++. -..+|..   -..+..+.. 
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-------~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~-  474 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-------QQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRD-  474 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-------hhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhc-
Confidence            65433     112234479999999999984       379999999999999999997 2222211   111222221 


Q ss_pred             cCCCCcCCCC-CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        234 DTEDTVSFPS-SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       234 ~~~~~l~fP~-~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                           -.+|+ ...--+.-.+|+.+|+. .|.+||++...-.|+|.
T Consensus       475 -----g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  475 -----GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             -----CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                 12221 11123556789999999 99999987777777764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=4.2e-15  Score=136.70  Aligned_cols=131  Identities=21%  Similarity=0.283  Sum_probs=110.7

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC--ChHHHHHHHHhcCC--CCcceeEEEEEeCCEEEEEEeccCCCC
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIERDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGD   94 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~--~~~~E~eIL~kL~H--PNIVkL~~vfede~~lyLVmEy~~GGs   94 (792)
                      +++.||.|+++.||++....  ..+++|.+.....  ....|..++..+.|  +++++++.++...+..|++|||++|+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            46789999999999998754  7899998876543  23678889998876  599999999988889999999998876


Q ss_pred             HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         95 FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL---GYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        95 L~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~---gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +..+         +......++.+++.+|.++|..   +++|+|++|.|||++..+.++++|||.+...
T Consensus        80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            6543         4556677899999999999985   6999999999999999899999999998643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=1.2e-14  Score=151.67  Aligned_cols=132  Identities=20%  Similarity=0.292  Sum_probs=102.2

Q ss_pred             EeEee-ecCceEEEEEEEecCCcEEEEEEeccCCC---------C--------hHHHHHHHHhcCCCCc--ceeEEEEEe
Q psy13735         20 KRFIQ-QGNFGDIYLVEEKQSHNTFVMKKVLREKM---------P--------NTIERDIMVKSKCPYI--VNLFYSFQD   79 (792)
Q Consensus        20 ~k~IG-sGsFGtVyla~~k~tGk~vAVKiI~Ks~~---------~--------~~~E~eIL~kL~HPNI--VkL~~vfed   79 (792)
                      ...|| .||.|+||.+...  |..+|+|.+.....         .        ...|..++..+.|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35688 8899999988664  77899998754221         0        1458999999998775  666666443


Q ss_pred             C-CE---EEEEEeccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEecc
Q psy13735         80 M-NH---VYFIMEYVTG-GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        80 e-~~---lyLVmEy~~G-GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                      . ..   .++|||+++| .+|.+++..   +.+++..    +.+|+.+|.+||++||+||||||.|||++.++.++|+||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence            2 22   2599999998 689988843   3366543    578999999999999999999999999999999999999


Q ss_pred             Cccccc
Q psy13735        155 GSATQV  160 (792)
Q Consensus       155 GLA~~l  160 (792)
                      |.+...
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            988653

>KOG0601|consensus

Probab=99.45  E-value=1.3e-13  Score=157.29  Aligned_cols=251  Identities=20%  Similarity=0.195  Sum_probs=191.5

Q ss_pred             CCCceEEeEeee--cCceEEEEEEE--ecCCcEEEEEEeccCC------CChHHHHHHHHhcC-CCCcceeEEEEEeCCE
Q psy13735         14 ASDFDIKRFIQQ--GNFGDIYLVEE--KQSHNTFVMKKVLREK------MPNTIERDIMVKSK-CPYIVNLFYSFQDMNH   82 (792)
Q Consensus        14 l~dY~I~k~IGs--GsFGtVyla~~--k~tGk~vAVKiI~Ks~------~~~~~E~eIL~kL~-HPNIVkL~~vfede~~   82 (792)
                      ...|.+...+|.  |.+|.||.+..  ..++..||+|.-....      .....|..-...++ |+|.++.+..++..+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345677889999  99999999988  8899999999732221      11245665556664 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCccCCCCCCceEeCCC-CceEEeccCcc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSA  157 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILs----AL~YLHs~gIVHRDLKPeNILLd~d-g~VKLiDFGLA  157 (792)
                      .|+-+|+| |.+|..+... ....++...++.++.+...    ||.++|+.+|+|-|++|.||++..+ ..++++|||+.
T Consensus       193 lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             ceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            99999999 6788888754 3445899999999999999    9999999999999999999999998 78999999999


Q ss_pred             cccccCCCccc----ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC--Chhhhhhhhh
Q psy13735        158 TQVDKNGRIKS----IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE--TLDMTYSSIL  231 (792)
Q Consensus       158 ~~l~~~~~~~s----~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~--d~~el~ekIl  231 (792)
                      ..+.+......    ...-|...|++||..++        -++...|+|++|.++.+-.+|..++...  +.........
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--------l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--------LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc--------ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            88875542211    11257889999999973        5889999999999999888876655332  1111111110


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                           ....|..  ..+..+...+..|+. +|..|++++.++.|+++....
T Consensus       343 -----ip~e~~~--~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  343 -----IPLEFCE--GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             -----Cchhhhc--CcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence                 1112222  345666668888888 899999999999999987543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.37  E-value=1.9e-12  Score=146.60  Aligned_cols=137  Identities=15%  Similarity=0.198  Sum_probs=94.7

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--------------------------------------------
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--------------------------------------------   55 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--------------------------------------------   55 (792)
                      .+.||+|++|.||+|+.+ +|+.||||+........                                            
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999875 68999999875431100                                            


Q ss_pred             HHHHHHHHhc----C-CCCcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q psy13735         56 TIERDIMVKS----K-CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ-AVQYLHGL  129 (792)
Q Consensus        56 ~~E~eIL~kL----~-HPNIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILs-AL~YLHs~  129 (792)
                      ..|...+..+    . +|++.-..-+....+..+|||||++|++|.++......+ ++   ...++..++. .+..+|..
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhC
Confidence            1233333333    2 333322111222234569999999999998876432212 22   2345555555 46789999


Q ss_pred             CCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735        130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus       130 gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      |++|+|++|.||+++.+|.++|+|||++..+.
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999999987765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=2.8e-12  Score=123.54  Aligned_cols=125  Identities=22%  Similarity=0.269  Sum_probs=96.0

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCC---CChHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEEeccCCCCH
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPYI-VNLFYSFQDMNHVYFIMEYVTGGDF   95 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~---~~~~~E~eIL~kL~HPNI-VkL~~vfede~~lyLVmEy~~GGsL   95 (792)
                      ++.|+.|.++.||++...  |..|++|......   .....|..++..+.+.++ ++++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            578899999999999864  7889999876553   223678889988865554 44554433  335799999999876


Q ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         96 VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY-----VHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        96 ~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gI-----VHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ...-       .   ....++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430       1   123457899999999999985     9999999999998 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=3.1e-12  Score=147.88  Aligned_cols=139  Identities=18%  Similarity=0.297  Sum_probs=97.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--------------------------h-------------
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--------------------------N-------------   55 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--------------------------~-------------   55 (792)
                      ..|+. +.||+|++|+||+|+.+++|+.||||++.+....                          .             
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 8999999999999999988999999998744100                          0             


Q ss_pred             -----HHHHHHHHhc----CCCCcceeEEEEEe-CCEEEEEEeccCCCCHHHHHHhCCCC----CCCHHHHHHHHHHHHH
Q psy13735         56 -----TIERDIMVKS----KCPYIVNLFYSFQD-MNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARFYIYELAQ  121 (792)
Q Consensus        56 -----~~E~eIL~kL----~HPNIVkL~~vfed-e~~lyLVmEy~~GGsL~dlL~r~~~g----~LSE~ea~~Im~QILs  121 (792)
                           ..|...+.++    .+.+.+.+-.+|.+ .+..+||||||.|+.+.++-.-...+    .+.+..+..++.||+ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence                 1233233222    23333333333332 44568999999999998753211222    255556666666665 


Q ss_pred             HHHHHHhCCCccCCCCCCceEeCCCC----ceEEeccCcccccc
Q psy13735        122 AVQYLHGLGYVHRDIKPDNMLLSATG----HLKLTDFGSATQVD  161 (792)
Q Consensus       122 AL~YLHs~gIVHRDLKPeNILLd~dg----~VKLiDFGLA~~l~  161 (792)
                            ..|++|+|+||.||+++.+|    .++++|||++..+.
T Consensus       278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  58999999999999999888    99999999987664

>KOG1243|consensus

Probab=99.25  E-value=4.7e-11  Score=138.10  Aligned_cols=181  Identities=15%  Similarity=0.229  Sum_probs=134.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC--Ch--HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PN--TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~--~~--~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      -|.+ ...+-++.+..-.+..+.++.++.+.....+..  ..  ..-+.-|+.++||||+++++.++.++.+|||+|-+ 
T Consensus        14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV-   91 (690)
T KOG1243|consen   14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV-   91 (690)
T ss_pred             Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc-
Confidence            3555 444444444433456677888988888776655  11  33456678889999999999999999999999998 


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH-GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH-s~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                       -.|..++.+     ++...+..-+.||+.||.||| ..+++|++|.-..|+|+..|..||++|-++......+. ....
T Consensus        92 -~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~  164 (690)
T KOG1243|consen   92 -RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKS  164 (690)
T ss_pred             -ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-cccc
Confidence             467778855     457888899999999999998 67899999999999999999999999998865543221 1111


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG  214 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG  214 (792)
                      ..-.-.|..|+.+.         +-+-..|.|.|||++++++.|
T Consensus       165 ~~~~~s~~~P~~~~---------~s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  165 LYLIESFDDPEEID---------PSEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhcccChhhcC---------ccccchhhhhHHHHHHHHhCc
Confidence            11223466776653         222457999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.23  E-value=6.1e-11  Score=121.33  Aligned_cols=134  Identities=13%  Similarity=0.161  Sum_probs=100.2

Q ss_pred             EeEeeecCceEEEEEEEec------CCcEEEEEEeccCCC---------------------Ch---------HHHHHHHH
Q psy13735         20 KRFIQQGNFGDIYLVEEKQ------SHNTFVMKKVLREKM---------------------PN---------TIERDIMV   63 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~------tGk~vAVKiI~Ks~~---------------------~~---------~~E~eIL~   63 (792)
                      ...||.|--+.||.|....      .+..+|+|+......                     ..         ..|...|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999997654      357999998752210                     00         25778888


Q ss_pred             hcC--CCCcceeEEEEEeCCEEEEEEeccCCCCHHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCC
Q psy13735         64 KSK--CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYLSESKARFYIYELAQAVQYL-HGLGYVHRDIKPD  139 (792)
Q Consensus        64 kL~--HPNIVkL~~vfede~~lyLVmEy~~GGsL~d-lL~r~~~g~LSE~ea~~Im~QILsAL~YL-Hs~gIVHRDLKPe  139 (792)
                      ++.  .-+++.++++    ..-+|||||+.|+.+.. .+.   ...+++..+..++.+++.+|..| |..||+|+||+|.
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~  154 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY  154 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            774  3566677654    45689999997654422 232   22366677788899999999999 8999999999999


Q ss_pred             ceEeCCCCceEEeccCcccccc
Q psy13735        140 NMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus       140 NILLd~dg~VKLiDFGLA~~l~  161 (792)
                      |||++ ++.+.|+|||.|....
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCC
Confidence            99996 5789999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266|consensus

Probab=99.20  E-value=9.7e-12  Score=133.93  Aligned_cols=203  Identities=17%  Similarity=0.294  Sum_probs=143.6

Q ss_pred             HHhcCCCCcceeEEEEEeCC-----EEEEEEeccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--Cc
Q psy13735         62 MVKSKCPYIVNLFYSFQDMN-----HVYFIMEYVTGGDFVTLLENQP--HGYLSESKARFYIYELAQAVQYLHGLG--YV  132 (792)
Q Consensus        62 L~kL~HPNIVkL~~vfede~-----~lyLVmEy~~GGsL~dlL~r~~--~g~LSE~ea~~Im~QILsAL~YLHs~g--IV  132 (792)
                      |-++.|.|||++|.||.+..     ...++.|||..|++..+|++..  ...+....-.+|+.||++||.|||+..  |+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            44567999999999987654     4799999999999999997532  345778888999999999999999875  99


Q ss_pred             cCCCCCCceEeCCCCceEEeccCccccccc---CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHH
Q psy13735        133 HRDIKPDNMLLSATGHLKLTDFGSATQVDK---NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSY  209 (792)
Q Consensus       133 HRDLKPeNILLd~dg~VKLiDFGLA~~l~~---~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILY  209 (792)
                      |+++...-|++..+|-||++--........   ..........|.++|.+||.=.       ....+.++|||++|.+..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-------~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-------TTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-------ccccccchhhhhhhHHHH
Confidence            999999999999999888764222111100   0001111224788999999632       335667899999999999


Q ss_pred             HhhcCCCC-CCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        210 ELLTGSTP-FNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       210 ELLTGk~P-F~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +|..|..- -...+.-.....|.+..    +.. .    .+.-++++..|+. .|..||++..++.||..-.+
T Consensus       274 emailEiq~tnseS~~~~ee~ia~~i----~~l-e----n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  274 EMAILEIQSTNSESKVEVEENIANVI----IGL-E----NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             HHHHheeccCCCcceeehhhhhhhhe----eec-c----CccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence            99887643 22332222222332210    000 0    2334678899999 99999999999999986543

>KOG0601|consensus

Probab=99.17  E-value=3e-11  Score=138.09  Aligned_cols=245  Identities=21%  Similarity=0.223  Sum_probs=181.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe-cCCcEEEEEEeccCCCCh------HHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK-QSHNTFVMKKVLREKMPN------TIERDIMVKS-KCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k-~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL-~HPNIVkL~~vfede~~l   83 (792)
                      ....+|..+..||.|.|+.|+.+..+ .++-.|++|-+.+.....      ..|+-+...+ .|.+++..+..|......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34568899999999999999998866 678899999876654443      4455555555 499999999888888888


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC-CceEEeccCccccccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDK  162 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d-g~VKLiDFGLA~~l~~  162 (792)
                      |+=-|||.|+++...+  .....+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..+++|||.++.+..
T Consensus       342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence            9999999999877665  233458889999999999999999999999999999999999876 7889999999875331


Q ss_pred             CCCcccccCCCCCCcc-ChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC-CCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGRIKSIVPVGTPEYV-APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~-APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P-F~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .    .....+.-+++ .+|++..      ...+..++|++|||.-+++.++|..- ..+..    ...|..    +  .
T Consensus       420 ~----~~~~~~~~r~~p~~~~~~e------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~----~--~  479 (524)
T KOG0601|consen  420 S----SGVFHHIDRLYPIAEILLE------DYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRS----G--D  479 (524)
T ss_pred             e----cccccccccccccchhhcc------ccccccccccccccccccccccCcccCccccc----ceeeec----c--c
Confidence            1    11222344455 3566542      24678899999999999999987642 22211    111211    1  1


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      .|.....+.++..+.+.++. ++..||.+.++..|+-|.
T Consensus       480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            22222345778888888888 899999998887776553

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=5.6e-10  Score=111.38  Aligned_cols=136  Identities=21%  Similarity=0.242  Sum_probs=105.7

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-----ChHHHHHHHHhcCC--CCcceeEEEEEeC---CEEEEEEec
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-----PNTIERDIMVKSKC--PYIVNLFYSFQDM---NHVYFIMEY   89 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-----~~~~E~eIL~kL~H--PNIVkL~~vfede---~~lyLVmEy   89 (792)
                      .+.||.|.++.||++.... |..|++|+......     ....|..++..+.+  .++++++.+....   +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            3678999999999998754 68999998876432     22689999998875  4567777776654   267899999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-----------------------------------------  128 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-----------------------------------------  128 (792)
                      ++|+++.+.+..   ..+++.....++.+++.+|..||+                                         
T Consensus        82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            999888776521   346777777888888888888884                                         


Q ss_pred             ---------------CCCccCCCCCCceEeCC--CCceEEeccCcccc
Q psy13735        129 ---------------LGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQ  159 (792)
Q Consensus       129 ---------------~gIVHRDLKPeNILLd~--dg~VKLiDFGLA~~  159 (792)
                                     ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           23589999999999988  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=1.4e-09  Score=110.36  Aligned_cols=127  Identities=25%  Similarity=0.321  Sum_probs=98.4

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ..|++|+-+.+|.+...  |.++++|.=.+.....            .+|+.++.++.--.|...+=++.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46789999999988653  4557777543333322            468899988876666666666667788899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      |++|-.|.+.+...         ...++..+-..+.-||..||+|+||.++||++... .+.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            99999999898542         24567778888889999999999999999999654 499999999874

>KOG2137|consensus

Probab=98.99  E-value=4.5e-10  Score=130.52  Aligned_cols=155  Identities=21%  Similarity=0.321  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc--------CCCCCCccChhhhhhhcc
Q psy13735        118 ELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV--------PVGTPEYVAPEVLEWMEG  188 (792)
Q Consensus       118 QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t--------~vGTp~Y~APEiL~~~~~  188 (792)
                      +...|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++.....+.......        ..-.+.|.|||++..   
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~---  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG---  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc---
Confidence            344999999965 89999999999999999999999999987665432222111        124568999999963   


Q ss_pred             CCCCCCCCcccccccchhhHHHhh-cCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcC
Q psy13735        189 NHGSDGYTGSCDLWSIGVVSYELL-TGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARL  266 (792)
Q Consensus       189 ~~~~~~ys~ksDIWSLGVILYELL-TGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRP  266 (792)
                          ...+.++|+||+||++|.+. .|+.-+........+..-..........+  ...+++++++-+.+++. ++.-||
T Consensus       184 ----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~--s~~~p~el~~~l~k~l~~~~~~rp  257 (700)
T KOG2137|consen  184 ----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGY--SNNLPSELRESLKKLLNGDSAVRP  257 (700)
T ss_pred             ----ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccc--cccCcHHHHHHHHHHhcCCcccCc
Confidence                36788999999999999999 57776755544433333322111122223  35889999999999999 999999


Q ss_pred             ChhHHhcCCCccCCC
Q psy13735        267 NMDQVLGHPVFDCLD  281 (792)
Q Consensus       267 TaeEIL~HPwF~~i~  281 (792)
                      ++..++.-|||.+..
T Consensus       258 ~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  258 TLDLLLSIPFFSDPG  272 (700)
T ss_pred             chhhhhcccccCCch
Confidence            999999999998754

>KOG3087|consensus

Probab=98.99  E-value=3.8e-09  Score=107.11  Aligned_cols=139  Identities=18%  Similarity=0.225  Sum_probs=106.4

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .+..|-+|+-+.|+++..  .|+.+++|.-.......            ..|+.+|.++.--.|.-..-+|.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            678899999999998865  48888888544333322            4688888887655665555667777778999


Q ss_pred             EeccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEEeccCcccc
Q psy13735         87 MEYVTG-GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQ  159 (792)
Q Consensus        87 mEy~~G-GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKLiDFGLA~~  159 (792)
                      |||++| .++.+++...-...........+++.|-..+.-||.++|+|+||..+||++..+|   .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999987 4677777543333333444478999999999999999999999999999997655   368999999864

>KOG3741|consensus

Probab=98.98  E-value=7.8e-09  Score=117.21  Aligned_cols=208  Identities=17%  Similarity=0.219  Sum_probs=152.8

Q ss_pred             ceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEe----CCEEEEEEeccCC-CCHHHH
Q psy13735         28 FGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQD----MNHVYFIMEYVTG-GDFVTL   98 (792)
Q Consensus        28 FGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfed----e~~lyLVmEy~~G-GsL~dl   98 (792)
                      -.+.|+|...-+|..|++|++.-.+...    ..-+++++++.|+|+|++.++|..    +..++||++|+++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578999999999999999994433322    456789999999999999999983    3468999999987 567665


Q ss_pred             HHhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         99 LENQ-------------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        99 L~r~-------------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      .-..             .+...+|...|.|+.|+..||.++|+.|+..+-|.|.+|+++.+.+++|..-|..-.+..+. 
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-  447 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-  447 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence            5211             12346889999999999999999999999999999999999988888888777655543221 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC-CCCCChhhh-hhhhhcccCCCCcCCCC
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMT-YSSILACDTEDTVSFPS  243 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P-F~~~d~~el-~ekIl~~~~~~~l~fP~  243 (792)
                             +       +.+.          --.+-|.-.||.++..|.||..- +........ ...|..           
T Consensus       448 -------~-------~~le----------~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~-----------  492 (655)
T KOG3741|consen  448 -------T-------EPLE----------SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT-----------  492 (655)
T ss_pred             -------C-------cchh----------HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh-----------
Confidence                   1       1111          11346888899999999999643 222222222 233322           


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        .+|.+++++|.-+.. .++. -++.+++.|
T Consensus       493 --~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  493 --TYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --hhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence              578899999998888 6665 677777654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.83  E-value=5.4e-08  Score=104.07  Aligned_cols=136  Identities=14%  Similarity=0.062  Sum_probs=94.6

Q ss_pred             EeeecCceEEEEEEEecCCcEEEEEEeccCCC---------------ChHHHHHHHHhcCCCCc--ceeEEEEEe-----
Q psy13735         22 FIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM---------------PNTIERDIMVKSKCPYI--VNLFYSFQD-----   79 (792)
Q Consensus        22 ~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~---------------~~~~E~eIL~kL~HPNI--VkL~~vfed-----   79 (792)
                      .+-......|+++..  .|+.|.+|.......               ....|...+..+..-+|  +.++++++.     
T Consensus        29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            333333334555543  467888896632221               12467777777643333  333445543     


Q ss_pred             CCEEEEEEeccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-------CCceEE
Q psy13735         80 MNHVYFIMEYVTGG-DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-------TGHLKL  151 (792)
Q Consensus        80 e~~lyLVmEy~~GG-sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-------dg~VKL  151 (792)
                      ...-+||||+++|. +|.+++........+......++.+|...+.-||..||+|+|++|.|||++.       ++.+.|
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence            23578999999886 7988885322344667788899999999999999999999999999999975       457999


Q ss_pred             eccCcccc
Q psy13735        152 TDFGSATQ  159 (792)
Q Consensus       152 iDFGLA~~  159 (792)
                      +||+.+..
T Consensus       187 IDl~r~~~  194 (268)
T PRK15123        187 IDLHRAQI  194 (268)
T ss_pred             EECCcccc
Confidence            99998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.82  E-value=8.4e-08  Score=106.88  Aligned_cols=244  Identities=19%  Similarity=0.175  Sum_probs=159.2

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhc-CCCCcce--------eEEEEEeCCEEEEEE
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKS-KCPYIVN--------LFYSFQDMNHVYFIM   87 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL-~HPNIVk--------L~~vfede~~lyLVm   87 (792)
                      ..++.||+|+-+.+|-+-..   .-.+.|++.+..... ..-+..|... .||-+-.        |++.- ....+.+.|
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGflm   89 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFLM   89 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEec
Confidence            44688999999999976433   234679888766544 2333444443 4664433        12211 122378999


Q ss_pred             eccCCCCH-HHHH----HhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         88 EYVTGGDF-VTLL----ENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        88 Ey~~GGsL-~dlL----~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      ..++|-.= ..++    .++....+.++.+....+.|+.+...||..|-+-+|++++|+|+++++.|.|+|=..-..-. 
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~-  168 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA-  168 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc-
Confidence            99987532 2222    12333446788999999999999999999999999999999999999999999855433222 


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCCh----hhhhh-hhhcc---
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETL----DMTYS-SILAC---  233 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~----~el~e-kIl~~---  233 (792)
                      + .......+|.+.|.+||.-+-  +.+..-.-+...|.|.|||+++++|.| +.||.+-..    ...++ .|...   
T Consensus       169 n-g~~~~cpVg~~eftPPElQ~~--~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         169 N-GTLHLCPVGVSEFTPPELQTL--PSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             C-CceEecccCccccCCHHHhcc--ccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            2 223345679999999998651  123333456679999999999999986 999964321    11111 22110   


Q ss_pred             -------cCCCCcCCCCCccccHHHHHHHHHHhhC---hhhcCChh
Q psy13735        234 -------DTEDTVSFPSSIRLSTAMVNFVQSLVQK---LDARLNMD  269 (792)
Q Consensus       234 -------~~~~~l~fP~~~~lS~elkdLIk~LL~D---P~kRPTae  269 (792)
                             .......-+++.-+++++..++.+|+.+   +.-|||++
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence                   0001111122345788999999999983   56899975

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.67  E-value=8.3e-08  Score=97.70  Aligned_cols=122  Identities=20%  Similarity=0.270  Sum_probs=79.5

Q ss_pred             EEEEEEEecCCcEEEEEEeccCCCC-------------------h-----------HHHHHHHHhcCCC--CcceeEEEE
Q psy13735         30 DIYLVEEKQSHNTFVMKKVLREKMP-------------------N-----------TIERDIMVKSKCP--YIVNLFYSF   77 (792)
Q Consensus        30 tVyla~~k~tGk~vAVKiI~Ks~~~-------------------~-----------~~E~eIL~kL~HP--NIVkL~~vf   77 (792)
                      .||.|... .|..+|+|+.......                   .           ..|.++|.++..-  ++++++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            37888664 5779999987532110                   0           4688999998755  566666442


Q ss_pred             EeCCEEEEEEeccC--CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccCCCCCCceEeCCCCceEEecc
Q psy13735         78 QDMNHVYFIMEYVT--GGDFVTLLENQPHGYLSESKARFYIYELAQAVQY-LHGLGYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        78 ede~~lyLVmEy~~--GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~Y-LHs~gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                          .-+|||||+.  |..+..+... .   ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.++||
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             ----CCEEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence                2379999998  6555544421 1   2245567788888885555 679999999999999999776 9999999


Q ss_pred             Ccccccc
Q psy13735        155 GSATQVD  161 (792)
Q Consensus       155 GLA~~l~  161 (792)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=5e-07  Score=92.33  Aligned_cols=103  Identities=22%  Similarity=0.272  Sum_probs=79.8

Q ss_pred             HHHHHHHHhcCC--CCcceeEEEEEeC----CEEEEEEeccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy13735         56 TIERDIMVKSKC--PYIVNLFYSFQDM----NHVYFIMEYVTGG-DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG  128 (792)
Q Consensus        56 ~~E~eIL~kL~H--PNIVkL~~vfede----~~lyLVmEy~~GG-sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs  128 (792)
                      ..|...+..+..  =..+..+++....    ...+||+|+++|. +|.+++.....  ++......++.++...+.-||.
T Consensus        59 ~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   59 KREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHH
Confidence            567776666642  2245555555542    2458999999885 79999854222  6777888999999999999999


Q ss_pred             CCCccCCCCCCceEeCCCC---ceEEeccCccccc
Q psy13735        129 LGYVHRDIKPDNMLLSATG---HLKLTDFGSATQV  160 (792)
Q Consensus       129 ~gIVHRDLKPeNILLd~dg---~VKLiDFGLA~~l  160 (792)
                      +||+|+|++|.|||++.++   .+.|+||+.+...
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999998887   7999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.47  E-value=6e-07  Score=96.05  Aligned_cols=132  Identities=18%  Similarity=0.222  Sum_probs=98.9

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC------------------C--------hHHHHHHHHhcCCC--
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM------------------P--------NTIERDIMVKSKCP--   68 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~------------------~--------~~~E~eIL~kL~HP--   68 (792)
                      +.++..||-|--|.||.|... .|.++|+|+=.....                  .        ...|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457789999999999999876 688999995321100                  0        04688888888544  


Q ss_pred             CcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc
Q psy13735         69 YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH  148 (792)
Q Consensus        69 NIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~  148 (792)
                      .+++.++    .+.-.+||||++|-.|...-       ++...+..++..|+.-+..+-..||+|+|+.+-||+++.+|.
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence            5666653    34568999999997665432       234555666777777777777999999999999999999999


Q ss_pred             eEEeccCccccc
Q psy13735        149 LKLTDFGSATQV  160 (792)
Q Consensus       149 VKLiDFGLA~~l  160 (792)
                      +.++||--+...
T Consensus       241 ~~vIDwPQ~v~~  252 (304)
T COG0478         241 IVVIDWPQAVPI  252 (304)
T ss_pred             EEEEeCcccccC
Confidence            999999766543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=7.7e-07  Score=103.14  Aligned_cols=137  Identities=15%  Similarity=0.174  Sum_probs=90.8

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--------------------------------------------H
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--------------------------------------------T   56 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--------------------------------------------~   56 (792)
                      ..|+.++-|+||+++.+. |+.||||+....-...                                            .
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            688999999999999875 9999999875332111                                            1


Q ss_pred             HHHHHHHhc-----CCCCcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy13735         57 IERDIMVKS-----KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY  131 (792)
Q Consensus        57 ~E~eIL~kL-----~HPNIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gI  131 (792)
                      .|..-+.++     +.|++.-..=+++-.+.-.|+|||+.|-.+.++..-.. ..++...+...+.++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            344334333     23444333333444566789999999999888743222 2244333222222211  222334899


Q ss_pred             ccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735        132 VHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus       132 VHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      +|.|.+|.||+++.+|.+.+.|||+...+.
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCC
Confidence            999999999999999999999999987665

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.27  E-value=1e-05  Score=84.73  Aligned_cols=133  Identities=17%  Similarity=0.292  Sum_probs=88.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------------HHHHHHHHhc---CCCCcceeEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------------TIERDIMVKS---KCPYIVNLFYS   76 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------------~~E~eIL~kL---~HPNIVkL~~v   76 (792)
                      ...+|.+.+++-......|.+..-  .|+.|++|.........             ......+..+   ....+..++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            456788999999988888887754  46889999765432111             1122222222   22333333322


Q ss_pred             EE-----eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEE
Q psy13735         77 FQ-----DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL  151 (792)
Q Consensus        77 fe-----de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKL  151 (792)
                      .+     -....+|||||++|..|.++..      +++.    +...|..++.-||..|++|+|.+|.|++++.+ .+++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence            22     2235678999999988776541      3332    44567788999999999999999999999855 4999


Q ss_pred             eccCccc
Q psy13735        152 TDFGSAT  158 (792)
Q Consensus       152 iDFGLA~  158 (792)
                      +||+..+
T Consensus       176 ID~~~k~  182 (229)
T PF06176_consen  176 IDTQGKR  182 (229)
T ss_pred             EECcccc
Confidence            9998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.27  E-value=1.3e-05  Score=83.46  Aligned_cols=134  Identities=10%  Similarity=0.150  Sum_probs=96.7

Q ss_pred             eecCceEEEEEEEecCCcEEEEEEeccC-------CCCh---HHHHHHHHhcCC--CCcceeEEEEEe----CCEEEEEE
Q psy13735         24 QQGNFGDIYLVEEKQSHNTFVMKKVLRE-------KMPN---TIERDIMVKSKC--PYIVNLFYSFQD----MNHVYFIM   87 (792)
Q Consensus        24 GsGsFGtVyla~~k~tGk~vAVKiI~Ks-------~~~~---~~E~eIL~kL~H--PNIVkL~~vfed----e~~lyLVm   87 (792)
                      |+||-+.|+.....  |+.|-+|.-...       ....   ..|...+..+..  -.++++..+-..    .-.-+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56888999987654  346778865311       1111   578888877742  225555522211    12468999


Q ss_pred             eccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc--eEEeccCcccc
Q psy13735         88 EYVTG-GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH--LKLTDFGSATQ  159 (792)
Q Consensus        88 Ey~~G-GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~--VKLiDFGLA~~  159 (792)
                      |-+.| -+|.+++....-...+......++.+|..++.-||+.|+.|+|+.+.||+++.+|.  |+++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98754 57888885544445678888899999999999999999999999999999987777  99999987664

>KOG0576|consensus

Probab=98.25  E-value=2.7e-07  Score=107.06  Aligned_cols=244  Identities=17%  Similarity=0.180  Sum_probs=164.8

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCC-cceeEEEEEeCCEEEEEEeccCCC-C
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPY-IVNLFYSFQDMNHVYFIMEYVTGG-D   94 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPN-IVkL~~vfede~~lyLVmEy~~GG-s   94 (792)
                      |.....+++|+++++++.+...+.... .+++... .....++++|.+++||| .+..++-++.+...+++|++|.+| +
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            344456789999999988776665444 6666544 55577899999999999 666677777788999999999887 2


Q ss_pred             HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCC
Q psy13735         95 FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT  174 (792)
Q Consensus        95 L~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGT  174 (792)
                      ....+.. ..-.+.+.....+.+.-+.+++++|+.-=+|+|    ||+. .++..+..||+....+....  ...+..++
T Consensus       322 ~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~--~~~t~~~~  393 (829)
T KOG0576|consen  322 SALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRTM--KPRTAIGT  393 (829)
T ss_pred             ccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc-cccccccccccCCcccCccc--ccccCCCC
Confidence            2211100 011133344455666677889999998878998    7776 44789999999998876543  33455799


Q ss_pred             CCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH-H
Q psy13735        175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV-N  253 (792)
Q Consensus       175 p~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk-d  253 (792)
                      +.++|||+...       ..+....|.|++|+--.+|.-|-+|-...-  ...-.+-  +..+...+-....+++... +
T Consensus       394 ~~~~~pev~~~-------~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g--~~p~s~~L~~~~aw~~~~~~~  462 (829)
T KOG0576|consen  394 PEPLAPEVIQE-------NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIG--NGPNSPMLTDKSAWSPVFHRD  462 (829)
T ss_pred             CCCCCchhhcc-------cccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCC--CCCCccccchhhhcCcccccC
Confidence            99999998863       367888999999988778888887764311  1111110  0111111111112222233 4


Q ss_pred             HHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        254 FVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       254 LIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +...|+. .|..|+....++-|-+|....
T Consensus       463 ~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  463 FPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             CcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            7777888 788899988998888888655

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.25  E-value=8.9e-06  Score=84.73  Aligned_cols=134  Identities=16%  Similarity=0.141  Sum_probs=83.2

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCC--CcceeEEEEEeCCEEEEEEeccCCCC-H
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCP--YIVNLFYSFQDMNHVYFIMEYVTGGD-F   95 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HP--NIVkL~~vfede~~lyLVmEy~~GGs-L   95 (792)
                      ..||.|..+.||++    .|..+++|.........  ..|.+++..+..-  .+++.+++..+.+..++||++++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            67899999999974    25568889876533222  6788888887533  35777888888888899999999863 1


Q ss_pred             HHHH--------------Hh----CC---CCCCCHHHHHH-HHH----------HHHH-HHHHHHh----CCCccCCCCC
Q psy13735         96 VTLL--------------EN----QP---HGYLSESKARF-YIY----------ELAQ-AVQYLHG----LGYVHRDIKP  138 (792)
Q Consensus        96 ~dlL--------------~r----~~---~g~LSE~ea~~-Im~----------QILs-AL~YLHs----~gIVHRDLKP  138 (792)
                      ...+              .+    -.   ....+...... +..          .+.. ...+|..    ..++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            1111              00    00   00111111000 100          0111 1122221    2468999999


Q ss_pred             CceEeCCCCceEEeccCcccc
Q psy13735        139 DNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       139 eNILLd~dg~VKLiDFGLA~~  159 (792)
                      .||+++.++ +.|+||+.+..
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CcEEEcCCC-cEEEechhcCc
Confidence            999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.18  E-value=8e-06  Score=81.50  Aligned_cols=138  Identities=20%  Similarity=0.277  Sum_probs=80.5

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCC--ChHHHHHHHHhcCCC--CcceeEEEEE---eCCEEEEEEeccCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIERDIMVKSKCP--YIVNLFYSFQ---DMNHVYFIMEYVTG   92 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~--~~~~E~eIL~kL~HP--NIVkL~~vfe---de~~lyLVmEy~~G   92 (792)
                      ++.|+.|..+.||++....  ..|++|.......  ....|..+++.+...  .++.++.+..   .....+++|++++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            5789999999999998765  4899998766511  115677787777422  3566666443   33457999999999


Q ss_pred             CCHHH----------------HHH---hC--CCCCCCHHH---H---HHH---------------HHHHHH-HHHHHHh-
Q psy13735         93 GDFVT----------------LLE---NQ--PHGYLSESK---A---RFY---------------IYELAQ-AVQYLHG-  128 (792)
Q Consensus        93 GsL~d----------------lL~---r~--~~g~LSE~e---a---~~I---------------m~QILs-AL~YLHs-  128 (792)
                      ..+..                .+.   ..  ....+....   .   ...               +..+.. .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87776                111   11  111111110   0   000               111222 2333332 


Q ss_pred             ------CCCccCCCCCCceEeC-CCCceEEeccCcccc
Q psy13735        129 ------LGYVHRDIKPDNMLLS-ATGHLKLTDFGSATQ  159 (792)
Q Consensus       129 ------~gIVHRDLKPeNILLd-~dg~VKLiDFGLA~~  159 (792)
                            ..++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                  3589999999999998 667778999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035|consensus

Probab=98.16  E-value=8.1e-06  Score=100.15  Aligned_cols=201  Identities=19%  Similarity=0.242  Sum_probs=140.4

Q ss_pred             HHHHHHHHhcCCCCcceeEEEEEeCCEE----EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy13735         56 TIERDIMVKSKCPYIVNLFYSFQDMNHV----YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY  131 (792)
Q Consensus        56 ~~E~eIL~kL~HPNIVkL~~vfede~~l----yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gI  131 (792)
                      ..|...+.++.|+|++.++.+--.....    .+..++|.+.++...+  +.-+.++...++.+..+++.||.|+|+...
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            4566777888999999998876544332    3456899999999999  445678999999999999999999999966


Q ss_pred             ccCCCCCC---ceEeCCCCceEEe--ccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchh
Q psy13735        132 VHRDIKPD---NMLLSATGHLKLT--DFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGV  206 (792)
Q Consensus       132 VHRDLKPe---NILLd~dg~VKLi--DFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGV  206 (792)
                      .|.-+...   +--.+..+.+..+  ||+.+..+....  ......-.+.+.+||.....     ........|+|++|.
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~~-----~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKEN-----TAKKSRLTDLWCLGL  380 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCccccccccccccc-----cchhhhhhHHHHHHH
Confidence            66655554   3334556667776  999888776443  22233456677788876532     223344479999999


Q ss_pred             hHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        207 VSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       207 ILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ....+..|..+-....   ....           +-.....+ ...++...|+. ++.+|+++.+++.|||.+.-
T Consensus       381 l~~~~~~~~~i~~~~~---~~~~-----------~l~~~~~~-~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSA---VPVS-----------LLDVLSTS-ELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             HHhhhhhcCccccccc---chhh-----------hhccccch-hhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            9999998765432111   1111           11111112 56777778887 89999999999999998743

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.09  E-value=2.4e-05  Score=83.14  Aligned_cols=133  Identities=17%  Similarity=0.163  Sum_probs=93.7

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------------------------HHHHHHHHhcC--CCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------------------------TIERDIMVKSK--CPY   69 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------------------------~~E~eIL~kL~--HPN   69 (792)
                      ...|++|--+.||++.. .++..+|+|++......-                            ..|..-|.++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            45888888899999865 467899999886433211                            23445555552  445


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCC-HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCC
Q psy13735         70 IVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        70 IVkL~~vfede~~lyLVmEy~~GGs-L~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg  147 (792)
                      +++.+.++.    -.|||||+.... -.-.|   ..-.+...++..+..+++..+.-|-. .++||+||..-|||+. ++
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence            566665543    379999994431 11112   11223344688888999999988887 8999999999999998 88


Q ss_pred             ceEEeccCcccccc
Q psy13735        148 HLKLTDFGSATQVD  161 (792)
Q Consensus       148 ~VKLiDFGLA~~l~  161 (792)
                      .+.++|||-|....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            99999999887654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.04  E-value=4.3e-05  Score=79.05  Aligned_cols=136  Identities=14%  Similarity=0.110  Sum_probs=83.5

Q ss_pred             EeeecCc-eEEEEEEEecCCcEEEEEEeccCCC-ChHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEeccCCCCHHHH
Q psy13735         22 FIQQGNF-GDIYLVEEKQSHNTFVMKKVLREKM-PNTIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTL   98 (792)
Q Consensus        22 ~IGsGsF-GtVyla~~k~tGk~vAVKiI~Ks~~-~~~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmEy~~GGsL~dl   98 (792)
                      .|..|.+ +.||++...  +..+++|+...... ....|+.++..+. +--+++++++....+..++||++++|.++...
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            3445555 789998653  36788887754421 2367888888774 45577888888777778999999999776533


Q ss_pred             H-------------------HhCCC--CCCCHH------HHHHHHH----------------HHHHHHHHHH-------h
Q psy13735         99 L-------------------ENQPH--GYLSES------KARFYIY----------------ELAQAVQYLH-------G  128 (792)
Q Consensus        99 L-------------------~r~~~--g~LSE~------ea~~Im~----------------QILsAL~YLH-------s  128 (792)
                      .                   .....  ..+...      .....+.                .+...+..|-       .
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            1                   01111  011100      0000000                0111112221       2


Q ss_pred             CCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       129 ~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ..++|+|+.|.|||++.++.+.|+||+.|..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            3489999999999999877789999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.95  E-value=6.8e-05  Score=91.73  Aligned_cols=143  Identities=19%  Similarity=0.340  Sum_probs=90.7

Q ss_pred             EEeEeeecCceEEEEEEEecCC--cEEEEEEeccCCCC-----hHHHHHHHHhcC-CCCc--ceeEEEEEeC---CEEEE
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSH--NTFVMKKVLREKMP-----NTIERDIMVKSK-CPYI--VNLFYSFQDM---NHVYF   85 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tG--k~vAVKiI~Ks~~~-----~~~E~eIL~kL~-HPNI--VkL~~vfede---~~lyL   85 (792)
                      -+..|+.|.++.+|++.....+  ..|++|+.......     ...|..+++.+. |+++  ++++.++.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            4688899999999999765433  46888876543321     257889999885 6665  7778877664   46789


Q ss_pred             EEeccCCCCHHH--------------------HHH---hCCC--------CC---CCHHHHHHHHHH-------------
Q psy13735         86 IMEYVTGGDFVT--------------------LLE---NQPH--------GY---LSESKARFYIYE-------------  118 (792)
Q Consensus        86 VmEy~~GGsL~d--------------------lL~---r~~~--------g~---LSE~ea~~Im~Q-------------  118 (792)
                      ||||++|..+.+                    .+.   ....        +.   +....+..|..+             
T Consensus       122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~  201 (822)
T PLN02876        122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN  201 (822)
T ss_pred             EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence            999998864321                    111   1000        00   111222222221             


Q ss_pred             --HHHHHHHHHh-----------CCCccCCCCCCceEeCCC-Cc-eEEeccCcccccc
Q psy13735        119 --LAQAVQYLHG-----------LGYVHRDIKPDNMLLSAT-GH-LKLTDFGSATQVD  161 (792)
Q Consensus       119 --ILsAL~YLHs-----------~gIVHRDLKPeNILLd~d-g~-VKLiDFGLA~~l~  161 (792)
                        +...+.+|..           ..++|+|++|.|||++.+ +. +-|.||+++....
T Consensus       202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence              2233556632           249999999999999853 33 6899999987654

>KOG1235|consensus

Probab=97.86  E-value=5.6e-05  Score=88.07  Aligned_cols=136  Identities=17%  Similarity=0.164  Sum_probs=88.6

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----------------------------------------HHHH
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----------------------------------------TIER   59 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----------------------------------------~~E~   59 (792)
                      +.||.-+.|+|++++.+. |..||||+-+..-...                                         ..|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            789999999999999987 9999999754321111                                         1232


Q ss_pred             H----HHHhcCCCC------cceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy13735         60 D----IMVKSKCPY------IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL  129 (792)
Q Consensus        60 e----IL~kL~HPN------IVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~  129 (792)
                      +    +...+.|-+      |+++|..+  ...-.|+||||+|..+.++-.-... .++...+...+.++..-.  +=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~q--If~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQ--IFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHH--HHhc
Confidence            2    222334444      45554333  3456899999999877554321222 256555444444433322  2346


Q ss_pred             CCccCCCCCCceEeCC----CCceEEeccCccccccc
Q psy13735        130 GYVHRDIKPDNMLLSA----TGHLKLTDFGSATQVDK  162 (792)
Q Consensus       130 gIVHRDLKPeNILLd~----dg~VKLiDFGLA~~l~~  162 (792)
                      |++|.|-+|.||+++.    ++.+.+-|||+...+..
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            8999999999999984    55799999999887653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.78  E-value=0.00033  Score=72.27  Aligned_cols=129  Identities=20%  Similarity=0.285  Sum_probs=91.1

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCC--------------------CChHHHHHHHHhcC------CCCccee
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK--------------------MPNTIERDIMVKSK------CPYIVNL   73 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~--------------------~~~~~E~eIL~kL~------HPNIVkL   73 (792)
                      ...||+|+.-.||.  |..+ ....||++....                    .....|..-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            45799999999994  4443 445778887766                    11134554444443      8899999


Q ss_pred             EEEEEeCCEEEEEEeccCCC------CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC
Q psy13735         74 FYSFQDMNHVYFIMEYVTGG------DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        74 ~~vfede~~lyLVmEy~~GG------sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg  147 (792)
                      +|+.+++....+|+|.+.+.      +|.+++.+   +.+++ .   +...+-.-..||-.++|+.+|++|.||++...+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence            99999999999999987542      47888833   33665 3   334445556788999999999999999995332


Q ss_pred             ----ceEEec-cCccc
Q psy13735        148 ----HLKLTD-FGSAT  158 (792)
Q Consensus       148 ----~VKLiD-FGLA~  158 (792)
                          .+.|+| ||...
T Consensus       156 ~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  156 SGEFRLVLIDGLGEKE  171 (199)
T ss_pred             CCceEEEEEeCCCCcc
Confidence                478887 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.68  E-value=0.00015  Score=75.05  Aligned_cols=71  Identities=4%  Similarity=-0.004  Sum_probs=44.1

Q ss_pred             EeEeeecCce-EEEEEEEecCCcEEEEEEeccCCCC--hHHHHHHHHhcCCC---CcceeEEEEEeC---CEEEEEEecc
Q psy13735         20 KRFIQQGNFG-DIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSKCP---YIVNLFYSFQDM---NHVYFIMEYV   90 (792)
Q Consensus        20 ~k~IGsGsFG-tVyla~~k~tGk~vAVKiI~Ks~~~--~~~E~eIL~kL~HP---NIVkL~~vfede---~~lyLVmEy~   90 (792)
                      ++.|+.|+.. .||++     +..+++|+.......  ...|..++..+...   .++.+++.....   ...|+||+++
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            4568877777 59977     245788875542222  26788888877521   344444443332   2358899999


Q ss_pred             CCCCH
Q psy13735         91 TGGDF   95 (792)
Q Consensus        91 ~GGsL   95 (792)
                      +|.++
T Consensus        77 ~G~~l   81 (235)
T cd05155          77 EGETA   81 (235)
T ss_pred             cCCCC
Confidence            99665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1826|consensus

Probab=97.65  E-value=1e-05  Score=100.91  Aligned_cols=250  Identities=14%  Similarity=0.022  Sum_probs=154.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---------HHHHHHHHhcCCCCcceeEEEEEeC--CE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---------TIERDIMVKSKCPYIVNLFYSFQDM--NH   82 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---------~~E~eIL~kL~HPNIVkL~~vfede--~~   82 (792)
                      ..+|++.--||-|..+.--..+.+..+  |-+++...-....         ..|++-++...|++++..+.-....  ..
T Consensus      1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred             hhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence            345566666666665544333223222  3344433222222         2344445556798887766554433  34


Q ss_pred             EEEEEeccCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCceEeCCCCceEEeccC
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPH--GYLSESKARFYIYELAQAVQYLHGLG-----YVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~--g~LSE~ea~~Im~QILsAL~YLHs~g-----IVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      .|..++||.+|.+++.|-....  ..+.+.-+....++.+.+..-+|+..     .+|+++|+-|.+|..+-+++++++|
T Consensus      1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred             HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence            6899999999999999964322  22333344444444488888888642     6999999999999999999999999


Q ss_pred             cccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC
Q psy13735        156 SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       156 LA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~  235 (792)
                      +.+...+ ........+++|.|+.|++.+..       .++.++|+|..|+.+|...-|..||-... +...+.+.....
T Consensus      1386 LdKIknp-~~sf~Gl~l~sp~~v~qli~N~i-------k~t~rsdilr~s~~ly~rs~~n~~fi~fl-q~~Lkgiidn~t 1456 (2724)
T KOG1826|consen 1386 LDKIKNP-VLSFFGLELCSPIYVLQLIKNEI-------KFTKRSDILRRSLSLYLRSDGNAYFIFFL-QPALKGIIDNHT 1456 (2724)
T ss_pred             cccccCc-hHhhhhhhhCCHHHHHHHHHHHH-------hhhhHHHHHHHHHHHHHHhcccHHHHHHH-HHHHcCcccccc
Confidence            9983322 22233455789999999999855       67778999999999999999998884222 222222222111


Q ss_pred             CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        236 EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       236 ~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      .....+.    .|.++-.....+|- +-..||+-..++.-|.|.
T Consensus      1457 f~sIe~l----~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1457 FFSIEKL----KPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             ccccccc----CCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            1112221    12333333334444 677888877777666553

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.55  E-value=0.00071  Score=69.42  Aligned_cols=72  Identities=15%  Similarity=0.195  Sum_probs=48.7

Q ss_pred             EeEeeecCceEEEEEEEec-CCcEEEEEEeccCCC---ChHHHHHHHHhcCC-CCcceeEEEEEeCCEEEEEEeccCCCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQ-SHNTFVMKKVLREKM---PNTIERDIMVKSKC-PYIVNLFYSFQDMNHVYFIMEYVTGGD   94 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~-tGk~vAVKiI~Ks~~---~~~~E~eIL~kL~H-PNIVkL~~vfede~~lyLVmEy~~GGs   94 (792)
                      ++.|+.|-...||++.... .+..|++|+......   ....|..++..+.. ...+++++.+..    .+||||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCc
Confidence            5678889999999996543 356888997654322   12478888888853 334555554432    47999999866


Q ss_pred             H
Q psy13735         95 F   95 (792)
Q Consensus        95 L   95 (792)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            4

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.53  E-value=0.00098  Score=69.21  Aligned_cols=123  Identities=22%  Similarity=0.265  Sum_probs=86.5

Q ss_pred             CCCCceEEeEeeecCc-eEEEEEEEecCCcEEEEEEeccCC----------CC----------h-----HHHHHHHHhc-
Q psy13735         13 SASDFDIKRFIQQGNF-GDIYLVEEKQSHNTFVMKKVLREK----------MP----------N-----TIERDIMVKS-   65 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsF-GtVyla~~k~tGk~vAVKiI~Ks~----------~~----------~-----~~E~eIL~kL-   65 (792)
                      ...++++++.||.|.- |.||++...  |+.||+|++..-.          ..          .     ..|-+...+| 
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk  112 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK  112 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence            3479999999999999 999999665  7799999932100          00          0     2344444444 


Q ss_pred             --CCCCc--ceeEEEEEeC------------------CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Q psy13735         66 --KCPYI--VNLFYSFQDM------------------NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV  123 (792)
Q Consensus        66 --~HPNI--VkL~~vfede------------------~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL  123 (792)
                        .+.++  |+.|+++--.                  ....||.||.+...           .++    ..=+.+|++-|
T Consensus       113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl  177 (207)
T PF13095_consen  113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDL  177 (207)
T ss_pred             hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHH
Confidence              45566  8999887321                  12467888876543           122    22356788888


Q ss_pred             HHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735        124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus       124 ~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      ..+|..||+-+|+++.|..     .=+|+|||.+
T Consensus       178 ~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            8999999999999999987     3489999965

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.40  E-value=0.00086  Score=68.50  Aligned_cols=128  Identities=20%  Similarity=0.263  Sum_probs=90.8

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcce-eEEEEEeCCEEEEEEeccCCCC
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVN-LFYSFQDMNHVYFIMEYVTGGD   94 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVk-L~~vfede~~lyLVmEy~~GGs   94 (792)
                      ...+.||+|.+|.||++...  |..+|+|+-..+....  ..|+++|..+.--++.+ +|.+..+    ++.|||+.|-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            45688999999999999776  5688999765544333  67899999998766644 4433322    45599999988


Q ss_pred             HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC-CCceEeCCCCceEEeccCccccc
Q psy13735         95 FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK-PDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        95 L~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLK-PeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      |.+.-.-     .+    ++-+..++..-.-|-..||-|+.|. |..+++..++.+.|+||..|+.-
T Consensus        99 L~~~~~~-----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          99 LGKLEIG-----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhc-----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            8776521     11    2334456666667778899999986 44455556669999999998854

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.38  E-value=0.0017  Score=68.00  Aligned_cols=132  Identities=19%  Similarity=0.257  Sum_probs=78.4

Q ss_pred             EeeecCceEEEEEEEecCCcEEEEEEeccCCC----ChHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEEeccCCCCHH
Q psy13735         22 FIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM----PNTIERDIMVKSKCPYI-VNLFYSFQDMNHVYFIMEYVTGGDFV   96 (792)
Q Consensus        22 ~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~----~~~~E~eIL~kL~HPNI-VkL~~vfede~~lyLVmEy~~GGsL~   96 (792)
                      .+..|-.+.+|++.  .+|..|++|.......    ....|..+++.+....+ +++++...    -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            35668888999886  4567888887654321    23678889988864333 44444432    26899999986543


Q ss_pred             H--------------HHHh---CC--CCCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCCccCCCCCC
Q psy13735         97 T--------------LLEN---QP--HGYLSE-SKARFYIYEL---------AQAVQYLHG--------LGYVHRDIKPD  139 (792)
Q Consensus        97 d--------------lL~r---~~--~g~LSE-~ea~~Im~QI---------LsAL~YLHs--------~gIVHRDLKPe  139 (792)
                      .              .+.+   ..  ...++. ..+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            1              1111   11  111121 1222222222         111222222        24899999999


Q ss_pred             ceEeCCCCceEEeccCccccc
Q psy13735        140 NMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus       140 NILLd~dg~VKLiDFGLA~~l  160 (792)
                      ||+++.++ +.|+||..|...
T Consensus       157 Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cEEEeCCC-CEEEeccccCcC
Confidence            99998877 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.37  E-value=0.0016  Score=69.31  Aligned_cols=142  Identities=13%  Similarity=0.076  Sum_probs=84.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-ChHHHHHHHHhcCCC--CcceeEEE------EEeCCEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTIERDIMVKSKCP--YIVNLFYS------FQDMNHVYFI   86 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-~~~~E~eIL~kL~HP--NIVkL~~v------fede~~lyLV   86 (792)
                      ...-++.|+.|....+|++...  +..+++|+...... ....|..++..+.+.  .+++++..      ....+..++|
T Consensus        15 ~~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          15 ELLSFEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             chhheecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            4444778888988999998643  45789998764211 124577777776422  24444432      2334567899


Q ss_pred             EeccCCCCHHH-----------HHHh---CCCC--------CC-CHHH--H--------HHHHHHHHHHHHHHHh-----
Q psy13735         87 MEYVTGGDFVT-----------LLEN---QPHG--------YL-SESK--A--------RFYIYELAQAVQYLHG-----  128 (792)
Q Consensus        87 mEy~~GGsL~d-----------lL~r---~~~g--------~L-SE~e--a--------~~Im~QILsAL~YLHs-----  128 (792)
                      ++|++|..+..           .+.+   ...+        .. ....  .        ......+..++.++..     
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99999866421           1110   0000        00 0000  0        0011122334444443     


Q ss_pred             --CCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        129 --LGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       129 --~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                        .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence              4699999999999999877789999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.28  E-value=0.0023  Score=68.55  Aligned_cols=73  Identities=12%  Similarity=0.090  Sum_probs=49.3

Q ss_pred             EeEeeecCceEEEEEEEec------CCcEEEEEEeccCCC---ChHHHHHHHHhcCCC-CcceeEEEEEeCCEEEEEEec
Q psy13735         20 KRFIQQGNFGDIYLVEEKQ------SHNTFVMKKVLREKM---PNTIERDIMVKSKCP-YIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~------tGk~vAVKiI~Ks~~---~~~~E~eIL~kL~HP-NIVkL~~vfede~~lyLVmEy   89 (792)
                      ++.|..|-...||++....      ++..|++|+......   ....|..++..+... -.+++++++.+    .+|++|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            4567777778999987643      367899998765422   236788888887532 24556666542    358999


Q ss_pred             cCCCCHH
Q psy13735         90 VTGGDFV   96 (792)
Q Consensus        90 ~~GGsL~   96 (792)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9987653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.23  E-value=0.0056  Score=66.06  Aligned_cols=144  Identities=16%  Similarity=0.176  Sum_probs=84.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCC--CcceeEEE------EEeCCE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCP--YIVNLFYS------FQDMNH   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HP--NIVkL~~v------fede~~   82 (792)
                      .+.....++.++.|....||++.. . +..|++|+........  ..|..++..|...  .+++++..      ....+.
T Consensus        20 ~~~~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        20 DLGELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             CCCCceeccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            345566788889998899999864 3 3468889875532222  3566667666321  24444432      123456


Q ss_pred             EEEEEeccCCCCHH-----------HHHH---hCCCCC---------CC-HHH--HH----------HHHHHHHHHHHHH
Q psy13735         83 VYFIMEYVTGGDFV-----------TLLE---NQPHGY---------LS-ESK--AR----------FYIYELAQAVQYL  126 (792)
Q Consensus        83 lyLVmEy~~GGsL~-----------dlL~---r~~~g~---------LS-E~e--a~----------~Im~QILsAL~YL  126 (792)
                      .+++|+|++|..+.           ..+.   ....+.         ++ +..  ..          .....+...+.++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            79999999985431           1111   100110         00 000  00          0011223345555


Q ss_pred             Hh-------CCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735        127 HG-------LGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus       127 Hs-------~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      ..       .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            32       579999999999999988877999999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10593 hypothetical protein; Provisional

Probab=97.23  E-value=0.0032  Score=68.29  Aligned_cols=78  Identities=8%  Similarity=0.040  Sum_probs=54.9

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--hHHHHHHHHhcCC---CCcceeEEEEEeC---CEEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSKC---PYIVNLFYSFQDM---NHVYFIM   87 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--~~~E~eIL~kL~H---PNIVkL~~vfede---~~lyLVm   87 (792)
                      .-.-.+.||.|..+.||.+...+ | .+++|........  -..|...|+.+.-   ..++++++++.+.   +..+|||
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCC-C-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34456789999999999885432 3 4667774431122  2678888888742   4688888877643   6689999


Q ss_pred             eccCCCCH
Q psy13735         88 EYVTGGDF   95 (792)
Q Consensus        88 Ey~~GGsL   95 (792)
                      |+++|+++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998754

>PRK05231 homoserine kinase; Provisional

Probab=97.20  E-value=0.0073  Score=65.17  Aligned_cols=140  Identities=14%  Similarity=0.071  Sum_probs=76.6

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-hHHHHHHHHhcCC--CCcceeEE------EEEeCCEEEEEEe
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-NTIERDIMVKSKC--PYIVNLFY------SFQDMNHVYFIME   88 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-~~~E~eIL~kL~H--PNIVkL~~------vfede~~lyLVmE   88 (792)
                      .-.+.|+.|....+|++...  +..|++|++...... ...+..++..|..  -.+++.+.      +....+..+++++
T Consensus        25 ~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         25 LSLKGIAEGIENSNFFLTTT--QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             hccchhccccccceEEEEeC--CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            34567888888899998653  337899987521111 1345556655531  11333332      1233566799999


Q ss_pred             ccCCCCHH-----------HHHHh---CCCC-------CCC--H-HH-H-----------HHHHHHHH-HHHHHHH----
Q psy13735         89 YVTGGDFV-----------TLLEN---QPHG-------YLS--E-SK-A-----------RFYIYELA-QAVQYLH----  127 (792)
Q Consensus        89 y~~GGsL~-----------dlL~r---~~~g-------~LS--E-~e-a-----------~~Im~QIL-sAL~YLH----  127 (792)
                      |++|..+.           ..+.+   ...+       ...  . .. .           ...+.+.+ ..+..+.    
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            99986431           11111   0000       001  0 00 0           01111111 1122222    


Q ss_pred             ---hCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        128 ---GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       128 ---s~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                         ..+++|+|+.|.|||++.+...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               23799999999999998665568999998753

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.17  E-value=0.0056  Score=69.55  Aligned_cols=75  Identities=19%  Similarity=0.288  Sum_probs=53.1

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEecc------CCCC-----hHHHHHHHHhcC---CCCcceeEEEEEeCCEE
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR------EKMP-----NTIERDIMVKSK---CPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~K------s~~~-----~~~E~eIL~kL~---HPNIVkL~~vfede~~l   83 (792)
                      .-.+.||.|.+..||++...+.++.+++|.-..      ..++     ...|.+.|..+.   ..++++++++  +....
T Consensus        29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~  106 (401)
T PRK09550         29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA  106 (401)
T ss_pred             ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence            346789999999999999865446899997431      1111     156788887753   3467777766  44667


Q ss_pred             EEEEeccCCCC
Q psy13735         84 YFIMEYVTGGD   94 (792)
Q Consensus        84 yLVmEy~~GGs   94 (792)
                      ++||||+++..
T Consensus       107 ~lVME~L~~~~  117 (401)
T PRK09550        107 VTVMEDLSDHK  117 (401)
T ss_pred             EEEEecCCCcc
Confidence            89999998754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.92  E-value=0.0024  Score=65.13  Aligned_cols=102  Identities=19%  Similarity=0.202  Sum_probs=79.4

Q ss_pred             HHHHHHHHhcCC-CCcceeEEEEEeCCEEEEEEeccCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q psy13735         56 TIERDIMVKSKC-PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIYELAQAVQYLHG---LG  130 (792)
Q Consensus        56 ~~E~eIL~kL~H-PNIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r-~~~g~LSE~ea~~Im~QILsAL~YLHs---~g  130 (792)
                      ..|.-+++.+.+ +++++++|++-    -++|.||...+++...... ......++.....++.+++..+.+++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            347778888876 69999999983    2678999987766421100 011225899999999999999999998   45


Q ss_pred             CccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735        131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus       131 IVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      +.-.|++|+|+-++.+|++|++|........
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            7889999999999999999999998776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.90  E-value=0.011  Score=63.14  Aligned_cols=29  Identities=31%  Similarity=0.536  Sum_probs=25.6

Q ss_pred             CCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735        129 LGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus       129 ~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2268|consensus

Probab=96.74  E-value=0.00084  Score=74.08  Aligned_cols=131  Identities=19%  Similarity=0.206  Sum_probs=91.8

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC--------------------------ChHHHHHHHHhcC-CC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--------------------------PNTIERDIMVKSK-CP   68 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~--------------------------~~~~E~eIL~kL~-HP   68 (792)
                      -+.++..||-|--+.||.+-+. .|.++++|+=.-...                          ....|...|..|. |-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4678999999999999999664 578899884211000                          0034666666664 32


Q ss_pred             -CcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC
Q psy13735         69 -YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        69 -NIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg  147 (792)
                       -+++.+    +.+.-++|||++.|..|...-.-     ..   +..+...++.-+.-|..+|+||+|..--|||++.++
T Consensus       172 fpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  172 FPVPKPI----DHNRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCCCcc----cccceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence             234443    34566899999999877654311     12   233455666677789999999999999999999999


Q ss_pred             ceEEeccCcccc
Q psy13735        148 HLKLTDFGSATQ  159 (792)
Q Consensus       148 ~VKLiDFGLA~~  159 (792)
                      .++++||--+..
T Consensus       240 ~i~vIDFPQmvS  251 (465)
T KOG2268|consen  240 KIVVIDFPQMVS  251 (465)
T ss_pred             CEEEeechHhhc
Confidence            999999975543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.69  E-value=0.019  Score=63.17  Aligned_cols=141  Identities=16%  Similarity=0.201  Sum_probs=81.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCC---ChHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKM---PNTIERDIMVKSKCPYI-VNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~---~~~~E~eIL~kL~HPNI-VkL~~vfede~~lyLV   86 (792)
                      .+...+.. |..|-...+|++.....   +..|++++......   ....|..+++.+..-++ +++++++.+ +   +|
T Consensus        14 ~~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i   88 (330)
T PLN02421         14 DSDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MI   88 (330)
T ss_pred             cCceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCC-c---Ee
Confidence            34555544 44488888999975532   34788887754322   23689999988865444 566666632 2   58


Q ss_pred             EeccCCCCHHH--------------HHHhCCCCC------C-CHHHHHHHHHHH----------------------HHHH
Q psy13735         87 MEYVTGGDFVT--------------LLENQPHGY------L-SESKARFYIYEL----------------------AQAV  123 (792)
Q Consensus        87 mEy~~GGsL~d--------------lL~r~~~g~------L-SE~ea~~Im~QI----------------------LsAL  123 (792)
                      .+|++|-.+..              .+.+-....      + ....+..++.++                      ..-+
T Consensus        89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  168 (330)
T PLN02421         89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI  168 (330)
T ss_pred             ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence            99998765411              111111100      1 122233333222                      1111


Q ss_pred             HHH---H-hCC----CccCCCCCCceEeCC-CCceEEeccCcccc
Q psy13735        124 QYL---H-GLG----YVHRDIKPDNMLLSA-TGHLKLTDFGSATQ  159 (792)
Q Consensus       124 ~YL---H-s~g----IVHRDLKPeNILLd~-dg~VKLiDFGLA~~  159 (792)
                      ..+   . ..+    ++|.|+.|.|||++. ++.++++||..|..
T Consensus       169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111   1 222    699999999999974 57899999998753

>PLN02236 choline kinase

Probab=96.51  E-value=0.024  Score=62.95  Aligned_cols=137  Identities=12%  Similarity=0.131  Sum_probs=81.1

Q ss_pred             EEeEeeecCceEEEEEEEec----CCcEEEEEEeccCCC---ChHHHHHHHHhcCCCC-cceeEEEEEeCCEEEEEEecc
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQ----SHNTFVMKKVLREKM---PNTIERDIMVKSKCPY-IVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~----tGk~vAVKiI~Ks~~---~~~~E~eIL~kL~HPN-IVkL~~vfede~~lyLVmEy~   90 (792)
                      -+..|..|-...+|++....    +++.|++++......   ....|..++..+..-+ -+++++.+.+.    .|++|+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            34456568888999987532    346889997765321   2267888988885433 34566666432    589999


Q ss_pred             CCCCHHH--------------HHHh---CC--CC--CCCHHHHHHHHHHHH-----------------HHHHHH----H-
Q psy13735         91 TGGDFVT--------------LLEN---QP--HG--YLSESKARFYIYELA-----------------QAVQYL----H-  127 (792)
Q Consensus        91 ~GGsL~d--------------lL~r---~~--~g--~LSE~ea~~Im~QIL-----------------sAL~YL----H-  127 (792)
                      +|.++..              .+.+   ..  ..  ......+..++.++.                 ..+..|    . 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            8765531              1111   00  00  111233333432221                 111111    1 


Q ss_pred             ---hCCCccCCCCCCceEeCC-CCceEEeccCcccc
Q psy13735        128 ---GLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQ  159 (792)
Q Consensus       128 ---s~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~~  159 (792)
                         ...++|+|+++.|||++. ++.+.|+||..|..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               225799999999999976 46899999988753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.50  E-value=0.013  Score=64.68  Aligned_cols=141  Identities=20%  Similarity=0.218  Sum_probs=85.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEecc-CCCC-----hHHHHHHHHhcCC--CCcceeEEEEEeCC--
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMP-----NTIERDIMVKSKC--PYIVNLFYSFQDMN--   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~K-s~~~-----~~~E~eIL~kL~H--PNIVkL~~vfede~--   81 (792)
                      ....+..++..+..|....+|.....  ++.+++. .+. ....     ...|..++..+.-  .-+...++.+.++.  
T Consensus        22 p~~~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g   98 (321)
T COG3173          22 PGYAGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLG   98 (321)
T ss_pred             cCcCCCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCC
Confidence            34456677777766655566665444  7888888 332 1111     1467777777642  23344455555554  


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHH-HHHHHHHHHH---------------------------------
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY-ELAQAVQYLH---------------------------------  127 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~-QILsAL~YLH---------------------------------  127 (792)
                      ..|.||+|+.|..+.+.+       ++......++. .+...|.-||                                 
T Consensus        99 ~pf~v~~~veGe~~~~~~-------~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~  171 (321)
T COG3173          99 TPFYVMEWVEGEVVWSAL-------PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKK  171 (321)
T ss_pred             CceEEEEEecceeccCcC-------CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHH
Confidence            679999999985332222       01111111222 3444444444                                 


Q ss_pred             -----------------hC--------CCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735        128 -----------------GL--------GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus       128 -----------------s~--------gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                                       .+        .++|+|+++.||+++..+-+-++||+++....+
T Consensus       172 ~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         172 ELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             hccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                             22        389999999999999988899999999886543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.47  E-value=0.018  Score=64.74  Aligned_cols=71  Identities=20%  Similarity=0.369  Sum_probs=46.6

Q ss_pred             EeeecCceEEEEEEEecCCcEEEEEEecc------CCCCh-----HHHHHHHHhcC--CC-CcceeEEEEEeCCEEEEEE
Q psy13735         22 FIQQGNFGDIYLVEEKQSHNTFVMKKVLR------EKMPN-----TIERDIMVKSK--CP-YIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        22 ~IGsGsFGtVyla~~k~tGk~vAVKiI~K------s~~~~-----~~E~eIL~kL~--HP-NIVkL~~vfede~~lyLVm   87 (792)
                      .||-|....||++.....++.++||.-..      ..++.     ..|.++|+...  .| .++++|++  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            58999999999999764446888885321      11111     57888887653  45 44555433  555667999


Q ss_pred             eccCCCC
Q psy13735         88 EYVTGGD   94 (792)
Q Consensus        88 Ey~~GGs   94 (792)
                      |+++...
T Consensus        80 EdL~~~~   86 (370)
T TIGR01767        80 EDLSHHK   86 (370)
T ss_pred             hhCccch
Confidence            9996543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.22  E-value=0.077  Score=60.73  Aligned_cols=70  Identities=16%  Similarity=0.221  Sum_probs=49.3

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEec-----cC-CC--C---hHHHHHHHHhcC---CCCcceeEEEEEeCCEEE
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL-----RE-KM--P---NTIERDIMVKSK---CPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~-----Ks-~~--~---~~~E~eIL~kL~---HPNIVkL~~vfede~~ly   84 (792)
                      ..+.||.|....||++...  +..++||.-.     .. .+  .   ...|...|..+.   ..++++++.+..  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            5788999999999999863  4568888654     11 11  1   156677776553   247888888776  4467


Q ss_pred             EEEeccCC
Q psy13735         85 FIMEYVTG   92 (792)
Q Consensus        85 LVmEy~~G   92 (792)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>KOG2270|consensus

Probab=96.15  E-value=0.023  Score=63.94  Aligned_cols=148  Identities=20%  Similarity=0.224  Sum_probs=96.1

Q ss_pred             hHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---------------------------
Q psy13735          3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---------------------------   55 (792)
Q Consensus         3 ~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---------------------------   55 (792)
                      |+.+|.+.+...   .+-..|..|--+-||.|... +|..||||++..+-+.-                           
T Consensus       135 vLfrll~RG~i~---~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk  210 (520)
T KOG2270|consen  135 VLFRLLNRGVIV---EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVK  210 (520)
T ss_pred             HHHHHHhcCeee---ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHH
Confidence            344555544322   35678999999999998664 67889999875432110                           


Q ss_pred             ---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCCCCH-HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCC
Q psy13735         56 ---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELAQAVQYLH-GLG  130 (792)
Q Consensus        56 ---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~GGsL-~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH-s~g  130 (792)
                         ..|..-|.+++...|+-.--+.-  ..-+|||+|+.+... .-.|   +...++...+..+-.|++..+.-|- ..+
T Consensus       211 ~WAEKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~  285 (520)
T KOG2270|consen  211 TWAEKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCR  285 (520)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhc
Confidence               23445555554333221111111  134799999943221 2233   2334787888888888888877765 569


Q ss_pred             CccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735        131 YVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus       131 IVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +||.||.--|+|+ .+|.+.++|-+-+...
T Consensus       286 LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  286 LVHADLSEFNLLY-HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             eeccchhhhhheE-ECCEEEEEEccccccC
Confidence            9999999999999 6789999998866543

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.99  E-value=0.049  Score=62.05  Aligned_cols=89  Identities=17%  Similarity=0.253  Sum_probs=55.6

Q ss_pred             hHHHHhcC--CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEecc-----CCCCh-----HHHHHHHHhcC--CC
Q psy13735          3 VVKELRQK--NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPN-----TIERDIMVKSK--CP   68 (792)
Q Consensus         3 ~~~~L~rk--~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~K-----s~~~~-----~~E~eIL~kL~--HP   68 (792)
                      ++..+.+.  .+....--..+.||-|.-..||++.....++.++||.-..     ..++.     ..|.++|+...  .|
T Consensus        15 v~~yl~~~l~~~~~~~~~~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P   94 (409)
T PRK12396         15 VIVYVKEKLSKFEHAKGLQCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAP   94 (409)
T ss_pred             HHHHHHHhcCCCCCcccceeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCC
Confidence            44445443  2333322247899999999999998854456788885321     11111     57888888663  45


Q ss_pred             -CcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         69 -YIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        69 -NIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                       +++++|++  +.....+|||+++..
T Consensus        95 ~~VP~vy~~--D~e~~~~vMEdL~~~  118 (409)
T PRK12396         95 GLVPKVYLF--DSVMNCCVMEDLSDH  118 (409)
T ss_pred             CcCCeEEEE--CcHHhhHHHHhCccc
Confidence             45555433  555678899999653

>TIGR02169 SMC_prok_A chromosome segregation protein SMC, primarily archaeal type

Probab=95.96  E-value=0.28  Score=61.87  Aligned_cols=27  Identities=26%  Similarity=0.163  Sum_probs=16.2

Q ss_pred             cceEEEEeecccCCchhhhhhhhhccc
Q psy13735        648 QGKIRLVYSLFKDPQPAQSKLEKAEGE  674 (792)
Q Consensus       648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (792)
                      .|-.-.|..|+.=|.--...++-|-|.
T Consensus       521 ~g~~g~l~dli~v~~~y~~Aie~~lg~  547 (1164)
T TIGR02169       521 QGVHGTVAQLGSVGERYATAIEVAAGN  547 (1164)
T ss_pred             CCceecHHHhcCcCHHHHHHHHHHhhh
Confidence            354445677776665555666666664

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.94  E-value=0.03  Score=60.33  Aligned_cols=31  Identities=26%  Similarity=0.422  Sum_probs=26.0

Q ss_pred             CCccCCCCCCceEeCCCCc-eEEeccCccccc
Q psy13735        130 GYVHRDIKPDNMLLSATGH-LKLTDFGSATQV  160 (792)
Q Consensus       130 gIVHRDLKPeNILLd~dg~-VKLiDFGLA~~l  160 (792)
                      .++|+|++|.|||++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            3799999999999987565 579999988754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.67  E-value=0.094  Score=56.84  Aligned_cols=30  Identities=20%  Similarity=0.211  Sum_probs=27.7

Q ss_pred             CCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       130 gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      +++|+|+.+.|||++.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=94.96  E-value=0.18  Score=57.12  Aligned_cols=73  Identities=16%  Similarity=0.260  Sum_probs=45.7

Q ss_pred             EEeEeeecCceEEEEEEEecC-CcEEEEE-----EeccCC---CChHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEe
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQS-HNTFVMK-----KVLREK---MPNTIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~t-Gk~vAVK-----iI~Ks~---~~~~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .++.|..|-...+|+|..... +..+.+|     ......   .....|..++..+. +-.-+++++.|.+    ++|.|
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            345666688899999976433 2233223     211110   11267899999886 4455677777753    69999


Q ss_pred             ccCCCCH
Q psy13735         89 YVTGGDF   95 (792)
Q Consensus        89 y~~GGsL   95 (792)
                      |++|-.|
T Consensus       130 fIeGr~l  136 (383)
T PTZ00384        130 WVEGNTM  136 (383)
T ss_pred             EeccccC
Confidence            9998665

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.88  E-value=0.25  Score=53.93  Aligned_cols=75  Identities=8%  Similarity=0.111  Sum_probs=47.5

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC---CCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK---CPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~---HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      ..-.+.||.|....+|++.  .+++.|.+|+-....... ..|..-|+.|.   --.+++++.+....+.-||||||++.
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            4456788999999999886  678899999877433332 56777777773   45678889888877777999999987


Q ss_pred             C
Q psy13735         93 G   93 (792)
Q Consensus        93 G   93 (792)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            7

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02169 SMC_prok_A chromosome segregation protein SMC, primarily archaeal type

Probab=94.77  E-value=1.6  Score=55.13  Aligned_cols=19  Identities=37%  Similarity=0.564  Sum_probs=7.5

Q ss_pred             hhHHHHHHHHhhhHHHHhh
Q psy13735        509 QTENEALKEKLTSLEQELK  527 (792)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~  527 (792)
                      +.+...++..+..+++++.
T Consensus       398 ~~~~~~~~~~~~~l~~~l~  416 (1164)
T TIGR02169       398 KREINELKRELDRLQEELQ  416 (1164)
T ss_pred             HHHHHHHHHHHHHHHHHHH
Confidence            3333334444444444333

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent.

>PF05701 WEMBL: Weak chloroplast movement under blue light; InterPro: IPR008545 This family consists of several plant proteins of unknown function

Probab=94.40  E-value=0.23  Score=58.53  Aligned_cols=249  Identities=28%  Similarity=0.338  Sum_probs=0.0

Q ss_pred             HHHHHHHHHHHhhhhHHhhhhhHHHHHHhhHHHHHHHHhhhcccccCcccceeeechhhhHHhhhhhhhhhhHHHHhhHH
Q psy13735        411 EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKD  490 (792)
Q Consensus       411 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  490 (792)
                      ||.++|+||..+-..+......+..+...+.....+                |+++++||..+.+.|+.-+.+..+=.+.
T Consensus       138 EL~~lr~e~~~~~~~k~~A~~~aeea~~~a~~~~~k----------------ve~L~~Ei~~lke~l~~~~~a~~eAeee  201 (522)
T PF05701_consen  138 ELEKLRQELASALDAKNAALKQAEEAVSAAEENEEK----------------VEELSKEIIALKESLESAKLAHIEAEEE  201 (522)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH----------------HHHHHHHHHHHHHHHHHHHHHHHHHHHH


Q ss_pred             HHHHHHHhhHHHHHHHHhhhHHHHHHHHhhhHHHHhhccHHHHHHhhhhhhHHHHHhHHhhhhHHHHHH-HHHhhhhhhh
Q psy13735        491 WYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQK-EMEQSAVRVR  569 (792)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  569 (792)
                      --.-+.+|..-...++..   .+...+++..|..++    ++....++.|+....+-..|..-++.... ++...+-..+
T Consensus       202 ~~~~~~~~~~~~~~~~~~---leeae~~l~~L~~e~----~~~k~Le~kL~~a~~~l~~Lq~El~~~~~~~l~~~~~~~~  274 (522)
T PF05701_consen  202 RIEIAAEREQDAEEWEKE---LEEAEEELEELKEEL----EAAKDLESKLAEASAELESLQAELEAAKESKLEEEAEAKE  274 (522)
T ss_pred             HHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhHHhhh


Q ss_pred             hccCchhhhhhhhhhHHhhhhhhhhhceeeeccccchhhhhhhhhcccccceeehhcch------------hhhhccccc
Q psy13735        570 EMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSK------------LEKAEGELT  637 (792)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~  637 (792)
                      .+..+......-++.|-+.|.--+...-|+.......+|.|.||+.-|...-.++.+..            |.++..+|.
T Consensus       275 ~~~~~~~~l~s~~~ELe~ak~~L~~~k~E~~~L~~~vesL~~ELe~~K~el~~lke~e~~a~~~v~~L~~eL~~~r~eLe  354 (522)
T PF05701_consen  275 KSSELQSSLASAKKELEEAKKELEKAKEEASSLRASVESLRSELEKEKEELERLKEREKEASSEVSSLEAELNKTRSELE  354 (522)
T ss_pred             hhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHhhHHHHHHHHHHHHH


Q ss_pred             hhhHhhhhcccceEEEEeecccCCchhhhhhhhhccccchhhhccccee
Q psy13735        638 TVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLK  686 (792)
Q Consensus       638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  686 (792)
                      .++.+.++.+.    ....+...-|-+.+-.+.|..+....+++..+++
T Consensus       355 a~~~~e~~~k~----~~~~l~~~Lqql~~Eae~Ak~ea~~~~~E~~~~k  399 (522)
T PF05701_consen  355 AAKAEEEKAKE----AMSELPKALQQLSSEAEEAKKEAEEAKEEVEKAK  399 (522)
T ss_pred             HHHhhhcchhh----hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH

Several sequences in this family are described as being myosin heavy chain-like.

>PF00038 Filament: Intermediate filament protein; InterPro: IPR016044 Intermediate filaments (IF) [, , ] are proteins which are primordial components of the cytoskeleton and the nuclear envelope

Probab=94.34  E-value=4.6  Score=43.93  Aligned_cols=224  Identities=25%  Similarity=0.404  Sum_probs=117.5

Q ss_pred             HHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHhhHhhhhcccc-------ccHHHHHHHHHHHHHhhhhHHhhhhhHHHH
Q psy13735        364 LQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLS-------KKEEEIDRLRQEMVKKESDLVATSSDLVAT  436 (792)
Q Consensus       364 ~~~~~~~~~s~ed~~~~~~~~~~~~~~~~~l~~D~~~~~~~~~-------~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~  436 (792)
                      ..++.++...++++.......-   .....+..++.-..--|.       .=|.+|..+|.++...-..+..++.-+.+.
T Consensus        53 e~el~~lr~~id~~~~eka~l~---~e~~~l~~e~~~~r~k~e~e~~~~~~le~el~~lrk~ld~~~~~r~~le~~i~~L  129 (312)
T PF00038_consen   53 EEELRELRRQIDDLSKEKARLE---LEIDNLKEELEDLRRKYEEELAERKDLEEELESLRKDLDEETLARVDLENQIQSL  129 (312)
T ss_dssp             HHHHHCHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHhHHhhhhHHHHhhHHh---hhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhHhHHHHHHHHH
Confidence            3455555566665555554432   233333333333322222       223377778877777777777777777777


Q ss_pred             HHhhHHHHHHHHh-hhcccccCc--ccce-----eeechhhhHHhhhhhhhhhhHHHHhhHHHHHHH-HHhh----HHHH
Q psy13735        437 RHELEEVRSELKE-KENLEKTDD--RKLE-----VCEVSKELEVLRGELEEQKTATKQWKKDWYQSV-KERN----AAVA  503 (792)
Q Consensus       437 ~~~~~~~~~~~~~-~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~  503 (792)
                      ...+.-++.-+.+ ...|...-.  ...+     --+++..|..+|.+.+..-...++=-..||+.- .+-+    ....
T Consensus       130 ~eEl~fl~~~heeEi~~L~~~~~~~~~~e~~~~~~~dL~~~L~eiR~~ye~~~~~~~~e~e~~y~~k~~~l~~~~~~~~~  209 (312)
T PF00038_consen  130 KEELEFLKQNHEEEIEELREQIQSSVTVEVDQFRSSDLSAALREIRAQYEEIAQKNREELEEWYQSKLEELRQQSEKSSE  209 (312)
T ss_dssp             HHHHHHHHHHHHHHHHTTSTT----------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhhhhhhhhhhhhccccccceeecccccccchhhhhhHHHHHHHHHhhhhhhhhhhccccccccccccccccc
Confidence            7777666655443 333333221  1111     134567788888888877666666566788753 2211    2334


Q ss_pred             HHHHhhhHHHHHHHHhhhHHHHhhc-------cHHHHHHhhhhhhHHHHHhHHhhhhHHHHHHHHHhhhhhhhhccCchh
Q psy13735        504 ELKQAQTENEALKEKLTSLEQELKV-------SEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISE  576 (792)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  576 (792)
                      ++..++.|+..++..+.+|+.++..       -+..++..+..++..+..|++   .|.++..++.+.-..   |.....
T Consensus       210 ~~~~~~~E~~~~r~~~~~l~~el~~l~~~~~~Le~~l~~le~~~~~~~~~~~~---~i~~le~el~~l~~~---~~~~~~  283 (312)
T PF00038_consen  210 ELESAKEELKELRRQIQSLQAELESLRAKNASLERQLRELEQRLDEEREEYQA---EIAELEEELAELREE---MARQLR  283 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHH---HHHHHH
T ss_pred             ccchhHhHHHHHHhhhhHhhhhhhccccchhhhhhhHHHHHHHHHHHHHHHHH---hhhccchhHHHHHHH---HHHHHH
Confidence            4666666777777776666655543       233444444455555555554   344444444433222   222222


Q ss_pred             hhhhhhhhHHhhhhhhhhhceeeeccc
Q psy13735        577 KYEKDRKTLLELKSAKERLELEVRGYK  603 (792)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  603 (792)
                      .|    ..|+   ..|-.|+.|+.-|.
T Consensus       284 ey----~~Ll---~~K~~Ld~EIatYR  303 (312)
T PF00038_consen  284 EY----QELL---DVKLALDAEIATYR  303 (312)
T ss_dssp             HH----HHHH---HHHHHHHHHHHHHH
T ss_pred             HH----HHHH---HHHHhHHHHHHHHH
Confidence            22    3344   45556777777775

They generally form filamentous structures 8 to 14 nm wide. IF proteins are members of a very large multigene family of proteins which has been subdivided in five major subgroups: Type I: Acidic cytokeratins. Type II: Basic cytokeratins. Type III: Vimentin, desmin, glial fibrillary acidic protein (GFAP), peripherin, and plasticin. Type IV: Neurofilaments L, H and M, alpha-internexin and nestin. Type V: Nuclear lamins A, B1, B2 and C. All IF proteins are structurally similar in that they consist of: a central rod domain comprising some 300 to 350 residues which is arranged in coiled-coiled alpha-helices, with at least two short characteristic interruptions; a N-terminal non-helical domain (head) of variable length; and a C-terminal domain (tail) which is also non-helical, and which shows extreme length variation between different IF proteins. While IF proteins are evolutionary and structurally related, they have limited sequence homologies except in several regions of the rod domain. This entry represents the central rod domain found in IF proteins.; PDB: 3TNU_B 3KLT_D 1GK4_F 3TRT_A 3G1E_A 3UF1_C 1GK6_B 1GK7_A 3TYY_B 3V4W_A ....

>PRK02224 chromosome segregation protein; Provisional

Probab=94.26  E-value=3.3  Score=51.53  Aligned_cols=37  Identities=14%  Similarity=0.249  Sum_probs=18.4

Q ss_pred             HHHHHHHHHHHhhhhHHhhhhhHHHHHHhhHHHHHHH
Q psy13735        411 EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSEL  447 (792)
Q Consensus       411 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  447 (792)
                      .|.+++.++...+..+..++..+......++.+..++
T Consensus       207 ~l~~~~~~l~el~~~i~~~~~~~~~l~~~l~~l~~~~  243 (880)
T PRK02224        207 RLNGLESELAELDEEIERYEEQREQARETRDEADEVL  243 (880)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            4555555555555555555555444444444444443

>TIGR02168 SMC_prok_B chromosome segregation protein SMC, common bacterial type

Probab=94.25  E-value=3.4  Score=52.08  Aligned_cols=35  Identities=11%  Similarity=0.361  Sum_probs=22.9

Q ss_pred             cccccchHHHHHHHHHHHHHhhcCC--ccccchHHHh
Q psy13735        743 STMTRSESYCKEMVEYLETLQKNND--ILSHDNEQLR  777 (792)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  777 (792)
                      .+..-.......+..++..+.++..  |.||+..-+.
T Consensus      1120 ~~~~ld~~~~~~~~~~~~~~~~~~~~i~~sh~~~~~~ 1156 (1179)
T TIGR02168      1120 VDAPLDDANVERFANLLKEFSKNTQFIVITHNKGTME 1156 (1179)
T ss_pred             ccccccHHHHHHHHHHHHHhccCCEEEEEEcChhHHH
Confidence            3344455667778888888866543  4689877654

SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.06  E-value=0.14  Score=57.98  Aligned_cols=85  Identities=15%  Similarity=0.260  Sum_probs=61.4

Q ss_pred             CCCcceeEEEE-EeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeC
Q psy13735         67 CPYIVNLFYSF-QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLS  144 (792)
Q Consensus        67 HPNIVkL~~vf-ede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd  144 (792)
                      .++..+.+-+- ....+.|++|++. |+++.-+-      .-...++..|+.+.+..+.-+..+ ..-|||+...||||+
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId  356 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID  356 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence            34444443333 2334678889986 66554221      134677788888888888777765 689999999999999


Q ss_pred             CCCceEEeccCcccc
Q psy13735        145 ATGHLKLTDFGSATQ  159 (792)
Q Consensus       145 ~dg~VKLiDFGLA~~  159 (792)
                       +|+|-|+||-+|+.
T Consensus       357 -~GnvtLIDfklsRl  370 (488)
T COG5072         357 -EGNVTLIDFKLSRL  370 (488)
T ss_pred             -cCceEEEEeeeeec
Confidence             99999999999984

>COG1196 Smc Chromosome segregation ATPases [Cell division and chromosome partitioning]

Probab=94.00  E-value=2.9  Score=53.92  Aligned_cols=152  Identities=24%  Similarity=0.324  Sum_probs=78.7

Q ss_pred             hhhhhhhhHHHHHHHHHHHHhhHhhhhccccccHHHHHHHHHHHHHhhhhHHhhhhhHHHHHHhhHHHHHHHHhhhcccc
Q psy13735        376 DLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEK  455 (792)
Q Consensus       376 d~~~~~~~~~~~~~~~~~l~~D~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (792)
                      .+......+..+...+..++....-....+.+.|.++.+++......+......+..+....+.+......+...+.+..
T Consensus       268 ~i~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~le~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (1163)
T COG1196         268 EIEELKSELEELREELEELQEELLELKEEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLE  347 (1163)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHH
Confidence            33444444444444444443333333335555566666666655555555555555555555555554444444332211


Q ss_pred             cCcc-cceeeechhhhHHhhh-hhhhhhhHHHHhhHHHHHHHHHhhHHHHHHHHhhhHHHHHHHHhhhHHHHhh
Q psy13735        456 TDDR-KLEVCEVSKELEVLRG-ELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELK  527 (792)
Q Consensus       456 ~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (792)
                      .-.. .-.+-..-.+++-.++ .+++..+....|+..|..-..+...+-+++-..+.+.+.+.+.++.+...+.
T Consensus       348 e~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~i~~l~~~~~~~~~~~~  421 (1163)
T COG1196         348 ELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEERLERLSERLE  421 (1163)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            1111 1122233344444444 3344555667888888887777776666776666666666665555555443

>KOG0994|consensus

Probab=93.46  E-value=2.4  Score=53.36  Aligned_cols=215  Identities=21%  Similarity=0.264  Sum_probs=0.0

Q ss_pred             HHHHHHHHHhhcchhhhhhhhHHHHHHHHHHHHhhHhhhhccccccHH-------HHHHHHHHHHHhhhhHHhhhhhHHH
Q psy13735        363 LLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE-------EIDRLRQEMVKKESDLVATSSDLVA  435 (792)
Q Consensus       363 ~~~~~~~~~~s~ed~~~~~~~~~~~~~~~~~l~~D~~~~~~~~~~~~~-------~~~~~~~e~~~~~~~~~~~~~~~~~  435 (792)
                      ++++|++.++++-+|.++-.+-..+..-...|+.+..--.+--..-..       -|...-.-+.+++...+.+.+|++.
T Consensus      1516 L~~~I~e~v~sL~nVd~IL~~T~~di~ra~~L~s~A~~a~~~A~~v~~~ae~V~eaL~~Ad~Aq~~a~~ai~~a~~~~~~ 1595 (1758)
T KOG0994|consen 1516 LTGEIQERVASLPNVDAILSRTKGDIARAENLQSEAERARSRAEDVKGQAEDVVEALEEADVAQGEAQDAIQGADRDIRL 1595 (1758)
T ss_pred             HHHHHHHHHHhcccHHHHHHhhhhhHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHH


Q ss_pred             HHHhhHHHHHHHHhhhcccccCcccceeeechhhhHHhhhhhhhhhhHHHHhhHHHHHHHHHhhHHHHHHHHhhhHHHHH
Q psy13735        436 TRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEAL  515 (792)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (792)
                      +..-|..|..+..--|.+         +-..++.+..|.+-+|+-|....|              --++-|+|++...+.
T Consensus      1596 a~~~l~kv~~~t~~aE~~---------~~~a~q~~~eL~~~~e~lk~~~~q--------------ns~~A~~a~~~a~sa 1652 (1758)
T KOG0994|consen 1596 AQQLLAKVQEETAAAEKL---------ATSATQQLGELETRMEELKHKAAQ--------------NSAEAKQAEKTAGSA 1652 (1758)
T ss_pred             HHHHHHHHHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHHh--------------ccHHHHHHHHHHHHH


Q ss_pred             HHHhhhHHHHhhccHHHHHHhhhhhhHHHHHhHHhhhhHHHHHHHHH----hhhhhhhhccCchhhhhhhhhhHHhhhhh
Q psy13735        516 KEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEME----QSAVRVREMSGISEKYEKDRKTLLELKSA  591 (792)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (792)
                      |+.-++.||.++.-.+++.++.+-+.++...-++-...+|+++.|.+    |.--....|-.++-+|+..-..|.....-
T Consensus      1653 ~~~A~~a~q~~~~lq~~~~~~~~l~~~r~~g~~~ar~rAe~L~~eA~~Ll~~a~~kl~~l~dLe~~y~~~~~~L~~~~ae 1732 (1758)
T KOG0994|consen 1653 KEQALSAEQGLEILQKYYELVDRLLEKRMEGSQAARERAEQLRTEAEKLLGQANEKLDRLKDLELEYLRNEQALEDKAAE 1732 (1758)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhHHHHHHHHH


Q ss_pred             hhhhceeee
Q psy13735        592 KERLELEVR  600 (792)
Q Consensus       592 ~~~~~~~~~  600 (792)
                      -.+||-+|+
T Consensus      1733 L~~Le~r~~ 1741 (1758)
T KOG0994|consen 1733 LAGLEKRVE 1741 (1758)
T ss_pred             hhhHHHHHH

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	792
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-55
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-55
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-55
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-55
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-54
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-54
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-53
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-45
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-37
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-37
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-37
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-35
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-35
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-35
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-34
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-34
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-34
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-34
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-34
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-34
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-34
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-34
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-34
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-34
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-34
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-34
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-34
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-34
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-34
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-34
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-34
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-34
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-34
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-33
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-33
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-33
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-33
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-33
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-33
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-33
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-33
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-33
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-33
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-33
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-33
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-33
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-33
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-33
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-33
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-33
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-33
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-33
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-32
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-32
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-32
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-32
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-32
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-32
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-32
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-32
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-32
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-32
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-32
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-32
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-32
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-32
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-32
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-32
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-32
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-32
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-32
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-32
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-32
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-32
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-32
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-32
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-32
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-32
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-32
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-32
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-32
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-32
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-31
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-31
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-31
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-31
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-31
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-31
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-31
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-31
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-31
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-31
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-31
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-31
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-31
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-30
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-30
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-30
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-30
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-30
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-30
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-30
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-30
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-30
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-30
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-30
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-30
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-30
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-30
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-30
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-30
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-30
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-30
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-30
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-30
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-30
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-30
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-30
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-30
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-30
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-30
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-30
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-30
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-30
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-30
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-30
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-30
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-29
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-29
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-29
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-29
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-29
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-29
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-29
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-29
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-29
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-29
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-29
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-29
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-29
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-29
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-29
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-29
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-29
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-29
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-29
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-29
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-29
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-29
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-29
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-29
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-29
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-29
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-29
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-28
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-28
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-28
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-28
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-28
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-28
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-27
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-25
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-25
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-25
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-24
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-24
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-24
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-24
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-24
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-24
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-24
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-24
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-24
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-24
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-23
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-23
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-23
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-23
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-23
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-23
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-23
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-23
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-23
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-23
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-23
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-23
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-23
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-23
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-23
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-23
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-23
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-22
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-22
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-22
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-22
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-22
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-22
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-22
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-22
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-22
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-22
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-22
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-22
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-22
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-22
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-22
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-22
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-22
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-22
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-22
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-22
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-22
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-22
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-22
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-22
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-22
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-22
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-22
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-22
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-22
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-22
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-22
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-22
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-22
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-22
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-22
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-22
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-21
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-21
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-21
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-21
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-21
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-21
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-21
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-21
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-21
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-21
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-21
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-21
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-21
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-21
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-21
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-21
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-21
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-21
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-21
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-21
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-21
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-21
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-21
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-21
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-21
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-21
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-21
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-21
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-21
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-21
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-21
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-21
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-21
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-21
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-21
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-21
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-21
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-21
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-21
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-21
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-21
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-20
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-20
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-20
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-20
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-20
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-20
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-20
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-20
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-20
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-20
3soa_A	444	Full-Length Human Camkii Length = 444		1e-19
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-19
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-19
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-19
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-19
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-19
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-18
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-18
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-18
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-18
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-18
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-18
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-18
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-18
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-18
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-18
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-18
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-18
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-18
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-18
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-18
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-18
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-18
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-18
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-18
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-18
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-18
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-17
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-17
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-17
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-17
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-17
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-17
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-17
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-16
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-16
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		8e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-15
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-15
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-15
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-13
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-12
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-09
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-09
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-09
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-09
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-09
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-09
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-09
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-09
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-09
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-09
3gni_B	389	Structure Of Strad And Mo25 Length = 389		5e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		5e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-09
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		9e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-06
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-06
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-06
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-06
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-06
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-06
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-06
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-06
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-06
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-06
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-06
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-05

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  215 bits (547), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 121/355 (34%), Positives = 196/355 (55%), Gaps = 41/355 (11%)
Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           KD + ++R   + A D+++ + I +G FG++ LV  K +   + MK + + +M       
Sbjct: 60  KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 119
Query: 58  ----ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  +  P++V LFY+FQD  ++Y +MEY+ GGD V L+ N     + E  AR
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAR 176
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY  E+  A+  +H +G++HRD+KPDNMLL  +GHLKL DFG+  +++K G ++    VG
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           TP+Y++PEVL+    + G DGY G  CD WS+GV  YE+L G TPF  ++L  TYS I+ 
Sbjct: 237 TPDYISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM- 291
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLD 281
            + +++++FP    +S    N + + +   + RL    ++++  H  F           D
Sbjct: 292 -NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 350
Query: 282 SDPPCIPPPSQE---NKF----HKKDKRKASPSLKAFQKEGRYLDSALPLIGISY 329
           +  P +P  S +   + F      K + +  P  KAF      + + LP +G +Y
Sbjct: 351 TVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAF------VGNQLPFVGFTY 399

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  215 bits (547), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 118/347 (34%), Positives = 191/347 (55%), Gaps = 29/347 (8%)
Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----- 57
           +VK++R   + A D+D+ + I +G FG++ LV  K S   + MK + + +M         
Sbjct: 63  IVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFF 122
Query: 58  --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
             ERDIM  +  P++V LF +FQD  ++Y +MEY+ GGD V L+ N     + E  A+FY
Sbjct: 123 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFY 179
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
             E+  A+  +H +G +HRD+KPDNMLL   GHLKL DFG+  ++D+ G +     VGTP
Sbjct: 180 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTP 239
Query: 176 EYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
           +Y++PEVL+    + G DGY G  CD WS+GV  +E+L G TPF  ++L  TYS I+  D
Sbjct: 240 DYISPEVLK----SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM--D 293
Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLDSD 283
            ++++ FP    +S    N + + +   + RL    ++++  HP F        +  ++ 
Sbjct: 294 HKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETA 353
Query: 284 PPCIPPPSQE-NKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISY 329
            P +P  S + +  +  D       ++ F     ++ + LP IG +Y
Sbjct: 354 APVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTY 400

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  214 bits (546), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 121/355 (34%), Positives = 196/355 (55%), Gaps = 41/355 (11%)
Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           KD + ++R   + A D+++ + I +G FG++ LV  K +   + MK + + +M       
Sbjct: 55  KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 58  ----ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  +  P++V LFY+FQD  ++Y +MEY+ GGD V L+ N     + E  AR
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAR 171
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY  E+  A+  +H +G++HRD+KPDNMLL  +GHLKL DFG+  +++K G ++    VG
Sbjct: 172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           TP+Y++PEVL+    + G DGY G  CD WS+GV  YE+L G TPF  ++L  TYS I+ 
Sbjct: 232 TPDYISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM- 286
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLD 281
            + +++++FP    +S    N + + +   + RL    ++++  H  F           D
Sbjct: 287 -NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 345
Query: 282 SDPPCIPPPSQE---NKF----HKKDKRKASPSLKAFQKEGRYLDSALPLIGISY 329
           +  P +P  S +   + F      K + +  P  KAF      + + LP +G +Y
Sbjct: 346 TVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAF------VGNQLPFVGFTY 394

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  214 bits (546), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 121/355 (34%), Positives = 196/355 (55%), Gaps = 41/355 (11%)
Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
           KD + ++R   + A D+++ + I +G FG++ LV  K +   + MK + + +M       
Sbjct: 60  KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 119
Query: 58  ----ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  +  P++V LFY+FQD  ++Y +MEY+ GGD V L+ N     + E  AR
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAR 176
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY  E+  A+  +H +G++HRD+KPDNMLL  +GHLKL DFG+  +++K G ++    VG
Sbjct: 177 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           TP+Y++PEVL+    + G DGY G  CD WS+GV  YE+L G TPF  ++L  TYS I+ 
Sbjct: 237 TPDYISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM- 291
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVF--------DCLD 281
            + +++++FP    +S    N + + +   + RL    ++++  H  F           D
Sbjct: 292 -NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRD 350
Query: 282 SDPPCIPPPSQE---NKF----HKKDKRKASPSLKAFQKEGRYLDSALPLIGISY 329
           +  P +P  S +   + F      K + +  P  KAF      + + LP +G +Y
Sbjct: 351 TVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAF------VGNQLPFVGFTY 399

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  209 bits (533), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 125/350 (35%), Positives = 191/350 (54%), Gaps = 28/350 (8%)
Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---- 58
           +VKE++   +   DF+I + I +G FG++ +V+ K +   + MK + + +M    E    
Sbjct: 81  LVKEMQ---LHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACF 137
Query: 59  ---RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
              RD++V   C +I  L Y+FQD NH+Y +M+Y  GGD +TLL ++    L E  ARFY
Sbjct: 138 REERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL-SKFEDKLPEDMARFY 196
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           I E+  A+  +H L YVHRDIKPDN+LL   GH++L DFGS  +++ +G ++S V VGTP
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTP 256
Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
           +Y++PE+L+ ME   G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  + 
Sbjct: 257 DYISPEILQAMEDGMGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NH 312
Query: 236 EDTVSFPSSIR-LSTAMVNFVQSLVQKLDARLNMDQV---LGHPVFDCLDS------DPP 285
           E+   FPS +  +S    + +Q L+   + RL  + +     H  F+ L+       + P
Sbjct: 313 EERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAP 372
Query: 286 CIP---PPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGE 332
            IP    PS  + F   D    +  +        +    LP IG ++T E
Sbjct: 373 YIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHTGFSGLHLPFIGFTFTTE 422

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  209 bits (533), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 123/352 (34%), Positives = 190/352 (53%), Gaps = 25/352 (7%)
Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-- 58
           K   + +++  +   DF+I + I +G FG++ +V+ K +   + MK + + +M    E  
Sbjct: 60  KPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETA 119
Query: 59  -----RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
                RD++V   C +I  L Y+FQD NH+Y +M+Y  GGD +TLL ++    L E  AR
Sbjct: 120 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL-SKFEDKLPEDMAR 178
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FYI E+  A+  +H L YVHRDIKPDN+LL   GH++L DFGS  +++ +G ++S V VG
Sbjct: 179 FYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVG 238
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TP+Y++PE+L+ ME   G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  
Sbjct: 239 TPDYISPEILQAMEDGMGK--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 294
Query: 234 DTEDTVSFPSSIR-LSTAMVNFVQSLVQKLDARLNMDQV---LGHPVFDCLDS------D 283
           + E+   FPS +  +S    + +Q L+   + RL  + +     H  F+ L+       +
Sbjct: 295 NHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLE 354
Query: 284 PPCIP---PPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGE 332
            P IP    PS  + F   D    +  +        +    LP IG ++T E
Sbjct: 355 APYIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHTGFSGLHLPFIGFTFTTE 406

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  207 bits (527), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 125/379 (32%), Positives = 202/379 (53%), Gaps = 37/379 (9%)
Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-- 58
           K    +++Q  +   DF+I + I +G FG++ +V+ K +   F MK + + +M    E  
Sbjct: 60  KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119
Query: 59  -----RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
                RD++V     +I  L Y+FQD N++Y +M+Y  GGD +TLL ++    L E  AR
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMAR 178
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY+ E+  A+  +H L YVHRDIKPDN+L+   GH++L DFGS  ++ ++G ++S V VG
Sbjct: 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TP+Y++PE+L+ MEG  G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  
Sbjct: 239 TPDYISPEILQAMEGGKGR--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 294
Query: 234 DTEDTVSFPSSIR-LSTAMVNFVQSLVQKLDARLNMDQV---LGHPVFDCLDSD------ 283
           + ++   FP+ +  +S    + ++ L+   + RL  + +     HP F  +D D      
Sbjct: 295 NHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCE 354
Query: 284 PPCIP---PPSQENKFH------KKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPM 334
            P IP    P+  + F       K  +    P+  AF          LP +G +YT   +
Sbjct: 355 APYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGH------HLPFVGFTYTSSCV 408
Query: 335 GANTNTSSDSTLPPSSEDM 353
            ++ +    +  P S+E++
Sbjct: 409 LSDRSCLRVTAGPTSAENL 427

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  180 bits (457), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 118/353 (33%), Positives = 183/353 (51%), Gaps = 28/353 (7%)
Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---- 58
           +V  L++  +   DF+I + I +G F ++ +V+ KQ+   + MK + +  M    E    
Sbjct: 49  IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 59  ---RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
              RD++V     +I  L ++FQD N++Y +MEY  GGD +TLL        +E  ARFY
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MARFY 167
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           + E+  A+  +H LGYVHRDIKPDN+LL   GH++L DFGS  ++  +G ++S+V VGTP
Sbjct: 168 LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
           +Y++PE+L+ + G  G+  Y   CD W++GV +YE+  G TPF  ++   TY  I+    
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV--HY 285
Query: 236 EDTVSFP-SSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVFDCLDSDP--PCIPP 289
           ++ +S P     +     +F+Q L+   + RL          HP F  LD D     +PP
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPP 345
Query: 290 --PSQENKFHKKDKRKASPSLKAFQ----------KEGRYLDSALPLIGISYT 330
             P  E      +       L A            +EG  L   LP +G SY+
Sbjct: 346 FTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYS 398

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  154 bits (389), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/238 (37%), Positives = 140/238 (58%), Gaps = 22/238 (9%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEE------KQSHNTFVMKKV---LREKMP 54
           VKE  +K    S F++ + + QG+FG ++LV++      +Q +   V+KK    +R+++ 
Sbjct: 14  VKEGHEK-ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR 72
Query: 55  NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
             +ERDI+V+   P+IV L Y+FQ    +Y I++++ GGD  T L  +     +E   +F
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKF 130
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVG 173
           Y+ ELA A+ +LH LG ++RD+KP+N+LL   GH+KLTDFG S   +D   +  S    G
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CG 188
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
           T EY+APEV+          G+T S D WS GV+ +E+LTG+ PF  +    T + IL
Sbjct: 189 TVEYMAPEVVN-------RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/238 (37%), Positives = 140/238 (58%), Gaps = 22/238 (9%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEE------KQSHNTFVMKKV---LREKMP 54
           VKE  +K    S F++ + + QG+FG ++LV++      +Q +   V+KK    +R+++ 
Sbjct: 15  VKEGHEK-ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR 73
Query: 55  NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
             +ERDI+V+   P+IV L Y+FQ    +Y I++++ GGD  T L  +     +E   +F
Sbjct: 74  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKF 131
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVG 173
           Y+ ELA A+ +LH LG ++RD+KP+N+LL   GH+KLTDFG S   +D   +  S    G
Sbjct: 132 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CG 189
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
           T EY+APEV+          G+T S D WS GV+ +E+LTG+ PF  +    T + IL
Sbjct: 190 TVEYMAPEVVN-------RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 240

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/238 (37%), Positives = 140/238 (58%), Gaps = 22/238 (9%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEE------KQSHNTFVMKKV---LREKMP 54
           VKE  +K    S F++ + + QG+FG ++LV++      +Q +   V+KK    +R+++ 
Sbjct: 14  VKEGHEK-ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR 72
Query: 55  NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
             +ERDI+V+   P+IV L Y+FQ    +Y I++++ GGD  T L  +     +E   +F
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKF 130
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVG 173
           Y+ ELA A+ +LH LG ++RD+KP+N+LL   GH+KLTDFG S   +D   +  S    G
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CG 188
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
           T EY+APEV+          G+T S D WS GV+ +E+LTG+ PF  +    T + IL
Sbjct: 189 TVEYMAPEVVN-------RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  146 bits (368), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 79/214 (36%), Positives = 125/214 (58%), Gaps = 21/214 (9%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEE---KQSHNTFVMKKV------LREKMPNTIERDIMVKS 65
           S F++ + + QG+FG ++LV +     S + + MK +      +R+++   +ERDI+   
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
             P++V L Y+FQ    +Y I++++ GGD  T L  +     +E   +FY+ ELA  + +
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALGLDH 145
Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           LH LG ++RD+KP+N+LL   GH+KLTDFG S   +D   +  S    GT EY+APEV+ 
Sbjct: 146 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF--CGTVEYMAPEVVN 203
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                    G++ S D WS GV+ +E+LTGS PF
Sbjct: 204 -------RQGHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  145 bits (367), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 128/229 (55%), Gaps = 23/229 (10%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNT---FVMKKVLREKM---------PNTIERDIMVK 64
           F++ R + +G +G ++ V +    NT   F MK VL++ M             ER+I+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
            K P+IV+L Y+FQ    +Y I+EY++GG+    LE +  G   E  A FY+ E++ A+ 
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALG 135
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           +LH  G ++RD+KP+N++L+  GH+KLTDFG   +   +G +      GT EY+APE+L 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-CGTIEYMAPEILM 194
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
                    G+  + D WS+G + Y++LTG+ PF  E    T   IL C
Sbjct: 195 -------RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  145 bits (366), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 81/229 (35%), Positives = 128/229 (55%), Gaps = 23/229 (10%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNT---FVMKKVLREKM---------PNTIERDIMVK 64
           F++ R + +G +G ++ V +    NT   F MK VL++ M             ER+I+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
            K P+IV+L Y+FQ    +Y I+EY++GG+    LE +  G   E  A FY+ E++ A+ 
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALG 135
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           +LH  G ++RD+KP+N++L+  GH+KLTDFG   +   +G +      GT EY+APE+L 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXF-CGTIEYMAPEILM 194
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
                    G+  + D WS+G + Y++LTG+ PF  E    T   IL C
Sbjct: 195 -------RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  144 bits (364), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--AGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 153
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 209
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 210 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 258
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 259 PS--HFSSDLKDLLRNLLQ 275

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--XGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  144 bits (363), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/242 (35%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N F MK     KV++ K + +T+ E+ I+     P++V L YSF+
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  144 bits (362), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/242 (35%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N F MK     KV++ K + +T+ E+ I+     P++V L YSF+
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  144 bits (362), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 86/242 (35%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N F MK     KV++ K + +T+ E+ I+     P++V L YSF+
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  +E  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFAEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+++   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 III-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  143 bits (360), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ Y++  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 145/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 22  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 81
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 139
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 140 TFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 195
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 196 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 244
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 245 PS--HFSSDLKDLLRNLLQ 261

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  142 bits (359), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 144/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G   E  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (358), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 144/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G   E  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  142 bits (358), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 144/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 30  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 89
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G   E  ARFY  ++  
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVL 147
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 148 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 203
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 204 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 252
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 253 PS--HFSSDLKDLLRNLLQ 269

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  142 bits (357), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 144/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G   E  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  142 bits (357), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 144/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+AP 
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPA 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  142 bits (357), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 144/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G   E  ARFY  ++  
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVL 173
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPEY+APE
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPE 229
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 230 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 278
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 279 PS--HFSSDLKDLLRNLLQ 295

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/259 (33%), Positives = 144/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 173
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V    +  +    GTPEY+APE
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLAPE 229
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 230 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 278
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 279 PS--HFSSDLKDLLRNLLQ 295

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  141 bits (355), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 157/309 (50%), Gaps = 34/309 (11%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERDIMVKS-K 66
           SDF   + I +G+FG + L   K     + +K      +L++K    I  ER++++K+ K
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            P++V L +SFQ  + +YF+++Y+ GG+    L+ +   +L E +ARFY  E+A A+ YL
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFL-EPRARFYAAEIASALGYL 155
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEW 185
           H L  V+RD+KP+N+LL + GH+ LTDFG   + ++ N    +    GTPEY+APEVL  
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF--CGTPEYLAPEVLH- 212
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                    Y  + D W +G V YE+L G  PF        Y +IL    +   +  +S 
Sbjct: 213 ------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA 266
Query: 246 RLSTAMVNFVQSLVQK-----LDARLNMDQVLGHPVFDCLDSDPPC---IPPPSQENKFH 297
           R      + ++ L+QK     L A+ +  ++  H  F  ++ D      I PP   N   
Sbjct: 267 R------HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSG 320
Query: 298 KKDKRKASP 306
             D R   P
Sbjct: 321 PNDLRHFDP 329

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/242 (34%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/242 (34%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 144/259 (55%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVL 152
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR   +   GTPE +APE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEALAPE 208
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 209 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 257
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 258 PS--HFSSDLKDLLRNLLQ 274

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  140 bits (354), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/242 (34%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  140 bits (353), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/242 (34%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 73  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 133 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 190
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 191 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 239
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 293
Query: 259 VQ 260
           +Q
Sbjct: 294 LQ 295

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  140 bits (353), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/242 (34%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 104
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 105 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 162
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 163 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 211
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 265
Query: 259 VQ 260
           +Q
Sbjct: 266 LQ 267

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  139 bits (351), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 139/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++K+TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 139/245 (56%), Gaps = 26/245 (10%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFY 75
           I  G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           SF+D +++Y +MEY+ GGD  + L     G  SE  ARFY  ++    +YLH L  ++RD
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP+N+L+   G++K+ DFG A +V   GR   +   GTPEY+APE++        S GY
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGY 215
Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV 255
             + D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLL 269
Query: 256 QSLVQ 260
           ++L+Q
Sbjct: 270 RNLLQ 274

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 139/245 (56%), Gaps = 26/245 (10%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFY 75
           I  G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           SF+D +++Y +MEY+ GGD  + L     G  SE  ARFY  ++    +YLH L  ++RD
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP+N+L+   G++K+ DFG A +V   GR   +   GTPEY+APE++        S GY
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGY 215
Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV 255
             + D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLL 269
Query: 256 QSLVQ 260
           ++L+Q
Sbjct: 270 RNLLQ 274

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  139 bits (351), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 98/315 (31%), Positives = 155/315 (49%), Gaps = 48/315 (15%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV------- 63
           ++   DFD+ R I +G++  + LV  K++   + MK V +E + +  + D +        
Sbjct: 16  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 75
Query: 64  -KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
             S  P++V L   FQ  + ++F++EYV GGD +  ++ Q    L E  ARFY  E++ A
Sbjct: 76  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLA 133
Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           + YLH  G ++RD+K DN+LL + GH+KLTD+G   +  + G   S    GTP Y+APE+
Sbjct: 134 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF-CGTPNYIAPEI 192
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSSILAC 233
           L       G D Y  S D W++GV+ +E++ G +PF+           T D  +  IL  
Sbjct: 193 L------RGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-- 243
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-------LDARLNMDQVLGHPVFDCLDSD--- 283
             E  +  P S+ +  A V  ++S + K          +     + GHP F  +D D   
Sbjct: 244 --EKQIRIPRSMSVKAASV--LKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMME 299
Query: 284 -----PPCIPPPSQE 293
                PP  P  S E
Sbjct: 300 QKQVVPPFKPNISGE 314

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  139 bits (350), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 155/315 (49%), Gaps = 48/315 (15%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV------- 63
           ++   DFD+ R I +G++  + LV  K++   + M+ V +E + +  + D +        
Sbjct: 48  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE 107
Query: 64  -KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
             S  P++V L   FQ  + ++F++EYV GGD +  ++ Q    L E  ARFY  E++ A
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLA 165
Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           + YLH  G ++RD+K DN+LL + GH+KLTD+G   +  + G   S    GTP Y+APE+
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIAPEI 224
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSSILAC 233
           L       G D Y  S D W++GV+ +E++ G +PF+           T D  +  IL  
Sbjct: 225 L------RGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-- 275
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-------LDARLNMDQVLGHPVFDCLDSD--- 283
             E  +  P S+ +  A V  ++S + K          +     + GHP F  +D D   
Sbjct: 276 --EKQIRIPRSLSVKAASV--LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 331
Query: 284 -----PPCIPPPSQE 293
                PP  P  S E
Sbjct: 332 QKQVVPPFKPNISGE 346

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR  ++   GTPEY+APE++        S GY  +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRV--KGRTWTL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  139 bits (349), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 98/315 (31%), Positives = 155/315 (49%), Gaps = 48/315 (15%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV------- 63
           ++   DFD+ R I +G++  + LV  K++   + MK V +E + +  + D +        
Sbjct: 1   SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 60
Query: 64  -KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
             S  P++V L   FQ  + ++F++EYV GGD +  ++ Q    L E  ARFY  E++ A
Sbjct: 61  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLA 118
Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           + YLH  G ++RD+K DN+LL + GH+KLTD+G   +  + G   S    GTP Y+APE+
Sbjct: 119 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF-CGTPNYIAPEI 177
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSSILAC 233
           L       G D Y  S D W++GV+ +E++ G +PF+           T D  +  IL  
Sbjct: 178 LR------GED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-- 228
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-------LDARLNMDQVLGHPVFDCLDSD--- 283
             E  +  P S+ +  A V  ++S + K          +     + GHP F  +D D   
Sbjct: 229 --EKQIRIPRSLSVKAASV--LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 284
Query: 284 -----PPCIPPPSQE 293
                PP  P  S E
Sbjct: 285 QKQVVPPFKPNISGE 299

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 139/245 (56%), Gaps = 26/245 (10%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFY 75
           I  G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP+N+L+   G++K+ DFG A +V   GR   +   GTPEY+APE++        S GY
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGY 215
Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFV 255
             + D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLL 269
Query: 256 QSLVQ 260
           ++L+Q
Sbjct: 270 RNLLQ 274

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 139/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  138 bits (348), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 139/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+ K++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 104
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G   E  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 105 DNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 162
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 163 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 211
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 265
Query: 259 VQ 260
           +Q
Sbjct: 266 LQ 267

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 139/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 139/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 139/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 139/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 131/241 (54%), Gaps = 21/241 (8%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ +DFD  + + +G FG + LV EK +   + MK       + ++++ +T+ E  ++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALE 119
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    V+RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYLAPEVLE 178
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP +
Sbjct: 179 -------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRT 227
Query: 245 I 245
           +
Sbjct: 228 L 228

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 140/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 38  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 97
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 98  DNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 155
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR  ++   GTPEY+APE++        S GY  +
Sbjct: 156 ENLLIDQQGYIQVTDFGFAKRV--KGRTWTL--CGTPEYLAPEIIL-------SKGYNKA 204
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 258
Query: 259 VQ 260
           +Q
Sbjct: 259 LQ 260

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 132/244 (54%), Gaps = 21/244 (8%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDI 61
           +  V+ +DFD  + + +G FG + LV EK +   + MK       + ++++ +T+ E  +
Sbjct: 2   RAKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 61
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +  ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  
Sbjct: 62  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVS 119
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A++YLH    V+RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APE
Sbjct: 120 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPE 178
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           VLE        + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + F
Sbjct: 179 VLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRF 227
Query: 242 PSSI 245
           P ++
Sbjct: 228 PRTL 231

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 131/241 (54%), Gaps = 21/241 (8%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ +DFD  + + +G FG + LV EK +   + MK       + ++++ +T+ E  ++  
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALE 124
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    V+RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE
Sbjct: 125 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYLAPEVLE 183
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP +
Sbjct: 184 -------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRT 232
Query: 245 I 245
           +
Sbjct: 233 L 233

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 98/314 (31%), Positives = 154/314 (49%), Gaps = 48/314 (15%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV-------- 63
           +   DFD+ R I +G++  + LV  K++   + MK V +E + +  + D +         
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
            S  P++V L   FQ  + ++F++EYV GGD +  ++ Q    L E  ARFY  E++ A+
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLAL 123
Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
            YLH  G ++RD+K DN+LL + GH+KLTD+G   +  + G   S    GTP Y+APE+L
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXF-CGTPNYIAPEIL 182
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSSILACD 234
                  G D Y  S D W++GV+ +E++ G +PF+           T D  +  IL   
Sbjct: 183 R------GED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--- 232
Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQK-------LDARLNMDQVLGHPVFDCLDSD---- 283
            E  +  P S+ +  A V  ++S + K          +     + GHP F  +D D    
Sbjct: 233 -EKQIRIPRSLSVKAASV--LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ 289
Query: 284 ----PPCIPPPSQE 293
               PP  P  S E
Sbjct: 290 KQVVPPFKPNISGE 303

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 131/241 (54%), Gaps = 21/241 (8%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ +DFD  + + +G FG + LV EK +   + MK       + ++++ +T+ E  ++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALE 119
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    V+RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYLAPEVLE 178
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP +
Sbjct: 179 -------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRT 227
Query: 245 I 245
           +
Sbjct: 228 L 228

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/259 (32%), Positives = 142/259 (54%), Gaps = 26/259 (10%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDI 61
           Q       F+  R +  G+FG + LV+ K++ N + MK     KV++ K + +T+ E+ I
Sbjct: 36  QNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
                 P++V L +SF+D +++Y ++EY  GG+  + L     G  SE  ARFY  ++  
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVL 153
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
             +YLH L  ++RD+KP+N+L+   G++K+ DFG A +V   GR   +   GTPEY+APE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXL--CGTPEYLAPE 209
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V F
Sbjct: 210 IIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRF 258
Query: 242 PSSIRLSTAMVNFVQSLVQ 260
           PS    S+ + + +++L+Q
Sbjct: 259 PS--HFSSDLKDLLRNLLQ 275

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 131/241 (54%), Gaps = 21/241 (8%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ +DFD  + + +G FG + LV EK +   + MK       + ++++ +T+ E  ++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    V+RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEVLE 178
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP +
Sbjct: 179 -------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRT 227
Query: 245 I 245
           +
Sbjct: 228 L 228

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 138/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++K+TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLMIDQQGYIKVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 131/241 (54%), Gaps = 21/241 (8%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ +DFD  + + +G FG + LV EK +   + MK       + ++++ +T+ E  ++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALE 119
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    V+RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEVLE 178
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP +
Sbjct: 179 -------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRT 227
Query: 245 I 245
           +
Sbjct: 228 L 228

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 138/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++K+TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLMIDQQGYIKVTDFGLAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  137 bits (344), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 131/241 (54%), Gaps = 21/241 (8%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ +DFD  + + +G FG + LV EK +   + MK       + ++++ +T+ E  ++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    V+RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF-CGTPEYLAPEVLE 178
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP +
Sbjct: 179 -------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRT 227
Query: 245 I 245
           +
Sbjct: 228 L 228

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 138/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G   E  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 138/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G   E  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 138/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEYV GG+  + L     G   E  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+L+   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  136 bits (342), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 142/260 (54%), Gaps = 24/260 (9%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD---------- 60
           +V+   F+I R I +G+FG + +V++  +   + MK + ++K    +ER+          
Sbjct: 11  DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK---CVERNEVRNVFKELQ 67
Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           IM   + P++VNL+YSFQD   ++ +++ + GGD    L+   H    E   + +I EL 
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELV 125
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            A+ YL     +HRD+KPDN+LL   GH+ +TDF  A  + +  +I ++   GT  Y+AP
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM--AGTKPYMAP 183
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E+    +G     GY+ + D WS+GV +YELL G  P++  +   +   +   +T   V+
Sbjct: 184 EMFSSRKGA----GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVT 238
Query: 241 FPSSIRLSTAMVNFVQSLVQ 260
           +PS+   S  MV+ ++ L++
Sbjct: 239 YPSA--WSQEMVSLLKKLLE 256

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 138/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLMIDQQGYIQVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  135 bits (341), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 132/242 (54%), Gaps = 22/242 (9%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ ++F+  + + +G FG + LV+EK +   + MK       V ++++ +T+ E  ++  
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           S+ P++  L YSFQ  + + F+MEY  GG+    L  +     SE +ARFY  E+  A+ 
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALD 265
Query: 125 YLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           YLH     V+RD+K +N++L   GH+K+TDFG   +  K+G        GTPEY+APEVL
Sbjct: 266 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPEVL 324
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           E        + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP 
Sbjct: 325 E-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPR 373
Query: 244 SI 245
           ++
Sbjct: 374 TL 375

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 138/242 (57%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++++TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLMIDQQGYIQVTDFGLAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 137/242 (56%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++V L +SF+
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G   E  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++K+TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 170 ENLMIDQQGYIKVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 218
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 272
Query: 259 VQ 260
           +Q
Sbjct: 273 LQ 274

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  135 bits (341), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 132/242 (54%), Gaps = 22/242 (9%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ ++F+  + + +G FG + LV+EK +   + MK       V ++++ +T+ E  ++  
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           S+ P++  L YSFQ  + + F+MEY  GG+    L  +     SE +ARFY  E+  A+ 
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALD 262
Query: 125 YLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           YLH     V+RD+K +N++L   GH+K+TDFG   +  K+G        GTPEY+APEVL
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPEVL 321
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           E        + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP 
Sbjct: 322 E-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPR 370
Query: 244 SI 245
           ++
Sbjct: 371 TL 372

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  135 bits (340), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 137/242 (56%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++  L +SF+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++K+TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  135 bits (340), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 137/242 (56%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++  L +SF+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G  SE  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++K+TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  135 bits (340), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 129/243 (53%), Gaps = 22/243 (9%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--------TIERDIMV 63
           +   +F+  R + +G+FG + L   K++ + + +K + ++ +          T +R + +
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
               P++  LF  FQ  + ++F+ME+V GGD   +   Q      E++ARFY  E+  A+
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
            +LH  G ++RD+K DN+LL   GH KL DFG   +   NG + +    GTP+Y+APE+L
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTATFCGTPDYIAPEIL 196
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           + M        Y  + D W++GV+ YE+L G  PF  E  D  + +IL     D V +P+
Sbjct: 197 QEML-------YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDEVVYPT 245
Query: 244 SIR 246
            + 
Sbjct: 246 WLH 248

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  135 bits (340), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 134/230 (58%), Gaps = 18/230 (7%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK--MPNTIE------RD 60
           Q  +   DF++ + + +G+FG ++L E K+++  F +K + ++   M + +E      R 
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           + +  + P++ ++F +FQ   +++F+MEY+ GGD +  +++  H +   S+A FY  E+ 
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKF-DLSRATFYAAEII 129
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
             +Q+LH  G V+RD+K DN+LL   GH+K+ DFG   + +  G  K+    GTP+Y+AP
Sbjct: 130 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNEFCGTPDYIAP 188
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
           E+L   + NH       S D WS GV+ YE+L G +PF+ +  +  + SI
Sbjct: 189 EILLGQKYNH-------SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 231

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 133/230 (57%), Gaps = 18/230 (7%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK--MPNTIE------RD 60
           Q  +   DF + + + +G+FG ++L E K+++  F +K + ++   M + +E      R 
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           + +  + P++ ++F +FQ   +++F+MEY+ GGD +  +++  H +   S+A FY  E+ 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKF-DLSRATFYAAEII 128
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
             +Q+LH  G V+RD+K DN+LL   GH+K+ DFG   + +  G  K+    GTP+Y+AP
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNXFCGTPDYIAP 187
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
           E+L   + NH       S D WS GV+ YE+L G +PF+ +  +  + SI
Sbjct: 188 EILLGQKYNH-------SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  134 bits (336), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 136/242 (56%), Gaps = 26/242 (10%)
Query: 26  GNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVKSKCPYIVNLFYSFQ 78
           G+FG + LV+  ++ N + MK     KV++ K + +T+ E+ I+     P++  L +SF+
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           D +++Y +MEY  GG+  + L     G   E  ARFY  ++    +YLH L  ++RD+KP
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 170
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+++   G++K+TDFG A +V   GR   +   GTPEY+APE++        S GY  +
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRV--KGRTWXL--CGTPEYLAPEIIL-------SKGYNKA 219
Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSL 258
            D W++GV+ YE+  G  PF  +     Y  I++      V FPS    S+ + + +++L
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS--HFSSDLKDLLRNL 273
Query: 259 VQ 260
           +Q
Sbjct: 274 LQ 275

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  133 bits (335), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 138/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 16  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 75
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 133
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 134 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYL 190
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 191 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 239
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 240 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 284

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 132/242 (54%), Gaps = 22/242 (9%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ ++F+  + + +G FG + LV+EK +   + MK       V ++++ +T+ E  ++  
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           S+ P++  L YSFQ  + + F+MEY  GG+    L  +     SE +ARFY  E+  A+ 
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALD 123
Query: 125 YLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           YLH     V+RD+K +N++L   GH+K+TDFG   +  K+G        GTPEY+APEVL
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF-CGTPEYLAPEVL 182
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           E        + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP 
Sbjct: 183 E-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPR 231
Query: 244 SI 245
           ++
Sbjct: 232 TL 233

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 134/255 (52%), Gaps = 24/255 (9%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-------PNTIERDIM-VKSK 66
           +DF+    + +G+FG + L E K +   + +K + ++ +          +E+ ++ +  K
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            P++  L   FQ M+ +YF+MEYV GGD +  ++    G   E  A FY  E+A  + +L
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFL 458
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
              G ++RD+K DN++L + GH+K+ DFG   +   +G + +    GTP+Y+APE++ + 
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKXFCGTPDYIAPEIIAYQ 517
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
                   Y  S D W+ GV+ YE+L G  PF  E  D  + SI+    E  V++P S  
Sbjct: 518 P-------YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHNVAYPKS-- 564
Query: 247 LSTAMVNFVQSLVQK 261
           +S   V   + L+ K
Sbjct: 565 MSKEAVAICKGLMTK 579

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 139/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G+     E Q      E +   YI E
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYK--ELQKLSKFDEQRTATYITE 121
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYL 178
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 179 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 227
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 228 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 141/262 (53%), Gaps = 24/262 (9%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-------PNTIERDIM-V 63
           V  +DF+    + +G+FG + L + K +   + +K + ++ +          +E+ ++ +
Sbjct: 16  VKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
             K P++  L   FQ ++ +YF+MEYV GGD +  ++    G   E +A FY  E++  +
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISIGL 133
Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
            +LH  G ++RD+K DN++L + GH+K+ DFG   +   +G + +    GTP+Y+APE++
Sbjct: 134 FFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG-VTTREFCGTPDYIAPEII 192
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
            +         Y  S D W+ GV+ YE+L G  PF+ E  D  + SI+    E  VS+P 
Sbjct: 193 AYQP-------YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM----EHNVSYPK 241
Query: 244 SIRLSTAMVNFVQSLVQKLDAR 265
           S  LS   V+  + L+ K  A+
Sbjct: 242 S--LSKEAVSICKGLMTKHPAK 261

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 132/242 (54%), Gaps = 22/242 (9%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ ++F+  + + +G FG + LV+EK +   + MK       V ++++ +T+ E  ++  
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           S+ P++  L YSFQ  + + F+MEY  GG+    L  +     SE +ARFY  E+  A+ 
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALD 124
Query: 125 YLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           YLH     V+RD+K +N++L   GH+K+TDFG   +  K+G        GTPEY+APEVL
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF-CGTPEYLAPEVL 183
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           E        + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP 
Sbjct: 184 E-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPR 232
Query: 244 SI 245
           ++
Sbjct: 233 TL 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 132/242 (54%), Gaps = 22/242 (9%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERDIMVK 64
           V+ ++F+  + + +G FG + LV+EK +   + MK       V ++++ +T+ E  ++  
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           S+ P++  L YSFQ  + + F+MEY  GG+    L  +     SE +ARFY  E+  A+ 
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALD 122
Query: 125 YLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           YLH     V+RD+K +N++L   GH+K+TDFG   +  K+G        GTPEY+APEVL
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF-CGTPEYLAPEVL 181
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           E        + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP 
Sbjct: 182 E-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPR 230
Query: 244 SI 245
           ++
Sbjct: 231 TL 232

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 78/228 (34%), Positives = 125/228 (54%), Gaps = 24/228 (10%)
Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--------ERDIMVK 64
           S  DF I R +  G+FG ++L+  + +   + MK VL++++   +        ER ++  
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMK-VLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
              P+I+ ++ +FQD   ++ IM+Y+ GG+  +LL            A+FY  E+  A++
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALE 120
Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    ++RD+KP+N+LL   GH+K+TDFG A  V       +    GTP+Y+APEV+ 
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIAPEVVS 176
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-TYSSIL 231
                  +  Y  S D WS G++ YE+L G TPF Y++  M TY  IL
Sbjct: 177 -------TKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKIL 216

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 138/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 142
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYL 199
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 200 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 248
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 249 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  132 bits (333), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 139/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G+     E Q      E +   YI E
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYK--ELQKLSKFDEQRTATYITE 121
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---XGTLDYL 178
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 179 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 227
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 228 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  132 bits (333), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMV 63
           ++  +  DFDI R + +G FG++YL  E+QS     +K + + ++      + + R++ +
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 64  KS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSRFDEQRTATYITELAN 123
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE
Sbjct: 124 ALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPE 180
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +F
Sbjct: 181 MIE-------GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI----SRVEFTF 229
Query: 242 PSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDP 284
           P  +  +    + +  L++     RL + +VL HP      S P
Sbjct: 230 PDFV--TEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  132 bits (331), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 138/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 142
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL---CGTLDYL 199
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 200 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 248
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 249 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 138/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 119
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYL 176
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 177 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 225
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 137/287 (47%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 121
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYL 178
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE +E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 179 PPEXIE-------GRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 227
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 228 FTFPDFV--TEGARDLISRLLKHNPSQRPXLREVLEHPWITANSSKP 272

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 138/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 121
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYL 178
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 179 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 227
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 228 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/284 (30%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMV 63
           ++  +  DFDI R + +G FG++YL  E+QS     +K + + ++      + + R++ +
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 64  KS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSRFDEQRTATYITELAN 123
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE
Sbjct: 124 ALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTL---CGTLDYLPPE 180
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +F
Sbjct: 181 MIE-------GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI----SRVEFTF 229
Query: 242 PSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDP 284
           P  +  +    + +  L++     RL + +VL HP      S P
Sbjct: 230 PDFV--TEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 138/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 118
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYL 175
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 176 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 224
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 225 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 142/283 (50%), Gaps = 30/283 (10%)
Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-KVL------REKMPN 55
            + E+ ++  +  DFDI R + +G FG++YL  EKQ  N F+M  KVL      +E + +
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQ--NKFIMALKVLFKSQLEKEGVEH 60
Query: 56  TIERDIMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
            + R+I ++S  + P I+ ++  F D   +Y ++E+   G+     E Q HG   E ++ 
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYK--ELQKHGRFDEQRSA 118
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
            ++ ELA A+ Y H    +HRDIKP+N+L+   G LK+ DFG +        ++     G
Sbjct: 119 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---LRRRXMCG 175
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           T +Y+ PE++E          +    DLW  GV+ YE L G  PF+  +   T+  I+  
Sbjct: 176 TLDYLPPEMIE-------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 228
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHP 275
           D    + FP    LS    + +  L++     RL +  V+ HP
Sbjct: 229 D----LKFPPF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHP 265

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  131 bits (329), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 134/255 (52%), Gaps = 24/255 (9%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-------PNTIERDIM-VKSK 66
           +DF+    + +G+FG + L E K +   + +K + ++ +          +E+ ++ +  K
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            P++  L   FQ M+ +YF+MEYV GGD +  +  Q  G   E  A FY  E+A  + +L
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
              G ++RD+K DN++L + GH+K+ DFG   +   +G + +    GTP+Y+APE++ + 
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKXFCGTPDYIAPEIIAYQ 196
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
                   Y  S D W+ GV+ YE+L G  PF  E  D  + SI+    E  V++P S  
Sbjct: 197 P-------YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHNVAYPKS-- 243
Query: 247 LSTAMVNFVQSLVQK 261
           +S   V   + L+ K
Sbjct: 244 MSKEAVAICKGLMTK 258

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 142/283 (50%), Gaps = 30/283 (10%)
Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-KVL------REKMPN 55
            + E+ ++  +  DFDI R + +G FG++YL  EKQ  N F+M  KVL      +E + +
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQ--NKFIMALKVLFKSQLEKEGVEH 59
Query: 56  TIERDIMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
            + R+I ++S  + P I+ ++  F D   +Y ++E+   G+     E Q HG   E ++ 
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYK--ELQKHGRFDEQRSA 117
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
            ++ ELA A+ Y H    +HRDIKP+N+L+   G LK+ DFG +        ++     G
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---LRRRXMCG 174
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           T +Y+ PE++E          +    DLW  GV+ YE L G  PF+  +   T+  I+  
Sbjct: 175 TLDYLPPEMIE-------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHP 275
           D    + FP    LS    + +  L++     RL +  V+ HP
Sbjct: 228 D----LKFPPF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  130 bits (327), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 137/285 (48%), Gaps = 26/285 (9%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIM 62
           +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 63  VKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELA 119
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ P
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL---CGTLDYLPP 176
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +
Sbjct: 177 EMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFT 225
Query: 241 FPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 FPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  130 bits (327), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 137/285 (48%), Gaps = 26/285 (9%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIM 62
           +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 63  VKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELA 119
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ P
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTL---SGTLDYLPP 176
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +
Sbjct: 177 EMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFT 225
Query: 241 FPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 FPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  130 bits (327), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 137/285 (48%), Gaps = 26/285 (9%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIM 62
           +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 63  VKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELA 123
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ P
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL---CGTLDYLPP 180
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +
Sbjct: 181 EMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFT 229
Query: 241 FPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 230 FPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  130 bits (327), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 134/277 (48%), Gaps = 26/277 (9%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKS--KCP 68
           DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ ++S  + P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA A+ Y H 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRDIKP+N+LL + G LK+ DFG +     + R +     GT +Y+ PE++E    
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL---CGTLDYLPPEMIE---- 179
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                 +    DLWS+GV+ YE L G  PF   T   TY  I    +    +FP  +  +
Sbjct: 180 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTFPDFV--T 230
Query: 249 TAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
               + +  L++   + R  + +VL HP      S P
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  130 bits (327), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 137/285 (48%), Gaps = 26/285 (9%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIM 62
           +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 63  VKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELA 118
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ P
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL---CGTLDYLPP 175
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +
Sbjct: 176 EMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFT 224
Query: 241 FPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 225 FPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  130 bits (326), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 118
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ +FG +     + R       GT +Y+
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTL---CGTLDYL 175
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 176 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 224
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 225 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  129 bits (325), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKS--KCP 68
           DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ ++S  + P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA A+ Y H 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE++E    
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL---CGTLDYLPPEMIE---- 179
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                 +    DLWS+GV+ YE L G  PF   T   TY  I    +    +FP  +  +
Sbjct: 180 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTFPDFV--T 230
Query: 249 TAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
               + +  L++   + R  + +VL HP      S P
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  129 bits (325), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKS--KCP 68
           DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ ++S  + P
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA A+ Y H 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE++E    
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIE---- 179
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                 +    DLWS+GV+ YE L G  PF   T   TY  I    +    +FP  +  +
Sbjct: 180 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTFPDFV--T 230
Query: 249 TAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
               + +  L++   + R  + +VL HP      S P
Sbjct: 231 EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  129 bits (325), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKS--KCP 68
           DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ ++S  + P
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA A+ Y H 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE++E    
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIE---- 182
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                 +    DLWS+GV+ YE L G  PF   T   TY  I    +    +FP  +  +
Sbjct: 183 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTFPDFV--T 233
Query: 249 TAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
               + +  L++   + R  + +VL HP      S P
Sbjct: 234 EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  129 bits (325), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 137/285 (48%), Gaps = 26/285 (9%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIM 62
           +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 63  VKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELA 119
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ P
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTL---CGTLDYLPP 176
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +
Sbjct: 177 EMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFT 225
Query: 241 FPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 FPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  129 bits (324), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMV 63
           ++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 64  KS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELAN 119
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPE 176
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +F
Sbjct: 177 MIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTF 225
Query: 242 PSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           P  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 PDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  129 bits (324), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 117/232 (50%), Gaps = 19/232 (8%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 119
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYL 176
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I
Sbjct: 177 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  129 bits (323), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMV 63
           ++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ +
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 64  KS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA 
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELAN 118
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE
Sbjct: 119 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPE 175
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +F
Sbjct: 176 MIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTF 224
Query: 242 PSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           P  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 225 PDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 266

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  129 bits (323), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 117/232 (50%), Gaps = 19/232 (8%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 119
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYL 176
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I
Sbjct: 177 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  129 bits (323), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMV 63
           ++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 64  KS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELAN 119
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL---CGTLDYLPPE 176
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +F
Sbjct: 177 MIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTF 225
Query: 242 PSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           P  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 PDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  129 bits (323), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMV 63
           ++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 64  KS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELAN 119
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPE 176
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +F
Sbjct: 177 MIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTF 225
Query: 242 PSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           P  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 PDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  129 bits (323), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 151
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R  S   VGT +YV+PE+L  
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF--VGTAQYVSPELLT- 208
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 209 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 262
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 263 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  129 bits (323), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 143/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 150
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 207
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + ++ I+  + +    F    
Sbjct: 208 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKA 261
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 262 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  129 bits (323), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 143/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 153
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 154 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 210
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +   +F    
Sbjct: 211 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKA 264
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 265 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 298

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  129 bits (323), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMV 63
           ++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++ +
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 64  KS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELAN 123
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE
Sbjct: 124 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPE 180
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +F
Sbjct: 181 MIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEFTF 229
Query: 242 PSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           P  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 230 PDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 271

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  129 bits (323), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 144/283 (50%), Gaps = 36/283 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 150
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 207
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + ++ I+  + +    F    
Sbjct: 208 ------EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKA 261
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFDCL 280
           R      + V+ L+  LDA  RL  +++ G      HP F+ +
Sbjct: 262 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  128 bits (322), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 26/287 (9%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERD 60
           E +++  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R+
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 61  IMVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           + ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI E
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITE 119
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           LA A+ Y H    +HRDIKP+N+LL + G LK+ +FG +     + R       GT +Y+
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTL---CGTLDYL 176
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
            PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +   
Sbjct: 177 PPEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVE 225
Query: 239 VSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
            +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 FTFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  128 bits (322), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 143/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 148
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R  +   VGT +YV+PE+L  
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF--VGTAQYVSPELLT- 205
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 206 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 260 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 147
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R  S   VGT +YV+PE+L  
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF--VGTAQYVSPELLT- 204
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 205 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 258
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 259 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 125
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 126 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 182
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 183 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 236
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 237 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 270

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 127
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 128 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 184
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 185 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 238
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 239 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 272

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 183
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 184 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 238 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 128
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 129 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 185
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 186 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 239
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 240 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 273

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G  +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 150
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R  S   VGT +YV+PE+L  
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF--VGTAQYVSPELLT- 207
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                     + S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 208 ------EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 261
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 262 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 150
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 207
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 208 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 261
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 262 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 150
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 207
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 208 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 261
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 262 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 26/286 (9%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDI 61
           L  +  +  DF+I R + +G FG++YL  EKQS     +K + + ++      + + R++
Sbjct: 3   LGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 62  MVKS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
            ++S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI EL
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITEL 120
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           A A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ 
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL---CGTLDYLP 177
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PE++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    
Sbjct: 178 PEMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEF 226
Query: 240 SFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           +FP  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 227 TFPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  127 bits (319), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 148
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 205
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 206 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 260 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  127 bits (319), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 151
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 208
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 209 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 262
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 263 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  127 bits (318), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 148
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 205
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 206 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 260 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  127 bits (318), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 24/269 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMV--KSKCPYIV 71
           +D +  +  G F ++ L E+K++     +K + +E +     ++E +I V  K K P IV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 72  NLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
            L   ++   H+Y IM+ V+GG+ F  ++E    G+ +E  A   I+++  AV+YLH LG
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 131 YVHRDIKPDNML---LSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            VHRD+KP+N+L   L     + ++DFG +   D    + +    GTP YVAPEVL    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYVAPEVL---- 190
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  Y+ + D WSIGV++Y LL G  PF  E     +  IL  + E     P    +
Sbjct: 191 ---AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FDSPYWDDI 245
Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           S +  +F++ L++K  + R   +Q L HP
Sbjct: 246 SDSAKDFIRHLMEKDPEKRFTCEQALQHP 274

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  127 bits (318), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 150
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 207
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 208 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 261
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 262 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  127 bits (318), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 132
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 133 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 189
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 190 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 243
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 244 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 277

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  126 bits (317), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 24/269 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMV--KSKCPYIV 71
           +D +  +  G F ++ L E+K++     +K + +E +     ++E +I V  K K P IV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 72  NLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
            L   ++   H+Y IM+ V+GG+ F  ++E    G+ +E  A   I+++  AV+YLH LG
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 131 YVHRDIKPDNML---LSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            VHRD+KP+N+L   L     + ++DFG +   D    + +    GTP YVAPEVL    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYVAPEVL---- 190
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  Y+ + D WSIGV++Y LL G  PF  E     +  IL  + E     P    +
Sbjct: 191 ---AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FDSPYWDDI 245
Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           S +  +F++ L++K  + R   +Q L HP
Sbjct: 246 SDSAKDFIRHLMEKDPEKRFTCEQALQHP 274

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  126 bits (317), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 141/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L++ FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 155
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 156 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 212
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 213 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 266
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 267 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 300

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  126 bits (316), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 131/238 (55%), Gaps = 26/238 (10%)
Query: 3   VVKELRQKN-------VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF------VMKKV- 48
           V  ELR  N       V   +F++ + +  G +G ++LV +   H+T       V+KK  
Sbjct: 35  VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 94
Query: 49  LREKMPNT----IERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQP 103
           + +K   T     ER ++   +  P++V L Y+FQ    ++ I++Y+ GG+  T L  + 
Sbjct: 95  IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE 154
Query: 104 HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN 163
               +E + + Y+ E+  A+++LH LG ++RDIK +N+LL + GH+ LTDFG + +   +
Sbjct: 155 R--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212
Query: 164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
              ++    GT EY+AP+++       G  G+  + D WS+GV+ YELLTG++PF  +
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRG-----GDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  126 bits (316), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 149/315 (47%), Gaps = 52/315 (16%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPNTIERD--IMVK 64
           +++ +DF + R I +G FG++Y   +  +   + MK    K ++ K   T+  +  IM+ 
Sbjct: 184 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 243
Query: 65  ----SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
                 CP+IV + Y+F   + + FI++ + GGD    L    HG  SE+  RFY  E+ 
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEII 301
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
             ++++H    V+RD+KP N+LL   GH++++D G A    K    K    VGT  Y+AP
Sbjct: 302 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 358
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN-------YETLDMTYSSILAC 233
           EVL+          Y  S D +S+G + ++LL G +PF        +E   MT +     
Sbjct: 359 EVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---- 408
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNM-----DQVLGHPVFDCLD------ 281
                V  P S   S  + + ++ L+Q+ ++ RL        +V   P F  LD      
Sbjct: 409 ----AVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 462
Query: 282 --SDPPCIPPPSQEN 294
               PP IPP  + N
Sbjct: 463 QKYPPPLIPPRGEVN 477

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  126 bits (316), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 147
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 204
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 205 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 258
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 259 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  126 bits (316), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 149/315 (47%), Gaps = 52/315 (16%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPNTIERD--IMVK 64
           +++ +DF + R I +G FG++Y   +  +   + MK    K ++ K   T+  +  IM+ 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 65  ----SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
                 CP+IV + Y+F   + + FI++ + GGD    L    HG  SE+  RFY  E+ 
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEII 302
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
             ++++H    V+RD+KP N+LL   GH++++D G A    K    K    VGT  Y+AP
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 359
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN-------YETLDMTYSSILAC 233
           EVL+          Y  S D +S+G + ++LL G +PF        +E   MT +     
Sbjct: 360 EVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---- 409
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNM-----DQVLGHPVFDCLD------ 281
                V  P S   S  + + ++ L+Q+ ++ RL        +V   P F  LD      
Sbjct: 410 ----AVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 463
Query: 282 --SDPPCIPPPSQEN 294
               PP IPP  + N
Sbjct: 464 QKYPPPLIPPRGEVN 478

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  126 bits (316), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 26/284 (9%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMV 63
           ++  +  DF+I R + +G FG++YL  EK S     +K + + ++      + + R++ +
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 64  KS--KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +S  + P I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA 
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELAN 119
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE
Sbjct: 120 ALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPE 176
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E          +    DLWS+GV+ YE L G  PF   T   TY  I    +    +F
Sbjct: 177 MIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI----SRVEFTF 225
Query: 242 PSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHPVFDCLDSDP 284
           P  +  +    + +  L++   + R  + +VL HP      S P
Sbjct: 226 PDFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  126 bits (316), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 149/315 (47%), Gaps = 52/315 (16%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPNTIERD--IMVK 64
           +++ +DF + R I +G FG++Y   +  +   + MK    K ++ K   T+  +  IM+ 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 65  ----SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
                 CP+IV + Y+F   + + FI++ + GGD    L    HG  SE+  RFY  E+ 
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEII 302
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
             ++++H    V+RD+KP N+LL   GH++++D G A    K    K    VGT  Y+AP
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 359
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN-------YETLDMTYSSILAC 233
           EVL+          Y  S D +S+G + ++LL G +PF        +E   MT +     
Sbjct: 360 EVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---- 409
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNM-----DQVLGHPVFDCLD------ 281
                V  P S   S  + + ++ L+Q+ ++ RL        +V   P F  LD      
Sbjct: 410 ----AVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 463
Query: 282 --SDPPCIPPPSQEN 294
               PP IPP  + N
Sbjct: 464 QKYPPPLIPPRGEVN 478

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  126 bits (316), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 149/315 (47%), Gaps = 52/315 (16%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPNTIERD--IMVK 64
           +++ +DF + R I +G FG++Y   +  +   + MK    K ++ K   T+  +  IM+ 
Sbjct: 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 65  ----SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
                 CP+IV + Y+F   + + FI++ + GGD    L    HG  SE+  RFY  E+ 
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEII 302
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
             ++++H    V+RD+KP N+LL   GH++++D G A    K    K    VGT  Y+AP
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 359
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN-------YETLDMTYSSILAC 233
           EVL+          Y  S D +S+G + ++LL G +PF        +E   MT +     
Sbjct: 360 EVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---- 409
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNM-----DQVLGHPVFDCLD------ 281
                V  P S   S  + + ++ L+Q+ ++ RL        +V   P F  LD      
Sbjct: 410 ----AVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 463
Query: 282 --SDPPCIPPPSQEN 294
               PP IPP  + N
Sbjct: 464 QKYPPPLIPPRGEVN 478

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  125 bits (315), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 24/269 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMV--KSKCPYIV 71
           +D +  +  G F ++ L E+K++     +K + +E +     ++E +I V  K K P IV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 72  NLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
            L   ++   H+Y IM+ V+GG+ F  ++E    G+ +E  A   I+++  AV+YLH LG
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 131 YVHRDIKPDNML---LSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            VHRD+KP+N+L   L     + ++DFG +   D    + +    GTP YVAPEVL    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYVAPEVL---- 190
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  Y+ + D WSIGV++Y LL G  PF  E     +  IL  + E     P    +
Sbjct: 191 ---AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FDSPYWDDI 245
Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           S +  +F++ L++K  + R   +Q L HP
Sbjct: 246 SDSAKDFIRHLMEKDPEKRFTCEQALQHP 274

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  125 bits (314), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 141/281 (50%), Gaps = 36/281 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLRE-KMPN-TIERDIMVKSKCP 68
           DF   + + +G+F    L  E  +   + +K      +++E K+P  T ERD+M +   P
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 148
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEW 185
            G +HRD+KP+N+LL+   H+++TDFG+A  +    K  R      VGT +YV+PE+L  
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF--VGTAQYVSPELLT- 205
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                       S DLW++G + Y+L+ G  PF      + +  I+  + +    F    
Sbjct: 206 ------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLG------HPVFD 278
           R      + V+ L+  LDA  RL  +++ G      HP F+
Sbjct: 260 R------DLVEKLLV-LDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  125 bits (314), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/222 (33%), Positives = 111/222 (50%), Gaps = 19/222 (8%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKS--KCP 68
           DF+I R + +G FG++YL  EKQ      +K + + ++      + + R++ ++S  + P
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            I+ L+  F D   VY I+EY   G      E Q      E +   YI ELA A+ Y H 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLG--TVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ PE++E    
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIE---- 176
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
                 +    DLWS+GV+ YE L G  PF   T   TY  I
Sbjct: 177 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 215

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 141/274 (51%), Gaps = 26/274 (9%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVK 64
           ++ +  DF+I R + +G FG++YL  EK+SH    +K + +     E + + + R+I ++
Sbjct: 18  RHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 77
Query: 65  SKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
           +    P I+ L+  F D   +Y I+EY   G+     E Q      E +    + ELA A
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYK--ELQKSCTFDEQRTATIMEELADA 135
Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           + Y HG   +HRDIKP+N+LL   G LK+ DFG +       R K++   GT +Y+ PE+
Sbjct: 136 LMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR-KTM--CGTLDYLPPEM 192
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
           +E    N          DLW IGV+ YELL G+ PF   + + TY  I+  D    + FP
Sbjct: 193 IEGRMHNE-------KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVD----LKFP 241
Query: 243 SSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLGHP 275
           +S+   T   + +  L++   + RL + QV  HP
Sbjct: 242 ASV--PTGAQDLISKLLRHNPSERLPLAQVSAHP 273

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  125 bits (313), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 143/269 (53%), Gaps = 24/269 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMV--KSKCPYIV 71
           +D +  +  G F ++ L E+K++     +K + ++ +     ++E +I V  K K P IV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 72  NLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
            L   ++   H+Y IM+ V+GG+ F  ++E    G+ +E  A   I+++  AV+YLH LG
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 131 YVHRDIKPDNML---LSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            VHRD+KP+N+L   L     + ++DFG  ++++  G + S    GTP YVAPEVL    
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFG-LSKMEDPGSVLSTA-CGTPGYVAPEVL---- 190
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  Y+ + D WSIGV++Y LL G  PF  E     +  IL  + E     P    +
Sbjct: 191 ---AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FDSPYWDDI 245
Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           S +  +F++ L++K  + R   +Q L HP
Sbjct: 246 SDSAKDFIRHLMEKDPEKRFTCEQALQHP 274

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  123 bits (309), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMPNTIERDIMVKS--KCPYIVN 72
           +DI   +  G FG ++ V E+ + N F  K V+   E    T+ ++I   S  + P +VN
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L  +F+D N +  I E+++GG+    + ++ H  +SE +A  Y+ ++ + + ++H   YV
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 133 HRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           H D+KP+N++ +   +  LKL DFG    +D    +K  V  GT E+ APEV E     +
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFAAPEVAEGKPVGY 229
Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-DTVSFPSSIRLST 249
               YT   D+WS+GV+SY LL+G +PF  E  D T  ++ +CD   D  +F     +S 
Sbjct: 230 ----YT---DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG---ISE 279
Query: 250 AMVNFVQS-LVQKLDARLNMDQVLGHP 275
              +F++  L+   + R+ + Q L HP
Sbjct: 280 DGKDFIRKLLLADPNTRMTIHQALEHP 306

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 142/269 (52%), Gaps = 24/269 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPY--IV 71
           F+ K  +  G F ++ L EEK +   F +K + ++ +    ++IE +I V  K  +  IV
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 72  NLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
            L   ++  NH+Y +M+ V+GG+ F  ++E    G+ +E  A   I ++  AV YLH +G
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEK---GFYTEKDASTLIRQVLDAVYYLHRMG 140
Query: 131 YVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            VHRD+KP+N+L  +      + ++DFG  ++++  G + S    GTP YVAPEVL    
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFG-LSKMEGKGDVMS-TACGTPGYVAPEVL---- 194
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  Y+ + D WSIGV++Y LL G  PF  E     +  IL  + E     P    +
Sbjct: 195 ---AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYE--FDSPYWDDI 249
Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           S +  +F+++L++K  + R   +Q   HP
Sbjct: 250 SDSAKDFIRNLMEKDPNKRYTCEQAARHP 278

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  122 bits (307), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMPNTIERDIMVKS--KCPYIVN 72
           +DI   +  G FG ++ V E+ + N F  K V+   E    T+ ++I   S  + P +VN
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L  +F+D N +  I E+++GG+    + ++ H  +SE +A  Y+ ++ + + ++H   YV
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 133 HRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           H D+KP+N++ +   +  LKL DFG    +D    +K  V  GT E+ APEV E     +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFAAPEVAEGKPVGY 335
Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-DTVSFPSSIRLST 249
               YT   D+WS+GV+SY LL+G +PF  E  D T  ++ +CD   D  +F     +S 
Sbjct: 336 ----YT---DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG---ISE 385
Query: 250 AMVNFVQS-LVQKLDARLNMDQVLGHP 275
              +F++  L+   + R+ + Q L HP
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHP 412

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  119 bits (298), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 139/268 (51%), Gaps = 23/268 (8%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIER-----DIMVKSKCP 68
           DF +   + +G+F  +Y  E   +     +K + ++ M     ++R      I  + K P
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            I+ L+  F+D N+VY ++E    G+    L+N+   + SE++AR +++++   + YLH 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF-SENEARHFMHQIITGMLYLHS 130
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
            G +HRD+   N+LL+   ++K+ DFG ATQ+ K    K     GTP Y++PE+      
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLCGTPNYISPEIAT--RS 187
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
            HG +      D+WS+G + Y LL G  PF+ +T+  T + ++  D E     PS   LS
Sbjct: 188 AHGLES-----DVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSF--LS 236
Query: 249 TAMVNFVQSLVQKLDA-RLNMDQVLGHP 275
               + +  L+++  A RL++  VL HP
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLDHP 264

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 118/222 (53%), Gaps = 20/222 (9%)
Query: 16  DFDIK-RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC---PYIV 71
           D D+K + + +G+F        K+S+  F +K ++ ++M    +++I     C   P IV
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK-IISKRMEANTQKEITALKLCEGHPNIV 69
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L   F D  H + +ME + GG+    ++ + H   SE++A + + +L  AV ++H +G 
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGV 127
Query: 132 VHRDIKPDNMLLSATG---HLKLTDFGSA-TQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
           VHRD+KP+N+L +       +K+ DFG A  +   N  +K+  P  T  Y APE+L    
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLN--- 182
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSS 229
                +GY  SCDLWS+GV+ Y +L+G  PF      +T +S
Sbjct: 183 ----QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 140/275 (50%), Gaps = 32/275 (11%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERDIMVKSKCPY--I 70
           F     +  G F +++LV+++ +   F +K +  +K P    +++E +I V  K  +  I
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           V L   ++   H Y +M+ V+GG+ F  +LE    G  +E  A   I ++  AV+YLH  
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 130 GYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           G VHRD+KP+N+L         + +TDFG  +++++NG + +    GTP YVAPEVL   
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFG-LSKMEQNGIMST--ACGTPGYVAPEVL--- 179
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
                   Y+ + D WSIGV++Y LL G  PF  ET    +  I     E    F S   
Sbjct: 180 ----AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI----KEGYYEFESPFW 231
Query: 247 --LSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFD 278
             +S +  +F+  L++K  + R   ++ L HP  D
Sbjct: 232 DDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 114/199 (57%), Gaps = 16/199 (8%)
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           CP ++NL   +++ + +  I+EY  GG+  +L   +    +SE+     I ++ + V YL
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 127 HGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           H    VH D+KP N+LLS+    G +K+ DFG + ++     ++ I  +GTPEY+APE+L
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI--MGTPEYLAPEIL 205
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT-VSFP 242
            +       D  T + D+W+IG+++Y LLT ++PF  E    TY +I   + + +  +F 
Sbjct: 206 NY-------DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258
Query: 243 SSIRLSTAMVNFVQSLVQK 261
           S  +L+T   +F+QSL+ K
Sbjct: 259 SVSQLAT---DFIQSLLVK 274

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 126/223 (56%), Gaps = 18/223 (8%)
Query: 3   VVKELRQKNVSASD-FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI 61
           +V++L + ++  +D +++K  I  G++        K ++  F +K + + K   T E +I
Sbjct: 9   IVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI 68
Query: 62  MVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           +++  + P I+ L   + D  +VY + E + GG+ +  +  Q   + SE +A   ++ + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTIT 126
Query: 121 QAVQYLHGLGYVHRDIKPDNML-LSATGH---LKLTDFGSATQV-DKNGRIKSIVPVGTP 175
           + V+YLH  G VHRD+KP N+L +  +G+   +++ DFG A Q+  +NG +  + P  T 
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTA 184
Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +VAPEVLE         GY  +CD+WS+GV+ Y +LTG TPF
Sbjct: 185 NFVAPEVLE-------RQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 21/265 (7%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC--PYIVNLF 74
           FD+   + +G++G +Y    K++     +K+V  E     I ++I +  +C  P++V  +
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 75  YSFQDMNHVYFIMEYVTGGDF--VTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
            S+     ++ +MEY   G    +  L N+    L+E +    +    + ++YLH +  +
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRDIK  N+LL+  GH KL DFG A Q+      ++ V +GTP ++APEV++ +      
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXV-IGTPFWMAPEVIQEI------ 200
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTEDTVSFPSSIRLSTAM 251
            GY    D+WS+G+ + E+  G  P+     D+    +I    T    +F      S   
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKPPYA----DIHPMRAIFMIPTNPPPTFRKPELWSDNF 255
Query: 252 VNFV-QSLVQKLDARLNMDQVLGHP 275
            +FV Q LV+  + R    Q+L HP
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQHP 280

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 124/233 (53%), Gaps = 20/233 (8%)
Query: 57  IERDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
           IER++ +  +   P I+ L   +++   V  I+E V+GG+    L  +    LSE +A  
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATS 119
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIV 170
           +I ++   V YLH     H D+KP+N++L        H+KL DFG A +++     K+I 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T ++I
Sbjct: 180 --GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 231 LACDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVFDCLDS 282
            A   +    F S  + S    +F++  LV++   RL + + L HP    +D+
Sbjct: 231 TAVSYDFDEEFFS--QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 124/223 (55%), Gaps = 18/223 (8%)
Query: 3   VVKELRQKNVSASD-FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI 61
           +V++L + ++  +D +++K  I  G++        K ++  F +K + + K   T E +I
Sbjct: 9   IVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI 68
Query: 62  MVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           +++  + P I+ L   + D  +VY + E   GG+ +  +  Q   + SE +A   ++ + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTIT 126
Query: 121 QAVQYLHGLGYVHRDIKPDNML-LSATGH---LKLTDFGSATQV-DKNGRIKSIVPVGTP 175
           + V+YLH  G VHRD+KP N+L +  +G+   +++ DFG A Q+  +NG + +  P  T 
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT--PCYTA 184
Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +VAPEVLE         GY  +CD+WS+GV+ Y  LTG TPF
Sbjct: 185 NFVAPEVLE-------RQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 111
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 229
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 230 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK--- 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 61  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 117
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 118 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 235
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 236 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK--- 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 67
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 185
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 186 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 65
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 183
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 184 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 114/213 (53%), Gaps = 10/213 (4%)
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+I+ L  S++  + ++ + + +  G+    L  +    LSE + R  +  L +AV +LH
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH 217
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW-M 186
               VHRD+KP+N+LL     ++L+DFG +  ++   +++ +   GTP Y+APE+L+  M
Sbjct: 218 ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--CGTPGYLAPEILKCSM 275
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
           +  H   GY    DLW+ GV+ + LL GS PF +    +    I+  + +   S P    
Sbjct: 276 DETH--PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM--EGQYQFSSPEWDD 331
Query: 247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD 278
            S+ + + +  L+Q   +ARL  +Q L HP F+
Sbjct: 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 118/216 (54%), Gaps = 17/216 (7%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK-SKC 67
           Q  V +  + +K  I  G++ +      K ++  + +K + + K   + E +I+++  + 
Sbjct: 21  QSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQH 80
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P I+ L   + D  HVY + E + GG+ +  +  Q   + SE +A F ++ + + V+YLH
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYLH 138
Query: 128 GLGYVHRDIKPDNML-LSATGH---LKLTDFGSATQV-DKNGRIKSIVPVGTPEYVAPEV 182
             G VHRD+KP N+L +  +G+   L++ DFG A Q+  +NG +  + P  T  +VAPEV
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANFVAPEV 196
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           L+         GY   CD+WS+G++ Y +L G TPF
Sbjct: 197 LK-------RQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 10  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 66
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 67  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 184
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 185 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK--- 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 67
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 185
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 186 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 16  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 72
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 73  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 190
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 191 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 15  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 71
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 72  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 189
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 190 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 117/213 (54%), Gaps = 17/213 (7%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK-SKCPYI 70
           V +  + +K  I  G++ +      K ++  + +K + + K   + E +I+++  + P I
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNI 83
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           + L   + D  HVY + E + GG+ +  +  Q   + SE +A F ++ + + V+YLH  G
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYLHSQG 141
Query: 131 YVHRDIKPDNML-LSATGH---LKLTDFGSATQV-DKNGRIKSIVPVGTPEYVAPEVLEW 185
            VHRD+KP N+L +  +G+   L++ DFG A Q+  +NG +  + P  T  +VAPEVL+ 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLK- 198
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                   GY   CD+WS+G++ Y +L G TPF
Sbjct: 199 ------RQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 17  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 73
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 74  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 191
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 192 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 116/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 65
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  +    P  TP Y
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTE--PCYTPYY 183
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 184 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 25  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 81
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 82  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 199
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 200 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 18/216 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTIER-----DIMVKSKCP 68
            ++ + + I +GNF  + L     +     +K + + ++ P ++++      IM     P
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            IV LF   +    +Y IMEY +GG+    L    HG + E +AR    ++  AVQY H 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              VHRD+K +N+LL A  ++K+ DFG + +    G++ +    G+P Y APE+ +    
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF--CGSPPYAAPELFQ---- 183
Query: 189 NHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
                 Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 184 ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 216

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/324 (28%), Positives = 150/324 (46%), Gaps = 42/324 (12%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKC-- 67
           A  ++I   + +G+FG++   +++ +   + +K + +    N    TI R++ +  K   
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P I+ LF   +D +  Y + E  TGG+    +  +     SE  A   I ++   + Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 128 GLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
               VHRD+KP+N+LL +      +K+ DFG +T   +N ++K    +GT  Y+APEVL 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVL- 195
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILACDTEDTVS 240
                 G+  Y   CD+WS GV+ Y LL+G+ PF     Y+ L    +   A D     +
Sbjct: 196 -----RGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248
Query: 241 FPSSIR-LSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPP-PSQENKFHK 298
                + L   M+ F  SL      R+   Q L HP      S+ P I   PS E+    
Sbjct: 249 ISDDAKDLIRKMLTFHPSL------RITATQCLEHPWIQKYSSETPTISDLPSLES---- 298
Query: 299 KDKRKASPSLKAFQKEGRYLDSAL 322
                A  +++ FQ E +   +AL
Sbjct: 299 -----AMTNIRQFQAEKKLAQAAL 317

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 113/210 (53%), Gaps = 22/210 (10%)
Query: 20  KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-------KCPYIVN 72
           +R + +G+FG++ L ++K +     +K + + ++    +++ +++          P I+ 
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L+  F+D  + Y + E  TGG+    + ++     SE  A   I ++   + Y+H    V
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIV 148
Query: 133 HRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           HRD+KP+N+LL   S   ++++ DFG +T  + + ++K    +GT  Y+APEVL      
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVL------ 200
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           HG+  Y   CD+WS GV+ Y LL+G  PFN
Sbjct: 201 HGT--YDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTIER-----DIMVKSKCP 68
            ++ + + I +GNF  + L     +     +K + + ++ P ++++      IM     P
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            IV LF   +    +Y IMEY +GG+    L    HG + E +AR    ++  AVQY H 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              VHRD+K +N+LL A  ++K+ DFG + +    G++ +    G P Y APE+ +    
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ---- 186
Query: 189 NHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
                 Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 187 ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 135/272 (49%), Gaps = 32/272 (11%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKKVLREKMPNTIERDIMVKSKCPYIVNL 73
           F+++  + +G    +Y  ++K +   +   V+KK + +K+  T E  ++++   P I+ L
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT-EIGVLLRLSHPNIIKL 113
Query: 74  FYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
              F+    +  ++E VTGG+ F  ++E    GY SE  A   + ++ +AV YLH  G V
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 133 HRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           HRD+KP+N+L +       LK+ DFG +  V+    +K++   GTP Y APE+L      
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CGTPGYCAPEILR----- 223
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-MTYSSILACDTEDTVSFPSSIRLS 248
                Y    D+WS+G+++Y LL G  PF  E  D   +  IL C+      +   + L+
Sbjct: 224 --GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 249 TAMVNFVQSLVQKLDA-----RLNMDQVLGHP 275
                  + LV+KL       RL   Q L HP
Sbjct: 282 A------KDLVRKLIVLDPKKRLTTFQALQHP 307

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 113/210 (53%), Gaps = 22/210 (10%)
Query: 20  KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-------KCPYIVN 72
           +R + +G+FG++ L ++K +     +K + + ++    +++ +++          P I+ 
Sbjct: 54  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 113
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L+  F+D  + Y + E  TGG+    + ++     SE  A   I ++   + Y+H    V
Sbjct: 114 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIV 171
Query: 133 HRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           HRD+KP+N+LL   S   ++++ DFG +T  + + ++K    +GT  Y+APEVL      
Sbjct: 172 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVL------ 223
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           HG+  Y   CD+WS GV+ Y LL+G  PFN
Sbjct: 224 HGT--YDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTIERDIMVKS--KCPYIVNL 73
           +++ + I  GNFG   L+ +KQS+    +K + R EK+   ++R+I+     + P IV  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRF 80
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
                   H+  +MEY +GG+    + N   G  SE +ARF+  +L   V Y H +   H
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 134 RDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           RD+K +N LL  S    LK+ DFG +     + + KS   VGTP Y+APEVL   E    
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE---- 192
Query: 192 SDGYTGS-CDLWSIGVVSYELLTGSTPF 218
              Y G   D+WS GV  Y +L G+ PF
Sbjct: 193 ---YDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 113/210 (53%), Gaps = 22/210 (10%)
Query: 20  KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-------KCPYIVN 72
           +R + +G+FG++ L ++K +     +K + + ++    +++ +++          P I+ 
Sbjct: 55  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 114
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L+  F+D  + Y + E  TGG+    + ++     SE  A   I ++   + Y+H    V
Sbjct: 115 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIV 172
Query: 133 HRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           HRD+KP+N+LL   S   ++++ DFG +T  + + ++K    +GT  Y+APEVL      
Sbjct: 173 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVL------ 224
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           HG+  Y   CD+WS GV+ Y LL+G  PFN
Sbjct: 225 HGT--YDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 133/258 (51%), Gaps = 22/258 (8%)
Query: 57  IERDIMVKSKCPY--IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
           IER++ +  +  +  ++ L   +++   V  I+E V+GG+    L  +    LSE +A  
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATS 119
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIV 170
           +I ++   V YLH     H D+KP+N++L        H+KL DFG A +++     K+I 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T ++I
Sbjct: 180 --GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 231 LACDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVFDCLDSDPPCIPP 289
            A   +    F S  + S    +F++  LV++   RL + + L HP    +D+    +  
Sbjct: 231 TAVSYDFDEEFFS--QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288
Query: 290 PSQEN--KFHKKDKRKAS 305
            S  N   F K+  R+ S
Sbjct: 289 ESVVNLENFRKQYVRRRS 306

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTIERDIMVKS--KCPYIVNL 73
           +++ + I  GNFG   L+ +KQS+    +K + R EK+   ++R+I+     + P IV  
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRF 79
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
                   H+  +MEY +GG+    + N   G  SE +ARF+  +L   V Y H +   H
Sbjct: 80  KEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCH 137
Query: 134 RDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           RD+K +N LL  S    LK+ DFG +     + + KS   VGTP Y+APEVL   E    
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE---- 191
Query: 192 SDGYTGS-CDLWSIGVVSYELLTGSTPF 218
              Y G   D+WS GV  Y +L G+ PF
Sbjct: 192 ---YDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 23/221 (10%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK--- 64
           +KN    D+ +  + +  G  G +  +  K++   F +K +  +  P    R++ +    
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL--QDCPKA-RREVELHWRA 111
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  + E + GG+  + ++++     +E +A      + 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP Y
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 229
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD WS+GV+ Y LL G  PF
Sbjct: 230 VAPEVL-------GPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 124/233 (53%), Gaps = 20/233 (8%)
Query: 57  IERDIMVKSKCPY--IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
           IER++ +  +  +  ++ L   +++   V  I+E V+GG+    L  +    LSE +A  
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATS 119
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIV 170
           +I ++   V YLH     H D+KP+N++L        H+KL DFG A +++     K+I 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T ++I
Sbjct: 180 --GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 231 LACDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVFDCLDS 282
            A   +    F S  + S    +F++  LV++   RL + + L HP    +D+
Sbjct: 231 TAVSYDFDEEFFS--QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDIMVKSKC--PYIVNLFYSF 77
           I +G+FG+++   + ++     +K +     E     I+++I V S+C  PY+   + S+
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                ++ IMEY+ GG  + LLE  P   L E++    + E+ + + YLH    +HRDIK
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIK-------QSAYDS 183
Query: 198 SCDLWSIGVVSYELLTGSTP 217
             D+WS+G+ + EL  G  P
Sbjct: 184 KADIWSLGITAIELARGEPP 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDIMVKSKC--PYIVNLFYSF 77
           I +G+FG+++   + ++     +K +     E     I+++I V S+C  PY+   + S+
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                ++ IMEY+ GG  + LLE  P   L E++    + E+ + + YLH    +HRDIK
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIK-------QSAYDS 198
Query: 198 SCDLWSIGVVSYELLTGSTP 217
             D+WS+G+ + EL  G  P
Sbjct: 199 KADIWSLGITAIELARGEPP 218

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTIERDIMVKS--KCPYIVNL 73
           +++ + I  GNFG   L+ +KQ++    +K + R EK+   ++R+I+     + P IV  
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRF 80
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
                   H+  +MEY +GG+    + N   G  SE +ARF+  +L   V Y H +   H
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYAHAMQVAH 138
Query: 134 RDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           RD+K +N LL  S    LK+ DFG +     + + KS   VGTP Y+APEVL   E    
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGTPAYIAPEVLLKKE---- 192
Query: 192 SDGYTGS-CDLWSIGVVSYELLTGSTPF 218
              Y G   D+WS GV  Y +L G+ PF
Sbjct: 193 ---YDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDIMVKSKC--PYIVNLFYSF 77
           I +G+FG+++   + ++     +K +     E     I+++I V S+C  PY+   + S+
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                ++ IMEY+ GG  + LLE  P   L E++    + E+ + + YLH    +HRDIK
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIK-------QSAYDS 183
Query: 198 SCDLWSIGVVSYELLTGSTP 217
             D+WS+G+ + EL  G  P
Sbjct: 184 KADIWSLGITAIELARGEPP 203

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/218 (34%), Positives = 111/218 (50%), Gaps = 20/218 (9%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMP-NTIERDIMVKSKC--PYIV 71
           F  KR +  G FGD++LVEE+ S    V+K +   R ++P   IE +I V      P I+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFV-TLLENQPHG-YLSESKARFYIYELAQAVQYLHGL 129
            +F  F+D +++Y +ME   GG+ +  ++  Q  G  LSE      + ++  A+ Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 130 GYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
             VH+D+KP+N+L   T     +K+ DFG A     +    S    GT  Y+APEV +  
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFK-- 199
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD 224
                    T  CD+WS GVV Y LLTG  PF   +L+
Sbjct: 200 ------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE 231

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 26/220 (11%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------------IMV 63
           ++ + + +  G  G++ L  E+++     +K + + K      R+            I+ 
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQA 122
           K   P I+ +  +F D    Y ++E + GG+ F  ++ N+    L E+  + Y Y++  A
Sbjct: 70  KLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 125
Query: 123 VQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           VQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   GTP Y+A
Sbjct: 126 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CGTPTYLA 183
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           PEVL     + G+ GY  + D WS+GV+ +  L+G  PF+
Sbjct: 184 PEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFS 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 26/220 (11%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------------IMV 63
           ++ + + +  G  G++ L  E+++     +K + + K      R+            I+ 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQA 122
           K   P I+ +  +F D    Y ++E + GG+ F  ++ N+    L E+  + Y Y++  A
Sbjct: 71  KLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 126
Query: 123 VQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           VQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   GTP Y+A
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CGTPTYLA 184
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           PEVL     + G+ GY  + D WS+GV+ +  L+G  PF+
Sbjct: 185 PEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 26/220 (11%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------------IMV 63
           ++ + + +  G  G++ L  E+++     +K + + K      R+            I+ 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQA 122
           K   P I+ +  +F D    Y ++E + GG+ F  ++ N+    L E+  + Y Y++  A
Sbjct: 71  KLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 126
Query: 123 VQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           VQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   GTP Y+A
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CGTPTYLA 184
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           PEVL     + G+ GY  + D WS+GV+ +  L+G  PF+
Sbjct: 185 PEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIER---DIMVKSKC--PYIVNL 73
           RF+ +G F   Y + +  +   F  K V +  +  P+  E+   +I +      P++V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
              F+D + VY ++E       + L + +    ++E +AR+++ +  Q VQYLH    +H
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRR--KAVTEPEARYFMRQTIQGVQYLHNNRVIH 165
Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+K  N+ L+    +K+ DFG AT+++ +G  K  +  GTP Y+APEVL          
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-CGTPNYIAPEVL-------CKK 217
Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
           G++   D+WS+G + Y LL G  PF    L  TY  I
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIER---DIMVKSKC--PYIVNL 73
           RF+ +G F   Y + +  +   F  K V +  +  P+  E+   +I +      P++V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
              F+D + VY ++E       + L + +    ++E +AR+++ +  Q VQYLH    +H
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRR--KAVTEPEARYFMRQTIQGVQYLHNNRVIH 165
Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+K  N+ L+    +K+ DFG AT+++ +G  K  +  GTP Y+APEVL          
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL-CGTPNYIAPEVL-------CKK 217
Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
           G++   D+WS+G + Y LL G  PF    L  TY  I
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 26/220 (11%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------------IMV 63
           ++ + + +  G  G++ L  E+++     +K + + K      R+            I+ 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQA 122
           K   P I+ +  +F D    Y ++E + GG+ F  ++ N+    L E+  + Y Y++  A
Sbjct: 71  KLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 126
Query: 123 VQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           VQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   GTP Y+A
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CGTPTYLA 184
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           PEVL     + G+ GY  + D WS+GV+ +  L+G  PF+
Sbjct: 185 PEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 16/200 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDIMVKSKC--PYIVNLFYSF 77
           I +G+FG+++   + ++     +K +     E     I+++I V S+C  PY+   + S+
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                ++ IMEY+ GG  + LLE  P   L E++    + E+ + + YLH    +HRDIK
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 152 AANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIK-------QSAYDS 203
Query: 198 SCDLWSIGVVSYELLTGSTP 217
             D+WS+G+ + EL  G  P
Sbjct: 204 KADIWSLGITAIELARGEPP 223

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 36/265 (13%)
Query: 22  FIQQGNFGDIYLVEEKQSHNTFVMKKVL---------REKMPNTIERDIMVKSKCPYIVN 72
           F+ +G F   + + +  +   F  K V          REKM  ++E  I       ++V 
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVG 103
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
               F+D + V+ ++E       + L + +    L+E +AR+Y+ ++    QYLH    +
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVI 161
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRD+K  N+ L+    +K+ DFG AT+V+ +G  K ++  GTP Y+APEVL         
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLS-------K 213
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV 252
            G++   D+WSIG + Y LL G  PF    L  TY  I     ++  S P  I    A  
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAA-- 267
Query: 253 NFVQSLVQKL-----DARLNMDQVL 272
               SL+QK+      AR  ++++L
Sbjct: 268 ----SLIQKMLQTDPTARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 36/265 (13%)
Query: 22  FIQQGNFGDIYLVEEKQSHNTFVMKKVL---------REKMPNTIERDIMVKSKCPYIVN 72
           F+ +G F   + + +  +   F  K V          REKM  ++E  I       ++V 
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVG 105
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
               F+D + V+ ++E       + L + +    L+E +AR+Y+ ++    QYLH    +
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRD+K  N+ L+    +K+ DFG AT+V+ +G  K ++  GTP Y+APEVL         
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLS-------K 215
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV 252
            G++   D+WSIG + Y LL G  PF    L  TY  I     ++  S P  I    A  
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAA-- 269
Query: 253 NFVQSLVQKL-----DARLNMDQVL 272
               SL+QK+      AR  ++++L
Sbjct: 270 ----SLIQKMLQTDPTARPTINELL 290

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 132/258 (51%), Gaps = 22/258 (8%)
Query: 57  IERDIMVKSKCPY--IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
           IER++ +  +  +  ++ L   +++   V  I+E V+GG+    L  +    LSE +A  
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATS 119
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIV 170
           +I ++   V YLH     H D+KP+N++L        H+KL DFG A +++     K+I 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T ++I
Sbjct: 180 --GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 231 LACDTE-DTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPP 289
            +   + D   F  +  L+   +   + LV++   RL + + L HP    +D+    +  
Sbjct: 231 TSVSYDFDEEFFSHTSELAKDFIR--KLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288
Query: 290 PSQEN--KFHKKDKRKAS 305
            S  N   F K+  R+ S
Sbjct: 289 ESVVNLENFRKQYVRRRS 306

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDIMVKSKC--PYIVNLFYSF 77
           I +G+FG++Y   +  +     +K +     E     I+++I V S+C  PYI   F S+
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                ++ IMEY+ GG  + LL+  P   L E+     + E+ + + YLH    +HRDIK
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQL-TDTQIKRNXFVGTPFWMAPEVIK-------QSAYDF 195
Query: 198 SCDLWSIGVVSYELLTGSTP 217
             D+WS+G+ + EL  G  P
Sbjct: 196 KADIWSLGITAIELAKGEPP 215

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 113/210 (53%), Gaps = 22/210 (10%)
Query: 20  KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-------KCPYIVN 72
           +R + +G+FG++ L ++K +     +K + + ++    +++ +++          P I+ 
Sbjct: 37  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 96
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L+  F+D  + Y + E  TGG+    + ++     SE  A   I ++   + Y+H    V
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIV 154
Query: 133 HRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           HRD+KP+N+LL   S   ++++ DFG +T  + + ++K    +GT  Y+APEVL      
Sbjct: 155 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVL------ 206
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           HG+  Y   CD+WS GV+ Y LL+G  PFN
Sbjct: 207 HGT--YDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 26/220 (11%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------------IMV 63
           ++ + + +  G  G++ L  E+++     +K + + K      R+            I+ 
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQA 122
           K   P I+ +  +F D    Y ++E + GG+ F  ++ N+    L E+  + Y Y++  A
Sbjct: 77  KLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 132
Query: 123 VQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           VQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   GTP Y+A
Sbjct: 133 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CGTPTYLA 190
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           PEVL     + G+ GY  + D WS+GV+ +  L+G  PF+
Sbjct: 191 PEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFS 226

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 20  KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-------KCPYIVN 72
           +R + +G+FG++ L ++K +     +K + + ++    +++ +++          P I  
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXK 90
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L+  F+D  + Y + E  TGG+    + ++     SE  A   I ++   + Y H    V
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYXHKNKIV 148
Query: 133 HRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
           HRD+KP+N+LL   S   ++++ DFG +T  + + + K    +GT  Y+APEVL      
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKD--KIGTAYYIAPEVL------ 200
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           HG+  Y   CD+WS GV+ Y LL+G  PFN
Sbjct: 201 HGT--YDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 123/233 (52%), Gaps = 20/233 (8%)
Query: 57  IERDIMVKSKCPY--IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
           IER++ +  +  +  ++ L   +++   V  I+E V+GG+    L  +    LSE +A  
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATS 119
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIV 170
           +I ++   V YLH     H D+KP+N++L        H+KL DFG A +++     K+I 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T ++I
Sbjct: 180 --GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 231 LACDTE-DTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDS 282
            +   + D   F  +  L+   +   + LV++   RL + + L HP    +D+
Sbjct: 231 TSVSYDFDEEFFSHTSELAKDFIR--KLLVKETRKRLTIQEALRHPWITPVDN 281

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIER---DIMVKSKC--PYIVNL 73
           RF+ +G F   Y + +  +   F  K V +  +  P+  E+   +I +      P++V  
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
              F+D + VY ++E       + L + +    ++E +AR+++ +  Q VQYLH    +H
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLELHKRR--KAVTEPEARYFMRQTIQGVQYLHNNRVIH 165
Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+K  N+ L+    +K+ DFG AT+++ +G  K  +  GTP Y+APEVL          
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-CGTPNYIAPEVL-------CKK 217
Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
           G++   D+WS+G + Y LL G  PF    L  TY  I
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 36/265 (13%)
Query: 22  FIQQGNFGDIYLVEEKQSHNTFVMKKVL---------REKMPNTIERDIMVKSKCPYIVN 72
           F+ +G F   + + +  +   F  K V          REKM  ++E  I       ++V 
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVG 79
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
               F+D + V+ ++E       + L + +    L+E +AR+Y+ ++    QYLH    +
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVI 137
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRD+K  N+ L+    +K+ DFG AT+V+ +G  K ++  GTP Y+APEVL         
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLS-------K 189
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV 252
            G++   D+WSIG + Y LL G  PF    L  TY  I     ++  S P  I    A  
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAA-- 243
Query: 253 NFVQSLVQKL-----DARLNMDQVL 272
               SL+QK+      AR  ++++L
Sbjct: 244 ----SLIQKMLQTDPTARPTINELL 264

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 123/233 (52%), Gaps = 20/233 (8%)
Query: 57  IERDIMVKSKCPY--IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
           IER++ +  +  +  ++ L   +++   V  I+E V+GG+    L  +    LSE +A  
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATS 119
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIV 170
           +I ++   V YLH     H D+KP+N++L        H+KL DFG A +++     K+I 
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T ++I
Sbjct: 180 --GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 231 LACDTE-DTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDS 282
            +   + D   F  +  L+   +   + LV++   RL + + L HP    +D+
Sbjct: 231 TSVSYDFDEEFFSHTSELAKDFIR--KLLVKETRKRLTIQEALRHPWITPVDN 281

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 115/223 (51%), Gaps = 11/223 (4%)
Query: 58  ERDIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           E DI+ K S  P I+ L  +++     + + + +  G+    L  +    LSE + R  +
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIM 130
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
             L + +  LH L  VHRD+KP+N+LL    ++KLTDFG + Q+D   +++S+   GTP 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV--CGTPS 188
Query: 177 YVAPEVLEW-MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
           Y+APE++E  M  NH   GY    D+WS GV+ Y LL GS PF +    +    I++ + 
Sbjct: 189 YLAPEIIECSMNDNH--PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 236 EDTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
           +     P     S  + + V + LV +   R   ++ L HP F
Sbjct: 247 Q--FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIER---DIMVKSKC--PYIVNL 73
           RF+ +G F   Y + +  +   F  K V +  +  P+  E+   +I +      P++V  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
              F+D + VY ++E       + L + +    ++E +AR+++ +  Q VQYLH    +H
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLELHKRR--KAVTEPEARYFMRQTIQGVQYLHNNRVIH 149
Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RD+K  N+ L+    +K+ DFG AT+++ +G  K  +  GTP Y+APEVL          
Sbjct: 150 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL-CGTPNYIAPEVL-------CKK 201
Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
           G++   D+WS+G + Y LL G  PF    L  TY  I
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 238

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 122/268 (45%), Gaps = 18/268 (6%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTIERDIMVKS--KCPYIVNL 73
           +D  + I  GNFG   L+ +K +     +K + R   +   ++R+I+     + P IV  
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF 81
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
                   H+  IMEY +GG+    + N   G  SE +ARF+  +L   V Y H +   H
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 134 RDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           RD+K +N LL  S    LK+ DFG +     + + KS   VGTP Y+APEVL   E    
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQE---- 193
Query: 192 SDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA 250
              Y G   D+WS GV  Y +L G+ PF        Y   +        S P  IR+S  
Sbjct: 194 ---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 251 MVNFVQSL-VQKLDARLNMDQVLGHPVF 277
             + +  + V     R+++ ++  H  F
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTIERDIMVKS--KCPYIVNL 73
           +++ + I  GNFG   L+ +KQS+    +K + R EK+   ++R+I+     + P IV  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRF 80
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
                   H+  +MEY +GG+    + N   G  SE +ARF+  +L   V Y H +   H
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 134 RDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           RD+K +N LL  S    LK+  FG +     + + KS   VGTP Y+APEVL   E    
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE---- 192
Query: 192 SDGYTGS-CDLWSIGVVSYELLTGSTPF 218
              Y G   D+WS GV  Y +L G+ PF
Sbjct: 193 ---YDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 130/269 (48%), Gaps = 32/269 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IERDIMVKSKCPYIVNLFYSFQ 78
           I +G++G++ +  +K +      KK+ +  + +      E +IM     P I+ L+ +F+
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 93
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHG-YLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           D   +Y +ME  TGG+   L E   H     ES A   + ++  AV Y H L   HRD+K
Sbjct: 94  DNTDIYLVMELCTGGE---LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 150
Query: 138 PDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           P+N L    S    LKL DFG A +      +++   VGTP YV+P+VL   EG +G + 
Sbjct: 151 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVL---EGLYGPE- 204
Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNF 254
               CD WS GV+ Y LL G  PF+      T   ++    E T +FP    L+ +    
Sbjct: 205 ----CDEWSAGVMMYVLLCGYPPFSAP----TDXEVMLKIREGTFTFPEKDWLNVSPQ-- 254
Query: 255 VQSLVQKL-----DARLNMDQVLGHPVFD 278
            +SL+++L       R+   Q L H  F+
Sbjct: 255 AESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 58/161 (36%), Positives = 89/161 (55%), Gaps = 17/161 (10%)
Query: 65  SKCPYIVNLFYSFQDMNH----VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S  P+IV +   +++M+H    +  IME + GG+  + ++ +     +E +A   + ++ 
Sbjct: 60  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 119
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
            A+Q+LH     HRD+KP+N+L ++      LKLTDFG A +  +N       P  TP Y
Sbjct: 120 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPYY 176
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 177 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 130/269 (48%), Gaps = 32/269 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IERDIMVKSKCPYIVNLFYSFQ 78
           I +G++G++ +  +K +      KK+ +  + +      E +IM     P I+ L+ +F+
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHG-YLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           D   +Y +ME  TGG+   L E   H     ES A   + ++  AV Y H L   HRD+K
Sbjct: 77  DNTDIYLVMELCTGGE---LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 138 PDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           P+N L    S    LKL DFG A +      +++   VGTP YV+P+VL   EG +G + 
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVL---EGLYGPE- 187
Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNF 254
               CD WS GV+ Y LL G  PF+      T   ++    E T +FP    L+ +    
Sbjct: 188 ----CDEWSAGVMMYVLLCGYPPFSAP----TDXEVMLKIREGTFTFPEKDWLNVSPQ-- 237
Query: 255 VQSLVQKL-----DARLNMDQVLGHPVFD 278
            +SL+++L       R+   Q L H  F+
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTIER-----DIMVKSKCP 68
            ++ +++ I +GNF  + L     +     +K + + ++ P ++++      IM     P
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            IV LF   +    +Y +MEY +GG+    L    HG + E +AR    ++  AVQY H 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              VHRD+K +N+LL    ++K+ DFG + +     ++ +    G+P Y APE+ +    
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTF--CGSPPYAAPELFQ---- 186
Query: 189 NHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
                 Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 187 ---GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 36/265 (13%)
Query: 22  FIQQGNFGDIYLVEEKQSHNTFVMKKVL---------REKMPNTIERDIMVKSKCPYIVN 72
           F+ +G F   + + +  +   F  K V          REKM  ++E  I       ++V 
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVG 85
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
               F+D + V+ ++E       + L + +    L+E +AR+Y+ ++    QYLH    +
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVI 143
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRD+K  N+ L+    +K+ DFG AT+V+ +G  K  +  GTP Y+APEVL         
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLS-------K 195
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV 252
            G++   D+WSIG + Y LL G  PF    L  TY  I     ++  S P  I    A  
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAA-- 249
Query: 253 NFVQSLVQKL-----DARLNMDQVL 272
               SL+QK+      AR  ++++L
Sbjct: 250 ----SLIQKMLQTDPTARPTINELL 270

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 151/300 (50%), Gaps = 27/300 (9%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-------DIMVKSKCPY 69
           +DI   +  G FG ++   EK +   FV K +     P  +++        IM +   P 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFI---NTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           ++NL  +F+D   +  I+E+++GG+    +  + +  +SE++   Y+ +  + ++++H  
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEH 168
Query: 130 GYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
             VH DIKP+N++        +K+ DFG AT+++ +  +K  V   T E+ APE+++   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK--VTTATAEFAAPEIVD--- 223
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-DTVSFPSSIR 246
                  YT   D+W+IGV+ Y LL+G +PF  E    T  ++  CD E D  +F S   
Sbjct: 224 -REPVGFYT---DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS--- 276
Query: 247 LSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKRKAS 305
           +S    +F+++L+QK    RL +   L HP      S+     P S+ NK  +K K K +
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 336

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 118/222 (53%), Gaps = 18/222 (8%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E +I+ + + P I+ L   F++   V  I+E V+GG+    L  +    L+E +A  ++ 
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLK 115
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           ++   V YLH     H D+KP+N++L         +KL DFG A +++     K+I   G
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--G 173
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  ET   T ++I A 
Sbjct: 174 TPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226
Query: 234 DTE-DTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGH 274
           + + D   F ++  L+   +   + LV+    R+ + Q L H
Sbjct: 227 NYDFDEEYFSNTSELAKDFIR--RLLVKDPKRRMTIAQSLEH 266

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 58/161 (36%), Positives = 89/161 (55%), Gaps = 17/161 (10%)
Query: 65  SKCPYIVNLFYSFQDMNH----VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S  P+IV +   +++M+H    +  IME + GG+  + ++ +     +E +A   + ++ 
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
            A+Q+LH     HRD+KP+N+L ++      LKLTDFG A +  +N       P  TP Y
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPYY 195
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VAPEVL       G + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 196 VAPEVL-------GPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 118/221 (53%), Gaps = 16/221 (7%)
Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------- 57
           K L ++ V+ + F   R + +G FG++   + + +   +  KK+ ++++           
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E+ I+ K    ++V+L Y+++  + +  ++  + GGD    + +       E++A FY  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           E+   ++ LH    V+RD+KP+N+LL   GH++++D G A  V +   IK    VGT  Y
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGY 351
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +APEV++       ++ YT S D W++G + YE++ G +PF
Sbjct: 352 MAPEVVK-------NERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 118/221 (53%), Gaps = 16/221 (7%)
Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------- 57
           K L ++ V+ + F   R + +G FG++   + + +   +  KK+ ++++           
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E+ I+ K    ++V+L Y+++  + +  ++  + GGD    + +       E++A FY  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           E+   ++ LH    V+RD+KP+N+LL   GH++++D G A  V +   IK    VGT  Y
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGY 351
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +APEV++       ++ YT S D W++G + YE++ G +PF
Sbjct: 352 MAPEVVK-------NERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 36/265 (13%)
Query: 22  FIQQGNFGDIYLVEEKQSHNTFVMKKVL---------REKMPNTIERDIMVKSKCPYIVN 72
           F+ +G F   + + +  +   F  K V          REKM  ++E  I       ++V 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVG 81
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
               F+D + V+ ++E       + L + +    L+E +AR+Y+ ++    QYLH    +
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRD+K  N+ L+    +K+ DFG AT+V+ +G  K  +  GTP Y+APEVL         
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLS-------K 191
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV 252
            G++   D+WSIG + Y LL G  PF    L  TY  I     ++  S P  I    A  
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAA-- 245
Query: 253 NFVQSLVQKL-----DARLNMDQVL 272
               SL+QK+      AR  ++++L
Sbjct: 246 ----SLIQKMLQTDPTARPTINELL 266

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 142/287 (49%), Gaps = 34/287 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTI---ERDIMVKSKCPYIVNLFYSFQ 78
           I +G+ G + +  EK +     +KK+ LR++    +   E  IM       +V+++ S+ 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 79  DMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
             + ++ +ME++ GG   D VT      H  ++E +       + +A+ YLH  G +HRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIVT------HTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           IK D++LL++ G +KL+DFG   QV K    +  + VGTP ++APEV+  +        Y
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL-VGTPYWMAPEVISRLP-------Y 218
Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI----RLSTAM 251
               D+WS+G++  E++ G  P+  E        I      D  S P  +    ++S+ +
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-----RD--SLPPRVKDLHKVSSVL 271
Query: 252 VNFVQ-SLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFH 297
             F+   LV++   R    ++LGHP F  L   P CI P  ++ + H
Sbjct: 272 RGFLDLMLVREPSQRATAQELLGHP-FLKLAGPPSCIVPLMRQYRHH 317

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 112/227 (49%), Gaps = 32/227 (14%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYL-------------VEEKQSHNTFVMKKVLREKMPNTI 57
           ++   ++ + + I +GNF  + L             + +K   N+  ++K+ RE      
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV----- 57
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
              IM     P IV LF   +    +Y +MEY +GG+    L    HG++ E +AR    
Sbjct: 58  --RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFR 113
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           ++  AVQY H    VHRD+K +N+LL A  ++K+ DFG + +     ++ +    G+P Y
Sbjct: 114 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF--CGSPPY 171
Query: 178 VAPEVLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
            APE+ +          Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 172 AAPELFQ-------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 211

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 36/265 (13%)
Query: 22  FIQQGNFGDIYLVEEKQSHNTFVMKKVL---------REKMPNTIERDIMVKSKCPYIVN 72
           F+ +G F   + + +  +   F  K V          REKM  ++E  I       ++V 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVG 81
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
               F+D + V+ ++E       + L + +    L+E +AR+Y+ ++    QYLH    +
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRD+K  N+ L+    +K+ DFG AT+V+ +G  K  +  GTP Y+APEVL         
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLS-------K 191
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV 252
            G++   D+WSIG + Y LL G  PF    L  TY  I     ++  S P  I    A  
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEYSIPKHINPVAA-- 245
Query: 253 NFVQSLVQKL-----DARLNMDQVL 272
               SL+QK+      AR  ++++L
Sbjct: 246 ----SLIQKMLQTDPTARPTINELL 266

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 3   FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 119
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 177
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 178 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 231 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 272

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 59/166 (35%), Positives = 98/166 (59%), Gaps = 14/166 (8%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYI 116
           E +I+ K   P I+ +  +F D    Y ++E + GG+ F  ++ N+    L E+  + Y 
Sbjct: 190 EIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYF 245
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVG 173
           Y++  AVQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   G
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CG 303
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           TP Y+APEVL     + G+ GY  + D WS+GV+ +  L+G  PF+
Sbjct: 304 TPTYLAPEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 118/222 (53%), Gaps = 18/222 (8%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E +I+ + + P I+ L   F++   V  I+E V+GG+    L  +    L+E +A  ++ 
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLK 122
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           ++   V YLH     H D+KP+N++L         +KL DFG A +++     K+I   G
Sbjct: 123 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--G 180
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  ET   T ++I A 
Sbjct: 181 TPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233
Query: 234 DTE-DTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGH 274
           + + D   F ++  L+   +   + LV+    R+ + Q L H
Sbjct: 234 NYDFDEEYFSNTSELAKDFIR--RLLVKDPKRRMXIAQSLEH 273

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVDDY-YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 59/166 (35%), Positives = 98/166 (59%), Gaps = 14/166 (8%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYI 116
           E +I+ K   P I+ +  +F D    Y ++E + GG+ F  ++ N+    L E+  + Y 
Sbjct: 204 EIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYF 259
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVG 173
           Y++  AVQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   G
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CG 317
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           TP Y+APEVL     + G+ GY  + D WS+GV+ +  L+G  PF+
Sbjct: 318 TPTYLAPEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 3   FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 119
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 177
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 178 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 231 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 272

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 114/223 (51%), Gaps = 11/223 (4%)
Query: 58  ERDIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           E DI+ K S  P I+ L  +++     + + + +  G+    L  +    LSE + R  +
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIM 117
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
             L + +  LH L  VHRD+KP+N+LL    ++KLTDFG + Q+D   +++ +   GTP 
Sbjct: 118 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--CGTPS 175
Query: 177 YVAPEVLEW-MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
           Y+APE++E  M  NH   GY    D+WS GV+ Y LL GS PF +    +    I++ + 
Sbjct: 176 YLAPEIIECSMNDNH--PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 233
Query: 236 EDTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
           +     P     S  + + V + LV +   R   ++ L HP F
Sbjct: 234 Q--FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 114/223 (51%), Gaps = 11/223 (4%)
Query: 58  ERDIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           E DI+ K S  P I+ L  +++     + + + +  G+    L  +    LSE + R  +
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIM 130
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
             L + +  LH L  VHRD+KP+N+LL    ++KLTDFG + Q+D   +++ +   GTP 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--CGTPS 188
Query: 177 YVAPEVLEW-MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
           Y+APE++E  M  NH   GY    D+WS GV+ Y LL GS PF +    +    I++ + 
Sbjct: 189 YLAPEIIECSMNDNH--PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 236 EDTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
           +     P     S  + + V + LV +   R   ++ L HP F
Sbjct: 247 Q--FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 112/210 (53%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I + +   +  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 183
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 184 ----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 119/220 (54%), Gaps = 18/220 (8%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--IERDIMVKSKCPY--IVNLFYSFQDMN 81
           G FG ++  EE  +      K +    M +   ++ +I V ++  +  ++ L+ +F+  N
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159
Query: 82  HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNM 141
            +  +MEYV GG+    + ++ +  L+E     ++ ++ + ++++H +  +H D+KP+N+
Sbjct: 160 DIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQMYILHLDLKPENI 218
Query: 142 LLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           L        +K+ DFG A +     ++K  V  GTPE++APEV+ +       D  +   
Sbjct: 219 LCVNRDAKQIKIIDFGLARRYKPREKLK--VNFGTPEFLAPEVVNY-------DFVSFPT 269
Query: 200 DLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC--DTED 237
           D+WS+GV++Y LL+G +PF  +    T ++ILAC  D ED
Sbjct: 270 DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 118/222 (53%), Gaps = 18/222 (8%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E +I+ + + P I+ L   F++   V  I+E V+GG+    L  +    L+E +A  ++ 
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLK 136
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           ++   V YLH     H D+KP+N++L         +KL DFG A +++     K+I   G
Sbjct: 137 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--G 194
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  ET   T ++I A 
Sbjct: 195 TPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGETKQETLTNISAV 247
Query: 234 DTE-DTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGH 274
           + + D   F ++  L+   +   + LV+    R+ + Q L H
Sbjct: 248 NYDFDEEYFSNTSELAKDFIR--RLLVKDPKRRMXIAQSLEH 287

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 181
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 182 ----FHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTIERDIMVKS--KCPYIVNL 73
           +++ + I  GNFG   L+ +KQS+    +K + R EK+   ++R+I+     + P IV  
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRF 80
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
                   H+  +MEY +GG+    + N   G  SE +ARF+  +L   V Y H +   H
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 134 RDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           RD+K +N LL  S    LK+  FG +     + + K    VGTP Y+APEVL   E    
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT--VGTPAYIAPEVLLKKE---- 192
Query: 192 SDGYTGS-CDLWSIGVVSYELLTGSTPF 218
              Y G   D+WS GV  Y +L G+ PF
Sbjct: 193 ---YDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 183
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 184 ----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 183
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 184 ----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 15  SDFDIKRFIQQGNFGDIYL-------------VEEKQSHNTFVMKKVLREKMPNTIERDI 61
            ++ + + I +GNF  + L             + +K   N+  ++K+ RE         I
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREV-------RI 66
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M     P IV LF   +    +Y +MEY +GG+    L    HG + E +AR    ++  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVS 124
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           AVQY H    VHRD+K +N+LL A  ++K+ DFG + +     ++ +    G+P Y APE
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF--CGSPPYAAPE 182
Query: 182 VLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
           + +          Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 183 LFQ-------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 183
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 184 ----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 183
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 184 ----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 183
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 184 ----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 15  SDFDIKRFIQQGNFGDIYL-------------VEEKQSHNTFVMKKVLREKMPNTIERDI 61
            ++ + + I +GNF  + L             + +K   N+  ++K+ RE         I
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV-------RI 66
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M     P IV LF   +    +Y +MEY +GG+    L    HG + E +AR    ++  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVS 124
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           AVQY H    VHRD+K +N+LL A  ++K+ DFG + +     ++ +    G+P Y APE
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF--CGSPPYAAPE 182
Query: 182 VLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
           + +          Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 183 LFQ-------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE-- 183
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 184 ----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVDDY-YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 15  SDFDIKRFIQQGNFGDIYL-------------VEEKQSHNTFVMKKVLREKMPNTIERDI 61
            ++ + + I +GNF  + L             + +K   N+  ++K+ RE         I
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV-------RI 66
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M     P IV LF   +    +Y +MEY +GG+    L    HG + E +AR    ++  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVS 124
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           AVQY H    VHRD+K +N+LL A  ++K+ DFG + +     ++ +    G+P Y APE
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF--CGSPPYAAPE 182
Query: 182 VLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
           + +          Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 183 LFQ-------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 32/223 (14%)
Query: 15  SDFDIKRFIQQGNFGDIYL-------------VEEKQSHNTFVMKKVLREKMPNTIERDI 61
            ++ + + I +GNF  + L             + +K   N+  ++K+ RE         I
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREV-------RI 66
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M     P IV LF   +    +Y +MEY +GG+    L    HG + E +AR    ++  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVS 124
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           AVQY H    VHRD+K +N+LL A  ++K+ DFG + +     ++ +    G P Y APE
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAF--CGAPPYAAPE 182
Query: 182 VLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
           + +          Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 183 LFQ-------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 21  RF--IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMV--KSKCPYIVNLF 74
           RF  I QG  G +Y   +  +     ++++  ++ P    I  +I+V  ++K P IVN  
Sbjct: 24  RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            S+   + ++ +MEY+ GG    ++       + E +      E  QA+++LH    +HR
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           DIK DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPYWMAPEVVT-------RKA 192
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y    D+WS+G+++ E++ G  P+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 139/284 (48%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I+E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTP +VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPAFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 21  RF--IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMV--KSKCPYIVNLF 74
           RF  I QG  G +Y   +  +     ++++  ++ P    I  +I+V  ++K P IVN  
Sbjct: 24  RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            S+   + ++ +MEY+ GG    ++       + E +      E  QA+++LH    +HR
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           DIK DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-------RKA 192
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y    D+WS+G+++ E++ G  P+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 21  RF--IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMV--KSKCPYIVNLF 74
           RF  I QG  G +Y   +  +     ++++  ++ P    I  +I+V  ++K P IVN  
Sbjct: 25  RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            S+   + ++ +MEY+ GG    ++       + E +      E  QA+++LH    +HR
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           DIK DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXM-VGTPYWMAPEVVT-------RKA 193
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y    D+WS+G+++ E++ G  P+
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G +G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 183
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 184 ----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 32/223 (14%)
Query: 15  SDFDIKRFIQQGNFGDIYL-------------VEEKQSHNTFVMKKVLREKMPNTIERDI 61
            ++ + + I +GNF  + L             + +K   N+  ++K+ RE         I
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREV-------RI 66
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M     P IV LF   +    +Y +MEY +GG+    L    HG + E +AR    ++  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVS 124
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           AVQY H    VHRD+K +N+LL A  ++K+ DFG + +     ++      G+P Y APE
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEF--CGSPPYAAPE 182
Query: 182 VLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
           + +          Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 183 LFQ-------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 141/286 (49%), Gaps = 22/286 (7%)
Query: 10  KNVSASDF-DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMV 63
           ++++  DF +I   +  G FG +Y  + K++ +     KV+  K         +E DI+ 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGG--DFVTLLENQPHGYLSESKARFYIYELAQ 121
               P IV L  +F   N+++ ++E+  GG  D V L   +P   L+ES+ +    +   
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLD 146
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAP 180
           A+ YLH    +HRD+K  N+L +  G +KL DFG SA       R  S   +GTP ++AP
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF--IGTPYWMAP 204
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           EV+  M        Y    D+WS+G+   E+     P ++E   M     +A     T++
Sbjct: 205 EVV--MCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKSEPPTLA 261
Query: 241 FPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPP 285
            PS  R S+   +F++  ++K +DAR    Q+L HP F  +DS+ P
Sbjct: 262 QPS--RWSSNFKDFLKKCLEKNVDARWTTSQLLQHP-FVTVDSNKP 304

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 139/284 (48%), Gaps = 29/284 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           R++ +  +   P ++ L   +++   V  I E V GG+    L  +    L+E +A  ++
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVPV 172
            ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-- 178
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GTPE+VAPE++     N+   G     D+WSIGV++Y LL+G++PF  +T   T +++ A
Sbjct: 179 GTPEFVAPEIV-----NYEPLGL--EADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
Query: 233 CDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            + E    + S+   S    +F++  LV+    R+ +   L HP
Sbjct: 232 VNYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHP 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 141/286 (49%), Gaps = 22/286 (7%)
Query: 10  KNVSASDF-DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMV 63
           ++++  DF +I   +  G FG +Y  + K++ +     KV+  K         +E DI+ 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGG--DFVTLLENQPHGYLSESKARFYIYELAQ 121
               P IV L  +F   N+++ ++E+  GG  D V L   +P   L+ES+ +    +   
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLD 146
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAP 180
           A+ YLH    +HRD+K  N+L +  G +KL DFG SA       R  S   +GTP ++AP
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAP 204
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           EV+  M        Y    D+WS+G+   E+     P ++E   M     +A     T++
Sbjct: 205 EVV--MCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKSEPPTLA 261
Query: 241 FPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPP 285
            PS  R S+   +F++  ++K +DAR    Q+L HP F  +DS+ P
Sbjct: 262 QPS--RWSSNFKDFLKKCLEKNVDARWTTSQLLQHP-FVTVDSNKP 304

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPY--I 70
           D+D+ + + +G  G++ L   + +     +K V  ++    P  I+++I +     +  +
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-GTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +  + GT  YVAPE+L+  E  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE-- 182
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                +    D+WS G+V   +L G  P++
Sbjct: 183 ----FHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 142/287 (49%), Gaps = 24/287 (8%)
Query: 10  KNVSASDF-DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMV 63
           ++++  DF +I   +  G FG +Y  + K++ +     KV+  K         +E DI+ 
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEEELEDYMVEIDILA 89
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGG--DFVTLLENQPHGYLSESKARFYIYELAQ 121
               P IV L  +F   N+++ ++E+  GG  D V L   +P   L+ES+ +    +   
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLD 146
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI--KSIVPVGTPEYVA 179
           A+ YLH    +HRD+K  N+L +  G +KL DFG +    KN R   +    +GTP ++A
Sbjct: 147 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRXIQRRDXFIGTPYWMA 203
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PEV+  M        Y    D+WS+G+   E+     P ++E   M     +A     T+
Sbjct: 204 PEVV--MCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKSEPPTL 260
Query: 240 SFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPP 285
           + PS  R S+   +F++  ++K +DAR    Q+L HP F  +DS+ P
Sbjct: 261 AQPS--RWSSNFKDFLKKCLEKNVDARWTTSQLLQHP-FVTVDSNKP 304

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 21  RF--IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMV--KSKCPYIVNLF 74
           RF  I QG  G +Y   +  +     ++++  ++ P    I  +I+V  ++K P IVN  
Sbjct: 24  RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            S+   + ++ +MEY+ GG    ++       + E +      E  QA+++LH    +HR
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           DIK DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM-VGTPYWMAPEVVT-------RKA 192
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y    D+WS+G+++ E++ G  P+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 116/227 (51%), Gaps = 22/227 (9%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERD--IMVKSKCPY 69
           ++D+K  + +G F  +     K +   F  K +  +K+       +ER+  I  K + P 
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           IV L  S Q+ +  Y + + VTGG+ F  ++  +   + SE+ A   I ++ +++ Y H 
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS 146
Query: 129 LGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
            G VHR++KP+N+LL++      +KL DFG A +V+ +         GTP Y++PEVL+ 
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK- 203
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
                  D Y+   D+W+ GV+ Y LL G  PF  E     Y+ I A
Sbjct: 204 ------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 32/276 (11%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKC-- 67
           A  ++I   + +G+FG++   +++ +   + +K + +    N    TI R++ +  K   
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P I+ LF   +D +  Y + E  TGG+    +  +     SE  A   I ++   + Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 128 GLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
               VHRD+KP+N+LL +      +K+ DFG +T   +N ++K    +GT  Y+APEVL 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR 196
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILACDTEDTVS 240
                     Y   CD+WS GV+ Y LL+G+ PF     Y+ L    +   A D     +
Sbjct: 197 --------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248
Query: 241 FPSSIR-LSTAMVNFVQSLVQKLDARLNMDQVLGHP 275
                + L   M+ F  SL      R+   Q L HP
Sbjct: 249 ISDDAKDLIRKMLTFHPSL------RITATQCLEHP 278

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---RDIMVKSKC 67
           +++  D++++  I  G    +             +K++  EK   +++   ++I   S+C
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 68  --PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN------QPHGYLSESKARFYIYEL 119
             P IV+ + SF   + ++ +M+ ++GG  + ++++         G L ES     + E+
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI------KSIVPVG 173
            + ++YLH  G +HRD+K  N+LL   G +++ DFG +  +   G I      K+   VG
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF--VG 188
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           TP ++APEV+E +       GY    D+WS G+ + EL TG+ P++
Sbjct: 189 TPCWMAPEVMEQVR------GYDFKADIWSFGITAIELATGAAPYH 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 124/252 (49%), Gaps = 28/252 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDIMVKSKC--PYIVNLFYSF 77
           I +G+FG+++   + ++     +K +     E     I+++I V S+C   Y+   + S+
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
              + ++ IMEY+ GG  + LL   P     E +    + E+ + + YLH    +HRDIK
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+LLS  G +KL DFG A Q+  + +IK    VGTP ++APEV++          Y  
Sbjct: 148 AANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIQ-------QSAYDS 199
Query: 198 SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQS 257
             D+WS+G+ + EL  G  P +    DM    +L    ++           T + +F +S
Sbjct: 200 KADIWSLGITAIELAKGEPPNS----DMHPMRVLFLIPKNNP--------PTLVGDFTKS 247
Query: 258 LVQKLDARLNMD 269
             + +DA LN D
Sbjct: 248 FKEFIDACLNKD 259

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 21  RF--IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMV--KSKCPYIVNLF 74
           RF  I QG  G +Y   +  +     ++++  ++ P    I  +I+V  ++K P IVN  
Sbjct: 25  RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 75  YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            S+   + ++ +MEY+ GG    ++       + E +      E  QA+++LH    +HR
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           +IK DN+LL   G +KLTDFG   Q+      +S + VGTP ++APEV+           
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-------RKA 193
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y    D+WS+G+++ E++ G  P+
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 32/276 (11%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKC-- 67
           A  ++I   + +G+FG++   +++ +   + +K + +    N    TI R++ +  K   
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P I+ LF   +D +  Y + E  TGG+    +  +     SE  A   I ++   + Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 128 GLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
               VHRD+KP+N+LL +      +K+ DFG +T   +N ++K    +GT  Y+APEVL 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR 196
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILACDTEDTVS 240
                     Y   CD+WS GV+ Y LL+G+ PF     Y+ L    +   A D     +
Sbjct: 197 --------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248
Query: 241 FPSSIR-LSTAMVNFVQSLVQKLDARLNMDQVLGHP 275
                + L   M+ F  SL      R+   Q L HP
Sbjct: 249 ISDDAKDLIRKMLTFHPSL------RITATQCLEHP 278

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 115/231 (49%), Gaps = 33/231 (14%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR---------------EK 52
           ++  +  S F +++ +  G +G++ L +EK  H+   +K + +               EK
Sbjct: 30  KEGKIGESYFKVRK-LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 53  MPNTIERDI-MVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSES 110
               I  +I ++KS   P I+ LF  F+D  + Y + E+  GG+    + N+      E 
Sbjct: 89  FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDEC 146
Query: 111 KARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIK 167
            A   + ++   + YLH    VHRDIKP+N+LL   ++  ++K+ DFG ++   K+ +++
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
               +GT  Y+APEVL+          Y   CD+WS GV+ Y LL G  PF
Sbjct: 207 D--RLGTAYYIAPEVLK--------KKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 138/274 (50%), Gaps = 29/274 (10%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNL 73
           R + +G FG+++  + K +   +  KK+ ++++          +E+ I+ K    +IV+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 74  FYSFQDMNHVYFIMEYVTGGDF----VTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
            Y+F+    +  +M  + GGD       + E+ P     E +A FY  ++   +++LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQIVSGLEHLHQR 308
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             ++RD+KP+N+LL   G+++++D G A ++ K G+ K+    GTP ++APE+L   E  
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELLLGEE-- 365
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
                Y  S D +++GV  YE++    PF      +    +     E  V++P   + S 
Sbjct: 366 -----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418
Query: 250 AMVNFVQSLVQK-LDARLNM-----DQVLGHPVF 277
           A  +F ++L+QK  + RL       D +  HP+F
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 138/274 (50%), Gaps = 29/274 (10%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNL 73
           R + +G FG+++  + K +   +  KK+ ++++          +E+ I+ K    +IV+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 74  FYSFQDMNHVYFIMEYVTGGDF----VTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
            Y+F+    +  +M  + GGD       + E+ P     E +A FY  ++   +++LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQIVSGLEHLHQR 308
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             ++RD+KP+N+LL   G+++++D G A ++ K G+ K+    GTP ++APE+L   E  
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELLLGEE-- 365
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
                Y  S D +++GV  YE++    PF      +    +     E  V++P   + S 
Sbjct: 366 -----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418
Query: 250 AMVNFVQSLVQK-LDARLNM-----DQVLGHPVF 277
           A  +F ++L+QK  + RL       D +  HP+F
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 138/274 (50%), Gaps = 29/274 (10%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNL 73
           R + +G FG+++  + K +   +  KK+ ++++          +E+ I+ K    +IV+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 74  FYSFQDMNHVYFIMEYVTGGDF----VTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
            Y+F+    +  +M  + GGD       + E+ P     E +A FY  ++   +++LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQIVSGLEHLHQR 308
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             ++RD+KP+N+LL   G+++++D G A ++ K G+ K+    GTP ++APE+L   E  
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELLLGEE-- 365
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
                Y  S D +++GV  YE++    PF      +    +     E  V++P   + S 
Sbjct: 366 -----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418
Query: 250 AMVNFVQSLVQK-LDARLNM-----DQVLGHPVF 277
           A  +F ++L+QK  + RL       D +  HP+F
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 116/227 (51%), Gaps = 22/227 (9%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERD--IMVKSKCPY 69
           ++D+K  + +G F  +     K +   F  K +  +K+       +ER+  I  K + P 
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           IV L  S Q+ +  Y + + VTGG+ F  ++  +   + SE+ A   I ++ +++ Y H 
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS 122
Query: 129 LGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
            G VHR++KP+N+LL++      +KL DFG A +V+ +         GTP Y++PEVL+ 
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK- 179
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
                  D Y+   D+W+ GV+ Y LL G  PF  E     Y+ I A
Sbjct: 180 ------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 116/227 (51%), Gaps = 22/227 (9%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERD--IMVKSKCPY 69
           ++D+K  + +G F  +     K +   F  K +  +K+       +ER+  I  K + P 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           IV L  S Q+ +  Y + + VTGG+ F  ++  +   + SE+ A   I ++ +++ Y H 
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS 123
Query: 129 LGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
            G VHR++KP+N+LL++      +KL DFG A +V+ +         GTP Y++PEVL+ 
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK- 180
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
                  D Y+   D+W+ GV+ Y LL G  PF  E     Y+ I A
Sbjct: 181 ------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 138/274 (50%), Gaps = 29/274 (10%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNL 73
           R + +G FG+++  + K +   +  KK+ ++++          +E+ I+ K    +IV+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 74  FYSFQDMNHVYFIMEYVTGGDF----VTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
            Y+F+    +  +M  + GGD       + E+ P     E +A FY  ++   +++LH  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQIVSGLEHLHQR 308
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             ++RD+KP+N+LL   G+++++D G A ++ K G+ K+    GTP ++APE+L   E  
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELLLGEE-- 365
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
                Y  S D +++GV  YE++    PF      +    +     E  V++P   + S 
Sbjct: 366 -----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSP 418
Query: 250 AMVNFVQSLVQK-LDARLNM-----DQVLGHPVF 277
           A  +F ++L+QK  + RL       D +  HP+F
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 115/226 (50%), Gaps = 25/226 (11%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE---RDIMVKSKC 67
           +++  D++++  I  G    +             +K++  EK   +++   ++I   S+C
Sbjct: 6   SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 65
Query: 68  --PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN------QPHGYLSESKARFYIYEL 119
             P IV+ + SF   + ++ +M+ ++GG  + ++++         G L ES     + E+
Sbjct: 66  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI------KSIVPVG 173
            + ++YLH  G +HRD+K  N+LL   G +++ DFG +  +   G I      K+   VG
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF--VG 183
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           TP ++APEV+E +       GY    D+WS G+ + EL TG+ P++
Sbjct: 184 TPCWMAPEVMEQVR------GYDFKADIWSFGITAIELATGAAPYH 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/182 (36%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           K P IV L  S  +  H Y I + VTGG+ F  ++  +   Y SE+ A   I ++ +AV 
Sbjct: 79  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVL 135
Query: 125 YLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           + H +G VHRD+KP+N+LL++      +KL DFG A +V+   +       GTP Y++PE
Sbjct: 136 HCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPE 194
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           VL         D Y    DLW+ GV+ Y LL G  PF  E     Y  I A        F
Sbjct: 195 VLR-------KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----GAYDF 243
Query: 242 PS 243
           PS
Sbjct: 244 PS 245

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 116/227 (51%), Gaps = 22/227 (9%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----NTIERD--IMVKSKCPY 69
           ++D+K  + +G F  +     K +   F  K +  +K+       +ER+  I  K + P 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           IV L  S Q+ +  Y + + VTGG+ F  ++  +   + SE+ A   I ++ +++ Y H 
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS 123
Query: 129 LGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
            G VHR++KP+N+LL++      +KL DFG A +V+ +         GTP Y++PEVL+ 
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK- 180
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
                  D Y+   D+W+ GV+ Y LL G  PF  E     Y+ I A
Sbjct: 181 ------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 17/222 (7%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMN--HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
           E  I+ K   P +V L     D N  H+Y + E V  G  + +   +P   LSE +ARFY
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSEDQARFY 142
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
             +L + ++YLH    +HRDIKP N+L+   GH+K+ DFG + +   +  + S   VGTP
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT-VGTP 201
Query: 176 EYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
            ++APE L     +     ++G + D+W++GV  Y  + G  PF  E +   +S I    
Sbjct: 202 AFMAPESL-----SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI---- 252
Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
               + FP    ++  + + +  ++ K  ++R+ + ++  HP
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 139/279 (49%), Gaps = 28/279 (10%)
Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ERD 60
           KEL +K + A D      + +G FG ++   E  S  T+ M K ++ K  + +    E  
Sbjct: 1   KELYEKYMIAED------LGRGEFGIVHRCVETSSKKTY-MAKFVKVKGTDQVLVKKEIS 53
Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           I+  ++   I++L  SF+ M  +  I E+++G D    + N     L+E +   Y++++ 
Sbjct: 54  ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVC 112
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           +A+Q+LH     H DI+P+N++     +  +K+ +FG A Q+      + +     PEY 
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYY 170
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-TED 237
           APEV       H  D  + + D+WS+G + Y LL+G  PF  ET      +I+  + T D
Sbjct: 171 APEV-------HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 238 TVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHP 275
             +F     +S   ++FV + LV++  +R+   + L HP
Sbjct: 224 EEAFKE---ISIEAMDFVDRLLVKERKSRMTASEALQHP 259

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-----PNTIERDI--MVKSKCPYIVNLFYSFQ 78
           G FG + + E + + +   +K + R+K+        I+R+I  +   + P+I+ L+    
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
                + +MEYV+GG+    +    HG + E +AR    ++  AV Y H    VHRD+KP
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP 139
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+LL A  + K+ DFG +  +     +++    G+P Y APEV+           Y G 
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGEFLRT--SCGSPNYAAPEVIS-------GRLYAGP 190
Query: 199 -CDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             D+WS GV+ Y LL G+ PF+ E +   +  I
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IERDIMVKSKC--P 68
            ++ + + I +GNF  + L     +     +K + + ++ ++    + R++ +      P
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            IV LF   +    +Y + EY +GG+    L    HG   E +AR    ++  AVQY H 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYL--VAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              VHRD+K +N+LL A  ++K+ DFG + +     ++ +    G P Y APE+ +  + 
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAF--CGAPPYAAPELFQGKK- 188
Query: 189 NHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETL 223
                 Y G   D+WS+GV+ Y L++GS PF+ + L
Sbjct: 189 ------YDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           K P IV L  S  +  H Y I + VTGG+ F  ++  +   Y SE+ A   I ++ +AV 
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVL 124
Query: 125 YLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           + H +G VHR++KP+N+LL++      +KL DFG A +V+   +       GTP Y++PE
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPE 183
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           VL         D Y    DLW+ GV+ Y LL G  PF  E     Y  I A        F
Sbjct: 184 VLR-------KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----GAYDF 232
Query: 242 PS 243
           PS
Sbjct: 233 PS 234

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-----PNTIERDI--MVKSKCPYIVNLFYSFQ 78
           G FG + + E + + +   +K + R+K+        I+R+I  +   + P+I+ L+    
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
                + +MEYV+GG+    +    HG + E +AR    ++  AV Y H    VHRD+KP
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP 139
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           +N+LL A  + K+ DFG +  +     ++     G+P Y APEV+           Y G 
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGEFLRD--SCGSPNYAAPEVIS-------GRLYAGP 190
Query: 199 -CDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             D+WS GV+ Y LL G+ PF+ E +   +  I
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 97/171 (56%), Gaps = 14/171 (8%)
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYL-SESKARFYIYELAQAV 123
           K P+IV L  ++     +Y + E++ G D    +++    G++ SE+ A  Y+ ++ +A+
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 124 QYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           +Y H    +HRD+KP+N+LL++   +  +KL DFG A Q+ ++G +     VGTP ++AP
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAG-GRVGTPHFMAP 202
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
           EV++        + Y    D+W  GV+ + LL+G  PF Y T +  +  I+
Sbjct: 203 EVVK-------REPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGII 245

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 27/244 (11%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-----PNTIERDI--MVKSKCPYIVNLFYSFQ 78
           G FG + + + + + +   +K + R+K+        I R+I  +   + P+I+ L+    
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 79  DMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
             + ++ +MEYV+GG+ F  + +N   G L E ++R    ++   V Y H    VHRD+K
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
           P+N+LL A  + K+ DFG +  +     ++     G+P Y APEV+           Y G
Sbjct: 144 PENVLLDAHMNAKIADFGLSNMMSDGEFLRX--SCGSPNYAAPEVI-------SGRLYAG 194
Query: 198 S-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQ 256
              D+WS GV+ Y LL G+ PF+ + +   +  I  CD      F +   L+ ++++ ++
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDG----IFYTPQYLNPSVISLLK 248
Query: 257 SLVQ 260
            ++Q
Sbjct: 249 HMLQ 252

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFYSFQ 78
           G +G++ L ++K +     +K + +  +  T        E  ++ +   P I+ L+  F+
Sbjct: 15  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE 74
Query: 79  DMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           D  + Y +ME   GG+ F  ++  Q     SE  A   + ++     YLH    VHRD+K
Sbjct: 75  DKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTTYLHKHNIVHRDLK 131
Query: 138 PDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           P+N+LL   S    +K+ DFG +   +  G++K    +GT  Y+APEVL           
Sbjct: 132 PENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE--RLGTAYYIAPEVLR--------KK 181
Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYET 222
           Y   CD+WS GV+ Y LL G  PF  +T
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPPFGGQT 209

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 109/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 16  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 72
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D+ ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 190
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 191 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL 143
           Y + E + GG  ++ +  + H   +E +A   + ++A A+ +LH  G  HRD+KP+N+L 
Sbjct: 87  YLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 144 ---SATGHLKLTDFGSATQVDKNGRIKSI------VPVGTPEYVAPEVLEWMEGNHGSDG 194
              +    +K+ DFG  + +  NG    I       P G+ EY+APEV+E    +  +  
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF--SEEASI 202
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDT----------EDTVSFPS 243
           Y   CDLWS+GV+ Y LL+G  PF      D  +    AC            E    FP 
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD 262
Query: 244 S--IRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
                +S A  + +   LV+    RL+  QVL HP
Sbjct: 263 KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC------PYIVNLFYSFQD 79
           G +G++ L  +K +H    +K + +  +  +    ++ +         P I+ L+  F+D
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107
Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGY-LSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
             + Y +ME   GG+   L +   H    +E  A   I ++   V YLH    VHRD+KP
Sbjct: 108 KRNYYLVMECYKGGE---LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKP 164
Query: 139 DNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +N+LL +      +K+ DFG +   +   ++K    +GT  Y+APEVL           Y
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLR--------KKY 214
Query: 196 TGSCDLWSIGVVSYELLTGSTPFNYET 222
              CD+WSIGV+ + LL G  PF  +T
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQT 241

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 27/229 (11%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           I+ L   F+D    Y + E + GG  +  ++ Q H   +E +A   + ++A A+ +LH  
Sbjct: 73  ILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH--FNEREASRVVRDVAAALDFLHTK 130
Query: 130 GYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSI------VPVGTPEYVAP 180
           G  HRD+KP+N+L  +      +K+ DF   + +  N     I       P G+ EY+AP
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDT---- 235
           EV+E       +  Y   CDLWS+GVV Y +L+G  PF  +   D  +     C      
Sbjct: 191 EVVEVFTDQ--ATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 248
Query: 236 ------EDTVSFPSS--IRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
                 E    FP      +S+   + +   LV+    RL+  QVL HP
Sbjct: 249 LFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHP 297

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           +  G +G++ L ++K +     +K + +  +  T        E  ++ +   P I+ L+ 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 76  SFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            F+D  + Y +ME   GG+ F  ++  Q     SE  A   + ++     YLH    VHR
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTTYLHKHNIVHR 145
Query: 135 DIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           D+KP+N+LL   S    +K+ DFG +   +  G++K    +GT  Y+APEVL        
Sbjct: 146 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE--RLGTAYYIAPEVLR------- 196
Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYET 222
              Y   CD+WS GV+ Y LL G  PF  +T
Sbjct: 197 -KKYDEKCDVWSCGVILYILLCGYPPFGGQT 226

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 50  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 106
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 224
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 225 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 28  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 84
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 202
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 203 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 35  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 91
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 152 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 209
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 210 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVKSKCPYIVNLFY 75
           I +G+FG   LV+  +    +V+K++   +M ++ ER+       ++   K P IV    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           SF++   +Y +M+Y  GGD    +  Q      E +   +  ++  A++++H    +HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           IK  N+ L+  G ++L DFG A  ++    +     +GTP Y++PE+ E       +  Y
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICE-------NKPY 202
Query: 196 TGSCDLWSIGVVSYELLT 213
               D+W++G V YEL T
Sbjct: 203 NNKSDIWALGCVLYELCT 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 24  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 80
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 141 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 198
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 199 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 107/219 (48%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL+ K     E  IM K   
Sbjct: 16  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDH 72
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 190
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 191 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 17  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 73
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 134 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 191
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 192 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 28  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 84
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 202
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 203 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 16  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 72
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 190
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 191 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 16  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 72
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 190
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 191 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           K P IV L  S  +    Y + + VTGG+ F  ++  +   Y SE+ A   I+++ ++V 
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIHQILESVN 144
Query: 125 YLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           ++H    VHRD+KP+N+LL++      +KL DFG A +V    +       GTP Y++PE
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ-AWFGFAGTPGYLSPE 203
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           VL         D Y    D+W+ GV+ Y LL G  PF  E     Y  I A        F
Sbjct: 204 VLR-------KDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKA----GAYDF 252
Query: 242 PSS--IRLSTAMVNFV-QSLVQKLDARLNMDQVLGHP 275
           PS     ++    N + Q L      R+  DQ L HP
Sbjct: 253 PSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHP 289

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 111/225 (49%), Gaps = 20/225 (8%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE-----KMPNTIERDI--MVKSKCPY 69
           + I+  + +G+FG + L    ++     +K + R+      M   +ER+I  +   + P+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           I+ L+        +  ++EY  G  F  ++E +    ++E + R +  ++  A++Y H  
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH 127
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             VHRD+KP+N+LL    ++K+ DFG +  +     +K+    G+P Y APEV+      
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEVIN----- 180
Query: 190 HGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
                Y G   D+WS G+V Y +L G  PF+ E +   +  + +C
Sbjct: 181 --GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC 223

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 50  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 106
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 224
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 225 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 29  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 85
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 146 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 203
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 204 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 44  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 100
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 161 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 218
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 219 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 21  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 77
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 138 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 195
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 196 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 52  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 108
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 169 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 226
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 227 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 20  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 76
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 137 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRYYRA 194
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 195 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 54  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 110
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 171 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 228
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 229 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 16  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 72
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 190
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 191 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/182 (35%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           K P IV L  S  +    Y + + VTGG+ F  ++  +   Y SE+ A   I ++ ++V 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILESVN 117
Query: 125 YLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           + H  G VHRD+KP+N+LL   S    +KL DFG A +V  + +       GTP Y++PE
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPGYLSPE 176
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           VL         D Y    D+W+ GV+ Y LL G  PF  E     Y  I A        F
Sbjct: 177 VLR-------KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKA----GAYDF 225
Query: 242 PS 243
           PS
Sbjct: 226 PS 227

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTI---ERDIMVKSKCPYIVNLFYSFQ 78
           I +G+ G + +   + S     +KK+ LR++    +   E  IM   +   +V ++ S+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
             + ++ +ME++ GG    ++    H  ++E +       + QA+  LH  G +HRDIK 
Sbjct: 219 VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKS 275
Query: 139 DNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
           D++LL+  G +KL+DFG   QV K   R K +  VGTP ++APE++  +        Y  
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLP-------YGP 326
Query: 198 SCDLWSIGVVSYELLTGSTPF 218
             D+WS+G++  E++ G  P+
Sbjct: 327 EVDIWSLGIMVIEMVDGEPPY 347

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL++K     E  IM K   
Sbjct: 95  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDH 151
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 212 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 269
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 270 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           IV L  S  +    Y + + VTGG+ F  ++  +   Y SE+ A   I ++ +AV + H 
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQ 121
Query: 129 LGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
           +G VHRD+KP+N+LL++      +KL DFG A +V  + +       GTP Y++PEVL  
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPGYLSPEVLR- 179
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
                  + Y    D+W+ GV+ Y LL G  PF  E     Y  I A        FPS
Sbjct: 180 ------KEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKA----GAYDFPS 227

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL 143
           Y + E + GG  ++ +  + H   +E +A   + ++A A+ +LH  G  HRD+KP+N+L 
Sbjct: 87  YLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144
Query: 144 ---SATGHLKLTDFGSATQVDKNGRIKSI------VPVGTPEYVAPEVLEWMEGNHGSDG 194
              +    +K+ DF   + +  NG    I       P G+ EY+APEV+E    +  +  
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF--SEEASI 202
Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDT----------EDTVSFPS 243
           Y   CDLWS+GV+ Y LL+G  PF      D  +    AC            E    FP 
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD 262
Query: 244 S--IRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
                +S A  + +   LV+    RL+  QVL HP
Sbjct: 263 KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
           + ++ +ME+   G    L++N     L E    +   E+ + + +LH    +HRDIK  N
Sbjct: 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 159
Query: 141 MLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +LL+    +KL DFG + Q+D+  GR  +   +GTP ++APEV+   E    +  Y    
Sbjct: 160 VLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDAT--YDFKS 215
Query: 200 DLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQS-L 258
           DLWS+G+ + E+  G+ P      DM     L     +      S + S    +F++S L
Sbjct: 216 DLWSLGITAIEMAEGAPPL----CDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCL 271
Query: 259 VQKLDARLNMDQVLGHPVF 277
           V+    R   +Q++ HP  
Sbjct: 272 VKNHSQRPATEQLMKHPFI 290

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 107/219 (48%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL+ K     E  IM K   
Sbjct: 16  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDH 72
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 190
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 191 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/182 (35%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           K P IV L  S  +    Y + + VTGG+ F  ++  +   Y SE+ A   I ++ ++V 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILESVN 117
Query: 125 YLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           + H  G VHRD+KP+N+LL   S    +KL DFG A +V  + +       GTP Y++PE
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ-AWFGFAGTPGYLSPE 176
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           VL         D Y    D+W+ GV+ Y LL G  PF  E     Y  I A        F
Sbjct: 177 VLR-------KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKA----GAYDF 225
Query: 242 PS 243
           PS
Sbjct: 226 PS 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 107/219 (48%), Gaps = 19/219 (8%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC 67
           R + VS +D    + I  G+FG +Y  +   S     +KKVL+ K     E  IM K   
Sbjct: 16  RPQEVSYTD---TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDH 72
Query: 68  PYIVNLFYSF------QDMNHVYFIMEYVTGGDF-VTLLENQPHGYLSESKARFYIYELA 120
             IV L Y F      +D  ++  +++YV    + V    ++    L     + Y+Y+L 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +++ Y+H  G  HRDIKP N+LL   T  LKL DFGSA Q+ +     ++  + +  Y A
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRA 190
Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           PE++       G+  YT S D+WS G V  ELL G   F
Sbjct: 191 PELI------FGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTI---ERDIMVKSKCPYIVNLFYSFQ 78
           I +G+ G + L  EK S     +K + LR++    +   E  IM   +   +V ++ S+ 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
               ++ +ME++ GG    ++       L+E +       + QA+ YLH  G +HRDIK 
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           D++LL+  G +KL+DFG   Q+ K+   +  + VGTP ++APEV+           Y   
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKXL-VGTPYWMAPEVIS-------RSLYATE 221
Query: 199 CDLWSIGVVSYELLTGSTPF 218
            D+WS+G++  E++ G  P+
Sbjct: 222 VDIWSLGIMVIEMVDGEPPY 241

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 20/224 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVL-REKMPNTIERDI--MVKSKC 67
            ++ I + + +G+FG + L     +     +K    KVL +  M   IER+I  +   + 
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 73
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+I+ L+   +  + +  ++EY     F  +++      +SE +AR +  ++  AV+Y H
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH 130
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP+N+LL    ++K+ DFG +  +     +K+    G+P Y APEV+    
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEVIS--- 185
Query: 188 GNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
                  Y G   D+WS GV+ Y +L    PF+ E++ + + +I
Sbjct: 186 ----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           +V ++ S+   + ++ +ME++ GG   D VT      H  ++E +       + QA+  L
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVL 141
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEW 185
           H  G +HRDIK D++LL+  G +KL+DFG   QV K   R K +  VGTP ++APE++  
Sbjct: 142 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISR 199
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +        Y    D+WS+G++  E++ G  P+
Sbjct: 200 LP-------YGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYL-SESKARFYIYELAQAV 123
           K P+IV L  ++     +Y + E++ G D    +++    G++ SE+ A  Y+ ++ +A+
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 124 QYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           +Y H    +HRD+KP  +LL++   +  +KL  FG A Q+ ++G +     VGTP ++AP
Sbjct: 146 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG-GRVGTPHFMAP 204
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
           EV++        + Y    D+W  GV+ + LL+G  PF Y T +  +  I+
Sbjct: 205 EVVK-------REPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGII 247

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           +V ++ S+   + ++ +ME++ GG   D VT      H  ++E +       + QA+  L
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVL 143
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEW 185
           H  G +HRDIK D++LL+  G +KL+DFG   QV K   R K +  VGTP ++APE++  
Sbjct: 144 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISR 201
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +        Y    D+WS+G++  E++ G  P+
Sbjct: 202 LP-------YGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 20/224 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVL-REKMPNTIERDI--MVKSKC 67
            ++ I + + +G+FG + L     +     +K    KVL +  M   IER+I  +   + 
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 72
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+I+ L+   +  + +  ++EY     F  +++      +SE +AR +  ++  AV+Y H
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH 129
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP+N+LL    ++K+ DFG +  +     +K+    G+P Y APEV+    
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEVIS--- 184
Query: 188 GNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
                  Y G   D+WS GV+ Y +L    PF+ E++ + + +I
Sbjct: 185 ----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           +V ++ S+   + ++ +ME++ GG   D VT      H  ++E +       + QA+  L
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVL 186
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEW 185
           H  G +HRDIK D++LL+  G +KL+DFG   QV K   R K +  VGTP ++APE++  
Sbjct: 187 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISR 244
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +        Y    D+WS+G++  E++ G  P+
Sbjct: 245 LP-------YGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 94/171 (54%), Gaps = 14/171 (8%)
Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYL-SESKARFYIYELAQAV 123
           K P+IV L  ++     +Y + E++ G D    +++    G++ SE+ A  Y+ ++ +A+
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 124 QYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           +Y H    +HRD+KP  +LL++   +  +KL  FG A Q+ ++G +     VGTP ++AP
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG-GRVGTPHFMAP 202
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
           EV++        + Y    D+W  GV+ + LL+G  PF Y T +  +  I+
Sbjct: 203 EVVK-------REPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGII 245

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 77/144 (53%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +  D    Y +M ++ G D   L++   H  L E + +F +Y++ + ++Y+H  G +HRD
Sbjct: 98  TLDDFTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 153
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A Q D     +    V T  Y APEV L WM        
Sbjct: 154 LKPGNLAVNEDCELKILDFGLARQADS----EMXGXVVTRWYRAPEVILNWMR------- 202
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           YT + D+WS+G +  E++TG T F
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKTLF 226

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 20/224 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVL-REKMPNTIERDI--MVKSKC 67
            ++ I + + +G+FG + L     +     +K    KVL +  M   IER+I  +   + 
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+I+ L+   +  + +  ++EY     F  +++      +SE +AR +  ++  AV+Y H
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH 120
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP+N+LL    ++K+ DFG +  +     +K+    G+P Y APEV+    
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEVIS--- 175
Query: 188 GNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
                  Y G   D+WS GV+ Y +L    PF+ E++ + + +I
Sbjct: 176 ----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 215

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           +V ++ S+   + ++ +ME++ GG   D VT      H  ++E +       + QA+  L
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVL 132
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEW 185
           H  G +HRDIK D++LL+  G +KL+DFG   QV K   R K +  VGTP ++APE++  
Sbjct: 133 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISR 190
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +        Y    D+WS+G++  E++ G  P+
Sbjct: 191 LP-------YGPEVDIWSLGIMVIEMVDGEPPY 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 20/224 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVL-REKMPNTIERDI--MVKSKC 67
            ++ I + + +G+FG + L     +     +K    KVL +  M   IER+I  +   + 
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P+I+ L+   +  + +  ++EY     F  +++      +SE +AR +  ++  AV+Y H
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCH 124
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP+N+LL    ++K+ DFG +  +     +K+    G+P Y APEV+    
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEVIS--- 179
Query: 188 GNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
                  Y G   D+WS GV+ Y +L    PF+ E++ + + +I
Sbjct: 180 ----GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 219

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 25/207 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNH 82
           + +G+FG+++ +E+KQ+     +KKV R ++    E         P IV L+ + ++   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAVREGPW 159
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           V   ME + GG    L++ Q  G L E +A +Y+ +  + ++YLH    +H D+K DN+L
Sbjct: 160 VNIFMELLEGGSLGQLVKEQ--GCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVL 217
Query: 143 LSATG-HLKLTDFGSATQVDKNGRIKSI-----VPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           LS+ G H  L DFG A  +  +G  KS+     +P GT  ++APEV+             
Sbjct: 218 LSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP-GTETHMAPEVV-----------LG 265
Query: 197 GSC----DLWSIGVVSYELLTGSTPFN 219
            SC    D+WS   +   +L G  P+ 
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHPWT 292

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           +V ++ S+   + ++ +ME++ GG   D VT      H  ++E +       + QA+  L
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVL 136
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEW 185
           H  G +HRDIK D++LL+  G +KL+DFG   QV K   R K +  VGTP ++APE++  
Sbjct: 137 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISR 194
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +        Y    D+WS+G++  E++ G  P+
Sbjct: 195 LP-------YGPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/157 (35%), Positives = 83/157 (52%), Gaps = 20/157 (12%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYL--SESKARFYIYELAQAVQYLH 127
           IV    SF +   +   ME V GG    LL ++  G L  +E    FY  ++ + ++YLH
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 128 GLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPV-----GTPEYVAPE 181
               VHRDIK DN+L++  +G LK++DFG++       R+  I P      GT +Y+APE
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK------RLAGINPCTETFTGTLQYMAPE 193
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           ++     + G  GY  + D+WS+G    E+ TG  PF
Sbjct: 194 II-----DKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVL-----REKMPNTIERDIMVKSKCPY--IVNLFYSFQ 78
           G    +YL E+   +    +K +      +E+     ER++   S+  +  IV++    +
Sbjct: 22  GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
           + +  Y +MEY+ G      +E+  HG LS   A  +  ++   +++ H +  VHRDIKP
Sbjct: 82  EDDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKP 139
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
            N+L+ +   LK+ DFG A  + +    ++   +GT +Y +PE              T  
Sbjct: 140 QNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--------QAKGEATDE 191
Query: 199 C-DLWSIGVVSYELLTGSTPFNYET 222
           C D++SIG+V YE+L G  PFN ET
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNL---FYSF 77
           + I  G+FG ++  +  +S +   +KKVL++K     E  IM   K P +V+L   FYS 
Sbjct: 46  KVIGNGSFGVVFQAKLVES-DEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSN 104
Query: 78  QDMNHVYF---IMEYV------TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            D     F   ++EYV          +  L +  P   +     + Y+Y+L +++ Y+H 
Sbjct: 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI-----KLYMYQLLRSLAYIHS 159
Query: 129 LGYVHRDIKPDNMLL-SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
           +G  HRDIKP N+LL   +G LKL DFGSA ++   G   ++  + +  Y APE++    
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSA-KILIAGE-PNVSXICSRYYRAPELI---- 213
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET 222
              G+  YT + D+WS G V  EL+ G   F  E+
Sbjct: 214 --FGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 85/157 (54%), Gaps = 18/157 (11%)
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIYELAQAVQYL 126
           P IV L+ +   +N V  +MEY  GG    +L   +P  Y + + A  +  + +Q V YL
Sbjct: 61  PNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 127 HGL---GYVHRDIKPDNMLLSATGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           H +     +HRD+KP N+LL A G  LK+ DFG+A  +  +         G+  ++APEV
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEV 174
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
            E      GS+ Y+  CD++S G++ +E++T   PF+
Sbjct: 175 FE------GSN-YSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 85/157 (54%), Gaps = 18/157 (11%)
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIYELAQAVQYL 126
           P IV L+ +   +N V  +MEY  GG    +L   +P  Y + + A  +  + +Q V YL
Sbjct: 62  PNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 127 HGL---GYVHRDIKPDNMLLSATGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           H +     +HRD+KP N+LL A G  LK+ DFG+A  +  +         G+  ++APEV
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEV 175
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
            E      GS+ Y+  CD++S G++ +E++T   PF+
Sbjct: 176 FE------GSN-YSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNH 82
           + +G+FG+++ +E+KQ+     +KKV R ++    E         P IV L+ + ++   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAVREGPW 140
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           V   ME + GG    L++ Q  G L E +A +Y+ +  + ++YLH    +H D+K DN+L
Sbjct: 141 VNIFMELLEGGSLGQLVKEQ--GCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVL 198
Query: 143 LSATG-HLKLTDFGSATQVDKNGRIKSI-----VPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           LS+ G H  L DFG A  +  +G  K +     +P GT  ++APEV+             
Sbjct: 199 LSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP-GTETHMAPEVV-----------LG 246
Query: 197 GSC----DLWSIGVVSYELLTGSTPFN 219
            SC    D+WS   +   +L G  P+ 
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHPWT 273

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 60/312 (19%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV----LREKMPNTIER-----DIMVKSKC 67
           + +K  I QG++G + +  E Q+     +K +    +R+  P  +ER      +M K   
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------------------- 100
           P I  L+  ++D  ++  +ME   GG  +  L                            
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 101 ----NQPHGYL-------SESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA--TG 147
                  HG+         E      + ++  A+ YLH  G  HRDIKP+N L S   + 
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 148 HLKLTDFGSATQVDK--NGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
            +KL DFG + +  K  NG    +    GTP +VAPEVL     N  ++ Y   CD WS 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL-----NTTNESYGPKCDAWSA 262
Query: 205 GVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-LD 263
           GV+ + LL G+ PF       T S +L  + +     P+   LS    + + +L+ + +D
Sbjct: 263 GVLLHLLLMGAVPFPGVNDADTISQVL--NKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
Query: 264 ARLNMDQVLGHP 275
            R +  + L HP
Sbjct: 321 ERFDAMRALQHP 332

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/157 (35%), Positives = 83/157 (52%), Gaps = 20/157 (12%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYL--SESKARFYIYELAQAVQYLH 127
           IV    SF +   +   ME V GG    LL ++  G L  +E    FY  ++ + ++YLH
Sbjct: 67  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 128 GLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPV-----GTPEYVAPE 181
               VHRDIK DN+L++  +G LK++DFG++       R+  I P      GT +Y+APE
Sbjct: 126 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK------RLAGINPCTETFTGTLQYMAPE 179
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +++      G  GY  + D+WS+G    E+ TG  PF
Sbjct: 180 IID-----KGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 77/143 (53%), Gaps = 11/143 (7%)
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL 143
           Y +MEYV G     ++  +  G ++  +A   I +  QA+ + H  G +HRD+KP N+++
Sbjct: 92  YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 144 SATGHLKLTDFGSATQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL 201
           SAT  +K+ DFG A  +  +G    ++   +GT +Y++PE           D      D+
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDV 202
Query: 202 WSIGVVSYELLTGSTPFNYETLD 224
           +S+G V YE+LTG  PF  ++ D
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDSPD 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 116/268 (43%), Gaps = 26/268 (9%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL------REKMPNTI 57
           V EL  K+     F   R I  G+FG +Y   + ++     +KK+        EK  + I
Sbjct: 4   VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63
Query: 58  -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTL-LENQPHGYLSESKARFY 115
            E   + K + P  +     +   +  + +MEY  G     L +  +P   L E +    
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAV 120
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
            +   Q + YLH    +HRD+K  N+LLS  G +KL DFGSA+ +           VGTP
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTP 175
Query: 176 EYVAPEVLEWM-EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
            ++APEV+  M EG      Y G  D+WS+G+   EL     P      +M   S L   
Sbjct: 176 YWMAPEVILAMDEGQ-----YDGKVDVWSLGITCIELAERKPPL----FNMNAMSALYHI 226
Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKL 262
            ++      S   S    NFV S +QK+
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKI 254

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 116/268 (43%), Gaps = 26/268 (9%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL------REKMPNTI 57
           V EL  K+     F   R I  G+FG +Y   + ++     +KK+        EK  + I
Sbjct: 43  VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 58  -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTL-LENQPHGYLSESKARFY 115
            E   + K + P  +     +   +  + +MEY  G     L +  +P   L E +    
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAV 159
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
            +   Q + YLH    +HRD+K  N+LLS  G +KL DFGSA+ +           VGTP
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTP 214
Query: 176 EYVAPEVLEWM-EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
            ++APEV+  M EG      Y G  D+WS+G+   EL     P      +M   S L   
Sbjct: 215 YWMAPEVILAMDEGQ-----YDGKVDVWSLGITCIELAERKPPL----FNMNAMSALYHI 265
Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKL 262
            ++      S   S    NFV S +QK+
Sbjct: 266 AQNESPALQSGHWSEYFRNFVDSCLQKI 293

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 76/141 (53%), Gaps = 11/141 (7%)
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL 143
           Y +MEYV G     ++  +  G ++  +A   I +  QA+ + H  G +HRD+KP N+L+
Sbjct: 92  YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILI 149
Query: 144 SATGHLKLTDFGSATQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL 201
           SAT  +K+ DFG A  +  +G    ++   +GT +Y++PE           D      D+
Sbjct: 150 SATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR-------GDSVDARSDV 202
Query: 202 WSIGVVSYELLTGSTPFNYET 222
           +S+G V YE+LTG  PF  ++
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDS 223

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 129/284 (45%), Gaps = 46/284 (16%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE-----RDIMVKSKCP--- 68
           +++ + + +G +G ++   ++++     +KK+  +   N+ +     R+IM+ ++     
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELSGHE 69
Query: 69  YIVNLFYSFQDMNH--VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            IVNL    +  N   VY + +Y+       +  N     L     ++ +Y+L + ++YL
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYL 125
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--------------- 171
           H  G +HRD+KP N+LL+A  H+K+ DFG +       R+ + +P               
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 172 -----VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT 226
                V T  Y APE+L       GS  YT   D+WS+G +  E+L G   F   +    
Sbjct: 186 ILTDYVATRWYRAPEILL------GSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 227 YSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQ 270
              I+       + FPS+  + +    F +++++ L  ++ + Q
Sbjct: 240 LERIIG-----VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQ 278

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 90/176 (51%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY +  ++ G D   LL+ Q  
Sbjct: 92  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYLV-THLMGADLYKLLKTQ-- 139
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 140 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 198
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 199 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 77/144 (53%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S +D + VY +   + G D   ++++Q    LS+   +F +Y+L + ++Y+H  G +HRD
Sbjct: 101 SIEDFSEVYLVTT-LMGADLNNIVKSQA---LSDEHVQFLVYQLLRGLKYIHSAGIIHRD 156
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    L++ DFG A Q D+    +    V T  Y APE+ L WM        
Sbjct: 157 LKPSNVAVNEDSELRILDFGLARQADE----EMTGYVATRWYRAPEIMLNWMH------- 205
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELL G   F
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALF 229

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 125/264 (47%), Gaps = 14/264 (5%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM 80
           G FG +Y  + K++       KV+  K         +E +I+     PYIV L  ++   
Sbjct: 30  GAFGKVYKAKNKET-GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88
Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
             ++ ++E+  GG    ++     G L+E + +    ++ +A+ +LH    +HRD+K  N
Sbjct: 89  GKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147
Query: 141 MLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCD 200
           +L++  G ++L DFG + +  K  + +    +GTP ++APEV+  M        Y    D
Sbjct: 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVV--MCETMKDTPYDYKAD 204
Query: 201 LWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQ-SLV 259
           +WS+G+   E+     P ++E   M     +A     T+  PS  + S    +F++ +L 
Sbjct: 205 IWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKSDPPTLLTPS--KWSVEFRDFLKIALD 261
Query: 260 QKLDARLNMDQVLGHPVFDCLDSD 283
           +  + R +  Q+L HP    + S+
Sbjct: 262 KNPETRPSAAQLLEHPFVSSITSN 285

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 74/137 (54%), Gaps = 11/137 (8%)
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL 143
           Y +MEYV G     ++  +  G ++  +A   I +  QA+ + H  G +HRD+KP N+++
Sbjct: 92  YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 144 SATGHLKLTDFGSATQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL 201
           SAT  +K+ DFG A  +  +G    ++   +GT +Y++PE           D      D+
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDV 202
Query: 202 WSIGVVSYELLTGSTPF 218
           +S+G V YE+LTG  PF
Sbjct: 203 YSLGCVLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 76/141 (53%), Gaps = 11/141 (7%)
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL 143
           Y +MEYV G     ++  +  G ++  +A   I +  QA+ + H  G +HRD+KP N+++
Sbjct: 92  YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 144 SATGHLKLTDFGSATQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL 201
           SAT  +K+ DFG A  +  +G    ++   +GT +Y++PE           D      D+
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDV 202
Query: 202 WSIGVVSYELLTGSTPFNYET 222
           +S+G V YE+LTG  PF  ++
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDS 223

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 74/137 (54%), Gaps = 11/137 (8%)
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL 143
           Y +MEYV G     ++  +  G ++  +A   I +  QA+ + H  G +HRD+KP N+++
Sbjct: 92  YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 149
Query: 144 SATGHLKLTDFGSATQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL 201
           SAT  +K+ DFG A  +  +G    ++   +GT +Y++PE           D      D+
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDV 202
Query: 202 WSIGVVSYELLTGSTPF 218
           +S+G V YE+LTG  PF
Sbjct: 203 YSLGCVLYEVLTGEPPF 219

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 44/221 (19%)
Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---K 64
           +KN    D+ +  + +  G  G +  +  K++   F +K  + +  P    R++ +    
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA-RREVELHWRA 67
Query: 65  SKCPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           S+CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +A+QYLH +   HRD+KP+N+L ++      LKLTDFG A +                  
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------- 171
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                          + Y  SCD+WS+GV+ Y LL G  PF
Sbjct: 172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S +D + VY +   + G D   +++ Q    LS+   +F +Y+L + ++Y+H  G +HRD
Sbjct: 101 SIEDFSEVYLVTT-LMGADLNNIVKCQA---LSDEHVQFLVYQLLRGLKYIHSAGIIHRD 156
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    L++ DFG A Q D+    +    V T  Y APE+ L WM        
Sbjct: 157 LKPSNVAVNEDSELRILDFGLARQADE----EMTGYVATRWYRAPEIMLNWMH------- 205
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELL G   F
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALF 229

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 21/249 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSK-CPYIVNLFYS 76
           +  G  G ++ +  +++ +   +K++ R     E     ++ D+++KS  CPYIV  F +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---HGLGYVH 133
           F     V+  ME +  G     L+ +  G + E         + +A+ YL   HG+  +H
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV--IH 148
Query: 134 RDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           RD+KP N+LL   G +KL DFG S   VD   + +S    G   Y+APE ++    +   
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPERID--PPDPTK 203
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV 252
             Y    D+WS+G+   EL TG  P  Y+     +  +     E+    P  +  S    
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP--YKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261
Query: 253 NFVQSLVQK 261
           +FV+  + K
Sbjct: 262 SFVKDCLTK 270

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 125/264 (47%), Gaps = 14/264 (5%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM 80
           G FG +Y  + K++       KV+  K         +E +I+     PYIV L  ++   
Sbjct: 22  GAFGKVYKAKNKET-GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 80
Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDN 140
             ++ ++E+  GG    ++     G L+E + +    ++ +A+ +LH    +HRD+K  N
Sbjct: 81  GKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 139
Query: 141 MLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCD 200
           +L++  G ++L DFG + +  K  + +    +GTP ++APEV+  M        Y    D
Sbjct: 140 VLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVV--MCETMKDTPYDYKAD 196
Query: 201 LWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQ-SLV 259
           +WS+G+   E+     P ++E   M     +A     T+  PS  + S    +F++ +L 
Sbjct: 197 IWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKSDPPTLLTPS--KWSVEFRDFLKIALD 253
Query: 260 QKLDARLNMDQVLGHPVFDCLDSD 283
           +  + R +  Q+L HP    + S+
Sbjct: 254 KNPETRPSAAQLLEHPFVSSITSN 277

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC--PYIVNLFY 75
           + +G +G +Y  + K S    V  K +R     E +P+T  R+I +  +   P IV+L  
Sbjct: 29  VGEGTYGVVY--KAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
                  +  + E++   D   +L+    G L +S+ + Y+Y+L + V + H    +HRD
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP N+L+++ G LKL DFG A       R      V T  Y AP+VL       GS  Y
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVL------MGSKKY 197
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
           + S D+WSIG +  E++TG   F
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLF 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S +D + VY +   + G D   +++ Q    LS+   +F +Y+L + ++Y+H  G +HRD
Sbjct: 93  SIEDFSEVYLVTT-LMGADLNNIVKCQA---LSDEHVQFLVYQLLRGLKYIHSAGIIHRD 148
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    L++ DFG A Q D+    +    V T  Y APE+ L WM        
Sbjct: 149 LKPSNVAVNEDCELRILDFGLARQADE----EMTGYVATRWYRAPEIMLNWMH------- 197
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELL G   F
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALF 221

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC--PYIVNLFY 75
           + +G +G +Y  + K S    V  K +R     E +P+T  R+I +  +   P IV+L  
Sbjct: 29  VGEGTYGVVY--KAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
                  +  + E++   D   +L+    G L +S+ + Y+Y+L + V + H    +HRD
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP N+L+++ G LKL DFG A       R      V T  Y AP+VL       GS  Y
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVL------MGSKKY 197
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
           + S D+WSIG +  E++TG   F
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLF 220

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 125/271 (46%), Gaps = 29/271 (10%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 143
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 144 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 194
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL-ACDTEDTVSFPSS 244
            +G H    Y+   D+WS+G+   E+  G  P    +  M    +L     E     PS 
Sbjct: 195 -QGTH----YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSG 249
Query: 245 IRLSTAMVNFV-QSLVQKLDARLNMDQVLGH 274
           +  S    +FV + L++    R ++ Q++ H
Sbjct: 250 V-FSLEFQDFVNKCLIKNPAERADLKQLMVH 279

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKXQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKXQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 74/137 (54%), Gaps = 11/137 (8%)
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL 143
           Y +MEYV G     ++  +  G ++  +A   I +  QA+ + H  G +HRD+KP N+++
Sbjct: 109 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 166
Query: 144 SATGHLKLTDFGSATQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDL 201
           SAT  +K+ DFG A  +  +G    ++   +GT +Y++PE           D      D+
Sbjct: 167 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDV 219
Query: 202 WSIGVVSYELLTGSTPF 218
           +S+G V YE+LTG  PF
Sbjct: 220 YSLGCVLYEVLTGEPPF 236

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 101 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 156
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 157 LKPSNLAVNEDSELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 205
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 97  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 152
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 153 LKPSNLAVNEDSELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 201
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGXVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 112/239 (46%), Gaps = 20/239 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------LREKMPNTIERDIMVKSKC 67
           ++F I++ I +G F ++Y            +KKV        + +     E D++ +   
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQY 125
           P ++  + SF + N +  ++E    GD   ++++  +    + E     Y  +L  A+++
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV-DKNGRIKSIVPVGTPEYVAPEVLE 184
           +H    +HRDIKP N+ ++ATG +KL D G       K     S+  VGTP Y++PE + 
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIH 209
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
                   +GY    D+WS+G + YE+    +PF  + +++ YS     +  D    PS
Sbjct: 210 -------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCDYPPLPS 260

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 115 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 171 LKPSNLAVNEDCELKILDFGLARHTDD----EMXGXVATRWYRAPEIMLNWMH------- 219
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 102 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 157
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 158 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 206
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 100 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 155
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 156 LKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 204
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 100 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 155
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 156 LKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 204
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 97  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 152
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 153 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 201
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 100 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 155
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 156 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 204
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 94  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 149
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 150 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 198
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 199 YNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 101 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 156
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 157 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 205
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 107 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 162
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 163 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 211
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 101 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 156
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 157 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 205
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 106 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 161
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 162 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 210
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 107 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 162
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 163 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 211
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 101 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 156
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 157 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 205
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 107 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 162
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 163 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 211
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 105 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 160
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 161 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 209
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 97  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 152
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 153 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 201
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 106 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 161
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 162 LKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 210
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 97  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 152
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 153 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 201
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   ++++Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKSQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG     D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDSELKILDFGLCRHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 118 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 173
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 174 LKPSNLAVNEDCELKILDFGLARHTDD----EMXGYVATRWYRAPEIMLNWMH------- 222
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 118 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 173
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 174 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 222
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 100 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 155
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 156 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 204
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 92  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 147
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 148 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 196
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 115 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 171 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 219
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 114 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 169
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 170 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 218
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 115 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 171 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 219
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 92  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 147
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 148 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 196
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 114 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 169
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 170 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 218
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 91  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 147 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 195
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 124 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 179
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 180 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 228
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLF 252

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 96/191 (50%), Gaps = 33/191 (17%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH-LKLTDFGSATQVDKNGRIKSIVPVG 173
           YIY+L +AV ++H LG  HRDIKP N+L+++  + LKL DFGSA ++  +    S+  + 
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAXIC 203
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LD--MTYSSI 230
           +  Y APE++       G+  YT S DLWSIG V  EL+ G   F+ ET +D  +    I
Sbjct: 204 SRFYRAPELML------GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQI 257
Query: 231 LACDTEDT----------VSFPS-----------SIRLSTAMVNFVQSLVQKLDARLNMD 269
           +   T++           V FP+               S A+    Q L  + D R+N  
Sbjct: 258 MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317
Query: 270 QVLGHPVFDCL 280
           + + HP FD L
Sbjct: 318 EAMAHPFFDHL 328

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 91  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 147 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 195
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 119/259 (45%), Gaps = 41/259 (15%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--------PN----TIERDIMVKSKCPYI 70
           +  G FG ++   +K+ +   V+K + +EK+        P     T+E  I+ + +   I
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 71  VNLFYSFQDMNHVYFIME-YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           + +   F++      +ME + +G D    ++  P   L E  A +   +L  AV YL   
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLK 149
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             +HRDIK +N++++    +KL DFGSA  +++     +    GT EY APEVL    GN
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPEVL---MGN 204
Query: 190 HGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV--SFPSSIR 246
                Y G   ++WS+GV  Y L+    PF              C+ E+TV  +      
Sbjct: 205 P----YRGPELEMWSLGVTLYTLVFEENPF--------------CELEETVEAAIHPPYL 246
Query: 247 LSTAMVNFVQSLVQKLDAR 265
           +S  +++ V  L+Q +  R
Sbjct: 247 VSKELMSLVSGLLQPVPER 265

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 91  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 147 LKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYRAPEIMLNWMH------- 195
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 93  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 148
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE+ L WM        
Sbjct: 149 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 197
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKC 67
           +   +++K  +  G FG +     + +     +K+  +E  P   ER      IM K   
Sbjct: 13  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 72
Query: 68  PYIVNL------FYSFQDMNHVYFIMEYVTGGD---FVTLLENQPHGYLSESKARFYIYE 118
           P +V+              +     MEY  GGD   ++   EN     L E   R  + +
Sbjct: 73  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSD 130
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHL---KLTDFGSATQVDKNGRIKSIVPVGTP 175
           ++ A++YLH    +HRD+KP+N++L         K+ D G A ++D+         VGT 
Sbjct: 131 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTL 188
Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +Y+APE+LE          YT + D WS G +++E +TG  PF
Sbjct: 189 QYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKC 67
           +   +++K  +  G FG +     + +     +K+  +E  P   ER      IM K   
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71
Query: 68  PYIVNL------FYSFQDMNHVYFIMEYVTGGD---FVTLLENQPHGYLSESKARFYIYE 118
           P +V+              +     MEY  GGD   ++   EN     L E   R  + +
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSD 129
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHL---KLTDFGSATQVDKNGRIKSIVPVGTP 175
           ++ A++YLH    +HRD+KP+N++L         K+ D G A ++D+         VGT 
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTL 187
Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +Y+APE+LE          YT + D WS G +++E +TG  PF
Sbjct: 188 QYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E+V   D  T ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 70  IHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 181
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 186
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 187 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 237
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +G H    Y+   D+WS+G+   E+  G  P 
Sbjct: 238 -QGTH----YSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKS 65
           N+S SDF +K  + +G +G +     K +     +KK+     P        E  I+   
Sbjct: 8   NIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF 66
Query: 66  KCPYIVNLFY-----SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           K   I+ +F      SF++ N VY I E +   D   ++  Q    LS+   +++IY+  
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQE-LMQTDLHRVISTQ---MLSDDHIQYFIYQTL 122
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN--------GRIKSIVP- 171
           +AV+ LHG   +HRD+KP N+L+++   LK+ DFG A  +D++        G+   +V  
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
           V T  Y APEV+        S  Y+ + D+WS G +  EL 
Sbjct: 183 VATRWYRAPEVML------TSAKYSRAMDVWSCGCILAELF 217

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 77/146 (52%), Gaps = 20/146 (13%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 102 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 157
Query: 136 IKPDNMLLSATGHLKLTDFGSA--TQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGS 192
           +KP N+ ++    LK+ DFG A  T  +  G       V T  Y APE+ L WM      
Sbjct: 158 LKPSNLAVNEDCELKILDFGLARHTADEMTGY------VATRWYRAPEIMLNWMH----- 206
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF 218
             Y  + D+WS+G +  ELLTG T F
Sbjct: 207 --YNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ D+G A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDYGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 32/221 (14%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC---PYIVNL 73
           F ++R   QG FG + L +EK +  +  +KKV+++      E  IM        P IV L
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 74  ---FYSF--QDMNHVYF--IMEYVTGGDFVTLLENQPHGYLSESKA------RFYIYELA 120
              FY+   +D   +Y   +MEYV        L      Y     A      + ++++L 
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 121 QAVQYLH--GLGYVHRDIKPDNMLLS-ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +++  LH   +   HRDIKP N+L++ A G LKL DFGSA ++  +    ++  + +  Y
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYY 197
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            APE++       G+  YT + D+WS+G +  E++ G   F
Sbjct: 198 RAPELI------FGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 77/146 (52%), Gaps = 20/146 (13%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 102 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 157
Query: 136 IKPDNMLLSATGHLKLTDFGSA--TQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGS 192
           +KP N+ ++    LK+ DFG A  T  +  G       V T  Y APE+ L WM      
Sbjct: 158 LKPSNLAVNEDCELKILDFGLARHTADEMTGY------VATRWYRAPEIMLNWMH----- 206
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF 218
             Y  + D+WS+G +  ELLTG T F
Sbjct: 207 --YNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 77/146 (52%), Gaps = 20/146 (13%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 102 SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 157
Query: 136 IKPDNMLLSATGHLKLTDFGSA--TQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGS 192
           +KP N+ ++    LK+ DFG A  T  +  G       V T  Y APE+ L WM      
Sbjct: 158 LKPSNLAVNEDCELKILDFGLARHTADEMTGY------VATRWYRAPEIMLNWMH----- 206
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF 218
             Y  + D+WS+G +  ELLTG T F
Sbjct: 207 --YNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNH 82
           + +G+FG+++ +++KQ+     +KKV R ++    E         P IV L+ + ++   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 140
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           V   ME + GG    L++    G L E +A +Y+ +  + ++YLH    +H D+K DN+L
Sbjct: 141 VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 198
Query: 143 LSATG-HLKLTDFGSATQVDKNGRIKSI-----VPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           LS+ G    L DFG A  +  +G  KS+     +P GT  ++APEV+             
Sbjct: 199 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-GTETHMAPEVVM-------GKPCD 250
Query: 197 GSCDLWSIGVVSYELLTGSTPFN 219
              D+WS   +   +L G  P+ 
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHPWT 273

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKS 65
           N+S SDF +K  + +G +G +     K +     +KK+     P        E  I+   
Sbjct: 8   NIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF 66
Query: 66  KCPYIVNLFY-----SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           K   I+ +F      SF++ N VY I E +   D   ++  Q    LS+   +++IY+  
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQE-LMQTDLHRVISTQ---MLSDDHIQYFIYQTL 122
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV----GTPE 176
           +AV+ LHG   +HRD+KP N+L+++   LK+ DFG A  +D++    S  P     G  E
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS-EPTGQQSGMTE 181
Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
           YVA       E    S  Y+ + D+WS G +  EL 
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 152 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 202
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +G H    Y+   D+WS+G+   E+  G  P 
Sbjct: 203 -QGTH----YSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNH 82
           + +G+FG+++ +++KQ+     +KKV R ++    E         P IV L+ + ++   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 124
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           V   ME + GG    L++    G L E +A +Y+ +  + ++YLH    +H D+K DN+L
Sbjct: 125 VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 182
Query: 143 LSATG-HLKLTDFGSATQVDKNGRIKSI-----VPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           LS+ G    L DFG A  +  +G  KS+     +P GT  ++APEV+             
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-GTETHMAPEVVM-------GKPCD 234
Query: 197 GSCDLWSIGVVSYELLTGSTPFN 219
              D+WS   +   +L G  P+ 
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPWT 257

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 88/208 (42%), Gaps = 45/208 (21%)
Query: 107 LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--NG 164
            SE K ++ +Y++ + ++Y+H  G VHRD+KP N+ ++    LK+ DFG A   D    G
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 165 RIKSIVPVGTPEYVAPEV-LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL 223
                  V T  Y APEV L WM        Y  + D+WS+G +  E+LTG T F  +  
Sbjct: 183 Y------VVTRWYRAPEVILSWMH-------YNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229
Query: 224 DMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK---------------------- 261
               + IL         F   +    A  +++QSL Q                       
Sbjct: 230 LDQLTQILKVTGVPGTEFVQKLN-DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288
Query: 262 -----LDARLNMDQVLGHPVFDCLDSDP 284
                +D RL   Q L HP F+    DP
Sbjct: 289 MLELDVDKRLTAAQALTHPFFEPF-RDP 315

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 72  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 119
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 120 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 178
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 179 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 76  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 123
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 165 RIKSIV--PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 183 DHTGFLXEXVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 77  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 124
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 125 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 183
Query: 165 RIKSIV--PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 184 DHTGFLXEXVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 76  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 123
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 183 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 70  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 117
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 118 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 176
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 177 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 77  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 124
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 125 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 183
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 184 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 78  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 125
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 126 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 184
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 185 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 69  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 116
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 117 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 175
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 176 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 76  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 123
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 183 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKS 65
           N+S SDF +K  + +G +G +     K +     +KK+     P        E  I+   
Sbjct: 8   NIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF 66
Query: 66  KCPYIVNLFY-----SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           K   I+ +F      SF++ N VY I E +   D   ++  Q    LS+   +++IY+  
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQE-LMQTDLHRVISTQ---MLSDDHIQYFIYQTL 122
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG------- 173
           +AV+ LHG   +HRD+KP N+L+++   LK+ DFG A  +D++    S  P G       
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS-EPTGQQSGMTE 181
Query: 174 ---TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
              T  Y APEV+        S  Y+ + D+WS G +  EL 
Sbjct: 182 XVATRWYRAPEVML------TSAKYSRAMDVWSCGCILAELF 217

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 70  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 117
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 118 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 176
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 177 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 72  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 119
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 120 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 179 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 80  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 127
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 128 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 186
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 187 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 72  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 119
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 120 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 178
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 179 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 72  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 119
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 120 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 179 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 76  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 123
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 182
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 183 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 74  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 121
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 122 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 180
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 181 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPY 69
           D  +   I +GNFG+++     ++ NT V  K  RE +P  +      E  I+ +   P 
Sbjct: 115 DLVLGEQIGRGNFGEVF-SGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV------ 123
           IV L         +Y +ME V GGDF+T L  +         AR  +  L Q V      
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGDAAAG 225
Query: 124 -QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ-----VDKNGRIKSIVPVGTPEY 177
            +YL     +HRD+   N L++    LK++DFG + +        +G ++  VPV   ++
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQ-VPV---KW 281
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            APE L     N+G   Y+   D+WS G++ +E  + G++P+
Sbjct: 282 TAPEAL-----NYGR--YSSESDVWSFGILLWETFSLGASPY 316

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 76  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 123
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 182
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 183 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 88/208 (42%), Gaps = 45/208 (21%)
Query: 107 LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--NG 164
            SE K ++ +Y++ + ++Y+H  G VHRD+KP N+ ++    LK+ DFG A   D    G
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 200
Query: 165 RIKSIVPVGTPEYVAPEV-LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL 223
                  V T  Y APEV L WM        Y  + D+WS+G +  E+LTG T F  +  
Sbjct: 201 Y------VVTRWYRAPEVILSWMH-------YNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247
Query: 224 DMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK---------------------- 261
               + IL         F   +    A  +++QSL Q                       
Sbjct: 248 LDQLTQILKVTGVPGTEFVQKLN-DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 306
Query: 262 -----LDARLNMDQVLGHPVFDCLDSDP 284
                +D RL   Q L HP F+    DP
Sbjct: 307 MLELDVDKRLTAAQALTHPFFEPF-RDP 333

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNH 82
           + +G+FG+++ +++KQ+     +KKV R ++    E         P IV L+ + ++   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 138
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           V   ME + GG    L++    G L E +A +Y+ +  + ++YLH    +H D+K DN+L
Sbjct: 139 VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 196
Query: 143 LSATG-HLKLTDFGSATQVDKNGRIKSI-----VPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           LS+ G    L DFG A  +  +G  KS+     +P GT  ++APEV+             
Sbjct: 197 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP-GTETHMAPEVVM-------GKPCD 248
Query: 197 GSCDLWSIGVVSYELLTGSTPFN 219
              D+WS   +   +L G  P+ 
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHPWT 271

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 40/220 (18%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G +  V+ + S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ---PHGYLSESKARFYIYELAQAVQYLH 127
           V  + +F     +   ME++ GG    +L+     P   L +            ++  L 
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV-----------SIAVLR 125
Query: 128 GLGYV-------HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYV 178
           GL Y+       HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y+
Sbjct: 126 GLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYM 180
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           APE L   +G H    Y+   D+WS+G+   EL  G  P 
Sbjct: 181 APERL---QGTH----YSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 76  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKCQ-- 123
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 183 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 72  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 119
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 120 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDH 178
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 179 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPY 69
           D  +   I +GNFG+++     ++ NT V  K  RE +P  +      E  I+ +   P 
Sbjct: 115 DLVLGEQIGRGNFGEVF-SGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV------ 123
           IV L         +Y +ME V GGDF+T L  +         AR  +  L Q V      
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGDAAAG 225
Query: 124 -QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ-----VDKNGRIKSIVPVGTPEY 177
            +YL     +HRD+   N L++    LK++DFG + +        +G ++  VPV   ++
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ-VPV---KW 281
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            APE L     N+G   Y+   D+WS G++ +E  + G++P+
Sbjct: 282 TAPEAL-----NYGR--YSSESDVWSFGILLWETFSLGASPY 316

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+  FG A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILGFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D  T ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 133 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 185
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 21/176 (11%)
Query: 45  MKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH 104
           +K +LR +  N I  + ++++          + + M  VY + + +   D   LL+ Q  
Sbjct: 92  IKILLRFRHENIIGINDIIRAP---------TIEQMKDVYIVQD-LMETDLYKLLKTQ-- 139
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
            +LS     +++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D + 
Sbjct: 140 -HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 198
Query: 165 RIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 199 DHTGFLTEYVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 20/146 (13%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++      L++   +F IY++ + ++Y+H    +HRD
Sbjct: 91  SLEEFNDVYLV-THLMGADLNNIVKC---AKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDK--NGRIKSIVPVGTPEYVAPEV-LEWMEGNHGS 192
           +KP N+ ++    LK+ DFG A   D    G       V T  Y APE+ L WM      
Sbjct: 147 LKPSNLAVNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMH----- 195
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF 218
             Y  + D+WS+G +  ELLTG T F
Sbjct: 196 --YNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 76/145 (52%), Gaps = 12/145 (8%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           + + M  VY + + +   D   LL+ Q   +LS     +++Y++ + ++Y+H    +HRD
Sbjct: 96  TIEQMKDVYIVQD-LMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRD 151
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEWMEGNHGSD 193
           +KP N+LL+ T  LK+ DFG A   D +      +   V T  Y APE++        S 
Sbjct: 152 LKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML------NSK 205
Query: 194 GYTGSCDLWSIGVVSYELLTGSTPF 218
           GYT S D+WS+G +  E+L+    F
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E+++  D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 72  IHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP+N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 131 KPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 183
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 76/145 (52%), Gaps = 12/145 (8%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           + + M  VY + + +   D   LL+ Q   +LS     +++Y++ + ++Y+H    +HRD
Sbjct: 96  TIEQMKDVYIVQD-LMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRD 151
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEWMEGNHGSD 193
           +KP N+LL+ T  LK+ DFG A   D +      +   V T  Y APE++        S 
Sbjct: 152 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML------NSK 205
Query: 194 GYTGSCDLWSIGVVSYELLTGSTPF 218
           GYT S D+WS+G +  E+L+    F
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 76/143 (53%), Gaps = 14/143 (9%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP N+ ++    LK+ DFG A   D     +    V T  Y APE++  +   H    Y
Sbjct: 151 LKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIM--LNAMH----Y 200
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+G +  ELLTG T F
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E+++  D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 74  IHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP+N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 133 KPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 185
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 125 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 175
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +G H    Y+   D+WS+G+   E+  G  P 
Sbjct: 176 -QGTH----YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 125 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 175
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +G H    Y+   D+WS+G+   E+  G  P 
Sbjct: 176 -QGTH----YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ D G A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDAGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 125 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 175
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +G H    Y+   D+WS+G+   E+  G  P 
Sbjct: 176 -QGTH----YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 75  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 133
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 134 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 186
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 234

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +V++ Y+ ++   +Y +MEY   G    +L++ P       +A  Y  +L   ++YLH  
Sbjct: 71  LVDVLYN-EEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQV-----DKNGRIKSIVPVGTPEYVAPEVLE 184
           G VH+DIKP N+LL+  G LK++  G A  +     D   R       G+P +  PE+  
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ----GSPAFQPPEI-- 182
Query: 185 WMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
                +G D ++G   D+WS GV  Y + TG  PF  + +   + +I
Sbjct: 183 ----ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ DF  A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDFYLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 125 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 175
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +G H    Y+   D+WS+G+   E+  G  P 
Sbjct: 176 -QGTH----YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--VGTPEYVAPEVLEW 185
            +  +HRD+KP N+L+++ G +KL DFG + Q+     I S+    VGT  Y++PE L  
Sbjct: 125 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERL-- 175
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +G H    Y+   D+WS+G+   E+  G  P 
Sbjct: 176 -QGTH----YSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ D G A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDRGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 16/144 (11%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S ++ N VY +  ++ G D   +++ Q    L++   +F IY++ + ++Y+H    +HRD
Sbjct: 95  SLEEFNDVYLV-THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRD 150
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV-LEWMEGNHGSDG 194
           +KP N+ ++    LK+ D G A   D     +    V T  Y APE+ L WM        
Sbjct: 151 LKPSNLAVNEDCELKILDGGLARHTDD----EMTGYVATRWYRAPEIMLNWMH------- 199
Query: 195 YTGSCDLWSIGVVSYELLTGSTPF 218
           Y  + D+WS+G +  ELLTG T F
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 181
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKC--PYI 70
           DF+    +  GN G ++ V  K S      K +  E  P   N I R++ V  +C  PYI
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL---H 127
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL   H
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 127
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEWM 186
            +  +HRD+KP N+L+++ G +KL DFG + Q +D+         VGT  Y++PE L   
Sbjct: 128 KI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEF----VGTRSYMSPERL--- 178
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTP----FNYETLDMTYSSILACDTEDTVSFP 242
           +G H    Y+   D+WS+G+   E+  G  P      +E LD   +       E     P
Sbjct: 179 QGTH----YSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVN-------EPPPKLP 227
Query: 243 SSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGH 274
           S++  S    +FV + L++    R ++ Q++ H
Sbjct: 228 SAV-FSLEFQDFVNKCLIKNPAERADLKQLMVH 259

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV------LREKMPNTIERDIMVKSKC 67
           A D+++   I  G++G    +  K      V K++        EK     E +++ + K 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 68  PYIVNLFYSFQDMNH--VYFIMEYVTGGDFVTLLE--NQPHGYLSESKARFYIYELAQAV 123
           P IV  +    D  +  +Y +MEY  GGD  +++    +   YL E      + +L  A+
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 124 QYLH-----GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           +  H     G   +HRD+KP N+ L    ++KL DFG A  ++ +        VGTP Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYM 183
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +PE +  M  N  S       D+WS+G + YEL     PF
Sbjct: 184 SPEQMNRMSYNEKS-------DIWSLGCLLYELCALMPPF 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E+++  D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 73  IHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 131
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 132 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 184
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV------LREKMPNTIERDIMVKSKC 67
           A D+++   I  G++G    +  K      V K++        EK     E +++ + K 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 68  PYIVNLFYSFQDMNH--VYFIMEYVTGGDFVTLLE--NQPHGYLSESKARFYIYELAQAV 123
           P IV  +    D  +  +Y +MEY  GGD  +++    +   YL E      + +L  A+
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 124 QYLH-----GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           +  H     G   +HRD+KP N+ L    ++KL DFG A  ++ +        VGTP Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYM 183
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +PE +  M  N  S       D+WS+G + YEL     PF
Sbjct: 184 SPEQMNRMSYNEKS-------DIWSLGCLLYELCALMPPF 216

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GXKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 131 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 183
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 181
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREK----MPNTIERDIMVKSKCPY--IVNLFYS 76
           I +G +G +Y  +      TF +KK+  EK    +P+T  R+I +  +  +  IV L+  
Sbjct: 10  IGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
                 +  + E++   D   LL+    G L    A+ ++ +L   + Y H    +HRD+
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G LK+ DFG A       R K    V T  Y AP+VL       GS  Y+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVR-KYTHEVVTLWYRAPDVL------MGSKKYS 179
Query: 197 GSCDLWSIGVVSYELLTGSTPF 218
            + D+WS+G +  E++ G+  F
Sbjct: 180 TTIDIWSVGCIFAEMVNGAPLF 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E+++  D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 74  IHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 133 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 185
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 131
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP+N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 132 KPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 184
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREK----MPNTIERDIMVKSKCPY--IVNLFYS 76
           I +G +G +Y  +      TF +KK+  EK    +P+T  R+I +  +  +  IV L+  
Sbjct: 10  IGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
                 +  + E++   D   LL+    G L    A+ ++ +L   + Y H    +HRD+
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G LK+ DFG A       R K    V T  Y AP+VL       GS  Y+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVR-KYTHEVVTLWYRAPDVL------MGSKKYS 179
Query: 197 GSCDLWSIGVVSYELLTGSTPF 218
            + D+WS+G +  E++ G+  F
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLF 201

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E+V   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 74  IHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 133 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 185
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP+N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 131 KPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 183
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP+N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 130 KPENLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 78  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 136
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 137 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 189
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 237

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 78  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 136
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 137 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GXKYYS 189
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 237

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREK----MPNTIERDIMVKSKCPY--IVNLFYS 76
           I +G +G +Y  +      TF +KK+  EK    +P+T  R+I +  +  +  IV L+  
Sbjct: 10  IGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
                 +  + E++   D   LL+    G L    A+ ++ +L   + Y H    +HRD+
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G LK+ DFG A       R K    + T  Y AP+VL       GS  Y+
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVL------MGSKKYS 179
Query: 197 GSCDLWSIGVVSYELLTGSTPF 218
            + D+WS+G +  E++ G+  F
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLF 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 181
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 131
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 132 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 184
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 75  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 133
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 134 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 186
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 234

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 131 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 183
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 181
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 133 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 185
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 131
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 132 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 184
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 133 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 185
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIERDIMVKSKCPYIVNLFYSF 77
           + QG   +++    K++ + F +K       LR       E +++ K     IV LF   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 78  QDMN--HVYFIMEYVTGGDFVTLLENQPHGY-LSESKARFYIYELAQAVQYLHGLGYVHR 134
           ++    H   IME+   G   T+LE   + Y L ES+    + ++   + +L   G VHR
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 135 DIKPDNML--LSATGH--LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE--WMEG 188
           +IKP N++  +   G    KLTDFG+A +++ + +  S+   GT EY+ P++ E   +  
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYERAVLRK 194
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +H    Y  + DLWSIGV  Y   TGS PF
Sbjct: 195 DH-QKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     +KK+      E +P+T  R+I +  +   P IV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R      V T  Y APE+L       G   Y+
Sbjct: 131 KPQNLLINTEGAIKLADFGLARAFGVPVRTYX-HEVVTLWYRAPEILL------GCKYYS 183
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV------LREKMPNTIERDIMVKSKC 67
           A D+++   I  G++G    +  K      V K++        EK     E +++ + K 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 68  PYIVNLFYSFQDMNH--VYFIMEYVTGGDFVTLLE--NQPHGYLSESKARFYIYELAQAV 123
           P IV  +    D  +  +Y +MEY  GGD  +++    +   YL E      + +L  A+
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 124 QYLH-----GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           +  H     G   +HRD+KP N+ L    ++KL DFG A  ++ +        VGTP Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEF-VGTPYYM 183
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +PE +  M  N  S       D+WS+G + YEL     PF
Sbjct: 184 SPEQMNRMSYNEKS-------DIWSLGCLLYELCALMPPF 216

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 23/177 (12%)
Query: 45  MKKVLREKMPNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQP 103
           ++ +LR +  N I  RDI+  S          + + M  VY + + +   D   LL++Q 
Sbjct: 92  IQILLRFRHENVIGIRDILRAS----------TLEAMRDVYIVQDLMET-DLYKLLKSQ- 139
Query: 104 HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN 163
              LS     +++Y++ + ++Y+H    +HRD+KP N+L++ T  LK+ DFG A   D  
Sbjct: 140 --QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPE 197
Query: 164 GRIKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                 +   V T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 198 HDHTGFLTEXVATRWYRAPEIML------NSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 29/270 (10%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL-----REKMPNTIERDIMVKSK-CPYIVNLFYS 76
           I +G +G +  +  K S     +K++      +E+    ++ D++++S  CPYIV  + +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 77  FQDMNHVYFIMEYVTGG--DFVTLLENQPHGYLSESKARFYIYELAQAVQYL-HGLGYVH 133
                  +  ME ++     F   + +     + E           +A+ +L   L  +H
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIH 149
Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           RDIKP N+LL  +G++KL DFG + Q VD   + +     G   Y+APE +   + +   
Sbjct: 150 RDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERI---DPSASR 203
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI------R 246
            GY    D+WS+G+  YEL TG  P+        ++S+    T+     P  +       
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYP------KWNSVFDQLTQVVKGDPPQLSNSEERE 257
Query: 247 LSTAMVNFVQSLVQKLDA-RLNMDQVLGHP 275
            S + +NFV   + K ++ R    ++L HP
Sbjct: 258 FSPSFINFVNLCLTKDESKRPKYKELLKHP 287

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL------REKMPNTI 57
           + +L   ++ A  +++K  I  G  G IYL  ++  +   V+ K L        +     
Sbjct: 69  LPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMA 128
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNH-----VYFIMEYVTGGDFVTLLENQPHGYLSESKA 112
           ER  + +   P IV +F   +  +       Y +MEYV GG  +   + Q    L  ++A
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRSKGQ---KLPVAEA 184
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV 172
             Y+ E+  A+ YLH +G V+ D+KP+N++L+    LKL D G+ ++++  G +      
Sbjct: 185 IAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----- 238
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIG 205
           GTP + APE++          G T + D++++G
Sbjct: 239 GTPGFQAPEIVR--------TGPTVATDIYTVG 263

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     + K+      E +P+T  R+I +  +   P IV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 130 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 182
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKC--PYIVNLFYS 76
           I +G +G +Y    K +     + K+      E +P+T  R+I +  +   P IV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
               N +Y + E++   D    ++      +     + Y+++L Q + + H    +HRD+
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G +KL DFG A       R  +   V T  Y APE+L       G   Y+
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILL------GCKYYS 181
Query: 197 GSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFPS 243
            + D+WS+G +  E++T    F  ++ +D  +       T D V +P 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 84/169 (49%), Gaps = 17/169 (10%)
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           S  ++N VY + EY+   D   +LE  P   L E  AR ++Y+L + ++Y+H    +HRD
Sbjct: 90  SLTELNSVYIVQEYMET-DLANVLEQGP---LLEEHARLFMYQLLRGLKYIHSANVLHRD 145
Query: 136 IKPDNMLLSATGH-LKLTDFGSATQVDKNGRIKSIVPVG--TPEYVAPEVLEWMEGNHGS 192
           +KP N+ ++     LK+ DFG A  +D +   K  +  G  T  Y +P +L         
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL------SP 199
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILACDTED 237
           + YT + D+W+ G +  E+LTG T F      E + +   SI     ED
Sbjct: 200 NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 22  FIQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDIMVKSKC------PYIVN 72
           F+ +G F  +Y   +K ++    +KK+    R +  + I R  + + K       P I+ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L  +F   +++  + +++     V + +N     L+ S  + Y+    Q ++YLH    +
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRD+KP+N+LL   G LKL DFG A       R      V T  Y APE+L       G+
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYXHQVVTRWYRAPELL------FGA 187
Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF 218
             Y    D+W++G +  ELL    PF
Sbjct: 188 RMYGVGVDMWAVGCILAELLL-RVPF 212

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIERDIMVKSKCPYIVNLFYSF 77
           + QG   +++    K++ + F +K       LR       E +++ K     IV LF   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 78  QDMN--HVYFIMEYVTGGDFVTLLENQPHGY-LSESKARFYIYELAQAVQYLHGLGYVHR 134
           ++    H   IME+   G   T+LE   + Y L ES+    + ++   + +L   G VHR
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 135 DIKPDNML--LSATGH--LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE--WMEG 188
           +IKP N++  +   G    KLTDFG+A +++ + +   +   GT EY+ P++ E   +  
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY--GTEEYLHPDMYERAVLRK 194
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +H    Y  + DLWSIGV  Y   TGS PF
Sbjct: 195 DH-QKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 17/142 (11%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +        L    H  L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     N  +     V T  Y APEV+  M       GY 
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTACTNFMMTPY--VVTRYYRAPEVILGM-------GYA 203
Query: 197 GSCDLWSIGVVSYELLTGSTPF 218
            + D+WS+G +  EL+ G   F
Sbjct: 204 ANVDIWSVGCIMGELVKGCVIF 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 38/230 (16%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGD----IYLVEE-----------KQSHNTFVMKKVLREK 52
           R   +     ++ R I +G FGD    IY+  E           K   +  V +K L+E 
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 53  MPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKA 112
           +        M +   P+IV L     + N V+ IME  T G+  + L+ +    L  +  
Sbjct: 443 L-------TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASL 493
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI--- 169
             Y Y+L+ A+ YL    +VHRDI   N+L+SAT  +KL DFG +  ++ +   K+    
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           +P+   +++APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 554 LPI---KWMAPESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 45/239 (18%)
Query: 10  KNVSASD-FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDIMV- 63
           KNV   D ++IK  I +G++G +YL  +K ++    +KKV R  E + +   I R+I + 
Sbjct: 22  KNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITIL 81
Query: 64  -KSKCPYIVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
            + K  YI+ L            + +Y ++E +   D   L +     +L+E   +  +Y
Sbjct: 82  NRLKSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTP--IFLTEQHVKTILY 138
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI-------- 169
            L    +++H  G +HRD+KP N LL+    +K+ DFG A  ++ +  I  +        
Sbjct: 139 NLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEE 198
Query: 170 --VP--------------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
              P              V T  Y APE++   E       YT S D+WS G +  ELL
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE------NYTNSIDIWSTGCIFAELL 251

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +        L    H  L   +  + +Y++   +++LH  G +HRD+
Sbjct: 99  FQD---VYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 150
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     N  +     V T  Y APEV+  M       GY 
Sbjct: 151 KPSNIVVKSDCTLKILDFGLARTASTNFMMTPY--VVTRYYRAPEVILGM-------GYK 201
Query: 197 GSCDLWSIGVVSYELLTGSTPF 218
            + D+WS+G +  EL+ GS  F
Sbjct: 202 ENVDIWSVGCIMGELVKGSVIF 223

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 21/221 (9%)
Query: 22  FIQQGNFGDIYLVEEKQSHNTFVMKKVLR---EKMPNTIE-RDIMVKSKCPY--IVNLFY 75
            + +G++G +     K +     +KK L    +KM   I  R+I +  +  +  +VNL  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 76  SFQDMNHVYFIMEYVTGGDFVTL--LENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
             +     Y + E+V   D   L  LE  P+G L     + Y++++   + + H    +H
Sbjct: 92  VCKKKKRWYLVFEFV---DHTILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSHNIIH 147
Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSD 193
           RDIKP+N+L+S +G +KL DFG A  +   G +     V T  Y APE+L       G  
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD-DEVATRWYRAPELLV------GDV 200
Query: 194 GYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILAC 233
            Y  + D+W+IG +  E+  G   F  ++ +D  Y  I+ C
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY-HIMMC 240

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 28/225 (12%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGD----IYLVEEKQSHNTFV------MKKVLREKMPNTI 57
           R   +     ++ R I +G FGD    IY+  E  +    +          +REK     
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ-- 60
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E   M +   P+IV L     + N V+ IME  T G+  + L+ +    L  +    Y Y
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAY 118
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGT 174
           +L+ A+ YL    +VHRDI   N+L+SAT  +KL DFG +  ++ +   K+    +P+  
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI-- 176
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            +++APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 177 -KWMAPESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC-----PYIVN 72
           I +G +G ++   + ++   FV  K +R     E MP +  R++ V         P +V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 73  LF----YSFQDM-NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           LF     S  D    +  + E+V   D  T L+  P   +     +  +++L + + +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP N+L++++G +KL DFG A        + S+  V T  Y APEVL    
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VVTLWYRAPEVLL--- 192
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELL 212
                  Y    DLWS+G +  E+ 
Sbjct: 193 ----QSSYATPVDLWSVGCIFAEMF 213

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 45/244 (18%)
Query: 17  FDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPNTIERDI---MVKSKCPYI 70
           F I+  I +G F  +YL   +          +K ++    P  I  ++    V      +
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNV 82
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           + + Y F+  +HV   M Y+    F+ +L +     LS  + R Y+  L +A++ +H  G
Sbjct: 83  MGVKYCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFG 137
Query: 131 YVHRDIKPDNMLLS-ATGHLKLTDFGSAT--------------------QVDKN------ 163
            VHRD+KP N L +       L DFG A                     +  +N      
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 164 GRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET 222
            R + + P  GTP + APEVL            T + D+WS GV+   LL+G  PF   +
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQ------TTAIDMWSAGVIFLSLLSGRYPFYKAS 251
Query: 223 LDMT 226
            D+T
Sbjct: 252 DDLT 255

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC-----PYIVN 72
           I +G +G ++   + ++   FV  K +R     E MP +  R++ V         P +V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 73  LF----YSFQDM-NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           LF     S  D    +  + E+V   D  T L+  P   +     +  +++L + + +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP N+L++++G +KL DFG A        + S+V   T  Y APEVL    
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL--- 192
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELL 212
                  Y    DLWS+G +  E+ 
Sbjct: 193 ----QSSYATPVDLWSVGCIFAEMF 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK-----MPNTIERD--IMV 63
           ++   D +IK  I  G+FG ++  E    H + V  K+L E+       N   R+  IM 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESKARFYIYELAQA 122
           + + P IV    +     ++  + EY++ G    LL ++     L E +     Y++A+ 
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 123 VQYLHGLG--YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           + YLH      VHRD+K  N+L+     +K+ DFG  +++  +  + S    GTPE++AP
Sbjct: 150 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFG-LSRLKASXFLXSKXAAGTPEWMAP 208
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           EVL     N  SD Y       S GV+ +EL T   P+ 
Sbjct: 209 EVLRDEPSNEKSDVY-------SFGVILWELATLQQPWG 240

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 42/236 (17%)
Query: 10  KNVSASD-FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDIMV- 63
           KNV   D + IK  I +G++G +YL  +K +     +KKV R  E + +   I R+I + 
Sbjct: 20  KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITIL 79
Query: 64  -KSKCPYIVNLFY-----SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
            + K  YI+ L+           + +Y ++E +   D   L +     +L+E   +  +Y
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTP--IFLTEEHIKTILY 136
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV----------------- 160
            L     ++H  G +HRD+KP N LL+    +K+ DFG A  +                 
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 161 ----DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
               +KN + +    V T  Y APE++   E       YT S D+WS G +  ELL
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQE------NYTKSIDIWSTGCIFAELL 246

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 46/296 (15%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR----EKMPNTIERDIMVKSKCPY--IVNLFYS 76
           I +G +G ++  + +++H    +K+V      E +P++  R+I +  +  +  IV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
                 +  + E+    D     ++  +G L     + ++++L + + + H    +HRD+
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G LKL DFG A       R  S   V T  Y  P+VL       G+  Y+
Sbjct: 128 KPQNLLINRNGELKLADFGLARAFGIPVRCYS-AEVVTLWYRPPDVL------FGAKLYS 180
Query: 197 GSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSI---LACDTEDTVSFPSSIRL----- 247
            S D+WS G +  EL   + P F    +D     I   L   TE+   +PS  +L     
Sbjct: 181 TSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEE--QWPSMTKLPDYKP 238
Query: 248 ------STAMVNFV-------QSLVQKL-----DARLNMDQVLGHPVFDCLDSDPP 285
                 +T++VN V       + L+Q L       R++ ++ L HP F   D  PP
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS--DFCPP 292

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC-----PYIVN 72
           I +G +G ++   + ++   FV  K +R     E MP +  R++ V         P +V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 73  LF----YSFQDM-NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           LF     S  D    +  + E+V   D  T L+  P   +     +  +++L + + +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP N+L++++G +KL DFG A        + S+V   T  Y APEVL    
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL--- 192
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELL 212
                  Y    DLWS+G +  E+ 
Sbjct: 193 ----QSSYATPVDLWSVGCIFAEMF 213

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 90  LLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 144
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEW 185
           H  G +HRD+KP N+++ +   LK+ DFG A      G    +VP V T  Y APEV+  
Sbjct: 145 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYYRAPEVILG 201
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           M       GY  + D+WS+G +  E++ G   F
Sbjct: 202 M-------GYKENVDIWSVGCIMGEMIKGGVLF 227

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 17  FDIKRFIQQGNFGD----IYLVEE-----------KQSHNTFVMKKVLREKMPNTIERDI 61
            ++ R I +G FGD    IY+  E           K   +  V +K L+E +        
Sbjct: 14  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-------T 66
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P+IV L     + N V+ IME  T G+  + L+ + +  L  +    Y Y+L+ 
Sbjct: 67  MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 124
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYV 178
           A+ YL    +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    +P+   +++
Sbjct: 125 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWM 181
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 182 APESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 17  FDIKRFIQQGNFGD----IYLVEE-----------KQSHNTFVMKKVLREKMPNTIERDI 61
            ++ R I +G FGD    IY+  E           K   +  V +K L+E +        
Sbjct: 15  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-------T 67
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P+IV L     + N V+ IME  T G+  + L+ + +  L  +    Y Y+L+ 
Sbjct: 68  MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 125
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYV 178
           A+ YL    +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    +P+   +++
Sbjct: 126 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWM 182
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 183 APESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 17  FDIKRFIQQGNFGD----IYLVEE-----------KQSHNTFVMKKVLREKMPNTIERDI 61
            ++ R I +G FGD    IY+  E           K   +  V +K L+E +        
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-------T 61
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P+IV L     + N V+ IME  T G+  + L+ + +  L  +    Y Y+L+ 
Sbjct: 62  MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 119
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYV 178
           A+ YL    +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    +P+   +++
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWM 176
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 177 APESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 38/230 (16%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGD----IYLVEE-----------KQSHNTFVMKKVLREK 52
           R   +     ++ R I +G FGD    IY+  E           K   +  V +K L+E 
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 53  MPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKA 112
           +        M +   P+IV L     + N V+ IME  T G+  + L+ +    L  +  
Sbjct: 443 L-------TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASL 493
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI--- 169
             Y Y+L+ A+ YL    +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           +P+   +++APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 554 LPI---KWMAPESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 19/143 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYIVME-LMDANLSQVIQME----LDHERMSYLLYQMLVGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+GV+  E++ G   F
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLF 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 19/143 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYIVME-LMDANLSQVIQME----LDHERMSYLLYQMLVGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+GV+  E++ G   F
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLF 225

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 17  FDIKRFIQQGNFGD----IYLVEEKQSHNTFV------MKKVLREKMPNTIERDIMVKSK 66
            ++ R I +G FGD    IY+  E  +    +          +REK     E   M +  
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ--EALTMRQFD 69
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            P+IV L     + N V+ IME  T G+  + L+ + +  L  +    Y Y+L+ A+ YL
Sbjct: 70  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYL 127
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYVAPEVL 183
               +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    +P+   +++APE +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMAPESI 184
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            +         +T + D+W  GV  +E+L  G  PF
Sbjct: 185 NFRR-------FTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 17  FDIKRFIQQGNFGD----IYLVEE-----------KQSHNTFVMKKVLREKMPNTIERDI 61
            ++ R I +G FGD    IY+  E           K   +  V +K L+E +        
Sbjct: 17  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-------T 69
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P+IV L     + N V+ IME  T G+  + L+ + +  L  +    Y Y+L+ 
Sbjct: 70  MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 127
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYV 178
           A+ YL    +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    +P+   +++
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWM 184
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 185 APESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 17  FDIKRFIQQGNFGD----IYLVEEKQSHNTFV------MKKVLREKMPNTIERDIMVKSK 66
            ++ R I +G FGD    IY+  E  +    +          +REK     E   M +  
Sbjct: 12  IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ--EALTMRQFD 69
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            P+IV L     + N V+ IME  T G+  + L+ +    L  +    Y Y+L+ A+ YL
Sbjct: 70  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYL 127
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYVAPEVL 183
               +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    +P+   +++APE +
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI---KWMAPESI 184
Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            +         +T + D+W  GV  +E+L  G  PF
Sbjct: 185 NFRR-------FTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 131/309 (42%), Gaps = 58/309 (18%)
Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDI--MVKSKC 67
           S+S F     +  G +  +Y    K +     +K+V     E  P+T  R+I  M + K 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-----NQPHGYLSESKARFYIYELAQA 122
             IV L+      N +  + E++   D    ++     N P G L  +  +++ ++L Q 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRG-LELNLVKYFQWQLLQG 120
Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--SATQVDKNGRIKSIVPVGTPEYVAP 180
           + + H    +HRD+KP N+L++  G LKL DFG   A  +  N     +V   T  Y AP
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV---TLWYRAP 177
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILACDTE 236
           +VL       GS  Y+ S D+WS G +  E++TG   F    + E L + +  I+    E
Sbjct: 178 DVLM------GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF-DIMGTPNE 230
Query: 237 DTVSFPSSIRLS---------------------------TAMVNFVQSLVQ-KLDARLNM 268
               +PS  +L                              +++F+  L+Q   D RL+ 
Sbjct: 231 SL--WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 269 DQVLGHPVF 277
            Q L HP F
Sbjct: 289 KQALHHPWF 297

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 38/230 (16%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGD----IYLVEE-----------KQSHNTFVMKKVLREK 52
           R   +     ++ R I +G FGD    IY+  E           K   +  V +K L+E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 62
Query: 53  MPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKA 112
           +        M +   P+IV L     + N V+ IME  T G+  + L+ + +  L  +  
Sbjct: 63  L-------TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASL 113
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI--- 169
             Y Y+L+ A+ YL    +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    
Sbjct: 114 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           +P+   +++APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 174 LPI---KWMAPESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 17  FDIKRFIQQGNFGD----IYLVEE-----------KQSHNTFVMKKVLREKMPNTIERDI 61
            ++ R I +G FGD    IY+  E           K   +  V +K L+E +        
Sbjct: 40  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-------T 92
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P+IV L     + N V+ IME  T G+  + L+ + +  L  +    Y Y+L+ 
Sbjct: 93  MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 150
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI---VPVGTPEYV 178
           A+ YL    +VHRDI   N+L+S+   +KL DFG +  ++ +   K+    +P+   +++
Sbjct: 151 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWM 207
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           APE + +         +T + D+W  GV  +E+L  G  PF
Sbjct: 208 APESINFRR-------FTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK-----MPNTIERD--IMV 63
           ++   D +IK  I  G+FG ++  E    H + V  K+L E+       N   R+  IM 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESKARFYIYELAQA 122
           + + P IV    +     ++  + EY++ G    LL ++     L E +     Y++A+ 
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 123 VQYLHGLG--YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           + YLH      VHR++K  N+L+     +K+ DFG  +++  +  + S    GTPE++AP
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG-LSRLKASTFLSSKSAAGTPEWMAP 208
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           EVL     N  SD Y       S GV+ +EL T   P+ 
Sbjct: 209 EVLRDEPSNEKSDVY-------SFGVILWELATLQQPWG 240

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 118/258 (45%), Gaps = 42/258 (16%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTIERDIMVKSKC--PYI 70
           ASDF+    + QG FG +           + +KK+   E+  +TI  ++M+ +     Y+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 71  VNLFYSFQDMNH-------------VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           V  + ++ +  +             ++  MEY   G    L+ ++      +   R +  
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-R 123
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI----VP-- 171
           ++ +A+ Y+H  G +HRD+KP N+ +  + ++K+ DFG A  V ++  I  +    +P  
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 172 -------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD 224
                  +GT  YVA EVL+      G+  Y    D++S+G++ +E++    PF   +  
Sbjct: 184 SDNLTSAIGTAMYVATEVLD------GTGHYNEKIDMYSLGIIFFEMI---YPF---STG 231
Query: 225 MTYSSILACDTEDTVSFP 242
           M   +IL      ++ FP
Sbjct: 232 MERVNILKKLRSVSIEFP 249

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 46/233 (19%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDIMVKSKC--PYI 70
           ++I+  I  G++G +    +K       +KK+LR  E + +   I R+I + ++    ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 71  VNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
           V +         +  + +Y ++E +   DF  L       YL+E   +  +Y L   V+Y
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKY 171
Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE--------- 176
           +H  G +HRD+KP N L++    +K+ DFG A  VD      S +P+   E         
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 177 -----------------YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
                            Y APE++   E       YT + D+WSIG +  ELL
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQE------NYTEAIDVWSIGCIFAELL 278

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 130/296 (43%), Gaps = 46/296 (15%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR----EKMPNTIERDIMVKSKCPY--IVNLFYS 76
           I +G +G ++  + +++H    +K+V      E +P++  R+I +  +  +  IV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
                 +  + E+    D     ++  +G L     + ++++L + + + H    +HRD+
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+L++  G LKL +FG A       R  S   V T  Y  P+VL       G+  Y+
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYS-AEVVTLWYRPPDVL------FGAKLYS 180
Query: 197 GSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSI---LACDTEDTVSFPSSIRL----- 247
            S D+WS G +  EL     P F    +D     I   L   TE+   +PS  +L     
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE--QWPSMTKLPDYKP 238
Query: 248 ------STAMVNFV-------QSLVQKL-----DARLNMDQVLGHPVFDCLDSDPP 285
                 +T++VN V       + L+Q L       R++ ++ L HP F   D  PP
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS--DFCPP 292

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 106/223 (47%), Gaps = 30/223 (13%)
Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSK 66
           + AS+  +   I  G+FG +Y    K   +  V  K+L+   P          ++ V  K
Sbjct: 33  IEASEVMLSTRIGSGSFGTVY----KGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRK 88
Query: 67  CPYI-VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL------ 119
             ++ + LF  +   +++  + ++  G           + +L   + +F +++L      
Sbjct: 89  TRHVNILLFMGYMTKDNLAIVTQWCEGSSL--------YKHLHVQETKFQMFQLIDIARQ 140
Query: 120 -AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEY 177
            AQ + YLH    +HRD+K +N+ L     +K+ DFG AT   + +G  +   P G+  +
Sbjct: 141 TAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY 220
           +APEV+   + N     ++   D++S G+V YEL+TG  P+++
Sbjct: 201 MAPEVIRMQDNN----PFSFQSDVYSYGIVLYELMTGELPYSH 239

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 142
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEW 185
           H  G +HRD+KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYYRAPEVILG 199
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           M       GY  + D+WS+G +  E++ G   F
Sbjct: 200 M-------GYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 142
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEW 185
           H  G +HRD+KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 199
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           M       GY  + D+WS+G +  E++ G   F
Sbjct: 200 M-------GYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYIVME-LMDANLSQVIQME----LDHERMSYLLYQMLVGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+G +  E++ G   F
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLF 225

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+G +  E++ G   F
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME----LDHERMSYLLYQMLCGIKHL 142
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEW 185
           H  G +HRD+KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 199
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           M       GY  + D+WS+G +  E++ G   F
Sbjct: 200 M-------GYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 143
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEW 185
           H  G +HRD+KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 200
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           M       GY  + D+WS+G +  E++ G   F
Sbjct: 201 M-------GYKENVDIWSVGCIMGEMIKGGVLF 226

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYIVME-LMDANLSQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+G +  E++ G   F
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME----LDHERMSYLLYQMLCGIKHL 142
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEW 185
           H  G +HRD+KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 199
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           M       GY  + D+WS+G +  E++ G   F
Sbjct: 200 M-------GYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYV-TGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           CP+ V  + +      V+  ME + T  D F   + ++      +   +  +  + +A++
Sbjct: 109 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV-SIVKALE 167
Query: 125 YLHG-LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEV 182
           +LH  L  +HRD+KP N+L++A G +K+ DFG S   VD    +   +  G   Y+APE 
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDS---VAKTIDAGCKPYMAPER 224
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
           +   E N    GY+   D+WS+G+   EL      F Y++    +  +     E +   P
Sbjct: 225 IN-PELNQ--KGYSVKSDIWSLGITMIELAI--LRFPYDSWGTPFQQLKQVVEEPSPQLP 279
Query: 243 SSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
           +  + S   V+F  Q L +    R    +++ HP F
Sbjct: 280 AD-KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 51/291 (17%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL---REKMPNTIERDI-MVKS-KCPYIVNLFYSF 77
           + +G +  +Y  + K + N   +K++     E  P T  R++ ++K  K   IV L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                +  + EY+   D    L++  +  ++    + ++++L + + Y H    +HRD+K
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP------VGTPEYVAPEVLEWMEGNHG 191
           P N+L++  G LKL DFG A       R KSI        V T  Y  P++L       G
Sbjct: 128 PQNLLINERGELKLADFGLA-------RAKSIPTKTYDNEVVTLWYRPPDILL------G 174
Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYETL---------------DMTYSSILACDTE 236
           S  Y+   D+W +G + YE+ TG   F   T+               + T+  IL+ +  
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 237 DTVSFP---------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF 277
            T ++P          + RL +   + +  L+Q +   R++ +  + HP F
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIV 71
           +KR +  G FG++++     +++T V  K L+   P T+       E ++M   +   +V
Sbjct: 18  VKR-LGAGQFGEVWM--GYYNNSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L+        +Y I EY+  G  +  L++   G +   K   +  ++A+ + Y+    Y
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 131
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD++  N+L+S +   K+ DFG A  ++ N    R  +  P+   ++ APE +     
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAI----- 183
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           N G   +T   D+WS G++ YE++T G  P+
Sbjct: 184 NFGC--FTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 106/234 (45%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E +       DF+T       G L E  
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFIT-----ERGALQEEL 115
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 116 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 169
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 170 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 217

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 37/235 (15%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IE 58
           +++K    S + +   +  G FG +Y       +    +K V +++      +PN   + 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 59  RDIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSES 110
            +++    V S    ++ L   F+  +    I+E         DF+T       G L E 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEE 115
Query: 111 KARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSI 169
            AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  
Sbjct: 116 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDT 169
Query: 170 VPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
           V     GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 37/235 (15%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IE 58
           +++K    S + +   +  G FG +Y       +    +K V +++      +PN   + 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 59  RDIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSES 110
            +++    V S    ++ L   F+  +    I+E         DF+T       G L E 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEE 115
Query: 111 KARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSI 169
            AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  
Sbjct: 116 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDT 169
Query: 170 VPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
           V     GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 117/258 (45%), Gaps = 42/258 (16%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-EKMPNTIERDIMVKSKC--PYI 70
           ASDF+    + QG FG +           + +KK+   E+  +TI  ++M+ +     Y+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 71  VNLFYSFQDMNH-------------VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           V  + ++ +  +             ++  MEY        L+ ++      +   R +  
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-R 123
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI----VP-- 171
           ++ +A+ Y+H  G +HRD+KP N+ +  + ++K+ DFG A  V ++  I  +    +P  
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 172 -------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD 224
                  +GT  YVA EVL+      G+  Y    D++S+G++ +E++    PF   +  
Sbjct: 184 SDNLTSAIGTAMYVATEVLD------GTGHYNEKIDMYSLGIIFFEMI---YPF---STG 231
Query: 225 MTYSSILACDTEDTVSFP 242
           M   +IL      ++ FP
Sbjct: 232 MERVNILKKLRSVSIEFP 249

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 21/132 (15%)
Query: 94  DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLT 152
           DF+T       G L E  AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL 
Sbjct: 146 DFIT-----ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 200
Query: 153 DFGSATQVDKNGRIKSIVPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSY 209
           DFGS         +K  V     GT  Y  PE + +    HG      S  +WS+G++ Y
Sbjct: 201 DFGSGAL------LKDTVYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLY 248
Query: 210 ELLTGSTPFNYE 221
           +++ G  PF ++
Sbjct: 249 DMVCGDIPFEHD 260

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 142
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H  G +HRD+KP N+++ +   LK+ DFG A     +  ++    V T  Y APEV+  M
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP--EVVTRYYRAPEVILGM 200
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                  GY  + DLWS+G +  E++     F
Sbjct: 201 -------GYKENVDLWSVGCIMGEMVCHKILF 225

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 143
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 197
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 198 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/230 (23%), Positives = 112/230 (48%), Gaps = 42/230 (18%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDI--MVKSK 66
           +DF+  + + +G FG ++  + K     + +K++   ++PN       + R++  + K +
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKLE 61
Query: 67  CPYIVNLFYSFQDMN------------HVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
            P IV  F ++ + N            ++Y  M+     +    +  +      E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-- 171
           +I+ ++A+AV++LH  G +HRD+KP N+  +    +K+ DFG  T +D++   ++++   
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 172 ---------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
                    VGT  Y++PE +      HG + Y+   D++S+G++ +ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQI------HG-NSYSHKVDIFSLGLILFELL 224

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 158
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 212
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 213 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 260

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 37/235 (15%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IE 58
           +++K    S + +   +  G FG +Y       +    +K V +++      +PN   + 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 59  RDIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSES 110
            +++    V S    ++ L   F+  +    I+E         DF+T       G L E 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEE 115
Query: 111 KARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSI 169
            AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  
Sbjct: 116 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDT 169
Query: 170 VPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
           V     GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIE----RDI-MVKS-KCPYIVNLFYS 76
           I +G++G ++    + +     +KK L  +    I+    R+I M+K  K P +VNL   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 77  FQDMNHVYFIMEYVTGGDFVTL--LENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR 134
           F+    ++ + EY    D   L  L+    G + E   +   ++  QAV + H    +HR
Sbjct: 71  FRRKRRLHLVFEYC---DHTVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           D+KP+N+L++    +KL DFG A  +           V T  Y +PE+L       G   
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYD-DEVATRWYRSPELLV------GDTQ 179
Query: 195 YTGSCDLWSIGVVSYELLTG 214
           Y    D+W+IG V  ELL+G
Sbjct: 180 YGPPVDVWAIGCVFAELLSG 199

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IERDIM---- 62
           S + +   +  G FG +Y       +    +K V +++      +PN   +  +++    
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESKARFYIYE 118
           V S    ++ L   F+  +    I+E         DF+T       G L E  AR + ++
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQ 165
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIVPV---GT 174
           + +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V     GT
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTVYTDFDGT 219
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
             Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 220 RVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 260

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IERDIM---- 62
           S + +   +  G FG +Y       +    +K V +++      +PN   +  +++    
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESKARFYIYE 118
           V S    ++ L   F+  +    I+E         DF+T       G L E  AR + ++
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQ 151
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIVPV---GT 174
           + +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V     GT
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTVYTDFDGT 205
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
             Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 206 RVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IERDIM---- 62
           S + +   +  G FG +Y       +    +K V +++      +PN   +  +++    
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESKARFYIYE 118
           V S    ++ L   F+  +    I+E         DF+T       G L E  AR + ++
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQ 150
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIVPV---GT 174
           + +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V     GT
Sbjct: 151 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTVYTDFDGT 204
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
             Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 205 RVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 130
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 184
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 185 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 232

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 130
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 131 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 184
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 185 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 232

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IERDIM---- 62
           S + +   +  G FG +Y       +    +K V +++      +PN   +  +++    
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESKARFYIYE 118
           V S    ++ L   F+  +    I+E         DF+T       G L E  AR + ++
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQ 151
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIVPV---GT 174
           + +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V     GT
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTVYTDFDGT 205
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
             Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 206 RVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 93  LLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 147
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H  G +HRD+KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+  M
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGM 205
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                  GY  + DLWS+G +  E++     F
Sbjct: 206 -------GYKENVDLWSVGCIMGEMVCHKILF 230

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IERDIM---- 62
           S + +   +  G FG +Y       +    +K V +++      +PN   +  +++    
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESKARFYIYE 118
           V S    ++ L   F+  +    I+E         DF+T       G L E  AR + ++
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQ 151
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIVPV---GT 174
           + +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V     GT
Sbjct: 152 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTVYTDFDGT 205
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
             Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 206 RVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 87/342 (25%), Positives = 137/342 (40%), Gaps = 84/342 (24%)
Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYL--------VEEKQSHNT---------- 42
           +D++ EL       S + ++RFI  G++G +          V  K+  NT          
Sbjct: 11  RDLIAELHAMQ---SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNIL 67
Query: 43  ---FVMKKVLRE-------KMPNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT 91
              F+ K+VLRE         PN +  RDI V  + P           M+ +Y + E + 
Sbjct: 68  SDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP----------AMHKLYLVTE-LM 116
Query: 92  GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL 151
             D   ++ +Q    +S    ++++Y +   +  LH  G VHRD+ P N+LL+    + +
Sbjct: 117 RTDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 152 TDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYE- 210
            DF  A +   +        V    Y APE++   +      G+T   D+WS G V  E 
Sbjct: 176 CDFNLAREDTADANKTHY--VTHRWYRAPELVMQFK------GFTKLVDMWSAGCVMAEM 227
Query: 211 -----LLTGSTPFNYETLDMTYSSILACDTEDTVSF--PSS------------IRLSTAM 251
                L  GST +N   L+     +     ED V F  PS+             R  TA+
Sbjct: 228 FNRKALFRGSTFYN--QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAV 285
Query: 252 VNFVQSLVQKLDA---------RLNMDQVLGHPVFDCLDSDP 284
           V     +   L A         R++ +Q L HP F+ L  DP
Sbjct: 286 VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL-FDP 326

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 30  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 87
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 147
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 148 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 197
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 198 DVWSFGILLTEIVTHGRIPY 217

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 144
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 145 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 198
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 199 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 246

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 143
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 197
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 198 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 131
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 185
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 186 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 143
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 144 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 197
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 198 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 17/142 (11%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 95  FQD---VYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 146
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+  M       GY 
Sbjct: 147 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGM-------GYK 197
Query: 197 GSCDLWSIGVVSYELLTGSTPF 218
            + DLWS+G +  E++     F
Sbjct: 198 ENVDLWSVGCIMGEMVCHKILF 219

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 131
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 185
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 186 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 32  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 89
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 149
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 150 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 199
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 200 DVWSFGILLTEIVTHGRIPY 219

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 21/132 (15%)
Query: 94  DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLT 152
           DF+T       G L E  AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL 
Sbjct: 103 DFIT-----ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 157
Query: 153 DFGSATQVDKNGRIKSIVPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSY 209
           DFGS         +K  V     GT  Y  PE + +    HG      S  +WS+G++ Y
Sbjct: 158 DFGSGAL------LKDTVYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLY 205
Query: 210 ELLTGSTPFNYE 221
           +++ G  PF ++
Sbjct: 206 DMVCGDIPFEHD 217

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 21/132 (15%)
Query: 94  DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLT 152
           DF+T       G L E  AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL 
Sbjct: 102 DFIT-----ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 156
Query: 153 DFGSATQVDKNGRIKSIVPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSY 209
           DFGS         +K  V     GT  Y  PE + +    HG      S  +WS+G++ Y
Sbjct: 157 DFGSGAL------LKDTVYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLY 204
Query: 210 ELLTGSTPFNYE 221
           +++ G  PF ++
Sbjct: 205 DMVCGDIPFEHD 216

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IERDIM---- 62
           S + +   +  G FG +Y       +    +K V +++      +PN   +  +++    
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 115
Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESKARFYIYE 118
           V S    ++ L   F+  +    I+E         DF+T       G L E  AR + ++
Sbjct: 116 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQ 170
Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIVPV---GT 174
           + +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V     GT
Sbjct: 171 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTVYTDFDGT 224
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
             Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 225 RVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 265

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 131
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 132 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 185
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 186 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 233

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 87/342 (25%), Positives = 137/342 (40%), Gaps = 84/342 (24%)
Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYL--------VEEKQSHNT---------- 42
           +D++ EL       S + ++RFI  G++G +          V  K+  NT          
Sbjct: 11  RDLIAELHAMQ---SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNIL 67
Query: 43  ---FVMKKVLRE-------KMPNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT 91
              F+ K+VLRE         PN +  RDI V  + P           M+ +Y + E + 
Sbjct: 68  SDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP----------AMHKLYLVTE-LM 116
Query: 92  GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL 151
             D   ++ +Q    +S    ++++Y +   +  LH  G VHRD+ P N+LL+    + +
Sbjct: 117 RTDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 152 TDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYE- 210
            DF  A +   +        V    Y APE++   +      G+T   D+WS G V  E 
Sbjct: 176 CDFNLAREDTADANKTHY--VTHRWYRAPELVMQFK------GFTKLVDMWSAGCVMAEM 227
Query: 211 -----LLTGSTPFNYETLDMTYSSILACDTEDTVSF--PSS------------IRLSTAM 251
                L  GST +N   L+     +     ED V F  PS+             R  TA+
Sbjct: 228 FNRKALFRGSTFYN--QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAV 285
Query: 252 VNFVQSLVQKLDA---------RLNMDQVLGHPVFDCLDSDP 284
           V     +   L A         R++ +Q L HP F+ L  DP
Sbjct: 286 VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL-FDP 326

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 37/236 (15%)
Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--I 57
            +++K    S + +   +  G FG +Y       +    +K V +++      +PN   +
Sbjct: 22  HMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 81
Query: 58  ERDIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSE 109
             +++    V S    ++ L   F+  +    I+E         DF+T       G L E
Sbjct: 82  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQE 136
Query: 110 SKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKS 168
             AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K 
Sbjct: 137 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKD 190
Query: 169 IVPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
            V     GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 191 TVYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 240

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 30  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 87
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 147
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 148 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 197
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 198 DVWSFGILLTEIVTHGRIPY 217

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 29  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 86
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 146
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 147 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 196
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 197 DVWSFGILLTEIVTHGRIPY 216

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 37/234 (15%)
Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNT--IER 59
           ++K    S + +   +  G FG +Y       +    +K V +++      +PN   +  
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 60  DIM----VKSKCPYIVNLFYSFQDMNHVYFIMEYVTG----GDFVTLLENQPHGYLSESK 111
           +++    V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEEL 150
Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS         +K  V
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTV 204
Query: 171 PV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
                GT  Y  PE + +    HG      S  +WS+G++ Y+++ G  PF ++
Sbjct: 205 YTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLYDMVCGDIPFEHD 252

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 25  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 82
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 142
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 143 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 192
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 193 DVWSFGILLTEIVTHGRIPY 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 24  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 81
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 191
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 192 DVWSFGILLTEIVTHGRIPY 211

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 21/132 (15%)
Query: 94  DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLT 152
           DF+T       G L E  AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL 
Sbjct: 99  DFIT-----ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 153
Query: 153 DFGSATQVDKNGRIKSIVPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSY 209
           DFGS         +K  V     GT  Y  PE + +    HG      S  +WS+G++ Y
Sbjct: 154 DFGSGAL------LKDTVYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLY 201
Query: 210 ELLTGSTPFNYE 221
           +++ G  PF ++
Sbjct: 202 DMVCGDIPFEHD 213

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 26  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 83
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 143
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 144 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 193
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 194 DVWSFGILLTEIVTHGRIPY 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 33  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 90
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 150
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 151 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 200
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 201 DVWSFGILLTEIVTHGRIPY 220

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 70  IVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           ++N+F    S ++   VY +ME +   +   +++ +    L   +  + +Y++   +++L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 142
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           H  G +HRD+KP N+++ +   LK+ DFG A     +  ++    V T  Y APEV+  M
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP--EVVTRYYRAPEVILGM 200
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                  GY  + D+WS+G +  E++     F
Sbjct: 201 -------GYKENVDIWSVGCIMGEMVCHKILF 225

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 24  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 81
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEXTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 191
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 192 DVWSFGILLTEIVTHGRIPY 211

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 21/132 (15%)
Query: 94  DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLT 152
           DF+T       G L E  AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL 
Sbjct: 99  DFIT-----ERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLI 153
Query: 153 DFGSATQVDKNGRIKSIVPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSY 209
           DFGS         +K  V     GT  Y  PE + +    HG      S  +WS+G++ Y
Sbjct: 154 DFGSGAL------LKDTVYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLY 201
Query: 210 ELLTGSTPFNYE 221
           +++ G  PF ++
Sbjct: 202 DMVCGDIPFEHD 213

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 21/132 (15%)
Query: 94  DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLT 152
           DF+T       G L E  AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL 
Sbjct: 99  DFIT-----ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 153
Query: 153 DFGSATQVDKNGRIKSIVPV---GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSY 209
           DFGS         +K  V     GT  Y  PE + +    HG      S  +WS+G++ Y
Sbjct: 154 DFGSGAL------LKDTVYTDFDGTRVYSPPEWIRYHR-YHGR-----SAAVWSLGILLY 201
Query: 210 ELLTGSTPFNYE 221
           +++ G  PF ++
Sbjct: 202 DMVCGDIPFEHD 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 26  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y +MEY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 191
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 192 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 34  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 91
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 151
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 152 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 201
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 202 DVWSFGILLTEIVTHGRIPY 221

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 24  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 81
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 191
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 192 DVWSFGILLTEIVTHGRIPY 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 26  GNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQDMNH 82
           G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+      
Sbjct: 19  GQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEP 76
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HRD++  N+L
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 136
Query: 143 LSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           +S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T   
Sbjct: 137 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI-----NYGT--FTIKS 186
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+WS G++  E++T G  P+
Sbjct: 187 DVWSFGILLTEIVTHGRIPY 206

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYLVME-LMDANLXQVIQME----LDHERMSYLLYQMLXGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELL 212
             + D+WS+G +  E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYLVME-LMDANLXQVIQME----LDHERMSYLLYQMLXGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELL 212
             + D+WS+G +  E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 139 FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 240
Query: 196 TGSCDLWSIGVVSYELL 212
             + D+WS+G +  E++
Sbjct: 241 KENVDIWSVGCIMGEMV 257

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/315 (25%), Positives = 130/315 (41%), Gaps = 57/315 (18%)
Query: 13  SASDFDIKRFIQ---QGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKS 65
           SA+  D  R I    +G +G++Y   +  ++ T  +K++      E +P T  R++ +  
Sbjct: 29  SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLK 88
Query: 66  KCPY--IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           +  +  I+ L       + ++ I EY    D    ++  P   +S    + ++Y+L   V
Sbjct: 89  ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGV 145
Query: 124 QYLHGLGYVHRDIKPDNMLLSA-----TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
            + H    +HRD+KP N+LLS      T  LK+ DFG A       R +    + T  Y 
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYR 204
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTED 237
            PE+L       GS  Y+ S D+WSI  +  E+L  +  F  ++ +D  +         D
Sbjct: 205 PPEILL------GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258
Query: 238 TVSFPSSIRLSTAMVNFVQSLVQ--------------------KLDARLNMDQV------ 271
             ++P      TA+ ++ QS  +                     L A L MD V      
Sbjct: 259 DTTWPG----VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314
Query: 272 --LGHPVFDCLDSDP 284
             L HP F   D DP
Sbjct: 315 NALEHPYFSHNDFDP 329

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 102 FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 153
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 203
Query: 196 TGSCDLWSIGVVSYELL 212
             + D+WS+G +  E++
Sbjct: 204 KENVDIWSVGCIMGEMV 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELL 212
             + D+WS+G +  E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 12/162 (7%)
Query: 119 LAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPE 176
           + +A+++LH  L  +HRD+KP N+L++A G +K+ DFG S   VD    +   +  G   
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKP 174
Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           Y+APE +   E N    GY+   D+WS+G+   EL      F Y++    +  +     E
Sbjct: 175 YMAPERIN-PELNQ--KGYSVKSDIWSLGITMIEL--AILRFPYDSWGTPFQQLKQVVEE 229
Query: 237 DTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
            +   P+  + S   V+F  Q L +    R    +++ HP F
Sbjct: 230 PSPQLPAD-KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+  M       GY 
Sbjct: 153 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGM-------GYK 203
Query: 197 GSCDLWSIGVVSYELL 212
            + D+WS+G +  E++
Sbjct: 204 ENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 102 FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 153
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 203
Query: 196 TGSCDLWSIGVVSYELL 212
             + D+WS+G +  E++
Sbjct: 204 KENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 100 FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 151
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+  M       GY 
Sbjct: 152 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGM-------GYK 202
Query: 197 GSCDLWSIGVVSYELL 212
            + D+WS+G +  E++
Sbjct: 203 ENVDIWSVGCIMGEMV 218

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 72/143 (50%), Gaps = 19/143 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELLTGSTPF 218
             + D+WS+G +  E++     F
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILF 225

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 139 FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 190
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 240
Query: 196 TGSCDLWSIGVVSYELL 212
             + D+WS+G +  E++
Sbjct: 241 KENVDIWSVGCIMGEMV 257

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 94  FQD---VYLVME-LMDANLXQVIQME----LDHERMSYLLYQMLXGIKHLHSAGIIHRDL 145
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+  M       GY 
Sbjct: 146 KPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGM-------GYK 196
Query: 197 GSCDLWSIGVVSYELL 212
            + D+WS+G +  E++
Sbjct: 197 ENVDIWSVGCIMGEMV 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 95  FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 146
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+  M       GY 
Sbjct: 147 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGM-------GYK 197
Query: 197 GSCDLWSIGVVSYELL 212
            + D+WS+G +  E++
Sbjct: 198 ENVDIWSVGCIMGEMV 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 26  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y ++EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI---KWTAPEA-----ALYGR 191
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 192 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 95  FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 146
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+  M       GY 
Sbjct: 147 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGM-------GYK 197
Query: 197 GSCDLWSIGVVSYELL 212
            + D+WS+G +  E++
Sbjct: 198 ENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 94  FQD---VYLVME-LMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 145
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+  M       GY 
Sbjct: 146 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVILGM-------GYK 196
Query: 197 GSCDLWSIGVVSYELL 212
            + D+WS+G +  E++
Sbjct: 197 ENVDIWSVGCIMGEMV 212

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 42/244 (17%)
Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERD- 60
           K +++K+   +D+ I R + QG F  I L E  + +  + +KK    L EK  +  + + 
Sbjct: 21  KYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNN 78
Query: 61  --IMVKSKCPYIVNLFYSFQDM---------------NHVYFIMEYVTGG------DFVT 97
             I +KSK     N      D+               + VY I EY+         ++  
Sbjct: 79  DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 98  LLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFG- 155
           +L+     ++     +  I  +  +  Y+H      HRD+KP N+L+   G +KL+DFG 
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 156 SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTG 214
           S   VDK  +IK     GT E++ PE       N  S  Y G+  D+WS+G+  Y +   
Sbjct: 199 SEYMVDK--KIKG--SRGTYEFMPPEFF----SNESS--YNGAKVDIWSLGICLYVMFYN 248
Query: 215 STPF 218
             PF
Sbjct: 249 VVPF 252

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 105 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 160 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 211
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 212 LGCMFAGMIFRKEPFFY 228

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 106 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 160
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 161 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 212
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 213 LGCMFAGMIFRKEPFFY 229

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           FQD   VY +ME +   +   +++ +    L   +  + +Y++   +++LH  G +HRD+
Sbjct: 101 FQD---VYLVME-LMDANLXQVIQME----LDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP-VGTPEYVAPEVLEWMEGNHGSDGY 195
           KP N+++ +   LK+ DFG A      G    + P V T  Y APEV+  M       GY
Sbjct: 153 KPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGM-------GY 202
Query: 196 TGSCDLWSIGVVSYELL 212
             + D+WS+G +  E++
Sbjct: 203 KENVDIWSVGCIMGEMV 219

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 275 LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 328
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE   +       
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGR----- 440
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 441 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 475

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 19  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 72
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 73  AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 184
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 185 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 219

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 106 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 160
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 161 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 212
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 213 LGCMFAGMIFRKEPFFY 229

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 49/237 (20%)
Query: 17  FDIKRFIQQGNFGDIYL---VEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYI--- 70
           F + R +  G FG + L   ++ K+ +   V++ + +      IE DI+ K +   I   
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 71  --VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
             V     F   +H+  I E +    +  +  N  +G+  E   + Y  E+ +A+ YL  
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIED-IKLYCIEILKALNYLRK 155
Query: 129 LGYVHRDIKPDNMLL--------------------------SATGHLKLTDFGSAT-QVD 161
           +   H D+KP+N+LL                           +TG +KL DFG AT + D
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG-IKLIDFGCATFKSD 214
Query: 162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +G I     + T +Y APEV+        + G+  S D+WS G V  EL TGS  F
Sbjct: 215 YHGSI-----INTRQYRAPEVIL-------NLGWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 72/126 (57%), Gaps = 25/126 (19%)
Query: 99  LENQPHGYLSESKARFYIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA 157
           LE++ HG         +I+ ++A+AV++LH  G +HRD+KP N+  +    +K+ DFG  
Sbjct: 158 LEDREHGVC------LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211
Query: 158 TQVDKNGRIKSIVP-----------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGV 206
           T +D++   ++++            VGT  Y++PE +      HG++ Y+   D++S+G+
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQI------HGNN-YSHKVDIFSLGL 264
Query: 207 VSYELL 212
           + +ELL
Sbjct: 265 ILFELL 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 26  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y ++EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 191
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 192 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 105 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 160 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 211
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 212 LGCMFAGMIFRKEPFFY 228

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 107 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 161
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 162 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 213
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 214 LGCMFAGMIFRKEPFFY 230

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 105 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 160 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 211
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 212 LGCMFAGMIFRKEPFFY 228

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 105 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 160 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 211
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 212 LGCMFAGMIFRKEPFFY 228

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 105 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 160 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 211
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 212 LGCMFAGMIFRKEPFFY 228

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 192 LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE    + G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAA--LYGR--- 357
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 358 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 105 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 160 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 211
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 212 LGCMFAGMIFRKEPFFY 228

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 106 YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ--VDKN 163
           +L+E +  + +  + + ++ +H  GY HRD+KP N+LL   G   L D GS  Q  +   
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 164 GRIKSI------VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP 217
           G  +++          T  Y APE+   ++ +   D  T   D+WS+G V Y ++ G  P
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFS-VQSHCVIDERT---DVWSLGCVLYAMMFGEGP 245
Query: 218 FNYETLDMTY--SSILACDTEDTVSFPSSIRLSTAMVNFVQSLV 259
           +     DM +     +A   ++ +S P S R S+A+   + S++
Sbjct: 246 Y-----DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMM 284

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 192 LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE    + G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAA--LYGR--- 357
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 358 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            I EYV   DF  L        L++   R+YIYEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 126 LIFEYVNNTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 180
Query: 145 A-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L  ++       Y  S D+WS
Sbjct: 181 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQ------DYDYSLDMWS 232
Query: 204 IGVVSYELLTGSTPFNY 220
           +G +   ++    PF Y
Sbjct: 233 LGCMFAGMIFRKEPFFY 249

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYI-VNLFYS 76
           I  G+FG +Y    K   +  V  K+L    P        + ++ V  K  ++ + LF  
Sbjct: 32  IGSGSFGTVY----KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-------AQAVQYLHGL 129
           +     +  + ++  G           + +L  S+ +F + +L       A+ + YLH  
Sbjct: 88  YSTAPQLAIVTQWCEGSSL--------YHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYVAPEVLEWMEG 188
             +HRD+K +N+ L     +K+ DFG AT+  + +G  +     G+  ++APEV+   + 
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD- 198
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
              S+ Y+   D+++ G+V YEL+TG  P++
Sbjct: 199 ---SNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 192 LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE    + G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAA--LYGR--- 357
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 358 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--- 171
           Y   + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  +    S+V    
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD--TTSVVKDSQ 216
Query: 172 VGTPEYVAPEVLEWM----EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VGT  Y+ PE ++ M    E        +   D+WS+G + Y +  G TPF
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 26  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 191
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 192 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 17  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 70
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 182
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 183 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 217

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC---PYIVN 72
           D+ + R + +G + +++      ++N  V+ K+L+    N I+R+I +       P I+ 
Sbjct: 38  DYQLVRKLGRGKYSEVFEAI-NITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIIT 96
Query: 73  LFYSFQD--MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           L    +D        + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G
Sbjct: 97  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG 151
Query: 131 YVHRDIKPDNMLLSATGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
            +HRD+KP N+++      L+L D+G A            V V +  +  PE+L      
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV----- 204
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPF-----NYETL 223
                Y  S D+WS+G +   ++    PF     NY+ L
Sbjct: 205 -DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 23  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY+  G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPI---KWTAPEA-----ALYGR 188
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 189 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 223

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 15  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 68
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 180
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 181 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 26  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQL-Y 79
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 191
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 192 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--- 171
           Y   + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  +    S+V    
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD--TTSVVKDSQ 216
Query: 172 VGTPEYVAPEVLEWM----EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VGT  Y+ PE ++ M    E        +   D+WS+G + Y +  G TPF
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           +  G FG++++     +++T V  K L+   P T+       E ++M   +   +V L+ 
Sbjct: 20  LGAGQFGEVWM--GYYNNSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
                  +Y I E++  G  +  L++   G +   K   +  ++A+ + Y+    Y+HRD
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 134
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+S +   K+ DFG A  ++ N    R  +  P+   ++ APE +     N G 
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAI-----NFGC 186
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF 218
             +T   ++WS G++ YE++T G  P+
Sbjct: 187 --FTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 26  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 191
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 192 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYI-VNLFYS 76
           I  G+FG +Y    K   +  V  K+L    P        + ++ V  K  ++ + LF  
Sbjct: 32  IGSGSFGTVY----KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-------AQAVQYLHGL 129
           +     +  + ++  G           + +L  S+ +F + +L       A+ + YLH  
Sbjct: 88  YSTKPQLAIVTQWCEGSSL--------YHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYVAPEVLEWMEG 188
             +HRD+K +N+ L     +K+ DFG AT+  + +G  +     G+  ++APEV+   + 
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD- 198
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
              S+ Y+   D+++ G+V YEL+TG  P++
Sbjct: 199 ---SNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 56/111 (50%), Gaps = 10/111 (9%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--- 171
           Y   + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  +    S+V    
Sbjct: 113 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD--TTSVVKDSQ 169
Query: 172 VGTPEYVAPEVLEWM----EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VGT  Y+ PE ++ M    E        +   D+WS+G + Y +  G TPF
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIKSIVPV 172
           Y   + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  D    +K    V
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD-SQV 189
Query: 173 GTPEYVAPEVLEWM----EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           GT  Y+ PE ++ M    E        +   D+WS+G + Y +  G TPF
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 23  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY+  G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 188
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 189 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 223

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI--ERDIMVKSKCPYIVNLFYSFQD 79
           +  G FG++++      H    +K + +  M P+    E ++M + +   +V L Y+   
Sbjct: 17  LGAGQFGEVWM-GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVT 74
Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
              +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+HR+++  
Sbjct: 75  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAA 134
Query: 140 NMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           N+L+S T   K+ DFG A  ++ N    R  +  P+   ++ APE +     N+G+  +T
Sbjct: 135 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAI-----NYGT--FT 184
Query: 197 GSCDLWSIGVVSYELLT-GSTPF 218
              D+WS G++  E++T G  P+
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIPY 207

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 121/282 (42%), Gaps = 39/282 (13%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + AS   I+R I  G FG++     K        V  K L+        RD      I
Sbjct: 17  KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASI 76
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P I++L         V  + EY+  G   T L+    G  +  +    +  ++ 
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKN-DGQFTVIQLVGMLRGISA 135
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGRIKSIVPV 172
            ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+I    P+
Sbjct: 136 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI----PI 191
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSIL 231
               + APE + + +       +T + D+WS G+V +E+++ G  P+     +MT   ++
Sbjct: 192 ---RWTAPEAIAFRK-------FTSASDVWSYGIVMWEVVSYGERPY----WEMTNQDVI 237
Query: 232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVL 272
               E+    PS +    A+   +    QK  ++R   D+++
Sbjct: 238 KA-VEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIV 278

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 119 LAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPE 176
           + +A+++LH  L  +HRD+KP N+L++A G +K  DFG S   VD    +   +  G   
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VAKDIDAGCKP 201
Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           Y APE +   E N    GY+   D+WS+G+   EL     P  Y++    +  +     E
Sbjct: 202 YXAPERIN-PELNQ--KGYSVKSDIWSLGITXIELAILRFP--YDSWGTPFQQLKQVVEE 256
Query: 237 DTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
            +   P+  + S   V+F  Q L +    R    ++  HP F
Sbjct: 257 PSPQLPAD-KFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIKSIVPV 172
           Y   + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  D    +K    V
Sbjct: 116 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD-SQV 173
Query: 173 GTPEYVAPEVLEWM----EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           GT  Y+ PE ++ M    E        +   D+WS+G + Y +  G TPF
Sbjct: 174 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD------KNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 127 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG--K 184
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 185 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSKCPYIVNLF 74
           DF     I  G FG ++  + +    T+V+K+V   K  N   ER++   +K  ++  + 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVH 68
Query: 75  Y-----------------SFQDMNHVYFI-MEYVTGGDFVTLLENQPHGYLSESKARFYI 116
           Y                 S +      FI ME+   G     +E +    L +  A    
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
            ++ + V Y+H    ++RD+KP N+ L  T  +K+ DFG  T +  +G  K     GT  
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRXRSKGTLR 186
Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
           Y++PE +        S  Y    DL+++G++  ELL
Sbjct: 187 YMSPEQIS-------SQDYGKEVDLYALGLILAELL 215

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+L+  
Sbjct: 112 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 26  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 191
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 192 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 46  KKVLRE-------KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTL 98
           K+ LRE       K  N I    +++   PY         +   VY +++ +       +
Sbjct: 98  KRTLRELKILKHFKHDNIIAIKDILRPTVPY--------GEFKSVYVVLDLMESDLHQII 149
Query: 99  LENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT 158
             +QP   L+    R+++Y+L + ++Y+H    +HRD+KP N+L++    LK+ DFG A 
Sbjct: 150 HSSQP---LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206
Query: 159 QVDKNGRIKSIVP---VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
            +  +           V T  Y APE++  +        YT + DLWS+G +  E+L 
Sbjct: 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLH------EYTQAIDLWSVGCIFGEMLA 258

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIKSIVPV 172
           Y   + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  D    +K    V
Sbjct: 112 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD-SQV 169
Query: 173 GTPEYVAPEVLEWM----EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           GT  Y+ PE ++ M    E        +   D+WS+G + Y +  G TPF
Sbjct: 170 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 26  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           +   N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEA-----ALYGR 191
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 192 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 112 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIKSIVPV 172
           Y   + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  D    +K    V
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKD-SQV 189
Query: 173 GTPEYVAPEVLEWM----EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           GT  Y+ PE ++ M    E        +   D+WS+G + Y +  G TPF
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 112 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 112 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 220 RL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 111 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 166 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 217
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 218 GCMLASMIFRKEPFFHGHDNYDQL 241

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 112 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 12/140 (8%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           + +   VY +++ +       +  +QP   L+    R+++Y+L + ++Y+H    +HRD+
Sbjct: 129 YGEFKSVYVVLDLMESDLHQIIHSSQP---LTLEHVRYFLYQLLRGLKYMHSAQVIHRDL 185
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---VGTPEYVAPEVLEWMEGNHGSD 193
           KP N+L++    LK+ DFG A  +  +           V T  Y APE++  +       
Sbjct: 186 KPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH------ 239
Query: 194 GYTGSCDLWSIGVVSYELLT 213
            YT + DLWS+G +  E+L 
Sbjct: 240 EYTQAIDLWSVGCIFGEMLA 259

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 19/145 (13%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++ 
Sbjct: 111 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165
Query: 145 ATGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L           Y  S D+WS
Sbjct: 166 HEHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWS 217
Query: 204 IGVVSYELLTGSTPF-----NYETL 223
           +G +   ++    PF     NY+ L
Sbjct: 218 LGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 112 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 112 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 111 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 166 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 217
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 218 GCMLASMIFRKEPFFHGHDNYDQL 241

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 110 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 164
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 165 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 216
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 217 GCMLASMIFRKEPFFHGHDNYDQL 240

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 145
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 266 RL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 55/111 (49%), Gaps = 10/111 (9%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--- 171
           Y   + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  +    S+V    
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPD--TTSVVKDSQ 216
Query: 172 VGTPEYVAPEVLEWM----EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           VG   Y+ PE ++ M    E        +   D+WS+G + Y +  G TPF
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 112 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYI-VNLFYS 76
           I  G+FG +Y    K   +  V  K+L    P        + ++ V  K  ++ + LF  
Sbjct: 20  IGSGSFGTVY----KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-------AQAVQYLHGL 129
           +     +  + ++  G           + +L  S+ +F + +L       A+ + YLH  
Sbjct: 76  YSTKPQLAIVTQWCEGSSL--------YHHLHASETKFEMKKLIDIARQTARGMDYLHAK 127
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYVAPEVLEWMEG 188
             +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  ++APEV+   + 
Sbjct: 128 SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD- 186
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
              S+ Y+   D+++ G+V YEL+TG  P++
Sbjct: 187 ---SNPYSFQSDVYAFGIVLYELMTGQLPYS 214

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 220 RL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD------KNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG--K 193
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 194 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIVNLFY 75
           + QG FG++++     +  T V  K L+   P T+       E  +M K +   +V L Y
Sbjct: 16  LGQGCFGEVWM--GTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL-Y 69
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           +      +  + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD
Sbjct: 70  AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           ++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE        +G 
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI---KWTAPEA-----ALYGR 181
Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
             +T   D+WS G++  EL T G  P+    N E LD
Sbjct: 182 --FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 216

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 112 VFEHVNNTDFKQLRQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 166
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 167 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 218
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 219 GCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 24/145 (16%)
Query: 83  VYFIMEYVTGGDFVTLLEN-----QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           +Y I E++  G  +  L++     QP   L +  A     ++A+ + ++    Y+HRD++
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QIAEGMAFIEQRNYIHRDLR 138
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
             N+L+SA+   K+ DFG A  ++ N    R  +  P+   ++ APE +     N GS  
Sbjct: 139 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAI-----NFGS-- 188
Query: 195 YTGSCDLWSIGVVSYELLT-GSTPF 218
           +T   D+WS G++  E++T G  P+
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 39/283 (13%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + AS   I+R I  G FG++     K     +  V  K L+        RD      I
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI 97
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P +V+L         V  ++E++  G     L     G  +  +    +  +A 
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKH-DGQFTVIQLVGMLRGIAA 156
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGRIKSIVPV 172
            ++YL  +GYVHRD+   N+L+++    K++DFG          A      G+I    PV
Sbjct: 157 GMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI----PV 212
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSIL 231
               + APE +++ +       +T + D+WS G+V +E+++ G  P+     DM+   ++
Sbjct: 213 ---RWTAPEAIQYRK-------FTSASDVWSYGIVMWEVMSYGERPY----WDMSNQDVI 258
Query: 232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDA-RLNMDQVLG 273
               E+    P+ +     +   +    QK  A R   +Q++G
Sbjct: 259 KA-IEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVG 300

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 19/144 (13%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G +HRD+KP N+++  
Sbjct: 117 VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 171
Query: 146 TGH-LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSI 204
               L+L D+G A            V V +  +  PE+L           Y  S D+WS+
Sbjct: 172 EHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWSL 223
Query: 205 GVVSYELLTGSTPF-----NYETL 223
           G +   ++    PF     NY+ L
Sbjct: 224 GCMLASMIFRKEPFFHGHDNYDQL 247

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFV-------MKKVLREKMPNTIERDIMVKSKCPY--IVNL 73
           + +G FG +Y   +   +NT V       M  +  E++    +++I V +KC +  +V L
Sbjct: 39  MGEGGFGVVY---KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 74  FYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
                D + +  +  Y+  G   D ++ L+  P   LS           A  + +LH   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQGAANGINFLHENH 153
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGN 189
           ++HRDIK  N+LL      K++DFG A   +K  + +     VGT  Y+APE L      
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE--- 210
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTG 214
                 T   D++S GVV  E++TG
Sbjct: 211 -----ITPKSDIYSFGVVLLEIITG 230

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 41/218 (18%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKCPY--IVNLF-- 74
           I QG FG+++    +++     +KKVL    +E  P T  R+I +     +  +VNL   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 75  -------YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL- 126
                  Y+ +    +Y + ++          E+   G LS    +F + E+ + +Q L 
Sbjct: 86  CRTKASPYN-RCKGSIYLVFDFC---------EHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 127 HGLGYVHR------DIKPDNMLLSATGHLKLTDFG--SATQVDKNGRIKSIVP-VGTPEY 177
           +GL Y+HR      D+K  N+L++  G LKL DFG   A  + KN +       V T  Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS 215
             PE+L       G   Y    DLW  G +  E+ T S
Sbjct: 196 RPPELL------LGERDYGPPIDLWGAGCIMAEMWTRS 227

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNTIERDIMVKSKC---P 68
            SD      + +G FG    V  +++    VMK+++R  E+   T  +++ V  +C   P
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV-MRCLEHP 67
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            ++           + FI EY+ GG    ++++    Y    +  F   ++A  + YLH 
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMAYLHS 126
Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSA-------TQ------VDKNGRIKSIVPVGTP 175
           +  +HRD+   N L+    ++ + DFG A       TQ      + K  R K    VG P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
            ++APE++           Y    D++S G+V  E++
Sbjct: 187 YWMAPEMIN-------GRSYDEKVDVFSFGIVLCEII 216

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 117/260 (45%), Gaps = 40/260 (15%)
Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL---REKMPNTIERDIMVK--SKCPYIVNL 73
           ++R + +G F  +Y  ++  S   + +K++L    EK    I+    +K  S  P IV  
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ- 90
Query: 74  FYSFQDMNHV--------YFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIYELAQAVQ 124
           F S   +           + ++  +  G  V  L+  +  G LS        Y+  +AVQ
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 125 YLH--GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK------NGRIKSIVP----- 171
           ++H      +HRD+K +N+LLS  G +KL DFGSAT +        + + +++V      
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPF----NYETLDMT 226
             TP Y  PE+++       S+   G   D+W++G + Y L     PF        ++  
Sbjct: 211 NTTPMYRTPEIIDLY-----SNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 227 YSSILACDTEDTVSFPSSIR 246
           Y SI   DT+ TV F S IR
Sbjct: 266 Y-SIPPHDTQYTV-FHSLIR 283

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 186
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 187 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 88
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 149 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 209 RL----PV---KWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 133 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 190
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 191 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 220 RL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL- 143
            + EY+   DF  L +      L++   RFY+YEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 112 LVFEYINNTDFKQLYQ-----ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMID 166
Query: 144 SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L           Y  S D+WS
Sbjct: 167 HQQKKLRLIDWGLAEFYHPAQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWS 218
Query: 204 IGVVSYELLTGSTPF-----NYETL 223
           +G +   ++    PF     NY+ L
Sbjct: 219 LGCMLASMIFRREPFFHGQDNYDQL 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 86
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 147 VSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 207 RL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 41/218 (18%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKCPY--IVNLF-- 74
           I QG FG+++    +++     +KKVL    +E  P T  R+I +     +  +VNL   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 75  -------YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL- 126
                  Y+ +    +Y + ++          E+   G LS    +F + E+ + +Q L 
Sbjct: 85  CRTKASPYN-RCKGSIYLVFDFC---------EHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 127 HGLGYVHR------DIKPDNMLLSATGHLKLTDFG--SATQVDKNGRIKSIVP-VGTPEY 177
           +GL Y+HR      D+K  N+L++  G LKL DFG   A  + KN +       V T  Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS 215
             PE+L       G   Y    DLW  G +  E+ T S
Sbjct: 195 RPPELLL------GERDYGPPIDLWGAGCIMAEMWTRS 226

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFV-------MKKVLREKMPNTIERDIMVKSKCPY--IVNL 73
           + +G FG +Y   +   +NT V       M  +  E++    +++I V +KC +  +V L
Sbjct: 39  MGEGGFGVVY---KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 74  FYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
                D + +  +  Y+  G   D ++ L+  P   LS           A  + +LH   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQGAANGINFLHENH 153
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGN 189
           ++HRDIK  N+LL      K++DFG A   +K  + +     VGT  Y+APE L      
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE--- 210
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTG 214
                 T   D++S GVV  E++TG
Sbjct: 211 -----ITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFV-------MKKVLREKMPNTIERDIMVKSKCPY--IVNL 73
           + +G FG +Y   +   +NT V       M  +  E++    +++I V +KC +  +V L
Sbjct: 33  MGEGGFGVVY---KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 74  FYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
                D + +  +  Y+  G   D ++ L+  P   LS           A  + +LH   
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--LSWHMRCKIAQGAANGINFLHENH 147
Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGN 189
           ++HRDIK  N+LL      K++DFG A   +K  + +     VGT  Y+APE L      
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE--- 204
Query: 190 HGSDGYTGSCDLWSIGVVSYELLTG 214
                 T   D++S GVV  E++TG
Sbjct: 205 -----ITPKSDIYSFGVVLLEIITG 224

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 91
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 152 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 212 RL----PV---KWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 192
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 193 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 199
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV            WM      DG +T   D+WS GVV +E+ T
Sbjct: 200 GLLPV-----------RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT+  + +G  +     G+  ++
Sbjct: 134 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 193
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 194 APEVIRMQDKN----PYSFQSDVYAFGIVLYELMTGQLPYS 230

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 41/218 (18%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKCPY--IVNLF-- 74
           I QG FG+++    +++     +KKVL    +E  P T  R+I +     +  +VNL   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 75  -------YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL- 126
                  Y+ +    +Y + ++          E+   G LS    +F + E+ + +Q L 
Sbjct: 86  CRTKASPYN-RCKGSIYLVFDFC---------EHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 127 HGLGYVHR------DIKPDNMLLSATGHLKLTDFG--SATQVDKNGRIKSIVP-VGTPEY 177
           +GL Y+HR      D+K  N+L++  G LKL DFG   A  + KN +       V T  Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS 215
             PE+L       G   Y    DLW  G +  E+ T S
Sbjct: 196 RPPELL------LGERDYGPPIDLWGAGCIMAEMWTRS 227

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            Y+      +Y I EY+  G  V  L+      L+ +K      ++A+ + ++    Y+H
Sbjct: 73  LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           RD++  N+L+S T   K+ DFG A  +   +   R  +  P+   ++ APE +     N+
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI---KWTAPEAI-----NY 184
Query: 191 GSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           G+  +T   D+WS G++  E++T G  P+
Sbjct: 185 GT--FTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 68  PYIVNLFYSFQDMN-HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           P++V + + F +++  +Y     + G D    L  Q  G L+  +A   + ++  A+   
Sbjct: 94  PHVVPI-HDFGEIDGQLYVDXRLINGVDLAAXLRRQ--GPLAPPRAVAIVRQIGSALDAA 150
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFG--SATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           H  G  HRD+KP+N+L+SA     L DFG  SAT  +K  ++ +   VGT  Y APE   
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT--VGTLYYXAPERFS 208
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                + +D Y  +C       V YE LTGS P+  + L     S+        +  PS+
Sbjct: 209 ESHATYRADIYALTC-------VLYECLTGSPPYQGDQL-----SVXGAHINQAIPRPST 256
Query: 245 IR 246
           +R
Sbjct: 257 VR 258

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 92
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 213 RL----PV---KWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT+  + +G  +     G+  ++
Sbjct: 142 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 202 APEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P IV    +F   N ++ +  ++  G    L+       ++E    + +  + +A+ Y+H
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 129
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV------PVGTPEYVAPE 181
            +GYVHR +K  ++L+S  G + L+   S   +  +G+ + +V       V    +++PE
Sbjct: 130 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 189
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN--------YETLDMTYSSILAC 233
           VL+         GY    D++S+G+ + EL  G  PF          E L+ T   +L  
Sbjct: 190 VLQ-----QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 244
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQV-----------LGHPVFDCLDS 282
            T        S   S A      SL        N D               H V  CL  
Sbjct: 245 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 304
Query: 283 DPPCIPPPSQ--ENKFHKKDKRKASPSL 308
           +P   P  S    + F K+ KR+AS +L
Sbjct: 305 NPDARPSASTLLNHSFFKQIKRRASEAL 332

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 37/172 (21%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF-----Y 115
           I+NL  +      +Y I+EY + G+    L   +P G         + E +  F      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NGRIK 167
            Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NGR+ 
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL- 221
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 222 ---PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD------I 61
           K + AS   I++ I  G FG++    ++        V  K L+    +   RD      I
Sbjct: 9   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I++L         V  I EY+  G            +L ++  RF + +L  
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL--------DAFLRKNDGRFTVIQLVG 120
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                   ++YL  + YVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 121 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + APE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 181 I----PI---RWTAPEAIAYRK-------FTSASDVWSYGIVMWEVMSYGERPY 220

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 192
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 193 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           VS     + R + QG+FG +Y      + + ++     +K V     LRE++    E  +
Sbjct: 11  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 70
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 71  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 130
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD------KNGRIK 167
            +  E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 131 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG--K 188
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYEL 211
            ++PV    ++APE L+        DG +T S D+WS GVV +E+
Sbjct: 189 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEI 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 193
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 194 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P IV    +F   N ++ +  ++  G    L+       ++E    + +  + +A+ Y+H
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV------PVGTPEYVAPE 181
            +GYVHR +K  ++L+S  G + L+   S   +  +G+ + +V       V    +++PE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN--------YETLDMTYSSILAC 233
           VL+         GY    D++S+G+ + EL  G  PF          E L+ T   +L  
Sbjct: 206 VLQ-----QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260
Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQV-----------LGHPVFDCLDS 282
            T        S   S A      SL        N D               H V  CL  
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320
Query: 283 DPPCIPPPSQ--ENKFHKKDKRKASPSL 308
           +P   P  S    + F K+ KR+AS +L
Sbjct: 321 NPDARPSASTLLNHSFFKQIKRRASEAL 348

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 77
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 198 RL----PV---KWMAPEAL-------FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCPYIV 71
           IKR +  G FG++++     + NT V  K L+   P T+       E  IM K K   +V
Sbjct: 14  IKR-LGNGQFGEVWM--GTWNGNTKVAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLV 67
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L Y+      +Y + EY+  G  +  L++     L          ++A  + Y+  + Y
Sbjct: 68  QL-YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 126
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE       
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPI---KWTAPEA-----A 178
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
            +G   +T   D+WS G++  EL+T G  P+
Sbjct: 179 LYGR--FTIKSDVWSFGILLTELVTKGRVPY 207

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 41/218 (18%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMVKSKCPY--IVNLF-- 74
           I QG FG+++    +++     +KKVL    +E  P T  R+I +     +  +VNL   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 75  -------YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL- 126
                  Y+ +    +Y + ++          E+   G LS    +F + E+ + +Q L 
Sbjct: 86  CRTKASPYN-RCKASIYLVFDFC---------EHDLAGLLSNVLVKFTLSEIKRVMQMLL 135
Query: 127 HGLGYVHR------DIKPDNMLLSATGHLKLTDFG--SATQVDKNGRIKSIVP-VGTPEY 177
           +GL Y+HR      D+K  N+L++  G LKL DFG   A  + KN +       V T  Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS 215
             PE+L       G   Y    DLW  G +  E+ T S
Sbjct: 196 RPPELL------LGERDYGPPIDLWGAGCIMAEMWTRS 227

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 81
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 142 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 202 RL----PV---KWMAPEAL-------FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC-----PYIVN 72
           I  G +G +Y   +  S + FV  K +R     E +P +  R++ +  +      P +V 
Sbjct: 12  IGVGAYGTVYKARDPHSGH-FVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 73  LF----YSFQDMN-HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           L      S  D    V  + E+V   D  T L+  P   L     +  + +  + + +LH
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP+N+L+++ G +KL DFG A        +  +  V T  Y APEVL    
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV--VVTLWYRAPEVLL--- 184
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELL 212
                  Y    D+WS+G +  E+ 
Sbjct: 185 ----QSTYATPVDMWSVGCIFAEMF 205

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL- 143
            + EY+   DF  L +      L++   RFY+YEL +A+ Y H  G +HRD+KP N+++ 
Sbjct: 117 LVFEYINNTDFKQLYQ-----ILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMID 171
Query: 144 SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWS 203
                L+L D+G A            V V +  +  PE+L           Y  S D+WS
Sbjct: 172 HQQKKLRLIDWGLAEFYHPAQEYN--VRVASRYFKGPELLV------DYQMYDYSLDMWS 223
Query: 204 IGVVSYELLTGSTPF-----NYETL 223
           +G +   ++    PF     NY+ L
Sbjct: 224 LGCMLASMIFRREPFFHGQDNYDQL 248

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 24/145 (16%)
Query: 83  VYFIMEYVTGGDFVTLLEN-----QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           +Y I E++  G  +  L++     QP   L +  A     ++A+ + ++    Y+HRD++
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QIAEGMAFIEQRNYIHRDLR 311
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
             N+L+SA+   K+ DFG A  ++ N    R  +  P+   ++ APE +     N GS  
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAI-----NFGS-- 361
Query: 195 YTGSCDLWSIGVVSYELLT-GSTPF 218
           +T   D+WS G++  E++T G  P+
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 34/180 (18%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E+D   K+ C   V +F  F    H+    E +    F  L +N    Y    + R   +
Sbjct: 89  EKDPDNKNLC---VQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPY-PIHQVRHMAF 144
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGH-------------------LKLTDFGSAT 158
           +L QAV++LH     H D+KP+N+L   + +                   +++ DFGSAT
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
              ++    S + V T  Y APEV+  +       G++  CD+WSIG + +E   G T F
Sbjct: 205 FDHEH---HSTI-VSTRHYRAPEVILEL-------GWSQPCDVWSIGCIIFEYYVGFTLF 253

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 44/229 (19%)
Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSKCPYIVNLF 74
           DF     I  G FG ++  + +    T+V+++V   K  N   ER++   +K  ++  + 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV---KYNNEKAEREVKALAKLDHVNIVH 69
Query: 75  Y------------------------------SFQDMNHVYFI-MEYVTGGDFVTLLENQP 103
           Y                              S +      FI ME+   G     +E + 
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 104 HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN 163
              L +  A     ++ + V Y+H    +HRD+KP N+ L  T  +K+ DFG  T +  +
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 189
Query: 164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
           G  K     GT  Y++PE +        S  Y    DL+++G++  ELL
Sbjct: 190 G--KRTRSKGTLRYMSPEQI-------SSQDYGKEVDLYALGLILAELL 229

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREK--MPNTI--ERDIMVKSKCPYIVNLFYSFQ 78
           + QG FG++++     +  T V  K L+     P     E  +M K +   +V L Y+  
Sbjct: 193 LGQGCFGEVWM--GTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQL-YAVV 249
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
               +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + YVHRD++ 
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 309
Query: 139 DNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
            N+L+      K+ DFG    ++ N    R  +  P+   ++ APE    + G      +
Sbjct: 310 ANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPI---KWTAPEAA--LYGR-----F 359
Query: 196 TGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
           T   D+WS G++  EL T G  P+    N E LD
Sbjct: 360 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 393

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--ERDIMVKSKCPYIVNLF-YSFQD 79
           I +G FGD+ L + +   N   +K +  +        E  +M + +   +V L     ++
Sbjct: 20  IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
              +Y + EY+  G  V  L ++    L       +  ++ +A++YL G  +VHRD+   
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 137
Query: 140 NMLLSATGHLKLTDFG---SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           N+L+S     K++DFG    A+     G++    PV   ++ APE L           ++
Sbjct: 138 NVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PV---KWTAPEALR-------EAAFS 183
Query: 197 GSCDLWSIGVVSYELLT-GSTPF 218
              D+WS G++ +E+ + G  P+
Sbjct: 184 TKSDVWSFGILLWEIYSFGRVPY 206

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           VS     + R + QG+FG +Y      + + ++     +K V     LRE++    E  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD------KNGRIK 167
            +  E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG--K 191
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYEL 211
            ++PV    ++APE L+        DG +T S D+WS GVV +E+
Sbjct: 192 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEI 225

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 25  QGNFGDIYLVEEKQSHNTFV-------MKKVLREKMPNTIERDIMVKSKCPY--IVNLFY 75
           +G FG +Y   +   +NT V       M  +  E++    +++I V +KC +  +V L  
Sbjct: 32  EGGFGVVY---KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 76  SFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
              D + +  +  Y   G   D ++ L+  P   LS           A  + +LH   ++
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP--LSWHXRCKIAQGAANGINFLHENHHI 146
Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHG 191
           HRDIK  N+LL      K++DFG A   +K  + +     VGT  Y APE L        
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE----- 201
Query: 192 SDGYTGSCDLWSIGVVSYELLTG 214
               T   D++S GVV  E++TG
Sbjct: 202 ---ITPKSDIYSFGVVLLEIITG 221

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC-----PYIVN 72
           I  G +G +Y   +  S + FV  K +R     E +P +  R++ +  +      P +V 
Sbjct: 12  IGVGAYGTVYKARDPHSGH-FVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 73  LF----YSFQDMN-HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           L      S  D    V  + E+V   D  T L+  P   L     +  + +  + + +LH
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP+N+L+++ G +KL DFG A        +  +  V T  Y APEVL    
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPV--VVTLWYRAPEVLL--- 184
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELL 212
                  Y    D+WS+G +  E+ 
Sbjct: 185 ----QSTYATPVDMWSVGCIFAEMF 205

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD------I 61
           K + AS   I++ I  G FG++    ++        V  K L+    +   RD      I
Sbjct: 3   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I++L         V  I EY+  G            +L ++  RF + +L  
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL--------DAFLRKNDGRFTVIQLVG 114
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                   ++YL  + YVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 115 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + APE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 175 I----PI---RWTAPEAIAYRK-------FTSASDVWSYGIVMWEVMSYGERPY 214

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 20/149 (13%)
Query: 107 LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA----TGHLKLTDFGSATQVDK 162
           L     +  +Y++   + YLH    +HRD+KP N+L+       G +K+ D G A     
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-- 182
Query: 163 NGRIKSIVP----VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           N  +K +      V T  Y APE+L       G+  YT + D+W+IG +  ELLT    F
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSEPIF 236
Query: 219 NYETLDMTYSSILACDTEDTV----SFPS 243
           +    D+  S+    D  D +     FP+
Sbjct: 237 HCRQEDIKTSNPYHHDQLDRIFNVMGFPA 265

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 84
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 145 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 205 RL----PV---KWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 85
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 146 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 206 RL----PV---KWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT+  + +G  +     G+  ++
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 173
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 174 APEVIRMQDKN----PYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +++ DFG A  ++         NG
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 220 RL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 92
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 213 RL----PV---KWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 92
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 213 RL----PV---KWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--ERDIMVKSKCPYIVNLF-YSFQD 79
           I +G FGD+ L + +   N   +K +  +        E  +M + +   +V L     ++
Sbjct: 14  IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
              +Y + EY+  G  V  L ++    L       +  ++ +A++YL G  +VHRD+   
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 131
Query: 140 NMLLSATGHLKLTDFG---SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           N+L+S     K++DFG    A+     G++    PV   ++ APE L           ++
Sbjct: 132 NVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PV---KWTAPEALR-------EKKFS 177
Query: 197 GSCDLWSIGVVSYELLT-GSTPF 218
              D+WS G++ +E+ + G  P+
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           VS     + R + QG+FG +Y      + + ++     +K V     LRE++    E  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD------KNGRIK 167
            +  E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGG--K 191
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYEL 211
            ++PV    ++APE L+        DG +T S D+WS GVV +E+
Sbjct: 192 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEI 225

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--ERDIMVKSKCPYIVNLF-YSFQD 79
           I +G FGD+ L + +   N   +K +  +        E  +M + +   +V L     ++
Sbjct: 29  IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
              +Y + EY+  G  V  L ++    L       +  ++ +A++YL G  +VHRD+   
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 146
Query: 140 NMLLSATGHLKLTDFG---SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           N+L+S     K++DFG    A+     G++    PV   ++ APE L           ++
Sbjct: 147 NVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PV---KWTAPEALR-------EKKFS 192
Query: 197 GSCDLWSIGVVSYELLT-GSTPF 218
              D+WS G++ +E+ + G  P+
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK-MPNTIERDIMV--------K 64
           A  +++ + I +G+FG +    + + H    +K V  EK        +I +        K
Sbjct: 96  AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
                ++++  +F   NH+    E ++   +  + +N+  G+ S    R + + + Q + 
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF-SLPLVRKFAHSILQCLD 214
Query: 125 YLHGLGYVHRDIKPDNMLLSATGH--LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
            LH    +H D+KP+N+LL   G   +K+ DFGS+    ++ R+ + +   +  Y APEV
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTXIQ--SRFYRAPEV 270
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
           +           Y    D+WS+G +  ELLTG
Sbjct: 271 ILGAR-------YGMPIDMWSLGCILAELLTG 295

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  ++
Sbjct: 141 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 200
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 201 APEVIRMQDKN----PYSFQSDVYAFGIVLYELMTGQLPYS 237

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 92
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 213 RL----PV---KWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 28/142 (19%)
Query: 83  VYFIMEYVTGGDFVTLLEN-----QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           +Y I E++  G  +  L++     QP   L +  A     ++A+ + ++    Y+HRD++
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QIAEGMAFIEQRNYIHRDLR 305
Query: 138 PDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG 197
             N+L+SA+   K+ DFG A       R+ +  P+   ++ APE +     N GS  +T 
Sbjct: 306 AANILVSASLVCKIADFGLA-------RVGAKFPI---KWTAPEAI-----NFGS--FTI 348
Query: 198 SCDLWSIGVVSYELLT-GSTPF 218
             D+WS G++  E++T G  P+
Sbjct: 349 KSDVWSFGILLMEIVTYGRIPY 370

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 35/169 (20%)
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSE--SKARFYIYELAQAVQYLHG 128
           V +   F+   H+  + E +    +  + EN   G+L       R   Y++ ++V +LH 
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 129 LGYVHRDIKPDNMLLSATGH-------------------LKLTDFGSATQVDKNGRIKSI 169
               H D+KP+N+L   + +                   +K+ DFGSAT  D++      
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS---- 192
Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             V T  Y APEV+  +       G++  CD+WSIG +  E   G T F
Sbjct: 193 TLVSTRHYRAPEVILAL-------GWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 19/196 (9%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIM-VKS-----KCPYIVNLFY 75
           +  G++G+++ V  K+    + +K+ +   + P    R +  V S     + P  V L  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 76  SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRD 135
           ++++   +Y   E + G       E      L E++   Y+ +   A+ +LH  G VH D
Sbjct: 125 AWEEGGILYLQTE-LCGPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           +KP N+ L   G  KL DFG   ++   G     V  G P Y+APE+L   +G++G+   
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELL---QGSYGT--- 234
Query: 196 TGSCDLWSIGVVSYEL 211
             + D++S+G+   E+
Sbjct: 235 --AADVFSLGLTILEV 248

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 103/235 (43%), Gaps = 39/235 (16%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNTI-ERDIMVKSKCPYI 70
           ASDF+    + QG FG +           + +KK+    EK+   + E  ++      Y+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYV 64
Query: 71  VNLFYSFQDMNH-------------VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           V  + ++ +  +             ++   EY        L+ ++      +   R +  
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-R 123
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI----VP-- 171
           ++ +A+ Y+H  G +HR++KP N+ +  + ++K+ DFG A  V ++  I  +    +P  
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 172 -------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                  +GT  YVA EVL+      G+  Y    D +S+G++ +E +    PF+
Sbjct: 184 SDNLTSAIGTAXYVATEVLD------GTGHYNEKIDXYSLGIIFFEXI---YPFS 229

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPE 176
           + AQ + YLH    +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           ++APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 200 WMAPEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK-MPNTIERDIMV--------K 64
           A  +++ + I +G+FG +    + + H    +K V  EK        +I +        K
Sbjct: 96  AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
                ++++  +F   NH+    E ++   +  + +N+  G+ S    R + + + Q + 
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF-SLPLVRKFAHSILQCLD 214
Query: 125 YLHGLGYVHRDIKPDNMLLSATGH--LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
            LH    +H D+KP+N+LL   G   +K+ DFGS+    ++ R+ + +   +  Y APEV
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTXIQ--SRFYRAPEV 270
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
           +           Y    D+WS+G +  ELLTG
Sbjct: 271 ILGAR-------YGMPIDMWSLGCILAELLTG 295

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 164 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 221
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 222 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L       EN P     S SK  
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N  ++    +K+ DFG    +       K G  K
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 186
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 187 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           VS     + R + QG+FG +Y      + + ++     +K V     LRE++    E  +
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 73  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 132
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
            +  E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 133 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG--K 190
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYEL 211
            ++PV    ++APE L+        DG +T S D+WS GVV +E+
Sbjct: 191 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEI 224

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMVKSKC-----PYIVN 72
           I  G +G +Y   +  S + FV  K +R     E +P +  R++ +  +      P +V 
Sbjct: 12  IGVGAYGTVYKARDPHSGH-FVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 73  LF----YSFQDMN-HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           L      S  D    V  + E+V   D  T L+  P   L     +  + +  + + +LH
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
               VHRD+KP+N+L+++ G +KL DFG A        +  +  V T  Y APEVL    
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV--VVTLWYRAPEVLL--- 184
Query: 188 GNHGSDGYTGSCDLWSIGVVSYELL 212
                  Y    D+WS+G +  E+ 
Sbjct: 185 ----QSTYATPVDMWSVGCIFAEMF 205

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--ERDIMVKSKCPYIVNLF-YSFQD 79
           I +G FGD+ L + +   N   +K +  +        E  +M + +   +V L     ++
Sbjct: 201 IGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 80  MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
              +Y + EY+  G  V  L ++    L       +  ++ +A++YL G  +VHRD+   
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318
Query: 140 NMLLSATGHLKLTDFG---SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           N+L+S     K++DFG    A+     G++    PV   ++ APE L           ++
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PV---KWTAPEALR-------EKKFS 364
Query: 197 GSCDLWSIGVVSYELLT-GSTPF 218
              D+WS G++ +E+ + G  P+
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 29/158 (18%)
Query: 85  FIMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHG---LGYVHRDIKPD 139
            +ME+  GG    +L  +  P   L       +  ++A+ + YLH    +  +HRD+K  
Sbjct: 83  LVMEFARGGPLNRVLSGKRIPPDILVN-----WAVQIARGMNYLHDEAIVPIIHRDLKSS 137
Query: 140 NMLLS--------ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           N+L+         +   LK+TDFG A +  +  ++ +    G   ++APEV+        
Sbjct: 138 NILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA---AGAYAWMAPEVIR------- 187
Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYS 228
           +  ++   D+WS GV+ +ELLTG  PF   + L + Y 
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG 225

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQ 78
           +  G FG + L + K  ++  V  K+++E   +      E   M+K   P +V  +    
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAV--KMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
               +Y + EY++ G  +  L +   G L  S+     Y++ + + +L    ++HRD+  
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 139 DNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
            N L+     +K++DFG    V  +  + S+      ++ APEV  + +       Y+  
Sbjct: 133 RNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-------YSSK 185
Query: 199 CDLWSIGVVSYELLT-GSTPFNYET 222
            D+W+ G++ +E+ + G  P++  T
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYT 210

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+ Y + G+    L   +P G         + E +  F   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 220 RL----PV---KWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  ++
Sbjct: 116 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 175
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 176 APEVIRMQDKN----PYSFQSDVYAFGIVLYELMTGQLPYS 212

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I++L  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 220 RL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  ++
Sbjct: 119 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 179 APEVIRMQDKN----PYSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  ++
Sbjct: 119 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 179 APEVIRMQDKNP----YSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-------NQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L        N P     S SK  
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 199
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV            WM      DG +T   D+WS GVV +E+ T
Sbjct: 200 GLLPV-----------RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           VS     + R + QG+FG +Y      + + ++     +K V     LRE++    E  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
            +  E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGG--K 191
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYEL 211
            ++PV    ++APE L+        DG +T S D+WS GVV +E+
Sbjct: 192 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEI 225

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  ++
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 174 APEVIRMQDKN----PYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK-MPNTIERDIMV--------K 64
           A  +++ + I +G FG +    + + H    +K V  EK        +I +        K
Sbjct: 96  AYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
                ++++  +F   NH+    E ++   +  + +N+  G+ S    R + + + Q + 
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF-SLPLVRKFAHSILQCLD 214
Query: 125 YLHGLGYVHRDIKPDNMLLSATGH--LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
            LH    +H D+KP+N+LL   G   +K+ DFGS+    +    +    + +  Y APEV
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYXXIQSRFYRAPEV 270
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
           +           Y    D+WS+G +  ELLTG
Sbjct: 271 ILGAR-------YGMPIDMWSLGCILAELLTG 295

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+ L  +      +Y I+EY + G+    L   +P G         + E +  F   
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 220 RL----PV---KWMAPEAL-------FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYV 178
           AQ + YLH    +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  ++
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           APEV+   + N     Y+   D+++ G+V YEL+TG  P++
Sbjct: 174 APEVIRMQDKN----PYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 113/260 (43%), Gaps = 46/260 (17%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNT----FVMKKVLREKMPNTIER------ 59
           +++   D  +KR + +G FG ++L E      T     V  K L++  P    R      
Sbjct: 10  QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQRE 67
Query: 60  -DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF-----------VTLLENQPH--- 104
            +++   +  +IV  +    D + +  + EY+  GD            + L++ QP    
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
           G L  S+      ++A  + YL    +VHRD+   N L+ A   +K+ DFG +  V    
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 165 RIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
             +    +++P+    ++ PE + + +       +T   D+WS GV+ +E+ T G  P+ 
Sbjct: 188 YYRVGGHTMLPI---RWMPPESIMYRK-------FTTESDVWSFGVILWEIFTYGKQPW- 236
Query: 220 YETLDMTYSSILACDTEDTV 239
                ++ + ++ C T+  V
Sbjct: 237 ---FQLSNTEVIECITQGRV 253

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 115/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 42  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 96
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 97  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 152
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 153 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 212
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           + G  +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 213 RAGYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 262
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 263 PYPSKSNQEVLEFVTSG 279

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           VS     + R + QG+FG +Y      + + ++     +K V     LRE++    E  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
            +  E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG--K 191
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYEL 211
            ++PV    ++APE L+        DG +T S D+WS GVV +E+
Sbjct: 192 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEI 225

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 38/227 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIY-----LVEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           V+     + R + QG+FG +Y      V + +      +K V     +RE++    E  +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-------NQP-HGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L        N P     S SK  
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    +       K G  K
Sbjct: 132 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG--K 189
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
            ++PV    +++PE L+        DG +T   D+WS GVV +E+ T
Sbjct: 190 GLLPV---RWMSPESLK--------DGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + + E      +K      V  K+L++   +  E+D+        M+K   K
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 99
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGY--------LSESKARF--- 114
              I+NL  +      +Y I+ Y + G+    L   +P G         + E +  F   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++         NG
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 220 RL----PV---KWMAPEALF-------DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 115/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 65  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 119
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 120 DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 175
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           + G  +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 236 RAGYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 285
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 286 PYPSKSNQEVLEFVTSG 302

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           V  + E+V   D  T L+  P   L     +  + +  + + +LH    VHRD+KP+N+L
Sbjct: 94  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 152
Query: 143 LSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLW 202
           +++ G +KL DFG A        +  +  V T  Y APEVL           Y    D+W
Sbjct: 153 VTSGGTVKLADFGLARIYSYQMALTPV--VVTLWYRAPEVLL-------QSTYATPVDMW 203
Query: 203 SIGVVSYELL 212
           S+G +  E+ 
Sbjct: 204 SVGCIFAEMF 213

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 23  IQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNTIERDI--------MVK--SK 66
           + +G FG + L E      +K +  T V  K+L+    +  E+D+        M+K   K
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGK 133
Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKA 112
              I+NL  +      +Y I+EY + G+    L+              + P   LS    
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--------NG 164
               Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +          NG
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           R+    PV   +++APE L           YT   D+WS GV+ +E+ T G +P+
Sbjct: 254 RL----PV---KWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLK-------------LTDFGSATQVD--- 161
           ++A  V +LH L  +HRD+KP N+L+S +                 ++DFG   ++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN- 219
            + R     P GT  + APE+LE           T S D++S+G V Y +L+ G  PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 220 -YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVF 277
            Y         I + D    +   S I  +T +++  Q +      R    +VL HP+F
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS--QMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 21/179 (11%)
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLK-------------LTDFGSATQVDKN- 163
           ++A  V +LH L  +HRD+KP N+L+S +                 ++DFG   ++D   
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 164 --GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN- 219
              R     P GT  + APE+LE           T S D++S+G V Y +L+ G  PF  
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 220 -YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVF 277
            Y         I + D    +   S I  +T +++  Q +      R    +VL HP+F
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS--QMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD------I 61
           K + AS   I++ I  G FG++    ++        V  K L+    +   RD      I
Sbjct: 24  KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 83
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I++L         V  I EY+  G            +L ++  RF + +L  
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL--------DAFLRKNDGRFTVIQLVG 135
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                   ++YL  +  VHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 136 MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + APE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 196 I----PI---RWTAPEAIAYRK-------FTSASDVWSYGIVMWEVMSYGERPY 235

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 35/169 (20%)
Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSE--SKARFYIYELAQAVQYLHG 128
           V +   F+   H+  + E +    +  + EN   G+L       R   Y++ ++V +LH 
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 129 LGYVHRDIKPDNMLLSATGH-------------------LKLTDFGSATQVDKNGRIKSI 169
               H D+KP+N+L   + +                   +K+ DFGSAT  D++      
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS---- 192
Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             V    Y APEV+  +       G++  CD+WSIG +  E   G T F
Sbjct: 193 TLVXXRHYRAPEVILAL-------GWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 122
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 183 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKN 163
           G L E  +R +  ++  A+Q+ H  G VHRDIK +N+L+    G  KL DFGS   +   
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
Query: 164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                    GT  Y  P   EW+   H       +  +WS+G++ Y+++ G  PF
Sbjct: 194 PYTDF---DGTRVYSPP---EWIS-RHQYHALPAT--VWSLGILLYDMVCGDIPF 239

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 24  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 78
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + +ME + GGD  + L E +P     
Sbjct: 79  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILMELMAGGDLKSFLRETRPRPSQP 134
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 195 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 244
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 245 PYPSKSNQEVLEFVTSG 261

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           VS     + R + QG+FG +Y      + + ++     +K V     LRE++    E  +
Sbjct: 15  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 74
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 75  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 134
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
            +  E+A  + YL+   +VHR++   N +++    +K+ DFG    +       K G  K
Sbjct: 135 QMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG--K 192
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYEL 211
            ++PV    ++APE L+        DG +T S D+WS GVV +E+
Sbjct: 193 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEI 226

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 107/244 (43%), Gaps = 31/244 (12%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K +  S   I++ I  G FG++     K       FV  K L+        RD      I
Sbjct: 28  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 87
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P +++L         V  I E++  G   + L  Q  G  +  +    +  +A 
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAA 146
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-------GRIKSIVPVGT 174
            ++YL  + YVHRD+   N+L+++    K++DFG +  ++ +         +   +P+  
Sbjct: 147 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI-- 204
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC 233
             + APE +++ +       +T + D+WS G+V +E+++ G  P+     DMT   ++  
Sbjct: 205 -RWTAPEAIQYRK-------FTSASDVWSYGIVMWEVMSYGERPY----WDMTNQDVINA 252
Query: 234 DTED 237
             +D
Sbjct: 253 IEQD 256

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 139
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 200 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 12  VSASDFDIKRFIQQGNFGDIYL-----VEEKQSHNTFVMKKV-----LREKMPNTIERDI 61
           VS     + R + QG+FG +Y      + + ++     +K V     LRE++    E  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARF 114
           M    C ++V L            +ME +  GD  + L       EN P       +   
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 115 YIY-ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV------DKNGRIK 167
            +  E+A  + YL+   +VHR++   N +++    +K+ DFG    +       K G  K
Sbjct: 134 QMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG--K 191
Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYEL 211
            ++PV    ++APE L+        DG +T S D+WS GVV +E+
Sbjct: 192 GLLPV---RWMAPESLK--------DGVFTTSSDMWSFGVVLWEI 225

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 38  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 149
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 210 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 249

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            +MEY+  G     L+      L  S+   Y  ++ + ++YL     VHRD+   N+L+ 
Sbjct: 87  LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 145
Query: 145 ATGHLKLTDFGSA--TQVDKNGRIKSIVPVGTPEY-VAPEVLEWMEGNHGSDGYTGSCDL 201
           +  H+K+ DFG A    +DK+  +    P  +P +  APE L         + ++   D+
Sbjct: 146 SEAHVKIADFGLAKLLPLDKDXXVVR-EPGQSPIFWYAPESLS-------DNIFSRQSDV 197
Query: 202 WSIGVVSYELLT 213
           WS GVV YEL T
Sbjct: 198 WSFGVVLYELFT 209

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           YIV+L   F   NH+  + E ++  +   LL N     +S +  R +  ++  A+ +L  
Sbjct: 98  YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 156
Query: 129 --LGYVHRDIKPDNMLLSAT--GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
             L  +H D+KP+N+LL       +K+ DFGS+ Q+ +  RI   +   +  Y +PEVL 
Sbjct: 157 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQ--SRFYRSPEVLL 212
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
            M        Y  + D+WS+G +  E+ TG   F+
Sbjct: 213 GMP-------YDLAIDMWSLGCILVEMHTGEPLFS 240

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 24/172 (13%)
Query: 113 RFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSI 169
           R +  ++ + +Q+LH      +HRD+K DN+ ++  TG +K+ D G AT + +    K++
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAV 190
Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDM 225
           +  GTPE+ APE  E        + Y  S D+++ G    E  T   P+    N   +  
Sbjct: 191 I--GTPEFXAPEXYE--------EKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYR 240
Query: 226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVF 277
             +S +   + D V+ P    +    +       Q  D R ++  +L H  F
Sbjct: 241 RVTSGVKPASFDKVAIPEVKEIIEGCIR------QNKDERYSIKDLLNHAFF 286

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 51  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 105
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 106 DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 161
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 162 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 221
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 222 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 271
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 272 PYPSKSNQEVLEFVTSG 288

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           YIV+L   F   NH+  + E ++  +   LL N     +S +  R +  ++  A+ +L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 129 --LGYVHRDIKPDNMLLSAT--GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
             L  +H D+KP+N+LL       +K+ DFGS+ Q+ +  RI   +   +  Y +PEVL 
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQ--SRFYRSPEVLL 231
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
            M        Y  + D+WS+G +  E+ TG   F+
Sbjct: 232 GMP-------YDLAIDMWSLGCILVEMHTGEPLFS 259

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 39  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 93
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + +ME + GGD  + L E +P     
Sbjct: 94  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILMELMAGGDLKSFLRETRPRPSQP 149
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 150 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 210 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 259
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 260 PYPSKSNQEVLEFVTSG 276

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           YIV+L   F   NH+  + E ++  +   LL N     +S +  R +  ++  A+ +L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 129 --LGYVHRDIKPDNMLLSATGH--LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
             L  +H D+KP+N+LL       +K+ DFGS+ Q+ +  RI   +   +  Y +PEVL 
Sbjct: 176 PELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ--RIYQXIQ--SRFYRSPEVLL 231
Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
            M        Y  + D+WS+G +  E+ TG   F+
Sbjct: 232 GMP-------YDLAIDMWSLGCILVEMHTGEPLFS 259

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 41  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 95
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 96  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 151
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 152 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 211
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 212 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 261
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 262 PYPSKSNQEVLEFVTSG 278

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 17/123 (13%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + KN           
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN----------- 252
Query: 175 PEYVAPE----VLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYS 228
           P+YV        L+WM      D  Y+   D+WS GV+ +E+ + G +P+    +D  + 
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFC 312
Query: 229 SIL 231
           S L
Sbjct: 313 SRL 315

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 16/134 (11%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            +MEY+  G     L+      L  S+   Y  ++ + ++YL     VHRD+   N+L+ 
Sbjct: 90  LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 148
Query: 145 ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE----VLEWMEGNHGSDG-YTGSC 199
           +  H+K+ DFG A           ++P+    YV  E     + W      SD  ++   
Sbjct: 149 SEAHVKIADFGLAK----------LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQS 198
Query: 200 DLWSIGVVSYELLT 213
           D+WS GVV YEL T
Sbjct: 199 DVWSFGVVLYELFT 212

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 25  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 79
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 80  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 135
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 136 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY 195
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 196 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 245
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 246 PYPSKSNQEVLEFVTSG 262

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 31  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 85
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 86  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 141
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 142 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 201
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 202 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 251
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 252 PYPSKSNQEVLEFVTSG 268

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 25  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 79
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 80  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 135
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 136 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 195
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 196 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 245
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 246 PYPSKSNQEVLEFVTSG 262

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/261 (21%), Positives = 115/261 (44%), Gaps = 44/261 (16%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEE----KQSHNTFVMKKVLREKMPNTI-- 57
           V+ +++ N+      +KR + +G FG ++L E      +     V  K L++   N    
Sbjct: 7   VQHIKRHNIV-----LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD 61
Query: 58  ---ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDF-----------VTLLENQP 103
              E +++   +  +IV  +    + + +  + EY+  GD            V + E  P
Sbjct: 62  FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNP 121
Query: 104 HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN 163
              L++S+      ++A  + YL    +VHRD+   N L+     +K+ DFG +  V   
Sbjct: 122 PTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 181
Query: 164 GRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              +    +++P+    ++ PE + + +       +T   D+WS+GVV +E+ T G  P+
Sbjct: 182 DYYRVGGHTMLPI---RWMPPESIMYRK-------FTTESDVWSLGVVLWEIFTYGKQPW 231
Query: 219 NYETLDMTYSSILACDTEDTV 239
                 ++ + ++ C T+  V
Sbjct: 232 ----YQLSNNEVIECITQGRV 248

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 24  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 78
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 79  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 134
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 195 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 244
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 245 PYPSKSNQEVLEFVTSG 261

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 25/179 (13%)
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLK-------------LTDFGSATQVDKNG 164
           ++A  V +LH L  +HRD+KP N+L+S +                 ++DFG   ++D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 165 ---RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN- 219
              R     P GT  + APE+LE           T S D++S+G V Y +L+ G  PF  
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLE----ESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256
Query: 220 -YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVF 277
            Y         I + D    +   S I  +T +++  Q +      R    +VL HP+F
Sbjct: 257 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS--QMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 25/179 (13%)
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLK-------------LTDFGSATQVDKNG 164
           ++A  V +LH L  +HRD+KP N+L+S +                 ++DFG   ++D   
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 165 ---RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN- 219
              R     P GT  + APE+LE           T S D++S+G V Y +L+ G  PF  
Sbjct: 201 XXFRXNLNNPSGTSGWRAPELLE----ESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256
Query: 220 -YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHPVF 277
            Y         I + D    +   S I  +T +++  Q +      R    +VL HP+F
Sbjct: 257 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS--QMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G FG++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAY--- 184
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 185 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 18/221 (8%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKV-----LREKMPNTIERD 60
           Q  ++  D  + R + +G FG++Y       K       +K       L  K     E  
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 61
Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           IM     P+IV L    ++    + IME    G+    LE   +  L       Y  ++ 
Sbjct: 62  IMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQIC 119
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           +A+ YL  +  VHRDI   N+L+++   +KL DFG +  ++     K+ V     ++++P
Sbjct: 120 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 179
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNY 220
           E + +         +T + D+W   V  +E+L+ G  PF +
Sbjct: 180 ESINFRR-------FTTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 18/221 (8%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKV-----LREKMPNTIERD 60
           Q  ++  D  + R + +G FG++Y       K       +K       L  K     E  
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           IM     P+IV L    ++    + IME    G+    LE   +  L       Y  ++ 
Sbjct: 78  IMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQIC 135
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           +A+ YL  +  VHRDI   N+L+++   +KL DFG +  ++     K+ V     ++++P
Sbjct: 136 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 195
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNY 220
           E + +         +T + D+W   V  +E+L+ G  PF +
Sbjct: 196 ESINFRR-------FTTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + EY+  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +G+VHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 16/134 (11%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            +MEY+  G     L+      L  S+   Y  ++ + ++YL     VHRD+   N+L+ 
Sbjct: 91  LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 149
Query: 145 ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE----VLEWMEGNHGSDG-YTGSC 199
           +  H+K+ DFG A           ++P+    YV  E     + W      SD  ++   
Sbjct: 150 SEAHVKIADFGLAK----------LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQS 199
Query: 200 DLWSIGVVSYELLT 213
           D+WS GVV YEL T
Sbjct: 200 DVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 16/134 (11%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            +MEY+  G     L+      L  S+   Y  ++ + ++YL     VHRD+   N+L+ 
Sbjct: 103 LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 161
Query: 145 ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE----VLEWMEGNHGSDG-YTGSC 199
           +  H+K+ DFG A           ++P+    YV  E     + W      SD  ++   
Sbjct: 162 SEAHVKIADFGLAK----------LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQS 211
Query: 200 DLWSIGVVSYELLT 213
           D+WS GVV YEL T
Sbjct: 212 DVWSFGVVLYELFT 225

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 21  RFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDI------MVKSKCPYIV 71
           + +  G FG +Y    + + ++    V  KVLRE       ++I      M     PY+ 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 72  NLFYSF--QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
            L        +  V  +M Y    D V   EN+  G L       +  ++A+ + YL  +
Sbjct: 83  RLLGICLTSTVQLVTQLMPYGCLLDHVR--ENR--GRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVD--------KNGRIKSIVPVGTPEYVAPE 181
             VHRD+   N+L+ +  H+K+TDFG A  +D          G+    VP+   +++A E
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK----VPI---KWMALE 191
Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
            +      H S       D+WS GV  +EL+T G+ P++
Sbjct: 192 SILRRRFTHQS-------DVWSYGVTVWELMTFGAKPYD 223

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 16  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 70
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 71  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 126
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 127 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 186
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 187 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 236
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 237 PYPSKSNQEVLEFVTSG 253

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 18/221 (8%)
Query: 9   QKNVSASDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKV-----LREKMPNTIERD 60
           Q  ++  D  + R + +G FG++Y       K       +K       L  K     E  
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           IM     P+IV L    ++    + IME    G+    LE   +  L       Y  ++ 
Sbjct: 66  IMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQIC 123
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           +A+ YL  +  VHRDI   N+L+++   +KL DFG +  ++     K+ V     ++++P
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183
Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNY 220
           E + +         +T + D+W   V  +E+L+ G  PF +
Sbjct: 184 ESINFRR-------FTTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 64/161 (39%), Gaps = 31/161 (19%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           F    H+    E +    F  L EN    Y      R   Y+L  A+++LH     H D+
Sbjct: 100 FNFHGHMCIAFELLGKNTFEFLKENNFQPY-PLPHVRHMAYQLCHALRFLHENQLTHTDL 158
Query: 137 KPDNMLLSAT-------------------GHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           KP+N+L   +                     +++ DFGSAT   ++        V T  Y
Sbjct: 159 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHY 214
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             PEV+  +       G+   CD+WSIG + +E   G T F
Sbjct: 215 RPPEVILEL-------GWAQPCDVWSIGCILFEYYRGFTLF 248

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 64/161 (39%), Gaps = 31/161 (19%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           F    H+    E +    F  L EN    Y      R   Y+L  A+++LH     H D+
Sbjct: 91  FNFHGHMCIAFELLGKNTFEFLKENNFQPY-PLPHVRHMAYQLCHALRFLHENQLTHTDL 149
Query: 137 KPDNMLLSAT-------------------GHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           KP+N+L   +                     +++ DFGSAT   ++        V T  Y
Sbjct: 150 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHY 205
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             PEV+  +       G+   CD+WSIG + +E   G T F
Sbjct: 206 RPPEVILEL-------GWAQPCDVWSIGCILFEYYRGFTLF 239

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 44/254 (17%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 25  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 79
Query: 60  DIMVKSKCPYIVN-------LFYSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESK 111
           D ++++     +N       +  S Q +   + ++E + GGD  + L E +P      S 
Sbjct: 80  DFLMEALIISKLNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 112 ARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNG 164
           A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + +  
Sbjct: 139 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 198
Query: 165 RIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF- 218
             +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  P+ 
Sbjct: 199 YYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYMPYP 248
Query: 219 ---NYETLDMTYSS 229
              N E L+   S 
Sbjct: 249 SKSNQEVLEFVTSG 262

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 33/227 (14%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYL--VEEKQSHNTFVMKKVLREKMPNTIERD------I 61
           + + AS   I++ I  G+ G++    +      +  V  K L+        RD      I
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P I+ L            + EY+  G   T L     G  +  +    +  +  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGA 162
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGRIKSIVPV 172
            ++YL  LGYVHRD+   N+L+ +    K++DFG          A      G+I    P+
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI----PI 218
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + APE + +         ++ + D+WS GVV +E+L  G  P+
Sbjct: 219 ---RWTAPEAIAFRT-------FSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 44/181 (24%)
Query: 106 YLSESKARFYIYEL-------AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--- 155
           +L E    F + +L       A  ++YL  + YVHRD+   N+L+++    K++DFG   
Sbjct: 136 FLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195
Query: 156 ------SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSY 209
                  AT     G+I    P+    + APE + + +       +T + D+WS G+V +
Sbjct: 196 VLEDDPEATYTTSGGKI----PI---RWTAPEAISYRK-------FTSASDVWSFGIVMW 241
Query: 210 ELLT-GSTPF----NYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDA 264
           E++T G  P+    N+E +             D    P+ +   +A+   +    Q+  A
Sbjct: 242 EVMTYGERPYWELSNHEVMKA---------INDGFRLPTPMDCPSAIYQLMMQCWQQERA 292
Query: 265 R 265
           R
Sbjct: 293 R 293

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 12/131 (9%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            +MEYV  G   +L +  P   +  ++   +  ++ + + YLH   Y+HRD+   N+LL 
Sbjct: 112 LVMEYVPLG---SLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168
Query: 145 ATGHLKLTDFGSATQVDKNGRIKSIVPVG-TPEY-VAPEVLEWMEGNHGSDGYTGSCDLW 202
               +K+ DFG A  V +      +   G +P +  APE L+  +  + S       D+W
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYAS-------DVW 221
Query: 203 SIGVVSYELLT 213
           S GV  YELLT
Sbjct: 222 SFGVTLYELLT 232

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 64/161 (39%), Gaps = 31/161 (19%)
Query: 77  FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDI 136
           F    H+    E +    F  L EN    Y      R   Y+L  A+++LH     H D+
Sbjct: 123 FNFHGHMCIAFELLGKNTFEFLKENNFQPY-PLPHVRHMAYQLCHALRFLHENQLTHTDL 181
Query: 137 KPDNMLLSAT-------------------GHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           KP+N+L   +                     +++ DFGSAT   ++        V T  Y
Sbjct: 182 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHY 237
Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             PEV+  +       G+   CD+WSIG + +E   G T F
Sbjct: 238 RPPEVILEL-------GWAQPCDVWSIGCILFEYYRGFTLF 271

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 106/244 (43%), Gaps = 31/244 (12%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K +  S   I++ I  G FG++     K       FV  K L+        RD      I
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 61
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P +++L         V  I E++  G   + L  Q  G  +  +    +  +A 
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAA 120
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-------GRIKSIVPVGT 174
            ++YL  + YVHR +   N+L+++    K++DFG +  ++ +         +   +P+  
Sbjct: 121 GMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI-- 178
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC 233
             + APE +++ +       +T + D+WS G+V +E+++ G  P+     DMT   ++  
Sbjct: 179 -RWTAPEAIQYRK-------FTSASDVWSYGIVMWEVMSYGERPY----WDMTNQDVINA 226
Query: 234 DTED 237
             +D
Sbjct: 227 IEQD 230

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVE-EKQSHNTFVMKKVLREKMPNTIERDIM--VKSKC---- 67
           +D   +  I +GNFG +     +K         K ++E       RD    ++  C    
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 68  -PYIVNLFYSFQDMNHVYFIMEYVTGG---DFVT---LLENQPHGYLSESKAR------- 113
            P I+NL  + +   ++Y  +EY   G   DF+    +LE  P   ++ S A        
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 114 -FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVP 171
             +  ++A+ + YL    ++HRD+   N+L+      K+ DFG S  Q     +    +P
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN-------YETL 223
           V    ++A E L +         YT + D+WS GV+ +E+++ G TP+        YE L
Sbjct: 205 V---RWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 224 DMTY--SSILACDTE 236
              Y     L CD E
Sbjct: 255 PQGYRLEKPLNCDDE 269

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 33/227 (14%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYL--VEEKQSHNTFVMKKVLREKMPNTIERD------I 61
           + + AS   I++ I  G+ G++    +      +  V  K L+        RD      I
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P I+ L            + EY+  G   T L     G  +  +    +  +  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGA 162
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGRIKSIVPV 172
            ++YL  LGYVHRD+   N+L+ +    K++DFG          A      G+I    P+
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI----PI 218
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + APE + +         ++ + D+WS GVV +E+L  G  P+
Sbjct: 219 ---RWTAPEAIAFRT-------FSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 44/254 (17%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 39  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 93
Query: 60  DIMVKSKCPYIVN-------LFYSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESK 111
           D ++++     +N       +  S Q +   + ++E + GGD  + L E +P      S 
Sbjct: 94  DFLMEALIISKLNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSL 152
Query: 112 ARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNG 164
           A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + +  
Sbjct: 153 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 212
Query: 165 RIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF- 218
             +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  P+ 
Sbjct: 213 YYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYMPYP 262
Query: 219 ---NYETLDMTYSS 229
              N E L+   S 
Sbjct: 263 SKSNQEVLEFVTSG 276

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + E +  G            +L +  A+F + +L  
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL--------DSFLRKHDAQFTVIQLVG 122
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 183 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVE-EKQSHNTFVMKKVLREKMPNTIERDIM--VKSKC---- 67
           +D   +  I +GNFG +     +K         K ++E       RD    ++  C    
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 68  -PYIVNLFYSFQDMNHVYFIMEYVTGG---DFVT---LLENQPHGYLSESKAR------- 113
            P I+NL  + +   ++Y  +EY   G   DF+    +LE  P   ++ S A        
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 114 -FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVP 171
             +  ++A+ + YL    ++HRD+   N+L+      K+ DFG S  Q     +    +P
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN-------YETL 223
           V    ++A E L +         YT + D+WS GV+ +E+++ G TP+        YE L
Sbjct: 195 V---RWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 244
Query: 224 DMTY--SSILACDTE 236
              Y     L CD E
Sbjct: 245 PQGYRLEKPLNCDDE 259

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 50/257 (19%)
Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ER 59
           +KE+ +KN++     + R +  G FG++Y  +     N     +V  + +P       E 
Sbjct: 39  LKEVPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDEL 93
Query: 60  DIMVKSKCPYIVNLF----------YSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLS 108
           D ++++    I++ F           S Q +   + ++E + GGD  + L E +P     
Sbjct: 94  DFLMEA---LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQP 149
Query: 109 ESKARFYIYELAQ----AVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVD 161
            S A   +  +A+      QYL    ++HRDI   N LL+  G     K+ DFG A  + 
Sbjct: 150 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209
Query: 162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST 216
           +    +    +++PV   +++ PE   +MEG      +T   D WS GV+ +E+ + G  
Sbjct: 210 RASYYRKGGCAMLPV---KWMPPEA--FMEGI-----FTSKTDTWSFGVLLWEIFSLGYM 259
Query: 217 PF----NYETLDMTYSS 229
           P+    N E L+   S 
Sbjct: 260 PYPSKSNQEVLEFVTSG 276

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           V  +MEYV  G   +L +  P   +  ++   +  ++ + + YLH   Y+HR +   N+L
Sbjct: 88  VQLVMEYVPLG---SLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVL 144
Query: 143 LSATGHLKLTDFGSATQVDKNGRIKSIVPVG-TPEY-VAPEVLEWMEGNHGSDGYTGSCD 200
           L     +K+ DFG A  V +      +   G +P +  APE L+  +  + S       D
Sbjct: 145 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYAS-------D 197
Query: 201 LWSIGVVSYELLT 213
           +WS GV  YELLT
Sbjct: 198 VWSFGVTLYELLT 210

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 251
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 307

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 12/131 (9%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            +MEYV  G   +L +  P   +  ++   +  ++ + + YLH   Y+HR++   N+LL 
Sbjct: 95  LVMEYVPLG---SLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLD 151
Query: 145 ATGHLKLTDFGSATQVDKNGRIKSIVPVG-TPEY-VAPEVLEWMEGNHGSDGYTGSCDLW 202
               +K+ DFG A  V +      +   G +P +  APE L+  +  + S       D+W
Sbjct: 152 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS-------DVW 204
Query: 203 SIGVVSYELLT 213
           S GV  YELLT
Sbjct: 205 SFGVTLYELLT 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I+E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAY--- 184
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 185 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 244
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 300

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLL--------------ENQPH-------GYLS 108
           IVNL  +      +Y I EY   GD +  L              ENQ           L+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 109 ESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRI 166
                 + Y++A+ +++L     VHRD+   N+L++    +K+ DFG A  +  D N  +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 167 K--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETL 223
           +  + +PV   +++APE L   EG      YT   D+WS G++ +E+ + G  P+    +
Sbjct: 231 RGNARLPV---KWMAPESL--FEGI-----YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 224 DMTYSSIL 231
           D  +  ++
Sbjct: 281 DANFYKLI 288

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           V  +MEYV  G   +L +  P   +  ++   +  ++ + + YLH   Y+HR +   N+L
Sbjct: 87  VQLVMEYVPLG---SLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVL 143
Query: 143 LSATGHLKLTDFGSATQVDKNGRIKSIVPVG-TPEY-VAPEVLEWMEGNHGSDGYTGSCD 200
           L     +K+ DFG A  V +      +   G +P +  APE L+  +  + S       D
Sbjct: 144 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYAS-------D 196
Query: 201 LWSIGVVSYELLT 213
           +WS GV  YELLT
Sbjct: 197 VWSFGVTLYELLT 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I+E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 186
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 187 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 246
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + E +  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +GYVHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 51/250 (20%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHN-------TFVMKKVLREKMPNTI-----E 58
           ++   D  +K  + +G FG ++L E    HN         V  K L+E   +       E
Sbjct: 14  HIKRRDIVLKWELGEGAFGKVFLAE---CHNLLPEQDKMLVAVKALKEASESARQDFQRE 70
Query: 59  RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------------ENQPHG 105
            +++   +  +IV  F    +   +  + EY+  GD    L             E+   G
Sbjct: 71  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 130
Query: 106 YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--- 162
            L   +      ++A  + YL GL +VHRD+   N L+     +K+ DFG +  +     
Sbjct: 131 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 190
Query: 163 ---NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               GR  +++P+    ++ PE + + +       +T   D+WS GVV +E+ T G  P+
Sbjct: 191 YRVGGR--TMLPI---RWMPPESILYRK-------FTTESDVWSFGVVLWEIFTYGKQPW 238
Query: 219 ----NYETLD 224
               N E +D
Sbjct: 239 YQLSNTEAID 248

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 253
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 309

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 41/231 (17%)
Query: 23  IQQGNFG-----DIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPY-------I 70
           + +G FG     D + +++  +  T V  K+L+E   ++  R +M + K          +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 71  VNLFYSF-QDMNHVYFIMEYVTGGDFVTLLENQ-----PH-----GYLSESKARFYIYEL 119
           VNL  +  +    +  I+E+   G+  T L ++     P+      +L+      Y +++
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV- 178
           A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           P+YV 
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD-----------PDYVR 202
Query: 179 ---APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
              A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 21  RFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSF 77
           + +  G FG +Y    V E ++    V  K+L E        + M ++       L  + 
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA-------LIMAS 73
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARF-------YIYELAQAVQYL 126
            D  H+  ++          + +  PHG    Y+ E K          +  ++A+ + YL
Sbjct: 74  MDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 133
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP-EYVAPEVLEW 185
                VHRD+   N+L+ +  H+K+TDFG A  ++ + +  +      P +++A E + +
Sbjct: 134 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 193
Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
            +  H S       D+WS GV  +EL+T G  P++
Sbjct: 194 RKFTHQS-------DVWSYGVTIWELMTFGGKPYD 221

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 21  RFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSF 77
           + +  G FG +Y    V E ++    V  K+L E        + M ++       L  + 
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA-------LIMAS 96
Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARF-------YIYELAQAVQYL 126
            D  H+  ++          + +  PHG    Y+ E K          +  ++A+ + YL
Sbjct: 97  MDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 156
Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI----VPVGTPEYVAPEV 182
                VHRD+   N+L+ +  H+K+TDFG A  ++ + +  +     +P+   +++A E 
Sbjct: 157 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI---KWMALEC 213
Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
           + + +  H S       D+WS GV  +EL+T G  P++
Sbjct: 214 IHYRKFTHQS-------DVWSYGVTIWELMTFGGKPYD 244

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 192
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER------------- 59
           + ++FD K  I  G FG +Y             K VLR+     ++R             
Sbjct: 37  ATNNFDHKFLIGHGVFGKVY-------------KGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 60  -DIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL--ENQPHGYLSESKARF 114
            +I   S C  P++V+L     + N +  I +Y+  G+    L   + P   +S  +   
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---SATQVDKNGRIKSIVP 171
                A+ + YLH    +HRD+K  N+LL      K+TDFG     T++D+   +  +V 
Sbjct: 144 ICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT-HLXXVVK 202
Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
            GT  Y+ PE   +++G       T   D++S GVV +E+L  
Sbjct: 203 -GTLGYIDPEY--FIKGR-----LTEKSDVYSFGVVLFEVLCA 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 51/250 (20%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHN-------TFVMKKVLREKMPNTI-----E 58
           ++   D  +K  + +G FG ++L E    HN         V  K L+E   +       E
Sbjct: 8   HIKRRDIVLKWELGEGAFGKVFLAE---CHNLLPEQDKMLVAVKALKEASESARQDFQRE 64
Query: 59  RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------------ENQPHG 105
            +++   +  +IV  F    +   +  + EY+  GD    L             E+   G
Sbjct: 65  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 124
Query: 106 YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--- 162
            L   +      ++A  + YL GL +VHRD+   N L+     +K+ DFG +  +     
Sbjct: 125 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 184
Query: 163 ---NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               GR  +++P+    ++ PE + + +       +T   D+WS GVV +E+ T G  P+
Sbjct: 185 YRVGGR--TMLPI---RWMPPESILYRK-------FTTESDVWSFGVVLWEIFTYGKQPW 232
Query: 219 ----NYETLD 224
               N E +D
Sbjct: 233 YQLSNTEAID 242

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 51/250 (20%)
Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHN-------TFVMKKVLREKMPNTI-----E 58
           ++   D  +K  + +G FG ++L E    HN         V  K L+E   +       E
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAE---CHNLLPEQDKMLVAVKALKEASESARQDFQRE 93
Query: 59  RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------------ENQPHG 105
            +++   +  +IV  F    +   +  + EY+  GD    L             E+   G
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 106 YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK--- 162
            L   +      ++A  + YL GL +VHRD+   N L+     +K+ DFG +  +     
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 163 ---NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               GR  +++P+    ++ PE + + +       +T   D+WS GVV +E+ T G  P+
Sbjct: 214 YRVGGR--TMLPI---RWMPPESILYRK-------FTTESDVWSFGVVLWEIFTYGKQPW 261
Query: 219 ----NYETLD 224
               N E +D
Sbjct: 262 YQLSNTEAID 271

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 12/131 (9%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS 144
            +MEYV  G   +L +  P   +  ++   +  ++ + + YLH   Y+HR++   N+LL 
Sbjct: 95  LVMEYVPLG---SLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLD 151
Query: 145 ATGHLKLTDFGSATQVDKNGRIKSIVPVG-TPEY-VAPEVLEWMEGNHGSDGYTGSCDLW 202
               +K+ DFG A  V +      +   G +P +  APE L+  +  + S       D+W
Sbjct: 152 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS-------DVW 204
Query: 203 SIGVVSYELLT 213
           S GV  YELLT
Sbjct: 205 SFGVTLYELLT 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 192
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I+E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 186
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 187 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 201
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 203
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 204 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 259

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 238
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+YV    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 239 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +  +  +       +  P+   ++ APE L +   
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI---KWTAPESLAY--- 184
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 185 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 41/231 (17%)
Query: 23  IQQGNFG-----DIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPY-------I 70
           + +G FG     D + +++  +  T V  K+L+E   ++  R +M + K          +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 71  VNLFYSF-QDMNHVYFIMEYVTGGDFVTLLENQ-----PH-----GYLSESKARFYIYEL 119
           VNL  +  +    +  I+E+   G+  T L ++     P+      +L+      Y +++
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV- 178
           A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           P+YV 
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD-----------PDYVR 202
Query: 179 ---APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
              A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER------------- 59
           + ++FD K  I  G FG +Y             K VLR+     ++R             
Sbjct: 37  ATNNFDHKFLIGHGVFGKVY-------------KGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 60  -DIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL--ENQPHGYLSESKARF 114
            +I   S C  P++V+L     + N +  I +Y+  G+    L   + P   +S  +   
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV-G 173
                A+ + YLH    +HRD+K  N+LL      K+TDFG + +  + G+      V G
Sbjct: 144 ICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
           T  Y+ PE   +++G       T   D++S GVV +E+L 
Sbjct: 204 TLGYIDPEY--FIKGR-----LTEKSDVYSFGVVLFEVLC 236

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I+E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAY--- 187
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMT 226
               + ++   D+W+ GV+ +E+ T G +P  Y  +D++
Sbjct: 188 ----NKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLS 220

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 137
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 191
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 192 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 186
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 187 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR--------FYIYELAQ 121
           IVNL  +      V  I EY   GD +  L  +    L +   R         +  ++AQ
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHL-KLTDFGSATQV--DKNGRIK--SIVPVGTPE 176
            + +L     +HRD+   N+LL+  GH+ K+ DFG A  +  D N  +K  + +PV   +
Sbjct: 172 GMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---K 227
Query: 177 YVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           ++APE + + +        YT   D+WS G++ +E+ + G  P+
Sbjct: 228 WMAPESIFDCV--------YTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 74/153 (48%), Gaps = 15/153 (9%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +V L+        ++ I EY+  G  +  L    H + ++        ++ +A++YL   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESK 139
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEWM 186
            ++HRD+   N L++  G +K++DFG +  V   ++   + S  PV    +  PEVL + 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPV---RWSPPEVLMYS 196
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           +       ++   D+W+ GV+ +E+ + G  P+
Sbjct: 197 K-------FSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/137 (23%), Positives = 67/137 (48%), Gaps = 9/137 (6%)
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           ++ I EY+  G  +  L    H + ++        ++ +A++YL    ++HRD+   N L
Sbjct: 74  IFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQFLHRDLAARNCL 132
Query: 143 LSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLW 202
           ++  G +K++DFG +  V  +    S+       +  PEVL + +       ++   D+W
Sbjct: 133 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-------FSSKSDIW 185
Query: 203 SIGVVSYELLT-GSTPF 218
           + GV+ +E+ + G  P+
Sbjct: 186 AFGVLMWEIYSLGKMPY 202

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/234 (21%), Positives = 98/234 (41%), Gaps = 49/234 (20%)
Query: 23  IQQGNFGDI-----YLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPYIVN 72
           + +G FG +     + ++ +  + T  +K +     P+ +     E +++ +   P+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQ---PHGYLSESKARF--------------- 114
           L+ +      +  I+EY   G     L        GYL    +R                
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 115 ----YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV----DKNGRI 166
               + ++++Q +QYL  +  VHRD+   N+L++    +K++DFG +  V        R 
Sbjct: 151 DLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 167 KSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
           +  +PV           +WM      D  YT   D+WS GV+ +E++T G  P+
Sbjct: 211 QGRIPV-----------KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 186
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 187 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 15  SDFDIKRFIQQGNFGDIYLVE-EKQSHNTFVMKKVLREKMPNTIERDIM--VKSKC---- 67
           +D   +  I +GNFG +     +K         K ++E       RD    ++  C    
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 68  -PYIVNLFYSFQDMNHVYFIMEYVTGG---DFVT---LLENQPHGYLSESKAR------- 113
            P I+NL  + +   ++Y  +EY   G   DF+    +LE  P   ++ S A        
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 114 -FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVP 171
             +  ++A+ + YL    ++HR++   N+L+      K+ DFG S  Q     +    +P
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN-------YETL 223
           V    ++A E L +         YT + D+WS GV+ +E+++ G TP+        YE L
Sbjct: 202 V---RWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 251
Query: 224 DMTYS--SILACDTE 236
              Y     L CD E
Sbjct: 252 PQGYRLEKPLNCDDE 266

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 69/140 (49%), Gaps = 15/140 (10%)
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           ++ I EY+  G  +  L    H + ++        ++ +A++YL    ++HRD+   N L
Sbjct: 78  IFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQFLHRDLAARNCL 136
Query: 143 LSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           ++  G +K++DFG +  V   +    + S  PV    +  PEVL + +       ++   
Sbjct: 137 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLMYSK-------FSSKS 186
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+W+ GV+ +E+ + G  P+
Sbjct: 187 DIWAFGVLMWEIYSLGKMPY 206

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 27/164 (16%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR--------FYIYELAQ 121
           IVNL  +      V  I EY   GD +  L  +    L +   R         +  ++AQ
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHL-KLTDFGSATQV--DKNGRIK--SIVPVGTPE 176
            + +L     +HRD+   N+LL+  GH+ K+ DFG A  +  D N  +K  + +PV   +
Sbjct: 164 GMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---K 219
Query: 177 YVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           ++APE + + +        YT   D+WS G++ +E+ + G  P+
Sbjct: 220 WMAPESIFDCV--------YTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 104/233 (44%), Gaps = 28/233 (12%)
Query: 2   DVVKELRQKNVSASDFDIKRFIQQGNFGDIYL--VEEKQSHNTFVMKKVL------REKM 53
           + V+E   K +  S   I+  I  G FG++    ++      + V  K L      R++ 
Sbjct: 4   EAVREF-AKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR 62
Query: 54  PNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               E  IM + + P I+ L     +   V  + E++  G   + L     G  +  +  
Sbjct: 63  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLN-DGQFTVIQLV 121
Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-------GRI 166
             +  +A  ++YL  + YVHRD+   N+L+++    K++DFG +  +++N         +
Sbjct: 122 GMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSL 181
Query: 167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              +P+    + APE + + +       +T + D WS G+V +E+++ G  P+
Sbjct: 182 GGKIPI---RWTAPEAIAFRK-------FTSASDAWSYGIVMWEVMSFGERPY 224

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 16/108 (14%)
Query: 122 AVQYLHGLGYVHRDIKPDNMLLS---ATGHLK--LTDFGSATQVDKNGRI----KSIVPV 172
            + +LH L  VHRD+KP N+L+S   A G +K  ++DFG   ++   GR     +S VP 
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL-AVGRHSFSRRSGVP- 187
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
           GT  ++APE+L         +  T + D++S G V Y +++ GS PF 
Sbjct: 188 GTEGWIAPEMLS----EDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/234 (21%), Positives = 98/234 (41%), Gaps = 49/234 (20%)
Query: 23  IQQGNFGDI-----YLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPYIVN 72
           + +G FG +     + ++ +  + T  +K +     P+ +     E +++ +   P+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQ---PHGYLSESKARF--------------- 114
           L+ +      +  I+EY   G     L        GYL    +R                
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 115 ----YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV----DKNGRI 166
               + ++++Q +QYL  +  VHRD+   N+L++    +K++DFG +  V        R 
Sbjct: 151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 167 KSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
           +  +PV           +WM      D  YT   D+WS GV+ +E++T G  P+
Sbjct: 211 QGRIPV-----------KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP---EYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +  +  +       P G     ++ APE L +   
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAPAGAKFPIKWTAPESLAY--- 187
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 188 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 31/168 (18%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVT-------LLENQPHGYLSESKAR-----FYIY 117
           IVNL  +      V  I EY   GD +        +LE  P   ++ S A       +  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHL-KLTDFGSATQV--DKNGRIK--SIVPV 172
           ++AQ + +L     +HRD+   N+LL+  GH+ K+ DFG A  +  D N  +K  + +PV
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 173 GTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              +++APE + + +        YT   D+WS G++ +E+ + G  P+
Sbjct: 231 ---KWMAPESIFDCV--------YTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 69/140 (49%), Gaps = 15/140 (10%)
Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
           ++ I EY+  G  +  L    H + ++        ++ +A++YL    ++HRD+   N L
Sbjct: 79  IFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESKQFLHRDLAARNCL 137
Query: 143 LSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
           ++  G +K++DFG +  V   +    + S  PV    +  PEVL + +       ++   
Sbjct: 138 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLMYSK-------FSSKS 187
Query: 200 DLWSIGVVSYELLT-GSTPF 218
           D+W+ GV+ +E+ + G  P+
Sbjct: 188 DIWAFGVLMWEIYSLGKMPY 207

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +V L+        ++ I EY+  G  +  L    H + ++        ++ +A++YL   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESK 139
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEWM 186
            ++HRD+   N L++  G +K++DFG +  V   +    + S  PV    +  PEVL + 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLMYS 196
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           +       ++   D+W+ GV+ +E+ + G  P+
Sbjct: 197 K-------FSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP---EYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +  +  +       P G     ++ APE L +   
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAPAGAKFPIKWTAPESLAY--- 188
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 189 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 23/173 (13%)
Query: 57  IERDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
            +R++ + S    P IV L+      N    +ME+V  GD    L ++ H      K R 
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 115 YIYELAQAVQYLHGLG--YVHRDIKPDNMLL-----SATGHLKLTDFGSATQVDKNGRIK 167
            + ++A  ++Y+       VHRD++  N+ L     +A    K+ DFG++ Q      + 
Sbjct: 128 ML-DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ-----SVH 181
Query: 168 SIVPV-GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           S+  + G  +++APE +   E     + YT   D +S  ++ Y +LTG  PF+
Sbjct: 182 SVSGLLGNFQWMAPETIGAEE-----ESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/234 (21%), Positives = 99/234 (42%), Gaps = 49/234 (20%)
Query: 23  IQQGNFGDI-----YLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPYIVN 72
           + +G FG +     + ++ +  + T  +K +     P+ +     E +++ +   P+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQ---PHGYLSESKARF--------------- 114
           L+ +      +  I+EY   G     L        GYL    +R                
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 115 ----YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----RI 166
               + ++++Q +QYL  +  VHRD+   N+L++    +K++DFG +  V +      R 
Sbjct: 151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210
Query: 167 KSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
           +  +PV           +WM      D  YT   D+WS GV+ +E++T G  P+
Sbjct: 211 QGRIPV-----------KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 37/229 (16%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFG----DIYLVEEKQSHNTFVMKKVLREKMPNTIERDIM 62
           L++ N+  +D ++      GNFG     +Y + +KQ     V  KVL++        ++M
Sbjct: 6   LKRDNLLIADIELG----CGNFGSVRQGVYRMRKKQID---VAIKVLKQGTEKADTEEMM 58
Query: 63  VKSKC------PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL----ENQPHGYLSESKA 112
            +++       PYIV L    Q    +  +ME   GG     L    E  P   ++E   
Sbjct: 59  REAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE--- 114
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV 172
              +++++  ++YL    +VHRD+   N+LL    + K++DFG +  +  +    +    
Sbjct: 115 --LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172
Query: 173 G-TP-EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           G  P ++ APE + + +       ++   D+WS GV  +E L+ G  P+
Sbjct: 173 GKWPLKWYAPECINFRK-------FSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 109 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 167
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 168 KFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 217
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 218 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 246

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I+E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 191
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 192 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +V L+        ++ I EY+  G  +  L    H + ++        ++ +A++YL   
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESK 130
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEWM 186
            ++HRD+   N L++  G +K++DFG +  V   +    + S  PV    +  PEVL + 
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLMYS 187
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           +       ++   D+W+ GV+ +E+ + G  P+
Sbjct: 188 K-------FSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 104/235 (44%), Gaps = 41/235 (17%)
Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI---MVKSKC------PY 69
           + + + +G FG +     KQ   T +   V   K+ N+ +R+I   + ++ C      P 
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 70  IVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLL-----ENQPHGYLSESKARFYIYEL 119
           ++ L       S Q +     I+ ++  GD  T L     E  P     ++  +F + ++
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV-DI 156
Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV-----DKNGRIKSIVPVGT 174
           A  ++YL    ++HRD+   N +L     + + DFG + ++      + GRI  + PV  
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM-PV-- 213
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
            +++A E L           YT   D+W+ GV  +E+ T G TP+    N+E  D
Sbjct: 214 -KWIAIESL-------ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 188
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 189 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAY--- 191
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 192 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 188
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 189 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       +S     +   +++ A++YL    +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HR++   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 393
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMT 226
               + ++   D+W+ GV+ +E+ T G +P  Y  +D++
Sbjct: 394 ----NKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLS 426

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 191
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 192 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 168
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 169 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 218
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 219 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 247

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD----------- 192
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+ V    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 85
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 199
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 200 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 109 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 167
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 168 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 217
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 218 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 246

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD----------- 192
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+ V    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYL--VEEKQSHNTFVMKKVL------REKMPNTIERDI 61
           K +  S   I+  I  G FG++    ++      + V  K L      R++     E  I
Sbjct: 9   KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 68
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M + + P I+ L     +   V  + E++  G   + L     G  +  +    +  +A 
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLN-DGQFTVIQLVGMLRGIAS 127
Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-------GRIKSIVPVGT 174
            ++YL  + YVHRD+   N+L+++    K++DFG +  +++N         +   +P+  
Sbjct: 128 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPI-- 185
Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
             + APE + + +       +T + D WS G+V +E+++ G  P+
Sbjct: 186 -RWTAPEAIAFRK-------FTSASDAWSYGIVMWEVMSFGERPY 222

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 129 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 187
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 188 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 237
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 238 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 266

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 168
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 169 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 218
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 219 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 247

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 102 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 160
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 161 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 210
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 211 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 239

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 191
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 192 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 165
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 166 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 215
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 216 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 244

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 108 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 166
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 167 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 216
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 217 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 245

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 106/233 (45%), Gaps = 43/233 (18%)
Query: 23  IQQGNFG-----DIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPY-------I 70
           + +G FG     D + +++  +  T V  K+L+E   ++  R +M + K          +
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRT-VAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 95
Query: 71  VNLFYSF-QDMNHVYFIMEYVTGGDFVTLLENQ-----PH-------GYLSESKARFYIY 117
           VNL  +  +    +  I+E+   G+  T L ++     P+        +L+      Y +
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           ++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           P+ 
Sbjct: 156 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD-----------PDX 204
Query: 178 V----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           V    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 163
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 213
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 214 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 242

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD----------- 201
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+ V    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ ++YL    +VHRD+   N +L  
Sbjct: 128 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKYLASKKFVHRDLAARNCMLDE 186
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 187 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 236
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 237 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 265

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD----------- 201
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+ V    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 34  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 87
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 88  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 139
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 140 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 192
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 193 FSVASDVWSFGVVLYELFT 211

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK------MPNTIERD 60
           LR+  V++ +F  K  + +G FG +Y  + + +  T V  K L+E+      +    E +
Sbjct: 30  LRELQVASDNFSNKNILGRGGFGKVY--KGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGY--LSESKARFYIYE 118
           ++  +    ++ L            +  Y+  G   + L  +P     L   K +     
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 119 LAQAVQYLHGLG---YVHRDIKPDNMLLSATGHLKLTDFGSATQVD-KNGRIKSIVPVGT 174
            A+ + YLH       +HRD+K  N+LL       + DFG A  +D K+  +   V  GT
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR-GT 206
Query: 175 PEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETL 223
             ++APE L        S G +    D++  GV+  EL+TG   F+   L
Sbjct: 207 IGHIAPEYL--------STGKSSEKTDVFGYGVMLLELITGQRAFDLARL 248

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 97/234 (41%), Gaps = 47/234 (20%)
Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++     K        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL-- 119
           M +   P I+ L         V  + E +  G            +L +  A+F + +L  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL--------DSFLRKHDAQFTVIQLVG 151
Query: 120 -----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG---------SATQVDKNGR 165
                A  ++YL  +G VHRD+   N+L+++    K++DFG          A    + G+
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           I    P+    + +PE + + +       +T + D+WS G+V +E+++ G  P+
Sbjct: 212 I----PI---RWTSPEAIAYRK-------FTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 190
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 191 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 19/193 (9%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 38  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 91
Query: 84  YFIMEYVTGGDFVTLLENQPHG-YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML 142
             IMEY+  G     L  Q H   +   K   Y  ++ + ++YL    Y+HRD+   N+L
Sbjct: 92  KLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL 149
Query: 143 LSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDGYTGSCD 200
           +     +K+ DFG    + ++     +  P  +P +  APE L           ++ + D
Sbjct: 150 VENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESKFSVASD 202
Query: 201 LWSIGVVSYELLT 213
           +WS GVV YEL T
Sbjct: 203 VWSFGVVLYELFT 215

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 33/170 (19%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--------------NQPHGYLSESKARFY 115
           IVNL  +      V  I EY   GD +  L               + P   LS      +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHL-KLTDFGSATQV--DKNGRIK--SIV 170
             ++AQ + +L     +HRD+   N+LL+  GH+ K+ DFG A  +  D N  +K  + +
Sbjct: 172 SSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 171 PVGTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           PV   +++APE + + +        YT   D+WS G++ +E+ + G  P+
Sbjct: 231 PV---KWMAPESIFDCV--------YTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 39  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 92
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 93  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 144
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 145 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 197
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 198 FSVASDVWSFGVVLYELFT 216

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 186
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 187 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 40  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 93
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 94  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 145
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 146 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 198
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 199 FSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 38  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 91
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 92  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 143
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 144 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 196
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 197 FSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 33  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 86
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 87  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 138
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 139 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 191
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 192 FSVASDVWSFGVVLYELFT 210

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 98  LLENQPHG----YLSESKARF-------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT 146
           ++E  P+G    YL + K R        Y  ++ + ++YL    Y+HRD+   N+L+   
Sbjct: 94  IMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 153
Query: 147 GHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDGYTGSCDLWSI 204
             +K+ DFG    + ++     +  P  +P +  APE L           ++ + D+WS 
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESKFSVASDVWSF 206
Query: 205 GVVSYELLT 213
           GVV YEL T
Sbjct: 207 GVVLYELFT 215

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E ++M +   PYIV +     +      +ME    G     L+   H  + +      ++
Sbjct: 420 EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVH 476
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--SATQVDKN---GRIKSIVPV 172
           +++  ++YL    +VHRD+   N+LL    + K++DFG   A + D+N    +     PV
Sbjct: 477 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              ++ APE + + +       ++   D+WS GV+ +E  + G  P+
Sbjct: 537 ---KWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 41  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 94
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 95  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 146
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 147 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 199
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 200 FSVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 35  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 88
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 89  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 141 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 193
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 57  IERDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
            +R++ + S    P IV L+      N    +ME+V  GD    L ++ H      K R 
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 115 YIYELAQAVQYLHGLG--YVHRDIKPDNMLL-----SATGHLKLTDFGSATQVDKNGRIK 167
            + ++A  ++Y+       VHRD++  N+ L     +A    K+ DFG + Q      + 
Sbjct: 128 ML-DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVH 181
Query: 168 SIVPV-GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
           S+  + G  +++APE +   E     + YT   D +S  ++ Y +LTG  PF+
Sbjct: 182 SVSGLLGNFQWMAPETIGAEE-----ESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ +++L    +VHRD+   N +L  
Sbjct: 111 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 169
Query: 146 TGHLKLTDFGSA-TQVDK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A   +DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 170 KFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 219
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 220 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 248

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 42  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 95
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 96  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 147
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 148 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 200
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 201 FSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLRE-KMPNTIERDIMVKSKCPYIVNLFYSFQDMNHV 83
           Q N G++  V++ Q      ++   RE ++  +++ D +VK K      + YS    N +
Sbjct: 35  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK-----GVCYSAGRRN-L 88
Query: 84  YFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVHRDI 136
             IMEY+  G            YL + K R        Y  ++ + ++YL    Y+HRD+
Sbjct: 89  KLIMEYLPYGSL--------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140
Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDG 194
              N+L+     +K+ DFG    + ++     +  P  +P +  APE L           
Sbjct: 141 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESK 193
Query: 195 YTGSCDLWSIGVVSYELLT 213
           ++ + D+WS GVV YEL T
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 31/183 (16%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF--------------- 114
           IVNL  +         I EY   GD +  L  +   ++    +                 
Sbjct: 105 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 115 -YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIK--SI 169
            + Y++A+ + +L     +HRD+   N+LL+     K+ DFG A  +  D N  +K  + 
Sbjct: 165 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 224
Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYS 228
           +PV   +++APE +        +  YT   D+WS G+  +EL + GS+P+    +D  + 
Sbjct: 225 LPV---KWMAPESIF-------NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 274
Query: 229 SIL 231
            ++
Sbjct: 275 KMI 277

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HRD+   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 186
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
               + ++   D+W+ GV+ +E+ T G +P+
Sbjct: 187 ----NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 17/116 (14%)
Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
           Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+           
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----------- 201
Query: 175 PEYV----APEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPFNYETLD 224
           P+ V    A   L+WM      D  YT   D+WS GV+ +E+ + G++P+    +D
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E ++M +   PYIV +     +      +ME    G     L+   H  + +      ++
Sbjct: 421 EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVH 477
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--SATQVDKN---GRIKSIVPV 172
           +++  ++YL    +VHRD+   N+LL    + K++DFG   A + D+N    +     PV
Sbjct: 478 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 537
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              ++ APE + + +       ++   D+WS GV+ +E  + G  P+
Sbjct: 538 ---KWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 15  SDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIV 71
           ++F   + +  G FG +Y    + E +     V  K LRE       ++I+ ++   Y++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA---YVM 73
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARF-------YIYELA 120
               +  D  HV  ++          +++  P G    Y+ E K          +  ++A
Sbjct: 74  ----ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD--------KNGRIKSIVPV 172
           + + YL     VHRD+   N+L+    H+K+TDFG A  +         + G+    VP+
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK----VPI 185
Query: 173 GTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
              +++A E +L  +        YT   D+WS GV  +EL+T GS P++
Sbjct: 186 ---KWMALESILHRI--------YTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 31/168 (18%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVT-------LLENQP-----HGYLSESKARFYIY 117
           IVNL  +      V  I EY   GD +        +LE  P     +  LS      +  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHL-KLTDFGSATQV--DKNGRIK--SIVPV 172
           ++AQ + +L     +HRD+   N+LL+  GH+ K+ DFG A  +  D N  +K  + +PV
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 173 GTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              +++APE + + +        YT   D+WS G++ +E+ + G  P+
Sbjct: 231 ---KWMAPESIFDCV--------YTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 98  LLENQPHG----YLSESKARF-------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT 146
           ++E  P+G    YL + K R        Y  ++ + ++YL    Y+HRD+   N+L+   
Sbjct: 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 147 GHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDGYTGSCDLWSI 204
             +K+ DFG    + ++     +  P  +P +  APE L           ++ + D+WS 
Sbjct: 182 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESKFSVASDVWSF 234
Query: 205 GVVSYELLT 213
           GVV YEL T
Sbjct: 235 GVVLYELFT 243

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ +++L    +VHRD+   N +L  
Sbjct: 108 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 166
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 167 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 216
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 217 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 245

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 98  LLENQPHG----YLSESKARF-------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT 146
           ++E  P+G    YL + K R        Y  ++ + ++YL    Y+HRD+   N+L+   
Sbjct: 91  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 150
Query: 147 GHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDGYTGSCDLWSI 204
             +K+ DFG    + ++     +  P  +P +  APE L           ++ + D+WS 
Sbjct: 151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT-------ESKFSVASDVWSF 203
Query: 205 GVVSYELLT 213
           GVV YEL T
Sbjct: 204 GVVLYELFT 212

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 32/225 (14%)
Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI---MVKSKC------ 67
           F + R + +G FG +   + KQ   +FV   V   K       DI   + ++ C      
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 68  PYIVNLF-YSFQD-----MNHVYFIMEYVTGGDFVTLL------ENQPHGYLSESKARFY 115
           P++  L   S +      +     I+ ++  GD    L      EN P     ++  RF 
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN-PFNLPLQTLVRFM 143
Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           + ++A  ++YL    ++HRD+   N +L+    + + DFG + ++      +       P
Sbjct: 144 V-DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 176 EYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
                  ++W+     +D  YT   D+W+ GV  +E++T G TP+
Sbjct: 203 -------VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 15  SDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIV 71
           ++F   + +  G FG +Y    + E +     V  K LRE       ++I+ ++   Y++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA---YVM 75
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARF-------YIYELA 120
               +  D  HV  ++          +++  P G    Y+ E K          +  ++A
Sbjct: 76  ----ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD--------KNGRIKSIVPV 172
           + + YL     VHRD+   N+L+    H+K+TDFG A  +         + G+    VP+
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK----VPI 187
Query: 173 GTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
              +++A E +L  +        YT   D+WS GV  +EL+T GS P++
Sbjct: 188 ---KWMALESILHRI--------YTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 15  SDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIV 71
           ++F   + +  G FG +Y    + E +     V  K LRE       ++I+ ++   Y++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA---YVM 73
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARF-------YIYELA 120
               +  D  HV  ++          +++  P G    Y+ E K          +  ++A
Sbjct: 74  ----ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD--------KNGRIKSIVPV 172
           + + YL     VHRD+   N+L+    H+K+TDFG A  +         + G+    VP+
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK----VPI 185
Query: 173 GTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
              +++A E +L  +        YT   D+WS GV  +EL+T GS P++
Sbjct: 186 ---KWMALESILHRI--------YTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 65/148 (43%), Gaps = 19/148 (12%)
Query: 85  FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH-----GLGY----VHRD 135
            +MEY   G     L      ++S  +     + + + + YLH     G  Y     HRD
Sbjct: 89  LVMEYYPNGSLXKYLSLHTSDWVSSCR---LAHSVTRGLAYLHTELPRGDHYKPAISHRD 145
Query: 136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIK-------SIVPVGTPEYVAPEVLEWMEG 188
           +   N+L+   G   ++DFG + ++  N  ++       +I  VGT  Y+APEVLE    
Sbjct: 146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN 205
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGST 216
               +      D++++G++ +E+    T
Sbjct: 206 LRDXESALKQVDMYALGLIYWEIFMRCT 233

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 98  LLENQPHG----YLSESKARF-------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT 146
           ++E  P+G    YL + K R        Y  ++ + ++YL    Y+HRD+   N+L+   
Sbjct: 109 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 168
Query: 147 GHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDGYTGSCDLWSI 204
             +K+ DFG    + ++     +  P  +P +  APE L           ++ + D+WS 
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESKFSVASDVWSF 221
Query: 205 GVVSYELLT 213
           GVV YEL T
Sbjct: 222 GVVLYELFT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ +++L    +VHRD+   N +L  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 168
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 169 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 218
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 219 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 247

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---NTIERDIMVKSKCPYIV 71
           +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P +V
Sbjct: 259 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 318
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L          Y I E++T G+ +  L       ++     +   +++ A++YL    +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
           +HR++   N L+     +K+ DFG +   T         +  P+   ++ APE L +   
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY--- 432
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMT 226
               + ++   D+W+ GV+ +E+ T G +P  Y  +D++
Sbjct: 433 ----NKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLS 465

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E ++M +   PYIV +     +      +ME    G     L+   H  + +      ++
Sbjct: 78  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVH 134
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--SATQVDKN---GRIKSIVPV 172
           +++  ++YL    +VHRD+   N+LL    + K++DFG   A + D+N    +     PV
Sbjct: 135 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              ++ APE + + +       ++   D+WS GV+ +E  + G  P+
Sbjct: 195 ---KWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E ++M +   PYIV +     +      +ME    G     L+   H  + +      ++
Sbjct: 78  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVH 134
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--SATQVDKN---GRIKSIVPV 172
           +++  ++YL    +VHRD+   N+LL    + K++DFG   A + D+N    +     PV
Sbjct: 135 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              ++ APE + + +       ++   D+WS GV+ +E  + G  P+
Sbjct: 195 ---KWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E ++M +   PYIV +     +      +ME    G     L+   H  + +      ++
Sbjct: 68  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVH 124
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--SATQVDKN---GRIKSIVPV 172
           +++  ++YL    +VHRD+   N+LL    + K++DFG   A + D+N    +     PV
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              ++ APE + + +       ++   D+WS GV+ +E  + G  P+
Sbjct: 185 ---KWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ +++L    +VHRD+   N +L  
Sbjct: 111 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 169
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 170 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 219
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 220 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 248

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 30/145 (20%)
Query: 81  NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIYELAQAVQYLHGLGYVH 133
           N +  IME++  G   +L E     YL ++K +        Y  ++ + + YL    YVH
Sbjct: 98  NGIKLIMEFLPSG---SLKE-----YLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVH 149
Query: 134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI-----VPVGTPEYVAPEVLEWMEG 188
           RD+   N+L+ +   +K+ DFG    ++ +    ++      PV    + APE L  M+ 
Sbjct: 150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV---FWYAPECL--MQ- 203
Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT 213
              S  Y  S D+WS GV  +ELLT
Sbjct: 204 ---SKFYIAS-DVWSFGVTLHELLT 224

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +V L+        ++ I EY+  G  +  L    H + ++        ++ +A++YL   
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLESK 124
Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPEVLEWM 186
            ++HRD+   N L++  G +K++DFG +  V   +      S  PV    +  PEVL + 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV---RWSPPEVLMYS 181
Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           +       ++   D+W+ GV+ +E+ + G  P+
Sbjct: 182 K-------FSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E ++M +   PYIV +     +      +ME    G     L+   H  + +      ++
Sbjct: 76  EANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVH 132
Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--SATQVDKN---GRIKSIVPV 172
           +++  ++YL    +VHRD+   N+LL    + K++DFG   A + D+N    +     PV
Sbjct: 133 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 192
Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
              ++ APE + + +       ++   D+WS GV+ +E  + G  P+
Sbjct: 193 ---KWYAPECINYYK-------FSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 98  LLENQPHG----YLSESKARF-------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT 146
           ++E  P+G    YL + K R        Y  ++ + ++YL    Y+HRD+   N+L+   
Sbjct: 109 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 168
Query: 147 GHLKLTDFGSATQVDKNGRIKSIV-PVGTPEY-VAPEVLEWMEGNHGSDGYTGSCDLWSI 204
             +K+ DFG    + ++     +  P  +P +  APE L           ++ + D+WS 
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT-------ESKFSVASDVWSF 221
Query: 205 GVVSYELLT 213
           GVV YEL T
Sbjct: 222 GVVLYELFT 230

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 15  SDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIV 71
           ++F   + +  G FG +Y    + E +     V  K LRE       ++I+ ++   Y++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA---YVM 78
Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHG----YLSESKARF-------YIYELA 120
               +  D  HV  ++          +++  P G    Y+ E K          +  ++A
Sbjct: 79  ----ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD--------KNGRIKSIVPV 172
           + + YL     VHRD+   N+L+    H+K+TDFG A  +         + G+    VP+
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK----VPI 190
Query: 173 GTPEYVAPE-VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN 219
              +++A E +L  +        YT   D+WS GV  +EL+T GS P++
Sbjct: 191 ---KWMALESILHRI--------YTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 37/229 (16%)
Query: 7   LRQKNVSASDFDIKRFIQQGNFG----DIYLVEEKQSHNTFVMKKVLREKMPNTIERDIM 62
           L++ N+  +D ++      GNFG     +Y + +KQ     V  KVL++        ++M
Sbjct: 332 LKRDNLLIADIELG----CGNFGSVRQGVYRMRKKQID---VAIKVLKQGTEKADTEEMM 384
Query: 63  VKSKC------PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL----ENQPHGYLSESKA 112
            +++       PYIV L    Q    +  +ME   GG     L    E  P   ++E   
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE--- 440
Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV 172
              +++++  ++YL    +VHR++   N+LL    + K++DFG +  +  +    +    
Sbjct: 441 --LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498
Query: 173 G--TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           G    ++ APE + + +       ++   D+WS GV  +E L+ G  P+
Sbjct: 499 GKWPLKWYAPECINFRK-------FSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 31/170 (18%)
Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF--------------- 114
           IVNL  +         I EY   GD +  L  +   ++    +                 
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 115 -YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIK--SI 169
            + Y++A+ + +L     +HRD+   N+LL+     K+ DFG A  +  D N  +K  + 
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNAR 231
Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           +PV   +++APE +        +  YT   D+WS G+  +EL + GS+P+
Sbjct: 232 LPV---KWMAPESIF-------NCVYTFESDVWSYGIFLWELFSLGSSPY 271

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ +++L    +VHRD+   N +L  
Sbjct: 115 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 173
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 174 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 223
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 224 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 252

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 86  IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA 145
           ++ Y+  GD    + N+ H    +    F + ++A+ +++L    +VHRD+   N +L  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAKGMKFLASKKFVHRDLAARNCMLDE 168
Query: 146 TGHLKLTDFGSATQV-DK-----NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSC 199
              +K+ DFG A  + DK     + +  + +PV   +++A E L+       +  +T   
Sbjct: 169 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV---KWMALESLQ-------TQKFTTKS 218
Query: 200 DLWSIGVVSYELLT-GSTPF-NYETLDMT 226
           D+WS GV+ +EL+T G+ P+ +  T D+T
Sbjct: 219 DVWSFGVLLWELMTRGAPPYPDVNTFDIT 247
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	792
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-91
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-90
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-73
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-73
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-73
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-71
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-69
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-68
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-68
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-68
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-66
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-66
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-66
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-64
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-64
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-64
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-64
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-63
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-62
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-62
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-62
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-61
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-61
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-61
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-61
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-61
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-60
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-59
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-58
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-58
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-58
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-58
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-57
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-57
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-57
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-57
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-56
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-56
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-56
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-56
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-56
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-56
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-56
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-56
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-56
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-56
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-55
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-55
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-55
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-54
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-54
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-54
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-54
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-54
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-54
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-54
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-54
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-54
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-53
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-53
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-53
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-53
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-52
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-52
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-52
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-52
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-52
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-50
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-50
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-49
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-48
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-48
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-47
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-47
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-47
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-46
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-46
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-46
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-46
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-45
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-45
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-45
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-44
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-44
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-44
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-43
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-43
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-43
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-42
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-42
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-42
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-41
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-40
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-39
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-39
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-39
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-39
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-38
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-37
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-37
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-36
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-36
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-32
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-31
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-30
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-30
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-29
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-29
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-29
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-29
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-28
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-28
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-28
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-28
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-28
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-28
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-25
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-24
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-23
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-22
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-22
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-22
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-22
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-22
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-20
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-20
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-20
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	9e-20
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	2e-18
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	2e-11
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	6e-07
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	2e-05
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-19
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-19
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-18
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-18
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-16
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-13
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-12
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	1e-12
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	6e-11
2dfs_A	1080	Myosin-5A; myosin-V, inhibited state, cryoelectron	7e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-11
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-11
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-11
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-11
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-10
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-09
1cii_A	602	Colicin IA; bacteriocin, ION channel formation, tr	1e-08
1cii_A	602	Colicin IA; bacteriocin, ION channel formation, tr	6e-05
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	1e-08
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	3e-08
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	5e-05
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	1e-04
3na7_A	256	HP0958; flagellar biogenesis, flagellum export, C4	1e-07
3na7_A	256	HP0958; flagellar biogenesis, flagellum export, C4	5e-05
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-07
2xs1_A	704	Programmed cell death 6-interacting protein; prote	9e-07
3vkg_A	3245	Dynein heavy chain, cytoplasmic; AAA+ protein, mol	3e-05
1g8x_A	1010	Myosin II heavy chain fused to alpha-actinin 3; mo	1e-04
1g8x_A	1010	Myosin II heavy chain fused to alpha-actinin 3; mo	6e-04

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  298 bits (765), Expect = 8e-94
 Identities = 112/357 (31%), Positives = 177/357 (49%), Gaps = 28/357 (7%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMP 54
           + +V  L++  +   DF+I + I +G F ++ +V+ KQ+   + MK       + R ++ 
Sbjct: 47  EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS 106

Query: 55  NTI-ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERD++V     +I  L ++FQD N++Y +MEY  GGD +TLL       +    AR
Sbjct: 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMAR 165

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY+ E+  A+  +H LGYVHRDIKPDN+LL   GH++L DFGS  ++  +G ++S+V VG
Sbjct: 166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TP+Y++PE+L+ + G  G+  Y   CD W++GV +YE+  G TPF  ++   TY  I+  
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-- 283

Query: 234 DTEDTVSFPSS-IRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVFDCLD------SD 283
             ++ +S P     +     +F+Q L+   + RL          HP F  LD      S 
Sbjct: 284 HYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSV 343

Query: 284 PPCIPPPSQEN------KFHKKDKRKASPSLKAFQKEGRYLDSA--LPLIGISYTGE 332
           PP  P                      S   +              LP +G SY+  
Sbjct: 344 PPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCM 400

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  291 bits (747), Expect = 4e-91
 Identities = 117/369 (31%), Positives = 190/369 (51%), Gaps = 39/369 (10%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMP 54
           KD + ++R   + A D+++ + I +G FG++ LV  K +   + MK       + R    
Sbjct: 55  KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114

Query: 55  NTI-ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERDIM  +  P++V LFY+FQD  ++Y +MEY+ GGD V L+ N     + E  AR
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWAR 171

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY  E+  A+  +H +G++HRD+KPDNMLL  +GHLKL DFG+  +++K G ++    VG
Sbjct: 172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TP+Y++PEVL   +   G   Y   CD WS+GV  YE+L G TPF  ++L  TYS I+  
Sbjct: 232 TPDYISPEVL---KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288

Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVFDCLD--------S 282
             +++++FP    +S    N + + +   + RL    ++++  H  F            +
Sbjct: 289 --KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT 346

Query: 283 DPPCIPPPSQE-------NKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMG 335
             P +P  S +       +    K + +  P  KAF          LP +G +Y      
Sbjct: 347 VAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGN------QLPFVGFTYYSNRRY 400

Query: 336 ANTNTSSDS 344
            ++   +D+
Sbjct: 401 LSSANPNDN 409

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  291 bits (746), Expect = 1e-90
 Identities = 121/375 (32%), Positives = 195/375 (52%), Gaps = 25/375 (6%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMP 54
           K    +++Q  +   DF+I + I +G FG++ +V+ K +   F MK       + R +  
Sbjct: 60  KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119

Query: 55  NTI-ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               ERD++V     +I  L Y+FQD N++Y +M+Y  GGD +TLL  +    L E  AR
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMAR 178

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           FY+ E+  A+  +H L YVHRDIKPDN+L+   GH++L DFGS  ++ ++G ++S V VG
Sbjct: 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 238

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TP+Y++PE+L+ MEG  G   Y   CD WS+GV  YE+L G TPF  E+L  TY  I+  
Sbjct: 239 TPDYISPEILQAMEGGKG--RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-- 294

Query: 234 DTEDTVSFPSSI-RLSTAMVNFVQSLVQKLDARL---NMDQVLGHPVFDCLD------SD 283
           + ++   FP+ +  +S    + ++ L+   + RL    ++    HP F  +D       +
Sbjct: 295 NHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCE 354

Query: 284 PPCIPPPSQEN---KFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNT 340
            P IP  S       F   D    +           +    LP +G +YT   + ++ + 
Sbjct: 355 APYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVLSDRSC 414

Query: 341 SSDSTLPPSSEDMRH 355
              +  P S+E++  
Sbjct: 415 LRVTAGPTSAENLYF 429

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  241 bits (617), Expect = 1e-73
 Identities = 80/291 (27%), Positives = 137/291 (47%), Gaps = 34/291 (11%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNT-IERD 60
           + +     DF   + + +G+F  + L  E  +   + +K      +++E  +P    ERD
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           +M +   P+ V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+ 
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIV 140

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEY 177
            A++YLHG G +HRD+KP+N+LL+   H+++TDFG+A   +   K  R  S   VGT +Y
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF--VGTAQY 198

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED 237
           V+PE+L              S DLW++G + Y+L+ G  PF      + +  I+  +   
Sbjct: 199 VSPELLT-------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--- 248

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQK-LDARL------NMDQVLGHPVFDCLD 281
              FP          + V+ L+      RL          +  HP F+ + 
Sbjct: 249 -YDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 296

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  242 bits (621), Expect = 3e-73
 Identities = 90/306 (29%), Positives = 153/306 (50%), Gaps = 34/306 (11%)

Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK---VLREKMPNTI-ERDI 61
            ++V+   F+I R I +G+FG + +V++  +   +    M K   V R ++ N   E  I
Sbjct: 9   NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI 68

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M   + P++VNL+YSFQD   ++ +++ + GGD    L  Q + +  E   + +I EL  
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVM 126

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           A+ YL     +HRD+KPDN+LL   GH+ +TDF  A  + +  +I ++   GT  Y+APE
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM--AGTKPYMAPE 184

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF---NYETLDMTYSSILACDTEDT 238
           +    +G     GY+ + D WS+GV +YELL G  P+   +  +      +         
Sbjct: 185 MFSSRKGA----GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTV 236

Query: 239 VSFPSSIRLSTAMVNFVQSLVQK-LDARL-NMDQVLGHPVFDCLDSD--------PPCIP 288
           V++PS+   S  MV+ ++ L++   D R   +  V   P  + ++ D        P  IP
Sbjct: 237 VTYPSA--WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIP 294

Query: 289 PPSQEN 294
              + N
Sbjct: 295 NKGRLN 300

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  239 bits (612), Expect = 3e-73
 Identities = 83/300 (27%), Positives = 140/300 (46%), Gaps = 28/300 (9%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI- 57
           + E+ ++  +  DFDI R + +G FG++YL  EKQ+     +K     ++ +E + + + 
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62

Query: 58  -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
            E +I    + P I+ ++  F D   +Y ++E+   G+    L  Q HG   E ++  ++
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFM 120

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
            ELA A+ Y H    +HRDIKP+N+L+   G LK+ DFG +       R       GT +
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLD 177

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           Y+ PE++E          +    DLW  GV+ YE L G  PF+  +   T+  I+  D  
Sbjct: 178 YLPPEMIE-------GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-- 228

Query: 237 DTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF--DCLDSDPPCIPPPSQE 293
             + FP    LS    + +  L++     RL +  V+ HP    +     PP       +
Sbjct: 229 --LKFPPF--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  234 bits (598), Expect = 3e-71
 Identities = 84/276 (30%), Positives = 131/276 (47%), Gaps = 26/276 (9%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTI--ERD 60
           +++  +  DF+I R + +G FG++YL  EKQS     +K     ++ +  + + +  E +
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           I    + P I+ L+  F D   VY I+EY   G     L  Q      E +   YI ELA
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELA 119

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            A+ Y H    +HRDIKP+N+LL + G LK+ DFG +     + R       GT +Y+ P
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL---CGTLDYLPP 176

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E++E          +    DLWS+GV+ YE L G  PF   T   TY  I   +     +
Sbjct: 177 EMIE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE----FT 225

Query: 241 FPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           FP  +  +    + +  L++     R  + +VL HP
Sbjct: 226 FPDFV--TEGARDLISRLLKHNPSQRPMLREVLEHP 259

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  229 bits (587), Expect = 5e-69
 Identities = 94/290 (32%), Positives = 155/290 (53%), Gaps = 33/290 (11%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF------VMKK---VLREKMPNTIE 58
             +    S F++ + + QG+FG ++LV++    +        V+KK    +R+++   +E
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76

Query: 59  RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           RDI+V+   P+IV L Y+FQ    +Y I++++ GGD  T L  +     +E   +FY+ E
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAE 134

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEY 177
           LA A+ +LH LG ++RD+KP+N+LL   GH+KLTDFG S   +D   +  S    GT EY
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEY 192

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED 237
           +APEV+          G+T S D WS GV+ +E+LTG+ PF  +    T + IL    + 
Sbjct: 193 MAPEVVN-------RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL----KA 241

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQKL-DARL-----NMDQVLGHPVFDCLD 281
            +  P    LS    + ++ L ++    RL      ++++  H  F  +D
Sbjct: 242 KLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  228 bits (584), Expect = 1e-68
 Identities = 92/299 (30%), Positives = 148/299 (49%), Gaps = 40/299 (13%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERDIMVK 64
            S  DF I R +  G+FG ++L+  + +   + MK      V+R K + +T  ER ++  
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
              P+I+ ++ +FQD   ++ IM+Y+ GG+  +LL            A+FY  E+  A++
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALE 120

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    ++RD+KP+N+LL   GH+K+TDFG A  V       ++   GTP+Y+APEV+ 
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTL--CGTPDYIAPEVVS 176

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                  +  Y  S D WS G++ YE+L G TPF       TY  IL  +    + FP  
Sbjct: 177 -------TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----LRFPPF 225

Query: 245 IRLSTAMVNFVQSLVQK-LDARL-NM----DQVLGHPVFDCLDSD--------PPCIPP 289
              +  + + +  L+ + L  RL N+    + V  HP F  +  +         P  PP
Sbjct: 226 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 282

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  227 bits (580), Expect = 5e-68
 Identities = 88/293 (30%), Positives = 151/293 (51%), Gaps = 37/293 (12%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNT---FVMKKVLREKM----PNTI--- 57
             + +    F++ R + +G +G ++ V +    NT   F MK VL++ M           
Sbjct: 10  GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTAHT 68

Query: 58  --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
             ER+I+ + K P+IV+L Y+FQ    +Y I+EY++GG+    LE +  G   E  A FY
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFY 126

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGT 174
           + E++ A+ +LH  G ++RD+KP+N++L+  GH+KLTDFG     +       +    GT
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF--CGT 184

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
            EY+APE+L          G+  + D WS+G + Y++LTG+ PF  E    T   IL   
Sbjct: 185 IEYMAPEILM-------RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--- 234

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARL-----NMDQVLGHPVFDCLD 281
            +  ++ P    L+    + ++ L+++   +RL     +  +V  HP F  ++
Sbjct: 235 -KCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  227 bits (581), Expect = 6e-68
 Identities = 96/303 (31%), Positives = 158/303 (52%), Gaps = 40/303 (13%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREK-MPNTI-ERD 60
            Q       FD  + +  G+FG + LV+ K+S N + MK     KV++ K + +T+ E+ 
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           I+     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  ++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
              +YLH L  ++RD+KP+N+L+   G++++TDFG A +V   GR  ++   GTPE +AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWTL--CGTPEALAP 207

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++      V 
Sbjct: 208 EIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----VR 256

Query: 241 FPSSIRLSTAMVNFVQSLVQK-LDARL-NM----DQVLGHPVFDCLD--------SDPPC 286
           FPS    S+ + + +++L+Q  L  R  N+    + +  H  F   D         + P 
Sbjct: 257 FPSHF--SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314

Query: 287 IPP 289
           IP 
Sbjct: 315 IPK 317

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  224 bits (572), Expect = 1e-66
 Identities = 81/286 (28%), Positives = 145/286 (50%), Gaps = 30/286 (10%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL-------REKMPNTI-ER 59
            Q  +   DF + + + +G+FG ++L E K+++  F +K  L        + +  T+ E+
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEK 68

Query: 60  DIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
            ++  + + P++ ++F +FQ   +++F+MEY+ GGD +  +  Q       S+A FY  E
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAE 126

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEY 177
           +   +Q+LH  G V+RD+K DN+LL   GH+K+ DFG     +  + +  +    GTP+Y
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDY 184

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED 237
           +APE+L           Y  S D WS GV+ YE+L G +PF+ +  +  + SI      D
Sbjct: 185 IAPEILL-------GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----MD 233

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQK-LDARL-NMDQVLGHPVFDCLD 281
              +P    L     + +  L  +  + RL     +  HP+F  ++
Sbjct: 234 NPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  224 bits (574), Expect = 1e-66
 Identities = 88/289 (30%), Positives = 148/289 (51%), Gaps = 33/289 (11%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-------PNTI-ER 59
              +   SDF   + I +G+FG + L   K     + +K VL++K         + + ER
Sbjct: 31  SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSER 89

Query: 60  DIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
           ++++K+ K P++V L +SFQ  + +YF+++Y+ GG+    L+ +      E +ARFY  E
Sbjct: 90  NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAE 147

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEY 177
           +A A+ YLH L  V+RD+KP+N+LL + GH+ LTDFG     ++ N    +    GTPEY
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF--CGTPEY 205

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED 237
           +APEVL           Y  + D W +G V YE+L G  PF        Y +IL      
Sbjct: 206 LAPEVLH-------KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL----NK 254

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQK-----LDARLNMDQVLGHPVFDCLD 281
            +    +  ++ +  + ++ L+QK     L A+ +  ++  H  F  ++
Sbjct: 255 PLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  222 bits (569), Expect = 3e-66
 Identities = 86/284 (30%), Positives = 151/284 (53%), Gaps = 31/284 (10%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK---VLREKMPNTI-ERDIMVK 64
           V+ +DFD  + + +G FG + LV EK +   +   +++K   + ++++ +T+ E  ++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           YLH    V+RDIK +N++L   GH+K+TDFG     +     +K+    GTPEY+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVL 177

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           E        + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + + FP 
Sbjct: 178 E-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEIRFPR 226

Query: 244 SIRLSTAMVNFVQSLVQKL-DARL-----NMDQVLGHPVFDCLD 281
           +  LS    + +  L++K    RL     +  +V+ H  F  ++
Sbjct: 227 T--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  218 bits (557), Expect = 2e-64
 Identities = 85/290 (29%), Positives = 142/290 (48%), Gaps = 33/290 (11%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK---VLREKMPNTI-ERD 60
               +   +F+  R + +G+FG + L   K++ + +   V+KK   +  + +  T+ E+ 
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75

Query: 61  IMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
           I+      P++  LF  FQ  + ++F+ME+V GGD +  ++        E++ARFY  E+
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEI 133

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYV 178
             A+ +LH  G ++RD+K DN+LL   GH KL DFG     +       +    GTP+Y+
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF--CGTPDYI 191

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           APE+L+          Y  + D W++GV+ YE+L G  PF  E  D  + +IL     D 
Sbjct: 192 APEILQ-------EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDE 240

Query: 239 VSFPSSIRLSTAMVNFVQSLVQKL-DARL------NMDQVLGHPVFDCLD 281
           V +P+   L       ++S + K    RL          +L HP F  +D
Sbjct: 241 VVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  218 bits (557), Expect = 2e-64
 Identities = 85/289 (29%), Positives = 141/289 (48%), Gaps = 32/289 (11%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK---VLREKMPNTI-ERD 60
            +  +  +DF+    + +G+FG + L E K +   +   ++KK   +  + +  T+ E+ 
Sbjct: 13  NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72

Query: 61  IMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
           ++    K P++  L   FQ M+ +YF+MEYV GGD +  ++    G   E  A FY  E+
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEI 130

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYV 178
           A  + +L   G ++RD+K DN++L + GH+K+ DFG     +      K+    GTP+Y+
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CGTPDYI 188

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           APE++           Y  S D W+ GV+ YE+L G  PF  E  D  + SI+    E  
Sbjct: 189 APEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHN 237

Query: 239 VSFPSSIRLSTAMVNFVQSLVQKL-DARL-----NMDQVLGHPVFDCLD 281
           V++P S  +S   V   + L+ K    RL         +  H  F  +D
Sbjct: 238 VAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  218 bits (557), Expect = 2e-64
 Identities = 83/299 (27%), Positives = 152/299 (50%), Gaps = 41/299 (13%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNT---FVMKKVLR--------EKMPNT 56
             + V   +F++ + +  G +G ++LV +   H+T   + MK VL+        +   +T
Sbjct: 47  HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK-VLKKATIVQKAKTTEHT 105

Query: 57  I-ERDIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
             ER ++    + P++V L Y+FQ    ++ I++Y+ GG+  T L  +     +E + + 
Sbjct: 106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQI 163

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ--VDKNGRIKSIVPV 172
           Y+ E+  A+++LH LG ++RDIK +N+LL + GH+ LTDFG + +   D+  R       
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF--C 221

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT----YS 228
           GT EY+AP+++   +      G+  + D WS+GV+ YELLTG++PF  +    +      
Sbjct: 222 GTIEYMAPDIVRGGD-----SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276

Query: 229 SILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARL-----NMDQVLGHPVFDCLD 281
            IL    +    +P    +S    + +Q L+ K    RL     + D++  H  F  ++
Sbjct: 277 RIL----KSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  222 bits (568), Expect = 9e-64
 Identities = 85/380 (22%), Positives = 159/380 (41%), Gaps = 40/380 (10%)

Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI- 57
           K L ++ V+ + F   R + +G FG++   + + +   +  KK        R+     + 
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN 233

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E+ I+ K    ++V+L Y+++  + +  ++  + GGD    + +       E++A FY  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           E+   ++ LH    V+RD+KP+N+LL   GH++++D G A  V +   IK    VGT  Y
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGY 351

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED 237
           +APEV++       ++ YT S D W++G + YE++ G +PF      +    +     E 
Sbjct: 352 MAPEVVK-------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQK-LDARL-----NMDQVLGHPVFDCLD--------SD 283
              +      S    +    L+ K    RL     +  +V  HP+F  L+         +
Sbjct: 405 PEEYSER--FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLE 462

Query: 284 PPCIPPPSQEN--------KFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMG 335
           PP  P P            +F      +  P+ + F ++       +P        E   
Sbjct: 463 PPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQDFYQKFATGSVPIPWQNEMVETECFQ 522

Query: 336 ANTNTSSDSTLPPSSEDMRH 355
                  D ++PP  +    
Sbjct: 523 ELNVFGLDGSVPPDLDWKGQ 542

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  214 bits (546), Expect = 5e-63
 Identities = 90/298 (30%), Positives = 144/298 (48%), Gaps = 42/298 (14%)

Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK---VLREKMPNTI-ERDI 61
              +   DFD+ R I +G++  + LV  K++   +   V+KK      E +     E+ +
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 62  MVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
             + S  P++V L   FQ  + ++F++EYV GGD +  +  Q    L E  ARFY  E++
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEIS 120

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVA 179
            A+ YLH  G ++RD+K DN+LL + GH+KLTD+G     +       +    GTP Y+A
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF--CGTPNYIA 178

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSSI 230
           PE+L         + Y  S D W++GV+ +E++ G +PF+           T D  +  I
Sbjct: 179 PEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

Query: 231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARL------NMDQVLGHPVFDCLD 281
           L    E  +  P S  LS    + ++S + K    RL          + GHP F  +D
Sbjct: 232 L----EKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  212 bits (541), Expect = 1e-62
 Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 31/280 (11%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTI-ERDI 61
           R ++     F     +  G++G+++ V  K+    + +K+ +            + E   
Sbjct: 50  RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109

Query: 62  MVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
             K  + P  V L  ++++   +Y   E   G       E      L E++   Y+ +  
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTL 167

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            A+ +LH  G VH D+KP N+ L   G  KL DFG   ++   G  +     G P Y+AP
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ--EGDPRYMAP 225

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYSSILACDTEDTV 239
           E+L+          Y  + D++S+G+   E+      P   E         L        
Sbjct: 226 ELLQ--------GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP------P 271

Query: 240 SFPSSIRLSTAMVNFVQSLVQKLD--ARLNMDQVLGHPVF 277
            F +   LS+ + + +  +++  D   R   + +L  PV 
Sbjct: 272 EFTAG--LSSELRSVLVMMLEP-DPKLRATAEALLALPVL 308

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  218 bits (557), Expect = 2e-62
 Identities = 77/324 (23%), Positives = 144/324 (44%), Gaps = 43/324 (13%)

Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI- 57
           K L  + +    F   R + +G FG+++  + K +   +  KK        R+     + 
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD--FVTLLENQPHGYLSESKARFY 115
           E+ I+ K    +IV+L Y+F+    +  +M  + GGD  +     ++ +    E +A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ-VDKNGRIKSIVPVGT 174
             ++   +++LH    ++RD+KP+N+LL   G+++++D G A +      + K     GT
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGT 352

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE----TLDMTYSSI 230
           P ++APE+L         + Y  S D +++GV  YE++    PF               +
Sbjct: 353 PGFMAPELLL-------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

Query: 231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARL-----NMDQVLGHPVFDCLD--- 281
           L    E  V++P     S A  +F ++L+QK  + RL     + D +  HP+F  +    
Sbjct: 406 L----EQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ 459

Query: 282 -----SDPPCIPPPSQENKFHKKD 300
                  PP +P        + +D
Sbjct: 460 LEAGMLTPPFVPDSRTVYAKNIQD 483

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  215 bits (549), Expect = 3e-62
 Identities = 88/301 (29%), Positives = 153/301 (50%), Gaps = 35/301 (11%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK---VLREKMPNTI-ERD 60
            +  V+ ++F+  + + +G FG + LV+EK +   +   ++KK   V ++++ +T+ E  
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200

Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           ++  S+ P++  L YSFQ  + + F+MEY  GG+    L  +     SE +ARFY  E+ 
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIV 258

Query: 121 QAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYV 178
            A+ YLH     V+RD+K +N++L   GH+K+TDFG     +     +K+    GTPEY+
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYL 316

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           APEVLE        + Y  + D W +GVV YE++ G  PF  +  +  +  IL     + 
Sbjct: 317 APEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----MEE 365

Query: 239 VSFPSSIRLSTAMVNFVQSLVQK-LDARL-----NMDQVLGHPVFDCLDSDP---PCIPP 289
           + FP +  L     + +  L++K    RL     +  +++ H  F  +         + P
Sbjct: 366 IRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSP 423

Query: 290 P 290
           P
Sbjct: 424 P 424

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  208 bits (532), Expect = 1e-61
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 33/288 (11%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIERDIMVKSKC--P 68
            +   RF+ +G F   + + +  +   F  K      +L+      +  +I +       
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           ++V     F+D + V+ ++E       + L +      L+E +AR+Y+ ++    QYLH 
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHR 133

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRD+K  N+ L+    +K+ DFG AT+V+ +G  K  V  GTP Y+APEVL     
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK-VLCGTPNYIAPEVLS---- 188

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                G++   D+WSIG + Y LL G  PF    L  TY  I   +     S P  I   
Sbjct: 189 ---KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE----YSIPKHINPV 241

Query: 249 TAMVNFVQSLVQKL-----DARLNMDQVLGHPVFDCLDSDPPCIPPPS 291
                   SL+QK+      AR  ++++L    F      P  +P   
Sbjct: 242 ------AASLIQKMLQTDPTARPTINELLNDEFFTS-GYIPARLPITC 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  209 bits (534), Expect = 2e-61
 Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 33/302 (10%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIE 58
           + E+     S   +   RF+ +G F   + + +  +   F  K      +L+      + 
Sbjct: 30  IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 89

Query: 59  RDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
            +I +       ++V     F+D + V+ ++E       + L   +    L+E +AR+Y+
Sbjct: 90  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYL 147

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
            ++    QYLH    +HRD+K  N+ L+    +K+ DFG AT+V+ +G  K  V  GTP 
Sbjct: 148 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK-VLCGTPN 206

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           Y+APEVL          G++   D+WSIG + Y LL G  PF    L  TY  I   +  
Sbjct: 207 YIAPEVLS-------KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-- 257

Query: 237 DTVSFPSSIRLSTAMVNFVQSLVQKL-----DARLNMDQVLGHPVFDCLDSDPPCIPPPS 291
              S P  I  +        SL+QK+      AR  ++++L    F      P  +P   
Sbjct: 258 --YSIPKHI--NPV----AASLIQKMLQTDPTARPTINELLNDEFFTS-GYIPARLPITC 308

Query: 292 QE 293
             
Sbjct: 309 LT 310

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  211 bits (539), Expect = 2e-61
 Identities = 90/299 (30%), Positives = 145/299 (48%), Gaps = 42/299 (14%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK---VLREKMPNTI-ERD 60
              ++   DFD+ R I +G++  + LV  K++   +   V+KK      E +     E+ 
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104

Query: 61  IMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
           +  + S  P++V L   FQ  + ++F++EYV GGD +  +  Q    L E  ARFY  E+
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEI 162

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYV 178
           + A+ YLH  G ++RD+K DN+LL + GH+KLTD+G     +       +    GTP Y+
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF--CGTPNYI 220

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSS 229
           APE+L         + Y  S D W++GV+ +E++ G +PF+           T D  +  
Sbjct: 221 APEILR-------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273

Query: 230 ILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARL------NMDQVLGHPVFDCLD 281
           IL    E  +  P S  LS    + ++S + K    RL          + GHP F  +D
Sbjct: 274 IL----EKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  217 bits (555), Expect = 3e-61
 Identities = 90/309 (29%), Positives = 146/309 (47%), Gaps = 40/309 (12%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF---VMKK---VLREKMPNTI-ERD 60
            +  +  +DF+    + +G+FG + L E K +   +   ++KK   +  + +  T+ E+ 
Sbjct: 334 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393

Query: 61  IMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
           ++    K P++  L   FQ M+ +YF+MEYV GGD +  +  Q  G   E  A FY  E+
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEI 451

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYV 178
           A  + +L   G ++RD+K DN++L + GH+K+ DFG     +      K+    GTP+Y+
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CGTPDYI 509

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           APE++           Y  S D W+ GV+ YE+L G  PF  E  D  + SI+    E  
Sbjct: 510 APEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHN 558

Query: 239 VSFPSSIRLSTAMVNFVQSLVQKL-DARL-----NMDQVLGHPVFDCLDSD--------P 284
           V++P S  +S   V   + L+ K    RL         +  H  F  +D +        P
Sbjct: 559 VAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP 616

Query: 285 PCIPPPSQE 293
           P  P  S  
Sbjct: 617 PYKPKASGR 625

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  207 bits (528), Expect = 3e-61
 Identities = 68/275 (24%), Positives = 131/275 (47%), Gaps = 33/275 (12%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIERDIMVKSKC--P 68
           DF +   + +G+F  +Y  E   +     +K      + +  M   ++ ++ +  +   P
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            I+ L+  F+D N+VY ++E    G+    L+N+     SE++AR +++++   + YLH 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS 130

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            G +HRD+   N+LL+   ++K+ DFG +      + +  ++   GTP Y++PE+     
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIAT--- 185

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  +    D+WS+G + Y LL G  PF+ +T+  T + ++  D       PS +  
Sbjct: 186 ----RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD----YEMPSFL-- 235

Query: 248 STAMVNFVQSLVQKL-----DARLNMDQVLGHPVF 277
           S       + L+ +L       RL++  VL HP  
Sbjct: 236 SIE----AKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  215 bits (550), Expect = 2e-60
 Identities = 87/320 (27%), Positives = 146/320 (45%), Gaps = 44/320 (13%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK------VLREKMPNTI-ERD 60
              +++ +DF + R I +G FG++Y   +  +   + MK        +++     + ER 
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 61  IMVK---SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           ++       CP+IV + Y+F   + + FI++ + GGD    L    HG  SE+  RFY  
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAA 299

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           E+   ++++H    V+RD+KP N+LL   GH++++D G A    K  +  +   VGT  Y
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGY 356

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF---NYETLDMTYSSILACD 234
           +APEVL+          Y  S D +S+G + ++LL G +PF     +         L   
Sbjct: 357 MAPEVLQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--- 407

Query: 235 TEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARL-----NMDQVLGHPVFDCLD------- 281
               V  P S   S  + + ++ L+Q+ ++ RL        +V   P F  LD       
Sbjct: 408 -TMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQ 464

Query: 282 -SDPPCIPPPSQENKFHKKD 300
              PP IPP  + N     D
Sbjct: 465 KYPPPLIPPRGEVNAADAFD 484

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  201 bits (514), Expect = 9e-59
 Identities = 85/325 (26%), Positives = 149/325 (45%), Gaps = 40/325 (12%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT------- 56
           ++  +Q+ V    +DI   +  G F  +    EK +   +  K + + +   +       
Sbjct: 2   MEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60

Query: 57  -IER--DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKA 112
            IER   I+ +     ++ L   +++   V  I+E V+GG+ F  L +      LSE +A
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEA 117

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKS 168
             +I ++   V YLH     H D+KP+N++L        H+KL DFG A +++     K+
Sbjct: 118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177

Query: 169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYS 228
           I   GTPE+VAPE++         +      D+WSIGV++Y LL+G++PF  +T   T +
Sbjct: 178 I--FGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228

Query: 229 SILACDTEDTVSFPSSI--RLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVFDCLDSDPP 285
           +I +        F        S    +F++  LV++   RL + + L HP    +D+   
Sbjct: 229 NITSVS----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284

Query: 286 CIPPPSQEN-----KFHKKDKRKAS 305
            +   S  N     K + + + K S
Sbjct: 285 MVRRESVVNLENFRKQYVRRRWKLS 309

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  199 bits (509), Expect = 2e-58
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 31/282 (10%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIM 62
            Q  +    F  KR +  G FGD++LVEE+ S    V+K + +++    +E+     +++
Sbjct: 16  FQGTID-DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVL 74

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYEL 119
                P I+ +F  F+D +++Y +ME   GG   + + +        LSE      + ++
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERI-VSAQARGKALSEGYVAELMKQM 133

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
             A+ Y H    VH+D+KP+N+L   T     +K+ DFG A     +    +    GT  
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA--AGTAL 191

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           Y+APEV +           T  CD+WS GVV Y LLTG  PF   +L+         +  
Sbjct: 192 YMAPEVFK--------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-- 241

Query: 237 DTVSFPSSIR-LSTAMVNFVQSLVQKLD--ARLNMDQVLGHP 275
              ++    R L+   V+ ++ ++ K D   R +  QVL H 
Sbjct: 242 --PNYAVECRPLTPQAVDLLKQMLTK-DPERRPSAAQVLHHE 280

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  199 bits (507), Expect = 4e-58
 Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 28/279 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK---------- 64
            +++ K  + +G    +     K +   + +K +      +    ++             
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 65  ----SKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYEL 119
               S  P I+ L  +++     + + + +  G+ F  L E      LSE + R  +  L
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRAL 133

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
            + +  LH L  VHRD+KP+N+LL    ++KLTDFG + Q+D   +++ +   GTP Y+A
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--CGTPSYLA 191

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PE++E    N    GY    D+WS GV+ Y LL GS PF +    +    I++ +     
Sbjct: 192 PEIIE-CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN----Y 246

Query: 240 SFPSSI--RLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            F S      S  + + V   LV +   R   ++ L HP
Sbjct: 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  200 bits (511), Expect = 6e-58
 Identities = 73/329 (22%), Positives = 136/329 (41%), Gaps = 29/329 (8%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPY 69
            +   + I +G+FG   LV+  +    +V+K++   +M +        E  ++   K P 
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV    SF++   +Y +M+Y  GGD    +  Q      E +   +  ++  A++++H  
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             +HRDIK  N+ L+  G ++L DFG A  ++    +     +GTP Y++PE+ E     
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICE----- 198

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
             +  Y    D+W++G V YEL T    F   ++      I++         P S+  S 
Sbjct: 199 --NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-----PVSLHYSY 251

Query: 250 AMVNFVQSLVQKL-DARLNMDQVLGHPVF---------DCLDSDPPCIPPPSQENKFHKK 299
            + + V  L ++    R +++ +L                L ++  C+   S+       
Sbjct: 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIP 311

Query: 300 DKRKASPSLKAFQKEGRYLDSALPLIGIS 328
            KR AS          + +       GI 
Sbjct: 312 AKRPASGQNSISVMPAQKITKPAAKYGIP 340

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  197 bits (504), Expect = 8e-58
 Identities = 76/277 (27%), Positives = 135/277 (48%), Gaps = 34/277 (12%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IER--DIMVKSK 66
           +++   +  G F  +    +K +   +  K + + ++ ++        IER  +I+ + +
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQY 125
            P I+ L   F++   V  I+E V+GG+ F  L E      L+E +A  ++ ++   V Y
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHY 123

Query: 126 LHGLGYVHRDIKPDNMLLSAT----GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           LH     H D+KP+N++L         +KL DFG A +++     K+I   GTPE+VAPE
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI--FGTPEFVAPE 181

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++ +       +      D+WSIGV++Y LL+G++PF  ET   T ++I A +      F
Sbjct: 182 IVNY-------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN----YDF 230

Query: 242 PSSI--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
                   S    +F++ L+ K    R+ + Q L H 
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  198 bits (505), Expect = 2e-57
 Identities = 84/329 (25%), Positives = 147/329 (44%), Gaps = 38/329 (11%)

Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++        IE
Sbjct: 4   FRQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62

Query: 59  R--DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFY 115
           R   I+ + + P ++ L   +++   V  I+E V GG+ F  L E      L+E +A  +
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEF 119

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSAT----GHLKLTDFGSATQVDKNGRIKSIVP 171
           + ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I  
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-- 177

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
            GTPE+VAPE++         +      D+WSIGV++Y LL+G++PF  +T   T +++ 
Sbjct: 178 FGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

Query: 232 ACDTEDTVSFPSSI--RLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVFDCLDSDPPC-- 286
           A +      F        S    +F++  LV+    R+ +   L HP     D+      
Sbjct: 231 AVN----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSR 286

Query: 287 IPPPSQENKFHKKD-KRKASPSLKAFQKE 314
                   KF K   ++K++        +
Sbjct: 287 KASAVNMEKFKKFAARKKSNNGSGGGLND 315

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  197 bits (502), Expect = 4e-57
 Identities = 58/283 (20%), Positives = 111/283 (39%), Gaps = 26/283 (9%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMPNTIER--DIMVKSKC 67
           +    +   + + +G F  + LVE     + + +K++L   ++     +R  D+      
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH 85

Query: 68  PYIVNLFYSFQD----MNHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQ 121
           P I+ L           +  + ++ +   G     +E       +L+E +  + +  + +
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS--------IVPVG 173
            ++ +H  GY HRD+KP N+LL   G   L D GS  Q   +                  
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           T  Y APE+                 D+WS+G V Y ++ G  P++        S  LA 
Sbjct: 206 TISYRAPELFS----VQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAV 260

Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHP 275
             ++ +S P S R S+A+   + S++      R ++  +L   
Sbjct: 261 --QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  198 bits (505), Expect = 5e-57
 Identities = 89/374 (23%), Positives = 158/374 (42%), Gaps = 39/374 (10%)

Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IE 58
            +Q+ V    +DI   +  G F  +    EK +   +  K + + +   +        IE
Sbjct: 5   FKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63

Query: 59  R--DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFY 115
           R   I+ +   P I+ L   +++   V  I+E V+GG+ F  L +      LSE +A  +
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSF 120

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSATQVDKNGRIKSIVP 171
           I ++   V YLH     H D+KP+N++L        H+KL DFG A +++     K+I  
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-- 178

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
            GTPE+VAPE++         +      D+WSIGV++Y LL+G++PF  +T   T ++I 
Sbjct: 179 FGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231

Query: 232 ACDTEDTVSFPSSI--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIP 288
           A        F      + S    +F++ L+ K    RL + + L HP    +D+    + 
Sbjct: 232 AVS----YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVR 287

Query: 289 PPSQENKFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPMGANTNTSSDSTLPP 348
             S  N     +  K     + ++     +     L         +  + +  +  +   
Sbjct: 288 RESVVN----LENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTE 343

Query: 349 SSEDMRHWKRDRLQ 362
            +   R     R +
Sbjct: 344 ENIARRKALHPRRR 357

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  196 bits (501), Expect = 9e-57
 Identities = 74/298 (24%), Positives = 132/298 (44%), Gaps = 30/298 (10%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------IMVK-SKCPYIVNLFYSF 77
           +G F  +     K +   +  K + + +       +      ++     CP ++NL   +
Sbjct: 39  RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           ++ + +  I+EY  GG+  +L   +    +SE+     I ++ + V YLH    VH D+K
Sbjct: 99  ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158

Query: 138 PDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
           P N+LL      G +K+ DFG + ++     ++ I  +GTPEY+APE+L         D 
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI--MGTPEYLAPEILN-------YDP 209

Query: 195 YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI--RLSTAMV 252
            T + D+W+IG+++Y LLT ++PF  E    TY +I   +    V +       +S    
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN----VDYSEETFSSVSQLAT 265

Query: 253 NFVQS-LVQKLDARLNMDQVLGHPVFDCLDSDPPCIP----PPSQENKFHKKDKRKAS 305
           +F+QS LV+  + R   +  L H      D +    P      SQ      +     +
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKT 323

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  197 bits (502), Expect = 9e-57
 Identities = 62/343 (18%), Positives = 128/343 (37%), Gaps = 61/343 (17%)

Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSH-----------------NTFVMKK 47
           K +++K+   +D+ I R + QG F  I L E+                           K
Sbjct: 21  KYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 48  VLREKMPNTIERDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGD------FVTLL 99
           +  +   +  + ++ + +     Y +       + + VY I EY+          +  +L
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 100 ENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSAT 158
           +     ++     +  I  +  +  Y+H      HRD+KP N+L+   G +KL+DFG + 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200

Query: 159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +  + +IK     GT E++ PE        +G+       D+WS+G+  Y +     PF
Sbjct: 201 YM-VDKKIKGS--RGTYEFMPPEFFSNESSYNGA-----KVDIWSLGICLYVMFYNVVPF 252

Query: 219 NYE-TLDMTYSSILACDTEDTVSFPSSIRLSTAMVNF-------------VQSLVQKL-- 262
           + + +L   +++I   +    + +P         +                   ++    
Sbjct: 253 SLKISLVELFNNIRTKN----IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR 308

Query: 263 ---DARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKR 302
                R+  +  L H      D++   +   S+E   +KK K+
Sbjct: 309 KNPAERITSEDALKHEWL--ADTNIEDLREFSKE--LYKKRKK 347

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  196 bits (500), Expect = 1e-56
 Identities = 69/305 (22%), Positives = 130/305 (42%), Gaps = 30/305 (9%)

Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIERDIMVK 64
           K +    + I   + +G FG ++   E  S  T++ K        +  +    E  I+  
Sbjct: 1   KELY-EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK--EISILNI 57

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAV 123
           ++   I++L  SF+ M  +  I E+++G D F  +  +     L+E +   Y++++ +A+
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEAL 115

Query: 124 QYLHGLGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           Q+LH     H DI+P+N++     +  +K+ +FG A Q+      + +     PEY APE
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPE 173

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           V +        D  + + D+WS+G + Y LL+G  PF  ET      +I+  +     +F
Sbjct: 174 VHQ-------HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE----YTF 222

Query: 242 PSSI--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHK 298
                  +S   ++FV  L+ K   +R+   + L HP       +               
Sbjct: 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL-KQKIERVSTKVIRTLKHRRY 281

Query: 299 KDKRK 303
                
Sbjct: 282 YHTLI 286

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  194 bits (495), Expect = 1e-56
 Identities = 68/274 (24%), Positives = 123/274 (44%), Gaps = 30/274 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCP 68
             ++I   + +G+FG++   +++ +   + +K + +    N           ++ K   P
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
            I+ LF   +D +  Y + E  TGG+ F  +++       SE  A   I ++   + Y+H
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMH 138

Query: 128 GLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
               VHRD+KP+N+LL +      +K+ DFG +T   +N ++K    +GT  Y+APEVL 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR 196

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                     Y   CD+WS GV+ Y LL+G+ PF  +        +         +F   
Sbjct: 197 --------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK----YAFDLP 244

Query: 245 I--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
               +S    + ++ ++      R+   Q L HP
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  195 bits (497), Expect = 1e-56
 Identities = 57/294 (19%), Positives = 116/294 (39%), Gaps = 45/294 (15%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTIERDIMVKSKC--PYI 70
           ASDF+    + QG FG +           + +KK+   E+  +TI  ++M+ +     Y+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 71  VNLFYSFQDMNH-------------VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           V  + ++ +  +             ++  MEY   G    L+ ++        +      
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-NQQRDEYWRLFR 123

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP------ 171
           ++ +A+ Y+H  G +HRD+KP N+ +  + ++K+ DFG A  V ++  I  +        
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 172 -------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD 224
                  +GT  YVA EVL+      G+  Y    D++S+G++ +E++            
Sbjct: 184 SDNLTSAIGTAMYVATEVLD------GTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERV 235

Query: 225 MTYSSILACDTEDTVSFPSSI--RLSTAMVNFVQSLVQKL-DARLNMDQVLGHP 275
                + +      + FP              ++ L+    + R     +L   
Sbjct: 236 NILKKLRSVS----IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  195 bits (498), Expect = 1e-56
 Identities = 66/304 (21%), Positives = 116/304 (38%), Gaps = 39/304 (12%)

Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMV 63
            ++ S   + +   + QG   +++    K++ + F +K          ++      +++ 
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62

Query: 64  KSKCPYIVNLFYSFQDMN--HVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELA 120
           K     IV LF   ++    H   IME+   G  +  L E      L ES+    + ++ 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSAT----GHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
             + +L   G VHR+IKP N++           KLTDFG+A +++ + +  S+   GT E
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEE 180

Query: 177 YVAPEVLE-WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSIL 231
           Y+ P++ E  +        Y  + DLWSIGV  Y   TGS PF               I+
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 232 ACDTEDTVS---------------FPSSIRLSTAMVNFVQSLVQKL-----DARLNMDQV 271
                  +S                P S  LS  +   +  ++  +     +     DQ 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 272 LGHP 275
               
Sbjct: 301 FAET 304

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  195 bits (498), Expect = 3e-56
 Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 30/289 (10%)

Query: 1   KDVVKELRQKNVSASD-FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER 59
             +V++L + ++  +D +++K  I  G++        K ++  F +K + + K   T E 
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI 66

Query: 60  DIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIY 117
           +I+++  + P I+ L   + D  +VY + E + GG+   LL+      + SE +A   ++
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE---LLDKILRQKFFSEREASAVLF 123

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGH----LKLTDFGSATQVDKNGRIKSIVPVG 173
            + + V+YLH  G VHRD+KP N+L          +++ DFG A Q+     +    P  
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-TPCY 182

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF---NYETLDMTYSSI 230
           T  +VAPEVLE         GY  +CD+WS+GV+ Y +LTG TPF     +T +   + I
Sbjct: 183 TANFVAPEVLE-------RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235

Query: 231 LACDTEDTVSFPSSI--RLSTAMVNFVQSLVQKLDA--RLNMDQVLGHP 275
            +       S        +S    + V  ++   D   RL    VL HP
Sbjct: 236 GSGK----FSLSGGYWNSVSDTAKDLVSKMLHV-DPHQRLTAALVLRHP 279

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  195 bits (497), Expect = 5e-56
 Identities = 83/313 (26%), Positives = 144/313 (46%), Gaps = 32/313 (10%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER--DIMVKSKCPYIVNLF 74
           F+++  + +G    +Y  ++K +   + +K + +      +     ++++   P I+ L 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 75  YSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
             F+    +  ++E VTGG+ F  ++E    GY SE  A   + ++ +AV YLH  G VH
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENGIVH 171

Query: 134 RDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           RD+KP+N+L +       LK+ DFG +  V+    +K++   GTP Y APE+L       
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CGTPGYCAPEILR------ 223

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTEDTVSFPS----SI 245
               Y    D+WS+G+++Y LL G  PF  E  D   +  IL C+      F S     +
Sbjct: 224 -GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE----YYFISPWWDEV 278

Query: 246 RLSTAMVNFVQS-LVQKLDARLNMDQVLGHP-VFDCLDSDPPCIPPPSQENKFHKKDK-R 302
             S    + V+  +V     RL   Q L HP V     +         +  +F+ + K +
Sbjct: 279 --SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLK 336

Query: 303 KASPSLKAFQKEG 315
            A  ++ A  + G
Sbjct: 337 AAVKAVVASSRLG 349

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  192 bits (491), Expect = 6e-56
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 29/274 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IER--DIMVKSKCP 68
            ++D+K  + +G F  +     K +   F  K +  +K+       +ER   I  K + P
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
            IV L  S Q+ +  Y + + VTGG+ F  ++      + SE+ A   I ++ +++ Y H
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH 122

Query: 128 GLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
             G VHR++KP+N+LL++      +KL DFG A +V+ +         GTP Y++PEVL+
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK 180

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   D Y+   D+W+ GV+ Y LL G  PF  E     Y+ I A        +PS 
Sbjct: 181 -------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA----YDYPSP 229

Query: 245 I--RLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
               ++    + + S L      R+  DQ L  P
Sbjct: 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  192 bits (490), Expect = 7e-56
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 30/273 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--IER--DIMVKSKCPYI 70
             + ++  I +G++G++ +  +K +      KK+ +  + +    ++  +IM     P I
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           + L+ +F+D   +Y +ME  TGG+ F  ++         ES A   + ++  AV Y H L
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 130 GYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
              HRD+KP+N L         LKL DFG A +      +++   VGTP YV+P+VLE  
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLE-- 181

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI- 245
                   Y   CD WS GV+ Y LL G  PF+  T       I         +FP    
Sbjct: 182 ------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT----FTFPEKDW 231

Query: 246 -RLSTAMVNFVQSLVQKLD--ARLNMDQVLGHP 275
             +S    + ++ L+ K     R+   Q L H 
Sbjct: 232 LNVSPQAESLIRRLLTK-SPKQRITSLQALEHE 263

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  200 bits (511), Expect = 9e-56
 Identities = 90/323 (27%), Positives = 150/323 (46%), Gaps = 29/323 (8%)

Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIER--DI 61
           E++  +V    +DI   +  G FG ++ V E+ + N F  K V+     +  T+ +    
Sbjct: 149 EIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 207

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--NQPHGYLSESKARFYIYEL 119
           M   + P +VNL  +F+D N +  I E+++GG+   L E     H  +SE +A  Y+ ++
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE---LFEKVADEHNKMSEDEAVEYMRQV 264

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATG--HLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
            + + ++H   YVH D+KP+N++ +      LKL DFG    +D    +K     GT E+
Sbjct: 265 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEF 322

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED 237
            APEV E               D+WS+GV+SY LL+G +PF  E  D T  ++ +CD   
Sbjct: 323 AAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD--- 372

Query: 238 TVSFPSSI--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIP-PPSQE 293
             +   S    +S    +F++ L+    + R+ + Q L HP     ++       P S+ 
Sbjct: 373 -WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 431

Query: 294 NKFHKKDKRKASPSLKAFQKEGR 316
            K     K K     +     GR
Sbjct: 432 TKIRDSIKTKYDAWPEPLPPLGR 454

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  194 bits (496), Expect = 9e-56
 Identities = 73/277 (26%), Positives = 129/277 (46%), Gaps = 29/277 (10%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------------ERDIMVK 64
           +D K  I +G    +     + + + F +K +       +             E  I+ +
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 65  -SKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQA 122
            +  P+I+ L  S++  + ++ + + +  G+ F  L E      LSE + R  +  L +A
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEA 212

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           V +LH    VHRD+KP+N+LL     ++L+DFG +  ++   +++ +   GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--CGTPGYLAPEI 270

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
           L+    +    GY    DLW+ GV+ + LL GS PF +    +    I+         F 
Sbjct: 271 LK-CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ----YQFS 325

Query: 243 SSI--RLSTAMVNFVQSLVQKLD--ARLNMDQVLGHP 275
           S      S+ + + +  L+Q  D  ARL  +Q L HP
Sbjct: 326 SPEWDDRSSTVKDLISRLLQV-DPEARLTAEQALQHP 361

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  197 bits (504), Expect = 1e-55
 Identities = 72/325 (22%), Positives = 141/325 (43%), Gaps = 39/325 (12%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD 60
             +  +      S   +  +R + +G+FG++ L ++K +     +K + + ++    +++
Sbjct: 13  PGMFVQHSTAIFS-DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71

Query: 61  -------IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKA 112
                  ++ +   P I+ L+  F+D  + Y + E  TGG+   L +        SE  A
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE---LFDEIISRKRFSEVDA 128

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSI 169
              I ++   + Y+H    VHRD+KP+N+LL +     ++++ DFG +T  + + ++K  
Sbjct: 129 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSS 229
             +GT  Y+APEVL           Y   CD+WS GV+ Y LL+G  PFN          
Sbjct: 189 --IGTAYYIAPEVLH--------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK 238

Query: 230 ILACDTEDTVSFPSS--IRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPC 286
           +         +F      ++S +  + ++ ++      R++    L H        +   
Sbjct: 239 VEKGK----YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294

Query: 287 IPPPSQEN------KFHKKDK-RKA 304
           +  PS +N      +F    K  +A
Sbjct: 295 VDVPSLDNAILNIRQFQGTQKLAQA 319

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  197 bits (504), Expect = 1e-55
 Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 30/274 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCP 68
             ++I   + +G+FG++   +++ +   + +K + +    N           ++ K   P
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIYELAQAVQYLH 127
            I+ LF   +D +  Y + E  TGG+   L +        SE  A   I ++   + Y+H
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 128 GLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
               VHRD+KP+N+LL        +K+ DFG +T   +N ++K    +GT  Y+APEVL 
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR 196

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                     Y   CD+WS GV+ Y LL+G+ PF  +        +         +F   
Sbjct: 197 --------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK----YAFDLP 244

Query: 245 --IRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
               +S    + ++ ++      R+   Q L HP
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  191 bits (487), Expect = 2e-55
 Identities = 57/282 (20%), Positives = 104/282 (36%), Gaps = 38/282 (13%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNL 73
             DF     I  G FG ++  + +    T+V+K+V         E   + K     IV+ 
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHY 69

Query: 74  FYSFQDMNH----------------VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
              +   ++                ++  ME+   G     +E +    L +  A     
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           ++ + V Y+H    ++RD+KP N+ L  T  +K+ DFG  T +  +G+       GT  Y
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--KGTLRY 187

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTE 236
           ++PE +        S  Y    DL+++G++  ELL    T F        ++ +      
Sbjct: 188 MSPEQIS-------SQDYGKEVDLYALGLILAELLHVCDTAFETSKF---FTDLRDG--- 234

Query: 237 DTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVF 277
                             +Q L+ K  + R N  ++L     
Sbjct: 235 ---IISDIF--DKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  189 bits (483), Expect = 1e-54
 Identities = 83/274 (30%), Positives = 134/274 (48%), Gaps = 32/274 (11%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIER--DIMVKSKCPYI 70
             F     +  G F +++LV+++ +   F +K + +      +++E    ++ K K   I
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           V L   ++   H Y +M+ V+GG+ F  +LE    G  +E  A   I ++  AV+YLH  
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 130 GYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           G VHRD+KP+N+L         + +TDFG +  +++NG + +    GTP YVAPEVL   
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTA--CGTPGYVAPEVLAQ- 181

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS--- 243
                   Y+ + D WSIGV++Y LL G  PF  ET    +  I          F S   
Sbjct: 182 ------KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY----YEFESPFW 231

Query: 244 -SIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
             I  S +  +F+  L++K  + R   ++ L HP
Sbjct: 232 DDI--SESAKDFICHLLEKDPNERYTCEKALSHP 263

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  192 bits (489), Expect = 1e-54
 Identities = 84/320 (26%), Positives = 150/320 (46%), Gaps = 24/320 (7%)

Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK--KVLREKMPNTIER--DI 61
           E++Q +V    +DI   +  G FG ++   EK +   FV K           T++    I
Sbjct: 43  EVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI 101

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P ++NL  +F+D   +  I+E+++GG+    +  + +   SE++   Y+ +  +
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-SEAEVINYMRQACE 160

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
            ++++H    VH DIKP+N++        +K+ DFG AT+++ +  +K      T E+ A
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAA 218

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PE+++        +      D+W+IGV+ Y LL+G +PF  E    T  ++  CD     
Sbjct: 219 PEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD----W 267

Query: 240 SFPSSI--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKF 296
            F       +S    +F+++L+QK    RL +   L HP      S+     P S+ NK 
Sbjct: 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI 327

Query: 297 HKKDKRKASPSLKAFQKEGR 316
            +K K K +         GR
Sbjct: 328 RQKIKEKYADWPAPQPAIGR 347

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  191 bits (487), Expect = 1e-54
 Identities = 73/309 (23%), Positives = 135/309 (43%), Gaps = 35/309 (11%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IER--DIMVKSKC 67
           +++   I +G F  +     +++   F +K V   K  ++       ++R   I    K 
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           P+IV L  ++     +Y + E++ G      +    +    Y SE+ A  Y+ ++ +A++
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY-SEAVASHYMRQILEALR 144

Query: 125 YLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           Y H    +HRD+KP  +LL++  +   +KL  FG A Q+ ++G +     VGTP ++APE
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPE 203

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           V++        + Y    D+W  GV+ + LL+G  PF Y T +  +  I+          
Sbjct: 204 VVK-------REPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGK----YKM 251

Query: 242 PSSI--RLSTAMVNFVQS-LVQKLDARLNMDQVLGHP---VFDCLDSDPPCIPPPSQENK 295
                  +S +  + V+  L+     R+ + + L HP     D             Q  K
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311

Query: 296 FHKKDKRKA 304
           F+ + K K 
Sbjct: 312 FNARRKLKG 320

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  190 bits (485), Expect = 2e-54
 Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 25/294 (8%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK-SKCPYIVNLFYSFQDMNH- 82
            G  G +     +++     +K +         E D   + S  P+IV +   +++M+H 
Sbjct: 39  LGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-EVDHHWQASGGPHIVCILDVYENMHHG 97

Query: 83  ---VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD 139
              +  IME + GG+  + ++ +     +E +A   + ++  A+Q+LH     HRD+KP+
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157

Query: 140 NMLLSATGH---LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYT 196
           N+L ++      LKLTDFG A +      +++  P  TP YVAPEVL       G + Y 
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETT-QNALQT--PCYTPYYVAPEVL-------GPEKYD 207

Query: 197 GSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI--RLSTAMVNF 254
            SCD+WS+GV+ Y LL G  PF   T       +          FP+     +S      
Sbjct: 208 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQL 267

Query: 255 VQS-LVQKLDARLNMDQVLGHP---VFDCLDSDPPCIPPPSQENKFHKKDKRKA 304
           ++  L      RL + Q + HP       +   P       QE+K H  + ++ 
Sbjct: 268 IRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEE 321

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  195 bits (497), Expect = 2e-54
 Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 31/288 (10%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD 60
             +    ++ ++S   +   + +  G +G++ L  +K +H    +K + +  +  +    
Sbjct: 24  PGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82

Query: 61  ------IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKAR 113
                 ++     P I+ L+  F+D  + Y +ME   GG+   L +        +E  A 
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE---LFDEIIHRMKFNEVDAA 139

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRIKSIV 170
             I ++   V YLH    VHRD+KP+N+LL        +K+ DFG +   +   ++K   
Sbjct: 140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER- 198

Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
            +GT  Y+APEVL           Y   CD+WSIGV+ + LL G  PF  +T       +
Sbjct: 199 -LGTAYYIAPEVLR--------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

Query: 231 LACDTEDTVSFPSS--IRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
                    +F S     +S    + ++ ++Q     R++  Q L HP
Sbjct: 250 EKGK----YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  190 bits (483), Expect = 3e-54
 Identities = 75/316 (23%), Positives = 121/316 (38%), Gaps = 64/316 (20%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI---------ERDIMVKS 65
             + +K  I QG++G + +  E Q+     +K + + K+             E  +M K 
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGD------------------------------- 94
             P I  L+  ++D  ++  +ME   GG                                
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 95  -------FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-- 145
                   +            E      + ++  A+ YLH  G  HRDIKP+N L S   
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 146 TGHLKLTDFGSATQVDKNGRIKSIV---PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLW 202
           +  +KL DFG + +  K    +        GTP +VAPEVL     N  ++ Y   CD W
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL-----NTTNESYGPKCDAW 260

Query: 203 SIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI--RLSTAMVNFVQSLVQ 260
           S GV+ + LL G+ PF       T S +L       + F +     LS    + + +L+ 
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKK----LCFENPNYNVLSPLARDLLSNLLN 316

Query: 261 K-LDARLNMDQVLGHP 275
           + +D R +  + L HP
Sbjct: 317 RNVDERFDAMRALQHP 332

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  189 bits (481), Expect = 4e-54
 Identities = 82/303 (27%), Positives = 131/303 (43%), Gaps = 26/303 (8%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-ERDIMVK-SKCPYIVNLFYSFQDMNH 82
           +G+F        K+S+  F +K + +    NT  E   +      P IV L   F D  H
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80

Query: 83  VYFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNM 141
            + +ME + GG+   L E  +   + SE++A + + +L  AV ++H +G VHRD+KP+N+
Sbjct: 81  TFLVMELLNGGE---LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137

Query: 142 LL---SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS 198
           L    +    +K+ DFG A     + +     P  T  Y APE+L         +GY  S
Sbjct: 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLN-------QNGYDES 189

Query: 199 CDLWSIGVVSYELLTGSTPFNYETLDMTYSS---ILACDTEDTVSFPSSI--RLSTAMVN 253
           CDLWS+GV+ Y +L+G  PF      +T +S   I+    +   SF       +S    +
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249

Query: 254 FVQSLVQKLDA--RLNMDQVLGHP-VFDCLDSDPPCIPPPSQENKFHKKDKRKASPSLKA 310
            +Q L+   D   RL M  +  +  + D        +  P                +  A
Sbjct: 250 LIQGLLTV-DPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHA 308

Query: 311 FQK 313
           F K
Sbjct: 309 FNK 311

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  191 bits (486), Expect = 5e-54
 Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 39/303 (12%)

Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMV 63
            ++ S   + +   + QG   +++    K++ + F +K          ++      +++ 
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62

Query: 64  KSKCPYIVNLFYSFQDMN--HVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELA 120
           K     IV LF   ++    H   IME+   G  +  L E      L ES+    + ++ 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSAT----GHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
             + +L   G VHR+IKP N++           KLTDFG+A +++ + +  S+   GT E
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEE 180

Query: 177 YVAPEVLE-WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA--- 232
           Y+ P++ E  +        Y  + DLWSIGV  Y   TGS PF           ++    
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 233 ----------------CDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-----DARLNMDQV 271
                              + +   P S  LS  +   +  ++  +     +     DQ 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 272 LGH 274
              
Sbjct: 301 FAE 303

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  189 bits (483), Expect = 6e-54
 Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 32/305 (10%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IER--DIMVKSKCPYI 70
           +D+K  + +G F  +     K +   F  K +  +K+       +ER   I  K + P I
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           V L  S Q+ +  Y + + VTGG+ F  ++      + SE+ A   I ++ +++ Y H  
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSN 147

Query: 130 GYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
           G VHR++KP+N+LL++      +KL DFG A +V+ +         GTP Y++PEVL+  
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK-- 203

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI- 245
                 D Y+   D+W+ GV+ Y LL G  PF  E     Y+ I A        +PS   
Sbjct: 204 -----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA----YDYPSPEW 254

Query: 246 -RLSTAMVNFVQS-LVQKLDARLNMDQVLGHP---VFDCLDSDPPCIPPPSQENKFHKKD 300
             ++    + + S L      R+  DQ L  P     + + S            KF+ + 
Sbjct: 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARR 314

Query: 301 KRKAS 305
           K K +
Sbjct: 315 KLKGA 319

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  193 bits (492), Expect = 9e-54
 Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 42/299 (14%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--- 57
             +    ++  +    +   R +  G +G++ L +EK  H+   +K + + +        
Sbjct: 23  PGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81

Query: 58  --------------ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN-Q 102
                         E  ++     P I+ LF  F+D  + Y + E+  GG+   L E   
Sbjct: 82  DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE---LFEQII 138

Query: 103 PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQ 159
                 E  A   + ++   + YLH    VHRDIKP+N+LL       ++K+ DFG ++ 
Sbjct: 139 NRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198

Query: 160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
             K+ +++    +GT  Y+APEVL+          Y   CD+WS GV+ Y LL G  PF 
Sbjct: 199 FSKDYKLRDR--LGTAYYIAPEVLK--------KKYNEKCDVWSCGVIMYILLCGYPPFG 248

Query: 220 YETLDMTYSSILACDTEDTVSFPSS--IRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
            +        +          F  +    +S      ++ ++    + R   ++ L   
Sbjct: 249 GQNDQDIIKKVEKGK----YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  187 bits (476), Expect = 1e-53
 Identities = 62/286 (21%), Positives = 120/286 (41%), Gaps = 24/286 (8%)

Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------E 58
              +  +V    + I + I  G    ++ V  ++    + +K V  E+  N        E
Sbjct: 18  LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNE 76

Query: 59  RDIM--VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
              +  ++     I+ L+       ++Y +ME     D  + L+      +   + + Y 
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERKSYW 133

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTP 175
             + +AV  +H  G VH D+KP N L+   G LKL DFG A Q+  +   +     VGT 
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 192

Query: 176 EYVAPEVLEWMEGNHGSD----GYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSI 230
            Y+ PE ++ M  +  +       +   D+WS+G + Y +  G TPF           +I
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252

Query: 231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           +  + E  + FP        + + ++  +++    R+++ ++L HP
Sbjct: 253 IDPNHE--IEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHP 294

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  187 bits (476), Expect = 2e-53
 Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 48/287 (16%)

Query: 25  QGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIER--DIMVK-SKCPYIVNLFYSFQD 79
           +G    +       +   + +K + ++     + + R  +++ +      ++ L   F++
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82

Query: 80  MNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
            +  Y + E + GG    +L +     + +E +A   + ++A A+ +LH  G  HRD+KP
Sbjct: 83  EDRFYLVFEKMRGGS---ILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKP 139

Query: 139 DNMLLSATGH---LKLTDFGSATQVDKNGRIKSIV------PVGTPEYVAPEVLEWMEGN 189
           +N+L         +K+ DF   + +  NG    I       P G+ EY+APEV+E    +
Sbjct: 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF--S 197

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT---------------YSSILACD 234
             +  Y   CDLWS+GV+ Y LL+G  PF                       + SI    
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257

Query: 235 TEDTVSFPS----SIRLSTAMVNFVQSLVQKLDA--RLNMDQVLGHP 275
                 FP      I  S A  + +  L+ + DA  RL+  QVL HP
Sbjct: 258 ----YEFPDKDWAHI--SCAAKDLISKLLVR-DAKQRLSAAQVLQHP 297

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  185 bits (473), Expect = 2e-53
 Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 29/278 (10%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPY 69
           D+++   I  G++G    +  K      V K++    M          E +++ + K P 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 70  IVNLFYSFQDM--NHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQY 125
           IV  +    D     +Y +MEY  GGD  +++    +   YL E      + +L  A++ 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 126 LHGLGY-----VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
            H         +HRD+KP N+ L    ++KL DFG A  ++ +        VGTP Y++P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSP 185

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E +           Y    D+WS+G + YEL     PF   +       I          
Sbjct: 186 EQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---- 234

Query: 241 FPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF 277
                R S  +   +  ++      R +++++L +P+ 
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  188 bits (479), Expect = 8e-53
 Identities = 73/280 (26%), Positives = 136/280 (48%), Gaps = 34/280 (12%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER------------DIMV 63
           ++ + + +  G  G++ L  E+++     ++ + + K      R            +I+ 
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQA 122
           K   P I+ +   F      Y ++E + GG+ F  ++    +  L E+  + Y Y++  A
Sbjct: 196 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLA 251

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           VQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   GTP Y+A
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CGTPTYLA 309

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-YSSILACDTEDT 238
           PEVL     + G+ GY  + D WS+GV+ +  L+G  PF+     ++    I +      
Sbjct: 310 PEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK---- 361

Query: 239 VSFPSSI--RLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
            +F   +   +S   ++ V+  LV    AR   ++ L HP
Sbjct: 362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  186 bits (475), Expect = 1e-52
 Identities = 67/280 (23%), Positives = 131/280 (46%), Gaps = 24/280 (8%)

Query: 6   ELRQKNVSAS-DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPNTIERD 60
             +Q  V++         +  G FG ++  EE  +      K    + +++K     E  
Sbjct: 79  TAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEIS 138

Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           +M +     ++ L+ +F+  N +  +MEYV GG+    + ++ +   +E     ++ ++ 
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL-TELDTILFMKQIC 197

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATG--HLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           + ++++H +  +H D+KP+N+L        +K+ DFG A +     ++K     GTPE++
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFL 255

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           APEV+         D  +   D+WS+GV++Y LL+G +PF  +    T ++ILAC     
Sbjct: 256 APEVVN-------YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR---- 304

Query: 239 VSFPSSI--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
                     +S     F+  L+ K    R++  + L HP
Sbjct: 305 WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  185 bits (471), Expect = 1e-52
 Identities = 82/321 (25%), Positives = 146/321 (45%), Gaps = 38/321 (11%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----------IER--DIMV 63
           ++ + + +  G  G++ L  E+++     +K + + K              +E   +I+ 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESKARFYIYELA 120
           K   P I+ +   F      Y ++E + GG   D V       +  L E+  + Y Y++ 
Sbjct: 71  KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQML 124

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
            AVQYLH  G +HRD+KP+N+LLS+      +K+TDFG +  + +   ++++   GTP Y
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CGTPTY 182

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-YSSILACDTE 236
           +APEVL     + G+ GY  + D WS+GV+ +  L+G  PF+     ++    I +    
Sbjct: 183 LAPEVLV----SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-- 236

Query: 237 DTVSFPSSI--RLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQE 293
              +F   +   +S   ++ V+  LV    AR   ++ L HP     D         S+E
Sbjct: 237 --YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 294

Query: 294 NKFHKKDKRKASPSLKAFQKE 314
           N+     +  A PS    +  
Sbjct: 295 NESTALPQVLAQPSTSRKRPR 315

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  188 bits (479), Expect = 2e-52
 Identities = 82/307 (26%), Positives = 130/307 (42%), Gaps = 31/307 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IER--DIMVKSKCP 68
            ++ +   + +G F  +    +  +   +    +  +K+       +ER   I    K P
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
            IV L  S  +  H Y I + VTGG+ F  ++      Y SE+ A   I ++ +AV + H
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCH 127

Query: 128 GLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
            +G VHR++KP+N+LL++      +KL DFG A +V+   +       GTP Y++PEVL 
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLSPEVLR 186

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   D Y    DLW+ GV+ Y LL G  PF  E     Y  I A        FPS 
Sbjct: 187 -------KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA----YDFPSP 235

Query: 245 I--RLSTAMVNFVQS-LVQKLDARLNMDQVLGHP---VFDCLDSDPPCIPPPSQENKFHK 298
               ++    + +   L      R+   + L HP       + S            KF+ 
Sbjct: 236 EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNA 295

Query: 299 KDKRKAS 305
           + K K +
Sbjct: 296 RRKLKGA 302

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  186 bits (475), Expect = 2e-52
 Identities = 73/304 (24%), Positives = 137/304 (45%), Gaps = 32/304 (10%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK-SKCPYIVNLFYSF 77
             + +  G  G +  +  K++   F +K +         E ++  + S+CP+IV +   +
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRASQCPHIVRIVDVY 124

Query: 78  QDM----NHVYFIMEYVTGGDFVTLLE---NQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           +++      +  +ME + GG+   L     ++     +E +A   +  + +A+QYLH + 
Sbjct: 125 ENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181

Query: 131 YVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
             HRD+KP+N+L ++      LKLTDFG A +   +  + +  P  TP YVAPEVL    
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLG--- 236

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI-- 245
                + Y  SCD+WS+GV+ Y LL G  PF           +          FP+    
Sbjct: 237 ----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292

Query: 246 RLSTAMVNFVQSLVQKLDA--RLNMDQVLGHP---VFDCLDSDPPCIPPPSQENKFHKKD 300
            +S  +   +++L++  +   R+ + + + HP       +   P       +E+K   +D
Sbjct: 293 EVSEEVKMLIRNLLKT-EPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351

Query: 301 KRKA 304
            ++ 
Sbjct: 352 VKEE 355

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  183 bits (467), Expect = 2e-52
 Identities = 63/273 (23%), Positives = 118/273 (43%), Gaps = 24/273 (8%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-------DIMVKSKC 67
           ++F I++ I +G F ++Y            +KKV    + +   R       D++ +   
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQY 125
           P ++  + SF + N +  ++E    GD   ++++  +    + E     Y  +L  A+++
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
           +H    +HRDIKP N+ ++ATG +KL D G              + VGTP Y++PE +  
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIH- 209

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT--YSSILACDTEDTVSFPS 243
                  +GY    D+WS+G + YE+    +PF  + +++      I  CD       PS
Sbjct: 210 ------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL---PS 260

Query: 244 SIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
               S  +   V   +    + R ++  V    
Sbjct: 261 D-HYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  184 bits (469), Expect = 3e-52
 Identities = 65/322 (20%), Positives = 125/322 (38%), Gaps = 24/322 (7%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIM--------V 63
           V    + I + I  G    ++ V  ++    + +K V  E+  N               +
Sbjct: 6   VKGRIYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           +     I+ L+       ++Y +ME     D  + L+      +   + + Y   + +AV
Sbjct: 65  QQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERKSYWKNMLEAV 121

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEV 182
             +H  G VH D+KP N L+   G LKL DFG A Q+  +   +     VGT  Y+ PE 
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 183 LEWMEGNHGSD----GYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTED 237
           ++ M  +  +       +   D+WS+G + Y +  G TPF           +I+  D   
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--DPNH 238

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKF 296
            + FP        + + ++  +++    R+++ ++L HP           +   + E   
Sbjct: 239 EIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK 296

Query: 297 HKKDKRKASPSLKAFQKEGRYL 318
           +   +     S  +  K  + L
Sbjct: 297 YVLGQLVGLNSPNSILKAAKTL 318

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  180 bits (459), Expect = 1e-50
 Identities = 43/321 (13%), Positives = 93/321 (28%), Gaps = 66/321 (20%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT------------------- 56
                  + Q +        ++++  +F +      + P +                   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 57  -------------IERDIMVKSKCPYIVNLFYSFQDMNHV-YFIMEYVTGGDFVTLLEN- 101
                           D++   +   ++ +    +DM  +  F +      +  T  E  
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 102 ----QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA 157
                 H  L          ++ + +  LH  G VH  ++P +++L   G + LT F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 158 TQVDKNGRIKSIVPVGTPEYVAPEVLE----WMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
            +          V   +  +  PE+                 T S D W++G+V Y +  
Sbjct: 254 VRDGARV-----VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 214 GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-----DARLNM 268
              P   +        I         + P            V++L++       + RL  
Sbjct: 309 ADLPITKDAALGGSEWIF----RSCKNIPQP----------VRALLEGFLRYPKEDRLLP 354

Query: 269 DQVLGHPVFDCLDSDPPCIPP 289
            Q +  P ++ L ++     P
Sbjct: 355 LQAMETPEYEQLRTELSAALP 375

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  180 bits (457), Expect = 4e-50
 Identities = 65/323 (20%), Positives = 128/323 (39%), Gaps = 24/323 (7%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IERDI----M 62
           +V    + I + I  G    ++ V  ++    + +K V  E+  N        +I     
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
           ++     I+ L+       ++Y +ME     D  + L+      +   + + Y   + +A
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERKSYWKNMLEA 167

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-RIKSIVPVGTPEYVAPE 181
           V  +H  G VH D+KP N L+   G LKL DFG A Q+  +   +     VG   Y+ PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 182 VLEWMEGNHGSDG----YTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTE 236
            ++ M  +  +       +   D+WS+G + Y +  G TPF           +I+  + E
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286

Query: 237 DTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENK 295
             + FP        + + ++  +++    R+++ ++L HP           +   + E  
Sbjct: 287 --IEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 342

Query: 296 FHKKDKRKASPSLKAFQKEGRYL 318
            +   +     S  +  K  + L
Sbjct: 343 KYVLGQLVGLNSPNSILKAAKTL 365

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  182 bits (464), Expect = 6e-49
 Identities = 107/654 (16%), Positives = 213/654 (32%), Gaps = 111/654 (16%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIM 62
                +   +++K  +  G FG +     + +     +K+  +E  P   ER      IM
Sbjct: 7   SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM 66

Query: 63  VKSKCPYIVNLFYSFQDMNHV------YFIMEYVTGGD-FVTLLENQPHGYLSESKARFY 115
            K   P +V+       +  +         MEY  GGD    L + +    L E   R  
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNGRIKSIVPV 172
           + +++ A++YLH    +HRD+KP+N++L         K+ D G A ++D+         V
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--V 184

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           GT +Y+APE+LE          YT + D WS G +++E +TG  PF      + +   + 
Sbjct: 185 GTLQYLAPELLE-------QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 233 C----------DTEDTVSFPSSIRLSTAMVNFVQSLVQKLDA---------RLNMDQVLG 273
                      D    V F S +     +   +   +++            R    Q   
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297

Query: 274 HPVFDCLDSDPP-----------------CIPPPSQENKFHKKDKRKASPSLKA---FQK 313
              F  LDS                     +             ++      +     Q 
Sbjct: 298 VGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQA 357

Query: 314 EGRYLDSALPLIGISYTGEPMGANTNTS--------------SDSTLPPSSEDMRHWKRD 359
            G  L+SA PL         +                        +LP   E +    +D
Sbjct: 358 SGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPESVSIVLQD 417

Query: 360 ------RLQLLQQLAEAKASLEDLS--------CSRTRVLALQAQVSSLQQDLTSHTSLL 405
                    L +   +   ++  L           RT ++ L    + L +   S TS  
Sbjct: 418 PKRPLTYTHLRRVWGQIWQTIRALKEDCARLLQGQRTSMVNLLRYNTELSKKKNSMTSEC 477

Query: 406 SKKEEEIDRLRQ------EMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDR 459
            + + ++D  R       E   ++ +   TS  L++   E+E+       +  ++   D+
Sbjct: 478 EQLKAKLDFFRSSIQIDLEKYSEQMEFGITSEKLLSAWREMEQAVELCGREREVQALVDK 537

Query: 460 ----KLEVCEVSKE---------LEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELK 506
               + +  ++ +          L+ L  +  +     ++  +D        +     + 
Sbjct: 538 MMALQTDSVDLQRNPLGRKHRGTLDDLEEQARDLYRRLRERPRDQRTPGDSNDMVRLLIL 597

Query: 507 QAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKE 560
             Q+  + +      L + +    +AL      +   +   +     +   Q++
Sbjct: 598 AIQSFEKRVILIYDQLSKTVVCKRKALE-LSPKVKEVMNLMREDEKIVVRRQEK 650

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  176 bits (448), Expect = 1e-48
 Identities = 43/315 (13%), Positives = 98/315 (31%), Gaps = 51/315 (16%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMK------------------------KVLREK 52
                 + Q +        ++++  +F +                          +   K
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 53  MPNTIER--------DIMVKSKCPYIVNLFYSFQDMN--HVYFIMEYVTG--GDFVTLLE 100
                +         D++   +   ++ +    +DM     +F+   +      F  +L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 101 NQP--HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT 158
           +    H  L          ++ + +  LH  G VH  ++P +++L   G + LT F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +   +           PE  A  +L + +  H     T + D W++G+  Y +     P 
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQ--HHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 219 NYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF 277
             +        I          F S   +   +   ++  ++   + RL   Q +  P +
Sbjct: 318 TDDAALGGSEWI----------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 367

Query: 278 DCLDSDPPCIPPPSQ 292
           + L ++     P  Q
Sbjct: 368 EQLRTELSAALPLYQ 382

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  171 bits (435), Expect = 4e-48
 Identities = 46/292 (15%), Positives = 104/292 (35%), Gaps = 48/292 (16%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIM-------VKSK 66
            ++F     I  G FG ++   ++     + +K+  +    +  E++ +       V  +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE--NQPHGYLSESKARFYIYELAQAVQ 124
             ++V  F ++ + +H+    EY  GG     +    +   Y  E++ +  + ++ + ++
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHL-------------------KLTDFGSATQVDKNGR 165
           Y+H +  VH DIKP N+ +S T                      K+ D G  T++     
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS---- 185

Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM 225
               V  G   ++A EVL        +  +    D++++ +                   
Sbjct: 186 -SPQVEEGDSRFLANEVL------QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236

Query: 226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPV 276
            +  I           P    LS      ++ ++    + R +   ++ H V
Sbjct: 237 -WHEIRQGRLPR---IPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  170 bits (432), Expect = 1e-47
 Identities = 71/298 (23%), Positives = 132/298 (44%), Gaps = 57/298 (19%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK-------------------------- 52
           +K  I +G++G + L   +  +  + MK + ++K                          
Sbjct: 17  LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76

Query: 53  --MPNTIERDIMVKSKC--PYIVNLF--YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGY 106
                 + ++I +  K   P +V L       + +H+Y + E V  G    ++E      
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP---VMEVPTLKP 133

Query: 107 LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGR 165
           LSE +ARFY  +L + ++YLH    +HRDIKP N+L+   GH+K+ DFG S      +  
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLD 224
           + +   VGTP ++APE L     +     ++G   D+W++GV  Y  + G  PF  E + 
Sbjct: 194 LSN--TVGTPAFMAPESL-----SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 225 MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-----DARLNMDQVLGHPVF 277
             +S I +      + FP    ++      ++ L+ ++     ++R+ + ++  HP  
Sbjct: 247 CLHSKIKS----QALEFPDQPDIAED----LKDLITRMLDKNPESRIVVPEIKLHPWV 296

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  171 bits (435), Expect = 1e-47
 Identities = 66/319 (20%), Positives = 114/319 (35%), Gaps = 41/319 (12%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIER--DIMVK-SKCPYIV 71
             ++R + +G F  +Y  ++  S   + +K++L  +      I +    M K S  P IV
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 72  NLFYSFQDMNH--------VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
               +                 + E   G     L + +  G LS        Y+  +AV
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 124 QYLHGLG--YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS-----------IV 170
           Q++H      +HRD+K +N+LLS  G +KL DFGSAT +                   I 
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
              TP Y  PE+++               D+W++G + Y L     PF     D     I
Sbjct: 210 RNTTPMYRTPEIIDLYSN----FPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRI 261

Query: 231 LACDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP--VFDCLDSDPPCI 287
           +        S P      T   + +++ L    + RL++ +V+     +    + +P   
Sbjct: 262 VNGK----YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP 317

Query: 288 PPPSQENKFHKKDKRKASP 306
                E          +  
Sbjct: 318 ITELLEQNGGYGSATLSRG 336

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  168 bits (427), Expect = 6e-47
 Identities = 59/298 (19%), Positives = 123/298 (41%), Gaps = 46/298 (15%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKCPY 69
           +DF+  + + +G FG ++  + K     + +K++         E+       + K + P 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 70  IVNLFYSFQDMN------------HVYFIMEYVTGGDFVTLLENQPHG-YLSESKARFYI 116
           IV  F ++ + N            ++Y  M+     +    +  +        S      
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP----- 171
            ++A+AV++LH  G +HRD+KP N+  +    +K+ DFG  T +D++   ++++      
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 172 ------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LD 224
                 VGT  Y++PE +         + Y+   D++S+G++ +ELL    PF+ +    
Sbjct: 185 ARHTGQVGTKLYMSPEQIH-------GNSYSHKVDIFSLGLILFELL---YPFSTQMERV 234

Query: 225 MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVFDCLD 281
            T + +           P   +        VQ ++      R     ++ + VF+ LD
Sbjct: 235 RTLTDVRNLKFP-----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  171 bits (435), Expect = 1e-46
 Identities = 57/287 (19%), Positives = 107/287 (37%), Gaps = 19/287 (6%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-ER 59
            D  +E     V    F  K  +  G  G I        +    +K++L E       E 
Sbjct: 10  DDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREV 68

Query: 60  DIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
            ++ +S + P ++  F + +D    Y  +E          +E Q        +    + +
Sbjct: 69  QLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQ 126

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGH-----LKLTDFGSATQVDKNGRIKSIV--P 171
               + +LH L  VHRD+KP N+L+S           ++DFG   ++       S     
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL 231
            GT  ++APE+L         +  T + D++S G V Y +++  +    ++L    + +L
Sbjct: 187 PGTEGWIAPEMLS----EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242

Query: 232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVF 277
              + D +               ++ ++      R +   VL HP F
Sbjct: 243 GACSLDCLHPEKHE--DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  167 bits (424), Expect = 2e-46
 Identities = 62/314 (19%), Positives = 129/314 (41%), Gaps = 39/314 (12%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT------IERDI--MVKSKCP 68
           + +   + +G++G +  V + ++     +K + ++K+         ++++I  + + +  
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 69  YIVNLF--YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            ++ L      ++   +Y +MEY   G    +L++ P       +A  Y  +L   ++YL
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGM-QEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFG-SAT--QVDKNGRIKSIVPVGTPEYVAPEVL 183
           H  G VH+DIKP N+LL+  G LK++  G +        +   ++    G+P +  PE+ 
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT--SQGSPAFQPPEIA 183

Query: 184 EWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
                  G D ++G   D+WS GV  Y + TG  PF  + +   + +I         + P
Sbjct: 184 N------GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS----YAIP 233

Query: 243 SSIRLSTAMVNFVQSLVQKL-----DARLNMDQVLGHPVFDC-LDSDPPCIPPPSQENKF 296
                       +  L++ +       R ++ Q+  H  F          +P P   +  
Sbjct: 234 GD--CGPP----LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287

Query: 297 HKKDKRKASPSLKA 310
            +       P L+ 
Sbjct: 288 DRWRSMTVVPYLED 301

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  164 bits (418), Expect = 6e-46
 Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 30/274 (10%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKCPYIV 71
           +D+ + + +G +G++ L   + +     +K V  ++  +  E       I        +V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
             +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126

Query: 132 VHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
            HRDIKP+N+LL    +LK++DFG +      N         GT  YVAPE+L+      
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK------ 180

Query: 191 GSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTEDTVSFPSSIRLS 248
               +     D+WS G+V   +L G  P++  +     YS                 ++ 
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----TYLNPWKKID 235

Query: 249 TAMVNFVQSLVQKL-----DARLNMDQVLGHPVF 277
           +A      +L+ K+      AR+ +  +     +
Sbjct: 236 SA----PLALLHKILVENPSARITIPDIKKDRWY 265

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  169 bits (429), Expect = 8e-46
 Identities = 63/326 (19%), Positives = 124/326 (38%), Gaps = 30/326 (9%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-ERDIMVKSK-CPYIVNLF 74
              ++ +  G+ G +   +         +K++L +     + E  ++ +S   P ++  +
Sbjct: 17  VVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 75  YSFQDMNHVYFIMEYVTGG--DFVT--LLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
            S      +Y  +E       D V    + ++      E      + ++A  V +LH L 
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135

Query: 131 YVHRDIKPDNMLLSATGH-------------LKLTDFGSATQVDKNGRIKSIV---PVGT 174
            +HRD+KP N+L+S +               + ++DFG   ++D            P GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC 233
             + APE+LE           T S D++S+G V Y +L+ G  PF  +      S+I+  
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRESNIIRG 253

Query: 234 D-TEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVFDCLDSDPPCIPPPS 291
             + D +       L     + +  ++      R    +VL HP+F         +   S
Sbjct: 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVS 313

Query: 292 QENKFHKKDKRKASPSLKAFQKEGRY 317
             ++   +++   S  L  F     +
Sbjct: 314 --DRLEIENRDPPSALLMKFDAGSDF 337

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  166 bits (421), Expect = 2e-45
 Identities = 36/250 (14%), Positives = 80/250 (32%), Gaps = 35/250 (14%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPN---- 55
           +K   +  + +    +   + +G F  +Y   +   ++    +    KV +   P     
Sbjct: 54  IKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI 113

Query: 56  -TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG---DFVTLLENQPHGYLSESK 111
            T   + +  S     +  + +    N    + E  + G   + + L +N P   + +  
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS-----------ATGHLKLTDFGSATQV 160
              +   +   ++ +H    +H DIKPDN +L             +  L L D G +  +
Sbjct: 174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233

Query: 161 ---DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP 217
               K     +     T  +   E+L        +  +    D + +    Y +L G+  
Sbjct: 234 KLFPKGTIFTAK--CETSGFQCVEMLS-------NKPWNYQIDYFGVAATVYCMLFGTYM 284

Query: 218 FNYETLDMTY 227
                     
Sbjct: 285 KVKNEGGECK 294

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  164 bits (418), Expect = 2e-45
 Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 26/303 (8%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IER--DI 61
             +     ++ + + I +GNF  + L     +     +K + + ++  T    + R   I
Sbjct: 8   ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI 67

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M     P IV LF   +    +Y IMEY +GG+    L    HG + E +AR    ++  
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVS 125

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
           AVQY H    VHRD+K +N+LL A  ++K+ DFG + +    G++ +    G P Y APE
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA--FCGAPPYAAPE 183

Query: 182 VLEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           + +          Y G   D+WS+GV+ Y L++GS PF+ + L      +L         
Sbjct: 184 LFQ-------GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK----YR 232

Query: 241 FPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKK 299
            P    +ST   N ++  LV     R  ++Q++          +   + P  +       
Sbjct: 233 IPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI-NAGHEEDELKPFVEPELDISD 289

Query: 300 DKR 302
            KR
Sbjct: 290 QKR 292

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  165 bits (418), Expect = 4e-45
 Identities = 49/322 (15%), Positives = 91/322 (28%), Gaps = 58/322 (18%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------------------- 55
              +   ++ G+   ++LV + +    F +K        +                    
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 56  -----------TIERDIMVKSKCPYIVNLFYSFQDMN--HVYFIMEYVTG--GDFVTLLE 100
                       +  D +     P    L     D    +   +M   +       + L+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 101 NQP--HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT 158
                 G            +L +    L   G VH    PDN+ +   G L L D  +  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +V   G            Y   E L        +  +T + + W +G+  Y +     PF
Sbjct: 243 KVGTRGP----ASSVPVTYAPREFLN-----ASTATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 219 NYETLDMTYSSILACD---TEDTVSFPSSIRLSTAMVNFVQSLVQKL-----DARLNMDQ 270
              T  +  S           D+++F S   L       V++L+ +        RL   +
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF----VKTLIGRFLNFDRRRRLLPLE 349

Query: 271 VLGHPVFDCLDSDPPCIPPPSQ 292
            +  P F  L ++        Q
Sbjct: 350 AMETPEFLQLQNEISSSLSTGQ 371

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  161 bits (410), Expect = 2e-44
 Identities = 67/305 (21%), Positives = 123/305 (40%), Gaps = 33/305 (10%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKCPYIV 71
           +D+ + + +G +G++ L   + +     +K V  ++  +  E       I        +V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
             +   ++ N  Y  +EY +GG+    +E  P   + E  A+ + ++L   V YLHG+G 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126

Query: 132 VHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
            HRDIKP+N+LL    +LK++DFG +      N         GT  YVAPE+L+      
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK------ 180

Query: 191 GSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTEDTVSFPSSIRLS 248
               +     D+WS G+V   +L G  P++  +     YS                 ++ 
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----TYLNPWKKID 235

Query: 249 TAMVNFVQSLVQKL-----DARLNMDQVLGHPVFDC---LDSDPPCIPPPSQENKFHKKD 300
           +A      +L+ K+      AR+ +  +     ++      +  P +             
Sbjct: 236 SA----PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFS 291

Query: 301 KRKAS 305
           K   S
Sbjct: 292 KHIQS 296

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  159 bits (405), Expect = 6e-44
 Identities = 64/304 (21%), Positives = 124/304 (40%), Gaps = 53/304 (17%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK-SKCPYIVNLFYSF 77
             + +  G  G +  +  K++   F +K +         E ++  + S+CP+IV +   +
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRASQCPHIVRIVDVY 80

Query: 78  QDM----NHVYFIMEYVTGGDFVTLLE---NQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           +++      +  +ME + GG+   L     ++     +E +A   +  + +A+QYLH + 
Sbjct: 81  ENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137

Query: 131 YVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
             HRD+KP+N+L ++      LKLTDFG                       A E      
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FAKETTG--- 172

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI-- 245
                + Y  SCD+WS+GV+ Y LL G  PF           +          FP+    
Sbjct: 173 -----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227

Query: 246 RLSTAMVNFVQSLVQKLD--ARLNMDQVLGHP---VFDCLDSDPPCIPPPSQENKFHKKD 300
            +S  +   +++L++  +   R+ + + + HP       +   P       +E+K   +D
Sbjct: 228 EVSEEVKMLIRNLLKT-EPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 286

Query: 301 KRKA 304
            ++ 
Sbjct: 287 VKEE 290

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  161 bits (409), Expect = 8e-44
 Identities = 82/296 (27%), Positives = 127/296 (42%), Gaps = 30/296 (10%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK-MPNTIERDIMVKSKC--PYIVNL 73
           +D  + I  GNFG   L+ +K +     +K + R   +   ++R+I+       P IV  
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF 81

Query: 74  FYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
                   H+  IMEY +GG+ +  +      G  SE +ARF+  +L   V Y H +   
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQIC 138

Query: 133 HRDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           HRD+K +N LL  S    LK+ DFG +     + + KS   VGTP Y+APEVL       
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVLL------ 190

Query: 191 GSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
               Y G   D+WS GV  Y +L G+ PF        Y   +        S P  IR+S 
Sbjct: 191 -RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249

Query: 250 AMVNFVQSLVQKL-----DARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKD 300
                   L+ ++       R+++ ++  H  F  L + P  +   S      ++ 
Sbjct: 250 E----CCHLISRIFVADPATRISIPEIKTHSWF--LKNLPADLMNESNTGSQFQEP 299

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  159 bits (404), Expect = 1e-43
 Identities = 60/301 (19%), Positives = 115/301 (38%), Gaps = 42/301 (13%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--------TIER 59
           + +    +++ +   + +G FG ++            +K + R ++          T   
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83

Query: 60  DIMV------KSKCPYIVNLFYSFQDMNHVYFIMEY-VTGGDFVTLLENQPHGYLSESKA 112
           ++ +          P ++ L   F+       ++E  +   D    +     G L E  +
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPS 141

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVP 171
           R +  ++  A+Q+ H  G VHRDIK +N+L+    G  KL DFGS   +  +        
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYT--DF 198

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
            GT  Y  PE +           Y      +WS+G++ Y+++ G  PF           I
Sbjct: 199 DGTRVYSPPEWIS-------RHQYHALPATVWSLGILLYDMVCGDIPFE------RDQEI 245

Query: 231 LACDTEDTVSFPSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVFDCLDSDPPCIPP 289
           L  +    + FP+   +S      ++  L  K  +R +++++L  P       D P  P 
Sbjct: 246 LEAE----LHFPA--HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPS 299

Query: 290 P 290
            
Sbjct: 300 K 300

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  157 bits (400), Expect = 2e-43
 Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 36/275 (13%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIERDI--MVKSKCPY 69
           + +   +  G FG + + E + + +   +K     K+    +   I+R+I  +   + P+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           I+ L+         + +MEYV+GG+ F  + +   HG + E +AR    ++  AV Y H 
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR 129

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              VHRD+KP+N+LL A  + K+ DFG +  +     +++    G+P Y APEV+     
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--SCGSPNYAAPEVIS---- 183

Query: 189 NHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                 Y G   D+WS GV+ Y LL G+ PF+ E +   +  I           P    L
Sbjct: 184 ---GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV----FYIPEY--L 234

Query: 248 STAMVNFVQSLVQKL-----DARLNMDQVLGHPVF 277
           + +    V +L+  +       R  +  +  H  F
Sbjct: 235 NRS----VATLLMHMLQVDPLKRATIKDIREHEWF 265

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  159 bits (403), Expect = 2e-43
 Identities = 70/316 (22%), Positives = 122/316 (38%), Gaps = 62/316 (19%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK--------MPNTIER 59
           ++K    S + +   +  G FG +Y       +    +K V +++            +  
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95

Query: 60  DI----MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGG----DFVTLLENQPHGYLSESK 111
           ++     V S    ++ L   F+  +    I+E         DF+T       G L E  
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-----RGALQEEL 150

Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIV 170
           AR + +++ +AV++ H  G +HRDIK +N+L+    G LKL DFGS   + K+       
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYT--D 207

Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFNYETLDMTYSS 229
             GT  Y  PE +           Y G S  +WS+G++ Y+++ G  PF ++        
Sbjct: 208 FDGTRVYSPPEWIR-------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EE 254

Query: 230 ILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-----DARLNMDQVLGH--------PV 276
           I+       V F    R+S+      Q L++         R   +++  H        P 
Sbjct: 255 IIRGQ----VFFRQ--RVSSE----CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304

Query: 277 FDCLDSDPPCIPPPSQ 292
                      P PS+
Sbjct: 305 ETAEIHLHSLSPGPSK 320

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  156 bits (396), Expect = 2e-42
 Identities = 61/265 (23%), Positives = 116/265 (43%), Gaps = 25/265 (9%)

Query: 20  KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC--PYIVNLFYSF 77
           +  + +G+FG+++ +++KQ+     +KKV   ++      +++  +    P IV L+ + 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKV---RLEVFRVEELVACAGLSSPRIVPLYGAV 119

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
           ++   V   ME + GG    L+  +  G L E +A +Y+ +  + ++YLH    +H D+K
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177

Query: 138 PDNMLLSATG-HLKLTDFGSATQVDKNGRIKSIVP----VGTPEYVAPEVLEWMEGNHGS 192
            DN+LLS+ G    L DFG A  +  +G  KS++      GT  ++APEV+         
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM-------G 230

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTEDTVSFPSSIRLSTAM 251
                  D+WS   +   +L G  P+  Y          L   +E           +   
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----PLCLKIASEPPPIREIPPSCAPLT 286

Query: 252 VNFVQSLVQK-LDARLNMDQVLGHP 275
              +Q  ++K    R +  ++    
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKV 311

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  155 bits (394), Expect = 5e-42
 Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 38/275 (13%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK----------MPNTIER--DIMV 63
            +     +  G FG ++   +K+ +   V+K + +EK              +     I+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIME-YVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
           + +   I+ +   F++      +ME + +G D    ++   H  L E  A +   +L  A
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSA 142

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           V YL     +HRDIK +N++++    +KL DFGSA  +++          GT EY APEV
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--TFCGTIEYCAPEV 200

Query: 183 LEWMEGNHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           L    GN     Y G   ++WS+GV  Y L+    PF            +       +  
Sbjct: 201 L---MGN----PYRGPELEMWSLGVTLYTLVFEENPFC------ELEETVEAA----IHP 243

Query: 242 PSSIRLSTAMVNFVQS-LVQKLDARLNMDQVLGHP 275
           P    +S  +++ V   L    + R  +++++  P
Sbjct: 244 PYL--VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  152 bits (385), Expect = 8e-41
 Identities = 70/297 (23%), Positives = 132/297 (44%), Gaps = 38/297 (12%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIER--DIMVKSKCPY 69
           + I+  + +G+FG + L    ++     +K      + +  M   +ER    +   + P+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           I+ L+        +  ++EY  G  F  ++E      ++E + R +  ++  A++Y H  
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             VHRD+KP+N+LL    ++K+ DFG +  +     +K+    G+P Y APEV+      
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAPEVIN----- 180

Query: 190 HGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                Y G   D+WS G+V Y +L G  PF+ E +   +  + +C        P    LS
Sbjct: 181 --GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV----YVMPDF--LS 232

Query: 249 TAMVNFVQSLVQKL-----DARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKD 300
                  QSL++++       R+ + ++   P F   + + P    P +E +    D
Sbjct: 233 PG----AQSLIRRMIVADPMQRITIQEIRRDPWF---NVNLPDYLRPMEEVQGSYAD 282

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  151 bits (384), Expect = 3e-40
 Identities = 70/331 (21%), Positives = 126/331 (38%), Gaps = 40/331 (12%)

Query: 14  ASDFDIKRFIQQG--NFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDI------MVKS 65
              +++   I +G  +   + L   K +     ++++  E   N +   +          
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
             P IV    +F   N ++ +  ++  G    L+       ++E    + +  + +A+ Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP------VGTPEYVA 179
           +H +GYVHR +K  ++L+S  G + L+   S   +  +G+ + +V       V    +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN--------YETLDMTYSSIL 231
           PEVL+         GY    D++S+G+ + EL  G  PF          E L+ T   +L
Sbjct: 204 PEVLQ-----QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258

Query: 232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLNMDQVLGHP-----------VFDCL 280
              T        S   S A      SL        N D                 V  CL
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318

Query: 281 DSDPPCIPPPSQ--ENKFHKKDKRKASPSLK 309
             +P   P  S    + F K+ KR+AS +L 
Sbjct: 319 QRNPDARPSASTLLNHSFFKQIKRRASEALP 349

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  148 bits (375), Expect = 6e-40
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 14/224 (6%)

Query: 2   DVVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV--LREKMPNTIER 59
           D   +L + +    +   +  + +G +G +Y   +  +     +K++     +    +  
Sbjct: 9   DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE 68

Query: 60  DIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYL--SESKARFY 115
           +I +        IV    SF +   +   ME V GG    LL ++  G L  +E    FY
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFY 127

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLL-SATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
             ++ + ++YLH    VHRDIK DN+L+ + +G LK++DFG++ ++            GT
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGT 186

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            +Y+APE++     + G  GY  + D+WS+G    E+ TG  PF
Sbjct: 187 LQYMAPEII-----DKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  147 bits (373), Expect = 2e-39
 Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 18/273 (6%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKS- 65
              +D +    +  G  G ++ +  +++ +   +K++ R       +R     D+++KS 
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH 81

Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
            CPYIV  F +F     V+  ME +        L+ +  G + E         + +A+ Y
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELMGTC--AEKLKKRMQGPIPERILGKMTVAIVKALYY 139

Query: 126 LHG-LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           L    G +HRD+KP N+LL   G +KL DFG S   VD   + +S    G   Y+APE +
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPERI 196

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           +  +       Y    D+WS+G+   EL TG  P  Y+     +  +     E+    P 
Sbjct: 197 DPPDPTKP--DYDIRADVWSLGISLVELATGQFP--YKNCKTDFEVLTKVLQEEPPLLPG 252

Query: 244 SIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHP 275
            +  S    +FV+  + K    R   +++L H 
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  151 bits (383), Expect = 2e-39
 Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 37/293 (12%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-----KVLREKMPNTIER--DIMVKSKCPY 69
           + +   +  G FG + + + + + +   +K     K+    +   I R    +   + P+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           I+ L+      + ++ +MEYV+GG+ F  + +   +G L E ++R    ++   V Y H 
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR 134

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              VHRD+KP+N+LL A  + K+ DFG +  +     +++    G+P Y APEV+     
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--SCGSPNYAAPEVIS---- 188

Query: 189 NHGSDGYTGS-CDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                 Y G   D+WS GV+ Y LL G+ PF+ + +   +  I           P    L
Sbjct: 189 ---GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----FYTPQY--L 239

Query: 248 STAMVNFVQSLVQKL-----DARLNMDQVLGHPVFDCLDSDPPCIPPPSQENK 295
           + +    V SL++ +       R  +  +  H  F   D      P     + 
Sbjct: 240 NPS----VISLLKHMLQVDPMKRATIKDIREHEWF-KQDLPKYLFPEDPSYSS 287

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  146 bits (370), Expect = 4e-39
 Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 22/283 (7%)

Query: 1   KDVVKELRQKNVSASD----FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT 56
           +  +K+L + +         FD+   + +G++G +Y    K++     +K+V  E     
Sbjct: 12  RRQLKKLDE-DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE 70

Query: 57  IER--DIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
           I +   IM +   P++V  + S+     ++ +MEY   G    ++  +    L+E +   
Sbjct: 71  IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIAT 129

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGT 174
            +    + ++YLH +  +HRDIK  N+LL+  GH KL DFG A Q+  +   K    +GT
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT-DTMAKRNTVIGT 188

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-YSSILAC 233
           P ++APEV++         GY    D+WS+G+ + E+  G  P+     D+    +I   
Sbjct: 189 PFWMAPEVIQ-------EIGYNCVADIWSLGITAIEMAEGKPPY----ADIHPMRAIFMI 237

Query: 234 DTEDTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHP 275
            T    +F      S    +FV Q LV+  + R    Q+L HP
Sbjct: 238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  145 bits (368), Expect = 7e-39
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 16/210 (7%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCP 68
              F     I +G+FG+++   + ++     +K +  E+  + I     E  ++ +   P
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           Y+   + S+     ++ IMEY+ GG  + LLE  P   L E++    + E+ + + YLH 
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS 137

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRDIK  N+LLS  G +KL DFG A Q+      ++   VGTP ++APEV++    
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIK---- 192

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                 Y    D+WS+G+ + EL  G  P 
Sbjct: 193 ---QSAYDSKADIWSLGITAIELARGEPPH 219

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  144 bits (366), Expect = 1e-38
 Identities = 59/265 (22%), Positives = 117/265 (44%), Gaps = 14/265 (5%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ERDIMVKSKCPYIVN 72
           ++I   +  G FG +Y  + K++      K +  +          E +I+     PYIV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           L  ++     ++ ++E+  GG    ++     G L+E + +    ++ +A+ +LH    +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRII 139

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
           HRD+K  N+L++  G ++L DFG + +       K    +GTP ++APEV+         
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKN-LKTLQKRDSFIGTPYWMAPEVVMCETMKDT- 197

Query: 193 DGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-YSSILACDTEDTVSFPSSIRLSTAM 251
             Y    D+WS+G+   E+     P      ++     +L     D  +  +  + S   
Sbjct: 198 -PYDYKADIWSLGITLIEMAQIEPPH----HELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252

Query: 252 VNFV-QSLVQKLDARLNMDQVLGHP 275
            +F+  +L +  + R +  Q+L HP
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHP 277

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  143 bits (362), Expect = 3e-38
 Identities = 56/274 (20%), Positives = 115/274 (41%), Gaps = 32/274 (11%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTIER-----DIMVKSKCPYIVN 72
               I +G+F  +Y   + ++       ++  R+   +  +R     +++   + P IV 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 73  LFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            + S++        +  + E +T G   T L+      +     R +  ++ + +Q+LH 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 129 LGY--VHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
                +HRD+K DN+ ++  TG +K+ D G AT    +   K+++  GTPE++APE+ E 
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-KAVI--GTPEFMAPEMYE- 203

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTEDTVSFPSS 244
                  + Y  S D+++ G+   E+ T   P+   +     Y  +    T         
Sbjct: 204 -------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----TSGVKPASFD 252

Query: 245 IRLSTAMVNFVQS-LVQKLDARLNMDQVLGHPVF 277
                 +   ++  + Q  D R ++  +L H  F
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  142 bits (361), Expect = 5e-38
 Identities = 61/275 (22%), Positives = 112/275 (40%), Gaps = 19/275 (6%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDI---MVK 64
            V A D +    + +G +G +  +    S     +K++   +  +    +  D+   M  
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGG-DFVTLLENQPHGYLSESKARFYIYELAQAV 123
             CP+ V  + +      V+  ME +    D            + E         + +A+
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 124 QYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAPE 181
           ++LH  L  +HRD+KP N+L++A G +K+ DFG S   VD   +       G   Y+APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID---AGCKPYMAPE 179

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
            +          GY+   D+WS+G+   EL     P  Y++    +  +     E +   
Sbjct: 180 RI---NPELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVVEEPSPQL 234

Query: 242 PSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
           P+  + S   V+F    ++K    R    +++ HP
Sbjct: 235 PAD-KFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  142 bits (361), Expect = 1e-37
 Identities = 72/278 (25%), Positives = 118/278 (42%), Gaps = 21/278 (7%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV---LREKMPNTIERDI---MVK 64
           + +A D      I +G +G +  +  K S     +K++   + EK    +  D+   M  
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGG--DFVTLLENQPHGYLSESKARFYIYELAQA 122
           S CPYIV  + +       +  ME ++     F   + +     + E           +A
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 123 VQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFG-SATQVDKNGRIKSIVPVGTPEYVAP 180
           + +L   L  +HRDIKP N+LL  +G++KL DFG S   VD   + +     G   Y+AP
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAP 194

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED--T 238
           E +   + +    GY    D+WS+G+  YEL TG  P  Y   +  +  +      D   
Sbjct: 195 ERI---DPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWNSVFDQLTQVVKGDPPQ 249

Query: 239 VSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHP 275
           +S       S + +NFV   + K    R    ++L HP
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  141 bits (358), Expect = 2e-37
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 15/216 (6%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-LREKMPNTIERDIMV---KSKCPY 69
           A  F++   +  G +G +Y     ++     +K + +       I+++I +    S    
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 70  IVNLFYSF------QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           I   + +F         + ++ +ME+   G    L++N     L E    +   E+ + +
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYVAPEV 182
            +LH    +HRDIK  N+LL+    +KL DFG + Q+D+  GR  +   +GTP ++APEV
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEV 200

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           +   E       Y    DLWS+G+ + E+  G+ P 
Sbjct: 201 IACDENPDA--TYDFKSDLWSLGITAIEMAEGAPPL 234

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  140 bits (355), Expect = 3e-37
 Identities = 65/286 (22%), Positives = 122/286 (42%), Gaps = 26/286 (9%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSK 66
           ++  D++++  I  G    +             +K++  EK   ++     E   M +  
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLE------NQPHGYLSESKARFYIYELA 120
            P IV+ + SF   + ++ +M+ ++GG  + +++          G L ES     + E+ 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP----VGTPE 176
           + ++YLH  G +HRD+K  N+LL   G +++ DFG +  +   G I         VGTP 
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET----LDMTYSSILA 232
           ++APEV+E         GY    D+WS G+ + EL TG+ P++       L +T  +   
Sbjct: 192 WMAPEVME------QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245

Query: 233 CDTEDTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHPVF 277
                        +   +    +   L +  + R    ++L H  F
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  141 bits (358), Expect = 5e-37
 Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 25/284 (8%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSK 66
           +   DF+    +  GN G ++ V  K S      K +  E  P    +      ++ +  
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89

Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
            PYIV  + +F     +   ME++ GG    +L  +  G + E         + + + YL
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYL 147

Query: 127 HG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
                 +HRD+KP N+L+++ G +KL DFG + Q+  +    S   VGT  Y++PE L+ 
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSF--VGTRSYMSPERLQ- 203

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                    Y+   D+WS+G+   E+  G  P                   D    P   
Sbjct: 204 ------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257

Query: 246 RLSTAMVNFVQSLVQKLDARLNMDQVLGHPVFDCLDSDPPCIPP 289
           R     +N      +   A   +           ++  PP +P 
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLD-------YIVNEPPPKLPS 294

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  139 bits (352), Expect = 1e-36
 Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 26/285 (9%)

Query: 1   KDVVKELRQKNVSASD----FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-- 54
           ++++++LR   VS  D    +     I QG  G +Y   +  +     ++++  ++ P  
Sbjct: 3   EEILEKLRS-IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 55  NTIERDIMVKSKC--PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKA 112
             I  +I+V  +   P IVN   S+   + ++ +MEY+ GG    ++       + E + 
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQI 118

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPV 172
                E  QA+++LH    +HRDIK DN+LL   G +KLTDFG   Q+    + K    V
Sbjct: 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMV 177

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSIL 231
           GTP ++APEV+           Y    D+WS+G+++ E++ G  P  N   L   Y  ++
Sbjct: 178 GTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LI 228

Query: 232 ACDTEDTVSFPSSIRLSTAMVNFV-QSLVQKLDARLNMDQVLGHP 275
           A  T  T    +  +LS    +F+ + L   ++ R +  ++L H 
Sbjct: 229 A--TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  139 bits (353), Expect = 2e-36
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 18/209 (8%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVKSKCPY 69
           F   R I  G+FG +Y   + ++     +KK+      +  +          + K + P 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
            +     +   +  + +MEY  G    + L       L E +     +   Q + YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             +HRD+K  N+LLS  G +KL DFGSA+ +           VGTP ++APEV+  M+  
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVILAMDEG 228

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                Y G  D+WS+G+   EL     P 
Sbjct: 229 ----QYDGKVDVWSLGITCIELAERKPPL 253

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  137 bits (346), Expect = 9e-36
 Identities = 70/266 (26%), Positives = 123/266 (46%), Gaps = 23/266 (8%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ERDIMVKSKCPYIVN 72
            D    I +G+ G + L  EK S     +K +   K         E  IM   +   +V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           ++ S+     ++ +ME++ GG    ++       L+E +       + QA+ YLH  G +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQGVI 163

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           HRDIK D++LL+  G +KL+DFG   Q+ K   + KS+  VGTP ++APEV+        
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVIS------- 214

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-YSSILACDTEDTVSFPSSIRLSTA 250
              Y    D+WS+G++  E++ G  P+       +   ++            +S ++S  
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPPY----FSDSPVQAMKRLRDSPPPKLKNSHKVSPV 270

Query: 251 MVNFV-QSLVQKLDARLNMDQVLGHP 275
           + +F+ + LV+    R    ++L HP
Sbjct: 271 LRDFLERMLVRDPQERATAQELLDHP 296

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  131 bits (332), Expect = 8e-34
 Identities = 43/289 (14%), Positives = 100/289 (34%), Gaps = 30/289 (10%)

Query: 3   VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIM 62
            + +L    +            +    ++  +  K     + +          +++   M
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSP-SPMDAPSVKIRRM 115

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQ 121
                   V          ++Y  M+     +    +  +                ++A+
Sbjct: 116 DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE 175

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---------- 171
           AV++LH  G +HRD+KP N+  +    +K+ DFG  T +D++   ++++           
Sbjct: 176 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 172 -VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
            VGT  Y++PE +         + Y+   D++S+G++ +ELL   +           + +
Sbjct: 236 QVGTKLYMSPEQIH-------GNNYSHKVDIFSLGLILFELLYSFSTQM--ERVRIITDV 286

Query: 231 LACDTEDTVSFPSSI-RLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVF 277
                     FP    +        VQ ++      R     ++ + +F
Sbjct: 287 RNLK------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (325), Expect = 5e-33
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 9/156 (5%)

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P++V +    +    +Y  M  + G D   +L     G L+  +A   + ++  A+   H
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAH 151

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
             G  HRD+KP+N+L+SA     L DFG A+        +    VGT  Y+APE      
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL 223
             + +D Y       ++  V YE LTGS P+  + L
Sbjct: 212 ATYRADIY-------ALTCVLYECLTGSPPYQGDQL 240

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (316), Expect = 5e-32
 Identities = 49/155 (31%), Positives = 81/155 (52%), Gaps = 9/155 (5%)

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
             IV++    ++ +  Y +MEY+ G      +E+  HG LS   A  +  ++   +++ H
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAH 128

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            +  VHRDIKP N+L+ +   LK+ DFG A  + +    ++   +GT +Y +PE  +   
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET 222
            +  +D Y       SIG+V YE+L G  PFN ET
Sbjct: 189 TDECTDIY-------SIGIVLYEMLVGEPPFNGET 216

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  125 bits (316), Expect = 6e-32
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 24/213 (11%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFV-MKKVLREKMPNTIER--DIMVKSKCPYIV 71
            + +++  + +G FG +   + +      V +K++  E            + +   P IV
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESESERKAFIVELRQLSRVNHPNIV 64

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQAVQYLHGL- 129
              Y    +N V  +MEY  GG    +L    P  Y + + A  +  + +Q V YLH + 
Sbjct: 65  -KLYGAC-LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 130 --GYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWM 186
               +HRD+KP N+LL A G  LK+ DFG+A  +  +         G+  ++APEV E  
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFE-- 176

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN 219
                   Y+  CD++S G++ +E++T   PF+
Sbjct: 177 -----GSNYSEKCDVFSWGIILWEVITRRKPFD 204

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  125 bits (317), Expect = 7e-32
 Identities = 76/338 (22%), Positives = 134/338 (39%), Gaps = 58/338 (17%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDI--MVKSKCPYI 70
            +     + +G +  +Y  + K + N   +K++  E     P T  R++  +   K   I
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V L         +  + EY+   D    L++  +  ++    + ++++L + + Y H   
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLLRGLAYCHRQK 120

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG--TPE-----YVAPEVL 183
            +HRD+KP N+L++  G LKL DFG A       R KSI P      E     Y  P++L
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLA-------RAKSI-PTKTYDNEVVTLWYRPPDIL 172

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILACDTEDT- 238
                  GS  Y+   D+W +G + YE+ TG   F      E L   +  IL   TE+T 
Sbjct: 173 ------LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF-RILGTPTEETW 225

Query: 239 -----------VSFPSSI---------RLSTAMVNFVQSLVQKLD--ARLNMDQVLGHPV 276
                       ++P            RL +   + +  L+Q  +   R++ +  + HP 
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQ-FEGRNRISAEDAMKHPF 284

Query: 277 FDCLDSDPPCIP-PPSQENKFHKKDKRKASPSLKAFQK 313
           F  L      +P   S       + +++AS        
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKEASLRSAHHHH 322

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (331), Expect = 7e-32
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 29/217 (13%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTI-----ERDIMVKSKCPYIVN 72
           +K  I  G  G IYL  ++  +   V+ K L              ER  + +   P IV 
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 73  LF----YSFQDMNHVYFI-MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           +F    ++ +  + V +I MEYV G      L+      L  ++A  Y+ E+  A+ YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQS----LKRSKGQKLPVAEAIAYLLEILPALSYLH 199

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            +G V+ D+KP+N++L+    LKL D G+ ++++  G +      GTP + APE++    
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL-----YGTPGFQAPEIVR--- 250

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD 224
                 G T + D++++G     L       N   +D
Sbjct: 251 -----TGPTVATDIYTVGRTLAALTLDLPTRNGRYVD 282

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  122 bits (308), Expect = 4e-31
 Identities = 39/235 (16%), Positives = 88/235 (37%), Gaps = 30/235 (12%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-IERD------ 60
           +   +     +    + + + G+++   + +     ++ KVL+ +  +T   RD      
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELW---KGRWQGNDIVVKVLKVRDWSTRKSRDFNEECP 59

Query: 61  IMVKSKCPYIVNLFY---SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
            +     P ++             H   I  ++  G    +L    +  + +S+A  +  
Sbjct: 60  RLRIFSHPNVL-PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 118 ELAQAVQYLHGLGY--VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           ++A+ + +LH L        +   ++++      +++           GR+        P
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAP 172

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
            +VAPE L+        D    S D+WS  V+ +EL+T   PF     D++   I
Sbjct: 173 AWVAPEALQ----KKPEDTNRRSADMWSFAVLLWELVTREVPFA----DLSNMEI 219

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  121 bits (306), Expect = 1e-30
 Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 25/230 (10%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMV 63
           ++   D +IK  I  G+FG ++     + H + V  K+L E+  +         E  IM 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVH---RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 89

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQA 122
           + + P IV    +     ++  + EY++ G  +  L ++     L E +     Y++A+ 
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 123 VQYLHGLGY--VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           + YLH      VHR++K  N+L+     +K+ DFG +        + S    GTPE++AP
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAP 208

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
           EVL         +      D++S GV+ +EL T   P+     ++  + +
Sbjct: 209 EVLR-------DEPSNEKSDVYSFGVILWELATLQQPWG----NLNPAQV 247

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  120 bits (302), Expect = 3e-30
 Identities = 51/240 (21%), Positives = 93/240 (38%), Gaps = 33/240 (13%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI---------- 57
           R   ++ ++ + ++ I +G FG ++         + V  K L                  
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEF 70

Query: 58  --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
             E  IM     P IV   Y     N    +ME+V  GD    L ++ H  +  S     
Sbjct: 71  QREVFIMSNLNHPNIV-KLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRL 127

Query: 116 IYELAQAVQYLHGLGY--VHRDIKPDNMLLSATG-----HLKLTDFGSATQVDKNGRIKS 168
           + ++A  ++Y+       VHRD++  N+ L +         K+ DFG +        +  
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSG 185

Query: 169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTY 227
           ++  G  +++APE +         + YT   D +S  ++ Y +LTG  PF  Y    + +
Sbjct: 186 LL--GNFQWMAPETI-----GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  120 bits (302), Expect = 5e-30
 Identities = 45/232 (19%), Positives = 91/232 (39%), Gaps = 25/232 (10%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVKSKC 67
              +I   I +G FG +Y        +  V  +++  +  N  +            +++ 
Sbjct: 33  EQLEIGELIGKGRFGQVY----HGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88

Query: 68  PYIVNLFY-SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
             +V LF  +     H+  I     G    +++ +     L  +K R    E+ + + YL
Sbjct: 89  ENVV-LFMGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYL 146

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI----KSIVPVGTPEYVAPEV 182
           H  G +H+D+K  N+     G + +TDFG  +            K  +  G   ++APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 183 LEWMEGNHGSDG--YTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA 232
           +  +  +   D   ++   D++++G + YEL     PF          +I+ 
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK----TQPAEAIIW 253

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  119 bits (301), Expect = 7e-30
 Identities = 72/324 (22%), Positives = 128/324 (39%), Gaps = 57/324 (17%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK----MPNTIERDI-MVKS-KCPY 69
            ++    I +G++G ++    + +     +KK L  +    +     R+I M+K  K P 
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           +VNL   F+    ++ + EY      +  L+    G + E   +   ++  QAV + H  
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCHKH 121

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI-VPVGTPE-----YVAPEVL 183
             +HRD+KP+N+L++    +KL DFG A       R+ +        E     Y +PE+L
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFA-------RLLTGPSDYYDDEVATRWYRSPELL 174

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTY--SSILACDTEDT-- 238
                  G   Y    D+W+IG V  ELL+G   +  ++ +D  Y     L         
Sbjct: 175 ------VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228

Query: 239 ----------VSFPSSI----------RLSTAMVNFVQSLVQKLD--ARLNMDQVLGHPV 276
                     V  P              +S   +  ++  +  +D   RL  +Q+L HP 
Sbjct: 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLH-MDPTERLTCEQLLHHPY 287

Query: 277 FDCLD--SDPPCIPPPSQENKFHK 298
           F+ +    D         EN + +
Sbjct: 288 FENIREIEDLAKEHDKPAENLYFQ 311

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  118 bits (299), Expect = 1e-29
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 17/162 (10%)

Query: 68  PYIVNLF----YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           P IV ++             Y +MEYV G     ++     G ++  +A   I +  QA+
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQAL 129

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR---IKSIVPVGTPEYVAP 180
            + H  G +HRD+KP N+++SAT  +K+ DFG A  +  +G      + V +GT +Y++P
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV-IGTAQYLSP 188

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET 222
           E       +  SD Y       S+G V YE+LTG  PF  ++
Sbjct: 189 EQARGDSVDARSDVY-------SLGCVLYEVLTGEPPFTGDS 223

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  118 bits (299), Expect = 1e-29
 Identities = 79/332 (23%), Positives = 133/332 (40%), Gaps = 64/332 (19%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDI--MVKSKC 67
           S+S F     +  G +  +Y    K +     +K+V  +     P+T  R+I  M + K 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH----GYLSESKARFYIYELAQAV 123
             IV L+      N +  + E++   D    ++++        L  +  +++ ++L Q +
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG--TPE----- 176
            + H    +HRD+KP N+L++  G LKL DFG A       R   I PV   + E     
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA-------RAFGI-PVNTFSSEVVTLW 173

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILA 232
           Y AP+VL       GS  Y+ S D+WS G +  E++TG   F    + E L + +  I+ 
Sbjct: 174 YRAPDVL------MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF-DIMG 226

Query: 233 CDTEDT-----------VSFP--------------SSIRLSTAMVNFVQSLVQKLD--AR 265
              E              +                +   L   +++F+  L+Q L+   R
Sbjct: 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ-LNPDMR 285

Query: 266 LNMDQVLGHPVFDCLDSDPPCIPPPSQENKFH 297
           L+  Q L HP F             S  +  H
Sbjct: 286 LSAKQALHHPWFAEYYHHASMGGSRSHHHHHH 317

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  118 bits (299), Expect = 2e-29
 Identities = 78/353 (22%), Positives = 144/353 (40%), Gaps = 66/353 (18%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------LREKMPNTIERDI--MV 63
            A  ++   F+ +G F  +Y   +K ++    +KK+        ++ +  T  R+I  + 
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           +   P I+ L  +F   +++  + +++   D   ++++     L+ S  + Y+    Q +
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGL 125

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG--TPE----- 176
           +YLH    +HRD+KP+N+LL   G LKL DFG A       +     P    T +     
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------KSFGS-PNRAYTHQVVTRW 177

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-----NYETLDMTYSSIL 231
           Y APE+L       G+  Y    D+W++G +  ELL    PF     + + L   +   L
Sbjct: 178 YRAPELL------FGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIF-ETL 229

Query: 232 ACDTEDT----------VSFPSS---------IRLSTAMVNFVQSLVQKLD--ARLNMDQ 270
              TE+           V+F S                +++ +Q L    +  AR+   Q
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL-FNPCARITATQ 288

Query: 271 VLGHPVFDCLDSDPPCIPPPS--QENKFHKKDKRKASPSLKAFQKEGRYLDSA 321
            L    F    + P   P     + N   +  K +++P+L   +K    L+  
Sbjct: 289 ALKMKYF---SNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQG 338

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  116 bits (294), Expect = 4e-29
 Identities = 67/315 (21%), Positives = 127/315 (40%), Gaps = 65/315 (20%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV----LREKMPNTIERDI--MVKSKCPY 69
            ++    I +G +G ++  + +++H    +K+V      E +P++  R+I  + + K   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV L         +  + E+    D     ++     L     + ++++L + + + H  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR 120

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG--TPE-----YVAPEV 182
             +HRD+KP N+L++  G LKL +FG A       R   I PV   + E     Y  P+V
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLA-------RAFGI-PVRCYSAEVVTLWYRPPDV 172

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-----NYETLDMTYSSILACDTED 237
           L       G+  Y+ S D+WS G +  EL     P        + L   +  +L   TE+
Sbjct: 173 L------FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF-RLLGTPTEE 225

Query: 238 T----------VSFPSSI----------RLSTAMVNFVQSLVQKLD--ARLNMDQVLGHP 275
                        +P             +L+    + +Q+L++  +   R++ ++ L HP
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK-CNPVQRISAEEALQHP 284

Query: 276 VFDCLDSDPPCIPPP 290
            F           PP
Sbjct: 285 YFSDF-------CPP 292

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (295), Expect = 4e-29
 Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 25/231 (10%)

Query: 7   LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNTIER--DIM 62
           +  +    SD      + +G FG    V  +++    VMK+++R  E+   T  +   +M
Sbjct: 2   MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVM 61

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
              + P ++           + FI EY+ GG    ++++        S+   +  ++A  
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASG 120

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG-------------SATQVDKNGRIKSI 169
           + YLH +  +HRD+   N L+    ++ + DFG                 + K  R K  
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY 220
             VG P ++APE++     N  S  Y    D++S G+V  E++        
Sbjct: 181 TVVGNPYWMAPEMI-----NGRS--YDEKVDVFSFGIVLCEIIGRVNADPD 224

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  116 bits (293), Expect = 6e-29
 Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 16/211 (7%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCP 68
               + + I  G+FG +Y   + + H    +K +          +       ++ K++  
Sbjct: 24  GQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            I+ LF  +     +  + ++  G      L           K      + A+ + YLH 
Sbjct: 81  NIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHA 138

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYVAPEVLEWME 187
              +HRD+K +N+ L     +K+ DFG AT+  + +G  +     G+  ++APEV+   +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            N     Y+   D+++ G+V YEL+TG  P+
Sbjct: 199 SNP----YSFQSDVYAFGIVLYELMTGQLPY 225

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  119 bits (299), Expect = 8e-29
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 34/215 (15%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYS 76
           +   + I  G+FG +Y  +   S     +KKVL++K     E  IM K     IV L Y 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 77  F------QDMNHVYFIMEYVTGGDFVTLLENQPHG--YLSESKARFYIYELAQAVQYLHG 128
           F      +D  ++  +++YV       +  +       L     + Y+Y+L +++ Y+H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174

Query: 129 LGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTP--EYV------A 179
            G  HRDIKP N+LL   T  LKL DFGSA         K +V  G P   Y+      A
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSA---------KQLVR-GEPNVSYICSRYYRA 224

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
           PE++       G+  YT S D+WS G V  ELL G
Sbjct: 225 PELI------FGATDYTSSIDVWSAGCVLAELLLG 253

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  115 bits (291), Expect = 2e-28
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 27/214 (12%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK----MPNTIERDI-MVKS-K 66
           S   ++    + +G++G +     K +     +KK L       +     R+I ++K  +
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82

Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
              +VNL    +     Y + E+V     +  LE  P+G L     + Y++++   + + 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFC 140

Query: 127 HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI-VPVGTPE-----YVAP 180
           H    +HRDIKP+N+L+S +G +KL DFG A       R  +    V   E     Y AP
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFA-------RTLAAPGEVYDDEVATRWYRAP 193

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
           E+L       G   Y  + D+W+IG +  E+  G
Sbjct: 194 ELL------VGDVKYGKAVDVWAIGCLVTEMFMG 221

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  115 bits (291), Expect = 2e-28
 Identities = 69/339 (20%), Positives = 128/339 (37%), Gaps = 65/339 (19%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFV-MKKVL----REKMPNTIERDI-----M 62
           +   ++    I +G +G ++   + ++   FV +K+V      E MP +  R++     +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68

Query: 63  VKSKCPYIVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
              + P +V LF             +  + E+V   D  T L+  P   +     +  ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE- 176
           +L + + +LH    VHRD+KP N+L++++G +KL DFG A       RI S     T   
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-------RIYSFQMALTSVV 180

Query: 177 ----YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYS 228
               Y APEVL        S  Y    DLWS+G +  E+      F    + + L     
Sbjct: 181 VTLWYRAPEVL------LQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL- 232

Query: 229 SILACDTEDT---------VSFPSSI---------RLSTAMVNFVQSLVQKLD--ARLNM 268
            ++    E+           +F S            +     + +   +   +   R++ 
Sbjct: 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT-FNPAKRISA 291

Query: 269 DQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKRKASPS 307
              L HP F   D +       S       ++  + + +
Sbjct: 292 YSALSHPYFQ--DLERCKENLDSH--LPPSQNTSELNTA 326

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  113 bits (286), Expect = 3e-28
 Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 48/242 (19%)

Query: 15  SDFDIKRFIQQGNFGDIY-------------LVEEKQSHNTFVMKKVLREKMPNTIERDI 61
           ++  ++  I  G FG +Y                +     +  ++ V +E         +
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAK-------L 59

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
               K P I+ L        ++  +ME+  GG    +L  +    +       +  ++A+
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIAR 116

Query: 122 AVQYLHGLGY---VHRDIKPDNMLLSATGH--------LKLTDFGSATQVDKNGRIKSIV 170
            + YLH       +HRD+K  N+L+             LK+TDFG A +  +  ++ +  
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-- 174

Query: 171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI 230
             G   ++APEV+        +  ++   D+WS GV+ +ELLTG  PF      +   ++
Sbjct: 175 -AGAYAWMAPEVIR-------ASMFSKGSDVWSYGVLLWELLTGEVPFR----GIDGLAV 222

Query: 231 LA 232
             
Sbjct: 223 AY 224

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  115 bits (291), Expect = 5e-28
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 35/209 (16%)

Query: 23  IQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSF----- 77
           I  G+FG ++  +  +S +   +KKVL++K     E  IM   K P +V+L   F     
Sbjct: 48  IGNGSFGVVFQAKLVES-DEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGD 106

Query: 78  -QDMNHVYFIMEYVTGGDFVTLLENQPH--GYLSESKARFYIYELAQAVQYLHGLGYVHR 134
            +D   +  ++EYV          +       +     + Y+Y+L +++ Y+H +G  HR
Sbjct: 107 KKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165

Query: 135 DIKPDNMLL-SATGHLKLTDFGSATQVDKNGRIKSIVPVGTP--EYV------APEVLEW 185
           DIKP N+LL   +G LKL DFGSA         K ++  G P   Y+      APE++  
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSA---------KILIA-GEPNVSYICSRYYRAPELI-- 213

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                G+  YT + D+WS G V  EL+ G
Sbjct: 214 ----FGATNYTTNIDIWSTGCVMAELMQG 238

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  113 bits (286), Expect = 6e-28
 Identities = 80/309 (25%), Positives = 133/309 (43%), Gaps = 59/309 (19%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFV-MKKVL----REKMPNTIERDI--MVKS 65
               +     + +G +G +Y  ++ Q     V +K++      E +P+T  R+I  + + 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ--GRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76

Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
             P IV+L         +  + E++   D   +L+    G L +S+ + Y+Y+L + V +
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAH 134

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG--TPE-----YV 178
            H    +HRD+KP N+L+++ G LKL DFG A       R   I PV   T E     Y 
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLA-------RAFGI-PVRSYTHEVVTLWYR 186

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILACD 234
           AP+VL       GS  Y+ S D+WSIG +  E++TG   F    + + L   + SIL   
Sbjct: 187 APDVL------MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF-SILGTP 239

Query: 235 TEDT------------VSFP--SSIRLSTAMVNFVQS---LVQKL-----DARLNMDQVL 272
                            +F        S+ +  F Q    L+  +     + R++    +
Sbjct: 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299

Query: 273 GHPVFDCLD 281
            HP F  LD
Sbjct: 300 NHPYFKDLD 308

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  115 bits (289), Expect = 6e-28
 Identities = 74/342 (21%), Positives = 124/342 (36%), Gaps = 62/342 (18%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMV--KSK 66
             S ++    I QG FG+++    +++     +KKVL    +E  P T  R+I +    K
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 74

Query: 67  CPYIVNLF--------YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
              +VNL            +    +Y + ++    D   LL N      + S+ +  +  
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQM 132

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE-- 176
           L   + Y+H    +HRD+K  N+L++  G LKL DFG A          S     T    
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA--KNSQPNRYTNRVV 190

Query: 177 ---YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET----LDMTYSS 229
              Y  PE+L       G   Y    DLW  G +  E+ T S      T    L +    
Sbjct: 191 TLWYRPPELL------LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS-Q 243

Query: 230 ILACDTEDT------------VSFPSSIR--LSTAMVNFVQS-----LVQKL-----DAR 265
           +    T +             +      +  +   +  +V+      L+ KL       R
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303

Query: 266 LNMDQVLGHPVF--DCLDSDPPCIP--PPSQENKFHKKDKRK 303
           ++ D  L H  F  D + SD   +     +   ++    +RK
Sbjct: 304 IDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRK 345

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  114 bits (287), Expect = 7e-28
 Identities = 74/316 (23%), Positives = 125/316 (39%), Gaps = 62/316 (19%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV----LREKMPNTIERDIMV--KSK 66
           S   +     + +G +G++Y   +  ++ T  +K++      E +P T  R++ +  + +
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91

Query: 67  CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
              I+ L       + ++ I EY    D    ++  P   +S    + ++Y+L   V + 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFC 148

Query: 127 HGLGYVHRDIKPDNMLLSA-----TGHLKLTDFGSATQVDKNGRIKSIVPVG--TPE--- 176
           H    +HRD+KP N+LLS      T  LK+ DFG A       R   I P+   T E   
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-------RAFGI-PIRQFTHEIIT 200

Query: 177 --YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSI 230
             Y  PE+L       GS  Y+ S D+WSI  +  E+L  +  F      + L   +  +
Sbjct: 201 LWYRPPEIL------LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF-EV 253

Query: 231 LACDTEDT-----------VSFP--SSIRLSTAMVNFVQS----LVQKL-----DARLNM 268
           L    + T            SFP      L   +   +      L+  +       R++ 
Sbjct: 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313

Query: 269 DQVLGHPVFDCLDSDP 284
              L HP F   D DP
Sbjct: 314 KNALEHPYFSHNDFDP 329

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  111 bits (281), Expect = 2e-27
 Identities = 74/305 (24%), Positives = 124/305 (40%), Gaps = 58/305 (19%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL----REKMPNTIERDIMV--KSKCPY 69
            +     I +G +G +Y  +      TF +KK+      E +P+T  R+I +  + K   
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV L+        +  + E++   D   LL+    G L    A+ ++ +L   + Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR 119

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG--TPE-----YVAPEV 182
             +HRD+KP N+L++  G LK+ DFG A       R   I PV   T E     Y AP+V
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLA-------RAFGI-PVRKYTHEIVTLWYRAPDV 171

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDMTYSSILACDTEDT 238
           L       GS  Y+ + D+WS+G +  E++ G+  F      + L   +  IL       
Sbjct: 172 L------MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPNSKN 224

Query: 239 -----------VSFPS----SIR-----LSTAMVNFVQSLVQKLD--ARLNMDQVLGHPV 276
                       +F              L  + ++ +  +++ LD   R+   Q L H  
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLK-LDPNQRITAKQALEHAY 283

Query: 277 FDCLD 281
           F   +
Sbjct: 284 FKENN 288

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  109 bits (276), Expect = 1e-26
 Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 37/224 (16%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL-------REKMPNTIERDI---- 61
           + S ++    I  G +G +Y   +  S +   +K V           +P +  R++    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 62  -MVKSKCPYIVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
            +   + P +V L              V  + E+V   D  T L+  P   L     +  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           + +  + + +LH    VHRD+KP+N+L+++ G +KL DFG A       RI S     TP
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-------RIYSYQMALTP 178

Query: 176 E-----YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                 Y APEVL        S  Y    D+WS+G +  E+   
Sbjct: 179 VVVTLWYRAPEVL------LQST-YATPVDMWSVGCIFAEMFRR 215

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  105 bits (263), Expect = 4e-25
 Identities = 25/179 (13%), Positives = 42/179 (23%), Gaps = 40/179 (22%)

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P +  +            + E++ GG    + +  P    S   A   +  LA A    H
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP----SPVGAIRAMQSLAAAADAAH 146

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
             G       P  + +S  G + L                          +         
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA------ 179

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
                       D+  IG   Y LL    P     +    +          +  P+ I 
Sbjct: 180 --------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-PADID 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  106 bits (267), Expect = 5e-25
 Identities = 91/376 (24%), Positives = 141/376 (37%), Gaps = 93/376 (24%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIV 71
            S+  + + + +  G+FG +  V + +S   F +KKVL++      E DIM       I+
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNII 63

Query: 72  NLFYSF--------------------------------------QDMNHVYFIMEYVTGG 93
            L   F                                          ++  IMEYV   
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PD 122

Query: 94  DFVTLLENQPHG--YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL-SATGHLK 150
               +L++       +  +    YIY+L +AV ++H LG  HRDIKP N+L+ S    LK
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLK 182

Query: 151 LTDFGSATQVDKNGRIKSIVPVGTP--EYV------APEVLEWMEGNHGSDGYTGSCDLW 202
           L DFGSA         K ++P   P   Y+      APE++       G+  YT S DLW
Sbjct: 183 LCDFGSA---------KKLIP-SEPSVAYICSRFYRAPELM------LGATEYTPSIDLW 226

Query: 203 SIGVVSYELLTGSTPF---NY-----ETLDM----TYSSILACDTEDT-VSFPS------ 243
           SIG V  EL+ G   F            + +    T   ++  +   T V FP+      
Sbjct: 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW 286

Query: 244 SIRLSTAMVNFVQSLVQKL-----DARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHK 298
              L     +    L++++     D R+N  + + HP FD L  +        + N    
Sbjct: 287 RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR-NSY--ESEVKNNSNFP 343

Query: 299 KDKRKASPSLKAFQKE 314
               +  P L  F   
Sbjct: 344 HGVNQNIPQLFNFSPY 359

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  101 bits (254), Expect = 8e-24
 Identities = 44/225 (19%), Positives = 80/225 (35%), Gaps = 28/225 (12%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMPNTIERDI--MVKSKCPY 69
           A D  +   + +G +G+++           V  K+   R++     E ++   V  +   
Sbjct: 7   ARDITLLECVGKGRYGEVWRG---SWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHEN 63

Query: 70  IVNLFY-----SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           I+  F      S      ++ I  Y   G     L+      L        +  +A  + 
Sbjct: 64  IL-GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLA 119

Query: 125 YLHGLGY--------VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---VG 173
           +LH   +         HRD+K  N+L+   G   + D G A    ++     +     VG
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           T  Y+APEVL+               D+W+ G+V +E+       
Sbjct: 180 TKRYMAPEVLD-ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  101 bits (255), Expect = 1e-23
 Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 30/215 (13%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMV---KSKCPYIV 71
            D+ + R + +G + +++      ++   V+K +   K      R+I +       P I+
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNII 94

Query: 72  NL---FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            L               + E+V   DF  L +      L++   RFY+YE+ +A+ Y H 
Sbjct: 95  TLADIVKDPVSRTPAL-VFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS 148

Query: 129 LGYVHRDIKPDNMLL-SATGHLKLTDFGSA----TQVDKNGRIKSIVPVGTPEYVAPEVL 183
           +G +HRD+KP N+++      L+L D+G A       + N R      V +  +  PE+L
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR------VASRYFKGPELL 202

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                      Y  S D+WS+G +   ++    PF
Sbjct: 203 ------VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  102 bits (255), Expect = 1e-23
 Identities = 47/229 (20%), Positives = 82/229 (35%), Gaps = 28/229 (12%)

Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMPNTIERDI--MVKS 65
           +   A    + + I +G +G++++    +     V  KV    E+     E +I   V  
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMG---KWRGEKVAVKVFFTTEEASWFRETEIYQTVLM 88

Query: 66  KCPYIVNLFY-----SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           +   I+  F             +Y I +Y   G     L++     L         Y   
Sbjct: 89  RHENIL-GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSV 144

Query: 121 QAVQYLHGLGY--------VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP- 171
             + +LH   +         HRD+K  N+L+   G   + D G A +   +     I P 
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 172 --VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             VGT  Y+ PEVL+    N          D++S G++ +E+       
Sbjct: 205 TRVGTKRYMPPEVLD-ESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  101 bits (254), Expect = 2e-23
 Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 40/224 (17%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC---PYI 70
              F ++R   QG FG + L +EK +  +  +KKV+++      E  IM        P I
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81

Query: 71  VNLFYSF-----QDMNHVYF--IMEYVTGGDFVTLLENQPHG--YLSESKARFYIYELAQ 121
           V L   F     +D   +Y   +MEYV          N             + ++++L +
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 122 AVQYLH--GLGYVHRDIKPDNMLL-SATGHLKLTDFGSATQVDKNGRIKSIVPVGTP--E 176
           ++  LH   +   HRDIKP N+L+  A G LKL DFGSA         K + P   P   
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA---------KKLSP-SEPNVA 190

Query: 177 YV------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
           Y+      APE++       G+  YT + D+WS+G +  E++ G
Sbjct: 191 YICSRYYRAPELI------FGNQHYTTAVDIWSVGCIFAEMMLG 228

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  100 bits (251), Expect = 9e-23
 Identities = 66/377 (17%), Positives = 140/377 (37%), Gaps = 73/377 (19%)

Query: 4   VKELRQKNVSASDFDIKRF-IQQGNFGDIYLVEEKQSHN--TFVMKKVLREKMPNTIERD 60
           VK   ++      F+ +   + +G +G +Y  + K   +   + +K++    +  +  R+
Sbjct: 9   VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE 68

Query: 61  IMV--KSKCPYIVNLF--YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF-- 114
           I +  + K P +++L   +       V+ + +Y    D   +++       ++   +   
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPR 127

Query: 115 -----YIYELAQAVQYLHGLGYVHRDIKPDNMLLSA----TGHLKLTDFGSATQVDKNGR 165
                 +Y++   + YLH    +HRD+KP N+L+       G +K+ D G A   +   +
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 166 IKSIVP--VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL 223
             + +   V T  Y APE+L       G+  YT + D+W+IG +  ELLT    F+    
Sbjct: 188 PLADLDPVVVTFWYRAPELL------LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

Query: 224 DMTYSSILACD------------TEDT--------------VSFPSSIRLSTAMVNFVQS 257
           D+  S+    D             +                  F  +   + +++ +++ 
Sbjct: 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301

Query: 258 LVQKLDA----------------RLNMDQVLGHPVFDCLDSDPPCIP--PPSQENKFHKK 299
              K D+                R+  +Q +  P F   +   P        Q     ++
Sbjct: 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL--EDPLPTSDVFAGCQIPYPKRE 359

Query: 300 DKRKASPSLKAFQKEGR 316
              +  P  K  +K  +
Sbjct: 360 FLTEEEPDDKGDKKNQQ 376

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 99.2 bits (248), Expect = 1e-22
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 49/231 (21%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV------------LREKM-------PNTI 57
           F +K  + +G +G +     K +     +KK+            LRE          N I
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72

Query: 58  E-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
              +I              SF++ N VY I E +   D   ++  Q    LS+   +++I
Sbjct: 73  TIFNIQRPD----------SFENFNEVYIIQELM-QTDLHRVISTQM---LSDDHIQYFI 118

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP- 175
           Y+  +AV+ LHG   +HRD+KP N+L+++   LK+ DFG A  +D++    S        
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 176 --EYV------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             E+V      APEV+        S  Y+ + D+WS G +  EL      F
Sbjct: 179 MVEFVATRWYRAPEVM------LTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 99.1 bits (247), Expect = 1e-22
 Identities = 47/224 (20%), Positives = 83/224 (37%), Gaps = 26/224 (11%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMPNTIERDI--MVKSKCPY 69
           A    ++  I +G FG+++     +     V  K+   RE+     E +I   V  +   
Sbjct: 41  ARTIVLQESIGKGRFGEVWRG---KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHEN 97

Query: 70  IVNLFYSFQDMN----HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
           I+    +    N     ++ + +Y   G     L       ++           A  + +
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 154

Query: 126 LHG--------LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---VGT 174
           LH             HRD+K  N+L+   G   + D G A + D       I P   VGT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
             Y+APEVL+    N          D++++G+V +E+    +  
Sbjct: 215 KRYMAPEVLD-DSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 33/227 (14%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-----------LREKM-------PN 55
            S +   + +  G  G ++   +        +KK+           LRE          N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 56  TIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
            ++  +I+       + +   S  ++N VY + EY+   D   +LE  P   L E  AR 
Sbjct: 70  IVKVFEIL-GPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP---LLEEHARL 124

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRIKSIVP-- 171
           ++Y+L + ++Y+H    +HRD+KP N+ ++     LK+ DFG A  +D +   K  +   
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           + T  Y +P +L         + YT + D+W+ G +  E+LTG T F
Sbjct: 185 LVTKWYRSPRLL------LSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 64/244 (26%)

Query: 9   QKNVSASDFDI------KRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------------L 49
           ++ V+ + +++       + +  G +G +    + ++     +KK+              
Sbjct: 13  RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 72

Query: 50  REKM-------PNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN 101
           RE          N I   D+    +         +  D    Y +M ++ G D   L+++
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDE---------TLDDFTDFYLVMPFM-GTDLGKLMKH 122

Query: 102 QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD 161
           +    L E + +F +Y++ + ++Y+H  G +HRD+KP N+ ++    LK+ DFG A Q D
Sbjct: 123 EK---LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179

Query: 162 KNGRIKSIVPVGTPEYV------APEV-LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                          YV      APEV L WM        YT + D+WS+G +  E++TG
Sbjct: 180 SE----------MTGYVVTRWYRAPEVILNWMR-------YTQTVDIWSVGCIMAEMITG 222

Query: 215 STPF 218
            T F
Sbjct: 223 KTLF 226

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 42/226 (18%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV------------LREKM-------PN 55
             +    +I +G +G +    +  +     +KK+            LRE          N
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86

Query: 56  TIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
            I   DI+             + + M  VY + + +   D   LL+ Q    LS     +
Sbjct: 87  IIGINDIIRAP----------TIEQMKDVYIVQDLM-ETDLYKLLKTQH---LSNDHICY 132

Query: 115 YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP--V 172
           ++Y++ + ++Y+H    +HRD+KP N+LL+ T  LK+ DFG A   D +      +   V
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            T  Y APE++        S GYT S D+WS+G +  E+L+    F
Sbjct: 193 ATRWYRAPEIM------LNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 97.1 bits (242), Expect = 4e-22
 Identities = 47/226 (20%), Positives = 84/226 (37%), Gaps = 27/226 (11%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REKMPNTIERDI--MVKSKCPYI 70
               +     +G FG ++     Q  N +V  K+   ++K     E ++  +   K   I
Sbjct: 24  MPLQLLEVKARGRFGCVWKA---QLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 71  VNLF----YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           +               ++ I  +   G     L+      +S ++       +A+ + YL
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYL 137

Query: 127 HG----------LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-RIKSIVPVGTP 175
           H               HRDIK  N+LL       + DFG A + +       +   VGT 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE 221
            Y+APEVLE     +         D++++G+V +EL +  T  +  
Sbjct: 198 RYMAPEVLE--GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 97.8 bits (244), Expect = 5e-22
 Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 64/244 (26%)

Query: 9   QKNVSASDFDI------KRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------------L 49
           ++ ++ + +++         +  G +G +    + ++     +KK+              
Sbjct: 17  RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 76

Query: 50  REKM-------PNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN 101
           RE          N I   D+   ++         S ++ N VY +   + G D   +++ 
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPAR---------SLEEFNDVYLVTHLM-GADLNNIVKC 126

Query: 102 QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD 161
           Q    L++   +F IY++ + ++Y+H    +HRD+KP N+ ++    LK+ DFG A    
Sbjct: 127 QK---LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183

Query: 162 KNGRIKSIVPVGTPEYV------APEV-LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                          YV      APE+ L WM        Y  + D+WS+G +  ELLTG
Sbjct: 184 DE----------MTGYVATRWYRAPEIMLNWMH-------YNQTVDIWSVGCIMAELLTG 226

Query: 215 STPF 218
            T F
Sbjct: 227 RTLF 230

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 42/233 (18%), Positives = 80/233 (34%), Gaps = 31/233 (13%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDI--MVKSK 66
           ++   +  +   I +G +G +Y           V  KV           E++I  +   +
Sbjct: 9   SLDLDNLKLLELIGRGRYGAVYKG---SLDERPVAVKVFSFANRQNFINEKNIYRVPLME 65

Query: 67  CPYIVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
              I          +         +MEY   G     L            +    + + +
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTR 122

Query: 122 AVQYLHG---------LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP- 171
            + YLH              HRD+   N+L+   G   ++DFG + ++  N  ++     
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 172 ------VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
                 VGT  Y+APEVLE        +      D++++G++ +E+    T  
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.9 bits (234), Expect = 8e-21
 Identities = 57/244 (23%), Positives = 102/244 (41%), Gaps = 65/244 (26%)

Query: 9   QKNVSASDFDI------KRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------------L 49
           +++V+ + +++         +  G +G +    +K+S     +KK+              
Sbjct: 12  KQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY 71

Query: 50  REKM-------PNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLEN 101
           RE +        N I   D+   +          S ++    Y +M ++   D   ++  
Sbjct: 72  RELLLLKHMQHENVIGLLDVFTPAS---------SLRNFYDFYLVMPFM-QTDLQKIMGL 121

Query: 102 QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD 161
           +     SE K ++ +Y++ + ++Y+H  G VHRD+KP N+ ++    LK+ DFG A   D
Sbjct: 122 K----FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177

Query: 162 KNGRIKSIVPVGTPEYV------APEV-LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                          YV      APEV L WM        Y  + D+WS+G +  E+LTG
Sbjct: 178 AE----------MTGYVVTRWYRAPEVILSWMH-------YNQTVDIWSVGCIMAEMLTG 220

Query: 215 STPF 218
            T F
Sbjct: 221 KTLF 224

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 95.3 bits (237), Expect = 9e-21
 Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 44/225 (19%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------------LREKM-------P 54
             +   + I  G  G +    +        +KK+              RE +        
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 55  NTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
           N I   ++    K         + ++   VY +ME +        L       L   +  
Sbjct: 122 NIISLLNVFTPQK---------TLEEFQDVYLVMELMD-----ANLCQVIQMELDHERMS 167

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
           + +Y++   +++LH  G +HRD+KP N+++ +   LK+ DFG A     +  +     V 
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VV 225

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
           T  Y APEV+          GY  + D+WS+G +  E++     F
Sbjct: 226 TRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMVRHKILF 263

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 47/229 (20%), Positives = 99/229 (43%), Gaps = 35/229 (15%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKS 65
           ++  +  + + I +G FGD+ L + +      V  K ++    +   +       +M + 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN---DATAQAFLAEASVMTQL 71

Query: 66  KCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           +   +V L     ++   +Y + EY+  G  V  L ++    L       +  ++ +A++
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV---DKNGRIKSIVPVGTPEYVAPE 181
           YL G  +VHRD+   N+L+S     K++DFG   +       G++    PV   ++ APE
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PV---KWTAPE 184

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
            L           ++   D+WS G++ +E+ + G  P+      + +  
Sbjct: 185 AL-----REKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 28/230 (12%)

Query: 12  VSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD------IMV 63
           +     ++ R I +G FGD++  +    ++    V  K  +    +++          M 
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           +   P+IV L       N V+ IME  T G+  + L+ +    L  +    Y Y+L+ A+
Sbjct: 72  QFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTAL 129

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG---RIKSIVPVGTPEYVAP 180
            YL    +VHRDI   N+L+S+   +KL DFG +  ++ +      K  +P+   +++AP
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMAP 186

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
           E +     N     +T + D+W  GV  +E+L  G  PF    N + +  
Sbjct: 187 ESI-----NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 39/226 (17%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDI--MVKSKCP---- 68
           + R +  G+F  ++L ++  + NT V  K++R  +        E  +   V         
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVN-NTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 69  -----YIVNLFYSFQ----DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
                +I+ L   F     +  HV  + E V G + + L++   H  +     +    +L
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 120 AQAVQYLH-GLGYVHRDIKPDNMLLS------ATGHLKLTDFGSATQVDKNGRIKSIVPV 172
              + Y+H   G +H DIKP+N+L+           +K+ D G+A   D+     + +  
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQ- 197

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF 218
            T EY +PEVL           +    D+WS   + +EL+TG   F
Sbjct: 198 -TREYRSPEVLLGA-------PWGCGADIWSTACLIFELITGDFLF 235

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 92.3 bits (230), Expect = 4e-20
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 27/229 (11%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKS 65
           ++  D  +   I +GNFG+++    + + NT V  K  RE +P  ++        I+ + 
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169

Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
             P IV L         +Y +ME V GGDF+T L  +    L        + + A  ++Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEY 228

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS----IVPVGTPEYVAPE 181
           L     +HRD+   N L++    LK++DFG + +        S     VPV   ++ APE
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV---KWTAPE 285

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
            L     N+G   Y+   D+WS G++ +E  + G++P+    N +T + 
Sbjct: 286 AL-----NYGR--YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 91.5 bits (228), Expect = 4e-20
 Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 54/241 (22%)

Query: 15  SDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKS 65
           ++F   + +  G FG +Y    + E +     V  K LRE       ++      +M   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 66  KCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIY 117
             P++  L          V  I + +  G    LL+     Y+ E K          +  
Sbjct: 75  DNPHVCRLLGICLTS--TVQLITQLMPFGC---LLD-----YVREHKDNIGSQYLLNWCV 124

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN--------GRIKSI 169
           ++A+ + YL     VHRD+   N+L+    H+K+TDFG A  +           G++   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--- 181

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
            P+   +++A E +      H    YT   D+WS GV  +EL+T GS P+      E   
Sbjct: 182 -PI---KWMALESI-----LHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230

Query: 225 M 225
           +
Sbjct: 231 I 231

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 92.0 bits (229), Expect = 4e-20
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 40/187 (21%)

Query: 46  KKVLREKM-------PNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT 97
           K+VLRE         PN +  RDI V           +    M+ +Y + E +   D   
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFV----------HFEEPAMHKLYLVTELM-RTDLAQ 122

Query: 98  LLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA 157
           ++ +Q    +S    ++++Y +   +  LH  G VHRD+ P N+LL+    + + DF  A
Sbjct: 123 VIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181

Query: 158 TQVDKNGRIKSIVPVGTPEYV------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYEL 211
            +   +             YV      APE++          G+T   D+WS G V  E+
Sbjct: 182 REDTADANK--------THYVTHRWYRAPELV------MQFKGFTKLVDMWSAGCVMAEM 227

Query: 212 LTGSTPF 218
                 F
Sbjct: 228 FNRKALF 234

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 52/236 (22%), Positives = 96/236 (40%), Gaps = 30/236 (12%)

Query: 9   QKNVSASDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERD----- 60
              +  S    ++ I  G FG++Y   L          V  K L+         D     
Sbjct: 38  TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97

Query: 61  -IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
            IM +     I+ L         +  I EY+  G     L  +  G  S  +    +  +
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGI 156

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIKSIVPVGT 174
           A  ++YL  + YVHRD+   N+L+++    K++DFG +  ++ +           +P+  
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI-- 214

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
             + APE +     ++    +T + D+WS G+V +E++T G  P+    N+E +  
Sbjct: 215 -RWTAPEAI-----SYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 91.7 bits (228), Expect = 5e-20
 Identities = 53/241 (21%), Positives = 91/241 (37%), Gaps = 50/241 (20%)

Query: 5   KELRQKNVSASDFDI-KRF-----IQQGNFGDIYLVEEKQSHNTFVMKKV---------- 48
                  +  S F + KR+     I  G  G +    +        +KK+          
Sbjct: 9   NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 68

Query: 49  ---LREKM-------PNTIE-RDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT 97
               RE +        N I   ++    K         S ++   VY +ME +       
Sbjct: 69  KRAYRELVLMKCVNHKNIIGLLNVFTPQK---------SLEEFQDVYIVMELMD-----A 114

Query: 98  LLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA 157
            L       L   +  + +Y++   +++LH  G +HRD+KP N+++ +   LK+ DFG A
Sbjct: 115 NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

Query: 158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP 217
                +  +     V T  Y APEV+          GY  + D+WS+G +  E++ G   
Sbjct: 175 RTAGTSFMMTPY--VVTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMIKGGVL 225

Query: 218 F 218
           F
Sbjct: 226 F 226

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 57/248 (22%), Positives = 101/248 (40%), Gaps = 57/248 (22%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDI--MVKSKCP-- 68
           ++I   + +G FG +    + ++    V  K+++  ++       E  +   + +  P  
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 69  --YIVNLFYSFQDMNHVYFIME------YVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
               V +   F+   H+  + E      Y    DF  + EN           R   Y++ 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGLSTY----DF--IKENGFLP-FRLDHIRKMAYQIC 128

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGH-------------------LKLTDFGSATQVD 161
           ++V +LH     H D+KP+N+L   + +                   +K+ DFGSAT  D
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188

Query: 162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF--- 218
           ++    ++V   T  Y APEV+  +       G++  CD+WSIG +  E   G T F   
Sbjct: 189 EH--HSTLVS--TRHYRAPEVILAL-------GWSQPCDVWSIGCILIEYYLGFTVFPTH 237

Query: 219 -NYETLDM 225
            + E L M
Sbjct: 238 DSKEHLAM 245

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 49/229 (21%), Positives = 102/229 (44%), Gaps = 29/229 (12%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVK 64
           +  +D  +K  +  G +G++Y    K  ++  V  K L+E   +T+E +       +M +
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKE---DTMEVEEFLKEAAVMKE 65

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
            K P +V L          Y I E++T G+ +  L       +S     +   +++ A++
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPE 181
           YL    ++HRD+   N L+     +K+ DFG +  +  +       +  P+   ++ APE
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPE 182

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
            L      +    ++   D+W+ GV+ +E+ T G +P+      +  ++
Sbjct: 183 SL-----AYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 93.7 bits (233), Expect = 9e-20
 Identities = 57/343 (16%), Positives = 143/343 (41%), Gaps = 28/343 (8%)

Query: 351  EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE 410
            E+M+    +  +  ++  +A+A L++L     +   L  + + LQ+ L + T L ++ EE
Sbjct: 857  EEMQAKDEELQRTKERQQKAEAELKEL---EQKHTQLCEEKNLLQEKLQAETELYAEAEE 913

Query: 411  EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKEL 470
               RL      K+ +L     ++ A   E EE   +L+ ++       +K++     +++
Sbjct: 914  MRVRLA----AKKQELEEILHEMEARIEEEEERSQQLQAEK-------KKMQ-----QQM 957

Query: 471  EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSE 530
              L  +LEE++ A ++ + +   +  +      ++   + +N  L ++   LE+ +    
Sbjct: 958  LDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLT 1017

Query: 531  EALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLL---- 586
              LA  +    +  +      + I  ++  +++     +E+  I  K E +   L     
Sbjct: 1018 TNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIA 1077

Query: 587  ELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKL 646
            EL++    L+ ++   + +L++    LE    Q        K+ + E  ++ ++E+ +  
Sbjct: 1078 ELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNA--LKKIRELESHISDLQEDLESE 1135

Query: 647  KQGKIRL---VYSLFKDPQPAQSKLEKAEGELTTVREENKKLK 686
            K  + +       L ++ +  +++LE       T +E      
Sbjct: 1136 KAARNKAEKQKRDLSEELEALKTELEDTLDTTATQQELRGSDY 1178

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 89.1 bits (221), Expect = 2e-18
 Identities = 41/281 (14%), Positives = 102/281 (36%), Gaps = 21/281 (7%)

Query: 354  RHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEID 413
            +  +    ++  ++ E +   + L   + +   +Q Q+  L++ L    +   K + E  
Sbjct: 923  QELEEILHEMEARIEEEEERSQQLQAEKKK---MQQQMLDLEEQLEEEEAARQKLQLEKV 979

Query: 414  RLRQEMVKKESDLVATSSDLVATRHELEEVRSELKE-KENLEKTDDRKLEVCEVSKELEV 472
                ++ K E D++           E + +   + +   NL + +++   + ++  + E 
Sbjct: 980  TADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHES 1039

Query: 473  LRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEA 532
            +  ELE +    ++ +++     K +     E      +   L+ ++  L+ +L   EE 
Sbjct: 1040 MISELEVRLKKEEKSRQEL---EKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEE 1096

Query: 533  LATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAK 592
            L  A   L+ +  +       I  ++  +            + E  E ++    + +  K
Sbjct: 1097 LQAALARLEDETSQKNNALKKIRELESHISD----------LQEDLESEKAARNKAEKQK 1146

Query: 593  ERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAE 633
              L  E+   K +LE T            ELR     +  +
Sbjct: 1147 RDLSEELEALKTELEDTLDTTA----TQQELRGSDYKDDDD 1183

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 53/311 (17%), Positives = 121/311 (38%), Gaps = 37/311 (11%)

Query: 492  YQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALS 551
             +  +E  A   EL++ +   +  + +L  LEQ+       L   +N L  KL+    L 
Sbjct: 853  TRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHT----QLCEEKNLLQEKLQAETELY 908

Query: 552  NTIESMQKEME-QSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTR 610
               E M+  +  +       +  +  + E++ +   +L++ K++++ ++           
Sbjct: 909  AEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQML---------- 958

Query: 611  RELETNKDQTIELRAKSKLEKA---------EGELTTVREENKKLKQGKIRLVYSLFKDP 661
             +LE   ++    R K +LEK          E ++  + ++N KL + +  L   +    
Sbjct: 959  -DLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLT 1017

Query: 662  QPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTERE 721
                 + EKA+  LT ++ +++ +       L+              S ++L+    + E
Sbjct: 1018 TNLAEEEEKAK-NLTKLKNKHESMISELEVRLKKEE----------KSRQELEKIKRKLE 1066

Query: 722  SKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKNN 781
             +    +E I E + +I  L++ + + E   +  +  LE      +       +L    +
Sbjct: 1067 GESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHIS 1126

Query: 782  DILSHDNEQLR 792
            D L  D E  +
Sbjct: 1127 D-LQEDLESEK 1136

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 35/242 (14%), Positives = 93/242 (38%), Gaps = 23/242 (9%)

Query: 560  EMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELE--------------VRGYKLD 605
             + +   +  EM    E+ ++ ++   + ++  + LE +              ++     
Sbjct: 848  PLLKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETEL 907

Query: 606  LESTRRELETNKDQTIELRAK-----SKLEKAEGELTTVREENKKLKQGKIRLVYSLFKD 660
                         +  EL        +++E+ E     ++ E KK++Q     +  L + 
Sbjct: 908  YAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQ----QMLDLEEQ 963

Query: 661  PQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTER 720
             +  ++  +K + E  T   + KK++       + N+    +       + DL +N  E 
Sbjct: 964  LEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEE 1023

Query: 721  ESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKKN 780
            E K ++  ++  ++E+ I+ LE  + + E   +E+ +    L+  +  L     +L+ + 
Sbjct: 1024 EEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQI 1083

Query: 781  ND 782
             +
Sbjct: 1084 AE 1085

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 35/212 (16%), Positives = 76/212 (35%), Gaps = 35/212 (16%)

Query: 574  ISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAK--SKLEK 631
            ++ + E+ +    EL+  KER +          E+  +ELE    Q  E +     KL+ 
Sbjct: 852  VTRQEEEMQAKDEELQRTKERQQKA--------EAELKELEQKHTQLCEEKNLLQEKLQA 903

Query: 632  AEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFF 691
                     E   +L   K  L   L +     ++++E+ E     ++ E KK++     
Sbjct: 904  ETELYAEAEEMRVRLAAKKQELEEILHE----MEARIEEEEERSQQLQAEKKKMQ----- 954

Query: 692  TLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESY 751
                              + DL+    E E+  +         + KI  +E  +   E  
Sbjct: 955  ----------------QQMLDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQ 998

Query: 752  CKEMVEYLETLQKNNDILSHDNEQLRKKNNDI 783
              ++ +  + L++    L+ +  +  +K  ++
Sbjct: 999  NNKLTKERKLLEERVSDLTTNLAEEEEKAKNL 1030

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 50/236 (21%), Positives = 92/236 (38%), Gaps = 45/236 (19%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVK 64
           +  S+    + I  G FG ++L          V  K +RE     +  +       +M+K
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIRE---GAMSEEDFIEEAEVMMK 59

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL----- 119
              P +V L+    +   +  + E++  G    L +     YL   +  F    L     
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGC---LSD-----YLRTQRGLFAAETLLGMCL 111

Query: 120 --AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGT 174
              + + YL     +HRD+   N L+     +K++DFG    V  +       +  PV  
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-- 169

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
            ++ +PEV      +     Y+   D+WS GV+ +E+ + G  P+    N E ++ 
Sbjct: 170 -KWASPEVF-----SFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 59/248 (23%), Positives = 96/248 (38%), Gaps = 57/248 (22%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDI--MVKSKCP-- 68
           ++I   + +G FG +    +     + V  K++R   K      +E ++   +K K    
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 69  --YIVNLFYSFQDMNHVYFIME------YVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
               V +   F    H+    E      +    +F  L EN           R   Y+L 
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLGKNTF----EF--LKENNFQP-YPLPHVRHMAYQLC 133

Query: 121 QAVQYLHGLGYVHRDIKPDNMLLSATGH-------------------LKLTDFGSATQVD 161
            A+++LH     H D+KP+N+L   +                     +++ DFGSAT   
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193

Query: 162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF--- 218
           ++    +IV   T  Y  PEV+  +       G+   CD+WSIG + +E   G T F   
Sbjct: 194 EH--HTTIVA--TRHYRPPEVILEL-------GWAQPCDVWSIGCILFEYYRGFTLFQTH 242

Query: 219 -NYETLDM 225
            N E L M
Sbjct: 243 ENREHLVM 250

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 90.9 bits (226), Expect = 2e-19
 Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 29/225 (12%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDI--MVKSKCP-- 68
           +++ + I +G+FG +    + +  +  V  K++R  ++       E  I   ++ +    
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKV-HQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157

Query: 69  --YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
              ++++  +F   NH+    E +   +   L++       S    R + + + Q +  L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 127 HGLGYVHRDIKPDNMLLSATGH--LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           H    +H D+KP+N+LL   G   +K+ DFGS+    +  R+ + +   +  Y APEV+ 
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQ--SRFYRAPEVIL 272

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDM 225
                     Y    D+WS+G +  ELLTG          + L  
Sbjct: 273 GA-------RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 55/236 (23%), Positives = 99/236 (41%), Gaps = 45/236 (19%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVK 64
           +   D    + +  G FG +     K      V  K+++E    ++  D       +M+ 
Sbjct: 21  IDPKDLTFLKELGTGQFGVVK--YGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMN 75

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL----- 119
                +V L+        ++ I EY+  G    LL      YL E + RF   +L     
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGC---LLN-----YLREMRHRFQTQQLLEMCK 127

Query: 120 --AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGT 174
              +A++YL    ++HRD+   N L++  G +K++DFG +  V  +     + S  PV  
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-- 185

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
             +  PEVL      +    ++   D+W+ GV+ +E+ + G  P+    N ET + 
Sbjct: 186 -RWSPPEVL-----MYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 92.2 bits (229), Expect = 2e-19
 Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 42/241 (17%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD----- 60
           R   +     ++ R I +G FGD++  +    ++    V  K  +    +++        
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442

Query: 61  -IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF----- 114
             M +   P+IV L       N V+ IME  T G+           +L   K        
Sbjct: 443 LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGEL--------RSFLQVRKFSLDLASL 493

Query: 115 --YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG---RIKSI 169
             Y Y+L+ A+ YL    +VHRDI   N+L+S+   +KL DFG +  ++ +      K  
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
           +P+   +++APE +     N     +T + D+W  GV  +E+L  G  PF    N + + 
Sbjct: 554 LPI---KWMAPESI-----NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603

Query: 225 M 225
            
Sbjct: 604 R 604

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 55/229 (24%), Positives = 105/229 (45%), Gaps = 31/229 (13%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVK 64
           V      +   +  G FG+++      + +T V  K L++    ++  D       +M +
Sbjct: 10  VPRETLKLVERLGAGQFGEVW--MGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQ 64

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
            +   +V L Y+      +Y I EY+  G  V  L+      L+ +K      ++A+ + 
Sbjct: 65  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPE 181
           ++    Y+HRD++  N+L+S T   K+ DFG A  ++ N    R  +  P+   ++ APE
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPE 180

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
            +     N+G+  +T   D+WS G++  E++T G  P+    N E +  
Sbjct: 181 AI-----NYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 54/243 (22%), Positives = 104/243 (42%), Gaps = 63/243 (25%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------------LREKM--------PN 55
           +++ + + +G +G ++   ++++     +KK+              RE M         N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 56  TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
            +            ++N+  +  +   VY + +Y+   D   ++       L     ++ 
Sbjct: 71  IVN-----------LLNVLRA-DNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYV 114

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           +Y+L + ++YLH  G +HRD+KP N+LL+A  H+K+ DFG +       R+ + +P+   
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 176 --------------EYV------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS 215
                         +YV      APE+L       GS  YT   D+WS+G +  E+L G 
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEIL------LGSTKYTKGIDMWSLGCILGEILCGK 228

Query: 216 TPF 218
             F
Sbjct: 229 PIF 231

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 46/229 (20%), Positives = 96/229 (41%), Gaps = 31/229 (13%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVK 64
           +   +  + + +  G FG +     K      V  K+++E    ++  D        M+K
Sbjct: 5   LKREEITLLKELGSGQFGVVK--LGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMK 59

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
              P +V  +        +Y + EY++ G  +  L +     L  S+     Y++ + + 
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMA 118

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPE 181
           +L    ++HRD+   N L+     +K++DFG    V  +     + +  PV   ++ APE
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPE 175

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
           V      ++    Y+   D+W+ G++ +E+ + G  P+    N E +  
Sbjct: 176 VF-----HYFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 29/232 (12%)

Query: 12  VSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD------IMV 63
           + AS   I++ I  G+ G++    +      +  V  K L+        RD      IM 
Sbjct: 46  IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           +   P I+ L            + EY+  G   T L     G  +  +    +  +   +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGM 164

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-----GRIKSIVPVGTPEYV 178
           +YL  LGYVHRD+   N+L+ +    K++DFG +  ++ +           +P+    + 
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI---RWT 221

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
           APE +        +  ++ + D+WS GVV +E+L  G  P+    N + +  
Sbjct: 222 APEAI-----AFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 28/230 (12%)

Query: 12  VSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD------IMV 63
           ++  D  + R + +G FG++Y  +    +     V  K  ++      +        IM 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
               P+IV L     +    + IME    G+    LE      L       Y  ++ +A+
Sbjct: 69  NLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAM 126

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG---RIKSIVPVGTPEYVAP 180
            YL  +  VHRDI   N+L+++   +KL DFG +  ++         + +P+   ++++P
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMSP 183

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
           E +     N     +T + D+W   V  +E+L+ G  PF    N + + +
Sbjct: 184 ESI-----NFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 89.8 bits (223), Expect = 5e-19
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 25/223 (11%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IERDIMVKSKCPYI 70
               ++  + QG FG+++      +  T V  K L+    +      E  +M K +   +
Sbjct: 184 ESLRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL 241

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V L+    +   +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + 
Sbjct: 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWME 187
           YVHRD++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE      
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAA---- 353

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
             +G   +T   D+WS G++  EL T G  P+    N E LD 
Sbjct: 354 -LYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 89.0 bits (221), Expect = 5e-19
 Identities = 55/227 (24%), Positives = 103/227 (45%), Gaps = 31/227 (13%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDI--MVKSKCP-- 68
           ++I   I +G+FG +    ++     +V  K+++  +   N   IE  +  ++       
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVE-QEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEM 114

Query: 69  --YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
             YIV+L   F   NH+  + E ++   +  L      G +S +  R +  ++  A+ +L
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFL 173

Query: 127 HG--LGYVHRDIKPDNMLLSATGH--LKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
               L  +H D+KP+N+LL       +K+ DFGS+ Q+ +  RI   +   +  Y +PEV
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQ--SRFYRSPEV 229

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF----NYETLDM 225
           L  M        Y  + D+WS+G +  E+ TG   F      + ++ 
Sbjct: 230 LLGM-------PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 89.5 bits (222), Expect = 6e-19
 Identities = 57/248 (22%), Positives = 98/248 (39%), Gaps = 48/248 (19%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR----EKMPNTIERDIMVKSKC--P 68
             ++I+  I  G++G +    +K       +KK+LR          I R+I + ++    
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 69  YIVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGYLSESKARFYIYELAQA 122
           ++V +         +  + +Y ++E     DF  L         L+E   +  +Y L   
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVG 168

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP------- 175
           V+Y+H  G +HRD+KP N L++    +K+ DFG A  VD      S +P+          
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

Query: 176 -------------EYV------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGST 216
                         +V      APE++         + YT + D+WSIG +  ELL    
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELI------LLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 217 PFNYETLD 224
                  D
Sbjct: 283 ENVAYHAD 290

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.9 bits (223), Expect = 6e-19
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 25/223 (11%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IERDIMVKSKCPYI 70
               ++  + QG FG+++      +  T V  K L+    +      E  +M K +   +
Sbjct: 267 ESLRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL 324

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V L+    +   +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+  + 
Sbjct: 325 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLEWME 187
           YVHRD++  N+L+      K+ DFG A  ++ N    R  +  P+   ++ APE      
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAA---- 436

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
             +G   +T   D+WS G++  EL T G  P+    N E LD 
Sbjct: 437 -LYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 88.7 bits (220), Expect = 1e-18
 Identities = 56/250 (22%), Positives = 96/250 (38%), Gaps = 57/250 (22%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------------LREKMPNTIERDI 61
            ++ IK  I +G++G +YL  +K +     +KKV             LRE         I
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT-------I 78

Query: 62  MVKSKCPYIVNLF-----YSFQDMNHVYFIMEYVTGGDFVTLLE-NQPHGYLSESKARFY 115
           + + K  YI+ L+           + +Y ++E     D   L +       L+E   +  
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF---LTEEHIKTI 134

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           +Y L     ++H  G +HRD+KP N LL+    +K+ DFG A  ++       +  +   
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 176 ---------------EYV------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
                           +V      APE++         + YT S D+WS G +  ELL  
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELI------LLQENYTKSIDIWSTGCIFAELLNM 248

Query: 215 STPFNYETLD 224
                 +  +
Sbjct: 249 LQSHINDPTN 258

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 49/234 (20%), Positives = 98/234 (41%), Gaps = 29/234 (12%)

Query: 10  KNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD------I 61
           K + A++  I + +  G FG++    ++        V  K L+        RD      I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P I+ L         V  + EY+  G   + L        +  +    +  +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIKSIVPVGTPE 176
            ++YL  +GYVHRD+   N+L+++    K++DFG    ++ +           +P+    
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI---R 215

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
           + +PE +      +    +T + D+WS G+V +E+++ G  P+    N + +  
Sbjct: 216 WTSPEAI-----AYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 88.7 bits (220), Expect = 1e-18
 Identities = 48/226 (21%), Positives = 101/226 (44%), Gaps = 29/226 (12%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD-------IMVKSKC 67
           +D  +K  +  G +G++Y    K  ++  V  K L+E   +T+E +       +M + K 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKH 275

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P +V L          Y I E++T G+ +  L       +S     +   +++ A++YL 
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLE 184
              ++HR++   N L+     +K+ DFG +  +  +       +  P+   ++ APE L 
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL- 391

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
                +    ++   D+W+ GV+ +E+ T G +P+      +  ++
Sbjct: 392 ----AYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 431

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 49/245 (20%), Positives = 84/245 (34%), Gaps = 50/245 (20%)

Query: 12  VSASDFDIKRFIQQGNFGDIY------LVEEKQSHNTFVMKKVLREKMPNTI-----ERD 60
           +   D      + QG F  I+      + +  Q H T V+ KVL +   N          
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64

Query: 61  IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL- 119
           +M K    ++V  +      +    + E+V  G    L       YL ++K    I    
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGS---LDT-----YLKKNKNCINILWKL 116

Query: 120 ------AQAVQYLHGLGYVHRDIKPDNMLLSATGHL--------KLTDFGSATQVDKNGR 165
                 A A+ +L     +H ++   N+LL              KL+D G +  V     
Sbjct: 117 EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176

Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NY 220
           ++    +    +V PE +E    N  +     + D WS G   +E+ + G  P     + 
Sbjct: 177 LQ--ERI---PWVPPECIE----NPKN--LNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225

Query: 221 ETLDM 225
             L  
Sbjct: 226 RKLQF 230

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 40/221 (18%)

Query: 15  SDFDIKRFIQQGNFGDIYL---VEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSK 66
                 + + +GNFG + +      + +    V  K L+      +     E +I+   +
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 67  CPYIVNLF--YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL----- 119
              IV            ++  IMEY+  G    L +     YL + K R    +L     
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGS---LRD-----YLQKHKERIDHIKLLQYTS 121

Query: 120 --AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIKSIVPV 172
              + ++YL    Y+HRD+   N+L+     +K+ DFG    + ++      +     P+
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
               + APE L           ++ + D+WS GVV YEL T
Sbjct: 182 ---FWYAPESL-----TESK--FSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 49/221 (22%), Positives = 87/221 (39%), Gaps = 40/221 (18%)

Query: 15  SDFDIKRFIQQGNFGDIYL---VEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSK 66
                 + + +GNFG + +      + +    V  K L+      +     E +I+   +
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 67  CPYIVNLF--YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIY 117
              IV            ++  IMEY+  G    L +     YL + K R        Y  
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGS---LRD-----YLQKHKERIDHIKLLQYTS 152

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIKSIVPV 172
           ++ + ++YL    Y+HRD+   N+L+     +K+ DFG    + ++      +     P+
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
               + APE L           ++ + D+WS GVV YEL T
Sbjct: 213 ---FWYAPESL-----TESK--FSVASDVWSFGVVLYELFT 243

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 47/253 (18%), Positives = 90/253 (35%), Gaps = 52/253 (20%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIE 58
           + VV       V          I +G+FG +Y   + +          K L         
Sbjct: 16  QHVVIGPSSLIVH-----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 70

Query: 59  RD------IMVKSKCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESK 111
                   IM     P +++L     +       ++ Y+  GD           ++    
Sbjct: 71  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL--------RNFIRNET 122

Query: 112 ARF-------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN- 163
                     +  ++A+ ++YL    +VHRD+   N +L     +K+ DFG A  +    
Sbjct: 123 HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182

Query: 164 -----GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GST 216
                 +  + +PV   +++A E L+           +T   D+WS GV+ +EL+T G+ 
Sbjct: 183 YYSVHNKTGAKLPV---KWMALESLQ--------TQKFTTKSDVWSFGVLLWELMTRGAP 231

Query: 217 PF----NYETLDM 225
           P+     ++    
Sbjct: 232 PYPDVNTFDITVY 244

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 87.5 bits (217), Expect = 3e-18
 Identities = 50/226 (22%), Positives = 105/226 (46%), Gaps = 25/226 (11%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ERDIMVKSKC 67
           +      +++ +  G FG++++    +  +T V  K ++    +      E ++M   + 
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNK--HTKVAVKTMKPGSMSVEAFLAEANVMKTLQH 242

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
             +V L ++      +Y I E++  G  +  L++         K   +  ++A+ + ++ 
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN---GRIKSIVPVGTPEYVAPEVLE 184
              Y+HRD++  N+L+SA+   K+ DFG A  ++ N    R  +  P+   ++ APE + 
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAI- 357

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
               N GS  +T   D+WS G++  E++T G  P+    N E +  
Sbjct: 358 ----NFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 53/234 (22%), Positives = 84/234 (35%), Gaps = 55/234 (23%)

Query: 15  SDFDIKRFIQQGNFGDIYL---VEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSK 66
                   + +GNFG + L        +    V  K L+   P+       E  I+    
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 67  CPYIVNLF--YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL----- 119
             +IV             +  +MEY+  G    L +     +L   +AR     L     
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGC---LRD-----FLQRHRARLDASRLLLYSS 134

Query: 120 --AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
              + ++YL     VHRD+   N+L+ +  H+K+ DFG A       +   ++P+    Y
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA-------K---LLPLDKDYY 184

Query: 178 V------------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF 218
           V            APE L     +     ++   D+WS GVV YEL T      
Sbjct: 185 VVREPGQSPIFWYAPESL-----SDNI--FSRQSDVWSFGVVLYELFTYCDKSC 231

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 87.0 bits (216), Expect = 4e-18
 Identities = 47/226 (20%), Positives = 97/226 (42%), Gaps = 35/226 (15%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCP 68
            +  + + I +G FGD+ L + +      V  K ++    +   +       +M + +  
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN---DATAQAFLAEASVMTQLRHS 246

Query: 69  YIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
            +V L     ++   +Y + EY+  G  V  L ++    L       +  ++ +A++YL 
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSA---TQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           G  +VHRD+   N+L+S     K++DFG     +     G++    PV   ++ APE L 
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PV---KWTAPEAL- 358

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
                     ++   D+WS G++ +E+ + G  P+      + +  
Sbjct: 359 ----REKK--FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 54/241 (22%)

Query: 15  SDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKS 65
           ++F   + +  G FG +Y    + E +     V  K LRE       ++      +M   
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 66  KCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF-------YIY 117
             P++  L          V  I + +  G    LL+     Y+ E K          +  
Sbjct: 75  DNPHVCRLLGICLTS--TVQLITQLMPFGC---LLD-----YVREHKDNIGSQYLLNWCV 124

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN--------GRIKSI 169
           ++A+ + YL     VHRD+   N+L+    H+K+TDFG A  +           G++   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--- 181

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLD 224
            P+   +++A E +      H    YT   D+WS GV  +EL+T GS P+      E   
Sbjct: 182 -PI---KWMALESI-----LHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230

Query: 225 M 225
           +
Sbjct: 231 I 231

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 83.9 bits (208), Expect = 9e-18
 Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 41/222 (18%)

Query: 15  SDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKS 65
                 R + +G+FG +       E  +    V  K L+ +       D      I+   
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 66  KCPYIVNLF--YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL---- 119
               IV      +    N +  IME++  G    L E     YL ++K +  + +     
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGS---LKE-----YLPKNKNKINLKQQLKYA 132

Query: 120 ---AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIKSIVP 171
               + + YL    YVHRD+   N+L+ +   +K+ DFG    ++ +      +     P
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
           V    + APE L           +  + D+WS GV  +ELLT
Sbjct: 193 V---FWYAPECL-----MQSK--FYIASDVWSFGVTLHELLT 224

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 83.6 bits (207), Expect = 9e-18
 Identities = 51/226 (22%), Positives = 85/226 (37%), Gaps = 29/226 (12%)

Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSK-- 66
           Q NV    + + R I +G+FG I+      ++    +K   R      +  +        
Sbjct: 4   QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63

Query: 67  -CPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
            C  I N++Y  Q+  H   +++   G     LL+     +  ++ A     ++   VQ 
Sbjct: 64  GCTGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSVKTVAMA-AKQMLARVQS 121

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLK-----LTDFGSATQVDKNGRIKSIVP-------VG 173
           +H    V+RDIKPDN L+            + DFG      ++   K  +P        G
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLSG 180

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSC--DLWSIGVVSYELLTGSTP 217
           T  Y++          +   G   S   DL ++G V    L GS P
Sbjct: 181 TARYMSI---------NTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 66/253 (26%), Positives = 99/253 (39%), Gaps = 63/253 (24%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDI--MVKSKCP-- 68
           F + R +  G FG + L +   +   +   KV+R  +K   +  IE DI   +++     
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDN-KKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95

Query: 69  -YIVNLFYSFQDMNHVYFIME------YVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
             IV     F   +H+  I E      Y    +   +  N  +G       + Y  E+ +
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLY----EI--ITRNNYNG-FHIEDIKLYCIEILK 148

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGH-------------------------LKLTDFGS 156
           A+ YL  +   H D+KP+N+LL                              +KL DFG 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGST 216
           AT         SI+   T +Y APEV+  +       G+  S D+WS G V  EL TGS 
Sbjct: 209 ATFKSDY--HGSII--NTRQYRAPEVILNL-------GWDVSSDMWSFGCVLAELYTGSL 257

Query: 217 PF----NYETLDM 225
            F    + E L M
Sbjct: 258 LFRTHEHMEHLAM 270

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 41/243 (16%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------I 61
           V   +  + R +  G FG++Y  +            V  K L E      E D      I
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127

Query: 62  MVKSKCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVT-LLENQPH----GYLSESKARFY 115
           + K     IV     S Q +   + ++E + GGD  + L E +P       L+       
Sbjct: 128 ISKFNHQNIVRCIGVSLQSL-PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNG----RIKS 168
             ++A   QYL    ++HRDI   N LL+  G     K+ DFG A  + + G       +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246

Query: 169 IVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF----NYET 222
           ++PV   +++ PE           +G +T   D WS GV+ +E+ + G  P+    N E 
Sbjct: 247 MLPV---KWMPPEAF--------MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295

Query: 223 LDM 225
           L+ 
Sbjct: 296 LEF 298

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 49/253 (19%), Positives = 105/253 (41%), Gaps = 40/253 (15%)

Query: 2   DVVKELRQKNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIER 59
           ++ ++L    +    F + R + +G FG +    ++++      V  K+L+  +  + + 
Sbjct: 10  ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69

Query: 60  D-------IMVKSKCPYIVNLF------YSFQDMNHVYFIMEYVTGGDFVT-LLENQPHG 105
           +        M +   P++  L        +   +     I+ ++  GD    LL ++   
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129

Query: 106 ---YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK 162
               L       ++ ++A  ++YL    ++HRD+   N +L+    + + DFG + ++  
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189

Query: 163 N----GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GST 216
                    S +PV   +++A E L         D  YT   D+W+ GV  +E++T G T
Sbjct: 190 GDYYRQGCASKLPV---KWLALESLA--------DNLYTVHSDVWAFGVTMWEIMTRGQT 238

Query: 217 PF----NYETLDM 225
           P+    N E  + 
Sbjct: 239 PYAGIENAEIYNY 251

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 45/257 (17%), Positives = 88/257 (34%), Gaps = 60/257 (23%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIE 58
           + VV       V          I +G+FG +Y   + +          K L         
Sbjct: 80  QHVVIGPSSLIVH-----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 134

Query: 59  RD------IMVKSKCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESK 111
                   IM     P +++L     +       ++ Y+  GD           ++    
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL--------RNFIRNET 186

Query: 112 ARF-------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG--------- 155
                     +  ++A+ +++L    +VHRD+   N +L     +K+ DFG         
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246

Query: 156 -SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT 213
             +       ++    PV   +++A E L+           +T   D+WS GV+ +EL+T
Sbjct: 247 FDSVHNKTGAKL----PV---KWMALESLQ--------TQKFTTKSDVWSFGVLLWELMT 291

Query: 214 -GSTPF----NYETLDM 225
            G+ P+     ++    
Sbjct: 292 RGAPPYPDVNTFDITVY 308

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 49/215 (22%), Positives = 77/215 (35%), Gaps = 29/215 (13%)

Query: 15  SDFDIKRFIQQGNFGDIYL---VEEKQSHNTFVMKKVLREKMPNTIERD------IMVKS 65
                 R + +G+FG + L             V  K L+                I+   
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 66  KCPYIVNLF--YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
              +I+             +  +MEYV  G     L       +  ++   +  ++ + +
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGM 147

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIKSIVPVGTPEYV 178
            YLH   Y+HRD+   N+LL     +K+ DFG A  V +       R     PV    + 
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FWY 204

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT 213
           APE L           +  + D+WS GV  YELLT
Sbjct: 205 APECL-----KEYK--FYYASDVWSFGVTLYELLT 232

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 49/253 (19%), Positives = 105/253 (41%), Gaps = 39/253 (15%)

Query: 1   KDVVKELRQKNVSASDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIE 58
           +++  +L    +  +   + + + +G FG +    ++++   +  V  K ++    +  E
Sbjct: 20  EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79

Query: 59  RD-------IMVKSKCPYIVNLF-----YSFQDMNHVYFIMEYVTGGDFVT-LLENQPHG 105
            +        M     P ++ L       S Q +     I+ ++  GD  T LL ++   
Sbjct: 80  IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139

Query: 106 ---YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK 162
              ++       ++ ++A  ++YL    ++HRD+   N +L     + + DFG + ++  
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199

Query: 163 N----GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GST 216
                    + +PV   +++A E L         D  YT   D+W+ GV  +E+ T G T
Sbjct: 200 GDYYRQGRIAKMPV---KWIAIESLA--------DRVYTSKSDVWAFGVTMWEIATRGMT 248

Query: 217 PF----NYETLDM 225
           P+    N+E  D 
Sbjct: 249 PYPGVQNHEMYDY 261

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 46/228 (20%), Positives = 89/228 (39%), Gaps = 33/228 (14%)

Query: 19  IKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCPYI 70
             R I +G+FG +Y     ++  +      K L                 +M     P +
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 71  VNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           + L           + ++ Y+  GD +  + + P    +      +  ++A+ ++YL   
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN------GRIKSIVPVGTPEYVAPEVL 183
            +VHRD+   N +L  +  +K+ DFG A  +             + +PV   ++ A E L
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV---KWTALESL 200

Query: 184 EWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
           +           +T   D+WS GV+ +ELLT G+ P+     ++    
Sbjct: 201 Q--------TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 41/243 (16%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------I 61
           V   +  + R +  G FG++Y  +            V  K L E      E D      I
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86

Query: 62  MVKSKCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVT-LLENQPHG----YLSESKARFY 115
           + K     IV     S Q +   + +ME + GGD  + L E +P       L+       
Sbjct: 87  ISKFNHQNIVRCIGVSLQSL-PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKNG----RIKS 168
             ++A   QYL    ++HRDI   N LL+  G     K+ DFG A  + +         +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205

Query: 169 IVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF----NYET 222
           ++PV   +++ PE           +G +T   D WS GV+ +E+ + G  P+    N E 
Sbjct: 206 MLPV---KWMPPEAF--------MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254

Query: 223 LDM 225
           L+ 
Sbjct: 255 LEF 257

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 49/243 (20%), Positives = 96/243 (39%), Gaps = 52/243 (21%)

Query: 12  VSASDFDIKRFIQQGNFGDIY---LVEEKQSHNTFVMKKVLREKMPNTIERD------IM 62
              ++    + +  G FG ++    + E +S    V  KV+ +K      +        +
Sbjct: 10  FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL--- 119
                 +IV L       + +  + +Y+  G    LL+     ++ + +       L   
Sbjct: 70  GSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGS---LLD-----HVRQHRGALGPQLLLNW 120

Query: 120 ----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN--------GRIK 167
               A+ + YL   G VHR++   N+LL +   +++ DFG A  +  +         +  
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT- 179

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYET 222
              P+   +++A E +     + G   YT   D+WS GV  +EL+T G+ P+      E 
Sbjct: 180 ---PI---KWMALESI-----HFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226

Query: 223 LDM 225
            D+
Sbjct: 227 PDL 229

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 50/243 (20%), Positives = 103/243 (42%), Gaps = 34/243 (13%)

Query: 4   VKELRQKN--VSASDFDIK-RFIQQGNFGDIYL-VEEKQSHNTFVMKKVLREKMPNTIER 59
           ++E+R K   +      ++ + +  GNFG +     + +     V  K+L+ +  +   +
Sbjct: 3   LEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 62

Query: 60  D-------IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKA 112
           D       +M +   PYIV +     +      +ME    G     L  Q + ++ +   
Sbjct: 63  DELLAEANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNI 119

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIK 167
              +++++  ++YL    +VHRD+   N+LL    + K++DFG +  +  +      +  
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYET 222
              PV   ++ APE +     N+    ++   D+WS GV+ +E  + G  P+      E 
Sbjct: 180 GKWPV---KWYAPECI-----NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

Query: 223 LDM 225
             M
Sbjct: 230 TAM 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 41/236 (17%)

Query: 19  IKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCP 68
           + R + QG+FG +Y        K    T V  K + E        +      +M +  C 
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 69  YIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLL--------ENQPHGYLSESKARFYIYEL 119
           ++V L     Q       IME +T GD  + L         N      S SK      E+
Sbjct: 89  HVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----RIKSIVPVGTP 175
           A  + YL+   +VHRD+   N +++    +K+ DFG    + +        K ++PV   
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV--- 204

Query: 176 EYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
            +++PE L         DG +T   D+WS GVV +E+ T    P+    N + L  
Sbjct: 205 RWMSPESL--------KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 78.4 bits (194), Expect = 5e-16
 Identities = 48/245 (19%), Positives = 83/245 (33%), Gaps = 60/245 (24%)

Query: 15  SDFDIKRFIQQGNFGDIY--LVEEKQSHNTFVMKKVLREKMPNTI--------ERDIMVK 64
            D  +   +  G+FG +     +        V  K L+  + +          E + M  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL----- 119
                ++ L Y       +  + E    G    LL+      L + +  F +  L     
Sbjct: 78  LDHRNLIRL-YGVVLTPPMKMVTELAPLGS---LLD-----RLRKHQGHFLLGTLSRYAV 128

Query: 120 --AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
             A+ + YL    ++HRD+   N+LL+    +K+ DFG         R    +P     Y
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-------R---ALPQNDDHY 178

Query: 178 V------------APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NY 220
           V            APE L        +  ++ + D W  GV  +E+ T G  P+      
Sbjct: 179 VMQEHRKVPFAWCAPESL-----KTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231

Query: 221 ETLDM 225
           + L  
Sbjct: 232 QILHK 236

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 80.0 bits (197), Expect = 6e-16
 Identities = 55/268 (20%), Positives = 93/268 (34%), Gaps = 79/268 (29%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR--EKMPNT--IERDIM-----VKSKC 67
           + + R +  G+F  ++L  + Q    FV  KV++  E    T   E  ++          
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQ-GKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97

Query: 68  P---YIVNLFYSFQ----DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA 120
           P    +V L   F+    +  H+  + E V G   +  +    +  L     +  I ++ 
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 121 QAVQYLHG-LGYVHRDIKPDNMLL------------------------------------ 143
           Q + YLH     +H DIKP+N+LL                                    
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 144 -------------SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
                        +    +K+ D G+A  V K+        + T +Y + EVL       
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE----DIQTRQYRSLEVLIGS---- 268

Query: 191 GSDGYTGSCDLWSIGVVSYELLTGSTPF 218
              GY    D+WS   +++EL TG   F
Sbjct: 269 ---GYNTPADIWSTACMAFELATGDYLF 293

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 81.4 bits (200), Expect = 6e-16
 Identities = 104/656 (15%), Positives = 202/656 (30%), Gaps = 170/656 (25%)

Query: 219 NYET--LDMTYSSILA---------CDTEDTVSFPSSIRLSTAMVNFVQSLVQKLDARLN 267
           ++ET      Y  IL+          D +D    P SI LS   +               
Sbjct: 8   DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI-LSKEEI--------------- 51

Query: 268 MDQVLGHP--------VFDCLDSDPPCIPPPSQENKFHKKDKRKASPSLK-AFQKEGRYL 318
            D ++           +F  L              KF ++  R     L    + E R  
Sbjct: 52  -DHIIMSKDAVSGTLRLFWTL-----LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-- 103

Query: 319 DSALPLIGISYTGEPMGANTNTSSDSTLPPSSEDMRHWKRDRLQLLQQLAEAKASLED-- 376
             ++         + +  N N          +         RLQ   +L +A   L    
Sbjct: 104 QPSMMTRMYIEQRDRL-YNDN----QVFAKYN-------VSRLQPYLKLRQALLELRPAK 151

Query: 377 -------LSCSRTRVLALQA-QVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKK-----E 423
                  L   +T  +AL       +Q  +      L+ K         EM++K     +
Sbjct: 152 NVLIDGVLGSGKT-WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210

Query: 424 SDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTA 483
            +  + S      +  +  +++EL+    L K   +  E C     L VL   ++  K  
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELR---RLLK--SKPYENC-----LLVLL-NVQNAKA- 258

Query: 484 TKQWKK-DWYQS---VKERNAAVAE-LKQAQTENEALKEKLTSLEQELKVSEEALATAQN 538
              W   +       +  R   V + L  A T + +L     +L  +    +  L    +
Sbjct: 259 ---WNAFN-LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE--VKSLLLKYLD 312

Query: 539 SLDSKLREHQALSN---TIESMQKEMEQSAVRVREMSGISEKYEK-DRKTLLE-LKSAKE 593
                L   + L+     + S+  E       +R+     + ++  +   L   ++S+  
Sbjct: 313 CRPQDLPR-EVLTTNPRRL-SIIAES------IRDGLATWDNWKHVNCDKLTTIIESSLN 364

Query: 594 RLE-LEVRGYKLDL----ESTR----------RELETNKDQTI--ELRAKSKLEKAEGEL 636
            LE  E R     L     S             ++  +    +  +L   S +EK   E 
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424

Query: 637 TT--------VREENKKLKQGKIRLV--YSLFK-----DPQPAQSK----------LEKA 671
           T         ++ + +        +V  Y++ K     D  P              L+  
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI 484

Query: 672 E-GELTTVREENKKLKVSFFF---TLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSA 727
           E  E        + + + F F    +  +S  W    + L++L+ LK  Y          
Sbjct: 485 EHPERM---TLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK-FYKPYICD---- 536

Query: 728 NEIIGEYETKITALESTMTRSESYCKEMVEYLETLQ-----KNNDILSHDNEQLRK 778
           N+   +YE  + A+   + + E       +Y + L+     ++  I    ++Q+++
Sbjct: 537 ND--PKYERLVNAILDFLPKIEENLICS-KYTDLLRIALMAEDEAIFEEAHKQVQR 589

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 29/224 (12%)

Query: 19  IKRFIQQGNFGDIYL-VEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCPYIV 71
               +  GNFG +   V   +     V  KVL++        +      IM +   PYIV
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L         +  +ME   GG     L  +    +  S     +++++  ++YL    +
Sbjct: 74  RL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF 131

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIKSIVPVGTPEYVAPEVLEWM 186
           VHRD+   N+LL    + K++DFG +  +  +      R     P+   ++ APE +   
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPECI--- 185

Query: 187 EGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
             N     ++   D+WS GV  +E L+ G  P+      E +  
Sbjct: 186 --NFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 55/246 (22%), Positives = 96/246 (39%), Gaps = 43/246 (17%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTI-----ERDIM 62
           +   D  +K  + +G FG ++L E      +     V  K L+E   +       E +++
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESKARFYIYEL-- 119
              +  +IV  F    +   +  + EY+  GD    L  + P   L           L  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 120 ----------AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----R 165
                     A  + YL GL +VHRD+   N L+     +K+ DFG +  +         
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217

Query: 166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF----N 219
            ++++P+    ++ PE +            +T   D+WS GVV +E+ T G  P+    N
Sbjct: 218 GRTMLPI---RWMPPESIL--------YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266

Query: 220 YETLDM 225
            E +D 
Sbjct: 267 TEAIDC 272

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 27/216 (12%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKK-VLREKMPN-TIERDIMVK-SKCPYIVNL 73
           + + R I  G+FGDIYL  +  +     +K   ++ K P   IE  I         I  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            +   + ++   +ME + G     L       +  ++       ++   ++Y+H   ++H
Sbjct: 71  RWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLL-ADQMISRIEYIHSKNFIH 128

Query: 134 RDIKPDNMLLSATGH---LKLTDFGSATQVDKNGRIKSIVP-------VGTPEYVAPEVL 183
           RD+KPDN L+        + + DFG A +  ++ R    +P        GT  Y +    
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKY-RDARTHQHIPYRENKNLTGTARYASI--- 184

Query: 184 EWMEGNHGSDGYTGSC--DLWSIGVVSYELLTGSTP 217
                 +   G   S   DL S+G V      GS P
Sbjct: 185 ------NTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 77.7 bits (191), Expect = 6e-15
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 29/218 (13%)

Query: 25  QGNFGDIYL-VEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCPYIVNLFYSF 77
            GNFG +   V   +     V  KVL++        +      IM +   PYIV L    
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL-IGV 404

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIK 137
                +  +ME   GG     L  +    +  S     +++++  ++YL    +VHR++ 
Sbjct: 405 CQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463

Query: 138 PDNMLLSATGHLKLTDFGSATQVDKN-----GRIKSIVPVGTPEYVAPEVLEWMEGNHGS 192
             N+LL    + K++DFG +  +  +      R     P+   ++ APE +     N   
Sbjct: 464 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPECI-----NFRK 515

Query: 193 DGYTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
             ++   D+WS GV  +E L+ G  P+      E +  
Sbjct: 516 --FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 551

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 76.2 bits (187), Expect = 1e-14
 Identities = 51/216 (23%), Positives = 83/216 (38%), Gaps = 27/216 (12%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMK--KVLREKMPNTIERDIMVK-SKCPYIVNL 73
           F + R I  G+FG+IYL    Q++    +K   V  +      E  I         I N+
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            +   + ++   +M+ + G     L        LS         ++   V+++H   ++H
Sbjct: 69  RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLH 126

Query: 134 RDIKPDNMLLSATGH---LKLTDFGSATQVDKNGRIKSIVP-------VGTPEYVAPEVL 183
           RDIKPDN L+        + + DFG A +  ++      +P        GT  Y +    
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTARYASV--- 182

Query: 184 EWMEGNHGSDGYTGSC--DLWSIGVVSYELLTGSTP 217
                 +   G   S   DL S+G V    L GS P
Sbjct: 183 ------NTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 51/240 (21%), Positives = 95/240 (39%), Gaps = 44/240 (18%)

Query: 19  IKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPY 69
           +KR + +G FG ++L E            V  K L++           E +++   +  +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-------ENQPHGYLSESKARFYIYEL--- 119
           IV  +    D + +  + EY+  GD    L            G   ++K    + ++   
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 120 ----AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN----GRIKSIVP 171
               A  + YL    +VHRD+   N L+ A   +K+ DFG +  V           +++P
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 172 VGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF----NYETLDM 225
           +    ++ PE +            +T   D+WS GV+ +E+ T G  P+    N E ++ 
Sbjct: 199 I---RWMPPESIM--------YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 49/256 (19%), Positives = 96/256 (37%), Gaps = 50/256 (19%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIER 59
           +KE+    V          + +  FG +Y               V  K L++K    +  
Sbjct: 3   LKEISLSAVR-----FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE 57

Query: 60  D------IMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESKA 112
           +      +  + + P +V L         +  I  Y + GD    L    PH  +  +  
Sbjct: 58  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117

Query: 113 RFYI-------------YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ 159
              +              ++A  ++YL     VH+D+   N+L+    ++K++D G   +
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 160 VDKN----GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT- 213
           V           S++P+    ++APE +          G ++   D+WS GVV +E+ + 
Sbjct: 178 VYAADYYKLLGNSLLPI---RWMAPEAIM--------YGKFSIDSDIWSYGVVLWEVFSY 226

Query: 214 GSTPF----NYETLDM 225
           G  P+    N + ++M
Sbjct: 227 GLQPYCGYSNQDVVEM 242

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 42/218 (19%), Positives = 81/218 (37%), Gaps = 29/218 (13%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMK--KVLREKMPNTIERDIMVK-SKCPYIVNL 73
           F + + I  GNFG++ L +   ++    +K   +        +E     +      I  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
           +Y      +   ++E +  G  +  L +      S         +L   ++Y+H    ++
Sbjct: 71  YYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIY 128

Query: 134 RDIKPDNMLLSATGHLK-----LTDFGSATQVDKNGRIKSIVP-------VGTPEYVAPE 181
           RD+KP+N L+   G+       + DF  A +   +   K  +P        GT  Y++  
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-IDPETKKHIPYREHKSLTGTARYMSI- 186

Query: 182 VLEWMEGNHGSDGYTGSC--DLWSIGVVSYELLTGSTP 217
                   +   G   S   DL ++G +    L GS P
Sbjct: 187 --------NTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 40/234 (17%), Positives = 78/234 (33%), Gaps = 43/234 (18%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQS-------HNTFVMKKVLREKMPNTIERDIMVKSKCPY 69
           + +K F  + N G +Y      +              K+  +      E++   ++  P 
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 70  IVNLFYSFQDMNHV----------------YFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
            VN +        +                + ++  + G    + L+  P   LSE    
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVL 162

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLK--LTDFGSATQVDKNGRIKSIVP 171
                L  A+++LH   YVH ++  +N+ +      +  L  +G A +   +G+  + V 
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 172 ------VGTPEYVAPEVLEWMEGNHGSDGYTGSC--DLWSIGVVSYELLTGSTP 217
                  G  E+++              G   S   DL S+G    + L G  P
Sbjct: 223 GSRSPHEGDLEFIS---------MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 49/232 (21%), Positives = 86/232 (37%), Gaps = 44/232 (18%)

Query: 19  IKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------IMVKSKC- 67
             + +  G FG +         K      V  K+L+     T          ++      
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL-ENQPHGYLSESKARFYI---------- 116
             IVNL  +         I EY   GD +  L   +     S++                
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 117 -----YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----RIK 167
                Y++A+ + +L     +HRD+   N+LL+     K+ DFG A  +  +     +  
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTP 217
           + +PV   +++APE +         +  YT   D+WS G+  +EL + GS+P
Sbjct: 207 ARLPV---KWMAPESIF--------NCVYTFESDVWSYGIFLWELFSLGSSP 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 52/250 (20%), Positives = 89/250 (35%), Gaps = 55/250 (22%)

Query: 19  IKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------IMVKSKCP 68
             R I +G FG ++             T V  K+L+E+    ++ D      +M +   P
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 69  YIVNLF-YSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYLSESKARF------------ 114
            IV L          +  + EY+  GD    L    PH   S S +              
Sbjct: 111 NIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 115 ---------YIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN-- 163
                       ++A  + YL    +VHRD+   N L+     +K+ DFG +  +     
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 164 --GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF- 218
                   +P+    ++ PE +            YT   D+W+ GVV +E+ + G  P+ 
Sbjct: 230 YKADGNDAIPI---RWMPPESIF--------YNRYTTESDVWAYGVVLWEIFSYGLQPYY 278

Query: 219 ---NYETLDM 225
              + E +  
Sbjct: 279 GMAHEEVIYY 288

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 51/232 (21%), Positives = 104/232 (44%), Gaps = 43/232 (18%)

Query: 19  IKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------IMVKSKC- 67
           + + + +G FG +   +    +K +    V  K+L+E   ++  R       I++     
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 68  PYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLL--------------ENQPHGYLSESKA 112
             +VNL     +    +  I+E+   G+  T L              E+    +L+    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 113 RFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----RIKS 168
             Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+     +  +
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210

Query: 169 IVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF 218
            +P+   +++APE +         D  YT   D+WS GV+ +E+ + G++P+
Sbjct: 211 RLPL---KWMAPETIF--------DRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 70.9 bits (174), Expect = 1e-12
 Identities = 39/276 (14%), Positives = 102/276 (36%), Gaps = 18/276 (6%)

Query: 351  EDMRHWK-RDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKE 409
              +R  +    +Q  Q++   +   + +   R   +ALQA +            L   K 
Sbjct: 811  TFLRRTRAAIIIQKFQRMYVVRKRYQCM---RDATIALQALLRGYLVRNKYQMMLREHKS 867

Query: 410  EEIDRLR---------QEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRK 460
              I +              +K    L      ++A + EL++++ E +  E  +K     
Sbjct: 868  IIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMA-KRELKKLKIEARSVERYKKLHI-G 925

Query: 461  LE--VCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEK 518
            LE  + ++ ++++    E +         +  +    ++  + V  L+ ++ E +    +
Sbjct: 926  LENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNR 985

Query: 519  LTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKY 578
            + SL++E+    + L   Q    +         +  E +  E+++    ++       + 
Sbjct: 986  VLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRR 1045

Query: 579  EKDRKTLLELKSAKERLELEVRGYKLDLESTRRELE 614
              D+   +  ++ +++L  E +  +LDL   R   +
Sbjct: 1046 IHDQAKEIT-ETMEKKLVEETKQLELDLNDERLRYQ 1080

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 65.1 bits (159), Expect = 6e-11
 Identities = 35/226 (15%), Positives = 79/226 (34%), Gaps = 20/226 (8%)

Query: 441  EEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNA 500
              +R  L   +      + K  + +      + R        A    +  + + + +R  
Sbjct: 847  ALLRGYLVRNKYQMMLREHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMAKR-- 904

Query: 501  AVAELKQAQTENEALKEKLTSLEQELKVSEEAL-----------ATAQNSLDSKLREHQA 549
             + +LK      E  K+    LE ++   +  +               N   +   E + 
Sbjct: 905  ELKKLKIEARSVERYKKLHIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEK 964

Query: 550  LSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLEST 609
            L + +E ++   E++      +  + E+  K RK L + ++ K+ +E     YK + E  
Sbjct: 965  LRSDVERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQL 1024

Query: 610  RRELETNKDQTIELRAK--SKLEKAEGELT-----TVREENKKLKQ 648
              EL+         + +   ++     E+T      + EE K+L+ 
Sbjct: 1025 VSELKEQNTLLKTEKEELNRRIHDQAKEITETMEKKLVEETKQLEL 1070

>2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080

 Score = 55.5 bits (134), Expect = 7e-08
 Identities = 40/323 (12%), Positives = 90/323 (27%), Gaps = 52/323 (16%)

Query: 474  RGELEEQKTATKQWKKDW--YQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEE 531
            RG          +  +     Q  +         +  +    AL+  L       K    
Sbjct: 802  RGHQARCYATFLRRTRAAIIIQKFQRMYVVRKRYQCMRDATIALQALLRGYLVRNKYQMM 861

Query: 532  ALATAQNSLDSKLREHQALSNTIESMQKEME-QSAVRVREMSGISEKYEKDRKTLLELKS 590
                    +   +R   A  +   +++  +  Q   R              ++ L +LK 
Sbjct: 862  LREHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRM----------MAKRELKKLKI 911

Query: 591  AKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGK 650
                +E   +   + LE+   +L+             K+++   E  ++ E+   L+   
Sbjct: 912  EARSVERYKK-LHIGLENKIMQLQ------------RKIDEQNKEYKSLLEKMNNLEITY 958

Query: 651  IRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSL 710
                  L  D      +L  +E E          L+                       +
Sbjct: 959  STETEKLRSD----VERLRMSEEEAKNATNRVLSLQ---------------------EEI 993

Query: 711  EDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLET-LQKNNDIL 769
              L+    + +++ ++  E   +Y+ +   L S +    +  K   E L   +      +
Sbjct: 994  AKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEI 1053

Query: 770  SHDNEQLRKKNNDILSHDNEQLR 792
            +   E+   +    L  D    R
Sbjct: 1054 TETMEKKLVEETKQLELDLNDER 1076

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 52/253 (20%), Positives = 104/253 (41%), Gaps = 53/253 (20%)

Query: 15  SDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------IMVK 64
            +  + + + +G FG +        + ++  T V  K+L+E    +  RD      ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYLSESKARFYI------- 116
              P+++ L+ +      +  I+EY   G     L E++  G                  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 117 --------------YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK 162
                         ++++Q +QYL  +  VHRD+   N+L++    +K++DFG +  V +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 163 NG----RIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GST 216
                 R +  +PV   +++A E L         D  YT   D+WS GV+ +E++T G  
Sbjct: 203 EDSYVKRSQGRIPV---KWMAIESL--------FDHIYTTQSDVWSFGVLLWEIVTLGGN 251

Query: 217 PF----NYETLDM 225
           P+         ++
Sbjct: 252 PYPGIPPERLFNL 264

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 66.9 bits (164), Expect = 5e-12
 Identities = 55/249 (22%), Positives = 98/249 (39%), Gaps = 50/249 (20%)

Query: 15  SDFDIKRFIQQGNFGDIY------LVEEKQSHNTFVMKKVLREKMPNTIERD------IM 62
               + + + +G FG +       + ++K      V  K+L++        D      +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 63  VKSKC-PYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLL--------------ENQPHGY 106
                   I+NL     QD   +Y I+EY + G+    L                 P   
Sbjct: 95  KMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153

Query: 107 LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-- 164
           ++        Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213

Query: 165 --RIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF-- 218
                  +PV   +++APE L         D  YT   D+WS GV+ +E+ T G +P+  
Sbjct: 214 KKTTNGRLPV---KWMAPEALF--------DRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 219 --NYETLDM 225
               E   +
Sbjct: 263 IPVEELFKL 271

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 46/234 (19%), Positives = 77/234 (32%), Gaps = 46/234 (19%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHN---TFVMK-------------KVLRE--KMPNTIE 58
           + + + I  G FG IYL             V+K             K  +   K     +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 59  RDIMVKSKCPYIVNLFYS----FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARF 114
                +     I   + S    F+  ++ + +ME + G D   +     +G   +     
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKK-STVL 154

Query: 115 YI-YELAQAVQYLHGLGYVHRDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIKSIVP 171
            +   +   ++Y+H   YVH DIK  N+LL       + L D+G + +   NG  K    
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 172 ------VGTPEYVAPEVLEWMEGNHGSDGYTGSC--DLWSIGVVSYELLTGSTP 217
                  GT E+ +              G   S   D+  +G      L G  P
Sbjct: 215 NPRKGHNGTIEFTS---------LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 56/244 (22%), Positives = 98/244 (40%), Gaps = 48/244 (19%)

Query: 19  IKRFIQQGNFGDIY------LVEEKQSHNTFVMKKVLREKMPNTIERD------IMVKSK 66
           + + + +G FG +       L ++K +  T V  K+L+         D      +M    
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 67  C-PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL--------------ENQPHGYLSESK 111
               I+NL  +      +Y I+EY + G+    L               + P   LS   
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----RIK 167
                Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +           
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF----NYE 221
             +PV   +++APE L         D  YT   D+WS GV+ +E+ T G +P+      E
Sbjct: 253 GRLPV---KWMAPEALF--------DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301

Query: 222 TLDM 225
              +
Sbjct: 302 LFKL 305

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 54/248 (21%), Positives = 97/248 (39%), Gaps = 48/248 (19%)

Query: 15  SDFDIKRFIQQGNFGDIY------LVEEKQSHNTFVMKKVLREKMPNTIERD------IM 62
               + + + +G FG +       + ++K      V  K+L++        D      +M
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 63  VKSKC-PYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYLSESKARFYI---- 116
                   I+NL  +      +Y I+EY + G+    L   +P G               
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 117 ---------YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG--- 164
                    Y+LA+ ++YL     +HRD+   N+L++    +K+ DFG A  ++      
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 165 -RIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF--- 218
                 +PV   +++APE L         D  YT   D+WS GV+ +E+ T G +P+   
Sbjct: 261 KTTNGRLPV---KWMAPEALF--------DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309

Query: 219 -NYETLDM 225
              E   +
Sbjct: 310 PVEELFKL 317

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 52/244 (21%), Positives = 96/244 (39%), Gaps = 48/244 (19%)

Query: 15  SDFDIKRFIQQGNFGDIYLVE-EKQSHNTFVMKKVLREKMPNTIERD------IMVKSKC 67
           +D   +  I +GNFG +     +K         K ++E       RD      ++ K   
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 68  -PYIVNLFYSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYLSESKARFYI--------- 116
            P I+NL  + +   ++Y  +EY   G+ +  L +++                       
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 117 ----YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD-----KNGRIK 167
                ++A+ + YL    ++HRD+   N+L+      K+ DFG +   +       GR+ 
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL- 203

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTPF----NYE 221
              PV    ++A E L            YT + D+WS GV+ +E+++ G TP+      E
Sbjct: 204 ---PV---RWMAIESLN--------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249

Query: 222 TLDM 225
             + 
Sbjct: 250 LYEK 253

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 50/228 (21%), Positives = 85/228 (37%), Gaps = 40/228 (17%)

Query: 19  IKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------IMVKSKC- 67
             + +  G FG +         K+     V  K+L+       +        IM      
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL------------ENQPHGYLSESKARFY 115
             IVNL  +      V  I EY   GD +  L                +   S      +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG----RIKSIVP 171
             ++AQ + +L     +HRD+   N+LL+     K+ DFG A  +  +     +  + +P
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 172 VGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTP 217
           V   +++APE +         D  YT   D+WS G++ +E+ + G  P
Sbjct: 230 V---KWMAPESIF--------DCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 51/238 (21%)

Query: 19  IKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPNTIERD------IMVKSKC- 67
             + +  G FG +         K   +  V  K+L+EK  ++          +M +    
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 68  PYIVNLF-YSFQDMNHVYFIMEYVTGGDFVT-LLENQPHGYLSESKARFYI--------- 116
             IVNL          +Y I EY   GD +  L   +      E +              
Sbjct: 109 ENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 117 -----------YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG- 164
                      Y++A+ +++L     VHRD+   N+L++    +K+ DFG A  +  +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 165 ---RIKSIVPVGTPEYVAPEVLEWMEGNHGSDG-YTGSCDLWSIGVVSYELLT-GSTP 217
              R  + +PV   +++APE L         +G YT   D+WS G++ +E+ + G  P
Sbjct: 228 YVVRGNARLPV---KWMAPESLF--------EGIYTIKSDVWSYGILLWEIFSLGVNP 274

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 13/98 (13%)

Query: 120 AQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---VGTPE 176
           A  + +LH   ++HRDIK  N+LL      K++DFG A   +K    ++++    VGT  
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTA 200

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG 214
           Y+APE    + G       T   D++S GVV  E++TG
Sbjct: 201 YMAPE---ALRGE-----ITPKSDIYSFGVVLLEIITG 230

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 48/243 (19%), Positives = 86/243 (35%), Gaps = 49/243 (20%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNT-----FVMKKVLREKMPNTIERDIMVKS 65
           +++A+ + +   I QG FG IYL +   S +       V+K    +  P   E     ++
Sbjct: 31  DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90

Query: 66  KCPYIVNLFYSFQDMNHV------YFIMEYVTGGDFVTL--------LENQPHGYLSESK 111
             P  +  +   + + ++         +    G  +  +        L+         + 
Sbjct: 91  AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK----IYEANA 146

Query: 112 ARFYI-------YELAQAVQYLHGLGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDK 162
            RF           +   ++Y+H   YVH DIK  N+LL+      + L D+G A +   
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 163 NGRIKSIVP------VGTPEYVAPEVLEWMEGNHGSDGYTGSC--DLWSIGVVSYELLTG 214
            G  K+          GT E+ +             +G   S   DL  +G    + LTG
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS---------IDAHNGVAPSRRGDLEILGYCMIQWLTG 257

Query: 215 STP 217
             P
Sbjct: 258 HLP 260

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.7 bits (147), Expect = 7e-10
 Identities = 41/205 (20%), Positives = 90/205 (43%), Gaps = 20/205 (9%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQ 78
           I  F + GN    YL  ++     +  K     +  + +    +       + ++  S  
Sbjct: 105 IVEFCKFGNLST-YLRSKRNEFVPYKTKGARFRQGKDYVGAIPV--DLKRRLDSITSSQS 161

Query: 79  DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP 138
             +  +   + ++  +     E+    +L+      Y +++A+ +++L     +HRD+  
Sbjct: 162 SASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 221

Query: 139 DNMLLSATGHLKLTDFGSATQVDKNG----RIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
            N+LLS    +K+ DFG A  + K+     +  + +P+   +++APE +         D 
Sbjct: 222 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL---KWMAPETIF--------DR 270

Query: 195 -YTGSCDLWSIGVVSYELLT-GSTP 217
            YT   D+WS GV+ +E+ + G++P
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGASP 295

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 59.1 bits (144), Expect = 2e-09
 Identities = 39/145 (26%), Positives = 61/145 (42%), Gaps = 21/145 (14%)

Query: 83  VYFIMEYVTGGDFVTLLENQPHGYLSES-----KARFYI-YELAQAVQYLHGLGYVHRDI 136
           +Y   +Y+  G+    L+   +G    +     + R  I    A+ + YLH    +HRD+
Sbjct: 113 IY---KYMENGN----LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV 165

Query: 137 KPDNMLLSATGHLKLTDFGSATQVDKNGRIK-SIVPVGTPEYVAPEVLEWMEGNHGSDGY 195
           K  N+LL      K+TDFG + +  +  +   S V  GT  Y+ PE          SD Y
Sbjct: 166 KSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVY 225

Query: 196 TGSCDLWSIGVVSYELLTGSTPFNY 220
                  S GVV +E+L   +    
Sbjct: 226 -------SFGVVLFEVLCARSAIVQ 243

>1cii_A Colicin IA; bacteriocin, ION channel formation, transmembrane protein; 3.00A {Escherichia coli} SCOP: f.1.1.1 h.4.3.1 Length = 602

 Score = 57.8 bits (138), Expect = 1e-08
 Identities = 43/447 (9%), Positives = 131/447 (29%), Gaps = 30/447 (6%)

Query: 348 PSSEDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVL-ALQAQVSSLQQDLTSHTSLLS 406
           P+  D+    ++       L+  +   E+      + L A  A     +  L +  +  +
Sbjct: 43  PTRSDIEKRDKEITAYKNTLSAQQKENENKRTEAGKRLSAAIAAREKDENTLKTLRAGNA 102

Query: 407 KKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEV 466
              +   +  + +  +  +    +         L      L      +       E   +
Sbjct: 103 DAADITRQEFRLLQAELREYGFRTEIAGYDALRLHTESRMLFADA--DSLRISPREARSL 160

Query: 467 SKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAEL-KQAQTENEALKEKLTSLEQE 525
            ++ E  + + +           ++ +     +  ++EL K        L  +   L  +
Sbjct: 161 IEQAEKRQKDAQNADKKAADMLAEYERRKGILDTRLSELEKNGGAALAVLDAQQARLLGQ 220

Query: 526 LKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTL 585
              ++ A++ A+N L S         N +   ++++ Q        + +S +    R + 
Sbjct: 221 QTRNDRAISEARNKLSSVTESLNTARNALTRAEQQLTQQKNTPDGKTIVSPEKFPGRSST 280

Query: 586 LELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKK 645
            +       +      +   ++ T   +  N+     L + S L+     L        +
Sbjct: 281 ND-----SIVVSGDPRFAGTIKITTSAVIDNRANLNYLLSHSGLDYKRNILNDRNPVVTE 335

Query: 646 LKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNT 705
             +G  ++  +   +    + +L  A  ++T+        +                   
Sbjct: 336 DVEGDKKIYNAEVAEWDKLRQRLLDARNKITSAESAVNSAR------------------- 376

Query: 706 FLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKN 765
             ++L    +        L +  +       +++ +   +   +    E+    + +   
Sbjct: 377 --NNLSARTNEQKHANDALNALLKEKENIRNQLSGINQKIAEEKRKQDELKATKDAINFT 434

Query: 766 NDILSHDNEQLRKKNNDILSHDNEQLR 792
            + L   +E+   K   +      Q +
Sbjct: 435 TEFLKSVSEKYGAKAEQLAREMAGQAK 461

>1cii_A Colicin IA; bacteriocin, ION channel formation, transmembrane protein; 3.00A {Escherichia coli} SCOP: f.1.1.1 h.4.3.1 Length = 602

 Score = 45.5 bits (106), Expect = 6e-05
 Identities = 42/360 (11%), Positives = 97/360 (26%), Gaps = 6/360 (1%)

Query: 422 KESDLVATSSDLVATRHELEEVRSELKE--KENLEKTDDRKLEVCEVSKELEVLRGELEE 479
           +  D   T SD+     E+   ++ L    KEN  K  +    +       E     L+ 
Sbjct: 37  EWVDDSPTRSDIEKRDKEITAYKNTLSAQQKENENKRTEAGKRLSAAIAAREKDENTLKT 96

Query: 480 QKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNS 539
            +           Q  +   A + E             +L +  + L    ++L  +   
Sbjct: 97  LRAGNADAADITRQEFRLLQAELREYGFRTEIAGYDALRLHTESRMLFADADSLRISPRE 156

Query: 540 LDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEV 599
             S + + +      ++  K+            GI +    +    LE         L+ 
Sbjct: 157 ARSLIEQAEKRQKDAQNADKKAADMLAEYERRKGILDTRLSE----LEKNGGAALAVLDA 212

Query: 600 RGYKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGKIRLVYSLFK 659
           +  +L  + TR +   ++ +         L  A   LT   ++  + K           +
Sbjct: 213 QQARLLGQQTRNDRAISEARNKLSSVTESLNTARNALTRAEQQLTQQKNTPDGKTIVSPE 272

Query: 660 DPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFLSSLEDLKSNYTE 719
                 S  +              K+  S      +N  + L  +        L      
Sbjct: 273 KFPGRSSTNDSIVVSGDPRFAGTIKITTSAVIDNRANLNYLLSHSGLDYKRNILNDRNPV 332

Query: 720 RESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETLQKNNDILSHDNEQLRKK 779
               +    +I      +   L   +  + +        + + + N    +++ +     
Sbjct: 333 VTEDVEGDKKIYNAEVAEWDKLRQRLLDARNKITSAESAVNSARNNLSARTNEQKHANDA 392

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 44/270 (16%), Positives = 103/270 (38%), Gaps = 18/270 (6%)

Query: 386 ALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRS 445
               +    + D  +      + E+E+  L++++   E +L   S  L   + +LE    
Sbjct: 17  NALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKYSEALKDAQEKLELAEK 76

Query: 446 ELKEKENL------------EKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQ 493
           +  + E              E+ D  +  +    ++LE      +E +   K  +    +
Sbjct: 77  KATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQK 136

Query: 494 SVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNT 553
             ++      +LK+A+   E    K   + ++L + E  L  A+   +    +   L   
Sbjct: 137 DEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEE 196

Query: 554 IESMQKEMEQSAVRVREMSGISEKYEKDRKTLL----ELKSAKERLELEVRGYKLDLEST 609
           I+++   ++    +  + S   +KYE++ K L     E ++  E  E  V   +  ++  
Sbjct: 197 IKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDL 256

Query: 610 RRELETNKDQTIELRAKSKLEKAEGELTTV 639
             EL   K +   +    +L+ A  ++T++
Sbjct: 257 EDELYAQKLKYKAISE--ELDHALNDMTSI 284

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 42/265 (15%), Positives = 102/265 (38%), Gaps = 4/265 (1%)

Query: 386 ALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRS 445
            L+    +         +     E+   +L  E+V  +  L AT  +L      L++ + 
Sbjct: 10  MLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKYSEALKDAQE 69

Query: 446 ELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAEL 505
           +L+  E  +K  D + +V  +++ +++   EL+  +       +   ++ K  + +   +
Sbjct: 70  KLELAE--KKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGM 127

Query: 506 KQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSA 565
           K  ++  +  +EK+   E +LK ++     A    +   R+   + + +E  ++  E S 
Sbjct: 128 KVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSE 187

Query: 566 VRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRA 625
            +  E+    +    + K+L        + E +       L    +E ET  +       
Sbjct: 188 GKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVT 247

Query: 626 K--SKLEKAEGELTTVREENKKLKQ 648
           K    ++  E EL   + + K + +
Sbjct: 248 KLEKSIDDLEDELYAQKLKYKAISE 272

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 42/272 (15%), Positives = 103/272 (37%), Gaps = 4/272 (1%)

Query: 513 EALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMS 572
           +A+K+K+  L+ + + + +    A+    +     + L + + S+QK+++ +     E+ 
Sbjct: 2   DAIKKKMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATE---DELD 58

Query: 573 GISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIELRAK-SKLEK 631
             SE  +  ++ L   +      E +V      ++    EL+  +++      K  + EK
Sbjct: 59  KYSEALKDAQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEK 118

Query: 632 AEGELTTVREENKKLKQGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFF 691
           A  E     +  +   Q     +       + A+   E A+ +   V  +   ++     
Sbjct: 119 AADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLER 178

Query: 692 TLESNSLFWLDPNTFLSSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESY 751
             E   L           ++ + +N    E++    ++   +YE +I  L   +  +E+ 
Sbjct: 179 AEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETR 238

Query: 752 CKEMVEYLETLQKNNDILSHDNEQLRKKNNDI 783
            +     +  L+K+ D L  +    + K   I
Sbjct: 239 AEFAERSVTKLEKSIDDLEDELYAQKLKYKAI 270

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 39/295 (13%), Positives = 102/295 (34%), Gaps = 13/295 (4%)

Query: 470 LEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVS 529
           ++ ++ +++  K   +       ++  ++ AA    KQ + E  +L++KL + E EL   
Sbjct: 1   MDAIKKKMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKY 60

Query: 530 EEALATAQNSLDSKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELK 589
            EAL  AQ  L+   ++       + S+ + ++     +           +  +   +  
Sbjct: 61  SEALKDAQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAA 120

Query: 590 SAKERLELEVRGYKLDLESTRRELETNKDQTIELR--AKSKLEKAEGELTTVREENKKLK 647
              ER    +       E      E    +   +   A  K E+   +L  +  + ++ +
Sbjct: 121 DESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAE 180

Query: 648 QGKIRLVYSLFKDPQPAQSKLEKAEGELTTVREENKKLKVSFFFTLESNSLFWLDPNTFL 707
           +             + ++ K  + E E+ TV    K L+       +    +  +     
Sbjct: 181 ERA-----------ELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLS 229

Query: 708 SSLEDLKSNYTERESKLRSANEIIGEYETKITALESTMTRSESYCKEMVEYLETL 762
             L++ ++     E  +    + I + E ++ A +             +  + ++
Sbjct: 230 DKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLKYKAISEELDHALNDMTSI 284

>3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} Length = 256

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 23/160 (14%), Positives = 65/160 (40%)

Query: 390 QVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKE 449
           ++S L +++ S   L+ +K +++D+   +   K   ++    + +A + ++ +    L++
Sbjct: 12  EISHLDKEIDSLEPLIREKRKDLDKALNDKEAKNKAILNLEEEKLALKLQVSKNEQTLQD 71

Query: 450 KENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQ 509
                 +  +K+   +  +EL  L  E +  K  + Q  ++      E      + +  +
Sbjct: 72  TNAKIASIQKKMSEIKSERELRSLNIEEDIAKERSNQANREIENLQNEIKRKSEKQEDLK 131

Query: 510 TENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQA 549
            E   L++    LE  ++   + +   Q  +  K  +   
Sbjct: 132 KEMLELEKLALELESLVENEVKNIKETQQIIFKKKEDLVE 171

>3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} Length = 256

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 18/195 (9%), Positives = 62/195 (31%), Gaps = 18/195 (9%)

Query: 443 VRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAV 502
             + LK+   +   D     +  + +E      +    K A            K      
Sbjct: 3   SNTHLKQLIEISHLDKEIDSLEPLIREKRKDLDKALNDKEAKN----------KAILNLE 52

Query: 503 AELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSNTIESMQKEME 562
            E    + +    ++ L     ++   ++ ++  ++      RE ++L+   +  ++   
Sbjct: 53  EEKLALKLQVSKNEQTLQDTNAKIASIQKKMSEIKSE-----RELRSLNIEEDIAKERSN 107

Query: 563 QSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLESTRRELETNKDQTIE 622
           Q+   +     +  + ++  +   +LK     LE      +  +E+  + ++  +    +
Sbjct: 108 QANREIEN---LQNEIKRKSEKQEDLKKEMLELEKLALELESLVENEVKNIKETQQIIFK 164

Query: 623 LRAKSKLEKAEGELT 637
            +     +      +
Sbjct: 165 KKEDLVEKTEPKIYS 179

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 31/110 (28%), Positives = 49/110 (44%), Gaps = 22/110 (20%)

Query: 120 AQAVQYLH---GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-----RIKSIVP 171
           A+ + YLH       +HRD+K  N+LL       + DFG A  +D         ++    
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR---- 196

Query: 172 VGTPEYVAPEVLEWMEGNHGSDGY-TGSCDLWSIGVVSYELLTGSTPFNY 220
            GT  ++APE        + S G  +   D++  GV+  EL+TG   F+ 
Sbjct: 197 -GTIGHIAPE--------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.4 bits (122), Expect = 6e-07
 Identities = 39/246 (15%), Positives = 75/246 (30%), Gaps = 59/246 (23%)

Query: 9   QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKV-------------------- 48
              +          I +G FG+++       H    +K +                    
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 49  -----------LREKMPNTIERD------IMVKSKCP--------------YIVNLFYSF 77
                      L  ++ N  E          V+   P                 N    F
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 78  QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH-GLGYVHRDI 136
              + ++ ++E+  GG     LE       S + A+  +++L  ++      L + HRD+
Sbjct: 132 FKDDQLFIVLEFEFGG---IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDL 188

Query: 137 KPDNMLLSATGHLKLTDF--GSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDG 194
              N+LL  T   KL     G ++ +   G   SI+           ++ + + +   D 
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248

Query: 195 YTGSCD 200
           +TG  D
Sbjct: 249 FTGDGD 254

>2xs1_A Programmed cell death 6-interacting protein; protein transport-viral protein complex, cell cycle; 2.30A {Homo sapiens} PDB: 2xs8_A 2oev_A 2r05_A 2r02_A 2r03_A 2oex_A 2ojq_A Length = 704

 Score = 51.5 bits (122), Expect = 9e-07
 Identities = 36/289 (12%), Positives = 81/289 (28%), Gaps = 29/289 (10%)

Query: 362 QLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEEEIDRLRQEMVK 421
           Q +   + +      +      +  L   +   ++ L     LL ++E   + LR +  K
Sbjct: 421 QSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAK-FK 479

Query: 422 KESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKELEVLRGELEEQK 481
           +      ++      R E    R+ L +    +       +       + +L     E  
Sbjct: 480 ERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQ--SHRDTIVLLCKPEPELN 537

Query: 482 TATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLD 541
                          + +  V  LK   +  + +K++   LE +LK       +    + 
Sbjct: 538 ---AAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLK-------SVNFDMT 587

Query: 542 SKLREHQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRG 601
           SK     A    I      + +          +   Y      + E    +E L   ++ 
Sbjct: 588 SKFLTALAQDGVINEEALSVTE----------LDRVYGGLTTKVQESLKKQEGLLKNIQV 637

Query: 602 YKLDLESTRRELETNKDQTIELRAKSKLEKAEGELTTVREENKKLKQGK 650
              +    ++       +      +  L+          E    LK+G 
Sbjct: 638 SHQEFSKMKQSNNEANLR------EEVLKNLATAYDNFVELVANLKEGT 680

>3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A* 3vkh_C* Length = 3245

 Score = 47.2 bits (112), Expect = 3e-05
 Identities = 35/235 (14%), Positives = 75/235 (31%), Gaps = 33/235 (14%)

Query: 401  HTSLLSKKEEEIDRLRQEMVKKES---DLVATSSDLVAT-RHELEEVRSELKEKENLEKT 456
            H ++       + R  ++         D +     L+   R +LEE +  L     L+K 
Sbjct: 1872 HQTIGEANIRLLKRQGRQNYVTPRHYLDFINQVVLLINEKRDQLEEEQLHLNI--GLKKL 1929

Query: 457  DDRKLEVCEVSKELEVLRGELEEQKTAT----KQWKKDWYQSVKERNAAVAELKQAQTEN 512
             D + +V ++   L     EL+ +        KQ  +D   +  ++  A     Q    N
Sbjct: 1930 RDTEAQVKDLQVSLAQKNRELDVKNEQANQKLKQMVQDQQAAEIKQKDARELQVQLDVRN 1989

Query: 513  E--------------------ALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSN 552
            +                     L+E++  LE      +        ++ +  +       
Sbjct: 1990 KEIAVQKVKAYADLEKAEPTGPLREEVEQLENAANELKLKQDEIVATITALEKSIATYKE 2049

Query: 553  TIESMQKEMEQSAVRVREMSGISEKYEKDRKTLLELKSAKERLELEVRGYKLDLE 607
               ++ +E EQ      ++     K ++    L  L S + R E +   +   + 
Sbjct: 2050 EYATLIRETEQIKTESSKV---KNKVDRSIALLDNLNSERGRWEQQSENFNTQMS 2101

>1g8x_A Myosin II heavy chain fused to alpha-actinin 3; motor, lever ARM, protein engineering, structural protein; HET: ADP; 2.80A {Dictyostelium discoideum} SCOP: k.1.1.1 Length = 1010

 Score = 45.0 bits (107), Expect = 1e-04
 Identities = 23/181 (12%), Positives = 58/181 (32%), Gaps = 16/181 (8%)

Query: 351  EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE 410
              +        ++    +  + + ++ + +    L  Q +++ L Q    +  +L K E 
Sbjct: 844  PFVAPAGLTPNEIDSTWSALEKAEQEHAEALRIELKRQKKIAVLLQ---KYNRILKKLEN 900

Query: 411  EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKEL 470
                    +   E     + + + A    LE    E +  E    +D   +   ++++  
Sbjct: 901  WATTKSVYLGSNE--TGDSITAVQAKLKNLEAFDGECQSLEGQSNSDLLSILA-QLTELN 957

Query: 471  EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSE 530
                 EL E+K              ++     +  +  +    A  E+L  +E +L    
Sbjct: 958  YNGVPELTERKDTFFA---------QQWTGVKSSAETYKNTLLAELERLQKIE-DLHHHH 1007

Query: 531  E 531
             
Sbjct: 1008 H 1008

>1g8x_A Myosin II heavy chain fused to alpha-actinin 3; motor, lever ARM, protein engineering, structural protein; HET: ADP; 2.80A {Dictyostelium discoideum} SCOP: k.1.1.1 Length = 1010

 Score = 42.7 bits (101), Expect = 6e-04
 Identities = 22/162 (13%), Positives = 51/162 (31%), Gaps = 15/162 (9%)

Query: 351  EDMRHWKRDRLQLLQQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSLLSKKEE 410
            E       + L++  +  +  A L        + L   A   S+          ++  + 
Sbjct: 864  EKAEQEHAEALRIELKRQKKIAVLLQKYNRILKKLENWATTKSVYLGSNETGDSITAVQA 923

Query: 411  EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENLEKTDDRKLEVCEVSKEL 470
            ++  L     + +S    ++SDL++   +L E+       E  E+ D         +++ 
Sbjct: 924  KLKNLEAFDGECQSLEGQSNSDLLSILAQLTELNYN-GVPELTERKDTFF------AQQW 976

Query: 471  EVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTEN 512
              ++   E  K               ER   + +L      +
Sbjct: 977  TGVKSSAETYKNTLLAEL--------ERLQKIEDLHHHHHHH 1010

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	792
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.9
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.45
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.43
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.22
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.13
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.12
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.12
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.98
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.58
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.42
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.4
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.37
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.28
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.01
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.92
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.88
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.88
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.75
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.74
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.67
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.5
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	96.22
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	95.96
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.85
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.59
1c1g_A	284	Tropomyosin; contractIle protein; 7.00A {Sus scrof	95.58
1i84_S	1184	Smooth muscle myosin heavy chain; muscle protein,	94.81
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.55
3vkg_A	3245	Dynein heavy chain, cytoplasmic; AAA+ protein, mol	91.77
3na7_A	256	HP0958; flagellar biogenesis, flagellum export, C4	90.0
3o0z_A	168	RHO-associated protein kinase 1; coiled-coil, tran	88.76
3na7_A	256	HP0958; flagellar biogenesis, flagellum export, C4	82.51
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.49

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.8e-60  Score=509.79  Aligned_cols=256  Identities=30%  Similarity=0.633  Sum_probs=231.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ....++|++++.||+|+||+||+|+++.+|+.||+|++.+.....       ..|+.+|+.++|||||+++++|++++.+
T Consensus        28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            345678999999999999999999999999999999997653211       5799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |||||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus       108 yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999999965  456999999999999999999999999999999999999999999999999999987543


Q ss_pred             C-CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        164 G-RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~-~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      . .....+.||||.|||||++.+.       .|+.++|||||||++|+|++|.+||.+.+...++.+|..    ..+.+|
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~-------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~----~~~~~p  254 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEK-------SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK----LEYDFP  254 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHS-------CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCCCCC
T ss_pred             CCcccccCcccCcccCCHHHHcCC-------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCC
Confidence            2 2344567999999999999853       789999999999999999999999999999999999987    456677


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhH------HhcCCCccCCC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQ------VLGHPVFDCLD  281 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeE------IL~HPwF~~i~  281 (792)
                      .  .+|+++++||.+||. ||.+|||+.+      +++||||++++
T Consensus       255 ~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          255 E--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             T--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             c--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            6  789999999999999 9999999988      58999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.8e-59  Score=501.70  Aligned_cols=262  Identities=35%  Similarity=0.674  Sum_probs=225.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +...++|++++.||+|+||+||+|++.   .+|+.||+|++.+....      ...|+.+|++++|||||+++++|++++
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            355678999999999999999999884   47889999999765332      257899999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|||||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999999965  4569999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ... ....+.+|||.|||||++.+       ..|+.++|||||||++|+|++|.+||.+.+...++..|..    ..+.+
T Consensus       178 ~~~-~~~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~~~~~  245 (304)
T 3ubd_A          178 DHE-KKAYSFCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----AKLGM  245 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHT-------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCC
T ss_pred             CCC-ccccccccCcccCCHHHhcc-------CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc----CCCCC
Confidence            332 23446789999999999974       3789999999999999999999999999999999999887    44556


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIP  288 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P  288 (792)
                      |.  .+|+++++||.+||+ ||.+|||     ++++++||||++++        ..||++|
T Consensus       246 p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P  304 (304)
T 3ubd_A          246 PQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP  304 (304)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred             CC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence            65  689999999999999 9999998     47999999999876        3566665

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.1e-58  Score=499.61  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=226.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ...|++++.||+|+||+||+|+++.+|+.||||++.+.....    ..|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            356999999999999999999999999999999997654433    6899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      |+||+|.+++.+   +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+.... ....
T Consensus       153 ~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~  228 (346)
T 4fih_A          153 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK  228 (346)
T ss_dssp             CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred             CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cccc
Confidence            999999999965   359999999999999999999999999999999999999999999999999999876433 2345


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      +.+|||.|||||++..       ..|+.++|||||||++|+|++|.+||.+.+....+..|...   ....++.+..+|+
T Consensus       229 ~~~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~~~~~~~~~~s~  298 (346)
T 4fih_A          229 SLVGTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LPPRLKNLHKVSP  298 (346)
T ss_dssp             CCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---SCCCCSCGGGSCH
T ss_pred             ccccCcCcCCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CCCCCCccccCCH
Confidence            6789999999999963       37999999999999999999999999998888888877652   1223444557899


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ++++||.+||. ||.+|||+.++|+||||+...
T Consensus       299 ~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          299 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999 999999999999999998643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5e-58  Score=499.58  Aligned_cols=254  Identities=26%  Similarity=0.443  Sum_probs=222.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++.+.....      ..|+.+|++++|||||+++++|++.+.+|||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4679999999999999999999999999999999998776554      5799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||||+||+|.++|.......+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+.... .
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~  180 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E  180 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence            999999999999987666778999999999999999999999999999999999999999999999999998775322 1


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      ...+.+|||.|||||++.+       ..|+.++|||||||++|+|++|++||.+.+...++..|.....   .  +.+..
T Consensus       181 ~~~~~~GT~~YmAPE~l~~-------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~--~~~~~  248 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICEN-------KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF---P--PVSLH  248 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---C--CCCTT
T ss_pred             cccccCCCccccCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---C--CCCcc
Confidence            2345689999999999974       3799999999999999999999999999999888888877322   1  22347


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +|+++++||.+||. ||.+|||+.++|+||||..
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            89999999999999 9999999999999999974

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.4e-58  Score=482.39  Aligned_cols=251  Identities=23%  Similarity=0.457  Sum_probs=208.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ..+++|++++.||+|+||+||+|+++.+|+.||+|++.+.....       ..|+.+++.++|||||+++++|++++.+|
T Consensus        10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            35679999999999999999999999999999999998765432       57999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||||| +|+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus        90 ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999999 7899999965  4569999999999999999999999999999999999999999999999999998765432


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                        ...+.+|||.|||||++.+.      ..++.++||||+||++|+|++|++||.+.+...++..|..    ..+.+|. 
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~------~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~----~~~~~p~-  233 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN----GVYTLPK-  233 (275)
T ss_dssp             ----------CTTSCHHHHSSS------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCCCCCT-
T ss_pred             --ccCCeeECcccCChhhhcCC------CCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CCCCCCC-
Confidence              33456899999999999732      3356899999999999999999999999998888888877    4455665 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                       .+|+++++||.+||. ||.+|||+.++++||||+.
T Consensus       234 -~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          234 -FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -CCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence             689999999999999 9999999999999999973

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-56  Score=500.05  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=226.0

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ...|++++.||+|+||.||+|+++.+|+.||||++.+.....    ..|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            356999999999999999999999999999999997665433    5899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      |+||+|.+++..   +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+.... ....
T Consensus       230 ~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~  305 (423)
T 4fie_A          230 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK  305 (423)
T ss_dssp             CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBC
T ss_pred             CCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cccc
Confidence            999999999964   349999999999999999999999999999999999999999999999999999876433 2345


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      +.||||.|||||++..       ..|+.++|||||||++|+|++|.+||.+.+....+..|...   ....++.+..+|+
T Consensus       306 ~~~GTp~YmAPEvl~~-------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~~~~~~~~~~~s~  375 (423)
T 4fie_A          306 SLVGTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LPPRLKNLHKVSP  375 (423)
T ss_dssp             CCEECTTTCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSCTTSSCH
T ss_pred             ccccCcCcCCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---CCCCCcccccCCH
Confidence            6789999999999963       37999999999999999999999999999888888877652   1223344457899


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ++++||.+||. ||.+|||+.++|+||||+..
T Consensus       376 ~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          376 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            99999999999 99999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-55  Score=468.79  Aligned_cols=247  Identities=23%  Similarity=0.415  Sum_probs=210.8

Q ss_pred             Cc-eEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe----CCEEE
Q psy13735         16 DF-DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD----MNHVY   84 (792)
Q Consensus        16 dY-~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed----e~~ly   84 (792)
                      +| ++.+.||+|+||+||+|.++.+|..||+|++.+.....      ..|+.++++++|||||+++++|++    ...+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            44 78889999999999999999999999999998766544      579999999999999999999976    35689


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCC-CCceEEeccCcccccc
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSA-TGHLKLTDFGSATQVD  161 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~-dg~VKLiDFGLA~~l~  161 (792)
                      ||||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++|  |+||||||+||||+. +|++||+|||+|+...
T Consensus       106 lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999999965  456999999999999999999999999  999999999999974 7999999999998644


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-hhhhhhhhhcccCCCCcC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVS  240 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-~~el~ekIl~~~~~~~l~  240 (792)
                      ..   ...+.+|||.|||||++.        +.|+.++|||||||++|+|+||.+||.+.+ ...++..+....  ....
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~--------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~--~~~~  250 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPAS  250 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CCGG
T ss_pred             CC---ccCCcccCccccCHHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC--CCCC
Confidence            22   344668999999999985        258999999999999999999999997544 445555554421  1112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ++  ...++++++||.+||. ||.+|||+.++|+||||+.
T Consensus       251 ~~--~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          251 FD--KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GG--GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CC--ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            22  3578999999999999 9999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-55  Score=478.69  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=220.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      ..+.|.+.++||+|+||.||+|+++.+|+.||||++.+.... ..|+.+++.++|||||+++++|.+.+.+|||||||+|
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  134 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG  134 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence            456789999999999999999999999999999999876543 5799999999999999999999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCCCc----c
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRI----K  167 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~~~----~  167 (792)
                      |+|.++|.+  .+.+++..++.|+.||+.||.|||++||+||||||+||||+.+| ++||+|||+|+.+......    .
T Consensus       135 g~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          135 GSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             CBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            999999965  45699999999999999999999999999999999999999988 6999999999887543221    2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+|||.|||||++.+       ..|+.++|||||||++|+|++|++||.+.+...++..|..... ....+|.  .+
T Consensus       213 ~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~--~~  282 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMG-------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-PIREIPP--SC  282 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-GGGGSCT--TS
T ss_pred             CCccccCccccCHHHHCC-------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-CchhcCc--cC
Confidence            234589999999999974       3799999999999999999999999998888888888876321 1123444  78


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHH-------------hcCCCccCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQV-------------LGHPVFDCL  280 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEI-------------L~HPwF~~i  280 (792)
                      |+.+.+||.+||. ||.+|||+.++             +.|||+...
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9999999999999 99999999987             679998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-55  Score=514.51  Aligned_cols=269  Identities=32%  Similarity=0.614  Sum_probs=230.6

Q ss_pred             HHHhc-CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHH---HHHHhcCCCCccee
Q psy13735          5 KELRQ-KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIER---DIMVKSKCPYIVNL   73 (792)
Q Consensus         5 ~~L~r-k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~---eIL~kL~HPNIVkL   73 (792)
                      +.+.. ..+++++|+++++||+|+||.||+|+++.+|+.||||++.+.....       ..|+   .++..++|||||++
T Consensus       178 k~~e~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l  257 (689)
T 3v5w_A          178 KNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM  257 (689)
T ss_dssp             HHHHTTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred             cccccCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEE
Confidence            34443 4789999999999999999999999999999999999997654321       3344   44556789999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEec
Q psy13735         74 FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD  153 (792)
Q Consensus        74 ~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiD  153 (792)
                      +++|++.+.+|||||||+||+|+++|.+  .+.|++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|
T Consensus       258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~D  335 (689)
T 3v5w_A          258 SYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD  335 (689)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEEECCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecc
Confidence            9999999999999999999999999965  46699999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh---hhhhhh
Q psy13735        154 FGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD---MTYSSI  230 (792)
Q Consensus       154 FGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~---el~ekI  230 (792)
                      ||+|+.+...   ...+.||||.|||||++..      ...|+.++|||||||++|+|++|.+||.+.+..   .+...+
T Consensus       336 FGlA~~~~~~---~~~t~~GTp~YmAPEvl~~------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i  406 (689)
T 3v5w_A          336 LGLACDFSKK---KPHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT  406 (689)
T ss_dssp             CTTCEECSSC---CCCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH
T ss_pred             cceeeecCCC---CCCCccCCcCccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Confidence            9999877543   3456789999999999952      246999999999999999999999999765433   334444


Q ss_pred             hcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCCC
Q psy13735        231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPPP  290 (792)
Q Consensus       231 l~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~~  290 (792)
                      ..    ..+.+|.  .+|+++++||.+||+ ||.+|++     +.+|++||||++++        ..||++|..
T Consensus       407 ~~----~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~  474 (689)
T 3v5w_A          407 LT----MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR  474 (689)
T ss_dssp             HH----CCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred             cC----CCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence            44    4555665  789999999999999 9999998     69999999999987        478888864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-54  Score=472.96  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=218.3

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe------CCE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD------MNH   82 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed------e~~   82 (792)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.....      ..|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999998765443      469999999999999999999864      367


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|||||||. |+|.+++.  ..+.+++..++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            999999995 67999994  456799999999999999999999999999999999999999999999999999987643


Q ss_pred             CC---CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        163 NG---RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       163 ~~---~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      ..   .....+.+||++|+|||++.+      ...|+.++||||+|||+|+|++|++||.+.+....+..|.........
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLS------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             CccccccccccceeChHhcCHHHhcC------CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            21   223346689999999999863      246799999999999999999999999999888888777653211110


Q ss_pred             ----------------CCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        240 ----------------SFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       240 ----------------~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                      .+|.         ...+|+++++||.+||. ||.+|||+.++|+||||+...
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                            0111         12468999999999999 999999999999999998653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-53  Score=461.85  Aligned_cols=257  Identities=25%  Similarity=0.453  Sum_probs=207.3

Q ss_pred             CCCceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCCh--HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPN--TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .+.|++++.||+|+||+||+|+++   .+++.||+|.+.+.....  ..|+.+|..+ +|||||+++++|++.+++||||
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            357999999999999999999986   467899999997665433  5788999988 6999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC-CceEEeccCcccccccCCC-
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGR-  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d-g~VKLiDFGLA~~l~~~~~-  165 (792)
                      |||+||+|.+++.     .+++..++.|+.||+.||.|||++||+||||||+|||++.+ +++||+|||+|+....... 
T Consensus       100 E~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A          100 PYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             ECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             eCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            9999999999992     38999999999999999999999999999999999999876 7999999999976542211 


Q ss_pred             --------------------------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC
Q psy13735        166 --------------------------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       166 --------------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~  219 (792)
                                                ....+.+|||+|+|||++.+      ...|+.++||||+||++|+|++|++||.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK------CPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcC------CCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence                                      11234589999999999963      2468999999999999999999999995


Q ss_pred             CCC-hhhhhhhhhccc--------------------------------------C----------CCCcCCCCCccccHH
Q psy13735        220 YET-LDMTYSSILACD--------------------------------------T----------EDTVSFPSSIRLSTA  250 (792)
Q Consensus       220 ~~d-~~el~ekIl~~~--------------------------------------~----------~~~l~fP~~~~lS~e  250 (792)
                      ..+ ....+..|....                                      .          ......+.+..+|++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            433 222222221100                                      0          000011223468999


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ++|||.+||+ ||.+|||+.++|+||||++++
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999 999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.3e-53  Score=451.96  Aligned_cols=252  Identities=24%  Similarity=0.422  Sum_probs=197.3

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC--------
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN--------   81 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~--------   81 (792)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.......     ..|+.+|++++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            47999999999999999999999999999999997655332     46999999999999999999997654        


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCc
Q psy13735         82 ----HVYFIMEYVTGGDFVTLLENQPH-GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        82 ----~lyLVmEy~~GGsL~dlL~r~~~-g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                          .+|||||||+||+|.+++..... ...++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence                47999999999999999965322 2345677899999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCc-----------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-h
Q psy13735        157 ATQVDKNGRI-----------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-D  224 (792)
Q Consensus       157 A~~l~~~~~~-----------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-~  224 (792)
                      |+.+......           ...+.+|||.|||||++.+       ..|+.++|||||||++|+|++   ||.+... .
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-------~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-------NSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHcC-------CCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence            9877543211           1234589999999999973       379999999999999999996   8864322 1


Q ss_pred             hhhhhhhcccCCCCcCCCC-CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        225 MTYSSILACDTEDTVSFPS-SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       225 el~ekIl~~~~~~~l~fP~-~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      .....+..      ..+|. ....++.+.+||.+||+ ||.+|||+.++++||||++++.
T Consensus       235 ~~~~~~~~------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          235 RTLTDVRN------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHHT------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHHhc------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            22222222      22332 23567888999999999 9999999999999999998754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.3e-53  Score=467.30  Aligned_cols=322  Identities=34%  Similarity=0.671  Sum_probs=265.6

Q ss_pred             hHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-------ChHHHHHHHHhcCCCCcceeEE
Q psy13735          3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-------PNTIERDIMVKSKCPYIVNLFY   75 (792)
Q Consensus         3 ~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-------~~~~E~eIL~kL~HPNIVkL~~   75 (792)
                      .+..++...+..++|.+++.||+|+||.||+|+++.+|+.||+|++.+...       ....|+.++..++|||||++++
T Consensus        57 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~  136 (410)
T 3v8s_A           57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY  136 (410)
T ss_dssp             HHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            345667778899999999999999999999999999999999999975321       1258999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         76 SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        76 vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      +|.+...+|||||||+||+|.+++.+.   .+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||
T Consensus       137 ~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          137 AFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccc
Confidence            999999999999999999999999653   48999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC
Q psy13735        156 SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       156 LA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~  235 (792)
                      +|............+.+||+.|+|||++...   .+...|+.++|||||||++|+|++|.+||.+.+....+..|.... 
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-  289 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-  289 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTT---TTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhcc---CCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-
Confidence            9988765544445567899999999999743   112237889999999999999999999999999999988887621 


Q ss_pred             CCCcCCCCCccccHHHHHHHHHHhh-Chhh--cCChhHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhh
Q psy13735        236 EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDA--RLNMDQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDK  301 (792)
Q Consensus       236 ~~~l~fP~~~~lS~elkdLIk~LL~-DP~k--RPTaeEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~  301 (792)
                       ..+.+|....+|+++++||.+||+ +|.+  ||++.+|++||||++++        ..||++|.   +.+..+|+....
T Consensus       290 -~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~  368 (410)
T 3v8s_A          290 -NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEE  368 (410)
T ss_dssp             -HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCS
T ss_pred             -ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCccc
Confidence             234566666889999999999999 7888  99999999999999865        36788886   456677776544


Q ss_pred             hccCCChhhhhhcccccccCCCcccccccCCCC
Q psy13735        302 RKASPSLKAFQKEGRYLDSALPLIGISYTGEPM  334 (792)
Q Consensus       302 ~k~~~s~k~f~~~~~~~~~~l~fig~s~~~~~~  334 (792)
                      .......  +.....+...+.+|.||+|..+..
T Consensus       369 ~~~~~~~--~~~~~~~~~~~~~f~~f~~~~~~~  399 (410)
T 3v8s_A          369 DKGEEET--FPIPKAFVGNQLPFVGFTYYSNRR  399 (410)
T ss_dssp             CCSCCCC--CCCCSSCCCTTGGGTTCCEECC--
T ss_pred             ccccccc--CCCchhhcccccccccceEeCccc
Confidence            3322111  111122344578899999987653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-52  Score=452.42  Aligned_cols=308  Identities=29%  Similarity=0.556  Sum_probs=247.3

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhc-CCCCcceeEEEEEeC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKS-KCPYIVNLFYSFQDM   80 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL-~HPNIVkL~~vfede   80 (792)
                      ...+..++|++++.||+|+||.||+|+++.+|+.||+|++.+....       ...|+.++..+ +||||++++++|.+.
T Consensus        17 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~   96 (353)
T 3txo_A           17 SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP   96 (353)
T ss_dssp             ------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence            4457889999999999999999999999999999999999764321       15688899887 699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +.+|+|||||+||+|..++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999999999965  355999999999999999999999999999999999999999999999999999864


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ... .......+||+.|+|||++...       .|+.++|||||||++|+|++|.+||.+.+....+..|..    ....
T Consensus       175 ~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~~~  242 (353)
T 3txo_A          175 ICN-GVTTATFCGTPDYIAPEILQEM-------LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----DEVV  242 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHH-------HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCC
T ss_pred             ccC-CccccccCCCcCeEChhhcCCC-------CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCC
Confidence            432 2234556899999999999754       688999999999999999999999999999999999987    5556


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCCh------hHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhhh
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNM------DQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDKR  302 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTa------eEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~~  302 (792)
                      +|.  .+++.+.+||.+||. ||.+||++      .++++||||+.++        ..||++|.   +.+..+|+.....
T Consensus       243 ~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~  320 (353)
T 3txo_A          243 YPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIK  320 (353)
T ss_dssp             CCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHT
T ss_pred             CCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCccccc
Confidence            666  689999999999999 99999998      8999999999876        46788776   4566778776554


Q ss_pred             ccCCChhhhhhcccccccCCCcccccccCCC
Q psy13735        303 KASPSLKAFQKEGRYLDSALPLIGISYTGEP  333 (792)
Q Consensus       303 k~~~s~k~f~~~~~~~~~~l~fig~s~~~~~  333 (792)
                      ......+. .........+..|.||+|..+.
T Consensus       321 ~~~~~~~~-~~~~~~~~~~~~f~~f~~~~~~  350 (353)
T 3txo_A          321 EEPVLTPI-DEGHLPMINQDEFRNFEYVSPE  350 (353)
T ss_dssp             SCCCCCCC-CTTSGGGSCGGGGTTCCEECC-
T ss_pred             CCCcCCCc-cccccCcccccccCCceeeCcc
Confidence            33211110 0000001123568899988654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-52  Score=467.49  Aligned_cols=325  Identities=35%  Similarity=0.677  Sum_probs=260.0

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-------ChHHHHHHHHhcCCCCcceeEEEE
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-------PNTIERDIMVKSKCPYIVNLFYSF   77 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-------~~~~E~eIL~kL~HPNIVkL~~vf   77 (792)
                      ..+++..+..++|+++++||+|+||.||+|+++.+|+.||+|++.+...       ....|+.++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3456667888999999999999999999999999999999999975321       126799999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      .+.+.+|||||||+||+|.+++.+. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999999999652 456999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC
Q psy13735        158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       158 ~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      ..............+||+.|+|||++....  .+...|+.++|||||||++|+|++|.+||.+.+....+..|....  .
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~  298 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAME--GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--E  298 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHH--TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--H
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcc--cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--c
Confidence            877655444455578999999999997321  123468999999999999999999999999999988888887521  2


Q ss_pred             CcCCCCC-ccccHHHHHHHHHHhh-Chhh--cCChhHHhcCCCccCCC------CCCCCCCC---CcccCcCChhhhhcc
Q psy13735        238 TVSFPSS-IRLSTAMVNFVQSLVQ-KLDA--RLNMDQVLGHPVFDCLD------SDPPCIPP---PSQENKFHKKDKRKA  304 (792)
Q Consensus       238 ~l~fP~~-~~lS~elkdLIk~LL~-DP~k--RPTaeEIL~HPwF~~i~------~~pP~~P~---~s~~~~f~~k~~~k~  304 (792)
                      .+.+|.. ..+|+++++||++||+ +|.+  ||++.+++.||||++++      ..||++|.   +.+..+|+.......
T Consensus       299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~  378 (437)
T 4aw2_A          299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLK  378 (437)
T ss_dssp             HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTSCCC-----
T ss_pred             cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCCCcCCCccchhhcCCcccccc
Confidence            2344443 4689999999999999 7777  89999999999999876      46777776   456677765543222


Q ss_pred             CCChhhhhhcccccccCCCcccccccCCCC
Q psy13735        305 SPSLKAFQKEGRYLDSALPLIGISYTGEPM  334 (792)
Q Consensus       305 ~~s~k~f~~~~~~~~~~l~fig~s~~~~~~  334 (792)
                      .+..........+.....+|.||+|..+..
T Consensus       379 ~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~  408 (437)
T 4aw2_A          379 NSETMPPPTHTAFSGHHLPFVGFTYTSSCV  408 (437)
T ss_dssp             -------------CCTTGGGTTCCEESSCT
T ss_pred             cccCCCCCccccccccCccccCCCcCCchh
Confidence            211111111223444567899999987654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-52  Score=482.01  Aligned_cols=256  Identities=30%  Similarity=0.506  Sum_probs=226.3

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +++|++++.||+|+||.||+|+++.+|+.||+|++.+.....    ..|+.+|+.++|||||+++++|++.+.+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999999999999999997654332    5799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC--CceEEeccCcccccccCCCcc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT--GHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d--g~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |+||+|+++|.. ..+.|++..++.|+.||+.||.|||++||+||||||+|||++.+  |++||+|||+|+.+....  .
T Consensus       236 ~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~  312 (573)
T 3uto_A          236 MSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S  312 (573)
T ss_dssp             CCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred             cCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence            999999999954 34569999999999999999999999999999999999999854  899999999999876543  3


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+|||.|||||++.+       ..|+.++|||||||++|+|++|.+||.+.+...++..|........  .+.+..+
T Consensus       313 ~~~~~GT~~y~APEv~~~-------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~  383 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--DSAFSGI  383 (573)
T ss_dssp             EEEECSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--SGGGTTS
T ss_pred             eeeeEECccccCHHHhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC--cccccCC
Confidence            345689999999999974       3789999999999999999999999999999999998887332211  1223478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      |+++++||.+||+ ||.+|||+.++|+||||+..+
T Consensus       384 s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            9999999999999 999999999999999998654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-52  Score=459.46  Aligned_cols=330  Identities=35%  Similarity=0.658  Sum_probs=260.9

Q ss_pred             hHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-------ChHHHHHHHHhcCCCCcceeEE
Q psy13735          3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-------PNTIERDIMVKSKCPYIVNLFY   75 (792)
Q Consensus         3 ~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-------~~~~E~eIL~kL~HPNIVkL~~   75 (792)
                      ++..+++..+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...       ....|+.++..++||||+++++
T Consensus        49 ~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            344567778899999999999999999999999999999999999975322       1267999999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         76 SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        76 vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      +|++.+.+|||||||+||+|.+++.+. ...+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeech
Confidence            999999999999999999999999653 2359999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC
Q psy13735        156 SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       156 LA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~  235 (792)
                      +|..............+||+.|+|||++.......+...|+.++|||||||++|+|++|.+||.+.+....+..|.... 
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-  286 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-  286 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Confidence            9988765544444566899999999999753222234568999999999999999999999999999888888887521 


Q ss_pred             CCCcCCCC-CccccHHHHHHHHHHhhChhhc---CChhHHhcCCCccCCC------CCCCCCCC---CcccCcCChhhhh
Q psy13735        236 EDTVSFPS-SIRLSTAMVNFVQSLVQKLDAR---LNMDQVLGHPVFDCLD------SDPPCIPP---PSQENKFHKKDKR  302 (792)
Q Consensus       236 ~~~l~fP~-~~~lS~elkdLIk~LL~DP~kR---PTaeEIL~HPwF~~i~------~~pP~~P~---~s~~~~f~~k~~~  302 (792)
                       ....+|. ...+|+++++||++||++|.+|   |++.+++.||||++++      ..||++|.   +.+..+|+.....
T Consensus       287 -~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~  365 (412)
T 2vd5_A          287 -EHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDG  365 (412)
T ss_dssp             -HHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC--CCC
T ss_pred             -cCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCcccccccCccccc
Confidence             1223342 2468999999999999999988   5899999999999876      36777776   3456677653221


Q ss_pred             ccC------CChhhhhhcccccccCCCcccccccCCCCCC
Q psy13735        303 KAS------PSLKAFQKEGRYLDSALPLIGISYTGEPMGA  336 (792)
Q Consensus       303 k~~------~s~k~f~~~~~~~~~~l~fig~s~~~~~~g~  336 (792)
                      ...      +..... ..........+|.||+|..+.++.
T Consensus       366 ~~~~~~~~~~~~~~~-~~~~~~~~~~~f~g~~~~~~~~~~  404 (412)
T 2vd5_A          366 LTAMVSGGGETLSDI-REGAPLGVHLPFVGYSYSCMALRD  404 (412)
T ss_dssp             CCTTSSSSSCCTTTC------CCTTGGGTTCCBSCCCCCG
T ss_pred             ccccccccCCCcccc-cCCCccccCCCCCCCcccCccccc
Confidence            111      001100 111223456789999998765443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-51  Score=442.87  Aligned_cols=276  Identities=33%  Similarity=0.616  Sum_probs=240.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC----C---hHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM----P---NTIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~----~---~~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      +..++|++++.||+|+||.||+|+++.+|+.||+|++.+...    .   ...|+.++..++||||++++++|++.+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            577899999999999999999999999999999999976421    1   157899999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||+||+|..++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus        82 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999999965  3569999999999999999999999999999999999999999999999999998644322


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                       ......+||+.|+|||++..       ..++.++|||||||++|+|++|.+||.+.+....+..+..    ....+|. 
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~p~-  226 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPR-  226 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSS-------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCT-
T ss_pred             -CcccccccChhhCChhhhcC-------CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCC-
Confidence             23345689999999999863       3689999999999999999999999999888888888876    4455665 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhhhc
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDKRK  303 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~~k  303 (792)
                       .+|+++.+||.+||. ||.+||     ++.+++.||||..++        ..||+.|.   +.+..+|+......
T Consensus       227 -~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~  301 (337)
T 1o6l_A          227 -TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ  301 (337)
T ss_dssp             -TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTS
T ss_pred             -CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccC
Confidence             689999999999999 999999     899999999999876        46777776   34667777655443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.5e-51  Score=451.68  Aligned_cols=308  Identities=29%  Similarity=0.553  Sum_probs=248.6

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~   81 (792)
                      ..+..++|+++++||+|+||.||+|+++.+|+.||+|++.+.....       ..|+.++.++ +|||||+++++|++.+
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            3467889999999999999999999999999999999998764432       5788888876 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|||||||+||+|..++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999999999965  3569999999999999999999999999999999999999999999999999998643


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC---------hhhhhhhhhc
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET---------LDMTYSSILA  232 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d---------~~el~ekIl~  232 (792)
                      ... ......+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||....         ....+..+..
T Consensus       205 ~~~-~~~~~~~gt~~Y~aPE~l~~-------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          205 RPG-DTTSTFCGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             CTT-CCBCCCCBCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             cCC-CccccccCCcccCCchhhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            222 23456789999999999974       368999999999999999999999996432         2334555554


Q ss_pred             ccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCCh------hHHhcCCCccCCC--------CCCCCCCC---CcccC
Q psy13735        233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNM------DQVLGHPVFDCLD--------SDPPCIPP---PSQEN  294 (792)
Q Consensus       233 ~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTa------eEIL~HPwF~~i~--------~~pP~~P~---~s~~~  294 (792)
                          ..+.+|.  .+|+++.+||.+||+ ||.+||++      .+++.||||++++        ..||++|.   +.+..
T Consensus       277 ----~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~  350 (396)
T 4dc2_A          277 ----KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLD  350 (396)
T ss_dssp             ----CCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGG
T ss_pred             ----cccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchh
Confidence                4556666  689999999999999 99999995      7999999999886        46888887   34677


Q ss_pred             cCChhhhhccCCChhhhhhcccccccCCCcccccccCCCC
Q psy13735        295 KFHKKDKRKASPSLKAFQKEGRYLDSALPLIGISYTGEPM  334 (792)
Q Consensus       295 ~f~~k~~~k~~~s~k~f~~~~~~~~~~l~fig~s~~~~~~  334 (792)
                      +|+...+.......+.-... .....+..|.||+|.++.+
T Consensus       351 ~fd~~~~~~~~~~~~~~~~~-~~~~~~~~f~~f~~~~~~~  389 (396)
T 4dc2_A          351 NFDSQFTNEPVQLTPDDDDI-VRKIDQSEFEGFEYINPLL  389 (396)
T ss_dssp             GSCHHHHTSCCCCCCCCHHH-HTTSCGGGGTTCCEECC--
T ss_pred             hcChhhccCCCccCCCcchh-hccccccccCCcEeECccc
Confidence            88876665433211110000 0011245799999987654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-51  Score=442.57  Aligned_cols=308  Identities=29%  Similarity=0.539  Sum_probs=233.6

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC----C---hHHHHHHHHhc-CCCCcceeEEEEEeC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM----P---NTIERDIMVKS-KCPYIVNLFYSFQDM   80 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~----~---~~~E~eIL~kL-~HPNIVkL~~vfede   80 (792)
                      +.++..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...    .   ...|+.++..+ +||||++++++|++.
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            446788999999999999999999999999999999999976431    1   15688888876 899999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +.+|+|||||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999999965  345999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .... ......+||+.|+|||++.+       ..++.++|||||||++|+|++|.+||.+.+....+..|..    ....
T Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~~~  236 (345)
T 1xjd_A          169 MLGD-AKTNTFCGTPDYIAPEILLG-------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----DNPF  236 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCC
T ss_pred             ccCC-CcccCCCCCcccCChhhhcC-------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh----CCCC
Confidence            4222 23456689999999999963       3689999999999999999999999999998888888876    3445


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChh-HHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhhhccCCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMD-QVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDKRKASPS  307 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTae-EIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~~k~~~s  307 (792)
                      +|.  .+|+.+.+||.+||. ||.+||++. +++.||||+.++        ..||+.|.   +.+..+|+..........
T Consensus       237 ~p~--~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~  314 (345)
T 1xjd_A          237 YPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL  314 (345)
T ss_dssp             CCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC--------------------------
T ss_pred             CCc--ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccC
Confidence            665  689999999999999 999999998 999999999876        46777776   345667765433221110


Q ss_pred             hhhhhhcccccccCCCcccccccCCC
Q psy13735        308 LKAFQKEGRYLDSALPLIGISYTGEP  333 (792)
Q Consensus       308 ~k~f~~~~~~~~~~l~fig~s~~~~~  333 (792)
                      ... .........+..|.||+|.++.
T Consensus       315 ~~~-~~~~~~~~~~~~f~~f~~~~~~  339 (345)
T 1xjd_A          315 SFA-DRALINSMDQNMFRNFSFMNPG  339 (345)
T ss_dssp             -------------CCTTTTCCC----
T ss_pred             Ccc-cccccccccccccCCCeeeChh
Confidence            000 0000011234578888887543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.7e-51  Score=442.10  Aligned_cols=307  Identities=28%  Similarity=0.575  Sum_probs=249.2

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhc-CCCCcceeEEEEEe
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKS-KCPYIVNLFYSFQD   79 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL-~HPNIVkL~~vfed   79 (792)
                      ...++..++|.+++.||+|+||.||+|+++.+|+.||+|++.+....       ...|+.++..+ +||||++++++|++
T Consensus        13 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   92 (353)
T 2i0e_A           13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT   92 (353)
T ss_dssp             ------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred             CcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence            45568899999999999999999999999999999999999764321       15688888877 79999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      .+.+|+|||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|..
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999999999965  34599999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      ..... ......+||+.|+|||++..       ..++.++|||||||++|+|++|.+||.+.+...++..|..    ...
T Consensus       171 ~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~~  238 (353)
T 2i0e_A          171 NIWDG-VTTKTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNV  238 (353)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTT-------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCC
T ss_pred             cccCC-cccccccCCccccChhhhcC-------CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh----CCC
Confidence            43222 23446689999999999963       3689999999999999999999999999999999988887    455


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCCCc--ccCcCChhhhhc
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPPPS--QENKFHKKDKRK  303 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~~s--~~~~f~~k~~~k  303 (792)
                      .+|.  .+|+++.+||.+||. ||.+||+     +.+++.||||+.++        ..||+.|...  +..+|+......
T Consensus       239 ~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~f~~~~~~~  316 (353)
T 2i0e_A          239 AYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRNAENFDRFFTRH  316 (353)
T ss_dssp             CCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC--CHHHHHHHHS
T ss_pred             CCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCcchhhccchhccC
Confidence            5665  789999999999999 9999995     58999999999876        4778887632  566666544433


Q ss_pred             cCC---ChhhhhhcccccccCCCcccccccCCCC
Q psy13735        304 ASP---SLKAFQKEGRYLDSALPLIGISYTGEPM  334 (792)
Q Consensus       304 ~~~---s~k~f~~~~~~~~~~l~fig~s~~~~~~  334 (792)
                      ...   .......    ...+..|.||+|..+..
T Consensus       317 ~~~~~~~~~~~~~----~~~~~~f~~f~~~~~~~  346 (353)
T 2i0e_A          317 PPVLTPPDQEVIR----NIDQSEFEGFSFVNSEF  346 (353)
T ss_dssp             CCCCCCCCHHHHH----HSCTTTTCSCCEECTTC
T ss_pred             CcccCCccccccc----cccccccCCCeeeCccc
Confidence            221   1111100    12346799999987643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-51  Score=436.47  Aligned_cols=257  Identities=21%  Similarity=0.289  Sum_probs=204.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      +..++|.+.+.||+|+||+||+|+++   ..+|||++.......      ..|+.++++++|||||++++++.+ +.+||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            56789999999999999999999765   358999987654433      479999999999999999998754 56899


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC-
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-  164 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~-  164 (792)
                      |||||+||+|.++|... .+.+++..+..|+.||+.||.|||+++|+||||||+||||+.++++||+|||+|+...... 
T Consensus       109 VmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999999653 4569999999999999999999999999999999999999999999999999998765322 


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                      .......+|||.|||||++...    ....|+.++|||||||++|+|+||+.||.+.+.......+.............+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  263 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQ----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY  263 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred             ceeecccccCCCccCHHHhhcc----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence            2233456899999999999732    234689999999999999999999999987665544444433111111101112


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHH------hcCCCc
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQV------LGHPVF  277 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEI------L~HPwF  277 (792)
                      ..+++.+.+|+..|+. ||.+|||+.++      |+|||.
T Consensus       264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            3679999999999999 99999999987      566653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.6e-52  Score=441.32  Aligned_cols=255  Identities=21%  Similarity=0.365  Sum_probs=215.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +..++|.+.+.||+|+||.||+|++.     .+|..||||++.......    ..|+.+|++++|||||+++++|.+.+.
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            55678999999999999999999875     468899999997543221    579999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEE
Q psy13735         83 VYFIMEYVTGGDFVTLLENQ-----------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL  151 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~-----------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKL  151 (792)
                      +|||||||+||+|.++|...           ....+++..+..|+.||+.||.|||+++|+||||||+||||+.++++||
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999999653           2346999999999999999999999999999999999999999999999


Q ss_pred             eccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhh
Q psy13735        152 TDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSS  229 (792)
Q Consensus       152 iDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ek  229 (792)
                      +|||+|+........ .....+||+.|||||++..       ..|+.++|||||||++|||+| |+.||.+.+..+....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999876543222 2233469999999999974       379999999999999999998 9999999888888888


Q ss_pred             hhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        230 ILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       230 Il~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +...   .....|.  .+|+++.+|+..|++ ||.+|||+.++  |+|++.+
T Consensus       243 i~~~---~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          243 ITQG---RVLQRPR--TCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHHT---CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HHcC---CCCCCCc--cchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            7662   2233444  789999999999999 99999999998  5566644

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.1e-50  Score=432.31  Aligned_cols=303  Identities=31%  Similarity=0.583  Sum_probs=244.6

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc-CCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS-KCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL-~HPNIVkL~~vfede~   81 (792)
                      ..+..++|.+++.||+|+||.||+|+++.+|+.||+|++.+.....       ..|+.++..+ +|||||+++++|.+..
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            4567889999999999999999999999999999999998765443       4688888887 8999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999999999965  3459999999999999999999999999999999999999999999999999998643


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC---------CChhhhhhhhhc
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY---------ETLDMTYSSILA  232 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~---------~d~~el~ekIl~  232 (792)
                      ... ......+||+.|+|||++..       ..++.++|||||||++|+|++|.+||..         ......+..+..
T Consensus       162 ~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  233 (345)
T 3a8x_A          162 RPG-DTTSTFCGTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  233 (345)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred             CCC-CcccccCCCccccCccccCC-------CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence            222 23445689999999999963       3689999999999999999999999965         223344555554


Q ss_pred             ccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCCh------hHHhcCCCccCCC--------CCCCCCCCC---cccC
Q psy13735        233 CDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNM------DQVLGHPVFDCLD--------SDPPCIPPP---SQEN  294 (792)
Q Consensus       233 ~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTa------eEIL~HPwF~~i~--------~~pP~~P~~---s~~~  294 (792)
                          ....+|.  .+|+.+.+||.+||. ||.+||++      .+++.||||.+++        ..||+.|..   .+..
T Consensus       234 ----~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~  307 (345)
T 3a8x_A          234 ----KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLD  307 (345)
T ss_dssp             ----CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGG
T ss_pred             ----CCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhh
Confidence                4455665  689999999999999 99999996      7999999999876        466777763   3456


Q ss_pred             cCChhhhhccC---CChhhhhhcccccccCCCcccccccCC
Q psy13735        295 KFHKKDKRKAS---PSLKAFQKEGRYLDSALPLIGISYTGE  332 (792)
Q Consensus       295 ~f~~k~~~k~~---~s~k~f~~~~~~~~~~l~fig~s~~~~  332 (792)
                      +|+........   +......    ....+..|.||+|..+
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~f~~f~~~~~  344 (345)
T 3a8x_A          308 NFDSQFTNEPVQLTPDDDDIV----RKIDQSEFEGFEYINP  344 (345)
T ss_dssp             GSCHHHHTSCSSCCCCCHHHH----TTSCGGGGTTCCEECC
T ss_pred             hcCcccccCcccCCCcccccc----ccccccccCCCEeeCC
Confidence            67654433221   1111110    0122456888888754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.5e-50  Score=440.84  Aligned_cols=277  Identities=31%  Similarity=0.615  Sum_probs=228.1

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHH-HHhcCCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDI-MVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eI-L~kL~HPNIVkL~~vfede~   81 (792)
                      ..+..++|.+++.||+|+||.||+|+++.+|..||+|++.+.....       ..|+.+ +..++|||||+++++|++.+
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            3467789999999999999999999999999999999998765432       345554 45678999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999999999965  3469999999999999999999999999999999999999999999999999998644


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ... ......+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+....+..|..    ....+
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~~~~  258 (373)
T 2r5t_A          191 EHN-STTSTFCGTPEYLAPEVLHK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----KPLQL  258 (373)
T ss_dssp             CCC-CCCCSBSCCCCCCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH----SCCCC
T ss_pred             cCC-CccccccCCccccCHHHhCC-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----cccCC
Confidence            322 23445689999999999963       3689999999999999999999999999999999988887    44555


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCCh----hHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhhhh
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNM----DQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKDKR  302 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTa----eEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~~~  302 (792)
                      |.  .+++.+.+||.+||+ ||.+||++    .+++.||||+.++        ..||+.|.   +.+..+|+.....
T Consensus       259 ~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~  333 (373)
T 2r5t_A          259 KP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTE  333 (373)
T ss_dssp             CS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC-------------
T ss_pred             CC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCccccc
Confidence            55  689999999999999 99999997    5899999999876        46788776   3456677654443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-50  Score=431.50  Aligned_cols=252  Identities=17%  Similarity=0.247  Sum_probs=214.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      .+..+++++++.||+|+||+||++...     .+++.||||++.......     ..|+.++.+++|||||++++++.+.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            467789999999999999999999864     467899999987543322     5799999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT  146 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d  146 (792)
                      +.+|||||||+||+|.++|....              .+.+++..+..|+.||+.||.|||+++|+||||||+||||+.+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK  181 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence            99999999999999999996432              2458999999999999999999999999999999999999999


Q ss_pred             CceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChh
Q psy13735        147 GHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLD  224 (792)
Q Consensus       147 g~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~  224 (792)
                      +++||+|||+|+....... ......+||+.|||||++..       ..|+.++|||||||++|||+| |..||.+.+..
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999987653322 22345579999999999974       379999999999999999998 99999998888


Q ss_pred             hhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        225 MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       225 el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .....+...   .....|  ..+++.+.+++..|+. ||.+|||+.+|+.+
T Consensus       255 ~~~~~i~~~---~~~~~p--~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          255 DVVEMIRNR---QVLPCP--DDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHTT---CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcC---CCCCCc--ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            888777652   122333  4789999999999999 99999999999765

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=434.35  Aligned_cols=251  Identities=21%  Similarity=0.347  Sum_probs=207.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +..++|.+.+.||+|+||.||+|+++     .+|..||||++.......    ..|+.+|.+++|||||+++++|.+.+.
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45678999999999999999999875     468899999997543222    579999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCce
Q psy13735         83 VYFIMEYVTGGDFVTLLENQP-------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHL  149 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~-------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~V  149 (792)
                      +|||||||+||+|.+++....             .+.+++..+..|+.||+.||.|||+++|+||||||+||||+.++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence            999999999999999996532             3469999999999999999999999999999999999999999999


Q ss_pred             EEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhh
Q psy13735        150 KLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTY  227 (792)
Q Consensus       150 KLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~  227 (792)
                      ||+|||+|+........ .....+||+.|||||++..       ..|+.++|||||||++|||+| |+.||.+.+....+
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-------~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-------RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcC-------CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999876543322 2334579999999999973       479999999999999999999 99999988888887


Q ss_pred             hhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        228 SSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       228 ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..+...   ..+.+|.  .+++++.+|+..|+. ||.+|||+.+++.+
T Consensus       271 ~~i~~g---~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          271 DCITQG---RELERPR--ACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHT---CCCCCCT--TCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHcC---CCCCCcc--cccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            777652   2234444  789999999999999 99999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-50  Score=424.17  Aligned_cols=260  Identities=34%  Similarity=0.649  Sum_probs=230.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ++..++|++++.||+|+||.||+|+++.+|+.||+|++.+....       ...|+.++..++||||++++++|.+...+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            35778999999999999999999999999999999999764321       14688999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+|||||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..... 
T Consensus        82 ~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            999999999999999965  35699999999999999999999999999999999999999999999999999987643 


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                         .....+||+.|+|||++..       ..++.++|||||||++|+|++|.+||...+....+..+..    ....+|.
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~p~  224 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVST-------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AELRFPP  224 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----CCCCCCT
T ss_pred             ---ccccccCCccccCHhHhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCC
Confidence               2345689999999999863       3688999999999999999999999999888888888877    4455665


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC--------CCCCCCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD--------SDPPCIPP  289 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~--------~~pP~~P~  289 (792)
                        .+++++.++|.+||. ||.+||     ++.+++.||||+.++        ..||+.|.
T Consensus       225 --~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~  282 (318)
T 1fot_A          225 --FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP  282 (318)
T ss_dssp             --TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred             --CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCC
Confidence              679999999999999 999999     899999999999876        35666665

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.1e-49  Score=419.44  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=227.5

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      .......++|.+++.||+|+||.||+|.+..+|+.||+|++.+.....      ..|+.+++.++||||+++++++.+.+
T Consensus         8 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A            8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            344566789999999999999999999999999999999998765543      46899999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEEEEEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999999999965  3559999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ...  .....+||+.|+|||++.+.      ..++.++|||||||++|+|++|.+||.+.+.......+..    +...+
T Consensus       166 ~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~  233 (328)
T 3fe3_A          166 VGG--KLDAFCGAPPYAAPELFQGK------KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR----GKYRI  233 (328)
T ss_dssp             SSC--GGGTTSSSGGGCCHHHHHTC------CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCC
T ss_pred             CCC--ccccccCCcceeCcccccCC------CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCC
Confidence            443  33456799999999999742      2345889999999999999999999999998888888876    44455


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      |.  .+|+++.+|+.+||. ||.+|||+.+++.||||....
T Consensus       234 p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          234 PF--YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             CT--TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             CC--CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            55  679999999999999 999999999999999998654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-49  Score=426.94  Aligned_cols=269  Identities=33%  Similarity=0.660  Sum_probs=236.2

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      .....++|.+++.||+|+||.||+|+++.+|+.||+|++.+....       ...|+.++..++||||++++++|.+...
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            346788999999999999999999999999999999999764321       1568999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+|||||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus       116 ~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999999999965  34599999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      .    ....+||+.|+|||++..       ..++.++|||||||++|+|++|.+||.+.+....+..+..    ....+|
T Consensus       194 ~----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~p  258 (350)
T 1rdq_E          194 R----TWTLCGTPEALAPEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFP  258 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCC
T ss_pred             C----cccccCCccccCHHHhcC-------CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc----CCCCCC
Confidence            2    335679999999999963       3688999999999999999999999999998888888877    445566


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCC---CcccCcCC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPP---PSQENKFH  297 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~  297 (792)
                      .  .+++.+.++|.+||. ||.+||+     +.++++||||..++        ..||+.|.   +.+..+|+
T Consensus       259 ~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~  328 (350)
T 1rdq_E          259 S--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD  328 (350)
T ss_dssp             T--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred             C--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc
Confidence            5  689999999999999 9999998     99999999999876        46777775   33445554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-49  Score=463.05  Aligned_cols=308  Identities=29%  Similarity=0.571  Sum_probs=252.2

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-----C--hHHHHHHHHhc-CCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-----P--NTIERDIMVKS-KCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-----~--~~~E~eIL~kL-~HPNIVkL~~vfede~   81 (792)
                      ..+..++|.+++.||+|+||.||+|+++.+|+.||+|++.+...     .  ...|+.++..+ +||||+.++++|++.+
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            45678899999999999999999999999999999999976421     1  15688888877 6999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|||||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEEEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999999965  3569999999999999999999999999999999999999999999999999998644


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ... ......+||+.|+|||++..       ..|+.++|||||||++|+|++|.+||.+.+...++..|..    ..+.+
T Consensus       494 ~~~-~~~~~~~GT~~Y~APE~l~~-------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----~~~~~  561 (674)
T 3pfq_A          494 WDG-VTTKTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNVAY  561 (674)
T ss_dssp             CTT-CCBCCCCSCSSSCCHHHHTC-------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS----SCCCC
T ss_pred             cCC-cccccccCCCcccCHhhhcC-------CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh----CCCCC
Confidence            332 23456689999999999963       4789999999999999999999999999999999999987    55667


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCCh-----hHHhcCCCccCCC--------CCCCCCCCCc--ccCcCChhhhhccC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNM-----DQVLGHPVFDCLD--------SDPPCIPPPS--QENKFHKKDKRKAS  305 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTa-----eEIL~HPwF~~i~--------~~pP~~P~~s--~~~~f~~k~~~k~~  305 (792)
                      |.  .+|+++.+||..||. ||.+||++     .+|+.||||+.++        ..||++|...  +..+|+...+....
T Consensus       562 p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~~~~~~f~~~~~~~~~  639 (674)
T 3pfq_A          562 PK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRNAENFDRFFTRHPP  639 (674)
T ss_dssp             CT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCGGGHHHHTTTTTSSCS
T ss_pred             Cc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCCCchhhcCchhccCCC
Confidence            76  789999999999999 99999998     8999999999886        4678888643  44556655444322


Q ss_pred             CChhhhhhcccccccCCCcccccccCCCC
Q psy13735        306 PSLKAFQKEGRYLDSALPLIGISYTGEPM  334 (792)
Q Consensus       306 ~s~k~f~~~~~~~~~~l~fig~s~~~~~~  334 (792)
                      ...+. .........+..|.||+|.++.+
T Consensus       640 ~~~~~-~~~~~~~~~~~~f~~f~~~~~~~  667 (674)
T 3pfq_A          640 VLTPP-DQEVIRNIDQSEFEGFSFVNSEF  667 (674)
T ss_dssp             SCCCC-CHHHHTTCCGGGGTTCCEECSSC
T ss_pred             ccCCC-chhhhhcccccccCCCcccChhh
Confidence            11110 00000111345799999987654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.9e-49  Score=429.33  Aligned_cols=252  Identities=20%  Similarity=0.352  Sum_probs=210.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCC-----cEEEEEEeccCCCCh-----HHHHHHHHhcCC-CCcceeEEEEEeC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSH-----NTFVMKKVLREKMPN-----TIERDIMVKSKC-PYIVNLFYSFQDM   80 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tG-----k~vAVKiI~Ks~~~~-----~~E~eIL~kL~H-PNIVkL~~vfede   80 (792)
                      +..++|++++.||+|+||.||+|.+..++     +.||+|++.......     ..|+.+|.++.| ||||+++++|...
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            55678999999999999999999987654     689999987654432     468999999965 9999999998664


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC
Q psy13735         81 -NHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA  145 (792)
Q Consensus        81 -~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~  145 (792)
                       +.+|||||||+||+|.++|....              ...+++..+..|+.||+.||.|||+++|+||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence             57999999999999999996532              345899999999999999999999999999999999999999


Q ss_pred             CCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCCh
Q psy13735        146 TGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETL  223 (792)
Q Consensus       146 dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~  223 (792)
                      ++++||+|||+|+.+..... ......+||+.|||||++..       ..|+.++|||||||++|||+| |..||.+.+.
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-------~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-------CCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999987754432 23345579999999999974       379999999999999999998 9999987665


Q ss_pred             hhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        224 DMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       224 ~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...+..+...  +..+..|.  .+++++.+++..|++ ||.+|||+.+++.|
T Consensus       294 ~~~~~~~i~~--g~~~~~p~--~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          294 DEEFCRRLKE--GTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             SHHHHHHHHH--TCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHc--CCCCCCCc--cCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4444433331  12233444  679999999999999 99999999999887

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.3e-48  Score=412.16  Aligned_cols=264  Identities=33%  Similarity=0.652  Sum_probs=222.8

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCC--------hHHHHHHHHhcCCCCcceeEEEEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMP--------NTIERDIMVKSKCPYIVNLFYSFQ   78 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~--------~~~E~eIL~kL~HPNIVkL~~vfe   78 (792)
                      ..+..++|++.+.||+|+||.||+|++.   .+|+.||+|++.+....        ...|+.+++.++||||++++++|.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3567789999999999999999999985   68999999999865421        146899999999999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      +.+.+|+|||||+||+|.+++.+  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999999999965  3458999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ...... ......+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+..    ..
T Consensus       170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~  237 (327)
T 3a62_A          170 ESIHDG-TVTHTFCGTIEYMAPEILMR-------SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK----CK  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTT-------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----TC
T ss_pred             ccccCC-ccccccCCCcCccCHhhCcC-------CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CC
Confidence            654322 22345579999999999863       3688999999999999999999999999888888888876    34


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC--------CCCCCCCC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD--------SDPPCIPP  289 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~--------~~pP~~P~  289 (792)
                      ..+|.  .+++.+.+||.+||. ||.+||     ++.+++.||||+.++        ..||+.|.
T Consensus       238 ~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~  300 (327)
T 3a62_A          238 LNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPL  300 (327)
T ss_dssp             CCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred             CCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCC
Confidence            45555  679999999999999 999999     788999999999875        34555554

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.1e-48  Score=421.81  Aligned_cols=254  Identities=30%  Similarity=0.504  Sum_probs=224.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      ..+.|.+++.||+|+||.||+|.++.+|..||+|++.+.....          ..|+.++..++||||++++++|.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3467999999999999999999999999999999998765421          578999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC----ceEEeccCccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG----HLKLTDFGSAT  158 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg----~VKLiDFGLA~  158 (792)
                      +|+|||||+||+|.+++.  ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++    ++||+|||++.
T Consensus        90 ~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           90 VVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            999999999999999994  456799999999999999999999999999999999999998777    79999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ......  .....+||+.|+|||++.+       ..++.++|||||||++|+|++|.+||.+.+....+..|...    .
T Consensus       168 ~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----~  234 (361)
T 2yab_A          168 EIEDGV--EFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----S  234 (361)
T ss_dssp             ECCTTC--CCCCCCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT----C
T ss_pred             EcCCCC--ccccCCCCccEECchHHcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----C
Confidence            776432  2345579999999999963       36899999999999999999999999999988888888763    3


Q ss_pred             cCCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        239 VSFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       239 l~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +.++.  +..+|+.+++||..||. ||.+|||+.+++.||||...+
T Consensus       235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            33332  24679999999999999 999999999999999998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.6e-49  Score=432.75  Aligned_cols=273  Identities=33%  Similarity=0.627  Sum_probs=229.1

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      ..+..++|++++.||+|+||.||+|.++.+|+.||+|++.+....       ...|+.++..++||||++++++|.+.+.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            346678999999999999999999999999999999999754211       1467888889999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      +|||||||+||+|.+++.+  .+.+++..+..++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EEEEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999999999965  3469999999999999999999998 999999999999999999999999999998644


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ... ......+||+.|+|||++..       ..|+.++|||||||++|+|++|..||.+.+....+..+..    ....+
T Consensus       301 ~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~  368 (446)
T 4ejn_A          301 KDG-ATMKTFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRF  368 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHT-------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCC
T ss_pred             CCC-cccccccCCccccCHhhcCC-------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh----CCCCC
Confidence            332 23345689999999999973       3689999999999999999999999999888888888876    44556


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC--------CCCCCCCCC---cccCcCCh
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD--------SDPPCIPPP---SQENKFHK  298 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~--------~~pP~~P~~---s~~~~f~~  298 (792)
                      |.  .+++.+.+||..||. ||.+||     ++.++++||||.+++        ..||+.|..   .+..+|+.
T Consensus       369 p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~  440 (446)
T 4ejn_A          369 PR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE  440 (446)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC--
T ss_pred             Cc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcch
Confidence            65  679999999999999 999999     999999999999876        466777663   34445544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=426.08  Aligned_cols=268  Identities=31%  Similarity=0.600  Sum_probs=229.6

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      ...+..++|.+++.||+|+||.||+|.++.+|+.||+|++.+.....       ..|+.++..++|||||+++++|.+..
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            45678899999999999999999999999999999999997643211       47999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||.||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999999999954  4569999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh---hhhhhhhhcccCCCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL---DMTYSSILACDTEDT  238 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~---~el~ekIl~~~~~~~  238 (792)
                      ...  .....+||+.|+|||++...    ....|+.++|||||||++|+|++|..||...+.   ......+..    ..
T Consensus       167 ~~~--~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~  236 (384)
T 4fr4_A          167 RET--QITTMAGTKPYMAPEMFSSR----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TV  236 (384)
T ss_dssp             TTC--CBCCCCSCGGGCCGGGTCCC----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CC
T ss_pred             CCC--ceeccCCCccccCCeeeccC----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----cc
Confidence            432  33456899999999998631    224588999999999999999999999975433   333344433    34


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCC-hhHHhcCCCccCCC--------CCCCCCCCC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLN-MDQVLGHPVFDCLD--------SDPPCIPPP  290 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPT-aeEIL~HPwF~~i~--------~~pP~~P~~  290 (792)
                      ..+|.  .+|+.+.+||.+||. ||.+||+ +.+++.||||.+++        ..||+.|..
T Consensus       237 ~~~p~--~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~  296 (384)
T 4fr4_A          237 VTYPS--AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK  296 (384)
T ss_dssp             CCCCT--TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred             cCCCC--cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCCCC
Confidence            45555  689999999999999 9999998 89999999999886        467777764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7e-48  Score=402.66  Aligned_cols=256  Identities=27%  Similarity=0.457  Sum_probs=222.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +-...+|.+.+.||+|+||.||+|.+..+|+.||+|++.......    ..|+.+++.++||||++++++|.+.+.+|+|
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            345568999999999999999999999999999999997655443    5788999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||||+||+|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            9999999999999653   489999999999999999999999999999999999999999999999999987764332 


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+...   ....++....
T Consensus       172 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~  241 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEK  241 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHC-------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSCGGG
T ss_pred             ccCCccCCcCccChhhhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCCCccc
Confidence            3345579999999999973       36899999999999999999999999887766655555431   1222333447


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +++.+.+|+.+||. ||.+|||+.++++||||+..
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            89999999999999 99999999999999999854

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.1e-48  Score=443.01  Aligned_cols=271  Identities=27%  Similarity=0.512  Sum_probs=234.2

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEE
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSF   77 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vf   77 (792)
                      +++.+..+..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+....       ...|+.++..++|||||+++++|
T Consensus       174 ~~l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  253 (576)
T 2acx_A          174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY  253 (576)
T ss_dssp             HHHHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence            45677889999999999999999999999999999999999999764321       15799999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      ++.+.+|+|||||+||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|
T Consensus       254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence            99999999999999999999997655556999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh----hhhhhhhhcc
Q psy13735        158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL----DMTYSSILAC  233 (792)
Q Consensus       158 ~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~----~el~ekIl~~  233 (792)
                      .......  .....+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+.    ..+...+.. 
T Consensus       334 ~~~~~~~--~~~~~~GT~~Y~APEvl~~-------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-  403 (576)
T 2acx_A          334 VHVPEGQ--TIKGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-  403 (576)
T ss_dssp             EECCTTC--CEECCCSCGGGCCHHHHTT-------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-
T ss_pred             eecccCc--cccccCCCccccCHHHHcC-------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-
Confidence            8775433  2334589999999999963       3689999999999999999999999987643    334444443 


Q ss_pred             cCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC--------CCCCCCCCC
Q psy13735        234 DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD--------SDPPCIPPP  290 (792)
Q Consensus       234 ~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~--------~~pP~~P~~  290 (792)
                         ....+|.  .+|+++.+||.+||+ ||.+||     ++.+++.||||+.++        ..||+.|.+
T Consensus       404 ---~~~~~p~--~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~  469 (576)
T 2acx_A          404 ---VPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP  469 (576)
T ss_dssp             ---CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred             ---ccccCCc--cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence               3444554  789999999999999 999999     789999999999876        467777764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.7e-48  Score=412.43  Aligned_cols=265  Identities=30%  Similarity=0.538  Sum_probs=219.6

Q ss_pred             hHHHHhcCCCC-CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhc-CCCCcceeEEEEEeC
Q psy13735          3 VVKELRQKNVS-ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKS-KCPYIVNLFYSFQDM   80 (792)
Q Consensus         3 ~~~~L~rk~l~-l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL-~HPNIVkL~~vfede   80 (792)
                      +++++.+.... .++|.+.+.||+|+||.||+|.++.+|+.||+|++.+.......|++++.++ +||||++++++|.+.
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A            9 IVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             ----------CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             HHHHhcccccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            45556665544 4579999999999999999999999999999999988877778899999888 799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC-C---ceEEeccCc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-G---HLKLTDFGS  156 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d-g---~VKLiDFGL  156 (792)
                      ..+|+|||||+||+|.+++.+  .+.+++..+..++.||+.||.|||++||+||||||+|||+... +   .+||+|||+
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            999999999999999999954  4569999999999999999999999999999999999998433 3   599999999


Q ss_pred             ccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC---CChhhhhhhhhcc
Q psy13735        157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY---ETLDMTYSSILAC  233 (792)
Q Consensus       157 A~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~---~d~~el~ekIl~~  233 (792)
                      +........ .....+||+.|+|||++...       .|+.++|||||||++|+|++|.+||.+   .+....+..+.. 
T Consensus       167 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-  237 (342)
T 2qr7_A          167 AKQLRAENG-LLMTPCYTANFVAPEVLERQ-------GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS-  237 (342)
T ss_dssp             CEECBCTTC-CBCCSSCCSSCCCHHHHHHH-------HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-
T ss_pred             cccCcCCCC-ceeccCCCccccCHHHhcCC-------CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-
Confidence            987654332 33456899999999999753       588899999999999999999999975   344555666655 


Q ss_pred             cCCCCcCCC--CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        234 DTEDTVSFP--SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       234 ~~~~~l~fP--~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                         +.+.++  .+..+|+.+.+||.+||. ||.+|||+.+++.||||..++
T Consensus       238 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          238 ---GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             ---CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             ---CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence               222222  234789999999999999 999999999999999997654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-47  Score=436.55  Aligned_cols=272  Identities=27%  Similarity=0.520  Sum_probs=234.0

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEE
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSF   77 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vf   77 (792)
                      +++...++..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+....       ...|+.++..++||||++++++|
T Consensus       175 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             HHHHTSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhcccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            35667889999999999999999999999999999999999999764321       15799999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQP--HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~--~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      ++...+|+|||||+||+|.+++....  ...+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence            99999999999999999999996543  4569999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC----hhhhhhhhh
Q psy13735        156 SATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET----LDMTYSSIL  231 (792)
Q Consensus       156 LA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d----~~el~ekIl  231 (792)
                      ++..+.... ......+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+    ...+...+.
T Consensus       335 la~~~~~~~-~~~~~~~GT~~Y~APE~l~~-------~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~  406 (543)
T 3c4z_A          335 LAVELKAGQ-TKTKGYAGTPGFMAPELLLG-------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL  406 (543)
T ss_dssp             TCEECCTTC-CCBCCCCSCTTTSCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH
T ss_pred             eeeeccCCC-cccccccCCccccChhhhcC-------CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh
Confidence            998765432 22344589999999999963       368999999999999999999999998753    344555555


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCCC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPPP  290 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~~  290 (792)
                      .    ....+|.  .+|+.+.+||.+||. ||.+||+     +.+++.||||+.++        ..||+.|.+
T Consensus       407 ~----~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~  473 (543)
T 3c4z_A          407 E----QAVTYPD--KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS  473 (543)
T ss_dssp             H----CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred             h----cccCCCc--ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence            4    4445665  789999999999999 9999996     48899999999875        467777764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=401.56  Aligned_cols=253  Identities=27%  Similarity=0.487  Sum_probs=220.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      ..+.|.+.+.||+|+||.||+|.++.+|..||+|++.+.....          ..|+.++..++||||++++++|.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3457999999999999999999999999999999997654321          478999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC----ceEEeccCccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG----HLKLTDFGSAT  158 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg----~VKLiDFGLA~  158 (792)
                      +|+|||||+||+|.+++.  ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        89 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           89 VILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            999999999999999994  356699999999999999999999999999999999999998887    79999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ......  .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+.......+....    
T Consensus       167 ~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----  233 (326)
T 2y0a_A          167 KIDFGN--EFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN----  233 (326)
T ss_dssp             ECCTTS--CCCCCCSCTTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC----
T ss_pred             ECCCCC--ccccccCCcCcCCceeecC-------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC----
Confidence            775433  2234579999999999863       368999999999999999999999999888877777776522    


Q ss_pred             cCCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        239 VSFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       239 l~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ..++.  ...+++.+.+||..||. ||.+|||+.+++.||||...
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            22222  23678999999999999 99999999999999999853

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-47  Score=407.41  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=221.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      .++|.+.+.||+|+||.||+|.++.+|..||+|++.......   ..|+.++..++||||++++++|.+.+.+|+|||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            578999999999999999999999999999999987543222   57899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC--CCceEEeccCcccccccCCCccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~--dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      +||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++.......  ..
T Consensus        84 ~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~  160 (321)
T 1tki_A           84 SGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NF  160 (321)
T ss_dssp             CCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EE
T ss_pred             CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--cc
Confidence            99999999954 2346999999999999999999999999999999999999987  7899999999998876443  22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC--Ccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS--SIR  246 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~--~~~  246 (792)
                      ...+|||.|+|||++..       ..++.++|||||||++|+|++|.+||.+.+.......+..    ....++.  +..
T Consensus       161 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~  229 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQH-------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN----AEYTFDEEAFKE  229 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCCCHHHHTT
T ss_pred             ccccCChhhcCcHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc----CCCCCChhhhcc
Confidence            34569999999999963       3578999999999999999999999999888888888876    2333332  246


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +|+++.+||.+||. ||.+|||+.++++||||+..
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            79999999999999 99999999999999999853

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.4e-47  Score=390.78  Aligned_cols=258  Identities=23%  Similarity=0.393  Sum_probs=211.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +++|++++.||+|+||+||+|.++.+|+.||+|++.......      ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            468999999999999999999999999999999997655432      46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||.| ++.+.+.. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus        81 e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  157 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C  157 (292)
T ss_dssp             ECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-C
T ss_pred             ecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-c
Confidence            99975 56555544 245699999999999999999999999999999999999999999999999999987653322 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC-CCCCChhhhhhhhhcccCCCC--------
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSILACDTEDT--------  238 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P-F~~~d~~el~ekIl~~~~~~~--------  238 (792)
                      ....+||+.|+|||++.+      ...++.++|||||||++|+|++|..| |.+.+.......+........        
T Consensus       158 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             ccCCccccCCcChHHHcC------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            334579999999999863      23589999999999999999987777 555555555554432100000        


Q ss_pred             --------cCC-------CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        239 --------VSF-------PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       239 --------l~f-------P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                              ..+       .....+++.+.+||.+||. ||.+|||+.++++||||.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                    000       0112578999999999999 99999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.9e-47  Score=408.82  Aligned_cols=251  Identities=30%  Similarity=0.502  Sum_probs=221.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++|.+.+.||+|+||.||+|.++.+|..||+|++.......      ..|+.+++.++|||||+++++|.+.+.+|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            47999999999999999999999999999999998766543      468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEEeccCcccccccCCC
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKLiDFGLA~~l~~~~~  165 (792)
                      ||+||+|.+++.  ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....... 
T Consensus       109 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-  185 (362)
T 2bdw_A          109 LVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  185 (362)
T ss_dssp             CCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred             cCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence            999999999994  345699999999999999999999999999999999999997654   59999999998775432 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC--
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS--  243 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~--  243 (792)
                       .....+||+.|+|||++..       ..++.++|||||||++|+|++|.+||.+.+....+..+..    +...+|.  
T Consensus       186 -~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~  253 (362)
T 2bdw_A          186 -AWHGFAGTPGYLSPEVLKK-------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA----GAYDYPSPE  253 (362)
T ss_dssp             -SCCCSCSCTTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCCCCCTTG
T ss_pred             -ccccCCCCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCccc
Confidence             2234579999999999963       3689999999999999999999999999888888888776    3333333  


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +..+++.+.+||.+||. ||.+||++.++|.||||...
T Consensus       254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            35789999999999999 99999999999999999753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=396.32  Aligned_cols=255  Identities=27%  Similarity=0.495  Sum_probs=216.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------------------------------hHHHHHH
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------------------------------NTIERDI   61 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------------------------------~~~E~eI   61 (792)
                      +..++|.+.+.||+|+||.||+|.+..+|+.||+|++.+....                              ...|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            5578999999999999999999999999999999999765421                              1569999


Q ss_pred             HHhcCCCCcceeEEEEEe--CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy13735         62 MVKSKCPYIVNLFYSFQD--MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD  139 (792)
Q Consensus        62 L~kL~HPNIVkL~~vfed--e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPe  139 (792)
                      ++.++||||+++++++.+  ...+|+|||||+||+|.+++   ..+.+++..+..++.||+.||.|||++||+||||||+
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            999999999999999987  67899999999999998876   3356999999999999999999999999999999999


Q ss_pred             ceEeCCCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC
Q psy13735        140 NMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       140 NILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~  219 (792)
                      |||++.++.+||+|||++........ .....+||+.|+|||++...    ....++.++|||||||++|+|++|..||.
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSET----RKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTT----CCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccC----CCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999987654322 23345799999999998632    11124778999999999999999999998


Q ss_pred             CCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        220 YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       220 ~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      ..+.......+..    ....+|....+++.+.+||.+||. ||.+|||+.+++.||||.
T Consensus       242 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          242 DERIMCLHSKIKS----QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             CSSHHHHHHHHHH----CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             CccHHHHHHHHhc----ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            8877766666655    344555556789999999999999 999999999999999995

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=422.44  Aligned_cols=254  Identities=28%  Similarity=0.452  Sum_probs=221.5

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++.+.....      ..|+.+++.++|||||+++++|.+.+.+|+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            57999999999999999999999999999999998766543      578999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC---CCCceEEeccCcccccccCCC
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS---ATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd---~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||.||+|.+.+..  .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........
T Consensus        91 ~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           91 LVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             eCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            9999999999965  35699999999999999999999999999999999999998   467899999999987754332


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                       .....+||+.|+|||++..       ..|+.++|||||||++|+|++|.+||.+.+....+..+.....  ....+.+.
T Consensus       169 -~~~~~~gt~~Y~APE~l~~-------~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~  238 (444)
T 3soa_A          169 -AWFGFAGTPGYLSPEVLRK-------DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY--DFPSPEWD  238 (444)
T ss_dssp             -BCCCSCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--CCCTTTTT
T ss_pred             -eeecccCCcccCCHHHhcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC--CCCccccc
Confidence             2345679999999999963       3689999999999999999999999999998888888877322  12223345


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+|+.+.+||..||. ||.+|||+.++|+||||...
T Consensus       239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            789999999999999 99999999999999999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.6e-47  Score=390.99  Aligned_cols=259  Identities=32%  Similarity=0.589  Sum_probs=222.6

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      ++..+..++|.+.+.||+|+||.||+|.+..++..||+|++.+.....       ..|..++..++||||++++++|.+.
T Consensus         2 k~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             --CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CcceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            345788999999999999999999999999999999999986543211       4688999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+|+||||++||+|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            9999999999999999999653  45999999999999999999999999999999999999999999999999998665


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ...   .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||...+.......+..    ....
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~  225 (279)
T 3fdn_A          160 PSS---RRTDLCGTLDYLPPEMIEG-------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR----VEFT  225 (279)
T ss_dssp             -----------CCCCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCC
T ss_pred             Ccc---cccccCCCCCccCHhHhcc-------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh----CCCC
Confidence            432   2234579999999999863       3678899999999999999999999998888888777765    3344


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                      +|.  .+++.+.+||..||. ||.+|||+.+++.||||......|
T Consensus       226 ~~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          226 FPD--FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             CCT--TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             CCC--cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence            454  679999999999999 999999999999999998765443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-46  Score=398.07  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=216.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++......     ...|+.+++.++||||+++++++.+.+..|+||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            457999999999999999999999999999999998655432     267999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-c
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-I  166 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~  166 (792)
                      |||+||+|.+++.  ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus        85 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           85 EYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             ECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EcCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            9999999999994  445699999999999999999999999999999999999999999999999999987643322 1


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh-hhhhhhcccCCCCcCCCCCc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e-l~ekIl~~~~~~~l~fP~~~  245 (792)
                      .....+||+.|+|||++...      ..++.++|||||||++|+|++|..||...+... .+..+..    .....+...
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~  232 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTYLNPWK  232 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCS------SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT----TCTTSTTGG
T ss_pred             ccCCCccCcCccCcHHhccC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----ccccCCccc
Confidence            22355799999999999732      234778999999999999999999997655432 2222222    222334445


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+++.+.+|+.+||. ||.+|||+.+++.||||...
T Consensus       233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            789999999999999 99999999999999999854

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=397.47  Aligned_cols=267  Identities=23%  Similarity=0.394  Sum_probs=214.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +++|.+++.||+|+||.||+|.+..+|+.||+|++.......     ..|+.+++.++||||++++++|.+.+.+|+|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            468999999999999999999999999999999997544322     468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus        81 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~  157 (324)
T 3mtl_A           81 YLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY  157 (324)
T ss_dssp             CCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence            996 5898888653 3459999999999999999999999999999999999999999999999999998655332 222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC-CcC-------
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED-TVS-------  240 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~-~l~-------  240 (792)
                      ...+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+.......+....... ...       
T Consensus       158 ~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----CGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             ccccCcccccChhhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            34578999999999863      2468999999999999999999999999888776666554311100 000       


Q ss_pred             -------CCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCCCCCCC
Q psy13735        241 -------FPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDPPCIPP  289 (792)
Q Consensus       241 -------fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~pP~~P~  289 (792)
                             ++.         ...+++.+.+||.+||. ||.+|||+.++++||||..+.......|.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  297 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD  297 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCT
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCC
Confidence                   110         12568999999999999 99999999999999999987754444443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-46  Score=403.80  Aligned_cols=265  Identities=22%  Similarity=0.351  Sum_probs=217.8

Q ss_pred             CCCCCceEEeEeeec--CceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQG--NFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsG--sFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ...++|++++.||+|  +||.||+|+++.+|+.||+|++.......      ..|+.+++.++|||||+++++|.+.+.+
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            356789999999999  99999999999999999999998765443      4589999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+|||||+||+|.+++.....+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            99999999999999998765677999999999999999999999999999999999999999999999999998655322


Q ss_pred             CC------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC
Q psy13735        164 GR------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       164 ~~------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      ..      ......+||+.|+|||++...     ...++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTT-----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             cccccccccccccccccccccCHHHHhcc-----CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            11      112234799999999999631     2468899999999999999999999998766555544433211100


Q ss_pred             ----------------------------------------CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCC
Q psy13735        238 ----------------------------------------TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPV  276 (792)
Q Consensus       238 ----------------------------------------~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPw  276 (792)
                                                              ....+....+++.+.+||.+||. ||.+|||+.++|+|||
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                                                    00111223678999999999999 9999999999999999


Q ss_pred             ccCCC
Q psy13735        277 FDCLD  281 (792)
Q Consensus       277 F~~i~  281 (792)
                      |+.+.
T Consensus       337 f~~~~  341 (389)
T 3gni_B          337 FKQIK  341 (389)
T ss_dssp             GGGC-
T ss_pred             HHHHh
Confidence            99764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-46  Score=387.63  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=209.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +++|.+++.||+|+||.||+|.+ .+|+.||+|++.......      ..|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            46899999999999999999998 678999999997554321      47899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++| +|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ .
T Consensus        80 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (288)
T ss_dssp             ECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence            99975 899988653 35699999999999999999999999999999999999999999999999999987653221 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------CCCCc-
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------TEDTV-  239 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------~~~~l-  239 (792)
                      ....+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+.......+....       +.... 
T Consensus       157 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cccccccccccCchheeC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            234469999999999863      2458999999999999999999999998877666555543310       00000 


Q ss_pred             ------CCC---------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        240 ------SFP---------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       240 ------~fP---------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                            .++         ....+++.+.+||.+||. ||.+|||+.+++.||||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                  000         012578999999999999 99999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.9e-47  Score=407.66  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=207.8

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..++|.+++.||+|+||.||+|+++.+|+.||+|++.+.....   ..|+.+++.++||||++++++|.+.+.+|+||||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            4678999999999999999999999999999999998755433   5788999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc--eEEeccCcccccccCCCcc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH--LKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~--VKLiDFGLA~~l~~~~~~~  167 (792)
                      |+||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......  .
T Consensus        98 ~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~  173 (361)
T 3uc3_A           98 ASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  173 (361)
T ss_dssp             CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--C
Confidence            999999999954  345999999999999999999999999999999999999987765  9999999997543222  2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++.+.      ...+.++|||||||++|+|++|..||.+......+..+..........+|....+
T Consensus       174 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLRQ------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI  247 (361)
T ss_dssp             -------CTTSCHHHHHCS------SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred             CCCCcCCCCcCChhhhcCC------CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence            2345799999999999732      2234459999999999999999999987655433333332222245566666678


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ++.+.+||.+||. ||.+|||+.+++.||||..
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            9999999999999 9999999999999999964

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.3e-47  Score=408.71  Aligned_cols=252  Identities=23%  Similarity=0.445  Sum_probs=218.3

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-----C--hHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-----P--NTIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-----~--~~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      +...++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...     .  ...|+.+++.++||||+++++++.+.+.+
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            4456899999999999999999999999999999999875321     1  15789999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||+ +|+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        85 ~lv~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEEECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEEEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999999 7899998854  345999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      .  .....+||+.|+|||++.+.      ..++.++|||||||++|+|++|..||.+......+..+..    ....+|.
T Consensus       162 ~--~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~----~~~~~p~  229 (336)
T 3h4j_B          162 N--FLKTSCGSPNYAAPEVINGK------LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS----CVYVMPD  229 (336)
T ss_dssp             B--TTCCCTTSTTTSCGGGSCCS------GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS----SCCCCCT
T ss_pred             c--ccccccCCcCcCCHHHHcCC------CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----CCCCCcc
Confidence            2  23455799999999998632      2347899999999999999999999988776666665544    3344454


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                        .+|+.+.+||.+||. ||.+|||+.++++||||+.
T Consensus       230 --~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          230 --FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             --TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             --cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence              689999999999999 9999999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=387.29  Aligned_cols=261  Identities=23%  Similarity=0.328  Sum_probs=212.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---------hHHHHHHHHhc---CCCCcceeEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---------NTIERDIMVKS---KCPYIVNLFYSFQD   79 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---------~~~E~eIL~kL---~HPNIVkL~~vfed   79 (792)
                      +..++|++++.||+|+||.||+|++..+|+.||+|++......         ...|..+++.+   .||||++++++|..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567999999999999999999999999999999999754321         14677777766   49999999999987


Q ss_pred             CC-----EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEecc
Q psy13735         80 MN-----HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        80 e~-----~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                      ..     .+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            65     5899999996 69999997766566999999999999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc
Q psy13735        155 GSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD  234 (792)
Q Consensus       155 GLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~  234 (792)
                      |++.......  .....+||+.|+|||++..       ..++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus       165 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  235 (308)
T 3g33_A          165 GLARIYSYQM--ALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI  235 (308)
T ss_dssp             SCTTTSTTCC--CSGGGGCCCSSCCHHHHHT-------SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccccccCCCc--ccCCccccccccCchHHcC-------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9998765332  2334579999999999974       368999999999999999999999999888877776665411


Q ss_pred             -------CCCCcCC-----CC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        235 -------TEDTVSF-----PS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       235 -------~~~~l~f-----P~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                             +.....+     +.         ...+++.+.+||.+||. ||.+|||+.++|+||||.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence                   1111110     00         12578999999999999 9999999999999999986543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.6e-46  Score=393.21  Aligned_cols=260  Identities=24%  Similarity=0.403  Sum_probs=212.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      ...++|++++.||+|+||.||+|.+. +|+.||+|++.......      ..|+.+++.++||||++++++|.+...+|+
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            35678999999999999999999985 58999999997554332      478999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||||+| +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        97 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             EEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            9999974 788887653 45599999999999999999999999999999999999999999999999999987653322


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC-cCC---
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT-VSF---  241 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~-l~f---  241 (792)
                       .....+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+.......+........ ..+   
T Consensus       175 -~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          175 -SYTHEVVTLWYRAPDVLMG------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ----CCCCCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             -cccCCcccCCcCCHHHhcC------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence             2334579999999999863      24689999999999999999999999988777666655543111000 000   


Q ss_pred             --------------CC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        242 --------------PS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       242 --------------P~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                    ..      ...+++++.+||.+||. ||.+|||+.++++||||+.++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                          00      12468899999999999 999999999999999999764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1e-46  Score=387.52  Aligned_cols=260  Identities=30%  Similarity=0.575  Sum_probs=223.6

Q ss_pred             HHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC----C---hHHHHHHHHhcCCCCcceeEEE
Q psy13735          4 VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM----P---NTIERDIMVKSKCPYIVNLFYS   76 (792)
Q Consensus         4 ~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~----~---~~~E~eIL~kL~HPNIVkL~~v   76 (792)
                      +..+....+..++|.+.+.||+|+||.||+|.+..++..||+|++.+...    .   ...|+.++..++||||++++++
T Consensus         3 l~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   82 (284)
T 2vgo_A            3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY   82 (284)
T ss_dssp             -------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence            56778889999999999999999999999999999999999999965421    1   1568899999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCc
Q psy13735         77 FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        77 fede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                      +.+.+.+|+||||++||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           83 FHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEcCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccc
Confidence            9999999999999999999999965  34599999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC
Q psy13735        157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       157 A~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      +......   .....+|++.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+..    
T Consensus       161 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----  226 (284)
T 2vgo_A          161 SVHAPSL---RRRTMCGTLDYLPPEMIEG-------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN----  226 (284)
T ss_dssp             CEECSSS---CBCCCCSCGGGCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----
T ss_pred             cccCccc---ccccccCCCCcCCHHHhcc-------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc----
Confidence            8765432   2234579999999999863       3678899999999999999999999998887777777765    


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ....+|.  .+++.+.+||..||. ||.+||++.+++.||||+...
T Consensus       227 ~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          227 VDLKFPP--FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             TCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             cccCCCC--cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            3344554  679999999999999 999999999999999998643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.9e-46  Score=394.75  Aligned_cols=263  Identities=25%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.......     ..|+.+++.++||||++++++|.+.+.+|+||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3568999999999999999999999999999999997654321     57999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         88 EYVTGGDFVTLLENQ----PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~----~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |||+ |+|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            9997 5999888642    1245899999999999999999999999999999999999999999999999999876533


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC-----
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT-----  238 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~-----  238 (792)
                      .. .....+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+.......+........     
T Consensus       162 ~~-~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          162 VN-TFSSEVVTLWYRAPDVLMG------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             CC-CCCCCCSCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred             cc-cCCCCcccccccCchHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence            22 2234579999999999863      24688999999999999999999999998887666655543110000     


Q ss_pred             ---------cCC--------------CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCC
Q psy13735        239 ---------VSF--------------PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSD  283 (792)
Q Consensus       239 ---------l~f--------------P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~  283 (792)
                               ..+              .....+++.+.+||.+||. ||.+|||+.++++||||......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                     000              0112578999999999999 99999999999999999976543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-46  Score=405.67  Aligned_cols=258  Identities=24%  Similarity=0.417  Sum_probs=205.1

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcC-CCCcceeEEEEEeCC--EEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSK-CPYIVNLFYSFQDMN--HVY   84 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~-HPNIVkL~~vfede~--~ly   84 (792)
                      .++|.+++.||+|+||.||+|.+..+|+.||+|++.+.....      ..|+.++..+. ||||++++++|...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            468999999999999999999999999999999997654332      46888999997 999999999998654  799


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||. |+|..++..   +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.+....
T Consensus        88 lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            9999996 689999865   358999999999999999999999999999999999999999999999999998654211


Q ss_pred             --------------------CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh
Q psy13735        165 --------------------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD  224 (792)
Q Consensus       165 --------------------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~  224 (792)
                                          .......+||++|+|||++.+      ...|+.++|||||||++|+|++|.+||.+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG------STKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcC------CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                                112234579999999999963      246899999999999999999999999988877


Q ss_pred             hhhhhhhcccCCCC---------------------------c----C----------CCCCccccHHHHHHHHHHhh-Ch
Q psy13735        225 MTYSSILACDTEDT---------------------------V----S----------FPSSIRLSTAMVNFVQSLVQ-KL  262 (792)
Q Consensus       225 el~ekIl~~~~~~~---------------------------l----~----------fP~~~~lS~elkdLIk~LL~-DP  262 (792)
                      ..+..|........                           .    .          .+....+++++.+|+.+||. ||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            77666653110000                           0    0          00112568999999999999 99


Q ss_pred             hhcCChhHHhcCCCccCCC
Q psy13735        263 DARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       263 ~kRPTaeEIL~HPwF~~i~  281 (792)
                      .+|||+.++|.||||..+.
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTC
T ss_pred             ccCCCHHHHhCCHHHHHhc
Confidence            9999999999999998653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-46  Score=417.34  Aligned_cols=254  Identities=26%  Similarity=0.488  Sum_probs=223.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.+.....       ..|+.++++++|||||+++++|.+.+.+|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357999999999999999999999999999999997664431       5799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe---CCCCceEEeccCcccccccC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL---d~dg~VKLiDFGLA~~l~~~  163 (792)
                      ||||.||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       105 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             ECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999954  4569999999999999999999999999999999999999   56789999999999877644


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      ..  ....+||+.|+|||++.        +.|+.++|||||||++|+|++|.+||.+.+.......+....  .....|.
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~  250 (484)
T 3nyv_A          183 KK--MKDKIGTAYYIAPEVLH--------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK--YTFELPQ  250 (484)
T ss_dssp             CS--HHHHTTGGGTCCHHHHH--------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCSGG
T ss_pred             cc--cccCCCCccccCceeec--------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCcc
Confidence            32  23457999999999986        258899999999999999999999999998888888887632  2223344


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +..+|+.+++||.+||. ||.+|||+.++|.||||+...
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            56789999999999999 999999999999999998654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5e-46  Score=381.00  Aligned_cols=256  Identities=29%  Similarity=0.475  Sum_probs=222.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ..++|++.+.||+|+||.||+|.++.+|..||+|++.......      ..|+.++..++||||+++++++.+.+..|+|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999999999999999998766543      4688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc---eEEeccCcccccccC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKN  163 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~---VKLiDFGLA~~l~~~  163 (792)
                      |||++||+|.+.+..  .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.   +||+|||++......
T Consensus        84 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            999999999988855  345999999999999999999999999999999999999986665   999999999876543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      .  ......||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+.......+.....  ....+.
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~  230 (284)
T 3kk8_A          162 E--AWHGFAGTPGYLSPEVLKK-------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--DYPSPE  230 (284)
T ss_dssp             C--BCCCSCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCTTT
T ss_pred             c--cccCCCCCcCCcCchhhcC-------CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc--cCCchh
Confidence            3  2234569999999999863       3688999999999999999999999998888888877766222  122233


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ...+++.+.+|+..||. ||.+|||+.+++.||||....
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          231 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            34789999999999999 999999999999999998654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.6e-47  Score=402.90  Aligned_cols=251  Identities=18%  Similarity=0.227  Sum_probs=191.2

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHH--HHhcCCCCcceeEEEEEeCC----EEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDI--MVKSKCPYIVNLFYSFQDMN----HVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eI--L~kL~HPNIVkL~~vfede~----~lyLVm   87 (792)
                      .+|.+.+.||+|+||+||++++  +|+.||||++....... ..|+++  +.+++|||||++++++..++    .+||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4688999999999999999987  58999999997654322 334444  45789999999999998654    689999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL--------GYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~--------gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      |||+||+|.+++.+.   .+++..+..++.|++.||.|||++        +|+||||||+||||+.++++||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999999653   489999999999999999999987        999999999999999999999999999987


Q ss_pred             cccCCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-------------
Q psy13735        160 VDKNGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-------------  223 (792)
Q Consensus       160 l~~~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-------------  223 (792)
                      .......   .....+||+.|||||++.+.. +.....|+.++|||||||++|||+||.+||.....             
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~-~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCS-CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccc-cccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            7543322   223457999999999996320 01122467899999999999999999887743321             


Q ss_pred             --hhhhhhhhcccCCCCcCCCCC---ccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        224 --DMTYSSILACDTEDTVSFPSS---IRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       224 --~el~ekIl~~~~~~~l~fP~~---~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                        ......+..  ....+.+|..   ...+..+.+++.+|+. ||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~--~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          237 SVEEMRKVVCE--QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CHHHHHHHHTT--SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhc--ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence              111111111  1111223321   2344678999999999 9999999999865

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.6e-46  Score=395.58  Aligned_cols=265  Identities=25%  Similarity=0.381  Sum_probs=212.1

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      .....++|.+++.||+|+||.||+|.+..+|+.||+|++.......      ..|+.+++.++||||+++++++.+...+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3456789999999999999999999999999999999997554322      5799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC-----CCCceEEeccCccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS-----ATGHLKLTDFGSAT  158 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd-----~dg~VKLiDFGLA~  158 (792)
                      |+|||||. |+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||++.
T Consensus       109 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99999997 5999999653  4599999999999999999999999999999999999994     45569999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-C
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-D  237 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-~  237 (792)
                      ....... .....+||+.|+|||++..      ...++.++|||||||++|+|++|.+||.+.+.......+...... .
T Consensus       186 ~~~~~~~-~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          186 AFGIPIR-QFTHEIITLWYRPPEILLG------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             HHC------------CCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccCCccc-ccCCCcCCccccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            7653322 2334568999999999963      235899999999999999999999999888776666655431100 0


Q ss_pred             Cc-------------CCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        238 TV-------------SFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       238 ~l-------------~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                      ..             .++.          ...+++++.+||.+||. ||.+|||+.++++||||+..+..|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P  329 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP  329 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence            00             0111          01268999999999999 999999999999999999876544

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=402.12  Aligned_cols=262  Identities=28%  Similarity=0.564  Sum_probs=216.0

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCC--------hHHHHHHHHhc-CCCCcceeEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMP--------NTIERDIMVKS-KCPYIVNLFYSFQ   78 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~--------~~~E~eIL~kL-~HPNIVkL~~vfe   78 (792)
                      .+..++|.+++.||+|+||.||+|++.   .+|+.||+|++.+....        ...|+.++..+ +||||++++++|.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            455689999999999999999999984   58999999998754321        14689999999 6999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      +...+|+|||||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eCceEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999999965  3459999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      .............+||+.|+|||++.+.     ...++.++|||||||++|+|++|..||...........+........
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  282 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE  282 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence            7654333334456799999999999631     23578899999999999999999999975443322222222111123


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD  281 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~  281 (792)
                      ..+|.  .+++.+.+||.+||. ||.+||     ++.++++||||..++
T Consensus       283 ~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          283 PPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             CCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CCCCc--ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            33444  679999999999999 999999     999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-46  Score=385.46  Aligned_cols=259  Identities=24%  Similarity=0.348  Sum_probs=211.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.......      ..|+.++..++||||++++++|.+.+.+|+||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            478999999999999999999999999999999997765443      46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus        82 e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  158 (311)
T 4agu_A           82 EYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y  158 (311)
T ss_dssp             ECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence            99999999998854  45599999999999999999999999999999999999999999999999999987653322 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC------------
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT------------  235 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~------------  235 (792)
                      ....+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+.......+.....            
T Consensus       159 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVG------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             -------GGGCCHHHHHT------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCCCcCCccccChHHHhc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            234579999999999963      24689999999999999999999999988776555444332100            


Q ss_pred             ---CCCcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        236 ---EDTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       236 ---~~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                         ......|.          ...+++.+.+|+..||. ||.+|||+.++++||||+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence               00111111          13578999999999999 999999999999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.8e-46  Score=418.45  Aligned_cols=258  Identities=27%  Similarity=0.482  Sum_probs=222.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ..++|++++.||+|+||+||+|.++.+|+.||+|++.+....      ...|+.+++.++|||||+++++|.+...+|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            345799999999999999999999999999999999653221      15799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC---CCCceEEeccCcccccccC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS---ATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd---~dg~VKLiDFGLA~~l~~~  163 (792)
                      ||||.||+|.+.+..  .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       100 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            999999999998855  34599999999999999999999999999999999999995   4567999999999876543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      .  .....+||+.|+|||++.        +.|+.++|||||||++|+|++|.+||.+.+.......+....  .....|.
T Consensus       178 ~--~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~  245 (486)
T 3mwu_A          178 T--KMKDRIGTAYYIAPEVLR--------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK--YAFDLPQ  245 (486)
T ss_dssp             ------CCTTGGGGCCGGGGG--------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCSCSGG
T ss_pred             C--ccCCCcCCCCCCCHHHhC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCcc
Confidence            3  233457999999999986        258999999999999999999999999998888888887632  2233444


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDP  284 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~p  284 (792)
                      +..+|+.+++||.+||. ||.+|||+.++|.||||+.....+
T Consensus       246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            56789999999999999 999999999999999999765443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-46  Score=405.29  Aligned_cols=257  Identities=27%  Similarity=0.439  Sum_probs=221.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ..+.|.+++.||+|+||.||+|.++.+|+.||+|++.......    ..|+.++..++||||++++++|.+...+|+|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            3468999999999999999999999999999999997653222    578999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC--CCceEEeccCcccccccCCCc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~--dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++........ 
T Consensus       129 ~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-  206 (387)
T 1kob_A          129 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-  206 (387)
T ss_dssp             CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred             cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence            99999999999542 346999999999999999999999999999999999999974  56799999999987754332 


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                       ....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+.......+....+.....  ....
T Consensus       207 -~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~  276 (387)
T 1kob_A          207 -VKVTTATAEFAAPEIVDR-------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED--AFSS  276 (387)
T ss_dssp             -EEEECSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS--TTTT
T ss_pred             -eeeeccCCCccCchhccC-------CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--cccc
Confidence             234479999999999963       368899999999999999999999999988888877777643322221  2246


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +++.+.+||..||. ||.+|||+.+++.||||....
T Consensus       277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            89999999999999 999999999999999998654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.9e-46  Score=389.84  Aligned_cols=253  Identities=28%  Similarity=0.493  Sum_probs=220.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      .++|.+.+.||+|+||.||+|.++.+|..||+|++.+.....          ..|+.++..++||||++++++|.+...+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            457999999999999999999999999999999997654321          5789999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC----ceEEeccCcccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG----HLKLTDFGSATQ  159 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg----~VKLiDFGLA~~  159 (792)
                      |+|||||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            999999999999999954  45689999999999999999999999999999999999999888    799999999987


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      .....  .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+.......+...    ..
T Consensus       169 ~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~----~~  235 (321)
T 2a2a_A          169 IEDGV--EFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----SY  235 (321)
T ss_dssp             CCTTC--CCCCCCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT----CC
T ss_pred             cCccc--cccccCCCCCccCcccccC-------CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----cc
Confidence            75432  2234569999999999863       36889999999999999999999999988888877777652    22


Q ss_pred             CCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        240 SFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       240 ~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .++.  ...+++.+.+||.+||. ||.+|||+.+++.||||..++
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            2222  13678999999999999 999999999999999998643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-46  Score=400.07  Aligned_cols=254  Identities=25%  Similarity=0.456  Sum_probs=214.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC------Ch---HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM------PN---TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~------~~---~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      .+.|++.+.||+|+||.||+|.++.+|+.||+|++.....      ..   ..|+.++..++||||++++++|.+.+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3579999999999999999999999999999999864321      11   57999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc---eEEeccCcccc
Q psy13735         85 FIMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQ  159 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~---VKLiDFGLA~~  159 (792)
                      +|||||+||+|.+.+...  ....+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998887532  2345899999999999999999999999999999999999986654   99999999987


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      ..... ......+||+.|+|||++..       ..++.++|||||||++|+|++|.+||.+. ....+..+..    ...
T Consensus       183 ~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~----~~~  249 (351)
T 3c0i_A          183 LGESG-LVAGGRVGTPHFMAPEVVKR-------EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIK----GKY  249 (351)
T ss_dssp             CCTTS-CBCCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHH----TCC
T ss_pred             ecCCC-eeecCCcCCcCccCHHHHcC-------CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHc----CCC
Confidence            76432 22345579999999999963       36899999999999999999999999775 3455555554    222


Q ss_pred             CCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        240 SFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       240 ~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .++.  +..+++.+.+||.+||. ||.+|||+.+++.||||+..
T Consensus       250 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          250 KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            2221  24679999999999999 99999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.6e-46  Score=379.49  Aligned_cols=251  Identities=31%  Similarity=0.511  Sum_probs=220.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      .++|.+.+.||+|+||.||+|.+..++..+|+|++.+.....    ..|+.+++.++||||++++++|.+...+|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            457999999999999999999999999999999997654433    5789999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe---CCCCceEEeccCcccccccCCCc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL---d~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.......  
T Consensus        88 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--  163 (277)
T 3f3z_A           88 CTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--  163 (277)
T ss_dssp             CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred             cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence            999999999865  3459999999999999999999999999999999999999   788899999999998765433  


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC--C
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS--S  244 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~--~  244 (792)
                      .....+||+.|+|||++.        +.++.++|||||||++|+|++|..||...+.......+..    ....+|.  .
T Consensus       164 ~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~  231 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLE--------GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE----GTFTFPEKDW  231 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHT--------TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCHHHH
T ss_pred             chhccCCCCCccChHHhc--------ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCchhh
Confidence            233457999999999985        2488899999999999999999999998888877777766    3333333  2


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ..+++.+.+||..||. ||.+|||+.+++.||||+..
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          232 LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            3679999999999999 99999999999999999853

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=395.17  Aligned_cols=254  Identities=29%  Similarity=0.488  Sum_probs=204.3

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      .+.|.+.+.||+|+||.||+|.+..+++.||+|++.......  ..|+.++..++||||++++++|.+...+|+|||||+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            456999999999999999999999999999999997654322  568999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCcccccccCCCccc
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||+|.+++.  ..+.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.......  ..
T Consensus       132 ~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~  207 (349)
T 2w4o_A          132 GGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LM  207 (349)
T ss_dssp             SCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--cc
Confidence            999999994  4566999999999999999999999999999999999999975   8899999999998765332  22


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh-hhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e-l~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ...+||+.|+|||++.+       ..++.++|||||||++|+|++|..||....... .+..+......  ...+.+..+
T Consensus       208 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~  278 (349)
T 2w4o_A          208 KTVCGTPGYCAPEILRG-------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--FISPWWDEV  278 (349)
T ss_dssp             -----CGGGSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC--CCTTTTTTS
T ss_pred             ccccCCCCccCHHHhcC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc--cCCchhhhC
Confidence            34579999999999863       368999999999999999999999997665443 55556552211  112223478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +..+.+||.+||. ||.+|||+.+++.||||...
T Consensus       279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999 99999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.2e-46  Score=378.96  Aligned_cols=254  Identities=29%  Similarity=0.527  Sum_probs=196.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      -..++|.+.+.||+|+||.||+|.+..+|+.||+|++.+....       ...|+.++..++||||+++++++.+.+.+|
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            3567899999999999999999999999999999999654321       156889999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        88 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999999999653 3569999999999999999999999999999999999999999999999999998765332


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                      . .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+..    ....+|. 
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~-  233 (278)
T 3cok_A          167 E-KHYTLCGTPNYISPEIATR-------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----ADYEMPS-  233 (278)
T ss_dssp             ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----SCCCCCT-
T ss_pred             C-cceeccCCCCcCCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----cccCCcc-
Confidence            1 2234579999999999863       3678899999999999999999999987766555554433    2233444 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                       .+++.+.++|.+||. ||.+|||+.+++.||||...
T Consensus       234 -~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          234 -FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             -TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             -ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence             679999999999999 99999999999999999853

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.1e-45  Score=388.34  Aligned_cols=261  Identities=28%  Similarity=0.471  Sum_probs=218.7

Q ss_pred             CceEE-eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEE
Q psy13735         16 DFDIK-RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        16 dY~I~-k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVm   87 (792)
                      .|.+. +.||+|+||.||+|.++.+|+.||+|++.+.....      ..|+.++..+. ||||++++++|.+...+|+||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            46776 89999999999999999999999999998654432      56888898885 799999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCcccccccCC
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||.||+|.+++.....+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.......
T Consensus       109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            9999999999996555577999999999999999999999999999999999999987   7899999999998775432


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                        .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+.......  ..+..
T Consensus       189 --~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~  257 (327)
T 3lm5_A          189 --ELREIMGTPEYLAPEILNY-------DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY--SEETF  257 (327)
T ss_dssp             -------CCCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--CTTTT
T ss_pred             --ccccccCCcCccCCeeecC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc--Cchhh
Confidence              2234579999999999963       368899999999999999999999999888887777776532222  22223


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCCCCC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDPPCI  287 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~pP~~  287 (792)
                      ..+++.+.+||..||. ||.+|||+.+++.||||+.++......
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~~  301 (327)
T 3lm5_A          258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFH  301 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC--
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccccC
Confidence            4689999999999999 999999999999999999877554433

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-46  Score=417.89  Aligned_cols=257  Identities=25%  Similarity=0.440  Sum_probs=225.9

Q ss_pred             HhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEEEe
Q psy13735          7 LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSFQD   79 (792)
Q Consensus         7 L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vfed   79 (792)
                      .....+..++|.+++.||+|+||.||+|.+..+|+.||+|++.+....       ...|+.+++.++||||+++++++.+
T Consensus         8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~   87 (476)
T 2y94_A            8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST   87 (476)
T ss_dssp             -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            345567889999999999999999999999999999999999754321       1578999999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      .+.+|+|||||+||+|.+++.  ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            999999999999999999994  456799999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      .....  .....+||+.|+|||++.+.      ..++.++|||||||++|+|++|..||.+.+....+..+..    +..
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----~~~  233 (476)
T 2y94_A          166 MSDGE--FLRTSCGSPNYAAPEVISGR------LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD----GIF  233 (476)
T ss_dssp             CCTTC--CBCCCCSCSTTCCHHHHTTC------CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT----TCC
T ss_pred             ccccc--cccccCCCcCeEChhhccCC------CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc----CCc
Confidence            65432  23456799999999999632      2347899999999999999999999998888888888766    333


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ..|.  .+++.+.+||.+||. ||.+|||+.+++.||||..
T Consensus       234 ~~p~--~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          234 YTPQ--YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             CCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             CCCc--cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            4444  679999999999999 9999999999999999985

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.7e-45  Score=387.66  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=218.3

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      .|...+.||+|+||.||+|+++.+|+.||+|++.......    ..|+.++..++||||++++++|...+.+|+||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            4888999999999999999999999999999997655433    578999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      ||+|.+++.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus       126 ~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  201 (321)
T 2c30_A          126 GGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL  201 (321)
T ss_dssp             SCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCC
T ss_pred             CCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccc
Confidence            9999999843   4599999999999999999999999999999999999999999999999999987654322 23345


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      +||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+....   ...++....+++.+
T Consensus       202 ~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l  271 (321)
T 2c30_A          202 VGTPYWMAPEVISR-------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNSHKVSPVL  271 (321)
T ss_dssp             CSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---CCCCTTGGGSCHHH
T ss_pred             cCCccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCcCccccCCHHH
Confidence            79999999999963       368899999999999999999999998887777666665421   12223334679999


Q ss_pred             HHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        252 VNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       252 kdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+|+.+||. ||.+|||+.+++.||||...
T Consensus       272 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          272 RDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            999999999 99999999999999999854

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-45  Score=379.81  Aligned_cols=253  Identities=30%  Similarity=0.501  Sum_probs=212.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..++|.+.+.||+|+||.||+|.++.+|..+|+|++.......     ..|+.+++.++||||++++++|.+...+|+||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            4467999999999999999999999999999999998765432     57899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe---CCCCceEEeccCccccccc
Q psy13735         88 EYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL---d~dg~VKLiDFGLA~~l~~  162 (792)
                      |||+||+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            999999999988532  23569999999999999999999999999999999999999   4567899999999987654


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      ..  .....+||+.|+|||++.        ..++.++|||||||++|+|++|..||.+.+.......+....    ..++
T Consensus       180 ~~--~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~~  245 (285)
T 3is5_A          180 DE--HSTNAAGTALYMAPEVFK--------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE----PNYA  245 (285)
T ss_dssp             ---------CTTGGGCCHHHHT--------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----CCCC
T ss_pred             cc--cCcCcccccCcCChHHhc--------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC----cccc
Confidence            32  233456999999999985        358899999999999999999999999888777666655421    1111


Q ss_pred             -CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        243 -SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       243 -~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                       ....+++.+.+|+.+||. ||.+|||+.+++.||||+.
T Consensus       246 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence             123478999999999999 9999999999999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-45  Score=392.25  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=213.4

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcC-----CCCcceeEEEEEeCCE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSK-----CPYIVNLFYSFQDMNH   82 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~-----HPNIVkL~~vfede~~   82 (792)
                      .+..++|.+++.||+|+||.||+|++..+|+.||+|++.......   ..|..++..+.     |||||+++++|...+.
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            345678999999999999999999999999999999997432211   56888999886     9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-----------------
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-----------------  145 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-----------------  145 (792)
                      +|+||||| ||+|.+++.+.....+++..++.++.||+.||.|||++||+||||||+|||++.                 
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~  189 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK  189 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred             eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence            99999999 999999998766667999999999999999999999999999999999999975                 


Q ss_pred             --------CCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC
Q psy13735        146 --------TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP  217 (792)
Q Consensus       146 --------dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P  217 (792)
                              ++.+||+|||++......    ....+||+.|+|||++.+       ..++.++|||||||++|+|++|..|
T Consensus       190 ~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          190 KIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN-------LGWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             EEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcC-------CCCCCccchHHHHHHHHHHHHCCCC
Confidence                    788999999999865432    234579999999999973       3689999999999999999999999


Q ss_pred             CCCCChhhhhhhhhcccCCC----------------------CcCCCCC------------------ccccHHHHHHHHH
Q psy13735        218 FNYETLDMTYSSILACDTED----------------------TVSFPSS------------------IRLSTAMVNFVQS  257 (792)
Q Consensus       218 F~~~d~~el~ekIl~~~~~~----------------------~l~fP~~------------------~~lS~elkdLIk~  257 (792)
                      |.+.+.......+.......                      ...+|..                  ...++.+.+||.+
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            98877665554443311100                      0011111                  1124778899999


Q ss_pred             Hhh-ChhhcCChhHHhcCCCcc
Q psy13735        258 LVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       258 LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      ||+ ||.+|||+.++|+||||+
T Consensus       339 ~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          339 ILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HhcCChhhCCCHHHHhcCcccC
Confidence            999 999999999999999995

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.6e-45  Score=374.93  Aligned_cols=255  Identities=26%  Similarity=0.434  Sum_probs=214.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.......     ..|..++..++||||+++++++.+.+.+|+||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            57999999999999999999999999999999997654432     5688999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-ccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKS  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~s  168 (792)
                      ++||+|.+++.  ....+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++........ ...
T Consensus        87 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            99999999984  345699999999999999999999999999999999999999999999999999987643321 122


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-hhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-MTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ...+||+.|+|||++...      ..++.++|||||||++|+|++|..||...... ..+..+..    .....+....+
T Consensus       165 ~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~  234 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTYLNPWKKI  234 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCS------SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT----TCTTSTTGGGS
T ss_pred             cCCccccCccChHHHhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh----cccccCchhhc
Confidence            345799999999998632      23477899999999999999999999765543 22222222    12223334578


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ++.+.+||..||. ||.+|||+.+++.||||+...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            9999999999999 999999999999999998643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-45  Score=384.70  Aligned_cols=261  Identities=25%  Similarity=0.478  Sum_probs=208.0

Q ss_pred             CCCCceEE-eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIK-RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~-k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL-~HPNIVkL~~vfede~~lyLV   86 (792)
                      -.+.|.+. +.||+|+||.||+|.+..+|+.||+|++.+.....    ..|+.++.++ +||||++++++|.+.+.+|+|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            34679985 78999999999999999999999999997654332    5688888884 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc---eEEeccCcccccccC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQVDKN  163 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~---VKLiDFGLA~~l~~~  163 (792)
                      ||||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999999965  345999999999999999999999999999999999999988776   999999998765422


Q ss_pred             CC------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh--------------
Q psy13735        164 GR------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL--------------  223 (792)
Q Consensus       164 ~~------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~--------------  223 (792)
                      ..      ......+||+.|+|||++....  .....++.++|||||||++|+|++|..||.+...              
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFS--EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTS--HHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             CccccccccccccccCCcCccChHHhhccc--ccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            11      1122446999999999986310  0012478899999999999999999999976542              


Q ss_pred             -hhhhhhhhcccCCCCcCCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        224 -DMTYSSILACDTEDTVSFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       224 -~el~ekIl~~~~~~~l~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                       ...+..+..    ....+|.  ...+++.+.+||.+||. ||.+|||+.++++||||+...
T Consensus       246 ~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          246 QNMLFESIQE----GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHH----CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHHhc----cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence             223344443    3333443  13579999999999999 999999999999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.8e-45  Score=377.66  Aligned_cols=254  Identities=29%  Similarity=0.509  Sum_probs=222.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ....+|.+.+.||+|+||.||+|.+..+|+.||+|++.+.....       ..|+.+++.++||||+++++++.+.+.+|
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            45678999999999999999999999999999999998765432       46889999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||+|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        92 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           92 VVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EEEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999999865  3459999999999999999999999999999999999999999999999999998765332


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                      . .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||........+..+..    ....+|. 
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~-  236 (294)
T 2rku_A          170 E-RKKVLCGTPNYIAPEVLSK-------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----NEYSIPK-  236 (294)
T ss_dssp             C-CBCCCCSCCSSCCHHHHTT-------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCCCCCT-
T ss_pred             c-ccccccCCCCcCCcchhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----ccCCCcc-
Confidence            2 2334579999999999863       3578899999999999999999999998887777766655    3334444 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                       .+++.+.+++.+||. ||.+|||+.++++||||....
T Consensus       237 -~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          237 -HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             -TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             -ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence             678999999999999 999999999999999998643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.3e-46  Score=414.10  Aligned_cols=252  Identities=27%  Similarity=0.492  Sum_probs=215.3

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +.|++++.||+|+||.||+|+++.+|..||+|++.+.....      ..|+.+++.++|||||+++++|.+...+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            36999999999999999999999999999999998654322      579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC---CceEEeccCcccccccCCC
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d---g~VKLiDFGLA~~l~~~~~  165 (792)
                      ||+||+|.+.+..  .+.+++..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||++....... 
T Consensus       117 ~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-  193 (494)
T 3lij_A          117 CYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-  193 (494)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence            9999999998854  3459999999999999999999999999999999999999764   459999999998775432 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                       .....+||+.|+|||++.        ..|+.++||||+||++|+|++|.+||.+.+.......+.....  ....|.+.
T Consensus       194 -~~~~~~gt~~y~aPE~l~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~  262 (494)
T 3lij_A          194 -KMKERLGTAYYIAPEVLR--------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY--TFDSPEWK  262 (494)
T ss_dssp             -CBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCSGGGT
T ss_pred             -cccccCCCcCeeCHHHHc--------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCchhcc
Confidence             234557999999999985        3588999999999999999999999999998888888876221  12223345


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+|+.+.+||.+||. ||.+|||+.++|.||||+..
T Consensus       263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            789999999999999 99999999999999999854

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.1e-45  Score=388.84  Aligned_cols=260  Identities=25%  Similarity=0.331  Sum_probs=213.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe-------
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD-------   79 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed-------   79 (792)
                      ..++|.+++.||+|+||.||+|++..+|+.||+|++.......      ..|+.++..++||||+++++++.+       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            3578999999999999999999999999999999987654432      479999999999999999999987       


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         80 -MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        80 -e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                       .+.+|+|||||.| +|.+.+... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence             4578999999965 777777543 3569999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC---CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC
Q psy13735        159 QVDKNG---RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       159 ~l~~~~---~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~  235 (792)
                      ......   .......+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cccccccccccccCCcccccCccCchhhcC------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            764221   122234579999999999863      24589999999999999999999999998887766665544211


Q ss_pred             CCCc-CCCCCc-------------------------cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        236 EDTV-SFPSSI-------------------------RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       236 ~~~l-~fP~~~-------------------------~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .... .++...                         ..++.+.+||.+||. ||.+|||+.++++||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            1111 111100                         127889999999999 99999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.1e-46  Score=393.31  Aligned_cols=253  Identities=28%  Similarity=0.491  Sum_probs=195.1

Q ss_pred             CCceEE---eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIK---RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~---k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ++|++.   +.||+|+||.||+|.++.+|+.||+|++.+..... ..|+.++..+. ||||++++++|.+...+|+||||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~   87 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL   87 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence            356664   78999999999999999999999999997653222 57889999997 99999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEEeccCcccccccCCCc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKLiDFGLA~~l~~~~~~  166 (792)
                      |+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....... .
T Consensus        88 ~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~  164 (325)
T 3kn6_A           88 LNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-Q  164 (325)
T ss_dssp             CCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-C
Confidence            999999999965  35699999999999999999999999999999999999997665   79999999998765332 2


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-------hhhhhhhhcccCCCCc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-------DMTYSSILACDTEDTV  239 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-------~el~ekIl~~~~~~~l  239 (792)
                      .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+.       ......+..    +..
T Consensus       165 ~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~----~~~  233 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQ-------NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK----GDF  233 (325)
T ss_dssp             --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT----TCC
T ss_pred             cccccCCCcCccCHHHhcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc----CCC
Confidence            3345579999999999863       3689999999999999999999999976543       334444443    333


Q ss_pred             CCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        240 SFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       240 ~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .++.  +..+|+++.+||..||. ||.+|||+.+++.||||+...
T Consensus       234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            3332  24689999999999999 999999999999999998643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-46  Score=392.39  Aligned_cols=260  Identities=29%  Similarity=0.448  Sum_probs=215.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC-----Ch----HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-----PN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~-----~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      ++|.+.+.||+|+||.||+|.+..++..||+|++.+...     ..    ..|+.++..++||||++++++|.+.+.+|+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            469999999999999999999999999999999975431     11    568999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy13735         86 IMEYVTGGDFVTLLENQ--------------------------------------PHGYLSESKARFYIYELAQAVQYLH  127 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~--------------------------------------~~g~LSE~ea~~Im~QILsAL~YLH  127 (792)
                      |||||+||+|.+++...                                      ....+++..++.++.||+.||.|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998410                                      0122467889999999999999999


Q ss_pred             hCCCccCCCCCCceEeCCCC--ceEEeccCcccccccCCC---cccccCCCCCCccChhhhhhhccCCCCCCCCcccccc
Q psy13735        128 GLGYVHRDIKPDNMLLSATG--HLKLTDFGSATQVDKNGR---IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLW  202 (792)
Q Consensus       128 s~gIVHRDLKPeNILLd~dg--~VKLiDFGLA~~l~~~~~---~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIW  202 (792)
                      ++||+||||||+|||++.++  .+||+|||++..+.....   .......||+.|+|||++...     ...++.++|||
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Diw  260 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-----NESYGPKCDAW  260 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-----SSCCCTHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-----CCCCCcHHHHH
Confidence            99999999999999998776  899999999987643221   123345799999999999631     24688999999


Q ss_pred             cchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        203 SIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       203 SLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ||||++|+|++|..||.+.+.......+....  .....+....+++.+.+||..||. ||.+||++.++++||||+.+.
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKK--LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc--cccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999888887777776622  112223334589999999999999 999999999999999998754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.6e-46  Score=406.18  Aligned_cols=255  Identities=27%  Similarity=0.508  Sum_probs=205.9

Q ss_pred             CCCCCceEE-eEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHH-HhcCCCCcceeEEEEEe----CCEEEE
Q psy13735         12 VSASDFDIK-RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIM-VKSKCPYIVNLFYSFQD----MNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~-k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL-~kL~HPNIVkL~~vfed----e~~lyL   85 (792)
                      ...++|.+. +.||.|+||+||+|.++.+|+.||+|++.... ....|+.++ +..+||||++++++|..    ...+||
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch-hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            355688887 79999999999999999999999999986432 225677776 45589999999999986    668999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCccccccc
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDK  162 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~~  162 (792)
                      |||||+||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999999997654556999999999999999999999999999999999999987   78899999999987653


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh----hhhhhhcccCCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM----TYSSILACDTEDT  238 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e----l~ekIl~~~~~~~  238 (792)
                      ..  .....+||+.|+|||++..       ..|+.++|||||||++|+|++|..||.+.+...    ....+..    +.
T Consensus       217 ~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~  283 (400)
T 1nxk_A          217 HN--SLTTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQ  283 (400)
T ss_dssp             ------------CTTCCGGGSCC-------CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TC
T ss_pred             CC--ccccCCCCCCccCHhhcCC-------CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Cc
Confidence            32  2345679999999999852       478999999999999999999999997665432    2333333    22


Q ss_pred             cCCC--CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        239 VSFP--SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       239 l~fP--~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +.+|  .+..+|+++.+||..||. ||.+|||+.+++.||||...
T Consensus       284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            2333  345789999999999999 99999999999999999853

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-45  Score=407.39  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=194.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe-----CCE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD-----MNH   82 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed-----e~~   82 (792)
                      .++|.+++.||+|+||.||+|.++.+|+.||+|++.+.....      ..|+.+|+.++|||||+++++|..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999999999999999997654332      469999999999999999999943     367


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+||||+ +|+|.+++..  .+.+++..++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+|+....
T Consensus       132 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            99999998 6799999954  45699999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC--------------------------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc---
Q psy13735        163 NGR--------------------------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT---  213 (792)
Q Consensus       163 ~~~--------------------------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT---  213 (792)
                      ...                          ......+||++|+|||++..      ...|+.++||||||||+|+|++   
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL------QENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhC------CCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            211                          11234579999999998742      2468999999999999999999   


Q ss_pred             --------CCCCCCCCCh--------------------hhhhhhhhccc------------------------CCCCcCC
Q psy13735        214 --------GSTPFNYETL--------------------DMTYSSILACD------------------------TEDTVSF  241 (792)
Q Consensus       214 --------Gk~PF~~~d~--------------------~el~ekIl~~~------------------------~~~~l~f  241 (792)
                              |.+||.+.+.                    ...+..|....                        ......+
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    6777765431                    11111111100                        0000000


Q ss_pred             -CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        242 -PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       242 -P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                       .....+++++.+||.+||. ||.+|||+.++|+||||+.+.
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence             0012468999999999999 999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-45  Score=414.80  Aligned_cols=254  Identities=26%  Similarity=0.459  Sum_probs=219.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----------------hHHHHHHHHhcCCCCcceeE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----------------NTIERDIMVKSKCPYIVNLF   74 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----------------~~~E~eIL~kL~HPNIVkL~   74 (792)
                      ...++|.+++.||+|+||.||+|.++.+|..||+|++.+....                 ...|+.+++.++|||||+++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3457899999999999999999999999999999999865432                 14689999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEE
Q psy13735         75 YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKL  151 (792)
Q Consensus        75 ~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKL  151 (792)
                      ++|.+...+|+|||||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999999999865  34599999999999999999999999999999999999998776   6999


Q ss_pred             eccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhh
Q psy13735        152 TDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       152 iDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl  231 (792)
                      +|||++.......  .....+||+.|+|||++.        ..++.++||||+||++|+|++|.+||.+.+.......+.
T Consensus       191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  260 (504)
T 3q5i_A          191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK--------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE  260 (504)
T ss_dssp             CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT--------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EECCCCEEcCCCC--ccccccCCcCCCCHHHhc--------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999998775432  234557999999999985        358899999999999999999999999999888888887


Q ss_pred             cccCCCCcCCC--CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        232 ACDTEDTVSFP--SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       232 ~~~~~~~l~fP--~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .    +.+.++  .+..+|+.+++||..||. ||.+|||+.++|.||||+...
T Consensus       261 ~----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          261 K----GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             H----CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             c----CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            6    233222  235789999999999999 999999999999999998643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-45  Score=382.78  Aligned_cols=251  Identities=21%  Similarity=0.386  Sum_probs=203.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC--------
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN--------   81 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~--------   81 (792)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.......     ..|+.++++++|||||+++++|.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            57999999999999999999999999999999997655432     57899999999999999999986543        


Q ss_pred             -------------------------------------------------EEEEEEeccCCCCHHHHHHhCCC-CCCCHHH
Q psy13735         82 -------------------------------------------------HVYFIMEYVTGGDFVTLLENQPH-GYLSESK  111 (792)
Q Consensus        82 -------------------------------------------------~lyLVmEy~~GGsL~dlL~r~~~-g~LSE~e  111 (792)
                                                                       .+|+|||||+||+|.+++.+... ...++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999975432 3356677


Q ss_pred             HHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-----------cccccCCCCCCccCh
Q psy13735        112 ARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-----------IKSIVPVGTPEYVAP  180 (792)
Q Consensus       112 a~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-----------~~s~t~vGTp~Y~AP  180 (792)
                      +..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........           ......+||+.|+||
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            899999999999999999999999999999999999999999999987764321           122345799999999


Q ss_pred             hhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC-CccccHHHHHHHHHHh
Q psy13735        181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS-SIRLSTAMVNFVQSLV  259 (792)
Q Consensus       181 EiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~-~~~lS~elkdLIk~LL  259 (792)
                      |++.+       ..++.++|||||||++|+|++|..|+...  ......+..      ..+|. ....++.+.+||..||
T Consensus       246 E~~~~-------~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l  310 (332)
T 3qd2_B          246 EQIHG-------NNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN------LKFPLLFTQKYPQEHMMVQDML  310 (332)
T ss_dssp             HHHHC-------CCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT------TCCCHHHHHHCHHHHHHHHHHH
T ss_pred             HHhcC-------CCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc------cCCCcccccCChhHHHHHHHHc
Confidence            99973       36899999999999999999998876321  122222222      11221 2356788999999999


Q ss_pred             h-ChhhcCChhHHhcCCCccCC
Q psy13735        260 Q-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       260 ~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      . ||.+|||+.++++||||+++
T Consensus       311 ~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          311 SPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             CSSGGGSCCHHHHHHSTTCCCC
T ss_pred             cCCCCcCCCHHHHhhchhhhcC
Confidence            9 99999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-45  Score=396.36  Aligned_cols=260  Identities=32%  Similarity=0.483  Sum_probs=214.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEe------------
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQD------------   79 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfed------------   79 (792)
                      ...++|.+++.||+|+||.||+|.+..+|+.||+|++.........|+.+++.++|||||+++++|..            
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            34678999999999999999999999999999999998776666789999999999999999999943            


Q ss_pred             --------------------------CCEEEEEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy13735         80 --------------------------MNHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGY  131 (792)
Q Consensus        80 --------------------------e~~lyLVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~gI  131 (792)
                                                ...+++|||||+ |+|.+.+..  ...+.+++..++.++.||+.||.|||++||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                      345899999997 577766642  234669999999999999999999999999


Q ss_pred             ccCCCCCCceEeC-CCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHH
Q psy13735        132 VHRDIKPDNMLLS-ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYE  210 (792)
Q Consensus       132 VHRDLKPeNILLd-~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYE  210 (792)
                      +||||||+|||++ .++.+||+|||+|.......  .....+||+.|+|||++.+      ...++.++||||+||++|+
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLG------ATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTT------CSSCCTHHHHHHHHHHHHH
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcC------CCCCCcchhhhhHHHHHHH
Confidence            9999999999997 68899999999998765433  2334579999999999863      2458999999999999999


Q ss_pred             hhcCCCCCCCCChhhhhhhhhcccCC-------------CCcCCCC----------CccccHHHHHHHHHHhh-ChhhcC
Q psy13735        211 LLTGSTPFNYETLDMTYSSILACDTE-------------DTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARL  266 (792)
Q Consensus       211 LLTGk~PF~~~d~~el~ekIl~~~~~-------------~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRP  266 (792)
                      |++|.+||.+.+.......+......             ....+|.          ...+++++.+||.+||. ||.+||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999988877666665431100             0111111          12578999999999999 999999


Q ss_pred             ChhHHhcCCCccCC
Q psy13735        267 NMDQVLGHPVFDCL  280 (792)
Q Consensus       267 TaeEIL~HPwF~~i  280 (792)
                      |+.+++.||||+.+
T Consensus       315 t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          315 NPYEAMAHPFFDHL  328 (383)
T ss_dssp             CHHHHHTSGGGHHH
T ss_pred             CHHHHhcCHHHHHH
Confidence            99999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=388.89  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=212.8

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---------hHHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---------NTIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---------~~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ..++|.+++.||+|+||.||+|.+..+|+.||+|++......         ...|+.++..++||||++++++|.+.+.+
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            457899999999999999999999999999999998754321         14799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+|||||.| +|..++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus        88 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            999999975 88888854 3356899999999999999999999999999999999999999999999999999877543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------CC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------TE  236 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------~~  236 (792)
                      .. .....+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+....+..+....       +.
T Consensus       166 ~~-~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          166 NR-AYTHQVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             CC-CCCCSCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             cc-cCCcccccccccCchHhhC------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            22 2334579999999999863      2358899999999999999999999999888777666665421       11


Q ss_pred             CCcCC---------CC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCC
Q psy13735        237 DTVSF---------PS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSD  283 (792)
Q Consensus       237 ~~l~f---------P~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~  283 (792)
                      .....         |.      ...+++.+.+||.+||. ||.+|||+.++++||||.....+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            10011         10      13567999999999999 99999999999999999876543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-44  Score=373.47  Aligned_cols=264  Identities=27%  Similarity=0.430  Sum_probs=223.7

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------------HHHHHHHHhcC-CCCcceeEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------------TIERDIMVKSK-CPYIVNLFYS   76 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------------~~E~eIL~kL~-HPNIVkL~~v   76 (792)
                      ....++|.+.+.||+|+||.||+|.++.+|+.||+|++.......             ..|..++.++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            345789999999999999999999999999999999997654211             46888999995 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCc
Q psy13735         77 FQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        77 fede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                      +.+...+|+||||++||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999999965  34599999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC
Q psy13735        157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       157 A~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      +.......  .....+|++.|+|||++..... .....++.++|||||||++|+|++|..||...+.......+..... 
T Consensus       171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  246 (298)
T 1phk_A          171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY-  246 (298)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHHC-TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-
T ss_pred             hhhcCCCc--ccccccCCccccCHHHhccccc-cccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc-
Confidence            98765433  2334569999999999864311 1234678899999999999999999999988887777777765221 


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                       ....+....+++.+.+++..||. ||.+|||+.+++.||||+...
T Consensus       247 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          247 -QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             -CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             -ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence             12223335789999999999999 999999999999999998654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-45  Score=375.18  Aligned_cols=255  Identities=26%  Similarity=0.452  Sum_probs=212.6

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      ...+..++|.+.+.||+|+||.||+|.+..+|+.||+|++......       ...|+.++..++||||+++++++.+.+
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            4567788999999999999999999999999999999998654321       146889999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+||||++|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             eEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999999999965  3458999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ...  .....+||+.|+|||++...      ...+.++|||||||++|+|++|..||...+....+..+..    ....+
T Consensus       163 ~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~  230 (276)
T 2h6d_A          163 DGE--FLRTSCGSPNYAAPEVISGR------LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG----GVFYI  230 (276)
T ss_dssp             C---------------CCTGGGTTS------CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCC
T ss_pred             CCc--ceecccCCccccCHHHHcCC------CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc----CcccC
Confidence            432  22344699999999998632      2346889999999999999999999998887777777665    33334


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      |.  .++..+.+++..||. ||.+|||+.+++.||||+.
T Consensus       231 ~~--~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          231 PE--YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ch--hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence            44  678999999999999 9999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.1e-45  Score=380.75  Aligned_cols=253  Identities=30%  Similarity=0.505  Sum_probs=217.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.......    ..|+.++..++||||++++++|.+...+|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457999999999999999999999999999999997654322    5789999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe---CCCCceEEeccCcccccccCCCc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL---d~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......   
T Consensus        88 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---  162 (304)
T 2jam_A           88 VSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---  162 (304)
T ss_dssp             CCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred             CCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence            999999999854  3458999999999999999999999999999999999999   77889999999998765422   


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+........  .+....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~  233 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQ-------KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE--SPFWDD  233 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSS-------CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC--TTTTTT
T ss_pred             ccccccCCCCccChHHhcc-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--cccccc
Confidence            2223469999999999863       3688999999999999999999999998888777777766322111  122346


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +++.+.+||..||. ||.+||++.+++.||||...
T Consensus       234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          234 ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            89999999999999 99999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.7e-45  Score=374.92  Aligned_cols=259  Identities=20%  Similarity=0.354  Sum_probs=198.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      .+..++|++++.||+|+||.||+|.+..+|+.||+|++.......      ..+..+++.++||||+++++++.+.+.+|
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            356789999999999999999999999999999999997654332      12333466789999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         85 FIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      +|||||+ |+|.+++..  ...+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus        83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9999996 588777643  2345699999999999999999999998 99999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC-ChhhhhhhhhcccCCCCcC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE-TLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~-d~~el~ekIl~~~~~~~l~  240 (792)
                      ...  ......||+.|+|||++...   .....++.++|||||||++|+|++|..||... ........+...   ....
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~  233 (290)
T 3fme_A          162 DDV--AKDIDAGCKPYMAPERINPE---LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE---PSPQ  233 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCC---TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS---CCCC
T ss_pred             ccc--cccccCCCccccChhhcChh---hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc---CCCC
Confidence            432  22334699999999997421   12346889999999999999999999999753 333333333321   1111


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      . ....+++.+.+|+..||. ||.+|||+.++++||||+.
T Consensus       234 ~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          234 L-PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             C-CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             c-ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            2 223679999999999999 9999999999999999984

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.7e-45  Score=375.41  Aligned_cols=253  Identities=27%  Similarity=0.506  Sum_probs=215.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ++|.+++.||+|+||.||+|.+..+|+.||+|++.......          ..|+.++..++||||+++++++.+...+|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46999999999999999999999999999999997654321          56889999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC----ceEEeccCccccc
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG----HLKLTDFGSATQV  160 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg----~VKLiDFGLA~~l  160 (792)
                      +||||++|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++...
T Consensus        85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            99999999999999965  34599999999999999999999999999999999999998877    7999999999876


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .....  .....||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+.......+..........
T Consensus       163 ~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T 3bhy_A          163 EAGNE--FKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE  233 (283)
T ss_dssp             C----------CCCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             cCCCc--ccccCCCcCccCcceecC-------CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence            54322  234469999999999863       368899999999999999999999999888777777765522211111


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .  ...+++.+.+|+.+||. ||.+||++.+++.||||+.+
T Consensus       234 ~--~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          234 Y--FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             H--HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             h--cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            1  13678999999999999 99999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-44  Score=368.22  Aligned_cols=248  Identities=18%  Similarity=0.327  Sum_probs=205.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL-~HPNIVkL~~vfede~~lyLV   86 (792)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.......      ..|..++..+ +||||+++++++.+.+.+|+|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            357999999999999999999999999999999998654433      4577777788 899999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC------------------
Q psy13735         87 MEYVTGGDFVTLLENQP--HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT------------------  146 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~--~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d------------------  146 (792)
                      ||||+||+|.+++....  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+                  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            99999999999996531  2568999999999999999999999999999999999999844                  


Q ss_pred             -CceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh
Q psy13735        147 -GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM  225 (792)
Q Consensus       147 -g~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e  225 (792)
                       +.+||+|||++.......     ...||+.|+|||++..      ...++.++|||||||++|+|++|.+|+.....  
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQE------NYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTT------CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ceEEEEcccccccccCCcc-----ccCCCccccChhHhcC------CCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence             479999999998765332     3359999999999963      23566899999999999999999988754432  


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                       ...+...   ....+|.  .+++.+.+|+..||. ||.+|||+.++++||||...
T Consensus       237 -~~~~~~~---~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 -WHEIRQG---RLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -HHHHHTT---CCCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -HHHHHcC---CCCCCCc--ccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence             2333321   1123333  679999999999999 99999999999999999853

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-44  Score=384.39  Aligned_cols=253  Identities=29%  Similarity=0.515  Sum_probs=222.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ....+|.+.+.||+|+||.||+|.+..+++.||+|++.+.....       ..|+.+++.++||||++++++|.+.+.+|
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            35678999999999999999999999999999999998765432       46889999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||.|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       118 lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          118 VVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999999865  3459999999999999999999999999999999999999999999999999998765332


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                      . .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||........+..+..    ....+|. 
T Consensus       196 ~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~~-  262 (335)
T 2owb_A          196 E-RKKVLCGTPNYIAPEVLSK-------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----NEYSIPK-  262 (335)
T ss_dssp             C-CBCCCCSCCSSCCHHHHHT-------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCCCT-
T ss_pred             c-cccccCCCccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc----CCCCCCc-
Confidence            2 2334579999999999973       3678899999999999999999999998887777776665    3344444 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                       .+++.+.+||.+||. ||.+||++.+++.||||...
T Consensus       263 -~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          263 -HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             -TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             -cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence             678999999999999 99999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-45  Score=411.87  Aligned_cols=254  Identities=21%  Similarity=0.352  Sum_probs=204.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------C
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------N   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------~   81 (792)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.+.....      ..|+.+++.++|||||+++++|...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999999999999999997653322      4788999999999999999999654      4


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|||||||.| +|...+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+...
T Consensus       141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            68999999965 4666662    238999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC----
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED----  237 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~----  237 (792)
                      ...  .....+||+.|+|||++.+       ..|+.++|||||||++|+|++|++||.+.+....+..|.......    
T Consensus       216 ~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          216 TSF--MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             -CC--CC----CCCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             CCc--ccCCCcccccccCHHHHcC-------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            432  2344579999999999973       368999999999999999999999999888766666554311100    


Q ss_pred             -------------------CcC----CCC-----C----ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        238 -------------------TVS----FPS-----S----IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       238 -------------------~l~----fP~-----~----~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                         ...    +|.     .    ...++++.+||.+||. ||.+|||+.++|+||||..+.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                               000    010     0    0126789999999999 999999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=377.67  Aligned_cols=262  Identities=23%  Similarity=0.372  Sum_probs=212.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhc-CCCCcceeEEEEEe------CC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKS-KCPYIVNLFYSFQD------MN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL-~HPNIVkL~~vfed------e~   81 (792)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.......   ..|+.++..+ +||||++++++|..      ..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            45678999999999999999999999999999999997654332   5788889988 79999999999987      56


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            89999999999999999977555679999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      .... .....+||+.|+|||++...  ......++.++|||||||++|+|++|..||...+.......+...    ....
T Consensus       181 ~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~  253 (326)
T 2x7f_A          181 RTVG-RRNTFIGTPYWMAPEVIACD--ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----PAPR  253 (326)
T ss_dssp             -----------CCGGGCCHHHHC----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCC
T ss_pred             cCcc-ccccccCCccccChhhhccc--cccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC----cccc
Confidence            3221 22345699999999998632  112346889999999999999999999999877766555555431    1111


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .....+++.+.+||..||. ||.+||++.+++.||||...
T Consensus       254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            1234679999999999999 99999999999999999863

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6e-46  Score=388.61  Aligned_cols=267  Identities=23%  Similarity=0.388  Sum_probs=214.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCC---
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMN---   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~---   81 (792)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++.......       ..|..++..++||||+++++++....   
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            34678999999999999999999999999999999998764433       46777888899999999999987654   


Q ss_pred             -EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         82 -HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        82 -~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                       .+|+|||||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence             35999999999999999964  346999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        161 DKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       161 ~~~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      .....  ......+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARG-------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP  239 (311)
T ss_dssp             ---------------CCTTCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred             cccccccccccccCcCcccCCHHHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence            54322  12234569999999999973       3688999999999999999999999998887666655554211111


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCCCCCCC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDPPCIPP  289 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~pP~~P~  289 (792)
                      ...  ...+++.+.++|.+||. ||.+||+..+++.|+|++.....||..|.
T Consensus       240 ~~~--~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~  289 (311)
T 3ork_A          240 SAR--HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK  289 (311)
T ss_dssp             HHH--STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred             ccc--cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence            111  23579999999999999 99999999999999999876655554443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-44  Score=372.37  Aligned_cols=250  Identities=22%  Similarity=0.398  Sum_probs=209.8

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe----CCE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD----MNH   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed----e~~   82 (792)
                      ....|.+.+.||+|+||.||+|.+..++..||+|++.......      ..|..+++.++||||++++++|..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            3445899999999999999999999999999999998765543      468899999999999999999876    456


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeC-CCCceEEeccCcccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLS-ATGHLKLTDFGSATQ  159 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd-~dg~VKLiDFGLA~~  159 (792)
                      +|+|||||+||+|.+++.+  .+.+++..+..++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++..
T Consensus       104 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999999965  345899999999999999999999999  99999999999997 789999999999976


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-hhhhhhhhcccCCCC
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-DMTYSSILACDTEDT  238 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-~el~ekIl~~~~~~~  238 (792)
                      ....   .....+||+.|+|||++.        ..++.++|||||||++|+|++|..||..... ...+..+....  ..
T Consensus       182 ~~~~---~~~~~~~t~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~  248 (290)
T 1t4h_A          182 KRAS---FAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KP  248 (290)
T ss_dssp             CCTT---SBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CC
T ss_pred             cccc---ccccccCCcCcCCHHHHh--------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC--Cc
Confidence            5432   223456999999999885        2588999999999999999999999976443 34444343311  11


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ..+  ....++.+.+||..||. ||.+|||+.+++.||||+.
T Consensus       249 ~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 ASF--DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GGG--GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ccc--CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            112  23567899999999999 9999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.9e-45  Score=396.47  Aligned_cols=261  Identities=29%  Similarity=0.448  Sum_probs=211.3

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeCC------EEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDMN------HVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede~------~lyLVm   87 (792)
                      ..+|.+++.||+|+||.||+|.+..++. +|+|++.........|+.+++.++||||++++++|...+      .+|+||
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            3479999999999999999999987765 888888766655578999999999999999999996543      489999


Q ss_pred             eccCCCCHHHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC-CCCceEEeccCcccccccCCC
Q psy13735         88 EYVTGGDFVTLLE-NQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS-ATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        88 Ey~~GGsL~dlL~-r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd-~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||+++.+..+.. ......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...... 
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-  196 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-  196 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-
Confidence            9997754433321 12345699999999999999999999999999999999999998 79999999999998765433 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC---------
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE---------  236 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~---------  236 (792)
                       .....+||+.|+|||++.+      ...|+.++|||||||++|+|++|.+||.+.+....+..+......         
T Consensus       197 -~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          197 -PNVSYICSRYYRAPELIFG------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             -CCCSSCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             -CCcccccCcCccCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence             2334579999999999863      246899999999999999999999999988876665555431000         


Q ss_pred             ----CCcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCC
Q psy13735        237 ----DTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSD  283 (792)
Q Consensus       237 ----~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~  283 (792)
                          ....+|.          ...+++++.+||.+||. ||.+|||+.+++.||||+.+...
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence                0011111          12478999999999999 99999999999999999987643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.5e-45  Score=383.51  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=212.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++.......      ..|..++..++||||+++++++.+.+.+|+|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            5678999999999999999999999999999999997665543      4688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      |||++|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus       103 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  179 (331)
T 4aaa_A          103 FEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  179 (331)
T ss_dssp             EECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence            999999999888743  45599999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC----------
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE----------  236 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~----------  236 (792)
                      .....+||+.|+|||++..      ...++.++|||||||++|+|++|.+||.+.+.......+......          
T Consensus       180 ~~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVG------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----CCCCCTTCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccCCCcCCccccCcccccC------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            2234579999999999863      246889999999999999999999999887765555444321000          


Q ss_pred             -----CCcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        237 -----DTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       237 -----~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                           ....+|.          ...+++.+.+|+.+||. ||.+|||+.++|+||||+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                 0011111          12578999999999999 9999999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=397.71  Aligned_cols=253  Identities=26%  Similarity=0.475  Sum_probs=213.0

Q ss_pred             CceE--EeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         16 DFDI--KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        16 dY~I--~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      .|.+  .+.||+|+||.||+|.+..+|..||+|++.......    ..|+.++..++||||++++++|.+.+.+||||||
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            3444  678999999999999999999999999997654322    5789999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe--CCCCceEEeccCcccccccCCCcc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL--SATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL--d~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||++.......  .
T Consensus       168 ~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~  244 (373)
T 2x4f_A          168 VDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K  244 (373)
T ss_dssp             CTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence            9999999988653 3458999999999999999999999999999999999999  667899999999998775443  2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.+.+....+..+....+....  +....+
T Consensus       245 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~  315 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNY-------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED--EEFQDI  315 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTT-------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS--GGGTTS
T ss_pred             cccccCCCcEeChhhccC-------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh--hhhccC
Confidence            334579999999999863       36889999999999999999999999998888888888774332211  112467


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ++.+.+||.+||. ||.+|||+.+++.||||...
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999 99999999999999999853

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-44  Score=397.74  Aligned_cols=259  Identities=29%  Similarity=0.439  Sum_probs=211.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEeC------CEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQDM------NHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfede------~~lyLVmE   88 (792)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++.........|+.+++.++|||||+++++|...      ..+++|||
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            369999999999999999999999999999999987665557899999999999999999998532      24789999


Q ss_pred             ccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC-CceEEeccCcccccccCCC
Q psy13735         89 YVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-GHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        89 y~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d-g~VKLiDFGLA~~l~~~~~  165 (792)
                      |+++ +|.+++..  .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++...... 
T Consensus       134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-  211 (420)
T 1j1b_A          134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-  211 (420)
T ss_dssp             CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred             cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC-
Confidence            9975 56655532  234569999999999999999999999999999999999999965 568999999998765433 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC----------
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT----------  235 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~----------  235 (792)
                       .....+||+.|+|||++.+      ...|+.++|||||||++|+|++|++||.+.+....+..+.....          
T Consensus       212 -~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          212 -PNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             -CCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             -CceeeeeCCCcCCHHHHcC------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence             2234579999999999863      24689999999999999999999999998876655555543100          


Q ss_pred             ---CCCcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        236 ---EDTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       236 ---~~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                         ...+.+|.          ...+++++.+||.+||. ||.+||++.+++.||||+.+..
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence               01112221          12568999999999999 9999999999999999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-44  Score=379.39  Aligned_cols=255  Identities=24%  Similarity=0.405  Sum_probs=208.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC-CCCcceeEEEEEe--CCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK-CPYIVNLFYSFQD--MNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~-HPNIVkL~~vfed--e~~lyLVmEy   89 (792)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++....... ..|+.++..+. ||||+++++++.+  ....++||||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            468999999999999999999999999999999987543322 67999999997 9999999999998  6789999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCCCccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      +.|++|.+++..     +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........  .
T Consensus       115 ~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~  187 (330)
T 3nsz_A          115 VNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y  187 (330)
T ss_dssp             CCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--C
T ss_pred             cCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--c
Confidence            999999999843     89999999999999999999999999999999999999777 899999999987654332  3


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-hhhhhhhhhc-------------c-
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILA-------------C-  233 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-~~el~ekIl~-------------~-  233 (792)
                      ...+||+.|+|||++..      ...++.++|||||||++|+|++|..||.... .......+..             . 
T Consensus       188 ~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          188 NVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             ccccccccccChhhhcC------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            34579999999999863      2468899999999999999999999995332 2111111110             0 


Q ss_pred             -----------------cCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        234 -----------------DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       234 -----------------~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                       .+...........+++.+.+||.+||. ||.+|||+.++|+||||+.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                             000001111123479999999999999 999999999999999999764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=377.42  Aligned_cols=257  Identities=21%  Similarity=0.428  Sum_probs=216.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--------hHHHHHHHHhcCCCCcceeEEEEE--eCCEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--------NTIERDIMVKSKCPYIVNLFYSFQ--DMNHV   83 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--------~~~E~eIL~kL~HPNIVkL~~vfe--de~~l   83 (792)
                      .++|.+++.||+|+||.||+|.+..+|..||+|++.+....        ...|+.++..++||||+++++++.  +...+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            47899999999999999999999999999999999764321        157889999999999999999984  45689


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+|||||.+| |.+++.....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999876 878887666677999999999999999999999999999999999999999999999999999876532


Q ss_pred             C-CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        164 G-RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~-~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      . ........||+.|+|||++...     ...++.++|||||||++|+|++|..||.+.+.......+..    ....+|
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~----~~~~~~  233 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGL-----DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK----GSYAIP  233 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCC-----SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----CCCCCC
T ss_pred             ccccccccCCCCCCCcChhhccCc-----ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc----CCCCCC
Confidence            2 1223345699999999998632     12347789999999999999999999998888777777765    333444


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      .  .+++.+.+||.+||. ||.+|||+.++++||||+....
T Consensus       234 ~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 G--DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             S--SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             C--ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            4  679999999999999 9999999999999999987543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.7e-44  Score=388.86  Aligned_cols=254  Identities=22%  Similarity=0.362  Sum_probs=202.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN------   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~------   81 (792)
                      .++|.+++.||+|+||.||+|.+..+|+.||+|++.......      ..|+.+++.++||||++++++|....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999999999999999997654332      46889999999999999999998765      


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||. |+|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            8999999996 57888884    238999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC----
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED----  237 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~----  237 (792)
                      ...  .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+....+..+.......    
T Consensus       179 ~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  249 (371)
T 2xrw_A          179 TSF--MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  249 (371)
T ss_dssp             -------------CTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred             ccc--ccCCceecCCccCHHHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            332  2234579999999999963       368899999999999999999999999888766666554321100    


Q ss_pred             --------------C--------------cCCCCC----ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        238 --------------T--------------VSFPSS----IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       238 --------------~--------------l~fP~~----~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                    .              ..+|..    ...++.+.+||.+||. ||.+|||+.++++||||....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                          0              001110    1126789999999999 999999999999999998654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.6e-45  Score=374.66  Aligned_cols=263  Identities=22%  Similarity=0.398  Sum_probs=215.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      -..+.|++++.||+|+||.||+|.+..+|..||+|++.......    ..|+.++..++||||+++++++.+.+.+|+||
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            34568999999999999999999999999999999987654332    56889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus        96 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  173 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK  173 (302)
T ss_dssp             ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred             EeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence            999999999998653 3459999999999999999999999999999999999999999999999999876432111 11


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      .....||+.|+|||++...  ......++.++|||||||++|+|++|..||...+.......+....   ....+....+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~  248 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCE--TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD---PPTLLTPSKW  248 (302)
T ss_dssp             -----CCGGGCCHHHHHHH--HTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CCCCSSGGGS
T ss_pred             cccccCChhhcCCeeeccc--cCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC---CcccCCcccc
Confidence            2234699999999998532  1123468899999999999999999999998877766666555421   1122233477


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +..+.++|..||. ||.+|||+.+++.||||..+.
T Consensus       249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            9999999999999 999999999999999998653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-44  Score=397.75  Aligned_cols=261  Identities=26%  Similarity=0.425  Sum_probs=205.1

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC-----C
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM-----N   81 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede-----~   81 (792)
                      ..++|.+++.||+|+||.||+|.++.+|+.||+|++.+.....      ..|+.+++.++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            4578999999999999999999999999999999997654332      4789999999999999999999876     5


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||. |+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             eEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            7999999995 699999954  4569999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCc---------------------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC---
Q psy13735        162 KNGRI---------------------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP---  217 (792)
Q Consensus       162 ~~~~~---------------------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P---  217 (792)
                      .....                     .....+||++|+|||++..      ...|+.++|||||||++|+|++|..|   
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL------QENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTT------CSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhc------CCCCCcccccchHHHHHHHHHhccccccc
Confidence            33211                     1245689999999999742      24689999999999999999985444   


Q ss_pred             --------CCCCCh-----------------hhhhhhhhcccCC--------------------CCcCCCC-----Cccc
Q psy13735        218 --------FNYETL-----------------DMTYSSILACDTE--------------------DTVSFPS-----SIRL  247 (792)
Q Consensus       218 --------F~~~d~-----------------~el~ekIl~~~~~--------------------~~l~fP~-----~~~l  247 (792)
                              |.+.+.                 ......|......                    .....+.     ...+
T Consensus       255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
T 3n9x_A          255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI  334 (432)
T ss_dssp             SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred             ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence                    433321                 0111111100000                    0000010     1357


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      ++++.+||.+||. ||.+|||+.++|.||||+.+..
T Consensus       335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            9999999999999 9999999999999999998753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=391.54  Aligned_cols=255  Identities=25%  Similarity=0.440  Sum_probs=209.0

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------C
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------N   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------~   81 (792)
                      .++|.+++.||+|+||.||+|.+..+|+.||+|++.......      ..|+.+++.++||||++++++|...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999999999999999997654332      4789999999999999999999866      3


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+||||+ |++|.+++..   +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            569999999 8999999965   349999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC---
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT---  238 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~---  238 (792)
                      ..    ....+||++|+|||++.+      ...++.++||||+||++|+|++|.+||.+.+....+..|........   
T Consensus       180 ~~----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          180 SE----MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             SS----CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cc----cCcCcCCCCcCCHHHHhC------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            32    234579999999999873      24689999999999999999999999998877666655543111000   


Q ss_pred             ---------------------cCCC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        239 ---------------------VSFP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       239 ---------------------l~fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                                           ..+. .....++.+.+|+.+||. ||.+|||+.++|.||||..+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                                 0000 013568999999999999 9999999999999999997653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=373.43  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=213.8

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|.+.......  ..|+.++..++||||+++++++.+.+.+|+|||||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            4568999999999999999999999999999999998765443  57899999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      +||+|.+++.. ....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....... .....
T Consensus       107 ~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~  184 (314)
T 3com_A          107 GAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNT  184 (314)
T ss_dssp             TTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCC
T ss_pred             CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCc
Confidence            99999999963 24569999999999999999999999999999999999999999999999999998765332 22334


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      ..||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+...   ....++....+++.
T Consensus       185 ~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  254 (314)
T 3com_A          185 VIGTPFWMAPEVIQE-------IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---PPPTFRKPELWSDN  254 (314)
T ss_dssp             CCSCGGGCCHHHHSS-------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSSGGGSCHH
T ss_pred             cCCCCCccChhhcCC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC---CCcccCCcccCCHH
Confidence            579999999999863       36888999999999999999999999876655544443331   12223333467999


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +.+||..||. ||.+|||+.+++.||||...
T Consensus       255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            9999999999 99999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-44  Score=389.16  Aligned_cols=257  Identities=28%  Similarity=0.478  Sum_probs=218.9

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------------hHHHHHHHHhc-CCCCcceeEEEEEeCC
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------------NTIERDIMVKS-KCPYIVNLFYSFQDMN   81 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------------~~~E~eIL~kL-~HPNIVkL~~vfede~   81 (792)
                      ++|.+.+.||+|+||.||+|.++.+|+.||||++......            ...|..++..+ +||||++++++|....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            4699999999999999999999999999999998765421            14688899998 7999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++..  ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+.
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            99999999999999999964  3459999999999999999999999999999999999999999999999999998776


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ...  .....+||+.|+|||++.+.. ......++.++|||||||++|+|++|..||...+.......+.....  ....
T Consensus       252 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~  326 (365)
T 2y7j_A          252 PGE--KLRELCGTPGYLAPEILKCSM-DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY--QFSS  326 (365)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHHTT-CTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CCCH
T ss_pred             CCc--ccccCCCCCCccChhhccccc-cccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--CCCC
Confidence            443  233457999999999986431 11233588999999999999999999999988877777777665221  1111


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      |.+..+++.+.+||.+||. ||.+|||+.++++||||+
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            2234678999999999999 999999999999999996

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.1e-45  Score=374.31  Aligned_cols=266  Identities=24%  Similarity=0.434  Sum_probs=198.8

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ..+..++|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..|+.++..++||||+++++++...+.+|
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            3467789999999999999999999999999999999886543222     46778888999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         85 FIMEYVTGGDFVTLLEN------QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r------~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      +||||++||+|.+++..      ...+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999999863      134569999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCCCc----ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc
Q psy13735        159 QVDKNGRI----KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD  234 (792)
Q Consensus       159 ~l~~~~~~----~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~  234 (792)
                      ........    ......||+.|+|||++...      ..++.++|||||||++|+|++|..||................
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  243 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQV------RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND  243 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHH------HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccc------cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence            76533211    12344699999999998642      257889999999999999999999998766555444333211


Q ss_pred             CCCCc----CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        235 TEDTV----SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       235 ~~~~l----~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .....    .......+++.+.+++..||. ||.+||++.++++||||....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            11100    011123678999999999999 999999999999999998643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.1e-44  Score=375.26  Aligned_cols=259  Identities=23%  Similarity=0.364  Sum_probs=210.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      +..++|++++.||+|+||.||+|.+..+|..||+|++.......       ..|..++..++||||+++++++.+.+.+|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            44578999999999999999999999999999999986654432       46888899999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||+||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++.......
T Consensus        88 lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999999965  3469999999999999999999999999999999999999999999999999998775443


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC-cCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT-VSFPS  243 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~-l~fP~  243 (792)
                      .......+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+................ ..+  
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  236 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKG-------EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV--  236 (294)
T ss_dssp             ---------CCSSCCHHHHHT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS--
T ss_pred             ccccCccccCccccCHhHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhc--
Confidence            334445679999999999974       3678899999999999999999999988876655444443111110 112  


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      ...+++.+.++|.+||. ||.+||+..+.+.++|...+.
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            23678999999999999 999999766777777665443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.4e-45  Score=387.19  Aligned_cols=262  Identities=24%  Similarity=0.350  Sum_probs=215.9

Q ss_pred             HhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735          7 LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus         7 L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      .+-..+..++|.+.+.||+|+||.||+|.+..+|..||+|++.......     ..|+.++..++||||++++++|.+.+
T Consensus        25 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            3445677889999999999999999999999999999999997654322     46888899999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      .+|+|||||+||+|.+++..  .+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++++||+|||++...
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEEEECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999999965  34599999999999999999999996 9999999999999999999999999999765


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc------
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD------  234 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~------  234 (792)
                      ...   .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||...+.......+....      
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          183 IDS---MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             HHH---C----CCCCTTCCHHHHTT-------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             ccc---cccCCCCCCCeECHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            422   2234579999999999963       368999999999999999999999998766544322211000      


Q ss_pred             --------------------------------CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        235 --------------------------------TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       235 --------------------------------~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                                      ............+++++.+||.+||. ||.+|||+.+++.||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                            00001111123578999999999999 99999999999999999854

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-44  Score=382.43  Aligned_cols=267  Identities=26%  Similarity=0.428  Sum_probs=203.3

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCE-------
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNH-------   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~-------   82 (792)
                      ..++|.+.+.||+|+||.||+|.++.+|..||+|++.......   ..+...+..++||||++++++|.....       
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            4578999999999999999999999999999999987654433   345566678899999999999976433       


Q ss_pred             EEEEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCceEeCC-CCceEEeccCcc
Q psy13735         83 VYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLH--GLGYVHRDIKPDNMLLSA-TGHLKLTDFGSA  157 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLH--s~gIVHRDLKPeNILLd~-dg~VKLiDFGLA  157 (792)
                      +|+|||||+|+ |...+..  .....+++..+..++.||+.||.|||  ++||+||||||+|||++. ++.+||+|||++
T Consensus       101 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          101 LNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            89999999764 4443321  34566899999999999999999999  999999999999999986 899999999999


Q ss_pred             cccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC
Q psy13735        158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       158 ~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      .......  .....+||+.|+|||++..      ...++.++|||||||++|+|++|.+||.+.+....+..+.......
T Consensus       180 ~~~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  251 (360)
T 3e3p_A          180 KKLSPSE--PNVAYICSRYYRAPELIFG------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP  251 (360)
T ss_dssp             BCCCTTS--CCCSTTSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eecCCCC--CcccccCCcceeCHHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence            8775433  2234569999999999853      2458999999999999999999999999888776666654311000


Q ss_pred             -------------CcC------------CC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCCCCCCC
Q psy13735        238 -------------TVS------------FP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSDPPCIP  288 (792)
Q Consensus       238 -------------~l~------------fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~pP~~P  288 (792)
                                   ...            ++ .....++.+.+||.+||+ ||.+|||+.++++||||+.+..+.+..|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~  329 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLP  329 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCT
T ss_pred             CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCC
Confidence                         000            00 112357899999999999 9999999999999999998765444333

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8e-45  Score=399.44  Aligned_cols=253  Identities=28%  Similarity=0.543  Sum_probs=204.1

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------------hHHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------------NTIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------------~~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.+....            ...|+.++.+++|||||+++++|.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            36899999999999999999999999999999999765321            1579999999999999999999864 5


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEEeccCccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLTDFGSAT  158 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKLiDFGLA~  158 (792)
                      .+|+|||||+||+|.+++.  ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             ceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            6899999999999999984  456799999999999999999999999999999999999997544   59999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh-hhhhhcccCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-YSSILACDTED  237 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el-~ekIl~~~~~~  237 (792)
                      ......  .....+||+.|+|||++...    +...++.++|||||||++|+|++|.+||........ ...+..    .
T Consensus       291 ~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~----~  360 (419)
T 3i6u_A          291 ILGETS--LMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----G  360 (419)
T ss_dssp             SCC-------------CTTCCTTTTC--------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----T
T ss_pred             ecCCCc--cccccCCCCCccCceeeecC----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----C
Confidence            765432  23356799999999998531    234688899999999999999999999976544333 333333    2


Q ss_pred             CcCCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        238 TVSFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       238 ~l~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ...++.  +..+++.+.+||.+||. ||.+|||+.++++||||+.
T Consensus       361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            222221  23679999999999999 9999999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=383.80  Aligned_cols=244  Identities=26%  Similarity=0.431  Sum_probs=209.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      .++|.+.+.||+|+||.||+|.++.+|..||+|++.+.....            ..|+.++..++||||++++++|.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            357999999999999999999999999999999998764321            56999999999999999999999999


Q ss_pred             EEEEEEeccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         82 HVYFIMEYVTGG-DFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        82 ~lyLVmEy~~GG-sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      .+|+||||+.+| +|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            999999999776 99999954  456999999999999999999999999999999999999999999999999999877


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ....  .....+||+.|+|||++...      ..++.++|||||||++|+|++|..||....      ....    ....
T Consensus       181 ~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~----~~~~  242 (335)
T 3dls_A          181 ERGK--LFYTFCGTIEYCAPEVLMGN------PYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVE----AAIH  242 (335)
T ss_dssp             CTTC--CBCEECSCGGGCCHHHHTTC------CBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTT----TCCC
T ss_pred             CCCC--ceeccCCCccccChhhhcCC------CCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHh----hccC
Confidence            5443  22345799999999999632      234789999999999999999999996422      1111    1222


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      .|  ..+++.+.+||..||. ||.+|||+.+++.||||..
T Consensus       243 ~~--~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          243 PP--YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             CS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             CC--cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence            22  3579999999999999 9999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=378.75  Aligned_cols=246  Identities=23%  Similarity=0.362  Sum_probs=201.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHh-cCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVK-SKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~k-L~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.......      ..|...+.. .+||||++++++|.+.+.+|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            56999999999999999999999999999999987654443      233333434 48999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||| +|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .
T Consensus       137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~  212 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--A  212 (311)
T ss_dssp             ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--C
Confidence            999 77998888653 3459999999999999999999999999999999999999999999999999998765432  2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++.        +.++.++|||||||++|+|++|..||.+...   ...+....  ....++  ..+
T Consensus       213 ~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~--~~~  277 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQ--------GSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFT--AGL  277 (311)
T ss_dssp             --CCCCCGGGCCGGGGG--------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHH--TTS
T ss_pred             CcccCCCccccCHhHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccc--cCC
Confidence            33456999999999986        2588999999999999999999776654322   22222210  111122  367


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ++.+.+||..||. ||.+|||+.+++.||||+.
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999 9999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-44  Score=379.21  Aligned_cols=252  Identities=29%  Similarity=0.545  Sum_probs=208.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC------------hHHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP------------NTIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~------------~~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+....            ...|+.++..++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            4799999999999999999999999999999999765321            257999999999999999999998765 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc---eEEeccCcccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGSATQ  159 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~---VKLiDFGLA~~  159 (792)
                      +|+|||||+||+|.+++.  ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        89 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            899999999999999994  4567999999999999999999999999999999999999987664   99999999987


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh-hhhhhhcccCCCC
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTEDT  238 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e-l~ekIl~~~~~~~  238 (792)
                      .....  .....+||+.|+|||++...    +...++.++|||||||++|+|++|..||....... ....+..    ..
T Consensus       167 ~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~  236 (322)
T 2ycf_A          167 LGETS--LMRTLCGTPTYLAPEVLVSV----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----GK  236 (322)
T ss_dssp             CCCCH--HHHHHHSCCTTCCHHHHHHT----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH----TC
T ss_pred             ccccc--ccccccCCcCccCchhhccC----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh----Cc
Confidence            65322  22334699999999998532    23468899999999999999999999997655432 2233332    11


Q ss_pred             cCCCC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        239 VSFPS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       239 l~fP~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ..++.  +..+++.+.+||.+||. ||.+||++.+++.||||..
T Consensus       237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            11211  13578999999999999 9999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.5e-44  Score=384.34  Aligned_cols=257  Identities=23%  Similarity=0.413  Sum_probs=213.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC-----CEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM-----NHVY   84 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede-----~~ly   84 (792)
                      .+|.+++.||+|+||.||+|.+..+|..||+|++.......     ..|+.++..++||||+++++++...     ..+|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            58999999999999999999999999999999997544322     4799999999999999999999765     4799


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||||+. |+|.+++..   +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       107 iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            9999996 599999965   349999999999999999999999999999999999999999999999999998765332


Q ss_pred             Ccc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC----
Q psy13735        165 RIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT----  238 (792)
Q Consensus       165 ~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~----  238 (792)
                      ...  ....+||+.|+|||++...      ..++.++|||||||++|+|++|.+||.+.+.......+........    
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNS------KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTB------CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             CccccccccccccCCCCCHHhcCC------CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            211  2345799999999997632      4588999999999999999999999998877766666543110000    


Q ss_pred             ------------cCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        239 ------------VSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       239 ------------l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                  ..+|.         ...+++.+.+||.+||. ||.+|||+.+++.||||....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                        00000         12568999999999999 999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.9e-44  Score=382.93  Aligned_cols=250  Identities=28%  Similarity=0.380  Sum_probs=213.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      ..|.+++.||+|+||.||+|.+..+|+.||+|++.......       ..|+.++..++||||++++++|.+.+.+|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            35999999999999999999999999999999997654432       46889999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||. |+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......    
T Consensus       134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred             ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence            9996 6788877542 356999999999999999999999999999999999999999999999999999876432    


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                       ...+||+.|+|||++...    ....++.++|||||||++|+|++|.+||...+.......+...    .........+
T Consensus       208 -~~~~gt~~y~aPE~~~~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~  278 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSGHW  278 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTT----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----CCCCCCCTTS
T ss_pred             -CcccCCcceeCHhhhccc----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCCCCC
Confidence             245799999999998632    1346889999999999999999999999887766655555442    1111223467


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ++.+.+||..||. ||.+|||+.+++.||||..
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence            9999999999999 9999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=391.95  Aligned_cols=261  Identities=23%  Similarity=0.383  Sum_probs=192.3

Q ss_pred             CCceE-EeEeeecCceEEEEEEEe--cCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEe--CCEEEEEE
Q psy13735         15 SDFDI-KRFIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQD--MNHVYFIM   87 (792)
Q Consensus        15 ~dY~I-~k~IGsGsFGtVyla~~k--~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfed--e~~lyLVm   87 (792)
                      +.|.+ +++||+|+||.||+|.++  .++..||+|++.......  ..|+.+++.++|||||+++++|..  ...+|+||
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            45666 558999999999999976  468999999998766554  579999999999999999999954  77899999


Q ss_pred             eccCCCCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe----CCCCceEEeccCc
Q psy13735         88 EYVTGGDFVTLLENQ-------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGS  156 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~-------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL----d~dg~VKLiDFGL  156 (792)
                      |||. |+|.+++...       ....+++..++.|+.||+.||.|||++||+||||||+||||    +.++.+||+|||+
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            9995 5888877421       22349999999999999999999999999999999999999    6778999999999


Q ss_pred             ccccccCCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh---------h
Q psy13735        157 ATQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD---------M  225 (792)
Q Consensus       157 A~~l~~~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~---------e  225 (792)
                      |........  ......+||+.|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+..         .
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTT------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcC------CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            987653211  12234579999999999963      245899999999999999999999999765432         2


Q ss_pred             hhhhhhccc-------CCCCcCCCC-------------------------CccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        226 TYSSILACD-------TEDTVSFPS-------------------------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       226 l~ekIl~~~-------~~~~l~fP~-------------------------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      .+..+....       |......|.                         ....++.+.+||.+||. ||.+|||+.++|
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            222222100       000000000                         01227789999999999 999999999999


Q ss_pred             cCCCccCCCC
Q psy13735        273 GHPVFDCLDS  282 (792)
Q Consensus       273 ~HPwF~~i~~  282 (792)
                      .||||.....
T Consensus       333 ~hp~f~~~~~  342 (405)
T 3rgf_A          333 QDPYFLEDPL  342 (405)
T ss_dssp             TSGGGTSSSC
T ss_pred             cChhhccCCC
Confidence            9999987543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.4e-44  Score=395.12  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=210.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhc------CCCCcceeEEEEEeCCEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKS------KCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL------~HPNIVkL~~vfede~~ly   84 (792)
                      ..+|++++.||+|+||.||+|.+..+|+.||+|++.......   ..|+.++..+      +||||+.++++|.....+|
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            457999999999999999999999999999999997543211   4577787766      5789999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc--eEEeccCccccccc
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH--LKLTDFGSATQVDK  162 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~--VKLiDFGLA~~l~~  162 (792)
                      +|||||. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.  +||+|||++.....
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            9999995 69999998766666999999999999999999999999999999999999999887  99999999976542


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC------
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE------  236 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~------  236 (792)
                      .    ....+||+.|+|||++.+.       .++.++|||||||++|+|++|.+||.+.+....+..+......      
T Consensus       255 ~----~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          255 R----VYTYIQSRFYRAPEVILGA-------RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             C----CCSSCSCGGGCCHHHHHTB-------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             c----ccccCCCCCccChHHHhCC-------CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            2    2345799999999999743       6899999999999999999999999988776655544321000      


Q ss_pred             -------------CCc-------------------------CC-CC--------CccccHHHHHHHHHHhh-ChhhcCCh
Q psy13735        237 -------------DTV-------------------------SF-PS--------SIRLSTAMVNFVQSLVQ-KLDARLNM  268 (792)
Q Consensus       237 -------------~~l-------------------------~f-P~--------~~~lS~elkdLIk~LL~-DP~kRPTa  268 (792)
                                   ...                         .. |.        ....++.+.+||.+||. ||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                         000                         00 00        01237889999999999 99999999


Q ss_pred             hHHhcCCCccCCCC
Q psy13735        269 DQVLGHPVFDCLDS  282 (792)
Q Consensus       269 eEIL~HPwF~~i~~  282 (792)
                      .++|+||||+....
T Consensus       404 ~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          404 GQALRHPWLRRRLP  417 (429)
T ss_dssp             HHHHTSTTTC----
T ss_pred             HHHhCChhhccCCC
Confidence            99999999986543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-43  Score=373.55  Aligned_cols=260  Identities=26%  Similarity=0.422  Sum_probs=211.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC-----CE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM-----NH   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede-----~~   82 (792)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..|+.++..++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3578999999999999999999999999999999996543322     4789999999999999999998764     67


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+||||+. |+|.+++..   +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            999999996 689999865   3599999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCc---------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcc
Q psy13735        163 NGRI---------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC  233 (792)
Q Consensus       163 ~~~~---------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~  233 (792)
                      ....         .....+||+.|+|||++..      ...++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLT------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHS------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccCccccccchhhccccccccCCeeecc------CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            2111         1223478999999999863      246889999999999999999999999887765544433221


Q ss_pred             cCCC--------------------CcCCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        234 DTED--------------------TVSFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       234 ~~~~--------------------~l~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      ....                    ...++.      ...+++.+.+||.+||. ||.+|||+.++++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            0000                    000111      13678999999999999 9999999999999999997653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-44  Score=382.20  Aligned_cols=257  Identities=24%  Similarity=0.464  Sum_probs=217.9

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------------------h--HHHHHHHHhcCC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------------------N--TIERDIMVKSKC   67 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------------------~--~~E~eIL~kL~H   67 (792)
                      ......++|.+++.||+|+||.||+|.+  +|+.||+|++......                   .  ..|+.++..++|
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            3445668999999999999999999998  8999999998754321                   1  578999999999


Q ss_pred             CCcceeEEEEEeCCEEEEEEeccCCCCHHHH------HHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCc
Q psy13735         68 PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTL------LENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDN  140 (792)
Q Consensus        68 PNIVkL~~vfede~~lyLVmEy~~GGsL~dl------L~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeN  140 (792)
                      |||+++++++.+.+.+|+|||||+||+|.++      +.....+.+++..++.++.||+.||.|||+ +||+||||+|+|
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999999999999999999999999999998      644335779999999999999999999999 999999999999


Q ss_pred             eEeCCCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCc-ccccccchhhHHHhhcCCCCCC
Q psy13735        141 MLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG-SCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       141 ILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~-ksDIWSLGVILYELLTGk~PF~  219 (792)
                      |+++.++.+||+|||++......   ......||+.|+|||++..      ...++. ++|||||||++|+|++|..||.
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSN------ESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSS------CCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcC------CCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999876533   3344579999999999862      124555 8999999999999999999998


Q ss_pred             CCCh-hhhhhhhhcccCCCCcCCCCC-----------------ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        220 YETL-DMTYSSILACDTEDTVSFPSS-----------------IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       220 ~~d~-~el~ekIl~~~~~~~l~fP~~-----------------~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ..+. ......+..    ....+|..                 ..+++.+.+|+.+||. ||.+|||+.+++.||||...
T Consensus       254 ~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          254 LKISLVELFNNIRT----KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             CSSCSHHHHHHHTS----CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             CCCcHHHHHHHHhc----cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            7766 556666654    22233311                 4689999999999999 99999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-43  Score=368.10  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=216.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .+.|.+++.||+|+||.||+|.+..+|+.||+|++.......     ..|+.++..++||||++++++|.+...+|+|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356999999999999999999999999999999997654432     568899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++..   +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....... ...
T Consensus       101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  176 (303)
T 3a7i_A          101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR  176 (303)
T ss_dssp             CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCB
T ss_pred             eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-ccc
Confidence            9999999999943   469999999999999999999999999999999999999999999999999998765432 223


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ....||+.|+|||++..       ..++.++|||||||++|+|++|..||...........+...   ....++  ..++
T Consensus       177 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~~  244 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---NPPTLE--GNYS  244 (303)
T ss_dssp             CCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCC--SSCC
T ss_pred             CccCCCcCccCHHHHhc-------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC---CCCCCc--cccC
Confidence            44579999999999963       36788999999999999999999999877766655555431   112223  3679


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ..+.+|+..||. ||.+|||+.+++.||||..
T Consensus       245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            999999999999 9999999999999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-43  Score=368.97  Aligned_cols=259  Identities=23%  Similarity=0.366  Sum_probs=214.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEe-cCCcEEEEEEeccCCCC------hHHHHHHHHhc---CCCCcceeEEEEE-----
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEK-QSHNTFVMKKVLREKMP------NTIERDIMVKS---KCPYIVNLFYSFQ-----   78 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k-~tGk~vAVKiI~Ks~~~------~~~E~eIL~kL---~HPNIVkL~~vfe-----   78 (792)
                      .++|.+++.||+|+||.||+|.+. .+|+.||+|++......      ...|..+++.+   .||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            468999999999999999999995 67899999998754322      25677777766   8999999999997     


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      ....+|+||||+. |+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            5678999999997 699999987666669999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc----
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD----  234 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~----  234 (792)
                      ......  ......||+.|+|||++..       ..++.++|||||||++|+|++|.+||.+.+.......+....    
T Consensus       169 ~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          169 IYSFQM--ALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             CCCGGG--GGCCCCCCCTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccCCC--CccccccccceeCHHHHhc-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            765322  2334579999999999963       368899999999999999999999999887766665554310    


Q ss_pred             ---CCCCcCCC--------------CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        235 ---TEDTVSFP--------------SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       235 ---~~~~l~fP--------------~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                         +......+              ....+++.+.+|+.+||. ||.+|||+.+++.||||..+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence               10000000              013578999999999999 9999999999999999997653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=381.31  Aligned_cols=259  Identities=24%  Similarity=0.402  Sum_probs=205.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCC--CCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKC--PYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~H--PNIVkL~~vfede~~l   83 (792)
                      +....|++++.||+|+||.||+|.+. +++.||+|++.......      ..|+.++..+.|  |||+++++++.+...+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            45678999999999999999999884 68999999998665543      468899999976  9999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||| +.+|+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus        85 ~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            99999 558899999965  35699999999999999999999999999999999999996 688999999999876543


Q ss_pred             CCc-ccccCCCCCCccChhhhhhhccC----CCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-hhhhhhhcccCCC
Q psy13735        164 GRI-KSIVPVGTPEYVAPEVLEWMEGN----HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-MTYSSILACDTED  237 (792)
Q Consensus       164 ~~~-~s~t~vGTp~Y~APEiL~~~~~~----~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-el~ekIl~~~~~~  237 (792)
                      ... .....+||+.|+|||++......    .....++.++|||||||++|+|++|..||...... .....+..  ...
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~  238 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNH  238 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC--TTS
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc--CCc
Confidence            221 22345799999999999642110    11246889999999999999999999999754322 22333332  112


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ...+|.  ..++.+.+|+..||. ||.+|||+.+++.||||+.
T Consensus       239 ~~~~~~--~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          239 EIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             ccCCcc--cCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            333444  568899999999999 9999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.2e-44  Score=363.57  Aligned_cols=250  Identities=20%  Similarity=0.344  Sum_probs=215.4

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .+..++|.+.+.||+|+||.||+|.+. ++..||+|++.......   ..|..++.+++||||+++++++.+.+.+|+||
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            356679999999999999999999887 57789999998765544   57999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||++||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             ECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             EeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            999999999999653 4569999999999999999999999999999999999999999999999999998765332223


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....||+.|+|||++...       .++.++|||||||++|+|++ |.+||...+.......+...     ...+....
T Consensus       164 ~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~  231 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFS-------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----FRLYKPRL  231 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----CCCCCCTT
T ss_pred             ccCcccccccCCHHHhcCC-------CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----ccCCCCCc
Confidence            3344578899999999743       68999999999999999999 99999988888777777652     11222236


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .++.+.+++..||. ||.+||++.+++.|
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            79999999999999 99999999999876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.3e-44  Score=373.86  Aligned_cols=268  Identities=18%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             hHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCc---EEEEEEeccCCCCh------HHHHHHHHhcCCCCccee
Q psy13735          3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPN------TIERDIMVKSKCPYIVNL   73 (792)
Q Consensus         3 ~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk---~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL   73 (792)
                      +...+....+..++|.+++.||+|+||.||+|.+..++.   .||+|++.......      ..|+.+++.++||||+++
T Consensus        11 ~~~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   90 (323)
T 3qup_A           11 LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL   90 (323)
T ss_dssp             -----CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             HHHHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehh
Confidence            344566666788899999999999999999999887775   89999987654332      578899999999999999


Q ss_pred             EEEEEeCCEE------EEEEeccCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe
Q psy13735         74 FYSFQDMNHV------YFIMEYVTGGDFVTLLENQP----HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL  143 (792)
Q Consensus        74 ~~vfede~~l------yLVmEy~~GGsL~dlL~r~~----~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL  143 (792)
                      ++++......      |+|||||.||+|.+++....    ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli  170 (323)
T 3qup_A           91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML  170 (323)
T ss_dssp             CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE
Confidence            9999887665      99999999999999985422    2258999999999999999999999999999999999999


Q ss_pred             CCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCC
Q psy13735        144 SATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYE  221 (792)
Q Consensus       144 d~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~  221 (792)
                      +.++.+||+|||++......... ......|++.|+|||++...       .++.++|||||||++|+|++ |.+||.+.
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~ell~~g~~p~~~~  243 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-------LYTVHSDVWAFGVTMWEIMTRGQTPYAGI  243 (323)
T ss_dssp             CTTSCEEECCCCC-----------------CCGGGCCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-------CCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence            99999999999999876543221 12233578899999999743       68999999999999999999 99999988


Q ss_pred             ChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCC-------hhHHhcCCCccCCCC
Q psy13735        222 TLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLN-------MDQVLGHPVFDCLDS  282 (792)
Q Consensus       222 d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPT-------aeEIL~HPwF~~i~~  282 (792)
                      +.......+....   ....+  ..+++.+.+|+.+||. ||.+|||       +++++.|||+.....
T Consensus       244 ~~~~~~~~~~~~~---~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          244 ENAEIYNYLIGGN---RLKQP--PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             CGGGHHHHHHTTC---CCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             ChHHHHHHHhcCC---CCCCC--CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            8877777766521   22233  3679999999999999 9999999       667799999986543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.7e-44  Score=372.38  Aligned_cols=259  Identities=23%  Similarity=0.375  Sum_probs=211.5

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEE-ecCCcEEEEEEeccCCCC---hHHHHHHHHhcCCC------CcceeEEEEEe
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEE-KQSHNTFVMKKVLREKMP---NTIERDIMVKSKCP------YIVNLFYSFQD   79 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~-k~tGk~vAVKiI~Ks~~~---~~~E~eIL~kL~HP------NIVkL~~vfed   79 (792)
                      ..+..++|++++.||+|+||.||+|.+ ..+|+.||+|++......   ...|..++..++|+      +|++++++|.+
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            445567999999999999999999998 568899999998754321   15688888877654      59999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC--------------
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA--------------  145 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~--------------  145 (792)
                      .+.+|+||||| +|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999999 899999997765557999999999999999999999999999999999999987              


Q ss_pred             -----CCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC
Q psy13735        146 -----TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY  220 (792)
Q Consensus       146 -----dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~  220 (792)
                           ++.+||+|||++......    ....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA-------LGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT-------SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC-------CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                 668999999999875432    234579999999999963       3689999999999999999999999988


Q ss_pred             CChhhhhhhhhcccCCC-----------------CcC---------------------CCCCccccHHHHHHHHHHhh-C
Q psy13735        221 ETLDMTYSSILACDTED-----------------TVS---------------------FPSSIRLSTAMVNFVQSLVQ-K  261 (792)
Q Consensus       221 ~d~~el~ekIl~~~~~~-----------------~l~---------------------fP~~~~lS~elkdLIk~LL~-D  261 (792)
                      .+.......+.......                 ...                     .......++.+.+||.+||. |
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            77655443332210000                 000                     01112346789999999999 9


Q ss_pred             hhhcCChhHHhcCCCccCC
Q psy13735        262 LDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       262 P~kRPTaeEIL~HPwF~~i  280 (792)
                      |.+|||+.+++.||||+.+
T Consensus       317 P~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          317 PAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             TTTSCCHHHHTTSGGGGGG
T ss_pred             cccccCHHHHhcCHHHHHH
Confidence            9999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-44  Score=384.29  Aligned_cols=255  Identities=23%  Similarity=0.367  Sum_probs=204.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcC--------CCCcceeEEEEE---
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSK--------CPYIVNLFYSFQ---   78 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~--------HPNIVkL~~vfe---   78 (792)
                      ..++|.+++.||+|+||.||+|.+..+|+.||+|++.......   ..|+.++..+.        ||||++++++|.   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            3578999999999999999999999999999999997543211   46888888875        788999999998   


Q ss_pred             -eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCC---------
Q psy13735         79 -DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATG---------  147 (792)
Q Consensus        79 -de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg---------  147 (792)
                       +...+|+||||| +|+|.+.+.....+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++         
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence             556899999999 67777777665556799999999999999999999998 999999999999998775         


Q ss_pred             ----------------------------------------ceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhc
Q psy13735        148 ----------------------------------------HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME  187 (792)
Q Consensus       148 ----------------------------------------~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~  187 (792)
                                                              .+||+|||++......    ....+||+.|+|||++.+  
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~--  267 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG--  267 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT--
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC--
Confidence                                                    7999999999876532    234479999999999974  


Q ss_pred             cCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh------hhhhhhcccCC-------------------CC----
Q psy13735        188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM------TYSSILACDTE-------------------DT----  238 (792)
Q Consensus       188 ~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e------l~ekIl~~~~~-------------------~~----  238 (792)
                           ..++.++|||||||++|+|++|..||.+.+...      ....+......                   ..    
T Consensus       268 -----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          268 -----SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             -----SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             -----CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence                 368999999999999999999999997654321      11111110000                   00    


Q ss_pred             c-------------CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        239 V-------------SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       239 l-------------~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      .             .++.....++.+.+||.+||. ||.+|||+.++|+||||++
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0             001112456789999999999 9999999999999999973

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=375.14  Aligned_cols=264  Identities=25%  Similarity=0.376  Sum_probs=211.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC--EE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN--HV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~--~l   83 (792)
                      ....++|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..|+.++..++||||+++++++....  .+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            345678999999999999999999999999999999997644322     57899999999999999999998765  88


Q ss_pred             EEEEeccCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe----CCCCceEEeccCccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPH-GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSAT  158 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~-g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL----d~dg~VKLiDFGLA~  158 (792)
                      |+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999999965322 338999999999999999999999999999999999999    778889999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccC-CCCCCCCcccccccchhhHHHhhcCCCCCCCCCh----hhhhhhhhcc
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN-HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL----DMTYSSILAC  233 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~-~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~----~el~ekIl~~  233 (792)
                      .......  ....+||+.|+|||++...... .....++.++|||||||++|+|++|..||.....    ......+...
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            7764432  2345699999999998632111 1234788999999999999999999999964332    2222233221


Q ss_pred             cCCC---------------CcCCCC----CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCC
Q psy13735        234 DTED---------------TVSFPS----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPV  276 (792)
Q Consensus       234 ~~~~---------------~l~fP~----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPw  276 (792)
                      ....               ...+|.    ...++..+.+|+..||. ||.+|||+.+++.||-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            1100               001111    23567789999999999 9999999999999973

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8e-44  Score=364.97  Aligned_cols=253  Identities=21%  Similarity=0.378  Sum_probs=200.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEe------------
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQD------------   79 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfed------------   79 (792)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.......   ..|+.++..++||||++++++|.+            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            47999999999999999999999999999999986532211   468899999999999999999865            


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         80 -MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        80 -e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                       ...+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  164 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK  164 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred             cCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence             45789999999999999999753 3458899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-------------CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC-CChh
Q psy13735        159 QVDKNG-------------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY-ETLD  224 (792)
Q Consensus       159 ~l~~~~-------------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~-~d~~  224 (792)
                      ......             .......+||+.|+|||++..      ...++.++|||||||++|+|++   ||.. .+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~  235 (303)
T 1zy4_A          165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG------TGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV  235 (303)
T ss_dssp             CTTC-------------------------CTTSCHHHHTS------CSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             hcccccchhccccccccccccccccCCCcccccCcccccC------CCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence            664221             112234569999999999862      2368899999999999999998   5543 2333


Q ss_pred             hhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        225 MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       225 el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      .....+..........++  ...++.+.+++..||. ||.+|||+.++++||||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          236 NILKKLRSVSIEFPPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHSTTCCCCTTCC--TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHHhccccccccCcccc--ccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            344444432211112222  3567889999999999 9999999999999999974

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.7e-44  Score=367.34  Aligned_cols=254  Identities=27%  Similarity=0.493  Sum_probs=217.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++.......      ..|..++.+++||||+++++++.+...+|+|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3468999999999999999999999999999999997654321      5789999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC---CceEEeccCcccccccC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLTDFGSATQVDKN  163 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d---g~VKLiDFGLA~~l~~~  163 (792)
                      |||++|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||+|+||+++.+   +.+||+|||++......
T Consensus       100 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999998854  3459999999999999999999999999999999999999754   46999999999876543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      ..  .....||+.|+|||++.        +.++.++|||||||++|+|++|..||.+.+.......+.....  ....+.
T Consensus       178 ~~--~~~~~~~~~y~aPE~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~  245 (287)
T 2wei_A          178 TK--MKDRIGTAYYIAPEVLR--------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY--AFDLPQ  245 (287)
T ss_dssp             SS--CSCHHHHHTTCCHHHHT--------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCSGG
T ss_pred             Cc--cccccCcccccChHHhc--------CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCchh
Confidence            22  22335899999999985        2488899999999999999999999998887777777665221  122333


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ...+++.+.+||..||. ||.+|||+.+++.||||...
T Consensus       246 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            35789999999999999 99999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-43  Score=373.30  Aligned_cols=255  Identities=23%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      .+..++|++.+.||+|+||.||+|.+  +|..||+|++.......      ..|+.++.+++||||++++++|.+...+|
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            35677999999999999999999976  58899999998766543      46899999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         85 FIMEYVTGGDFVTLLENQPH-GYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~-g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      +|||||+||+|.+++..... ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999999964321 23899999999999999999999999  9999999999999999999999999998654


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ... ......+||+.|+|||++.+       ..++.++|||||||++|+|++|..||...+.......+..  ......+
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~~~  260 (309)
T 3p86_A          191 STF-LSSKSAAGTPEWMAPEVLRD-------EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF--KCKRLEI  260 (309)
T ss_dssp             ------------CCTTSCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH--SCCCCCC
T ss_pred             ccc-cccccCCCCccccChhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCC
Confidence            322 22334579999999999973       3678899999999999999999999998887776666543  1122334


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhc--CCCccC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG--HPVFDC  279 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~--HPwF~~  279 (792)
                      |.  .+++.+.+||..||. ||.+|||+.+++.  +++++.
T Consensus       261 ~~--~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          261 PR--NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             Cc--cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            44  789999999999999 9999999999976  566654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.1e-44  Score=364.13  Aligned_cols=254  Identities=26%  Similarity=0.429  Sum_probs=215.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEE--eCCEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQ--DMNHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfe--de~~ly   84 (792)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|.+.......      ..|+.++..++||||+++++++.  ....+|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4578999999999999999999999999999999998765543      46889999999999999999885  467899


Q ss_pred             EEEeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCceEeCCCCceEEeccCcc
Q psy13735         85 FIMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLG-----YVHRDIKPDNMLLSATGHLKLTDFGSA  157 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~g-----IVHRDLKPeNILLd~dg~VKLiDFGLA  157 (792)
                      +|||||+||+|.+++...  ....+++..++.++.||+.||.|||+.|     |+||||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999999999642  2345899999999999999999999999     999999999999999999999999999


Q ss_pred             cccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC
Q psy13735        158 TQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED  237 (792)
Q Consensus       158 ~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~  237 (792)
                      ........ ......||+.|+|||++..       ..++.++|||||||++|+|++|..||...+.......+....   
T Consensus       164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~---  232 (279)
T 2w5a_A          164 RILNHDTS-FAKTFVGTPYYMSPEQMNR-------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---  232 (279)
T ss_dssp             HHC---CH-HHHHHHSCCTTCCHHHHHC-------C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---
T ss_pred             eeeccccc-cccccCCCccccChHHhcc-------CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc---
Confidence            87653321 1223469999999999973       368899999999999999999999999888777777666522   


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ...+|.  .+++.+.++|..||. ||.+||++.+++.|||+..
T Consensus       233 ~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          233 FRRIPY--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             CCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             cccCCc--ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            112333  679999999999999 9999999999999999974

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-44  Score=387.94  Aligned_cols=254  Identities=24%  Similarity=0.395  Sum_probs=196.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC------C
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM------N   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede------~   81 (792)
                      .++|.+++.||+|+||.||+|.+..+|+.||+|++.......      ..|+.+++.++||||++++++|...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            368999999999999999999999999999999997654332      4789999999999999999999754      5


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+||||+ |++|.+++..   +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            689999999 7899998843   459999999999999999999999999999999999999999999999999998754


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC---
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT---  238 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~---  238 (792)
                      ..    ....+||++|+|||++.+      ...++.++|||||||++|+|++|.+||.+.+....+..|........   
T Consensus       184 ~~----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          184 DE----MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------CCCTTCCHHHHTT------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             cc----CCCcCcCcCccChHHHcC------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            32    234579999999999863      24688999999999999999999999998877666655543111000   


Q ss_pred             ----------------cCCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        239 ----------------VSFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       239 ----------------l~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                      ...+.      ....++.+.+||.+||. ||.+|||+.++|.||||....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                            00010      12468999999999999 999999999999999998754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3e-44  Score=382.03  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=186.8

Q ss_pred             CCCCceEEe-EeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEe----CCEEEEEE
Q psy13735         13 SASDFDIKR-FIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQD----MNHVYFIM   87 (792)
Q Consensus        13 ~l~dY~I~k-~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfed----e~~lyLVm   87 (792)
                      ..++|.+.+ .||+|+||.||+|.++.+|+.||+|++.............+..+.||||++++++|..    ...+|+||
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  105 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM  105 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence            457899965 6999999999999999999999999997643222333344667799999999999986    55689999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCcccccccCC
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...... 
T Consensus       106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-  184 (336)
T 3fhr_A          106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-  184 (336)
T ss_dssp             ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-
Confidence            9999999999998765567999999999999999999999999999999999999976   445999999999866532 


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc--CCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV--SFP  242 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l--~fP  242 (792)
                        .....+||+.|+|||++..       ..++.++|||||||++|+|++|..||.....................  ..+
T Consensus       185 --~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          185 --ALQTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             ----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             --ccccCCCCcCccChhhhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence              2234579999999999853       36788999999999999999999999766554432222211111222  223


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .+..+++.+.+||..||. ||.+|||+.++++||||...
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            345789999999999999 99999999999999999853

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-43  Score=360.15  Aligned_cols=250  Identities=20%  Similarity=0.367  Sum_probs=215.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .+..++|++.+.||+|+||.||+|.++ ++..||+|++.......   ..|+.++..++||||+++++++.+...+|+||
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            466789999999999999999999776 56789999998765544   57899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..........
T Consensus        83 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           83 EYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             ECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             EccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            999999999999653 3458999999999999999999999999999999999999999999999999998776544334


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....||+.|+|||++.+.       .++.++|||||||++|+|++ |..||...+.......+...   .....|  ..
T Consensus       162 ~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~  229 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYF-------KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG---HRLYRP--HL  229 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHS-------EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCC--TT
T ss_pred             ccCCCcCcccCCHHHHhcc-------CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC---CCCCCC--Cc
Confidence            4444577889999999743       57889999999999999999 99999888877776666541   112222  35


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .++.+.+++..||. ||.+|||+.+++.|
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999999 99999999999876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.5e-44  Score=365.17  Aligned_cols=253  Identities=20%  Similarity=0.325  Sum_probs=220.0

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      .-.+..++|.+.+.||+|+||.||+|.+..++..||+|++.......   ..|..+++.++||||+++++++.+...+|+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            44567789999999999999999999999999999999997654432   578999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999999999876667799999999999999999999999999999999999999999999999999987764443


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                      .......||+.|+|||++...       .++.++|||||||++|+|++ |.+||...+.......+...     ...+..
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~  234 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYN-------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----YRMERP  234 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----CCCCCC
T ss_pred             ccccCCccccCcCChhhhccC-------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-----CCCCCC
Confidence            333444578899999999743       68899999999999999999 99999888777766666541     122223


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+++.+.+|+..||. ||.+|||+.+++.
T Consensus       235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            4789999999999999 9999999999865

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.9e-44  Score=368.97  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=205.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEE-----------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQ-----------   78 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfe-----------   78 (792)
                      .++|.+++.||+|+||.||+|.+..+|+.||+|++.......    ..|+.+++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999999999999999987553221    56899999999999999999884           


Q ss_pred             ---eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC-CCCceEEecc
Q psy13735         79 ---DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS-ATGHLKLTDF  154 (792)
Q Consensus        79 ---de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd-~dg~VKLiDF  154 (792)
                         +...+|+||||+. |+|.+++..   +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence               4468999999997 699999943   5599999999999999999999999999999999999997 5678999999


Q ss_pred             CcccccccCCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhc
Q psy13735        155 GSATQVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA  232 (792)
Q Consensus       155 GLA~~l~~~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~  232 (792)
                      |++........  .......||+.|+|||++..      ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHC------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcC------cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99987643211  11223458999999999863      24688999999999999999999999998877666555543


Q ss_pred             ccCCC------------------CcCCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        233 CDTED------------------TVSFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       233 ~~~~~------------------~l~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      .....                  ....+.      ...+++.+.+||.+||. ||.+|||+.++++||||...+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            11000                  000000      12578999999999999 9999999999999999997543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-43  Score=386.79  Aligned_cols=257  Identities=23%  Similarity=0.401  Sum_probs=206.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcC--CCCcceeEEEEEeCCEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSK--CPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~--HPNIVkL~~vfede~~lyLV   86 (792)
                      .+|.+++.||+|+||.||+|.+.. |+.||+|++.......      ..|+.++..+.  ||||+++++++...+.+|||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            459999999999999999998865 8999999998765443      57889999996  59999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-  165 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-  165 (792)
                      || |.+|+|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+..... 
T Consensus       135 ~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             Ee-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            99 5689999999663  4689999999999999999999999999999999999995 68999999999987654322 


Q ss_pred             cccccCCCCCCccChhhhhhhcc----CCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-hhhhhhhhcccCCCCcC
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEG----NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-DMTYSSILACDTEDTVS  240 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~----~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-~el~ekIl~~~~~~~l~  240 (792)
                      ......+||+.|+|||++.....    ......++.++|||||||++|+|++|.+||..... ...+..+..  ......
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~--~~~~~~  288 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHEIE  288 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC--TTSCCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC--ccccCC
Confidence            12345579999999999964210    01123689999999999999999999999976432 233344433  112233


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      +|.  ..+..+.+||..||. ||.+||++.+++.||||...
T Consensus       289 ~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          289 FPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCc--cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            444  558899999999999 99999999999999999853

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=364.38  Aligned_cols=261  Identities=23%  Similarity=0.368  Sum_probs=210.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      .+..++|.....||+|+||.||+|.+..+|..||+|.+.......    ..|+.++..++||||++++++|.+.+.+++|
T Consensus        18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            344555666669999999999999999999999999997654332    5788999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEeccCcccccccCC
Q psy13735         87 MEYVTGGDFVTLLENQP-HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~-~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~~l~~~~  164 (792)
                      |||++||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999999997642 234679999999999999999999999999999999999987 8999999999998765322


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh-hhhhhhcccCCCCcCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-TYSSILACDTEDTVSFPS  243 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e-l~ekIl~~~~~~~l~fP~  243 (792)
                      . ......||+.|+|||++...     ...++.++|||||||++|+|++|..||....... .......  ......+|.
T Consensus       178 ~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~  249 (295)
T 2clq_A          178 P-CTETFTGTLQYMAPEIIDKG-----PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FKVHPEIPE  249 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHG-----GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HCCCCCCCT
T ss_pred             C-cccccCCCccccChhhhcCC-----CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--ccccccccc
Confidence            1 22345699999999999742     1237889999999999999999999996543221 1111111  112223333


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                        .+++.+.+|+.+||. ||.+||++.+++.||||+...
T Consensus       250 --~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          250 --SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             --TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             --cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence              679999999999999 999999999999999998643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-43  Score=380.64  Aligned_cols=252  Identities=26%  Similarity=0.440  Sum_probs=208.1

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEE-----
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHV-----   83 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~l-----   83 (792)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.......      ..|+.+++.++||||++++++|...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            68999999999999999999999999999999998654433      4688999999999999999999877654     


Q ss_pred             -EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         84 -YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        84 -yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                       |+||||+. |+|.+++.    ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             EEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence             99999996 68888872    3499999999999999999999999999999999999999999999999999986643


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc---
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV---  239 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l---  239 (792)
                      .    ....+||+.|+|||++..      ...++.++|||||||++|+|++|..||.+.+.......+.........   
T Consensus       197 ~----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          197 E----MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             C----cCCcccCccccCHHHhcC------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            2    234579999999999863      246889999999999999999999999988776666555431110000   


Q ss_pred             ----------------CCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        240 ----------------SFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       240 ----------------~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                      ..+.      ...+++.+.+||.+||. ||.+|||+.++++||||+.+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                            0000      12568999999999999 999999999999999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.9e-44  Score=385.98  Aligned_cols=255  Identities=16%  Similarity=0.212  Sum_probs=193.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhc--CCCCcceeE-------EEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKS--KCPYIVNLF-------YSFQ   78 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL--~HPNIVkL~-------~vfe   78 (792)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++.......       ..|+.++..+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45999999999999999999999999999999998876533       3564444444  699988755       5554


Q ss_pred             eC-----------------CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCccCC
Q psy13735         79 DM-----------------NHVYFIMEYVTGGDFVTLLENQPHGYLSESKA------RFYIYELAQAVQYLHGLGYVHRD  135 (792)
Q Consensus        79 de-----------------~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea------~~Im~QILsAL~YLHs~gIVHRD  135 (792)
                      ..                 ..+|||||||+ |+|.+++.... ..+++...      ..++.||+.||.|||++||+|||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            43                 34899999998 89999996532 22444444      56779999999999999999999


Q ss_pred             CCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCC
Q psy13735        136 IKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS  215 (792)
Q Consensus       136 LKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk  215 (792)
                      |||+||||+.+|.+||+|||+|......    .....||+.|+|||++..     +...++.++|||||||++|+|++|.
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~-----~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNA-----STATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTC-----SEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccC-----CCCCcCccccHHHHHHHHHHHHhCC
Confidence            9999999999999999999999876422    113357799999999963     1136899999999999999999999


Q ss_pred             CCCCCCChhhh--hhhhh-cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        216 TPFNYETLDMT--YSSIL-ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       216 ~PF~~~d~~el--~ekIl-~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .||........  +..+. .........++....+++.+.+||.+||. ||.+|||+.+++.||||+.+
T Consensus       291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            99987643321  11111 11122344455556889999999999999 99999999999999999854

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.3e-43  Score=374.19  Aligned_cols=259  Identities=22%  Similarity=0.413  Sum_probs=204.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---------------HHHHHHHHhcCCCCcceeEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---------------TIERDIMVKSKCPYIVNLFYS   76 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---------------~~E~eIL~kL~HPNIVkL~~v   76 (792)
                      ...++|.+.+.||+|+||.||+|.+.. |..||+|++.......               ..|+.++..++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            346799999999999999999998865 8999999996543321               478999999999999999999


Q ss_pred             EEe-----CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEE
Q psy13735         77 FQD-----MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKL  151 (792)
Q Consensus        77 fed-----e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKL  151 (792)
                      |..     ...+|+|||||. |+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence            943     347999999997 688888864 3456999999999999999999999999999999999999999999999


Q ss_pred             eccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhh
Q psy13735        152 TDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       152 iDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl  231 (792)
                      +|||++.......  .....+||+.|+|||++..      ...++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       176 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          176 CDFNLAREDTADA--NKTHYVTHRWYRAPELVMQ------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             CCTTC-----------------CGGGCCHHHHTT------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EecCccccccccc--ccceecccceecCcHHhcC------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999998654332  2234569999999999863      2468899999999999999999999999887666655554


Q ss_pred             cccCC--------------------CCcCCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        232 ACDTE--------------------DTVSFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       232 ~~~~~--------------------~~l~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .....                    .....+.      ....++.+.+||.+||. ||.+|||+.++++||||+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            31100                    0001111      12568899999999999 999999999999999999764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.7e-43  Score=361.29  Aligned_cols=250  Identities=20%  Similarity=0.348  Sum_probs=211.6

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .+..++|.+++.||+|+||.||++.+. ++..||+|++.......   ..|+.++..++||||+++++++.+.+.+|+||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            356679999999999999999999776 67789999998765544   57899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        99 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A           99 EYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             eccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            999999999999652 3459999999999999999999999999999999999999999999999999998765332222


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....||+.|+|||++...       .++.++|||||||++|+|++ |..||...+.......+...     ...+....
T Consensus       178 ~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~  245 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYS-------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHL  245 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHC-------CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----CCCCCCTT
T ss_pred             ccCCccCcccCCHHHhccC-------CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-----cCCCCCCc
Confidence            3334578899999999743       68999999999999999998 99999988887777777652     11222236


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .++.+.+++..||. ||.+|||+.+++.|
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            68999999999999 99999999999876

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.9e-43  Score=370.81  Aligned_cols=258  Identities=21%  Similarity=0.336  Sum_probs=209.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCC-cEEEEEEeccCCCCh---HHHHHHHHhcCCCC------cceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSH-NTFVMKKVLREKMPN---TIERDIMVKSKCPY------IVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tG-k~vAVKiI~Ks~~~~---~~E~eIL~kL~HPN------IVkL~~vfede~   81 (792)
                      ...++|.+++.||+|+||.||+|.+..++ ..||+|++.......   ..|+.++..+.|++      ++.++++|...+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            44679999999999999999999998877 689999987532211   46888888887655      999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe------------------
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL------------------  143 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL------------------  143 (792)
                      .+|+||||| +|++.+++.......+++..+..++.||+.||.|||++||+||||||+|||+                  
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence            999999999 7778787766555679999999999999999999999999999999999999                  


Q ss_pred             -CCCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC
Q psy13735        144 -SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET  222 (792)
Q Consensus       144 -d~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d  222 (792)
                       +.++.+||+|||++......    ....+||+.|+|||++..       ..++.++|||||||++|+|++|..||...+
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE-------LGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeec-------CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence             56788999999999865432    234579999999999963       368999999999999999999999998877


Q ss_pred             hhhhhhhhhcccCCC-----------------C---------------------cCCCCCccccHHHHHHHHHHhh-Chh
Q psy13735        223 LDMTYSSILACDTED-----------------T---------------------VSFPSSIRLSTAMVNFVQSLVQ-KLD  263 (792)
Q Consensus       223 ~~el~ekIl~~~~~~-----------------~---------------------l~fP~~~~lS~elkdLIk~LL~-DP~  263 (792)
                      .......+.......                 .                     .........++.+.+||.+||. ||.
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            654443332210000                 0                     0011112346789999999999 999


Q ss_pred             hcCChhHHhcCCCccCCC
Q psy13735        264 ARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       264 kRPTaeEIL~HPwF~~i~  281 (792)
                      +|||+.++++||||..++
T Consensus       324 ~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             TSCCHHHHTTSGGGGGCC
T ss_pred             hCcCHHHHhcChhhcCCC
Confidence            999999999999999764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-44  Score=390.86  Aligned_cols=249  Identities=16%  Similarity=0.190  Sum_probs=197.9

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHH---HHHhcCCCCcceeE-------EE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERD---IMVKSKCPYIVNLF-------YS   76 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~e---IL~kL~HPNIVkL~-------~v   76 (792)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.....       ..|+.   ++..++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467999999999999999999999999999999997653322       46774   44556899999998       77


Q ss_pred             EEeCCE-----------------EEEEEeccCCCCHHHHHHhCCCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCc
Q psy13735         77 FQDMNH-----------------VYFIMEYVTGGDFVTLLENQPHGYLS-------ESKARFYIYELAQAVQYLHGLGYV  132 (792)
Q Consensus        77 fede~~-----------------lyLVmEy~~GGsL~dlL~r~~~g~LS-------E~ea~~Im~QILsAL~YLHs~gIV  132 (792)
                      +.+.+.                 .||||||| +|+|.+++...  +.++       +..+..|+.||+.||.|||++||+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            776642                 89999999 78999999642  2244       478888999999999999999999


Q ss_pred             cCCCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhc----cCCCCCCCCcccccccchhhH
Q psy13735        133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME----GNHGSDGYTGSCDLWSIGVVS  208 (792)
Q Consensus       133 HRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~----~~~~~~~ys~ksDIWSLGVIL  208 (792)
                      ||||||+|||++.+|.+||+|||+|.....    .....+| +.|+|||++....    .......++.++|||||||++
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999999999999999986432    3345578 9999999997420    000112588999999999999


Q ss_pred             HHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        209 YELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       209 YELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      |+|++|..||.+.+.......+..          ....+++.+.+||.+||. ||.+|||+.+++.||||+.+
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWIFR----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHSSCCC------CCSGGGGS----------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhhhh----------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            999999999987766555554433          113678999999999999 99999999999999999853

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-43  Score=375.42  Aligned_cols=253  Identities=20%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEE-----EecCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEe
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVE-----EKQSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQD   79 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~-----~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfed   79 (792)
                      .+..++|.+++.||+|+||.||+|.     +..+|+.||+|++.......     ..|+.++..+ +|||||+++++|.+
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            3567899999999999999999999     45567999999997654322     5688999999 79999999999987


Q ss_pred             CC-EEEEEEeccCCCCHHHHHHhCCC------------------------------------------------------
Q psy13735         80 MN-HVYFIMEYVTGGDFVTLLENQPH------------------------------------------------------  104 (792)
Q Consensus        80 e~-~lyLVmEy~~GGsL~dlL~r~~~------------------------------------------------------  104 (792)
                      .+ .+|+|||||+||+|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            65 49999999999999999965432                                                      


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-cccccCCC
Q psy13735        105 ----------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVG  173 (792)
Q Consensus       105 ----------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~s~t~vG  173 (792)
                                ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......|
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                      1289999999999999999999999999999999999999999999999999987643322 22334568


Q ss_pred             CCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHH
Q psy13735        174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMV  252 (792)
Q Consensus       174 Tp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elk  252 (792)
                      |+.|+|||++..       ..++.++|||||||++|+|++ |..||.+..............  .....|  ..+++.+.
T Consensus       258 t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~  326 (359)
T 3vhe_A          258 PLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--TRMRAP--DYTTPEMY  326 (359)
T ss_dssp             CGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--CCCCCC--TTCCHHHH
T ss_pred             CceeEChhhhcC-------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--CCCCCC--CCCCHHHH
Confidence            999999999974       368899999999999999998 999998776554444443311  122333  36799999


Q ss_pred             HHHHHHhh-ChhhcCChhHHhcC
Q psy13735        253 NFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       253 dLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +++..||. ||.+|||+.+++.|
T Consensus       327 ~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          327 QTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHHHH
Confidence            99999999 99999999999876

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.4e-43  Score=371.92  Aligned_cols=253  Identities=26%  Similarity=0.438  Sum_probs=207.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCE-----
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNH-----   82 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~-----   82 (792)
                      ..+|.+.+.||+|+||.||+|.++.+|+.||+|++.......      ..|+.++..++||||++++++|.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            368999999999999999999999999999999997654433      468899999999999999999987654     


Q ss_pred             -EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         83 -VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        83 -lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                       +|+||||+. |+|.+++.    ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence             599999996 68888772    349999999999999999999999999999999999999999999999999998654


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC------
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT------  235 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~------  235 (792)
                      ..    ....+||+.|+|||++..      ...++.++|||||||++|+|++|..||.+.+....+..+.....      
T Consensus       178 ~~----~~~~~~t~~y~aPE~~~~------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          178 AE----MTGYVVTRWYRAPEVILS------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             ----------CCSBCCSCHHHHSC------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             CC----ccccccCcCcCCHHHHhC------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            32    234569999999999863      24688999999999999999999999988776555544432100      


Q ss_pred             ------------------CCCcCCC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        236 ------------------EDTVSFP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       236 ------------------~~~l~fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                        .....++ ....+++.+.+||.+||. ||.+|||+.+++.||||..+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                              0001111 123679999999999999 999999999999999998654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-43  Score=368.33  Aligned_cols=257  Identities=19%  Similarity=0.293  Sum_probs=216.4

Q ss_pred             HHhcCCCCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEE
Q psy13735          6 ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFY   75 (792)
Q Consensus         6 ~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~   75 (792)
                      .+....+..++|.+++.||+|+||.||+|.+.     .+++.||+|++.......     ..|+.++..++||||+++++
T Consensus        38 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~  117 (343)
T 1luf_A           38 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG  117 (343)
T ss_dssp             HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            44455678889999999999999999999998     456899999997654322     56899999999999999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy13735         76 SFQDMNHVYFIMEYVTGGDFVTLLENQP----------------------HGYLSESKARFYIYELAQAVQYLHGLGYVH  133 (792)
Q Consensus        76 vfede~~lyLVmEy~~GGsL~dlL~r~~----------------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVH  133 (792)
                      +|.+.+.+|+|||||+||+|.+++....                      ...+++..+..++.||+.||.|||++||+|
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH  197 (343)
T 1luf_A          118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  197 (343)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            9999999999999999999999997632                      156999999999999999999999999999


Q ss_pred             CCCCCCceEeCCCCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhh
Q psy13735        134 RDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL  212 (792)
Q Consensus       134 RDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELL  212 (792)
                      |||||+|||++.++.+||+|||++........ .......||+.|+|||++...       .++.++|||||||++|+|+
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~Di~slG~il~el~  270 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-------RYTTESDVWAYGVVLWEIF  270 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-------CCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-------CcCcccccHHHHHHHHHHH
Confidence            99999999999999999999999987643221 122334689999999999743       6899999999999999999


Q ss_pred             c-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        213 T-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       213 T-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      + |..||.+.+.......+....   ...+|.  .+++.+.+++..||. ||.+||++.+++.+
T Consensus       271 t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          271 SYGLQPYYGMAHEEVIYYVRDGN---ILACPE--NCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTTCCTTTTSCHHHHHHHHHTTC---CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCcCCCCChHHHHHHHhCCC---cCCCCC--CCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9 999999888777777665521   122333  679999999999999 99999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1e-42  Score=354.18  Aligned_cols=245  Identities=22%  Similarity=0.385  Sum_probs=198.2

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      ++..++|.+.+.||+|+||.||+|.+.  |..||+|++.......        ..|..++..++||||+++++++.+.+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            356789999999999999999999874  8899999987643321        468899999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCceEeCC--------CCceEE
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG---YVHRDIKPDNMLLSA--------TGHLKL  151 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g---IVHRDLKPeNILLd~--------dg~VKL  151 (792)
                      +|+||||++||+|.+++.   .+.+++..+..++.||+.||.|||++|   |+||||||+|||++.        ++.+||
T Consensus        81 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             eEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            999999999999999994   346999999999999999999999999   899999999999986        678999


Q ss_pred             eccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhh
Q psy13735        152 TDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       152 iDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl  231 (792)
                      +|||++.......   .....||+.|+|||++...       .++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       158 ~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  227 (271)
T 3dtc_A          158 TDFGLAREWHRTT---KMSAAGAYAWMAPEVIRAS-------MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA  227 (271)
T ss_dssp             CCCCC----------------CCGGGSCHHHHHHC-------CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred             ccCCccccccccc---ccCCCCccceeCHHHhccC-------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh
Confidence            9999998765332   2244699999999999743       68899999999999999999999998877766665554


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .    .....+....+++.+.+++.+|+. ||.+|||+.+++.|
T Consensus       228 ~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          228 M----NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             T----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c----CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            4    222333334789999999999999 99999999999865

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=366.21  Aligned_cols=251  Identities=19%  Similarity=0.298  Sum_probs=205.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +..++|.+++.||+|+||.||+|.+..+|..||+|++.......    ..|+.++..++||||+++++++.+.+.+|+||
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            56789999999999999999999999999999999986533221    47899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc-
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-  166 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-  166 (792)
                      |||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... 
T Consensus        87 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           87 EYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             ECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             EecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999999763 456999999999999999999999999999999999999999999999999999876433211 


Q ss_pred             ------------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc
Q psy13735        167 ------------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD  234 (792)
Q Consensus       167 ------------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~  234 (792)
                                  .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||................
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMING-------RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             cccccccccccccccccCCCcceeCHHHhcC-------CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence                        1124579999999999963       368899999999999999999999996543322111100000


Q ss_pred             CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        235 TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       235 ~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                       ......|.  .+++.+.+++..|+. ||.+|||+.+++.
T Consensus       239 -~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          239 -FLDRYCPP--NCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             -HHHHTCCT--TCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -cccccCCC--CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             00011222  668899999999999 9999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.7e-43  Score=353.17  Aligned_cols=249  Identities=20%  Similarity=0.346  Sum_probs=213.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|.+.+.||+|+||.||+|.+. ++..||+|++.......   ..|..++..++||||+++++++.+.+.+|+|||
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            45679999999999999999999886 67899999998765543   578999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            99999999999763 35689999999999999999999999999999999999999999999999999987643222222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....|++.|+|||++...       .++.++|||||||++|+|++ |.+||...+.......+...   .....|  ..+
T Consensus       163 ~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~---~~~~~~--~~~  230 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFS-------RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKP--RLA  230 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCC--TTS
T ss_pred             ccccccccccChhhhcCC-------CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC---CcCCCC--ccC
Confidence            334578899999999743       68899999999999999999 99999988877777766552   112222  367


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ++.+.+++..|+. ||.+||++.+++.+
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8999999999999 99999999999764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-43  Score=375.47  Aligned_cols=258  Identities=22%  Similarity=0.379  Sum_probs=206.6

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcC-----------CCCcceeEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSK-----------CPYIVNLFY   75 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~-----------HPNIVkL~~   75 (792)
                      ..+...+|.+++.||+|+||.||+|.+..+|+.||+|++.......   ..|+.++..+.           ||||+++++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            3356679999999999999999999999999999999997543221   56788888775           899999999


Q ss_pred             EEEeCC----EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeC------
Q psy13735         76 SFQDMN----HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLS------  144 (792)
Q Consensus        76 vfede~----~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd------  144 (792)
                      +|...+    .+++||||+ |++|.+++.....+.+++..+..++.||+.||.|||++ ||+||||||+|||++      
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            998654    799999999 99999999876666799999999999999999999998 999999999999994      


Q ss_pred             CCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh
Q psy13735        145 ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD  224 (792)
Q Consensus       145 ~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~  224 (792)
                      ..+.+||+|||++......    ....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG-------APWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-------CCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence            4447999999999876532    233469999999999974       36899999999999999999999999765421


Q ss_pred             ------hhhhhhhcccCC--------------------------------------CCcCCCCCccccHHHHHHHHHHhh
Q psy13735        225 ------MTYSSILACDTE--------------------------------------DTVSFPSSIRLSTAMVNFVQSLVQ  260 (792)
Q Consensus       225 ------el~ekIl~~~~~--------------------------------------~~l~fP~~~~lS~elkdLIk~LL~  260 (792)
                            .....+......                                      ....++  ..+++.+.+||.+||.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~  319 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQ  319 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGC
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhc
Confidence                  111111110000                                      001112  2567899999999999


Q ss_pred             -ChhhcCChhHHhcCCCccCCC
Q psy13735        261 -KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       261 -DP~kRPTaeEIL~HPwF~~i~  281 (792)
                       ||.+|||+.++++||||+...
T Consensus       320 ~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          320 LDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             SSTTTCBCHHHHHTCGGGTTCT
T ss_pred             cCccccCCHHHHhhChhhhccc
Confidence             999999999999999999754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=369.87  Aligned_cols=251  Identities=22%  Similarity=0.357  Sum_probs=211.3

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCc---EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk---~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      ..+..++|.+.+.||+|+||.||++.+..+|.   .||+|++.......     ..|+.++..++||||++++++|.+.+
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34667789999999999999999999986554   59999997643322     46889999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             ccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999999999653 4569999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        162 KNGRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       162 ~~~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      .....  ......||+.|+|||++...       .++.++|||||||++|+|++ |..||...+.......+...     
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----  270 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFR-------TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-----  270 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHC-------EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----
T ss_pred             cCccceeeccCCCCcccccCHhHhcCC-------CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----
Confidence            43221  22233468899999999743       68899999999999999999 99999988887777776542     


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ...+....+++.+.+++..||. ||.+||++.+++.
T Consensus       271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2233344789999999999999 9999999999865

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-43  Score=368.97  Aligned_cols=254  Identities=19%  Similarity=0.322  Sum_probs=210.2

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEe
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQD   79 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfed   79 (792)
                      .+..++|.+.+.||+|+||.||+|.+.     .++..||+|++.......     ..|+.++.++ +||||+++++++.+
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            456679999999999999999999973     466789999997543222     5789999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPH---------------------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP  138 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~---------------------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKP  138 (792)
                      .+.+|+|||||+||+|.+++.....                     ..+++..+..++.||+.||.|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            9999999999999999999975432                     2379999999999999999999999999999999


Q ss_pred             CceEeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCC
Q psy13735        139 DNMLLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST  216 (792)
Q Consensus       139 eNILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~  216 (792)
                      +|||++.++.+||+|||++......... ......||+.|+|||++..       ..++.++|||||||++|+|++ |..
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-------CCCChhHhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999876543322 2233457889999999874       368999999999999999998 999


Q ss_pred             CCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCC
Q psy13735        217 PFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHP  275 (792)
Q Consensus       217 PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HP  275 (792)
                      ||.+.........+..    .....+....+++.+.+++..||. ||.+|||+.+++.|.
T Consensus       274 p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          274 PYPGIPVDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             SSTTCCCSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcccCCcHHHHHHHHh----cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            9987766555555444    122222334679999999999999 999999999998774

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.6e-43  Score=376.57  Aligned_cols=252  Identities=21%  Similarity=0.364  Sum_probs=212.3

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe-------cCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK-------QSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSF   77 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k-------~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vf   77 (792)
                      .+..++|.+++.||+|+||.||+|.+.       .++..||+|++.......     ..|+.++..+ +||||++++++|
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            356679999999999999999999975       345689999987653322     5789999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL  143 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL  143 (792)
                      .+.+.+|+|||||+||+|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999999999999997643              2358999999999999999999999999999999999999


Q ss_pred             CCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCC
Q psy13735        144 SATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYE  221 (792)
Q Consensus       144 d~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~  221 (792)
                      +.+|.+||+|||++......... ......||+.|+|||++..       ..++.++|||||||++|+|++ |..||.+.
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-------CCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999876543221 2233457899999999973       368999999999999999999 99999988


Q ss_pred             ChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        222 TLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       222 d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +....+..+...   .....|  ..+++.+.+++..||. ||.+||++.+++.+
T Consensus       310 ~~~~~~~~~~~~---~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          310 PVEELFKLLKEG---HRMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             CGGGHHHHHHTT---CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcC---CCCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            777776666542   122233  3679999999999999 99999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=380.93  Aligned_cols=256  Identities=21%  Similarity=0.316  Sum_probs=213.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEE-----EecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVE-----EKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~-----~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      .+..++|.+++.||+|+||.||+|.     +..++..||+|++.......     ..|+.++..++|||||+++++|.+.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4566789999999999999999999     45678899999986543322     4688999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---ceEEe
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQP-----HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---HLKLT  152 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~-----~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---~VKLi  152 (792)
                      ...|+|||||+||+|.+++....     ...+++..+..++.||+.||.|||++||+||||||+|||++.+|   .+||+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999999997532     24589999999999999999999999999999999999999655   49999


Q ss_pred             ccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhh
Q psy13735        153 DFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSI  230 (792)
Q Consensus       153 DFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekI  230 (792)
                      |||+++....... .......||+.|+|||++..       ..++.++|||||||++|+|++ |.+||...+.......+
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999986532221 12234468999999999974       368999999999999999998 99999988888777777


Q ss_pred             hcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       231 l~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      ....   ....+  ..+++.+.+|+..||. ||.+||++.+++.|.++-
T Consensus       300 ~~~~---~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          300 TSGG---RMDPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HTTC---CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCC---CCCCC--ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            6521   12223  3678999999999999 999999999999998775

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.1e-43  Score=362.98  Aligned_cols=252  Identities=20%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      .+..++|.+.+.||+|+||.||+|.+.     .++..||+|++.......     ..|+.+++.++||||+++++++.+.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            466789999999999999999999984     456899999987554322     4688999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPH----------------------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKP  138 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~----------------------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKP  138 (792)
                      +.+|+|||||+||+|.+++.....                      ..+++..+..++.||+.||.|||++||+||||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            999999999999999999976432                      3489999999999999999999999999999999


Q ss_pred             CceEeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCC
Q psy13735        139 DNMLLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GST  216 (792)
Q Consensus       139 eNILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~  216 (792)
                      +|||++.++.+||+|||++......... ......||+.|+|||++...       .++.++|||||||++|+|++ |..
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-------IYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-------EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-------CcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999876543221 22334578899999999743       68899999999999999999 999


Q ss_pred             CCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        217 PFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       217 PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ||.+.+.......+...   .....|  ..+++.+.+++..||. ||.+||++.+++.|
T Consensus       252 p~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTG---HRMERP--DNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             SSTTCCGGGHHHHHHTT---CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHhhcC---CcCCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99888877776666542   122233  3789999999999999 99999999999765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.9e-43  Score=352.78  Aligned_cols=249  Identities=15%  Similarity=0.227  Sum_probs=210.1

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC--
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM--   80 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede--   80 (792)
                      ..++..++|.+.+.||+|+||.||+|.+.  |..||+|++.......      ..|+.++..++||||+++++++.+.  
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            45678899999999999999999999885  8899999998765543      4677888889999999999999887  


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      ..+|+|||||+||+|.+++.......+++..+..++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            78999999999999999997655556999999999999999999999999  9999999999999999999999998876


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ....      ....||+.|+|||++...    ....++.++|||||||++|+|++|..||...+.......+....  ..
T Consensus       162 ~~~~------~~~~~t~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~  229 (271)
T 3kmu_A          162 SFQS------PGRMYAPAWVAPEALQKK----PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG--LR  229 (271)
T ss_dssp             TTSC------TTCBSCGGGSCHHHHHSC----GGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC--CC
T ss_pred             eecc------cCccCCccccChhhhccC----CCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC--CC
Confidence            5332      234689999999999732    11234457999999999999999999998887777666665411  12


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+|  ..+++.+.+++..||. ||.+|||+.+++.
T Consensus       230 ~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 PTIP--PGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2333  3689999999999999 9999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-42  Score=356.21  Aligned_cols=253  Identities=21%  Similarity=0.246  Sum_probs=208.3

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL-~HPNIVkL~~vfede~~lyLV   86 (792)
                      ..+..++|.+.+.||+|+||.||+|.+..+|+.||+|++.......  ..|..++..+ +|||++.+++++.+....|+|
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            4456788999999999999999999999999999999987654433  6789999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc-----eEEeccCcccccc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH-----LKLTDFGSATQVD  161 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~-----VKLiDFGLA~~l~  161 (792)
                      |||+ ||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++....
T Consensus        85 ~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            9999 99999999753 345999999999999999999999999999999999999987776     9999999998765


Q ss_pred             cCCCc------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh---hhhhhhhhc
Q psy13735        162 KNGRI------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL---DMTYSSILA  232 (792)
Q Consensus       162 ~~~~~------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~---~el~ekIl~  232 (792)
                      .....      .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+.   ...+..+..
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcC-------CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            43221      2234579999999999863       3689999999999999999999999987432   333333322


Q ss_pred             ccCCC-CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        233 CDTED-TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       233 ~~~~~-~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..... ...++  ..+++.+.+++..|+. ||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          236 KKQSTPLRELC--AGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHSCHHHHT--TTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccCccHHHHH--hhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            11000 01111  2578999999999999 9999999999854

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.3e-43  Score=377.02  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=208.2

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcC-CC-----CcceeEEEEEeCCEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSK-CP-----YIVNLFYSFQDMNHV   83 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~-HP-----NIVkL~~vfede~~l   83 (792)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++.......   ..|..++..+. |+     +|+.++++|...+.+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            3578999999999999999999999999999999997543211   45777887774 44     499999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCceEeC--CCCceEEeccCcccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH--GLGYVHRDIKPDNMLLS--ATGHLKLTDFGSATQ  159 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH--s~gIVHRDLKPeNILLd--~dg~VKLiDFGLA~~  159 (792)
                      |+|||||. |+|.+++.....+.+++..++.++.||+.||.|||  ..||+||||||+|||++  .++.+||+|||++..
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            99999995 59999998766567999999999999999999999  57999999999999994  477899999999987


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC--
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED--  237 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~--  237 (792)
                      ....    ....+||+.|+|||++.+       ..++.++|||||||++|+|++|.+||.+.+....+..+.......  
T Consensus       211 ~~~~----~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          211 LGQR----IYQYIQSRFYRSPEVLLG-------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             TTCC----CCSSCSCGGGCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             cccc----cccccCCccccChHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            6532    234579999999999973       368999999999999999999999999887766655554310000  


Q ss_pred             -----------------------------C--cCCCCCc-------------------------cccHHHHHHHHHHhh-
Q psy13735        238 -----------------------------T--VSFPSSI-------------------------RLSTAMVNFVQSLVQ-  260 (792)
Q Consensus       238 -----------------------------~--l~fP~~~-------------------------~lS~elkdLIk~LL~-  260 (792)
                                                   .  ...|...                         ..++.+.+||.+||. 
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                                         0  0000000                         012478999999999 


Q ss_pred             ChhhcCChhHHhcCCCccCC
Q psy13735        261 KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       261 DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ||.+|||+.++|+||||+..
T Consensus       360 dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC-
T ss_pred             ChhhCCCHHHHhcCcccccC
Confidence            99999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.3e-43  Score=358.55  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=199.7

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      .-.+..++|++.+.||+|+||.||+|.+..+   +..+|+|.+.......     ..|..++..++||||+++++++. +
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            3446678999999999999999999998654   5579999887543322     46889999999999999999985 5


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      +.+|+||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            6789999999999999999753 345999999999999999999999999999999999999999999999999999877


Q ss_pred             ccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        161 DKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       161 ~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      ............|++.|+|||++..       ..++.++|||||||++|+|++ |.+||.+.+.......+...   ...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~---~~~  236 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERL  236 (281)
T ss_dssp             ------------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCC
T ss_pred             CcccccccccCCCcccccChhhccc-------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC---CCC
Confidence            5443333334457889999999974       368899999999999999996 99999988777777666542   122


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+|  ..+++.+.+++..||. ||.+|||+.+++.+
T Consensus       237 ~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 PMP--PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            233  3789999999999999 99999999998754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-42  Score=365.90  Aligned_cols=246  Identities=18%  Similarity=0.249  Sum_probs=204.5

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++.......  ..|+.++..+ +||||+++++++.+....|+||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            3578999999999999999999999999999999987554332  6899999999 899999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc-----eEEeccCcccccccCC
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH-----LKLTDFGSATQVDKNG  164 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~-----VKLiDFGLA~~l~~~~  164 (792)
                      | ||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++.......
T Consensus        87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            9 99999999764 456999999999999999999999999999999999999998887     9999999998765332


Q ss_pred             Cc------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh---hhhhhhhcccC
Q psy13735        165 RI------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD---MTYSSILACDT  235 (792)
Q Consensus       165 ~~------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~---el~ekIl~~~~  235 (792)
                      ..      .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+..   ..+..+...  
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--  235 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLG-------KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT--  235 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH--
T ss_pred             CCccccccccCCcCCCccccChHHHcC-------CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh--
Confidence            21      1235579999999999873       36899999999999999999999999875433   334444321  


Q ss_pred             CCCcCCCCC---ccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        236 EDTVSFPSS---IRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       236 ~~~l~fP~~---~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                        ....|..   ..++ .+.+++..|+. ||.+||++.+++
T Consensus       236 --~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~  273 (330)
T 2izr_A          236 --KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLR  273 (330)
T ss_dssp             --HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             --hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHH
Confidence              1111110   1234 99999999999 999999998874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9e-43  Score=360.97  Aligned_cols=255  Identities=20%  Similarity=0.285  Sum_probs=212.9

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEE-----ecCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEE
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEE-----KQSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSF   77 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~-----k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vf   77 (792)
                      ...+..++|.+.+.||+|+||.||+|.+     ..++..||+|++.......     ..|+.++.++ +||||+++++++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            3456778999999999999999999985     4577899999997654322     4788999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCce
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQPH----------------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNM  141 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~~----------------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNI  141 (792)
                      .+.+.+|+|||||+||+|.+++.....                ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            999999999999999999999976432                2489999999999999999999999999999999999


Q ss_pred             EeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCC
Q psy13735        142 LLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFN  219 (792)
Q Consensus       142 LLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~  219 (792)
                      |++.++.+||+|||++......... ......||+.|+|||++..       ..++.++|||||||++|+|++ |..||.
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999877544322 1223457889999999874       368899999999999999999 999998


Q ss_pred             CCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        220 YETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       220 ~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +.........+...    ....+....+++.+.+++..||. ||.+|||+.+++.+
T Consensus       250 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          250 GMPVDSKFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             TCCSSHHHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchhHHHHHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            77655544444431    12222234679999999999999 99999999999764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.5e-43  Score=361.58  Aligned_cols=261  Identities=23%  Similarity=0.398  Sum_probs=197.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ....++|.+++.||+|+||.||+|.++.+|+.||+|++.......      ..+..++..++||||+++++++.+.+.+|
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            356789999999999999999999999999999999997665432      12334567789999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      +||||+ |+.+..+... ..+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus       101 lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999999 6666666543 245699999999999999999999995 9999999999999999999999999999776533


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC-ChhhhhhhhhcccCCCCcCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE-TLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~-d~~el~ekIl~~~~~~~l~fP  242 (792)
                      .  ......||+.|+|||++...  ......++.++|||||||++|+|++|..||... ........+...   ....+|
T Consensus       179 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~  251 (318)
T 2dyl_A          179 K--AKDRSAGCAAYMAPERIDPP--DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE---EPPLLP  251 (318)
T ss_dssp             ----------CCTTCCHHHHC----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS---CCCCCC
T ss_pred             c--cccccCCCccccChhhcccc--cccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc---CCCCCC
Confidence            2  22334699999999998521  112346888999999999999999999999763 334444444431   223344


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ....+++.+.+||..||. ||.+||++.+++.||||+..
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            445689999999999999 99999999999999999854

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1e-42  Score=366.75  Aligned_cols=250  Identities=24%  Similarity=0.451  Sum_probs=211.6

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------HHHHHHHHhcC--CCCcceeEEE
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------TIERDIMVKSK--CPYIVNLFYS   76 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------~~E~eIL~kL~--HPNIVkL~~v   76 (792)
                      ......++|.+.+.||+|+||.||+|.+..+|+.||+|++.......          ..|+.++..+.  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            34456789999999999999999999999999999999997654321          57999999996  5999999999


Q ss_pred             EEeCCEEEEEEeccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC-CCCceEEecc
Q psy13735         77 FQDMNHVYFIMEYVTG-GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS-ATGHLKLTDF  154 (792)
Q Consensus        77 fede~~lyLVmEy~~G-GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd-~dg~VKLiDF  154 (792)
                      |.+.+.+++|||++.+ ++|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            9999999999999976 899999965  35699999999999999999999999999999999999998 7889999999


Q ss_pred             CcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc
Q psy13735        155 GSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD  234 (792)
Q Consensus       155 GLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~  234 (792)
                      |++......   ......||+.|+|||++...      ..++.++|||||||++|+|++|..||....      .+..  
T Consensus       195 g~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--  257 (320)
T 3a99_A          195 GSGALLKDT---VYTDFDGTRVYSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--  257 (320)
T ss_dssp             TTCEECCSS---CBCCCCSCGGGSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--
T ss_pred             ccccccccc---cccCCCCCccCCChHHhccC------CCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--
Confidence            999876532   22345699999999998743      234788999999999999999999996532      1222  


Q ss_pred             CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        235 TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       235 ~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                        ....++.  .+++.+.+||.+||. ||.+|||+.++++||||....
T Consensus       258 --~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          258 --GQVFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             --CCCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             --ccccccc--cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence              1222333  679999999999999 999999999999999999754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=364.14  Aligned_cols=251  Identities=23%  Similarity=0.445  Sum_probs=202.3

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----------hHHHHHHHHhc----CCCCcceeEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----------NTIERDIMVKS----KCPYIVNLFY   75 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----------~~~E~eIL~kL----~HPNIVkL~~   75 (792)
                      .....++|.+.+.||+|+||.||+|.+..+|+.||+|++......          ...|..++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999999999999999999765432          14688999888    8999999999


Q ss_pred             EEEeCCEEEEEEec-cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC-CCCceEEec
Q psy13735         76 SFQDMNHVYFIMEY-VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS-ATGHLKLTD  153 (792)
Q Consensus        76 vfede~~lyLVmEy-~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd-~dg~VKLiD  153 (792)
                      +|.+.+.+++|||+ +.|++|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence            99999999999999 789999999965  34599999999999999999999999999999999999998 889999999


Q ss_pred             cCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcc
Q psy13735        154 FGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC  233 (792)
Q Consensus       154 FGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~  233 (792)
                      ||++......   ......||+.|+|||++...      ..++.++|||||||++|+|++|..||....      .+.. 
T Consensus       184 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~-  247 (312)
T 2iwi_A          184 FGSGALLHDE---PYTDFDGTRVYSPPEWISRH------QYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE-  247 (312)
T ss_dssp             CSSCEECCSS---CBCCCCSCTTTSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH-
T ss_pred             cchhhhcccC---cccccCCcccccCceeeecC------CCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh-
Confidence            9999876543   22345699999999998742      234568999999999999999999996532      1222 


Q ss_pred             cCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCC
Q psy13735        234 DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSD  283 (792)
Q Consensus       234 ~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~  283 (792)
                         ....++.  .+++.+.+||.+||. ||.+||++.+++.||||+.....
T Consensus       248 ---~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          248 ---AELHFPA--HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             ---TCCCCCT--TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             ---hccCCcc--cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence               2233444  679999999999999 99999999999999999975543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-42  Score=364.14  Aligned_cols=262  Identities=24%  Similarity=0.401  Sum_probs=190.8

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHH-HHHhcCCCCcceeEEEEEeCCEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERD-IMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~e-IL~kL~HPNIVkL~~vfede~~l   83 (792)
                      -.+..++|.+++.||+|+||.||+|.++.+|+.||+|++.......     ..|.. +++.++||||+++++++.+.+.+
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            3577899999999999999999999999999999999997654322     23333 55677899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         84 YFIMEYVTGGDFVTLLEN---QPHGYLSESKARFYIYELAQAVQYLHGL-GYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r---~~~g~LSE~ea~~Im~QILsAL~YLHs~-gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      |+||||+.| +|.+++..   .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999999975 77777642   2356699999999999999999999999 999999999999999999999999999987


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh-hhhhhhhhcccCCCC
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL-DMTYSSILACDTEDT  238 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~-~el~ekIl~~~~~~~  238 (792)
                      .....  ......||+.|+|||++...   .....++.++|||||||++|+|++|..||..... ......+..   ...
T Consensus       176 ~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~  247 (327)
T 3aln_A          176 LVDSI--AKTRDAGCRPYMAPERIDPS---ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK---GDP  247 (327)
T ss_dssp             -----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC---SCC
T ss_pred             ccccc--ccccCCCCccccCceeeccc---cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc---CCC
Confidence            65332  22234699999999998421   1234688999999999999999999999976432 122222222   111


Q ss_pred             cCCC--CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        239 VSFP--SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       239 l~fP--~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ..++  ....+++.+.+|+..||. ||.+||++.+++.||||...
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            1222  224679999999999999 99999999999999999753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-42  Score=354.51  Aligned_cols=246  Identities=22%  Similarity=0.366  Sum_probs=210.4

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEe---------------
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQD---------------   79 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfed---------------   79 (792)
                      .+|.+++.||+|+||.||+|.+..+|+.||+|++.........|..++..++||||++++++|..               
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   90 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS   90 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence            47999999999999999999999999999999998766556889999999999999999999865               


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         80 -MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        80 -e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                       ...+|+|||||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  170 (284)
T 2a19_B           91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT  170 (284)
T ss_dssp             EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence             4568999999999999999976555679999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ......  ......||+.|+|||++..       ..++.++|||||||++|+|++|..||...  ......+..    . 
T Consensus       171 ~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~----~-  234 (284)
T 2a19_B          171 SLKNDG--KRTRSKGTLRYMSPEQISS-------QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD----G-  234 (284)
T ss_dssp             ESSCCS--CCCCCCSCCTTSCHHHHHC-------SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT----T-
T ss_pred             eccccc--cccccCCcccccChhhhcc-------CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc----c-
Confidence            775433  2234469999999999973       36889999999999999999999988532  222222222    1 


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                       .++.  .+++.+.++|..||. ||.+||++.+++.|++.-.
T Consensus       235 -~~~~--~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 -IISD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -CCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -cccc--cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence             1222  578999999999999 9999999999999987653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.3e-42  Score=362.14  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=209.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEE--EEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF--VMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~v--AVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede~~l   83 (792)
                      +..++|.+.+.||+|+||.||+|.+..+|..+  |+|.+.......     ..|+.++.++ +||||+++++++.+.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            56689999999999999999999999999866  899886532221     5688999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCce
Q psy13735         84 YFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHL  149 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~V  149 (792)
                      |+|||||+||+|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence            99999999999999996532              2469999999999999999999999999999999999999999999


Q ss_pred             EEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhh
Q psy13735        150 KLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYS  228 (792)
Q Consensus       150 KLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~e  228 (792)
                      ||+|||++.......  ......+++.|+|||++...       .++.++|||||||++|+|++ |..||.+.+......
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYS-------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  252 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHC-------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccc-------cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence            999999997543221  22233578999999999743       57899999999999999998 999999888777777


Q ss_pred             hhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        229 SILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       229 kIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+...     ...+....+++.+.+||.+||. ||.+|||+.+++.|
T Consensus       253 ~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          253 KLPQG-----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HGGGT-----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhcC-----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            66542     1222233789999999999999 99999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.4e-42  Score=364.16  Aligned_cols=251  Identities=17%  Similarity=0.248  Sum_probs=208.2

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcE----EEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNT----FVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~----vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      .-+..++|++++.||+|+||.||+|.+..+|..    +|+|.+......     ...|..++..++||||+++++++. .
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            346788999999999999999999999988876    667766433221     157899999999999999999987 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+++|||||.||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            5689999999999999999653 356999999999999999999999999999999999999999999999999999887


Q ss_pred             ccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        161 DKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       161 ~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ...... ......||+.|+|||++...       .++.++|||||||++|+|++ |..||.+.........+...   ..
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~  235 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFG-------KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---ER  235 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT---CB
T ss_pred             CcccccccccCCCCcccccChHHhccC-------CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC---CC
Confidence            543322 22344688899999999743       68999999999999999999 99999887776666666541   12


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...|.  .+++.+.+++..||. ||.+||++.+++.|
T Consensus       236 ~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 LAQPQ--ICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CCCCT--TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCCCC--cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22333  578899999999999 99999999999876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-42  Score=369.40  Aligned_cols=252  Identities=21%  Similarity=0.354  Sum_probs=214.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecC-------CcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQS-------HNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSF   77 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~t-------Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vf   77 (792)
                      .+..++|.+.+.||+|+||.||+|.+..+       +..||+|++.......     ..|+.++..+ +|||||+++++|
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            45667899999999999999999998643       3579999997654332     4788999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL  143 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL  143 (792)
                      .+.+.+|+|||||+||+|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999999999999997643              2459999999999999999999999999999999999999


Q ss_pred             CCCCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCC
Q psy13735        144 SATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYE  221 (792)
Q Consensus       144 d~dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~  221 (792)
                      +.++.+||+|||++........ .......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.+.
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999987654322 12233457889999999973       368999999999999999999 99999988


Q ss_pred             ChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        222 TLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       222 d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +.......+...   .....|  ..+++.+.+|+..||. ||.+|||+.+++.+
T Consensus       298 ~~~~~~~~~~~~---~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 PVEELFKLLKEG---HRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHTT---CCCCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcC---CCCCCC--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            877777766542   122233  3679999999999999 99999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.6e-42  Score=362.17  Aligned_cols=249  Identities=20%  Similarity=0.294  Sum_probs=201.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEE----EEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF----VMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~v----AVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +..++|++.+.||+|+||.||+|.+..+|..+    |+|.+.......     ..|+.++.+++||||++++++|.+.. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            56678999999999999999999998888765    666664333221     56899999999999999999998765 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .++||+|+.+|+|.+++... .+.+++..+..|+.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            78999999999999999764 35699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .... ......||+.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+.......+..     ...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-----~~~  237 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-----GER  237 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----TCC
T ss_pred             CcccccccCCCccccccChHHhcc-------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-----CCC
Confidence            3222 2223457889999999974       368999999999999999999 9999988777666555543     112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+....++..+.+++..||. ||.+||++.+++.|
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            23334679999999999999 99999999999876

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-42  Score=356.26  Aligned_cols=245  Identities=18%  Similarity=0.246  Sum_probs=203.8

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCC-------cEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEe
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSH-------NTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQD   79 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tG-------k~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfed   79 (792)
                      ++..++|.+.+.||+|+||.||+|.+..+|       ..||+|++.......    ..|+.++..++||||+++++++.+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            456789999999999999999999999887       479999986654332    568899999999999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc--------eEE
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH--------LKL  151 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~--------VKL  151 (792)
                      .+..|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.        +||
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999999763 334899999999999999999999999999999999999988887        999


Q ss_pred             eccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCChhhhhhhh
Q psy13735        152 TDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYSSI  230 (792)
Q Consensus       152 iDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~~el~ekI  230 (792)
                      +|||++......     ....||+.|+|||++...      ..++.++|||||||++|+|++| .+||...+........
T Consensus       163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~  231 (289)
T 4fvq_A          163 SDPGISITVLPK-----DILQERIPWVPPECIENP------KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY  231 (289)
T ss_dssp             CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCG------GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             ccCcccccccCc-----cccCCcCcccCHHHhCCC------CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence            999998765422     223589999999999732      3588999999999999999995 5555554443333322


Q ss_pred             hcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       231 l~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                       .    ....+|.  ..++.+.+|+..||. ||.+|||+.+++.|
T Consensus       232 -~----~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          232 -E----DRHQLPA--PKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -H----TTCCCCC--CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -h----ccCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             2    2223333  457889999999999 99999999999876

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.8e-42  Score=351.06  Aligned_cols=249  Identities=20%  Similarity=0.322  Sum_probs=206.2

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----------HHHHHHHHhcCCCCcceeEEEE
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----------TIERDIMVKSKCPYIVNLFYSF   77 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----------~~E~eIL~kL~HPNIVkL~~vf   77 (792)
                      ...+..++|.+.+.||+|+||.||+|.+..+++.||+|++.......           ..|..++..++||||+++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            34467789999999999999999999999999999999987654321           4688999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCCCCc-----eE
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSATGH-----LK  150 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~dg~-----VK  150 (792)
                      .+..  ++||||++||+|.+.+... ...+++..+..++.||+.||.|||++|  |+||||||+|||++.++.     +|
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence            8766  6999999999999988653 456999999999999999999999999  999999999999988776     99


Q ss_pred             EeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh--hh
Q psy13735        151 LTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT--YS  228 (792)
Q Consensus       151 LiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el--~e  228 (792)
                      |+|||++.....    ......||+.|+|||++...     ...++.++|||||||++|+|++|..||...+....  ..
T Consensus       170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  240 (287)
T 4f0f_A          170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAE-----EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN  240 (287)
T ss_dssp             ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCS-----SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred             eCCCCccccccc----cccccCCCccccCchhhccC-----CCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence            999999985442    23345799999999998421     23578899999999999999999999976554333  22


Q ss_pred             hhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        229 SILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       229 kIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+..  ......+|.  .+++.+.+++..||. ||.+|||+.+++.
T Consensus       241 ~~~~--~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          241 MIRE--EGLRPTIPE--DCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHH--SCCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhc--cCCCCCCCc--ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            2222  112223333  779999999999999 9999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-42  Score=360.92  Aligned_cols=257  Identities=22%  Similarity=0.317  Sum_probs=215.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|.+.+.||+|+||.||+|.+.     .++..||+|++.......     ..|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            45678999999999999999999887     467899999997654332     46889999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEec
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQP--------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD  153 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~--------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiD  153 (792)
                      .+|+|||||+||+|.+++....        ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence            9999999999999999986421        24579999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhh
Q psy13735        154 FGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSIL  231 (792)
Q Consensus       154 FGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl  231 (792)
                      ||++......... ......||+.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             CccccccccccccccccCCCCCCCccChhhhcc-------CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            9999866433221 2233457899999999874       368899999999999999999 899999888777776665


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC------CCccCC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH------PVFDCL  280 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H------PwF~~i  280 (792)
                      ...   ....+  ..+++.+.+++..||. ||.+|||+.+++.|      |+|+.+
T Consensus       255 ~~~---~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          255 EGG---LLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             TTC---CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             cCC---cCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            421   12223  3679999999999999 99999999999765      666544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.5e-42  Score=352.47  Aligned_cols=251  Identities=21%  Similarity=0.361  Sum_probs=206.2

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEec---CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQ---SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~---tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      -++..++|.+.+.||+|+||.||+|.+..   ++..||+|++.......     ..|+.+++.++||||+++++++.+. 
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            35677899999999999999999998764   34569999987654322     4688999999999999999998754 


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      ..|+||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            568999999999999999653 3458999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ...........|++.|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+...   ..  
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~---~~--  232 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINF-------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG---DR--  232 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---CC--
T ss_pred             cccccccccCCCCcceeCchhhcc-------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---CC--
Confidence            443333344468889999999974       368899999999999999998 99999877766666555441   11  


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+....+++.+.+++..||. ||.+||++.+++.+
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            22233679999999999999 99999999999765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-42  Score=359.16  Aligned_cols=253  Identities=20%  Similarity=0.352  Sum_probs=207.9

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEe
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQD   79 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfed   79 (792)
                      .+..++|.+.+.||+|+||.||+|.+.     .+++.||+|++.......     ..|..++..+ +||||+++++++..
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            356679999999999999999999853     567899999997654332     4688899999 69999999999987


Q ss_pred             CC-EEEEEEeccCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC
Q psy13735         80 MN-HVYFIMEYVTGGDFVTLLENQPH--------------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS  144 (792)
Q Consensus        80 e~-~lyLVmEy~~GGsL~dlL~r~~~--------------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd  144 (792)
                      .+ .+|+|||||+||+|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence            65 59999999999999999975432              2289999999999999999999999999999999999999


Q ss_pred             CCCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCC
Q psy13735        145 ATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYET  222 (792)
Q Consensus       145 ~dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d  222 (792)
                      .++.+||+|||++........ .......||+.|+|||++..       ..++.++|||||||++|+|++ |..||.+..
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-------ccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999987654322 22234468899999999974       368899999999999999998 999998766


Q ss_pred             hhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        223 LDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       223 ~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...........  ......|  ..+++.+.+++..||. ||.+|||+.+++.|
T Consensus       256 ~~~~~~~~~~~--~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          256 IDEEFCRRLKE--GTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CSHHHHHHHHH--TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHHhcc--CccCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            54433333321  1122233  3679999999999999 99999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-42  Score=362.91  Aligned_cols=254  Identities=19%  Similarity=0.282  Sum_probs=211.1

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCc-----EEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHN-----TFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQ   78 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk-----~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfe   78 (792)
                      ..+..++|.+.+.||+|+||.||+|.+..+|.     .||+|.+.......     ..|+.++..+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34677899999999999999999999987665     79999987654322     5788999999 8999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQP------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT  146 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d  146 (792)
                      +.+.+|+|||||+||+|.+++....            ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            9999999999999999999996421            3458999999999999999999999999999999999999999


Q ss_pred             CceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChh
Q psy13735        147 GHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLD  224 (792)
Q Consensus       147 g~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~  224 (792)
                      +.+||+|||++......... ......||+.|+|||++..       ..++.++|||||||++|+|++ |..||.+....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-------CCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            99999999999876543322 2233457889999999874       368899999999999999998 99999876655


Q ss_pred             hhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        225 MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       225 el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .....+...    ....+.....++.+.+++..||. ||.+|||+.+++.+
T Consensus       274 ~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          274 SKFYKLVKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            554444431    12222233678999999999999 99999999999764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.1e-42  Score=350.01  Aligned_cols=248  Identities=21%  Similarity=0.357  Sum_probs=209.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|++++.||+|+||.||+|.+. ++..||+|.+.......   ..|+.++..++||||+++++++.+ +.+|+|||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            45678999999999999999999875 56789999997665443   578999999999999999999874 45899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence            99999999999542223589999999999999999999999999999999999999999999999999987764433333


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....|++.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+.......+...   .....+  ..+
T Consensus       168 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~  235 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRP--DNC  235 (279)
T ss_dssp             TTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCC--TTC
T ss_pred             cCCCCccCccChhhhcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc---cCCCCc--ccc
Confidence            34457889999999974       368889999999999999999 99999888777776666541   112222  367


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+.+++..|+. ||.+|||+.+++.
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999 9999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-42  Score=356.36  Aligned_cols=251  Identities=18%  Similarity=0.295  Sum_probs=200.7

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEE----EecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEe--
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQD--   79 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~----~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfed--   79 (792)
                      ..+..++|++++.||+|+||.||+|+    +..+|+.||+|++.......    ..|+.++..++||||+++++++..  
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            35677899999999999999999998    56789999999987553222    478999999999999999999864  


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ...+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            45699999999999999999764 34599999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh------------
Q psy13735        160 VDKNGRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM------------  225 (792)
Q Consensus       160 l~~~~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e------------  225 (792)
                      .......  ......|++.|+|||++...       .++.++|||||||++|+|++|..||.......            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTES-------KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHC-------CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCC-------CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            6543221  12233577889999999743       68999999999999999999999986432210            


Q ss_pred             ----hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        226 ----TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       226 ----l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                          ....+.     .....+....+++.+.+++..|+. ||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 IVFHLIELLK-----NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHH-----TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHh-----ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                011111     112233344789999999999999 9999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.5e-42  Score=373.26  Aligned_cols=249  Identities=22%  Similarity=0.374  Sum_probs=209.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----hHHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----NTIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +..++|.+.+.||+|+||.||+|.++.+|..||+|++......     ...|+.+++.++|||||++++++.+.+.+|+|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            4567899999999999999999999999999999998754322     15799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       191 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            9999999999999652 345899999999999999999999999999999999999999999999999999865432111


Q ss_pred             cc-ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        167 KS-IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       167 ~s-~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                      .. ....+++.|+|||++...       .++.++|||||||++|+|++ |..||.+.+.......+...   .....|  
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~--  337 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYG-------RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPCP--  337 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHC-------EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT---CCCCCC--
T ss_pred             ecCCCCCCCcCcCCHhHhccC-------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCC--
Confidence            11 112356789999999743       68899999999999999998 99999888776666555431   222233  


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+++.+.+++..|+. ||.+|||+.+++.
T Consensus       338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3679999999999999 9999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.8e-42  Score=358.71  Aligned_cols=253  Identities=22%  Similarity=0.337  Sum_probs=197.6

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +.+...++|.+.+.||+|+||.||+|.+..+|+.||+|++.......       ..|+.++..++||||+++++++.+.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            44567889999999999999999999999999999999997654322       46888999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+||||++|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             eEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999999999965  3459999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ...........|++.|+|||++..       ..++.++|||||||++|+|++|..||.+.+.......+.. .......+
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~  257 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSE-------SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTV  257 (309)
T ss_dssp             -----------CCGGGCCGGGTCC-----------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-CCCCGGGT
T ss_pred             ccccccccccCCCcCccCHHHHcC-------CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-CCCCcccc
Confidence            433233334579999999999863       3678899999999999999999999987766544333332 11111122


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcC-ChhHHhc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARL-NMDQVLG  273 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRP-TaeEIL~  273 (792)
                      +  ..+++.+.++|.+||. ||.+|| ++.+++.
T Consensus       258 ~--~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          258 R--PGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             S--TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             C--CCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            2  3678999999999999 999999 7777653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-42  Score=362.87  Aligned_cols=258  Identities=20%  Similarity=0.258  Sum_probs=206.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +..++|.+.+.||+|+||.||+|.+. +|..||+|++.......     ..|+.++..++||||++++++|.+....|+|
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  105 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV  105 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence            46789999999999999999999754 68999999987654332     5788999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         87 MEYVTGGDFVTLLENQP--HGYLSESKARFYIYELAQAVQYLHGL---GYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~--~g~LSE~ea~~Im~QILsAL~YLHs~---gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      ||||.||+|.+++....  ...+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  185 (326)
T 3uim_A          106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD  185 (326)
T ss_dssp             EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence            99999999999997543  23489999999999999999999999   99999999999999999999999999998776


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC----hhhhhhhhh----cc
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET----LDMTYSSIL----AC  233 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d----~~el~ekIl----~~  233 (792)
                      ...........||+.|+|||++...       .++.++|||||||++|+|++|..||....    .........    ..
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          186 YKDTHVTTAVRGTIGHIAPEYLSTG-------KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSSSCEECCCCSCGGGCCHHHHHHS-------EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             cccccccccccCCcCccCHHHhccC-------CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            5444444556799999999999743       58899999999999999999999995211    111111110    00


Q ss_pred             cC-----CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        234 DT-----EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       234 ~~-----~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ..     ......+.....++.+.+++..||. ||.+|||+.++++|..-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            00     0001111123456889999999999 99999999999988653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.6e-42  Score=361.06  Aligned_cols=256  Identities=21%  Similarity=0.300  Sum_probs=209.2

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEE-----EecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVE-----EKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~-----~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      .+..++|.+++.||+|+||.||+|.     +..+|..||+|++.......     ..|+.++..++||||+++++++.+.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            4667899999999999999999998     56788899999986543322     4688999999999999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC---CceEEe
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPH-----GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT---GHLKLT  152 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~-----g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d---g~VKLi  152 (792)
                      ..+|+|||||+||+|.+++.....     ..+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999999976432     458999999999999999999999999999999999999844   469999


Q ss_pred             ccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhh
Q psy13735        153 DFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSI  230 (792)
Q Consensus       153 DFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekI  230 (792)
                      |||++........ .......||+.|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence            9999976543221 12223468999999999974       368899999999999999998 99999888777766666


Q ss_pred             hcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        231 LACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       231 l~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      ...   .....+  ..+++.+.++|..||. ||.+||++.+++.|+|+-
T Consensus       259 ~~~---~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSG---GRMDPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTT---CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcC---CCCCCC--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            542   112223  3679999999999999 999999999999998875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7e-42  Score=384.47  Aligned_cols=250  Identities=20%  Similarity=0.331  Sum_probs=216.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +...+|.+.+.||+|+||.||++.++.++..||+|++.......   ..|+.++.+++|||||+++++|.+...+|||||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45668999999999999999999999999999999997665443   579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  376 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  376 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence            99999999999775556799999999999999999999999999999999999999999999999999987654332223


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+++.|+|||++...       .++.++|||||||++|+|++ |..||.+.+.......+..     ....+....+
T Consensus       377 ~~~~~~~~y~aPE~~~~~-------~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~  444 (495)
T 1opk_A          377 AGAKFPIKWTAPESLAYN-------KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----DYRMERPEGC  444 (495)
T ss_dssp             TTCCCCGGGCCHHHHHHC-------EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----TCCCCCCTTC
T ss_pred             CCCcCCcceeCHhHHhcC-------CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCC
Confidence            334577899999999743       68899999999999999999 9999998887776665543     1222333478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+.+||..||. ||.+|||+.+++.
T Consensus       445 ~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          445 PEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            9999999999999 9999999999865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.2e-42  Score=352.78  Aligned_cols=256  Identities=19%  Similarity=0.276  Sum_probs=197.7

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHh--cCCCCcceeEEEEEe----CCEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVK--SKCPYIVNLFYSFQD----MNHV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~k--L~HPNIVkL~~vfed----e~~l   83 (792)
                      +...++|.+.+.||+|+||.||++.+  +|+.||+|++....... ..|.+++..  ++||||+++++++.+    ...+
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            45678999999999999999999977  68999999987654322 457777776  789999999998654    3568


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH--------GLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH--------s~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      |+|||||+||+|.+++..   ..+++..+..++.||+.||.|||        +.||+||||||+|||++.++.+||+|||
T Consensus        82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            999999999999999943   45999999999999999999999        9999999999999999999999999999


Q ss_pred             cccccccCCCcc---cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC----------CCCCCCCC
Q psy13735        156 SATQVDKNGRIK---SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG----------STPFNYET  222 (792)
Q Consensus       156 LA~~l~~~~~~~---s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG----------k~PF~~~d  222 (792)
                      ++..........   ....+||+.|+|||++..... .....++.++|||||||++|+|++|          ..||....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ-VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCC-TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCC-CCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            998765433221   223479999999999963200 0000345789999999999999999          88885432


Q ss_pred             hh----hhhhhhhcccCCCCcCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        223 LD----MTYSSILACDTEDTVSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       223 ~~----el~ekIl~~~~~~~l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..    .....+... ......+|.   ....++.+.+|+..||. ||.+|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCV-DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTT-SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhc-cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            21    111222111 111122222   12457889999999999 9999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.7e-42  Score=355.61  Aligned_cols=240  Identities=25%  Similarity=0.482  Sum_probs=196.3

Q ss_pred             CCCCCCceEE-eEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHH-HhcCCCCcceeEEEEEe----CCEEE
Q psy13735         11 NVSASDFDIK-RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIM-VKSKCPYIVNLFYSFQD----MNHVY   84 (792)
Q Consensus        11 ~l~l~dY~I~-k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL-~kL~HPNIVkL~~vfed----e~~ly   84 (792)
                      +...++|.+. +.||+|+||.||+|.+..+|+.||+|++.... ....|..++ +.++||||++++++|.+    ...+|
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH-HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3456788888 78999999999999999999999999986432 235677777 56689999999999987    77899


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCcccccc
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVD  161 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~  161 (792)
                      +|||||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            9999999999999998766567999999999999999999999999999999999999988   7889999999986532


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      .                              ..++.++|||||||++|+|++|..||...+.......+..........+
T Consensus       172 ~------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  221 (299)
T 3m2w_A          172 G------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  221 (299)
T ss_dssp             T------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred             c------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence            1                              2467789999999999999999999977655444333332222233333


Q ss_pred             CC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        242 PS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       242 P~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      |.  ...+++.+.+|+..||. ||.+|||+.+++.||||....
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            32  14689999999999999 999999999999999998643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.8e-42  Score=352.51  Aligned_cols=255  Identities=19%  Similarity=0.284  Sum_probs=202.4

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEE----EecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~----~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      ..+....|++++.||+|+||.||+|+    +..+|+.||+|++.......     ..|+.++..++||||+++++++.+.
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            34556679999999999999999998    56789999999997654322     5789999999999999999999877


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         81 --NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        81 --~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                        ..+|+|||||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence              6799999999999999999653 3459999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-----------hhh
Q psy13735        159 QVDKNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-----------LDM  225 (792)
Q Consensus       159 ~l~~~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-----------~~e  225 (792)
                      .......  .......||+.|+|||++...       .++.++|||||||++|+|++|..||....           ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQS-------KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM  247 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHC-------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCC-------CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence            7764432  122344688999999999743       67889999999999999999999864221           011


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ....+... .......+....+++.+.+|+..||. ||.+|||+.++++
T Consensus       248 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          248 TVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHH-HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            11111110 00112223334789999999999999 9999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-41  Score=353.45  Aligned_cols=257  Identities=18%  Similarity=0.274  Sum_probs=203.8

Q ss_pred             HHhcCCCCCCCceEEeEeeecCceEEEEEEEec---CCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEE
Q psy13735          6 ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQ---SHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYS   76 (792)
Q Consensus         6 ~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~---tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~v   76 (792)
                      .+..-.+..++|.+.+.||+|+||.||+|....   ++..||+|++.......      ..|+.++..++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            344555677899999999999999999998875   56689999997665443      468899999999999999999


Q ss_pred             EEeCC-----EEEEEEeccCCCCHHHHHHh----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC
Q psy13735         77 FQDMN-----HVYFIMEYVTGGDFVTLLEN----QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG  147 (792)
Q Consensus        77 fede~-----~lyLVmEy~~GGsL~dlL~r----~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg  147 (792)
                      +.+..     ..|+||||++||+|.+++..    .....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence            98765     35999999999999999853    2345699999999999999999999999999999999999999999


Q ss_pred             ceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhh
Q psy13735        148 HLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDM  225 (792)
Q Consensus       148 ~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~e  225 (792)
                      .+||+|||++......... ......|++.|+|||++..       ..++.++|||||||++|+|++ |.+||.+.+...
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  257 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-------RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE  257 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHS-------SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcC-------CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence            9999999999876533221 1223457889999999973       368899999999999999999 999998888777


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ....+...   ....+|  ..+++.+.+++..||. ||.+||++.+++.|
T Consensus       258 ~~~~~~~~---~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          258 MYDYLLHG---HRLKQP--EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHHHHTT---CCCCCB--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcC---CCCCCC--ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77666542   122233  3678999999999999 99999999999765

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-41  Score=355.32  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=203.2

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcC--CCCcceeEEEEEeCCEEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSK--CPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~--HPNIVkL~~vfede~~ly   84 (792)
                      ...+|.+++.||+|+||.||+|.+. +|+.||+|++.......      ..|+.++..+.  ||||+++++++.+...+|
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            4567999999999999999999885 58999999997665443      46888999987  599999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +||| +.+|+|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus       105 lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             EEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence            9999 5589999999653  4689999999999999999999999999999999999996 5899999999998765332


Q ss_pred             Cc-ccccCCCCCCccChhhhhhhccC----CCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-hhhhhhhcccCCCC
Q psy13735        165 RI-KSIVPVGTPEYVAPEVLEWMEGN----HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-MTYSSILACDTEDT  238 (792)
Q Consensus       165 ~~-~s~t~vGTp~Y~APEiL~~~~~~----~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-el~ekIl~~~~~~~  238 (792)
                      .. .....+||+.|+|||++......    .....++.++|||||||++|+|++|..||...... .....+..  ....
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~  258 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PNHE  258 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC--TTSC
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh--cccc
Confidence            21 22344699999999998642100    01236888999999999999999999999754322 22333332  1122


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ..+|.  ..++.+.+++..||. ||.+||++.+++.||||..
T Consensus       259 ~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          259 IEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             CCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             cCCcc--cchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            33443  568999999999999 9999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.4e-41  Score=345.64  Aligned_cols=247  Identities=19%  Similarity=0.255  Sum_probs=201.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEE-EEeCCEEEEEEecc
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYS-FQDMNHVYFIMEYV   90 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~v-fede~~lyLVmEy~   90 (792)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|++.......  ..|..++..+.|++++..+.+ +.....+|+||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            468999999999999999999999999999999987655433  679999999998776655544 46778899999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC---CCCceEEeccCcccccccCCCc-
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS---ATGHLKLTDFGSATQVDKNGRI-  166 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd---~dg~VKLiDFGLA~~l~~~~~~-  166 (792)
                       ||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......... 
T Consensus        88 -~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (296)
T 3uzp_A           88 -GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             -CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence             99999999643 35699999999999999999999999999999999999994   7889999999999876543221 


Q ss_pred             -----ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh---hhhhhhhhcccCCCC
Q psy13735        167 -----KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL---DMTYSSILACDTEDT  238 (792)
Q Consensus       167 -----~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~---~el~ekIl~~~~~~~  238 (792)
                           ......||+.|+|||++.+       ..++.++|||||||++|+|++|..||...+.   ...+..+..    ..
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~  234 (296)
T 3uzp_A          166 HIPYRENKNLTGTARYASINTHLG-------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----KK  234 (296)
T ss_dssp             BCCCCCSCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH----HH
T ss_pred             ccccccccccccccccCChhhhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc----cc
Confidence                 1234579999999999873       3688999999999999999999999976432   233333332    11


Q ss_pred             cCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        239 VSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       239 l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ...|.   ...+++.+.+++..||. ||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            11221   13578999999999999 9999999998854

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=349.97  Aligned_cols=251  Identities=20%  Similarity=0.308  Sum_probs=209.7

Q ss_pred             CCCCCceEEe-EeeecCceEEEEEEEe--cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKR-FIQQGNFGDIYLVEEK--QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k-~IGsGsFGtVyla~~k--~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      +..++|.+.+ .||+|+||.||+|.+.  .++..||+|++.......     ..|+.++..++||||+++++++ ..+.+
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   84 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL   84 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence            4567888887 9999999999999854  568899999997654322     4689999999999999999999 45669


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+||||++||+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        85 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            999999999999999954 3456999999999999999999999999999999999999999999999999999877543


Q ss_pred             CCcc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        164 GRIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       164 ~~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ....  .....||+.|+|||++...       .++.++|||||||++|+|++ |..||...+.......+...   ....
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~---~~~~  233 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFR-------KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRME  233 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHC-------EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---CCCC
T ss_pred             cceeeccccccccccccCHHHhccC-------CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC---CcCC
Confidence            3221  2233578999999999743       68899999999999999998 99999887777766666542   1223


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPV  276 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPw  276 (792)
                      +|.  .+++.+.++|..||. ||.+||++.+++.|.+
T Consensus       234 ~~~--~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          234 CPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC--CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            343  779999999999999 9999999999987743

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=357.81  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=201.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEE----EEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF----VMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~v----AVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +..++|++++.||+|+||.||+|.+..+|..+    |+|.+.......     ..|+.++..++||||++++++|.+.. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            56789999999999999999999999888765    555554332221     56899999999999999999998765 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      .++||+|+.+|+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            88999999999999999764 35699999999999999999999999999999999999999999999999999987653


Q ss_pred             CCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ... .......||+.|+|||++...       .++.++|||||||++|+|++ |.+||.+.+.......+..     ...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-----~~~  237 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHR-------IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-----GER  237 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----TCC
T ss_pred             ccccccccCCCccccccCHHHHcCC-------CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-----CCC
Confidence            322 122233578899999999743       68999999999999999999 9999988877766665544     122


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+....+++.+.+++..||. ||.+||++.+++..
T Consensus       238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33334689999999999999 99999999999763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-41  Score=358.07  Aligned_cols=253  Identities=21%  Similarity=0.356  Sum_probs=211.1

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEe-------cCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEK-------QSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYS   76 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k-------~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~v   76 (792)
                      -.+..++|.+.+.||+|+||.||+|.+.       .++..||+|++.......     ..|..++..+ +||||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3456789999999999999999999985       467889999987654322     4688999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceE
Q psy13735         77 FQDMNHVYFIMEYVTGGDFVTLLENQPH--------------GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNML  142 (792)
Q Consensus        77 fede~~lyLVmEy~~GGsL~dlL~r~~~--------------g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNIL  142 (792)
                      +.+.+.+|+|||||+||+|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence            9999999999999999999999975431              34899999999999999999999999999999999999


Q ss_pred             eCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCC
Q psy13735        143 LSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNY  220 (792)
Q Consensus       143 Ld~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~  220 (792)
                      ++.++.+||+|||++......... ......||+.|+|||++...       .++.++|||||||++|+|++ |..||.+
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-------VYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-------EECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-------CcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            999999999999999876543221 12234578899999998743       58899999999999999999 9999998


Q ss_pred             CChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        221 ETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       221 ~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+.......+....   ....+  ..+++.+.+++..||. ||.+||++.+++.+
T Consensus       263 ~~~~~~~~~~~~~~---~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          263 IPVEELFKLLKEGH---RMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CCHHHHHHHHHHTC---CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHhcCC---CCCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            88777766665421   12233  3679999999999999 99999999999765

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-41  Score=345.71  Aligned_cols=247  Identities=19%  Similarity=0.255  Sum_probs=198.0

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEE-EEeCCEEEEEEecc
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYS-FQDMNHVYFIMEYV   90 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~v-fede~~lyLVmEy~   90 (792)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.......  ..|..++..+.|++++..+.. +......|+||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            468999999999999999999999999999999876554433  789999999988776665554 47788999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe---CCCCceEEeccCcccccccCCC--
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGR--  165 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL---d~dg~VKLiDFGLA~~l~~~~~--  165 (792)
                       ||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........  
T Consensus        88 -~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~  165 (296)
T 4hgt_A           88 -GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             -CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             -CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence             99999999653 3459999999999999999999999999999999999999   7889999999999987654322  


Q ss_pred             ----cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh---hhhhhhcccCCCC
Q psy13735        166 ----IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM---TYSSILACDTEDT  238 (792)
Q Consensus       166 ----~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e---l~ekIl~~~~~~~  238 (792)
                          .......||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+.+...   .+..+..    ..
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~  234 (296)
T 4hgt_A          166 HIPYRENKNLTGTARYASINTHLG-------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----KK  234 (296)
T ss_dssp             BCCCCCSCCCCSCGGGCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH----HH
T ss_pred             cCCCCcccccCCCccccchHHhcC-------CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc----cc
Confidence                12234579999999999973       368899999999999999999999997654332   2222222    11


Q ss_pred             cCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        239 VSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       239 l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ...|.   ...+++.+.+++..|+. ||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11121   13568999999999999 9999999999854

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-41  Score=376.22  Aligned_cols=261  Identities=23%  Similarity=0.335  Sum_probs=194.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.|.+.+.||+|+||+||.+ ...+|+.||+|++....... ..|+.++..+ +|||||++++++.+.+.+|||||||. 
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            34556789999999999875 55689999999987643222 5788899876 89999999999999999999999995 


Q ss_pred             CCHHHHHHhCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC-------------CceEEecc
Q psy13735         93 GDFVTLLENQPHGY-----LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT-------------GHLKLTDF  154 (792)
Q Consensus        93 GsL~dlL~r~~~g~-----LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d-------------g~VKLiDF  154 (792)
                      |+|.+++.......     .++..+..++.||+.||.|||++||+||||||+|||++.+             +++||+||
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            69999996532211     1333457899999999999999999999999999999654             47999999


Q ss_pred             CcccccccCCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhh
Q psy13735        155 GSATQVDKNGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSI  230 (792)
Q Consensus       155 GLA~~l~~~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekI  230 (792)
                      |+|.........   .....+||+.|+|||++.+.........++.++|||||||++|+|++ |..||.......  ..+
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i  250 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNI  250 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHH
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHH
Confidence            999877543221   12245799999999999643222233578999999999999999999 999997554332  223


Q ss_pred             hcccCC-CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        231 LACDTE-DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       231 l~~~~~-~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ...... ..........+++++.+||.+||. ||.+|||+.+++.||||..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            221111 111112223567899999999999 9999999999999999974

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.3e-41  Score=348.63  Aligned_cols=251  Identities=24%  Similarity=0.426  Sum_probs=196.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ....+|++.+.||+|+||.||+|.+..+|..||+|++.......       ..|+.++..++||||+++++++.+.+.+|
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            35678999999999999999999999999999999997644332       46889999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         85 FIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r--~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +||||+.||+|.+++..  .....+++..+..++.||+.||.|||++||+||||+|+||+++.+|.+||+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999999864  1345689999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh--hhhhhhhhcccCCCCcC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL--DMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~--~el~ekIl~~~~~~~l~  240 (792)
                      ... ......|++.|+|||++..       ..++.++|||||||++|+|++|..||.+...  ......+...    ...
T Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~  256 (310)
T 2wqm_A          189 KTT-AAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----DYP  256 (310)
T ss_dssp             -----------CCSSCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT----CSC
T ss_pred             CCc-cccccCCCeeEeChHHhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc----cCC
Confidence            322 2234469999999999863       3688999999999999999999999976432  2333333331    111


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ......+++.+.+++..||. ||.+||++.+++.+
T Consensus       257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            11124679999999999999 99999999999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-41  Score=344.89  Aligned_cols=245  Identities=20%  Similarity=0.288  Sum_probs=201.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCc---EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE-EEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV-YFI   86 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk---~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l-yLV   86 (792)
                      .|.+.+.||+|+||.||+|.+..++.   .+|+|++.......     ..|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667999999999999999876655   79999987644322     4788999999999999999999877665 999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC--
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG--  164 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~--  164 (792)
                      |||+.||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999999999999965 34568999999999999999999999999999999999999999999999999998654321  


Q ss_pred             -CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        165 -RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       165 -~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                       ........|++.|+|||.+..       ..++.++|||||||++|+|++ |.+||...+.......+...     ...+
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----~~~~  248 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQT-------YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-----RRLP  248 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-----CCCC
T ss_pred             ccccCcCCCCCccccChhhhcc-------CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-----CCCC
Confidence             112233468899999999963       368899999999999999999 55666666655555555431     1223


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ....+++.+.+++..||. ||.+|||+.+++.
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            334679999999999999 9999999998864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.9e-42  Score=361.83  Aligned_cols=253  Identities=19%  Similarity=0.226  Sum_probs=198.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCC----EEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMN----HVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~----~ly   84 (792)
                      +..++|++.+.||+|+||.||+|++.  |+.||+|++.......   ..|+.++..++|||||++++++.+..    .+|
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            46678999999999999999999775  7999999996543322   34677788999999999999998744    479


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCccCCCCCCceEeCCCCceEEecc
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL----------GYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~----------gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                      +|||||+||+|.+++...   .+++..+..++.||+.||.|||+.          ||+||||||+|||++.++.+||+||
T Consensus        99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            999999999999999653   399999999999999999999999          9999999999999999999999999


Q ss_pred             CcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh--------
Q psy13735        155 GSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM--------  225 (792)
Q Consensus       155 GLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e--------  225 (792)
                      |++......... .....+||+.|+|||++.+.  ......++.++|||||||++|+|++|..||.+.....        
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA--INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC--CCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             CcccccccccCccccccCccCccccCHhhcccc--cccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            999876543222 22345799999999999631  0111245678899999999999999999997643211        


Q ss_pred             --------hhhhhhcccCCCCcCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        226 --------TYSSILACDTEDTVSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       226 --------l~ekIl~~~~~~~l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                              ....+..  ......++.   ....++.+.+||.+||. ||.+|||+.+++.
T Consensus       254 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          254 GQHPSLEDMQEVVVH--KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CSSCCHHHHHHHHTT--SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCchhhhhhhhhc--ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    1111111  001111111   12345679999999999 9999999999865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-41  Score=377.23  Aligned_cols=248  Identities=19%  Similarity=0.365  Sum_probs=209.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|.+.+.||+|+||.||++.+. ++..||+|++.......   ..|+.+++.++|||||++++++. ...+|+|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            45678999999999999999999886 46789999998655433   57999999999999999999986 567899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~  342 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  342 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence            99999999999643334589999999999999999999999999999999999999999999999999987653221122


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+++.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+.......+...     ...|....+
T Consensus       343 ~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~  410 (454)
T 1qcf_A          343 EGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-----YRMPRPENC  410 (454)
T ss_dssp             CSSSSCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-----CCCCCCTTS
T ss_pred             CCCcccccccCHHHhcc-------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCC
Confidence            23347789999999974       368999999999999999999 99999988877777766541     223334478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+.+++..|+. ||.+|||+.+++.
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            9999999999999 9999999999854

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-41  Score=348.98  Aligned_cols=253  Identities=19%  Similarity=0.302  Sum_probs=193.1

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ..+..++|.+.+.||+|+||.||++.+.   ..+|+|++.......      ..|+.+++.++||||+.+++++ ....+
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            3467889999999999999999999754   359999997665443      4688999999999999999965 55678


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      ++|||||.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999999999543 456999999999999999999999999999999999999999999999999999765432


Q ss_pred             C-CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhc-ccCCCC-cC
Q psy13735        164 G-RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA-CDTEDT-VS  240 (792)
Q Consensus       164 ~-~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~-~~~~~~-l~  240 (792)
                      . ........||+.|+|||++...    ....++.++|||||||++|+|++|..||...........+.. ...... ..
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQ----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             ----------CCCTTCCHHHHC--------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccCCCccccCchhhccc----CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            1 1222345699999999998522    234688899999999999999999999987554433333322 111111 11


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +  ...+++.+.+|+..||. ||.+|||+.+++.
T Consensus       250 ~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          250 V--RSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             S--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c--cccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1  23678999999999999 9999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8e-42  Score=358.32  Aligned_cols=255  Identities=22%  Similarity=0.257  Sum_probs=205.6

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      ..++|.+.+.||+|+||.||+|.++ +|..||+|++.......    ..|+.++..++||||+++++++.+.+.+|+|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            4578999999999999999999864 68999999887654433    568889999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC-
Q psy13735         89 YVTGGDFVTLLENQP--HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-  165 (792)
Q Consensus        89 y~~GGsL~dlL~r~~--~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-  165 (792)
                      ||+||+|.+++....  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999999999985432  23589999999999999999999999999999999999999999999999999986543221 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhh-------cccCC--
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSIL-------ACDTE--  236 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl-------~~~~~--  236 (792)
                      .......||+.|+|||++..       ..++.++|||||||++|+|++|..||....+......+.       .....  
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIK-------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI  268 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHH-------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred             ccccccCCCccccCHHHhcC-------CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence            12234468999999999974       368899999999999999999999997655433221110       00000  


Q ss_pred             --CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCC
Q psy13735        237 --DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHP  275 (792)
Q Consensus       237 --~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HP  275 (792)
                        ...........+..+.+++..||. ||.+|||+.+++.|.
T Consensus       269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence              011111123567889999999999 999999999998763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-41  Score=368.27  Aligned_cols=250  Identities=20%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEe---cCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEK---QSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k---~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      .+..++|.+.+.||+|+||.||+|+++   .++..||+|++.......     ..|+.++.+++||||+++++++.+...
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            456678999999999999999999887   567789999987543222     468899999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999999999653 34699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        163 NGRIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       163 ~~~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      .....  .....+++.|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+..     ..
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-----~~  267 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAY-------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-----GY  267 (373)
T ss_dssp             --------------CTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-----TE
T ss_pred             CCccceeccCCCcCCCccChhhhcc-------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CC
Confidence            32211  122245788999999974       368999999999999999998 9999988877776666644     22


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ..+....++..+.+++..|+. ||.+||++.+++.
T Consensus       268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            333444789999999999999 9999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=374.49  Aligned_cols=258  Identities=22%  Similarity=0.335  Sum_probs=199.3

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhc-CCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKS-KCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL-~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      ...+|.+.+.||+|+||+|+. ....+|+.||||++....... ..|+.+++.+ +|||||++++++.+...+|||||||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            345699999999999999763 456789999999997654332 7899999999 7999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CC--ceEEeccCcccccccCCC
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TG--HLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg--~VKLiDFGLA~~l~~~~~  165 (792)
                      . |+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.   ++  .+||+|||+|........
T Consensus       101 ~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          101 A-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             S-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             C-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            5 69999997543 34566677899999999999999999999999999999953   23  588999999987653321


Q ss_pred             --cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        166 --IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       166 --~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                        ......+||+.|+|||++...    ....++.++|||||||++|+|++ |.+||...........+...   .....+
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~  251 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSED----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC---SLDCLH  251 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC-------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC---CCTTSC
T ss_pred             ceeeccccCCCcCccChhhhhcc----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC---CccccC
Confidence              223345799999999998621    12457789999999999999999 99999655433332222111   111122


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .....+..+.+||.+||. ||.+|||+.+++.||||..+
T Consensus       252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            223567889999999999 99999999999999999854

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.5e-41  Score=346.37  Aligned_cols=244  Identities=20%  Similarity=0.375  Sum_probs=199.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEeC-CEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQDM-NHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfede-~~lyLVmE   88 (792)
                      +..++|++.+.||+|+||.||++.+.  |..||+|++.......  ..|+.++..++||||+++++++... +.+|+|||
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            56789999999999999999999764  8899999997655433  5788999999999999999997554 57899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      |++||+|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......    
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence            9999999999965433348999999999999999999999999999999999999999999999999998654321    


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+++.|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+...   .....+  ..+
T Consensus       172 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~--~~~  239 (278)
T 1byg_A          172 DTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAP--DGC  239 (278)
T ss_dssp             ----CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---CCCCCC--TTC
T ss_pred             cCCCccccccCHHHhCC-------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCCCc--ccC
Confidence            23358899999999974       368899999999999999998 99999887776666665441   122233  477


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++.+.+++..||. ||.+||++.+++.
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999 9999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-40  Score=369.68  Aligned_cols=245  Identities=20%  Similarity=0.378  Sum_probs=208.2

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEeCC-EEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQDMN-HVYFIM   87 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfede~-~lyLVm   87 (792)
                      .+..++|.+.+.||+|+||.||++.+.  |..||+|++.......  ..|+.++.+++|||||++++++.... .+|+||
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            356789999999999999999999875  7899999998765433  67999999999999999999987665 799999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....    
T Consensus       267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  342 (450)
T ss_dssp             ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence            9999999999997655455899999999999999999999999999999999999999999999999999865422    


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....+++.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+.......+...   .....|  ..
T Consensus       343 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~p--~~  410 (450)
T 1k9a_A          343 QDTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAP--DG  410 (450)
T ss_dssp             ----CCCTTTSCHHHHHS-------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT---CCCCCC--TT
T ss_pred             ccCCCCCcceeCHHHhcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCC--Cc
Confidence            122358899999999973       368999999999999999998 99999887777766666541   122333  47


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +++.+.++|..|+. ||.+|||+.+++.
T Consensus       411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          411 CPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            89999999999999 9999999998853

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-41  Score=354.54  Aligned_cols=251  Identities=21%  Similarity=0.345  Sum_probs=204.7

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCC----cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSH----NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tG----k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      .+..++|.+.+.||+|+||.||+|.++.++    ..||+|++.......     ..|+.++..++||||+++++++.+.+
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            456789999999999999999999987654    469999987543322     46889999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999999999753 3569999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        162 KNGRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       162 ~~~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      .....  ......||+.|+|||++..       ..++.++|||||||++|+|++ |..||...+.......+...     
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-----  266 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISY-------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-----  266 (333)
T ss_dssp             ------------CCCGGGSCHHHHHS-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----
T ss_pred             cccccccccCCCCccccccCchhccc-------CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-----
Confidence            33211  1222346889999999963       368899999999999999998 99999888777776666541     


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...+....+++.+.+++..||. +|.+||++.+++.+
T Consensus       267 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2233334789999999999999 99999999998654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=356.04  Aligned_cols=254  Identities=22%  Similarity=0.384  Sum_probs=202.0

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEe----CCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQD----MNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfed----e~~l   83 (792)
                      +..++|.+++.||+|+||.||+|.+..+|+.||+|++.......    ..|+.+++.++||||+++++++..    ...+
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            34568999999999999999999999999999999986543222    578999999999999999999973    3578


Q ss_pred             EEEEeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      |+|||||.||+|.+++.+.  ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            9999999999999998652  34669999999999999999999999999999999999999999999999999987653


Q ss_pred             cCCCc--------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh--hhhhhhhh
Q psy13735        162 KNGRI--------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL--DMTYSSIL  231 (792)
Q Consensus       162 ~~~~~--------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~--~el~ekIl  231 (792)
                      .....        ......||+.|+|||++...    ....++.++|||||||++|+|++|..||.....  ......+.
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ----SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC----SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             cccccccccccccccccccCCcccCCHhHhccC----CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            21100        01123589999999998532    112368899999999999999999999953211  11111111


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                           ....+|....+++.+.++|..||. ||.+||++.+++.|
T Consensus       262 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 -----NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -----CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                 123344445789999999999999 99999999999886

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.5e-41  Score=355.52  Aligned_cols=254  Identities=20%  Similarity=0.297  Sum_probs=205.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEE----EecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEE--eCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQ--DMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~----~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfe--de~   81 (792)
                      +..++|++++.||+|+||.||+|+    +..+|..||+|++.......    ..|+.+++.++||||+++++++.  +..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            567799999999999999999999    46789999999997654322    57899999999999999999986  556


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             eEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            799999999999999999653 2359999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhh-----------h
Q psy13735        162 KNGRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTY-----------S  228 (792)
Q Consensus       162 ~~~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~-----------e  228 (792)
                      .....  ......||+.|+|||++.+.       .++.++|||||||++|+|++|..||.........           .
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDN-------IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS  251 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHC-------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccC-------CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence            43321  22334688899999999743       5788999999999999999999999654322110           0


Q ss_pred             hhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        229 SILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       229 kIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+... .......+....+++.+.+|+..||. ||.+|||+.+++.|
T Consensus       252 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          252 RLLEL-LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHH-hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00000 00112223334789999999999999 99999999999544

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.4e-41  Score=347.39  Aligned_cols=247  Identities=19%  Similarity=0.313  Sum_probs=204.4

Q ss_pred             CCCCCceEEe-EeeecCceEEEEEEE--ecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKR-FIQQGNFGDIYLVEE--KQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k-~IGsGsFGtVyla~~--k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      +...+|.+.+ .||+|+||.||+|.+  ..+++.||+|++.......      ..|+.++..++||||+++++++ ..+.
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            4456799998 999999999999954  5678999999997654322      4688999999999999999999 5677


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+||||++||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             cEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            8999999999999999965  34599999999999999999999999999999999999999999999999999987754


Q ss_pred             CCCcc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        163 NGRIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       163 ~~~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      .....  .....|++.|+|||++...       .++.++|||||||++|+|++ |..||.+.+.......+...   ...
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~  239 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYY-------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERM  239 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHC-------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCC
T ss_pred             CCCcccccccCCCCceeeChHHhccC-------CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCC
Confidence            43221  1223467899999999743       57889999999999999999 99999988877766666542   122


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+|.  .+++.+.+++..||. ||.+||++.+++.
T Consensus       240 ~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 GCPA--GCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3333  679999999999999 9999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=358.30  Aligned_cols=250  Identities=17%  Similarity=0.249  Sum_probs=201.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecC--------CcEEEEEEeccCCCChHHHHHHHHhcCCCCcce-------------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQS--------HNTFVMKKVLREKMPNTIERDIMVKSKCPYIVN-------------   72 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~t--------Gk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVk-------------   72 (792)
                      .++|.+.+.||+|+||.||+|.+..+        |+.||+|++... .....|+.++..++||||++             
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            47899999999999999999999884        889999998765 23478999999999999987             


Q ss_pred             --eEEEEEe-CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC--
Q psy13735         73 --LFYSFQD-MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG--  147 (792)
Q Consensus        73 --L~~vfed-e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg--  147 (792)
                        +++++.. ...+|+||||| ||+|.+++.....+.+++..+..++.||+.||.|||++||+||||||+|||++.++  
T Consensus       120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~  198 (352)
T 2jii_A          120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS  198 (352)
T ss_dssp             CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEE
T ss_pred             cchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCc
Confidence              6777776 78999999999 99999999765446799999999999999999999999999999999999999998  


Q ss_pred             ceEEeccCcccccccCCCc------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC
Q psy13735        148 HLKLTDFGSATQVDKNGRI------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE  221 (792)
Q Consensus       148 ~VKLiDFGLA~~l~~~~~~------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~  221 (792)
                      .+||+|||++.........      ......||+.|+|||++.+       ..++.++|||||||++|+|++|..||...
T Consensus       199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-------CGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            8999999999876532211      1133479999999999863       36899999999999999999999999765


Q ss_pred             C--hhhhhhhhhcccCCCCcC----CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        222 T--LDMTYSSILACDTEDTVS----FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       222 d--~~el~ekIl~~~~~~~l~----fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .  ............ .....    ...+..+++.+.+|+..||. ||.+||++.+++.
T Consensus       272 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFV-DKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHH-HSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CcCHHHHHHHHHhcc-CChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            3  222222221100 01111    11223578999999999999 9999999999854

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-41  Score=347.11  Aligned_cols=250  Identities=18%  Similarity=0.272  Sum_probs=199.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-CCc--EEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-SHN--TFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-tGk--~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|++++.||+|+||.||+|.+.. ++.  .||+|++.......       ..|..++..++||||+++++++.+..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            456789999999999999999998754 333  68999987654322       46889999999999999999998765


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                       .++||||+++|+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             -ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence             89999999999999999653 3458999999999999999999999999999999999999999999999999998775


Q ss_pred             cCCCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        162 KNGRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       162 ~~~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      .....  ......||+.|+|||++...       .++.++|||||||++|+|++ |..||.+.+.......+..    ..
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----~~  241 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTR-------TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----EG  241 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHC-------EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----SC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCC-------CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc----cC
Confidence            43321  12234588899999999743       57889999999999999999 9999998888777777755    22


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..++....+++.+.+++..||. ||.+||++.+++.+
T Consensus       242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            2334444789999999999999 99999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.3e-40  Score=343.68  Aligned_cols=247  Identities=19%  Similarity=0.271  Sum_probs=200.3

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEE-EeCCEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSF-QDMNHVY   84 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vf-ede~~ly   84 (792)
                      ...|.+.+.||+|+||.||+|.+..+   +..+|+|.+.......     ..|..++++++||||+++++++ ..++..|
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            44689999999999999999987543   3468999887644322     4688999999999999999985 5567889


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||+||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       104 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            99999999999999965 34568999999999999999999999999999999999999999999999999998664322


Q ss_pred             C---cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        165 R---IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       165 ~---~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      .   .......||+.|+|||++...       .++.++|||||||++|+|++ |.+||...+.......+...   ....
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~  252 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQ-------KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLL  252 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT---CCCC
T ss_pred             hhccccccCCCCCccccChHHhcCC-------CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC---CCCC
Confidence            1   112234578899999999743       68899999999999999999 77788776666655555441   1112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .|  ..+++.+.+++..||. ||.+||++.+++.
T Consensus       253 ~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          253 QP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC--ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            22  3678999999999999 9999999999865

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=352.77  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=186.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcC-CCCcceeEEEEE--------e
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSK-CPYIVNLFYSFQ--------D   79 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~-HPNIVkL~~vfe--------d   79 (792)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++.......    ..|..++..+. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457999999999999999999999999999999986553322    56888899996 999999999994        4


Q ss_pred             CCEEEEEEeccCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeCCCCceEEeccCc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLEN-QPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLSATGHLKLTDFGS  156 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r-~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd~dg~VKLiDFGL  156 (792)
                      ...+|+|||||. |+|.+++.. ...+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            456899999995 789888854 23456999999999999999999999999  99999999999999999999999999


Q ss_pred             ccccccCCCc-----------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh
Q psy13735        157 ATQVDKNGRI-----------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM  225 (792)
Q Consensus       157 A~~l~~~~~~-----------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e  225 (792)
                      +.........           .....+||+.|+|||++...    ....++.++|||||||++|+|++|..||.......
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY----SNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CC----TTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhcc----ccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            9876543221           11134699999999998421    23468889999999999999999999997654433


Q ss_pred             hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCC
Q psy13735        226 TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPV  276 (792)
Q Consensus       226 l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPw  276 (792)
                      ...        .....+.....++.+.+|+..||. ||.+||++.+++.|.+
T Consensus       261 ~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          261 IVN--------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hhc--------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            222        222334444667889999999999 9999999999998743

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=369.68  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC--EE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN--HV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~--~l   83 (792)
                      ....+.|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..|+.+++.++||||+++++++....  .+
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            345678999999999999999999999999999999997644322     47999999999999999999998765  78


Q ss_pred             EEEEeccCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe----CCCCceEEeccCccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQP-HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL----SATGHLKLTDFGSAT  158 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~-~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL----d~dg~VKLiDFGLA~  158 (792)
                      |+|||||+||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++.
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999999995432 2239999999999999999999999999999999999999    777889999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCC-CCCCCCcccccccchhhHHHhhcCCCCCCCCCh----hhhhhhhhcc
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNH-GSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL----DMTYSSILAC  233 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~-~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~----~el~ekIl~~  233 (792)
                      ......  .....+||+.|+|||++....... ....++.++|||||||++|+|++|..||.....    ......+...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            765432  233457999999999986420000 012577899999999999999999999964322    2233333221


Q ss_pred             cCCC---------------CcCCCC----CccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        234 DTED---------------TVSFPS----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       234 ~~~~---------------~l~fP~----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ....               ...+|.    ...++..+.+++..||. ||.+||++.+++.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            1100               001121    13467789999999999 9999999998743

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=356.86  Aligned_cols=269  Identities=18%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             HhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHH--hcCCCCcceeEEEEEe----
Q psy13735          7 LRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMV--KSKCPYIVNLFYSFQD----   79 (792)
Q Consensus         7 L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~--kL~HPNIVkL~~vfed----   79 (792)
                      .....+..++|.+++.||+|+||.||++..  +|+.||+|++....... ..|.+++.  .++||||+++++.+..    
T Consensus         5 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             ----CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             ccCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            345578899999999999999999999965  68999999997554322 34455543  4789999999986543    


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCceEeCCCCce
Q psy13735         80 -MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL---------GYVHRDIKPDNMLLSATGHL  149 (792)
Q Consensus        80 -e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~---------gIVHRDLKPeNILLd~dg~V  149 (792)
                       ...+|+|||||+||+|.+++....   +++..+..++.||+.||.|||+.         ||+||||||+|||++.++.+
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence             336899999999999999996543   58999999999999999999999         99999999999999999999


Q ss_pred             EEeccCcccccccCC-------CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC
Q psy13735        150 KLTDFGSATQVDKNG-------RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET  222 (792)
Q Consensus       150 KLiDFGLA~~l~~~~-------~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d  222 (792)
                      ||+|||++..+....       .......+||+.|+|||++.+.........++.++|||||||++|+|++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998764321       1122344799999999999631000001246678999999999999999977664322


Q ss_pred             hhhhhhhhh----------------cccCCCCcCCC----CCccccHHHHHHHHHHhh-ChhhcCChhHH------hcCC
Q psy13735        223 LDMTYSSIL----------------ACDTEDTVSFP----SSIRLSTAMVNFVQSLVQ-KLDARLNMDQV------LGHP  275 (792)
Q Consensus       223 ~~el~ekIl----------------~~~~~~~l~fP----~~~~lS~elkdLIk~LL~-DP~kRPTaeEI------L~HP  275 (792)
                      ....+....                .........+|    .....++.+.+||.+||. ||.+|||+.++      +.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            211110000                00011112222    223467789999999999 99999999998      5678


Q ss_pred             CccCC
Q psy13735        276 VFDCL  280 (792)
Q Consensus       276 wF~~i  280 (792)
                      |-++-
T Consensus       320 ~~~~~  324 (336)
T 3g2f_A          320 WERNK  324 (336)
T ss_dssp             CCC--
T ss_pred             HHhcc
Confidence            87753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.2e-41  Score=372.57  Aligned_cols=254  Identities=19%  Similarity=0.353  Sum_probs=207.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|.+.+.||+|+||.||++.+.. +..||+|++.......   ..|+.++++++||||+++++++.+ ..+|+|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            455689999999999999999999875 4679999998765443   579999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||+||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  338 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  338 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence            99999999999643335589999999999999999999999999999999999999999999999999987654322222


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....|++.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+.......+...     ...+....+
T Consensus       339 ~~~~~~~~y~aPE~~~~-------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~  406 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPEC  406 (452)
T ss_dssp             ----CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTS
T ss_pred             cCCcccccccCHhHHhc-------CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCC
Confidence            33457889999999974       368999999999999999999 99999988877777666541     222333478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc--CCCccC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG--HPVFDC  279 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~--HPwF~~  279 (792)
                      ++.+.+++..|+. ||.+|||+.+++.  ..+|..
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            9999999999999 9999999999865  355543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=360.39  Aligned_cols=246  Identities=15%  Similarity=0.203  Sum_probs=197.0

Q ss_pred             CCCCCceEEeEeeecCceEEEEE-----EEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC---CCCcceeEEEEEeCCE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLV-----EEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK---CPYIVNLFYSFQDMNH   82 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla-----~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~---HPNIVkL~~vfede~~   82 (792)
                      +..++|.+.+.||+|+||.||+|     .+..+++.||+|++....... ..|..++..+.   |+||+.+++++...+.
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            45578999999999999999999     467789999999997654322 56778888887   9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-----------CCc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQ---PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-----------TGH  148 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~---~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-----------dg~  148 (792)
                      .|||||||+||+|.+++...   ..+.+++..++.|+.||+.||.|||++||+||||||+||||+.           ++.
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence            99999999999999999642   3456999999999999999999999999999999999999988           899


Q ss_pred             eEEeccCcccccccC-CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhh
Q psy13735        149 LKLTDFGSATQVDKN-GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTY  227 (792)
Q Consensus       149 VKLiDFGLA~~l~~~-~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~  227 (792)
                      +||+|||+|...... ........+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.........
T Consensus       222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-------KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-------CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-------CCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence            999999999765422 2223445689999999999973       35899999999999999999999999644322110


Q ss_pred             hhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        228 SSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       228 ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        +.       ..++. ...++.+.+++..||. +|.+|++..+.+.+
T Consensus       295 --~~-------~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          295 --PE-------GLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             --EC-------SCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             --ec-------hhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence              10       01111 1347889999999999 99998765554444

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-41  Score=349.40  Aligned_cols=248  Identities=20%  Similarity=0.294  Sum_probs=192.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhc--CCCCcceeEEEEEeC----CEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKS--KCPYIVNLFYSFQDM----NHVYFI   86 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL--~HPNIVkL~~vfede----~~lyLV   86 (792)
                      .++|++.+.||+|+||.||+|.+.  |..||+|++....... ..|.+++..+  +||||+++++++...    ..+|+|
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            458999999999999999999875  8999999986543322 4566666554  899999999999887    789999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL--------GYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~--------gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      ||||+||+|.+++...   .+++..+..++.||+.||.|||++        ||+||||||+|||++.++.+||+|||++.
T Consensus       114 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          114 TDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             ECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            9999999999999653   499999999999999999999999        99999999999999999999999999997


Q ss_pred             ccccCCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCc------ccccccchhhHHHhhcC----------CCCCC
Q psy13735        159 QVDKNGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTG------SCDLWSIGVVSYELLTG----------STPFN  219 (792)
Q Consensus       159 ~l~~~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~------ksDIWSLGVILYELLTG----------k~PF~  219 (792)
                      ........   .....+||+.|+|||++...       .++.      ++|||||||++|+|++|          ..||.
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDES-------LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTC-------CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccc-------cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            76533221   12245799999999999632       2333      48999999999999999          66665


Q ss_pred             CCChhh----hhhhhhcccCCCCcCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        220 YETLDM----TYSSILACDTEDTVSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       220 ~~d~~e----l~ekIl~~~~~~~l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ......    ....... .......+|.   ...+++.+.+|+..||. ||.+|||+.+++.|
T Consensus       264 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVC-IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTSCSSCCHHHHHHHHT-TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcCCCCchhhhHHHHh-hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            432211    1111111 0111122222   13567889999999999 99999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=359.58  Aligned_cols=253  Identities=19%  Similarity=0.222  Sum_probs=194.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec---CCcEEEEEEeccCCCCh---------------HHHHHHHHhcCCCCccee
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ---SHNTFVMKKVLREKMPN---------------TIERDIMVKSKCPYIVNL   73 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~---tGk~vAVKiI~Ks~~~~---------------~~E~eIL~kL~HPNIVkL   73 (792)
                      +..++|.+.+.||+|+||.||+|.+..   ++..+|+|++.......               ..|..++..++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            445789999999999999999999987   88999999998664322               245566777899999999


Q ss_pred             EEEEEe----CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC--
Q psy13735         74 FYSFQD----MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG--  147 (792)
Q Consensus        74 ~~vfed----e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg--  147 (792)
                      ++++.+    ...+|+||||| ||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++  
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            999988    78899999999 9999999954  34699999999999999999999999999999999999998877  


Q ss_pred             ceEEeccCcccccccCCC------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCC
Q psy13735        148 HLKLTDFGSATQVDKNGR------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYE  221 (792)
Q Consensus       148 ~VKLiDFGLA~~l~~~~~------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~  221 (792)
                      .+||+|||+++.+.....      ......+||+.|+|||++.+       ..++.++|||||||++|+|++|..||...
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-------VALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            999999999987643211      11234579999999999973       36899999999999999999999999653


Q ss_pred             Chh--hhhhhhhcccCCCC---cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        222 TLD--MTYSSILACDTEDT---VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       222 d~~--el~ekIl~~~~~~~---l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...  ..............   ........+++.+.+++..||. ||.+||++.+++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          264 LKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             TTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             ccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            221  11111111000000   0011112678999999999999 99999999998653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.5e-41  Score=360.28  Aligned_cols=252  Identities=21%  Similarity=0.265  Sum_probs=196.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecC-----CcEEEEEEeccCCCChHHH---------------HHHHHhcCCCCcc
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQS-----HNTFVMKKVLREKMPNTIE---------------RDIMVKSKCPYIV   71 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~t-----Gk~vAVKiI~Ks~~~~~~E---------------~eIL~kL~HPNIV   71 (792)
                      ...++|.+++.||+|+||.||+|.+..+     ++.||+|++.........|               ..++..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3456899999999999999999998765     5889999987654332333               3344566799999


Q ss_pred             eeEEEEEeC----CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC--C
Q psy13735         72 NLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS--A  145 (792)
Q Consensus        72 kL~~vfede----~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd--~  145 (792)
                      ++++++...    ..+||||||| ||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++  .
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            999999765    5689999999 99999999763 35699999999999999999999999999999999999998  8


Q ss_pred             CCceEEeccCcccccccCCCc------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCC
Q psy13735        146 TGHLKLTDFGSATQVDKNGRI------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       146 dg~VKLiDFGLA~~l~~~~~~------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~  219 (792)
                      ++.+||+|||+++.+......      .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-------VAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-------CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            899999999999876532211      1133469999999999963       368999999999999999999999998


Q ss_pred             CCChhhhhhhhhcccCCCC------cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        220 YETLDMTYSSILACDTEDT------VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       220 ~~d~~el~ekIl~~~~~~~------l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +......+...........      ..++ ...+++.+.+|+..|+. +|.+||++.+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          263 DNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             GGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            6443322221111000000      0011 13568999999999999 9999999998853

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.4e-40  Score=343.21  Aligned_cols=248  Identities=23%  Similarity=0.254  Sum_probs=199.5

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---h-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---N-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      |..++.||+|+||.||+|.+  +|..||+|++......   .     ..|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44458999999999999975  6889999998754321   1     468899999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc-
Q psy13735         89 YVTGGDFVTLLENQ-PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-  166 (792)
Q Consensus        89 y~~GGsL~dlL~r~-~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-  166 (792)
                      |++||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... 
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            99999999999642 2345899999999999999999999999999999999999999999999999999876543221 


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC---------
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED---------  237 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~---------  237 (792)
                      ......||+.|+|||++.+        .++.++|||||||++|+|++|.+||...........+.......         
T Consensus       191 ~~~~~~g~~~y~aPE~~~~--------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRG--------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID  262 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTT--------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC
T ss_pred             cccccCCCcCcCChHHhcC--------CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc
Confidence            2234579999999999852        47889999999999999999999998765444333332110000         


Q ss_pred             CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        238 TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       238 ~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ....+.....++.+.+++..||. ||.+||++.+++.+
T Consensus       263 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          263 KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00011123557889999999999 99999999999764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4e-40  Score=346.10  Aligned_cols=247  Identities=21%  Similarity=0.325  Sum_probs=199.4

Q ss_pred             CCCCc-eEEeEeeecCceEEEEEEE----ecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEe--C
Q psy13735         13 SASDF-DIKRFIQQGNFGDIYLVEE----KQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQD--M   80 (792)
Q Consensus        13 ~l~dY-~I~k~IGsGsFGtVyla~~----k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfed--e   80 (792)
                      ...+| ++++.||+|+||.||++..    ..+|+.||+|++.......     ..|+.+++.++||||+++++++.+  .
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            33445 9999999999999988754    4588999999998664322     578999999999999999999988  4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ..+|+|||||+||+|.+++.+.   .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            6899999999999999999553   3999999999999999999999999999999999999999999999999999877


Q ss_pred             ccCCCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhh-------------
Q psy13735        161 DKNGRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDM-------------  225 (792)
Q Consensus       161 ~~~~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~e-------------  225 (792)
                      ......  ......||+.|+|||++...       .++.++|||||||++|+|++|..||.......             
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEY-------KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV  257 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHC-------EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCC-------CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence            543321  12334688899999999743       57889999999999999999999996532210             


Q ss_pred             -hhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        226 -TYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       226 -l~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                       .......    .....+....+++.+.+||..||. ||.+|||+.+++.
T Consensus       258 ~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          258 LRLTELLE----RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHh----cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             0011111    112233334789999999999999 9999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=345.52  Aligned_cols=258  Identities=17%  Similarity=0.274  Sum_probs=206.7

Q ss_pred             hcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735          8 RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus         8 ~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      ....+..++|.+.+.||+|+||.||+|.+..   .+|+|++.......      ..|+.++..++||||+++++++.+..
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            4556788999999999999999999998764   48999987543321      56888999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            999999999999999999542 34689999999999999999999999999999999999997 7899999999987653


Q ss_pred             cCC----CcccccCCCCCCccChhhhhhhccC--CCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC
Q psy13735        162 KNG----RIKSIVPVGTPEYVAPEVLEWMEGN--HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT  235 (792)
Q Consensus       162 ~~~----~~~s~t~vGTp~Y~APEiL~~~~~~--~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~  235 (792)
                      ...    ........||+.|+|||++......  .....++.++|||||||++|+|++|..||...+.......+...  
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--  258 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG--  258 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT--
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC--
Confidence            211    1122334699999999999642111  01345788999999999999999999999988877766666542  


Q ss_pred             CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        236 EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       236 ~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        .........++..+.+++..||. ||.+|||+.+++..
T Consensus       259 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          259 --MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             --CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             --CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence              11112223578899999999999 99999999999763

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=341.10  Aligned_cols=243  Identities=24%  Similarity=0.456  Sum_probs=192.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      +..++|++.+.||+|+||.||++.+.  ++.||+|.+.......  ..|..++.+++||||+++++++.+  ..|+||||
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            46678999999999999999999874  7899999986543222  578899999999999999998874  47999999


Q ss_pred             cCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCCceEeCCCCc-eEEeccCcccccccCC
Q psy13735         90 VTGGDFVTLLENQPH-GYLSESKARFYIYELAQAVQYLHG---LGYVHRDIKPDNMLLSATGH-LKLTDFGSATQVDKNG  164 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~-g~LSE~ea~~Im~QILsAL~YLHs---~gIVHRDLKPeNILLd~dg~-VKLiDFGLA~~l~~~~  164 (792)
                      |+||+|.+++..... ..++...+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            999999999965332 247899999999999999999999   89999999999999998887 799999999765432 


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh--hhhhhhhcccCCCCcCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD--MTYSSILACDTEDTVSFP  242 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~--el~ekIl~~~~~~~l~fP  242 (792)
                         .....||+.|+|||++..       ..++.++|||||||++|+|++|..||......  .....+..   .....+ 
T Consensus       160 ---~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~-  225 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEG-------SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN---GTRPPL-  225 (307)
T ss_dssp             --------CCTTSSCHHHHTC-------CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT---TCCCCC-
T ss_pred             ---cccCCCCCceEChhhhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc---CCCCCc-
Confidence               123459999999999863       36889999999999999999999999754322  12222221   111222 


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                       ...+++.+.+++.+||. ||.+|||+.+++.+
T Consensus       226 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             -BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -ccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence             23679999999999999 99999999999763

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.1e-40  Score=373.82  Aligned_cols=253  Identities=19%  Similarity=0.354  Sum_probs=211.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|.+.+.||+|+||.||++.+.. +..||+|++.......   ..|+.+|+.++|||||++++++.+ ..+|||||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            455689999999999999999999875 4679999998765443   579999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...........
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence            99999999999643334589999999999999999999999999999999999999999999999999987643211122


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+++.|+|||++..       ..++.++|||||||++|+|++ |..||.+.........+...     ...+....+
T Consensus       422 ~~~~~~~~y~aPE~~~~-------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-----~~~~~~~~~  489 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----YRMPCPPEC  489 (535)
T ss_dssp             CSTTSCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-----CCCCCCTTC
T ss_pred             cCCcCcccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCC
Confidence            23357789999999974       368999999999999999999 99999988877777666541     222333478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcC--CCcc
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGH--PVFD  278 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~H--PwF~  278 (792)
                      ++.+.+||..||. ||.+|||+.+++..  .+|.
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            9999999999999 99999999998653  4554

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.8e-40  Score=344.11  Aligned_cols=256  Identities=18%  Similarity=0.290  Sum_probs=203.0

Q ss_pred             cCCCCCCCceEEeEeeecCceEEEEEE----EecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeC
Q psy13735          9 QKNVSASDFDIKRFIQQGNFGDIYLVE----EKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDM   80 (792)
Q Consensus         9 rk~l~l~dY~I~k~IGsGsFGtVyla~----~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede   80 (792)
                      ...+...+|++++.||+|+||.||+|.    +..+|..||+|++.......    ..|+.+++.++||||+++++++...
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            345667789999999999999999998    46689999999997654322    5789999999999999999998765


Q ss_pred             C--EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         81 N--HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        81 ~--~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      +  .+++||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            4  789999999999999999764 3459999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh------------
Q psy13735        159 QVDKNGRIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD------------  224 (792)
Q Consensus       159 ~l~~~~~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~------------  224 (792)
                      .........  .....|++.|+|||++...       .++.++|||||||++|+|++|..||......            
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTES-------KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ  266 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHC-------EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred             hccccccccccccCCCCceeEECchhhcCC-------CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence            775443211  2233578889999999743       5788999999999999999999998643111            


Q ss_pred             hhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        225 MTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       225 el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .....+.... ......+....+++.+.++|..||. ||.+|||+.+++.
T Consensus       267 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          267 MIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHh-hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0000010000 0111223334789999999999999 9999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-40  Score=354.80  Aligned_cols=246  Identities=19%  Similarity=0.264  Sum_probs=193.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCC---cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEE-eCCEEEEE
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSH---NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQ-DMNHVYFI   86 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tG---k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfe-de~~lyLV   86 (792)
                      .|.+.+.||+|+||.||+|....++   ..+|+|.+.......     ..|..++.+++||||+++++++. ..+..|+|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            5788999999999999999986543   468999886544332     46888899999999999999864 55688999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||||+||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            999999999999965 3355899999999999999999999999999999999999999999999999999866432211


Q ss_pred             ---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        167 ---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       167 ---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                         ......||+.|+|||++..       ..++.++|||||||++|+|++ |.+||...+.......+...   .....|
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~---~~~~~p  318 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLLQP  318 (373)
T ss_dssp             ---------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---CCCCCC
T ss_pred             cccccCCCCCcccccChHHhcC-------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---CCCCCC
Confidence               1123357889999999974       368999999999999999999 78899877666655555441   112223


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        ..+++.+.+++..|+. ||.+||++.+++.+
T Consensus       319 --~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          319 --EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              3678999999999999 99999999998754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.5e-39  Score=341.59  Aligned_cols=252  Identities=18%  Similarity=0.241  Sum_probs=198.7

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHh--cCCCCcceeEEEEEeCC----EEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVK--SKCPYIVNLFYSFQDMN----HVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~k--L~HPNIVkL~~vfede~----~lyLVm   87 (792)
                      ++|.+.+.||+|+||.||++.+  +|+.||+|++....... ..|.+++..  ++||||+++++++....    .+|+||
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence            5799999999999999999987  58999999997543322 567888887  78999999999998876    899999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH--------GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH--------s~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ||++||+|.+++.+.   .+++..++.++.||+.||.|||        +.||+||||||+|||++.++.+||+|||++..
T Consensus       120 e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  196 (342)
T 1b6c_B          120 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  196 (342)
T ss_dssp             CCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence            999999999999653   4899999999999999999999        89999999999999999999999999999987


Q ss_pred             cccCCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC----------CCCCCCCCh---
Q psy13735        160 VDKNGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG----------STPFNYETL---  223 (792)
Q Consensus       160 l~~~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG----------k~PF~~~d~---  223 (792)
                      .......   .....+||+.|+|||++..... .....++.++|||||||++|+|++|          ..||.....   
T Consensus       197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  275 (342)
T 1b6c_B          197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  275 (342)
T ss_dssp             EETTTTEEEECCCSCCCCGGGCCHHHHTSCCC-TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ccccccccccccccCCcCcccCCHhhhccccc-ccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence            6544321   2234579999999999863200 0000233689999999999999999          788865432   


Q ss_pred             --hhhhhhhhcccCCCCcCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        224 --DMTYSSILACDTEDTVSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       224 --~el~ekIl~~~~~~~l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        ......+..  ......+|.   ....++.+.+++..||. ||.+|||+.+++.|
T Consensus       276 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          276 SVEEMRKVVCE--QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CHHHHHHHHTT--SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHH--HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence              222222222  111122222   12456789999999999 99999999999865

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-41  Score=358.34  Aligned_cols=243  Identities=14%  Similarity=0.209  Sum_probs=190.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----------h--HHHHHHHHhcC---------CCCc
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----------N--TIERDIMVKSK---------CPYI   70 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----------~--~~E~eIL~kL~---------HPNI   70 (792)
                      +..++|.+++.||+|+||.||+|++  +|+.||+|++.+....          .  ..|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3456899999999999999999987  6899999999876432          1  57888888875         7777


Q ss_pred             ceeEEEEE-----------------e-------------CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHH
Q psy13735         71 VNLFYSFQ-----------------D-------------MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELA  120 (792)
Q Consensus        71 VkL~~vfe-----------------d-------------e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QIL  120 (792)
                      |++.+++.                 +             .+.+|||||||+||++.+.+.+   +.+++..++.++.||+
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT  171 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence            77766643                 2             6889999999999987777632   4589999999999999


Q ss_pred             HHHHHHH-hCCCccCCCCCCceEeCCCC--------------------ceEEeccCcccccccCCCcccccCCCCCCccC
Q psy13735        121 QAVQYLH-GLGYVHRDIKPDNMLLSATG--------------------HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA  179 (792)
Q Consensus       121 sAL~YLH-s~gIVHRDLKPeNILLd~dg--------------------~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~A  179 (792)
                      .||.||| ++||+||||||+|||++.+|                    .+||+|||+|+.....      ..+||+.|+|
T Consensus       172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a  245 (336)
T 2vuw_A          172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred             HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence            9999999 99999999999999999887                    8999999999876532      3369999999


Q ss_pred             hhhhhhhccCCCCCCCCcccccccchhh-HHHhhcCCCCCCCCCh-hhhhhhhhcc-cCCCCcCCCCCccccHHHHHHHH
Q psy13735        180 PEVLEWMEGNHGSDGYTGSCDLWSIGVV-SYELLTGSTPFNYETL-DMTYSSILAC-DTEDTVSFPSSIRLSTAMVNFVQ  256 (792)
Q Consensus       180 PEiL~~~~~~~~~~~ys~ksDIWSLGVI-LYELLTGk~PF~~~d~-~el~ekIl~~-~~~~~l~fP~~~~lS~elkdLIk  256 (792)
                      ||++.+        ..+.++||||+|++ .+++++|..||..... ......+... ........+....+|+++.+||.
T Consensus       246 PE~~~g--------~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          246 EDLFTG--------DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             SGGGCC--------CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred             hhhhcC--------CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHH
Confidence            999963        23789999998766 8889999999953211 1122222211 11111111112368999999999


Q ss_pred             HHhh-ChhhcCChhHHh-cCCCcc
Q psy13735        257 SLVQ-KLDARLNMDQVL-GHPVFD  278 (792)
Q Consensus       257 ~LL~-DP~kRPTaeEIL-~HPwF~  278 (792)
                      +||. |     |+.++| +||||+
T Consensus       318 ~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          318 TMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHhccC-----CHHHHHhcCCCcC
Confidence            9999 5     999999 999995

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=371.19  Aligned_cols=252  Identities=20%  Similarity=0.319  Sum_probs=205.3

Q ss_pred             CCCCceEEe-EeeecCceEEEEEEEec--CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         13 SASDFDIKR-FIQQGNFGDIYLVEEKQ--SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        13 ~l~dY~I~k-~IGsGsFGtVyla~~k~--tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ..++|.+.+ .||+|+||.||+|.++.  ++..||+|++.......     ..|+.++..++|||||++++++.+ +.+|
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            345566666 89999999999998764  56679999997653322     579999999999999999999986 5699


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      ||||||.||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus       412 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999999999999999543 4569999999999999999999999999999999999999999999999999998765332


Q ss_pred             Ccc--cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        165 RIK--SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       165 ~~~--s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ...  .....+++.|+|||++..       ..++.++|||||||++|+|++ |..||.+.+.......+...   ....+
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~-------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~---~~~~~  560 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMEC  560 (613)
T ss_dssp             -----------CCTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT---CCCCC
T ss_pred             ceeeeccCCCCccceeCHhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCC
Confidence            211  122346789999999974       368999999999999999998 99999988877777776542   22333


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHH---hcCCCcc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQV---LGHPVFD  278 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEI---L~HPwF~  278 (792)
                      |.  .+++.+.++|..|+. ||.+||++.++   |.+.|+.
T Consensus       561 p~--~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          561 PP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CT--TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CC--cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            43  689999999999999 99999999987   5555554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.8e-40  Score=358.75  Aligned_cols=251  Identities=16%  Similarity=0.200  Sum_probs=194.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCC-CCc---------------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKC-PYI---------------   70 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~H-PNI---------------   70 (792)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++.......       ..|..++..+.| +|.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345889999999999999999999999999999987443332       467788888876 211               


Q ss_pred             ------ceeEEEEEe-----CCEEEEEEeccCCCCHHHHHH-----hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q psy13735         71 ------VNLFYSFQD-----MNHVYFIMEYVTGGDFVTLLE-----NQPHGYLSESKARFYIYELAQAVQYLHGLGYVHR  134 (792)
Q Consensus        71 ------VkL~~vfed-----e~~lyLVmEy~~GGsL~dlL~-----r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHR  134 (792)
                            ..+..++..     ...++++|+++ +|+|.+++.     ....+.+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  111122222     22467888877 789999884     2234557888999999999999999999999999


Q ss_pred             CCCCCceEeCCCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccC---CCCCCCCcccccccchhhHHHh
Q psy13735        135 DIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN---HGSDGYTGSCDLWSIGVVSYEL  211 (792)
Q Consensus       135 DLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~---~~~~~ys~ksDIWSLGVILYEL  211 (792)
                      ||||+||||+.++.+||+|||+++.....    ....+| +.|+|||++......   +....++.++|||||||++|+|
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            99999999999999999999998875432    345578 999999999532100   0233578899999999999999


Q ss_pred             hcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        212 LTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       212 LTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ++|+.||...+.......+..          ....+++.+.+||..||. ||.+||++.+++.||||+.+
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIFR----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGGS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHCCCCCCCcchhhhHHHHHh----------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            999999987766555554433          222568999999999999 99999999999999999854

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.1e-39  Score=373.04  Aligned_cols=238  Identities=19%  Similarity=0.325  Sum_probs=197.8

Q ss_pred             eEeeecCceEEEEEEE--ecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEE--KQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~--k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.+  +.+++.||+|++.......      ..|+.++..++|||||++++++.+ ..+|||||||+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4899999999999955  4567899999997654322      579999999999999999999975 458999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc--cccc
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI--KSIV  170 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~--~s~t  170 (792)
                      |+|.+++..  .+.+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......  ....
T Consensus       454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence            999999965  456999999999999999999999999999999999999999999999999999876543221  1223


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ..||+.|+|||++...       .++.++|||||||++|+|++ |..||.+.+.......+...   ....+|.  .+++
T Consensus       532 ~~~t~~y~APE~~~~~-------~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~---~~~~~p~--~~~~  599 (635)
T 4fl3_A          532 GKWPVKWYAPECINYY-------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPA--GCPR  599 (635)
T ss_dssp             ---CGGGSCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCT--TCCH
T ss_pred             CCCceeeeChhhhcCC-------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCC--CCCH
Confidence            3578899999999743       68999999999999999998 99999988887777776552   1223333  6899


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      .+.+||..|+. ||.+||++.+++.
T Consensus       600 ~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          600 EMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999 9999999999854

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.9e-39  Score=373.25  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=205.7

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      .+..++|.+.+.||+|+||.||+|.+..+   +..+|+|.+.......     ..|+.++..++||||+++++++. ++.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            45567899999999999999999998654   4679999886543322     46889999999999999999985 456


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            89999999999999999753 34589999999999999999999999999999999999999999999999999987754


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ..........||+.|+|||++..       ..++.++|||||||++|+|++ |.+||.+.+.......+...   ....+
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~---~~~~~  613 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPM  613 (656)
T ss_dssp             ----------CCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---CCCCC
T ss_pred             CcceeccCCCCCcceeCHHHhcC-------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CCCCC
Confidence            43333334467889999999974       368999999999999999997 99999988887777777552   12233


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      |.  .+++.+.+++.+||. ||.+||++.+++.
T Consensus       614 ~~--~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          614 PP--NCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cc--cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            33  779999999999999 9999999999865

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.8e-40  Score=382.75  Aligned_cols=261  Identities=27%  Similarity=0.421  Sum_probs=204.8

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEe------C
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQD------M   80 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfed------e   80 (792)
                      ...++|.+.+.||+|+||.||+|.+..+|..||+|++.......     ..|+.++..++||||+++++++..      .
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            45689999999999999999999999999999999987643322     468999999999999999999765      6


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCc---eEEeccCc
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQP-HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGH---LKLTDFGS  156 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~-~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~---VKLiDFGL  156 (792)
                      +..|+|||||+||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            77899999999999999997533 235899999999999999999999999999999999999987765   99999999


Q ss_pred             ccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhc----
Q psy13735        157 ATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILA----  232 (792)
Q Consensus       157 A~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~----  232 (792)
                      +.......  .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+......+.....    
T Consensus       171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~-------~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          171 AKELDQGE--LCTEFVGTLQYLAPELLEQ-------KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN  241 (676)
T ss_dssp             CCBTTSCC--CCCCCCSCCTTCSSCSSCC-------SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred             cccccccc--ccccccCCcccCChHHhcc-------CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence            98775443  2234579999999999863       4689999999999999999999999976433221111100    


Q ss_pred             ------ccCCCCcCC------CC--CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        233 ------CDTEDTVSF------PS--SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       233 ------~~~~~~l~f------P~--~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                            ....+...+      |.  ...+++.+.+||..||. ||.+|||+.+++.||||..+.
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence                  000011111      11  23478999999999999 999999999999999998654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-38  Score=358.09  Aligned_cols=258  Identities=21%  Similarity=0.263  Sum_probs=208.0

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--hHHHHHHHHhcCC-CCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSKC-PYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--~~~E~eIL~kL~H-PNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..++|.+++.||+|+||.||+|.+..+|+.||||++......  ...|..++..+.| ++|+.+..++......||||||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            357899999999999999999999999999999988755433  3789999999986 6677777777888999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe---CCCCceEEeccCcccccccCCCc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL---SATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL---d~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      | ||+|.+++... .+.+++..++.|+.||+.||.|||++||+||||||+||||   +.++.+||+|||+++........
T Consensus        85 ~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             C-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            9 99999999753 3569999999999999999999999999999999999999   58889999999999876543221


Q ss_pred             ------ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCCh---hhhhhhhhcccCCC
Q psy13735        167 ------KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL---DMTYSSILACDTED  237 (792)
Q Consensus       167 ------~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~---~el~ekIl~~~~~~  237 (792)
                            .....+||+.|+|||++.+       ..++.++|||||||++|+|++|..||.+...   ...+..+.......
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLG-------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             cccccccccccCCCccccCHHHhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence                  1225579999999999974       3689999999999999999999999976543   23333332211000


Q ss_pred             C-cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHH----------hcCCCccCCC
Q psy13735        238 T-VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQV----------LGHPVFDCLD  281 (792)
Q Consensus       238 ~-l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEI----------L~HPwF~~i~  281 (792)
                      . ..++  ..+++++.+|+..|+. +|.+||++.++          ..|+|+..++
T Consensus       236 ~~~~l~--~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~d  289 (483)
T 3sv0_A          236 SIEALC--RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFD  289 (483)
T ss_dssp             CHHHHH--TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCH
T ss_pred             cHHHHh--cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcC
Confidence            0 0111  2568999999999999 99999999876          3567775543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.1e-39  Score=371.95  Aligned_cols=240  Identities=23%  Similarity=0.404  Sum_probs=198.4

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEec-CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCE-
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQ-SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNH-   82 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~-tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~-   82 (792)
                      ..+..++|.+.+.||+|+||.||++.+.. +|+.||+|++.......     ..|+.++..++|||||+++++|...+. 
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            34455899999999999999999999986 78999999987543322     468889999999999999999987665 


Q ss_pred             ----EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         83 ----VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        83 ----lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                          +|||||||+|++|.+++..    .+++..+..|+.||+.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence                7999999999999988732    59999999999999999999999999999999999999875 99999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      .....     ...+||+.|+|||++..        .++.++|||||||++|+|++|.+||.+......            
T Consensus       230 ~~~~~-----~~~~gt~~y~aPE~~~~--------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------  284 (681)
T 2pzi_A          230 RINSF-----GYLYGTPGFQAPEIVRT--------GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------  284 (681)
T ss_dssp             ETTCC-----SCCCCCTTTSCTTHHHH--------CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------
T ss_pred             hcccC-----CccCCCccccCHHHHcC--------CCCCceehhhhHHHHHHHHhCCCCCcccccccc------------
Confidence            76533     34569999999999863        358899999999999999999999865321110            


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      .........++.+.++|.+||. ||.+||+..+++.|+|+..
T Consensus       285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            0111112357889999999999 9999999999999999864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.3e-37  Score=320.00  Aligned_cols=222  Identities=13%  Similarity=0.103  Sum_probs=182.6

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      +..++|++.+.||+|+||.||+|.+..+|+.||+|++.......       ..|..++..++||||+++++++.+.+.+|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            34567999999999999999999999999999999998765432       56888899999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||+|++|.+++.+   + .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.        
T Consensus       108 lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~--------  175 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------  175 (286)
T ss_dssp             EEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred             EEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence            99999999999999943   2 46667899999999999999999999999999999999999999985432        


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC--
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP--  242 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP--  242 (792)
                                   ++              .++.++|||||||++|+|++|..||.+.+............. .....+  
T Consensus       176 -------------~~--------------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~  227 (286)
T 3uqc_A          176 -------------MP--------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIEPAD  227 (286)
T ss_dssp             -------------CT--------------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCCHHH
T ss_pred             -------------cC--------------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCChhh
Confidence                         22              367889999999999999999999987665433211111000 111111  


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ....+++.+.++|.+||. ||.+| |+.+++..
T Consensus       228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             cccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            013679999999999999 99999 99998653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.2e-33  Score=319.24  Aligned_cols=184  Identities=15%  Similarity=0.095  Sum_probs=134.9

Q ss_pred             eEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--------------HHHHHHHHhc-CCCCcceeEEEEEeCCEEEE
Q psy13735         21 RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--------------TIERDIMVKS-KCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--------------~~E~eIL~kL-~HPNIVkL~~vfede~~lyL   85 (792)
                      ..++.|++|.+..++..-.|+.||+|++.+.....              .+|+++|+++ .|+||++++++|++++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            34677888888888888899999999998764321              4689999999 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||||+||+|.++|.+  .+.+++.   .|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.......
T Consensus       320 VMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             EEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            9999999999999954  4567764   4899999999999999999999999999999999999999999987754332


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCC
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF  218 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF  218 (792)
                       ...+.+|||.|||||++.+        .+...+|+||+|+++|.|.+|..||
T Consensus       395 -~~~t~vGTp~YmAPE~l~g--------~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          395 -WPTNLVQSFFVFVNELFAE--------NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -CSHHHHHHHHHHHHHHC-------------------------CCCCTTHHHH
T ss_pred             -cccCceechhhccHHHhCC--------CCCCcccccccccchhhhccccchh
Confidence             3345689999999999963        4667899999999999998876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.3e-26  Score=264.58  Aligned_cols=181  Identities=18%  Similarity=0.237  Sum_probs=142.2

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------------~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      ..+.||+|+||.||++  ...+..+|+|.+.......            ..|+.++.+++||||+.+..++.+.+..|||
T Consensus       340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3569999999999999  4567889999876544321            4789999999999999666666677778999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||||+||+|.+++..          +..++.||+.||.|||++||+||||||+|||++.  ++||+|||+|+........
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            999999999999943          5689999999999999999999999999999988  9999999999987542211


Q ss_pred             c------cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCC
Q psy13735        167 K------SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF  218 (792)
Q Consensus       167 ~------s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF  218 (792)
                      .      ....+||+.|+|||++...     ...|+..+|+||.++-..+.+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~-----~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERF-----LEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHH-----HHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHH-----HHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1      1345799999999999753     125788899999988888877777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.3e-23  Score=220.52  Aligned_cols=138  Identities=16%  Similarity=0.174  Sum_probs=112.4

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC----------------------hHHHHHHHHhcCCCCcceeEE
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP----------------------NTIERDIMVKSKCPYIVNLFY   75 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~----------------------~~~E~eIL~kL~HPNIVkL~~   75 (792)
                      .+++.||+|+||.||+|.+ .+|+.||+|++......                      ...|..++..++|   +++++
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~  168 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK  168 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred             EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence            3449999999999999999 88999999999643221                      1478999999984   55555


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccC
Q psy13735         76 SFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFG  155 (792)
Q Consensus        76 vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFG  155 (792)
                      ++.. +..|+|||||+||+|.+ +.      .  ..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             EEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            5544 45699999999999998 51      1  23457999999999999999999999999999999 9999999999


Q ss_pred             cccccccCCCcccccCCCCCCccChhhhh
Q psy13735        156 SATQVDKNGRIKSIVPVGTPEYVAPEVLE  184 (792)
Q Consensus       156 LA~~l~~~~~~~s~t~vGTp~Y~APEiL~  184 (792)
                      +|..              +..+.|||++.
T Consensus       238 ~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          238 QSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TCEE--------------TTSTTHHHHHH
T ss_pred             CCeE--------------CCCCCHHHHHH
Confidence            9863              44578999885

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=5.5e-20  Score=189.68  Aligned_cols=134  Identities=16%  Similarity=0.190  Sum_probs=107.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcE--EEEEEeccCCCC----------------------------hHHHHHHHHhc
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNT--FVMKKVLREKMP----------------------------NTIERDIMVKS   65 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~--vAVKiI~Ks~~~----------------------------~~~E~eIL~kL   65 (792)
                      -|.+.+.||+|+||.||+|.+..+|..  ||+|++......                            ...|..++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378999999999999999999888999  999987543211                            14688889999


Q ss_pred             CCCCc--ceeEEEEEeCCEEEEEEeccCC-C----CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCC
Q psy13735         66 KCPYI--VNLFYSFQDMNHVYFIMEYVTG-G----DFVTLLENQPHGYLSESKARFYIYELAQAVQYLH-GLGYVHRDIK  137 (792)
Q Consensus        66 ~HPNI--VkL~~vfede~~lyLVmEy~~G-G----sL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH-s~gIVHRDLK  137 (792)
                      .|+++  +.++++    ...|||||||.+ |    +|.++...     +++..+..++.||+.||.||| +.||+|||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk  198 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS  198 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence            88754  444432    246899999942 3    67766522     345678899999999999999 9999999999


Q ss_pred             CCceEeCCCCceEEeccCccccc
Q psy13735        138 PDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus       138 PeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=1.2e-16  Score=176.87  Aligned_cols=133  Identities=16%  Similarity=0.101  Sum_probs=97.6

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC---------------h-----------HHHHHHHHhcCCCCc
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP---------------N-----------TIERDIMVKSKCPYI   70 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~---------------~-----------~~E~eIL~kL~HPNI   70 (792)
                      |.++..||.|+||.||+|.+. +|+.||+|++......               .           ..|...|.++.++++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            999999999999999999875 6999999987532110               0           124455555544443


Q ss_pred             ceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC---
Q psy13735         71 VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG---  147 (792)
Q Consensus        71 VkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg---  147 (792)
                      .-..-+....  .+|||||++|++|..+.        ..+.+..++.||+.+|.+||++|||||||||.|||++.+|   
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            2221121222  27999999998886543        1123567889999999999999999999999999998776   


Q ss_pred             -------ceEEeccCccccc
Q psy13735        148 -------HLKLTDFGSATQV  160 (792)
Q Consensus       148 -------~VKLiDFGLA~~l  160 (792)
                             .+.|+||+-+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3899999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=3e-12  Score=130.12  Aligned_cols=137  Identities=13%  Similarity=0.147  Sum_probs=111.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccC----CCChHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLRE----KMPNTIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks----~~~~~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +.+|.+...+|.|+++.||++...  |..+++|+....    ......|..+++.+. +..++++++++.+.+..|+|||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            457999999999999999999643  689999998742    222378999999884 6788899999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG----------------------------------------  128 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs----------------------------------------  128 (792)
                      |++|.+|.+.+.       +......++.++..+|..||+                                        
T Consensus        91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            999999887641       122334688899999999998                                        


Q ss_pred             -------------------CCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        129 -------------------LGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       129 -------------------~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                                         ..++|+|++|.|||++.++.+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               4489999999999997655567999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.21  E-value=2.6e-11  Score=121.26  Aligned_cols=135  Identities=14%  Similarity=0.138  Sum_probs=101.0

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-hHHHHHHHHhcCCCC--cceeEEEEEeCCEEEEEEecc
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-NTIERDIMVKSKCPY--IVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-~~~E~eIL~kL~HPN--IVkL~~vfede~~lyLVmEy~   90 (792)
                      ..+|.+....+.|+.+.||++.. .+|..+++|+....... ...|..+++.+.+.+  ++++++++.+.+..|+||||+
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            45677755555677799999954 46778999987654222 267899998885434  566889888888899999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG----------------------------------------  130 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g----------------------------------------  130 (792)
                      +|.+|.  .  ..   .+   ...++.++...|..||+..                                        
T Consensus        98 ~G~~l~--~--~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           98 PGQDLL--S--SH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             SSEETT--T--SC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             CCcccC--c--Cc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            998874  2  11   12   2256777788888888653                                        


Q ss_pred             ------------------CccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        131 ------------------YVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       131 ------------------IVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                                        ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              99999999999998766677999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=2.2e-10  Score=122.45  Aligned_cols=150  Identities=18%  Similarity=0.202  Sum_probs=112.1

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEec--cCC-----CChHHHHHHHHhcC--CCCcceeEE
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVL--REK-----MPNTIERDIMVKSK--CPYIVNLFY   75 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~--Ks~-----~~~~~E~eIL~kL~--HPNIVkL~~   75 (792)
                      ..+.+.-........++.|+.|.++.||++...  +..+++|+..  ...     .....|..+++.+.  +..+++++.
T Consensus        28 ~~l~~~~~~~~~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~  105 (359)
T 3dxp_A           28 AWMRQHVEGFAGPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYA  105 (359)
T ss_dssp             HHHHHHSTTCCCCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEE
T ss_pred             HHHHHhCCCCCCCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence            334433323344556788999999999998754  4688899876  322     12267999999887  456888998


Q ss_pred             EEEeC---CEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------
Q psy13735         76 SFQDM---NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG------------------------  128 (792)
Q Consensus        76 vfede---~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs------------------------  128 (792)
                      ++.+.   +..|+||||++|..+.+..    ...++......++.++..+|..||+                        
T Consensus       106 ~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3dxp_A          106 LCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIER  181 (359)
T ss_dssp             EECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHH
T ss_pred             ECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHH
Confidence            88776   4589999999998775422    2237888889999999999999997                        


Q ss_pred             ----------------------------------CCCccCCCCCCceEeCCCCc--eEEeccCccccc
Q psy13735        129 ----------------------------------LGYVHRDIKPDNMLLSATGH--LKLTDFGSATQV  160 (792)
Q Consensus       129 ----------------------------------~gIVHRDLKPeNILLd~dg~--VKLiDFGLA~~l  160 (792)
                                                        ..++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          182 WTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                              35899999999999987753  699999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.90  E-value=4.4e-10  Score=117.53  Aligned_cols=189  Identities=17%  Similarity=0.180  Sum_probs=121.7

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCCC--ChHHHHHHHHhcC-CCC--cceeEEEEEeCC---EEEEEEeccC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--PNTIERDIMVKSK-CPY--IVNLFYSFQDMN---HVYFIMEYVT   91 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~--~~~~E~eIL~kL~-HPN--IVkL~~vfede~---~lyLVmEy~~   91 (792)
                      ++.++.|.++.||++.     ..+++|+......  ....|..+++.+. +..  ++.++....+..   ..|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4569999999999873     5688898653311  1157888888773 333  445555443333   3489999999


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-------------------------------------------  128 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-------------------------------------------  128 (792)
                      |.++.....    ..++......++.++...|..||+                                           
T Consensus       100 G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A          100 GVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            988875432    226788888889999999999986                                           


Q ss_pred             ---------------CCCccCCCCCCceEeCC--CCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCC
Q psy13735        129 ---------------LGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG  191 (792)
Q Consensus       129 ---------------~gIVHRDLKPeNILLd~--dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~  191 (792)
                                     ..++|+|++|.||+++.  .+.+.|+||+.+....+..... ... ....-..|+........++
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-~~~-~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-SLM-EDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-TTC-CTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-HHH-hhccccCHHHHHHHHHHcC
Confidence                           13699999999999987  4568999999987643221110 000 0000133443321111010


Q ss_pred             CC-------CCCcccccccchhhHHHhhcCCCCCC
Q psy13735        192 SD-------GYTGSCDLWSIGVVSYELLTGSTPFN  219 (792)
Q Consensus       192 ~~-------~ys~ksDIWSLGVILYELLTGk~PF~  219 (792)
                      ..       ....-.+.|++|+++|.+.+|..||.
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            00       01112589999999999999998873

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.45  E-value=6.6e-07  Score=94.33  Aligned_cols=134  Identities=17%  Similarity=0.150  Sum_probs=94.4

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--hHHHHHHHHhcCCC---CcceeEEEEE-eCCEEEEEEeccCC
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSKCP---YIVNLFYSFQ-DMNHVYFIMEYVTG   92 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--~~~E~eIL~kL~HP---NIVkL~~vfe-de~~lyLVmEy~~G   92 (792)
                      -+..++.|....||++     |..+++|+-......  ...|..+|..+.+.   .++.++.+.. ..+..|+||++++|
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            4567899999999988     567888985322111  15789999988642   3566666664 44567899999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-------------------------------------------  129 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-------------------------------------------  129 (792)
                      ..+....-    ..++......++.++...|..||+.                                           
T Consensus        98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88876421    1145556666666666666666642                                           


Q ss_pred             -----------------CCccCCCCCCceEeCC---CCc-eEEeccCcccccc
Q psy13735        130 -----------------GYVHRDIKPDNMLLSA---TGH-LKLTDFGSATQVD  161 (792)
Q Consensus       130 -----------------gIVHRDLKPeNILLd~---dg~-VKLiDFGLA~~l~  161 (792)
                                       .++|+|++|.|||++.   ++. +.|+||+.+....
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                             3489999999999987   455 4899999887543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.43  E-value=1.3e-06  Score=88.67  Aligned_cols=138  Identities=15%  Similarity=0.149  Sum_probs=99.0

Q ss_pred             CceEEeEeeecCce-EEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         16 DFDIKRFIQQGNFG-DIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        16 dY~I~k~IGsGsFG-tVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      .|++. .+..|..| .||++.....+..+++|+-....... ..|..+|+.+. +--++++++++.+.+..|+|||+++|
T Consensus        26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            34443 44455554 79999887778889999865432211 56888888774 33478889999999999999999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL-------------------------------------------  129 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~-------------------------------------------  129 (792)
                      .++.+.....      ......+..++...|..||..                                           
T Consensus       105 ~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          105 KTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             EEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            8887765331      122334566666667777731                                           


Q ss_pred             ---------------CCccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735        130 ---------------GYVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus       130 ---------------gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                                     .++|+|+.|.|||++.++.+-|+||+.+...
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                           1689999999999988777789999988653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.13  E-value=7e-06  Score=88.84  Aligned_cols=74  Identities=18%  Similarity=0.317  Sum_probs=48.8

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC--------C---hHHHHHHHHhcCC--CC-cceeEEEEEeCCEE
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM--------P---NTIERDIMVKSKC--PY-IVNLFYSFQDMNHV   83 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~--------~---~~~E~eIL~kL~H--PN-IVkL~~vfede~~l   83 (792)
                      ...+.||.|.++.||++....+++.+++|.......        .   ...|.+++..+..  |. +++++.+  +....
T Consensus        33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~  110 (397)
T 2olc_A           33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA  110 (397)
T ss_dssp             CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred             eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence            357789999999999997766678999997643211        1   1568888887742  43 4455543  34456


Q ss_pred             EEEEeccCCC
Q psy13735         84 YFIMEYVTGG   93 (792)
Q Consensus        84 yLVmEy~~GG   93 (792)
                      ++|||+++|.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            8999999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.12  E-value=6.8e-06  Score=87.24  Aligned_cols=80  Identities=10%  Similarity=0.123  Sum_probs=56.4

Q ss_pred             ceEEeEe-eecCceEEEEEEEe--c----CCcEEEEEEeccCC-------CChHHHHHHHHhcC-C--CCcceeEEEEEe
Q psy13735         17 FDIKRFI-QQGNFGDIYLVEEK--Q----SHNTFVMKKVLREK-------MPNTIERDIMVKSK-C--PYIVNLFYSFQD   79 (792)
Q Consensus        17 Y~I~k~I-GsGsFGtVyla~~k--~----tGk~vAVKiI~Ks~-------~~~~~E~eIL~kL~-H--PNIVkL~~vfed   79 (792)
                      ....+.| +.|..+.+|++...  .    +|..+++|+.....       .....|..+++.+. +  ..+++++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3446788 88999999998754  1    25689999875433       22367888888774 3  357778887766


Q ss_pred             C---CEEEEEEeccCCCCHH
Q psy13735         80 M---NHVYFIMEYVTGGDFV   96 (792)
Q Consensus        80 e---~~lyLVmEy~~GGsL~   96 (792)
                      .   +..|+||||++|..+.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            5   3568999999986543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.12  E-value=1.1e-05  Score=83.93  Aligned_cols=139  Identities=13%  Similarity=0.140  Sum_probs=79.2

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcC--CCCcceeEE------EEEeCCEEEEEEecc
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSK--CPYIVNLFY------SFQDMNHVYFIMEYV   90 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~--HPNIVkL~~------vfede~~lyLVmEy~   90 (792)
                      -+..|+.|..+.||++...  +..|++|+..........|..++..+.  .-.+++++.      +....+..++||+|+
T Consensus        36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EEEECC----CEEEEEEET--TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             EeeeccccccCcEEEEEeC--CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            3456777889999999763  345999998753211133556665542  112333332      223567889999999


Q ss_pred             CCCCHH-----------HHH---Hh--CC---C-C-----CC-CHHH-------------------------------HH
Q psy13735         91 TGGDFV-----------TLL---EN--QP---H-G-----YL-SESK-------------------------------AR  113 (792)
Q Consensus        91 ~GGsL~-----------dlL---~r--~~---~-g-----~L-SE~e-------------------------------a~  113 (792)
                      +|..+.           ..+   ..  ..   . +     .+ .+..                               ..
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986431           111   11  10   0 0     00 1110                               11


Q ss_pred             HHHHHHHHHHHHHH-------------hCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        114 FYIYELAQAVQYLH-------------GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       114 ~Im~QILsAL~YLH-------------s~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      .++.++..++.+|+             ...++|+|++|.|||++.++.+.|+||+.+..
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            12223344566665             35799999999999998888999999998753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.58  E-value=0.00019  Score=78.70  Aligned_cols=71  Identities=17%  Similarity=0.225  Sum_probs=47.4

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEecc-------C-CC--C-hHHHHHHHHhc---CCCCcceeEEEEEeCCEE
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-------E-KM--P-NTIERDIMVKS---KCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~K-------s-~~--~-~~~E~eIL~kL---~HPNIVkL~~vfede~~l   83 (792)
                      .-++.||.|..+.||++..  ++..+++|....       . ..  . ...|.+++..+   ....+++++.+.  ....
T Consensus        37 ~~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~  112 (420)
T 2pyw_A           37 LVIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMA  112 (420)
T ss_dssp             CEEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTT
T ss_pred             eEEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCcc
Confidence            3567899999999999953  567899994221       1 11  1 14566665443   234567777665  5667


Q ss_pred             EEEEecc-CC
Q psy13735         84 YFIMEYV-TG   92 (792)
Q Consensus        84 yLVmEy~-~G   92 (792)
                      ++||||+ +|
T Consensus       113 ~lv~e~l~~g  122 (420)
T 2pyw_A          113 LIGMRYLEPP  122 (420)
T ss_dssp             EEEECCCCTT
T ss_pred             EEEEeecCCc
Confidence            9999999 87

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.42  E-value=0.00041  Score=72.23  Aligned_cols=132  Identities=8%  Similarity=0.017  Sum_probs=75.6

Q ss_pred             EeEeeecCceEEEEEEEecCCcEEEEEEeccCC---CChHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEEecc-CCCC
Q psy13735         20 KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPYI-VNLFYSFQDMNHVYFIMEYV-TGGD   94 (792)
Q Consensus        20 ~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~---~~~~~E~eIL~kL~HPNI-VkL~~vfede~~lyLVmEy~-~GGs   94 (792)
                      ++.|+.|....+|++      ..|++|+.....   .....|..+++.+...++ +++++++  ...-++|++|+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            788999999999999      458888876432   223678888877642222 5666543  33347899999 6643


Q ss_pred             HHH---------------HHH---hCCC---CCCC-HHHHHHHHHH--------------HHHHHH----HHHh----CC
Q psy13735         95 FVT---------------LLE---NQPH---GYLS-ESKARFYIYE--------------LAQAVQ----YLHG----LG  130 (792)
Q Consensus        95 L~d---------------lL~---r~~~---g~LS-E~ea~~Im~Q--------------ILsAL~----YLHs----~g  130 (792)
                      +..               .+.   ....   ..+. ...+..+...              +...+.    .+..    ..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            321               011   1110   0011 1111111111              111111    1111    23


Q ss_pred             CccCCCCCCceEeCCCCceEEeccCccccc
Q psy13735        131 YVHRDIKPDNMLLSATGHLKLTDFGSATQV  160 (792)
Q Consensus       131 IVHRDLKPeNILLd~dg~VKLiDFGLA~~l  160 (792)
                      ++|+|+.|.||| ..++.+.|+||..+...
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            799999999999 56778999999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.40  E-value=0.00086  Score=70.56  Aligned_cols=140  Identities=12%  Similarity=0.128  Sum_probs=75.3

Q ss_pred             EEeEeeecCceE-EEEEEEecCCcEEEEEEeccCC-CChHHHHHHHHhcC-C-CCcceeEEEEEeCCEEEEEEeccCCCC
Q psy13735         19 IKRFIQQGNFGD-IYLVEEKQSHNTFVMKKVLREK-MPNTIERDIMVKSK-C-PYIVNLFYSFQDMNHVYFIMEYVTGGD   94 (792)
Q Consensus        19 I~k~IGsGsFGt-Vyla~~k~tGk~vAVKiI~Ks~-~~~~~E~eIL~kL~-H-PNIVkL~~vfede~~lyLVmEy~~GGs   94 (792)
                      -++.|+.|+... +|++.. .+|..|++|...... .....|..++..+. + -.+++++.+..+.+  ++|||++.|..
T Consensus        22 ~~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           22 NRTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             EECC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eeeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            345666665554 667743 236778887655433 33367888887764 2 23556666533333  78999997766


Q ss_pred             HHHHHHhC---------------------CC---CCCCHHHHH-------H-HH------------HHHHHHHHHH----
Q psy13735         95 FVTLLENQ---------------------PH---GYLSESKAR-------F-YI------------YELAQAVQYL----  126 (792)
Q Consensus        95 L~dlL~r~---------------------~~---g~LSE~ea~-------~-Im------------~QILsAL~YL----  126 (792)
                      +.+.+...                     ..   ..++.....       . +.            ..+...+..+    
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65433210                     00   112221110       0 00            0111122222    


Q ss_pred             --HhCCCccCCCCCCceEeCCC----CceEEeccCcccccc
Q psy13735        127 --HGLGYVHRDIKPDNMLLSAT----GHLKLTDFGSATQVD  161 (792)
Q Consensus       127 --Hs~gIVHRDLKPeNILLd~d----g~VKLiDFGLA~~l~  161 (792)
                        +...++|+|+.|.|||++.+    +.+.|+||+.+....
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence              13468999999999999874    679999999887543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.37  E-value=0.0008  Score=71.93  Aligned_cols=76  Identities=14%  Similarity=0.180  Sum_probs=58.7

Q ss_pred             eEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-hHHHHHHHHhcC---CCCcceeEEEEEeCCEEEEEEeccCCC
Q psy13735         18 DIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-NTIERDIMVKSK---CPYIVNLFYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        18 ~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-~~~E~eIL~kL~---HPNIVkL~~vfede~~lyLVmEy~~GG   93 (792)
                      .-.+.|+.|.+..+|++..  ++..|++|+....... ...|...|+.+.   ...+++++.+....+..|+||||++|.
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            4567899999999999864  4678899987654211 156778887773   367888898888888999999999997


Q ss_pred             CH
Q psy13735         94 DF   95 (792)
Q Consensus        94 sL   95 (792)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.28  E-value=0.0012  Score=68.61  Aligned_cols=144  Identities=13%  Similarity=0.087  Sum_probs=79.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--hHHHHHHHHhcCCCC--cceeEEE------EEeCCEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSKCPY--IVNLFYS------FQDMNHV   83 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--~~~E~eIL~kL~HPN--IVkL~~v------fede~~l   83 (792)
                      .....-++.|+.|....||++... +| .|++|+.......  ...|..++..+...+  ++.++..      ....+..
T Consensus        21 ~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           21 VGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             CCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             CCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            344556778889999999999754 33 6889988763211  245777776653111  2333311      2234678


Q ss_pred             EEEEeccCCCCHH-----------HH---HHhC--C--CC---CCCHHHHHH---------------HHHHHHHHHHHHH
Q psy13735         84 YFIMEYVTGGDFV-----------TL---LENQ--P--HG---YLSESKARF---------------YIYELAQAVQYLH  127 (792)
Q Consensus        84 yLVmEy~~GGsL~-----------dl---L~r~--~--~g---~LSE~ea~~---------------Im~QILsAL~YLH  127 (792)
                      +++|+|++|..+.           ..   +...  .  ..   ......-..               +-..+...+..++
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            9999999986431           11   1110  0  00   011000000               0011334455555


Q ss_pred             h-------CCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        128 G-------LGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       128 s-------~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      .       .+++|+|++|.|||++.++.+.|+||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            2       3689999999999998766668999998753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.01  E-value=0.006  Score=63.60  Aligned_cols=151  Identities=14%  Similarity=0.136  Sum_probs=83.6

Q ss_pred             hHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCC--CCcceeEEE-
Q psy13735          3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKC--PYIVNLFYS-   76 (792)
Q Consensus         3 ~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~H--PNIVkL~~v-   76 (792)
                      +...+.+.++...  .-+..|+ |....||++.. .+|..|++|+........   ..|..++..+..  -.++.++.. 
T Consensus        16 i~~~l~~~g~~~~--~~~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~   91 (328)
T 1zyl_A           16 IMDALFEHGIRVD--SGLTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFN   91 (328)
T ss_dssp             HHHHHHHTTCCCC--SCCEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBT
T ss_pred             HHHHHHHcCCCCC--ceEEeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecC
Confidence            4455555555443  1234566 88889998854 346689999986433222   457777766631  123444332 


Q ss_pred             ----EEeCCEEEEEEeccCCCCHH-----------HHH---Hh--C--CC---CCCCHHHH-------------------
Q psy13735         77 ----FQDMNHVYFIMEYVTGGDFV-----------TLL---EN--Q--PH---GYLSESKA-------------------  112 (792)
Q Consensus        77 ----fede~~lyLVmEy~~GGsL~-----------dlL---~r--~--~~---g~LSE~ea-------------------  112 (792)
                          +...+..++||++++|..+.           ..+   ..  .  ..   ..++....                   
T Consensus        92 g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  171 (328)
T 1zyl_A           92 GQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLK  171 (328)
T ss_dssp             TBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTH
T ss_pred             CcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHH
Confidence                23356778999999884321           111   00  0  00   01121110                   


Q ss_pred             ---HHHHHHHHHHHHHH----HhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        113 ---RFYIYELAQAVQYL----HGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       113 ---~~Im~QILsAL~YL----Hs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                         ...+..++..+.-+    +...++|+|++|.|||++ + .+.|+||+.+..
T Consensus       172 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          172 AAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               11112222222222    124589999999999998 4 899999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.92  E-value=0.0095  Score=66.93  Aligned_cols=72  Identities=15%  Similarity=0.162  Sum_probs=49.6

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEeccCC---CChHHHHHHHHhcCCCCc-ceeEEEEEeCCEEEEEEeccCCCC
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREK---MPNTIERDIMVKSKCPYI-VNLFYSFQDMNHVYFIMEYVTGGD   94 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~---~~~~~E~eIL~kL~HPNI-VkL~~vfede~~lyLVmEy~~GGs   94 (792)
                      -++.|+.|....+|++.....+..|++|+.....   .....|..++..+...++ +++++++.  +  .+||+|++|-.
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4678899999999999876545789999875432   122589999998864444 67777773  2  25999998843

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.88  E-value=0.0027  Score=67.92  Aligned_cols=72  Identities=14%  Similarity=0.105  Sum_probs=45.2

Q ss_pred             EEeEeeecCceEEEEEEEecC--------CcEEEEEEeccCC---CChHHHHHHHHhcCCCC-cceeEEEEEeCCEEEEE
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQS--------HNTFVMKKVLREK---MPNTIERDIMVKSKCPY-IVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~t--------Gk~vAVKiI~Ks~---~~~~~E~eIL~kL~HPN-IVkL~~vfede~~lyLV   86 (792)
                      -...|+.|....+|++.....        +..+++|+.....   .....|..++..+...+ ++++++.+  .+  ++|
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v  112 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI  112 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence            456788898999999986541        3688888765421   12357888888775223 45676655  22  689


Q ss_pred             EeccCCCC
Q psy13735         87 MEYVTGGD   94 (792)
Q Consensus        87 mEy~~GGs   94 (792)
                      |+|++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998843

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.88  E-value=0.0016  Score=72.26  Aligned_cols=71  Identities=14%  Similarity=0.112  Sum_probs=49.1

Q ss_pred             EEeEeeecCceEEEEEEEec-------CCcEEEEEEeccCCC--ChHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEe
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQ-------SHNTFVMKKVLREKM--PNTIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~-------tGk~vAVKiI~Ks~~--~~~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmE   88 (792)
                      -++.|+.|....||++....       .+..+++|+......  ....|..++..+. +...+++++++.+    .+||+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            46788999999999998753       357899998844221  1146888888774 3334677776643    38999


Q ss_pred             ccCCC
Q psy13735         89 YVTGG   93 (792)
Q Consensus        89 y~~GG   93 (792)
                      |++|-
T Consensus       153 ~l~G~  157 (429)
T 1nw1_A          153 YIPSR  157 (429)
T ss_dssp             CCCEE
T ss_pred             EeCCc
Confidence            99873

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.75  E-value=0.007  Score=64.59  Aligned_cols=72  Identities=13%  Similarity=0.084  Sum_probs=46.4

Q ss_pred             EeEe--eecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcC---CCCcceeEEE------EEeCCEEEEEEe
Q psy13735         20 KRFI--QQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSK---CPYIVNLFYS------FQDMNHVYFIME   88 (792)
Q Consensus        20 ~k~I--GsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~---HPNIVkL~~v------fede~~lyLVmE   88 (792)
                      ++.|  |.|....||++... +| .|++|+......  ..|..++..|.   -|+++.++..      ....+..++||+
T Consensus        26 ~~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~--~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~  101 (339)
T 3i1a_A           26 AQFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYHD--EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYP  101 (339)
T ss_dssp             EEEETTTSCSSCEEEEEECS-SC-EEEEEEEECSSC--CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred             eEEeeccCccccceEEEEeC-CC-CEEEEEecCccc--hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEe
Confidence            4445  34446899999643 44 899998766543  45666666552   3335555432      234578899999


Q ss_pred             ccCCCCH
Q psy13735         89 YVTGGDF   95 (792)
Q Consensus        89 y~~GGsL   95 (792)
                      |++|..+
T Consensus       102 ~i~G~~~  108 (339)
T 3i1a_A          102 FIHAPNG  108 (339)
T ss_dssp             CCCCCBT
T ss_pred             ccCCCcC
Confidence            9998654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.74  E-value=0.0025  Score=69.92  Aligned_cols=140  Identities=14%  Similarity=0.158  Sum_probs=82.3

Q ss_pred             CCceEEeEeeecCceEEEEEEEec-------CCcEEEEEEeccCCCCh---HHHHHHHHhcC-CCCcceeEEEEEeCCEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQ-------SHNTFVMKKVLREKMPN---TIERDIMVKSK-CPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~-------tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~-HPNIVkL~~vfede~~l   83 (792)
                      +... ++.|..|....+|++....       .+..|++++........   ..|..+++.+. +.-.+++++++.+    
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            4444 4567778889999998643       35789999863321111   46888887774 3334677777654    


Q ss_pred             EEEEeccCCCCHH--------------HHHH---hC--C-CCCC--CHHHHHHHHHHHHH-------------------H
Q psy13735         84 YFIMEYVTGGDFV--------------TLLE---NQ--P-HGYL--SESKARFYIYELAQ-------------------A  122 (792)
Q Consensus        84 yLVmEy~~GGsL~--------------dlL~---r~--~-~g~L--SE~ea~~Im~QILs-------------------A  122 (792)
                      .+||||++|..|.              ..|.   ..  . ....  -...+..|+.++-.                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            2999999985432              1111   11  1 1111  13455666655422                   1


Q ss_pred             HHHHH----h----CCCccCCCCCCceEeCCC----CceEEeccCcccc
Q psy13735        123 VQYLH----G----LGYVHRDIKPDNMLLSAT----GHLKLTDFGSATQ  159 (792)
Q Consensus       123 L~YLH----s----~gIVHRDLKPeNILLd~d----g~VKLiDFGLA~~  159 (792)
                      +..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            23332    2    248999999999999876    6899999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.67  E-value=0.0093  Score=61.53  Aligned_cols=75  Identities=12%  Similarity=-0.013  Sum_probs=52.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--h--HHHHHHHHhcC-C--CCcceeEEEEEeCCEEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--N--TIERDIMVKSK-C--PYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--~--~~E~eIL~kL~-H--PNIVkL~~vfede~~lyLVm   87 (792)
                      ....-+..+|.|..+.||+++. .+|+.|++|+-......  .  ..|...|+.+. .  -.+++++++  +.  -++||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~   89 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAM   89 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEE
Confidence            4566788999999999999976 46889999986543322  1  46888888874 2  234555554  22  37899


Q ss_pred             eccCCCC
Q psy13735         88 EYVTGGD   94 (792)
Q Consensus        88 Ey~~GGs   94 (792)
                      ||+.++.
T Consensus        90 e~l~~~~   96 (288)
T 3f7w_A           90 EWVDERP   96 (288)
T ss_dssp             ECCCCCC
T ss_pred             EeecccC
Confidence            9998765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.50  E-value=0.0058  Score=62.95  Aligned_cols=122  Identities=15%  Similarity=0.142  Sum_probs=80.4

Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccccC
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH-GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP  171 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLH-s~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t~  171 (792)
                      .+|.++|.. .+.+++|+++|.++.|.+.+|.-+- ...-..+=+.|..|+|..+|+|.+.+ +.+.             
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            368999975 3567999999999999999987762 12223455567999999999998874 2211             


Q ss_pred             CCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHH
Q psy13735        172 VGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAM  251 (792)
Q Consensus       172 vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~el  251 (792)
                      .....|.|||...        ...+.+.=|||||+++|.-+-=..|-                       .....+|+.+
T Consensus        98 ~~~~~~~~pe~~~--------~~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~L  146 (229)
T 2yle_A           98 AGEPPPVAGKLGY--------SQCMETEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPL  146 (229)
T ss_dssp             ---------CCSS--------SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHH
T ss_pred             ccccCCCChhhcc--------ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHH
Confidence            0223466787652        24556778999999999877411111                       1123689999


Q ss_pred             HHHHHHHhh
Q psy13735        252 VNFVQSLVQ  260 (792)
Q Consensus       252 kdLIk~LL~  260 (792)
                      -.||..|..
T Consensus       147 E~LL~~Mt~  155 (229)
T 2yle_A          147 EQLIDHMAN  155 (229)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHHHHh
Confidence            999999986

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A

Probab=96.22  E-value=0.29  Score=48.35  Aligned_cols=13  Identities=8%  Similarity=0.000  Sum_probs=5.0

Q ss_pred             hhhhHHHHHHHHH
Q psy13735        550 LSNTIESMQKEME  562 (792)
Q Consensus       550 ~~~~~~~~~~~~~  562 (792)
                      +.+.+..+...++
T Consensus       179 ~~~~~~~~~~~~~  191 (284)
T 1c1g_A          179 AEERAELSEGKCA  191 (284)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            3333333333333

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A

Probab=95.96  E-value=0.0099  Score=74.13  Aligned_cols=23  Identities=9%  Similarity=0.076  Sum_probs=12.3

Q ss_pred             ecCceEEEEEEEecCCcEEEEEE
Q psy13735         25 QGNFGDIYLVEEKQSHNTFVMKK   47 (792)
Q Consensus        25 sGsFGtVyla~~k~tGk~vAVKi   47 (792)
                      +.-||......-..+|..+-.++
T Consensus       244 SSRfgk~~~i~f~~~g~i~ga~i  266 (1184)
T 1i84_S          244 SSRFGKFIRINFDVTGYIVGANI  266 (1184)
T ss_dssp             EECSCEEEEEEECSSSCEEEEEE
T ss_pred             ccccceeEEEEECCCCCEeeeEE
Confidence            34455555555555565555554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.59  E-value=0.024  Score=63.18  Aligned_cols=72  Identities=15%  Similarity=0.203  Sum_probs=49.7

Q ss_pred             EEeEeeecCceEEEEEEEecC-------CcEEEEEEeccCC---CChHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEE
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQS-------HNTFVMKKVLREK---MPNTIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~t-------Gk~vAVKiI~Ks~---~~~~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVm   87 (792)
                      -++.|..|....+|++.....       +..|++++.....   .....|..+++.+. +.-.+++++.+.  +  ++||
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~  149 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE  149 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence            456778888899999987531       5789999865422   12257888888774 333566666443  2  7899


Q ss_pred             eccCCCC
Q psy13735         88 EYVTGGD   94 (792)
Q Consensus        88 Ey~~GGs   94 (792)
                      +|++|..
T Consensus       150 efI~G~~  156 (424)
T 3mes_A          150 EFIDGEP  156 (424)
T ss_dssp             ECCCSEE
T ss_pred             EEeCCcc
Confidence            9999854

>1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A

Probab=95.58  E-value=1.3  Score=43.66  Aligned_cols=10  Identities=30%  Similarity=0.378  Sum_probs=3.6

Q ss_pred             HHhhhhhhhh
Q psy13735        471 EVLRGELEEQ  480 (792)
Q Consensus       471 ~~~~~~~~~~  480 (792)
                      ..++..+.+.
T Consensus       142 ~~~~~~l~~~  151 (284)
T 1c1g_A          142 EIQEIQLKEA  151 (284)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            3333333333

>1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A

Probab=94.81  E-value=0.036  Score=69.19  Aligned_cols=23  Identities=17%  Similarity=0.416  Sum_probs=12.4

Q ss_pred             HHHHHHHHhcCCCCcceeEEEEE
Q psy13735         56 TIERDIMVKSKCPYIVNLFYSFQ   78 (792)
Q Consensus        56 ~~E~eIL~kL~HPNIVkL~~vfe   78 (792)
                      .+|..+|..|++.+--.++++|.
T Consensus        94 l~e~~vl~~L~~Ry~~~~iyT~~  116 (1184)
T 1i84_S           94 LNEASVLHNLRERYFSGLIYTYS  116 (1184)
T ss_dssp             CCTTHHHHHHHHHHHHTCCEEEE
T ss_pred             ccHHHHHHHHHHHhcCCCcEEec
Confidence            34666666665554445555553

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.55  E-value=0.37  Score=52.53  Aligned_cols=29  Identities=34%  Similarity=0.555  Sum_probs=24.6

Q ss_pred             CccCCCCCCceEe------CCCCceEEeccCcccc
Q psy13735        131 YVHRDIKPDNMLL------SATGHLKLTDFGSATQ  159 (792)
Q Consensus       131 IVHRDLKPeNILL------d~dg~VKLiDFGLA~~  159 (792)
                      ++|+|+.+.|||+      +.++.+.++||-+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3456799999998754

>3vkg_A Dynein heavy chain, cytoplasmic; AAA+ protein, molecular motor, microtubles, motor protein; HET: ADP SPM; 2.81A {Dictyostelium discoideum} PDB: 3vkh_A*

Probab=91.77  E-value=1.1  Score=60.95  Aligned_cols=169  Identities=14%  Similarity=0.193  Sum_probs=90.3

Q ss_pred             hhccccccHHHHHHHHHHHHHhhhhHHhhhhhHHHHHHhhHHHHHHHHhhhcc-----cccCcccceeeechhhhHHhhh
Q psy13735        401 HTSLLSKKEEEIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEKENL-----EKTDDRKLEVCEVSKELEVLRG  475 (792)
Q Consensus       401 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  475 (792)
                      -..+|.+|-.++..-+.-|..-=..+..+.+.+.....+|....-++.++..-     ++....+-++-+..++.+....
T Consensus      1904 y~~ll~~K~~el~~~~~rl~~GL~KL~et~~~V~~l~~~L~~~~~~L~~k~~ea~~~l~~i~~~~~~ae~~k~~v~~~~~ 1983 (3245)
T 3vkg_A         1904 VVLLINEKRDQLEEEQLHLNIGLKKLRDTEAQVKDLQVSLAQKNRELDVKNEQANQKLKQMVQDQQAAEIKQKDARELQV 1983 (3245)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            35677777776666655555444455555666666666666665555554321     0000000111111112222222


Q ss_pred             hhhhhhhHHHHhhHHHHHHHHHhh---HHHHHHHHhhhHHHHHHHHhhhHHHHhhccHHHHHHhhhhhhHHHHHhHHhhh
Q psy13735        476 ELEEQKTATKQWKKDWYQSVKERN---AAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLREHQALSN  552 (792)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  552 (792)
                      ++++|......=|.+=-..+.+-.   .--++|.+|+.+.++.+++|...+++|+.-++.|+..+..++...+|-++|.+
T Consensus      1984 ~~~~~~~ei~~~k~~~e~dL~~A~Pa~Pkr~~l~~ae~~l~~~~~~L~~~~~~L~~le~~l~~L~~~~~~~~~ek~~L~~ 2063 (3245)
T 3vkg_A         1984 QLDVRNKEIAVQKVKAYADLEKAEPTGPLREEVEQLENAANELKLKQDEIVATITALEKSIATYKEEYATLIRETEQIKT 2063 (3245)
T ss_dssp             HHHHHHHHHHHHHHHHHHCC-------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            222222222211111111100000   00135666677777777788888888888888888888888888889999999


Q ss_pred             hHHHHHHHHHhhhhhhh
Q psy13735        553 TIESMQKEMEQSAVRVR  569 (792)
Q Consensus       553 ~~~~~~~~~~~~~~~~~  569 (792)
                      .++.+++.++.+..-|.
T Consensus      2064 e~~~~~~kl~rA~~Li~ 2080 (3245)
T 3vkg_A         2064 ESSKVKNKVDRSIALLD 2080 (3245)
T ss_dssp             HHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHH
Confidence            88888888876654443

>3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori}

Probab=90.00  E-value=5.9  Score=40.88  Aligned_cols=99  Identities=22%  Similarity=0.233  Sum_probs=50.6

Q ss_pred             hhhhHHhhhhhhhhhhHHHHhhHHHHHHHHHhhHHHHHHHHhhhHHHHHHHHhhhHHHHhhccHHHHHHhhhhhhHHHHH
Q psy13735        467 SKELEVLRGELEEQKTATKQWKKDWYQSVKERNAAVAELKQAQTENEALKEKLTSLEQELKVSEEALATAQNSLDSKLRE  546 (792)
Q Consensus       467 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  546 (792)
                      .||+..|..|++.++...              ..+-.++..+....+++++.+..++.++.--++.+..++..+|..+.+
T Consensus        89 ~kE~~aL~kEie~~~~~i--------------~~lE~eile~~e~ie~~~~~l~~~~~~l~~~~~~l~~~~~~~~~~~~e  154 (256)
T 3na7_A           89 ERELRSLNIEEDIAKERS--------------NQANREIENLQNEIKRKSEKQEDLKKEMLELEKLALELESLVENEVKN  154 (256)
T ss_dssp             SSHHHHHHHHHHHHHHHH--------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHH--------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            467777777777554322              222334444444555555555555555555556666666666665544


Q ss_pred             hHHhhhhHHHHHHHHHhhhhhhhhccCchhhhhhhhhh
Q psy13735        547 HQALSNTIESMQKEMEQSAVRVREMSGISEKYEKDRKT  584 (792)
Q Consensus       547 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (792)
                      -.+   .++.+.++-+.-+-.|  -..+-..|++-|+.
T Consensus       155 ~~~---e~~~l~~~r~~l~~~i--~~~lL~~Yerir~~  187 (256)
T 3na7_A          155 IKE---TQQIIFKKKEDLVEKT--EPKIYSFYERIRRW  187 (256)
T ss_dssp             HHH---HHHHHHHHHHHHHHTS--CHHHHHHHHHHHHH
T ss_pred             HHH---HHHHHHHHHHHHHhcC--CHHHHHHHHHHHHh
Confidence            332   2222222222222111  12455678887764

>3o0z_A RHO-associated protein kinase 1; coiled-coil, transferase; HET: MSE; 2.33A {Homo sapiens}

Probab=88.76  E-value=9.8  Score=37.43  Aligned_cols=47  Identities=23%  Similarity=0.342  Sum_probs=39.7

Q ss_pred             HHHHhhhHHHHHHHHhhhHHHHhhccH----HHHHHhhhhhhHHHHHhHHh
Q psy13735        504 ELKQAQTENEALKEKLTSLEQELKVSE----EALATAQNSLDSKLREHQAL  550 (792)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  550 (792)
                      -+.++.++|..|.++++.||.|-..-+    --|.++|++++...++|++-
T Consensus       112 ~~~k~~~e~r~L~Ekl~~lEKe~a~~eid~~~eLKalQ~~~eqE~~~H~~T  162 (168)
T 3o0z_A          112 NLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVT  162 (168)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCC-
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            345688899999999999999877666    55899999999999999964

>3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori}

Probab=82.51  E-value=29  Score=35.70  Aligned_cols=40  Identities=15%  Similarity=0.196  Sum_probs=21.1

Q ss_pred             HHHHHHHHHHHhhhhHHhhhhhHHHHHHhhHHHHHHHHhh
Q psy13735        411 EIDRLRQEMVKKESDLVATSSDLVATRHELEEVRSELKEK  450 (792)
Q Consensus       411 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  450 (792)
                      .+..+..|+...+..+..+...+.+....+..+....+.+
T Consensus        26 ~~~~lp~el~~le~~~~~l~~~~~~~~~~l~d~~~~~~~~   65 (256)
T 3na7_A           26 LIREKRKDLDKALNDKEAKNKAILNLEEEKLALKLQVSKN   65 (256)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            3444455555555555555555555555555555554444

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.49  E-value=4.3  Score=41.50  Aligned_cols=116  Identities=13%  Similarity=0.064  Sum_probs=80.9

Q ss_pred             cCCCCcceeEEEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC
Q psy13735         65 SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS  144 (792)
Q Consensus        65 L~HPNIVkL~~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd  144 (792)
                      ..||++  -..+-.+++.+.|.++.-+++.=+..+..     ++..+.+.++.+|+.... -|...-+|--|+|+||+++
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~  118 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFN  118 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEEC
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEe
Confidence            358888  34445788889898888766655556632     688888888888887554 1235568888999999999


Q ss_pred             CCCceEEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCC
Q psy13735        145 ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF  218 (792)
Q Consensus       145 ~dg~VKLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF  218 (792)
                      .++.+++.=.|+-..+.             |.=+.+|-+.                 -++-|++..++.++..|
T Consensus       119 ~~~~p~i~hRGi~~~lp-------------P~e~~ee~fl-----------------~qyKali~all~~K~~F  162 (219)
T 4ano_A          119 RALEPFFLHVGVKESLP-------------PDEWDDERLL-----------------REVKATVLALTEGEYRF  162 (219)
T ss_dssp             TTCCEEESCCEETTTBS-------------SCSCCHHHHH-----------------HHHHHHHHHHTTCSSCH
T ss_pred             CCCcEEEEEcCCcccCC-------------CCCCCHHHHH-----------------HHHHHHHHHHHcCCCCH
Confidence            99999999888643321             2223444443                 23457788888887776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	792
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-57
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-57
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-56
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-55
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-52
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-51
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-51
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-48
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-47
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-47
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-45
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-42
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-41
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-41
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-41
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-37
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-35
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-14

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-60
 Identities = 82/276 (29%), Positives = 127/276 (46%), Gaps = 26/276 (9%)

Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIM 62
           +  +  DF+I R + +G FG++YL  EKQS     +K + + ++           E +I 
Sbjct: 1   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
              + P I+ L+  F D   VY I+EY   G     L+        E +   YI ELA A
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANA 118

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           + Y H    +HRDIKP+N+LL + G LK+ DFG +     +   +     GT +Y+ PE+
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEM 175

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
           +E          +    DLWS+GV+ YE L G  PF   T   TY  I   +     +FP
Sbjct: 176 IE-------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE----FTFP 224

Query: 243 SSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF 277
             +  +    + +  L++     R  + +VL HP  
Sbjct: 225 DFV--TEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 2e-59
 Identities = 74/294 (25%), Positives = 134/294 (45%), Gaps = 17/294 (5%)

Query: 9   QKNVSASD-FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIM 62
            ++++  D ++I   +  G FG +Y  + K++ +     KV+  K    +     E DI+
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEEELEDYMVEIDIL 63

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
                P IV L  +F   N+++ ++E+  GG    ++       L+ES+ +    +   A
Sbjct: 64  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDA 122

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           + YLH    +HRD+K  N+L +  G +KL DFG + +  +  + +    +GTP ++APEV
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEV 181

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
           +  M        Y    D+WS+G+   E+     P +          I   +     +  
Sbjct: 182 V--MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP---TLA 236

Query: 243 SSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENK 295
              R S+   +F++  ++K +DAR    Q+L HP    +DS+ P I     E K
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV-TVDSNKP-IRELIAEAK 288

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-57
 Identities = 65/270 (24%), Positives = 124/270 (45%), Gaps = 18/270 (6%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPYI 70
           D+D+ + + +G +G++ L   + +     +K V  ++  +       E  I        +
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V  +   ++ N  Y  +EY +GG+    +  +P   + E  A+ + ++L   V YLHG+G
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 131 YVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI-VPVGTPEYVAPEVLEWMEGN 189
             HRDIKP+N+LL    +LK++DFG AT    N R + +    GT  YVAPE+L+     
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK----- 178

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
              + +    D+WS G+V   +L G  P++  +      S      E         ++ +
Sbjct: 179 -RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKTYLNPWKKIDS 234

Query: 250 AMVNFVQSLVQK-LDARLNMDQVLGHPVFD 278
           A +  +  ++ +   AR+ +  +     ++
Sbjct: 235 APLALLHKILVENPSARITIPDIKKDRWYN 264

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  196 bits (499), Expect = 7e-57
 Identities = 86/318 (27%), Positives = 152/318 (47%), Gaps = 20/318 (6%)

Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ERDI 61
           E++Q +V    +DI   +  G FG ++   EK +   FV K +      +      E  I
Sbjct: 21  EVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI 79

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P ++NL  +F+D   +  I+E+++GG+    +  + +  +SE++   Y+ +  +
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACE 138

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSAT--GHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
            ++++H    VH DIKP+N++        +K+ DFG AT+++ +      V   T E+ A
Sbjct: 139 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAA 196

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PE+++        +      D+W+IGV+ Y LL+G +PF  E    T  ++  CD E   
Sbjct: 197 PEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 249

Query: 240 SFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHK 298
              SS+  S    +F+++L+QK    RL +   L HP      S+     P S+ NK  +
Sbjct: 250 DAFSSV--SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 307

Query: 299 KDKRKASPSLKAFQKEGR 316
           K K K +         GR
Sbjct: 308 KIKEKYADWPAPQPAIGR 325

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  192 bits (489), Expect = 2e-56
 Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 22/277 (7%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------------ERDIM 62
           +++ K  + +G    +     K +   + +K +      +               E DI+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 63  VK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
            K S  P I+ L  +++     + + + +  G+    L       LSE + R  +  L +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLE 121

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPE 181
            +  LH L  VHRD+KP+N+LL    ++KLTDFG + Q+D   +++ +   GTP Y+APE
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--CGTPSYLAPE 179

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF 241
           ++E    N    GY    D+WS GV+ Y LL GS PF +    +    I++ + +     
Sbjct: 180 IIECSM-NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--FGS 236

Query: 242 PSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF 277
           P     S  + + V   +      R   ++ L HP F
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  194 bits (494), Expect = 3e-56
 Identities = 90/319 (28%), Positives = 148/319 (46%), Gaps = 21/319 (6%)

Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ERDI 61
           E++  +V    +DI   +  G FG ++ V E+ + N F  K V+     +      E   
Sbjct: 18  EIKHDHV-LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M   + P +VNL  +F+D N +  I E+++GG+    + ++ H  +SE +A  Y+ ++ +
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCK 135

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
            + ++H   YVH D+KP+N++ +   +  LKL DFG    +D    +K     GT E+ A
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAA 193

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PEV E               D+WS+GV+SY LL+G +PF  E  D T  ++ +CD     
Sbjct: 194 PEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246

Query: 240 SFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCL-DSDPPCIPPPSQENKFH 297
           S  S I  S    +F++ L+    + R+ + Q L HP              P S+  K  
Sbjct: 247 SAFSGI--SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304

Query: 298 KKDKRKASPSLKAFQKEGR 316
              K K     +     GR
Sbjct: 305 DSIKTKYDAWPEPLPPLGR 323

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 8e-56
 Identities = 79/294 (26%), Positives = 140/294 (47%), Gaps = 36/294 (12%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCP 68
           DF   + + +G+F  + L  E  +   + +K + +  +         T ERD+M +   P
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           + V L+++FQD   +YF + Y   G+ +  +     G   E+  RFY  E+  A++YLHG
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHG 126

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWME 187
            G +HRD+KP+N+LL+   H+++TDFG+A  +    +  ++   VGT +YV+PE+L    
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT--- 183

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                     S DLW++G + Y+L+ G  PF      + +  I+  +      FP     
Sbjct: 184 ----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE----YDFPEKF-- 233

Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLG------HPVFDCLDSD------PPCIP 288
                + V+ L+      RL  +++ G      HP F+ +  +      PP + 
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 7e-55
 Identities = 79/303 (26%), Positives = 137/303 (45%), Gaps = 27/303 (8%)

Query: 2   DVVKELRQKNVSASD----FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-- 55
           +++++LR   VS  D    +     I QG  G +Y   +  +     ++++  ++ P   
Sbjct: 4   EILEKLRSI-VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62

Query: 56  --TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKAR 113
               E  +M ++K P IVN   S+   + ++ +MEY+ GG    L +      + E +  
Sbjct: 63  LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS---LTDVVTETCMDEGQIA 119

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVG 173
               E  QA+++LH    +HRDIK DN+LL   G +KLTDFG   Q+      +S + VG
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VG 178

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TP ++APEV+           Y    D+WS+G+++ E++ G  P+  E        I   
Sbjct: 179 TPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-- 229

Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF---DCLDSDPPCIPP 289
            T  T    +  +LS    +F+   +   ++ R +  ++L H        L S  P I  
Sbjct: 230 -TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288

Query: 290 PSQ 292
             +
Sbjct: 289 AKE 291

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (471), Expect = 2e-53
 Identities = 86/304 (28%), Positives = 140/304 (46%), Gaps = 22/304 (7%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPYI 70
            +D +  +  G F ++ L E+K++     +K + ++ +         E  ++ K K P I
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           V L   ++   H+Y IM+ V+GG+    +     G+ +E  A   I+++  AV+YLH LG
Sbjct: 70  VALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 131 YVHRDIKPDNMLLS---ATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            VHRD+KP+N+L         + ++DFG +   D    + +    GTP YVAPEVL    
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVL---- 181

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  Y+ + D WSIGV++Y LL G  PF  E     +  IL  + E    +   I  
Sbjct: 182 ---AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 236

Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKRKASP 306
           S +  +F++ L++K  + R   +Q L HP      +    I     E       K K   
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 296

Query: 307 SLKA 310
           +  A
Sbjct: 297 AFNA 300

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (470), Expect = 2e-53
 Identities = 74/319 (23%), Positives = 120/319 (37%), Gaps = 23/319 (7%)

Query: 4   VKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ 57
           V EL  K+     F   R I  G+FG +Y   + ++     +KK+      +        
Sbjct: 4   VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63

Query: 58  -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
            E   + K + P  +     +   +  + +MEY  G     L  ++    L E +     
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVT 121

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPE 176
           +   Q + YLH    +HRD+K  N+LLS  G +KL DFGSA+ +           VGTP 
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPY 176

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           ++APEV+  M+       Y G  D+WS+G+   EL     P            I     +
Sbjct: 177 WMAPEVILAMDEGQ----YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----Q 228

Query: 237 DTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVFDCLDSDPPCIPPPSQENK 295
           +      S   S    NFV S +QK+   R   + +L H            +    +   
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 288

Query: 296 FHKKDKRKASPSLKAFQKE 314
             ++        +K    +
Sbjct: 289 AVRELDNLQYRKMKKILFQ 307

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-53
 Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 29/278 (10%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKC 67
           A D+++   I  G++G    +  K      V K++    M          E +++ + K 
Sbjct: 3   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 68  PYIVNLFYSFQDM--NHVYFIMEYVTGGDFVTLLEN--QPHGYLSESKARFYIYELAQAV 123
           P IV  +    D     +Y +MEY  GGD  +++    +   YL E      + +L  A+
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 124 QYLH-----GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYV 178
           +  H     G   +HRD+KP N+ L    ++KL DFG A  ++ +          TP Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-TPYYM 181

Query: 179 APEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT 238
           +PE +           Y    D+WS+G + YEL     PF   +       I        
Sbjct: 182 SPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 233

Query: 239 VSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHP 275
              P   R S  +   +  ++      R +++++L +P
Sbjct: 234 --IPY--RYSDELNEIITRMLNLKDYHRPSVEEILENP 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 7e-52
 Identities = 67/314 (21%), Positives = 121/314 (38%), Gaps = 57/314 (18%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-----ERDIMVKSKCPYI 70
           DF+    +  GN G ++ V  K S      K +  E  P        E  ++ +   PYI
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 71  VNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH-GL 129
           V  + +F     +   ME++ GG    +L+    G + E         + + + YL    
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             +HRD+KP N+L+++ G +KL DFG + Q+  +    +   VGT  Y++PE L+     
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQ----- 176

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPF---NYETLDMTYSSILACDTEDTVSFPSSI- 245
                Y+   D+WS+G+   E+  G  P    + + L++ +   +  D  +T   P +  
Sbjct: 177 --GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 246 ----------------------------------RLSTAMVNFVQSLVQK-LDARLNMDQ 270
                                               S    +FV   + K    R ++ Q
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 271 VLGHPVFDCLDSDP 284
           ++ H      D++ 
Sbjct: 295 LMVHAFIKRSDAEE 308

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-51
 Identities = 77/318 (24%), Positives = 140/318 (44%), Gaps = 30/318 (9%)

Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI---ERDI 61
           KEL +K      + I   + +G FG ++   E  S  T++ K V  +     +   E  I
Sbjct: 1   KELYEK------YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISI 54

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           +  ++   I++L  SF+ M  +  I E+++G D    +       L+E +   Y++++ +
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCE 113

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSA--TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           A+Q+LH     H DI+P+N++     +  +K+ +FG A Q+      + +     PEY A
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYA 171

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PEV       H  D  + + D+WS+G + Y LL+G  PF  ET      +I+  +     
Sbjct: 172 PEV-------HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE----Y 220

Query: 240 SFPSSI--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF--DCLDSDPPCIPPPSQEN 294
           +F       +S   ++FV  L+ K   +R+   + L HP             I       
Sbjct: 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRR 280

Query: 295 KFHKKDKRKASPSLKAFQ 312
            +H   K+  +  + A +
Sbjct: 281 YYHTLIKKDLNMVVSAAR 298

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 6e-51
 Identities = 55/271 (20%), Positives = 103/271 (38%), Gaps = 17/271 (6%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKS 65
           +      + + I  G+FG +Y  +         +K +               E  ++ K+
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
           +   I+ LF  +     +  + ++  G      L           K      + AQ + Y
Sbjct: 62  RHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDY 119

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK-NGRIKSIVPVGTPEYVAPEVLE 184
           LH    +HRD+K +N+ L     +K+ DFG AT   + +G  +     G+  ++APEV+ 
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
             + N     Y+   D+++ G+V YEL+TG  P++          ++             
Sbjct: 180 MQDKNP----YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 245 IRLSTAMVNFVQSLVQK-LDARLNMDQVLGH 274
                AM   +   ++K  D R    Q+L  
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-50
 Identities = 75/310 (24%), Positives = 144/310 (46%), Gaps = 25/310 (8%)

Query: 9   QKNVSASDFDI-KRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK-SK 66
           +KN    D+ +  + +  G  G +  +  K++   F +K +         E ++  + S+
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRASQ 63

Query: 67  CPYIVNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
           CP+IV +   ++++      +  +ME + GG+  + ++++     +E +A   +  + +A
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123

Query: 123 VQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVA 179
           +QYLH +   HRD+KP+N+L ++      LKLTDFG A +   +  + +     TP YVA
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVA 181

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PEVL       G + Y  SCD+WS+GV+ Y LL G  PF           +         
Sbjct: 182 PEVL-------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234

Query: 240 SFPSSI--RLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF---DCLDSDPPCIPPPSQE 293
            FP+     +S  +   +++L++     R+ + + + HP       +   P       +E
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294

Query: 294 NKFHKKDKRK 303
           +K   +D ++
Sbjct: 295 DKERWEDVKE 304

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 7e-50
 Identities = 82/304 (26%), Positives = 148/304 (48%), Gaps = 34/304 (11%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKS-KC 67
           DF + + + +G+FG ++L E K+++  F +K + ++ +          +E+ ++  + + 
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
           P++ ++F +FQ   +++F+MEY+ GGD +  +  Q       S+A FY  E+   +Q+LH
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
             G V+RD+K DN+LL   GH+K+ DFG   +        +    GTP+Y+APE+L    
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEILL--- 176

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                  Y  S D WS GV+ YE+L G +PF+ +  +  + SI      D   +P  +  
Sbjct: 177 ----GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----MDNPFYPRWL-- 226

Query: 248 STAMVNFVQSLVQK-LDARLNM-DQVLGHPVFDCLDSD--------PPCIPPPSQENKFH 297
                + +  L  +  + RL +   +  HP+F  ++ +        PP  P         
Sbjct: 227 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCS 286

Query: 298 KKDK 301
             DK
Sbjct: 287 NFDK 290

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  176 bits (448), Expect = 1e-49
 Identities = 86/306 (28%), Positives = 142/306 (46%), Gaps = 38/306 (12%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----------IERDIM 62
           + +DF + R I +G FG++Y   +  +   + MK + ++++             I   ++
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
               CP+IV + Y+F   + + FI++ + GGD    L    HG  SE+  RFY  E+   
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILG 119

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           ++++H    V+RD+KP N+LL   GH++++D G A    K    K    VGT  Y+APEV
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEV 176

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
           L+          Y  S D +S+G + ++LL G +PF        +  I        V  P
Sbjct: 177 LQ------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELP 229

Query: 243 SSIRLSTAMVNFVQSLVQK-LDARLNM-----DQVLGHPVFDCLDSD--------PPCIP 288
            S   S  + + ++ L+Q+ ++ RL        +V   P F  LD          PP IP
Sbjct: 230 DSF--SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 287

Query: 289 PPSQEN 294
           P  + N
Sbjct: 288 PRGEVN 293

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-49
 Identities = 58/275 (21%), Positives = 120/275 (43%), Gaps = 32/275 (11%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPYI 70
           FDI+  I +G+F  +Y   + ++       ++   K+  +       E +++   + P I
Sbjct: 13  FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 71  VNLFYSFQDM----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYL 126
           V  + S++        +  + E +T G   T L+      +     R +  ++ + +Q+L
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFL 128

Query: 127 H--GLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           H      +HRD+K DN+ ++  TG +K+ D G AT + +    K++  +GTPE++APE+ 
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAV--IGTPEFMAPEMY 185

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
           E        + Y  S D+++ G+   E+ T   P++        + I    T        
Sbjct: 186 E--------EKYDESVDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRVTSGVKPASF 234

Query: 244 SIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF 277
                  +   ++  +++  D R ++  +L H  F
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  171 bits (435), Expect = 2e-48
 Identities = 87/330 (26%), Positives = 147/330 (44%), Gaps = 47/330 (14%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVKS 65
           S  DF I R +  G+FG ++L+  + +   + MK + +E +           ER ++   
Sbjct: 2   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 66  KCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
             P+I+ ++ +FQD   ++ IM+Y+ GG+  +L   +         A+FY  E+  A++Y
Sbjct: 62  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 126 LHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEW 185
           LH    ++RD+KP+N+LL   GH+K+TDFG A  V            GTP+Y+APEV+  
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCGTPDYIAPEVVS- 174

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                 +  Y  S D WS G++ YE+L G TPF       TY  IL  +    + FP   
Sbjct: 175 ------TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----LRFPPFF 224

Query: 246 RLSTAMVNFVQSLVQK------LDARLNMDQVLGHPVFDCLDSD--------PPCIPPPS 291
             +  + + +  L+ +       + +   + V  HP F  +  +         P  PP  
Sbjct: 225 --NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 282

Query: 292 QEN-------KFHKKDKRKASPSLKAFQKE 314
           Q         K+ ++D          +   
Sbjct: 283 QGQGDTSQFDKYPEEDINYGVQGEDPYADL 312

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-47
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 33/302 (10%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI---------- 57
           RQ+NV    +D    +  G F  +    EK +   +  K + + +  ++           
Sbjct: 4   RQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E  I+ + + P ++ L   +++   V  I+E V GG+            L+E +A  ++ 
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLK 120

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATG----HLKLTDFGSATQVDKNGRIKSIVPVG 173
           ++   V YLH L   H D+KP+N++L         +K+ DFG A ++D     K+I   G
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--G 178

Query: 174 TPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC 233
           TPE+VAPE++         +      D+WSIGV++Y LL+G++PF  +T   T +++ A 
Sbjct: 179 TPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSD----PPCIP 288
           + E    + S+   S    +F++ L+ K    R+ +   L HP     D+          
Sbjct: 232 NYEFEDEYFSNT--SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289

Query: 289 PP 290
           P 
Sbjct: 290 PQ 291

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 3e-47
 Identities = 88/303 (29%), Positives = 147/303 (48%), Gaps = 37/303 (12%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT-------IERDIMVK 64
           V+ +DFD  + + +G FG + LV EK +   + MK + +E +           E  ++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 65  SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ P++  L Y+FQ  + + F+MEY  GG+    L  +     +E +ARFY  E+  A++
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           YLH    V+RDIK +N++L   GH+K+TDFG   +   +G        GTPEY+APEVLE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLE 178

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                   + Y  + D W +GVV YE++ G  PF  +  +  +  IL  +    + FP +
Sbjct: 179 -------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----IRFPRT 227

Query: 245 IRLSTAMVNFVQSLVQK------LDARLNMDQVLGHPVFDCLDSD--------PPCIPPP 290
           +  S    + +  L++K           +  +V+ H  F  ++          PP  P  
Sbjct: 228 L--SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285

Query: 291 SQE 293
           + E
Sbjct: 286 TSE 288

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-45
 Identities = 80/312 (25%), Positives = 151/312 (48%), Gaps = 35/312 (11%)

Query: 8   RQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNT---FVMKKVLREKMPNT-------- 56
             + V   +F++ + +  G +G ++LV +   H+T   + MK + +  +           
Sbjct: 17  HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 57  IERDIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFY 115
            ER ++    + P++V L Y+FQ    ++ I++Y+ GG+  T L  +     +E + + Y
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIY 134

Query: 116 IYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTP 175
           + E+  A+++LH LG ++RDIK +N+LL + GH+ LTDFG + +   +   ++    GT 
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
           EY+AP+++       G  G+  + D WS+GV+ YELLTG++PF  +    + + I     
Sbjct: 195 EYMAPDIVR-----GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249

Query: 236 EDTVSFPSSIRLSTAMVNFVQSLVQK------LDARLNMDQVLGHPVFDCLDSD------ 283
           +    +P  +  S    + +Q L+ K           + D++  H  F  ++ D      
Sbjct: 250 KSEPPYPQEM--SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 307

Query: 284 --PPCIPPPSQE 293
              P  P    E
Sbjct: 308 VPAPFKPVIRDE 319

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-45
 Identities = 59/278 (21%), Positives = 113/278 (40%), Gaps = 36/278 (12%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----------IERDIM- 62
            S + +   +  G FG +Y       +    +K V ++++ +           +E  ++ 
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 63  -VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
            V S    ++ L   F+  +    I+E       +     +  G L E  AR + +++ +
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLE 121

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAP 180
           AV++ H  G +HRDIK +N+L+    G LKL DFGS   +            GT  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---FDGTRVYSPP 178

Query: 181 EVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS 240
           E +           +  S  +WS+G++ Y+++ G  PF ++        I+       V 
Sbjct: 179 EWI------RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII----RGQVF 222

Query: 241 FPSSIRLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVF 277
           F    R+S+   + ++  +      R   +++  HP  
Sbjct: 223 FRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 9e-45
 Identities = 82/322 (25%), Positives = 126/322 (39%), Gaps = 40/322 (12%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFY 75
            +   + I  G+FG +Y  +   S     +KKVL++K     E  IM K     IV L Y
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 80

Query: 76  SF------QDMNHVYFIMEYVTGGDFVTLLE-NQPHGYLSESKARFYIYELAQAVQYLHG 128
            F      +D  ++  +++YV    +      ++    L     + Y+Y+L +++ Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140

Query: 129 LGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            G  HRDIKP N+LL      LKL DFGSA Q+ +     S +   +  Y APE++    
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELI---- 194

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
              G+  YT S D+WS G V  ELL G   F  ++       I+      T      +  
Sbjct: 195 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 248 STAMVNFVQ-------------------SLVQKL-----DARLNMDQVLGHPVFDCLDSD 283
           +     F Q                   +L  +L      ARL   +   H  FD L   
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 284 PPCIPPPSQENKFHKKDKRKAS 305
              +P             ++ S
Sbjct: 313 NVKLPNGRDTPALFNFTTQELS 334

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 4e-44
 Identities = 50/268 (18%), Positives = 105/268 (39%), Gaps = 23/268 (8%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--ERDIMVKSKCPY 69
           ++  +  + + I +G FGD+ L + +   N   +K +  +        E  +M + +   
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQAFLAEASVMTQLRHSN 61

Query: 70  IVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
           +V L     ++   +Y + EY+  G  V  L ++    L       +  ++ +A++YL G
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
             +VHRD+   N+L+S     K++DFG   +                ++ APE L     
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALR---- 173

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                 ++   D+WS G++ +E+ + G  P+    L      +     E      +    
Sbjct: 174 ---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDAPDGC 225

Query: 248 STAMVNFVQSLVQK-LDARLNMDQVLGH 274
             A+   +++        R +  Q+   
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 1e-43
 Identities = 63/305 (20%), Positives = 112/305 (36%), Gaps = 43/305 (14%)

Query: 21  RFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI---------ERDIMVKSKCPYIV 71
            F+ +G F  +Y   +K ++    +KK+                  E  ++ +   P I+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 72  NLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGY 131
            L  +F   +++  + +++       ++       L+ S  + Y+    Q ++YLH    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121

Query: 132 VHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHG 191
           +HRD+KP+N+LL   G LKL DFG A       R  +   V T  Y APE+L        
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLFGAR---- 176

Query: 192 SDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC-------DTEDTVSFPSS 244
              Y    D+W++G +  ELL        ++     + I             D  S P  
Sbjct: 177 --MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 245 I---------------RLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVF--DCLDSDPPC 286
           +                    +++ +Q L      AR+   Q L    F      +    
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

Query: 287 IPPPS 291
           +P P+
Sbjct: 295 LPRPN 299

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  156 bits (395), Expect = 2e-43
 Identities = 57/259 (22%), Positives = 108/259 (41%), Gaps = 24/259 (9%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI-------ERDIMVKSKCP 68
            +++   +  G   +++L  + + H    +K +  +   +         E         P
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 69  YIVNLFYSFQDMNH----VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
            IV ++ + +         Y +MEYV G     ++     G ++  +A   I +  QA+ 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALN 125

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIKSIVPVGTPEYVAPEV 182
           + H  G +HRD+KP N+++SAT  +K+ DFG A  +    N   ++   +GT +Y++PE 
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
                     D      D++S+G V YE+LTG  PF  ++        +  D     +  
Sbjct: 186 AR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 243 SSIRLSTAMVNFVQSLVQK 261
             +  S  +   V   + K
Sbjct: 239 EGL--SADLDAVVLKALAK 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 58/291 (19%), Positives = 110/291 (37%), Gaps = 28/291 (9%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT----IERDIMVKSKC 67
           +      ++  + QG FG++++        T V  K L+    +      E  +M K + 
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 71

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
             +V L Y+      +Y + EY++ G  +  L+ +   YL   +      ++A  + Y+ 
Sbjct: 72  EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
            + YVHRD++  N+L+      K+ DFG A  ++ N            ++ APE      
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--- 187

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
                  +T   D+WS G++  EL T G  P+           +     E     P    
Sbjct: 188 ----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-----ERGYRMPCPPE 238

Query: 247 LSTAMVNFVQSLVQKL-DARLNMDQVLG--HPVFDCLDSDPPCIPPPSQEN 294
              ++ + +    +K  + R   + +       F    ++P   P    EN
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF--TSTEPQYQP---GEN 284

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (395), Expect = 1e-42
 Identities = 88/311 (28%), Positives = 149/311 (47%), Gaps = 40/311 (12%)

Query: 5   KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------- 57
           +   Q       FD  + +  G+FG + LV+ K+S N + MK + ++K+           
Sbjct: 31  ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN 90

Query: 58  ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
           E+ I+     P++V L +SF+D +++Y +MEYV GG+  + L     G  SE  ARFY  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAA 148

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           ++    +YLH L  ++RD+KP+N+L+   G++++TDFG A +V            GTPE 
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEA 204

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED 237
           +APE++        S GY  + D W++GV+ YE+  G  PF  +     Y  I++     
Sbjct: 205 LAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--- 254

Query: 238 TVSFPSSIRLSTAMVNFVQSLVQK------LDARLNMDQVLGHPVFDCLDSD-------- 283
            V FPS    S+ + + +++L+Q        + +  ++ +  H  F   D          
Sbjct: 255 -VRFPSHF--SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311

Query: 284 PPCIPPPSQEN 294
            P IP      
Sbjct: 312 APFIPKFKGPG 322

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-42
 Identities = 49/268 (18%), Positives = 99/268 (36%), Gaps = 19/268 (7%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCP 68
           +   D    + +  G FG +   + +       +K +    M       E  +M+     
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 59

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            +V L+        ++ I EY+  G  +  L  +        +      ++ +A++YL  
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
             ++HRD+   N L++  G +K++DFG +  V  +    S+       +  PEVL     
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM---- 174

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL 247
                 ++   D+W+ GV+ +E+ + G  P+   T   T   I        +        
Sbjct: 175 ---YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-----QGLRLYRPHLA 226

Query: 248 STAMVNFVQSLVQKL-DARLNMDQVLGH 274
           S  +   + S   +  D R     +L +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-42
 Identities = 67/330 (20%), Positives = 129/330 (39%), Gaps = 47/330 (14%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIER-----DIMVKSKCPYIV 71
           +    +I +G +G +    +  +     +KK+   +     +R      I+++ +   I+
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 72  NLFYSFQDMNHV----YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
            +    +          +++ ++ G D   LL+ Q    LS     +++Y++ + ++Y+H
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH 126

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV--PVGTPEYVAPEVLEW 185
               +HRD+KP N+LL+ T  LK+ DFG A   D +      +   V T  Y APE++  
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM-- 184

Query: 186 MEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI 245
                 S GYT S D+WS+G +  E+L+    F  +      + IL      +    + I
Sbjct: 185 ----LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 246 -------------------------RLSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDC 279
                                       +  ++ +  ++      R+ ++Q L HP  + 
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

Query: 280 LDSDPPCIPPPSQENKFHKKDKRKASPSLK 309
              DP   P      KF  +        LK
Sbjct: 301 Y-YDPSDEPIAEAPFKFDMELDDLPKEKLK 329

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  151 bits (382), Expect = 1e-41
 Identities = 64/293 (21%), Positives = 111/293 (37%), Gaps = 40/293 (13%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPY 69
            +     I +G +G +Y  +      TF +KK+  EK    I      E  I+ + K   
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV L+        +  + E++       L      G L    A+ ++ +L   + Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             +HRD+KP N+L++  G LK+ DFG A       R K    + T  Y AP+VL      
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVL------ 172

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI---- 245
            GS  Y+ + D+WS+G +  E++ G+  F   +       I             ++    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 246 -------------------RLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVFD 278
                               L  + ++ +  +++   + R+   Q L H  F 
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 1e-41
 Identities = 53/267 (19%), Positives = 108/267 (40%), Gaps = 21/267 (7%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI----ERDIMVKSKC 67
           V      +   +  G FG++++       +T V  K L++   +      E ++M + + 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMSPDAFLAEANLMKQLQH 67

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
             +V L Y+      +Y I EY+  G  V  L+      L+ +K      ++A+ + ++ 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 128 GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWME 187
              Y+HRD++  N+L+S T   K+ DFG A  ++ N            ++ APE + +  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 188 GNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIR 246
                  +T   D+WS G++  E++T G  P+   T      ++     E          
Sbjct: 187 -------FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----ERGYRMVRPDN 234

Query: 247 LSTAMVNFVQSLVQKL-DARLNMDQVL 272
               +   ++   ++  + R   D + 
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLR 261

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (382), Expect = 1e-41
 Identities = 48/265 (18%), Positives = 100/265 (37%), Gaps = 15/265 (5%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT---IERDIMVKSKCP 68
           +  +D  +K  +  G +G++Y    K+   T  +K +  + M       E  +M + K P
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP 73

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            +V L          Y I E++T G+ +  L       +S     +   +++ A++YL  
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
             ++HRD+   N L+     +K+ DFG +  +  +            ++ APE L     
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA---- 189

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
               + ++   D+W+ GV+ +E+ T                +L    E            
Sbjct: 190 ---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERPEGCP 242

Query: 249 TAMVNFVQSLVQKL-DARLNMDQVL 272
             +   +++  Q     R +  ++ 
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIH 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 55/298 (18%), Positives = 107/298 (35%), Gaps = 46/298 (15%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTF----VMKKVLREKMPNTI------ERDI 61
               + +  + +  G FG +          T     V  K+L+EK  ++       E  +
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 62  MVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL--------------------- 99
           M +      IVNL  +      +Y I EY   GD +  L                     
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 100 ENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ 159
           E +    L+      + Y++A+ +++L     VHRD+   N+L++    +K+ DFG A  
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 160 VDKNGRIKSIV-PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTP 217
           +  +             +++APE L           YT   D+WS G++ +E+ + G  P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLF-------EGIYTIKSDVWSYGILLWEIFSLGVNP 266

Query: 218 FNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGH 274
           +    +D  +  ++    ++          +  +   +QS        R +   +   
Sbjct: 267 YPGIPVDANFYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 56/277 (20%), Positives = 111/277 (40%), Gaps = 27/277 (9%)

Query: 10  KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT--------IERDI 61
           K +  S   I++ I  G FG++     K      +   +   K   T         E  I
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +   P +++L         V  I E++  G  +     Q  G  +  +    +  +A 
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS-LDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI----KSIVPVGTPEY 177
            ++YL  + YVHRD+   N+L+++    K++DFG +  ++ +        ++       +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTE 236
            APE ++          +T + D+WS G+V +E+++ G  P+   T     ++I     E
Sbjct: 200 TAPEAIQ-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-----E 247

Query: 237 DTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVL 272
                P  +   +A+   +    QK  + R    Q++
Sbjct: 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 67/306 (21%), Positives = 116/306 (37%), Gaps = 47/306 (15%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR-----EKMPNTIERDIMV---- 63
           +   ++    I +G +G ++   + ++   FV  K +R     E MP +  R++ V    
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 64  -KSKCPYIVNLFYSFQDM-----NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIY 117
              + P +V LF             +  + E+V      T L+  P   +     +  ++
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMF 123

Query: 118 ELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEY 177
           +L + + +LH    VHRD+KP N+L++++G +KL DFG A        + S+  V T  Y
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VVTLWY 181

Query: 178 VAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC---- 233
            APEVL           Y    DLWS+G +  E+      F   +       IL      
Sbjct: 182 RAPEVLLQS-------SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 234 ---DTEDTVSFPSSI--------------RLSTAMVNFVQSLVQK-LDARLNMDQVLGHP 275
              D    V+ P                  +     + +   +      R++    L HP
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294

Query: 276 VFDCLD 281
            F  L+
Sbjct: 295 YFQDLE 300

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 7e-41
 Identities = 56/289 (19%), Positives = 101/289 (34%), Gaps = 32/289 (11%)

Query: 5   KELRQKNVSASDFDIKRF-IQQGNFGDIYLVEEKQSHN-TFVMKKVLREKMPNTI----- 57
           K+L  K     +  I    +  GNFG +     +       V  KVL++           
Sbjct: 1   KKLFLKR---DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 57

Query: 58  -ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYI 116
            E  IM +   PYIV L    Q    +  +ME   GG     L  +    +  S     +
Sbjct: 58  REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELL 115

Query: 117 YELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG--RIKSIVPVGT 174
           ++++  ++YL    +VHRD+   N+LL    + K++DFG +  +  +             
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILAC 233
            ++ APE +           ++   D+WS GV  +E L+ G  P+         + I   
Sbjct: 176 LKWYAPECIN-------FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228

Query: 234 DTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQV---LGHPVFD 278
              +    P        +   +        + R +   V   +    + 
Sbjct: 229 KRME---CPPEC--PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 38/300 (12%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPY 69
           +F     I +G +G +Y    K +     +KK+  +     +      E  ++ +   P 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV L       N +Y + E++   D    ++      +     + Y+++L Q + + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             +HRD+KP N+L++  G +KL DFG A       R  +   V T  Y APE+L      
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE-VVTLWYRAPEIL------ 174

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC--------------DT 235
            G   Y+ + D+WS+G +  E++T    F  ++       I                   
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 236 EDTVSFPSSIR---------LSTAMVNFVQSLVQK-LDARLNMDQVLGHPVFDCLDSDPP 285
           +   SFP   R         L     + +  ++    + R++    L HP F  +    P
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 4e-40
 Identities = 63/309 (20%), Positives = 101/309 (32%), Gaps = 52/309 (16%)

Query: 13  SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSK 66
             S ++    I QG FG+++    +++     +KKVL E            E  I+   K
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67

Query: 67  CPYIVNLFYSFQDM--------NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYE 118
              +VNL    +            +Y + ++         L +      + S+ +  +  
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQM 125

Query: 119 LAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---VGTP 175
           L   + Y+H    +HRD+K  N+L++  G LKL DFG A         +       V T 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 176 EYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT 235
            Y  PE+L       G   Y    DLW  G +  E+ T S      T     + I     
Sbjct: 186 WYRPPELL------LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 236 EDTVSFPSSIRLSTAMVNF----------------------VQSLVQKL-----DARLNM 268
             T     ++                                  L+ KL       R++ 
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 269 DQVLGHPVF 277
           D  L H  F
Sbjct: 300 DDALNHDFF 308

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 7e-40
 Identities = 46/267 (17%), Positives = 96/267 (35%), Gaps = 17/267 (6%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNT---IERDIMVKSKCP 68
           +  S+    + I  G FG ++L     + +   +K +    M       E ++M+K   P
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 60

Query: 69  YIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
            +V L+    +   +  + E++  G     L  Q   + +         ++ + + YL  
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEE 119

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEG 188
              +HRD+   N L+     +K++DFG    V  +    S       ++ +PEV      
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS---- 175

Query: 189 NHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS 248
                 Y+   D+WS GV+ +E+ +          +      +  D             S
Sbjct: 176 ---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTGFRLYKPRLAS 228

Query: 249 TAMVNFVQSLVQKL-DARLNMDQVLGH 274
           T +   +    ++  + R    ++L  
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 8e-40
 Identities = 50/276 (18%), Positives = 108/276 (39%), Gaps = 30/276 (10%)

Query: 21  RFIQQGNFGDIYLV--EEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPYIVN 72
           + +  GNFG +     + K+   T  +K +  E     +      E ++M +   PYIV 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 73  LFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYV 132
           +     +      +ME    G     L+   + ++ +      +++++  ++YL    +V
Sbjct: 73  M-IGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFV 129

Query: 133 HRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIKSIVPVGTPEYVAPEVLEWMEGNH 190
           HRD+   N+LL    + K++DFG +  +  D+N            ++ APE +       
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN------ 183

Query: 191 GSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST 249
               ++   D+WS GV+ +E  + G  P+         + +   +  + +  P+      
Sbjct: 184 -YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---EKGERMGCPAGC--PR 237

Query: 250 AMVNFVQSLVQKL-DARLNMDQV---LGHPVFDCLD 281
            M + +        + R     V   L +  +D ++
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 58/273 (21%), Positives = 104/273 (38%), Gaps = 24/273 (8%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI--------ERDIMV 63
           +     ++ R I +G FGD++        N  +   +   K   +         E   M 
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 64  KSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           +   P+IV L     + N V+ IME  T G+  +         L  +    Y Y+L+ A+
Sbjct: 64  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTAL 121

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
            YL    +VHRDI   N+L+S+   +KL DFG +  ++ +   K+       +++APE +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP 242
            +         +T + D+W  GV  +E+L  G  PF     +     I   +       P
Sbjct: 182 NFR-------RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-----LP 229

Query: 243 SSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGH 274
                   + + +          R    ++   
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 49/278 (17%), Positives = 87/278 (31%), Gaps = 26/278 (9%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSK---C 67
           NV    + + R I +G+FG I+      ++    +K   R      +  +         C
Sbjct: 1   NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC 60

Query: 68  PYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLH 127
             I N++Y  Q+  H   +++ +       L         S         ++   VQ +H
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIH 118

Query: 128 GLGYVHRDIKPDNMLLSA-----TGHLKLTDFGSATQVDKNGRIKSIVP------VGTPE 176
               V+RDIKPDN L+          + + DFG           + I         GT  
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 177 YVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE 236
           Y++       E        +   DL ++G V    L GS P+                 +
Sbjct: 179 YMSINTHLGRE-------QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231

Query: 237 DTVSFPSSIR--LSTAMVNFVQSLVQK-LDARLNMDQV 271
              +    +          ++        DA  + D +
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 5e-38
 Identities = 56/298 (18%), Positives = 104/298 (34%), Gaps = 28/298 (9%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK---KVLREKMPNTI------ERDIM 62
           +  ++F   + +  G FG +Y            +    K LRE            E  +M
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 63  VKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
                P++  L       + V  I + +  G  +     +    +       +  ++A+ 
Sbjct: 66  ASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKG 123

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG-RIKSIVPVGTPEYVAPE 181
           + YL     VHRD+   N+L+    H+K+TDFG A  +        +       +++A E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 182 VLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS 240
            +           YT   D+WS GV  +EL+T GS P++        S +     E    
Sbjct: 184 SIL-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-----EKGER 231

Query: 241 FPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVFDCLDSDPPCIPPPSQENKFH 297
            P     +  +   +        D+R    +++    F  +  DP        + + H
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE--FSKMARDPQRYLVIQGDERMH 287

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 7e-38
 Identities = 61/294 (20%), Positives = 116/294 (39%), Gaps = 40/294 (13%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPY 69
            ++    I +G +G ++  + +++H    +K+V  +     +      E  ++ + K   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 70  IVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGL 129
           IV L         +  + E+      +    +  +G L     + ++++L + + + H  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 130 GYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
             +HRD+KP N+L++  G LKL +FG A       R  S   V T  Y  P+VL      
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVL------ 173

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSILACDTEDTVSFPSSI--- 245
            G+  Y+ S D+WS G +  EL     P F    +D     I       T     S+   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 246 --------------------RLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVFD 278
                               +L+    + +Q+L++     R++ ++ L HP F 
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  142 bits (358), Expect = 7e-38
 Identities = 66/307 (21%), Positives = 122/307 (39%), Gaps = 53/307 (17%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC---PYIVN 72
           D+ + R + +G + +++      ++   V+K +L+      I+R+I +       P I+ 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVK-ILKPVKKKKIKREIKILENLRGGPNIIT 94

Query: 73  LFYSFQD--MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG 130
           L    +D        + E+V   DF  L +      L++   RFY+YE+ +A+ Y H +G
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG 149

Query: 131 YVHRDIKPDNMLL-SATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGN 189
            +HRD+KP N+++      L+L D+G A              V +  +  PE+       
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPEL------L 201

Query: 190 HGSDGYTGSCDLWSIGVVSYELLTGSTPF-----NYETLDM---------TYSSILACDT 235
                Y  S D+WS+G +   ++    PF     NY+ L            Y  I   + 
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 236 EDTVSFPSSIR------------------LSTAMVNFVQSLVQK-LDARLNMDQVLGHPV 276
           E    F   +                   +S   ++F+  L++    +RL   + + HP 
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

Query: 277 FDCLDSD 283
           F  +  D
Sbjct: 322 FYTVVKD 328

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-37
 Identities = 47/275 (17%), Positives = 94/275 (34%), Gaps = 27/275 (9%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQS--HNTFVMKKVLREKMPNTI--------ERDI 61
           +   D  +   +  G+FG +   E          V  K L+  + +          E + 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M       ++ L+        +  + E    G  +     +  G+        Y  ++A+
Sbjct: 65  MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAE 122

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR--IKSIVPVGTPEYVA 179
            + YL    ++HRD+   N+LL+    +K+ DFG    + +N    +          + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDT 238
           PE L+       +  ++ + D W  GV  +E+ T G  P+      +  S IL    ++ 
Sbjct: 183 PESLK-------TRTFSHASDTWMFGVTLWEMFTYGQEPWI----GLNGSQILHKIDKEG 231

Query: 239 VSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVL 272
              P        + N +        + R     + 
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-37
 Identities = 54/287 (18%), Positives = 110/287 (38%), Gaps = 38/287 (13%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK-KVLREKMPNTI------ERDIMVK 64
           +  +D   +  I +GNFG +     K+         K ++E            E +++ K
Sbjct: 7   LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 65  -SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPH--------------GYLSE 109
               P I+NL  + +   ++Y  +EY   G+ +  L                     LS 
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 110 SKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI 169
            +   +  ++A+ + YL    ++HRD+   N+L+      K+ DFG +   +    +K  
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKT 184

Query: 170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYS 228
           +      ++A E L +         YT + D+WS GV+ +E+++ G TP+   T    Y 
Sbjct: 185 MGRLPVRWMAIESLNYS-------VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237

Query: 229 SILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGH 274
            +              +     + + ++   ++    R +  Q+L  
Sbjct: 238 KLPQG-----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-37
 Identities = 54/274 (19%), Positives = 103/274 (37%), Gaps = 24/274 (8%)

Query: 11  NVSASDFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPNTI------ERDI 61
            +  S    ++ I  G FG++Y    K S       V  K L+             E  I
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQ 121
           M +     I+ L         +  I EY+  G        +  G  S  +    +  +A 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAA 121

Query: 122 AVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV--DKNGRIKSIVPVGTPEYVA 179
            ++YL  + YVHRD+   N+L+++    K++DFG +  +  D      +        + A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 180 PEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV 239
           PE + + +       +T + D+WS G+V +E++T      +E  +      +     D  
Sbjct: 182 PEAISYRK-------FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI----NDGF 230

Query: 240 SFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVL 272
             P+ +   +A+   +    Q+    R     ++
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (348), Expect = 7e-37
 Identities = 54/302 (17%), Positives = 105/302 (34%), Gaps = 47/302 (15%)

Query: 6   ELRQKNVSASDFDIKRFIQQGNFGDIYLVEEK----QSHNTFVMKKVLREKMPNTI---- 57
           +L       ++ +  R I +G FG ++             T V  K+L+E+    +    
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 58  --ERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGY--------- 106
             E  +M +   P IV L         +  + EY+  GD    L +              
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 107 -------------LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD 153
                        LS ++      ++A  + YL    +VHRD+   N L+     +K+ D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183

Query: 154 FGSATQVDKNGRIKSI-VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELL 212
           FG +  +      K+         ++ PE + +         YT   D+W+ GVV +E+ 
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-------RYTTESDVWAYGVVLWEIF 236

Query: 213 TGS-TPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQ 270
           +    P+     +     +      + ++ P +      + N ++    KL   R +   
Sbjct: 237 SYGLQPYYGMAHEEVIYYVR---DGNILACPENC--PLELYNLMRLCWSKLPADRPSFCS 291

Query: 271 VL 272
           + 
Sbjct: 292 IH 293

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 8e-37
 Identities = 67/327 (20%), Positives = 124/327 (37%), Gaps = 52/327 (15%)

Query: 15  SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCP 68
           + +   + +  G +G +    + ++     +KK+ R             E  ++   +  
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 69  YIVNLFYSFQ------DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQA 122
            ++ L   F       D    Y +M ++ G D   L++   H  L E + +F +Y++ + 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKG 133

Query: 123 VQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV 182
           ++Y+H  G +HRD+KP N+ ++    LK+ DFG A Q D     +    V T  Y APEV
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEV 189

Query: 183 LEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP 242
           +           YT + D+WS+G +  E++TG T F           I+         F 
Sbjct: 190 I------LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243

Query: 243 SSI-------------------------RLSTAMVNFVQSLVQK-LDARLNMDQVLGHPV 276
             +                           S   VN ++ ++    + R+   + L HP 
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

Query: 277 FDCLDSDPPCIPPPSQENKFHKKDKRK 303
           F+ L            ++ F   D+  
Sbjct: 304 FESLHDTEDEPQVQKYDDSFDDVDRTL 330

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (345), Expect = 2e-36
 Identities = 43/271 (15%), Positives = 87/271 (32%), Gaps = 24/271 (8%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKC---PYIVNL 73
           + + R I  G+FGDIYL  +  +     +K    +     +  +  +         I  +
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 74  FYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVH 133
            +   + ++   +ME +        L N      S         ++   ++Y+H   ++H
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 134 RDIKPDNMLLSATGH---LKLTDFGSATQVDKNG------RIKSIVPVGTPEYVAPEVLE 184
           RD+KPDN L+        + + DFG A +             ++    GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT-- 184

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                H     +   DL S+G V      GS P+                 +   +    
Sbjct: 185 -----HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 245 IR--LSTAMVNFVQSLVQKL-DARLNMDQVL 272
           +     +    ++        D + +   + 
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 9e-36
 Identities = 60/291 (20%), Positives = 115/291 (39%), Gaps = 42/291 (14%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVE------EKQSHNTFVMKKVLREKMPNT------IER 59
           +      + + + +G FG + L E      +K +  T V  K+L+             E 
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 60  DIMVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQ--------------PH 104
           ++M    K   I+NL  +      +Y I+EY + G+    L+ +              P 
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 105 GYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
             LS        Y++A+ ++YL     +HRD+   N+L++    +K+ DFG A  +    
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 165 -RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYET 222
              K+       +++APE L           YT   D+WS GV+ +E+ T G +P+    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

Query: 223 LDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVL 272
           ++  +  +      D    PS+   +  +   ++     +   R    Q++
Sbjct: 243 VEELFKLLKEGHRMD---KPSNC--TNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-35
 Identities = 48/290 (16%), Positives = 94/290 (32%), Gaps = 39/290 (13%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVE-----EKQSHNTFVMKKVLREKMPNTIER-----DI 61
              +     + +  G FG +         +  +  T  +K +         E       +
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 62  MVK-SKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLLENQPHGY-------------- 106
           +        IVNL  +         I EY   GD +  L  +   +              
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 107 --LSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG 164
             L       + Y++A+ + +L     +HRD+   N+LL+     K+ DFG A  +  + 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 165 R-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETL 223
             +         +++APE +        +  YT   D+WS G+  +EL +  +       
Sbjct: 200 NYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWSYGIFLWELFSLGSSPYP--- 249

Query: 224 DMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVL 272
            M   S      ++     S       M + +++        R    Q++
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 6e-35
 Identities = 66/329 (20%), Positives = 119/329 (36%), Gaps = 54/329 (16%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPY 69
            +     +  G +G +    + ++     +KK+ R             E  ++   K   
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 70  IVNLFYSFQDMNHV-----YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQ 124
           ++ L   F     +      +++ ++ G D   +++ Q    L++   +F IY++ + ++
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLK 135

Query: 125 YLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLE 184
           Y+H    +HRD+KP N+ ++    LK+ DFG A   D          V T  Y APE++ 
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----GYVATRWYRAPEIM- 190

Query: 185 WMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS 244
                     Y  + D+WS+G +  ELLTG T F           IL             
Sbjct: 191 -----LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245

Query: 245 I-------------------------RLSTAMVNFVQSLVQKL-DARLNMDQVLGHPVFD 278
           I                           +   V+ ++ ++    D R+   Q L H  F 
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

Query: 279 CL--DSDPPCIPP--PSQENKFHKKDKRK 303
                 D P   P   S E++    D+ K
Sbjct: 306 QYHDPDDEPVADPYDQSFESRDLLIDEWK 334

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 59/282 (20%), Positives = 107/282 (37%), Gaps = 33/282 (11%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEK----QSHNTFVMKKVLREKMPNTI------ERDI 61
           V+     + R + QG+FG +Y    K        T V  K + E            E  +
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 62  MVKSKCPYIVNLFYSFQDMNHVYFIMEYVTGGDFVTLL--------ENQPHGYLSESKAR 113
           M +  C ++V L            IME +T GD  + L         N      S SK  
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 114 FYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQV-DKNGRIKSIVPV 172
               E+A  + YL+   +VHRD+   N +++    +K+ DFG    + + +   K    +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGS-TPFNYETLDMTYSSIL 231
               +++PE L+          +T   D+WS GVV +E+ T +  P+   + +     ++
Sbjct: 197 LPVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249

Query: 232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVL 272
                D    P +      +   ++   Q     R +  +++
Sbjct: 250 EGGLLD---KPDNC--PDMLFELMRMCWQYNPKMRPSFLEII 286

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 5e-34
 Identities = 50/295 (16%), Positives = 93/295 (31%), Gaps = 43/295 (14%)

Query: 14  ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERD----IMVKSKCPY 69
           A    ++  I +G FG+++  + +      V  K+   +   +  R+      V  +   
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN 58

Query: 70  IVNLFYSFQDMN----HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQY 125
           I+    +    N     ++ + +Y   G     L       ++           A  + +
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 115

Query: 126 LH--------GLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVP---VGT 174
           LH             HRD+K  N+L+   G   + D G A + D       I P   VGT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 175 PEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD 234
             Y+APEVL     N          D++++G+V +E+    +              L   
Sbjct: 176 KRYMAPEVL-DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234

Query: 235 TE----------------DTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVL 272
                             +  +   S      M   ++        ARL   ++ 
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 6e-34
 Identities = 59/343 (17%), Positives = 114/343 (33%), Gaps = 63/343 (18%)

Query: 16  DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTI------ERDIMVKSKCPY 69
            +   + I  G  G +    +        +KK+ R     T       E  +M       
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 70  IVNLFYSF------QDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAV 123
           I++L   F      ++   VY +ME +       +        L   +  + +Y++   +
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMELDHERMSYLLYQMLCGI 132

Query: 124 QYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVL 183
           ++LH  G +HRD+KP N+++ +   LK+ DFG A     +  +     V T  Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVI 190

Query: 184 EWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS 243
             M       GY  + D+WS+G +  E++     F        ++ ++         F  
Sbjct: 191 LGM-------GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 244 SI------------------------------------RLSTAMVNFVQSLVQKL-DARL 266
            +                                      ++   + +  ++      R+
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 267 NMDQVLGHPVFDCLDSDPPCIPPPSQENKFHKKDKRKASPSLK 309
           ++D  L HP  +          PP Q       ++       K
Sbjct: 304 SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 2e-33
 Identities = 50/292 (17%), Positives = 112/292 (38%), Gaps = 40/292 (13%)

Query: 12  VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMK----KVLREKMPNTIERD------- 60
                  + + + +G FG +   +      T   +    K+L+E   ++  R        
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 61  IMVKSKCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPH--------------G 105
           ++       +VNL     +    +  I+E+   G+  T L ++ +               
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 106 YLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG- 164
           +L+      Y +++A+ +++L     +HRD+   N+LLS    +K+ DFG A  + K+  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETL 223
            ++        +++APE +           YT   D+WS GV+ +E+ +  ++P+    +
Sbjct: 190 YVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 224 DMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGH 274
           D  +   L    ++     +    +  M   +          R    +++ H
Sbjct: 243 DEEFCRRL----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 9e-32
 Identities = 48/288 (16%), Positives = 105/288 (36%), Gaps = 27/288 (9%)

Query: 2   DVVKELRQKNVSASDFDI--KRFIQQGNFGDIYLVEEKQSHNTFV---MKKVLREKMPNT 56
           ++V+ ++   +  S   +     I +G+FG +Y      +    +   +K + R      
Sbjct: 12  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71

Query: 57  I-----ERDIMVKSKCPYIVNLF-YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSES 110
           +     E  IM     P +++L     +       ++ Y+  GD    + N+ H   +  
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVK 130

Query: 111 KARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG---RIK 167
               +  ++A+ +++L    +VHRD+   N +L     +K+ DFG A  +          
Sbjct: 131 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190

Query: 168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTY 227
                   +++A E L+       +  +T   D+WS GV+ +EL+T   P      D+  
Sbjct: 191 KTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYP---DVNT 240

Query: 228 SSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQKL-DARLNMDQVLGH 274
             I     +              +   +        + R +  +++  
Sbjct: 241 FDITVYLLQGRRLLQPE-YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (261), Expect = 5e-25
 Identities = 63/352 (17%), Positives = 121/352 (34%), Gaps = 81/352 (23%)

Query: 17  FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM-PNTIERDIMVKSK--------- 66
           + + R +  G+F  ++L ++  ++    MK V  +K+     E +I +  +         
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 67  ----CPYIVNLFYSFQDM---NHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYEL 119
                 +I+ L   F           ++  V G + + L++   H  +     +    +L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 120 AQAVQYLH-GLGYVHRDIKPDNMLLSATG------HLKLTDFGSATQVDKNGRIKSIVPV 172
              + Y+H   G +H DIKP+N+L+           +K+ D G+A   D++        +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SI 190

Query: 173 GTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSI-- 230
            T EY +PEVL           +    D+WS   + +EL+TG   F  +           
Sbjct: 191 QTREYRSPEVLLGAP-------WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

Query: 231 LACDTEDTVSFPSSI----------------------------------------RLSTA 250
           +A   E     PS +                                          +  
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303

Query: 251 MVNFVQSLVQKL-DARLNMDQVLGHPVF-DCLDSDPPCIPPPSQENKFHKKD 300
           + +F+  ++Q     R +   ++ HP   D L  +   I  P +E      D
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE--IRVPDRELYGSGSD 353

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 70.6 bits (172), Expect = 2e-14
 Identities = 27/200 (13%), Positives = 63/200 (31%), Gaps = 30/200 (15%)

Query: 19  IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSF- 77
           I + + +G    ++    ++      + K  +    +  +          +   L     
Sbjct: 4   IGKLMGEGKESAVFNCYSEK--FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 78  -------QDMNHVYFIMEYVTGGDFV--TLLENQPHGYLSESKARFYIYELAQAVQYLHG 128
                  Q +  +     Y   G+ V   L++ +    +        +  + + V   + 
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 129 LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEV---LEW 185
            G VH D+   N+L+S  G + + DF  + +V +          G  E +  +V   + +
Sbjct: 122 RGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEE---------GWREILERDVRNIITY 171

Query: 186 MEGNHGSDGYTGSCDLWSIG 205
                    Y    D+ S  
Sbjct: 172 FSRT-----YRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	792
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.89
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.75
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.75
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.64
d1rsob_	56	Peripheral plasma membrane protein cask {Rat (Ratt	95.33

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-58  Score=491.28  Aligned_cols=274  Identities=33%  Similarity=0.614  Sum_probs=240.5

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----h--HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----N--TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~--~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ++++++|++++.||+|+||.||+|+++.+|+.||+|++.+....     .  ..|+.+|+.++|||||+++++|++.+.+
T Consensus         1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            46789999999999999999999999999999999999765321     1  5799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+|||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus        81 ~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             ccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999999999965  456999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      . ......+|||.|+|||++.+       ..|+.++|||||||++|+|++|++||.+.+...++..+..    ..+.+|.
T Consensus       159 ~-~~~~~~~GT~~Y~aPE~~~~-------~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~----~~~~~p~  226 (337)
T d1o6la_         159 G-ATMKTFCGTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPR  226 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSS-------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCT
T ss_pred             C-cccccceeCHHHhhhhhccC-------CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc----CCCCCCc
Confidence            2 23445689999999999974       3789999999999999999999999999999999988887    5566666


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCC---CcccCcCChhh
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPP---PSQENKFHKKD  300 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~---~s~~~~f~~k~  300 (792)
                        .+|+++++||.+||+ ||.+||+     +.++++||||..++        ..||+.|.   +.+..+|+...
T Consensus       227 --~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~  298 (337)
T d1o6la_         227 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEF  298 (337)
T ss_dssp             --TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHH
T ss_pred             --cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchh
Confidence              789999999999999 9999995     89999999999875        46777775   23445665543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=472.68  Aligned_cols=251  Identities=33%  Similarity=0.591  Sum_probs=225.7

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ++++++|++++.||+|+||+||+|+++.+|+.||+|++.+.....       ..|+.+++.++|||||+++++|.+++.+
T Consensus         2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            467899999999999999999999999999999999997543211       5689999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |||||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|......
T Consensus        82 ~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             EEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999999999965  345999999999999999999999999999999999999999999999999999876533


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                         .....+||+.|+|||++.+       ..|+.++|||||||++|+|++|++||.+.+....+..+..    ..+.+|.
T Consensus       160 ---~~~~~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~~~~~p~  225 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPPEMIEG-------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR----VEFTFPD  225 (263)
T ss_dssp             ---CCEETTEEGGGCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCCCCCT
T ss_pred             ---cccccCCCCcccCHHHHcC-------CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCc
Confidence               2345579999999999973       3689999999999999999999999999998888888876    4455665


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                        .+|+++++||.+||. ||.+|||+.++|+||||..
T Consensus       226 --~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         226 --FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             --cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence              689999999999999 9999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-57  Score=476.69  Aligned_cols=255  Identities=30%  Similarity=0.630  Sum_probs=224.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++.+....       ...|+.++++++|||||+++++|.+++.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            4557899999999999999999999999999999999754321       157999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      ||||||+||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus        85 ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            99999999999999854  4569999999999999999999999999999999999999999999999999998775432


Q ss_pred             C-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        165 R-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       165 ~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                      . ......+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+....+..|..    ..+.+|.
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~----~~~~~p~  231 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----LEYDFPE  231 (288)
T ss_dssp             -------CCCCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT----TCCCCCT
T ss_pred             cccccccccCCccccCceeecc-------CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc----CCCCCCc
Confidence            2 23345689999999999974       3689999999999999999999999999999898888877    4455665


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcCChhH------HhcCCCccCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARLNMDQ------VLGHPVFDCLD  281 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRPTaeE------IL~HPwF~~i~  281 (792)
                        .+|+++++||.+||. ||.+|||+++      +++||||++++
T Consensus       232 --~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         232 --KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             --TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             --cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence              789999999999999 9999999988      58899999876

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=467.26  Aligned_cols=254  Identities=26%  Similarity=0.444  Sum_probs=216.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.....     ..|+.++++++|||||+++++|.+.+.+|||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            578999999999999999999999999999999997654332     579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCc-c
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRI-K  167 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~-~  167 (792)
                      ||+||+|.+++.  ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+........ .
T Consensus        84 y~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            999999999994  4567999999999999999999999999999999999999999999999999999877544322 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh-hhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-YSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el-~ekIl~~~~~~~l~fP~~~~  246 (792)
                      ....+|||.|+|||++.+.      ..++.++|||||||++|+|++|++||........ +..+..    .....+.+..
T Consensus       162 ~~~~~GT~~Y~APE~~~~~------~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~  231 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRR------EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTYLNPWKK  231 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCS------SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT----TCTTSTTGGG
T ss_pred             ccceeeCcCccCHhHhcCC------CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCcccc
Confidence            3456899999999999732      2356789999999999999999999976554332 222222    2223334457


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +|+++.+||.+||. ||.+|||+.++|+||||+.
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            89999999999999 9999999999999999973

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.6e-56  Score=470.73  Aligned_cols=259  Identities=34%  Similarity=0.650  Sum_probs=230.1

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVY   84 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~ly   84 (792)
                      +++++|++++.||+|+||+||+|+++.+|+.||||++.+.....       ..|+.+++.++|||||+++++|.+.+.+|
T Consensus         1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            36789999999999999999999999999999999997543211       57999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      +|||||.||+|..++..  .+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+..... 
T Consensus        81 ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          81 MIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             EEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            99999999999999965  455899999999999999999999999999999999999999999999999999876532 


Q ss_pred             CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        165 RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       165 ~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                         ..+.+|||.|+|||++.+       ..|+.++|||||||++|+|++|+.||.+.+....+..+..    ....+|. 
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~-------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~p~-  222 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVST-------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AELRFPP-  222 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----CCCCCCT-
T ss_pred             ---cccccCcccccCHHHHcC-------CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc----CCCCCCC-
Confidence               335689999999999963       3689999999999999999999999999999998888877    4455565 


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC--------CCCCCCCC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD--------SDPPCIPP  289 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~--------~~pP~~P~  289 (792)
                       .+|+++.+++.+||. ||.+|+     |++++++||||++++        ..||+.|+
T Consensus       223 -~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~  280 (316)
T d1fota_         223 -FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP  280 (316)
T ss_dssp             -TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred             -CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCC
Confidence             689999999999999 999996     899999999999875        35566554

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=466.20  Aligned_cols=251  Identities=27%  Similarity=0.466  Sum_probs=221.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      .+|++++.||+|+||+||+|+++.+|+.||+|++.+.....    ..|+.+++.++|||||+++++|.+.+.+|||||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999999999999999998765543    57999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      +||+|.+++.+   +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.... .....
T Consensus       100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  175 (293)
T d1yhwa1         100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST  175 (293)
T ss_dssp             TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred             CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccc
Confidence            99999998855   349999999999999999999999999999999999999999999999999998875433 23445


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      .+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+.......+...   ....++.+..+|+.
T Consensus       176 ~~gt~~Y~aPE~~~~-------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~  245 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GTPELQNPEKLSAI  245 (293)
T ss_dssp             CCSCGGGCCHHHHSS-------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CSCCCSSGGGSCHH
T ss_pred             cccCCCccChhhhcC-------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---CCCCCCCcccCCHH
Confidence            689999999999973       36899999999999999999999999888776666655542   22233334578999


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +++||.+||. ||.+|||+.++|+||||+.
T Consensus       246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            9999999999 9999999999999999984

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=470.39  Aligned_cols=260  Identities=32%  Similarity=0.633  Sum_probs=224.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-------hHHHHHHHH-hcCCCCcceeEEEEEeCCEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-------NTIERDIMV-KSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-------~~~E~eIL~-kL~HPNIVkL~~vfede~~lyL   85 (792)
                      +++|.+++.||+|+||+||+|.++.+|+.||||++.+....       ...|..++. .++|||||+++++|.+.+.+||
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            47899999999999999999999999999999999754321       145666654 6899999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||||+||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...... 
T Consensus        81 vmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence            9999999999999964  4569999999999999999999999999999999999999999999999999998765433 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                      ......+||+.|+|||++.+       ..|+.++|||||||++|+|++|+.||.+.+....+..+..    ..+.+|.  
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~~~~~p~--  224 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLG-------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----DNPFYPR--  224 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCT--
T ss_pred             ccccccCCCCCcCCHHHHcC-------CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCc--
Confidence            23345679999999999974       3789999999999999999999999999999998888876    4455665  


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChh-HHhcCCCccCCC--------CCCCCCCC
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMD-QVLGHPVFDCLD--------SDPPCIPP  289 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTae-EIL~HPwF~~i~--------~~pP~~P~  289 (792)
                      .+|+.+.+||++||. ||.+|||+. +++.||||+.++        ..||+.|.
T Consensus       225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~  278 (320)
T d1xjda_         225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPK  278 (320)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC-----
T ss_pred             cCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHHhcCCCCCCCCC
Confidence            689999999999999 999999995 899999999864        35666654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-55  Score=466.58  Aligned_cols=253  Identities=32%  Similarity=0.574  Sum_probs=209.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .+.|++++.||+|+||+||+|+++.+|+.||+|++.+.....     ..|+.+|+.++|||||+++++|.+++.+|||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356999999999999999999999999999999998765433     469999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC---CCCceEEeccCcccccccCCC
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS---ATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd---~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||+||+|.+++.+  .+.+++..+..|+.||+.||.|||++||+||||||+|||+.   .+|.+||+|||+|+...... 
T Consensus        88 ~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          88 LVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             CCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             ccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            9999999999954  56699999999999999999999999999999999999994   57899999999998765433 


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCc
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSI  245 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~  245 (792)
                       ...+.+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+.......+......  ...|...
T Consensus       165 -~~~~~~GT~~y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~  234 (307)
T d1a06a_         165 -VLSTACGTPGYVAPEVLAQ-------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FDSPYWD  234 (307)
T ss_dssp             ---------CTTSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC--CCTTTTT
T ss_pred             -eeeeeeeCccccCcHHHcC-------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--CCCcccc
Confidence             2335679999999999973       36899999999999999999999999999888888888773322  2223334


Q ss_pred             cccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        246 RLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       246 ~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      .+|+++.+||.+||. ||.+|||+.++++||||++
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            789999999999999 9999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=461.37  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=223.8

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      +.|++++.||+|+||.||+|+++.+|..||+|++.+.....    ..|+.+|++++|||||+++++|.+++.+|||||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999999999999999997654332    57999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSIV  170 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~t  170 (792)
                      +||+|.+++.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|....... .....
T Consensus        92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTC
T ss_pred             CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccc
Confidence            999999997543 3569999999999999999999999999999999999999999999999999997654321 22335


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccHH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTA  250 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~e  250 (792)
                      .+||+.|+|||++...  ......|+.++|||||||++|+|++|.+||.+.+....+..+....   ...++.+..+|++
T Consensus       170 ~~Gt~~y~APE~l~~~--~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~s~~  244 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCE--TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPTLAQPSRWSSN  244 (288)
T ss_dssp             CCSCCTTCCHHHHTTC--STTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC---CCCCSSGGGSCHH
T ss_pred             cccccccCCHHHHhhc--ccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---CCCCCccccCCHH
Confidence            6799999999998632  1224568999999999999999999999999988888888777632   1223334578999


Q ss_pred             HHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        251 MVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       251 lkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +.+||.+||+ ||.+|||+.++++||||+.
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            9999999999 9999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-55  Score=474.42  Aligned_cols=260  Identities=34%  Similarity=0.660  Sum_probs=231.4

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ...+++|++++.||+|+||.||+|+++.+|+.||||++.+.....       ..|+.+|+.++|||||+++++|.+...+
T Consensus        37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            355789999999999999999999999999999999997543211       5799999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+|||||.||+|..++.+  .+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+...
T Consensus       117 ~~v~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999999999965  346999999999999999999999999999999999999999999999999999887532


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS  243 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~  243 (792)
                          ....+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+....+..|..    ..+.+|.
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~p~  259 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----GKVRFPS  259 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCT
T ss_pred             ----cccccCccccCCHHHHcC-------CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc----CCCCCCc
Confidence                235679999999999974       3689999999999999999999999999998888888877    4445555


Q ss_pred             CccccHHHHHHHHHHhh-ChhhcC-----ChhHHhcCCCccCCC--------CCCCCCCC
Q psy13735        244 SIRLSTAMVNFVQSLVQ-KLDARL-----NMDQVLGHPVFDCLD--------SDPPCIPP  289 (792)
Q Consensus       244 ~~~lS~elkdLIk~LL~-DP~kRP-----TaeEIL~HPwF~~i~--------~~pP~~P~  289 (792)
                        .+|+++.+||++||. ||.+|+     |++++++||||++++        ..||++|.
T Consensus       260 --~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~  317 (350)
T d1rdqe_         260 --HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK  317 (350)
T ss_dssp             --TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             --cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCC
Confidence              789999999999999 999995     899999999999876        36677765

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.7e-55  Score=473.08  Aligned_cols=265  Identities=31%  Similarity=0.597  Sum_probs=222.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHH---HHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIE---RDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E---~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +++++|++++.||+|+||.||+|+++.+|+.||+|++.+.....       ..|   ..+++.++|||||+++++|.+.+
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            47899999999999999999999999999999999997543321       233   45566678999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|||||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999999965  4568999999999999999999999999999999999999999999999999998775


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ..   .....+||+.|+|||++..      ...|+.++|||||||++|+|++|++||.+.+.......+ .........+
T Consensus       159 ~~---~~~~~~GT~~y~APE~~~~------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~  228 (364)
T d1omwa3         159 KK---KPHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVEL  228 (364)
T ss_dssp             SS---CCCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCC
T ss_pred             CC---cccccccccccchhHHhhc------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCC
Confidence            43   2345679999999999852      246899999999999999999999999876544333222 1122234444


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCCC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPPP  290 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~~  290 (792)
                      |.  .+|+++++||.+||. ||.+|||     ++++++||||++++        ..||++|+.
T Consensus       229 ~~--~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~  289 (364)
T d1omwa3         229 PD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR  289 (364)
T ss_dssp             CS--SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred             CC--CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCC
Confidence            44  789999999999999 9999999     69999999999876        356666653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-55  Score=456.03  Aligned_cols=256  Identities=27%  Similarity=0.484  Sum_probs=222.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++.+.....          ..|+.+|++++|||||+++++|.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            356999999999999999999999999999999998654422          4699999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC----ceEEeccCcccc
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG----HLKLTDFGSATQ  159 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg----~VKLiDFGLA~~  159 (792)
                      |||||||+||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|    ++||+|||+|..
T Consensus        89 ~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            999999999999999965  34699999999999999999999999999999999999998776    599999999988


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      .....  .....+||+.|+|||++.+       ..++.++||||+||++|+|++|..||.+.+....+..+.........
T Consensus       167 ~~~~~--~~~~~~~t~~y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         167 IDFGN--EFKNIFGTPEFVAPEIVNY-------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             CTTSC--BCSCCCCCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cCCCc--cccccCCCCcccCHHHHcC-------CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            76443  2335579999999999973       36899999999999999999999999999998888888773322222


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                      .+  ...+|+.+++||.+||. ||.+|||+.++++||||+..+.
T Consensus       238 ~~--~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         238 EY--FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             HH--HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             hh--cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence            22  23689999999999999 9999999999999999986553

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-54  Score=467.19  Aligned_cols=257  Identities=30%  Similarity=0.503  Sum_probs=225.1

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .+++|++++.||+|+||.||+|+++.+|+.||||++.+.....    ..|+.+|++++|||||+++++|.+.+.+|||||
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            3568999999999999999999999999999999997654332    469999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC--CCCceEEeccCcccccccCCCc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS--ATGHLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd--~dg~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||+||+|.+++.+ ..+.+++..+..|+.||+.||.|||++||+||||||+|||++  .+|.+||+|||+|+.+....  
T Consensus       104 ~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--  180 (350)
T d1koaa2         104 FMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  180 (350)
T ss_dssp             CCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred             cCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence            9999999999854 345699999999999999999999999999999999999995  46789999999998876443  


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      ...+.+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+....+..|....+...  .+....
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~  251 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--DSAFSG  251 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHT-------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC--CGGGGG
T ss_pred             ccceecCcccccCHHHHcC-------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--cccccC
Confidence            2334579999999999974       3689999999999999999999999999999888888877432221  112246


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      +|+++++||.+||. ||.+|||+.++|+||||...+
T Consensus       252 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            89999999999999 999999999999999998654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-55  Score=464.40  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=213.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFI   86 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~lyLV   86 (792)
                      +..++|++++.||+|+||+||+|+++.+|+.||+|++.+.....     ..|+.+|+.++|||||+++++|.+.+.+|||
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            55689999999999999999999999999999999997654432     4688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      ||||+||+|.+++.+  .+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|......  
T Consensus        83 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             EECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999999965  3569999999999999999999997 59999999999999999999999999999876532  


Q ss_pred             cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcc------------
Q psy13735        166 IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILAC------------  233 (792)
Q Consensus       166 ~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~------------  233 (792)
                       ...+.+||+.|+|||++.+       ..|+.++||||+||++|+|++|+.||.+.+...........            
T Consensus       159 -~~~~~~GT~~Y~APEvl~~-------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHC-------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             -ccccccCCccccCchHHcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence             2345689999999999974       37999999999999999999999999766543221110000            


Q ss_pred             ---------------------------cCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        234 ---------------------------DTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       234 ---------------------------~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                                 .......+| ...+|+++.+||.+||+ ||.+|||+.++|+||||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCC-BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccccccccccccchhHHHHHhhhhccCCccCc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                                       000001111 13478999999999999 99999999999999999853

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.6e-54  Score=466.29  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=224.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+.....    ..|+.+|++++|||||+++++|.+++.+||||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            467999999999999999999999999999999997654322    4699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC--CCCceEEeccCcccccccCCCcc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS--ATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd--~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |+||+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+  .+|++||+|||+|..+....  .
T Consensus       108 ~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~  184 (352)
T d1koba_         108 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I  184 (352)
T ss_dssp             CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred             CCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence            999999998844 334699999999999999999999999999999999999997  67899999999999876543  2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....+||+.|+|||++.+       ..|+.++|||||||++|+|++|.+||.+.+....+..|...........  ...+
T Consensus       185 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~  255 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDR-------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA--FSSV  255 (352)
T ss_dssp             EEEECSSGGGCCHHHHTT-------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST--TTTS
T ss_pred             eeeccCcccccCHHHHcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc--ccCC
Confidence            344579999999999973       3689999999999999999999999999998888888877433222222  2478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      |+++.+||.+||+ ||.+|||+.++|.||||+...
T Consensus       256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            9999999999999 999999999999999998643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=452.16  Aligned_cols=251  Identities=26%  Similarity=0.450  Sum_probs=209.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe--CCEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD--MNHVYF   85 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed--e~~lyL   85 (792)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+.....      ..|+.++++++|||||+++++|.+  .+.+||
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            468999999999999999999999999999999998876654      468899999999999999999965  456899


Q ss_pred             EEeccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         86 IMEYVTGGDFVTLLENQ--PHGYLSESKARFYIYELAQAVQYLHGLG-----YVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~--~~g~LSE~ea~~Im~QILsAL~YLHs~g-----IVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      |||||+||+|.+++.+.  ..+.+++..++.++.||+.||.|||+.|     |+||||||+|||++.+|.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998532  2456999999999999999999999976     9999999999999999999999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      .+..... .....+|||.|+|||++..       ..|+.++|||||||++|+|++|.+||.+.+.......+.....   
T Consensus       163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~-------~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~---  231 (269)
T d2java1         163 ILNHDTS-FAKAFVGTPYYMSPEQMNR-------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---  231 (269)
T ss_dssp             HC------------CCCSCCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---
T ss_pred             ecccCCC-ccccCCCCcccCCHHHHcC-------CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---
Confidence            8764332 3345689999999999963       3689999999999999999999999999988888888876321   


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCc
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVF  277 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF  277 (792)
                      ..+|.  .+|+++.+||.+||. ||.+|||+.++++|||+
T Consensus       232 ~~~~~--~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 RRIPY--RYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCCc--ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            12333  789999999999999 99999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-54  Score=459.09  Aligned_cols=249  Identities=27%  Similarity=0.370  Sum_probs=219.0

Q ss_pred             CceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         16 DFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        16 dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+.....       ..|+.+|++++|||||+++++|.+.+.+|||||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4999999999999999999999999999999998776543       468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||.||+|..++..  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....     .
T Consensus        96 ~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~  168 (309)
T d1u5ra_          96 YCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A  168 (309)
T ss_dssp             CCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----B
T ss_pred             ecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----C
Confidence            9999999877644  35699999999999999999999999999999999999999999999999999987643     2


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...+|||.|+|||++.+.    ....|+.++|||||||++|+|++|..||.+.+....+..+..    .....+....+|
T Consensus       169 ~~~~GT~~Y~APE~~~~~----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~s  240 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPALQSGHWS  240 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTT----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----SCCCCCSCTTSC
T ss_pred             CccccCccccCHHHHhcc----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCCCCCCC
Confidence            345799999999999632    234689999999999999999999999988887777777665    222223334689


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +.+.+||.+||. ||.+|||+.++|+||||..
T Consensus       241 ~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            999999999999 9999999999999999974

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-53  Score=444.53  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=227.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------------HHHHHHHHhcC-CCCcceeEEEEEe
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------------TIERDIMVKSK-CPYIVNLFYSFQD   79 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------------~~E~eIL~kL~-HPNIVkL~~vfed   79 (792)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.....             ..|+.++++++ |||||+++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999998765432             46899999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ++.+|||||||+||+|.+++..  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            9999999999999999999964  45699999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      +....  .....+||+.|+|||++..... .....++.++||||+||++|+|++|+.||.+.+.......+.....  .+
T Consensus       160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~-~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~--~~  234 (277)
T d1phka_         160 LDPGE--KLREVCGTPSYLAPEIIECSMN-DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY--QF  234 (277)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHHHHHC-TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--CC
T ss_pred             ccCCC--ceeeeeccCCCCCHHHhhcccc-ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC--CC
Confidence            76543  2344679999999999975422 2334688999999999999999999999999998888888876322  22


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      ..+....+|+++++|+.+||+ ||.+|||+.++|+||||+.
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            333445899999999999999 9999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=444.21  Aligned_cols=245  Identities=22%  Similarity=0.416  Sum_probs=209.4

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe----CCEEEEE
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD----MNHVYFI   86 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed----e~~lyLV   86 (792)
                      |++.+.||+|+||+||+|+++.+|..||+|.+.......      ..|+++|++++|||||+++++|.+    ...+|||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            478889999999999999999999999999998766543      469999999999999999999975    4578999


Q ss_pred             EeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCceEeC-CCCceEEeccCcccccccC
Q psy13735         87 MEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLG--YVHRDIKPDNMLLS-ATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        87 mEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~g--IVHRDLKPeNILLd-~dg~VKLiDFGLA~~l~~~  163 (792)
                      ||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+|+.....
T Consensus        91 mE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            999999999999965  356999999999999999999999999  99999999999996 5789999999999865432


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCC-hhhhhhhhhcccCCCCcCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYET-LDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d-~~el~ekIl~~~~~~~l~fP  242 (792)
                         .....+|||.|+|||++.        ..|+.++|||||||++|+|++|++||.... ...++..+....  ....++
T Consensus       169 ---~~~~~~GT~~Y~aPE~~~--------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~--~~~~~~  235 (270)
T d1t4ha_         169 ---FAKAVIGTPEFMAPEMYE--------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFD  235 (270)
T ss_dssp             ---SBEESCSSCCCCCGGGGG--------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CCGGGG
T ss_pred             ---ccCCcccCccccCHHHhC--------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC--CCcccC
Confidence               234568999999999986        258999999999999999999999997543 445555554421  111222


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                        ...++++.+||.+||. ||.+|||+.++|+||||+
T Consensus       236 --~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         236 --KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             --GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             --ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence              3578999999999999 999999999999999995

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=443.71  Aligned_cols=255  Identities=25%  Similarity=0.362  Sum_probs=212.2

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      .+++||+|+||+||+|+++.+|+.||||++.+.....         ..|+.++++++|||||+++++|.+++.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            5789999999999999999999999999997654321         4799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      |.||++..+.  ...+.+++..++.+++||+.||.|||++||+||||||+|||++.+|.+||+|||+|........ ...
T Consensus        82 ~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~  158 (299)
T d1ua2a_          82 METDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT  158 (299)
T ss_dssp             CSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred             hcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence            9988877776  4456799999999999999999999999999999999999999999999999999987654332 334


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------CCCCc---
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------TEDTV---  239 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------~~~~l---  239 (792)
                      ..+||+.|+|||++..      ...|+.++||||+||++|+|++|.+||.+.+....+..|....       +....   
T Consensus       159 ~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CSCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             ceecChhhccHHHHcc------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence            5679999999999863      2468999999999999999999999999888777766664311       00000   


Q ss_pred             ------CCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        240 ------SFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       240 ------~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                            .++.      ...+|+++.+||.+||+ ||.+|||+.++|+||||++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence                  0111      12568999999999999 9999999999999999987553

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=452.43  Aligned_cols=252  Identities=27%  Similarity=0.446  Sum_probs=222.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEecc
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYV   90 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~   90 (792)
                      .++|.+++.||+|+||+||+|.++.+|+.||+|++.+.....   ..|+.+|+.++|||||+++++|++.+.+|||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            578999999999999999999999999999999998764332   57999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCC--CceEEeccCcccccccCCCccc
Q psy13735         91 TGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSAT--GHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        91 ~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~d--g~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      +||+|.+++... .+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+  +.+||+|||++.......  ..
T Consensus        84 ~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~  160 (321)
T d1tkia_          84 SGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NF  160 (321)
T ss_dssp             CCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EE
T ss_pred             CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC--cc
Confidence            999999999542 3469999999999999999999999999999999999999854  479999999998875433  23


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCC--Ccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPS--SIR  246 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~--~~~  246 (792)
                      ...+|||.|+|||.+.+       ..|+.++|||||||++|+|++|.+||.+.+....+..|..    ..+.++.  +..
T Consensus       161 ~~~~~t~~y~ape~~~~-------~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~  229 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQH-------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN----AEYTFDEEAFKE  229 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCCCHHHHTT
T ss_pred             cccccccccccchhccC-------CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCChhhccC
Confidence            44579999999999863       3689999999999999999999999999999999999887    3333333  236


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      +|+++++||.+||. ||.+|||+.++++||||+.
T Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            89999999999999 9999999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=437.95  Aligned_cols=262  Identities=23%  Similarity=0.382  Sum_probs=215.2

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +++|++++.||+|+||+||+|.+..+|+.||+|++.......      ..|+.++++++|||||+++++|.+.+.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            479999999999999999999999999999999997654322      57999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||.| .+..++.....+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+...... ..
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~  158 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT  158 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BC
T ss_pred             eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-cc
Confidence            99965 45555544556679999999999999999999999999999999999999999999999999998775433 23


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC-----------
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE-----------  236 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~-----------  236 (792)
                      ....+||+.|+|||++...      ..++.++||||+||++|+|++|+.||.+.+.......+......           
T Consensus       159 ~~~~~gt~~y~apE~~~~~------~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGC------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTC------SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ceeecccceeeehhhhccc------cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            3455799999999998632      35688999999999999999999999887766555444321000           


Q ss_pred             ---CCcCCCC---------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCCC
Q psy13735        237 ---DTVSFPS---------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDSD  283 (792)
Q Consensus       237 ---~~l~fP~---------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~~  283 (792)
                         ....++.         ...+|+++++|+.+||. ||.+|||+.++|+||||+.+..+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence               0001111         13568999999999999 99999999999999999977543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-53  Score=454.00  Aligned_cols=259  Identities=27%  Similarity=0.490  Sum_probs=214.6

Q ss_pred             CCCCCceEEe-EeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHh-cCCCCcceeEEEEEe----CCEEEE
Q psy13735         12 VSASDFDIKR-FIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVK-SKCPYIVNLFYSFQD----MNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~k-~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~k-L~HPNIVkL~~vfed----e~~lyL   85 (792)
                      ...++|.++. +||+|+||+||+|+++.+|+.||||++.+.. ....|+.++.+ ++|||||+++++|++    ...+||
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i   86 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   86 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH-HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence            3467999875 6999999999999999999999999986543 23568888655 589999999999986    467999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCccccccc
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDK  162 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~~  162 (792)
                      |||||+||+|.+++.+.....|++..++.|+.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|+....
T Consensus        87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccC
Confidence            999999999999997655567999999999999999999999999999999999999975   56799999999987764


Q ss_pred             CCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        163 NGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       163 ~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      ..  .....+|||.|+|||++.+.       .|+.++|||||||++|+|+||++||.+.+.......+..........+|
T Consensus       167 ~~--~~~~~~gt~~y~aPE~~~~~-------~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         167 HN--SLTTPCYTPYYVAPEVLGPE-------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             CC--CCCCCSCCCSSCCCCCCCGG-------GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             CC--ccccccCCcccCCcHHHcCC-------CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            43  23456799999999998743       6899999999999999999999999877655554444433333445555


Q ss_pred             CC--ccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        243 SS--IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       243 ~~--~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      ..  ..+|+++.+||++||+ ||.+|||+.++++||||...
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            43  4689999999999999 99999999999999999753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=432.19  Aligned_cols=244  Identities=24%  Similarity=0.464  Sum_probs=210.4

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh----------HHHHHHHHhcC--CCCcceeEEEEEeCC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN----------TIERDIMVKSK--CPYIVNLFYSFQDMN   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~----------~~E~eIL~kL~--HPNIVkL~~vfede~   81 (792)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+.....          ..|+.++++++  |||||+++++|.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999999999999999998654332          57999999986  899999999999999


Q ss_pred             EEEEEEeccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-CCceEEeccCcccc
Q psy13735         82 HVYFIMEYVTG-GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-TGHLKLTDFGSATQ  159 (792)
Q Consensus        82 ~lyLVmEy~~G-GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-dg~VKLiDFGLA~~  159 (792)
                      .+|+||||+.| +++.+++..  .+.+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|..
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence            99999999976 678888854  356999999999999999999999999999999999999985 47899999999987


Q ss_pred             cccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        160 VDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       160 l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      ....   .....+||+.|+|||++...      ..++.++|||||||++|+|++|..||.+.+      .+..    ...
T Consensus       161 ~~~~---~~~~~~GT~~y~aPE~~~~~------~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~----~~~  221 (273)
T d1xwsa_         161 LKDT---VYTDFDGTRVYSPPEWIRYH------RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR----GQV  221 (273)
T ss_dssp             CCSS---CBCCCCSCGGGSCHHHHHHS------CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH----CCC
T ss_pred             cccc---cccccccCCCcCCHHHHcCC------CCCCcccccccceeeehhHhhCCCCCCCch------HHhh----ccc
Confidence            5432   23456799999999999743      345778999999999999999999997532      2333    333


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                      .++.  .+|+++++||.+||. ||.+|||+.++++||||+++
T Consensus       222 ~~~~--~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         222 FFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCC--CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            4554  689999999999999 99999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=426.11  Aligned_cols=258  Identities=22%  Similarity=0.325  Sum_probs=211.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecC-CcEEEEEEeccCCCC------hHHHHHHHHhc---CCCCcceeEEEEEe----
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQS-HNTFVMKKVLREKMP------NTIERDIMVKS---KCPYIVNLFYSFQD----   79 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~t-Gk~vAVKiI~Ks~~~------~~~E~eIL~kL---~HPNIVkL~~vfed----   79 (792)
                      .++|++++.||+|+||+||+|++..+ ++.||+|++......      ...|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36899999999999999999999765 677999998754332      25688887766   79999999999863    


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         80 -MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        80 -e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                       ...+|++||||.||.+..... .....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence             357899999998877654443 355669999999999999999999999999999999999999999999999999988


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc----
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD----  234 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~----  234 (792)
                      ......  .....+||+.|+|||++.+       ..|+.++||||+||++|+|++|++||.+.+....+..+....    
T Consensus       165 ~~~~~~--~~~~~~gT~~Y~APE~~~~-------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  235 (305)
T d1blxa_         165 IYSFQM--ALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  235 (305)
T ss_dssp             CCCGGG--GGCCCCCCCTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhcccc--cCCCcccChhhcCcchhcC-------CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence            654332  3345679999999999963       378999999999999999999999999888777666654311    


Q ss_pred             ---CCCCcCC--------------CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        235 ---TEDTVSF--------------PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       235 ---~~~~l~f--------------P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                         +......              .....+|+.+.+||.+||+ ||.+|||+.++|+||||+.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence               0000000              0113578999999999999 999999999999999999775

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=439.07  Aligned_cols=270  Identities=28%  Similarity=0.558  Sum_probs=228.4

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEE---ecCCcEEEEEEeccCCCC--------hHHHHHHHHhcCC-CCcceeEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEE---KQSHNTFVMKKVLREKMP--------NTIERDIMVKSKC-PYIVNLFYSFQ   78 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~---k~tGk~vAVKiI~Ks~~~--------~~~E~eIL~kL~H-PNIVkL~~vfe   78 (792)
                      ++.+++|++++.||+|+||+||+|.+   +.+|+.||+|++.+....        ...|+.++++++| |||+++++++.
T Consensus        20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            35778999999999999999999987   447899999998754321        1479999999976 89999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccc
Q psy13735         79 DMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSAT  158 (792)
Q Consensus        79 de~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~  158 (792)
                      +...+|+|||||.||+|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             cCCceeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999999999954  4458999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC
Q psy13735        159 QVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       159 ~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ...........+..|++.|+|||.+...     ...++.++|||||||++|+|++|..||.+.+.......+........
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~-----~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~  252 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGG-----DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE  252 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTC-----C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred             hhcccccccccccccccccchhHHhhcC-----CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence            7654444444566799999999999632     23578899999999999999999999988777666666665443444


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCC-----hhHHhcCCCccCCC--------CCCCCCCC
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLN-----MDQVLGHPVFDCLD--------SDPPCIPP  289 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPT-----aeEIL~HPwF~~i~--------~~pP~~P~  289 (792)
                      ..+|.  .+|+++.+|+.+||. ||.+|||     ++++++||||+.++        .+||++|.
T Consensus       253 ~~~~~--~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~  315 (322)
T d1vzoa_         253 PPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV  315 (322)
T ss_dssp             CCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             CCCcc--cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence            55555  789999999999999 9999994     89999999999876        35666664

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.2e-51  Score=421.95  Aligned_cols=256  Identities=24%  Similarity=0.355  Sum_probs=210.7

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +++|++++.||+|+||+||+|+++ +|+.||||++.......      ..|+.+|++++|||||+++++|.+.+.+|++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            478999999999999999999886 78999999997654322      57999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      +|+.|+.+..+.  ...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.|....... ..
T Consensus        80 e~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~  156 (286)
T d1ob3a_          80 EHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK  156 (286)
T ss_dssp             ECCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EeehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence            999887777776  345779999999999999999999999999999999999999999999999999998775432 23


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhccc-------CCCC--
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACD-------TEDT--  238 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~-------~~~~--  238 (792)
                      ....+|++.|+|||++..      ...++.++||||+||++|+|++|++||.+.+....+..+....       +...  
T Consensus       157 ~~~~~~~~~y~~pE~~~~------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cceecccchhhhHHHHhC------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            344579999999999963      2467999999999999999999999998877665555543210       0000  


Q ss_pred             -----cCC---------CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        239 -----VSF---------PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       239 -----l~f---------P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                           ..+         .....+|+.+.+||.+||+ ||.+|||+.|+|+||||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                 000         0013578999999999999 9999999999999999973

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=431.46  Aligned_cols=260  Identities=29%  Similarity=0.429  Sum_probs=214.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCChHHHHHHHHhcCCCCcceeEEEEEe------CCEEEEEEe
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPNTIERDIMVKSKCPYIVNLFYSFQD------MNHVYFIME   88 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~~~E~eIL~kL~HPNIVkL~~vfed------e~~lyLVmE   88 (792)
                      -+|..+++||+|+||+||+|+++.+|+.||||++.+.......|+.+|++++|||||+++++|..      ..++|||||
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            37999999999999999999999999999999998877666789999999999999999999853      346899999


Q ss_pred             ccCCCCHHHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCCCc
Q psy13735         89 YVTGGDFVTLLE-NQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRI  166 (792)
Q Consensus        89 y~~GGsL~dlL~-r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~~~  166 (792)
                      ||+||.+..+.. ......+++..++.|++||+.||.|||++||+||||||+|||++.++ .+||+|||+|.......  
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~--  177 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--  177 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS--
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc--
Confidence            997764443332 12445699999999999999999999999999999999999999876 89999999998775443  


Q ss_pred             ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccC-----------
Q psy13735        167 KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDT-----------  235 (792)
Q Consensus       167 ~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~-----------  235 (792)
                      ...+.+||+.|+|||++..      ...|+.++||||+||++|+|++|.+||...+....+..+.....           
T Consensus       178 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ccccccccccccChHHhhc------ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            2344579999999999863      24689999999999999999999999988877666655542100           


Q ss_pred             --CCCcCCCC----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCCC
Q psy13735        236 --EDTVSFPS----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLDS  282 (792)
Q Consensus       236 --~~~l~fP~----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~~  282 (792)
                        .....++.          ...+++++.+||.+||. ||.+|||+.|+|+||||+.+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence              00111111          23578999999999999 9999999999999999987643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.1e-51  Score=426.09  Aligned_cols=251  Identities=20%  Similarity=0.324  Sum_probs=216.1

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      .+..++|++.+.||+|+||+||+|+++.+|+.||||++.+.....   ..|+.+|++++|||||+++++|.+.+.+||||
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            356678999999999999999999999999999999997765543   57999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      |||++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.........
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~  172 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  172 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence            99999999999987666789999999999999999999999999999999999999999999999999998876544444


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCC-CCCCChhhhhhhhhcccCCCCcCCCCCcc
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTP-FNYETLDMTYSSILACDTEDTVSFPSSIR  246 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~P-F~~~d~~el~ekIl~~~~~~~l~fP~~~~  246 (792)
                      .....|++.|+|||++..       ..|+.++|||||||++|+|++|..| |.+.+....+..+..   .....+|  ..
T Consensus       173 ~~~~~g~~~y~aPE~~~~-------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~---~~~~~~~--~~  240 (287)
T d1opja_         173 HAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERP--EG  240 (287)
T ss_dssp             ETTEEECGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT---TCCCCCC--TT
T ss_pred             eccccccccccChHHHcC-------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc---CCCCCCC--cc
Confidence            444468999999999974       3789999999999999999996555 555555555554433   1223333  37


Q ss_pred             ccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        247 LSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       247 lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +|+.+.+|+..||. ||.+|||+.+++.
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            89999999999999 9999999999965

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=427.39  Aligned_cols=252  Identities=19%  Similarity=0.327  Sum_probs=211.0

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCc-----EEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHN-----TFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDM   80 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk-----~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede   80 (792)
                      +..++|++++.||+|+||+||+|++..+++     .||+|.+.......     ..|..++.++ +|||||+++++|.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            456789999999999999999999987654     68999886543332     5688999888 899999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQP---------------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPD  139 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~---------------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPe  139 (792)
                      +.+|||||||+||+|.++|....                     .+.+++..+..|+.||+.||.|||++||+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            99999999999999999996532                     135899999999999999999999999999999999


Q ss_pred             ceEeCCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCC
Q psy13735        140 NMLLSATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTP  217 (792)
Q Consensus       140 NILLd~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~P  217 (792)
                      |||++.++++||+|||+|+........ .....+||+.|+|||++..       ..|+.++|||||||++|+|++ |.+|
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-------CCCCcceeccchhHHHHHHHhCCCCC
Confidence            999999999999999999876544332 2234568999999999974       378999999999999999998 9999


Q ss_pred             CCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        218 FNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       218 F~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      |.+.+....+..+..    ....++.+..+|+++.+||..||+ ||.+|||+.+|++|
T Consensus       267 f~~~~~~~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         267 YPGIPVDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             STTCCCSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHh----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            988776666666655    223333344789999999999999 99999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=418.96  Aligned_cols=254  Identities=20%  Similarity=0.358  Sum_probs=215.9

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|++++.||+|+||.||+|.++ ++..||||++.......   ..|+.++++++|||||++++++.+ +.+|+|||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            45679999999999999999999876 57889999998765543   689999999999999999998754 56799999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||++|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+..........
T Consensus        88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~  167 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (272)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence            99999999988543334599999999999999999999999999999999999999999999999999998765544444


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....||+.|+|||++..       ..++.++|||||||++|+|+| |.+||...+.......+...   .....|  ..+
T Consensus       168 ~~~~gt~~y~APE~~~~-------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~---~~~~~p--~~~  235 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRP--DNC  235 (272)
T ss_dssp             TTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCC--TTC
T ss_pred             cccCCcccccChHHHhC-------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---CCCCCc--ccC
Confidence            45679999999999974       368999999999999999999 56677777777776666541   122233  478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc--CCCccC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG--HPVFDC  279 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~--HPwF~~  279 (792)
                      ++++.+|+.+|+. ||.+|||+.+++.  |+||..
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999 9999999999987  788864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-50  Score=413.18  Aligned_cols=248  Identities=20%  Similarity=0.348  Sum_probs=203.9

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..++|++++.||+|+||.||+|.++ ++..||||++.+.....   ..|+.++++++|||||+++++|.+.+.+|+||||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            4679999999999999999999876 56789999998766554   5799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      |++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++++||+|||+|+...........
T Consensus        82 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             cCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            9999999998653 456899999999999999999999999999999999999999999999999999877654444444


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...||+.|+|||++..       ..|+.++|||||||++|+|+| |.+||...+.......+...   .....|  ...+
T Consensus       161 ~~~gt~~y~aPE~l~~-------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---~~~~~p--~~~~  228 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKP--RLAS  228 (263)
T ss_dssp             ----CTTSCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT---CCCCCC--TTSC
T ss_pred             ceecCcccCChHHhcC-------CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc---CCCCCc--cccC
Confidence            5679999999999973       368999999999999999999 67788777777777777652   122233  3678


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +++.+|+..|++ ||.+|||+.+++.|
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999 99999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.4e-50  Score=416.61  Aligned_cols=254  Identities=23%  Similarity=0.381  Sum_probs=207.5

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCC----E
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMN----H   82 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~----~   82 (792)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++.+.....       ..|+.+++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            357999999999999999999999999999999998765543       46899999999999999999998654    4


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +|||||||+||+|..++..  .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||.+.....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence            8999999999999999854  45699999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        163 NGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       163 ~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ...  ......+||+.|+|||++.+       ..|+.++|||||||++|+|+||.+||.+.+.......+..........
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARG-------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  236 (277)
T ss_dssp             ---------------TTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG
T ss_pred             ccccccccccccCcccccCHHHHcC-------CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch
Confidence            221  23345679999999999963       368999999999999999999999999988887777776632221112


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCcc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFD  278 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~  278 (792)
                      .  ...+|+.+.+||.+||. ||.+||+..+.+.|+|++
T Consensus       237 ~--~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         237 R--HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             T--SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             h--ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            2  24789999999999999 999999555555677764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=417.70  Aligned_cols=258  Identities=23%  Similarity=0.295  Sum_probs=208.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe--------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD--------   79 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed--------   79 (792)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.....      ..|+.+|+.++||||++++++|..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            578999999999999999999999999999999987654432      579999999999999999999865        


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         80 MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        80 e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      .+.+|+|||||.++.+..+.  .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence            34689999999877666554  4456799999999999999999999999999999999999999999999999999976


Q ss_pred             cccCC---CcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC
Q psy13735        160 VDKNG---RIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       160 l~~~~---~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      +....   .......+||+.|+|||++.+      ...|+.++||||+||++|+|++|++||.+.+.......+......
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccccccceecCHHHhhHHHHcC------CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            65322   122334579999999999863      246899999999999999999999999988776666555432111


Q ss_pred             CCcCC---------------CC-----------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccC
Q psy13735        237 DTVSF---------------PS-----------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDC  279 (792)
Q Consensus       237 ~~l~f---------------P~-----------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~  279 (792)
                      .....               ..           ....++.+.|||.+||. ||.+|||+.++|.||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            00000               00           01237789999999999 9999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-50  Score=425.07  Aligned_cols=254  Identities=25%  Similarity=0.445  Sum_probs=207.8

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCC------
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMN------   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~------   81 (792)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.+.....      ..|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            578999999999999999999999999999999998655443      46999999999999999999998665      


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+||||| |++|..++..   +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence            579999999 7788888754   359999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC----
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED----  237 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~----  237 (792)
                      ..    ....+||+.|+|||++.+.      ..++.++||||+||++|+|++|.+||.+.+....+..+.......    
T Consensus       173 ~~----~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         173 SE----MTGYVVTRWYRAPEVILNW------MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             SS----CCSSCSCGGGCCTHHHHTT------TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             Cc----cccccccccccCHHHHcCC------CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            32    2345799999999998632      467899999999999999999999998877655544433211000    


Q ss_pred             --------------------CcCCC-CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        238 --------------------TVSFP-SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       238 --------------------~l~fP-~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                          ...++ ....+|+++.+||.+||. ||.+|||+.++|+||||+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                                00000 113578999999999999 999999999999999999765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=406.08  Aligned_cols=258  Identities=22%  Similarity=0.347  Sum_probs=214.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEE
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIM   87 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVm   87 (792)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.......      ..|+.+++.++|||||+++++|.+...+++||
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            468999999999999999999999999999999997655432      57999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~  167 (792)
                      +++.|+++..++.  ..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||.|........ .
T Consensus        81 ~~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~  157 (292)
T d1unla_          81 EFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C  157 (292)
T ss_dssp             ECCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred             eeccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence            9999999988874  456789999999999999999999999999999999999999999999999999987754332 2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCC-CCCChhhhhhhhhcccCCC---------
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPF-NYETLDMTYSSILACDTED---------  237 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF-~~~d~~el~ekIl~~~~~~---------  237 (792)
                      .....+++.|+|||++...      ..++.++||||+||++|+|++|..|| .+.+....+..+.......         
T Consensus       158 ~~~~~~~~~~~~pe~~~~~------~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGA------KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTC------SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             ceeeccccchhhhhHhccC------CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            3344688999999998632      35789999999999999999999886 4445444444433210000         


Q ss_pred             --------------CcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        238 --------------TVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       238 --------------~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                    .........+|+.+.+|+.+||+ ||.+|||++++|+||||+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                          00001123678999999999999 99999999999999999853

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-50  Score=416.49  Aligned_cols=254  Identities=20%  Similarity=0.264  Sum_probs=202.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYF   85 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyL   85 (792)
                      +..++|.+++.||+|+||.||+|+.+   ..||||++.......      ..|+.++.+++|||||++++++. ...+||
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence            56789999999999999999999654   369999997654433      46899999999999999999865 456899


Q ss_pred             EEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCC
Q psy13735         86 IMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR  165 (792)
Q Consensus        86 VmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~  165 (792)
                      |||||+||+|.+++... .+.+++..+..|+.||+.||.|||++||+||||||+||||+.++++||+|||+|+.......
T Consensus        81 v~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999999999653 45699999999999999999999999999999999999999999999999999987653322


Q ss_pred             -cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCCCC
Q psy13735        166 -IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFPSS  244 (792)
Q Consensus       166 -~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP~~  244 (792)
                       ......+||+.|||||++...    ....|+.++|||||||++|+|+||+.||.+.+.......+..............
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQ----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred             cccccccccCcccCCHHHHhcc----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence             233455799999999999632    234689999999999999999999999987665444433332111111101112


Q ss_pred             ccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        245 IRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       245 ~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ..+++.+.+|+.+||. ||.+|||+.+++.|
T Consensus       236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            3678999999999999 99999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=408.77  Aligned_cols=248  Identities=21%  Similarity=0.345  Sum_probs=218.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..++|+++++||+|+||+||+|+++ ++..||||++.+.....   ..|+.++.+++|||||+++++|.+++.+|+||||
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            5689999999999999999999985 77899999998876654   5799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcccc
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKSI  169 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s~  169 (792)
                      |++|+|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          81 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             CTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             cCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            9999999997543 355899999999999999999999999999999999999999999999999999877654444444


Q ss_pred             cCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCcccc
Q psy13735        170 VPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLS  248 (792)
Q Consensus       170 t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS  248 (792)
                      ...||+.|+|||++...       .++.++|||||||++|+|+| |+.||.+.+..++...+...   .....|  ...+
T Consensus       160 ~~~~t~~y~aPE~~~~~-------~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~p--~~~~  227 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYS-------KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRP--HLAS  227 (258)
T ss_dssp             CSCCCGGGCCHHHHHHC-------CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCC--TTCC
T ss_pred             ccCCCCCcCCcHHhcCC-------CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC---CCCCCc--cccc
Confidence            56799999999999853       68999999999999999998 89999999888888877652   122333  4778


Q ss_pred             HHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        249 TAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       249 ~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      +.+.+||.+|++ ||.+|||+.++++|
T Consensus       228 ~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         228 EKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999 99999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-49  Score=418.99  Aligned_cols=256  Identities=24%  Similarity=0.406  Sum_probs=208.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC-CCCcceeEEEEEeC--CEEEEEEe
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK-CPYIVNLFYSFQDM--NHVYFIME   88 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~-HPNIVkL~~vfede--~~lyLVmE   88 (792)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++.+..... ..|+.+|..+. ||||++++++|...  ..+|+|||
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            3467999999999999999999999999999999997654332 57999999995 99999999999854  57999999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCC-ceEEeccCcccccccCCCcc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATG-HLKLTDFGSATQVDKNGRIK  167 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg-~VKLiDFGLA~~l~~~~~~~  167 (792)
                      ||.+|+|..+.     +.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+|.......  .
T Consensus       113 ~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~  185 (328)
T d3bqca1         113 HVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--E  185 (328)
T ss_dssp             CCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--C
T ss_pred             ecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC--c
Confidence            99999987764     3499999999999999999999999999999999999998665 59999999998776443  2


Q ss_pred             cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChh-hhhhhhhc-------------c
Q psy13735        168 SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLD-MTYSSILA-------------C  233 (792)
Q Consensus       168 s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~-el~ekIl~-------------~  233 (792)
                      ....+||+.|+|||++..      ...++.++||||+||++|+|++|..||...... .....+..             .
T Consensus       186 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         186 YNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             ccccccCccccCcccccC------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            345579999999999863      245889999999999999999999999654321 11111100             0


Q ss_pred             c------------------CCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        234 D------------------TEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       234 ~------------------~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                      .                  +......+....+|+++.+||++||+ ||.+|||+.++|+||||+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            0                  00001111224578999999999999 999999999999999999764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-49  Score=417.13  Aligned_cols=252  Identities=21%  Similarity=0.359  Sum_probs=202.8

Q ss_pred             CCCCCCCceEEeEeeecCceEEEEEEEecCCc---EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         10 KNVSASDFDIKRFIQQGNFGDIYLVEEKQSHN---TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        10 k~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk---~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      ..+..++|++.+.||+|+||+||+|.++.+|+   .+|+|.+.......     ..|+.+|++++|||||++++++.+.+
T Consensus        21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            34677899999999999999999999987765   57888876544332     57899999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||+||+|.+++.. ..+.+++..+..|+.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+.
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            99999999999999998865 34569999999999999999999999999999999999999999999999999998775


Q ss_pred             cCCCcc----cccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCC
Q psy13735        162 KNGRIK----SIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTE  236 (792)
Q Consensus       162 ~~~~~~----s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~  236 (792)
                      ......    .....||+.|+|||++..       ..|+.++|||||||++|+|+| |.+||.+.+.......+..    
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~----  248 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----  248 (299)
T ss_dssp             ----------------CGGGSCHHHHHS-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----
T ss_pred             CCCCcceeeecccccCCccccCHHHHhc-------CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc----
Confidence            432211    122358999999999873       478999999999999999998 8999998888877777754    


Q ss_pred             CCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        237 DTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       237 ~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                       ....|.+..+++.+.+|+..||. ||.+|||+.+++++
T Consensus       249 -~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         249 -DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence             12233344789999999999999 99999999988654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=413.23  Aligned_cols=255  Identities=19%  Similarity=0.340  Sum_probs=209.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmE   88 (792)
                      +..++|++++.||+|+||.||+|+++.+ ..||||++.......   ..|+.++++++|||||++++++.+ +.+|+|||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            5668999999999999999999998765 579999997666544   579999999999999999999965 56799999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||++|+|..++.....+.+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+..........
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            99999999998654455699999999999999999999999999999999999999999999999999987754433344


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....||+.|+|||++..       ..++.++|||||||++|+|++| .+||.+......+..+...   .  ..|....+
T Consensus       172 ~~~~gt~~y~aPE~~~~-------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~---~--~~~~~~~~  239 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---Y--RMPCPPEC  239 (285)
T ss_dssp             ----CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---C--CCCCCTTS
T ss_pred             ccccccccccChHHHhC-------CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---C--CCCCCccc
Confidence            44679999999999974       3789999999999999999995 5666666666666666541   1  22333478


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhc--CCCccCC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLG--HPVFDCL  280 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~--HPwF~~i  280 (792)
                      |+.+++||.+||. ||.+||++.+++.  |+||...
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999999 9999999999977  8899764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-49  Score=406.31  Aligned_cols=249  Identities=23%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecC---CcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQS---HNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~t---Gk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      +..++|++++.||+|+||.||+|++..+   +..||+|.+.......     ..|+.++++++|||||+++++|. ++.+
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            4567999999999999999999998754   3568888876543332     46899999999999999999996 4678


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |+|||||+||+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        83 ~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999999988653 456999999999999999999999999999999999999999999999999999887654


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                      ........+||+.|+|||++..       ..|+.++|||||||++|+|++ |.+||.+.+....+..+...   ....+|
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~-------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~---~~~~~~  231 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMP  231 (273)
T ss_dssp             ---------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCCCCC
T ss_pred             cceeccceecCcccchhhHhcc-------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCC
Confidence            4444455678999999999974       378999999999999999998 99999998888888887652   122333


Q ss_pred             CCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        243 SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       243 ~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        ..+|+.+.+||.+||. ||.+|||+.+++.|
T Consensus       232 --~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         232 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence              4789999999999999 99999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=410.99  Aligned_cols=253  Identities=20%  Similarity=0.325  Sum_probs=212.8

Q ss_pred             CCCCCceEEeE-eeecCceEEEEEEEec--CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRF-IQQGNFGDIYLVEEKQ--SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~-IGsGsFGtVyla~~k~--tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      +..++|.+.+. ||+|+||.||+|.++.  ++..||||++.+.....     ..|+.+|.+++|||||++++++.++ .+
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~   83 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL   83 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence            34567888885 9999999999998764  45589999997654332     4699999999999999999999754 58


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      |||||||+||+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus        84 ~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            999999999999999844 3456999999999999999999999999999999999999999999999999999887644


Q ss_pred             CCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcC
Q psy13735        164 GRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVS  240 (792)
Q Consensus       164 ~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~  240 (792)
                      ...  .....+||+.|+|||++..       ..++.++|||||||++|+|+| |.+||.+.+..+....+...   ..+.
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~---~~~~  232 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRME  232 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT---CCCC
T ss_pred             ccccccccccccCccccChHHHhC-------CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCC
Confidence            322  2234468999999999974       368999999999999999998 99999988877777777652   2233


Q ss_pred             CCCCccccHHHHHHHHHHhh-ChhhcCChhHH---hcCCCcc
Q psy13735        241 FPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQV---LGHPVFD  278 (792)
Q Consensus       241 fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEI---L~HPwF~  278 (792)
                      +|.  .+|+++.+||..|+. ||.+|||+.++   |+|+|+.
T Consensus       233 ~p~--~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         233 CPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC--cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            444  789999999999999 99999999888   7888875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-49  Score=416.45  Aligned_cols=254  Identities=23%  Similarity=0.376  Sum_probs=209.5

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeC-----CEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDM-----NHV   83 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede-----~~l   83 (792)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.....      ..|+.+|+.++|||||+++++|...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            67999999999999999999999999999999998765443      4799999999999999999999643     334


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      ++||+||.||+|.+++..   +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|++|||+|..... 
T Consensus        98 ~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             EEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence            666777789999999943   4599999999999999999999999999999999999999999999999999976542 


Q ss_pred             CCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCC-----
Q psy13735        164 GRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDT-----  238 (792)
Q Consensus       164 ~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~-----  238 (792)
                         .....+||+.|+|||++..      ...++.++|||||||++|+|++|.+||.+.+.......+........     
T Consensus       174 ---~~~~~~g~~~y~apE~~~~------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         174 ---EMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             ---GGSSSCHHHHTSCHHHHTT------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ---ccccccccccccCchhhcC------CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence               3345579999999999763      24578899999999999999999999998887766666654211110     


Q ss_pred             --------------cCCCC------CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        239 --------------VSFPS------SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       239 --------------l~fP~------~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                    ...+.      ...+|+++++||.+||. ||.+|||+.++|+||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                          00111      13578999999999999 999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-49  Score=408.30  Aligned_cols=243  Identities=19%  Similarity=0.330  Sum_probs=202.5

Q ss_pred             eEeeecCceEEEEEEEec--CCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEeCCEEEEEEeccCC
Q psy13735         21 RFIQQGNFGDIYLVEEKQ--SHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQDMNHVYFIMEYVTG   92 (792)
Q Consensus        21 k~IGsGsFGtVyla~~k~--tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfede~~lyLVmEy~~G   92 (792)
                      +.||+|+||.||+|.++.  +++.||+|++.......      ..|+.+|++++|||||++++++.++ .+|||||||+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            479999999999998754  56789999997554322      5799999999999999999999765 57899999999


Q ss_pred             CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCcc--ccc
Q psy13735         93 GDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIK--SIV  170 (792)
Q Consensus        93 GsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~--s~t  170 (792)
                      |+|.+++.+  ...+++..+..|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+.......  ...
T Consensus        92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence            999999965  4559999999999999999999999999999999999999999999999999998765433222  233


Q ss_pred             CCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccccH
Q psy13735        171 PVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRLST  249 (792)
Q Consensus       171 ~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~  249 (792)
                      ..||+.|+|||++...       .++.++|||||||++|+|++ |.+||.+.+.......+...   ..+.+|.  .+|+
T Consensus       170 ~~gt~~y~APE~l~~~-------~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~---~~~~~p~--~~~~  237 (277)
T d1xbba_         170 GKWPVKWYAPECINYY-------KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPA--GCPR  237 (277)
T ss_dssp             -CCCGGGCCHHHHHHC-------EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCT--TCCH
T ss_pred             cCCCceecCchhhcCC-------CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC---CCCCCCc--ccCH
Confidence            4699999999999743       68999999999999999998 99999988877777766542   2233444  7899


Q ss_pred             HHHHHHHHHhh-ChhhcCChhHH---hcCCCcc
Q psy13735        250 AMVNFVQSLVQ-KLDARLNMDQV---LGHPVFD  278 (792)
Q Consensus       250 elkdLIk~LL~-DP~kRPTaeEI---L~HPwF~  278 (792)
                      ++.+|+.+|+. ||.+|||+.++   |+|+|++
T Consensus       238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999 99999999998   6777765

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=417.47  Aligned_cols=257  Identities=24%  Similarity=0.404  Sum_probs=206.6

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC-----EEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN-----HVY   84 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~-----~ly   84 (792)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+.....     ..|+.+|++++||||+++++++....     .+|
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            56999999999999999999999999999999997655432     57999999999999999999997653     345


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCC
Q psy13735         85 FIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        85 LVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~  164 (792)
                      ++ +|+.||+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus        88 l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          88 LV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            55 556699999999653   49999999999999999999999999999999999999999999999999998764332


Q ss_pred             C--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCC------
Q psy13735        165 R--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTE------  236 (792)
Q Consensus       165 ~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~------  236 (792)
                      .  ......+||+.|+|||++...      ..++.++||||+||++|+|++|.+||.+.+.......+......      
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNS------KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTB------CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccceeeccccccceechHHHhhcC------CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            2  123455799999999998532      46788999999999999999999999887755444433221000      


Q ss_pred             ----------------CCcCCC---CCccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCCC
Q psy13735        237 ----------------DTVSFP---SSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCLD  281 (792)
Q Consensus       237 ----------------~~l~fP---~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i~  281 (792)
                                      .....+   ....+|+.+++|+.+||. ||.+|||+.++|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence                            000000   013578899999999999 999999999999999998653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=403.33  Aligned_cols=249  Identities=20%  Similarity=0.286  Sum_probs=204.4

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCc----EEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCCEE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHN----TFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk----~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~~l   83 (792)
                      ..++|+++++||+|+||+||+|.+..+|+    .||+|.+.......     ..|+.++++++|||||+++++|.++ ..
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            44689999999999999999999988886    47778776443222     5799999999999999999999865 56


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccC
Q psy13735         84 YFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKN  163 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~  163 (792)
                      +++|+||.+|+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus        86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            7888999999999988764 456999999999999999999999999999999999999999999999999999887543


Q ss_pred             CCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCC
Q psy13735        164 GRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSF  241 (792)
Q Consensus       164 ~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~f  241 (792)
                      ... ......||+.|+|||++..       ..|+.++|||||||++|+|+| |.+||.+.+.......+...   ..+..
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~---~~~~~  234 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQ  234 (317)
T ss_dssp             CC--------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---CCCCC
T ss_pred             cccccccccccCccccChHHHhc-------CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCC
Confidence            322 2334468999999999974       368999999999999999998 89999988877777666541   22233


Q ss_pred             CCCccccHHHHHHHHHHhh-ChhhcCChhHHhcCC
Q psy13735        242 PSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHP  275 (792)
Q Consensus       242 P~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HP  275 (792)
                      |  ..+++.+.+++.+|+. ||.+|||+.+++.|.
T Consensus       235 p--~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         235 P--PICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             C--TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             C--cccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            3  4789999999999999 999999999999883

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=396.76  Aligned_cols=250  Identities=21%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCC----cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSH----NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tG----k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      .+..++|.+.++||+|+||.||+|.++.++    ..||||++.......     ..|+.++.+++|||||++++++.+..
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            466789999999999999999999988765    479999987554332     47899999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+++|||||.+|++.+++... .+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             ceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999999988653 4569999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC--cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCChhhhhhhhhcccCCCC
Q psy13735        162 KNGR--IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYSSILACDTEDT  238 (792)
Q Consensus       162 ~~~~--~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~~el~ekIl~~~~~~~  238 (792)
                      ....  .......||+.|+|||++..       ..++.++|||||||++|+|++| .+||...+....+..+..     .
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~-------~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-----~  229 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISY-------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-----G  229 (283)
T ss_dssp             ------------CCCGGGSCHHHHHS-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----T
T ss_pred             CCCccceEeccCCCCccccCHHHHcc-------CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc-----c
Confidence            4322  12233468999999999973       4789999999999999999995 556666666666666544     1


Q ss_pred             cCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        239 VSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       239 l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ...|.+..+++.+.+++..|+. ||.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            2233334789999999999999 9999999999865

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=414.36  Aligned_cols=253  Identities=21%  Similarity=0.350  Sum_probs=199.6

Q ss_pred             CCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh------HHHHHHHHhcCCCCcceeEEEEEe------CC
Q psy13735         14 ASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN------TIERDIMVKSKCPYIVNLFYSFQD------MN   81 (792)
Q Consensus        14 l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~------~~E~eIL~kL~HPNIVkL~~vfed------e~   81 (792)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+.....      ..|+.++++++|||||+++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999999999999999998765543      478999999999999999999964      47


Q ss_pred             EEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccc
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVD  161 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~  161 (792)
                      .+|+|||||.|| +...+    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus        96 ~~~iv~Ey~~~~-l~~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEEECCSEE-HHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eeEEEEeccchH-HHHhh----hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            899999999665 44454    2348999999999999999999999999999999999999999999999999988765


Q ss_pred             cCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCC----
Q psy13735        162 KNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTED----  237 (792)
Q Consensus       162 ~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~----  237 (792)
                      ...  .....+||+.|+|||++.+       ..++.++||||+||++|+|++|++||.+.+.......+.......    
T Consensus       171 ~~~--~~~~~~~t~~y~aPE~l~~-------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         171 TSF--MMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             ------------CCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccc--ccccccccccccChhhhcC-------CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence            433  3334579999999999973       378999999999999999999999998887666555543211100    


Q ss_pred             --------------Cc--------------CCCC----CccccHHHHHHHHHHhh-ChhhcCChhHHhcCCCccCC
Q psy13735        238 --------------TV--------------SFPS----SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGHPVFDCL  280 (792)
Q Consensus       238 --------------~l--------------~fP~----~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~HPwF~~i  280 (792)
                                    ..              ..+.    ....|+++.+||++||. ||.+|||++++|+||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                          00              0000    12357889999999999 99999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=400.11  Aligned_cols=252  Identities=20%  Similarity=0.336  Sum_probs=197.0

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDM   80 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede   80 (792)
                      +..++|++++.||+|+||.||+|.+..     +++.||+|++.......     ..|..++.++ +|||||.+++++...
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            566889999999999999999999865     45789999987554432     3455566655 689999999988654


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC
Q psy13735         81 -NHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA  145 (792)
Q Consensus        81 -~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~  145 (792)
                       ..+|+|||||+||+|.+++....              ...+++..+..|+.||+.||.|||++||+||||||+||||+.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence             56899999999999999996432              235899999999999999999999999999999999999999


Q ss_pred             CCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCCh
Q psy13735        146 TGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETL  223 (792)
Q Consensus       146 dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~  223 (792)
                      ++++||+|||+|+....... ......+||+.|+|||++..       ..++.++|||||||++|+|++| .+||.+.+.
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-------CCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999987654332 23345579999999999974       3789999999999999999986 578877665


Q ss_pred             hhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        224 DMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       224 ~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...+..+...  +..+..|  ..+++++.+|+.+||. ||.+|||+.++++|
T Consensus       243 ~~~~~~~~~~--~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         243 DEEFCRRLKE--GTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             SHHHHHHHHH--TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhc--CCCCCCC--ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5555444431  1222333  3689999999999999 99999999999887

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-46  Score=394.91  Aligned_cols=257  Identities=19%  Similarity=0.277  Sum_probs=217.4

Q ss_pred             HHHhcCCCCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeE
Q psy13735          5 KELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLF   74 (792)
Q Consensus         5 ~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~   74 (792)
                      |++..-.+..++|++++.||+|+||+||+|+.+.     ++..||||++.......     ..|+.++++++||||++++
T Consensus         3 p~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~   82 (301)
T d1lufa_           3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL   82 (301)
T ss_dssp             HHHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cchhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccce
Confidence            5667777888999999999999999999999864     56899999987654332     5799999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy13735         75 YSFQDMNHVYFIMEYVTGGDFVTLLENQP----------------------HGYLSESKARFYIYELAQAVQYLHGLGYV  132 (792)
Q Consensus        75 ~vfede~~lyLVmEy~~GGsL~dlL~r~~----------------------~g~LSE~ea~~Im~QILsAL~YLHs~gIV  132 (792)
                      ++|.+.+.+++|||||++|+|.+++....                      ...+++..+..|+.||+.||.|||++||+
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv  162 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV  162 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence            99999999999999999999999995421                      22488999999999999999999999999


Q ss_pred             cCCCCCCceEeCCCCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHh
Q psy13735        133 HRDIKPDNMLLSATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYEL  211 (792)
Q Consensus       133 HRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYEL  211 (792)
                      ||||||+||||+.++++||+|||+|+...+... ......+||+.|+|||++...       .|+.++|||||||++|+|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~t~ksDVwS~Gvvl~el  235 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-------RYTTESDVWAYGVVLWEI  235 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-------CCCHHHHHHHHHHHHHHH
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-------CCChhhhhccchhhHHHH
Confidence            999999999999999999999999986643322 233455799999999999853       799999999999999999


Q ss_pred             hcCC-CCCCCCChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        212 LTGS-TPFNYETLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       212 LTGk-~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ++|. +||.+.+..+....+....   ....|  ..+++++.+|+..|++ +|.+|||+.+|++
T Consensus       236 l~~~~~p~~~~~~~e~~~~v~~~~---~~~~p--~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         236 FSYGLQPYYGMAHEEVIYYVRDGN---ILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HTTTCCTTTTSCHHHHHHHHHTTC---CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HccCCCCCCCCCHHHHHHHHHcCC---CCCCC--ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9984 7898888888888776521   22233  3789999999999999 9999999999854

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-47  Score=393.44  Aligned_cols=245  Identities=20%  Similarity=0.383  Sum_probs=203.5

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCCcceeEEEEE-eCCEEEEEEe
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPYIVNLFYSFQ-DMNHVYFIME   88 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPNIVkL~~vfe-de~~lyLVmE   88 (792)
                      +..++|++++.||+|+||.||+|+++  |..||+|++.+.....  ..|+.++++++|||||++++++. +.+.+|+|||
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            56789999999999999999999884  7799999997765444  57999999999999999999985 4567899999


Q ss_pred             ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCcccccccCCCccc
Q psy13735         89 YVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDKNGRIKS  168 (792)
Q Consensus        89 y~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~~~~~~s  168 (792)
                      ||++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++.....    .
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~  157 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q  157 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence            999999999996543345899999999999999999999999999999999999999999999999999876432    2


Q ss_pred             ccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCcCCCCCccc
Q psy13735        169 IVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTVSFPSSIRL  247 (792)
Q Consensus       169 ~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l~fP~~~~l  247 (792)
                      ....||+.|+|||++..       ..++.++|||||||++|+|+| |.+||...+.......+...   ..+.+|.  .+
T Consensus       158 ~~~~~~~~y~aPE~l~~-------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~---~~~~~~~--~~  225 (262)
T d1byga_         158 DTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPD--GC  225 (262)
T ss_dssp             ----CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---CCCCCCT--TC
T ss_pred             ccccccccCCChHHHhC-------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCCc--cC
Confidence            23468999999999974       368999999999999999998 89999988888888877542   2233444  67


Q ss_pred             cHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        248 STAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       248 S~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ++.+.+||.+|+. ||.+|||+.+++++
T Consensus       226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         226 PPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            9999999999999 99999999998764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=396.69  Aligned_cols=249  Identities=21%  Similarity=0.357  Sum_probs=210.2

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEecCCcE--EEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeCCEE
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQSHNT--FVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDMNHV   83 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~--vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede~~l   83 (792)
                      +..++|++.++||+|+||.||+|+++.+|..  ||||.+.......     ..|+.+|.++ +|||||+++++|.+.+.+
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            4668999999999999999999999998875  5677765433221     5799999998 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCce
Q psy13735         84 YFIMEYVTGGDFVTLLENQ--------------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHL  149 (792)
Q Consensus        84 yLVmEy~~GGsL~dlL~r~--------------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~V  149 (792)
                      |+|||||+||+|.+++...              ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence            9999999999999999643              23569999999999999999999999999999999999999999999


Q ss_pred             EEeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCChhhhhh
Q psy13735        150 KLTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYS  228 (792)
Q Consensus       150 KLiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~~el~e  228 (792)
                      ||+|||+|+......  ......||+.|+|||.+..       ..|+.++|||||||++|+|++| .+||.+.+....+.
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~-------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  237 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhcc-------CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999998665332  2234469999999999974       3789999999999999999996 56888888888888


Q ss_pred             hhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        229 SILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       229 kIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      .+...   ..+..  +..+++++.+||.+||. ||++|||+.+++.|
T Consensus       238 ~i~~~---~~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         238 KLPQG---YRLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HGGGT---CCCCC--CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhc---CCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            77652   22233  34789999999999999 99999999999887

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=392.78  Aligned_cols=251  Identities=21%  Similarity=0.360  Sum_probs=208.0

Q ss_pred             CCCCCCceEEeEeeecCceEEEEEEEecCC-------cEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEE
Q psy13735         11 NVSASDFDIKRFIQQGNFGDIYLVEEKQSH-------NTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSF   77 (792)
Q Consensus        11 ~l~l~dY~I~k~IGsGsFGtVyla~~k~tG-------k~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vf   77 (792)
                      .+..++|.+++.||+|+||.||+|++..++       ..||+|++.+.....     ..|..++.++ +|||||+++++|
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            356789999999999999999999987655       479999987655432     4577777777 799999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEe
Q psy13735         78 QDMNHVYFIMEYVTGGDFVTLLENQP--------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLL  143 (792)
Q Consensus        78 ede~~lyLVmEy~~GGsL~dlL~r~~--------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILL  143 (792)
                      .+++.+|+|||||+||+|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            99999999999999999999996432              2458999999999999999999999999999999999999


Q ss_pred             CCCCceEEeccCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCC
Q psy13735        144 SATGHLKLTDFGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYE  221 (792)
Q Consensus       144 d~dg~VKLiDFGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~  221 (792)
                      +.++.+||+|||++......... .....+||+.|+|||++..       ..|+.++|||||||++|+|++ |.+||.+.
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-------~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~  241 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  241 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-------CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence            99999999999999877544322 2344579999999999974       379999999999999999998 79999988


Q ss_pred             ChhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        222 TLDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       222 d~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      +....+..+...   ..+.+|  ..+|+.+.+||.+|++ ||.+|||+.++++
T Consensus       242 ~~~~~~~~i~~~---~~~~~p--~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         242 PVEELFKLLKEG---HRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CHHHHHHHHHTT---CCCCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHcC---CCCCCC--ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            888777766541   223334  3789999999999999 9999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=393.03  Aligned_cols=247  Identities=18%  Similarity=0.266  Sum_probs=199.9

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecC-C--cEEEEEEeccCCCCh-------HHHHHHHHhcCCCCcceeEEEEEeCCE
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQS-H--NTFVMKKVLREKMPN-------TIERDIMVKSKCPYIVNLFYSFQDMNH   82 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~t-G--k~vAVKiI~Ks~~~~-------~~E~eIL~kL~HPNIVkL~~vfede~~   82 (792)
                      ...+|++.+.||+|+||.||+|+...+ +  ..||+|++.+.....       ..|+.+|++++|||||+++++|.+ ..
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~   84 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP   84 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence            457899999999999999999987543 3  368999987654322       578999999999999999999976 46


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEeccCccccccc
Q psy13735         83 VYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDFGSATQVDK  162 (792)
Q Consensus        83 lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~l~~  162 (792)
                      +++|||||++|++.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             hheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            78999999999999887653 35599999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCc--ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCChhhhhhhhhcccCCCCc
Q psy13735        163 NGRI--KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYETLDMTYSSILACDTEDTV  239 (792)
Q Consensus       163 ~~~~--~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d~~el~ekIl~~~~~~~l  239 (792)
                      ....  ......|++.|+|||++...       .++.++|||||||++|+|+| |.+||.+.+.......+..    ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~----~~~  232 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTR-------TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----EGE  232 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHC-------EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----SCC
T ss_pred             CCCcceecCccccCcccCCHHHHhCC-------CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh----CCC
Confidence            4322  22234688899999999853       68999999999999999998 8999999998888888866    333


Q ss_pred             CCCCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        240 SFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       240 ~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                      .++....+|+.+.++|..|+. ||.+|||+.+++
T Consensus       233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            344445789999999999999 999999999985

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-46  Score=390.91  Aligned_cols=251  Identities=20%  Similarity=0.295  Sum_probs=211.7

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEe-----cCCcEEEEEEeccCCCCh-----HHHHHHHHhc-CCCCcceeEEEEEeC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEK-----QSHNTFVMKKVLREKMPN-----TIERDIMVKS-KCPYIVNLFYSFQDM   80 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k-----~tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL-~HPNIVkL~~vfede   80 (792)
                      +..++|++++.||+|+||.||+|++.     .+++.||||++.+.....     ..|..++..+ +|||||++++++.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            55689999999999999999999874     467899999997655433     4688899988 699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeC
Q psy13735         81 NHVYFIMEYVTGGDFVTLLENQP----------------HGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLS  144 (792)
Q Consensus        81 ~~lyLVmEy~~GGsL~dlL~r~~----------------~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd  144 (792)
                      +.+|+|||||+||+|.+++....                ...+++..+..|+.||+.||.|||++||+||||||+|||++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            99999999999999999996532                23589999999999999999999999999999999999999


Q ss_pred             CCCceEEeccCcccccccCCC-cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhc-CCCCCCCCC
Q psy13735        145 ATGHLKLTDFGSATQVDKNGR-IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLT-GSTPFNYET  222 (792)
Q Consensus       145 ~dg~VKLiDFGLA~~l~~~~~-~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLT-Gk~PF~~~d  222 (792)
                      .++++|++|||+++....... ......+||+.|+|||++..       ..++.++|||||||++|+|+| |.+||.+.+
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-------CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            999999999999987764433 23344579999999999974       378999999999999999998 777787777


Q ss_pred             hhhhhhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc
Q psy13735        223 LDMTYSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG  273 (792)
Q Consensus       223 ~~el~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~  273 (792)
                      ....+..+...    ....+....+|+.+.+||.+|++ ||.+|||+.+++.
T Consensus       253 ~~~~~~~~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         253 VDSKFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SSHHHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            66666666542    22222234679999999999999 9999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=386.87  Aligned_cols=256  Identities=22%  Similarity=0.305  Sum_probs=216.4

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-----CCcEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-----SHNTFVMKKVLREKMPN-----TIERDIMVKSKCPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-----tGk~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIVkL~~vfede~   81 (792)
                      +..++|.+++.||+|+||.||+|.++.     ++..||||++.+.....     ..|+.++++++|||||++++++..+.
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            556899999999999999999999863     35789999997654332     47899999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEec
Q psy13735         82 HVYFIMEYVTGGDFVTLLENQ--------PHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTD  153 (792)
Q Consensus        82 ~lyLVmEy~~GGsL~dlL~r~--------~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiD  153 (792)
                      .+++|||||++|+|.+++...        ....+++..+..++.||+.||.|||+++|+||||||+|||++.++++||+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence            999999999999999988531        123478999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCCc-ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcC-CCCCCCCChhhhhhhhh
Q psy13735        154 FGSATQVDKNGRI-KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTG-STPFNYETLDMTYSSIL  231 (792)
Q Consensus       154 FGLA~~l~~~~~~-~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTG-k~PF~~~d~~el~ekIl  231 (792)
                      ||+|+........ .....+||+.|+|||.+..       ..++.++|||||||++|+|+|| .+||.+.+....+..+.
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-------~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHcc-------CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999876543322 2233468999999999974       3788999999999999999998 58898888888888776


Q ss_pred             cccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhc------CCCccC
Q psy13735        232 ACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLG------HPVFDC  279 (792)
Q Consensus       232 ~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~------HPwF~~  279 (792)
                      ...   ....|  ..+++.+.+++..|++ +|.+|||+.+++.      +|+|+.
T Consensus       250 ~~~---~~~~p--~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         250 EGG---LLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             TTC---CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             hCC---CCCCc--ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            521   22233  3789999999999999 9999999999976      666653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-44  Score=380.28  Aligned_cols=260  Identities=18%  Similarity=0.256  Sum_probs=205.9

Q ss_pred             hhHHHHhcCCCCCCCceE--EeEeeecCceEEEEEEEecCC---cEEEEEEeccCCCCh-----HHHHHHHHhcCCCCcc
Q psy13735          2 DVVKELRQKNVSASDFDI--KRFIQQGNFGDIYLVEEKQSH---NTFVMKKVLREKMPN-----TIERDIMVKSKCPYIV   71 (792)
Q Consensus         2 ~~~~~L~rk~l~l~dY~I--~k~IGsGsFGtVyla~~k~tG---k~vAVKiI~Ks~~~~-----~~E~eIL~kL~HPNIV   71 (792)
                      ++++.++.--+..+.+.+  .++||+|+||+||+|++..++   ..||||++.+.....     ..|+.+|.+++|||||
T Consensus        12 ~~~~~~~~~~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv   91 (311)
T d1r0pa_          12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL   91 (311)
T ss_dssp             HHHHHHGGGBCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             HHHHHhhceEeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEe
Confidence            345666665555555543  789999999999999986643   368999987543322     5799999999999999


Q ss_pred             eeEEEEEe-CCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceE
Q psy13735         72 NLFYSFQD-MNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLK  150 (792)
Q Consensus        72 kL~~vfed-e~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VK  150 (792)
                      ++++++.+ ++.+++|||||+||+|.+++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus        92 ~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~k  170 (311)
T d1r0pa_          92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK  170 (311)
T ss_dssp             CCCEEEEETTTEEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred             EEeEEEEecCCceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEE
Confidence            99999765 5689999999999999999865 345578899999999999999999999999999999999999999999


Q ss_pred             EeccCcccccccCCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCC-CChhhh
Q psy13735        151 LTDFGSATQVDKNGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNY-ETLDMT  226 (792)
Q Consensus       151 LiDFGLA~~l~~~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~-~d~~el  226 (792)
                      |+|||+++........   ......||+.|+|||.+..       ..++.++|||||||++|+|++|..||.. .+....
T Consensus       171 L~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~  243 (311)
T d1r0pa_         171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI  243 (311)
T ss_dssp             ECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------C
T ss_pred             EecccchhhccccccccceecccccccccccChHHHhc-------CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence            9999999876533221   2223468999999999874       3789999999999999999997776654 333444


Q ss_pred             hhhhhcccCCCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        227 YSSILACDTEDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       227 ~ekIl~~~~~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                      ...+...   ..+..|.  .+++.+.+|+..|+. ||.+||++.+++.|
T Consensus       244 ~~~i~~g---~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         244 TVYLLQG---RRLLQPE--YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHTT---CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcC---CCCCCcc--cCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            4544432   2223333  678999999999999 99999999999877

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-44  Score=375.77  Aligned_cols=254  Identities=19%  Similarity=0.247  Sum_probs=199.1

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcCCCC-cceeEEEEEeCCEEEEEEeccC
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSKCPY-IVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~HPN-IVkL~~vfede~~lyLVmEy~~   91 (792)
                      ++|++++.||+|+||.||+|++..+|+.||||++.......  ..|+++++.++|+| |+.+.+++.+.+..++||||| 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            46999999999999999999999999999999987654432  67999999998665 556667778889999999999 


Q ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC---CCceEEeccCcccccccCCC---
Q psy13735         92 GGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA---TGHLKLTDFGSATQVDKNGR---  165 (792)
Q Consensus        92 GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~---dg~VKLiDFGLA~~l~~~~~---  165 (792)
                      ||++...+.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|+.+.....   
T Consensus        86 ~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          86 GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            5667666644 3456999999999999999999999999999999999999864   45699999999988754321   


Q ss_pred             ---cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhhhhhhhcccCCCCcCCC
Q psy13735        166 ---IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMTYSSILACDTEDTVSFP  242 (792)
Q Consensus       166 ---~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el~ekIl~~~~~~~l~fP  242 (792)
                         ......+||+.|+|||++.+       ..++.++|||||||++|+|++|..||...........+..... .....|
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~~~~~  236 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLG-------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-KKMSTP  236 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTT-------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH-HHHHSC
T ss_pred             eeccccCCcCCCccccCHHHHhC-------CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc-ccCCCC
Confidence               12234579999999999974       3689999999999999999999999987655444333321100 001111


Q ss_pred             C---CccccHHHHHHHHHHhh-ChhhcCChhH---HhcCCCcc
Q psy13735        243 S---SIRLSTAMVNFVQSLVQ-KLDARLNMDQ---VLGHPVFD  278 (792)
Q Consensus       243 ~---~~~lS~elkdLIk~LL~-DP~kRPTaeE---IL~HPwF~  278 (792)
                      .   ...+|+++.+|+..|+. +|.+||++.+   +|+|+|.+
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            1   12678999999999999 9999999865   47888765

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-43  Score=370.04  Aligned_cols=249  Identities=20%  Similarity=0.208  Sum_probs=202.7

Q ss_pred             CCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC--hHHHHHHHHhcCC-CCcceeEEEEEeCCEEEEEEec
Q psy13735         13 SASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP--NTIERDIMVKSKC-PYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        13 ~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~--~~~E~eIL~kL~H-PNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..++|++++.||+|+||+||+|++..+|+.||+|++......  ...|.+++..+.| ||++.+++++......|+||||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            356899999999999999999999999999999998665433  2678999999975 8999999999999999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCC-----CCceEEeccCcccccccCC
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSA-----TGHLKLTDFGSATQVDKNG  164 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~-----dg~VKLiDFGLA~~l~~~~  164 (792)
                      | ||+|.+++... ...++...+..++.|++.||.|||++||+||||||+|||++.     ++.+||+|||+|+......
T Consensus        83 ~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          83 L-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             c-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            9 78999988653 456999999999999999999999999999999999999964     5789999999998764321


Q ss_pred             C------cccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh---hhhhhcccC
Q psy13735        165 R------IKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT---YSSILACDT  235 (792)
Q Consensus       165 ~------~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el---~ekIl~~~~  235 (792)
                      .      ......+|||.|+|||++.+       ..++.++|||||||++|+|++|..||.+......   +..+.....
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLG-------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcC-------CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            1      12334579999999999973       3689999999999999999999999976544322   222322100


Q ss_pred             -CCCcCCCCCccccHHHHHHHHHHhh-ChhhcCChhHHh
Q psy13735        236 -EDTVSFPSSIRLSTAMVNFVQSLVQ-KLDARLNMDQVL  272 (792)
Q Consensus       236 -~~~l~fP~~~~lS~elkdLIk~LL~-DP~kRPTaeEIL  272 (792)
                       ......+  ..+|+++.+++..|+. +|.+||+++.+.
T Consensus       234 ~~~~~~l~--~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         234 STPLRELC--AGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HSCHHHHT--TTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             CCChHHhc--CCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence             0001111  2578999999999999 999999977663

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=372.68  Aligned_cols=254  Identities=19%  Similarity=0.230  Sum_probs=191.5

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHH--HhcCCCCcceeEEEEEeCC----EEEEEE
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIM--VKSKCPYIVNLFYSFQDMN----HVYFIM   87 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL--~kL~HPNIVkL~~vfede~----~lyLVm   87 (792)
                      .+|.+.+.||+|+||.||+|++  +|+.||+|++....... ..|.+++  .+++|||||++++++.+.+    .+|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4788999999999999999976  58999999986554322 3455555  4678999999999998654    689999


Q ss_pred             eccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735         88 EYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG--------LGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus        88 Ey~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs--------~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      |||++|+|.+++.+.   .+++.....++.|++.||.|||+        +||+||||||+||||+.+|++||+|||++..
T Consensus        81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999764   38999999999999999999996        5999999999999999999999999999987


Q ss_pred             cccCCCc---ccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh-h--------
Q psy13735        160 VDKNGRI---KSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT-Y--------  227 (792)
Q Consensus       160 l~~~~~~---~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el-~--------  227 (792)
                      .......   .....+||+.|+|||++.... ......++.++|||||||++|+|+||.+||........ +        
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSI-NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCS-CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccc-cccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            7544322   223457999999999986421 11112367789999999999999999988853221110 0        


Q ss_pred             --hhhhccc--CCCCcCCCC---CccccHHHHHHHHHHhh-ChhhcCChhHHhcC
Q psy13735        228 --SSILACD--TEDTVSFPS---SIRLSTAMVNFVQSLVQ-KLDARLNMDQVLGH  274 (792)
Q Consensus       228 --ekIl~~~--~~~~l~fP~---~~~lS~elkdLIk~LL~-DP~kRPTaeEIL~H  274 (792)
                        ..+....  ......+|.   .......+.+++.+|+. ||.+|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              1111000  001112222   12234568999999999 99999999998653

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-42  Score=366.04  Aligned_cols=256  Identities=22%  Similarity=0.370  Sum_probs=195.1

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcC-----------CCCcceeEEEEE--
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSK-----------CPYIVNLFYSFQ--   78 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~-----------HPNIVkL~~vfe--   78 (792)
                      .+|+++++||+|+||+||+|+++.+|+.||||++.+.....   ..|+.+++.+.           |||||++++++.  
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            45999999999999999999999999999999998654322   56778877664           588999998875  


Q ss_pred             eCCEEEEEEeccCCCC-HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCceEeCCCCc------eE
Q psy13735         79 DMNHVYFIMEYVTGGD-FVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-LGYVHRDIKPDNMLLSATGH------LK  150 (792)
Q Consensus        79 de~~lyLVmEy~~GGs-L~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-~gIVHRDLKPeNILLd~dg~------VK  150 (792)
                      .....+++|.++.++. ............+++..++.++.||+.||.|||+ .||+||||||+|||++.++.      ++
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence            4467777777765554 3344444556779999999999999999999998 89999999999999976653      99


Q ss_pred             EeccCcccccccCCCcccccCCCCCCccChhhhhhhccCCCCCCCCcccccccchhhHHHhhcCCCCCCCCChhhh----
Q psy13735        151 LTDFGSATQVDKNGRIKSIVPVGTPEYVAPEVLEWMEGNHGSDGYTGSCDLWSIGVVSYELLTGSTPFNYETLDMT----  226 (792)
Q Consensus       151 LiDFGLA~~l~~~~~~~s~t~vGTp~Y~APEiL~~~~~~~~~~~ys~ksDIWSLGVILYELLTGk~PF~~~d~~el----  226 (792)
                      ++|||.|......    ....+||+.|+|||++..       ..|+.++||||+||++++|++|+.||.+......    
T Consensus       173 l~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         173 IADLGNACWYDEH----YTNSIQTREYRSPEVLLG-------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             ECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-------CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             Eeecccccccccc----cccccccccccChhhccc-------cCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence            9999999865432    245579999999999874       3689999999999999999999999975432110    


Q ss_pred             --hhhhhcc-------------------------cCCCCc-----------CCCCCccccHHHHHHHHHHhh-ChhhcCC
Q psy13735        227 --YSSILAC-------------------------DTEDTV-----------SFPSSIRLSTAMVNFVQSLVQ-KLDARLN  267 (792)
Q Consensus       227 --~ekIl~~-------------------------~~~~~l-----------~fP~~~~lS~elkdLIk~LL~-DP~kRPT  267 (792)
                        ...+...                         ......           .+......++.+.+||.+||. ||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence              0000000                         000000           111123467899999999999 9999999


Q ss_pred             hhHHhcCCCccCCC
Q psy13735        268 MDQVLGHPVFDCLD  281 (792)
Q Consensus       268 aeEIL~HPwF~~i~  281 (792)
                      +.++|+||||+...
T Consensus       322 a~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         322 AGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhcCcccCCCC
Confidence            99999999998554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=6.9e-24  Score=206.83  Aligned_cols=158  Identities=15%  Similarity=0.149  Sum_probs=118.5

Q ss_pred             ceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCC-----h-----------------HHHHHHHHhcCCCCcceeE
Q psy13735         17 FDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMP-----N-----------------TIERDIMVKSKCPYIVNLF   74 (792)
Q Consensus        17 Y~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~-----~-----------------~~E~eIL~kL~HPNIVkL~   74 (792)
                      +.+++.||+|+||+||+|++. +|+.||+|++......     .                 ..|..++.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999885 6899999987532111     0                 2467788899999999988


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCceEeCCCCceEEecc
Q psy13735         75 YSFQDMNHVYFIMEYVTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHGLGYVHRDIKPDNMLLSATGHLKLTDF  154 (792)
Q Consensus        75 ~vfede~~lyLVmEy~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs~gIVHRDLKPeNILLd~dg~VKLiDF  154 (792)
                      ++..    .+++|||++++.+..         ++...+..++.||+.+|.|||++||+||||||+|||++.+ .++|+||
T Consensus        81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence            6532    279999998865432         4455677899999999999999999999999999999865 5899999


Q ss_pred             CcccccccCCCcccccCCCCCCccC------hhhhhhhccCCCCCCCCcccccccchh
Q psy13735        155 GSATQVDKNGRIKSIVPVGTPEYVA------PEVLEWMEGNHGSDGYTGSCDLWSIGV  206 (792)
Q Consensus       155 GLA~~l~~~~~~~s~t~vGTp~Y~A------PEiL~~~~~~~~~~~ys~ksDIWSLGV  206 (792)
                      |.|.....+..         ..|..      .+.+.        ..|+.++|+||+.-
T Consensus       147 G~a~~~~~~~~---------~~~l~rd~~~~~~~f~--------r~y~~~~d~~s~~~  187 (191)
T d1zara2         147 PQSVEVGEEGW---------REILERDVRNIITYFS--------RTYRTEKDINSAID  187 (191)
T ss_dssp             TTCEETTSTTH---------HHHHHHHHHHHHHHHH--------HHHCCCCCHHHHHH
T ss_pred             CCcccCCCCCc---------HHHHHHHHHHHHHHHc--------CCCCCcccHHHHHH
Confidence            99976543221         11222      12222        25788999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=4.6e-07  Score=89.22  Aligned_cols=136  Identities=13%  Similarity=0.142  Sum_probs=95.0

Q ss_pred             CCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCC----ChHHHHHHHHhcC-CCCcceeEEEEEeCCEEEEEEec
Q psy13735         15 SDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKM----PNTIERDIMVKSK-CPYIVNLFYSFQDMNHVYFIMEY   89 (792)
Q Consensus        15 ~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~----~~~~E~eIL~kL~-HPNIVkL~~vfede~~lyLVmEy   89 (792)
                      ..|++.+..+.|+.+.||++.  ..+..+++|+......    ....|..++..+. +--++++++++.+++..|+||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            467777776666678999884  4566788898765432    2257888887764 44467888888899999999999


Q ss_pred             cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy13735         90 VTGGDFVTLLENQPHGYLSESKARFYIYELAQAVQYLHG-----------------------------------------  128 (792)
Q Consensus        90 ~~GGsL~dlL~r~~~g~LSE~ea~~Im~QILsAL~YLHs-----------------------------------------  128 (792)
                      ++|..+......       ......++.++...+..||+                                         
T Consensus        92 l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          92 ADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             CSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             cccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            999887655411       11122234444444455552                                         


Q ss_pred             ------------------CCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        129 ------------------LGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       129 ------------------~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                                        ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                              1278999999999998766677999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.89  E-value=2.9e-05  Score=75.63  Aligned_cols=78  Identities=12%  Similarity=0.132  Sum_probs=54.1

Q ss_pred             CceEEeEeeecC-ceEEEEEEEecCCcEEEEEEeccCCCCh-HHHHHHHHhcC--CCCcceeEEEEEeCCEEEEEEeccC
Q psy13735         16 DFDIKRFIQQGN-FGDIYLVEEKQSHNTFVMKKVLREKMPN-TIERDIMVKSK--CPYIVNLFYSFQDMNHVYFIMEYVT   91 (792)
Q Consensus        16 dY~I~k~IGsGs-FGtVyla~~k~tGk~vAVKiI~Ks~~~~-~~E~eIL~kL~--HPNIVkL~~vfede~~lyLVmEy~~   91 (792)
                      .+++. .+..|. .+.||++.. .+|..+++|......... ..|...++.+.  .-.+++++.+..+.+..++||++++
T Consensus        12 g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          12 GYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             TCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             CCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            34444 444444 468998865 456678889776554433 56888887664  3346778888888889999999998


Q ss_pred             CCCH
Q psy13735         92 GGDF   95 (792)
Q Consensus        92 GGsL   95 (792)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.75  E-value=2.5e-05  Score=82.89  Aligned_cols=74  Identities=20%  Similarity=0.420  Sum_probs=47.8

Q ss_pred             EEeEeeecCceEEEEEEEecCCcEEEEEEecc------CCCC-----hHHHHHHHHhcC-C-C-CcceeEEEEEeCCEEE
Q psy13735         19 IKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLR------EKMP-----NTIERDIMVKSK-C-P-YIVNLFYSFQDMNHVY   84 (792)
Q Consensus        19 I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~K------s~~~-----~~~E~eIL~kL~-H-P-NIVkL~~vfede~~ly   84 (792)
                      -.+.||.|....||++....+|+.+++|.-..      ...+     ...|...|..+. + | .+++++.+  +....+
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence            36689999999999999888888999996432      1111     145888887663 2 3 45555544  445567


Q ss_pred             EEEeccCCCC
Q psy13735         85 FIMEYVTGGD   94 (792)
Q Consensus        85 LVmEy~~GGs   94 (792)
                      +|||++.+..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            8999997754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.75  E-value=0.0022  Score=67.19  Aligned_cols=78  Identities=15%  Similarity=0.175  Sum_probs=53.3

Q ss_pred             CCCCCceEEeEeeecCceEEEEEEEec-------CCcEEEEEEeccCCCCh--HHHHHHHHhcC-CCCcceeEEEEEeCC
Q psy13735         12 VSASDFDIKRFIQQGNFGDIYLVEEKQ-------SHNTFVMKKVLREKMPN--TIERDIMVKSK-CPYIVNLFYSFQDMN   81 (792)
Q Consensus        12 l~l~dY~I~k~IGsGsFGtVyla~~k~-------tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~-HPNIVkL~~vfede~   81 (792)
                      +..+++++ +.|+.|-.-.+|+|....       .+..|++++........  ..|..+++.+. +.-.++++++|.+  
T Consensus        40 ~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--  116 (395)
T d1nw1a_          40 VPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG--  116 (395)
T ss_dssp             CCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred             CCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence            44555555 678889999999998753       34567777665322221  57888888774 5445678887754  


Q ss_pred             EEEEEEeccCCCC
Q psy13735         82 HVYFIMEYVTGGD   94 (792)
Q Consensus        82 ~lyLVmEy~~GGs   94 (792)
                        ++||+|++|..
T Consensus       117 --g~I~efi~g~~  127 (395)
T d1nw1a_         117 --GRLEEYIPSRP  127 (395)
T ss_dssp             --EEEECCCCEEE
T ss_pred             --ceEEEEecccc
Confidence              68999998743

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.16  E-value=0.018  Score=57.55  Aligned_cols=153  Identities=16%  Similarity=0.106  Sum_probs=80.6

Q ss_pred             hHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh--HHHHHHHHhcC-----CCCcceeE-
Q psy13735          3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN--TIERDIMVKSK-----CPYIVNLF-   74 (792)
Q Consensus         3 ~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~--~~E~eIL~kL~-----HPNIVkL~-   74 (792)
                      +.+.+.+  ..+....-.+.|..|.--+.|++... +| .|++|+........  ..|..++..|.     .|..+... 
T Consensus         8 l~~~l~~--Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~   83 (316)
T d2ppqa1           8 LRNFLTQ--YDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD   83 (316)
T ss_dssp             HHHHHTT--BCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             HHHHHHh--CCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecC
Confidence            3444544  34566777778888988999998754 34 58999987643322  34555666553     23222211 


Q ss_pred             --EEEEeCCEEEEEEeccCCCCHHH-----------HH---H---hCC----CCCCCHH------------------HHH
Q psy13735         75 --YSFQDMNHVYFIMEYVTGGDFVT-----------LL---E---NQP----HGYLSES------------------KAR  113 (792)
Q Consensus        75 --~vfede~~lyLVmEy~~GGsL~d-----------lL---~---r~~----~g~LSE~------------------ea~  113 (792)
                        .+..-....+.++.++.|.....           .+   .   ...    .......                  ...
T Consensus        84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (316)
T d2ppqa1          84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR  163 (316)
T ss_dssp             CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred             CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence              11223455667777776643210           00   0   000    0000111                  111


Q ss_pred             HHHHHHHHHHHHHHh----CCCccCCCCCCceEeCCCCceEEeccCcccc
Q psy13735        114 FYIYELAQAVQYLHG----LGYVHRDIKPDNMLLSATGHLKLTDFGSATQ  159 (792)
Q Consensus       114 ~Im~QILsAL~YLHs----~gIVHRDLKPeNILLd~dg~VKLiDFGLA~~  159 (792)
                      ..+..+...+.-.+.    .|+||+|+.+.||+++.+...-|+||+.|..
T Consensus       164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            222223333333222    4699999999999999887779999998753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.64  E-value=0.023  Score=57.62  Aligned_cols=87  Identities=13%  Similarity=0.217  Sum_probs=49.5

Q ss_pred             hHHHHhcCCCCCCCceEEeEeeecCceEEEEEEEecCCcEEEEEEeccCCCCh---HHHHHHHHhcC---CC--Cccee-
Q psy13735          3 VVKELRQKNVSASDFDIKRFIQQGNFGDIYLVEEKQSHNTFVMKKVLREKMPN---TIERDIMVKSK---CP--YIVNL-   73 (792)
Q Consensus         3 ~~~~L~rk~l~l~dY~I~k~IGsGsFGtVyla~~k~tGk~vAVKiI~Ks~~~~---~~E~eIL~kL~---HP--NIVkL-   73 (792)
                      |+.++...++..+. .+ ..|+ |.--.||++.. .+|..||+|+........   ..|...+..|.   -|  ..+.. 
T Consensus        13 i~~al~~~g~~~~~-~~-~~L~-s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~   88 (325)
T d1zyla1          13 IMDALFEHGIRVDS-GL-TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFN   88 (325)
T ss_dssp             HHHHHHHTTCCCCS-CC-EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBT
T ss_pred             HHHHHHHcCCCCCc-Cc-cccc-cccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecC
Confidence            34455555554331 22 2232 33468999966 468889999986654433   34666666553   12  11111 


Q ss_pred             -EEEEEeCCEEEEEEeccCCC
Q psy13735         74 -FYSFQDMNHVYFIMEYVTGG   93 (792)
Q Consensus        74 -~~vfede~~lyLVmEy~~GG   93 (792)
                       -..+...+..+.+++++.|.
T Consensus        89 g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          89 GQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             TBSCEEETTEEEEEEECCCCE
T ss_pred             CCeeeeeeeEEEEEEeecCCc
Confidence             12234567789999999873

>d1rsob_ a.194.1.1 (B:) Peripheral plasma membrane protein cask {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: L27 domain
superfamily: L27 domain
family: L27 domain
domain: Peripheral plasma membrane protein cask
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=95.33  E-value=0.0037  Score=48.66  Aligned_cols=40  Identities=23%  Similarity=0.175  Sum_probs=37.5

Q ss_pred             HHHHHHHhhcchhhhhhhhHHHHHHHHHHHHhhHhhhhcc
Q psy13735        365 QQLAEAKASLEDLSCSRTRVLALQAQVSSLQQDLTSHTSL  404 (792)
Q Consensus       365 ~~~~~~~~s~ed~~~~~~~~~~~~~~~~~l~~D~~~~~~~  404 (792)
                      ++|++++||+|||.++++..-.....+.++.+|..+|.++
T Consensus         7 ~AV~~iLDSLddI~~Lqd~~~~d~d~L~~~~~D~~LhaLL   46 (56)
T d1rsob_           7 RAVSQVLDSLEEIHALTDSSEKDLDFLHSVFQDQHLHTLL   46 (56)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHCHHHHHHH
T ss_pred             HHHHHHHHhHHHHHHHHcccccCHHHHHHHHHHHHHHHHH
Confidence            5899999999999999999889999999999999999765